Citrus Sinensis ID: 016347
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 391 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.826 | 0.312 | 0.544 | 2e-97 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.831 | 0.314 | 0.523 | 6e-96 | |
| C0LGE0 | 1014 | Probable LRR receptor-lik | no | no | 0.792 | 0.305 | 0.554 | 4e-94 | |
| C0LGN2 | 1020 | Probable leucine-rich rep | no | no | 0.790 | 0.302 | 0.528 | 1e-93 | |
| C0LGG9 | 1035 | Probable LRR receptor-lik | no | no | 0.769 | 0.290 | 0.558 | 3e-92 | |
| C0LGG8 | 1038 | Probable LRR receptor-lik | no | no | 0.769 | 0.289 | 0.562 | 3e-92 | |
| C0LGG7 | 953 | Probable LRR receptor-lik | no | no | 0.754 | 0.309 | 0.535 | 2e-89 | |
| Q9ASQ6 | 1019 | Probable LRR receptor-lik | no | no | 0.759 | 0.291 | 0.513 | 8e-87 | |
| Q9FXF2 | 1021 | Probable LRR receptor-lik | no | no | 0.787 | 0.301 | 0.507 | 2e-83 | |
| Q9CAL2 | 646 | Cysteine-rich receptor-li | no | no | 0.803 | 0.486 | 0.442 | 9e-74 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 356 bits (913), Expect = 2e-97, Method: Compositional matrix adjust.
Identities = 183/336 (54%), Positives = 231/336 (68%), Gaps = 13/336 (3%)
Query: 6 FLFRRRDSPRNRVPEVDEEFSGIHNVK--LYSYKELSIATDDFSPINKIGEGGFGSVYKG 63
F R+R R R + DEE G+ +VK +++Y EL AT DF P NK+GEGGFG VYKG
Sbjct: 657 FTIRKR---RKRYTD-DEELLGM-DVKPYIFTYSELKSATQDFDPSNKLGEGGFGPVYKG 711
Query: 64 RLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLE 123
L DG++ A+K+LS SRQG +F+ EI IS + H NLVKLYGCC EG HR+LVY YL
Sbjct: 712 NLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISSVLHRNLVKLYGCCFEGEHRMLVYEYLP 771
Query: 124 NNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLD 183
N SL Q L G + W TR IC+G+ARGL +LHEE I+HRD+KASNILLD
Sbjct: 772 NGSLDQALFGD----KTLHLDWSTRYEICLGVARGLVYLHEEASVRIVHRDVKASNILLD 827
Query: 184 KDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEI 243
L P+ISDFGLAKL TH+STRVAGTIGYLAPEYA+RG +T K D+Y+FGV+ +E+
Sbjct: 828 SRLVPQISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALEL 887
Query: 244 VSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQ 303
VSGR N++ L E++YLLE W+L+E+ I L+D L DF+ EEA R + + LLCTQ
Sbjct: 888 VSGRPNSDENLEEEKKYLLEWAWNLHEKSRDIELIDDKLT-DFNMEEAKRMIGIALLCTQ 946
Query: 304 DTPKLRPSMSTVVQMLMGEKDIDDDKITKPGLISDF 339
+ LRP MS VV ML G+ +I D +KPG +SD+
Sbjct: 947 TSHALRPPMSRVVAMLSGDVEI-GDVTSKPGYVSDW 981
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 351 bits (900), Expect = 6e-96, Method: Compositional matrix adjust.
Identities = 175/334 (52%), Positives = 227/334 (67%), Gaps = 9/334 (2%)
Query: 6 FLFRRRDSPRNRVPEVDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRL 65
F+ R+R R R + +E S ++Y EL AT DF P NK+GEGGFG VYKG+L
Sbjct: 656 FIIRKR---RKRYTDDEEILSMDVKPYTFTYSELKSATQDFDPSNKLGEGGFGPVYKGKL 712
Query: 66 KDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENN 125
DG+ A+K+LS SRQG +F+ EI IS ++H NLVKLYGCC EG HR+LVY YL N
Sbjct: 713 NDGREVAVKLLSVGSRQGKGQFVAEIVAISAVQHRNLVKLYGCCYEGEHRLLVYEYLPNG 772
Query: 126 SLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD 185
SL Q L G + W TR IC+G+ARGL +LHEE R I+HRD+KASNILLD
Sbjct: 773 SLDQALFG----EKTLHLDWSTRYEICLGVARGLVYLHEEARLRIVHRDVKASNILLDSK 828
Query: 186 LTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
L PK+SDFGLAKL TH+STRVAGTIGYLAPEYA+RG +T K D+Y+FGV+ +E+VS
Sbjct: 829 LVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELVS 888
Query: 246 GRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDT 305
GR N++ L E++YLLE W+L+E+ + L+D L +F+ EE R + + LLCTQ +
Sbjct: 889 GRPNSDENLEDEKRYLLEWAWNLHEKGREVELIDHQLT-EFNMEEGKRMIGIALLCTQTS 947
Query: 306 PKLRPSMSTVVQMLMGEKDIDDDKITKPGLISDF 339
LRP MS VV ML G+ ++ D +KPG ++D+
Sbjct: 948 HALRPPMSRVVAMLSGDVEV-SDVTSKPGYLTDW 980
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 345 bits (884), Expect = 4e-94, Method: Compositional matrix adjust.
Identities = 177/319 (55%), Positives = 227/319 (71%), Gaps = 9/319 (2%)
Query: 6 FLFRRRDSPRNRVPEVDEEFSGIH-NVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGR 64
F +RRD ++D+E G+ ++ +++ ATD+F KIGEGGFGSVYKG
Sbjct: 642 FWKKRRDKN-----DIDKELRGLDLQTGTFTLRQIKAATDNFDVTRKIGEGGFGSVYKGE 696
Query: 65 LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLEN 124
L +GK+ A+K LSA+SRQG +EF+ EI +IS ++H NLVKLYGCCVEGN ILVY YLEN
Sbjct: 697 LSEGKLIAVKQLSAKSRQGNREFVNEIGMISALQHPNLVKLYGCCVEGNQLILVYEYLEN 756
Query: 125 NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK 184
N L++ L G S ++ W TR +I +GIA+GL FLHEE R I+HRDIKASN+LLDK
Sbjct: 757 NCLSRALFGKDES-SRLKLDWSTRKKIFLGIAKGLTFLHEESRIKIVHRDIKASNVLLDK 815
Query: 185 DLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIV 244
DL KISDFGLAKL TH+STR+AGTIGY+APEYA+RG +T KAD+YSFGV+ +EIV
Sbjct: 816 DLNAKISDFGLAKLNDDGNTHISTRIAGTIGYMAPEYAMRGYLTEKADVYSFGVVALEIV 875
Query: 245 SGRCNTNMRLPTEE-QYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQ 303
SG+ NTN R PTE+ YLL+ + L ER L+ LVD +L D+ EEA L V L+CT
Sbjct: 876 SGKSNTNFR-PTEDFVYLLDWAYVLQERGSLLELVDPTLASDYSEEEAMLMLNVALMCTN 934
Query: 304 DTPKLRPSMSTVVQMLMGE 322
+P LRP+MS VV ++ G+
Sbjct: 935 ASPTLRPTMSQVVSLIEGK 953
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 343 bits (880), Expect = 1e-93, Method: Compositional matrix adjust.
Identities = 165/312 (52%), Positives = 226/312 (72%), Gaps = 3/312 (0%)
Query: 20 EVDEEFSGI-HNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSA 78
+++++F + + +S +++ +ATD+F P NKIGEGGFG V+KG + DG + A+K LSA
Sbjct: 645 QMEKDFKNLDFQISSFSLRQIKVATDNFDPANKIGEGGFGPVHKGIMTDGTVIAVKQLSA 704
Query: 79 ESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHY 138
+S+QG +EFL EI +IS ++H +LVKLYGCCVEG+ +LVY YLENNSLA+ L G
Sbjct: 705 KSKQGNREFLNEIAMISALQHPHLVKLYGCCVEGDQLLLVYEYLENNSLARALFG--PQE 762
Query: 139 SNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198
+ I +W R +IC+GIARGLA+LHEE R I+HRDIKA+N+LLDK+L PKISDFGLAKL
Sbjct: 763 TQIPLNWPMRQKICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKELNPKISDFGLAKL 822
Query: 199 IPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEE 258
TH+STRVAGT GY+APEYA+RG +T KAD+YSFGV+ +EIV G+ NT+ R +
Sbjct: 823 DEEENTHISTRVAGTYGYMAPEYAMRGHLTDKADVYSFGVVALEIVHGKSNTSSRSKADT 882
Query: 259 QYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318
YLL+ L E+ L+ +VD L D++ +EA +++G+LCT P RPSMSTVV M
Sbjct: 883 FYLLDWVHVLREQNTLLEVVDPRLGTDYNKQEALMMIQIGMLCTSPAPGDRPSMSTVVSM 942
Query: 319 LMGEKDIDDDKI 330
L G ++ +K+
Sbjct: 943 LEGHSTVNVEKL 954
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 339 bits (869), Expect = 3e-92, Method: Compositional matrix adjust.
Identities = 171/306 (55%), Positives = 217/306 (70%), Gaps = 5/306 (1%)
Query: 20 EVDE--EFSGIH-NVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVL 76
EVDE E G+ ++ K++ AT++F P NKIGEGGFG VYKG L DG A+K L
Sbjct: 638 EVDENEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQL 697
Query: 77 SAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGH 136
S++S+QG +EF+TEI +IS ++H NLVKLYGCC+EG +LVY YLENNSLA+ L G
Sbjct: 698 SSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFG--T 755
Query: 137 HYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196
+ W TR+++CIGIA+GLA+LHEE R I+HRDIKA+N+LLD L KISDFGLA
Sbjct: 756 EKQRLHLDWSTRNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLA 815
Query: 197 KLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPT 256
KL TH+STR+AGTIGY+APEYA+RG +T KAD+YSFGV+ +EIVSG+ NTN R
Sbjct: 816 KLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKE 875
Query: 257 EEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVV 316
E YLL+ + L E+ L+ LVD L F +EA R L + LLCT +P LRP MS+VV
Sbjct: 876 EFIYLLDWAYVLQEQGSLLELVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVV 935
Query: 317 QMLMGE 322
ML G+
Sbjct: 936 SMLQGK 941
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 338 bits (868), Expect = 3e-92, Method: Compositional matrix adjust.
Identities = 172/306 (56%), Positives = 217/306 (70%), Gaps = 5/306 (1%)
Query: 20 EVDE--EFSGIH-NVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVL 76
EVDE E G+ ++ K++ AT++F P NKIGEGGFG VYKG L DG A+K L
Sbjct: 640 EVDENEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQL 699
Query: 77 SAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGH 136
S++S+QG +EF+TEI +IS ++H NLVKLYGCC+EG +LVY YLENNSLA+ L G
Sbjct: 700 SSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFG--T 757
Query: 137 HYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196
+ W TR++ICIGIA+GLA+LHEE R I+HRDIKA+N+LLD L KISDFGLA
Sbjct: 758 EKQRLHLDWSTRNKICIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLA 817
Query: 197 KLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPT 256
KL TH+STR+AGTIGY+APEYA+RG +T KAD+YSFGV+ +EIVSG+ NTN R
Sbjct: 818 KLNDDENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKE 877
Query: 257 EEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVV 316
E YLL+ + L E+ L+ LVD L F +EA R L + LLCT +P LRP MS+VV
Sbjct: 878 EFVYLLDWAYVLQEQGSLLELVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVV 937
Query: 317 QMLMGE 322
ML G+
Sbjct: 938 SMLEGK 943
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 329 bits (844), Expect = 2e-89, Method: Compositional matrix adjust.
Identities = 159/297 (53%), Positives = 213/297 (71%), Gaps = 2/297 (0%)
Query: 34 YSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQV 93
+S +++ IAT++F N+IGEGGFG VYKG+L DG I A+K LS S+QG +EFL EI +
Sbjct: 612 FSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNEIGM 671
Query: 94 ISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICI 153
IS + H NLVKLYGCCVEG +LVY ++ENNSLA+ L G + ++ W TR +ICI
Sbjct: 672 ISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFG--PQETQLRLDWPTRRKICI 729
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213
G+ARGLA+LHEE R I+HRDIKA+N+LLDK L PKISDFGLAKL + TH+STR+AGT
Sbjct: 730 GVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRIAGT 789
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRE 273
GY+APEYA+RG +T KAD+YSFG++ +EIV GR N R YL++ L E+
Sbjct: 790 FGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVLREKNN 849
Query: 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKDIDDDKI 330
L+ LVD L +++ EEA +++ ++CT P RPSMS VV+ML G+K ++ +K+
Sbjct: 850 LLELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVKMLEGKKMVEVEKL 906
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ASQ6|Y1972_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g29720 OS=Arabidopsis thaliana GN=RFK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 320 bits (821), Expect = 8e-87, Method: Compositional matrix adjust.
Identities = 155/302 (51%), Positives = 213/302 (70%), Gaps = 5/302 (1%)
Query: 34 YSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQV 93
+S+++L AT++F NK+GEGGFGSV+KG L DG I A+K LS++S QG +EF+ EI +
Sbjct: 661 FSWRQLQTATNNFDQANKLGEGGFGSVFKGELSDGTIIAVKQLSSKSSQGNREFVNEIGM 720
Query: 94 ISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICI 153
IS + H NLVKLYGCCVE + +LVY Y+ENNSLA L G ++++ W R +IC+
Sbjct: 721 ISGLNHPNLVKLYGCCVERDQLLLVYEYMENNSLALALFG----QNSLKLDWAARQKICV 776
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213
GIARGL FLH+ ++HRDIK +N+LLD DL KISDFGLA+L A TH+ST+VAGT
Sbjct: 777 GIARGLEFLHDGSAMRMVHRDIKTTNVLLDTDLNAKISDFGLARLHEAEHTHISTKVAGT 836
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRE 273
IGY+APEYA+ GQ+T KAD+YSFGV+ +EIVSG+ NT + + L+ L + +
Sbjct: 837 IGYMAPEYALWGQLTEKADVYSFGVVAMEIVSGKSNTKQQGNADSVSLINWALTLQQTGD 896
Query: 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKDIDDDKITKP 333
++ +VD L G+F+ EA R +KV L+CT +P LRP+MS V+ML GE +I ++ P
Sbjct: 897 ILEIVDRMLEGEFNRSEAVRMIKVALVCTNSSPSLRPTMSEAVKMLEGEIEI-TQVMSDP 955
Query: 334 GL 335
G+
Sbjct: 956 GI 957
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FXF2|RKF1_ARATH Probable LRR receptor-like serine/threonine-protein kinase RFK1 OS=Arabidopsis thaliana GN=RKF1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 310 bits (793), Expect = 2e-83, Method: Compositional matrix adjust.
Identities = 159/313 (50%), Positives = 212/313 (67%), Gaps = 5/313 (1%)
Query: 34 YSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQV 93
++ +++ ATDDF+P NKIGEGGFG+V+KG L DG++ A+K LS++SRQG +EFL EI
Sbjct: 669 FTLRQIKFATDDFNPTNKIGEGGFGAVFKGVLADGRVVAVKQLSSKSRQGNREFLNEIGA 728
Query: 94 ISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICI 153
IS ++H NLVKL+G CVE +L Y Y+ENNSL+ L H I W TR +IC
Sbjct: 729 ISCLQHPNLVKLHGFCVERAQLLLAYEYMENNSLSSALFSPKHK--QIPMDWPTRFKICC 786
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213
GIA+GLAFLHEE +HRDIKA+NILLDKDLTPKISDFGLA+L TH+ST+VAGT
Sbjct: 787 GIAKGLAFLHEESPLKFVHRDIKATNILLDKDLTPKISDFGLARLDEEEKTHISTKVAGT 846
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRE 273
IGY+APEYA+ G +T KAD+YSFGVL++EIV+G N+N + LLE + E
Sbjct: 847 IGYMAPEYALWGYLTFKADVYSFGVLVLEIVAGITNSNFMGAGDSVCLLEFANECVESGH 906
Query: 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKDIDDDKITKP 333
L+ +VD L + D +EA +KV L+C+ +P RP MS VV ML G + + + P
Sbjct: 907 LMQVVDERLRPEVDRKEAEAVIKVALVCSSASPTDRPLMSEVVAMLEGLYPVPE---STP 963
Query: 334 GLISDFMDLKVRG 346
G+ + D++ +
Sbjct: 964 GVSRNAGDIRFKA 976
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL2|CRK3_ARATH Cysteine-rich receptor-like protein kinase 3 OS=Arabidopsis thaliana GN=CRK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 277 bits (709), Expect = 9e-74, Method: Compositional matrix adjust.
Identities = 143/323 (44%), Positives = 205/323 (63%), Gaps = 9/323 (2%)
Query: 6 FLFRRRDSPRNR-VPEVDEEFSGIHNVKL-YSYKELSIATDDFSPINKIGEGGFGSVYKG 63
FL ++R + + R ++ F + L +SY+ L ATD FS NK+G+GG GSVYKG
Sbjct: 281 FLLKKRHAKKQREKKQLGSLFMLANKSNLCFSYENLERATDYFSDKNKLGQGGSGSVYKG 340
Query: 64 RLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLE 123
L +GK A+K L ++Q V F E+ +IS+++H+NLVKL GC + G +LVY Y+
Sbjct: 341 VLTNGKTVAVKRLFFNTKQWVDHFFNEVNLISQVDHKNLVKLLGCSITGPESLLVYEYIA 400
Query: 124 NNSLAQTLIGGGHHYSNIQ-FSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL 182
N SL L ++Q +W R +I +G A G+A+LHEE IIHRDIK SNILL
Sbjct: 401 NQSLHDYLF----VRKDVQPLNWAKRFKIILGTAEGMAYLHEESNLRIIHRDIKLSNILL 456
Query: 183 DKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVE 242
+ D TP+I+DFGLA+L P + TH+ST +AGT+GY+APEY +RG++T KAD+YSFGVL++E
Sbjct: 457 EDDFTPRIADFGLARLFPEDKTHISTAIAGTLGYMAPEYVVRGKLTEKADVYSFGVLMIE 516
Query: 243 IVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCT 302
+++G+ N + +L+ W LY + VD L +F+ EA R L++GLLC
Sbjct: 517 VITGK--RNNAFVQDAGSILQSVWSLYRTSNVEEAVDPILGDNFNKIEASRLLQIGLLCV 574
Query: 303 QDTPKLRPSMSTVVQMLMGEKDI 325
Q RP+MS VV+M+ G +I
Sbjct: 575 QAAFDQRPAMSVVVKMMKGSLEI 597
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 391 | ||||||
| 255578162 | 419 | ATP binding protein, putative [Ricinus c | 0.992 | 0.926 | 0.766 | 0.0 | |
| 225462205 | 385 | PREDICTED: probable LRR receptor-like se | 0.979 | 0.994 | 0.764 | 1e-172 | |
| 449460042 | 397 | PREDICTED: probable LRR receptor-like se | 0.994 | 0.979 | 0.748 | 1e-168 | |
| 449526092 | 397 | PREDICTED: probable LRR receptor-like se | 0.994 | 0.979 | 0.746 | 1e-168 | |
| 147821126 | 419 | hypothetical protein VITISV_024862 [Viti | 0.979 | 0.914 | 0.701 | 1e-167 | |
| 224115212 | 382 | predicted protein [Populus trichocarpa] | 0.938 | 0.960 | 0.775 | 1e-166 | |
| 357451463 | 390 | Protein kinase catalytic domain-containi | 0.994 | 0.997 | 0.738 | 1e-164 | |
| 356528720 | 402 | PREDICTED: probable LRR receptor-like se | 0.879 | 0.855 | 0.800 | 1e-164 | |
| 388512177 | 390 | unknown [Medicago truncatula] | 0.994 | 0.997 | 0.735 | 1e-163 | |
| 356555160 | 385 | PREDICTED: probable LRR receptor-like se | 0.923 | 0.937 | 0.756 | 1e-163 |
| >gi|255578162|ref|XP_002529950.1| ATP binding protein, putative [Ricinus communis] gi|223530548|gb|EEF32427.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 648 bits (1671), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 316/412 (76%), Positives = 346/412 (83%), Gaps = 24/412 (5%)
Query: 1 MHCFSFLFRRRDSPRNRVPEVDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSV 60
M CFSFLF R++ + VDEE +GIHNVKLY+Y+EL ATDDFSP KIGEGGFGSV
Sbjct: 1 MTCFSFLFSRKEKLSS---GVDEEVAGIHNVKLYTYRELKNATDDFSPRTKIGEGGFGSV 57
Query: 61 YKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120
YKGRLKDGK AAIKVLSAESRQG KEFLTEI VISEIEHENLVKLYGCCVEGNHRILVYN
Sbjct: 58 YKGRLKDGKFAAIKVLSAESRQGAKEFLTEINVISEIEHENLVKLYGCCVEGNHRILVYN 117
Query: 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNI 180
YLENNSLAQTL+G GH+ SNIQFSWRTRS+ICIG+ARGLAFLHE+VRPHI+HRDIKASNI
Sbjct: 118 YLENNSLAQTLLGVGHNQSNIQFSWRTRSKICIGVARGLAFLHEQVRPHIVHRDIKASNI 177
Query: 181 LLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLL 240
LLDKDLTP+ISDFGLAKLIP NMTHVSTRVAGTIGYLAPEYAIRGQ+TR+ADIYSFGVLL
Sbjct: 178 LLDKDLTPRISDFGLAKLIPPNMTHVSTRVAGTIGYLAPEYAIRGQLTRRADIYSFGVLL 237
Query: 241 VEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLL 300
VEIVSGRCNTN RLP EEQYLLERTW+LYERREL+ LVDTSLNGDFDAEEAC+FLK+GLL
Sbjct: 238 VEIVSGRCNTNTRLPVEEQYLLERTWELYERRELVGLVDTSLNGDFDAEEACKFLKIGLL 297
Query: 301 CTQDTPKLRPSMSTVVQMLMGEKDIDDDKITKPGLISDFMDLKVRGPPKPKLETTTSSTY 360
CTQD PKLRPSMSTVV++L GEKD+DD KITKPGLI+DFMDLK+R PPK K + T+
Sbjct: 298 CTQDAPKLRPSMSTVVKLLTGEKDVDDSKITKPGLITDFMDLKIRAPPKTKSQKKTACPD 357
Query: 361 N---------------------SSDNPDNSNLSSAATSAATMTFTVSYDRST 391
N S+N D+ LSS T++ TFT YDRST
Sbjct: 358 NLSPQNETVYEAKNMSSCNMSSGSENLDDLTLSSGNTTSIGTTFTAPYDRST 409
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225462205|ref|XP_002268737.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g53430 [Vitis vinifera] gi|296082791|emb|CBI21796.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 610 bits (1573), Expect = e-172, Method: Compositional matrix adjust.
Identities = 299/391 (76%), Positives = 330/391 (84%), Gaps = 8/391 (2%)
Query: 1 MHCFSFLFRRRDSPRNRVPEVDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSV 60
M FS RR SP +VDEE SGIHNV+LY YKEL ATDDFSP NKIGEGGFGSV
Sbjct: 1 MPWFSCFGRRASSPAGETDKVDEEVSGIHNVRLYMYKELKNATDDFSPANKIGEGGFGSV 60
Query: 61 YKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120
YKGRLKDG IAAIKVL+AES+QGV+EFLTEI VIS IEHE LVKLYGCCVE NHRILVYN
Sbjct: 61 YKGRLKDGTIAAIKVLAAESKQGVREFLTEINVISNIEHEYLVKLYGCCVEANHRILVYN 120
Query: 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNI 180
+LENNSLAQTL+GGG YS +QFSWRTRSRICIG+ARGLAFLHEEVRP+I+HRDIKASNI
Sbjct: 121 FLENNSLAQTLLGGG--YSGMQFSWRTRSRICIGVARGLAFLHEEVRPYIVHRDIKASNI 178
Query: 181 LLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLL 240
LLD +L PKI+DFGLAKLIP+NMTHVSTRVAGTIGYLAPEYAIRGQ+TRKADIYSFGVLL
Sbjct: 179 LLDGNLNPKIADFGLAKLIPSNMTHVSTRVAGTIGYLAPEYAIRGQLTRKADIYSFGVLL 238
Query: 241 VEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLL 300
VEIV GRCNTN RLP EQYLLERTW+LYER+EL+ LVD SLNG FDAEEACRFLK+GLL
Sbjct: 239 VEIVCGRCNTNTRLPIGEQYLLERTWELYERKELVGLVDESLNGAFDAEEACRFLKIGLL 298
Query: 301 CTQDTPKLRPSMSTVVQMLMGEKDIDDDKITKPGLISDFMDLKVRGPPKPKLETTTSSTY 360
CTQDTPKLRPSMS+VV+ML+GE D+D ITKPGLISDFMDLK+R PKP
Sbjct: 299 CTQDTPKLRPSMSSVVKMLIGEMDVDSRAITKPGLISDFMDLKIRSEPKP-----VPDAK 353
Query: 361 NSSDN-PDNSNLSSAATSAATMTFTVSYDRS 390
N SDN S++ ++T ++ +TFT YDRS
Sbjct: 354 NVSDNLSSGSDIQDSSTMSSGITFTAVYDRS 384
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449460042|ref|XP_004147755.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56140-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 597 bits (1539), Expect = e-168, Method: Compositional matrix adjust.
Identities = 295/394 (74%), Positives = 338/394 (85%), Gaps = 5/394 (1%)
Query: 1 MHCFSFLFRRRDSPRNRVPEVDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSV 60
M CF FLF +R R +E+FS + NVK Y+YKEL +AT+DFS NKIGEGGFGSV
Sbjct: 1 MTCFPFLFSKRVKGPTRSSVDEEDFSSMQNVKFYTYKELKVATEDFSLANKIGEGGFGSV 60
Query: 61 YKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120
YKG+LKDGK+AAIKVLSAESRQG++EFLTEI VIS+IEHENLV+LYGCCV+ NHRILVYN
Sbjct: 61 YKGKLKDGKLAAIKVLSAESRQGLREFLTEINVISKIEHENLVQLYGCCVDDNHRILVYN 120
Query: 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNI 180
YLENNSLAQTL+G G YS+IQF+WRTRS+ICIGIARGLAFLHE+V+PHIIHRDIKASNI
Sbjct: 121 YLENNSLAQTLLGRG--YSSIQFNWRTRSKICIGIARGLAFLHEDVQPHIIHRDIKASNI 178
Query: 181 LLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLL 240
LLD DL+PKISDFGLAKLIPA+MTHVSTRVAGTIGYLAPEYAIRGQVTRK+DIYSFGVLL
Sbjct: 179 LLDHDLSPKISDFGLAKLIPASMTHVSTRVAGTIGYLAPEYAIRGQVTRKSDIYSFGVLL 238
Query: 241 VEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLL 300
VEIVSGR NTN +LP EQYLLERTW+LYE+ EL+LLVDTSLNGDFDAE AC++LK+GLL
Sbjct: 239 VEIVSGRWNTNTQLPIGEQYLLERTWNLYEQGELVLLVDTSLNGDFDAEMACKYLKIGLL 298
Query: 301 CTQDTPKLRPSMSTVVQMLMGEKDIDDDKITKPGLISDFMDLKVRGPPKPK--LETTTSS 358
CTQD+PKLRPSMSTVV+ML GE ++D KI+KPGLISDFMDLKVR P + K E +S
Sbjct: 299 CTQDSPKLRPSMSTVVKMLTGEMSVEDRKISKPGLISDFMDLKVRNPEENKGNREGVSSD 358
Query: 359 TYNSSDNP-DNSNLSSAATSAATMTFTVSYDRST 391
+ +S N NS +SS A++ T TFT YDR+T
Sbjct: 359 SLSSGSNILGNSTMSSEASTVTTGTFTAQYDRNT 392
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449526092|ref|XP_004170048.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56140-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 596 bits (1537), Expect = e-168, Method: Compositional matrix adjust.
Identities = 294/394 (74%), Positives = 338/394 (85%), Gaps = 5/394 (1%)
Query: 1 MHCFSFLFRRRDSPRNRVPEVDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSV 60
M CF FLF +R R +E+FS + NVK Y+YK+L +AT+DFS NKIGEGGFGSV
Sbjct: 1 MTCFPFLFSKRGKGPTRSSVDEEDFSSMQNVKFYTYKQLKVATEDFSLANKIGEGGFGSV 60
Query: 61 YKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120
YKG+LKDGK+AAIKVLSAESRQG++EFLTEI VIS+IEHENLV+LYGCCV+ NHRILVYN
Sbjct: 61 YKGKLKDGKLAAIKVLSAESRQGLREFLTEINVISKIEHENLVQLYGCCVDDNHRILVYN 120
Query: 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNI 180
YLENNSLAQTL+G G YS+IQF+WRTRS+ICIGIARGLAFLHE+V+PHIIHRDIKASNI
Sbjct: 121 YLENNSLAQTLLGRG--YSSIQFNWRTRSKICIGIARGLAFLHEDVQPHIIHRDIKASNI 178
Query: 181 LLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLL 240
LLD DL+PKISDFGLAKLIPA+MTHVSTRVAGTIGYLAPEYAIRGQVTRK+DIYSFGVLL
Sbjct: 179 LLDHDLSPKISDFGLAKLIPASMTHVSTRVAGTIGYLAPEYAIRGQVTRKSDIYSFGVLL 238
Query: 241 VEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLL 300
VEIVSGR NTN +LP EQYLLERTW+LYE+ EL+LLVDTSLNGDFDAE AC++LK+GLL
Sbjct: 239 VEIVSGRWNTNTQLPIGEQYLLERTWNLYEQGELVLLVDTSLNGDFDAEMACKYLKIGLL 298
Query: 301 CTQDTPKLRPSMSTVVQMLMGEKDIDDDKITKPGLISDFMDLKVRGPPKPK--LETTTSS 358
CTQD+PKLRPSMSTVV+ML GE ++D KI+KPGLISDFMDLKVR P + K E +S
Sbjct: 299 CTQDSPKLRPSMSTVVKMLTGEMSVEDRKISKPGLISDFMDLKVRNPEENKGNREGVSSD 358
Query: 359 TYNSSDNP-DNSNLSSAATSAATMTFTVSYDRST 391
+ +S N NS +SS A++ T TFT YDR+T
Sbjct: 359 SLSSGSNILGNSTMSSEASTVTTGTFTAQYDRNT 392
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147821126|emb|CAN64306.1| hypothetical protein VITISV_024862 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 593 bits (1529), Expect = e-167, Method: Compositional matrix adjust.
Identities = 298/425 (70%), Positives = 329/425 (77%), Gaps = 42/425 (9%)
Query: 1 MHCFSFLFRRRDSPRNRVPEVDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSV 60
M FS RR SP +VDEE SGIHNV++Y YKEL ATDDFSP NKIGEGGFGSV
Sbjct: 1 MXWFSCFGRRASSPAGETDKVDEEVSGIHNVRIYXYKELKNATDDFSPANKIGEGGFGSV 60
Query: 61 YKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120
YKGRLKDG IAAIKVL+AES+QGV+EFLTEI VIS IEHE LVKLYGCCVE NHRILVYN
Sbjct: 61 YKGRLKDGTIAAIKVLAAESKQGVREFLTEINVISNIEHEYLVKLYGCCVEANHRILVYN 120
Query: 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNI 180
+LENNSLAQTL+GGG YS +QFSWRTRSRICIG+ARGLAFLHEEVRP+I+HRDIKASNI
Sbjct: 121 FLENNSLAQTLLGGG--YSGMQFSWRTRSRICIGVARGLAFLHEEVRPYIVHRDIKASNI 178
Query: 181 LLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLL 240
LLD +L PKI+DFGLAKLIP+NMTHVSTRVAGTIGYLAPEYAIRGQ+TRKADIYSFGVLL
Sbjct: 179 LLDGNLNPKIADFGLAKLIPSNMTHVSTRVAGTIGYLAPEYAIRGQLTRKADIYSFGVLL 238
Query: 241 VEIVSGRCNTNMRLPTEEQYLLER----------------------------------TW 266
VEIV GRCNTN RLP EQYLLER TW
Sbjct: 239 VEIVCGRCNTNTRLPIGEQYLLERXFWQXLTRSNKRIRAIVGFQLSGEQIDTKTIIBATW 298
Query: 267 DLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKDID 326
+LYER+EL+ LVD SLNG FDAEEACRFLK+GLLCTQDTPKLRPSMS+VV+ML+GE D+D
Sbjct: 299 ELYERKELVGLVDESLNGXFDAEEACRFLKIGLLCTQDTPKLRPSMSSVVKMLIGEMDVD 358
Query: 327 DDKITKPGLISDFMDLKVRGPPKPKLETTTSSTYNSSDN-PDNSNLSSAATSAATMTFTV 385
ITKPGLISDFMDLK+R PKP N SDN S++ +T ++ +TFT
Sbjct: 359 SRAITKPGLISDFMDLKIRSEPKP-----VPDAKNVSDNLSSGSDIQDXSTMSSGITFTA 413
Query: 386 SYDRS 390
YDRS
Sbjct: 414 VYDRS 418
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115212|ref|XP_002332189.1| predicted protein [Populus trichocarpa] gi|222875296|gb|EEF12427.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 589 bits (1518), Expect = e-166, Method: Compositional matrix adjust.
Identities = 286/369 (77%), Positives = 319/369 (86%), Gaps = 2/369 (0%)
Query: 24 EFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQG 83
E I NV+ Y+Y+EL AT+ FS NKIGEGGFGSVYKGRLK GKIAAIKVLSAESRQG
Sbjct: 13 ELGSIKNVRCYTYRELRNATEGFSAANKIGEGGFGSVYKGRLKHGKIAAIKVLSAESRQG 72
Query: 84 VKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQF 143
V+EFL EI+ +SEIEHENLVKLYGCCVE NHRILVYNYLENNSLAQTL+ GGH +SNIQF
Sbjct: 73 VEEFLAEIKAMSEIEHENLVKLYGCCVEDNHRILVYNYLENNSLAQTLLDGGHSHSNIQF 132
Query: 144 SWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANM 203
SWRTR++ICIG+ARGL FLHEEV+P+I+HRDIKASNILLDKDLT KISDFGLAKLIP N
Sbjct: 133 SWRTRTKICIGVARGLTFLHEEVKPYIVHRDIKASNILLDKDLTAKISDFGLAKLIPDNQ 192
Query: 204 THVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLE 263
THVSTRVAGT+GYLAPEYAIRG++TRKAD+YSFGVLL+EIVSGR NTN RLP EEQYLLE
Sbjct: 193 THVSTRVAGTLGYLAPEYAIRGKLTRKADLYSFGVLLLEIVSGRNNTNTRLPVEEQYLLE 252
Query: 264 RTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323
RTW+LYERREL+ LVD SLNGDF+AEEACRFLK+GLLCTQD P LRPSMSTVV+ML G K
Sbjct: 253 RTWELYERRELVSLVDASLNGDFNAEEACRFLKIGLLCTQDDPNLRPSMSTVVKMLTGRK 312
Query: 324 DIDDDKITKPGLISDFMDLKVRGPPKPKLETTTSSTYNS-SDNPDNSNLSSAATSAATMT 382
+ D+ KITKPGLISDFMDLKVR P K K +TS +S SDN D S L+S +S+ TMT
Sbjct: 313 NFDERKITKPGLISDFMDLKVRAPSKTKASASTSFNVSSGSDNQDTSILTSENSSSVTMT 372
Query: 383 -FTVSYDRS 390
FT Y+RS
Sbjct: 373 AFTELYNRS 381
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357451463|ref|XP_003596008.1| Protein kinase catalytic domain-containing protein [Medicago truncatula] gi|355485056|gb|AES66259.1| Protein kinase catalytic domain-containing protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 584 bits (1506), Expect = e-164, Method: Compositional matrix adjust.
Identities = 288/390 (73%), Positives = 332/390 (85%), Gaps = 1/390 (0%)
Query: 1 MHCFSFLFRRRDSPRNRVPEVDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSV 60
M CF F F + S + P+ DE+ S IH+VK+Y++KEL ATD+FSP NKIGEGGFGSV
Sbjct: 1 MTCFPFSFSKTPSSSRQHPDNDEDISSIHDVKIYTFKELRNATDNFSPANKIGEGGFGSV 60
Query: 61 YKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120
Y GRLK GK+AAIKVLSAESRQGVKEFLTEI VIS +EHENLVKLYGCCVE N+RILVYN
Sbjct: 61 YMGRLKGGKLAAIKVLSAESRQGVKEFLTEINVISAVEHENLVKLYGCCVEKNNRILVYN 120
Query: 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNI 180
YLENNSL++TL+GGGH+ +I F WRTR RICIG+ARGLAFLHEEVRP IIHRDIKASNI
Sbjct: 121 YLENNSLSRTLLGGGHNSDSIYFDWRTRCRICIGVARGLAFLHEEVRPPIIHRDIKASNI 180
Query: 181 LLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLL 240
LLDKDLTPKISDFGLAKLIPAN THVSTRVAGT+GYLAPEYAI G++TRKADIYSFGVLL
Sbjct: 181 LLDKDLTPKISDFGLAKLIPANATHVSTRVAGTLGYLAPEYAIGGRLTRKADIYSFGVLL 240
Query: 241 VEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLL 300
VEIVSGRCNTN RLP EEQ++LERTWDLYER+EL+ LVDTSLNG+FDAE+AC+FLK+GLL
Sbjct: 241 VEIVSGRCNTNSRLPIEEQFILERTWDLYERKELVGLVDTSLNGEFDAEQACKFLKIGLL 300
Query: 301 CTQDTPKLRPSMSTVVQMLMGEKDIDDDKITKPGLISDFMDLKVRGPPKPKLETTTSSTY 360
CTQ++PK RPSMSTVV+ML GE +DD +TKP LISDFMDLKVR + + TSS+Y
Sbjct: 301 CTQESPKSRPSMSTVVKMLTGEMKVDDSMMTKPALISDFMDLKVRHKQESITDMKTSSSY 360
Query: 361 NSSDNPDNSNLSSAATSAATMTFTVSYDRS 390
N+S ++ + ++ +SAAT TFT YD S
Sbjct: 361 NTSSASEHQD-TTIISSAATSTFTTQYDHS 389
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356528720|ref|XP_003532947.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56140-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 584 bits (1505), Expect = e-164, Method: Compositional matrix adjust.
Identities = 281/351 (80%), Positives = 314/351 (89%), Gaps = 7/351 (1%)
Query: 19 PEVDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSA 78
PE+DE GIHNVKLYSYKEL AT+DFSP NKIGEGGFGSVYKGRLKDGK+AAIKVLSA
Sbjct: 44 PEIDE---GIHNVKLYSYKELRNATEDFSPANKIGEGGFGSVYKGRLKDGKVAAIKVLSA 100
Query: 79 ESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHY 138
ESRQGVKEFLTEI VISEI+HENLVKLYGCCVE N+RILVYNYLENNSL+QTL+GGGH
Sbjct: 101 ESRQGVKEFLTEINVISEIQHENLVKLYGCCVEKNNRILVYNYLENNSLSQTLLGGGH-- 158
Query: 139 SNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198
S++ F WRTR +ICIG+ARGLA+LHEEVRPHI+HRDIKASNILLDKDLTPKISDFGLAKL
Sbjct: 159 SSLYFDWRTRCKICIGVARGLAYLHEEVRPHIVHRDIKASNILLDKDLTPKISDFGLAKL 218
Query: 199 IPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEE 258
IPANMTHVSTRVAGTIGYLAPEYAI G++TRKADIYSFGVLL EI+SGRCNTN RLP EE
Sbjct: 219 IPANMTHVSTRVAGTIGYLAPEYAIGGKLTRKADIYSFGVLLGEIISGRCNTNSRLPIEE 278
Query: 259 QYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318
Q+LLERTWDLYER+EL+ LVD SLNG+FDAE+AC+FLK+GLLCTQ++PK RPSMS+VV+M
Sbjct: 279 QFLLERTWDLYERKELVGLVDMSLNGEFDAEQACKFLKIGLLCTQESPKHRPSMSSVVKM 338
Query: 319 LMGEKDIDDDKITKPGLISDFMDLKVRGPPKPKLETTTSSTYN--SSDNPD 367
L G+ D+DD KITKP LISD +DLKVRG + ++ SS Y SSDN D
Sbjct: 339 LTGKMDVDDSKITKPALISDLLDLKVRGNEESSIDMKNSSMYTTFSSDNHD 389
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388512177|gb|AFK44150.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 582 bits (1499), Expect = e-163, Method: Compositional matrix adjust.
Identities = 287/390 (73%), Positives = 332/390 (85%), Gaps = 1/390 (0%)
Query: 1 MHCFSFLFRRRDSPRNRVPEVDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSV 60
M CF F F + S + P+ DE+ S IH+VK+Y++KEL ATD+FSP NKIGEGGFGSV
Sbjct: 1 MTCFPFSFSKTPSSSRQHPDNDEDISSIHDVKIYTFKELRNATDNFSPANKIGEGGFGSV 60
Query: 61 YKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120
Y GRLK GK+AAIKVLSAESRQGVKEFLTEI VIS +EHENLVKLYGCCVE N+RILVYN
Sbjct: 61 YMGRLKGGKLAAIKVLSAESRQGVKEFLTEINVISTVEHENLVKLYGCCVEKNNRILVYN 120
Query: 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNI 180
YLENNSL++TL+GGGH+ +I F WRTR RICIG+ARGLAFLHEEVRP IIHRDIKASNI
Sbjct: 121 YLENNSLSRTLLGGGHNSDSIYFDWRTRCRICIGVARGLAFLHEEVRPPIIHRDIKASNI 180
Query: 181 LLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLL 240
LLDKDLTPKISDFGLAKLIPA+ THVSTRVAGT+GYLAPEYAI G++TRKADIYSFGVLL
Sbjct: 181 LLDKDLTPKISDFGLAKLIPADATHVSTRVAGTLGYLAPEYAIGGRLTRKADIYSFGVLL 240
Query: 241 VEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLL 300
VEIVSGRCNTN RLP EEQ++LERTWDLYER+EL+ LVDTSLNG+FDAE+AC+FLK+GLL
Sbjct: 241 VEIVSGRCNTNSRLPIEEQFILERTWDLYERKELVGLVDTSLNGEFDAEQACKFLKIGLL 300
Query: 301 CTQDTPKLRPSMSTVVQMLMGEKDIDDDKITKPGLISDFMDLKVRGPPKPKLETTTSSTY 360
CTQ++PK RPSMSTVV+ML GE +DD +TKP LISDFMDLKVR + + TSS+Y
Sbjct: 301 CTQESPKSRPSMSTVVKMLTGEMKVDDSMMTKPALISDFMDLKVRHKQESITDMKTSSSY 360
Query: 361 NSSDNPDNSNLSSAATSAATMTFTVSYDRS 390
N+S ++ + ++ +SAAT TFT YD S
Sbjct: 361 NTSSASEHRD-TTIISSAATSTFTTQYDHS 389
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356555160|ref|XP_003545904.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g56140-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 579 bits (1492), Expect = e-163, Method: Compositional matrix adjust.
Identities = 280/370 (75%), Positives = 317/370 (85%), Gaps = 9/370 (2%)
Query: 23 EEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQ 82
E + IHNVKLYSYK+L AT+ FSP NKIGEGGFGSVYKGRLKDGK+AAIKVLSAESRQ
Sbjct: 22 ENYECIHNVKLYSYKQLRNATEKFSPANKIGEGGFGSVYKGRLKDGKVAAIKVLSAESRQ 81
Query: 83 GVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQ 142
GVKEFLTEI VISEIEHENLVKLYGCCVE N+RILVYNYLENNSL+QTL+GGGH+ ++
Sbjct: 82 GVKEFLTEINVISEIEHENLVKLYGCCVEKNNRILVYNYLENNSLSQTLLGGGHN--SLY 139
Query: 143 FSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN 202
F W TR +ICIG+ARGLA+LHEEVRPHI+HRDIKASNILLDKDLTPKISDFGLAKLIPAN
Sbjct: 140 FDWGTRCKICIGVARGLAYLHEEVRPHIVHRDIKASNILLDKDLTPKISDFGLAKLIPAN 199
Query: 203 MTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLL 262
MTHVSTRVAGT+GYLAPEYAI G++TRKADIYSFGVLL EI+SGRCN N RLP EEQ+LL
Sbjct: 200 MTHVSTRVAGTLGYLAPEYAIGGKLTRKADIYSFGVLLAEIISGRCNINSRLPIEEQFLL 259
Query: 263 ERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322
ERTWDLYER+EL+ LVD SLNG+FDAE+AC+FLK+ LLCTQ++PKLRPSMS+VV+ML G+
Sbjct: 260 ERTWDLYERKELVELVDISLNGEFDAEQACKFLKISLLCTQESPKLRPSMSSVVKMLTGK 319
Query: 323 KDIDDDKITKPGLISDFMDLKVRGPPKPKLETTTSSTY--NSSDNPDNSNLSSAATSAAT 380
D++D KITKP LISDFMDLKVR + ++ SS Y +SSDN D S + A T
Sbjct: 320 MDVNDSKITKPALISDFMDLKVRRNEESSIDMKNSSMYTTSSSDNHD-----STMSFATT 374
Query: 381 MTFTVSYDRS 390
TF YD S
Sbjct: 375 TTFAAIYDES 384
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 391 | ||||||
| TAIR|locus:2017923 | 390 | AT1G16670 [Arabidopsis thalian | 0.867 | 0.869 | 0.787 | 2.3e-142 | |
| TAIR|locus:2095334 | 393 | AT3G09010 [Arabidopsis thalian | 0.841 | 0.837 | 0.543 | 5.5e-93 | |
| TAIR|locus:2205250 | 1032 | AT1G56130 [Arabidopsis thalian | 0.826 | 0.312 | 0.544 | 4e-90 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.813 | 0.303 | 0.527 | 2.6e-86 | |
| TAIR|locus:2203718 | 1035 | AT1G53440 [Arabidopsis thalian | 0.767 | 0.289 | 0.563 | 4.9e-85 | |
| TAIR|locus:2019367 | 1078 | AT1G29740 [Arabidopsis thalian | 0.777 | 0.282 | 0.554 | 6.2e-85 | |
| TAIR|locus:2019317 | 969 | AT1G29730 [Arabidopsis thalian | 0.780 | 0.314 | 0.548 | 1.7e-84 | |
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.790 | 0.324 | 0.512 | 8.2e-83 | |
| TAIR|locus:2203847 | 1021 | RKF1 "receptor-like kinase in | 0.785 | 0.300 | 0.509 | 1.9e-76 | |
| TAIR|locus:2026785 | 646 | CRK3 "cysteine-rich RLK (RECEP | 0.803 | 0.486 | 0.442 | 1e-68 |
| TAIR|locus:2017923 AT1G16670 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1392 (495.1 bits), Expect = 2.3e-142, P = 2.3e-142
Identities = 267/339 (78%), Positives = 298/339 (87%)
Query: 15 RNRVPEVDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIK 74
R EVD E + I NVK+Y Y+E+ ATDDFS NKIGEGGFGSVYKG LKDGK+AAIK
Sbjct: 10 RREATEVDGEIAAIDNVKIYKYREIRQATDDFSAENKIGEGGFGSVYKGCLKDGKLAAIK 69
Query: 75 VLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGG 134
VLSAESRQGVKEFLTEI VISEI+HENLVKLYGCCVEGNHRILVYN+LENNSL +TL+ G
Sbjct: 70 VLSAESRQGVKEFLTEINVISEIQHENLVKLYGCCVEGNHRILVYNFLENNSLDKTLLAG 129
Query: 135 GHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194
G+ S IQF W +R+ IC+G+A+GLAFLHEEVRPHIIHRDIKASNILLDK L+PKISDFG
Sbjct: 130 GYTRSGIQFDWSSRANICVGVAKGLAFLHEEVRPHIIHRDIKASNILLDKYLSPKISDFG 189
Query: 195 LAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRL 254
LA+L+P NMTHVSTRVAGTIGYLAPEYA+RGQ+TRKADIYSFGVLL+EIVSGR N N RL
Sbjct: 190 LARLMPPNMTHVSTRVAGTIGYLAPEYAVRGQLTRKADIYSFGVLLMEIVSGRSNKNTRL 249
Query: 255 PTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMST 314
PTE QYLLER W+LYER EL+ LVD+ LNG FDAEEACR+LK+GLLCTQD+PKLRPSMST
Sbjct: 250 PTEYQYLLERAWELYERNELVDLVDSGLNGVFDAEEACRYLKIGLLCTQDSPKLRPSMST 309
Query: 315 VVQMLMGEKDIDDDKITKPGLISDFMDLKVRGPPKPKLE 353
VV++L GEKDID KI++PGLISDFMDLKVRGP K E
Sbjct: 310 VVRLLTGEKDIDYKKISRPGLISDFMDLKVRGPVATKTE 348
|
|
| TAIR|locus:2095334 AT3G09010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 926 (331.0 bits), Expect = 5.5e-93, P = 5.5e-93
Identities = 182/335 (54%), Positives = 234/335 (69%)
Query: 2 HCFSFLFRRRDSPRNRVPEVDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVY 61
+CF L S R E +E + +NV+++SY L ATD F P N+IG GG+G V+
Sbjct: 4 NCFGLLDMCNGSDRLGQREAEEICT--NNVRVFSYNSLRSATDSFHPTNRIGGGGYGVVF 61
Query: 62 KGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121
KG L+DG A+K LSAES+QG +EFLTEI +IS I H NLVKL GCC+EGN+RILVY Y
Sbjct: 62 KGVLRDGTQVAVKSLSAESKQGTREFLTEINLISNIHHPNLVKLIGCCIEGNNRILVYEY 121
Query: 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNIL 181
LENNSLA L+G Y + W R+ IC+G A GLAFLHEEV PH++HRDIKASNIL
Sbjct: 122 LENNSLASVLLGSRSRY--VPLDWSKRAAICVGTASGLAFLHEEVEPHVVHRDIKASNIL 179
Query: 182 LDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLV 241
LD + +PKI DFGLAKL P N+THVSTRVAGT+GYLAPEYA+ GQ+T+KAD+YSFG+L++
Sbjct: 180 LDSNFSPKIGDFGLAKLFPDNVTHVSTRVAGTVGYLAPEYALLGQLTKKADVYSFGILVL 239
Query: 242 EIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLC 301
E++SG +T E L+E W L E R L+ VD L F A+E RF+KV L C
Sbjct: 240 EVISGNSSTRAAFGDEYMVLVEWVWKLREERRLLECVDPELT-KFPADEVTRFIKVALFC 298
Query: 302 TQDTPKLRPSMSTVVQMLMG-EKDIDDDKITKPGL 335
TQ + RP+M V++ML E ++++D +T+PG+
Sbjct: 299 TQAAAQKRPNMKQVMEMLRRKELNLNEDALTEPGV 333
|
|
| TAIR|locus:2205250 AT1G56130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 899 (321.5 bits), Expect = 4.0e-90, P = 4.0e-90
Identities = 183/336 (54%), Positives = 231/336 (68%)
Query: 6 FLFRRRDSPRNRVPEVDEEFSGIHNVK--LYSYKELSIATDDFSPINKIGEGGFGSVYKG 63
F R+R R R + DEE G+ +VK +++Y EL AT DF P NK+GEGGFG VYKG
Sbjct: 657 FTIRKR---RKRYTD-DEELLGM-DVKPYIFTYSELKSATQDFDPSNKLGEGGFGPVYKG 711
Query: 64 RLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLE 123
L DG++ A+K+LS SRQG +F+ EI IS + H NLVKLYGCC EG HR+LVY YL
Sbjct: 712 NLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISSVLHRNLVKLYGCCFEGEHRMLVYEYLP 771
Query: 124 NNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLD 183
N SL Q L G + W TR IC+G+ARGL +LHEE I+HRD+KASNILLD
Sbjct: 772 NGSLDQALFGD----KTLHLDWSTRYEICLGVARGLVYLHEEASVRIVHRDVKASNILLD 827
Query: 184 KDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEI 243
L P+ISDFGLAKL TH+STRVAGTIGYLAPEYA+RG +T K D+Y+FGV+ +E+
Sbjct: 828 SRLVPQISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALEL 887
Query: 244 VSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQ 303
VSGR N++ L E++YLLE W+L+E+ I L+D L DF+ EEA R + + LLCTQ
Sbjct: 888 VSGRPNSDENLEEEKKYLLEWAWNLHEKSRDIELIDDKLT-DFNMEEAKRMIGIALLCTQ 946
Query: 304 DTPKLRPSMSTVVQMLMGEKDIDDDKITKPGLISDF 339
+ LRP MS VV ML G+ +I D +KPG +SD+
Sbjct: 947 TSHALRPPMSRVVAMLSGDVEIGD-VTSKPGYVSDW 981
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 863 (308.9 bits), Expect = 2.6e-86, P = 2.6e-86
Identities = 172/326 (52%), Positives = 224/326 (68%)
Query: 15 RNRVPEVDEEFSGIHNVKLYS--YKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAA 72
+ R P D+E +VK Y+ Y EL AT DF NK+GEGGFG+VYKG L DG+ A
Sbjct: 677 KRRKPYTDDEEILSMDVKPYTFTYSELKNATQDFDLSNKLGEGGFGAVYKGNLNDGREVA 736
Query: 73 IKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLI 132
+K LS SRQG +F+ EI IS + H NLVKLYGCC EG+HR+LVY YL N SL Q L
Sbjct: 737 VKQLSIGSRQGKGQFVAEIIAISSVLHRNLVKLYGCCFEGDHRLLVYEYLPNGSLDQALF 796
Query: 133 GGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISD 192
G ++ W TR IC+G+ARGL +LHEE IIHRD+KASNILLD +L PK+SD
Sbjct: 797 GD----KSLHLDWSTRYEICLGVARGLVYLHEEASVRIIHRDVKASNILLDSELVPKVSD 852
Query: 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNM 252
FGLAKL TH+STRVAGTIGYLAPEYA+RG +T K D+Y+FGV+ +E+VSGR N++
Sbjct: 853 FGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRKNSDE 912
Query: 253 RLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSM 312
L ++YLLE W+L+E+ + L+D L+ +++ EE R + + LLCTQ + LRP M
Sbjct: 913 NLEEGKKYLLEWAWNLHEKNRDVELIDDELS-EYNMEEVKRMIGIALLCTQSSYALRPPM 971
Query: 313 STVVQMLMGEKDIDDDKITKPGLISD 338
S VV ML G+ +++D +KPG ++D
Sbjct: 972 SRVVAMLSGDAEVND-ATSKPGYLTD 996
|
|
| TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 851 (304.6 bits), Expect = 4.9e-85, P = 4.9e-85
Identities = 173/307 (56%), Positives = 219/307 (71%)
Query: 20 EVDE--EFSGIH-NVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVL 76
EVDE E G+ ++ K++ AT++F P NKIGEGGFG VYKG L DG A+K L
Sbjct: 638 EVDENEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQL 697
Query: 77 SAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGH 136
S++S+QG +EF+TEI +IS ++H NLVKLYGCC+EG +LVY YLENNSLA+ L G
Sbjct: 698 SSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGT-- 755
Query: 137 HYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196
+ W TR+++CIGIA+GLA+LHEE R I+HRDIKA+N+LLD L KISDFGLA
Sbjct: 756 EKQRLHLDWSTRNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLA 815
Query: 197 KLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPT 256
KL TH+STR+AGTIGY+APEYA+RG +T KAD+YSFGV+ +EIVSG+ NTN R P
Sbjct: 816 KLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYR-PK 874
Query: 257 EEQ-YLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTV 315
EE YLL+ + L E+ L+ LVD L F +EA R L + LLCT +P LRP MS+V
Sbjct: 875 EEFIYLLDWAYVLQEQGSLLELVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSV 934
Query: 316 VQMLMGE 322
V ML G+
Sbjct: 935 VSMLQGK 941
|
|
| TAIR|locus:2019367 AT1G29740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 850 (304.3 bits), Expect = 6.2e-85, P = 6.2e-85
Identities = 173/312 (55%), Positives = 224/312 (71%)
Query: 34 YSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQV 93
+S ++L +ATDDF+P+NKIGEGGFGSVYKGRL +G + A+K LS++S QG KEF+ EI +
Sbjct: 665 FSLRQLKVATDDFNPLNKIGEGGFGSVYKGRLPNGTLIAVKKLSSKSCQGNKEFINEIGI 724
Query: 94 ISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICI 153
I+ ++H NLVKLYGCCVE +LVY YLENN LA L G S ++ WRTR +IC+
Sbjct: 725 IACLQHPNLVKLYGCCVEKTQLLLVYEYLENNCLADALFGR----SGLKLDWRTRHKICL 780
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213
GIARGLAFLHE+ IIHRDIK +NILLDKDL KISDFGLA+L + +H++TRVAGT
Sbjct: 781 GIARGLAFLHEDSAVKIIHRDIKGTNILLDKDLNSKISDFGLARLHEDDQSHITTRVAGT 840
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQY--LLERTWDLYER 271
IGY+APEYA+RG +T KAD+YSFGV+ +EIVSG+ N N P E LL+ + L ++
Sbjct: 841 IGYMAPEYAMRGHLTEKADVYSFGVVAMEIVSGKSNANYT-PDNECCVGLLDWAFVLQKK 899
Query: 272 RELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKDIDDDKIT 331
++D L G FD EA R +KV LLC+ +P LRP+MS VV+ML GE +I++ I+
Sbjct: 900 GAFDEILDPKLEGVFDVMEAERMIKVSLLCSSKSPTLRPTMSEVVKMLEGETEIEEI-IS 958
Query: 332 KPGLISDFMDLK 343
PG D + K
Sbjct: 959 DPGAYGDELRFK 970
|
|
| TAIR|locus:2019317 AT1G29730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 846 (302.9 bits), Expect = 1.7e-84, P = 1.7e-84
Identities = 171/312 (54%), Positives = 224/312 (71%)
Query: 34 YSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQV 93
+S ++L +AT+DF P+NKIGEGGFGSVYKGRL DG + A+K LS++S QG KEF+ EI +
Sbjct: 628 FSLRQLKVATNDFDPLNKIGEGGFGSVYKGRLPDGTLIAVKKLSSKSHQGNKEFVNEIGM 687
Query: 94 ISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICI 153
I+ ++H NLVKLYGCCVE N +LVY YLENN L+ L G S ++ W TR +IC+
Sbjct: 688 IACLQHPNLVKLYGCCVEKNQLLLVYEYLENNCLSDALFAGR---SCLKLEWGTRHKICL 744
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213
GIARGLAFLHE+ IIHRDIK +N+LLDKDL KISDFGLA+L N +H++TRVAGT
Sbjct: 745 GIARGLAFLHEDSAVKIIHRDIKGTNVLLDKDLNSKISDFGLARLHEDNQSHITTRVAGT 804
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQY--LLERTWDLYER 271
IGY+APEYA+RG +T KAD+YSFGV+ +EIVSG+ N P +E LL+ + L ++
Sbjct: 805 IGYMAPEYAMRGHLTEKADVYSFGVVAMEIVSGKSNAKYT-PDDECCVGLLDWAFVLQKK 863
Query: 272 RELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKDIDDDKIT 331
++ ++D L G FD EA R +KV LLC + LRP+MS VV+ML GE +I+ I+
Sbjct: 864 GDIAEILDPRLEGMFDVMEAERMIKVSLLCANKSSTLRPNMSQVVKMLEGETEIEQI-IS 922
Query: 332 KPGLISDFMDLK 343
PG+ SD + K
Sbjct: 923 DPGVYSDNLHFK 934
|
|
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 830 (297.2 bits), Expect = 8.2e-83, P = 8.2e-83
Identities = 160/312 (51%), Positives = 221/312 (70%)
Query: 20 EVDEEFSGIH-NVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSA 78
+++++F + + +S +++ IAT++F N+IGEGGFG VYKG+L DG I A+K LS
Sbjct: 597 QMEKDFKSLELMIASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLST 656
Query: 79 ESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHY 138
S+QG +EFL EI +IS + H NLVKLYGCCVEG +LVY ++ENNSLA+ L G
Sbjct: 657 GSKQGNREFLNEIGMISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQE-- 714
Query: 139 SNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198
+ ++ W TR +ICIG+ARGLA+LHEE R I+HRDIKA+N+LLDK L PKISDFGLAKL
Sbjct: 715 TQLRLDWPTRRKICIGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKL 774
Query: 199 IPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEE 258
+ TH+STR+AGT GY+APEYA+RG +T KAD+YSFG++ +EIV GR N R
Sbjct: 775 DEEDSTHISTRIAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNT 834
Query: 259 QYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318
YL++ L E+ L+ LVD L +++ EEA +++ ++CT P RPSMS VV+M
Sbjct: 835 FYLIDWVEVLREKNNLLELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVKM 894
Query: 319 LMGEKDIDDDKI 330
L G+K ++ +K+
Sbjct: 895 LEGKKMVEVEKL 906
|
|
| TAIR|locus:2203847 RKF1 "receptor-like kinase in flowers 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 770 (276.1 bits), Expect = 1.9e-76, P = 1.9e-76
Identities = 159/312 (50%), Positives = 212/312 (67%)
Query: 34 YSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQV 93
++ +++ ATDDF+P NKIGEGGFG+V+KG L DG++ A+K LS++SRQG +EFL EI
Sbjct: 669 FTLRQIKFATDDFNPTNKIGEGGFGAVFKGVLADGRVVAVKQLSSKSRQGNREFLNEIGA 728
Query: 94 ISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICI 153
IS ++H NLVKL+G CVE +L Y Y+ENNSL+ L H I W TR +IC
Sbjct: 729 ISCLQHPNLVKLHGFCVERAQLLLAYEYMENNSLSSALFSPKH--KQIPMDWPTRFKICC 786
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213
GIA+GLAFLHEE +HRDIKA+NILLDKDLTPKISDFGLA+L TH+ST+VAGT
Sbjct: 787 GIAKGLAFLHEESPLKFVHRDIKATNILLDKDLTPKISDFGLARLDEEEKTHISTKVAGT 846
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRE 273
IGY+APEYA+ G +T KAD+YSFGVL++EIV+G N+N + LLE + E
Sbjct: 847 IGYMAPEYALWGYLTFKADVYSFGVLVLEIVAGITNSNFMGAGDSVCLLEFANECVESGH 906
Query: 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKDIDDDKITKP 333
L+ +VD L + D +EA +KV L+C+ +P RP MS VV ML G + + + P
Sbjct: 907 LMQVVDERLRPEVDRKEAEAVIKVALVCSSASPTDRPLMSEVVAMLEGLYPVPE---STP 963
Query: 334 GLISDFMDLKVR 345
G+ + D++ +
Sbjct: 964 GVSRNAGDIRFK 975
|
|
| TAIR|locus:2026785 CRK3 "cysteine-rich RLK (RECEPTOR-like protein kinase) 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 697 (250.4 bits), Expect = 1.0e-68, P = 1.0e-68
Identities = 143/323 (44%), Positives = 205/323 (63%)
Query: 6 FLFRRRDSPRNRVP-EVDEEFSGIHNVKL-YSYKELSIATDDFSPINKIGEGGFGSVYKG 63
FL ++R + + R ++ F + L +SY+ L ATD FS NK+G+GG GSVYKG
Sbjct: 281 FLLKKRHAKKQREKKQLGSLFMLANKSNLCFSYENLERATDYFSDKNKLGQGGSGSVYKG 340
Query: 64 RLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLE 123
L +GK A+K L ++Q V F E+ +IS+++H+NLVKL GC + G +LVY Y+
Sbjct: 341 VLTNGKTVAVKRLFFNTKQWVDHFFNEVNLISQVDHKNLVKLLGCSITGPESLLVYEYIA 400
Query: 124 NNSLAQTLIGGGHHYSNIQ-FSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL 182
N SL L ++Q +W R +I +G A G+A+LHEE IIHRDIK SNILL
Sbjct: 401 NQSLHDYLFVR----KDVQPLNWAKRFKIILGTAEGMAYLHEESNLRIIHRDIKLSNILL 456
Query: 183 DKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVE 242
+ D TP+I+DFGLA+L P + TH+ST +AGT+GY+APEY +RG++T KAD+YSFGVL++E
Sbjct: 457 EDDFTPRIADFGLARLFPEDKTHISTAIAGTLGYMAPEYVVRGKLTEKADVYSFGVLMIE 516
Query: 243 IVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCT 302
+++G+ N + +L+ W LY + VD L +F+ EA R L++GLLC
Sbjct: 517 VITGKRNN--AFVQDAGSILQSVWSLYRTSNVEEAVDPILGDNFNKIEASRLLQIGLLCV 574
Query: 303 QDTPKLRPSMSTVVQMLMGEKDI 325
Q RP+MS VV+M+ G +I
Sbjct: 575 QAAFDQRPAMSVVVKMMKGSLEI 597
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.02020026 | hypothetical protein (382 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 391 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-55 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-53 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-51 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-50 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-50 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-49 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-47 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-42 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-37 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-35 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-34 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-33 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-33 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-32 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-32 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-31 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-30 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-29 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-28 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-28 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-28 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-27 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-27 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-26 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-26 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-25 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-25 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-25 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-24 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-24 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-24 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-24 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-23 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-23 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-23 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-23 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-23 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-23 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-22 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-21 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-21 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-21 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-21 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-21 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-21 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-20 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-20 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-19 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-19 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-19 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-19 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-18 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-18 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-18 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-18 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-18 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-18 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-17 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-17 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-15 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-13 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-10 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 6e-55
Identities = 80/197 (40%), Positives = 114/197 (57%), Gaps = 15/197 (7%)
Query: 52 IGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKE-FLTEIQVISEIEHENLVKLYGCC 109
+GEGGFG+VY R K GK AIK++ E + E L EI+++ ++ H N+VKLYG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 110 VEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPH 169
+ NH LV Y E SL L+ + + S RI + I GL +LH
Sbjct: 61 EDENHLYLVMEYCEGGSLKD-LL----KENEGKLSEDEILRILLQILEGLEYLHSN---G 112
Query: 170 IIHRDIKASNILLDKD-LTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQ-- 226
IIHRD+K NILLD D K++DFGL+KL+ ++ + + T V GT Y+APE + G+
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPE-VLLGKGY 170
Query: 227 VTRKADIYSFGVLLVEI 243
+ K+DI+S GV+L E+
Sbjct: 171 YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 4e-53
Identities = 90/275 (32%), Positives = 136/275 (49%), Gaps = 32/275 (11%)
Query: 51 KIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKE--FLTEIQVISEIEHENLVKLYG 107
K+G G FG+VYK + K GKI A+K+L S + K+ EI+++ + H N+V+L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 108 CCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVR 167
+ +H LV Y E L L GG S +I + I RGL +LH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGP------LSEDEAKKIALQILRGLEYLHSN-- 117
Query: 168 PHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQ- 226
IIHRD+K NILLD++ KI+DFGLAK + + + ++T V GT Y+APE + G
Sbjct: 118 -GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPE-VLLGGN 174
Query: 227 -VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGD 285
K D++S GV+L E+++G + P + +L D + IL +
Sbjct: 175 GYGPKVDVWSLGVILYELLTG------KPPFSGENIL----DQLQLIRRILGPPLEFDEP 224
Query: 286 FD---AEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317
+EEA +K +D P RP+ ++Q
Sbjct: 225 KWSSGSEEAKDLIKK--CLNKD-PSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 2e-51
Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 13/204 (6%)
Query: 46 FSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLS-AESRQGVKEFLTEIQVISEIEHENLV 103
+ + K+GEG FG VY R K GK+ AIKV+ + ++ + L EI+++ +++H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 104 KLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH 163
+LY + + LV Y E L L + S I L +LH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLK------KRGRLSEDEARFYLRQILSALEYLH 114
Query: 164 EEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAI 223
+ I+HRD+K NILLD+D K++DFGLA+ + + T GT Y+APE +
Sbjct: 115 SK---GIVHRDLKPENILLDEDGHVKLADFGLARQL--DPGEKLTTFVGTPEYMAPEVLL 169
Query: 224 RGQVTRKADIYSFGVLLVEIVSGR 247
+ DI+S GV+L E+++G+
Sbjct: 170 GKGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 4e-50
Identities = 71/203 (34%), Positives = 107/203 (52%), Gaps = 14/203 (6%)
Query: 49 INKIGEGGFGSVYKGRLKDGKIA-----AIKVLSAE-SRQGVKEFLTEIQVISEIEHENL 102
K+GEG FG VYKG+LK A+K L + S Q ++EFL E +++ +++H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 103 VKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFL 162
VKL G C E +V Y+E L L S + IARG+ +L
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-----LSLSDLLSFALQIARGMEYL 118
Query: 163 HEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYA 222
+ + IHRD+ A N L+ ++L KISDFGL++ + + + I ++APE
Sbjct: 119 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESL 175
Query: 223 IRGQVTRKADIYSFGVLLVEIVS 245
G+ T K+D++SFGVLL EI +
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 4e-50
Identities = 87/296 (29%), Positives = 124/296 (41%), Gaps = 61/296 (20%)
Query: 50 NKIGEGGFGSVYKGRLKDGK----IAAIKVL-SAESRQGVKEFLTEIQVISEIEHENLVK 104
K+GEG FG VYKG+LK A+K L S + K+FL E +V+ ++ H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 105 LYGCCVEGNHRILVYNYLENNSLAQTLI---GGGHHYSNIQFSWRTRSRICIGIARGLAF 161
L G C E LV Y+E L L S + I IA+G+ +
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT-IGYLAPE 220
L + +HRD+ A N L+ +DL KISDFGL++ + + + I ++APE
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 221 YAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT 280
G T K+D++SFGVLL EI T P Y
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIF-----TLGATP----Y-------------------- 208
Query: 281 SLNGDFDAEEACRFLKVG-----------------LLCTQDTPKLRPSMSTVVQML 319
EE +L+ G L C Q P+ RP+ S +V+ L
Sbjct: 209 ---PGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 1e-49
Identities = 70/203 (34%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 49 INKIGEGGFGSVYKGRLKDGKI-----AAIKVLSAE-SRQGVKEFLTEIQVISEIEHENL 102
K+GEG FG VYKG LK A+K L + S Q ++EFL E +++ +++H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 103 VKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFL 162
VKL G C E ++V Y+ L L S + IARG+ +L
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE----LSLSDLLSFALQIARGMEYL 119
Query: 163 HEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYA 222
+ + IHRD+ A N L+ ++L KISDFGL++ + + + I ++APE
Sbjct: 120 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESL 176
Query: 223 IRGQVTRKADIYSFGVLLVEIVS 245
G+ T K+D++SFGVLL EI +
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 5e-47
Identities = 83/292 (28%), Positives = 132/292 (45%), Gaps = 58/292 (19%)
Query: 49 INKIGEGGFGSVYKGRLKDGK-----IAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENL 102
K+GEG FG VYKG LK A+K L S + +EFL E ++ ++ H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63
Query: 103 VKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHY---SNIQFSWRTRSRICIGIARGL 159
V+L G C +G +V Y+ L + + + + ++ + IA+G+
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDL--------LDFLRKHGEKLTLKDLLQMALQIAKGM 115
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT-IGYLA 218
+L + + +HRD+ A N L+ ++L KISDFGL++ I + + I ++A
Sbjct: 116 EYLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMA 172
Query: 219 PEYAIRGQVTRKADIYSFGVLLVEIVS-------GRCNTNMRLPTEEQYLLER----TWD 267
PE G+ T K+D++SFGVLL EI + G N + E+ Y L R +
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDE 232
Query: 268 LYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319
LY EL+ L C P+ RP+ S +V+ L
Sbjct: 233 LY---ELM-----------------------LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 3e-42
Identities = 72/205 (35%), Positives = 107/205 (52%), Gaps = 17/205 (8%)
Query: 50 NKIGEGGFGSVYKGRLKD-GKIAAIKV--LSAESRQGVKEFLTEIQVISEIEHENLVKLY 106
+G G FGSVY KD G++ A+K LS +S + ++ EI+++S ++H N+V+ Y
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 107 GCCV--EGNHRILVYNYLENNSLAQTLIGGGH-HYSNIQFSWRTRSRICIGIARGLAFLH 163
G E N + Y+ SL+ L G I+ TR I GLA+LH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRK--YTRQ-----ILEGLAYLH 118
Query: 164 EEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTR-VAGTIGYLAPEYA 222
I+HRDIK +NIL+D D K++DFG AK + T T V GT ++APE
Sbjct: 119 SN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 223 IRGQVTRKADIYSFGVLLVEIVSGR 247
+ R ADI+S G ++E+ +G+
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 9e-42
Identities = 71/206 (34%), Positives = 107/206 (51%), Gaps = 15/206 (7%)
Query: 45 DFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLV 103
F + KIG+GGFG VYK R + GK AIKV+ ES++ ++ + EIQ++ + +H N+V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 104 KLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHY--SNIQFSWRTRSRICIGIARGLAF 161
K YG ++ + +V + SL L S I + +C + +GL +
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY-------VCKELLKGLEY 113
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEY 221
LH IIHRDIKA+NILL D K+ DFGL+ + + GT ++APE
Sbjct: 114 LHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM--VGTPYWMAPEV 168
Query: 222 AIRGQVTRKADIYSFGVLLVEIVSGR 247
KADI+S G+ +E+ G+
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 8e-37
Identities = 67/210 (31%), Positives = 108/210 (51%), Gaps = 21/210 (10%)
Query: 45 DFSPINKIGEGGFGSVYKG-RLKDGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHEN 101
++ + IG G FG VYKG L+ G AIK +S E + +K + EI ++ ++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIA---RG 158
+VK G + ++ Y EN SL Q + + S + + + +G
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQII----KKFGPFP-----ESLVAVYVYQVLQG 111
Query: 159 LAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLA 218
LA+LHE+ +IHRDIKA+NIL KD K++DFG+A + + V GT ++A
Sbjct: 112 LAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDV-SKDDASVVGTPYWMA 167
Query: 219 PEYAIRGQ-VTRKADIYSFGVLLVEIVSGR 247
PE I + +DI+S G ++E+++G
Sbjct: 168 PE-VIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 4e-35
Identities = 70/209 (33%), Positives = 113/209 (54%), Gaps = 17/209 (8%)
Query: 52 IGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVE 111
IG+G FG V G + G+ A+K L +S + FL E V++ + H NLV+L G ++
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 112 GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHII 171
GN +V Y+ SL L G + + + + G+ +L E+ + +
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLA----QQLGFALDVCEGMEYLEEK---NFV 124
Query: 172 HRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIR-GQVTRK 230
HRD+ A N+L+ +DL K+SDFGLAK A+ S ++ + + APE A+R + + K
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLP--VKWTAPE-ALREKKFSTK 179
Query: 231 ADIYSFGVLLVEIVS-GRCNTNMRLPTEE 258
+D++SFG+LL EI S GR R+P ++
Sbjct: 180 SDVWSFGILLWEIYSFGR-VPYPRIPLKD 207
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 2e-34
Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 20/207 (9%)
Query: 45 DFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVK 104
+F+ K+G G FG V++G K+ AIK+L ++ ++F E+Q + + H++L+
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66
Query: 105 LYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHY--SNIQFSWRTRSRICIG--IARGLA 160
L+ C G ++ +E SL + S S I + +A G+A
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSL--------LAFLRSPEGQVLPVASLIDMACQVAEGMA 118
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI--PANMTHVSTRVAGTIGYLA 218
+L E+ + IHRD+ A NIL+ +DL K++DFGLA+LI ++ ++ + A
Sbjct: 119 YLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS-DKKIP--YKWTA 172
Query: 219 PEYAIRGQVTRKADIYSFGVLLVEIVS 245
PE A G + K+D++SFG+LL E+ +
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 4e-34
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 45 DFSPINKIGEGGFGSVYKGR-LKDGKIAAIKV--LSAESRQGVKEFLTEIQVISEIEHEN 101
+ I +IG+G FG VY R DGK+ +K LS S + ++ L E++++ ++ H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTL---IGGGHHYS--NIQFSWRTRSRICIGIA 156
++K Y E +V Y + L+Q + G + I + +
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILD-------WFVQLC 113
Query: 157 RGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGY 216
L +LH I+HRDIK NI L + K+ DFG++K++ + + T V GT Y
Sbjct: 114 LALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYY 169
Query: 217 LAPEYAIRGQ-VTRKADIYSFGVLLVEIVSGR 247
L+PE + + K+DI+S G +L E+ + +
Sbjct: 170 LSPE-LCQNKPYNYKSDIWSLGCVLYELCTLK 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 69/201 (34%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 51 KIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCV 110
K+G G FG V+ G A+K L + FL E Q++ ++ H+ LV+LY C
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 111 EGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHI 170
E +V Y+ SL L G + + IA G+A+L +
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLP----QLVDMAAQIAEGMAYLESR---NY 124
Query: 171 IHRDIKASNILLDKDLTPKISDFGLAKLIPAN--MTHVSTRVAGTIGYLAPEYAIRGQVT 228
IHRD+ A NIL+ ++L KI+DFGLA+LI + + I + APE A G+ T
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP--IKWTAPEAANYGRFT 182
Query: 229 RKADIYSFGVLLVEIVS-GRC 248
K+D++SFG+LL EIV+ GR
Sbjct: 183 IKSDVWSFGILLTEIVTYGRV 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 6e-33
Identities = 72/201 (35%), Positives = 101/201 (50%), Gaps = 16/201 (7%)
Query: 52 IGEGGFGSVYKGRLKD-GKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYG 107
+G+G FG V R KD GK+ A+KVL + R+ V+ LTE ++S I H +VKL+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 108 CCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIG-IARGLAFLHEEV 166
LV Y L H +FS R+R I L +LH
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFS------HLSKEGRFS-EERARFYAAEIVLALEYLHSL- 112
Query: 167 RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQ 226
II+RD+K NILLD D K++DFGLAK + + + +T GT YLAPE +
Sbjct: 113 --GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKG 169
Query: 227 VTRKADIYSFGVLLVEIVSGR 247
+ D +S GVLL E+++G+
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 7e-33
Identities = 62/202 (30%), Positives = 104/202 (51%), Gaps = 11/202 (5%)
Query: 46 FSPINKIGEGGFGSVYKG-RLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVK 104
+ + KIGEG G VYK GK AIK + Q + + EI ++ + +H N+V
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVD 79
Query: 105 LYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHE 164
Y + G+ +V Y++ SL + + ++ + + +C + +GL +LH
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSLTDIIT-----QNFVRMNEPQIAYVCREVLQGLEYLH- 133
Query: 165 EVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIR 224
++IHRDIK+ NILL KD + K++DFG A + + ++ V GT ++APE R
Sbjct: 134 --SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKR 190
Query: 225 GQVTRKADIYSFGVLLVEIVSG 246
K DI+S G++ +E+ G
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 86/281 (30%), Positives = 134/281 (47%), Gaps = 32/281 (11%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGV-KEFLTEIQVISEIEHEN 101
D + +G+G G VYK R K GKI A+K + + + K+ L E++ + E
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 102 LVKLYGC-CVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
+VK YG EG I V Y++ SLA L + + I I +GL
Sbjct: 61 VVKCYGAFYKEGEISI-VLEYMDGGSLADLL------KKVGKIPEPVLAYIARQILKGLD 113
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPE 220
+LH + HIIHRDIK SN+L++ KI+DFG++K++ + +T V GT+ Y++PE
Sbjct: 114 YLHTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPE 170
Query: 221 YAIRGQV-TRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279
I+G+ + ADI+S G+ L+E G+ P +L +E + I
Sbjct: 171 -RIQGESYSYAADIWSLGLTLLECALGKF------P----FLPPGQPSFFELMQAICDGP 219
Query: 280 T-SLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319
SL + + E F+ C Q PK RP + ++L
Sbjct: 220 PPSLPAEEFSPEFRDFIS---ACLQKDPKKRP---SAAELL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 4e-32
Identities = 64/205 (31%), Positives = 106/205 (51%), Gaps = 12/205 (5%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENL 102
+ F + K+GEG +GSVYK K+ G++ AIKV+ E ++E + EI ++ + + +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYI 60
Query: 103 VKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFL 162
VK YG + +V Y S++ + +N + + I +GL +L
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIM-----KITNKTLTEEEIAAILYQTLKGLEYL 115
Query: 163 HEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYA 222
H IHRDIKA NILL+++ K++DFG++ + M +T V GT ++APE
Sbjct: 116 H---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVI 171
Query: 223 IRGQVTRKADIYSFGVLLVEIVSGR 247
KADI+S G+ +E+ G+
Sbjct: 172 QEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 69/213 (32%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 50 NKIGEGGFGSVYKG-RLKDGKIAAIKV--LSAESRQGVKEFLTEIQVISEIEHENLVKLY 106
NKIG G FG VY L G++ A+K + + +KE E++V+ ++H NLVK Y
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIG-----IARGLAF 161
G V + Y +L + L G R I + GLA+
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHG-----------RILDEHVIRVYTLQLLEGLAY 114
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIG---YLA 218
LH I+HRDIK +NI LD + K+ DFG A + N T + V G Y+A
Sbjct: 115 LHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMA 171
Query: 219 PEYAIRGQVT----RKADIYSFGVLLVEIVSGR 247
PE I G R ADI+S G +++E+ +G+
Sbjct: 172 PE-VITGGKGKGHGRAADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (303), Expect = 7e-31
Identities = 74/216 (34%), Positives = 107/216 (49%), Gaps = 21/216 (9%)
Query: 45 DFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAE---SRQGVKEFLTEIQVISEI-EHE 100
+ + K+GEG FG VY +D K+ A+KVL+ + + V+ FL EIQ+++ +
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
N+VKLY + LV Y++ SL L S I I L
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLL---KKIGRKGPLSESEALFILAQILSALE 115
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLT-PKISDFGLAKLIPANMTHVSTR-----VAGTI 214
+LH + IIHRDIK NILLD+D K+ DFGLAKL+P + S GT
Sbjct: 116 YLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 215 GYLAPEYAI---RGQVTRKADIYSFGVLLVEIVSGR 247
GY+APE + + +DI+S G+ L E+++G
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 68/225 (30%), Positives = 112/225 (49%), Gaps = 27/225 (12%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLKDGK------IAAIKVLS-AESRQGVKEFLTEIQV 93
+ D ++GEG FG V+ G + + A+K L S K+F E ++
Sbjct: 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL 61
Query: 94 ISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWR------T 147
++ +HEN+VK YG C EG+ I+V+ Y+E+ L + L G + S T
Sbjct: 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPD-AAFLKSPDSPMGELT 120
Query: 148 RS---RICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204
S +I + IA G+ +L + H +HRD+ N L+ DL KI DFG+++ +
Sbjct: 121 LSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY 177
Query: 205 HVSTRVAGT----IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
+ RV G I ++ PE + + T ++D++SFGV+L EI +
Sbjct: 178 Y---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-30
Identities = 84/273 (30%), Positives = 131/273 (47%), Gaps = 34/273 (12%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHEN 101
+ F+ + IG+G FG VYK K ++ AIKV+ E + +++ EIQ +S+
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
+ K YG ++G+ ++ Y S L G + I F I + GL +
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-------ILREVLLGLEY 113
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEY 221
LHEE + IHRDIKA+NILL ++ K++DFG++ + + M+ +T V GT ++APE
Sbjct: 114 LHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEV 169
Query: 222 AIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT- 280
+ KADI+S G+ +E+ G E DL+ R L L+
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKG----------EPPLS-----DLHPMRVLFLIPKNN 214
Query: 281 --SLNGDFDAEEACRFLKVGLLCTQDTPKLRPS 311
SL G+ ++ F+ LC PK RPS
Sbjct: 215 PPSLEGNKFSKPFKDFVS---LCLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 61/200 (30%), Positives = 106/200 (53%), Gaps = 9/200 (4%)
Query: 49 INKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGC 108
+ K+G G FG V++G + A+K L + K+FL E Q++ ++ H L++LY
Sbjct: 11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 109 CVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRP 168
C +V ++ SL + L GG + + +A G+A+L +
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLP----QLIDMAAQVASGMAYLEAQ--- 122
Query: 169 HIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVT 228
+ IHRD+ A N+L+ ++ K++DFGLA++I ++ I + APE A+ + +
Sbjct: 123 NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFS 182
Query: 229 RKADIYSFGVLLVEIVS-GR 247
K+D++SFG+LL EIV+ GR
Sbjct: 183 IKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 44 DDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENL 102
+D+ I +IG G +G VYK R + G++ AIKV+ E + EI ++ E H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 103 VKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFL 162
V +G + + +V Y SL S +Q ++ +C +GLA+L
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAY-----VCRETLKGLAYL 117
Query: 163 HEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYA 222
HE IHRDIK +NILL +D K++DFG++ + A + + + GT ++APE A
Sbjct: 118 HET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVA 173
Query: 223 ---IRGQVTRKADIYSFGVLLVE 242
+G K DI++ G+ +E
Sbjct: 174 AVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 11/206 (5%)
Query: 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKV--LSAESRQGVKEFLTEIQVISEIEHEN 101
DF +NKIG+G FG V+K K D ++ A+K LS +R+ +E + E +V+++++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
+++ Y ++ +V Y EN L + L R I I GLA
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLL----KMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEY 221
LH + I+HRDIK+ N+ LD KI D G+AKL+ N +T V GT YL+PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPEL 172
Query: 222 AIRGQVTRKADIYSFGVLLVEIVSGR 247
K+D+++ GV+L E +G+
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-29
Identities = 76/283 (26%), Positives = 128/283 (45%), Gaps = 29/283 (10%)
Query: 49 INKIGEGGFGSVYKGRL-----KDGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENL 102
I ++GEG FG V R G+ A+K L+ Q +F EI+++ ++HEN+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 103 VKLYGCCVEGNHRI--LVYNYLENNSLAQTLIGGGHHYSNIQ---FSWRTRSRICIGIAR 157
VK G C + R L+ YL + SL L + + FS + I +
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ--------ICK 120
Query: 158 GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT--IG 215
G+ +L + IHRD+ A NIL++ + KISDFGLAK++P + + + G I
Sbjct: 121 GMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177
Query: 216 YLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275
+ APE + + +D++SFGV L E+ + + + P E ++ L+
Sbjct: 178 WYAPECLRTSKFSSASDVWSFGVTLYELFT-YGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236
Query: 276 LLVDTSLNGDFDAEEAC--RFLKVGLLCTQDTPKLRPSMSTVV 316
L+ +C + LC + P+ RPS + ++
Sbjct: 237 ELLKE--GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGV-KEFLTEIQVISEIEHEN 101
DD + ++G G G V K + GKI A+K + E + + K+ L E+ ++ +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
+V YG + Y++ SL + L + R +I + + +GL +
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKIL-----KEVQGRIPERILGKIAVAVLKGLTY 115
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEY 221
LHE+ IIHRD+K SNIL++ K+ DFG++ + ++ GT Y+APE
Sbjct: 116 LHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF---VGTSSYMAPER 170
Query: 222 AIRGQVTRKADIYSFGVLLVEIVSGR 247
+ K+DI+S G+ L+E+ +GR
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 49 INKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGV--KEFLTEIQVISEIEHENLVKL 105
+ KIGEG +G VYK R G+I AIK + K L EI+++ E+ H N++KL
Sbjct: 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKL 63
Query: 106 YGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRIC---IGIARGLAFL 162
LV+ +++ + L + + S I + +GLAF
Sbjct: 64 LDVFRHKGDLYLVFEFMDTD-LYKLIKDRQRGLPE--------SLIKSYLYQLLQGLAFC 114
Query: 163 HEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI---PANMTH-VSTRVAGTIGYLA 218
H I+HRD+K N+L++ + K++DFGLA+ TH V TR Y A
Sbjct: 115 H---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRA 166
Query: 219 PEYAIR-GQVTRKADIYSFGVLLVEIVSGR 247
PE + + DI+S G + E++S R
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 80/275 (29%), Positives = 132/275 (48%), Gaps = 36/275 (13%)
Query: 52 IGEGGFGSVYKG-RLKDGKIAAIKVLS-----AESRQGVKEFLTEIQVISEIEHENLVKL 105
+G G FGSVY+G L DG A+K +S ++ VK+ EI ++S+++H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 106 YGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEE 165
G E ++ + + SLA+ L G + TR I GL +LH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGS-FPEPVIRLYTRQ-----ILLGLEYLHDR 121
Query: 166 VRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIR- 224
+ +HRDIK +NIL+D + K++DFG+AK + S G+ ++APE +
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVIAQQ 176
Query: 225 GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNG 284
G ADI+S G ++E+ +G + P + + + + +EL + D
Sbjct: 177 GGYGLAADIWSLGCTVLEMATG------KPPWSQLEGVAAVFKIGRSKELPPIPDHL--- 227
Query: 285 DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319
++EA F+ L C Q P LRP T ++L
Sbjct: 228 ---SDEAKDFI---LKCLQRDPSLRP---TAAELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 8e-28
Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 41/221 (18%)
Query: 46 FSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAES-RQGVKEF----LTEIQVISEIEH 99
+ I +IGEG +G VYK R K G++ A+K + E+ ++G F + EI+++ ++ H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEG---FPITAIREIKLLQKLRH 57
Query: 100 ENLVKLYGCCVE--GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR 157
N+V+L +V+ Y++++ L G ++F+ +
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDHD-LT-----GLLDSPEVKFTESQIKCYMKQLLE 111
Query: 158 GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI----PANMTHVSTRVAGT 213
GL +LH I+HRDIK SNIL++ D K++DFGLA+ A+ T+ RV T
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN---RVI-T 164
Query: 214 IGYLAPE-------YAIRGQVTRKADIYSFGVLLVEIVSGR 247
+ Y PE Y + D++S G +L E+ G+
Sbjct: 165 LWYRPPELLLGATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 25/207 (12%)
Query: 50 NKIGEGGFGSVYKG--RLKDGKI--AAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVK 104
++G G FGSV KG +K GK A+K L E G KEFL E V+++++H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 105 LYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFS----WRTRSRICIGIARGLA 160
L G C +G +LV L + L I S + +A G+A
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKK----RREIPVSDLKELAHQ------VAMGMA 109
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT--IGYLA 218
+L + H +HRD+ A N+LL KISDFG+++ + A + AG + + A
Sbjct: 110 YLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYA 166
Query: 219 PEYAIRGQVTRKADIYSFGVLLVEIVS 245
PE G+ + K+D++S+GV L E S
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 71/212 (33%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 44 DDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQ-GVKEFLTEIQVISEIEHEN 101
DD+ I IG G VY L + + AIK + E Q V E E+Q +S+ H N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
+VK Y V G+ LV YL SL + Y + + + +GL +
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIM---KSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT---HVSTRVAGTIGYLA 218
LH + IHRDIKA NILL +D + KI+DFG++ + V GT ++A
Sbjct: 118 LHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 219 PEYAIRGQV---TRKADIYSFGVLLVEIVSGR 247
PE + QV KADI+SFG+ +E+ +G
Sbjct: 175 PE--VMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 35/229 (15%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQG-VKEFLTEIQVISEIE- 98
DDF IGEG F +V + K K AIK+L ++ VK E +V++ +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 99 HENLVKLYGCCVEGNHRI-LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR 157
H ++KLY + + V Y N L Q + Y + + I
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI----RKYGS--LDEKCTRFYAAEILL 113
Query: 158 GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVA------ 211
L +LH + IIHRD+K NILLDKD+ KI+DFG AK++ N + S +
Sbjct: 114 ALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 212 -------------GTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
GT Y++PE + +D+++ G ++ ++++G+
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-27
Identities = 78/281 (27%), Positives = 125/281 (44%), Gaps = 21/281 (7%)
Query: 49 INKIGEGGFGSVYKGRLK-----DGKIAAIKVLSAESRQGVKE-FLTEIQVISEIEHENL 102
I +GEG FG V G++ A+K L E Q + EI ++ + HEN+
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 103 VKLYGCCVEGNHRI--LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
VK GCC E + L+ Y+ SL L H N+ +IC G+A
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQIC----EGMA 121
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT--IGYLA 218
+LH + H IHRD+ A N+LLD D KI DFGLAK +P + R G + + A
Sbjct: 122 YLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 178
Query: 219 PEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278
E + + +D++SFGV L E+++ C++ P + + ++ LI L+
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237
Query: 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319
+ + + C + K RP+ +++ +L
Sbjct: 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 71/211 (33%), Positives = 109/211 (51%), Gaps = 24/211 (11%)
Query: 52 IGEGGFGSVYKG-RLKDGKIAAIK--VLSAESRQGVKE-------FLTEIQVISEIEHEN 101
IG G FGSVY G G++ A+K L + S EI ++ E++HEN
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
+V+ G ++ +H + Y+ S+A L G + ++ + I +GL +
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ------ILKGLNY 121
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVA-----GTIGY 216
LH IIHRDIK +NIL+D KISDFG++K + AN T A G++ +
Sbjct: 122 LHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 217 LAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
+APE + TRKADI+S G L+VE+++G+
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 30/214 (14%)
Query: 46 FSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAE-SRQGV-KEFLTEIQVISEIEHENL 102
+ + K+GEG +G VYK R K G+I A+K + + +G+ L EI ++ E++H N+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 103 VKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFL 162
VKL LV+ Y + + L + L S I + RGLA+
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDMD-LKKYL-----DKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 163 HEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPE-- 220
H I+HRD+K NIL+++D K++DFGLA+ + + V T+ Y APE
Sbjct: 115 H---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEIL 170
Query: 221 -------YAIRGQVTRKADIYSFGVLLVEIVSGR 247
A+ DI+S G + E+++G+
Sbjct: 171 LGSKHYSTAV--------DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-27
Identities = 64/201 (31%), Positives = 109/201 (54%), Gaps = 16/201 (7%)
Query: 52 IGEGGFGSVYKGRL----KDGKIAAIKVLSAESRQGVK-EFLTEIQVISEIEHENLVKLY 106
IG G FG V +GRL K AIK L A S + +FLTE ++ + +H N+++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV 166
G + +++ Y+EN SL + L + + +F+ + GIA G+ +L E
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFL---REN--DGKFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 167 RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIG--YLAPEYAIR 224
+HRD+ A NIL++ +L K+SDFGL++ + + +T+ G I + APE
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-GGKIPIRWTAPEAIAY 182
Query: 225 GQVTRKADIYSFGVLLVEIVS 245
+ T +D++SFG+++ E++S
Sbjct: 183 RKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-27
Identities = 65/207 (31%), Positives = 108/207 (52%), Gaps = 28/207 (13%)
Query: 52 IGEGGFGSVYKGRLK-DG---KIA-AIKVL-SAESRQGVKEFLTEIQVISEIEHENLVKL 105
+G G FG+VYKG +G KI AIKVL S + KE L E V++ ++H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 106 YGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQ----FSWRTRSRICIGIARGLAF 161
G C+ + L+ + L + +H NI +W C+ IA+G+++
Sbjct: 75 LGICLSSQVQ-LITQLMPLGCLLDYV---RNHKDNIGSQYLLNW------CVQIAKGMSY 124
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAG---TIGYLA 218
L E+ ++HRD+ A N+L+ KI+DFGLAKL+ + G I ++A
Sbjct: 125 LEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVPIKWMA 179
Query: 219 PEYAIRGQVTRKADIYSFGVLLVEIVS 245
E + T K+D++S+GV + E+++
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 61/205 (29%), Positives = 109/205 (53%), Gaps = 9/205 (4%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHE 100
I + + + +IG G FG V+ G + + AIK + E ++F+ E QV+ ++ H
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHP 59
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
LV+LYG C E + LV+ ++E+ L+ L +FS T +C+ + G+A
Sbjct: 60 KLVQLYGVCTERSPICLVFEFMEHGCLSDYL-----RAQRGKFSQETLLGMCLDVCEGMA 114
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPE 220
+L ++IHRD+ A N L+ ++ K+SDFG+ + + + ST + + +PE
Sbjct: 115 YLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPE 171
Query: 221 YAIRGQVTRKADIYSFGVLLVEIVS 245
+ + K+D++SFGVL+ E+ S
Sbjct: 172 VFSFSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 70/200 (35%), Positives = 103/200 (51%), Gaps = 10/200 (5%)
Query: 49 INKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGC 108
+ K+G G FG V+ G AIK L + + FL E ++ +++H LV+LY
Sbjct: 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 109 CVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRP 168
V ++ Y+EN SL L I+ + + IA G+AF+ R
Sbjct: 70 -VTQEPIYIITEYMENGSLVDFL----KTPEGIKLTINKLIDMAAQIAEGMAFIE---RK 121
Query: 169 HIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVT 228
+ IHRD++A+NIL+ + L KI+DFGLA+LI N I + APE G T
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 181
Query: 229 RKADIYSFGVLLVEIVS-GR 247
K+D++SFG+LL EIV+ GR
Sbjct: 182 IKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 80/278 (28%), Positives = 130/278 (46%), Gaps = 31/278 (11%)
Query: 45 DFSPINKIGEGGFGSVYK-GRLKDGKIAAIKV--LSAESRQGVKEFLTEIQVISEIEHEN 101
DF + K+G+G +GSVYK RL D + A+K L + S++ ++ + EI++++ + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNI--QFSWRTRSRICIGIARGL 159
++ ++GN +V Y L++ + I Q WR I I + RGL
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IFIQLLRGL 116
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAP 219
LHE+ I+HRD+K++NILL + KI D G++K++ NM GT Y+AP
Sbjct: 117 QALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAP 170
Query: 220 EYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279
E + K+DI+S G LL E+ + R + +Y ++R Y
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK--YPP-------- 220
Query: 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317
D + R Q PKLRP+ ++
Sbjct: 221 IPPIYSQDLQNFIRS------MLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 83/299 (27%), Positives = 129/299 (43%), Gaps = 44/299 (14%)
Query: 40 SIATDDFSPINKIGEGGFGSVYKG--RLKDGKIA----AIKVL-SAESRQGVKEFLTEIQ 92
+ D + + +G G FG VY+G R +DG A+K L + S Q +FL E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 93 VISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSN-IQFSWRTRSRI 151
++S+ H+N+V+L G E R ++ + L L + +
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 152 CIGIARGLAFLHEEVRPHIIHRDIKASNILLD---KDLTPKISDFGLAKLI-PANMTHVS 207
+A+G +L E H IHRDI A N LL KI+DFG+A+ I A+
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 208 TRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GR----CNTNMRLPTEEQYLL 262
R I ++ PE + G T K D++SFGVLL EI S G TN
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN----------- 227
Query: 263 ERTWDLYERRELILLVDTSLNGDFDAEEAC--RFLKVGLLCTQDTPKLRPSMSTVVQML 319
+E++ V + G D + C ++ C Q TP+ RP+ +T+++ +
Sbjct: 228 ---------QEVMEFV--TGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 5e-26
Identities = 70/198 (35%), Positives = 106/198 (53%), Gaps = 10/198 (5%)
Query: 51 KIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCV 110
K+G+G FG V+ G AIK L + + FL E QV+ ++ HE LV+LY
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 111 EGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHI 170
E I V Y+ SL L G Y + ++I A G+A++ R +
Sbjct: 72 EEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI----ASGMAYVE---RMNY 123
Query: 171 IHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRK 230
+HRD++A+NIL+ ++L K++DFGLA+LI N I + APE A+ G+ T K
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 231 ADIYSFGVLLVEIVS-GR 247
+D++SFG+LL E+ + GR
Sbjct: 184 SDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 69/208 (33%), Positives = 105/208 (50%), Gaps = 10/208 (4%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHE 100
I + I K+G G FG V+ G A+K L + + FL E Q++ ++ H+
Sbjct: 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHD 61
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
LV+LY E I V Y+ SL L G + + +A G+A
Sbjct: 62 KLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKDGEGRALKLP----NLVDMAAQVAAGMA 116
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPE 220
++ R + IHRD++++NIL+ L KI+DFGLA+LI N I + APE
Sbjct: 117 YIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 221 YAIRGQVTRKADIYSFGVLLVEIVS-GR 247
A+ G+ T K+D++SFG+LL E+V+ GR
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 65/221 (29%), Positives = 112/221 (50%), Gaps = 24/221 (10%)
Query: 49 INKIGEGGFGSVYKGR---LKD--GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLV 103
I ++G+G FGSV R L+D G++ A+K L + + +++F EI+++ ++H+N+V
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68
Query: 104 KLYGCCVEGNHR--ILVYNYLENNSLAQTLIGGGH---HYSNIQFSWRTRSRICIGIARG 158
K G C R LV YL SL L H + ++ + IC +G
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ----IC----KG 120
Query: 159 LAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT--IGY 216
+ +L + +HRD+ NIL++ + KI DFGL K++P + + R G I +
Sbjct: 121 MEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFW 177
Query: 217 LAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTE 257
APE + + +D++SFGV+L E+ + + + P E
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFT-YSDKSCSPPAE 217
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 9/205 (4%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHE 100
I D + + ++G G FG V G+ + AIK++ E EF+ E +V+ ++ HE
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHE 59
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
LV+LYG C + +V Y+ N L L G + Q +C + G+A
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-----LEMCKDVCEGMA 114
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPE 220
+L + IHRD+ A N L+D K+SDFGL++ + + S + + PE
Sbjct: 115 YLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 171
Query: 221 YAIRGQVTRKADIYSFGVLLVEIVS 245
+ + + K+D+++FGVL+ E+ S
Sbjct: 172 VLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 64/224 (28%), Positives = 97/224 (43%), Gaps = 32/224 (14%)
Query: 42 ATDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EH 99
T F + IGEG +G VYK R K G++ AIK++ + +E E ++ + H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNH 62
Query: 100 ENLVKLYGCCVEGNHRI------LVYNYLENNS---LAQTLIGGGHHYSNIQFSWRTRSR 150
N+ YG ++ N LV S L + L G ++
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY----- 117
Query: 151 ICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTR- 209
I RGLA+LHE +IHRDIK NILL K+ K+ DFG++ A + R
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVS----AQLDSTLGRR 170
Query: 210 --VAGTIGYLAPE-----YAIRGQVTRKADIYSFGVLLVEIVSG 246
GT ++APE ++D++S G+ +E+ G
Sbjct: 171 NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-25
Identities = 70/213 (32%), Positives = 110/213 (51%), Gaps = 23/213 (10%)
Query: 52 IGEGGFGSVYKGRL------KDGKIAAIKVLSAESRQGVK-EFLTEIQVISEIEHENLVK 104
+GEG FG VYKG L AIK L + V+ EF E +++S+++H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 105 LYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRS-----------RICI 153
L G C + +++ YL + L + L+ H S++ + I I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPH-SDVGAESGDETVKSSLDCSDFLHIAI 131
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI-PANMTHVSTRVAG 212
IA G+ +L H +HRD+ A N L+ + LT KISDFGL++ I A+ V ++
Sbjct: 132 QIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 213 TIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
+ ++ PE + G+ T ++DI+SFGV+L EI S
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-24
Identities = 71/199 (35%), Positives = 105/199 (52%), Gaps = 12/199 (6%)
Query: 51 KIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCV 110
K+G+G FG V+ G AIK L + + FL E Q++ ++ H+ LV LY
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 111 EGNHRILVYNYLENNSLAQTLI-GGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPH 169
E I V ++ SL L G G + Q + IA G+A++ R +
Sbjct: 72 EEPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQLV-----DMAAQIADGMAYIE---RMN 122
Query: 170 IIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTR 229
IHRD++A+NIL+ +L KI+DFGLA+LI N I + APE A+ G+ T
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 230 KADIYSFGVLLVEIVS-GR 247
K+D++SFG+LL E+V+ GR
Sbjct: 183 KSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 64/222 (28%), Positives = 102/222 (45%), Gaps = 34/222 (15%)
Query: 45 DFSPINKIGEGGFGSVYK-GRLKDGKIAAIKVLSAES-RQGVKEFLT-EIQVISEIEHEN 101
D+ + IG+G FG+V K R DGKI K + + + K+ L E+ ++ E++H N
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60
Query: 102 LVKLYGCCVEGNHRIL------VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRS------ 149
+V+ Y RI+ +Y +E GG IQ + R
Sbjct: 61 IVRYY-------DRIIDRSNQTLYIVME-------YCEGGDLAQLIQKCKKERKYIEEEF 106
Query: 150 --RICIGIARGLAFLH--EEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTH 205
RI + L H + ++HRD+K +NI LD + K+ DFGLAK++ + +
Sbjct: 107 IWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF 166
Query: 206 VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
T V GT Y++PE K+DI+S G L+ E+ +
Sbjct: 167 AKTYV-GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 64/225 (28%), Positives = 108/225 (48%), Gaps = 25/225 (11%)
Query: 51 KIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKE-FLTEIQVISEIEHENLVKLYGCC 109
KIG+G FG VYKG LK A+K + +K FL E +++ + +H N+VKL G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 110 VEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPH 169
V+ +V + SL L + + + + ++ + A G+ +L + +
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKN-----RLTVKKLLQMSLDAAAGMEYLESK---N 113
Query: 170 IIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT-IGYLAPEYAIRGQVT 228
IHRD+ A N L+ ++ KISDFG+++ + VS + I + APE G+ T
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 229 RKADIYSFGVLLVEIVSG---------------RCNTNMRLPTEE 258
++D++S+G+LL E S R + R+P +
Sbjct: 174 SESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQ 218
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 61/215 (28%), Positives = 109/215 (50%), Gaps = 26/215 (12%)
Query: 51 KIGEGGFGSVYKGR------LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVK 104
++GEG FG V+ KD + A+K L + K+F E ++++ ++HE++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 105 LYGCCVEGNHRILVYNYLENNSL----------AQTLIGGGHHYSNIQFSWRTRSRICIG 154
YG C +G+ I+V+ Y+++ L A L+ G + + I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAG-- 212
IA G+ +L + H +HRD+ N L+ +L KI DFG+++ + + + RV G
Sbjct: 132 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY---RVGGHT 185
Query: 213 --TIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
I ++ PE + + T ++D++SFGV+L EI +
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 71/235 (30%), Positives = 114/235 (48%), Gaps = 23/235 (9%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHE 100
I + + K+G G FG V+ G + A+K L + V+ FL E ++ ++H+
Sbjct: 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHD 61
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIG--GGHHY--SNIQFSWRTRSRICIGIA 156
LV+LY + ++ Y+ SL L GG I FS + IA
Sbjct: 62 KLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ--------IA 113
Query: 157 RGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGY 216
G+A++ R + IHRD++A+N+L+ + L KI+DFGLA++I N I +
Sbjct: 114 EGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 170
Query: 217 LAPEYAIRGQVTRKADIYSFGVLLVEIVS-------GRCNTNMRLPTEEQYLLER 264
APE G T K+D++SFG+LL EIV+ G N+++ + Y + R
Sbjct: 171 TAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPR 225
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 19/204 (9%)
Query: 51 KIGEGGFGSVYKGRLKD--GKI--AAIKVLSAESRQG-VKEFLTEIQVISEIEHENLVKL 105
K+G+G FG V +G GK+ A+K L ++ + +FL E ++ ++HENL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 106 YGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEE 165
YG V + ++V SL L + F T + IA G+ +L +
Sbjct: 62 YGV-VLTHPLMMVTELAPLGSLLDRL----RKDALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 166 VRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVST----RVAGTIGYLAPEY 221
IHRD+ A NILL D KI DFGL + +P N H +V + APE
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP--FAWCAPES 171
Query: 222 AIRGQVTRKADIYSFGVLLVEIVS 245
+ +D++ FGV L E+ +
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 45 DFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGV---KEFLTEIQVISEIEHEN 101
+ + + ++G G FG V+ G+ + AIK++ R+G +F+ E +V+ ++ H N
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMI----REGAMSEDDFIEEAKVMMKLSHPN 60
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
LV+LYG C + +V Y+ N L L + +C + + +
Sbjct: 61 LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG-----KLGTEWLLDMCSDVCEAMEY 115
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEY 221
L IHRD+ A N L+ +D K+SDFGLA+ + + S + + PE
Sbjct: 116 LESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEV 172
Query: 222 AIRGQVTRKADIYSFGVLLVEIVSG 246
+ + K+D++SFGVL+ E+ S
Sbjct: 173 FDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 69/216 (31%), Positives = 105/216 (48%), Gaps = 34/216 (15%)
Query: 46 FSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEF--------LTEIQVISE 96
+ I ++G+G FGSVY R K+ G++ AIK + K+F L E++ + +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRK 53
Query: 97 I-EHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGI 155
+ EH N+VKL E + V+ Y+E N L Q L+ FS I I
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYMEGN-LYQ-LM---KDRKGKPFSESVIRSIIYQI 108
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI---PANMTHVSTRVAG 212
+GLA +H + HRD+K N+L+ KI+DFGLA+ I P +VSTR
Sbjct: 109 LQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR--- 162
Query: 213 TIGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGR 247
Y APE +R + DI++ G ++ E+ + R
Sbjct: 163 --WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 18/211 (8%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKDGK-IAAIKVLSAESRQGV-KEFLTEIQVISEIEHEN 101
+ ++++GEG GSV K RLK+ I A+K ++ + + K+ L E+++ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 102 LVKLYGCCV---EGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARG 158
+VK YG + + I + Y E SL I + + +I + +G
Sbjct: 61 IVKYYGAFLDESSSSIGIAM-EYCEGGSLDS--IYKKVKKRGGRIGEKVLGKIAESVLKG 117
Query: 159 LAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA-KLIPANMTHVSTRVAGTIGYL 217
L++LH IIHRDIK SNILL + K+ DFG++ +L+ ++ GT Y+
Sbjct: 118 LSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV----NSLAGTFTGTSFYM 170
Query: 218 APEYAIRGQ-VTRKADIYSFGVLLVEIVSGR 247
APE I+G+ + +D++S G+ L+E+ R
Sbjct: 171 APE-RIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 62/201 (30%), Positives = 110/201 (54%), Gaps = 17/201 (8%)
Query: 52 IGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQG-VKEFLTEIQVISEIEH---ENLVKLY 106
IG G +G+VY+G+ + G++ A+K+++ ++ V + E+ ++S++ N+ K Y
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV 166
G ++G ++ Y E S+ +TL+ G + + S I + L ++H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV-RTLMKAG------PIAEKYISVIIREVLVALKYIHKV- 120
Query: 167 RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQ 226
+IHRDIKA+NIL+ K+ DFG+A L+ N + ST V GT ++APE G+
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGK 177
Query: 227 V-TRKADIYSFGVLLVEIVSG 246
KADI+S G+ + E+ +G
Sbjct: 178 YYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 6e-24
Identities = 78/299 (26%), Positives = 129/299 (43%), Gaps = 46/299 (15%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLK-------DGKIAAIKVLS-AESRQGVKEFLTEIQ 92
+ + + I ++G+G FG VY+G K + ++A IK ++ S + EFL E
Sbjct: 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVA-IKTVNENASMRERIEFLNEAS 61
Query: 93 VISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWR---TRS 149
V+ E ++V+L G G ++V + L L T
Sbjct: 62 VMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLGPPTLQ 119
Query: 150 RI---CIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHV 206
+ IA G+A+L + +HRD+ A N ++ +DLT KI DFG+ + I
Sbjct: 120 KFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDI---YETD 173
Query: 207 STRVAGT----IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLL 262
R G + ++APE G T K+D++SFGV+L E+ + L
Sbjct: 174 YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT---------------LA 218
Query: 263 ERTWDLYERRELILLVDTSLNGDFDAEEAC--RFLKVGLLCTQDTPKLRPSMSTVVQML 319
E+ + E++ V G D E C + L++ +C Q PK+RP+ +V L
Sbjct: 219 EQPYQGLSNEEVLKFV--IDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 8e-24
Identities = 61/201 (30%), Positives = 109/201 (54%), Gaps = 15/201 (7%)
Query: 52 IGEGGFGSVYKGRLK-DGK---IAAIKVLSA-ESRQGVKEFLTEIQVISEIEHENLVKLY 106
IG G FG V++G LK G+ AIK L + + ++FL+E ++ + H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV 166
G + +++ Y+EN +L + L +S+ Q R GIA G+ +L +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-----GIAAGMKYLSDM- 126
Query: 167 RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIG--YLAPEYAIR 224
+ +HRD+ A NIL++ +L K+SDFGL++++ + T G I + APE
Sbjct: 127 --NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 225 GQVTRKADIYSFGVLLVEIVS 245
+ T +D++SFG+++ E++S
Sbjct: 185 RKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 8e-24
Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 52 IGEGGFGSVYKGRLKD------GKI-AAIKVL-SAESRQGVKEFLTEIQVISEIEHENLV 103
+G G FG VY+G D G I A+K L + Q KEFL E ++S H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 104 KLYGCCVEGNHRILVYNYLENNSLAQTLIGG-GHHYSNIQFSWRTRSRICIGIARGLAFL 162
KL G C+ + ++ +E L L + + + IC+ +A+G +L
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 163 HEEVRPHIIHRDIKASNILL-----DKDLTPKISDFGLAKLIPANMTHVSTRVAG----T 213
+ H IHRD+ A N L+ D D KI DFGLA+ I + + R G
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGEGLLP 176
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
+ ++APE + G+ T ++D++SFGVL+ EI++
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 1e-23
Identities = 59/210 (28%), Positives = 109/210 (51%), Gaps = 26/210 (12%)
Query: 52 IGEGGFGSVYKGR-LKDGKIAAIKVLS------AESRQGVKEFLTEIQVISEIEHENLVK 104
+G G F S Y+ R +K G + A+K ++ +E + V+ EI++++ + H ++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 105 LYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHE 164
+ G E +H L ++ S++ L Y F + RGL++LHE
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLL----SKYG--AFKEAVIINYTEQLLRGLSYLHE 121
Query: 165 EVRPHIIHRDIKASNILLD---KDLTPKISDFGLAKLIPANMT---HVSTRVAGTIGYLA 218
IIHRD+K +N+L+D + L +I+DFG A + A T ++ GTI ++A
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 219 PEYAIRGQ-VTRKADIYSFGVLLVEIVSGR 247
PE +RG+ R D++S G +++E+ + +
Sbjct: 177 PE-VLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 2e-23
Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 35/218 (16%)
Query: 46 FSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKE-----FLTEIQVISEIEH 99
+ K+GEG + VYK R + G+I AIK + R+ K+ L EI+++ E++H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 100 ENLVKLYGCCVEGNHRILVYNYLE--------NNSLAQTLIGGGHHYSNIQFSWRTRSRI 151
N++ L ++ LV+ ++E + S+ T ++I+ S+
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTP-------ADIK-SY------ 107
Query: 152 CIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVA 211
+ RGL +LH I+HRD+K +N+L+ D K++DFGLA+ + ++ +V
Sbjct: 108 MLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV 164
Query: 212 GTIGYLAPE--YAIRGQVTRKADIYSFGVLLVEIVSGR 247
T Y APE + R D++S G + E++
Sbjct: 165 -TRWYRAPELLFGAR-HYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 2e-23
Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 37/214 (17%)
Query: 49 INKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLT-EIQVISEIEHENLVKLY 106
+N+IG G G+VYK + G++ A+KV+ V+ + EI+++ ++ H N+VK +
Sbjct: 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCH 138
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV 166
++ +++ SL T I +++ I G+A+LH
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ----------ILSGIAYLH--- 185
Query: 167 RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPE------ 220
R HI+HRDIK SN+L++ KI+DFG+++++ M ++ V GTI Y++PE
Sbjct: 186 RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDL 244
Query: 221 -------YAIRGQVTRKADIYSFGVLLVEIVSGR 247
YA DI+S GV ++E GR
Sbjct: 245 NHGAYDGYA--------GDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 2e-23
Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 49 INKIGEGGFGSVYKGRLKD-GKIAAIK-VLSAESRQGVKEF-LTEIQVISEIEHENLVKL 105
+ +GEG +G V K R K G+I AIK +E + VK+ L E++V+ ++ HEN+V L
Sbjct: 6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNL 65
Query: 106 YGCCVEGNHRILVYNYLENNSLAQ-TLIGGGHHYSNIQ-FSWRTRSRICIGIARGLAFLH 163
LV+ Y+E L GG ++ + W+ + + +A+ H
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ--------LLQAIAYCH 117
Query: 164 EEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAI 223
+IIHRDIK NIL+ + K+ DFG A+ + A T T Y APE +
Sbjct: 118 ---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLV 174
Query: 224 RGQVTRKA-DIYSFGVLLVEIVSGR 247
K D+++ G ++ E++ G
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-23
Identities = 66/213 (30%), Positives = 104/213 (48%), Gaps = 29/213 (13%)
Query: 46 FSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHEN 101
F + IG+G FG V + +D K+ A+K ++ + + V+ L E +++ E+ H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 102 LVKLYGCCVEGNHRILVYNY--LENNSLAQTLIGGG----HHYSNIQFS-WRTRSRICIG 154
LV L+ Y++ EN L L+ GG H ++FS + + IC
Sbjct: 62 LVNLW------------YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC-E 108
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTI 214
I L +LH + IIHRDIK NILLD+ I+DF +A + + ++T +GT
Sbjct: 109 IVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD--TLTTSTSGTP 163
Query: 215 GYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
GY+APE R + D +S GV E + G+
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 5e-23
Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 25/209 (11%)
Query: 49 INKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQG--VKEFLTEIQVISEIEHENLVKL 105
+ +IGEG G V+K + + G+ A+K ++ +G + L EI+ + +H +VKL
Sbjct: 5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKL 64
Query: 106 YGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEE 165
G+ +LV Y+ + L++ L + +G+A++H
Sbjct: 65 LDVFPHGSGFVLVMEYMPS-DLSEVL----RDEER-PLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 166 VRPHIIHRDIKASNILLDKDLTPKISDFGLAKL----IPANMTH-VSTRVAGTIGYLAPE 220
I+HRD+K +N+L+ D KI+DFGLA+L P +H V+TR Y APE
Sbjct: 119 ---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR-----WYRAPE 170
Query: 221 --YAIRGQVTRKADIYSFGVLLVEIVSGR 247
Y R + D+++ G + E+++G
Sbjct: 171 LLYGAR-KYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 5e-23
Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQG---VKEFLTEIQVISEIEHENLVKLYG 107
I +G +G V+ + K G I AIKV+ V + LTE ++S+ + +VKLY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 108 CCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIG-IARGLAFLHEEV 166
+ LV YL LA L + ++ +RI I I L +LH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLL----ENVGSLDEDV---ARIYIAEIVLALEYLH--- 110
Query: 167 RPHIIHRDIKASNILLDKDLTPKISDFGLAKLI-------PANMTHVSTRVAGTIGYLAP 219
IIHRD+K NIL+D + K++DFGL+K+ + R+ GT Y+AP
Sbjct: 111 SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 220 EYAIRGQVTRKADIYSFGVLLVEIVSG 246
E + ++ D +S G +L E + G
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 6e-23
Identities = 60/211 (28%), Positives = 106/211 (50%), Gaps = 19/211 (9%)
Query: 51 KIGEGGFGSVYKGRL------KDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVK 104
++GEG FG V+ +D + A+K L S ++F E ++++ ++H+++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 105 LYGCCVEGNHRILVYNYLENNSLAQTL---------IGGGHHYSNIQFSWRTRSRICIGI 155
YG C EG ++V+ Y+ + L + L + GG + Q + I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI-PANMTHVSTRVAGTI 214
A G+ +L H +HRD+ N L+ + L KI DFG+++ I + V R I
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 215 GYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
++ PE + + T ++DI+SFGV+L EI +
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 83/330 (25%), Positives = 140/330 (42%), Gaps = 44/330 (13%)
Query: 4 FSFLFRRRDSPRNRVPEVDEEFSGIHNVKLYSYKEL-SIATDDF----SPINKIGEGGFG 58
F F+ R + RV D G ++ + K SI +D N I G G
Sbjct: 649 FVFIRGRNNLELKRVENED----GTWELQFFDSKVSKSITINDILSSLKEENVISRGKKG 704
Query: 59 SVYKGRLKDGKIAAIKVLSAESRQGVKEF-------LTEIQVISEIEHENLVKLYGCCVE 111
+ YKG+ + + VKE +EI + +++H N+VKL G C
Sbjct: 705 ASYKGKSIKNGMQFV----------VKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRS 754
Query: 112 GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHII 171
L++ Y+E +L++ L SW R +I IGIA+ L FLH P ++
Sbjct: 755 EKGAYLIHEYIEGKNLSEVLRN---------LSWERRRKIAIGIAKALRFLHCRCSPAVV 805
Query: 172 HRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKA 231
++ I++D P + +L + T+ + Y+APE +T K+
Sbjct: 806 VGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSAYVAPETRETKDITEKS 859
Query: 232 DIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGD--FDAE 289
DIY FG++L+E+++G+ + ++E Y L + +D S+ GD +
Sbjct: 860 DIYGFGLILIELLTGKSPADAEFGVHGS-IVEWARYCYSDCHLDMWIDPSIRGDVSVNQN 918
Query: 290 EACRFLKVGLLCTQDTPKLRPSMSTVVQML 319
E + + L CT P RP + V++ L
Sbjct: 919 EIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 9e-23
Identities = 65/201 (32%), Positives = 107/201 (53%), Gaps = 15/201 (7%)
Query: 52 IGEGGFGSVYKGRLK-DGK---IAAIKVLSA-ESRQGVKEFLTEIQVISEIEHENLVKLY 106
IG G FG V GRLK GK AIK L A + + ++FL+E ++ + +H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV 166
G + ++V Y+EN SL L ++ IQ R GIA G+ +L +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR-----GIASGMKYLSDM- 125
Query: 167 RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIG--YLAPEYAIR 224
+HRD+ A NIL++ +L K+SDFGL++++ + T G I + APE
Sbjct: 126 --GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183
Query: 225 GQVTRKADIYSFGVLLVEIVS 245
+ T +D++S+G+++ E++S
Sbjct: 184 RKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 1e-22
Identities = 59/209 (28%), Positives = 106/209 (50%), Gaps = 17/209 (8%)
Query: 51 KIGEGGFGSVYKGRL------KDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVK 104
++GEG FG V+ +D + A+K L S K+F E ++++ ++HE++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 105 LYGCCVEGNHRILVYNYLENNSLAQTLIGGG-------HHYSNIQFSWRTRSRICIGIAR 157
YG CVEG+ I+V+ Y+++ L + L G + + I IA
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 158 GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK-LIPANMTHVSTRVAGTIGY 216
G+ +L + H +HRD+ N L+ ++L KI DFG+++ + + V I +
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 217 LAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
+ PE + + T ++D++S GV+L EI +
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 1e-22
Identities = 63/204 (30%), Positives = 113/204 (55%), Gaps = 19/204 (9%)
Query: 52 IGEGGFGSVYKGRLK-DGK---IAAIKVLSA-ESRQGVKEFLTEIQVISEIEHENLVKLY 106
IG G FG V +GRLK GK AIK L + + + ++FL+E ++ + +H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV 166
G + +++ ++EN +L L ++ IQ R GIA G+ +L E
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYLSEM- 125
Query: 167 RPHIIHRDIKASNILLDKDLTPKISDFGLAKLI---PANMTHVSTRVAGTIG--YLAPEY 221
+ +HRD+ A NIL++ +L K+SDFGL++ + ++ T+ S+ + G I + APE
Sbjct: 126 --NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS-LGGKIPIRWTAPEA 182
Query: 222 AIRGQVTRKADIYSFGVLLVEIVS 245
+ T +D++S+G+++ E++S
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 1e-22
Identities = 71/212 (33%), Positives = 107/212 (50%), Gaps = 22/212 (10%)
Query: 45 DFSPINKIGEGGFGSVYKGR-LKDGKIAAIK-VLSAESRQGVK-EFLTEIQVISEIEHEN 101
+F +N+IGEG +G VY+ R G+I A+K V R G+ L EI ++ + H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 102 LVKLYGCCVEGNHR---ILVYNYLENNSLAQTLIGGGHHYSNIQ--FSWRTRSRICIGIA 156
+V+L V G H LV Y E + LA L N+ FS + + +
Sbjct: 68 IVELKE-VVVGKHLDSIFLVMEYCEQD-LASLL-------DNMPTPFSESQVKCLMLQLL 118
Query: 157 RGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGY 216
RGL +LHE IIHRD+K SN+LL KI+DFGLA+ ++ +V T+ Y
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWY 174
Query: 217 LAPEYAIRGQV-TRKADIYSFGVLLVEIVSGR 247
APE + T D+++ G +L E+++ +
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 17/206 (8%)
Query: 49 INKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYG 107
I ++G+G FG VYK + K+ G AA K++ ES + +++F+ EI ++SE +H N+V LY
Sbjct: 10 IGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYE 69
Query: 108 CCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVR 167
N ++ + + +L ++ + Q + +C + L FLH
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-----VCRQMLEALNFLHSH-- 122
Query: 168 PHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQV 227
+IHRD+KA NILL D K++DFG++ + + T + GT ++APE + +
Sbjct: 123 -KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPE-VVACET 179
Query: 228 TR------KADIYSFGVLLVEIVSGR 247
+ KADI+S G+ L+E+
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 3e-22
Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 45 DFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLV 103
KIGEG G V K G+ A+K + +Q + E+ ++ + +H N+V
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 104 KLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH 163
++Y + G+ +V +LE +L + + I + +C+ + + L+FLH
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-------ATVCLAVLKALSFLH 132
Query: 164 EEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAI 223
+ +IHRDIK+ +ILL D K+SDFG + + + V GT ++APE
Sbjct: 133 AQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVIS 188
Query: 224 RGQVTRKADIYSFGVLLVEIVSG 246
R + DI+S G++++E+V G
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 4e-22
Identities = 73/221 (33%), Positives = 103/221 (46%), Gaps = 45/221 (20%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLS----AESRQGVKEFLTEIQVISEIE 98
DDF I +G G FG V R K GK A+K+LS + +Q V+ L E +++ I
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59
Query: 99 HENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSW-RTRSRICIGIAR 157
H LV LYG + ++ LV Y + GG FS R R +AR
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEY----------VPGGE-----LFSHLRKSGRFPEPVAR 104
Query: 158 --------GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTR 209
L +LH I++RD+K N+LLD D KI+DFG AK V R
Sbjct: 105 FYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAK-------RVKGR 154
Query: 210 ---VAGTIGYLAPEYAIRGQ-VTRKADIYSFGVLLVEIVSG 246
+ GT YLAPE I + + D ++ G+L+ E+++G
Sbjct: 155 TYTLCGTPEYLAPE-IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 5e-22
Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 27/226 (11%)
Query: 44 DDFSPINKIGEGGFGSVYKGRL------KDGKIAAIKVLSAE-SRQGVKEFLTEIQVISE 96
++ + IG+G FG V++ R + + A+K+L E S +F E +++E
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 97 IEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIG-- 154
+H N+VKL G C G L++ Y+ L + L + +R C
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 155 --------------IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI- 199
+A G+A+L E +HRD+ N L+ +++ KI+DFGL++ I
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
A+ S A I ++ PE + T ++D++++GV+L EI S
Sbjct: 182 SADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 1e-21
Identities = 58/202 (28%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 45 DFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLV 103
D + +K+G G +G VY+G K A+K L ++ + V+EFL E V+ EI+H NLV
Sbjct: 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 65
Query: 104 KLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH 163
+L G C ++ ++ +L L N ++ I+ + +L
Sbjct: 66 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ----ISSAMEYLE 121
Query: 164 EEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAI 223
+ + IHRD+ A N L+ ++ K++DFGL++L+ + I + APE
Sbjct: 122 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 178
Query: 224 RGQVTRKADIYSFGVLLVEIVS 245
+ + K+D+++FGVLL EI +
Sbjct: 179 YNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-21
Identities = 61/202 (30%), Positives = 107/202 (52%), Gaps = 24/202 (11%)
Query: 51 KIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCV 110
IGEG FG+V +G G+ A+K + + + FL E V++++ H+NLV+L G +
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 111 EGNHRILVYNYLENNSLAQTLIGGGHHYSN----IQFSWRTRSRICIGIARGLAFLHEEV 166
N +V + +L L G + +QFS + +A G+ +L +
Sbjct: 70 H-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFS--------LDVAEGMEYLESK- 119
Query: 167 RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQ 226
++HRD+ A NIL+ +D K+SDFGLA++ + ++++ + + APE +
Sbjct: 120 --KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD--NSKLP--VKWTAPEALKHKK 173
Query: 227 VTRKADIYSFGVLLVEIVS-GR 247
+ K+D++S+GVLL E+ S GR
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-21
Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 52 IGEGGFGSVYKGRLKDGKIA-AIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCV 110
+G+G +G VY R ++ AIK + + V+ EI + S ++H N+V+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 111 EGNHRILVYNYLENNSLAQTLIGG----GHHYSNIQFSWRTRSRICIGIARGLAFLHEEV 166
E + + SL+ L + I F + I GL +LH+
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ-------ILEGLKYLHDN- 127
Query: 167 RPHIIHRDIKASNILLDK-DLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRG 225
I+HRDIK N+L++ KISDFG +K + A + + GT+ Y+APE +G
Sbjct: 128 --QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETFTGTLQYMAPEVIDKG 184
Query: 226 Q--VTRKADIYSFGVLLVEIVSGR 247
ADI+S G +VE+ +G+
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-21
Identities = 69/243 (28%), Positives = 117/243 (48%), Gaps = 40/243 (16%)
Query: 52 IGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVK-EFLTEIQVISEIEHENLVKLYGCCV 110
+G+G FG V+KG LKD A+K + Q +K +FL+E +++ + +H N+VKL G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 111 EGNHRILVYNYLENNSLAQTLIGGGHHYSNI-----QFSWRTRSRICIGIARGLAFLHEE 165
+ R +Y +E L+ GG S + + + + + A G+A+L +
Sbjct: 63 Q---RQPIYIVME-------LVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112
Query: 166 VRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRG 225
+ IHRD+ A N L+ ++ KISDFG+++ + S I + APE G
Sbjct: 113 ---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYG 169
Query: 226 QVTRKADIYSFGVLLVEIVS-------GRCNTNMRLPTEEQY--------------LLER 264
+ + ++D++S+G+LL E S G N R E+ Y +++R
Sbjct: 170 RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQR 229
Query: 265 TWD 267
WD
Sbjct: 230 CWD 232
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 3e-21
Identities = 63/203 (31%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 46 FSPINKIGEGGFGSVYKG-RLKDGKIAAIKVLS-AESRQGVKEFLTEIQVISEIEHENLV 103
F+ + +IG+G FG V+KG + ++ AIK++ E+ +++ EI V+S+ + +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 104 KLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH 163
K YG ++G ++ YL S L G + Q + + I +GL +LH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP--FDEFQIATMLKE-----ILKGLDYLH 118
Query: 164 EEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAI 223
E + IHRDIKA+N+LL + K++DFG+A + +T V GT ++APE
Sbjct: 119 SEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQ 174
Query: 224 RGQVTRKADIYSFGVLLVEIVSG 246
+ KADI+S G+ +E+ G
Sbjct: 175 QSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 3e-21
Identities = 57/197 (28%), Positives = 104/197 (52%), Gaps = 12/197 (6%)
Query: 51 KIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCC 109
KIGEG G V +K GK+ A+K + +Q + E+ ++ + +HEN+V++Y
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 110 VEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPH 169
+ G+ +V +LE +L + ++ + + + +C+ + + L+ LH +
Sbjct: 87 LVGDELWVVMEFLEGGALTDIV-------THTRMNEEQIAAVCLAVLKALSVLHAQ---G 136
Query: 170 IIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTR 229
+IHRDIK+ +ILL D K+SDFG + + + V GT ++APE R
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGP 195
Query: 230 KADIYSFGVLLVEIVSG 246
+ DI+S G++++E+V G
Sbjct: 196 EVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 3e-21
Identities = 67/207 (32%), Positives = 107/207 (51%), Gaps = 25/207 (12%)
Query: 46 FSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEF---LTEIQVISEIEHEN 101
F+ + +IG G FG+VY R ++ ++ AIK +S +Q +++ + E++ + ++ H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 102 LVKLYGCCVEGNHRILVYNY-LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
++ GC + + LV Y L + S + I + IC G +GLA
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEI-------AAICHGALQGLA 129
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI-PANMTHVSTRVAGTIGYLAP 219
+LH R IHRDIKA NILL + T K++DFG A L+ PAN GT ++AP
Sbjct: 130 YLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPAN------SFVGTPYWMAP 180
Query: 220 EYAI---RGQVTRKADIYSFGVLLVEI 243
E + GQ K D++S G+ +E+
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 4e-21
Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 52 IGEGGFGSVYKGRLKDG--KIAAIKVLS----------AESRQGVKEFLTEIQVISE-IE 98
+G G FG VYK R K+ + A+K ++ E + + + ++E+ +I E +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 99 HENLVKLYGCCVEGNHRILVYNYLENNSLAQ---TLIGGGHHYSNIQFSWRTRSRICIGI 155
H N+V+ Y +E + +V + +E L + +L ++ + W ++ +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI-WNIFVQMVLA- 125
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIG 215
L +LH+E R I+HRD+ +NI+L +D I+DFGLAK T V GTI
Sbjct: 126 ---LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTIL 178
Query: 216 YLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
Y PE KAD+++FG +L ++ +
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 5e-21
Identities = 66/203 (32%), Positives = 99/203 (48%), Gaps = 14/203 (6%)
Query: 46 FSPINKIGEGGFGSVYKG-RLKDGKIAAIKVLSAESRQGVKEFL-TEIQVISEIEHENLV 103
++ KIG+G G+VY + G+ AIK ++ +Q KE + EI V+ E +H N+V
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELIINEILVMRENKHPNIV 79
Query: 104 KLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH 163
+ G+ +V YL SL + I + +C + L FLH
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-------AAVCRECLQALEFLH 132
Query: 164 EEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAI 223
+IHRDIK+ NILL D + K++DFG I + ST V GT ++APE
Sbjct: 133 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVT 188
Query: 224 RGQVTRKADIYSFGVLLVEIVSG 246
R K DI+S G++ +E+V G
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 5e-21
Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 46 FSPINKIGEGGFGSVYKGR-LKDGKIAAIK-VLSAESRQGVKEF-LTEIQVISEIE---H 99
+ + +IGEG +G+VYK R L G+ A+K V S +G+ L EI ++ ++E H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 100 ENLVKLYGCC-VEGNHRI----LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIG 154
N+V+L C R LV+ +++ + LA L T +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQD-LATYL----SKCPKPGLPPETIKDLMRQ 115
Query: 155 IARGLAFLHEEVRPH-IIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213
+ RG+ FLH H I+HRD+K NIL+ D KI+DFGLA++ M T V T
Sbjct: 116 LLRGVDFLHS----HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVT 169
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEI 243
+ Y APE ++ D++S G + E+
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 6e-21
Identities = 65/211 (30%), Positives = 109/211 (51%), Gaps = 20/211 (9%)
Query: 45 DFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESR-QGVKEF-LTEIQVISEIEHEN 101
D++ I KIGEG +G VYKGR K G+I A+K + ES +GV + EI ++ E++H N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 102 LVKLYGCCVEGNHRILVYNYLENN--SLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGL 159
+V L ++ + L++ +L + +L G + + + S+ + I +G+
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQ------ILQGI 114
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL--IPANMTHVSTRVAGTIGYL 217
F H ++HRD+K N+L+D K++DFGLA+ IP V T T+ Y
Sbjct: 115 LFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP---VRVYTHEVVTLWYR 168
Query: 218 APEYAIRGQ-VTRKADIYSFGVLLVEIVSGR 247
APE + + DI+S G + E+ + +
Sbjct: 169 APEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 7e-21
Identities = 76/274 (27%), Positives = 127/274 (46%), Gaps = 29/274 (10%)
Query: 46 FSPINKIGEGGFGSVYKGRLKDGK-IAAIKVLS-AESRQGVKEFLTEIQVISEIEHENLV 103
F+ + +IG+G FG VYKG K + AIK++ E+ +++ EI V+S+ + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 104 KLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH 163
+ YG ++G ++ YL S L G + I R I +GL +LH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILRE-------ILKGLDYLH 118
Query: 164 EEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAI 223
E + IHRDIKA+N+LL + K++DFG+A + +T V GT ++APE
Sbjct: 119 SERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIK 174
Query: 224 RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLN 283
+ KADI+S G+ +E+ G + DL+ R L L+ S
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEPPNS---------------DLHPMRVLFLIPKNS-P 218
Query: 284 GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317
+ + + F + C P+ RP+ +++
Sbjct: 219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 7e-21
Identities = 56/197 (28%), Positives = 102/197 (51%), Gaps = 12/197 (6%)
Query: 51 KIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCC 109
KIGEG G V R K G+ A+K++ +Q + E+ ++ + +H+N+V++Y
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 110 VEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPH 169
+ G ++ +L+ +L + S + + + +C + + L +LH +
Sbjct: 88 LVGEELWVLMEFLQGGALTDIV-------SQTRLNEEQIATVCESVLQALCYLHSQ---G 137
Query: 170 IIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTR 229
+IHRDIK+ +ILL D K+SDFG I ++ + V GT ++APE R
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGT 196
Query: 230 KADIYSFGVLLVEIVSG 246
+ DI+S G++++E+V G
Sbjct: 197 EVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 9e-21
Identities = 64/212 (30%), Positives = 117/212 (55%), Gaps = 25/212 (11%)
Query: 46 FSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEF-LTEIQVISEIEHENLV 103
F + K+GEG + +VYKGR + G+I A+K + ++ +G + EI ++ E++HEN+V
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 104 KLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHH-----YSNIQFSWRTRSRICIGIARG 158
+L+ N +LV+ Y++ + L + + G + F+++ + +G
Sbjct: 62 RLHDVIHTENKLMLVFEYMDKD-LKKYMDTHGVRGALDPNTVKSFTYQ--------LLKG 112
Query: 159 LAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL--IPANMTHVSTRVAGTIGY 216
+AF HE ++HRD+K N+L++K K++DFGLA+ IP N S V T+ Y
Sbjct: 113 IAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT--FSNEVV-TLWY 166
Query: 217 LAPEYAIRGQV-TRKADIYSFGVLLVEIVSGR 247
AP+ + + + DI+S G ++ E+++GR
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 1e-20
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 21/204 (10%)
Query: 52 IGEGGFGSVY------KGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKL 105
+G+G FG VY GR K S E+++ V EIQ++ ++HE +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 106 YGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEE 165
YGC + + Y+ S+ L G + R +R I G+ +LH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVT---RKYTR---QILEGVEYLH-- 121
Query: 166 VRPHIIHRDIKASNILLDKDLTPKISDFGLAK---LIPANMTHVSTRVAGTIGYLAPEYA 222
I+HRDIK +NIL D K+ DFG +K I ++ T + + V GT +++PE
Sbjct: 122 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWMSPE-V 178
Query: 223 IRGQ-VTRKADIYSFGVLLVEIVS 245
I G+ RKAD++S G +VE+++
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 1e-20
Identities = 61/211 (28%), Positives = 110/211 (52%), Gaps = 24/211 (11%)
Query: 52 IGEGGFGSVYKGRLK--DGKI--AAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKL 105
+GEG FGSV +G+L DG A+K + + + ++EFL+E + + +H N++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 106 YGCCVEGNHR------ILVYNYLENNSLAQTL----IGGGHHYSNIQFSWRTRSRICIGI 155
G C E + +++ ++++ L L +GG +Q T + + I
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQ----TLLKFMVDI 122
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT-I 214
A G+ +L + IHRD+ A N +L +D+T ++DFGL+K I + + R+A +
Sbjct: 123 ALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 215 GYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
++A E T K+D+++FGV + EI +
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 66/202 (32%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 49 INKIGEGGFGSVYKGRLKD-GKIAAIKV-LSAESRQGVKEF-LTEIQVISEIEHENLVKL 105
+ +GEG +G V K + K+ G+I AIK L +E + VK+ + EI+++ ++ HENLV L
Sbjct: 6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 106 YGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEE 165
LV+ ++++ T++ Y N R R + I RG+ F H
Sbjct: 66 IEVFRRKKRLYLVFEFVDH-----TVLDDLEKYPNGLDESRVR-KYLFQILRGIEFCH-- 117
Query: 166 VRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRG 225
+IIHRDIK NIL+ + K+ DFG A+ + A V T T Y APE +
Sbjct: 118 -SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYTDYVATRWYRAPELLVGD 175
Query: 226 -QVTRKADIYSFGVLLVEIVSG 246
+ R DI++ G L+ E+++G
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 2e-20
Identities = 83/311 (26%), Positives = 141/311 (45%), Gaps = 67/311 (21%)
Query: 52 IGEGGFGSVYKG---RLKDGK----IAAIKVLSAESRQG-VKEFLTEIQVISEIEHENLV 103
+GEG FG V K RLK G+ A+K+L + +++ L+E ++ ++ H +++
Sbjct: 8 LGEGEFGKVVKATAFRLK-GRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 104 KLYGCCVEGNHRILVYNYLENNSLAQTL-----IGGGHHYSN------------------ 140
KLYG C + +L+ Y + SL L +G + S+
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 141 ---IQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197
I F+W+ I+RG+ +L E ++HRD+ A N+L+ + KISDFGL++
Sbjct: 127 GDLISFAWQ--------ISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 198 LIPANMTHVSTRVAGTI--GYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLP 255
+ ++V R G I ++A E T ++D++SFGVLL EIV+ N +
Sbjct: 176 DVYEEDSYVK-RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234
Query: 256 TEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPS---M 312
E + L +T ER E +EE + L C + P RP+ +
Sbjct: 235 PERLFNLLKTGYRMERPENC------------SEEMYNLM---LTCWKQEPDKRPTFADI 279
Query: 313 STVVQMLMGEK 323
S ++ +M +
Sbjct: 280 SKELEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 2e-20
Identities = 60/207 (28%), Positives = 106/207 (51%), Gaps = 15/207 (7%)
Query: 44 DDFSPINKIGEGGFGSVYK-GRLKDGKIAAIKVLSAESRQGV-KEFLTEIQVISEIEHEN 101
+D I+ +G G GSV K + G + A KV+ ++ V K+ L E+Q++ E
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPY 64
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
+V YG + N+ + +++ SL + GG I +I + + GL +
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEIL------GKIAVAVVEGLTY 118
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA-KLIPANMTHVSTRVAGTIGYLAPE 220
L+ I+HRDIK SNIL++ K+ DFG++ +LI + ++ GT Y++PE
Sbjct: 119 LYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IADTFVGTSTYMSPE 172
Query: 221 YAIRGQVTRKADIYSFGVLLVEIVSGR 247
G+ T K+D++S G+ ++E+ G+
Sbjct: 173 RIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-20
Identities = 70/226 (30%), Positives = 105/226 (46%), Gaps = 24/226 (10%)
Query: 51 KIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCV 110
K+G G FG V+ A+K + S V+ FL E V+ ++H+ LVKL+ V
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV-V 70
Query: 111 EGNHRILVYNYLENNSLAQTLIGGGHHYSN----IQFSWRTRSRICIGIARGLAFLHEEV 166
++ ++ SL L I FS + IA G+AF+ +
Sbjct: 71 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ--------IAEGMAFIEQR- 121
Query: 167 RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQ 226
+ IHRD++A+NIL+ L KI+DFGLA++I N I + APE G
Sbjct: 122 --NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 179
Query: 227 VTRKADIYSFGVLLVEIVS-------GRCNTNMRLPTEEQYLLERT 265
T K+D++SFG+LL+EIV+ G N + E Y + R
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP 225
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 4e-20
Identities = 65/274 (23%), Positives = 125/274 (45%), Gaps = 30/274 (10%)
Query: 49 INKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGC 108
+ ++G G FG V+ G+ + AIK ++ E ++F+ E +V+ ++ H LV+LYG
Sbjct: 9 MKELGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 109 CVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRP 168
C + +V ++EN L L + S +C + G+ +L R
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYL-----RQRQGKLSKDMLLSMCQDVCEGMEYLE---RN 119
Query: 169 HIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVT 228
IHRD+ A N L+ K+SDFG+ + + + S+ + + PE + +
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 229 RKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGD--F 286
K+D++SFGVL+ E+ T ++P E++ E +V+ G +
Sbjct: 180 SKSDVWSFGVLMWEVF-----TEGKMPFEKKSNYE-------------VVEMISRGFRLY 221
Query: 287 DAEEACRFL-KVGLLCTQDTPKLRPSMSTVVQML 319
+ A + +V C + P+ RP+ + +++ +
Sbjct: 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 6e-20
Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 36/223 (16%)
Query: 46 FSPINKIGEGGFGSVYKGRLK---DGKIAAIKVLSAESRQGVKEFLT---EIQVISEIEH 99
+ IG G +G VYK + K DGK AIK + Q + EI ++ E++H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 100 ENLVKLYGCCVEGNHRI--LVYNYLENNSLAQTLIGGGHHYSN--IQFSWRTRSRICIGI 155
EN+V L +E + L+++Y E++ +I H + + I
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQ--IIK--FHRQAKRVSIPPSMVKSLLWQI 117
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILLDKDLTP----KISDFGLAKLI--PANMTHVSTR 209
G+ +LH ++HRD+K +NIL+ + KI D GLA+L P
Sbjct: 118 LNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174
Query: 210 VAGTIGYLAPE-------YAIRGQVTRKADIYSFGVLLVEIVS 245
V TI Y APE Y T+ DI++ G + E+++
Sbjct: 175 VVVTIWYRAPELLLGARHY------TKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 6e-20
Identities = 65/203 (32%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 46 FSPINKIGEGGFGSVYKG-RLKDGKIAAIKVLS-AESRQGVKEFLTEIQVISEIEHENLV 103
F+ + KIG+G FG V+KG + K+ AIK++ E+ +++ EI V+S+ + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 104 KLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH 163
K YG ++ ++ YL S L G + I R I +GL +LH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILRE-------ILKGLDYLH 118
Query: 164 EEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAI 223
E + IHRDIKA+N+LL + K++DFG+A + +T V GT ++APE
Sbjct: 119 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIK 174
Query: 224 RGQVTRKADIYSFGVLLVEIVSG 246
+ KADI+S G+ +E+ G
Sbjct: 175 QSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 7e-20
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 18/212 (8%)
Query: 41 IATDDFSPINKIGEGGFGSVYKG---RLKDGKIA-AIKVLSAESRQGVKE-FLTEIQVIS 95
I +D + IGEG FG VY+G ++ KIA A+K + V+E FL E ++
Sbjct: 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMR 62
Query: 96 EIEHENLVKLYGCCVEGNHRIL--VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICI 153
+ +H ++VKL G E I+ + E S Q +
Sbjct: 63 QFDHPHIVKLIGVITENPVWIVMELAPLGELRSYLQV-------NKY-SLDLASLILYSY 114
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213
++ LA+L + +HRDI A N+L+ K+ DFGL++ + + +++
Sbjct: 115 QLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP 171
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
I ++APE + T +D++ FGV + EI+
Sbjct: 172 IKWMAPESINFRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 9e-20
Identities = 60/213 (28%), Positives = 106/213 (49%), Gaps = 19/213 (8%)
Query: 49 INKIGEGGFGSVYKGRL-----KDGKIAAIKVLSAESRQG-VKEFLTEIQVISEIEHENL 102
I +GEG FG V R G+ A+K L ES + + EI+++ + HEN+
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 103 VKLYGCCVE--GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
VK G C E GN L+ +L + SL + L + + + + + + I +G+
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-----INLKQQLKYAVQICKGMD 123
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTR--VAGTIGYLA 218
+L +HRD+ A N+L++ + KI DFGL K I + + + + + + + A
Sbjct: 124 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA 180
Query: 219 PEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTN 251
PE I+ + +D++SFGV L E+++ C++
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELLT-YCDSE 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 9e-20
Identities = 69/290 (23%), Positives = 115/290 (39%), Gaps = 36/290 (12%)
Query: 47 SPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAESRQGVK-EFLTEIQVISEIEH 99
I +G G FG V+ + K + +K L + ++ EF E+ + ++ H
Sbjct: 8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH 67
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLI---GGGHHYSNIQFSWRTRSRICIGIA 156
+N+V+L G C E ++ Y + L Q L S + + +C IA
Sbjct: 68 KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127
Query: 157 RGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGY 216
G+ L +HRD+ A N L+ K+S L+K + + + + +
Sbjct: 128 LGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRW 184
Query: 217 LAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL 276
LAPE + K+D++SFGVL+ E+ + L EE
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE------------------ 226
Query: 277 LVDTSLNGDFD--AEEAC--RFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322
+++ G + E C R K+ C PK RPS S +V +GE
Sbjct: 227 VLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVS-ALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 1e-19
Identities = 57/197 (28%), Positives = 101/197 (51%), Gaps = 12/197 (6%)
Query: 51 KIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCC 109
KIGEG G V K GK A+K + +Q + E+ ++ + HEN+V +Y
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 110 VEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPH 169
+ G+ +V +LE +L + ++ + + + +C+ + R L++LH +
Sbjct: 89 LVGDELWVVMEFLEGGALTDIV-------THTRMNEEQIATVCLSVLRALSYLHNQ---G 138
Query: 170 IIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTR 229
+IHRDIK+ +ILL D K+SDFG + + + V GT ++APE R
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGT 197
Query: 230 KADIYSFGVLLVEIVSG 246
+ DI+S G++++E++ G
Sbjct: 198 EVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 1e-19
Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 46 FSPINKIGEGGFGS--VYKGRLKDGKIAAIKV--LSAESRQGVKEFLTEIQVISEIEHEN 101
+ PI +G+G FG +Y+ R +D + K L+ S + ++ L EI ++S ++H N
Sbjct: 2 YIPIRVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
++ Y ++ N ++ Y +L ++ F I +++
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIV----RQKGQLFEEEMVLWYLFQIVSAVSY 116
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEY 221
+H+ I+HRDIK NI L K K+ DFG++K++ + + T V GT Y++PE
Sbjct: 117 IHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPEL 172
Query: 222 AIRGQVTRKADIYSFGVLLVEI 243
+ K+DI++ G +L E+
Sbjct: 173 CQGVKYNFKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 14/203 (6%)
Query: 45 DFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLV 103
D+ I ++G G +G VYK R L G++AA+K++ E EI ++ E +H N+V
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69
Query: 104 KLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH 163
+G + + Y SL Q + S +Q ++ +C +GLA+LH
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSL-QDIYHVTGPLSELQIAY-----VCRETLQGLAYLH 123
Query: 164 EEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAI 223
+ + +HRDIK +NILL + K++DFG+A I A + + + GT ++APE A
Sbjct: 124 SKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAA 179
Query: 224 ---RGQVTRKADIYSFGVLLVEI 243
G + DI++ G+ +E+
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 25/206 (12%)
Query: 52 IGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYG 107
+G+GGFG V ++K GK+ A K L + R+G + L E +++ ++ +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-- 58
Query: 108 CCVEGNHRILVYNYLENNSLAQTLIGGG---HHYSNIQFSWRTRSRICI---GIARGLAF 161
+ ++ L TL+ GG +H N+ +R I GL
Sbjct: 59 --------AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEH 110
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEY 221
LH+ I++RD+K N+LLD +ISD GLA + AGT GY+APE
Sbjct: 111 LHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEV 165
Query: 222 AIRGQVTRKADIYSFGVLLVEIVSGR 247
D ++ G L E+++GR
Sbjct: 166 LQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 67/242 (27%), Positives = 123/242 (50%), Gaps = 27/242 (11%)
Query: 51 KIGEGGFGSVY----KGRLK---------DGK--IAAIKVLSAESRQGVK-EFLTEIQVI 94
K+GEG FG V+ +G + DG+ + A+K+L A+ + + +FL EI+++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 95 SEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLI-----GGGHHYSNI-QFSWRTR 148
S +++ N+++L G CV + ++ Y+EN L Q L H +NI S
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 149 SRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK-LIPANMTHVS 207
+ + IA G+ +L + +HRD+ N L+ T KI+DFG+++ L + +
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 208 TRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWD 267
R I ++A E + G+ T +D+++FGV L E+ + L ++EQ ++E T +
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-VIENTGE 247
Query: 268 LY 269
+
Sbjct: 248 FF 249
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 2e-19
Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 12/216 (5%)
Query: 32 KLYSYKELSIATDDFSPINKIGEGGFGSVYKG-RLKDGKIAAIKVLSAESRQGVKEFLTE 90
KL S + ++ KIG+G G+VY + G+ AIK ++ + + + + E
Sbjct: 7 KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINE 66
Query: 91 IQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSR 150
I V+ E ++ N+V + G+ +V YL SL + I +
Sbjct: 67 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-------AA 119
Query: 151 ICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRV 210
+C + L FLH +IHRDIK+ NILL D + K++DFG I + ST V
Sbjct: 120 VCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176
Query: 211 AGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSG 246
GT ++APE R K DI+S G++ +E+V G
Sbjct: 177 -GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 74/284 (26%), Positives = 132/284 (46%), Gaps = 38/284 (13%)
Query: 44 DDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENL 102
+DF I +IG G +G VYK R + G++AAIKV+ E + EI ++ + +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 103 VKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFL 162
V +G + + + + SL Q + S Q ++ +R + +GL +L
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSL-QDIYHVTGPLSESQIAYVSRETL-----QGLYYL 122
Query: 163 HEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYA 222
H + + +HRDIK +NILL + K++DFG++ I A + + + GT ++APE A
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVA 178
Query: 223 I---RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279
+G + DI++ G+ +E+ L +DL+ R L L+
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAE---------------LQPPMFDLHPMRALFLMTK 223
Query: 280 TSLNGDFDAEEA------CRFLKVGLLCTQDTPKLRPSMSTVVQ 317
++ ++ F+K+ L PK RP+ ++Q
Sbjct: 224 SNFQPPKLKDKMKWSNSFHHFVKMAL---TKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 62/216 (28%), Positives = 111/216 (51%), Gaps = 32/216 (14%)
Query: 45 DFSPINKIGEGGFGSVYKGR-LKDG---KI-AAIKVL-SAESRQGVKEFLTEIQVISEIE 98
+F I +G G FG+VYKG + +G KI AIK L A S + KE L E V++ ++
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 99 HENLVKLYGCCVEGNHRIL--------VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSR 150
+ ++ +L G C+ +++ + +Y+ + + IG + +W
Sbjct: 68 NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQY-----LLNW----- 114
Query: 151 ICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRV 210
C+ IA+G+ +L E ++HRD+ A N+L+ KI+DFGLAKL+ A+
Sbjct: 115 -CVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG 170
Query: 211 AGT-IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
I ++A E + T ++D++S+GV + E+++
Sbjct: 171 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-19
Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 49 INKIGEGGFGSVYKGRL-----KDGKIAAIKVLS-AESRQGVKEFLTEIQVISEIEHENL 102
+ ++GE FG +YKG L ++ AIK L + Q EF E +++E+ H N+
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNI 69
Query: 103 VKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRS------------R 150
V L G + +++ YL L + LI H S++ S
Sbjct: 70 VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPH-SDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 151 ICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI-PANMTHVSTR 209
I I IA G+ +L +H+D+ A NIL+ + L KISD GL++ I A+ V +
Sbjct: 129 IAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 210 VAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
I ++ PE + G+ + +DI+SFGV+L EI S
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 3e-19
Identities = 61/234 (26%), Positives = 108/234 (46%), Gaps = 48/234 (20%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-----GKIA-AIKVLSAE-SRQGVKEFLTEIQVISE 96
D + +GEG FG V K A+K+L + + + + + ++E++++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 97 I-EHENLVKLYGCC---------VE----GNHRILV---------YNYLENNSLAQTLIG 133
I +H+N++ L G C VE GN R + + + +TL
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT- 130
Query: 134 GGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193
+ F+++ +ARG+ FL + IHRD+ A N+L+ +D KI+DF
Sbjct: 131 ---QKDLVSFAYQ--------VARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADF 176
Query: 194 GLAKLIPANMTHVSTRVAG--TIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
GLA+ I ++ + G + ++APE T ++D++SFGVLL EI +
Sbjct: 177 GLARDI-HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-19
Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 36/215 (16%)
Query: 45 DFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVK 104
+ + IG+G FG V G + G A+K + ++ + FL E V++++ H NLV+
Sbjct: 7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQ 63
Query: 105 LYGCCVEGNHRI-LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIG--------- 154
L G VE + +V Y+ SL L R+R R +G
Sbjct: 64 LLGVIVEEKGGLYIVTEYMAKGSLVDYL--------------RSRGRSVLGGDCLLKFSL 109
Query: 155 -IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213
+ + +L + +HRD+ A N+L+ +D K+SDFGL K A+ T + ++
Sbjct: 110 DVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP-- 162
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GR 247
+ + APE + + K+D++SFG+LL EI S GR
Sbjct: 163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 4e-19
Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 19/209 (9%)
Query: 44 DDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVK-EFLTEIQVISEIEHEN 101
DDF + ++G G G V K G I A K++ E + ++ + + E++V+ E
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
+V YG + +++ SL Q L G NI +I I + RGL +
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENIL------GKISIAVLRGLTY 114
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA-KLIP--ANMTHVSTRVAGTIGYLA 218
L E+ + I+HRD+K SNIL++ K+ DFG++ +LI AN + V TR Y++
Sbjct: 115 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTR-----SYMS 166
Query: 219 PEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
PE T ++DI+S G+ LVE+ GR
Sbjct: 167 PERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-19
Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 13/206 (6%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVK-EFLTEIQVISEIEHEN 101
DDF I+++G G G V K + K G I A K++ E + ++ + + E+QV+ E
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
+V YG + +++ SL Q L I ++ I + RGLA+
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEIL------GKVSIAVLRGLAY 118
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEY 221
L E + I+HRD+K SNIL++ K+ DFG++ + +M + GT Y++PE
Sbjct: 119 LRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPER 173
Query: 222 AIRGQVTRKADIYSFGVLLVEIVSGR 247
+ ++DI+S G+ LVE+ GR
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 6e-19
Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 12/202 (5%)
Query: 46 FSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVK 104
++ KIG+G G+V+ + G+ AIK ++ + + + + EI V+ E+++ N+V
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 105 LYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHE 164
+ G+ +V YL SL + + I + +C + L FLH
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQI-------AAVCRECLQALEFLHA 133
Query: 165 EVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIR 224
+IHRDIK+ N+LL D + K++DFG I + ST V GT ++APE R
Sbjct: 134 N---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 189
Query: 225 GQVTRKADIYSFGVLLVEIVSG 246
K DI+S G++ +E+V G
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 6e-19
Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 41/220 (18%)
Query: 46 FSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESR-QGVKEF-LTEIQVISEIEHENL 102
+ + KIGEG +G VYK R G+I A+K + E+ +GV + EI ++ E+ H N+
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 103 VKLYGCCVEGNHRILVYNYLE-----------NNSLAQTLIGGGHHYSNIQFSWRTRSRI 151
V+L N LV+ +L+ L LI + ++
Sbjct: 61 VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKS--------YLYQ----- 107
Query: 152 CIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL--IPA-NMTHVST 208
+ +G+A+ H ++HRD+K N+L+D++ K++DFGLA+ +P TH
Sbjct: 108 ---LLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH--- 158
Query: 209 RVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGR 247
V T+ Y APE + Q + DI+S G + E+V+ R
Sbjct: 159 EVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 72/235 (30%), Positives = 114/235 (48%), Gaps = 45/235 (19%)
Query: 42 ATDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIK-VLSAESRQGVKEF----LTEIQVIS 95
D+ + K+GEG FG VYK R +K G++ A+K +L + G F L EI+++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILK 62
Query: 96 EIEHENLVKLYGCCVE---GNHRI-----LVYNYLENNSLAQTLIGGGHHYSNIQFSWRT 147
+++H N+V L VE + R +V Y++++ L+ L +++ T
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHD-LSGLL-----ENPSVKL---T 113
Query: 148 RSRI-CI--GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI----- 199
S+I C + G+ +LHE HI+HRDIKA+NIL+D KI+DFGLA+
Sbjct: 114 ESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
Query: 200 -----PANMTHVSTRVAGTIGYLAPEYAIRG--QVTRKADIYSFGVLLVEIVSGR 247
T T + T Y PE + G + T DI+ G + E+ + R
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPEL-LLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 61/190 (32%), Positives = 98/190 (51%), Gaps = 31/190 (16%)
Query: 49 INKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKE-F----LTEIQVISEIEHENL 102
+ KIG+G FG V+K R K +I A+K + E+ KE F L EI+++ ++HEN+
Sbjct: 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE---KEGFPITALREIKILQLLKHENV 73
Query: 103 VKLYGCC-----VEGNHR---ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIG 154
V L C ++ LV+ + E++ LA L N++F+ ++
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEFCEHD-LAGLL-----SNKNVKFTLSEIKKVMKM 127
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANM----THVSTRV 210
+ GL ++H R I+HRD+KA+NIL+ KD K++DFGLA+ + + RV
Sbjct: 128 LLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184
Query: 211 AGTIGYLAPE 220
T+ Y PE
Sbjct: 185 V-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-18
Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 24/211 (11%)
Query: 50 NKIGEGGFGSVYKGRLKDGKIAAIK--------VLSAESRQGVKEFLTEIQVISEIEHEN 101
+G+G +G+VY G G++ A+K VL+AE ++ E+ ++ ++H N
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKE--YEKLQEEVDLLKSLKHVN 63
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
+V+ G C++ N + ++ S++ L G F T+ I G+A+
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP-LPEPVFCKYTKQ-----ILDGVAY 117
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK---LIPANMTH--VSTRVAGTIGY 216
LH ++HRDIK +N++L + K+ DFG A+ + + TH + + GT +
Sbjct: 118 LHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 217 LAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
+APE RK+DI+S G + E+ +G+
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 43 TDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIK------VLSAESRQGVKEFLTEIQVIS 95
+F KIG+G F VYK L DG++ A+K ++ A++RQ + L EI ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLK 57
Query: 96 EIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQ--FSWRTRSRICI 153
+++H N++K +E N +V + L++ + H+ + RT + +
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMI----KHFKKQKRLIPERTIWKYFV 113
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213
+ L +H + I+HRDIK +N+ + K+ D GL + + T + V GT
Sbjct: 114 QLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GT 169
Query: 214 IGYLAPEYAIRGQ-VTRKADIYSFGVLLVEI 243
Y++PE I K+DI+S G LL E+
Sbjct: 170 PYYMSPE-RIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 23/205 (11%)
Query: 49 INKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYG 107
I ++G+G FG VYK + K+ G +AA KV+ +S + +++++ EI++++ H +VKL G
Sbjct: 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLG 76
Query: 108 CCVEGNHRILVYNYLENNSLAQTLI--GGGHHYSNIQFSWRTRSRICIGIARGLAFLHEE 165
++ + ++ ++ G IQ IC + L +LH
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-------ICRQMLEALQYLHSM 129
Query: 166 VRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVA--GTIGYLAPEYAI 223
IIHRD+KA N+LL D K++DFG++ N+ + R + GT ++APE +
Sbjct: 130 ---KIIHRDLKAGNVLLTLDGDIKLADFGVSA---KNVKTLQRRDSFIGTPYWMAPEVVM 183
Query: 224 -----RGQVTRKADIYSFGVLLVEI 243
KADI+S G+ L+E+
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-18
Identities = 67/226 (29%), Positives = 112/226 (49%), Gaps = 27/226 (11%)
Query: 52 IGEGGFGSVYKG-RLKDG---KI-AAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKL 105
+G G FG+V+KG + +G KI AIK + S RQ +E + + ++H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 106 YGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQ----FSWRTRSRICIGIARGLAF 161
G C G LV SL + H ++ +W C+ IA+G+ +
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHV---RQHRDSLDPQRLLNW------CVQIAKGMYY 124
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI-PANMTHVSTRVAGTIGYLAPE 220
L E ++HR++ A NILL D +I+DFG+A L+ P + + + I ++A E
Sbjct: 125 LEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 221 YAIRGQVTRKADIYSFGVLLVEIVS--GRCNTNMRLPTEEQYLLER 264
+ G+ T ++D++S+GV + E++S MR E LLE+
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-EVPDLLEK 226
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 29/220 (13%)
Query: 51 KIGEGGFGSVY--------KGRLKDGKIA---------AIKVLSA-ESRQGVKEFLTEIQ 92
K+GEG FG V+ K A+KVL S ++FL E++
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 93 VISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTL------IGGGHHYSNIQFSWR 146
++S + N+ +L G C ++ Y+EN L Q L G S S+
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK-SLSFS 130
Query: 147 TRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK-LIPANMTH 205
T + IA G+ +L + +HRD+ N L+ K+ T KI+DFG+++ L ++
Sbjct: 131 TLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYR 187
Query: 206 VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
V R I ++A E + G+ T K+D+++FGV L EI++
Sbjct: 188 VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-18
Identities = 59/213 (27%), Positives = 108/213 (50%), Gaps = 29/213 (13%)
Query: 52 IGEGGFGSVYKG-RLKDGKIAAIKVLS---------AESRQG-VKEFLTEIQVISEIEHE 100
IG+G +G VY + G++ A+K + ++ VK +EI+ + +++H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 101 NLVKLYGCCVEGNHRILVY-NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGL 159
N+V+ G + ++ Y+ S+ L G +F + + GL
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYG------RFEEQLVRFFTEQVLEGL 121
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL---IPANMTHVSTRVAGTIGY 216
A+LH + I+HRD+KA N+L+D D KISDFG++K I N ++S + G++ +
Sbjct: 122 AYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ--GSVFW 176
Query: 217 LAPE--YAIRGQVTRKADIYSFGVLLVEIVSGR 247
+APE ++ + K DI+S G +++E+ +GR
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 55/206 (26%), Positives = 110/206 (53%), Gaps = 22/206 (10%)
Query: 49 INKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESR-QGVKEF-LTEIQVISEIEHENLVKL 105
+ KIGEG +G+V+K + ++ +I A+K + + +GV L EI ++ E++H+N+V+L
Sbjct: 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 64
Query: 106 YGCCVEGNHRI-LVYNYLENNSLAQTL--IGGGHHYSNIQ-FSWRTRSRICIGIARGLAF 161
Y + + ++ LV+ Y + + L + G ++ F ++ + +GLAF
Sbjct: 65 YDV-LHSDKKLTLVFEYCDQD-LKKYFDSCNGDIDPEIVKSFMFQ--------LLKGLAF 114
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEY 221
H +++HRD+K N+L++K+ K++DFGLA+ + S V T+ Y P+
Sbjct: 115 CHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDV 170
Query: 222 AIRGQV-TRKADIYSFGVLLVEIVSG 246
++ + D++S G + E+ +
Sbjct: 171 LFGAKLYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 3e-18
Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 12/216 (5%)
Query: 32 KLYSYKELSIATDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTE 90
KL S + ++ KIG+G G+VY + G+ AI+ ++ + + + + E
Sbjct: 8 KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 67
Query: 91 IQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSR 150
I V+ E ++ N+V + G+ +V YL SL + I +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-------AA 120
Query: 151 ICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRV 210
+C + L FLH +IHRDIK+ NILL D + K++DFG I + ST V
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177
Query: 211 AGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSG 246
GT ++APE R K DI+S G++ +E++ G
Sbjct: 178 -GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-18
Identities = 65/208 (31%), Positives = 113/208 (54%), Gaps = 25/208 (12%)
Query: 49 INKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVK-EFLTEIQVISEIEHENLVKLY 106
+ K+GEG + +VYKG + +G++ A+KV+S ++ +GV + E ++ ++H N+V L+
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLH 69
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLI---GGGHHYSNIQFSWRTRSRICIGIARGLAFLH 163
V+ Y+ + LAQ +I GG H Y+ F ++ + RGLA++H
Sbjct: 70 DIIHTKETLTFVFEYMHTD-LAQYMIQHPGGLHPYNVRLFMFQ--------LLRGLAYIH 120
Query: 164 EEVRPHIIHRDIKASNILLDKDLTPKISDFGLA--KLIPANMTHVSTRVAGTIGYLAPEY 221
HI+HRD+K N+L+ K++DFGLA K IP+ T+ S V T+ Y P+
Sbjct: 121 ---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-TYSSEVV--TLWYRPPD- 173
Query: 222 AIRGQV--TRKADIYSFGVLLVEIVSGR 247
+ G + DI+ G + +E++ G+
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 3e-18
Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 23/206 (11%)
Query: 46 FSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGV---KEFLTEIQVISEIEHEN 101
F+ + +IG G FG+VY R ++ ++ AIK +S +Q ++ + E++ + I+H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
++ GC + + LV Y S + L ++ + T G +GLA+
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITH-----GALQGLAY 140
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI-PANMTHVSTRVAGTIGYLAPE 220
LH ++IHRDIKA NILL + K++DFG A + PAN GT ++APE
Sbjct: 141 LHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN------SFVGTPYWMAPE 191
Query: 221 YAI---RGQVTRKADIYSFGVLLVEI 243
+ GQ K D++S G+ +E+
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 4e-18
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 46 FSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKE---FLTEIQVISEIEHEN 101
+ I KIGEG FG +Y + K D + IK + + VKE E+ ++++++H N
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLT-KMPVKEKEASKKEVILLAKMKHPN 60
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTL-IGGGHHYSNIQ-FSWRTRSRICIGIARGL 159
+V + E +V Y + L + + G +S Q SW + I+ GL
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGL 114
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKD-LTPKISDFGLAKLIPANMTHVSTRVAGTIGYLA 218
+H+ I+HRDIK+ NI L K+ + K+ DFG+A+ + +M T GT YL+
Sbjct: 115 KHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLS 170
Query: 219 PEYAIRGQVTRKADIYSFGVLLVEIVS 245
PE K DI+S G +L E+ +
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 5e-18
Identities = 59/230 (25%), Positives = 111/230 (48%), Gaps = 41/230 (17%)
Query: 51 KIGEGGFGSVY--------------------KGRLKDGKIAAIKVLSAESRQGVK-EFLT 89
K+GEG FG V+ KGR + A+K+L ++ + + +FL
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGR---PLLVAVKILRPDANKNARNDFLK 68
Query: 90 EIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTL-------------IGGGH 136
E++++S ++ N+++L G CV+ + ++ Y+EN L Q L
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 137 HYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196
+ S+ + + + IA G+ +L + +HRD+ N L+ ++LT KI+DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 197 K-LIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
+ L + + R I ++A E + G+ T +D+++FGV L EI+
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 5e-18
Identities = 61/213 (28%), Positives = 110/213 (51%), Gaps = 22/213 (10%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAES-RQGVKEF----LTEIQVISEI 97
D++ +N+I EG +G VY+ R K G+I A+K L E ++G F L EI ++ ++
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKL 61
Query: 98 EHENLVKLYGCCVEGNHR--ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGI 155
+H N+V + V N +V Y+E++ ++L+ F + + +
Sbjct: 62 QHPNIVTVKEVVVGSNLDKIYMVMEYVEHD--LKSLMETMKQ----PFLQSEVKCLMLQL 115
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIG 215
G+A LH+ I+HRD+K SN+LL+ KI DFGLA+ + + T++ T+
Sbjct: 116 LSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY-TQLVVTLW 171
Query: 216 YLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGR 247
Y APE + + + D++S G + E+++ +
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 6e-18
Identities = 67/208 (32%), Positives = 101/208 (48%), Gaps = 29/208 (13%)
Query: 52 IGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQVISEI-EHENLVKLY 106
+G+G FG V LK ++ A+KVL + V+ +TE +V++ +H L +L+
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWR---TRSRICIG-IARGLAFL 162
C + V Y + GG +IQ S R R+R I GL FL
Sbjct: 63 SCFQTKDRLFFVMEY----------VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFL 112
Query: 163 HEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTH-VSTRV-AGTIGYLAPE 220
HE II+RD+K N+LLD + KI+DFG+ K + V+T GT Y+APE
Sbjct: 113 HER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCGTPDYIAPE 166
Query: 221 YAIRGQ-VTRKADIYSFGVLLVEIVSGR 247
+ Q D ++ GVLL E+++G+
Sbjct: 167 -ILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 6e-18
Identities = 66/211 (31%), Positives = 106/211 (50%), Gaps = 35/211 (16%)
Query: 49 INKIGEGGFGSVYKGRLKDGKI-AAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYG 107
I ++G+G FG VYK + K+ + AA KV+ +S + +++++ EI +++ +H N+VKL
Sbjct: 10 IGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL-- 67
Query: 108 CCVEGNHRILVYNYLENN--SLAQTLIGGGHHYSNIQFSWR-TRSRI---CIGIARGLAF 161
L Y ENN L + GG ++ T +I C L +
Sbjct: 68 ---------LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNY 118
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIG---YLA 218
LHE IIHRD+KA NIL D K++DFG++ A T R IG ++A
Sbjct: 119 LHEN---KIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFIGTPYWMA 171
Query: 219 PEYAIRGQVTR------KADIYSFGVLLVEI 243
PE + + ++ KAD++S G+ L+E+
Sbjct: 172 PE-VVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 6e-18
Identities = 63/215 (29%), Positives = 88/215 (40%), Gaps = 28/215 (13%)
Query: 46 FSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTE---IQVISEIE 98
F + +G G FG V K G++ AIK L +R V+ + E + +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 99 HENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR- 157
H LV L+ C +H V Y GG +I + R A
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEY----------AAGGDLMMHIHTDVFSEPRAVFYAACV 110
Query: 158 --GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVST--RVAGT 213
GL +LHE I++RD+K N+LLD + KI+DFGL K M GT
Sbjct: 111 VLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGT 164
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRC 248
+LAPE TR D + GVL+ E++ G
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGES 199
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 7e-18
Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 13/206 (6%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVK-EFLTEIQVISEIEHEN 101
DDF I+++G G G V+K K G I A K++ E + ++ + + E+QV+ E
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
+V YG + +++ SL Q L G + + ++ I + +GL +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTY 118
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEY 221
L E+ + I+HRD+K SNIL++ K+ DFG++ + +M + GT Y++PE
Sbjct: 119 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPER 173
Query: 222 AIRGQVTRKADIYSFGVLLVEIVSGR 247
+ ++DI+S G+ LVE+ GR
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 9e-18
Identities = 63/232 (27%), Positives = 101/232 (43%), Gaps = 59/232 (25%)
Query: 46 FSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSA--ESRQGVKEFLTEIQVISEIEHENL 102
+ + IG G +G V + G+ AIK +S + K L EI+++ + HEN+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 103 VKLYGCCVEGNHRILVYNYLENNS-------LAQT----LIGGGHHYSN--IQFSWRTRS 149
+ L IL E+ + L +T +I ++ IQ+
Sbjct: 62 IGL--------LDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQY------ 107
Query: 150 RICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI------PANM 203
I RGL +LH ++IHRD+K SNIL++ + KI DFGLA+ + +
Sbjct: 108 -FLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163
Query: 204 T-HVSTRVAGTIGYLAPE-------YAIRGQVTRKADIYSFGVLLVEIVSGR 247
T +V TR Y APE Y T+ DI+S G + E+++ +
Sbjct: 164 TEYVVTRW-----YRAPELLLSSSRY------TKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 23/206 (11%)
Query: 46 FSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQG---VKEFLTEIQVISEIEHEN 101
FS + +IG G FG+VY R +++ ++ AIK +S +Q ++ + E++ + ++ H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
++ GC + + LV Y S + L ++ + T G +GLA+
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTH-----GALQGLAY 130
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI-PANMTHVSTRVAGTIGYLAPE 220
LH ++IHRD+KA NILL + K+ DFG A ++ PAN GT ++APE
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPE 181
Query: 221 YAI---RGQVTRKADIYSFGVLLVEI 243
+ GQ K D++S G+ +E+
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 70/232 (30%), Positives = 108/232 (46%), Gaps = 48/232 (20%)
Query: 44 DDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKE----FLTEIQVISEIE 98
+D + +IG G G VYK R K G + A+K + R G KE L ++ V+ +
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNKEENKRILMDLDVVLK-S 70
Query: 99 HE--NLVKLYGCCVEGNHRILVYNYLENNSLAQTL--IGGGHHYSNIQFSWRTRSRICIG 154
H+ +VK YG + + + + L + L + L I G ++ +
Sbjct: 71 HDCPYIVKCYGYFIT-DSDVFICMELMSTCLDKLLKRIQGP-------IPEDILGKMTVA 122
Query: 155 IARGLAFLHEEVRPH-IIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213
I + L +L E+ H +IHRD+K SNILLD K+ DFG++ + + TR AG
Sbjct: 123 IVKALHYLKEK---HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGC 177
Query: 214 IGYLAPE----------YAIRGQVTRKADIYSFGVLLVEIVSGR-----CNT 250
Y+APE Y IR AD++S G+ LVE+ +G+ C T
Sbjct: 178 AAYMAPERIDPPDPNPKYDIR------ADVWSLGISLVELATGQFPYKNCKT 223
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 1e-17
Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 52 IGEGGFGSVY------KGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKL 105
+G+G FG VY GR K S E+ + V EIQ++ ++HE +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 106 YGCCVEGNHRILV--YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH 163
YGC + + L Y+ S+ L G ++ + TR I G+++LH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKY-TRQ-----ILEGMSYLH 123
Query: 164 EEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK-LIPANMTHVSTR-VAGTIGYLAPEY 221
+ I+HRDIK +NIL D K+ DFG +K L M+ R V GT +++PE
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 222 AIRGQVTRKADIYSFGVLLVEIVSGR 247
RKAD++S G +VE+++ +
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-17
Identities = 54/206 (26%), Positives = 105/206 (50%), Gaps = 15/206 (7%)
Query: 52 IGEGGFGSVYKGRL-KDGKIAAIKVLSAE----SRQGVKEFLTEIQVISEIEHENLVKLY 106
+GEG FGSV +G+L +D I + V + + +R +++FL+E + E +H N+++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 107 GCCVEGNHR------ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
G C++ +++ ++++ L L+ + + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT-IGYLAP 219
+L + IHRD+ A N +L++++ ++DFGL+K I + R+A + ++A
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 220 EYAIRGQVTRKADIYSFGVLLVEIVS 245
E T K+D++SFGV + EI +
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-17
Identities = 57/203 (28%), Positives = 106/203 (52%), Gaps = 19/203 (9%)
Query: 51 KIGEGGFGSVYKG--RLKDGKI-AAIKVLSAESRQGVK-EFLTEIQVISEIEHENLVKLY 106
++G G FG V KG +++ +I AIKVL E+ + V+ E + E +++ ++++ +V++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHH--YSNIQFSWRTRSRICIGIARGLAFLHE 164
G C E +LV L + L G SN+ + ++ G+ +L
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNV-------VELMHQVSMGMKYLEG 113
Query: 165 EVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT--IGYLAPEYA 222
+ + +HRD+ A N+LL KISDFGL+K + A+ ++ R AG + + APE
Sbjct: 114 K---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI 170
Query: 223 IRGQVTRKADIYSFGVLLVEIVS 245
+ + ++D++S+G+ + E S
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 58/210 (27%), Positives = 108/210 (51%), Gaps = 21/210 (10%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVK-EFLTEIQVISEIEHEN 101
D + + K+GEG + +VYKG+ K +GK+ A+KV+ + +G + E ++ ++H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIG--GGHHYSNIQFSWRTRSRICIGIARGL 159
+V L+ LV+ Y+ + L Q + GG H N++ + RGL
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTD-LCQYMDKHPGGLHPENVKL-------FLFQLLRGL 116
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL--AKLIPANMTHVSTRVAGTIGYL 217
+++H+ +I+HRD+K N+L+ K++DFGL AK +P +H + T+ Y
Sbjct: 117 SYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP---SHTYSNEVVTLWYR 170
Query: 218 APEYAI-RGQVTRKADIYSFGVLLVEIVSG 246
P+ + + + D++ G + VE++ G
Sbjct: 171 PPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 2e-17
Identities = 57/219 (26%), Positives = 108/219 (49%), Gaps = 27/219 (12%)
Query: 51 KIGEGGFGSVY----KGRLK-------------DGKIAAIKVLSAESRQGVK-EFLTEIQ 92
K+GEG FG V+ +G K + A+K+L ++ + + +FL EI+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 93 VISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLI-----GGGHHYSNIQFSWRT 147
++S ++ N+++L C+ + ++ Y+EN L Q L + S+ T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 148 RSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK-LIPANMTHV 206
+ IA G+ +L + +HRD+ N L+ K+ T KI+DFG+++ L + +
Sbjct: 132 LIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 207 STRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
R I +++ E + G+ T +D+++FGV L EI++
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 72/278 (25%), Positives = 114/278 (41%), Gaps = 36/278 (12%)
Query: 51 KIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVK-EFLTEIQVISEIEHENLVKLYGC 108
+IG G FG V+ GRL+ D A+K +K +FL E +++ + H N+V+L G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 109 CVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRP 168
C + +V ++ L G + ++ A G+ +L +
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPR-----LKVKELIQMVENAAAGMEYLESK--- 113
Query: 169 HIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT----IGYLAPEYAIR 224
H IHRD+ A N L+ + KISDFG+++ V G + + APE
Sbjct: 114 HCIHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNY 170
Query: 225 GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNG 284
G+ + ++D++SFG+LL E S L ++ RE I
Sbjct: 171 GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT------------REAI-----EQGV 213
Query: 285 DFDAEEAC--RFLKVGLLCTQDTPKLRPSMSTVVQMLM 320
E C ++ C + P RPS STV Q L
Sbjct: 214 RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 2e-17
Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 50 NKIGEGGFGSVYKGRLKDGKIAA---IKVLSAESRQGVKE---FLTEIQVISEIEHENLV 103
++IG G FG V G G A +K L A + E FL E+Q E+ H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVL 58
Query: 104 KLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH 163
+ G C+E +LV + L L + + R+ +A GL +LH
Sbjct: 59 QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK-DVLQRMACEVASGLLWLH 117
Query: 164 EEVRPHIIHRDIKASNILLDKDLTPKISDFGLA-KLIPANMTHVSTRVAGTIGYLAPEYA 222
+ IH D+ N L DL+ KI D+GLA + P + A + +LAPE
Sbjct: 118 ---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 223 -IRGQ------VTRKADIYSFGVLLVEI 243
IRGQ T+K++I+S GV + E+
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-17
Identities = 67/219 (30%), Positives = 107/219 (48%), Gaps = 49/219 (22%)
Query: 52 IGEGGFGSVYKGRLKDG---KI-AAIKVLSA-ESRQGVKEFLTEIQVISEIEHENLVKLY 106
IG+G FG VY G L D KI A+K L+ + V++FL E ++ + H N++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 107 GCCV--EGN-HRILVY-------NYL---ENNSLAQTLIGGGHHYSNIQFSWRTRSRICI 153
G C+ EG+ +L Y N++ +N + LIG G +
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFG-----------------L 105
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI-------PANMTHV 206
+A+G+ +L + +HRD+ A N +LD+ T K++DFGLA+ I N T
Sbjct: 106 QVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGA 162
Query: 207 STRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
V ++A E + T K+D++SFGVLL E+++
Sbjct: 163 KLPVK----WMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 4e-17
Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 28/209 (13%)
Query: 52 IGEGGFGSVYK----GRLKDGKI--AAIKVLSAESRQGVKEFL-TEIQVISEI-EHENLV 103
+G G FG V + G K + A+K+L + +E L +E++++S + HEN+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 104 KLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSN----IQFSWRTRSRICIGIARGL 159
L G C G +++ Y L L + + FS++ +A+G+
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQ--------VAKGM 154
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHV---STRVAGTIGY 216
AFL + + IHRD+ A N+LL KI DFGLA+ I + +V + R+ + +
Sbjct: 155 AFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP--VKW 209
Query: 217 LAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
+APE T ++D++S+G+LL EI S
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 4e-17
Identities = 66/208 (31%), Positives = 99/208 (47%), Gaps = 29/208 (13%)
Query: 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYG 107
+G+GGFG V +++ GK+ A K L + R+G L E Q++ ++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-- 65
Query: 108 CCVEGNHRILVYNYLENNSL--AQTLIGGG------HHYSNIQFSWRTRSRICIGIARGL 159
Y Y ++L TL+ GG +H F I GL
Sbjct: 66 ----------AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGL 115
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAP 219
LH+E I++RD+K NILLD +ISD GLA +P T + RV GT+GY+AP
Sbjct: 116 EDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAP 170
Query: 220 EYAIRGQVTRKADIYSFGVLLVEIVSGR 247
E + T D ++ G LL E+++G+
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 4e-17
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 15/205 (7%)
Query: 46 FSPINKIGEGGFGSVYKGRLK-DGKIAAIKVL--SAESRQGVKEFLTEIQVISEIEHENL 102
+ + KIGEG FG + K DGK IK + S S + +E E+ V+S ++H N+
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 103 VKLYGCCVEGNHRILVYNYLENNSLAQTLIGG-GHHYSNIQ-FSWRTRSRICIGIARGLA 160
V+ E + +V +Y E L + + G + Q W + IC+ L
Sbjct: 62 VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ--ICLA----LK 115
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPE 220
+H+ I+HRDIK+ NI L KD T K+ DFG+A+++ + + T + GT YL+PE
Sbjct: 116 HVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPE 171
Query: 221 YAIRGQVTRKADIYSFGVLLVEIVS 245
K+DI++ G +L E+ +
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 5e-17
Identities = 69/245 (28%), Positives = 118/245 (48%), Gaps = 29/245 (11%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIK--VLSAESRQGVKEFLTEIQVISEIEHE 100
+ + ++KIGEG +G V+K R ++ G+I AIK V S + K L EI+++ +++H
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 101 NLVKLYGCCVEGNHRILVYNYLEN---NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR 157
NLV L LV+ Y ++ N L + G H +I +
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEH---------LIKKIIWQTLQ 111
Query: 158 GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI---PANMT-HVSTRVAGT 213
+ F H+ + IHRD+K NIL+ K K+ DFG A+++ + T +V+TR
Sbjct: 112 AVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR---- 164
Query: 214 IGYLAPEYAI-RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTW-DLYER 271
Y APE + Q D+++ G + E+++G+ + ++ YL+ +T DL R
Sbjct: 165 -WYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR 223
Query: 272 RELIL 276
+ I
Sbjct: 224 HQQIF 228
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 6e-17
Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 46 FSPINKIGEGGFGSVYKGR-LKDGKIAAIKV--LSAESRQGVKEFLTEIQVISEIEHENL 102
F + KIGEG +G VYK R G++ A+K L E+ + EI ++ E+ H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 103 VKLYGCCVEGNHRILVYNYLENN--SLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
VKL N LV+ +L + G I+ S+ + + +GLA
Sbjct: 62 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK-SYLFQ------LLQGLA 114
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPE 220
F H ++HRD+K N+L++ + K++DFGLA+ + + V T+ Y APE
Sbjct: 115 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 170
Query: 221 YAIRGQVTRKA-DIYSFGVLLVEIVSGR 247
+ + A DI+S G + E+V+ R
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 6e-17
Identities = 65/232 (28%), Positives = 107/232 (46%), Gaps = 56/232 (24%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQ-GVKEFLTEIQVISEIEH-E 100
+D + +IG G FG+V K K G I A+K + + + K L ++ V+
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63
Query: 101 NLVKLYG-------C--CVE------GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSW 145
+VK YG C C+E VY L++ + + ++G
Sbjct: 64 YIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSV-IPEEILG------------ 110
Query: 146 RTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA-KLIPANMT 204
+I + + L +L EE+ IIHRD+K SNILLD++ K+ DFG++ +L+ +
Sbjct: 111 ----KIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD---S 161
Query: 205 HVSTRVAGTIGYLAPE---------YAIRGQVTRKADIYSFGVLLVEIVSGR 247
TR AG Y+APE Y +R +D++S G+ L E+ +G+
Sbjct: 162 IAKTRDAGCRPYMAPERIDPSARDGYDVR------SDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 7e-17
Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 31/208 (14%)
Query: 52 IGEGGFGSVYKGRLK-DGKIAAIKVLS----AESRQGVKEFLTEIQVISEIEHENLVKLY 106
+G GGFG V ++K + A+K + E+ Q + +E +++ E H +VKLY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECNHPFIVKLY 59
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQ----FSWRTRSRICIG-IARGLAF 161
+ + +Y +E GG ++ ++ F T +R I + +
Sbjct: 60 RTFKDKKY---IYMLME-------YCLGGELWTILRDRGLFDEYT-ARFYIACVVLAFEY 108
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI-PANMTHVSTRVAGTIGYLAPE 220
LH II+RD+K N+LLD + K+ DFG AK + T GT Y+APE
Sbjct: 109 LHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPE 162
Query: 221 YAIRGQ-VTRKADIYSFGVLLVEIVSGR 247
I + D +S G+LL E+++GR
Sbjct: 163 -IILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 75/297 (25%), Positives = 131/297 (44%), Gaps = 42/297 (14%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLKD-------GKIAAIKVLSAESRQGVKEFLTEIQV 93
++ + + + ++G+G FG VY+G +D ++A V + S + EFL E V
Sbjct: 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 62
Query: 94 ISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFS----WRTRS 149
+ ++V+L G +G ++V + + L L N +
Sbjct: 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122
Query: 150 RICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTR 209
++ IA G+A+L+ + +HRD+ A N ++ D T KI DFG+ + I + R
Sbjct: 123 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY---R 176
Query: 210 VAGT----IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERT 265
G + ++APE G T +D++SFGV+L EI S L E+
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQP 221
Query: 266 WD-LYERRELILLVDTSLNGDFDAEEAC--RFLKVGLLCTQDTPKLRPSMSTVVQML 319
+ L + L ++D G D + C R + +C Q PK+RP+ +V +L
Sbjct: 222 YQGLSNEQVLKFVMD---GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 17/202 (8%)
Query: 51 KIGEGGFGSVYKG---RLKDGKIAAIKVLSAESR-QGVK-EFLTEIQVISEIEHENLVKL 105
++G G FG+V KG K K A+K+L ++ +K E L E V+ ++++ +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 106 YGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEE 165
G C E +LV E L + L N + + + + ++ G+ +L E
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFL------QKNKHVTEKNITELVHQVSMGMKYLEET 114
Query: 166 VRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT--IGYLAPEYAI 223
+ +HRD+ A N+LL KISDFGL+K + A+ + + G + + APE
Sbjct: 115 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN 171
Query: 224 RGQVTRKADIYSFGVLLVEIVS 245
+ + K+D++SFGVL+ E S
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 28/213 (13%)
Query: 52 IGEGGFGSVYKGRLK-DGKI--AAIKVLSA-ESRQGVKEFLTEIQVISEI-EHENLVKLY 106
IGEG FG V + +K DG AAIK+L S ++F E++V+ ++ H N++ L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 107 GCCVEGNHRILVYNYLENNSLAQTL----------IGGGHHYSNIQFSWRTRSRICIGIA 156
G C + + Y +L L H + + + + +A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 157 RGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK----LIPANMTHVSTRVAG 212
G+ +L E+ IHRD+ A N+L+ ++L KI+DFGL++ + M + R
Sbjct: 130 TGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR--- 183
Query: 213 TIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
++A E T K+D++SFGVLL EIVS
Sbjct: 184 ---WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 76/283 (26%), Positives = 128/283 (45%), Gaps = 35/283 (12%)
Query: 52 IGEGGFGSVYKGRL-KDG--KIAAIKVLSA-ESRQGVKEFLTEIQVISEI-EHENLVKLY 106
IGEG FG V K R+ KDG AAIK + S+ ++F E++V+ ++ H N++ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIG----------IA 156
G C + L Y + +L L ++ F+ + + +A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 157 RGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGY 216
RG+ +L ++ IHRD+ A NIL+ ++ KI+DFGL++ + R+ + +
Sbjct: 135 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP--VRW 189
Query: 217 LAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL 276
+A E T +D++S+GVLL EIVS + E LYE+
Sbjct: 190 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------LYEKLPQGY 240
Query: 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319
++ LN D + + R C ++ P RPS + ++ L
Sbjct: 241 RLEKPLNCDDEVYDLMR------QCWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 61/232 (26%), Positives = 102/232 (43%), Gaps = 40/232 (17%)
Query: 46 FSPINK-IGEGGFGSVYKGR-LKDGKIAAIKVLSA--------ESRQGVKE------FLT 89
+ +GEG +G V K GKI AIK + + RQ V L
Sbjct: 10 YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69
Query: 90 EIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRS 149
E+++++EI+HEN++ L VEG+ LV + + ++ L + + I+ +
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASD-LKKVV------DRKIRLTESQVK 122
Query: 150 RICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA------------- 196
I + I GL LH+ + +HRD+ +NI ++ KI+DFGLA
Sbjct: 123 CILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179
Query: 197 KLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKA-DIYSFGVLLVEIVSGR 247
K T T+ Y APE + + A D++S G + E+++G+
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-16
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 20/209 (9%)
Query: 52 IGEGGFGSVYKGRLKDGKI---AAIKVLSA-ESRQGVKEFLTEIQVISEI-EHENLVKLY 106
IGEG FG V K R+K + AAIK + S+ ++F E++V+ ++ H N++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 107 GCCVEGNHRILVYNYLENNSLAQTL----------IGGGHHYSNIQFSWRTRSRICIGIA 156
G C + L Y + +L L + + S + +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 157 RGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGY 216
RG+ +L ++ IHRD+ A NIL+ ++ KI+DFGL++ + R+ + +
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP--VRW 177
Query: 217 LAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
+A E T +D++S+GVLL EIVS
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 61/233 (26%), Positives = 116/233 (49%), Gaps = 26/233 (11%)
Query: 52 IGEGGFGSVY--------KGRLKDGKIAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHEN 101
+GEG FG V K + K+ A+K+L + + + + + ++E++++ I +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGG---GHHYS-------NIQFSWRTRSRI 151
++ L G C + ++ Y +L + L G YS + Q +++
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 152 CIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVA 211
+ARG+ +L + IHRD+ A N+L+ ++ KI+DFGLA+ + N+ +
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDV-NNIDYYKKTTN 198
Query: 212 G--TIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLL 262
G + ++APE T ++D++SFGVL+ EI + + +P EE + L
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-16
Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 23/208 (11%)
Query: 52 IGEGGFGSVYKGRLKD-GKIAAIKVL-----SAESRQGVKEFLTEIQVISEIEHENLVKL 105
+G+G FG VY D G+ A+K + S E+ + V EIQ++ + HE +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 106 YGCCVEGNHRIL--VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH 163
YGC + R L ++ S+ L G N+ R +R I G+++LH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVT---RKYTR---QILEGVSYLH 123
Query: 164 EEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK---LIPANMTHVSTRVAGTIGYLAPE 220
+ I+HRDIK +NIL D K+ DFG +K I + T + + V GT +++PE
Sbjct: 124 SNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMSPE 179
Query: 221 YAIRGQ-VTRKADIYSFGVLLVEIVSGR 247
I G+ RKADI+S G +VE+++ +
Sbjct: 180 -VISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 4e-16
Identities = 65/209 (31%), Positives = 97/209 (46%), Gaps = 33/209 (15%)
Query: 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQV-ISEIEHENLVKLY 106
IG+G FG V + K DGK A+KVL ++ ++ K + E V + ++H LV L+
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 107 GCCVEGNHRILVYNYLENNSLAQTL--IGGGHHYSNIQ----FSWRTRSRICIG-IARGL 159
Y++ + L L + GG + ++Q F R+R IA L
Sbjct: 63 ------------YSFQTADKLYFVLDYVNGGELFFHLQRERSFP-EPRARFYAAEIASAL 109
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVST--RVAGTIGYL 217
+LH +II+RD+K NILLD ++DFGL K + H T GT YL
Sbjct: 110 GYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYL 163
Query: 218 APEYAIRGQVTRKADIYSFGVLLVEIVSG 246
APE + R D + G +L E++ G
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 5e-16
Identities = 56/207 (27%), Positives = 106/207 (51%), Gaps = 16/207 (7%)
Query: 52 IGEGGFGSVYKGRLK----DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKL 105
+G+G FGSV + +LK + A+K+L A+ S ++EFL E + E +H N++KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 106 YGCCVEGNHR------ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGL 159
G + + +++ ++++ L L+ +T R I IA G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAG-TIGYLA 218
+L + + IHRD+ A N +L++++T ++DFGL+K I + + + + +LA
Sbjct: 127 EYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 219 PEYAIRGQVTRKADIYSFGVLLVEIVS 245
E T +D+++FGV + EI++
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 81/340 (23%), Positives = 147/340 (43%), Gaps = 52/340 (15%)
Query: 52 IGEGGFGSVY--------KGRLKDGKIAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHEN 101
+GEG FG V K + A+K+L + + + + + ++E++++ I +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIG---GGHHYS-------NIQFSWRTRSRI 151
++ L G C + ++ Y +L + L G YS Q +++
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 152 CIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVA 211
+ARG+ +L + IHRD+ A N+L+ +D KI+DFGLA+ + N+ +
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDV-HNIDYYKKTTN 195
Query: 212 G--TIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLY 269
G + ++APE T ++D++SFGVLL EI + + +P EE + L L
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL-----LK 250
Query: 270 ERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKDIDDDK 329
E + D N + R C P RP+ +V+ D D+
Sbjct: 251 EGHRM----DKPANCTHELYMIMR------ECWHAVPSQRPTFKQLVE--------DLDR 292
Query: 330 ITKPGLISDFMDLKVRGPPKPKLETTTSSTYNSSDNPDNS 369
+ +++DL V P + + +S + D+S
Sbjct: 293 VLTVTSTDEYLDLSV---PFEQYSPGCPDSPSSCSSGDDS 329
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 6e-16
Identities = 65/209 (31%), Positives = 110/209 (52%), Gaps = 32/209 (15%)
Query: 52 IGEGGFGSVYKG-RLKDG---KI-AAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKL 105
+G G FG+VYKG + DG KI AIKVL S + KE L E V++ + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 106 YGCCVEGNHRIL--------VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR 157
G C+ +++ + +Y+ N + IG S +W C+ IA+
Sbjct: 75 LGICLTSTVQLVTQLMPYGCLLDYVREN---KDRIG-----SQDLLNW------CVQIAK 120
Query: 158 GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT-IGY 216
G+++L EEVR ++HRD+ A N+L+ KI+DFGLA+L+ + T I +
Sbjct: 121 GMSYL-EEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 177
Query: 217 LAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
+A E + + T ++D++S+GV + E+++
Sbjct: 178 MALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 6e-16
Identities = 61/221 (27%), Positives = 111/221 (50%), Gaps = 24/221 (10%)
Query: 49 INKIGEGGFGSVYKG-RLKDGKIA----AIKVLSAESRQGVK-EFLTEIQVISEIEHENL 102
+ +G G FG+VYKG + +G+ AIK+L+ + EF+ E +++ ++H +L
Sbjct: 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71
Query: 103 VKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQ----FSWRTRSRICIGIARG 158
V+L G C+ + LV + + L + H NI +W C+ IA+G
Sbjct: 72 VRLLGVCLSPTIQ-LVTQLMPHGCLLDYV---HEHKDNIGSQLLLNW------CVQIAKG 121
Query: 159 LAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT-IGYL 217
+ +L E ++HRD+ A N+L+ KI+DFGLA+L+ + + I ++
Sbjct: 122 MMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM 178
Query: 218 APEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEE 258
A E + T ++D++S+GV + E+++ +PT E
Sbjct: 179 ALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 219
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 7e-16
Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 52 IGEGGFGSVY------KGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKL 105
+G G FG VY GR K S E+ + V EIQ++ + H+ +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 106 YGCCVEGNHRIL--VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH 163
YGC + + L Y+ S+ L G N+ TR R I +G+++LH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV-----TR-RYTRQILQGVSYLH 123
Query: 164 EEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA-NMTHVSTR-VAGTIGYLAPEY 221
+ I+HRDIK +NIL D K+ DFG +K I M+ + V GT +++PE
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE- 179
Query: 222 AIRGQ-VTRKADIYSFGVLLVEIVS 245
I G+ RKAD++S +VE+++
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 7e-16
Identities = 67/204 (32%), Positives = 98/204 (48%), Gaps = 23/204 (11%)
Query: 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVIS-EIEHENLVKLY 106
+G+G FG V RLK G++ A+KVL + V+ +TE +++S H L +LY
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWR---TRSRICIG-IARGLAFL 162
CC + R+ + GG +IQ S R R+R I L FL
Sbjct: 63 -CCFQTPDRLF---------FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFL 112
Query: 163 HEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYA 222
H++ II+RD+K N+LLD + K++DFG+ K N ST GT Y+APE
Sbjct: 113 HDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEIL 168
Query: 223 IRGQVTRKADIYSFGVLLVEIVSG 246
D ++ GVLL E++ G
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 7e-16
Identities = 64/210 (30%), Positives = 95/210 (45%), Gaps = 34/210 (16%)
Query: 48 PINKIGEGGFGSVYKGRLK-DGKIAAIKVL---SAESRQGVKEFLTEIQVI-SEIEHENL 102
PI+K G FGSVY + + G AIKVL ++ V E ++ + E +
Sbjct: 3 PISK---GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYV 59
Query: 103 VKLYGCCVEGNHRILVYNYLENN---SLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR-- 157
KLY ++ LV YL SL +TL GG + W IA
Sbjct: 60 AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL--GG-----LPEDW-----AKQYIAEVV 107
Query: 158 -GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGY 216
G+ LH+ IIHRDIK N+L+D+ K++DFGL++ + + GT Y
Sbjct: 108 LGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDY 159
Query: 217 LAPEYAIRGQVTRKADIYSFGVLLVEIVSG 246
LAPE + + +D +S G ++ E + G
Sbjct: 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 33/218 (15%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKDGKI-AAIKVLSA--ESRQGVKEFLTEIQVISEIEHE 100
D + ++ +G G +G V AIK LS +S K E++++ ++HE
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 101 NLVKLYGCCVEGNHR------ILVYNYLE---NNSLAQTLIGGGHHYSNIQFSWRTRSRI 151
N++ L + LV + + NN + + H IQF +
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDH----IQF-------L 123
Query: 152 CIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT-HVSTRV 210
I RGL ++H IIHRD+K SNI +++D KI DFGLA+ MT +V+TR
Sbjct: 124 VYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR- 179
Query: 211 AGTIGYLAPEYAI-RGQVTRKADIYSFGVLLVEIVSGR 247
Y APE + + DI+S G ++ E+++G+
Sbjct: 180 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 8e-16
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 46 FSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENL 102
+ I +G G FG V+ R K D K+ IK + E ++ E QV+ + H N+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 103 VKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFL 162
++ Y +E ++V Y +LA+ + + T + I L +
Sbjct: 62 IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL----LDEDTILHFFVQILLALHHV 117
Query: 163 HEEVRPHIIHRDIKASNILLDK-DLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEY 221
H ++ I+HRD+K NILLDK + KI DFG++K++ ++ + T V GT Y++PE
Sbjct: 118 HTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYT-VVGTPCYISPEL 172
Query: 222 AIRGQVTRKADIYSFGVLLVEIVS 245
+K+DI++ G +L E+ S
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 1e-15
Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 46 FSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENLV 103
F + +G G +G VYKGR +K G++AAIKV+ + +E EI ++ + H N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66
Query: 104 KLYGCCVEGN------HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR 157
YG ++ N LV + S+ + + ++ W + IC I R
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWI--AYICREILR 122
Query: 158 GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYL 217
GL+ LH+ +IHRDIK N+LL ++ K+ DFG++ + + +T + GT ++
Sbjct: 123 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWM 178
Query: 218 APEYAI-----RGQVTRKADIYSFGVLLVEIVSG 246
APE K+D++S G+ +E+ G
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 23/206 (11%)
Query: 46 FSPINKIGEGGFGSVY-KGRLKDGKIAAIKVLSAESRQ---GVKEFLTEIQVISEIEHEN 101
F +++IG G FG+VY ++ A+K +S +Q ++ + E++ + +++H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
++ GC ++ + LV Y S + L ++ + T G +GLA+
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITH-----GALQGLAY 136
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI-PANMTHVSTRVAGTIGYLAPE 220
LH ++IHRDIKA NILL + K++DFG A PAN GT ++APE
Sbjct: 137 LHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN------SFVGTPYWMAPE 187
Query: 221 YAI---RGQVTRKADIYSFGVLLVEI 243
+ GQ K D++S G+ +E+
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 22/214 (10%)
Query: 45 DFSPINKIGEGGFGSVY----KGRLKDGKIAAIKVLS----AESRQGVKEFLTEIQVISE 96
+F + +G G +G V+ G GK+ A+KVL + + + TE QV+
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 97 IEHEN-LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIG- 154
+ LV L+ L+ +Y+ L H Y F+ + R+ I
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFT------HLYQREHFT-ESEVRVYIAE 113
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTI 214
I L LH+ II+RDIK NILLD + ++DFGL+K A + GTI
Sbjct: 114 IVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTI 170
Query: 215 GYLAPEYAIRGQV--TRKADIYSFGVLLVEIVSG 246
Y+APE G + D +S GVL E+++G
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 25/211 (11%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKDG------KIAAI-KVLSAESRQGVKEFLTEIQVISE 96
DD I +G G FG V+ R + K+ AI +V+ + Q V E +V+ E
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVH---NEKRVLKE 57
Query: 97 IEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIA 156
+ H +++L+ + ++ Y+ L L G +SN + +C
Sbjct: 58 VSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR-FSNSTGLFYASEIVC---- 112
Query: 157 RGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK-LIPANMTHVSTRVAGTIG 215
L +LH + I++RD+K NILLDK+ K++DFG AK L T + GT
Sbjct: 113 -ALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT-----LCGTPE 163
Query: 216 YLAPEYAIRGQVTRKADIYSFGVLLVEIVSG 246
YLAPE + D ++ G+L+ E++ G
Sbjct: 164 YLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 61/227 (26%), Positives = 114/227 (50%), Gaps = 25/227 (11%)
Query: 38 ELSIATDDFSPINKIGEGGFGSVYKGRL------KDGKIAAIKVLSAESRQGVKE-FLTE 90
E++++T F + ++GE FG VYKG L + + AIK L ++ ++E F E
Sbjct: 1 EINLSTVRF--MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 91 IQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRS- 149
+ S ++H N+V L G + ++++Y ++ L + L+ H S++ + ++
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPH-SDVGSTDDDKTV 117
Query: 150 ----------RICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199
I IA G+ FL H++H+D+ N+L+ L KISD GL + +
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREV 174
Query: 200 -PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
A+ + I +++PE + G+ + +DI+S+GV+L E+ S
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 62/218 (28%), Positives = 109/218 (50%), Gaps = 23/218 (10%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAES-RQGVK-EFLTEIQVISEIEHE 100
D F I +IGEG +G VYK R KD G++ A+K + ++ ++G + EI+++ ++ H
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66
Query: 101 NLVKLYGCCVEGNHRI----------LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSR 150
N+V L + + LV+ Y++++ L L G H+S +
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHD-LMGLLESGLVHFSEDHIKSFMKQ- 124
Query: 151 ICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRV 210
+ GL + H++ + +HRDIK SNILL+ K++DFGLA+L + + T
Sbjct: 125 ----LLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177
Query: 211 AGTIGYLAPEYAI-RGQVTRKADIYSFGVLLVEIVSGR 247
T+ Y PE + + D++S G +L E+ + +
Sbjct: 178 VITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 26/215 (12%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLK--DGKIAAIKVLSAESRQGV-KEFLTEIQVISEIEHE 100
D + + KIGEG +G VYK R + + IA K+ + +GV + EI ++ E++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 101 NLVKLYGCCVEGNHRI-LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTR--SRICIGIAR 157
N+V+L V R+ LV+ YL+ L H S+ F+ R I R
Sbjct: 62 NIVRLQD-VVHSEKRLYLVFEYLD-------LDLKKHMDSSPDFAKNPRLIKTYLYQILR 113
Query: 158 GLAFLHEEVRPHIIHRDIKASNILLDKDL-TPKISDFGLAKL--IPA-NMTHVSTRVAGT 213
G+A+ H ++HRD+K N+L+D+ K++DFGLA+ IP TH T
Sbjct: 114 GIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----T 166
Query: 214 IGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGR 247
+ Y APE + + DI+S G + E+V+ +
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 46 FSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENLV 103
F + +G G +G VYKGR +K G++AAIKV+ + +E EI ++ + H N+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIA 76
Query: 104 KLYGCCVE------GNHRILVYNYLENNS---LAQTLIGGGHHYSNIQFSWRTRSRICIG 154
YG ++ + LV + S L + G I + IC
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-------ICRE 129
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTI 214
I RGLA LH +IHRDIK N+LL ++ K+ DFG++ + + +T + GT
Sbjct: 130 ILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTP 185
Query: 215 GYLAPEYAI-----RGQVTRKADIYSFGVLLVEIVSG 246
++APE ++DI+S G+ +E+ G
Sbjct: 186 YWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 71/204 (34%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 52 IGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQVIS-EIEHENLVKLY 106
+G+G FG V LK + AIK L + V+ + E +V++ EH L L+
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 107 GCCVEGN-HRILVYNYLENNSLAQTLIGGGHHYSNIQFS-WRTRSRICIGIARGLAFLHE 164
C + H V YL L H S+ +F R R I GL FLH+
Sbjct: 63 -CTFQTKEHLFFVMEYLNGGDLMF------HIQSSGRFDEARARFYAA-EIICGLQFLHK 114
Query: 165 EVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIR 224
+ II+RD+K N+LLDKD KI+DFG+ K ST GT Y+APE ++
Sbjct: 115 K---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPE-ILK 169
Query: 225 GQ-VTRKADIYSFGVLLVEIVSGR 247
GQ D +SFGVLL E++ G+
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 29/208 (13%)
Query: 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYG 107
+G+GGFG V +++ GK+ A K L + R+G L E Q++ ++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-- 65
Query: 108 CCVEGNHRILVYNYLENNSLAQ--TLIGGG------HHYSNIQFSWRTRSRICIGIARGL 159
Y Y ++L TL+ GG ++ N F I GL
Sbjct: 66 ----------AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGL 115
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAP 219
LH E I++RD+K NILLD +ISD GLA IP T + RV GT+GY+AP
Sbjct: 116 EDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAP 170
Query: 220 EYAIRGQVTRKADIYSFGVLLVEIVSGR 247
E + T D + G L+ E++ G+
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 45 DFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHE 100
DF + ++G+GG+G V+ + KD G+I A+K + V+ LTE +++ + E
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
LVKL + + L Y+ L G + R + + +
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED-----HARFYM-AEMFEAVD 115
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPE 220
LH IHRD+K N L+D K++DFGL+K + + V G+ Y+APE
Sbjct: 116 ALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPE 168
Query: 221 YAIRGQ-VTRKADIYSFGVLLVEIVSG 246
+RG+ D +S G +L E + G
Sbjct: 169 -VLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 58/219 (26%), Positives = 104/219 (47%), Gaps = 30/219 (13%)
Query: 44 DDFSPINKIGEGGFGSVYKG-RLKDGKIAAIKVLSAESR--QGVKEFLTEIQVISEIEHE 100
+ PI IG G +G V + GK AIK + K L E++++ +H+
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 101 NLVKLYGCC-VEGNHRILVYNYLENNSLAQTLIGGGHH--YSNIQFSWRTRSRICIGIAR 157
N++ + G VY ++ L ++ + HH +S+ + + R
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMD---LMESDL---HHIIHSDQPLTEEHIRYFLYQLLR 118
Query: 158 GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN-------MT-HVSTR 209
GL ++H ++IHRD+K SN+L+++D +I DFG+A+ + ++ MT +V+TR
Sbjct: 119 GLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175
Query: 210 VAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGR 247
Y APE + + T D++S G + E++ GR
Sbjct: 176 -----WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GR 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 74/293 (25%), Positives = 130/293 (44%), Gaps = 40/293 (13%)
Query: 41 IATDDFSPINKIGEGGFGSVY----KGRLKD---GKIAAIKVLSAESRQGVKEFLTEIQV 93
+A + + ++G+G FG VY KG +KD ++A V A S + EFL E V
Sbjct: 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 62
Query: 94 ISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTL--IGGGHHYSNIQFSWRTRSRI 151
+ E ++V+L G +G +++ + L L + + +Q + I
Sbjct: 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 152 CIG--IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTR 209
+ IA G+A+L+ +HRD+ A N ++ +D T KI DFG+ + I + R
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY---R 176
Query: 210 VAGT----IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERT 265
G + +++PE G T +D++SFGV+L EI + L E+
Sbjct: 177 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQP 221
Query: 266 WDLYERRELILLVDTSLNGDFDAEEAC--RFLKVGLLCTQDTPKLRPSMSTVV 316
+ +++ V G D + C ++ +C Q PK+RPS ++
Sbjct: 222 YQGMSNEQVLRFVMEG--GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 43 TDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGV--KEFLTEIQVISEIEH 99
T+ + + +G G FG V R G+ AIK + V K E++++ + H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGL 159
EN++ L + I L L + L IQ+ I RGL
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQY-------FLYQILRGL 121
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT-HVSTRVAGTIGYLA 218
++H ++HRD+K SNIL++++ KI DFGLA++ MT +VSTR Y A
Sbjct: 122 KYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRA 173
Query: 219 PEYAIRGQ-VTRKADIYSFGVLLVEIVSGR 247
PE + Q + DI+S G + E++ G+
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 46 FSPINKIGEGGFGSVYKGR-LKDGK--IAAIKVLSAESRQGVK-EFLTEIQVISEIE--- 98
+ + +IGEG +G V+K R LK+G +A +V +G+ + E+ V+ +E
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 99 HENLVKLYGCC-VEGNHR----ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICI 153
H N+V+L+ C V R LV+ +++ Q L T +
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVD-----QDLTTYLDKVPEPGVPTETIKDMMF 117
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213
+ RGL FLH ++HRD+K NIL+ K++DFGLA++ M T V T
Sbjct: 118 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVT 172
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
+ Y APE ++ D++S G + E+ +
Sbjct: 173 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 53/216 (24%), Positives = 105/216 (48%), Gaps = 20/216 (9%)
Query: 37 KELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKE-----FLTEI 91
++ + +DF+ I +G G FG V K+ + + E + +K+ +E
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82
Query: 92 QVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRI 151
++++ I H V LYG + ++ LV + + GG ++ ++ + R + +
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEF----------VIGGEFFTFLRRNKRFPNDV 132
Query: 152 CIGIARGLAFLHEEVRP-HIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRV 210
A + + E ++ +I++RD+K N+LLDKD K++DFG AK++ + +
Sbjct: 133 GCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTL 188
Query: 211 AGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSG 246
GT Y+APE + + AD ++ G+ + EI+ G
Sbjct: 189 CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-15
Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 45 DFSPINKIGEGGFGSVYKGR-LKDGKIAAIK------VLSAESRQGVKEFLTEIQVISEI 97
+F KIG G F VY+ L DG A+K ++ A++R + + EI ++ ++
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQL 59
Query: 98 EHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQ--FSWRTRSRICIGI 155
H N++K Y +E N +V + L++ + H+ + +T + + +
Sbjct: 60 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMI----KHFKKQKRLIPEKTVWKYFVQL 115
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIG 215
L +H ++HRDIK +N+ + K+ D GL + + T + V GT
Sbjct: 116 CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPY 171
Query: 216 YLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
Y++PE K+DI+S G LL E+ +
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 5e-15
Identities = 65/201 (32%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVIS-EIEHENLVKLY 106
+G+G FG V+ LK + AIK L + V+ + E +V+S EH L LY
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV 166
+ V YL L I H + + ++ IC GL FLH +
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFH-IQSCHKFDLPRATFYAAEIIC-----GLQFLHSK- 115
Query: 167 RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQ 226
I++RD+K NILLD D KI+DFG+ K T GT Y+APE + +
Sbjct: 116 --GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLGQK 172
Query: 227 VTRKADIYSFGVLLVEIVSGR 247
D +SFGVLL E++ G+
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 6e-15
Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 35/215 (16%)
Query: 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHE 100
DF +G G FG V + K G+ AIK L + V+ E ++ E+ H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
+V + C + +R VY LE + GG ++++ R R +A+
Sbjct: 79 FIVNMM-CSFQDENR--VYFLLE-------FVVGGELFTHL----RKAGRFPNDVAK--- 121
Query: 161 FLHEEV--------RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAG 212
F H E+ II+RD+K N+LLD K++DFG AK +P + + G
Sbjct: 122 FYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCG 177
Query: 213 TIGYLAPEYAIRGQVTRKA-DIYSFGVLLVEIVSG 246
T YLAPE I+ + KA D ++ GVLL E ++G
Sbjct: 178 TPEYLAPE-VIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 7e-15
Identities = 60/220 (27%), Positives = 106/220 (48%), Gaps = 32/220 (14%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEH-E 100
DD I ++G G +G V K R G I A+K + A + Q K L ++ +
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60
Query: 101 NLVKLYGCCV-EGNHRILVYNYLE--NNSLAQTLIGGGHHYSNIQFSWRT-----RSRIC 152
V YG EG+ V+ +E + SL + Y + T +I
Sbjct: 61 YTVTFYGALFREGD----VWICMEVMDTSLDK-------FYKKVYDKGLTIPEDILGKIA 109
Query: 153 IGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAG 212
+ I + L +LH ++ +IHRD+K SN+L++++ K+ DFG++ + ++ T AG
Sbjct: 110 VSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV--AKTIDAG 165
Query: 213 TIGYLAPEYAIRGQVTR-----KADIYSFGVLLVEIVSGR 247
Y+APE I ++ + K+D++S G+ ++E+ +GR
Sbjct: 166 CKPYMAPE-RINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 8e-15
Identities = 57/204 (27%), Positives = 103/204 (50%), Gaps = 17/204 (8%)
Query: 49 INKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVK-EFLTEIQVISEIEHENLVKLY 106
+ K+GEG + +V+KGR K + A+K + E +G + E+ ++ +++H N+V L+
Sbjct: 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYS--NIQFSWRTRSRICIGIARGLAFLHE 164
LV+ YL+ + L Q + G+ S N++ I RGLA+ H
Sbjct: 71 DIVHTDKSLTLVFEYLDKD-LKQYMDDCGNIMSMHNVKI-------FLYQILRGLAYCH- 121
Query: 165 EVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAI- 223
R ++HRD+K N+L+++ K++DFGLA+ S V T+ Y P+ +
Sbjct: 122 --RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLG 178
Query: 224 RGQVTRKADIYSFGVLLVEIVSGR 247
+ + + D++ G + E+ SGR
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 63/207 (30%), Positives = 93/207 (44%), Gaps = 26/207 (12%)
Query: 49 INKIGEGGFGSVYKGR-LKDGKIAAIKVLSA--ESRQGVKEFLTEIQVISEIE-HENLVK 104
+ KIGEG F V K + K GK AIK + +S + V L EIQ + + H N+++
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSPHPNILR 62
Query: 105 LYGCCVEGNHR--ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFL 162
L + LV+ ++ N LI G + + + L +
Sbjct: 63 LIEVLFDRKTGRLALVFELMDMN--LYELIKGRKRP----LPEKRVKSYMYQLLKSLDHM 116
Query: 163 HEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI---PANMTHVSTRVAGTIGYLAP 219
H R I HRDIK NIL+ D+ K++DFG + I P ++STR Y AP
Sbjct: 117 H---RNGIFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPYTEYISTR-----WYRAP 167
Query: 220 EYAIR-GQVTRKADIYSFGVLLVEIVS 245
E + G K DI++ G + EI+S
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 67/230 (29%), Positives = 116/230 (50%), Gaps = 45/230 (19%)
Query: 32 KLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVK-EFLT 89
KL +YK+L +K+GEG + +VYKGR K G++ A+K + E +G +
Sbjct: 3 KLETYKKL----------DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR 52
Query: 90 EIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTL--IGGGHHYSNIQ-FSWR 146
E ++ +++H N+V L+ LV+ YL+ + L Q + GGG N++ F ++
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTD-LKQYMDDCGGGLSMHNVRLFLFQ 111
Query: 147 TRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL--AKLIPANMT 204
+ RGLA+ H + ++HRD+K N+L+ + K++DFGL AK +P+ T
Sbjct: 112 --------LLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-T 159
Query: 205 HVSTRVAGTIGYLAP-------EYAIRGQVTRKADIYSFGVLLVEIVSGR 247
+ + V T+ Y P EY + D++ G + E+ +GR
Sbjct: 160 YSNEVV--TLWYRPPDVLLGSTEY------STSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 57/206 (27%), Positives = 104/206 (50%), Gaps = 21/206 (10%)
Query: 49 INKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVK-EFLTEIQVISEIEHENLVKLY 106
++K+GEG + +VYKGR K + A+K + E +G + E+ ++ +++H N+V L+
Sbjct: 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGH--HYSNIQFSWRTRSRICIGIARGLAFLHE 164
LV+ YL+ + L Q L G+ + N++ + RGL + H
Sbjct: 71 DIIHTEKSLTLVFEYLDKD-LKQYLDDCGNSINMHNVKL-------FLFQLLRGLNYCH- 121
Query: 165 EVRPHIIHRDIKASNILLDKDLTPKISDFGL--AKLIPANMTHVSTRVAGTIGYLAPEYA 222
R ++HRD+K N+L+++ K++DFGL AK IP T + T+ Y P+
Sbjct: 122 --RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP---TKTYSNEVVTLWYRPPDIL 176
Query: 223 I-RGQVTRKADIYSFGVLLVEIVSGR 247
+ + + D++ G + E+ +GR
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 56/230 (24%), Positives = 96/230 (41%), Gaps = 43/230 (18%)
Query: 49 INKIGEGGFGSVYKGRLK--DGKIAAIKVLS--AESRQGVKEFLTEIQVISEIEHENLVK 104
I IG+GG G VY ++A K+ +E+ K FL E ++ +++ H +V
Sbjct: 7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 105 LYGCCVEGNHRILVY---NYLENNSLAQTL--------IGGGHHYSNIQFSWRTRSRICI 153
+Y C +G+ VY Y+E +L L + + S I
Sbjct: 67 VYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELA---EKTSVGAFLSIFH 120
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA------------ 201
I + ++H + ++HRD+K NILL I D+G A
Sbjct: 121 KICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 202 ------NMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
+MT + ++ GT Y+APE + + DIY+ GV+L ++++
Sbjct: 178 RNICYSSMT-IPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 56/204 (27%), Positives = 104/204 (50%), Gaps = 17/204 (8%)
Query: 49 INKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVK-EFLTEIQVISEIEHENLVKLY 106
++K+GEG + +V+KGR K + A+K + E +G + E+ ++ ++H N+V L+
Sbjct: 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLH 69
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYS--NIQFSWRTRSRICIGIARGLAFLHE 164
LV+ YL+++ L Q L G+ S N++ + RGL++ H+
Sbjct: 70 DIIHTERCLTLVFEYLDSD-LKQYLDNCGNLMSMHNVKI-------FMFQLLRGLSYCHK 121
Query: 165 EVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAI- 223
I+HRD+K N+L+++ K++DFGLA+ S V T+ Y P+ +
Sbjct: 122 R---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLG 177
Query: 224 RGQVTRKADIYSFGVLLVEIVSGR 247
+ + D++ G +L E+ +GR
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 68/233 (29%), Positives = 105/233 (45%), Gaps = 25/233 (10%)
Query: 29 HNVKLYSYKELSIATDDFSPINKIGEGGFGSVYK-GRLKDGKIAAIKVLSAESRQGVKEF 87
+N + + L TD + I IG+G +G VYK KDG +AA+K+L S +E
Sbjct: 7 YNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEI 65
Query: 88 LTEIQVISEI-EHENLVKLYGCCVEGNHRI-----LVYNYLENNS---LAQTLIGGGHHY 138
E ++ + H N+VK YG + + + LV S L + L+ G
Sbjct: 66 EAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRL 125
Query: 139 SNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198
S+ I G GL LH IIHRD+K +NILL + K+ DFG++
Sbjct: 126 DEAMISY-----ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177
Query: 199 IPANMTHVSTRVAGTIGYLAPEYAIRGQ-----VTRKADIYSFGVLLVEIVSG 246
+ + +T V GT ++APE Q + D++S G+ +E+ G
Sbjct: 178 LTSTRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 63/236 (26%), Positives = 115/236 (48%), Gaps = 32/236 (13%)
Query: 52 IGEGGFGSVYKG------RLKDGKIA--AIKVLSAE-SRQGVKEFLTEIQVISEI-EHEN 101
+GEG FG V + K ++ A+K+L ++ + + + + ++E++++ I +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIG---GGHHYS-------NIQFSWRTRSRI 151
++ L G C + ++ Y +L + L G Y Q S++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 152 CIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVA 211
+ARG+ +L + IHRD+ A N+L+ +D KI+DFGLA+ ++ H+
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKK 198
Query: 212 GTIG-----YLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLL 262
T G ++APE T ++D++SFGVLL EI + + +P EE + L
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 76/288 (26%), Positives = 124/288 (43%), Gaps = 51/288 (17%)
Query: 52 IGEGGFGSV-YKGRLKDGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGC 108
+G G G+V R+ DG+ A+KV+ E S E+ + + ++VK
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK---- 95
Query: 109 CVEGNHRILVYNYLENNSLAQTLIGGGHHYSN---IQFSWRTRSRICIGIAR---GLAFL 162
C H N +I Y+N ++ ++R++ GL F+
Sbjct: 96 C----HEDFAKKD-PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFI 150
Query: 163 ------HEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT-HVSTRVAGTIG 215
H H+IHRDIK++NILL + K+ DFG +K+ A ++ V GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 216 YLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275
Y+APE R ++KAD++S GVLL E+++ L+R +D E++
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLT----------------LKRPFDGENMEEVM 254
Query: 276 LLVDTSLNGDFDA-----EEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318
+L G +D + + LL + PK RPS S ++ M
Sbjct: 255 ---HKTLAGRYDPLPPSISPEMQEIVTALLSSD--PKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-14
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 46 FSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQG------VKEFLTEIQVISEIE 98
+ P+ +IG G +G+VYK R G A+K + ++ + V+E + ++ + +
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVRE-VALLKRLEAFD 60
Query: 99 HENLVKLYGCCVEGN-----HRILVYNYLENN--SLAQTLIGGGHHYSNIQFSWRTRSRI 151
H N+V+L C LV+ +++ + + + G I+ R
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQ---- 116
Query: 152 CIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVA 211
RGL FLH I+HRD+K NIL+ K++DFGLA++ M T V
Sbjct: 117 ---FLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVV 168
Query: 212 GTIGYLAPEYAIRGQVTRKADIYSFGVLLVEI 243
T+ Y APE ++ D++S G + E+
Sbjct: 169 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-14
Identities = 64/208 (30%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYG 107
+G+GGFG V +++ GK+ A K L + R+G L E Q++ ++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-- 65
Query: 108 CCVEGNHRILVYNYLENNSL--AQTLIGGGH---HYSNIQFSWRTRSRICIGIAR---GL 159
Y Y ++L T++ GG H N+ R A GL
Sbjct: 66 ----------AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGL 115
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAP 219
LH E + ++RD+K NILLD +ISD GLA IP + + RV GT+GY+AP
Sbjct: 116 EDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IRGRV-GTVGYMAP 170
Query: 220 EYAIRGQVTRKADIYSFGVLLVEIVSGR 247
E + T D + G L+ E++ G+
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 7e-14
Identities = 82/271 (30%), Positives = 114/271 (42%), Gaps = 47/271 (17%)
Query: 52 IGEGGFGSVYKGRLKD-GKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYG 107
IG GGFG VY R D GK+ A+K L + +QG L E ++S LV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVSTGD 55
Query: 108 C----CVEGNHRILVYNYLENNSLAQTLI---GGGHHYSNIQ---FSWRTRSRICIGIAR 157
C C + Y + + L+ L GG HY Q FS I
Sbjct: 56 CPFIVC-------MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIIL 108
Query: 158 GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYL 217
GL +H +++RD+K +NILLD+ +ISD GLA H S GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162
Query: 218 APEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL 276
APE +G AD +S G +L +++ G P + +T D +E + L
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHS------PFRQH----KTKDKHEIDRMTL 212
Query: 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPK 307
+ L F E R L GLL +D +
Sbjct: 213 TMAVELPDSFSPE--LRSLLEGLL-QRDVNR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 39/225 (17%)
Query: 45 DFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLV 103
D P+ G G G V+ D K A+K + Q VK L EI++I ++H+N+V
Sbjct: 9 DLRPL---GCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIV 65
Query: 104 KLYGCCVEGNHRI--------------LVYNYLEN---NSLAQTLIGGGHHYSNIQFSWR 146
K+Y + +V Y+E N L Q + H F ++
Sbjct: 66 KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHAR---LFMYQ 122
Query: 147 TRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLD-KDLTPKISDFGLAKLIPANMTH 205
+ RGL ++H +++HRD+K +N+ ++ +DL KI DFGLA+++ + +H
Sbjct: 123 --------LLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH 171
Query: 206 VSTRVAGTIG--YLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGR 247
G + Y +P + T+ D+++ G + E+++G+
Sbjct: 172 KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 7e-14
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 25/205 (12%)
Query: 51 KIGEGGFGSVYKGRLKDGKIAA---IKVLSAESRQGVKEFLT-----EIQVISEIEHENL 102
++G+G FG+VY +KD K A +KVL + T E Q++S+++H +
Sbjct: 7 RLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64
Query: 103 VKLYGCCVEGNHRILVYNYLENNSL---AQTLIGGGHHYSNIQF-SWRTRSRICIGIARG 158
VK + +E + ++ Y E L + L G S Q W I + G
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW------FIQLLLG 118
Query: 159 LAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLA 218
+ ++H+ I+HRD+KA NI L +L KI DFG+++L+ + ++T GT Y++
Sbjct: 119 VHYMHQR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGS-CDLATTFTGTPYYMS 173
Query: 219 PEYAIRGQVTRKADIYSFGVLLVEI 243
PE K+DI+S G +L E+
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 8e-14
Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 52 IGEGGFGSVYKGRLKDGKIA----AIKVLSAES---RQGVKEFLTEIQVISEIEHENLVK 104
+G+G FG V+ R G A A+KVL + R V+ + E +++E+ H +VK
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFIVK 62
Query: 105 L-YGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH 163
L Y EG L+ ++L L L + F+ +A L LH
Sbjct: 63 LHYAFQTEGK-LYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALALDHLH 115
Query: 164 EEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAI 223
II+RD+K NILLD++ K++DFGL+K + + GT+ Y+APE
Sbjct: 116 ---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 224 RGQVTRKADIYSFGVLLVEIVSG 246
R T+ AD +SFGVL+ E+++G
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 8e-14
Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 24/216 (11%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQG-VKEFLTEIQVISEIEHEN 101
D+ ++++G+G +GSVYK + G A+K + E + + + E+ ++ +
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPY 60
Query: 102 LVKLYGC-CVEGNHRILVY---NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR 157
+V YG +EG VY Y++ SL L GG I RI + +
Sbjct: 61 IVDFYGAFFIEGA----VYMCMEYMDAGSL-DKLYAGGVATEGIPED--VLRRITYAVVK 113
Query: 158 GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYL 217
GL FL EE +IIHRD+K +N+L++ + K+ DFG++ + A++ + G Y+
Sbjct: 114 GLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI---GCQSYM 168
Query: 218 APEY------AIRGQVTRKADIYSFGVLLVEIVSGR 247
APE T ++D++S G+ ++E+ GR
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 9e-14
Identities = 65/236 (27%), Positives = 92/236 (38%), Gaps = 43/236 (18%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEH 99
DDF I IG G FG V+ R KD G++ A+KVL R + E ++++ +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGL 159
+VKLY + H LV Y+ L LI R IA +
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLI----RKDVFPEET-AR----FYIAELV 111
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN----------------- 202
L + IHRDIK NIL+D D K++DFGL K +
Sbjct: 112 LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 203 ------------MTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSG 246
++ GT Y+APE + D +S GV+L E++ G
Sbjct: 172 NVLVRRRDHKQRRVRANS-TVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-13
Identities = 50/198 (25%), Positives = 95/198 (47%), Gaps = 18/198 (9%)
Query: 52 IGEGGFGSVYKG-RLKDGKIAAIKVLSAESRQGV-KEFLTEIQVISEIEHENLVKLYGCC 109
+G G G+VYK L +I A+KV+ + + K+ ++E++++ + + ++ YG
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 110 VEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPH 169
N + +++ SL Y I RI + + +GL +L
Sbjct: 69 FVENRISICTEFMDGGSLDV--------YRKI--PEHVLGRIAVAVVKGLTYLWSL---K 115
Query: 170 IIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTR 229
I+HRD+K SN+L++ K+ DFG++ + + ++ GT Y+APE Q
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTYVGTNAYMAPERISGEQYGI 172
Query: 230 KADIYSFGVLLVEIVSGR 247
+D++S G+ +E+ GR
Sbjct: 173 HSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 65/221 (29%), Positives = 103/221 (46%), Gaps = 31/221 (14%)
Query: 44 DDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAES-RQGV-KEFLTEI---QVISEI 97
D + + KIGEG +G VYK R GK+ A+K E +G+ L EI Q++SE
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 98 EHENLVKLYGCCVE----GNHRI---LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSR 150
+ +V+L VE N + LV+ YL+++ L + + G +T
Sbjct: 61 IY--IVRLL--DVEHVEEKNGKPSLYLVFEYLDSD-LKKFMDSNGRGPGR-PLPAKTIKS 114
Query: 151 ICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTP-KISDFGLAK--LIP-ANMTHV 206
+ +G+A H+ ++HRD+K N+L+DK KI+D GL + IP + TH
Sbjct: 115 FMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHE 171
Query: 207 STRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSG 246
T+ Y APE + + DI+S G + E+
Sbjct: 172 IV----TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 67/248 (27%), Positives = 97/248 (39%), Gaps = 63/248 (25%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAES---RQGVKEFLTEIQVISEIEH 99
F I +G+G G V+ RLK GK+ A+KVL + R VK LTE ++++ ++H
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 100 ENLVKLYGCCVEGNHRILVYNYL---ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIA 156
L LY + LV +Y E L Q + + +A
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQR---------------QPGKCLSEEVA 105
Query: 157 R--------GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVS- 207
R L +LH I++RD+K NILL + +SDF L+K VS
Sbjct: 106 RFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK 162
Query: 208 -----------------TRVA----------GTIGYLAPEYAIRGQVTRKA-DIYSFGVL 239
T GT Y+APE I G A D ++ G+L
Sbjct: 163 ALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGIL 221
Query: 240 LVEIVSGR 247
L E++ G
Sbjct: 222 LYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 23/205 (11%)
Query: 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYG 107
+G+GGFG V +++ GK+ A K L + R+G L E +++ ++ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-- 65
Query: 108 CCVEGNHRILVYNYLENNSL--AQTLIGGGH---HYSNIQFSWRTRSRICIGIARGLAFL 162
Y Y ++L T++ GG H N+ R A L
Sbjct: 66 ----------AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGL 115
Query: 163 HEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYA 222
+ R I++RD+K NILLD +ISD GLA IP T V RV GT+GY+APE
Sbjct: 116 EDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVI 173
Query: 223 IRGQVTRKADIYSFGVLLVEIVSGR 247
+ T D + G L+ E++ G+
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 89/319 (27%), Positives = 128/319 (40%), Gaps = 48/319 (15%)
Query: 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYG 107
+G+G FG V R K GK A+K+L E ++ V LTE +V+ H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 108 CCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRIC-IGIARGLAFLHEEV 166
+ V Y+ L H S + R+R I L +LH
Sbjct: 63 SFQTKDRLCFVMEYVNGGELF-------FHLSRERVFSEDRTRFYGAEIVSALDYLHSG- 114
Query: 167 RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQ 226
I++RD+K N++LDKD KI+DFGL K + + T GT YLAPE
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDND 171
Query: 227 VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDF 286
R D + GV++ E++ G RLP Q D + ELIL+ D
Sbjct: 172 YGRAVDWWGLGVVMYEMMCG------RLPFYNQ-------DHEKLFELILMEDIKFPRTL 218
Query: 287 DAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKDIDDDKITKPGLIS-----DFMD 341
A+ + L GLL +L G D +I + + D D
Sbjct: 219 SAD--AKSLLSGLLIKDPNKRL------------GGGPDDAKEIMRHSFFTGVNWQDVYD 264
Query: 342 LKVRGPPKPKLETTTSSTY 360
K+ P KP++ + T + Y
Sbjct: 265 KKLVPPFKPQVTSETDTRY 283
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 54/202 (26%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 54 EGGFGSVYKGRLKDGKI-----AAIK-VLSAESRQGVKEFLTEIQVISEIEHENLVKLYG 107
EG FG ++ G L D K +K V S V L E ++ + H+N++ +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 108 CCVEGNHRILV-YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIG--IARGLAFLHE 164
C+E V Y Y+ +L L +N + T+ + + IA G+++LH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134
Query: 165 EVRPHIIHRDIKASNILLDKDLTPKISDFGLAK-LIPANMTHVSTRVAGTIGYLAPEYAI 223
+ +IH+DI A N ++D++L KI+D L++ L P + + + ++A E +
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLV 192
Query: 224 RGQVTRKADIYSFGVLLVEIVS 245
+ + +D++SFGVLL E+++
Sbjct: 193 NKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 52/191 (27%), Positives = 90/191 (47%), Gaps = 26/191 (13%)
Query: 72 AIKVLSAESRQG---VKEFLTEIQVISEIEHENLVKLYGCCVEGNHRIL-VYNYLENNSL 127
AIK+L ++ + F E + + + H N+V L + V+ Y+ +L
Sbjct: 7 AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTL 66
Query: 128 AQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLD-KDL 186
+ L G R+ + + LA H I+HRD+K NI++ +
Sbjct: 67 REVLAADG------ALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGV 117
Query: 187 TP--KISDFGLAKLIP-------ANMTHVSTRVAGTIGYLAPEYAIRGQ-VTRKADIYSF 236
P K+ DFG+ L+P A +T +T V GT Y APE +RG+ VT +D+Y++
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLT-RTTEVLGTPTYCAPE-QLRGEPVTPNSDLYAW 175
Query: 237 GVLLVEIVSGR 247
G++ +E ++G+
Sbjct: 176 GLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 63/206 (30%), Positives = 94/206 (45%), Gaps = 26/206 (12%)
Query: 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYG 107
+G+G FG V R K GK A+K+L E ++ V LTE +V+ H L L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK- 61
Query: 108 CCVEGNHRILVYNYLENNSLAQTL--IGGGH---HYSNIQFSWRTRSRIC-IGIARGLAF 161
Y++ ++ L + GG H S + R+R I L +
Sbjct: 62 -----------YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGY 110
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEY 221
LH +++RD+K N++LDKD KI+DFGL K ++ + T GT YLAPE
Sbjct: 111 LHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEV 166
Query: 222 AIRGQVTRKADIYSFGVLLVEIVSGR 247
R D + GV++ E++ GR
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 28/213 (13%)
Query: 46 FSPINKIGEGGFGSVYKG-RLKDGKIAAIKVLSA--ESRQGVKEFLTEIQVISEIEHENL 102
++ + ++G G +GSV + G+ AIK LS +S K E+ ++ ++HEN+
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 103 VKL---YGCCVEGNHR---ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIA 156
+ L + V G+ LV Y++ + L + + GH S + + +C
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYMQTD-LQKIM---GHPLSEDKVQYLVYQMLC---- 128
Query: 157 RGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT-HVSTRVAGTIG 215
GL ++H IIHRD+K N+ +++D KI DFGLA+ A MT +V TR
Sbjct: 129 -GLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 179
Query: 216 YLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGR 247
Y APE + + DI+S G ++ E+++G+
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 45 DFSPINKIGEGGFGSVYKGR-LKDGKIAAIK------VLSAESRQGVKEFLTEIQVISEI 97
+F KIG G F VY+ L D K A+K ++ A++RQ + + EI ++ ++
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQL 59
Query: 98 EHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQ--FSWRTRSRICIGI 155
H N++K +E N +V + L+Q + ++ + RT + + +
Sbjct: 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIK----YFKKQKRLIPERTVWKYFVQL 115
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIG 215
+ +H ++HRDIK +N+ + K+ D GL + + T + V GT
Sbjct: 116 CSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPY 171
Query: 216 YLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
Y++PE K+DI+S G LL E+ +
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 45 DFSPINKIGEGGFGS--VYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENL 102
++ + +GEG FG + + D K A ++ +S V++ E ++++++H N+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 103 VKLYGCCVEGNHRILVYNYLENNSLAQT--LIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
V H +V Y + L Q L G + W + +C+G+
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ--MCLGVQH--- 115
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPE 220
+HE+ ++HRDIK+ NI L ++ K+ DFG A+L+ + + T V GT Y+ PE
Sbjct: 116 -IHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPE 170
Query: 221 YAIRGQVTRKADIYSFGVLLVEIVS 245
K+DI+S G +L E+ +
Sbjct: 171 IWENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-13
Identities = 62/203 (30%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 52 IGEGGFGSVYKGRLKDG-KIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYG 107
IG+G FG V + R +D +I A+K + SR V L E V++++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59
Query: 108 CCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWR---TRSRICIG-IARGLAFLH 163
+ E L I GG + ++Q R +R+R + L LH
Sbjct: 60 ---------FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLH 110
Query: 164 EEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAI 223
+ ++I+RD+K NILLD + DFGL KL + +T GT YLAPE +
Sbjct: 111 KF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLL 166
Query: 224 RGQVTRKADIYSFGVLLVEIVSG 246
T+ D ++ GVLL E+++G
Sbjct: 167 GHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 44 DDFSPINKIGEGGFGSVYKG-RLKDGKIAAIKVLSAESRQGV-KEFLTEIQVISEIEHEN 101
+ ++ IGEG +G V G AIK +S Q + L EI+++ +HEN
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 102 LVKLYGC----CVEGNHRI-LVYNYLENNSLAQTLIGGGHHYSNIQ-FSWRTRSRICIGI 155
++ + E + + +V +E + L + + +IQ F ++ I
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETD-LYKLIKTQHLSNDHIQYFLYQ--------I 115
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVS--TRVAGT 213
RGL ++H +++HRD+K SN+LL+ + KI DFGLA++ H T T
Sbjct: 116 LRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT 172
Query: 214 IGYLAPEYAIRGQVTRKA-DIYSFGVLLVEIVSGR 247
Y APE + + KA DI+S G +L E++S R
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-13
Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 30/209 (14%)
Query: 52 IGEGGFGSVYKGRLKDG----KIAAIKVLS----AESRQGVKEFLTEIQVISEIEHENLV 103
+G+GG+G V++ R G KI A+KVL +++ E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 104 KLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQ----FSWRTRSRICIGIARGL 159
L G L+ YL GG + +++ F T I+ L
Sbjct: 64 DLIYAFQTGGKLYLILEYL----------SGGELFMHLEREGIFMEDTACFYLSEISLAL 113
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK--LIPANMTHVSTRVAGTIGYL 217
LH++ II+RD+K NILLD K++DFGL K + +TH GTI Y+
Sbjct: 114 EHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYM 167
Query: 218 APEYAIRGQVTRKADIYSFGVLLVEIVSG 246
APE +R + D +S G L+ ++++G
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHE 100
DF+ + +G+G FG V K ++ AIK+L + V+ + E +V++ +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 101 N-LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNI-QFSWRTRSRICIGIARG 158
L +L+ C + V Y+ L +H + +F I+ G
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLM-------YHIQQVGKFKEPQAVFYAAEISVG 113
Query: 159 LAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRV-AGTIGYL 217
L FLH II+RD+K N++LD + KI+DFG+ K + V+TR GT Y+
Sbjct: 114 LFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYI 168
Query: 218 APEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
APE + D +++GVLL E+++G+
Sbjct: 169 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 12/207 (5%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKDGK--IAAIKVLSAESRQGVKEF-LTEIQVISEIEHE 100
+ F + +GEG +G V K R K+ K +A K +E + VKE L E++++ ++ E
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
N+V+L LV+ Y+E N L N + RS I + + +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELL-----EEMPNGVPPEKVRSYI-YQLIKAIH 114
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPE 220
+ H+ I+HRDIK N+L+ + K+ DFG A+ + T T Y +PE
Sbjct: 115 WCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171
Query: 221 YAIRGQVTRKADIYSFGVLLVEIVSGR 247
+ + D++S G +L E+ G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 6e-13
Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 45 DFSPINKIGEGGFGSVYKGRLKDG-KIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHE 100
DF+ + +G+G FG V K ++ AIK+L + V+ + E +V++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 101 N-LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICI----GI 155
L +L+ C + V Y + GG +IQ + + + I
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEY----------VNGGDLMYHIQQVGKFKEPHAVFYAAEI 110
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTH-VSTRV-AGT 213
A GL FLH + II+RD+K N++LD + KI+DFG+ K N+ +TR GT
Sbjct: 111 AIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRTFCGT 164
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
Y+APE + D ++FGVLL E+++G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-13
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGC 108
+G+G +G V R + DGK IK L+ SR+ K E Q++S+++H N+V Y
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-AYRE 66
Query: 109 CVEGNHRIL--VYNYLENNSLAQTLI--GGGHHYSNIQFSWRTRSRICIGIARGLAFLHE 164
EG +L V + E L L G N W + IA L +LHE
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW------FVQIAMALQYLHE 120
Query: 165 EVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIR 224
+ HI+HRD+K N+ L + K+ D G+A+++ ST + GT Y++PE
Sbjct: 121 K---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSN 176
Query: 225 GQVTRKADIYSFGVLLVEIVS 245
K+D+++ G + E+ +
Sbjct: 177 KPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 9e-13
Identities = 73/250 (29%), Positives = 106/250 (42%), Gaps = 38/250 (15%)
Query: 52 IGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGC-- 108
IG GGFG VY R D GK+ A+K L ++ +K E ++E +LV C
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 109 --CVEGNHRILVYNYLENNSLA---QTLIGGGHHYSNIQ---FSWRTRSRICIGIARGLA 160
C + Y + + L + GG HY Q FS + I GL
Sbjct: 59 IVC-------MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLE 111
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPE 220
+H +++RD+K +NILLD+ +ISD GLA H S GT GY+APE
Sbjct: 112 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPE 165
Query: 221 YAIRGQV-TRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279
+G AD +S G +L +++ G + +T D +E + L V+
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRG----------HSPFRQHKTKDKHEIDRMTLTVN 215
Query: 280 TSLNGDFDAE 289
L F E
Sbjct: 216 VELPDSFSPE 225
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 9e-13
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 32/211 (15%)
Query: 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYG 107
+G+GGFG V +++ GK+ A K L+ + R+G + + E ++++++ +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 108 CCVEGNHRILVYNYLENNSLAQTLIGGG----HHYS----NIQFSWRTRSRICIGIAR-- 157
+ + L T++ GG H Y+ N F R C A+
Sbjct: 60 YAFQTKTDL---------CLVMTIMNGGDLRYHIYNVDEENPGFP---EPRACFYTAQII 107
Query: 158 -GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGY 216
GL LH+ II+RD+K N+LLD D +ISD GLA + + + AGT G+
Sbjct: 108 SGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGF 163
Query: 217 LAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
+APE + D ++ GV L E+++ R
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 66/209 (31%), Positives = 99/209 (47%), Gaps = 30/209 (14%)
Query: 52 IGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTE---IQVISEIEHENLVK 104
IG+G FG VY+ R KD +I A+KVLS + +++ V + E + E +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 105 LYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWR---TRSRICIG-IARGLA 160
L + LV +Y+ GG + ++Q R R++ I + L
Sbjct: 61 LKFSFQTDSDLYLVTDYM----------SGGELFWHLQKEGRFSEDRAKFYIAELVLALE 110
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVST--RVAGTIGYLA 218
LH+ I++RD+K NILLD + DFGL+K AN+T T GT YLA
Sbjct: 111 HLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK---ANLTDNKTTNTFCGTTEYLA 164
Query: 219 PEYAIRGQ-VTRKADIYSFGVLLVEIVSG 246
PE + + T+ D +S GVL+ E+ G
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 29/208 (13%)
Query: 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVIS-EIEHENLVKLY 106
+G+G FG V LK ++ AIKVL + V +TE ++++ +H L L+
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 107 GCCVEGNHRIL-VYNYLENNSLAQTLIGGGHHYSNIQFSWR---TRSRICIG-IARGLAF 161
CC + R+ V Y + GG IQ S + RSR + L F
Sbjct: 63 -CCFQTKDRLFFVMEY----------VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMF 111
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK--LIPANMTHVSTRVAGTIGYLAP 219
LH R +I+RD+K NILLD + K++DFG+ K ++ T T GT Y+AP
Sbjct: 112 LH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAP 165
Query: 220 EYAIRGQVTRKADIYSFGVLLVEIVSGR 247
E + D ++ GVL+ E+++G+
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 63/201 (31%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVIS-EIEHENLVKLY 106
+G+G FG V LK G+ A+K L + V+ + E +V++ E+ L LY
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV 166
H V +L L + G +F + I GL FLH +
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKG------RFDLYRATFYAAEIVCGLQFLHSK- 115
Query: 167 RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQ 226
II+RD+K N++LD+D KI+DFG+ K ST GT Y+APE +
Sbjct: 116 --GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLK 172
Query: 227 VTRKADIYSFGVLLVEIVSGR 247
T D +SFGVLL E++ G+
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 26/225 (11%)
Query: 52 IGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYG 107
+G+GGFG V ++K+ GK+ A K L + + G K L E +++ ++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 108 CCVEGNHRILVYNYLENNSLAQTLIGGG---HHYSNIQFSWRTRSRI---CIGIARGLAF 161
H LV +L+ GG +H N+ R+ I G+
Sbjct: 61 AFESKTHLCLV----------MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILH 110
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEY 221
LH I++RD+K N+LLD ++SD GLA + T T+ AGT GY+APE
Sbjct: 111 LHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEI 165
Query: 222 AIRGQVTRKADIYSFGVLLVEIVSGRCN-TNMRLPTEEQYLLERT 265
+ D ++ G + E+V+GR + + ++ L RT
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRT 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 43/168 (25%), Positives = 72/168 (42%), Gaps = 31/168 (18%)
Query: 88 LTEIQVISEIEHENLVKL-----YG---CCVEGNHRILVYNYLENNSLAQTLIGGGHHYS 139
L E ++ + H +++++ G C V ++ +Y YL S +
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPI-------- 156
Query: 140 NIQFSWRTRSRICI--GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197
+ I I GL +LH + IIHRD+K NI ++ I D G A+
Sbjct: 157 --------DQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
Query: 198 LIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
+ +AGT+ APE R + KADI+S G++L E+++
Sbjct: 206 FPVVAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 29/207 (14%)
Query: 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVI-SEIEHENLVKLY 106
IG+G FG V + K DGK A+KVL + +R+ K + E V+ ++H LV L+
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 107 GCCVEGNHRILVYNYLENNSLAQTL--IGGGHHYSNIQFSWRT----RSRICIG-IARGL 159
Y++ L L + GG + ++Q R+ R+R IA L
Sbjct: 63 ------------YSFQTTEKLYFVLDFVNGGELFFHLQRE-RSFPEPRARFYAAEIASAL 109
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAP 219
+LH +I++RD+K NILLD ++DFGL K A + +T GT YLAP
Sbjct: 110 GYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA-QSDTTTTFCGTPEYLAP 165
Query: 220 EYAIRGQVTRKADIYSFGVLLVEIVSG 246
E + D + G +L E++ G
Sbjct: 166 EVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 36/215 (16%)
Query: 52 IGEGGFGSVYKGRLKD----GKI----AAIKVLSAESRQGVKEFLTEIQVISEIEHENLV 103
+G+G F ++KG ++ G++ +KVL R + F ++S++ H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 104 KLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF-L 162
YG CV G+ I+V Y++ SL T + + NI SW+ + +A+ LA+ L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSL-DTYLKKNKNLINI--SWK------LEVAKQLAWAL 113
Query: 163 HEEVRPHIIHRDIKASNILL-----DKDLTP---KISDFGLA-KLIPANMTHVSTRVAGT 213
H + H ++ A N+LL K P K+SD G++ ++P + +
Sbjct: 114 HFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI------LLER 167
Query: 214 IGYLAPEYAIRG--QVTRKADIYSFGVLLVEIVSG 246
I ++ PE I ++ AD +SFG L EI SG
Sbjct: 168 IPWVPPE-CIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 3e-12
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 52 IGEGGFGSVYKGRLK-DGK---IAAIKVL----SAESRQGVKEFLTEIQVISEIEHENLV 103
+G G FG + +G LK K AI L S + R+G FL E + + +H N+V
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG---FLAEALTLGQFDHSNIV 69
Query: 104 KLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH 163
+L G GN ++V Y+ N +L L H Q + G+A G+ +L
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFL---RKHEG--QLVAGQLMGMLPGLASGMKYLS 124
Query: 164 EEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAG--TIGYLAPEY 221
E +H+ + A +L++ DL KIS F +L + T ++G + + APE
Sbjct: 125 EM---GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEA 179
Query: 222 AIRGQVTRKADIYSFGVLLVEIVS 245
+ +D++SFG+++ E++S
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 23/214 (10%)
Query: 45 DFSPINKIGEGGFG---SVYKGRLKDGKIAAIKVLSA--ESRQGVKEFLTEIQVISEIEH 99
D P IG G FG SV R DGK A+K + ++ K E++++ +H
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPR--DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKH 58
Query: 100 ENLVKLYGCCVEGN----HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGI 155
+N++ + I V L + L + ++ S S I
Sbjct: 59 DNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIV------SPQPLSSDHVKVFLYQI 112
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI-PANMTHVSTRVAGTI 214
RGL +LH I+HRDIK N+L++ + KI DFGLA++ P H++ V T
Sbjct: 113 LRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQ 168
Query: 215 GYLAPEYAIRGQ-VTRKADIYSFGVLLVEIVSGR 247
Y APE + + T DI+S G + E++ R
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 4e-12
Identities = 59/235 (25%), Positives = 109/235 (46%), Gaps = 26/235 (11%)
Query: 52 IGEGGFGSVY--------KGRLKDGKIAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHEN 101
+GEG FG V K R A+K+L + + + + ++E++++ I +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIG----------GGHHYSNIQFSWRTRSRI 151
++ L G C + ++ Y +L + L Q S++
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 152 CIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVA 211
+ARG+ +L IHRD+ A N+L+ +D KI+DFGLA+ + ++ +
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGV-HDIDYYKKTSN 195
Query: 212 G--TIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLER 264
G + ++APE T ++D++SFG+L+ EI + + +P EE + L R
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 61/201 (30%), Positives = 89/201 (44%), Gaps = 16/201 (7%)
Query: 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYG 107
+G+G FG V R K G+ A+K+L E ++ V +TE +V+ H L L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 108 CCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRIC-IGIARGLAFLHEEV 166
+ V Y L H S + R+R I L +LH
Sbjct: 63 AFQTHDRLCFVMEYANGGELF-------FHLSRERVFTEERARFYGAEIVSALEYLHSR- 114
Query: 167 RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQ 226
+++RDIK N++LDKD KI+DFGL K ++ + T GT YLAPE
Sbjct: 115 --DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDND 171
Query: 227 VTRKADIYSFGVLLVEIVSGR 247
R D + GV++ E++ GR
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 87/314 (27%), Positives = 129/314 (41%), Gaps = 37/314 (11%)
Query: 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYG 107
+G+G FG V + K G+ A+K+L E ++ V LTE +V+ H L L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 108 CCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRIC-IGIARGLAFLHEEV 166
+ V Y L H S + R+R I L +LH E
Sbjct: 63 SFQTHDRLCFVMEYANGGELF-------FHLSRERVFSEDRARFYGAEIVSALDYLHSE- 114
Query: 167 RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQ 226
++++RD+K N++LDKD KI+DFGL K + + T GT YLAPE
Sbjct: 115 -KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDND 172
Query: 227 VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDF 286
R D + GV++ E++ G RLP Q D + ELIL+ +
Sbjct: 173 YGRAVDWWGLGVVMYEMMCG------RLPFYNQ-------DHEKLFELILMEEIRFPRTL 219
Query: 287 DAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKDIDDDKITKPGLISDFMDLKVRG 346
E + L GLL + PK R K+I K + D + K+
Sbjct: 220 SPE--AKSLLSGLL--KKDPKQRLGGGP-----DDAKEIMQHKFFAGIVWQDVYEKKLVP 270
Query: 347 PPKPKLETTTSSTY 360
P KP++ + T + Y
Sbjct: 271 PFKPQVTSETDTRY 284
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 33/218 (15%)
Query: 44 DDFSPINKIGEGGFGSVYKG-RLKDGKIAAIKVLSA--ESRQGVKEFLTEIQVISEIEHE 100
+ + ++ +G G +GSV K G A+K LS +S K E++++ ++HE
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 101 NLVKLYGCCV------EGNHRILVYNYLE---NNSLAQTLIGGGHHYSNIQFSWRTRSRI 151
N++ L E N LV + + NN + + H +QF +
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH----VQF-------L 125
Query: 152 CIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT-HVSTRV 210
I RGL ++H IIHRD+K SN+ +++D KI DFGLA+ MT +V+TR
Sbjct: 126 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 181
Query: 211 AGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGR 247
Y APE + + DI+S G ++ E+++GR
Sbjct: 182 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 9e-12
Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 22/214 (10%)
Query: 45 DFSPINKIGEGGFGSVYKGRL----KDGKIAAIKVLS----AESRQGVKEFLTEIQVISE 96
+F + +G G +G V+ R GK+ A+KVL + + + TE QV+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 97 IEHEN-LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIG- 154
I LV L+ L+ +Y+ L H +F +I G
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFT------HLSQRERFK-EQEVQIYSGE 113
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTI 214
I L LH + II+RDIK NILLD + ++DFGL+K + + GTI
Sbjct: 114 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTI 170
Query: 215 GYLAPEYAIRGQV--TRKADIYSFGVLLVEIVSG 246
Y+AP+ G + D +S GVL+ E+++G
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 91/354 (25%), Positives = 146/354 (41%), Gaps = 52/354 (14%)
Query: 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVI-SEIEHENLVKLY 106
IG+G FG V R K + K A+KVL ++ ++ K ++E V+ ++H LV L+
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIG-IARGLAFLHEE 165
+ V +Y+ L +H + R+R IA L +LH
Sbjct: 63 FSFQTADKLYFVLDYINGGELF-------YHLQRERCFLEPRARFYAAEIASALGYLHSL 115
Query: 166 VRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVST--RVAGTIGYLAPEYAI 223
+I++RD+K NILLD ++DFGL K N+ H T GT YLAPE
Sbjct: 116 ---NIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPEVLH 169
Query: 224 RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLN 283
+ R D + G +L E++ G LP + T ++Y+ +++ L
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG-------LPP---FYSRNTAEMYDN-----ILNKPLQ 214
Query: 284 GDFDAEEACRFLKVGLLCTQDTPKLRPS------MSTVVQMLMGEKDIDDDKITKPGLIS 337
+ + R L GLL T +L + + + D+ + KIT P
Sbjct: 215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPP---- 270
Query: 338 DFMDLKVRGPPKPKL---ETTTSSTYNS-SDNPDNSNLSSAATSAATMTFTVSY 387
+ V GP + E T NS +PD+ ++++ AA SY
Sbjct: 271 --FNPNVSGPNDLRHFDPEFTEEPVPNSIGQSPDSILVTASVKEAAEAFLGFSY 322
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 54/168 (32%), Positives = 83/168 (49%), Gaps = 22/168 (13%)
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHV---STRVA 211
+ARG+ FL IHRD+ A NILL ++ KI DFGLA+ I + +V S R+
Sbjct: 183 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 212 GTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYER 271
+ ++APE T ++D++SFGVLL EI S + + E++ +R D
Sbjct: 240 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF-CQRLKD---- 292
Query: 272 RELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319
T + +A ++ L C Q PK RP+ S +V++L
Sbjct: 293 -------GTRMRAPENATPEIY--RIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 41/221 (18%)
Query: 46 FSPINKIGEGGFGSV--YKGRLKDGKIAAIKVLSA-ESRQGVKEFLTEIQVISEIEHENL 102
+ PI IG G +G V K + K+A K+ +A ++R K L EI+++ ++HEN+
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66
Query: 103 VKLYGCCVEGNHR------ILVYNYLENN-----SLAQTLIGGGHHYSNIQFSWRTRSRI 151
+ + + HR +VY ++ + +QTL Y Q
Sbjct: 67 IAIKDI-MPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQ--------- 116
Query: 152 CIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN---MT-HVS 207
+ RGL ++H +++HRD+K SN+LL+ + KI DFGLA+ MT +V
Sbjct: 117 ---LLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV 170
Query: 208 TRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGR 247
TR Y APE + + T D++S G + E++ GR
Sbjct: 171 TR-----WYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GR 205
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 22/215 (10%)
Query: 46 FSPINKIGEGGFGSV----YKGRLKDGKIAAIKVLSAESRQ-GVKEFLTEIQVISEI-EH 99
+ I ++G+G +G V ++ +A K+ + S++ K L E++++ H
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 100 ENLVKLYGCCV--EGNHR-ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIA 156
+N+ LY + GN + +Y L L Q +I G ++ F +C
Sbjct: 62 KNITCLYDMDIVFPGNFNELYLYEELMEADLHQ-IIRSGQPLTDAHFQSFIYQILC---- 116
Query: 157 RGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVS---TRVAGT 213
GL ++H +++HRD+K N+L++ D KI DFGLA+ N + T T
Sbjct: 117 -GLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172
Query: 214 IGYLAPEYAIRGQVTRKA-DIYSFGVLLVEIVSGR 247
Y APE + Q KA D++S G +L E++ +
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 38/92 (41%), Positives = 53/92 (57%), Gaps = 4/92 (4%)
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAG-T 213
+ARG+ FL IHRD+ A NILL ++ KI DFGLA+ I + +V A
Sbjct: 182 VARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
+ ++APE T ++D++SFGVLL EI S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 73/240 (30%), Positives = 110/240 (45%), Gaps = 51/240 (21%)
Query: 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIE-HENLVKLY 106
IG G + V RLK + +I A+KV+ E + + TE V + + LV L+
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTR-----------SRICIGI 155
C + LV Y + GG ++Q R R + ICI
Sbjct: 63 SCFQTTSRLFLVIEY----------VNGGDLMFHMQ---RQRKLPEEHARFYAAEICIA- 108
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK--LIPANMTHVSTRVAGT 213
L FLHE II+RD+K N+LLD D K++D+G+ K L P + T + GT
Sbjct: 109 ---LNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGT 159
Query: 214 IGYLAPEYAIRGQ-VTRKADIYSFGVLLVEIVSGRC-----NTNMRLPTEE---QYLLER 264
Y+APE +RG+ D ++ GVL+ E+++GR N + TE+ Q +LE+
Sbjct: 160 PNYIAPE-ILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK 218
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-11
Identities = 68/220 (30%), Positives = 100/220 (45%), Gaps = 35/220 (15%)
Query: 45 DFSPINKIGEGGFGSVYKGRLKDG----KIAAIKVLS----AESRQGVKEFLTEIQVISE 96
+F + +G G +G V+ R G K+ A+KVL + + V+ TE V+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 97 I-EHENLVKL-YGCCVEGN-HRILVYNYLENNSLAQTLIGGG----HHYSNIQFSWRTRS 149
+ + LV L Y E H IL Y + GG H Y FS
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDY------------VSGGEMFTHLYQRDNFS-EDEV 107
Query: 150 RICIG-IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVST 208
R G I L LH + I++RDIK NILLD + ++DFGL+K + +
Sbjct: 108 RFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY 164
Query: 209 RVAGTIGYLAPEYAIRGQV--TRKADIYSFGVLLVEIVSG 246
GTI Y+APE IRG+ + D +S G+L+ E+++G
Sbjct: 165 SFCGTIEYMAPE-IIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 59/211 (27%), Positives = 91/211 (43%), Gaps = 28/211 (13%)
Query: 51 KIGEGGFGSVYKGRLKDGKIAAIKVL----SAESRQGVKEFLTEIQVISEIEHENLVKLY 106
+IG G FG V G + G A V+ + S Q +FL E Q ++H NL++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV 166
G C E +LV + L L + T R+ IA GL LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMACEIALGLLHLH--- 117
Query: 167 RPHIIHRDIKASNILLDKDLTPKISDFGLAKL-------IPANMTHVSTRVAGTIGYLAP 219
+ + IH D+ N LL DLT KI D+GL+ + + V R ++AP
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR------WIAP 171
Query: 220 EYA--IRGQV-----TRKADIYSFGVLLVEI 243
E + G + T++++++S GV + E+
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 62/219 (28%), Positives = 94/219 (42%), Gaps = 20/219 (9%)
Query: 37 KELSIATDDFSPINKIGEGGFGSVYKGRLKDG-KIAAIKVLSAES---RQGVKEFLTEIQ 92
+L + +DF I IG G FG V R K ++ A+K+LS R F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 93 VISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRIC 152
+++ E +V+L+ + + +V Y+ L + SN +
Sbjct: 96 IMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM-------SNYDIPEKWARFYT 148
Query: 153 IGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN-MTHVSTRVA 211
+ L +H IHRD+K N+LLDK K++DFG + AN M T V
Sbjct: 149 AEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV- 204
Query: 212 GTIGYLAPEY----AIRGQVTRKADIYSFGVLLVEIVSG 246
GT Y++PE G R+ D +S GV L E++ G
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 6e-11
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 35/215 (16%)
Query: 52 IGEGGFGSVYKGRLK---DGKIAA--------IKVLSAESRQGVKEFLTEIQVISEIEHE 100
+G+G F ++YKG L+ D I +KVL ++ R + F ++S++ H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLSHK 61
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
+LVKLYG CV + I+V Y++ L L +N+ W+ + +A L
Sbjct: 62 HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREK---NNVSLHWKL--DVAKQLASALH 115
Query: 161 FLHEEVRPHIIHRDIKASNILLDKD-----LTP--KISDFGLAKLIPANMTHVSTRVAGT 213
+L ++ ++H ++ NIL+ + P K+SD G IP + RV
Sbjct: 116 YLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG----IPITVLSREERVE-R 167
Query: 214 IGYLAPEYAIRGQV--TRKADIYSFGVLLVEIVSG 246
I ++APE GQ T AD +SFG L+EI S
Sbjct: 168 IPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 20/219 (9%)
Query: 37 KELSIATDDFSPINKIGEGGFGSVYKGRLKDG-KIAAIKVLSAES---RQGVKEFLTEIQ 92
++L + +D+ + IG G FG V R K K+ A+K+LS R F E
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 93 VISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRIC 152
+++ +V+L+ + + +V Y+ L + SN +
Sbjct: 96 IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM-------SNYDVPEKWAKFYT 148
Query: 153 IGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA-KLIPANMTHVSTRVA 211
+ L +H +IHRD+K N+LLDK K++DFG K+ M T V
Sbjct: 149 AEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV- 204
Query: 212 GTIGYLAPEYAIR----GQVTRKADIYSFGVLLVEIVSG 246
GT Y++PE G R+ D +S GV L E++ G
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 38/218 (17%)
Query: 49 INKIGEGGFGSVYKGRLKD-GKIAAIK-VLSA-ESRQGVKEFLTEIQVISEI-EHENLVK 104
+ K+G+G +G V+K + ++ A+K + A + + EI + E+ +H N+VK
Sbjct: 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVK 71
Query: 105 LYGCCVEGNHR--ILVYNYLE---NNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGL 159
L N + LV+ Y+E + + ++ H ++ I + + L
Sbjct: 72 LLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHK----RY-------IMYQLLKAL 120
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI---------PANMTHVSTRV 210
++H ++IHRD+K SNILL+ D K++DFGLA+ + P +V+TR
Sbjct: 121 KYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR- 176
Query: 211 AGTIGYLAPEYAIRGQVTRKA-DIYSFGVLLVEIVSGR 247
Y APE + K D++S G +L E++ G+
Sbjct: 177 ----WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 37/212 (17%)
Query: 52 IGEGGFGSV---YKGRLKDGKIAAIKVLSA--ESRQGVKEFLTEIQVISEIEHENLVKLY 106
+G G +GSV Y RL+ + A+K LS +S + E++++ ++HEN++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 107 GCCV------EGNHRILVYNYLE---NNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR 157
N LV N + NN + + H +QF + + R
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEH----VQF-------LIYQLLR 129
Query: 158 GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT-HVSTRVAGTIGY 216
GL ++H IIHRD+K SN+ +++D +I DFGLA+ MT +V+TR Y
Sbjct: 130 GLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WY 181
Query: 217 LAPEYAIRG-QVTRKADIYSFGVLLVEIVSGR 247
APE + + DI+S G ++ E++ G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 57/229 (24%), Positives = 101/229 (44%), Gaps = 43/229 (18%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKDGKIA-AIKVLSAES---RQGVKEFLTEIQVISEIEH 99
+DF I I G +G+VY R K+ + A+K ++ ++ R +++ E +++ E+
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR-- 157
+V ++ H +V Y+E A L G + + +AR
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG--------------ALPVDMARMY 106
Query: 158 ------GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT------- 204
L +LH I+HRD+K N+L+ K++DFGL+K+ ++T
Sbjct: 107 FAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGH 163
Query: 205 -HVSTR------VAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSG 246
TR V GT Y+APE +R + D ++ G++L E + G
Sbjct: 164 IEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 51 KIGEGGFGSVYKGRL-KDGKIAAIKVLSAESRQGVKE---FLTEIQVISEIEHENLVKLY 106
+IG G FG V + D +A + V ++ KE FL + ++H N+++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV 166
G CVE +LV+ Y E L L H N Q R+ IA G+ +H+
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQL--LLLQRMACEIAAGVTHMHKH- 118
Query: 167 RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT--HVST--RVAGTIGYLAPEYA 222
+ +H D+ N L DLT K+ D+G+ P+ ++ T + +LAPE
Sbjct: 119 --NFLHSDLALRNCFLTSDLTVKVGDYGIG---PSRYKEDYIETEDDKCVPLRWLAPELV 173
Query: 223 -------IRGQVTRKADIYSFGVLLVEI 243
I + T+ +++++ GV L E+
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 45 DFSPINKIGEGGFGSVYKGRLKDG-KIAAIKVLSAE---SRQGVKEFLTEIQVIS-EIEH 99
DF+ + +G+G FG V K ++ AIK+L + V+ + E +V++ +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICI----GI 155
L +L+ C + V Y + GG IQ R + + I
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEY----------VNGGDLMYQIQQVGRFKEPHAVFYAAEI 110
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANM-THVSTRV-AGT 213
A GL FLH + II+RD+K N++LD + KI+DFG+ K NM V+T+ GT
Sbjct: 111 AIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGT 164
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
Y+APE + D ++FGVLL E+++G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 27/206 (13%)
Query: 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKE---FLTEIQVI-SEIEHENLVKLY 106
IG+G FG V + K DG A+KVL ++ KE + E V+ ++H LV L+
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWR---TRSRICIG-IARGLAFL 162
V +Y + GG + ++Q R+R +A + +L
Sbjct: 63 YSFQTAEKLYFVLDY----------VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYL 112
Query: 163 HEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK--LIPANMTHVSTRVAGTIGYLAPE 220
H +II+RD+K NILLD ++DFGL K + P T + GT YLAPE
Sbjct: 113 HSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGTPEYLAPE 166
Query: 221 YAIRGQVTRKADIYSFGVLLVEIVSG 246
+ R D + G +L E++ G
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 5e-10
Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 52 IGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQVISEIE-HENLVKLY 106
IG G + V RLK +I A+KV+ E + + TE V + H LV L+
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV 166
C + V Y+ L H + I+ L +LHE
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLM------FHMQRQRKLPEEHARFYSAEISLALNYLHER- 115
Query: 167 RPHIIHRDIKASNILLDKDLTPKISDFGLAK--LIPANMTHVSTRVAGTIGYLAPEYAIR 224
II+RD+K N+LLD + K++D+G+ K L P + T + GT Y+APE +R
Sbjct: 116 --GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPE-ILR 169
Query: 225 GQ-VTRKADIYSFGVLLVEIVSGR 247
G+ D ++ GVL+ E+++GR
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 9e-10
Identities = 60/223 (26%), Positives = 97/223 (43%), Gaps = 33/223 (14%)
Query: 43 TDDFSPINKIGEGGFGSVYK-GRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEI---- 97
+D + I IG+G +G V+K K+G AA+K+L + + EI+ I
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP-----IHDIDEEIEAEYNILKAL 71
Query: 98 -EHENLVKLYGC-----CVEGNHRILVYNYLENNS---LAQTLIGGGHHYSNIQFSWRTR 148
+H N+VK YG G+ LV S L + + G ++
Sbjct: 72 SDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILH 131
Query: 149 SRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVST 208
+ GL LH IHRD+K +NILL + K+ DFG++ + + +T
Sbjct: 132 EAL-----MGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 183
Query: 209 RVAGTIGYLAPEY-AIRGQVTR----KADIYSFGVLLVEIVSG 246
V GT ++APE A Q+ + D++S G+ +E+ G
Sbjct: 184 SV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 64/264 (24%), Positives = 103/264 (39%), Gaps = 59/264 (22%)
Query: 46 FSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHEN 101
F I +G G FG V R D + A+K L + R V E +++E ++E
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
+V+LY + ++ V +Y+ + LI G ++ + + + F
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA------------------------- 196
IHRDIK NIL+D+D K++DFGL
Sbjct: 123 ---------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDF 173
Query: 197 --------------KLIP----ANMTH---VSTRVAGTIGYLAPEYAIRGQVTRKADIYS 235
+L P A H ++ + GT Y+APE +R T+ D +S
Sbjct: 174 SNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233
Query: 236 FGVLLVEIVSGRCNTNMRLPTEEQ 259
GV+L E++ G+ + P E Q
Sbjct: 234 VGVILYEMLVGQPPFLAQTPLETQ 257
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 36/95 (37%), Positives = 55/95 (57%), Gaps = 10/95 (10%)
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT- 213
+A+G++FL + + IHRD+ A NILL KI DFGLA+ I + +V V G
Sbjct: 223 VAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV---VKGNA 276
Query: 214 ---IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
+ ++APE T ++D++S+G+LL EI S
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 52/207 (25%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 51 KIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVK-EFLTEIQVISEIEHENLVKLYGCC 109
K+G G +G VYK + KDGK L G+ EI ++ E++H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 110 VEGNHR--ILVYNYLENN--SLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEE 165
+ + R L+++Y E++ + + + +Q + I G+ +LH
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 166 VRPHIIHRDIKASNILLDKDLTP----KISDFGLAKLIPANMTHVS--TRVAGTIGYLAP 219
++HRD+K +NIL+ + KI+D G A+L + + ++ V T Y AP
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 220 EYAIRGQ-VTRKADIYSFGVLLVEIVS 245
E + + T+ DI++ G + E+++
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 35/95 (36%), Positives = 54/95 (56%), Gaps = 10/95 (10%)
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT- 213
+A+G+ FL + + IHRD+ A N+LL KI DFGLA+ I + +V V G
Sbjct: 221 VAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---VKGNA 274
Query: 214 ---IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
+ ++APE T ++D++S+G+LL EI S
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 37/92 (40%), Positives = 53/92 (57%), Gaps = 4/92 (4%)
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAG-T 213
+A+G+ FL IHRD+ A NILL ++ KI DFGLA+ I + +V A
Sbjct: 188 VAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
+ ++APE T ++D++SFGVLL EI S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 18/214 (8%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEH 99
DF + +G G FG V R K G I A+KV+ +++ V F E ++S
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGL 159
+ +L + ++ LV Y L L + Y + QF +A +
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL----NRYED-QFD---EDMAQFYLAELV 112
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAP 219
+H + +HRDIK N+L+D+ K++DFG A + AN S GT Y+AP
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAP 172
Query: 220 EY------AIRGQVTRKADIYSFGVLLVEIVSGR 247
E +G + D +S GV+ E++ GR
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 29/208 (13%)
Query: 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIE-HENLVKLY 106
IG G + V LK +I A+KV+ E + + TE V H LV L+
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWR---TRSRICIG-IARGLAFL 162
C + V + + GG ++Q + +R I+ L FL
Sbjct: 63 SCFQTESRLFFVIEF----------VSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFL 112
Query: 163 HEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK--LIPANMTHVSTRVAGTIGYLAPE 220
HE II+RD+K N+LLD + K++D+G+ K + P + T + GT Y+APE
Sbjct: 113 HER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPE 166
Query: 221 YAIRGQ-VTRKADIYSFGVLLVEIVSGR 247
+RG+ D ++ GVL+ E+++GR
Sbjct: 167 -ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 64/261 (24%), Positives = 103/261 (39%), Gaps = 57/261 (21%)
Query: 46 FSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHEN 101
F I IG G FG V R D + A+K L R E +++E ++E
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIG-IARGLA 160
+VKLY + ++ V +Y+ + LI G ++ +R I + +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL-------ARFYIAELTCAIE 115
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL------------------------- 195
+H + IHRDIK NIL+D+D K++DFGL
Sbjct: 116 SVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSME 172
Query: 196 -----AKLIPANMTHVSTR------------VAGTIGYLAPEYAIRGQVTRKADIYSFGV 238
+++ + + R + GT Y+APE +R T+ D +S GV
Sbjct: 173 PSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232
Query: 239 LLVEIVSGRCNTNMRLPTEEQ 259
+L E++ G+ P E Q
Sbjct: 233 ILYEMLVGQPPFLADTPAETQ 253
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 67/261 (25%), Positives = 97/261 (37%), Gaps = 84/261 (32%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAES---RQGVKEFLTEIQVISEIEH 99
DDF I IG G FG V + KD G I A+K L ++ V E +++E ++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGL 159
+VKLY + N+ L+ YL + L+ +
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLM------------------------KKD 96
Query: 160 AFLHEEVRPHI---------------IHRDIKASNILLDKDLTPKISDFGLAK------- 197
F EE R +I IHRDIK N+LLD K+SDFGL
Sbjct: 97 TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156
Query: 198 -----------------LIPANMTHVSTRVA---------------GTIGYLAPEYAIRG 225
I M+ S R A GT Y+APE ++
Sbjct: 157 TEFYRILSHALPSNFLDFISKPMS--SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT 214
Query: 226 QVTRKADIYSFGVLLVEIVSG 246
++ D +S GV++ E++ G
Sbjct: 215 GYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 50/190 (26%), Positives = 78/190 (41%), Gaps = 47/190 (24%)
Query: 75 VLSAESRQGVKEFLTEIQVISEIEHENLVKLYG--------CCVEGNHRILVYNYLENNS 126
V+ A R G TE ++ I H ++++L G C + ++ +Y YL
Sbjct: 121 VIKAGQRGGT---ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYL---- 173
Query: 127 LAQTLIGGGHHYSNIQFSWRTRSRICIGIA------RGLAFLHEEVRPHIIHRDIKASNI 180
+ + IC +A R + +LHE IIHRDIKA NI
Sbjct: 174 -----------------AAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENI 213
Query: 181 LLDKDLTPKISDFGLAKLIPANMTHVSTRV---AGTIGYLAPEYAIRGQVTRKADIYSFG 237
++ + DFG A P ++ + + AGTI APE R DI+S G
Sbjct: 214 FINHPGDVCLGDFG-AACFPVDIN--ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAG 270
Query: 238 VLLVEIVSGR 247
++L E+ +
Sbjct: 271 IVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 10/95 (10%)
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT-HVSTRVAGT 213
+ +GL ++H IIHRD+K N+ +++D KI DFGLA+ + MT +V TR
Sbjct: 127 MLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR---- 179
Query: 214 IGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGR 247
Y APE + T+ DI+S G ++ E+++G+
Sbjct: 180 -WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 4/92 (4%)
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVST-RVAGT 213
+ARG+ FL + + +HRD+ A N+LL + KI DFGLA+ I + +VS
Sbjct: 246 VARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
+ ++APE T +D++S+G+LL EI S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 7e-09
Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 51 KIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVK-EFLTEIQVISEIEHENLVKLYGCC 109
K+G G +G VYK + KDGK L G+ EI ++ E++H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 110 VEGNHR--ILVYNYLENN--SLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEE 165
+ R L+++Y E++ + + + +Q + I G+ +LH
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 166 VRPHIIHRDIKASNILLDKDLTP----KISDFGLAKLIPANMTHVS--TRVAGTIGYLAP 219
++HRD+K +NIL+ + KI+D G A+L + + ++ V T Y AP
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 220 EYAIRGQ-VTRKADIYSFGVLLVEIVS 245
E + + T+ DI++ G + E+++
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 33/81 (40%), Positives = 45/81 (55%), Gaps = 8/81 (9%)
Query: 170 IIHRDIKASNILLDKDLTPKISDFGLAKLIPAN--MT-HVSTRVAGTIGYLAPEYAIRGQ 226
IIHRD+K SNI++ D T KI DFGLA+ + MT +V TR Y APE +
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVILGMG 193
Query: 227 VTRKADIYSFGVLLVEIVSGR 247
DI+S G ++ E++ G
Sbjct: 194 YKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 63/264 (23%), Positives = 102/264 (38%), Gaps = 59/264 (22%)
Query: 46 FSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHEN 101
F I +G G FG V D + A+K L + +R V E +++E ++E
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
+VKLY + ++ V +Y+ + LI + + + I + F
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA---------------------KLIP 200
IHRDIK NIL+D D K++DFGL + P
Sbjct: 123 ---------IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP 173
Query: 201 ANM----------------------TH---VSTRVAGTIGYLAPEYAIRGQVTRKADIYS 235
+++ H ++ + GT Y+APE +R T+ D +S
Sbjct: 174 SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233
Query: 236 FGVLLVEIVSGRCNTNMRLPTEEQ 259
GV+L E++ G+ PTE Q
Sbjct: 234 VGVILFEMLVGQPPFLAPTPTETQ 257
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 59/219 (26%), Positives = 93/219 (42%), Gaps = 20/219 (9%)
Query: 37 KELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQ 92
++L + +D+ + IG G FG V R K K+ A+K+LS R F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 93 VISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRIC 152
+++ +V+L+ + + +V Y+ L + SN +
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-------SNYDVPEKWARFYT 148
Query: 153 IGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA-KLIPANMTHVSTRVA 211
+ L +H IHRD+K N+LLDK K++DFG K+ M T V
Sbjct: 149 AEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV- 204
Query: 212 GTIGYLAPEYAIR----GQVTRKADIYSFGVLLVEIVSG 246
GT Y++PE G R+ D +S GV L E++ G
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKDG-KIAAIKVLSAES---RQGVKEFLTEIQVISEIEH 99
DDF I IG G FG V ++K +I A+K+L+ R F E V+ +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRIC-IGIARG 158
+ + L+ + N+ LV +Y L TL+ +F R + IA
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLL-TLLS--------KFEDRLPEDMARFYIAEM 111
Query: 159 LAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLA 218
+ +H + H +HRDIK N+LLD + +++DFG + + T S+ GT Y++
Sbjct: 112 VLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYIS 171
Query: 219 PEY--AIR---GQVTRKADIYSFGVLLVEIVSG 246
PE A+ G+ + D +S GV + E++ G
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 38/92 (41%), Positives = 49/92 (53%), Gaps = 11/92 (11%)
Query: 158 GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN--MT-HVSTRVAGTI 214
G+ LH IIHRD+K SNI++ D T KI DFGLA+ N MT +V TR
Sbjct: 135 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY---- 187
Query: 215 GYLAPEYAIRGQVTRKADIYSFGVLLVEIVSG 246
Y APE + DI+S G ++ E+V G
Sbjct: 188 -YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 31/219 (14%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSA---ESRQGVKEFLTEIQVISEIEH 99
DDF + IG G FG V ++K+ G++ A+K+L+ R F E V+ +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGL 159
+ L+ + N+ LV +Y L TL+ + R+ +AR
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLL-TLLS------------KFEDRLPEDMAR-- 105
Query: 160 AFLHEEV-------RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAG 212
+L E V + +HRDIK N+LLDK+ +++DFG + A+ T S G
Sbjct: 106 FYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVG 165
Query: 213 TIGYLAPEY--AI---RGQVTRKADIYSFGVLLVEIVSG 246
T Y++PE A+ +G+ + D +S GV + E++ G
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 29/77 (37%), Positives = 50/77 (64%), Gaps = 1/77 (1%)
Query: 170 IIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVT 228
++HRD+K++NI L K+ DFG +K +++ V++ GT YLAPE R + +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 229 RKADIYSFGVLLVEIVS 245
+KAD++S GV+L E+++
Sbjct: 250 KKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 48/158 (30%), Positives = 73/158 (46%), Gaps = 15/158 (9%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQ----VISEIE 98
+DF + IG+G FG V + KD GKI A+K L +S K+ L ++ V++E +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL-LKSEMFKKDQLAHVKAERDVLAESD 59
Query: 99 HENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARG 158
+V LY + + L+ +L L LI ++ + + I
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHK 119
Query: 159 LAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196
L F IHRDIK NIL+D+ K+SDFGL+
Sbjct: 120 LGF---------IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 58/241 (24%), Positives = 94/241 (39%), Gaps = 47/241 (19%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEH 99
DDF + IG G FG V + KD G I A+K+L ++ V E ++ E +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGL 159
+VK++ + + L+ +L + L+ + + + I L
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA--------NMTH------ 205
F IHRDIK N+LLD K+SDFGL + N+TH
Sbjct: 121 GF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171
Query: 206 --------------------VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
++ GT Y+APE ++ + D +S GV++ E++
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 246 G 246
G
Sbjct: 232 G 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 31/219 (14%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKDG-KIAAIKVLSAES---RQGVKEFLTEIQVISEIEH 99
+DF + IG G FG V +LK+ K+ A+K+L+ R F E V+ ++
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGL 159
+ + L+ + N+ LV +Y L L + R+ +AR
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLS-------------KFEDRLPEDMAR-- 105
Query: 160 AFLHEEV-------RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAG 212
+L E V + H +HRDIK NIL+D + +++DFG + + T S+ G
Sbjct: 106 FYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVG 165
Query: 213 TIGYLAPEYAI-----RGQVTRKADIYSFGVLLVEIVSG 246
T Y++PE +G+ + D +S GV + E++ G
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 4/107 (3%)
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVST-RVAGT 213
+A G+ FL + + +HRD+ A N+L+ + KI DFGLA+ I + ++S
Sbjct: 248 VANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQY 260
+ ++APE T +D++SFG+LL EI + LP EQ+
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 7e-08
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 13/159 (8%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVL-SAE--SRQGVKEFLTEIQVISEIEH 99
++F + I G FG VY GR K + K+ A+KV+ A+ ++ V + E ++ +
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGL 159
+V LY N+ LV YL + L H Y F + +A L
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLL----HIYG--YFDEEMAVKYISEVALAL 117
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198
+LH R IIHRD+K N+L+ + K++DFGL+K+
Sbjct: 118 DYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 43/212 (20%), Positives = 83/212 (39%), Gaps = 38/212 (17%)
Query: 55 GGFGSVYKGRLKDGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG 112
+ K + + A+K ++ + S++ +K EI +++H N++ +
Sbjct: 13 LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71
Query: 113 NHRILVYNYLENNSLAQTLIGGGHHYSN------IQFSWRTRSRICIGIARGLAFLHEEV 166
+ +V + S L H+ I F I + L ++H +
Sbjct: 72 SELYVVSPLMAYGSCEDLL---KTHFPEGLPELAIAF-------ILKDVLNALDYIHSK- 120
Query: 167 RPHIIHRDIKASNILLDKDLTPKISDF---------GLAKLIPANMTHVSTRVAGTIGYL 217
IHR +KAS+ILL D +S G + + + S + + +L
Sbjct: 121 --GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN---LPWL 175
Query: 218 APEY---AIRGQVTRKADIYSFGVLLVEIVSG 246
+PE ++G K+DIYS G+ E+ +G
Sbjct: 176 SPEVLQQNLQG-YNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 49/230 (21%), Positives = 93/230 (40%), Gaps = 24/230 (10%)
Query: 28 IHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVL---SAESRQGV 84
I + K + D I E S+YKG + K I+ + +
Sbjct: 4 ITRSYINDIKCIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLI 62
Query: 85 KEFLTEIQVISEIEHENLVKLYG----CCVEGNHRILVYNYLENNSLAQTLIGGGHHYSN 140
EI+ + I+ N++K+YG + L+ Y L + L
Sbjct: 63 DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL------DKE 116
Query: 141 IQFSWRTRSRICIGIARGLAFLHEEV-RPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199
S++T+ + I +GL L++ +P+ +++ + + L+ ++ KI GL K+
Sbjct: 117 KDLSFKTKLDMAIDCCKGLYNLYKYTNKPY---KNLTSVSFLVTENYKLKIICHGLEKI- 172
Query: 200 PANMTHVSTRVAGTIGYLAPEYA--IRGQVTRKADIYSFGVLLVEIVSGR 247
++ + + Y + + I + T K DIYS GV+L EI +G+
Sbjct: 173 ---LSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 21/207 (10%)
Query: 50 NKIGEGGFGSVYKGRLKDG--KIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKL-- 105
N IG G FG VY+ D K+A KVL + E+ ++ + H N++ L
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN-----RELLIMKNLNHINIIFLKD 126
Query: 106 --YGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYS--NIQFSWRTRSRICIGIARGLAF 161
Y C + N + + N + + QT+ HY+ N + R LA+
Sbjct: 127 YYYTECFKKNEKNIFLNVVME-FIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185
Query: 162 LHEEVRPHIIHRDIKASNILLDKDL-TPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPE 220
+H + I HRD+K N+L+D + T K+ DFG AK + A VS + Y APE
Sbjct: 186 IHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF--YRAPE 240
Query: 221 YAIRG-QVTRKADIYSFGVLLVEIVSG 246
+ T D++S G ++ E++ G
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 22/207 (10%)
Query: 45 DFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSA--ESRQGVKEFLTEIQVISEIEHENL 102
+ PI +G + Y L + AIK LS +++ K E+ ++ + H+N+
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 103 VKLYGC-----CVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR 157
+ L +E + + L + +L Q + ++ S + +
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI--------QMELDHERMSYLLYQMLC 130
Query: 158 GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYL 217
G+ LH IIHRD+K SNI++ D T KI DFGLA+ A + + T T Y
Sbjct: 131 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 185
Query: 218 APEYAIRGQVTRKADIYSFGVLLVEIV 244
APE + DI+S G ++ E+V
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 22/210 (10%)
Query: 45 DFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSA--ESRQGVKEFLTEIQVISEIEHENL 102
+ PI +G + Y L+ + AIK LS +++ K E+ ++ + H+N+
Sbjct: 28 NLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 103 VKLYGC-----CVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR 157
+ L +E + + L + +L Q + H + S+ +C
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE---RMSYLLYQMLC----- 137
Query: 158 GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYL 217
G+ LH IIHRD+K SNI++ D T KI DFGLA+ A + + T T Y
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 192
Query: 218 APEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
APE + DI+S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 41/166 (24%), Positives = 69/166 (41%), Gaps = 25/166 (15%)
Query: 90 EIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENN----SLAQTLIGGGHHYSNIQFSW 145
EI + + HEN++K +E R Y+ L + + +
Sbjct: 213 EILALGRLNHENILK-----IEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLK 267
Query: 146 RTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTH 205
+TR I + + ++H++ +IHRDIK NI L+ D + DFG A M
Sbjct: 268 QTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTA------MPF 317
Query: 206 VSTRVA------GTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
R A GT+ +PE DI+S G++L++++S
Sbjct: 318 EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 60/225 (26%), Positives = 106/225 (47%), Gaps = 30/225 (13%)
Query: 73 IKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLI 132
+KVL R F ++S++ H +L ++G CV G+ I+V ++E+ L L
Sbjct: 49 LKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLR 108
Query: 133 GGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK-----DLT 187
+ +W+ + +A L++L ++ +++H ++ A NILL + +
Sbjct: 109 KEKGR---VPVAWKI--TVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTS 160
Query: 188 P--KISDFGLAKLIPANMTHVS--TRVAGTIGYLAPEYAIRG--QVTRKADIYSFGVLLV 241
P K+SD G++ T +S RV I ++APE + G ++ AD +SFG L+
Sbjct: 161 PFIKLSDPGVS------FTALSREERVE-RIPWIAPE-CVPGGNSLSTAADKWSFGTTLL 212
Query: 242 EIV-SGRCNTNMRLPTEEQYLLERTWDLYER--RELILLVDTSLN 283
EI G R P+E++ E+ L E +EL L+ L
Sbjct: 213 EICFDGEVPLKERTPSEKERFYEKKHRLPEPSCKELATLISQCLT 257
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 31/95 (32%), Positives = 46/95 (48%), Gaps = 7/95 (7%)
Query: 157 RGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK--LIPANMTHVSTRVAGTI 214
R L ++H ++ HRD+K NIL + D KI DFGLA+ T T
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 215 GYLAPEY--AIRGQVTRKADIYSFGVLLVEIVSGR 247
Y APE + + T DI+S G + E+++G+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 7e-07
Identities = 39/152 (25%), Positives = 67/152 (44%), Gaps = 19/152 (12%)
Query: 98 EHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR 157
++ N +KLY +L+ +Y I G + ++ + I R
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDY----------IKDGDLFDLLKKEGKLSEAEVKKIIR 116
Query: 158 GLAF-LHEEVRPHIIHRDIKASNILLDKDLTP-KISDFGLAKLIPANMTHVSTRVAGTIG 215
L L++ + +IIH DIK N+L D+ + D+GL K+I + GT+
Sbjct: 117 QLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLD 171
Query: 216 YLAPEYAIRGQV-TRKADIYSFGVLLVEIVSG 246
Y +PE I+G D ++ GVL E+++G
Sbjct: 172 YFSPE-KIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 55/241 (22%), Positives = 94/241 (39%), Gaps = 47/241 (19%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEH 99
+DF + IG G FG V + KD G + A+K+L ++ V E ++ E +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGL 159
+VK++ + + L+ +L + L+ + + + I L
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK----------------LIPANM 203
F IHRDIK N+LLD K+SDFGL +P++
Sbjct: 121 GF---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 204 T------------------HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
T ++ GT Y+APE ++ + D +S GV++ E++
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 246 G 246
G
Sbjct: 232 G 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-06
Identities = 31/156 (19%), Positives = 55/156 (35%), Gaps = 18/156 (11%)
Query: 47 SPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLV--K 104
S I + G VY KD +K+ + + + E+ ++ + + L K
Sbjct: 1 SSIKLLKGGLTNRVYLLGTKDEDYV-LKINPSREKG--ADREREVAILQLLARKGLPVPK 57
Query: 105 LYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHE 164
+ L+ ++E +L + S + I +A LA LH+
Sbjct: 58 VLASGESDGWSYLLMEWIEGETLDEV-------------SEEEKEDIAEQLAELLAKLHQ 104
Query: 165 EVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200
+ H D+ NIL+D I D+ A P
Sbjct: 105 LPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 5e-06
Identities = 62/241 (25%), Positives = 106/241 (43%), Gaps = 50/241 (20%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKE-----FLTEIQVISEIE 98
+++ I KIG G FG V+ +K + A S +G+KE + E+ V+ E++
Sbjct: 13 NEYEVIKKIGNGRFGEVF--LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK 70
Query: 99 HENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRI----CIG 154
H+N+V+ + ++ L Y +E G NIQ ++ +I +
Sbjct: 71 HKNIVRYIDRFLNKANQKL-YILME-------FCDAGDLSRNIQKCYKMFGKIEEHAIVD 122
Query: 155 IAR----GLAFLHE-EVRPH---IIHRDIKASNILLDKDL-----------------TPK 189
I R LA+ H + P+ ++HRD+K NI L + K
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 190 ISDFGLAKLIP-ANMTHVSTRVAGTIGYLAPEYAIRGQVT--RKADIYSFGVLLVEIVSG 246
I DFGL+K I +M H GT Y +PE + + K+D+++ G ++ E+ SG
Sbjct: 183 IGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239
Query: 247 R 247
+
Sbjct: 240 K 240
|
Length = 1021 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 35/96 (36%), Positives = 46/96 (47%), Gaps = 8/96 (8%)
Query: 153 IGIARGL----AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA-KLIPANMTHVS 207
I I R L A+LH IIHRD+K NI LD+ + DFG A KL T
Sbjct: 188 ITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC 244
Query: 208 TRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEI 243
+GT+ +PE K DI+S G++L E+
Sbjct: 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 59/235 (25%), Positives = 100/235 (42%), Gaps = 41/235 (17%)
Query: 52 IGEGGFGSVYKGRLKD------------GKIAAI-KVLSAESRQGVKEFLTEIQVISEIE 98
+G G +Y G L +I I KVL R F ++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 99 HENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSN-IQFSWRTRSRICIGIAR 157
H+++V LYG CV I+V ++E L + H S+ + W+ ++ +A
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFM----HRKSDVLTTPWKF--KVAKQLAS 116
Query: 158 GLAFLHEEVRPHIIHRDIKASNILL-----DKDLTP--KISDFGLAKLIPANMTHVSTRV 210
L++L ++ ++H ++ NILL D + P K+SD G IP + V
Sbjct: 117 ALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPG----IPITVLSRQECV 169
Query: 211 AGTIGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLER 264
I ++APE + + AD +SFG L EI N +P +++ L E+
Sbjct: 170 E-RIPWIAPECVEDSKNLSIAADKWSFGTTLWEIC-----YNGEIPLKDKTLAEK 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 26/74 (35%), Positives = 37/74 (50%), Gaps = 1/74 (1%)
Query: 170 IIHRDIKASNILLDKDLTPKISDFGLAKLIPANM-THVSTRVAGTIGYLAPEYAIRGQVT 228
IIHRDIK N+L++ + DFG A + T +AGT+ APE T
Sbjct: 281 IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT 340
Query: 229 RKADIYSFGVLLVE 242
DI+S G+++ E
Sbjct: 341 PSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 37/111 (33%), Positives = 55/111 (49%), Gaps = 23/111 (20%)
Query: 151 ICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL-----------I 199
I G RGL +LH+ IHR+IKAS+IL+ D +S GL+ L +
Sbjct: 106 ILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKV 160
Query: 200 PANMTHVSTRVAGTIGYLAPEYAIRGQV---TRKADIYSFGVLLVEIVSGR 247
+ ST V + +L+PE +R + K+DIYS G+ E+ +GR
Sbjct: 161 VYDFPQFSTSV---LPWLSPEL-LRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 391 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.68 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.67 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.58 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.52 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.5 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.5 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.46 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.46 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.42 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.3 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.3 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.28 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.26 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.25 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.19 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.14 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.14 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.07 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.98 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.86 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.85 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.84 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.83 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.8 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.75 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.61 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.61 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.52 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.4 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.38 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.34 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.28 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.27 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.2 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.19 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.17 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.13 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.12 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.04 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.95 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.92 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.88 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.87 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.87 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.75 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.74 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.69 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.66 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.53 | |
| PLN02236 | 344 | choline kinase | 97.47 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.32 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.31 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.18 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.17 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.13 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.06 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.03 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.91 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.67 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.65 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.64 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.55 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.49 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.47 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.2 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.45 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 95.35 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-54 Score=404.47 Aligned_cols=289 Identities=49% Similarity=0.823 Sum_probs=254.7
Q ss_pred cceeechHHHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEE
Q 016347 30 NVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCC 109 (391)
Q Consensus 30 ~~~~~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 109 (391)
..+.|+++|+..++++|.-...||+|+||.||+|...+|..||||.+.........+|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 68889999999999999999999999999999999999999999988765432145699999999999999999999999
Q ss_pred EeCC-eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcE
Q 016347 110 VEGN-HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTP 188 (391)
Q Consensus 110 ~~~~-~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~ 188 (391)
.+.+ ..+|||||+++|+|.+.+..... . +++|..+++|+.++|+||+|||..+.+.|+||||||.|||+|.++.+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~---~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKG---E-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCC---C-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 9988 59999999999999999976542 1 78999999999999999999999987789999999999999999999
Q ss_pred EEEecccccccCCCCceeeeee-cccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 016347 189 KISDFGLAKLIPANMTHVSTRV-AGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWD 267 (391)
Q Consensus 189 kl~Dfg~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 267 (391)
||+|||+++..+.. ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+.+.+...+.....+..|.+.
T Consensus 217 KlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP 295 (361)
T ss_pred EccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence 99999999765431 1111222 799999999999999999999999999999999999988887665666667888888
Q ss_pred HhhhcccceeeeccCC-CCCCH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 268 LYERRELILLVDTSLN-GDFDA-EEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 268 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
.+....+..++|+.+. ..+.. .....+..++.+|++.+|++||+|.||+++|+...
T Consensus 296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 8888899999999987 55554 68888999999999999999999999999995543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-52 Score=371.69 Aligned_cols=257 Identities=28% Similarity=0.440 Sum_probs=216.2
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC-eeEEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN-HRILVY 119 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 119 (391)
..+.+.++.||+|..|+||+++++ +++.+|+|++..+ +....+++.+|+++++.++||+||.+||.|+.+. ...++|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 347888999999999999999987 5899999999655 5566788999999999999999999999999988 599999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHE-EVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|||++|||++++...+ .+++...-.|+.+|++||.|||. + +|+||||||+||||+.+|.|||+|||.+..
T Consensus 158 EYMDgGSLd~~~k~~g------~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~ 228 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVG------RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGI 228 (364)
T ss_pred hhcCCCCHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHH
Confidence 9999999999997544 49999999999999999999996 6 999999999999999999999999999998
Q ss_pred cCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
+.+. ...+++||..|||||.+.+..|+.++||||||++++|+.+|+.|+....+.....+.... .. .
T Consensus 229 lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~-~I---------v 295 (364)
T KOG0581|consen 229 LVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC-AI---------V 295 (364)
T ss_pred hhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH-HH---------h
Confidence 7554 456789999999999999999999999999999999999999999765222211111110 00 1
Q ss_pred eccCCCCCCH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 279 DTSLNGDFDA-EEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 279 ~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
+. .....+. .++.++..++..||++||.+||++.|+++|-+-.
T Consensus 296 ~~-ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~ 339 (364)
T KOG0581|consen 296 DE-PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIK 339 (364)
T ss_pred cC-CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHh
Confidence 10 0112223 3677899999999999999999999999886443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-51 Score=367.07 Aligned_cols=256 Identities=25% Similarity=0.336 Sum_probs=210.6
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchh-------cHHHHHHHHHHHhcCCCCceeEEEEEEEeCC
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQ-------GVKEFLTEIQVISEIEHENLVKLYGCCVEGN 113 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (391)
..+.|.+.+.||.|+||.|-+|..+ +|+.||||+++..... ......+|+++|++++|||||+++++|++..
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4677999999999999999999876 6999999999865221 1223568999999999999999999999999
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC---CcEEE
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD---LTPKI 190 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~---~~~kl 190 (391)
..||||||++||.|.+.+..++ .+.+.....++.|++.|+.|||++ ||+||||||+|||+..+ ..+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk------~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK------YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc------ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEe
Confidence 9999999999999999997654 488888899999999999999999 99999999999999776 78999
Q ss_pred EecccccccCCCCceeeeeecccccccChhhhhcCCC---CCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 016347 191 SDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQV---TRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWD 267 (391)
Q Consensus 191 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 267 (391)
+|||+++..+ ....+.+.|||+.|.|||++.++.+ ..+.|+||||||||-+++|..||........ +.+..
T Consensus 321 tDFGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l~eQI-- 394 (475)
T KOG0615|consen 321 TDFGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--LKEQI-- 394 (475)
T ss_pred cccchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--HHHHH--
Confidence 9999999875 3456788999999999999987653 3488999999999999999999975543320 11110
Q ss_pred HhhhcccceeeeccCC--CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 268 LYERRELILLVDTSLN--GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 268 ~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
....+. ...-.....+.++||.+||..||++|||+.|+|++-|..
T Consensus 395 ----------~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 395 ----------LKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred ----------hcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 000010 011235567888999999999999999999999886543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-50 Score=360.07 Aligned_cols=251 Identities=30% Similarity=0.506 Sum_probs=205.7
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
.++|.+.++||+|+||+||+|+++ ++..||||.+.+. .....+.+..|+.+|+.++|||||.+++++..++..++||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 478999999999999999999987 5899999999877 5566677889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC------CcEEEEec
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD------LTPKISDF 193 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~------~~~kl~Df 193 (391)
|||.||+|.++|+..+ .+++..++.++.||+.||++||++ +|+||||||+|||++.+ -.+||+||
T Consensus 89 EyC~gGDLs~yi~~~~------~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG------RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred EeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 9999999999998654 599999999999999999999999 99999999999999775 46899999
Q ss_pred ccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcc
Q 016347 194 GLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRE 273 (391)
Q Consensus 194 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (391)
|+++.+.. .....+.+|++.|||||++..++|+.|+|+||+|+|||+|++|+.||....+.+-... .-...+
T Consensus 160 GfAR~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~------~~k~~~ 231 (429)
T KOG0595|consen 160 GFARFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLY------IKKGNE 231 (429)
T ss_pred chhhhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH------Hhcccc
Confidence 99998763 3345678999999999999999999999999999999999999999986554332111 111122
Q ss_pred cceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
....+ +......+.+++...++.+|.+|-+..+-..+
T Consensus 232 ~~~~~--------~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 232 IVPVL--------PAELSNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred ccCch--------hhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence 22221 12222234456666677777777766655443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=370.05 Aligned_cols=265 Identities=32% Similarity=0.502 Sum_probs=217.4
Q ss_pred HHHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccch--hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC-
Q 016347 37 KELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESR--QGVKEFLTEIQVISEIEHENLVKLYGCCVEGN- 113 (391)
Q Consensus 37 ~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 113 (391)
.++.+......+.+.||.|+||+||+|.+.+...||||++..... ...+.|.+|+.+|.+++|||||+++|.+.+..
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 344555566777777999999999999998544499999986532 22568999999999999999999999999887
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCC-eeecCCCCCcEEECCCC-cEEEE
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPH-IIHRDIKASNILLDKDL-TPKIS 191 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~-i~H~dikp~NIlv~~~~-~~kl~ 191 (391)
..++||||+++|+|.+++... ....+++..+..|+.||++||.|||++ + ||||||||+|||++.++ ++||+
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~----~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~ 186 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKK----RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIA 186 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhc----ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEEC
Confidence 799999999999999999763 245799999999999999999999999 8 99999999999999998 99999
Q ss_pred ecccccccCCCCceeeeeecccccccChhhhh--cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh
Q 016347 192 DFGLAKLIPANMTHVSTRVAGTIGYLAPEYAI--RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLY 269 (391)
Q Consensus 192 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 269 (391)
|||+++...... .......||+.|||||++. ...|+.|+||||||++||||+||..||....+.+... ..
T Consensus 187 DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~------~v- 258 (362)
T KOG0192|consen 187 DFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVAS------AV- 258 (362)
T ss_pred CCccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHH------HH-
Confidence 999998764332 2233367999999999998 5689999999999999999999999998765522111 11
Q ss_pred hhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 016347 270 ERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKD 324 (391)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~ 324 (391)
.........+......+..++.+||+.||..||++.+++..|.....
T Consensus 259 --------~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 259 --------VVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred --------HhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 11112223344467788899999999999999999999999876543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-50 Score=375.02 Aligned_cols=251 Identities=25% Similarity=0.408 Sum_probs=214.8
Q ss_pred CCCCCCceeeccCceEEEEEEe-CCCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRL-KDGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
.+|...+.||+|||+.||.+++ .+|+.||+|++.+. .....+...+|+++.+.|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999998 67999999999864 4455677899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
|+|..++|..++.. .+++++..++.++.||+.||.|||++ +|+|||||-.|+|++.+.+|||+||||+..+
T Consensus 98 ELC~~~sL~el~Kr------rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l 168 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR------RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQL 168 (592)
T ss_pred EecCCccHHHHHHh------cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeee
Confidence 99999999999963 34699999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
... .....+.||||.|+|||++.....+..+||||+|||||-|++|++||..+.-.+ .+......+.
T Consensus 169 e~~-~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-------ty~~Ik~~~Y----- 235 (592)
T KOG0575|consen 169 EYD-GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-------TYNKIKLNEY----- 235 (592)
T ss_pred cCc-ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-------HHHHHHhcCc-----
Confidence 543 334567899999999999999999999999999999999999999997643211 1111111110
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
..|........+||.++|+.||.+|||+++|+.+-..
T Consensus 236 -----~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 236 -----SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred -----ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 2233445567788999999999999999999976433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-50 Score=357.73 Aligned_cols=283 Identities=27% Similarity=0.344 Sum_probs=227.3
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
+..++|++++.||+|+||+||.++.+ +++.+|+|++++.. ....+....|..+|..++||.||+++-.|++...+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 44689999999999999999999976 49999999998762 334567888999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+|+||+.||.|...|.+.+ .+++..+..++..|+.||.|||++ ||+||||||+|||+|.+|+++|+|||++
T Consensus 102 lVld~~~GGeLf~hL~~eg------~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~ 172 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREG------RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLC 172 (357)
T ss_pred EEEeccCCccHHHHHHhcC------CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccc
Confidence 9999999999999998665 499999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccce
Q 016347 197 KLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL 276 (391)
Q Consensus 197 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (391)
+..... .....+++||+.|||||++.+..|+.++|.||||+++|+|++|..||...........+ ...+.
T Consensus 173 k~~~~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I-------~~~k~-- 242 (357)
T KOG0598|consen 173 KEDLKD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKI-------LKGKL-- 242 (357)
T ss_pred hhcccC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHH-------hcCcC--
Confidence 865333 23455689999999999999999999999999999999999999999876543221111 11110
Q ss_pred eeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCCCCCCCCCCccccccccccCCCCCCCCCC
Q 016347 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKDIDDDKITKPGLISDFMDLKVRGPPKPKLETT 355 (391)
Q Consensus 277 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 355 (391)
...+.-......+++...|..||++|.. .......+..+++-....|..+...+..+|-.|.....
T Consensus 243 -------~~~p~~ls~~ardll~~LL~rdp~~RLg------~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~ 308 (357)
T KOG0598|consen 243 -------PLPPGYLSEEARDLLKKLLKRDPRQRLG------GPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGL 308 (357)
T ss_pred -------CCCCccCCHHHHHHHHHHhccCHHHhcC------CCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCc
Confidence 0111123446777888999999999974 11222224455666666677766666666666666543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=347.59 Aligned_cols=258 Identities=26% Similarity=0.412 Sum_probs=210.0
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEE-EEEeCC-eeEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYG-CCVEGN-HRILV 118 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~~~-~~~lv 118 (391)
.+|+++++||+|.||+||++... +|..+|.|.+... +....+.+..|+.+|++|+|||||++++ .+.++. .+++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 56888999999999999999854 7999999988755 4556678899999999999999999998 444444 48999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcC-CCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV-RPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~-~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
||+|.+|+|..+|..... ..+.+++..+|+++.|++.||..+|++. +.-++||||||.||+++.+|.|||+|||+++
T Consensus 99 mE~c~~GDLsqmIk~~K~--qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKK--QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHhhcccCHHHHHHHHHh--ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 999999999999976433 4457999999999999999999999943 2249999999999999999999999999999
Q ss_pred ccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccccee
Q 016347 198 LIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILL 277 (391)
Q Consensus 198 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (391)
.+.... ......+|||.||+||.+.+.+|+.|+||||+||++|||+.-+.||.++. +.... ....+.+.
T Consensus 177 ~l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~~L~-~KI~qgd~--- 245 (375)
T KOG0591|consen 177 FLSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LLSLC-KKIEQGDY--- 245 (375)
T ss_pred Hhcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HHHHH-HHHHcCCC---
Confidence 875543 33456789999999999999999999999999999999999999998761 11111 11111111
Q ss_pred eeccCCCCCC-HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 278 VDTSLNGDFD-AEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 278 ~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
...+ .-.+.++.++|..|+..||+.||+...++..+.
T Consensus 246 ------~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 246 ------PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ------CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1222 345678999999999999999999666665543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-49 Score=365.16 Aligned_cols=263 Identities=30% Similarity=0.461 Sum_probs=222.8
Q ss_pred hHHHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 36 YKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 36 ~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
...+++..+.+.+++.||+|.||+||+|.++....||+|.+... ....+.|.+|+++|+.|+|++||+++++|..++.+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 45566666777889999999999999999998889999998764 33347789999999999999999999999998899
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
+|||||++.|+|.+++... ....+.....+.++.|||+||+||+++ ++|||||.++||||+.++.+||+|||+
T Consensus 277 yIVtE~m~~GsLl~yLr~~----~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGL 349 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTR----EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGL 349 (468)
T ss_pred EEEEEecccCcHHHHhhhc----CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccc
Confidence 9999999999999999762 344689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
++...+..........-...|.|||.+..+.++.|+|||||||+||||+| |+.|+..... .++
T Consensus 350 Ar~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn----------------~ev 413 (468)
T KOG0197|consen 350 ARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN----------------EEV 413 (468)
T ss_pred ccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH----------------HHH
Confidence 99655443333333344678999999999999999999999999999998 5555544322 333
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
...++.+.+-..|..++..+.+++..||+.+|++|||++.+...|...
T Consensus 414 ~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 414 LELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred HHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 444555666677778899999999999999999999999998887654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=336.08 Aligned_cols=265 Identities=26% Similarity=0.347 Sum_probs=214.0
Q ss_pred CCCCCCceeeccCceEEEEEEeCC-CcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
+.|+.+.++|+|+||+||+.++++ |+.||||.+... ++...+-..+|+.+|++++|+|+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 578999999999999999999885 999999998754 23445567899999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
||+.. +.+.+.... ..++.+.+..++.|++.|+.|+|++ +++||||||+||||+.+|.+||||||+++.+.
T Consensus 82 ~~dhT-vL~eLe~~p-----~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 82 YCDHT-VLHELERYP-----NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLS 152 (396)
T ss_pred ecchH-HHHHHHhcc-----CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhc
Confidence 99774 445554432 2589999999999999999999999 99999999999999999999999999999886
Q ss_pred CCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc-------
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR------- 272 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 272 (391)
. .....+..+.|..|+|||.+.+ -+|+...|||++||++.||++|..-|.+....+..+.+......+..+
T Consensus 153 ~-pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~ 231 (396)
T KOG0593|consen 153 A-PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSS 231 (396)
T ss_pred C-CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhcc
Confidence 5 3445566789999999999988 589999999999999999999999998888777666555444332211
Q ss_pred --ccceeeeccCC-----CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 273 --ELILLVDTSLN-----GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 273 --~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
....+.-+... ....+....-+++++..||+.||.+|++-++++.+
T Consensus 232 N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 232 NPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred CCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11111111111 01112334468899999999999999999999864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-47 Score=342.56 Aligned_cols=267 Identities=26% Similarity=0.371 Sum_probs=216.9
Q ss_pred HHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch-hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 38 ELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR-QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 38 e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
++.+..++|++.+.||.|..++||+|+.. .++.||||++..+.. ...+.+.+|++.++.++||||++++..|..+..+
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence 34445599999999999999999999965 689999999987733 3368899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||.||.+||+.+++... -...+++..+..|+.+++.||.|||++ |.+|||||+.||||+.+|.|||+|||.
T Consensus 100 WvVmpfMa~GS~ldIik~~----~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTY----YPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred EEeehhhcCCcHHHHHHHH----ccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCcee
Confidence 9999999999999999653 334599999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCce---eeeeecccccccChhhhhc--CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh
Q 016347 196 AKLIPANMTH---VSTRVAGTIGYLAPEYAIR--GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE 270 (391)
Q Consensus 196 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 270 (391)
+.-+...... ...++.||++|||||++.. ..|+.|+||||||++..||.+|+.||....|..... ... .
T Consensus 173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl--~tL----q 246 (516)
T KOG0582|consen 173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL--LTL----Q 246 (516)
T ss_pred eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH--HHh----c
Confidence 8765433322 1145789999999999654 469999999999999999999999998765544321 111 1
Q ss_pred hcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 271 RRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
+.........+..+........+.+++..||+.||.+|||+++++++
T Consensus 247 -n~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 247 -NDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred -CCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 11111111122222233445589999999999999999999999965
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=327.58 Aligned_cols=273 Identities=28% Similarity=0.364 Sum_probs=231.3
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
-++|++++.||.|+||.|.+++.+ +|..+|+|++.... ....+...+|..+|+.+.||.++++++.+.+.+.++||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 478999999999999999999987 58899999998763 34455677899999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|||++||-|..++++.+ ++++..++.++.||+.||+|||+. +|++|||||+|||+|.+|.+||+|||.++.
T Consensus 123 meyv~GGElFS~Lrk~~------rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~ 193 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSG------RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKR 193 (355)
T ss_pred EeccCCccHHHHHHhcC------CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEE
Confidence 99999999999997654 599999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
.... ..+.||||.|+|||++..++|..++|.|+|||++|||+.|..||....+.... +... . .+
T Consensus 194 v~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY---~KI~---~-~~----- 257 (355)
T KOG0616|consen 194 VSGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIY---EKIL---E-GK----- 257 (355)
T ss_pred ecCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHH---HHHH---h-Cc-----
Confidence 6443 56789999999999999999999999999999999999999999887763321 1111 1 11
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCCCCCCCCCCccccccccccCCCCC
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKDIDDDKITKPGLISDFMDLKVRGPPKP 350 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p 350 (391)
-.++.-...++.+|+...|+.|-.+|- -..-.+..++-.++|-+...|..+.+.++..|-.|
T Consensus 258 -----v~fP~~fs~~~kdLl~~LL~vD~t~R~-----gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~p 319 (355)
T KOG0616|consen 258 -----VKFPSYFSSDAKDLLKKLLQVDLTKRF-----GNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEP 319 (355)
T ss_pred -----ccCCcccCHHHHHHHHHHHhhhhHhhh-----cCcCCCccccccCcccccccHHHHhhccccCCCCC
Confidence 133444556788889999999999992 12223667777888888888888887777777766
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=346.05 Aligned_cols=253 Identities=26% Similarity=0.359 Sum_probs=211.7
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 116 (391)
...+|.+.+.||+|+|++|++|+.. +++.||||++.+. .+...+-...|-++|.+| .||.|++++-.|.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 4578999999999999999999976 5999999998765 233334466788899999 8999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+|+||+++|.|.++|.+.+ .|++..++.++.+|+.||+|||++ |||||||||+|||++.+++++|+|||.+
T Consensus 151 FvLe~A~nGdll~~i~K~G------sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYG------SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred EEEEecCCCcHHHHHHHhC------cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence 9999999999999998765 499999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCce------------eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 016347 197 KLIPANMTH------------VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLER 264 (391)
Q Consensus 197 ~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~ 264 (391)
+.+...... ....++||..|.+||++..+..+..+|+|+||||||+|+.|..||....+.. ..+.
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl---iFqk 298 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL---IFQK 298 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH---HHHH
Confidence 987532211 1144899999999999999999999999999999999999999997654321 1111
Q ss_pred HHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 265 TWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
... +.-.++...+..+.+||.+.|..||++|++..+|-++..
T Consensus 299 I~~--------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpF 340 (604)
T KOG0592|consen 299 IQA--------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPF 340 (604)
T ss_pred HHH--------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcc
Confidence 110 011333444567888999999999999999999988753
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=342.10 Aligned_cols=257 Identities=23% Similarity=0.310 Sum_probs=209.5
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
.+..++|++++.||+|+||.||+|+-+ +|..+|+|++++. ........+.|-.+|....+|+||+++-.|++..++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 456799999999999999999999976 5999999999876 345566788899999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
||||||++||++..+|...+ .|++..+..++.+++.|+..||+. |++||||||+|+|||.+|++||+||||
T Consensus 217 YLiMEylPGGD~mTLL~~~~------~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGL 287 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKD------TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGL 287 (550)
T ss_pred EEEEEecCCccHHHHHHhcC------cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccc
Confidence 99999999999999997655 599999999999999999999999 999999999999999999999999999
Q ss_pred ccccCC--------------------CCceee--------------------------eeecccccccChhhhhcCCCCC
Q 016347 196 AKLIPA--------------------NMTHVS--------------------------TRVAGTIGYLAPEYAIRGQVTR 229 (391)
Q Consensus 196 ~~~~~~--------------------~~~~~~--------------------------~~~~gt~~y~aPE~~~~~~~~~ 229 (391)
+.-+.. ...... ...+|||.|+|||++.+..|+.
T Consensus 288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~ 367 (550)
T KOG0605|consen 288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGK 367 (550)
T ss_pred cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCc
Confidence 843211 000000 0157999999999999999999
Q ss_pred CCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCC
Q 016347 230 KADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLR 309 (391)
Q Consensus 230 k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 309 (391)
.+|.||||||+||||.|.+||....+.+...-+..-...+. -........+..+||.+||. ||.+|
T Consensus 368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~-------------fP~~~~~s~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 368 ECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK-------------FPEEVDLSDEAKDLITRLLC-DPENR 433 (550)
T ss_pred cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc-------------CCCcCcccHHHHHHHHHHhc-CHHHh
Confidence 99999999999999999999999887654322111111111 11111223577788889999 99999
Q ss_pred CC---HHHHHHHh
Q 016347 310 PS---MSTVVQML 319 (391)
Q Consensus 310 ps---~~evl~~l 319 (391)
.. ++||-++-
T Consensus 434 LG~~G~~EIK~HP 446 (550)
T KOG0605|consen 434 LGSKGAEEIKKHP 446 (550)
T ss_pred cCcccHHHHhcCC
Confidence 85 55655443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=338.53 Aligned_cols=258 Identities=27% Similarity=0.407 Sum_probs=208.2
Q ss_pred hCCCCCCceeeccCceEEEEEEeCC-CcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC--eeEEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN--HRILVY 119 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~ 119 (391)
..+|...+.||+|+||.||++.+.+ |...|||.+...+....+.+.+|+.+|++++|||||+++|...... .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 4668889999999999999999875 8999999987764434677899999999999999999999754433 689999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-CCcEEEEecccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK-DLTPKISDFGLAKL 198 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~-~~~~kl~Dfg~~~~ 198 (391)
||+++|+|.+++...+. .+++..+..++.||++||.|||++ |++|+||||+|||++. ++.+||+|||++..
T Consensus 96 Ey~~~GsL~~~~~~~g~-----~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG-----KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred eccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 99999999999976541 599999999999999999999999 9999999999999999 79999999999987
Q ss_pred cCC--CCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCC-CCcchhhHHHHHHHHhhhccc
Q 016347 199 IPA--NMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMR-LPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 199 ~~~--~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~ 274 (391)
... ..........||+.|||||++..+ ....++|||||||++.||+||..||... ... ..........
T Consensus 168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~------~~~~~ig~~~-- 239 (313)
T KOG0198|consen 168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA------EALLLIGRED-- 239 (313)
T ss_pred cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH------HHHHHHhccC--
Confidence 653 122233457899999999999864 3345999999999999999999999753 111 1111111111
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
....++...+....+++.+|++.||++|||+.++|++..-..
T Consensus 240 -------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 240 -------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred -------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 111344456667888899999999999999999999875544
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=346.62 Aligned_cols=256 Identities=21% Similarity=0.343 Sum_probs=212.5
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc----ch-hcHHHHHHHHHHHhcCC-CCceeEEEEEEEeCC
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE----SR-QGVKEFLTEIQVISEIE-HENLVKLYGCCVEGN 113 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 113 (391)
...++|.+.+.||+|+||+|++|.+. +|..||+|++... .. .....+.+|+.+++++. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 44689999999999999999999866 6899999987654 11 23456678999999998 999999999999999
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC-CcEEEEe
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD-LTPKISD 192 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~-~~~kl~D 192 (391)
..++||||+.||.|.+++...+ ++.+..+..++.||+.|++|||++ ||+||||||+|||++.+ +.+||+|
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g------~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~D 164 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG------RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSD 164 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC------CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEec
Confidence 9999999999999999997643 588999999999999999999999 99999999999999999 9999999
Q ss_pred cccccccCCCCceeeeeecccccccChhhhhcCC-CC-CCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh
Q 016347 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQ-VT-RKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE 270 (391)
Q Consensus 193 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 270 (391)
||++.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||........ ... ..
T Consensus 165 FG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l---~~k----i~ 236 (370)
T KOG0583|consen 165 FGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL---YRK----IR 236 (370)
T ss_pred cccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH---HHH----Hh
Confidence 99999874 2334566789999999999999977 85 899999999999999999999986332211 111 11
Q ss_pred hcccceeeeccCCCCCCHHH-HHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 271 RRELILLVDTSLNGDFDAEE-ACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
... + .++... ..++..|+.+||..||.+|+++.+++++-|...
T Consensus 237 ~~~--------~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 237 KGE--------F--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred cCC--------c--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 110 0 112222 678889999999999999999999997655443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=338.13 Aligned_cols=282 Identities=25% Similarity=0.327 Sum_probs=220.2
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC--CeeEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEG--NHRIL 117 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 117 (391)
.+.|+.+++||+|.||.||+|++. +|+.||+|.++.+. ........+||.+|++|.||||+++.+...+. +.+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 466899999999999999999965 69999999998775 45566678899999999999999999999876 68999
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
|+|||+. +|.-++... ...|++.++..++.||+.||+|||++ |++|||||..|||||.+|.+||+||||++
T Consensus 196 VFeYMdh-DL~GLl~~p-----~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSP-----GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred EEecccc-hhhhhhcCC-----CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEecccccee
Confidence 9999976 788877543 34799999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc-
Q 016347 198 LIPANMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI- 275 (391)
Q Consensus 198 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 275 (391)
.+........+..+-|..|+|||++.+. .|+.+.|+||.||||.||++|+..|.+....+....+-..........+.
T Consensus 267 ~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 267 FYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPV 346 (560)
T ss_pred eccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccc
Confidence 8866555555666779999999999886 69999999999999999999999998877666544444333222222211
Q ss_pred ------eeeeccCCCC-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC-CCCCCCCCCCCC
Q 016347 276 ------LLVDTSLNGD-----FDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG-EKDIDDDKITKP 333 (391)
Q Consensus 276 ------~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~-~~~~~~~~~~~~ 333 (391)
..+.+...-. .....+...++|+..+|..||.+|.|+.++|+.=.. ..+...++...|
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p~~Lp 416 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDPSSLP 416 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCcccCC
Confidence 1111110000 011223467788889999999999999999975322 334433333333
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=314.87 Aligned_cols=266 Identities=23% Similarity=0.313 Sum_probs=214.4
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch--hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR--QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
++|..+++||+|.||.||+|++. +|+.||||.+...+. .......+|++.|+.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 57999999999999999999965 699999999976532 234567899999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|++. +|...|.+. ...++...+..++.+++.|++|||++ .|+||||||.|+||+.+|.+||+|||+++.+.
T Consensus 82 fm~t-dLe~vIkd~-----~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDK-----NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFG 152 (318)
T ss_pred eccc-cHHHHhccc-----ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccC
Confidence 9965 899998763 44789999999999999999999999 99999999999999999999999999999987
Q ss_pred CCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee-
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV- 278 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 278 (391)
......... +.|..|+|||.+.| ..|+...||||.|||+.||+-|.+-|.+....+....+-........+.+..+.
T Consensus 153 ~p~~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 153 SPNRIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred CCCcccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence 655443333 67889999998876 469999999999999999999987777766655443333333322222221111
Q ss_pred ----------eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 279 ----------DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 279 ----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
...........+..+.++|+..||..||.+|.++.|++++-
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 01111112334556779999999999999999999999874
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=346.36 Aligned_cols=252 Identities=27% Similarity=0.413 Sum_probs=217.1
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
...|....+||+|+.|.||.|... +++.||||.+........+-+.+|+.+|+..+|+|||.+++.|...+.+++||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 356899999999999999999865 5889999999888766667789999999999999999999999988999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
++||+|.+.+.. ..+++.++..|+.++++||+|||.+ ||+|||||.+|||++.+|.+||+|||++..+..
T Consensus 352 m~ggsLTDvVt~-------~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 352 MEGGSLTDVVTK-------TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred cCCCchhhhhhc-------ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 999999999943 4599999999999999999999999 999999999999999999999999999988755
Q ss_pred CCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
... ...+.+|||.|||||++..+.|++|.||||||++++||+.|..||-...+....+++. .++...
T Consensus 422 ~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa------~ng~P~------ 488 (550)
T KOG0578|consen 422 EQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------TNGTPK------ 488 (550)
T ss_pred ccC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh------hcCCCC------
Confidence 433 3345689999999999999999999999999999999999999997666644433332 222211
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
-..+......|.+|+.+||+.|+.+|+++.|+|++-
T Consensus 489 --lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~Hp 524 (550)
T KOG0578|consen 489 --LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHP 524 (550)
T ss_pred --cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcCh
Confidence 122334566888999999999999999999999874
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=341.44 Aligned_cols=273 Identities=25% Similarity=0.339 Sum_probs=215.2
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchh-cHHHHHHHHHHHhcCC-CCceeEEEEEEEeCC-eeE
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQ-GVKEFLTEIQVISEIE-HENLVKLYGCCVEGN-HRI 116 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~-~~~ 116 (391)
+.-++|.++++||.|.||.||+|+.. +|..||||.++..-.. ....-++|+..|+++. |||||++++++.+.. .++
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 44689999999999999999999966 5999999998755222 1223467999999998 999999999999887 999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+|||||+. +|.+++... ++.+++..++.|+.||++||+|+|.+ |+.|||+||+||||..+..+||+|||++
T Consensus 87 fVfE~Md~-NLYqLmK~R-----~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLA 157 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR-----NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLA 157 (538)
T ss_pred eeHHhhhh-hHHHHHhhc-----CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccc
Confidence 99999965 899999764 45899999999999999999999999 9999999999999998899999999999
Q ss_pred cccCCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 197 KLIPANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 197 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
+.+.... ..+..+.|..|+|||++.. +.|+.+.|||++|||++|+.+-+..|.+....+..+.+-..........+.
T Consensus 158 Rev~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 158 REVRSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred cccccCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 9875433 3456788999999999765 568999999999999999999998888776655433332222221111111
Q ss_pred e------eeeccCC-------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 016347 276 L------LVDTSLN-------GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKD 324 (391)
Q Consensus 276 ~------~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~ 324 (391)
. .+.-.+. ...-.....+..+++.+|+++||.+|||+.+++++--....
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 1 1110000 11122466789999999999999999999999998654433
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=340.63 Aligned_cols=250 Identities=28% Similarity=0.469 Sum_probs=215.2
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
...|+..+.||+|+||.||+|.+. +++.||+|++..+ ..+....+.+|+.+|.+++++||.++|+.+..+..+.++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 456888899999999999999976 5999999999877 45567889999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
||.||++.+.+..+. .+.+..+.-++.+++.|+.|||.+ +.+|||||+.|||+..+|.|||+|||++....
T Consensus 92 y~~gGsv~~lL~~~~------~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGN------ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLT 162 (467)
T ss_pred HhcCcchhhhhccCC------CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeee
Confidence 999999999997554 358888888999999999999999 99999999999999999999999999998876
Q ss_pred CCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeec
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT 280 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (391)
..... ..+++||+.|||||++.+..|+.|+||||||++.+||++|.+|+....|....++ +.+
T Consensus 163 ~~~~r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl----------------Ipk 225 (467)
T KOG0201|consen 163 NTVKR-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL----------------IPK 225 (467)
T ss_pred chhhc-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe----------------ccC
Confidence 54433 3778999999999999988999999999999999999999999987666333222 222
Q ss_pred cCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 281 SLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 281 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
.............+.+|+..||++||+.||++.+++++
T Consensus 226 ~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 226 SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 22222233556679999999999999999999999965
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-45 Score=340.89 Aligned_cols=248 Identities=25% Similarity=0.339 Sum_probs=204.8
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
.++|++.+.||+|+||.||+|++. +++.||+|++.... ......+.+|+.++++++||||+++++++.+++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 377999999999999999999987 58999999987542 23345688999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|||+++++|.+.+...+ .+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++..
T Consensus 97 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 167 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG------RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKK 167 (329)
T ss_pred EcCCCCChHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence 99999999999996543 488999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....+... ... ......
T Consensus 168 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~----i~~~~~---- 232 (329)
T PTZ00263 168 VPDR----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI---YEK----ILAGRL---- 232 (329)
T ss_pred cCCC----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH---HHH----HhcCCc----
Confidence 5432 2245799999999999999999999999999999999999999975433211 111 111100
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHhc
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPS-----MSTVVQMLM 320 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l~ 320 (391)
..+......+.+++.+||+.||.+||+ +.+++.+-+
T Consensus 233 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~ 273 (329)
T PTZ00263 233 ------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY 273 (329)
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCc
Confidence 111123456788999999999999996 688887654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-46 Score=347.87 Aligned_cols=266 Identities=26% Similarity=0.464 Sum_probs=217.1
Q ss_pred chHHHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC
Q 016347 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG 112 (391)
Q Consensus 35 ~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (391)
+.++|+|..+...+...||+|.||+||+|+|. | .||||+++.. +.+..+.|++|+.+++.-+|.||+-+.|++..+
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 44999999999999999999999999999997 3 5899999876 456778899999999999999999999999988
Q ss_pred CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEe
Q 016347 113 NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISD 192 (391)
Q Consensus 113 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~D 192 (391)
.. .||+.+|+|.+|..+++.. ...|...+.+.|+.||++|+.|||.+ +|+|+|||..||++.++++|||+|
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~-----etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgD 531 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQ-----ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGD 531 (678)
T ss_pred ce-eeeehhccCchhhhhccch-----hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEec
Confidence 77 9999999999999999753 34799999999999999999999999 999999999999999999999999
Q ss_pred cccccccCC-CCceeeeeecccccccChhhhhc---CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 016347 193 FGLAKLIPA-NMTHVSTRVAGTIGYLAPEYAIR---GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDL 268 (391)
Q Consensus 193 fg~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 268 (391)
||++..-.- ..........|...|||||++.. .+|+..+||||||||+|||+||..|+......+..+.....+..
T Consensus 532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~ 611 (678)
T KOG0193|consen 532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLM 611 (678)
T ss_pred ccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccC
Confidence 999865311 11112223457889999999975 46999999999999999999999999843332222211111000
Q ss_pred hhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 269 YERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
. + .......++.++.+|+..||..++++||.+.+|+..|....
T Consensus 612 p---------d---~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 612 P---------D---LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred c---------c---chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 0 0 01123356678999999999999999999999999776553
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=336.33 Aligned_cols=244 Identities=27% Similarity=0.320 Sum_probs=199.4
Q ss_pred ceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCC
Q 016347 50 NKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENN 125 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 125 (391)
+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.+++.++||||+++++++......++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999976 58999999987542 233456788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCce
Q 016347 126 SLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTH 205 (391)
Q Consensus 126 sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~ 205 (391)
+|.+++...+ .+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++..... ..
T Consensus 81 ~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~ 150 (323)
T cd05571 81 ELFFHLSRER------VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GA 150 (323)
T ss_pred cHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CC
Confidence 9999986543 589999999999999999999999 9999999999999999999999999998753222 12
Q ss_pred eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCC
Q 016347 206 VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGD 285 (391)
Q Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (391)
......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..... .... ..
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~~----~~~~----------~~ 213 (323)
T cd05571 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELI----LMEE----------IR 213 (323)
T ss_pred cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HHHHH----HcCC----------CC
Confidence 2334679999999999999999999999999999999999999996533211 11110 0000 01
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHhc
Q 016347 286 FDAEEACRFLKVGLLCTQDTPKLRP-----SMSTVVQMLM 320 (391)
Q Consensus 286 ~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~ 320 (391)
++......+.+++.+||+.||++|| ++.+++++-+
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~ 253 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRF 253 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCC
Confidence 2223455788899999999999999 7999987653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=342.79 Aligned_cols=266 Identities=26% Similarity=0.387 Sum_probs=206.9
Q ss_pred HHHhhCCCCCCceeeccCceEEEEEEeC------CCcEEEEEEecccc-hhcHHHHHHHHHHHhcC-CCCceeEEEEEEE
Q 016347 39 LSIATDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAES-RQGVKEFLTEIQVISEI-EHENLVKLYGCCV 110 (391)
Q Consensus 39 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 110 (391)
+.+..++|++.++||+|+||.||+|.+. +++.||+|++.... ......+.+|+.++..+ +||||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 4567789999999999999999999742 35679999987542 33446788999999999 8999999999887
Q ss_pred eC-CeeEEEEecccCCCHHHHHhcCCCCC---------------------------------------------------
Q 016347 111 EG-NHRILVYNYLENNSLAQTLIGGGHHY--------------------------------------------------- 138 (391)
Q Consensus 111 ~~-~~~~lv~e~~~~~sL~~~i~~~~~~~--------------------------------------------------- 138 (391)
.. ...++||||+++|+|.+++.......
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 54 46889999999999999987532110
Q ss_pred -----CccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCce-eeeeecc
Q 016347 139 -----SNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTH-VSTRVAG 212 (391)
Q Consensus 139 -----~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~g 212 (391)
....+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++........ ......+
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 123578889999999999999999999 9999999999999999999999999999865322211 1122345
Q ss_pred cccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHH
Q 016347 213 TIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEA 291 (391)
Q Consensus 213 t~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (391)
+..|+|||++.+..++.++|||||||+||||++ |..||........ .. ........ ...+...+
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~----~~~~~~~~---------~~~~~~~~ 303 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FC----QRLKDGTR---------MRAPENAT 303 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HH----HHHhcCCC---------CCCCCCCC
Confidence 678999999999999999999999999999997 9999975433211 11 11111110 01122334
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 292 CRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 292 ~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
..+.+++.+||+.||.+||++.|+++.|+..
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 5788999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=339.98 Aligned_cols=247 Identities=27% Similarity=0.425 Sum_probs=213.2
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
++|.+.+.||+|+||.||+|+-+ +.+.||+|.+.+. .+...+.+.+|+++++.++|||||.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57889999999999999999876 5899999999776 34557789999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+.| +|..++...+ .++++.+..++.+++.||.|||+. +|+|+|+||+|||++.+|.+|++|||+++.+.
T Consensus 82 ~a~g-~L~~il~~d~------~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~ 151 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG------KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMS 151 (808)
T ss_pred hhhh-hHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcc
Confidence 9987 9999998665 499999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeec
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT 280 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (391)
.+ ......+.|||.|||||++.+++|+..+|+||||||+|||.+|++||....- .+-...... +
T Consensus 152 ~~-t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si------~~Lv~~I~~---------d 215 (808)
T KOG0597|consen 152 TN-TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI------TQLVKSILK---------D 215 (808)
T ss_pred cC-ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH------HHHHHHHhc---------C
Confidence 54 4455667899999999999999999999999999999999999999964211 111111111 0
Q ss_pred cCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 281 SLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 281 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
....+.+....+..++...|++||.+|.+..+++.+
T Consensus 216 --~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 216 --PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred --CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 112344677789999999999999999999999976
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=345.51 Aligned_cols=294 Identities=25% Similarity=0.348 Sum_probs=233.2
Q ss_pred cceeechHHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcC-CCCceeE
Q 016347 30 NVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEI-EHENLVK 104 (391)
Q Consensus 30 ~~~~~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~ 104 (391)
....++-.+..+.-++|.+++.||+|+||+|+++..+ +++.+|||++++. ..+..+....|..++... +||.+++
T Consensus 354 ~~~~~~~~~~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~ 433 (694)
T KOG0694|consen 354 GPPEFPPRRGPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVN 433 (694)
T ss_pred CcccCCCCCCcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEee
Confidence 3444444445666799999999999999999999987 4889999999887 345667788888888887 5999999
Q ss_pred EEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC
Q 016347 105 LYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK 184 (391)
Q Consensus 105 ~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~ 184 (391)
++.+|....++++||||+.||++..++ ....+++..+..++..|+.||.|||++ ||+|||||-+|||+|.
T Consensus 434 L~~~fQT~~~l~fvmey~~Ggdm~~~~-------~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~ 503 (694)
T KOG0694|consen 434 LFSCFQTKEHLFFVMEYVAGGDLMHHI-------HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDT 503 (694)
T ss_pred cccccccCCeEEEEEEecCCCcEEEEE-------ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcc
Confidence 999999999999999999999854444 234699999999999999999999999 9999999999999999
Q ss_pred CCcEEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 016347 185 DLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLER 264 (391)
Q Consensus 185 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~ 264 (391)
+|.+||+|||+++.--. ......+++|||.|+|||++.+..|+.++|.|||||+||||+.|..||.+++..+.-
T Consensus 504 eGh~kiADFGlcKe~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F----- 577 (694)
T KOG0694|consen 504 EGHVKIADFGLCKEGMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF----- 577 (694)
T ss_pred cCcEEecccccccccCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-----
Confidence 99999999999986422 234667899999999999999999999999999999999999999999877653321
Q ss_pred HHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH----HHHHHHhcCCCCCCCCCCCCCCCccccc
Q 016347 265 TWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSM----STVVQMLMGEKDIDDDKITKPGLISDFM 340 (391)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~----~evl~~l~~~~~~~~~~~~~~~~~~~~~ 340 (391)
+..... ...++.-.+.+...++.++|.+||++|..+ .+.+.. +++-+...|..+.
T Consensus 578 --dsI~~d----------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~---------hpFFr~i~w~~L~ 636 (694)
T KOG0694|consen 578 --DSIVND----------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKK---------HPFFRSIDWDDLL 636 (694)
T ss_pred --HHHhcC----------CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhh---------CCccccCCHHHHh
Confidence 111111 113344556677788889999999999976 333333 3333444456666
Q ss_pred cccccCCCCCCCCCCCCCCC
Q 016347 341 DLKVRGPPKPKLETTTSSTY 360 (391)
Q Consensus 341 ~~~~~~~~~p~~~~~~~~~~ 360 (391)
+.+..+|-.|...+....++
T Consensus 637 ~r~i~PPf~P~i~~~~D~sn 656 (694)
T KOG0694|consen 637 NRRIKPPFVPTIKGPEDVSN 656 (694)
T ss_pred hccCCCCCCcccCChhhhcc
Confidence 67777777777766554444
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=333.85 Aligned_cols=248 Identities=25% Similarity=0.302 Sum_probs=204.8
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++|++++.||+|+||.||+|.+. +|+.||+|++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999987 58999999986542 233456888999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++...+ .+++..+..++.||+.||+|||++ |++||||||+|||++.+|.+||+|||++...
T Consensus 81 e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~ 151 (291)
T cd05612 81 EYVPGGELFSYLRNSG------RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKL 151 (291)
T ss_pred eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhc
Confidence 9999999999996543 489999999999999999999999 9999999999999999999999999998865
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
... .....|++.|+|||++.+..++.++|||||||++|+|++|..||........ .... ....
T Consensus 152 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~---~~~i----~~~~------ 214 (291)
T cd05612 152 RDR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI---YEKI----LAGK------ 214 (291)
T ss_pred cCC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH----HhCC------
Confidence 332 2235689999999999988999999999999999999999999976543211 1110 0010
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHhcC
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPS-----MSTVVQMLMG 321 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l~~ 321 (391)
..++......+.+++.+||+.||.+||+ +.+++++.+.
T Consensus 215 ----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~ 257 (291)
T cd05612 215 ----LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF 257 (291)
T ss_pred ----cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccc
Confidence 0112223457888999999999999995 8888877543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=326.85 Aligned_cols=253 Identities=26% Similarity=0.354 Sum_probs=203.5
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
.|+..+.||+|+||.||+|.+. +|+.||+|.+.... ......+.+|+.+++.++|+||+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3778899999999999999875 69999999986542 2223457789999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+++|+|.+.+.... ...+++..+..++.|++.||.|||+. +++||||||+|||++.++.++|+|||++....
T Consensus 81 ~~~~g~L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05631 81 IMNGGDLKFHIYNMG----NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIP 153 (285)
T ss_pred ecCCCcHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcC
Confidence 999999998885422 23589999999999999999999999 99999999999999999999999999998653
Q ss_pred CCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeec
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT 280 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (391)
... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.............. ....
T Consensus 154 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~---~~~~--------- 219 (285)
T cd05631 154 EGE--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR---RVKE--------- 219 (285)
T ss_pred CCC--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH---Hhhc---------
Confidence 321 22345689999999999999999999999999999999999999976544322111110 0000
Q ss_pred cCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHh
Q 016347 281 SLNGDFDAEEACRFLKVGLLCTQDTPKLRPS-----MSTVVQML 319 (391)
Q Consensus 281 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l 319 (391)
....++...+..+.+|+.+||+.||++||+ +++++++-
T Consensus 220 -~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~ 262 (285)
T cd05631 220 -DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHP 262 (285)
T ss_pred -ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence 001122234557888999999999999997 78888754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=329.55 Aligned_cols=267 Identities=21% Similarity=0.288 Sum_probs=204.8
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
++|++.+.||+|+||.||+|++. +++.||+|++.... ......+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999987 58899999987542 2334567889999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|++++.+..+... ...+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 81 ~~~~~~l~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 151 (287)
T cd07848 81 YVEKNMLELLEEM------PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLS 151 (287)
T ss_pred cCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccc
Confidence 9998877655432 22589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH--------h-hh
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDL--------Y-ER 271 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~--------~-~~ 271 (391)
...........|++.|+|||++.+..++.++|||||||++|+|++|+.||.................. + ..
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 152 EGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred ccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence 33322333457899999999999889999999999999999999999999765432221111111000 0 00
Q ss_pred cccceeeeccCCC------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 272 RELILLVDTSLNG------DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 272 ~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
........+.... ......+..+.+++.+||+.||++|||+++++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp 285 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCC
Confidence 0000000000000 00112345689999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=331.50 Aligned_cols=254 Identities=25% Similarity=0.322 Sum_probs=202.2
Q ss_pred CCCCCceeeccCceEEEEEEeC----CCcEEEEEEecccc----hhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCee
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK----DGKIAAIKVLSAES----RQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 115 (391)
+|++++.||+|+||.||+++.. +++.||+|++.... ......+..|+.+++.+ +||||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5889999999999999999853 58899999986532 23345677899999999 599999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||+
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~ 151 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD------NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGL 151 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcC
Confidence 99999999999999986433 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
+...............||+.|+|||++.+. .++.++|||||||++|+|++|..||.............. ....
T Consensus 152 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~---~~~~--- 225 (332)
T cd05614 152 SKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR---RILK--- 225 (332)
T ss_pred CccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH---HHhc---
Confidence 986543333333446799999999998765 478999999999999999999999975433221111110 0000
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHhc
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRP-----SMSTVVQMLM 320 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~ 320 (391)
.+. ..+......+.+++.+||+.||++|| ++++++++-+
T Consensus 226 ---~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 226 ---CDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred ---CCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence 011 11223345678899999999999999 7788887754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=340.14 Aligned_cols=250 Identities=25% Similarity=0.372 Sum_probs=213.2
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
+-|++.+.||.|+.|.|-+|++. +|+.+|||++.... ......+.+|+-+|+.+.|||++++++.+++.+++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 56899999999999999999976 69999999998762 233455788999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||++||-|.+++...+ ++++..+.+++.||+.|+.|||.. +|+|||+||+|+|++.++.+||+|||++.+-
T Consensus 92 Eyv~gGELFdylv~kG------~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe 162 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG------PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLE 162 (786)
T ss_pred EecCCchhHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecc
Confidence 9999999999997665 599999999999999999999999 9999999999999999999999999999874
Q ss_pred CCCCceeeeeecccccccChhhhhcCCC-CCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
.. ...-.+.||+|.|.|||++.+.+| +.++||||.|||||.|+||+.||+.+. .+.++... ..+..
T Consensus 163 ~~--gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---ir~LLlKV----~~G~f---- 229 (786)
T KOG0588|consen 163 VP--GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---IRVLLLKV----QRGVF---- 229 (786)
T ss_pred cC--CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---HHHHHHHH----HcCcc----
Confidence 33 345567899999999999999998 589999999999999999999998432 22222221 11111
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
+.+...+.+.++|+.+||..||.+|.|++||++|.+-
T Consensus 230 ------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l 266 (786)
T KOG0588|consen 230 ------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFL 266 (786)
T ss_pred ------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchh
Confidence 2334556688899999999999999999999998543
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=334.76 Aligned_cols=256 Identities=25% Similarity=0.321 Sum_probs=207.6
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++|++++.||+|+||.||+|++. +++.||+|++.... ......+.+|++++..++||||+++++++......++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999987 48999999987542 234456888999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++...+ .+++..+..++.||+.||.|||++ +++||||||+||+++.++.+||+|||++...
T Consensus 81 e~~~g~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~ 151 (333)
T cd05600 81 EYVPGGDFRTLLNNLG------VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGI 151 (333)
T ss_pred eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence 9999999999996433 488999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||.............. + .. .+.
T Consensus 152 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~----~--~~---~~~ 218 (333)
T cd05600 152 VT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY----W--KE---TLQ 218 (333)
T ss_pred cc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHh----c--cc---ccc
Confidence 33 22345789999999999999999999999999999999999999976543221110000 0 00 000
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
..............+.+++.+||..+|.+||++.+++++.+.
T Consensus 219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~ 260 (333)
T cd05600 219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFF 260 (333)
T ss_pred CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCccc
Confidence 000000012345678889999999999999999999987543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=336.59 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=216.5
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCe-eEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNH-RILV 118 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv 118 (391)
-++|..++++|+|+||.+++++.+ +++.+|+|.+.... ....+...+|+.++++++|||||.+.+.+++++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 368999999999999999999977 58899999987663 3445578899999999999999999999998887 9999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|+||+||+|.+.|.... ...++++.+..|+.|++.|+.|||++ .|+|||||+.|||++.++.|+|+|||+++.
T Consensus 83 m~Y~eGg~l~~~i~~~k----~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~ 155 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK----GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKI 155 (426)
T ss_pred EeecCCCCHHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhh
Confidence 99999999999997643 45689999999999999999999998 999999999999999999999999999999
Q ss_pred cCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
+.... ....++.||+.|++||++.+.+|..|+|||||||++|||++-+.+|....... +....
T Consensus 156 l~~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~ki------------- 218 (426)
T KOG0589|consen 156 LNPED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LILKI------------- 218 (426)
T ss_pred cCCch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHHHH-------------
Confidence 86543 24566889999999999999999999999999999999999999997654322 11111
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
........+.....++..++..||+.+|..||++.++|.+
T Consensus 219 ~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 219 NRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred hhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1111235556677889999999999999999999999976
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=328.98 Aligned_cols=241 Identities=25% Similarity=0.322 Sum_probs=195.6
Q ss_pred eeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCCCH
Q 016347 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSL 127 (391)
Q Consensus 52 lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 127 (391)
||+|+||.||+|.+. +++.||+|++... .......+..|+.+++.++||||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999987 4889999998653 233456678899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCceee
Q 016347 128 AQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVS 207 (391)
Q Consensus 128 ~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~~ 207 (391)
.+++...+ .+++..+..++.||+.||.|||++ +++||||||+|||++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~ 150 (312)
T cd05585 81 FHHLQREG------RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKT 150 (312)
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccc
Confidence 99996533 489999999999999999999999 99999999999999999999999999987542221 223
Q ss_pred eeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCC
Q 016347 208 TRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFD 287 (391)
Q Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (391)
....||+.|+|||++.+..++.++|||||||++|+|++|..||....... .... ... .. ...+
T Consensus 151 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~---~~~~---~~~-~~----------~~~~ 213 (312)
T cd05585 151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE---MYRK---ILQ-EP----------LRFP 213 (312)
T ss_pred ccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH---HHHH---HHc-CC----------CCCC
Confidence 34579999999999999999999999999999999999999997543211 1111 000 00 0122
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCC---HHHHHHHh
Q 016347 288 AEEACRFLKVGLLCTQDTPKLRPS---MSTVVQML 319 (391)
Q Consensus 288 ~~~~~~l~~li~~cl~~dP~~Rps---~~evl~~l 319 (391)
......+.+++.+||+.||.+||+ +.+++.+.
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp 248 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHP 248 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCC
Confidence 234457888999999999999985 56666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=325.89 Aligned_cols=267 Identities=24% Similarity=0.400 Sum_probs=204.8
Q ss_pred hhCCCCCCceeeccCceEEEEEEeCC-----------------CcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCcee
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLKD-----------------GKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLV 103 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv 103 (391)
..++|++.++||+|+||.||+|.+.+ +..||+|++... .......+.+|++++..++||||+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 45789999999999999999997532 346999998765 334456789999999999999999
Q ss_pred EEEEEEEeCCeeEEEEecccCCCHHHHHhcCCC-------------CCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 016347 104 KLYGCCVEGNHRILVYNYLENNSLAQTLIGGGH-------------HYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHI 170 (391)
Q Consensus 104 ~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~-------------~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i 170 (391)
++++++.+....++||||+++++|.+++..... ......+++..+..++.||+.||.|||+. ++
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NF 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence 999999999999999999999999999865321 11123578889999999999999999999 99
Q ss_pred eecCCCCCcEEECCCCcEEEEecccccccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh--CC
Q 016347 171 IHRDIKASNILLDKDLTPKISDFGLAKLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS--GR 247 (391)
Q Consensus 171 ~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt--g~ 247 (391)
+|+||||+|||++.++.+||+|||++........ .......++..|+|||++.++.++.++|||||||++|+|++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999976533221 11223345788999999988999999999999999999987 45
Q ss_pred CCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 248 CNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.||....... ............. ... ....+...+..+.+++.+||+.||++|||+.+|.+.|+
T Consensus 240 ~p~~~~~~~~---~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 240 QPYGELTDEQ---VIENAGEFFRDQG-RQV-----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCcCCHHH---HHHHHHHHhhhcc-ccc-----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 6665433221 1111111111000 000 00112234467899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=332.34 Aligned_cols=269 Identities=26% Similarity=0.357 Sum_probs=208.7
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
..++|++++.||+|+||.||++++. ++..||+|++... .......+.+|+++++.++||||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 4589999999999999999999987 5889999998765 3344567899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++.... .+++..+..++.|++.||.|||++. +++||||||+|||++.++.++|+|||++...
T Consensus 83 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 154 (331)
T cd06649 83 EHMDGGSLDQVLKEAK------RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (331)
T ss_pred ecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence 9999999999996533 4889999999999999999999852 5999999999999999999999999998765
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccc-----
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERREL----- 274 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 274 (391)
... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||......+.................
T Consensus 155 ~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 155 IDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISP 231 (331)
T ss_pred ccc---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCc
Confidence 332 123356899999999999889999999999999999999999999654332111100000000000000
Q ss_pred -------------------------ce-eeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 275 -------------------------IL-LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 275 -------------------------~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.. +...............++.+|+.+||+.||++|||+.|++++.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 00 000000000011245578999999999999999999999988643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=336.15 Aligned_cols=255 Identities=27% Similarity=0.415 Sum_probs=215.8
Q ss_pred chHHHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCe
Q 016347 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNH 114 (391)
Q Consensus 35 ~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (391)
.-+.|+|..+....++-||.|+.|.||+|++. ++.||||.++.-.+ .+++-|+.|+||||+.+.|+|...-.
T Consensus 115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPc 186 (904)
T KOG4721|consen 115 QEELWEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPC 186 (904)
T ss_pred hhhhccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCce
Confidence 34567788888888899999999999999997 78899998764332 36788999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
++||||||..|-|..++..+. .+.......|..+||.|+.|||.+ .|+|||||.-||||+.+..|||+|||
T Consensus 187 yCIiMEfCa~GqL~~VLka~~------~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFG 257 (904)
T KOG4721|consen 187 YCIIMEFCAQGQLYEVLKAGR------PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFG 257 (904)
T ss_pred eEEeeeccccccHHHHHhccC------ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEecccc
Confidence 999999999999999997654 588999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 195 LAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 195 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
.++.+.+.. ..-.++||..|||||++...+.++|+||||||||||||+||..|+..-.... .+
T Consensus 258 TS~e~~~~S--TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA---------------II 320 (904)
T KOG4721|consen 258 TSKELSDKS--TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA---------------II 320 (904)
T ss_pred chHhhhhhh--hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe---------------eE
Confidence 998765442 2234789999999999999999999999999999999999999986432211 11
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
..+=...+.-..+..++..|.-|+++||+-.|..||++++++.+|....
T Consensus 321 wGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 321 WGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred EeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 1112233444566788889999999999999999999999999986543
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=334.64 Aligned_cols=254 Identities=25% Similarity=0.333 Sum_probs=199.4
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
.|++++.||+|+||+||+|++. +++.||+|++.... ......+.+|+++++.++||||+++++++.+....++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5889999999999999999876 58899999987542 3345668899999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|++||+|.+++...+ .+++..+..++.||+.||.|||+. ||+||||||+||||+.++.+||+|||++..+.
T Consensus 82 ~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~ 152 (381)
T cd05626 82 YIPGGDMMSLLIRME------VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFR 152 (381)
T ss_pred cCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccc
Confidence 999999999986543 488999999999999999999999 99999999999999999999999999975431
Q ss_pred CCCc----------------------------------------------eeeeeecccccccChhhhhcCCCCCCCcEe
Q 016347 201 ANMT----------------------------------------------HVSTRVAGTIGYLAPEYAIRGQVTRKADIY 234 (391)
Q Consensus 201 ~~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dvw 234 (391)
.... .......||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (381)
T cd05626 153 WTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232 (381)
T ss_pred cccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcccee
Confidence 1000 011235799999999999989999999999
Q ss_pred ehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhh--ccCCCCCCCCCH
Q 016347 235 SFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLL--CTQDTPKLRPSM 312 (391)
Q Consensus 235 SlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~Rps~ 312 (391)
||||++|||++|..||....+..... ...... ..+...........+.+++.+ |+..+|..||++
T Consensus 233 SlG~il~elltG~~Pf~~~~~~~~~~------~i~~~~-------~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 233 SVGVILFEMLVGQPPFLAPTPTETQL------KVINWE-------NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred ehhhHHHHHHhCCCCCcCCCHHHHHH------HHHccc-------cccCCCCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence 99999999999999997654322111 000000 000001111223456667766 556677779999
Q ss_pred HHHHHHhc
Q 016347 313 STVVQMLM 320 (391)
Q Consensus 313 ~evl~~l~ 320 (391)
.+++++-+
T Consensus 300 ~~~l~hp~ 307 (381)
T cd05626 300 DDIKAHPF 307 (381)
T ss_pred HHHhcCcc
Confidence 99998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=325.56 Aligned_cols=269 Identities=27% Similarity=0.381 Sum_probs=213.2
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch--------------hcHHHHHHHHHHHhcCCCCceeE
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR--------------QGVKEFLTEIQVISEIEHENLVK 104 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~iv~ 104 (391)
...-++|++++.||+|.||.|-+|++. +++.||||++.+... ...+...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 344578999999999999999999977 599999999864411 12457889999999999999999
Q ss_pred EEEEEEe--CCeeEEEEecccCCCHHHHHhcCCCCCCccc-cCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 016347 105 LYGCCVE--GNHRILVYNYLENNSLAQTLIGGGHHYSNIQ-FSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNIL 181 (391)
Q Consensus 105 ~~~~~~~--~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~-l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIl 181 (391)
++++..+ ...+|||+|||..|.+...= ...+ +++.++++++.+++.||.|||.+ ||+||||||.|+|
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p-------~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLL 242 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP-------PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLL 242 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC-------CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheE
Confidence 9999875 45899999999988664322 3344 99999999999999999999999 9999999999999
Q ss_pred ECCCCcEEEEecccccccCCCC----ceeeeeecccccccChhhhhcCC----CCCCCcEeehhHHHHHHHhCCCCCCCC
Q 016347 182 LDKDLTPKISDFGLAKLIPANM----THVSTRVAGTIGYLAPEYAIRGQ----VTRKADIYSFGVLLVEIVSGRCNTNMR 253 (391)
Q Consensus 182 v~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~k~DvwSlG~vl~elltg~~p~~~~ 253 (391)
|+.+|+|||+|||.+....... ........|||.|+|||.+.++. .+.+.||||+||+||-|+.|++||..+
T Consensus 243 l~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 243 LSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred EcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 9999999999999998763221 11223368999999999988743 367899999999999999999999765
Q ss_pred CCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCCCCCCCC
Q 016347 254 LPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKDIDDDKITKP 333 (391)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~~~~~~~~~ 333 (391)
...+- .. ++++..+.-.-..+....+.+||.+||++||++|.+..+|..+.+-....+.+.-+.+
T Consensus 323 ~~~~l-------~~--------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~~~s~~ 387 (576)
T KOG0585|consen 323 FELEL-------FD--------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSPQSSEP 387 (576)
T ss_pred hHHHH-------HH--------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCCccCCc
Confidence 33221 11 1222222222233566788899999999999999999999999988877665544433
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=327.23 Aligned_cols=245 Identities=26% Similarity=0.363 Sum_probs=197.6
Q ss_pred CceeeccCceEEEEEEeC----CCcEEEEEEecccc----hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 49 INKIGEGGFGSVYKGRLK----DGKIAAIKVLSAES----RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 49 ~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
++.||+|+||.||+++.. .++.||+|++.... ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 468999999999999853 48899999987532 2233557789999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+++++|.+.+...+ .+.+..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (323)
T cd05584 81 YLSGGELFMHLEREG------IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESI 151 (323)
T ss_pred CCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence 999999999986543 478889999999999999999999 99999999999999999999999999987542
Q ss_pred CCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeec
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT 280 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (391)
... .......|++.|+|||++.+..++.++|||||||++|+|++|+.||........ ... .....
T Consensus 152 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~---~~~----~~~~~------- 216 (323)
T cd05584 152 HEG-TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT---IDK----ILKGK------- 216 (323)
T ss_pred cCC-CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH---HHH----HHcCC-------
Confidence 221 122345789999999999988899999999999999999999999975432111 011 01110
Q ss_pred cCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHhc
Q 016347 281 SLNGDFDAEEACRFLKVGLLCTQDTPKLRP-----SMSTVVQMLM 320 (391)
Q Consensus 281 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~ 320 (391)
...+......+.+++.+||+.||++|| ++.+++++-+
T Consensus 217 ---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~ 258 (323)
T cd05584 217 ---LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258 (323)
T ss_pred ---CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCC
Confidence 011222345688999999999999999 7888887643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=321.14 Aligned_cols=258 Identities=26% Similarity=0.426 Sum_probs=209.2
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
.+..++|+++++||+|++|.||+|...+++.||+|.+..... ..+.+.+|+.+++.++|+||+++++++......+++|
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 455688999999999999999999988888899998765432 3567899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++... ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 81 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 81 EYMAKGSLLDFLKSD----EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVI 153 (261)
T ss_pred ecCCCCcHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceec
Confidence 999999999998643 223578889999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
............++..|+|||++.+..++.++|||||||++|+|++ |..||........ .... ....
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~----~~~~----- 221 (261)
T cd05072 154 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSAL----QRGY----- 221 (261)
T ss_pred CCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHHH----HcCC-----
Confidence 4432222222345678999999988889999999999999999998 8999865432211 1111 1100
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
........+..+.+++.+||+.+|++||+++++.+.|+.
T Consensus 222 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 222 ----RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 001111234578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=329.47 Aligned_cols=255 Identities=25% Similarity=0.290 Sum_probs=204.7
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++|++.+.||+|+||+||+|... +|+.||+|++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999976 58999999987642 234456788999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++.... ..+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 152 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-----DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARL 152 (330)
T ss_pred CCCCCCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeEC
Confidence 9999999999996531 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCceeeeeecccccccChhhhh------cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcc
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAI------RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRE 273 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (391)
............||+.|+|||++. ...++.++|||||||++|+|++|..||......... . .......
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~---~---~i~~~~~ 226 (330)
T cd05601 153 TANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY---N---NIMNFQR 226 (330)
T ss_pred CCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH---H---HHHcCCC
Confidence 543333333457899999999986 456789999999999999999999999754432110 1 1111110
Q ss_pred cceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
. +...........+.+++..||+ +|.+||++.+++++-+
T Consensus 227 ~-------~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~ 265 (330)
T cd05601 227 F-------LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF 265 (330)
T ss_pred c-------cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCC
Confidence 0 0001111234567888889998 9999999999987653
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=327.85 Aligned_cols=244 Identities=27% Similarity=0.319 Sum_probs=198.8
Q ss_pred ceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCC
Q 016347 50 NKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENN 125 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 125 (391)
+.||+|+||.||++... +|+.||+|++... .......+.+|+.+++.++||||+++++++......++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999976 5899999998754 2334566788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCce
Q 016347 126 SLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTH 205 (391)
Q Consensus 126 sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~ 205 (391)
+|...+.... .+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~ 150 (328)
T cd05593 81 ELFFHLSRER------VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AA 150 (328)
T ss_pred CHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cc
Confidence 9998886432 589999999999999999999999 9999999999999999999999999998753222 11
Q ss_pred eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCC
Q 016347 206 VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGD 285 (391)
Q Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (391)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ... ..... ..
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~---~~~----~~~~~----------~~ 213 (328)
T cd05593 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FEL----ILMED----------IK 213 (328)
T ss_pred ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH---HHH----hccCC----------cc
Confidence 22345799999999999988999999999999999999999999965432111 000 00000 01
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHhc
Q 016347 286 FDAEEACRFLKVGLLCTQDTPKLRP-----SMSTVVQMLM 320 (391)
Q Consensus 286 ~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~ 320 (391)
++......+.+++.+||+.||++|+ ++.+++++.+
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 253 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSF 253 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCC
Confidence 2223445788899999999999997 8999988754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=329.90 Aligned_cols=239 Identities=26% Similarity=0.338 Sum_probs=193.4
Q ss_pred CceeeccCceEEEEEEe----CCCcEEEEEEecccch--hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecc
Q 016347 49 INKIGEGGFGSVYKGRL----KDGKIAAIKVLSAESR--QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYL 122 (391)
Q Consensus 49 ~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 122 (391)
++.||+|+||.||+++. .+|+.||+|++..... .....+..|++++++++||||+++++++..+...++||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 36799999999999975 2588999999875422 23345678999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCC
Q 016347 123 ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN 202 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~ 202 (391)
++++|.+++... ..+++..+..++.||+.||.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 81 RGGDLFTRLSKE------VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 151 (318)
T ss_pred CCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence 999999998643 2489999999999999999999999 9999999999999999999999999998765332
Q ss_pred CceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccC
Q 016347 203 MTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSL 282 (391)
Q Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (391)
. .......|++.|+|||++.+..++.++|||||||++|+|++|+.||........ .... .. ..
T Consensus 152 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~~~i---~~-~~--------- 214 (318)
T cd05582 152 E-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET---MTMI---LK-AK--------- 214 (318)
T ss_pred C-CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH---HHHH---Hc-CC---------
Confidence 1 223346789999999999888899999999999999999999999975432111 1110 00 00
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 016347 283 NGDFDAEEACRFLKVGLLCTQDTPKLRPSMST 314 (391)
Q Consensus 283 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 314 (391)
...+......+.+++.+||+.||++||++.+
T Consensus 215 -~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 -LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0112233456788999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=331.81 Aligned_cols=249 Identities=23% Similarity=0.302 Sum_probs=204.3
Q ss_pred hhCCCCCCceeeccCceEEEEEEeCC--CcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLKD--GKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
..++|++.+.||+|+||.||+|.+.. +..||+|.+... .......+.+|+.+++.++||||+++++++.+....+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34689999999999999999998653 468999998654 2334556888999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+||||+++|+|.+++.... .+++..+..++.||+.||.|||++ |++||||||+|||++.++.+||+|||++
T Consensus 108 lv~Ey~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a 178 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNK------RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFA 178 (340)
T ss_pred EEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCC
Confidence 9999999999999996543 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccce
Q 016347 197 KLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL 276 (391)
Q Consensus 197 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (391)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....+... .... .....
T Consensus 179 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~---~~~i----~~~~~-- 245 (340)
T PTZ00426 179 KVVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI---YQKI----LEGII-- 245 (340)
T ss_pred eecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH---HHHH----hcCCC--
Confidence 865322 2346799999999999998899999999999999999999999975433211 1111 11100
Q ss_pred eeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHhc
Q 016347 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRP-----SMSTVVQMLM 320 (391)
Q Consensus 277 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~ 320 (391)
..+......+.+++.+||+.||.+|+ ++++++++.+
T Consensus 246 --------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~ 286 (340)
T PTZ00426 246 --------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286 (340)
T ss_pred --------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCC
Confidence 11122334677899999999999995 8999987754
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=328.66 Aligned_cols=244 Identities=27% Similarity=0.315 Sum_probs=198.4
Q ss_pred ceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCC
Q 016347 50 NKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENN 125 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 125 (391)
+.||+|+||.||++... +|+.||+|++... .......+.+|+.+++.++||||+++++++......++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999976 5899999998754 2234456778999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCce
Q 016347 126 SLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTH 205 (391)
Q Consensus 126 sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~ 205 (391)
+|..++.... .+++..++.++.||+.||.|||++ |++||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~ 150 (323)
T cd05595 81 ELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GA 150 (323)
T ss_pred cHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CC
Confidence 9998886433 589999999999999999999999 9999999999999999999999999998753221 11
Q ss_pred eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCC
Q 016347 206 VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGD 285 (391)
Q Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (391)
......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .... .... ..
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~---~~~~----~~~~----------~~ 213 (323)
T cd05595 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FELI----LMEE----------IR 213 (323)
T ss_pred ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHH----hcCC----------CC
Confidence 22345789999999999999999999999999999999999999965432211 0110 0000 01
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHhc
Q 016347 286 FDAEEACRFLKVGLLCTQDTPKLRP-----SMSTVVQMLM 320 (391)
Q Consensus 286 ~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~ 320 (391)
.+......+.+++.+||+.||++|| ++.+++++-+
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~ 253 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 253 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCC
Confidence 1223345778899999999999998 8999887653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=320.22 Aligned_cols=245 Identities=20% Similarity=0.277 Sum_probs=198.1
Q ss_pred ceeeccCceEEEEEEeCCCcEEEEEEecccchhc---HHHHHHHHHHHhcCCCCceeEEEEEEEe----CCeeEEEEecc
Q 016347 50 NKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQG---VKEFLTEIQVISEIEHENLVKLYGCCVE----GNHRILVYNYL 122 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~ 122 (391)
..||+|++|.||+|.+ +|+.||||.+....... .+.+.+|+.+|++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 48899999987653322 5678899999999999999999999876 34789999999
Q ss_pred cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCC
Q 016347 123 ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN 202 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~ 202 (391)
++|+|.+++... ..+++.....++.|++.||.|||+.. +++||||||+||+++.++.+||+|||++......
T Consensus 105 ~~g~L~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 105 TRGYLREVLDKE------KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred CCCcHHHHHhhC------CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 999999999653 25889999999999999999999732 7889999999999999999999999998865332
Q ss_pred CceeeeeecccccccChhhhhc--CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeec
Q 016347 203 MTHVSTRVAGTIGYLAPEYAIR--GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT 280 (391)
Q Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (391)
. ....|+..|+|||++.+ ..++.++|||||||++|||++|..||......+. .... ...
T Consensus 177 ~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~---~~~i---~~~--------- 237 (283)
T PHA02988 177 P----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI---YDLI---INK--------- 237 (283)
T ss_pred c----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH---HHHH---Hhc---------
Confidence 1 23457889999999876 6899999999999999999999999975432211 1110 000
Q ss_pred cCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 281 SLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 281 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
......+...+..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 238 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 238 NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 001112223456788999999999999999999999998654
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=325.19 Aligned_cols=266 Identities=23% Similarity=0.328 Sum_probs=202.1
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
++|++.++||.|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 67999999999999999999976 58999999987543 22345677899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++ +|.+++...+ ..+++..+..++.||+.||+|||++ |++||||||+|||++.++.+||+|||++.....
T Consensus 85 ~~~-~l~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 85 LDS-DLKQYLDNCG-----NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred CCc-CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 975 8988886432 2478899999999999999999999 999999999999999999999999999876432
Q ss_pred CCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhh---------
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYER--------- 271 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 271 (391)
.. .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......+..............
T Consensus 156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 156 PT-KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred CC-ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 21 12233467899999998865 56899999999999999999999999765443322111111000000
Q ss_pred cccceeeeccCCCCC----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 272 RELILLVDTSLNGDF----DAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 272 ~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
........+...... ......++.+++.+||+.||.+|||++|++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp 286 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHS 286 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCC
Confidence 000000000000000 011234678899999999999999999998763
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=327.48 Aligned_cols=246 Identities=26% Similarity=0.372 Sum_probs=196.4
Q ss_pred CCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHH---hcCCCCceeEEEEEEEeCCeeEEE
Q 016347 46 FSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVI---SEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
|++++.||+|+||.||+|.+. +|+.||||++.... ....+.+..|+.++ +.++||||+++++++......++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999976 58999999987542 22334566666554 566899999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|||+++++|...+.. ..+++..+..++.||+.||.|||+. |++||||||+||+++.++.+||+|||++..
T Consensus 81 ~E~~~~~~L~~~~~~-------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05589 81 MEYAAGGDLMMHIHT-------DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKE 150 (324)
T ss_pred EcCCCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence 999999999988843 3589999999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
.... ........|++.|+|||++.+..++.++|||||||++|+|++|..||........ ... ......
T Consensus 151 ~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~---~~~----i~~~~~---- 218 (324)
T cd05589 151 GMGF-GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV---FDS----IVNDEV---- 218 (324)
T ss_pred CCCC-CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH---HHH----HHhCCC----
Confidence 3222 1223346799999999999999999999999999999999999999975433211 111 110100
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHh
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRP-----SMSTVVQML 319 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l 319 (391)
..+...+..+.+++.+||+.||.+|| ++.+++++.
T Consensus 219 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 219 ------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 11222345678899999999999999 577777654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=334.60 Aligned_cols=254 Identities=26% Similarity=0.334 Sum_probs=199.7
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
.+|+++++||+|+||.||+|++. +++.||+|++.... ......+.+|+++|+.++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 37999999999999999999976 58999999986542 233456788999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.++|+|||++..+
T Consensus 81 E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 81 DYIPGGDMMSLLIRLG------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred eCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 9999999999996543 488999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCC------------------------------------------ceeeeeecccccccChhhhhcCCCCCCCcEeehh
Q 016347 200 PANM------------------------------------------THVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFG 237 (391)
Q Consensus 200 ~~~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG 237 (391)
.... ........||+.|+|||++.+..++.++||||||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 231 (376)
T cd05598 152 RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 231 (376)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecc
Confidence 1000 0001134699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCC---CHHH
Q 016347 238 VLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRP---SMST 314 (391)
Q Consensus 238 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~e 314 (391)
|++|+|++|+.||....+........ .+. ..+...........+.+++.+|+ .+|.+|+ ++.+
T Consensus 232 vilyell~G~~Pf~~~~~~~~~~~i~----~~~---------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~e 297 (376)
T cd05598 232 VILYEMLVGQPPFLADTPAETQLKVI----NWE---------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADE 297 (376)
T ss_pred ceeeehhhCCCCCCCCCHHHHHHHHh----ccC---------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence 99999999999997655432211000 000 00000111123345666777766 4999999 8999
Q ss_pred HHHHhc
Q 016347 315 VVQMLM 320 (391)
Q Consensus 315 vl~~l~ 320 (391)
++++-+
T Consensus 298 ll~h~~ 303 (376)
T cd05598 298 IKAHPF 303 (376)
T ss_pred HhCCCC
Confidence 988754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=330.63 Aligned_cols=263 Identities=22% Similarity=0.280 Sum_probs=206.2
Q ss_pred hHHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEe
Q 016347 36 YKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVE 111 (391)
Q Consensus 36 ~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 111 (391)
.+++....++|++.+.||+|+||.||+|++. +++.+|+|++... .......+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred HHhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 3445556789999999999999999999987 4889999998643 22234557789999999999999999999999
Q ss_pred CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEE
Q 016347 112 GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKIS 191 (391)
Q Consensus 112 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~ 191 (391)
+...++||||+++|+|.+++... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~-------~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~ 184 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSNY-------DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLA 184 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEE
Confidence 99999999999999999998532 478899999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCceeeeeecccccccChhhhhcCC----CCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 016347 192 DFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQ----VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWD 267 (391)
Q Consensus 192 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 267 (391)
|||++...............||+.|+|||++.+.. ++.++|||||||++|+|++|..||........ ...
T Consensus 185 DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~------~~~ 258 (370)
T cd05621 185 DFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT------YSK 258 (370)
T ss_pred ecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH------HHH
Confidence 99999876433322334567999999999987643 78999999999999999999999975533211 111
Q ss_pred HhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHhcC
Q 016347 268 LYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKL--RPSMSTVVQMLMG 321 (391)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~l~~ 321 (391)
....... +.-.........+.+++..||..++.+ |+++.|++++-+.
T Consensus 259 i~~~~~~-------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~ 307 (370)
T cd05621 259 IMDHKNS-------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFF 307 (370)
T ss_pred HHhCCcc-------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCccc
Confidence 1111000 000111123456778888899855543 8899999987543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=321.78 Aligned_cols=257 Identities=23% Similarity=0.322 Sum_probs=205.2
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC----CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK----DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
+..++|++.+.||+|+||.||+|.+. .+..||+|.+.... ......+.+|+..++.++||||+++++++..+...
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 34578999999999999999999754 36789999987653 33345788999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||||+++++|.+++.... ..+++..++.++.||+.||+|||++ +++|+||||+||+++.++.++++|||.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~ 153 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHE-----GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRR 153 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcc
Confidence 99999999999999986532 2589999999999999999999999 999999999999999999999999998
Q ss_pred ccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
................++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~~----~~~~-- 224 (266)
T cd05064 154 LQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IKA----VEDG-- 224 (266)
T ss_pred cccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHH----HHCC--
Confidence 76532221111112334678999999999999999999999999999775 9999865433211 111 1111
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.....+...+..+.+++..||+.+|.+||++.++++.|..
T Consensus 225 -------~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 225 -------FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred -------CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 0111223345678889999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=327.97 Aligned_cols=242 Identities=26% Similarity=0.340 Sum_probs=191.0
Q ss_pred ceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHH-HHhcCCCCceeEEEEEEEeCCeeEEEEecccC
Q 016347 50 NKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQ-VISEIEHENLVKLYGCCVEGNHRILVYNYLEN 124 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 124 (391)
+.||+|+||+||+|.+. +|+.||+|++.... ......+..|.. +++.++||||+++++.+......++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999986 58999999987542 122234444544 56789999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc
Q 016347 125 NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204 (391)
Q Consensus 125 ~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~ 204 (391)
++|..++.... .+++..+..++.||+.||.|||++ |++||||||+|||++.++.+||+|||++...... .
T Consensus 81 g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~ 150 (323)
T cd05575 81 GELFFHLQRER------SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-S 150 (323)
T ss_pred CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-C
Confidence 99999886433 588999999999999999999999 9999999999999999999999999998753222 1
Q ss_pred eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCC
Q 016347 205 HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNG 284 (391)
Q Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (391)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .... ..... .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~----i~~~~------~---- 213 (323)
T cd05575 151 KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---MYDN----ILNKP------L---- 213 (323)
T ss_pred CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH---HHHH----HHcCC------C----
Confidence 22334579999999999999999999999999999999999999997543211 1111 00000 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHH----HHHHH
Q 016347 285 DFDAEEACRFLKVGLLCTQDTPKLRPSMS----TVVQM 318 (391)
Q Consensus 285 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~----evl~~ 318 (391)
......+..+.+++.+||+.||.+||++. +++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 214 RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 11112355688899999999999999985 55544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=332.70 Aligned_cols=254 Identities=25% Similarity=0.336 Sum_probs=202.4
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++|++++.||+|+||.||+|++. +|+.||||++.... ......+.+|++++..++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999986 58999999987542 233456788999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++|+|.+++...+ .+++..+..++.||+.||.|||++ +++||||||+|||++.++.++|+|||++..+
T Consensus 81 E~~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 81 EYLPGGDMMTLLMKKD------TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred CCCCCcHHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceec
Confidence 9999999999996543 489999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCce-------------------------------------eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHH
Q 016347 200 PANMTH-------------------------------------VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVE 242 (391)
Q Consensus 200 ~~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~e 242 (391)
...... .....+||+.|+|||++.+..++.++|||||||++|+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 231 (364)
T cd05599 152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231 (364)
T ss_pred cccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHH
Confidence 221100 1112469999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHHh
Q 016347 243 IVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPS---MSTVVQML 319 (391)
Q Consensus 243 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~evl~~l 319 (391)
|++|..||....+.... .. ...... .+...........+.+++.+|+. +|.+|++ +.+++++-
T Consensus 232 l~~G~~Pf~~~~~~~~~---~~---i~~~~~-------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 232 MLVGYPPFCSDNPQETY---RK---IINWKE-------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred hhcCCCCCCCCCHHHHH---HH---HHcCCC-------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 99999999765432211 10 000000 00000111224467788888997 9999998 99998875
Q ss_pred c
Q 016347 320 M 320 (391)
Q Consensus 320 ~ 320 (391)
+
T Consensus 298 ~ 298 (364)
T cd05599 298 F 298 (364)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=331.99 Aligned_cols=255 Identities=27% Similarity=0.344 Sum_probs=206.8
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++|++.+.||+|+||.||+|.+. +|+.||+|++.... ......+.+|++++..++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999987 58999999987542 234566888999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++... ..+++..+..++.||+.||.|||++ |++||||||+|||++.++.++|+|||++...
T Consensus 81 e~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 151 (350)
T cd05573 81 EYMPGGDLMNLLIRK------DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKM 151 (350)
T ss_pred cCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccC
Confidence 999999999999654 3589999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCC----------------------------ceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCC
Q 016347 200 PANM----------------------------THVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTN 251 (391)
Q Consensus 200 ~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~ 251 (391)
.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~ 231 (350)
T cd05573 152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY 231 (350)
T ss_pred cccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCC
Confidence 4332 112233568999999999999999999999999999999999999997
Q ss_pred CCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHHhcC
Q 016347 252 MRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPS-MSTVVQMLMG 321 (391)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl~~l~~ 321 (391)
........ .. ..... ..+........+..+.+++.+||+ ||.+||+ +.+++++.+.
T Consensus 232 ~~~~~~~~---~~---i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~ 288 (350)
T cd05573 232 SDTLQETY---NK---IINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF 288 (350)
T ss_pred CCCHHHHH---HH---HhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCc
Confidence 65432111 00 00000 000001111135678888999998 9999999 9999987543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=350.95 Aligned_cols=265 Identities=28% Similarity=0.440 Sum_probs=217.7
Q ss_pred HHHhhCCCCCCceeeccCceEEEEEEeC------CCcEEEEEEecccchh-cHHHHHHHHHHHhcCCCCceeEEEEEEEe
Q 016347 39 LSIATDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAESRQ-GVKEFLTEIQVISEIEHENLVKLYGCCVE 111 (391)
Q Consensus 39 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 111 (391)
.++...+.+..+.||+|+||+||+|+.. +.+.||||.++..... ...+|++|++++..++|||||+++|.|.+
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 3445567788899999999999999843 3567999999887554 78899999999999999999999999999
Q ss_pred CCeeEEEEecccCCCHHHHHhcCCCCC--------CccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC
Q 016347 112 GNHRILVYNYLENNSLAQTLIGGGHHY--------SNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLD 183 (391)
Q Consensus 112 ~~~~~lv~e~~~~~sL~~~i~~~~~~~--------~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~ 183 (391)
++..+||+|||..|+|.++|...+... ...+++..+.+.||.|||.||.||-++ .+|||||-.+|.||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence 999999999999999999998543221 133488999999999999999999999 999999999999999
Q ss_pred CCCcEEEEecccccccCCCCceeee-eecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhH
Q 016347 184 KDLTPKISDFGLAKLIPANMTHVST-RVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYL 261 (391)
Q Consensus 184 ~~~~~kl~Dfg~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~ 261 (391)
++..|||+|||+++.+-...-+... ...-..+|||||.|..++|+.++|||||||||||+++ |.-|+.+....+...
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe- 716 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE- 716 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH-
Confidence 9999999999999976433222211 2234579999999999999999999999999999987 667776554433221
Q ss_pred HHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 262 LERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.+..+---..+..++..+..|+..||+.+|++||+++||-..|...
T Consensus 717 ---------------~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 717 ---------------CIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred ---------------HHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 1111111255677888999999999999999999999998888654
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=335.84 Aligned_cols=262 Identities=23% Similarity=0.282 Sum_probs=207.9
Q ss_pred HHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC
Q 016347 37 KELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG 112 (391)
Q Consensus 37 ~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (391)
.+..+..++|++.+.||+|+||.||+|+.. +++.||+|++... .......+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~ 115 (370)
T cd05596 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD 115 (370)
T ss_pred ccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 344556788999999999999999999976 5889999998643 223334577899999999999999999999999
Q ss_pred CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEe
Q 016347 113 NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISD 192 (391)
Q Consensus 113 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~D 192 (391)
...++||||++||+|.+++... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~D 185 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY-------DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD 185 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEe
Confidence 9999999999999999998532 478889999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCceeeeeecccccccChhhhhcC----CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 016347 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRG----QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDL 268 (391)
Q Consensus 193 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 268 (391)
||++...............||+.|+|||++.+. .++.++|||||||++|+|++|..||........ .. ..
T Consensus 186 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~---~i 259 (370)
T cd05596 186 FGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---YS---KI 259 (370)
T ss_pred ccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH---HH---HH
Confidence 999987543322223346799999999998653 478999999999999999999999976543211 11 11
Q ss_pred hhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHhcC
Q 016347 269 YERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKL--RPSMSTVVQMLMG 321 (391)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~l~~ 321 (391)
...... +.-......+..+.+++.+||+.+|.+ |+++.+++++.+.
T Consensus 260 ~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~ 307 (370)
T cd05596 260 MDHKNS-------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFF 307 (370)
T ss_pred HcCCCc-------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCccc
Confidence 110000 000111123557788999999999988 9999999988643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=342.43 Aligned_cols=262 Identities=21% Similarity=0.284 Sum_probs=214.8
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeCCC-cEEEEEEecccchhcHHHHHHHHHHHhcCC-CCceeEEEE-EEEe-----
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLKDG-KIAAIKVLSAESRQGVKEFLTEIQVISEIE-HENLVKLYG-CCVE----- 111 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~-~~~~----- 111 (391)
.+...++++.+.|.+|||+.||+|.+..+ ..||+|++...++...+.+.+|+++|+.|+ |+|||.+++ ....
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 44567789999999999999999998765 999999998888888899999999999996 999999999 3321
Q ss_pred -CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEE
Q 016347 112 -GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKI 190 (391)
Q Consensus 112 -~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl 190 (391)
.-+.+|.||||.||+|-+++.... ...|++.++++|+.|+++|+++||.. .+.|+|||||-+||||+.+|..||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rl----q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRL----QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHH----hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEe
Confidence 136789999999999999997532 23499999999999999999999996 556999999999999999999999
Q ss_pred EecccccccCCCCce---e-----eeeecccccccChhhh---hcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchh
Q 016347 191 SDFGLAKLIPANMTH---V-----STRVAGTIGYLAPEYA---IRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQ 259 (391)
Q Consensus 191 ~Dfg~~~~~~~~~~~---~-----~~~~~gt~~y~aPE~~---~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~ 259 (391)
||||.+.-.-..... . .-...-|+.|+|||++ .+..+++|+|||+|||+||-|+....||+..-.
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---- 263 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---- 263 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----
Confidence 999998743211110 0 0012468999999987 467899999999999999999999999975322
Q ss_pred hHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 016347 260 YLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKDI 325 (391)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~ 325 (391)
..+++..+.-.........|.+||..||+.||.+||++.+|++.+..+...
T Consensus 264 ---------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 264 ---------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ---------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 234444444444568889999999999999999999999999887665443
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=332.42 Aligned_cols=267 Identities=21% Similarity=0.273 Sum_probs=210.1
Q ss_pred eeechHHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEE
Q 016347 32 KLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYG 107 (391)
Q Consensus 32 ~~~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 107 (391)
+..+.+++.+..++|++.+.||+|+||.||+|.+. +++.+|+|++... .......+.+|+.+++.++||||+++++
T Consensus 31 ~~~~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~ 110 (371)
T cd05622 31 TINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110 (371)
T ss_pred HhhHHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 34557777888899999999999999999999987 5889999998643 2233455778999999999999999999
Q ss_pred EEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCc
Q 016347 108 CCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLT 187 (391)
Q Consensus 108 ~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~ 187 (391)
.+.++...++||||+++|+|.+++... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.
T Consensus 111 ~~~~~~~~~lv~Ey~~gg~L~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ 180 (371)
T cd05622 111 AFQDDRYLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGH 180 (371)
T ss_pred EEEcCCEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCC
Confidence 999999999999999999999998532 478889999999999999999999 9999999999999999999
Q ss_pred EEEEecccccccCCCCceeeeeecccccccChhhhhcCC----CCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHH
Q 016347 188 PKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQ----VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLE 263 (391)
Q Consensus 188 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~ 263 (391)
+||+|||++...............||+.|+|||++.+.. ++.++|||||||++|+|++|..||........
T Consensus 181 ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~----- 255 (371)
T cd05622 181 LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT----- 255 (371)
T ss_pred EEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH-----
Confidence 999999999876443322334567999999999987543 78999999999999999999999975433111
Q ss_pred HHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHhcC
Q 016347 264 RTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKL--RPSMSTVVQMLMG 321 (391)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~l~~ 321 (391)
............. .........+.+++.+||..++.+ |+++.+++++.+.
T Consensus 256 -~~~i~~~~~~~~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~ 307 (371)
T cd05622 256 -YSKIMNHKNSLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 307 (371)
T ss_pred -HHHHHcCCCcccC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence 1111111100000 111123456778888999844433 7899999988754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=327.77 Aligned_cols=244 Identities=27% Similarity=0.305 Sum_probs=197.7
Q ss_pred ceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCC
Q 016347 50 NKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENN 125 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 125 (391)
+.||+|+||.||++.+. +|+.||+|++.... ......+..|+++++.++||||+++++++......++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999976 58999999987542 233456778999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc
Q 016347 126 SLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHE-EVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204 (391)
Q Consensus 126 sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~ 204 (391)
+|..++.... .+++..+..++.||+.||.|||+ . |++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~- 150 (325)
T cd05594 81 ELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG- 150 (325)
T ss_pred cHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-
Confidence 9998886432 58999999999999999999997 6 99999999999999999999999999987532221
Q ss_pred eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCC
Q 016347 205 HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNG 284 (391)
Q Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (391)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ... ..... .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~---~~~----i~~~~----------~ 213 (325)
T cd05594 151 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FEL----ILMEE----------I 213 (325)
T ss_pred cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH---HHH----HhcCC----------C
Confidence 122345799999999999999999999999999999999999999965432111 010 00000 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHhc
Q 016347 285 DFDAEEACRFLKVGLLCTQDTPKLRP-----SMSTVVQMLM 320 (391)
Q Consensus 285 ~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~ 320 (391)
.++......+.+++.+||+.||++|+ ++.+++++.+
T Consensus 214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 254 (325)
T cd05594 214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF 254 (325)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCC
Confidence 11222345688899999999999996 8999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=331.55 Aligned_cols=255 Identities=24% Similarity=0.306 Sum_probs=200.0
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++|+++++||+|+||.||+|... +++.||+|++... .......+.+|+++++.+.||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999876 5899999998654 2334566788999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++|+|.+++...+ .+++..+..++.|++.||.|||+. |++||||||+|||++.++.++|+|||+++.+
T Consensus 81 E~~~gg~L~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 81 EFLPGGDLMTMLIKYD------TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred eCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999986433 588999999999999999999999 9999999999999999999999999998633
Q ss_pred CCCCc----------------------------------------------eeeeeecccccccChhhhhcCCCCCCCcE
Q 016347 200 PANMT----------------------------------------------HVSTRVAGTIGYLAPEYAIRGQVTRKADI 233 (391)
Q Consensus 200 ~~~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv 233 (391)
..... ......+||+.|+|||++.+..++.++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 231 (377)
T cd05629 152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW 231 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceee
Confidence 11000 00012469999999999999999999999
Q ss_pred eehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCC---C
Q 016347 234 YSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLR---P 310 (391)
Q Consensus 234 wSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---p 310 (391)
|||||++|+|++|..||....+.... ... ........ +.. .......+.+++.+||+ +|.+| +
T Consensus 232 wSlGvil~elltG~~Pf~~~~~~~~~---~~i---~~~~~~~~-----~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 232 WSLGAIMFECLIGWPPFCSENSHETY---RKI---INWRETLY-----FPD--DIHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred EecchhhhhhhcCCCCCCCCCHHHHH---HHH---HccCCccC-----CCC--CCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 99999999999999999765432211 110 00000000 000 01223467788889997 66665 5
Q ss_pred CHHHHHHHhcC
Q 016347 311 SMSTVVQMLMG 321 (391)
Q Consensus 311 s~~evl~~l~~ 321 (391)
++.|++++.+.
T Consensus 298 ~~~~~l~hp~~ 308 (377)
T cd05629 298 GAHEIKSHPFF 308 (377)
T ss_pred CHHHHhcCCCc
Confidence 99999987543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=316.91 Aligned_cols=251 Identities=24% Similarity=0.427 Sum_probs=202.9
Q ss_pred CCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEeccc
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLE 123 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 123 (391)
++|++.+.||+|+||.||+|.++++..+|+|.+.... .....+.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 5688999999999999999999888889999876442 234678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCC
Q 016347 124 NNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANM 203 (391)
Q Consensus 124 ~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~ 203 (391)
+|+|.+++.... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 83 NGCLLNYLRQRQ-----GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred CCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 999999986432 2488999999999999999999999 99999999999999999999999999987653322
Q ss_pred ceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccC
Q 016347 204 THVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSL 282 (391)
Q Consensus 204 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (391)
........++..|+|||.+.+..++.++||||||+++|+|++ |+.||........ .... .... ..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~i----~~~~--~~----- 220 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEMI----SRGF--RL----- 220 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH----HCCC--CC-----
Confidence 211122234568999999988899999999999999999999 8889865433211 1111 1000 00
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 283 NGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 283 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
..+......+.+++.+||+.+|++||++.++++.|
T Consensus 221 --~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 221 --YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 01112235688999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=323.93 Aligned_cols=242 Identities=29% Similarity=0.375 Sum_probs=192.1
Q ss_pred ceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEEEEecccC
Q 016347 50 NKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILVYNYLEN 124 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 124 (391)
+.||+|+||.||+|.+. +++.||+|++.... ......+..|..++..+ +||||+++++++......++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 48899999987542 22334455666677654 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc
Q 016347 125 NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204 (391)
Q Consensus 125 ~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~ 204 (391)
|+|..++...+ .+++..+..++.||+.||.|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 81 g~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~- 150 (316)
T cd05592 81 GDLMFHIQSSG------RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE- 150 (316)
T ss_pred CcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-
Confidence 99999886433 489999999999999999999999 99999999999999999999999999987643222
Q ss_pred eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCC
Q 016347 205 HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNG 284 (391)
Q Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (391)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .... .... ..
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~~~~----i~~~----------~~ 213 (316)
T cd05592 151 GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---LFDS----ILND----------RP 213 (316)
T ss_pred CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---HHHH----HHcC----------CC
Confidence 22334679999999999999899999999999999999999999997643311 1111 0000 01
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHH-HHHHH
Q 016347 285 DFDAEEACRFLKVGLLCTQDTPKLRPSMS-TVVQM 318 (391)
Q Consensus 285 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl~~ 318 (391)
..+......+.+++.+||+.||++||++. +++++
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 11222345677889999999999999875 55444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=322.75 Aligned_cols=251 Identities=23% Similarity=0.323 Sum_probs=197.0
Q ss_pred ceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEEEEecccC
Q 016347 50 NKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILVYNYLEN 124 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 124 (391)
+.||+|+||.||+|.+. +++.||+|++... .......+..|..++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999976 5889999999754 223345678899999888 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc
Q 016347 125 NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204 (391)
Q Consensus 125 ~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~ 204 (391)
|+|.+++...+ .+++..+..++.||+.||.|||++ |++||||||+||+++.++.+||+|||++...... .
T Consensus 81 g~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~ 150 (329)
T cd05588 81 GDLMFHMQRQR------KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-G 150 (329)
T ss_pred CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-C
Confidence 99998886432 589999999999999999999999 9999999999999999999999999998743211 1
Q ss_pred eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcc--hhhHHHHHHHHhhhcccceeeeccC
Q 016347 205 HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTE--EQYLLERTWDLYERRELILLVDTSL 282 (391)
Q Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (391)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ................ .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~ 222 (329)
T cd05588 151 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------I 222 (329)
T ss_pred CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--------C
Confidence 22334679999999999999999999999999999999999999996432211 0000011111111110 0
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCC------HHHHHHHhc
Q 016347 283 NGDFDAEEACRFLKVGLLCTQDTPKLRPS------MSTVVQMLM 320 (391)
Q Consensus 283 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps------~~evl~~l~ 320 (391)
..+......+.+++.+||+.||.+|++ +.+++++-+
T Consensus 223 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~ 264 (329)
T cd05588 223 --RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPF 264 (329)
T ss_pred --CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCC
Confidence 112223456788999999999999997 677776643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=320.52 Aligned_cols=251 Identities=23% Similarity=0.374 Sum_probs=212.8
Q ss_pred hCCCCCCceeeccCceEEEEEEe-CCCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRL-KDGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
..+|++.+.||+|.||+|-+|.. ..|+.||||.++++ ++...-.+.+|+++|..|+||||++++.+|++.+..++|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 47899999999999999999986 57999999999877 344556688999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|||..+|.|.+++...+ .+++..++.++.||..|+.|||.+ +++|||||-+|||+|.|+.+||+|||++-.
T Consensus 132 MEYaS~GeLYDYiSer~------~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG------SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EEecCCccHHHHHHHhc------cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhh
Confidence 99999999999997654 599999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCceeeeeecccccccChhhhhcCCC-CCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccccee
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILL 277 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (391)
+.. ...-+++||++-|.+||++.+.+| ++..|-|||||+||-|+.|..||++.+-.. ++.. ...+.
T Consensus 203 y~~--~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---lvrQ----Is~Ga---- 269 (668)
T KOG0611|consen 203 YAD--KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---LVRQ----ISRGA---- 269 (668)
T ss_pred hcc--ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---HHHH----hhccc----
Confidence 653 335578999999999999999988 689999999999999999999998753211 1111 11111
Q ss_pred eeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 278 VDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 278 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
+. .++.+.+..-||+|||..||++|.|+.+|..++|-.
T Consensus 270 ----Yr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 270 ----YR---EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred ----cc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 11 122333455678899999999999999999887643
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=335.87 Aligned_cols=266 Identities=24% Similarity=0.376 Sum_probs=206.2
Q ss_pred HHHHhhCCCCCCceeeccCceEEEEEEe------CCCcEEEEEEecccc-hhcHHHHHHHHHHHhcC-CCCceeEEEEEE
Q 016347 38 ELSIATDDFSPINKIGEGGFGSVYKGRL------KDGKIAAIKVLSAES-RQGVKEFLTEIQVISEI-EHENLVKLYGCC 109 (391)
Q Consensus 38 e~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 109 (391)
++.+..++|++.+.||+|+||.||+|.+ .++..||||++.... ......+.+|+.++..+ +||||+++++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 3444556899999999999999999974 236689999987542 33446788999999999 899999999999
Q ss_pred EeCCeeEEEEecccCCCHHHHHhcCCCC----------------------------------------------------
Q 016347 110 VEGNHRILVYNYLENNSLAQTLIGGGHH---------------------------------------------------- 137 (391)
Q Consensus 110 ~~~~~~~lv~e~~~~~sL~~~i~~~~~~---------------------------------------------------- 137 (391)
......++||||+++|+|.+++......
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 9999999999999999999998643210
Q ss_pred -----------------CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 138 -----------------YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 138 -----------------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
.....+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||++....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 0112578889999999999999999999 99999999999999999999999999998654
Q ss_pred CCCce-eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 201 ANMTH-VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 201 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
..... ......++..|+|||++.+..++.++|||||||++|+|++ |..||........ ... .....
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~~~----~~~~~------ 333 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--FYK----MIKEG------ 333 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--HHH----HHHhC------
Confidence 32221 1112334567999999999999999999999999999998 8888865332111 111 11111
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.....+...+.++.+++.+||+.||++||++.||++.|+.
T Consensus 334 ---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 334 ---YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ---ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 0001111224578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=319.31 Aligned_cols=257 Identities=28% Similarity=0.459 Sum_probs=211.7
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
.+..+|++.++||.|+||.||+|.+.+++.+++|.+..........+..|+.+++.++||||+++++++......++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567999999999999999999998899999999987766556788999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+++++|.+++... ....+++..++.++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 83 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 83 LMEKGSLLAFLRSP----EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIK 155 (261)
T ss_pred ecccCCHHHHHhcC----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcC
Confidence 99999999999653 223589999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
.... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||........ .....
T Consensus 156 ~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~~~~~------------- 218 (261)
T cd05148 156 EDVY-LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---YDQIT------------- 218 (261)
T ss_pred Cccc-cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---HHHHH-------------
Confidence 3221 1123345678999999988899999999999999999998 8899865432111 11111
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.......+...+..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 219 AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 001111223445678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=323.48 Aligned_cols=237 Identities=24% Similarity=0.322 Sum_probs=187.7
Q ss_pred ceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHH-HHHhcCCCCceeEEEEEEEeCCeeEEEEecccC
Q 016347 50 NKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEI-QVISEIEHENLVKLYGCCVEGNHRILVYNYLEN 124 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 124 (391)
+.||+|+||.||+|++. +++.||+|++.... ......+..|. .+++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999986 58899999986542 12233444454 467889999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc
Q 016347 125 NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204 (391)
Q Consensus 125 ~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~ 204 (391)
++|...+... ..+++..+..++.||+.||.|||+. +++||||||+||+++.+|.+||+|||++...... .
T Consensus 81 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~ 150 (321)
T cd05603 81 GELFFHLQRE------RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-E 150 (321)
T ss_pred CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-C
Confidence 9999888543 3488899999999999999999999 9999999999999999999999999998753221 1
Q ss_pred eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCC
Q 016347 205 HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNG 284 (391)
Q Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (391)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..... .... .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i----~~~~----------~ 213 (321)
T cd05603 151 ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---MYDNI----LHKP----------L 213 (321)
T ss_pred CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---HHHHH----hcCC----------C
Confidence 12334578999999999998899999999999999999999999997543211 11111 0000 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 016347 285 DFDAEEACRFLKVGLLCTQDTPKLRPSMS 313 (391)
Q Consensus 285 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 313 (391)
..+......+.+++.+||+.||.+||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11223345688899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=322.48 Aligned_cols=244 Identities=24% Similarity=0.334 Sum_probs=196.8
Q ss_pred ceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEEEEecccC
Q 016347 50 NKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILVYNYLEN 124 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 124 (391)
+.||+|+||.||+|++. +++.||+|++... .......+..|.+++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999987 4889999998754 233445677788888866 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc
Q 016347 125 NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204 (391)
Q Consensus 125 ~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~ 204 (391)
++|...+.... .+++..+..++.||+.||.|||++ |++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~- 150 (321)
T cd05591 81 GDLMFQIQRSR------KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG- 150 (321)
T ss_pred CcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-
Confidence 99999886543 488999999999999999999999 99999999999999999999999999987542221
Q ss_pred eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCC
Q 016347 205 HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNG 284 (391)
Q Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (391)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ... ......
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~---~~~----i~~~~~---------- 213 (321)
T cd05591 151 VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL---FES----ILHDDV---------- 213 (321)
T ss_pred ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH---HHH----HHcCCC----------
Confidence 223345789999999999988999999999999999999999999976543211 111 111100
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCC-------CHHHHHHHhc
Q 016347 285 DFDAEEACRFLKVGLLCTQDTPKLRP-------SMSTVVQMLM 320 (391)
Q Consensus 285 ~~~~~~~~~l~~li~~cl~~dP~~Rp-------s~~evl~~l~ 320 (391)
..+......+.+++..||+.||++|| ++.+++++.+
T Consensus 214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~ 256 (321)
T cd05591 214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256 (321)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCc
Confidence 11112345678899999999999999 8888887653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=317.10 Aligned_cols=258 Identities=27% Similarity=0.456 Sum_probs=208.7
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++..++|++.+.||+|++|.||+|.+.+++.||+|.+.... .....+.+|+.++++++||||+++++++...+..++||
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 45668899999999999999999998878889999987543 23467889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++.... ...+++..+..++.|++.||.+||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 81 ELMKYGSLLEYLQGGA----GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVI 153 (261)
T ss_pred ecccCCcHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence 9999999999996532 23589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
.............+..|+|||++.+..++.++||||||+++|+|++ |+.||........ .......
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-------~~~~~~~------ 220 (261)
T cd05068 154 KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV-------LQQVDQG------ 220 (261)
T ss_pred cCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHHcC------
Confidence 4322111111223457999999988899999999999999999999 9989865432111 1111110
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.....+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 221 ---~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 221 ---YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ---CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0011122345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=326.66 Aligned_cols=269 Identities=26% Similarity=0.407 Sum_probs=206.4
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
+..++|++.++||.|+||.||+|.+. ++..+|+|++... .......+.+|+++++.++||||+++++++.+++..++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 45689999999999999999999987 5888999988765 333456788999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|||+++++|.+++...+ .+++..+..++.|++.||.|||+.. +++|+||||+|||++.++.+||+|||++..
T Consensus 82 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 82 MEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (333)
T ss_pred EecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence 99999999999996533 4889999999999999999999741 699999999999999999999999999876
Q ss_pred cCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH----------
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDL---------- 268 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~---------- 268 (391)
.... ......|+..|+|||++.+..++.++|||||||++|+|++|..||..................
T Consensus 154 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 154 LIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred hhhh---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 5322 122346899999999998888999999999999999999999999754332111100000000
Q ss_pred ----------h--hhc------ccce-eeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 269 ----------Y--ERR------ELIL-LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 269 ----------~--~~~------~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
. ..+ .... +................+.+|+.+||+.||++||++.|++++-.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 0 000 0000 00000000000113456889999999999999999999987654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=320.29 Aligned_cols=260 Identities=29% Similarity=0.483 Sum_probs=208.2
Q ss_pred hCCCCCCceeeccCceEEEEEEeCC------CcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLKD------GKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
.++|++.+.||+|+||.||+|.... ...||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 4689999999999999999998653 2579999987543 33456688999999999999999999999998899
Q ss_pred EEEEecccCCCHHHHHhcCCCCC----------CccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHY----------SNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD 185 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~----------~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~ 185 (391)
+++|||+++++|.+++....... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.+
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCC
Confidence 99999999999999997542211 124688999999999999999999999 99999999999999999
Q ss_pred CcEEEEecccccccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHH
Q 016347 186 LTPKISDFGLAKLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLE 263 (391)
Q Consensus 186 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~ 263 (391)
+.++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+. .
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~---~- 236 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV---I- 236 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---H-
Confidence 9999999999876532221 12223456788999999988899999999999999999998 9999875433211 1
Q ss_pred HHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 264 RTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
....... ....+...+..+.+|+.+||+.||.+||++.+|+++|+.
T Consensus 237 ---~~i~~~~---------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 ---EMIRSRQ---------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ---HHHHcCC---------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111111 112233456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=299.82 Aligned_cols=267 Identities=25% Similarity=0.320 Sum_probs=212.8
Q ss_pred HHHHhhCCCCCCceeeccCceEEEEEEe-CCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC----
Q 016347 38 ELSIATDDFSPINKIGEGGFGSVYKGRL-KDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG---- 112 (391)
Q Consensus 38 e~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 112 (391)
.+.|.+++|++.+.||+|||+-||+++. .++..||+|.+.....+..+..++|++..++++|||+++++++...+
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 3456789999999999999999999994 46899999999888777888999999999999999999998876533
Q ss_pred -CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEE
Q 016347 113 -NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKIS 191 (391)
Q Consensus 113 -~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~ 191 (391)
...+++++|+..|+|.+.|..... ....+++.+++.|+.+|++||.+||+. .+.++||||||.||+++..+.++|.
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~--kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKI--KGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhh--cCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEE
Confidence 358999999999999999976432 334689999999999999999999998 2339999999999999999999999
Q ss_pred ecccccccCCCCceee--------eeecccccccChhhhhc---CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhh
Q 016347 192 DFGLAKLIPANMTHVS--------TRVAGTIGYLAPEYAIR---GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQY 260 (391)
Q Consensus 192 Dfg~~~~~~~~~~~~~--------~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~ 260 (391)
|||.+...+-...... ..-..|..|+|||.+.- ...++++|||||||+||.|+.|..||+....
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~----- 246 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ----- 246 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----
Confidence 9999986532111100 11235889999998853 4578999999999999999999999964221
Q ss_pred HHHHHHHHhhhcccce-eeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 261 LLERTWDLYERRELIL-LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 261 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.++.+.. +....+.-......+..+.+++.+||+.||.+||++.+++..+..
T Consensus 247 ---------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 247 ---------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred ---------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 1122211 222233222233467789999999999999999999999988754
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=322.41 Aligned_cols=249 Identities=24% Similarity=0.315 Sum_probs=195.7
Q ss_pred ceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEEEEecccC
Q 016347 50 NKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILVYNYLEN 124 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 124 (391)
+.||+|+||.||+|... +++.||+|++.... ......+..|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 58899999997642 23445678899999888 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc
Q 016347 125 NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204 (391)
Q Consensus 125 ~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~ 204 (391)
++|..++...+ .+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++...... .
T Consensus 81 ~~L~~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~ 150 (327)
T cd05617 81 GDLMFHMQRQR------KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-G 150 (327)
T ss_pred CcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC-C
Confidence 99998886432 589999999999999999999999 9999999999999999999999999998753221 1
Q ss_pred eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCC
Q 016347 205 HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNG 284 (391)
Q Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (391)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||....................... .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------~ 220 (327)
T cd05617 151 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP----------I 220 (327)
T ss_pred CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC----------C
Confidence 223346799999999999999999999999999999999999999964332211111111111111110 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 016347 285 DFDAEEACRFLKVGLLCTQDTPKLRPSM------STVVQM 318 (391)
Q Consensus 285 ~~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~~ 318 (391)
..+...+..+.+++.+||+.||.+|+++ .+++++
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 1122234567789999999999999984 566554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=322.38 Aligned_cols=247 Identities=25% Similarity=0.340 Sum_probs=198.1
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCC-ceeEEEEEEEeCCeeEEEE
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHE-NLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~ 119 (391)
+|++++.||+|+||.||+|+.. +++.||+|++... .......+..|..++..+.|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5889999999999999999977 4789999998754 223455678899999999665 6888999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++|+|.+++...+ .+++..+..++.||+.||.|||++ +++||||||+|||++.++.++|+|||++...
T Consensus 81 E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 81 EYVNGGDLMYHIQQVG------KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred cCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 9999999999986543 488999999999999999999999 9999999999999999999999999998753
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .... ....
T Consensus 152 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~~~i----~~~~------ 217 (324)
T cd05587 152 IFG-GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---FQSI----MEHN------ 217 (324)
T ss_pred CCC-CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHH----HcCC------
Confidence 221 1123346799999999999999999999999999999999999999975432211 1111 0000
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSM-----STVVQM 318 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~ 318 (391)
...+......+.+++.+||+.||.+|++. .+++++
T Consensus 218 ----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 218 ----VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 01122234567889999999999999976 566554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=317.24 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=207.1
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
+...+|++.++||+|++|.||+|.+. .++.||+|.+.... .....+.+|+++++.++||||+++++++..+...+++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 44567899999999999999999976 48899999987543 33567889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++... ....+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++...
T Consensus 82 e~~~~~~L~~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~ 154 (263)
T cd05052 82 EFMTYGNLLDYLREC----NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM 154 (263)
T ss_pred EeCCCCcHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccc
Confidence 999999999998643 223588999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
............++..|+|||.+.+..++.++|||||||++|+|++ |..||....... .+......
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~------ 221 (263)
T cd05052 155 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKG------ 221 (263)
T ss_pred ccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCC------
Confidence 4332221122234568999999998999999999999999999998 888886543211 11111110
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.....+...+..+.+++.+||+.||++||++.++++.|+.
T Consensus 222 ---~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 222 ---YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 1111222334678889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=326.76 Aligned_cols=203 Identities=25% Similarity=0.400 Sum_probs=176.5
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++|++++.||+|+||+||+|... +++.||+|++.... ......+..|+.++..++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 57999999999999999999876 58999999987542 233456788999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||++||+|.+++...+ .+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++..+
T Consensus 81 E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~ 151 (363)
T cd05628 81 EFLPGGDMMTLLMKKD------TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL 151 (363)
T ss_pred cCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence 9999999999996543 589999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCc----------------------------------eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh
Q 016347 200 PANMT----------------------------------HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245 (391)
Q Consensus 200 ~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt 245 (391)
..... ......+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 231 (363)
T cd05628 152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (363)
T ss_pred cccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHh
Confidence 22100 00123579999999999999999999999999999999999
Q ss_pred CCCCCCCCCC
Q 016347 246 GRCNTNMRLP 255 (391)
Q Consensus 246 g~~p~~~~~~ 255 (391)
|..||....+
T Consensus 232 G~~Pf~~~~~ 241 (363)
T cd05628 232 GYPPFCSETP 241 (363)
T ss_pred CCCCCCCCCH
Confidence 9999976543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=334.16 Aligned_cols=265 Identities=25% Similarity=0.407 Sum_probs=206.3
Q ss_pred HHHhhCCCCCCceeeccCceEEEEEEeC------CCcEEEEEEecccc-hhcHHHHHHHHHHHhcC-CCCceeEEEEEEE
Q 016347 39 LSIATDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAES-RQGVKEFLTEIQVISEI-EHENLVKLYGCCV 110 (391)
Q Consensus 39 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 110 (391)
|....++|++.+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|+++++.+ +|+||+++++.+.
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 3455678999999999999999999853 24579999987543 33456688999999999 8999999999999
Q ss_pred eCCeeEEEEecccCCCHHHHHhcCCCC-----------------------------------------------------
Q 016347 111 EGNHRILVYNYLENNSLAQTLIGGGHH----------------------------------------------------- 137 (391)
Q Consensus 111 ~~~~~~lv~e~~~~~sL~~~i~~~~~~----------------------------------------------------- 137 (391)
.....++||||+++|+|.+++......
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 999999999999999999998642110
Q ss_pred -----------CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCce-
Q 016347 138 -----------YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTH- 205 (391)
Q Consensus 138 -----------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~- 205 (391)
....++++..++.++.||+.||.|||++ |++||||||+|||++.++.++|+|||++.........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence 0123578889999999999999999999 9999999999999999999999999998765432211
Q ss_pred eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCC
Q 016347 206 VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNG 284 (391)
Q Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (391)
......++..|+|||++.+..++.++|||||||++|+|++ |..||........ . ....... ...
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~----~~~~~~~---------~~~ 334 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--F----YKMVKRG---------YQM 334 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--H----HHHHHcc---------cCc
Confidence 1112234567999999988899999999999999999997 9999865432211 0 0101100 010
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 285 DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 285 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
..+...+..+.+++.+||+.||.+||++.+|++.|+.
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1111224578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=314.93 Aligned_cols=253 Identities=26% Similarity=0.444 Sum_probs=203.8
Q ss_pred hCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecc
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYL 122 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 122 (391)
.++|++.+.||+|+||.||+|++.++..+|+|.+.... .....+.+|+.+++.++||||+++++++......++||||+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 46789999999999999999998877779999887543 23467899999999999999999999999888899999999
Q ss_pred cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCC
Q 016347 123 ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN 202 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~ 202 (391)
.+++|.+++.... ..+++..++.++.||+.||.|||+. +++|+||||.||+++.++.+||+|||.+......
T Consensus 82 ~~~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 82 SNGCLLNYLREHG-----KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred CCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 9999999986532 2589999999999999999999999 9999999999999999999999999998765433
Q ss_pred CceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 203 MTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
.........++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ... .....
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~~----~~~~~-------- 218 (256)
T cd05113 154 EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET---VEK----VSQGL-------- 218 (256)
T ss_pred ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHH----HhcCC--------
Confidence 2211112235568999999988889999999999999999998 9989864432111 011 11100
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
....+......+.+++.+||+.+|.+||++.++++.|+
T Consensus 219 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 219 -RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00111123467889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=331.08 Aligned_cols=265 Identities=20% Similarity=0.181 Sum_probs=201.0
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
+...+|++++.||+|+||.||++.+. +++.||+|.... ..+.+|++++++++||||+++++++......++|+
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 34578999999999999999999976 588999997432 34678999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
|++. ++|..++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 163 e~~~-~~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 163 PRYK-TDLYCYLAAK------RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFP 232 (391)
T ss_pred ecCC-CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence 9995 6788887543 2488999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchh----hHHHHHHHHhhh----
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQ----YLLERTWDLYER---- 271 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~----~~~~~~~~~~~~---- 271 (391)
............||+.|+|||++.+..++.++|||||||++|+|++|..||......... ............
T Consensus 233 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~ 312 (391)
T PHA03212 233 VDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE 312 (391)
T ss_pred ccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence 332222334567999999999999999999999999999999999999887543221100 000000000000
Q ss_pred ---------ccc----ceeeeccCCCCC----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 272 ---------REL----ILLVDTSLNGDF----DAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 272 ---------~~~----~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
... ............ ....+..+.+|+.+||+.||.+|||+.|++++-+.
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f 379 (391)
T PHA03212 313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAF 379 (391)
T ss_pred cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhh
Confidence 000 000000000000 01234578899999999999999999999986543
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=342.03 Aligned_cols=254 Identities=19% Similarity=0.290 Sum_probs=205.6
Q ss_pred CCCCCCceeeccCceEEEEEEeC-C-CcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-D-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
..|.+.+.||+|++|.||+|... + ++.||+|.+..........+..|+.+|+.++||||+++++++..++..++||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 34999999999999999999865 3 678899987666555556788899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
++||+|.+.+..... ...++++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 147 ~~gg~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 147 GSGGDLNKQIKQRLK--EHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred CCCCCHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 999999998854211 234688999999999999999999999 999999999999999999999999999987643
Q ss_pred CCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeec
Q 016347 202 NMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT 280 (391)
Q Consensus 202 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (391)
... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..... .. ...
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~~~~~---~~-~~~------ 288 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---IMQQV---LY-GKY------ 288 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH---Hh-CCC------
Confidence 321 22344679999999999999999999999999999999999999996543211 11110 00 000
Q ss_pred cCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 281 SLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 281 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
...+......+.+++.+||+.||++||++.+++++
T Consensus 289 ---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 289 ---DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ---CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 01122334578899999999999999999999753
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=298.11 Aligned_cols=252 Identities=27% Similarity=0.378 Sum_probs=213.2
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
-++|++.+.||+|.||.||+|+.+ ++..||+|++.+.. .....++.+|+++-..|+||||++++++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 388999999999999999999976 58889999987662 33456788999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
+||..+|+|...+..+ ...++++.....++.|+|.||.|+|.+ +++||||||+|+|++.+|.+|++|||.+..
T Consensus 101 lEya~~gel~k~L~~~----~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG----RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred EEecCCchHHHHHHhc----ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceee
Confidence 9999999999999754 334689999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
-+ .....+.|||..|++||...+..++.+.|+|++|++.||++.|..||......+. .... ..-
T Consensus 174 ~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et---YkrI----~k~------ 237 (281)
T KOG0580|consen 174 AP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET---YKRI----RKV------ 237 (281)
T ss_pred cC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH---HHHH----HHc------
Confidence 43 2234568999999999999999999999999999999999999999975542111 1111 100
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.-.++...+....++|..|+..+|.+|.+..|++++.+.
T Consensus 238 ----~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 238 ----DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred ----cccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence 012234556678899999999999999999999998754
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=323.78 Aligned_cols=241 Identities=25% Similarity=0.313 Sum_probs=189.3
Q ss_pred ceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHH-HHHHhcCCCCceeEEEEEEEeCCeeEEEEecccC
Q 016347 50 NKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTE-IQVISEIEHENLVKLYGCCVEGNHRILVYNYLEN 124 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e-~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 124 (391)
+.||+|+||.||+|++. +++.||+|++.... ......+..| ..+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999987 47889999987542 1222333444 3456788999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc
Q 016347 125 NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204 (391)
Q Consensus 125 ~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~ 204 (391)
++|.+++.... .+.+..+..++.||+.||.|||++ |++||||||+|||++.++.+||+|||++...... .
T Consensus 81 ~~L~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~ 150 (325)
T cd05602 81 GELFYHLQRER------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-N 150 (325)
T ss_pred CcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccC-C
Confidence 99999986533 478888999999999999999999 9999999999999999999999999998754222 1
Q ss_pred eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCC
Q 016347 205 HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNG 284 (391)
Q Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (391)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .... .... .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i----~~~~--------~-- 213 (325)
T cd05602 151 GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YDNI----LNKP--------L-- 213 (325)
T ss_pred CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---HHHH----HhCC--------c--
Confidence 123346799999999999999999999999999999999999999975432211 1111 0000 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016347 285 DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317 (391)
Q Consensus 285 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 317 (391)
.........+.+++.+||+.||.+||++.+.+.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 111223456788899999999999999874443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=303.95 Aligned_cols=268 Identities=24% Similarity=0.287 Sum_probs=209.0
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch--hcHHHHHHHHHHHhcCCCCceeEEEEEEEe--CCeeEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR--QGVKEFLTEIQVISEIEHENLVKLYGCCVE--GNHRILV 118 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 118 (391)
+.|+++..|++|.||.||+|+++ +++.||+|.++.+.+ ..--...+|+.+|.+++|||||.+-.+..- -+..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 56899999999999999999987 599999999987642 223346789999999999999999998873 3579999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
||||+. +|..++.... .++...++..++.|++.|++|||.. .|+||||||+|+|++..|.+||+|||+++.
T Consensus 156 Me~~Eh-DLksl~d~m~-----q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK-----QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred HHHHHh-hHHHHHHhcc-----CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhh
Confidence 999976 7888886533 4799999999999999999999999 999999999999999999999999999999
Q ss_pred cCCCCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccccee
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILL 277 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (391)
++.. ....+..+-|..|+|||++.+. .|+.+.|+||+|||+.||+++.+.|.+....+....+-..........+..+
T Consensus 227 ygsp-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 227 YGSP-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred hcCC-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 8765 3345566779999999999875 5999999999999999999999989887665543333222211111111110
Q ss_pred -----e---------eccCCCCCCHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 278 -----V---------DTSLNGDFDAE-EACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 278 -----~---------~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
+ -..+...+... ....-.+|+..+|..||.+|.|++|.|++=..
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F 364 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYF 364 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccc
Confidence 0 00111111111 22445677889999999999999999987543
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=328.74 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=199.6
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
.++|+.+++||+|+||.||+|.+. +++.||||++.... ......+.+|+++++.++|+||+++++++...+..++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 356788899999999999999976 58999999986543 3345678899999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+++++|.+.. ...+..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++....
T Consensus 153 ~~~~~~L~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~ 219 (353)
T PLN00034 153 FMDGGSLEGTH----------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILA 219 (353)
T ss_pred cCCCCcccccc----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence 99999886432 356778889999999999999999 99999999999999999999999999998654
Q ss_pred CCCceeeeeecccccccChhhhhc-----CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIR-----GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
... .......||..|+|||++.. ...+.++|||||||++|+|++|+.||............... .. .
T Consensus 220 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~---~~-~--- 291 (353)
T PLN00034 220 QTM-DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI---CM-S--- 291 (353)
T ss_pred ccc-ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH---hc-c---
Confidence 321 12234578999999998743 23456899999999999999999999743222111111000 00 0
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
............+.+|+.+||+.||++||++.|++++-+-..
T Consensus 292 ------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~ 333 (353)
T PLN00034 292 ------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILR 333 (353)
T ss_pred ------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence 001122234567889999999999999999999999865443
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=318.67 Aligned_cols=266 Identities=23% Similarity=0.357 Sum_probs=197.1
Q ss_pred CCCCCCceeeccCceEEEEEEeC--CCcEEEEEEecccc--hhcHHHHHHHHHHHhcC---CCCceeEEEEEEE-----e
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK--DGKIAAIKVLSAES--RQGVKEFLTEIQVISEI---EHENLVKLYGCCV-----E 111 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~-----~ 111 (391)
++|++.+.||+|+||.||+|++. +++.||+|.+.... ......+.+|+.+++.+ .||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47999999999999999999874 47889999886542 22234456677777665 6999999999885 2
Q ss_pred CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEE
Q 016347 112 GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKIS 191 (391)
Q Consensus 112 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~ 191 (391)
....++||||++ ++|.+++... ....+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~ 152 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV----PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 152 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEc
Confidence 456899999996 5898888643 223588999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhh
Q 016347 192 DFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYER 271 (391)
Q Consensus 192 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 271 (391)
|||++...... .......|++.|+|||++.+..++.++|||||||++|+|++|..||.....................
T Consensus 153 Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~ 230 (290)
T cd07862 153 DFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 230 (290)
T ss_pred cccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence 99999765432 2233456899999999998889999999999999999999999999865443221111110000000
Q ss_pred cccc---eeeeccCC--C-----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 272 RELI---LLVDTSLN--G-----DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 272 ~~~~---~~~~~~~~--~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.... ......+. . .........+.+++.+||+.||++|||+.|++++-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp 288 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 288 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCC
Confidence 0000 00000000 0 00012345678999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=313.74 Aligned_cols=257 Identities=30% Similarity=0.493 Sum_probs=206.2
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++..++|++.++||+|++|.||+|.+.++..+|+|.+..... ....+.+|+.++++++|+|++++++++. ....+++|
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT 79 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence 456689999999999999999999988888899999876433 3467889999999999999999999875 45688999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 80 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 80 EYMSKGSLLDFLKDGE----GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLI 152 (260)
T ss_pred EecCCCcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeec
Confidence 9999999999986532 23588999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
............++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .... ....
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~----~~~~------ 219 (260)
T cd05070 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQ----VERG------ 219 (260)
T ss_pred cCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH----HHcC------
Confidence 4332222222335567999999988899999999999999999999 888886543211 1111 1110
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.....+...+..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 220 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 ---YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111223345678999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=318.30 Aligned_cols=259 Identities=27% Similarity=0.463 Sum_probs=208.0
Q ss_pred hCCCCCCceeeccCceEEEEEEeCC------CcEEEEEEecccchh-cHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLKD------GKIAAIKVLSAESRQ-GVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
.++|.+.+.||+|+||.||+|.+.+ +..||+|.+...... ....+.+|+++++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4679999999999999999998642 478999998765433 456889999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCC--------CCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCc
Q 016347 116 ILVYNYLENNSLAQTLIGGGH--------HYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLT 187 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~--------~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~ 187 (391)
++||||+++++|.+++...+. ......+++..+..++.|++.|+.|||++ +++|+||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 999999999999999976432 12334588999999999999999999999 9999999999999999999
Q ss_pred EEEEecccccccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHH
Q 016347 188 PKISDFGLAKLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERT 265 (391)
Q Consensus 188 ~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 265 (391)
++|+|||++........ .......+++.|+|||++.+..++.++|||||||++|+|++ |..||........ ...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~~- 236 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IEC- 236 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHH-
Confidence 99999999875432211 11223345678999999999999999999999999999998 9999865433211 111
Q ss_pred HHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 266 WDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
..... ....+...+..+.+++.+||+.||++||++.||++.|.
T Consensus 237 ---~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 ---ITQGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ---HHcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11111 11112234567889999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=321.38 Aligned_cols=243 Identities=26% Similarity=0.388 Sum_probs=195.2
Q ss_pred ceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEEEEecccC
Q 016347 50 NKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILVYNYLEN 124 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 124 (391)
+.||+|+||.||+|++. +++.||+|++... .......+..|..++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999986 5889999998754 223445677788888776 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc
Q 016347 125 NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204 (391)
Q Consensus 125 ~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~ 204 (391)
++|.+++.... .+++..+..++.||+.||.|||++ +++||||||+|||++.++.++|+|||++...... .
T Consensus 81 g~L~~~i~~~~------~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~ 150 (320)
T cd05590 81 GDLMFHIQKSR------RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-G 150 (320)
T ss_pred chHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-C
Confidence 99999886543 489999999999999999999999 9999999999999999999999999998753222 1
Q ss_pred eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCC
Q 016347 205 HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNG 284 (391)
Q Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (391)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ... ......
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~~~----i~~~~~---------- 213 (320)
T cd05590 151 KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL---FEA----ILNDEV---------- 213 (320)
T ss_pred CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HHH----HhcCCC----------
Confidence 223345799999999999988999999999999999999999999975433211 111 111110
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHHh
Q 016347 285 DFDAEEACRFLKVGLLCTQDTPKLRPSM------STVVQML 319 (391)
Q Consensus 285 ~~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~~l 319 (391)
..+......+.+++.+||+.||.+||++ ++++.+-
T Consensus 214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~ 254 (320)
T cd05590 214 VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHP 254 (320)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCC
Confidence 1112234567889999999999999998 6666543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=313.54 Aligned_cols=257 Identities=30% Similarity=0.479 Sum_probs=207.4
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++..++|+++++||+|+||.||+|...+++.||+|.+..... ....+.+|+.++++++|+||+++++++. ....+++|
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 566789999999999999999999988899999999875433 3467889999999999999999999874 45689999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+.+++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 80 e~~~~~~L~~~~~~~----~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 152 (260)
T cd05067 80 EYMENGSLVDFLKTP----EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLI 152 (260)
T ss_pred EcCCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeec
Confidence 999999999998643 233688999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
............++..|+|||++.+..++.++||||||+++|+|++ |+.||........ ... ....
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~----~~~~------ 219 (260)
T cd05067 153 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQN----LERG------ 219 (260)
T ss_pred CCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HHH----HHcC------
Confidence 4322222222345678999999988899999999999999999999 9999975432211 111 1110
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.....+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 220 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 220 ---YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0011112234578899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=329.43 Aligned_cols=252 Identities=26% Similarity=0.348 Sum_probs=197.4
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
+|+++++||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+++.++||||+++++.+.+....++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 6899999999999999999976 58899999987542 2344568889999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+++|+|.+++...+ .+++..+..++.||+.||.|||++ +|+||||||+|||++.+|.+||+|||++..+.
T Consensus 82 ~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~ 152 (382)
T cd05625 82 YIPGGDMMSLLIRMG------IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (382)
T ss_pred CCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccc
Confidence 999999999986543 488999999999999999999999 99999999999999999999999999975321
Q ss_pred CCC----------------------------------------------ceeeeeecccccccChhhhhcCCCCCCCcEe
Q 016347 201 ANM----------------------------------------------THVSTRVAGTIGYLAPEYAIRGQVTRKADIY 234 (391)
Q Consensus 201 ~~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dvw 234 (391)
... .......+||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (382)
T cd05625 153 WTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEE
Confidence 000 0001234689999999999999999999999
Q ss_pred ehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCC---
Q 016347 235 SFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPS--- 311 (391)
Q Consensus 235 SlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps--- 311 (391)
||||++|+|++|+.||....+....... ... ...+...........+.+++.+|+ .+|.+|++
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~~~~i------~~~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~ 298 (382)
T cd05625 233 SVGVILYEMLVGQPPFLAQTPLETQMKV------INW-------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNG 298 (382)
T ss_pred echHHHHHHHhCCCCCCCCCHHHHHHHH------Hcc-------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCC
Confidence 9999999999999999765442211100 000 000000111122345666666665 49999997
Q ss_pred HHHHHHHh
Q 016347 312 MSTVVQML 319 (391)
Q Consensus 312 ~~evl~~l 319 (391)
+.+++++-
T Consensus 299 ~~ei~~hp 306 (382)
T cd05625 299 ADEIKAHP 306 (382)
T ss_pred HHHHhcCC
Confidence 88887664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=318.32 Aligned_cols=250 Identities=24% Similarity=0.326 Sum_probs=195.6
Q ss_pred ceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEEEEecccC
Q 016347 50 NKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILVYNYLEN 124 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 124 (391)
+.||+|+||.||+|.+. +++.||+|++... .......+..|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 5889999998754 223445677888888776 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc
Q 016347 125 NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204 (391)
Q Consensus 125 ~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~ 204 (391)
++|...+... ..+++..+..++.||+.||.|||++ +++||||||+||+++.++.+||+|||++...... .
T Consensus 81 ~~L~~~~~~~------~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~ 150 (329)
T cd05618 81 GDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-G 150 (329)
T ss_pred CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-C
Confidence 9999888643 2589999999999999999999999 9999999999999999999999999998753221 1
Q ss_pred eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcch--hhHHHHHHHHhhhcccceeeeccC
Q 016347 205 HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEE--QYLLERTWDLYERRELILLVDTSL 282 (391)
Q Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 282 (391)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...............
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--------- 221 (329)
T cd05618 151 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--------- 221 (329)
T ss_pred CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC---------
Confidence 122346789999999999999999999999999999999999999963221111 000111111111110
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCC------HHHHHHHh
Q 016347 283 NGDFDAEEACRFLKVGLLCTQDTPKLRPS------MSTVVQML 319 (391)
Q Consensus 283 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps------~~evl~~l 319 (391)
...+......+.+++.+||+.||++||+ +.+++++-
T Consensus 222 -~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp 263 (329)
T cd05618 222 -IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 263 (329)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCC
Confidence 1122334456788999999999999998 46776653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=322.80 Aligned_cols=240 Identities=26% Similarity=0.323 Sum_probs=189.5
Q ss_pred ceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHH-HHhcCCCCceeEEEEEEEeCCeeEEEEecccC
Q 016347 50 NKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQ-VISEIEHENLVKLYGCCVEGNHRILVYNYLEN 124 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 124 (391)
+.||+|+||.||+|+.. +|+.||+|++.... ......+..|.. +++.++||||+++++.+......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999976 58999999987542 223344455554 56778999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc
Q 016347 125 NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204 (391)
Q Consensus 125 ~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~ 204 (391)
++|...+.... .+++..+..++.||+.||.|||++ |++||||||+|||++.++.+||+|||++...... .
T Consensus 81 ~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~ 150 (325)
T cd05604 81 GELFFHLQRER------SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-S 150 (325)
T ss_pred CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-C
Confidence 99998886433 589999999999999999999999 9999999999999999999999999998753221 1
Q ss_pred eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCC
Q 016347 205 HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNG 284 (391)
Q Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (391)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ... ......
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~---~~~----~~~~~~---------- 213 (325)
T cd05604 151 DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM---YDN----ILHKPL---------- 213 (325)
T ss_pred CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH---HHH----HHcCCc----------
Confidence 123346799999999999999999999999999999999999999975432211 111 111100
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 016347 285 DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVV 316 (391)
Q Consensus 285 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 316 (391)
.........+.+++.+||+.+|.+||++.+.+
T Consensus 214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 214 VLRPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 01112345677889999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=319.39 Aligned_cols=266 Identities=23% Similarity=0.344 Sum_probs=200.3
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch-hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR-QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
.++|++.++||+|+||.||+|+.. +++.||+|++..... .....+.+|+.+++.++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999987 589999999875432 223457789999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+. ++|.+++.... ..+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 84 YVH-TDLCQYMDKHP-----GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCC-cCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 996 57777775432 3488899999999999999999999 99999999999999999999999999987543
Q ss_pred CCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcc---c--
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRE---L-- 274 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~-- 274 (391)
... .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||......... ............ .
T Consensus 155 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 155 VPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ--LERIFLVLGTPNEDTWPG 231 (303)
T ss_pred CCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhCCCChhhccc
Confidence 221 12233567899999999865 45789999999999999999999999764332111 111110000000 0
Q ss_pred ----ceeeeccCC--CCCCH-------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 275 ----ILLVDTSLN--GDFDA-------EEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 275 ----~~~~~~~~~--~~~~~-------~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
......... ..... .....+.+++.+||+.||++|||+.|++++-+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~ 290 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence 000000000 00000 01245778999999999999999999998654
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=342.15 Aligned_cols=262 Identities=25% Similarity=0.343 Sum_probs=209.2
Q ss_pred hHHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC
Q 016347 36 YKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG 112 (391)
Q Consensus 36 ~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (391)
..+.....++|++.+.||+|+||+||+|++. +|+.||||++... .......+.+|+..+..++|+||+++++.+...
T Consensus 24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 3445556789999999999999999999865 6999999998654 334456688899999999999999998876532
Q ss_pred C--------eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC
Q 016347 113 N--------HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK 184 (391)
Q Consensus 113 ~--------~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~ 184 (391)
. ..++||||+++|+|.+++..... ....+++..+..++.|++.||.|||++ +|+||||||+|||++.
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~--~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~ 178 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAK--TNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCS 178 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeC
Confidence 2 36899999999999999865322 345689999999999999999999999 9999999999999999
Q ss_pred CCcEEEEecccccccCCCC-ceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHH
Q 016347 185 DLTPKISDFGLAKLIPANM-THVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLE 263 (391)
Q Consensus 185 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~ 263 (391)
++.+||+|||+++.+.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ...
T Consensus 179 ~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~---~~~ 255 (496)
T PTZ00283 179 NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE---VMH 255 (496)
T ss_pred CCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHH
Confidence 9999999999998654321 222344679999999999999999999999999999999999999997543211 111
Q ss_pred HHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 264 RTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
.. .. .. ....+...+..+.+++.+||+.||.+||++.+++++
T Consensus 256 ~~---~~-~~---------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 KT---LA-GR---------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HH---hc-CC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 10 00 00 011222345678899999999999999999999875
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=312.08 Aligned_cols=269 Identities=24% Similarity=0.311 Sum_probs=211.1
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEec--ccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEe-----C
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLS--AESRQGVKEFLTEIQVISEIEHENLVKLYGCCVE-----G 112 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~ 112 (391)
.....|..++.||+|+||.|+.|.+. +|+.||||.+. ..+....++..+|+.+|+.++|+||+.+.+++.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34567777899999999999999977 69999999987 4466677888999999999999999999999865 3
Q ss_pred CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEe
Q 016347 113 NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISD 192 (391)
Q Consensus 113 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~D 192 (391)
+..|+|+|+| +.+|...|..+. .++...+..+++||++||.|+|+. +++||||||.|++++.+..+|++|
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~------~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~D 168 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQ------DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICD 168 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCc------cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecc
Confidence 5789999999 558999996543 499999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCC-CceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh
Q 016347 193 FGLAKLIPAN-MTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE 270 (391)
Q Consensus 193 fg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 270 (391)
||+++..... .....+..+.|..|.|||++.. ..|+.+.||||.||||.||++|+.-|.+........++........
T Consensus 169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS 248 (359)
T ss_pred ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence 9999987543 1223456678999999998754 6799999999999999999999999988765544333322221111
Q ss_pred hcc--------cceeeeccC---CC---CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 271 RRE--------LILLVDTSL---NG---DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 271 ~~~--------~~~~~~~~~---~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
... +...+.... .. ...+......++|+.+||..||.+|+|++|.|++.
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 111 111111100 00 11113445678888899999999999999999874
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=319.38 Aligned_cols=243 Identities=27% Similarity=0.364 Sum_probs=193.5
Q ss_pred ceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEEEEecccC
Q 016347 50 NKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILVYNYLEN 124 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 124 (391)
+.||+|+||.||+|++. +|+.||+|++.... ......+..|..++... +||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999987 58899999987542 22345566777787754 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc
Q 016347 125 NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204 (391)
Q Consensus 125 ~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~ 204 (391)
++|..++...+ .+++..+..++.||+.||+|||++ |++||||||+||+++.++.++|+|||++...... .
T Consensus 81 g~L~~~i~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 150 (316)
T cd05620 81 GDLMFHIQDKG------RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-D 150 (316)
T ss_pred CcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-C
Confidence 99999886533 488999999999999999999999 9999999999999999999999999998743211 1
Q ss_pred eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCC
Q 016347 205 HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNG 284 (391)
Q Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (391)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..... ... ..
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~~~~----~~~------~~---- 213 (316)
T cd05620 151 NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LFESI----RVD------TP---- 213 (316)
T ss_pred CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHH----HhC------CC----
Confidence 22344679999999999999999999999999999999999999997543211 11111 000 01
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHH-HHHHHh
Q 016347 285 DFDAEEACRFLKVGLLCTQDTPKLRPSMS-TVVQML 319 (391)
Q Consensus 285 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl~~l 319 (391)
..+......+.+++.+||+.||++||++. +++++-
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~ 249 (316)
T cd05620 214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHP 249 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCC
Confidence 11112345678899999999999999985 565443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=313.17 Aligned_cols=252 Identities=25% Similarity=0.412 Sum_probs=203.0
Q ss_pred hCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecc
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYL 122 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 122 (391)
..+|++.+.||+|+||.||+|.+.++..+|+|++..... ....+.+|+++++.++||||+++++++......++||||+
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 356899999999999999999988777899999864322 3356888999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCC
Q 016347 123 ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN 202 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~ 202 (391)
++++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 82 ANGCLLNYLRERK-----GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred CCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 9999999986532 2589999999999999999999999 9999999999999999999999999998765332
Q ss_pred CceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 203 MTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
.........++..|+|||.+.+..++.++||||||+++|+|++ |..||....+... ... ....
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~----~~~~--------- 217 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---VES----VSAG--------- 217 (256)
T ss_pred cccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---HHH----HHcC---------
Confidence 2111111223457999999998999999999999999999999 7888865433211 111 1000
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.....+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 218 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 218 YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 01111223456789999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=326.45 Aligned_cols=265 Identities=21% Similarity=0.288 Sum_probs=197.8
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC-----CeeE
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG-----NHRI 116 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 116 (391)
+|++.++||+|+||.||+|.+. +|+.||+|.+... .......+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5889999999999999999976 5899999998643 223345688999999999999999999988643 2579
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+||||+. ++|.+++.... .+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++
T Consensus 81 lv~e~~~-~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~ 150 (338)
T cd07859 81 VVFELME-SDLHQVIKAND------DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLA 150 (338)
T ss_pred EEEecCC-CCHHHHHHhcc------cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccc
Confidence 9999995 68988886433 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCc--eeeeeecccccccChhhhhc--CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHH------
Q 016347 197 KLIPANMT--HVSTRVAGTIGYLAPEYAIR--GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTW------ 266 (391)
Q Consensus 197 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~------ 266 (391)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||................
T Consensus 151 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 151 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230 (338)
T ss_pred cccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 76432211 11234578999999999866 678999999999999999999999997644322111000000
Q ss_pred --HHhhhc---ccceeeeccCCCCC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 267 --DLYERR---ELILLVDTSLNGDF---DAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 267 --~~~~~~---~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
...... .....+........ .......+.+++.+||+.||++||+++|++++-
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp 291 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADP 291 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCc
Confidence 000000 00000000000000 001234678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=316.64 Aligned_cols=262 Identities=25% Similarity=0.382 Sum_probs=205.3
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeC------CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEG 112 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (391)
.+..++|++.+.||+|+||.||+|.+. .+..||+|.+.... ......+.+|+.+++.++||||+++++++..+
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 456789999999999999999999753 25679999886432 23445688999999999999999999999998
Q ss_pred CeeEEEEecccCCCHHHHHhcCCCCC----CccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcE
Q 016347 113 NHRILVYNYLENNSLAQTLIGGGHHY----SNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTP 188 (391)
Q Consensus 113 ~~~~lv~e~~~~~sL~~~i~~~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~ 188 (391)
...++||||+++++|.+++....... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence 99999999999999999986532211 123467889999999999999999998 99999999999999999999
Q ss_pred EEEecccccccCCCCcee-eeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 016347 189 KISDFGLAKLIPANMTHV-STRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTW 266 (391)
Q Consensus 189 kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 266 (391)
+|+|||++.......... .....+++.|+|||++.++.++.++|||||||++|+|++ |..||........ .
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~---~---- 231 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV---L---- 231 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---H----
Confidence 999999987653322211 112345678999999998899999999999999999999 6788865432111 1
Q ss_pred HHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 267 DLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
........ ...+...+..+.+++.+||+.||++||++.|+++.|+
T Consensus 232 ~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 232 RFVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 10111100 0111223457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=312.33 Aligned_cols=255 Identities=28% Similarity=0.418 Sum_probs=205.1
Q ss_pred hCCCCCCceeeccCceEEEEEEeCC----CcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLKD----GKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (391)
.++|++.+.||+|+||.||+|.+.. ...||+|.+.... ......+..|+.+++.++||||+++++++......++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 4789999999999999999998752 4579999987543 3345678889999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
+|||+++++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 83 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~ 154 (266)
T cd05033 83 ITEYMENGSLDKFLREND-----GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (266)
T ss_pred EEEcCCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhh
Confidence 999999999999986532 2689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCce-eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 198 LIPANMTH-VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 198 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ..... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~----~~~--- 224 (266)
T cd05033 155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAV----EDG--- 224 (266)
T ss_pred cccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHH----HcC---
Confidence 76422211 1122334678999999988899999999999999999998 998885432211 11111 100
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.....+...+..+.+++.+||+.+|++||++.+|+++|..
T Consensus 225 ------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 225 ------YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred ------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0001122345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=313.06 Aligned_cols=257 Identities=30% Similarity=0.466 Sum_probs=205.6
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
.+..++|++.++||+|+||.||+|.+.+...||+|.+..... ....+.+|+++++.++||||+++++++. ....++||
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT 79 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEE
Confidence 355688999999999999999999987767799999875432 2357889999999999999999999875 45689999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++... ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+...
T Consensus 80 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~ 152 (262)
T cd05071 80 EYMSKGSLLDFLKGE----MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI 152 (262)
T ss_pred EcCCCCcHHHHHhhc----cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeec
Confidence 999999999999642 223578999999999999999999999 9999999999999999999999999999766
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
............++..|+|||+..+..++.++|||||||++|+|++ |..||........ .... ...
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~---~~~~----~~~------ 219 (262)
T cd05071 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQV----ERG------ 219 (262)
T ss_pred cccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH---HHHH----hcC------
Confidence 4332222222345678999999988899999999999999999999 7778865432211 1110 000
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.........+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 220 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 220 ---YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred ---CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 0011223455678899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=316.04 Aligned_cols=258 Identities=22% Similarity=0.247 Sum_probs=199.3
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++|++++.||+|+||.||+++.. +++.||+|++... .......+.+|+.++..++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 57999999999999999999976 5899999998753 2233456888999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++... ...+++..+..++.||+.||+|||++ +++||||||+|||++.++.++|+|||++...
T Consensus 81 e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 152 (331)
T cd05597 81 DYYVGGDLLTLLSKF-----EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRL 152 (331)
T ss_pred ecCCCCcHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeec
Confidence 999999999999642 23588999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCceeeeeecccccccChhhhhc-----CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIR-----GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
............||+.|+|||++.. +.++.++|||||||++|+|++|+.||......+. ..........
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------~~~i~~~~~~ 226 (331)
T cd05597 153 LADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKEH 226 (331)
T ss_pred CCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------HHHHHcCCCc
Confidence 4333222233568999999999863 4578899999999999999999999975432211 0011111100
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCC--CCCCCCHHHHHHHhcC
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDT--PKLRPSMSTVVQMLMG 321 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d--P~~Rps~~evl~~l~~ 321 (391)
.. +. ......+..+.+++.+||..+ +..|+++.+++++-+.
T Consensus 227 ~~-----~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~ 269 (331)
T cd05597 227 FQ-----FP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF 269 (331)
T ss_pred cc-----CC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCC
Confidence 00 00 001123456677777777543 3348899999988543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=318.29 Aligned_cols=244 Identities=26% Similarity=0.343 Sum_probs=197.1
Q ss_pred ceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEEEEecccC
Q 016347 50 NKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILVYNYLEN 124 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 124 (391)
+.||+|+||+||+|.+. +++.||+|++.... ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999987 48899999987542 23445677888888887 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc
Q 016347 125 NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204 (391)
Q Consensus 125 ~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~ 204 (391)
++|...+...+ .+++..+..++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 150 (318)
T cd05570 81 GDLMFHIQRSG------RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG- 150 (318)
T ss_pred CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-
Confidence 99999886543 589999999999999999999999 99999999999999999999999999986532211
Q ss_pred eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCC
Q 016347 205 HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNG 284 (391)
Q Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (391)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||........ ... ..... .
T Consensus 151 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~---~~~----i~~~~----------~ 213 (318)
T cd05570 151 VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL---FQS----ILEDE----------V 213 (318)
T ss_pred CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH---HHH----HHcCC----------C
Confidence 122345789999999999999999999999999999999999999975432111 111 11110 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHHhc
Q 016347 285 DFDAEEACRFLKVGLLCTQDTPKLRPSM-----STVVQMLM 320 (391)
Q Consensus 285 ~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~l~ 320 (391)
..+...+..+.+++.+||+.||++||++ .+++++-+
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~ 254 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPF 254 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCC
Confidence 1122334578899999999999999999 88877643
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=313.55 Aligned_cols=254 Identities=26% Similarity=0.343 Sum_probs=203.8
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
.|++.+.||+|+||.||++.+. +++.||+|++.... ......+.+|+.+++.++||||+++++.+..+...++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4888999999999999999976 58999999986542 1223456789999999999999999999999899999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 81 LMNGGDLKFHIYNM----GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIP 153 (285)
T ss_pred ccCCCcHHHHHHhc----CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999888543 223589999999999999999999999 99999999999999999999999999988654
Q ss_pred CCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeec
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT 280 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (391)
.... .....|+..|+|||++.+..++.++|||||||++|+|++|..||......... .........
T Consensus 154 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~--------- 219 (285)
T cd05605 154 EGET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKE--------- 219 (285)
T ss_pred CCCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhh---------
Confidence 3221 22346899999999999889999999999999999999999999754332111 011000000
Q ss_pred cCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHhc
Q 016347 281 SLNGDFDAEEACRFLKVGLLCTQDTPKLRP-----SMSTVVQMLM 320 (391)
Q Consensus 281 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~ 320 (391)
.....+...+..+.+++.+||+.||.+|| ++.+++++-+
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~ 263 (285)
T cd05605 220 -DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPF 263 (285)
T ss_pred -cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcC
Confidence 00122233556788999999999999999 8889887643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=318.01 Aligned_cols=247 Identities=26% Similarity=0.354 Sum_probs=197.8
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEEEE
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
+|++.+.||+|+||.||+|.+. +++.||+|++.... ......+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5889999999999999999977 47899999987542 22334566778888777 6899999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++|+|.+.+...+ .+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++...
T Consensus 81 E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~ 151 (323)
T cd05616 81 EYVNGGDLMYQIQQVG------RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 151 (323)
T ss_pred cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceec
Confidence 9999999999886433 488999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...... . ..
T Consensus 152 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~~i~---~-~~------ 217 (323)
T cd05616 152 MWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIM---E-HN------ 217 (323)
T ss_pred CCCC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HHHHHH---h-CC------
Confidence 2211 12234578999999999999999999999999999999999999997543321 111110 0 00
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSM-----STVVQM 318 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~ 318 (391)
..++......+.+++.+||+.||.+|++. .+++++
T Consensus 218 ----~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 218 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred ----CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 01222344577889999999999999984 566544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=316.64 Aligned_cols=257 Identities=22% Similarity=0.265 Sum_probs=198.9
Q ss_pred CCCCCCceeeccCceEEEEEEeCC-CcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++|+++++||+|+||.||++++.. ++.+|+|++... .......+.+|+.++..++|++|+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 579999999999999999999874 788999998643 2223345788999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++|+|.+++.... ..+++..+..++.||+.||.|||++ +++||||||+|||++.++.++|+|||++...
T Consensus 81 ey~~~g~L~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~ 152 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-----DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKL 152 (332)
T ss_pred eccCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheec
Confidence 9999999999996532 2589999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCceeeeeecccccccChhhhh-----cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAI-----RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
............||+.|+|||++. ...++.++|||||||++|+|++|+.||......... . ........
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~---~---~i~~~~~~ 226 (332)
T cd05623 153 MEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY---G---KIMNHKER 226 (332)
T ss_pred ccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH---H---HHhCCCcc
Confidence 333222233457999999999986 346889999999999999999999999754322211 1 11110000
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHhc
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKL--RPSMSTVVQMLM 320 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~l~ 320 (391)
.. .. .........+.+++.+|+..++++ |+++.+++++-+
T Consensus 227 ~~-----~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~ 268 (332)
T cd05623 227 FQ-----FP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPF 268 (332)
T ss_pred cc-----CC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCC
Confidence 00 00 011123456777888888654443 689999988743
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=317.87 Aligned_cols=257 Identities=22% Similarity=0.259 Sum_probs=200.0
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++|++.+.||+|+||.||++++. +++.||+|++... .......+.+|..++..++|++|+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999977 5888999998653 2223445788999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||++||+|.+++.... ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++...
T Consensus 81 Ey~~gg~L~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~ 152 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-----DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKM 152 (331)
T ss_pred eCCCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeec
Confidence 9999999999996522 2588999999999999999999999 9999999999999999999999999998766
Q ss_pred CCCCceeeeeecccccccChhhhhc-----CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIR-----GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
............|++.|+|||++.+ +.++.++|||||||+||+|++|+.||......... . ........
T Consensus 153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~---~---~i~~~~~~ 226 (331)
T cd05624 153 NQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY---G---KIMNHEER 226 (331)
T ss_pred cCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH---H---HHHcCCCc
Confidence 4333322334579999999999875 56889999999999999999999999754332110 1 11110000
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHhc
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKL--RPSMSTVVQMLM 320 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~l~ 320 (391)
.. +... ....+..+.+++.+||..++++ |+++++++++.+
T Consensus 227 ~~-~p~~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~ 268 (331)
T cd05624 227 FQ-FPSH-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAF 268 (331)
T ss_pred cc-CCCc-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCC
Confidence 00 0000 1123456778888888865544 468888887754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=305.98 Aligned_cols=269 Identities=25% Similarity=0.335 Sum_probs=209.0
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch--hcHHHHHHHHHHHhcCCCCc-eeEEEEEEEeCC-----
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR--QGVKEFLTEIQVISEIEHEN-LVKLYGCCVEGN----- 113 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~----- 113 (391)
...|+.+++||+|.||+||+|+.. +|+.||+|.++.+.. ..-....+|+.+|++++|+| |+.+++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 456888889999999999999976 589999999987643 23445678999999999999 999999998776
Q ss_pred -eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEe
Q 016347 114 -HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISD 192 (391)
Q Consensus 114 -~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~D 192 (391)
.+++|+||++ .+|..++...... ...++...+..++.||+.||+|||++ +|+||||||+||||+.+|.+||+|
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~--~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaD 163 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKK--PQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLAD 163 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhcccc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeec
Confidence 8899999995 4899999764321 14577789999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhh
Q 016347 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYER 271 (391)
Q Consensus 193 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 271 (391)
||+++.+.-... .....++|..|+|||++.+. .|+...||||+|||++||++++.-|.+....+....+-........
T Consensus 164 FGlAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 164 FGLARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNE 242 (323)
T ss_pred cchHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCc
Confidence 999997643322 23445688999999999887 7999999999999999999999889887765443333333222222
Q ss_pred cccceee-----eccCCCC-----CCH---HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 272 RELILLV-----DTSLNGD-----FDA---EEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 272 ~~~~~~~-----~~~~~~~-----~~~---~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
..+..+. +...... ... .......+++.+||+.+|.+|.|+..++++
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 2111111 0000000 001 111367889999999999999999999887
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=312.66 Aligned_cols=249 Identities=24% Similarity=0.314 Sum_probs=197.5
Q ss_pred eeccCceEEEEEEeC-CCcEEEEEEecccch---hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCCCH
Q 016347 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAESR---QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSL 127 (391)
Q Consensus 52 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 127 (391)
||+|+||+||++.+. +++.||+|.+..... .....+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999976 588999999865422 2335677899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCceee
Q 016347 128 AQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVS 207 (391)
Q Consensus 128 ~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~~ 207 (391)
...+..... ....+++..+..++.||+.||.|||++ +++||||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~ 154 (280)
T cd05608 81 RYHIYNVDE--ENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KT 154 (280)
T ss_pred HHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cc
Confidence 988754221 334689999999999999999999999 999999999999999999999999999876543322 22
Q ss_pred eeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCC
Q 016347 208 TRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFD 287 (391)
Q Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (391)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||.......... ..... ..... ...+
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~---~~~~~--------~~~~~--~~~~ 221 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK---ELKQR--------ILNDS--VTYP 221 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH---HHHHh--------hcccC--CCCc
Confidence 33578999999999999999999999999999999999999997543321110 00000 00000 0122
Q ss_pred HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHh
Q 016347 288 AEEACRFLKVGLLCTQDTPKLRP-----SMSTVVQML 319 (391)
Q Consensus 288 ~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l 319 (391)
...+..+.+++.+||+.||++|| ++++++++-
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~ 258 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHP 258 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcCh
Confidence 23456788899999999999999 677887753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=329.21 Aligned_cols=266 Identities=32% Similarity=0.462 Sum_probs=216.3
Q ss_pred chHHHHHhhCCCCCCceeeccCceEEEEEEeCC--C--cE-EEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEE
Q 016347 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLKD--G--KI-AAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLY 106 (391)
Q Consensus 35 ~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~--~~-vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~ 106 (391)
....|++.+++-.+.++||+|+||.||+|.+.. + .. ||+|..... ......+|.+|+++++.++|||||+++
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 445678888999999999999999999998653 2 23 899998853 466778899999999999999999999
Q ss_pred EEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC
Q 016347 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL 186 (391)
Q Consensus 107 ~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~ 186 (391)
|+......+++|||+|.||+|.+++...+. .++..+...++.+.+.||+|||++ +++||||-.+|+|++.++
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-----~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~ 299 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNKK-----SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKG 299 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCC
Confidence 999999999999999999999999986542 589999999999999999999999 999999999999999999
Q ss_pred cEEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHH
Q 016347 187 TPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERT 265 (391)
Q Consensus 187 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 265 (391)
.+||+|||+++.-. ..........-...|+|||.+..+.|+.++|||||||++||+++ |..|+.+....+....
T Consensus 300 ~vKISDFGLs~~~~-~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~k---- 374 (474)
T KOG0194|consen 300 VVKISDFGLSRAGS-QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAK---- 374 (474)
T ss_pred eEEeCccccccCCc-ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHH----
Confidence 99999999987532 11100101124578999999999999999999999999999998 7778876554322111
Q ss_pred HHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 016347 266 WDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKD 324 (391)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~ 324 (391)
+....+....+...+..+..++.+||..+|++||+|.++.+.|.....
T Consensus 375 -----------I~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 375 -----------IVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK 422 (474)
T ss_pred -----------HHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence 111222333444566677788889999999999999999998866543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=309.31 Aligned_cols=263 Identities=24% Similarity=0.314 Sum_probs=204.8
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC--C---eeEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG--N---HRIL 117 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~---~~~l 117 (391)
-.|+..+.+|.|+||.||+|... +++.||||.+-.+..- -.+|+++|+.+.|||||++.-+|... + ...+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 35788899999999999999976 4799999998765432 23599999999999999999888642 2 4568
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC-CcEEEEecccc
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD-LTPKISDFGLA 196 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~-~~~kl~Dfg~~ 196 (391)
||||++. +|.+.+..... .+..++...+.-++.||++||+|||+. ||+||||||+|+|||.+ |.+||+|||.+
T Consensus 100 VleymP~-tL~~~~r~~~~--~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTR--ANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHhchH-HHHHHHHHHhh--cCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 9999976 89999875322 345688888899999999999999998 99999999999999988 99999999999
Q ss_pred cccCCCCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 197 KLIPANMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 197 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
+.+..+... ....-|..|+|||.+.+. .|+.+.||||.|||+.||+-|+.-|.++........+-........+++.
T Consensus 174 K~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 174 KVLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred eeeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 987654433 234457889999998875 69999999999999999999999999877665544444443333322221
Q ss_pred eeeec------------cCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 276 LLVDT------------SLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 276 ~~~~~------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
.+... .+..-.......+.++|+.++|+.+|.+|.++.|++.+
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 11111 11111223456688899999999999999999999976
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=322.66 Aligned_cols=281 Identities=21% Similarity=0.270 Sum_probs=215.3
Q ss_pred echHHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCC-C-----CceeEEE
Q 016347 34 YSYKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIE-H-----ENLVKLY 106 (391)
Q Consensus 34 ~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~~~ 106 (391)
|.+..-+...-+|++++.||+|.||.|.++.+. +++.||||+++.. .....+...|+.+|..++ | -|+|+++
T Consensus 176 Y~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~ 254 (586)
T KOG0667|consen 176 YQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRML 254 (586)
T ss_pred eeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEee
Confidence 444444445558999999999999999999876 5999999999864 455677788999999996 3 4899999
Q ss_pred EEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC-
Q 016347 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD- 185 (391)
Q Consensus 107 ~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~- 185 (391)
++|...++.|||+|.+ ..+|.++|..+ .-..++...++.++.||+.||..||+. +|||+||||+|||+..-
T Consensus 255 d~F~fr~HlciVfELL-~~NLYellK~n----~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~ 326 (586)
T KOG0667|consen 255 DYFYFRNHLCIVFELL-STNLYELLKNN----KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPK 326 (586)
T ss_pred eccccccceeeeehhh-hhhHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCC
Confidence 9999999999999999 45899999765 345699999999999999999999999 99999999999999654
Q ss_pred -CcEEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 016347 186 -LTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLER 264 (391)
Q Consensus 186 -~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~ 264 (391)
..+||+|||.++..... ..+...+..|+|||++.+.+|+.+.||||||||++||++|.+.|.++...+.-..+..
T Consensus 327 r~~vKVIDFGSSc~~~q~----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e 402 (586)
T KOG0667|consen 327 RSRIKVIDFGSSCFESQR----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIE 402 (586)
T ss_pred cCceeEEecccccccCCc----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHH
Confidence 47999999999874322 2356778899999999999999999999999999999999877877665543222221
Q ss_pred HHHHhhh------cccceeeec-----------------------------cCC-----------CCCCHHHHHHHHHHH
Q 016347 265 TWDLYER------RELILLVDT-----------------------------SLN-----------GDFDAEEACRFLKVG 298 (391)
Q Consensus 265 ~~~~~~~------~~~~~~~~~-----------------------------~~~-----------~~~~~~~~~~l~~li 298 (391)
....... .+....++. ... ..........+.+++
T Consensus 403 ~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dfl 482 (586)
T KOG0667|consen 403 VLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFL 482 (586)
T ss_pred HhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHH
Confidence 1110000 000000000 000 001113445789999
Q ss_pred hhccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 016347 299 LLCTQDTPKLRPSMSTVVQMLMGEKDIDD 327 (391)
Q Consensus 299 ~~cl~~dP~~Rps~~evl~~l~~~~~~~~ 327 (391)
++||++||.+|+|+.+.+++-+.......
T Consensus 483 k~~L~~dP~~R~tp~qal~Hpfl~~~~~~ 511 (586)
T KOG0667|consen 483 KRCLEWDPAERITPAQALNHPFLTGTSLE 511 (586)
T ss_pred HHHhccCchhcCCHHHHhcCccccccccc
Confidence 99999999999999999998765544333
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=309.21 Aligned_cols=260 Identities=22% Similarity=0.332 Sum_probs=208.1
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++|++.+.||+|+||.||+|+.. +++.||+|.+... .......+.+|+++++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 58999999999999999999976 6899999987542 2334456888999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++..... ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++...
T Consensus 82 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 82 ELADAGDLSQMIKYFKK--QKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EecCCCcHHHHHHHhhh--ccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 99999999988854221 233578999999999999999999999 9999999999999999999999999998865
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
..... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......... .... .....
T Consensus 157 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~-~~~~----~~~~~------ 224 (267)
T cd08228 157 SSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS-LCQK----IEQCD------ 224 (267)
T ss_pred cchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHH-HHHH----HhcCC------
Confidence 43221 112346788999999998888999999999999999999999998654322111 1111 01000
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
............+.+++.+||+.+|++||++.+|++.++..
T Consensus 225 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 225 --YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 01111223456788999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=315.18 Aligned_cols=266 Identities=25% Similarity=0.396 Sum_probs=209.4
Q ss_pred HHHHhhCCCCCCceeeccCceEEEEEEeCC------CcEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCceeEEEEEE
Q 016347 38 ELSIATDDFSPINKIGEGGFGSVYKGRLKD------GKIAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHENLVKLYGCC 109 (391)
Q Consensus 38 e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 109 (391)
++.+..++|++.+.||+|+||.||+|.... ...+|+|.+... .......+.+|+++++++ +|+||+++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345667889999999999999999998642 467999998754 233445688899999999 899999999999
Q ss_pred EeCCeeEEEEecccCCCHHHHHhcCCC----------CCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 016347 110 VEGNHRILVYNYLENNSLAQTLIGGGH----------HYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASN 179 (391)
Q Consensus 110 ~~~~~~~lv~e~~~~~sL~~~i~~~~~----------~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~N 179 (391)
..++..+++|||+++++|..++..... ......+++..++.++.|++.||.|||+. +++|+||||+|
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~N 162 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARN 162 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccceee
Confidence 999999999999999999999965321 01345689999999999999999999999 99999999999
Q ss_pred EEECCCCcEEEEecccccccCCCCce-eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcc
Q 016347 180 ILLDKDLTPKISDFGLAKLIPANMTH-VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTE 257 (391)
Q Consensus 180 Ilv~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~ 257 (391)
|+++.++.++|+|||++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 99999999999999999875432211 1112234568999999988899999999999999999997 888886433211
Q ss_pred hhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 258 EQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
. ....... .....+......+.+++.+||+.||++|||+.|+++.|...
T Consensus 243 ~-------~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 243 L-------FKLLKEG---------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred H-------HHHHHcC---------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 1 1111111 01112223455788999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=309.98 Aligned_cols=258 Identities=31% Similarity=0.497 Sum_probs=208.8
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++..++|++.+.||+|++|.||+|.+.+++.+|+|.+.... .....+.+|+.+++.++|+||+++++++......++||
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 45678999999999999999999998888889999987543 33467889999999999999999999999888999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++.... ...+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 81 e~~~~~~L~~~i~~~~----~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 81 EYMSKGSLLDFLKSGE----GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLI 153 (261)
T ss_pred eccCCCCHHHHHhccc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceec
Confidence 9999999999996532 23589999999999999999999999 9999999999999999999999999998876
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
............++..|+|||.+.+..++.++|||||||++|+|++ |+.||....... ..... ...
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~----~~~------ 220 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQV----ERG------ 220 (261)
T ss_pred cchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcC------
Confidence 4322111122234568999999998899999999999999999998 999986543211 11111 000
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.....+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 221 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 221 ---YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011112234578899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=314.64 Aligned_cols=263 Identities=26% Similarity=0.463 Sum_probs=208.6
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC------CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
..++|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|++++++++||||+++++++......
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3578999999999999999999852 3556899998766555667899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCC-------CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcE
Q 016347 116 ILVYNYLENNSLAQTLIGGGHH-------YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTP 188 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~-------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~ 188 (391)
++||||+++++|.+++...+.. .....+++..++.++.|++.||+|||++ |++||||||+||+++.++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 9999999999999999653310 1223589999999999999999999999 99999999999999999999
Q ss_pred EEEecccccccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 016347 189 KISDFGLAKLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTW 266 (391)
Q Consensus 189 kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 266 (391)
+|+|||++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ...
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~--- 233 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIE--- 233 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---
Confidence 9999999886533221 11122345678999999988899999999999999999998 888886543211 111
Q ss_pred HHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 267 DLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
........ ..+...+..+.+++.+||+.||.+||++.++++.|+...
T Consensus 234 -~i~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 234 -CITQGRVL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred -HHHcCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 11111110 011123456899999999999999999999998886553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=323.98 Aligned_cols=253 Identities=23% Similarity=0.347 Sum_probs=198.7
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++|++++.||+|+||.||+|... +++.||+|++... .......+.+|+.++..++||+|+++++.+.+....++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999976 5899999998753 2334556788999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||++||+|.+++...+ .+++..+..++.|++.||.|||++ |++||||||+|||++.+|.++|+|||++...
T Consensus 81 E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~ 151 (360)
T cd05627 81 EFLPGGDMMTLLMKKD------TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151 (360)
T ss_pred eCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence 9999999999996543 489999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCc----------------------------------eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh
Q 016347 200 PANMT----------------------------------HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245 (391)
Q Consensus 200 ~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt 245 (391)
..... ......+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~t 231 (360)
T cd05627 152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (360)
T ss_pred ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeeccc
Confidence 21100 01123579999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHHh
Q 016347 246 GRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPS---MSTVVQML 319 (391)
Q Consensus 246 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~evl~~l 319 (391)
|..||....+.... ... ...... ..+.+ . ......+.+++.+|+. ||.+|++ +.+++++-
T Consensus 232 G~~Pf~~~~~~~~~---~~i---~~~~~~-~~~p~----~--~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp 294 (360)
T cd05627 232 GYPPFCSETPQETY---RKV---MNWKET-LVFPP----E--VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHP 294 (360)
T ss_pred CCCCCCCCCHHHHH---HHH---HcCCCc-eecCC----C--CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCC
Confidence 99999765443211 100 000000 00000 0 1123456677777664 9999985 67776654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=314.68 Aligned_cols=261 Identities=26% Similarity=0.442 Sum_probs=209.5
Q ss_pred hCCCCCCceeeccCceEEEEEEeC------CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
.++|.+.+.||+|+||.||+|... ++..+++|.+..........+.+|++++++++||||+++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 467889999999999999999753 35568999987666555677899999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCC----------CCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC
Q 016347 117 LVYNYLENNSLAQTLIGGGH----------HYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL 186 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~----------~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~ 186 (391)
+||||+++++|.+++...+. ......+++..++.++.||+.||+|||++ +++|+||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 99999999999999975432 11223589999999999999999999999 999999999999999999
Q ss_pred cEEEEecccccccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHH
Q 016347 187 TPKISDFGLAKLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLER 264 (391)
Q Consensus 187 ~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 264 (391)
.++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |..||........
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~------ 234 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV------ 234 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH------
Confidence 999999999876533221 11223456788999999999999999999999999999999 9998865433211
Q ss_pred HHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 265 TWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
......... ...+...+..+.+++.+||+.+|++||++.+|++.|...
T Consensus 235 -~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 235 -IECITQGRV---------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred -HHHHhCCCC---------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111111111 011223455788999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=308.72 Aligned_cols=256 Identities=30% Similarity=0.466 Sum_probs=204.5
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
+..++|++.++||+|++|.||+|.+..+..+|+|.+.... .....+.+|+.+++.++|||++++++++. ....+++||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTE 80 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEE
Confidence 4457899999999999999999998877789999876543 23466888999999999999999999875 456889999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05069 81 FMGKGSLLDFLKEG----DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIE 153 (260)
T ss_pred cCCCCCHHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEcc
Confidence 99999999999643 223578999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
...........++..|+|||.+.+..++.++||||||+++|+|++ |..||....+... ... ....
T Consensus 154 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~----~~~~------- 219 (260)
T cd05069 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LEQ----VERG------- 219 (260)
T ss_pred CCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----HHcC-------
Confidence 332212222345678999999988899999999999999999999 8888865432211 111 1100
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.....+...+..+.+++.+||+.||++||+++++++.|+.
T Consensus 220 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 220 --YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0011222345678899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=308.14 Aligned_cols=258 Identities=28% Similarity=0.428 Sum_probs=207.5
Q ss_pred HHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 39 LSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 39 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
|++..++|++.++||+|+||.||+|.+.++..+|+|.+.... .....+.+|+++++.++|+||+++++++.. ...+++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII 78 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence 356779999999999999999999998778889999887542 334678899999999999999999999887 778999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|||+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 79 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 151 (260)
T cd05073 79 TEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV 151 (260)
T ss_pred EEeCCCCcHHHHHHhC----CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceee
Confidence 9999999999999653 223578889999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhccccee
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILL 277 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (391)
.............++..|+|||++..+.++.++|+|||||++|+|++ |+.||......... .. ....
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~~----~~~~----- 219 (260)
T cd05073 152 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---RA----LERG----- 219 (260)
T ss_pred ccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH---HH----HhCC-----
Confidence 54332222222345677999999988889999999999999999999 88888654322111 11 1111
Q ss_pred eeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 278 VDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 278 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.........+..+.+++.+||+.+|++||++.++++.|..
T Consensus 220 ----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 220 ----YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0011122344578899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=311.79 Aligned_cols=261 Identities=29% Similarity=0.417 Sum_probs=204.6
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeCC------CcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLKD------GKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN 113 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (391)
+.+++|.+.+.||+|++|.||+|.+.. +..|++|.+.... ......+..|+.+++.++|+||+++++++.+..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 456789999999999999999998753 5678999886543 333456889999999999999999999999888
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCC-CccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC---cEE
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHY-SNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL---TPK 189 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~-~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~---~~k 189 (391)
..++||||+++++|.+++....... ....+++..+..++.||+.||.|||++ +++|+||||+||+++.++ .+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceE
Confidence 9999999999999999997643211 223589999999999999999999999 999999999999998764 689
Q ss_pred EEecccccccCCCCce-eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 016347 190 ISDFGLAKLIPANMTH-VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWD 267 (391)
Q Consensus 190 l~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 267 (391)
|+|||+++........ .......+..|+|||++.+..++.++|||||||++|+|++ |..||........ ..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~---~~---- 232 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV---ME---- 232 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH----
Confidence 9999999865322111 1112233567999999998999999999999999999997 9999875433211 11
Q ss_pred HhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 268 LYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
..... .....+...+..+.+++.+||+.+|++||++.+|+++|.
T Consensus 233 ~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 FVTGG---------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHcC---------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 01100 001112233467889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=313.98 Aligned_cols=242 Identities=28% Similarity=0.376 Sum_probs=192.8
Q ss_pred ceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEEEEecccC
Q 016347 50 NKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILVYNYLEN 124 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 124 (391)
+.||+|+||.||+|.+. +++.||+|++.... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999987 48899999987642 23344566677788764 999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc
Q 016347 125 NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204 (391)
Q Consensus 125 ~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~ 204 (391)
|+|.+++... ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.++|+|||++...... .
T Consensus 81 g~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 150 (316)
T cd05619 81 GDLMFHIQSC------HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-D 150 (316)
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCC-C
Confidence 9999998643 2488999999999999999999999 9999999999999999999999999998753221 1
Q ss_pred eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCC
Q 016347 205 HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNG 284 (391)
Q Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (391)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .... ..... .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~----i~~~~------~---- 213 (316)
T cd05619 151 AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQS----IRMDN------P---- 213 (316)
T ss_pred CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHH----HHhCC------C----
Confidence 12334678999999999999899999999999999999999999997543211 1111 11000 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHH-HHHHH
Q 016347 285 DFDAEEACRFLKVGLLCTQDTPKLRPSMS-TVVQM 318 (391)
Q Consensus 285 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl~~ 318 (391)
..+......+.+++.+||+.||++||++. +++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 11122345678899999999999999997 56544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=325.45 Aligned_cols=245 Identities=28% Similarity=0.401 Sum_probs=206.7
Q ss_pred eeeccCceEEEEEEeCC-CcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCCCHHH
Q 016347 51 KIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQ 129 (391)
Q Consensus 51 ~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~ 129 (391)
.||+|.||+||-|++.+ ...+|||-+...+....+-+.+|+.+.++++|.|||+++|.+-+++..-+.||.++||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 59999999999999875 66789999987776777789999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCcccc--CHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-CCcEEEEecccccccCCCCcee
Q 016347 130 TLIGGGHHYSNIQF--SWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK-DLTPKISDFGLAKLIPANMTHV 206 (391)
Q Consensus 130 ~i~~~~~~~~~~~l--~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~-~~~~kl~Dfg~~~~~~~~~~~~ 206 (391)
++...-. ++ ++.+.-.+..||++||.|||+. .|||||||-+||||+. .|.+||+|||.++.+..- ...
T Consensus 662 LLrskWG-----PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~ 732 (1226)
T KOG4279|consen 662 LLRSKWG-----PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPC 732 (1226)
T ss_pred HHHhccC-----CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-Ccc
Confidence 9975321 34 7788889999999999999999 9999999999999964 599999999999876433 445
Q ss_pred eeeecccccccChhhhhcC--CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCC
Q 016347 207 STRVAGTIGYLAPEYAIRG--QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNG 284 (391)
Q Consensus 207 ~~~~~gt~~y~aPE~~~~~--~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (391)
..++.||..|||||++..+ .|+.++|||||||++.||.||++||......+.-.+..- ++ ....
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG------------my--KvHP 798 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG------------MY--KVHP 798 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc------------ce--ecCC
Confidence 6678999999999999876 489999999999999999999999975544332211100 00 1133
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 285 DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 285 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
..+.+.......+|++|+.+||.+||++.++|+.
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 5667888899999999999999999999999874
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=307.79 Aligned_cols=255 Identities=27% Similarity=0.440 Sum_probs=203.9
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
.++|++.++||+|+||.||+|.+. +++.||+|++..........+.+|+.+++.++||||+++++++......++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 468999999999999999999975 5889999998765545556788899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++++|.+++...+ .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 88 ~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 88 CGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred CCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 99999999886432 489999999999999999999999 999999999999999999999999999986543
Q ss_pred CCceeeeeecccccccChhhhh---cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAI---RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
... ......|+..|+|||.+. ...++.++|||||||++|+|++|..||....+....... .... ..
T Consensus 159 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-------~~~~---~~ 227 (267)
T cd06646 159 TIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-------SKSN---FQ 227 (267)
T ss_pred ccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-------ecCC---CC
Confidence 221 122346888999999874 345788999999999999999999998543322111000 0000 00
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.+.. ......+..+.+++.+||+.+|++||++++++++|
T Consensus 228 ~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 228 PPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0000 00112345788999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=312.13 Aligned_cols=268 Identities=28% Similarity=0.421 Sum_probs=202.6
Q ss_pred CCC-CCCceeeccCceEEEEEEe-----CCCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEe--CCe
Q 016347 44 DDF-SPINKIGEGGFGSVYKGRL-----KDGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVE--GNH 114 (391)
Q Consensus 44 ~~y-~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 114 (391)
++| ++++.||+|+||+||++.. .+++.||+|.+.... ......+.+|+++++.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 455 8999999999999988753 247889999987653 2345678899999999999999999998865 346
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.++||||+++++|.+++... .+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~-------~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg 152 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH-------KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFG 152 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecc
Confidence 88999999999999999542 489999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCce--eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 195 LAKLIPANMTH--VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 195 ~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
++......... ......++..|+|||.+.+..++.++||||||+++|+|++|..|+........... ..........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~ 231 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI-GPKQGQMTVV 231 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhh-cccccccchh
Confidence 99866432211 11122356679999999888899999999999999999999999864332111100 0000000000
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
......+.......+...+..+.+++.+||+.+|++||+++++++.|+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 232 RLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111111111122233456889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=305.38 Aligned_cols=259 Identities=24% Similarity=0.353 Sum_probs=209.8
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++|++.+.||.|++|.||+|... +|+.||+|.+... .......+.+|++++++++|+||+++++++......++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999987 6899999988642 2333567889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++..... ....+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++...
T Consensus 82 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 82 ELADAGDLSRMIKHFKK--QKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred ecCCCCCHHHHHHHhcc--cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 99999999999864321 334589999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
..... ......++..|+|||.+.+..++.++|||||||++|+|++|..||......... ........
T Consensus 157 ~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~------- 223 (267)
T cd08224 157 SSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-----LCKKIEKC------- 223 (267)
T ss_pred cCCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHH-----HHhhhhcC-------
Confidence 43322 123346888999999998888999999999999999999999998644321110 00000000
Q ss_pred ccCCCCCCH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 280 TSLNGDFDA-EEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 280 ~~~~~~~~~-~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.....+. .....+.+++.+||..+|++||++.+|++.|...
T Consensus 224 --~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 224 --DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred --CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 0111122 4456788999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=324.52 Aligned_cols=266 Identities=22% Similarity=0.306 Sum_probs=201.1
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC-----eeE
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN-----HRI 116 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 116 (391)
+|++.++||+|+||.||+|.+. +|+.||+|.+... .......+.+|+++++.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 5889999999999999999975 6899999998643 2334567889999999999999999999998766 789
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+|+||+. ++|.+.+... ..+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a 150 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP------QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLA 150 (372)
T ss_pred EEeeccc-cCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccce
Confidence 9999996 5788877543 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc---
Q 016347 197 KLIPANMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR--- 272 (391)
Q Consensus 197 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 272 (391)
...............+++.|+|||++.+. .++.++|||||||++|+|++|+.||....+......+..........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 151 RVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR 230 (372)
T ss_pred eecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 86543322223334678999999998774 47999999999999999999999997655432211111000000000
Q ss_pred ----ccce-eeeccCCC-------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 273 ----ELIL-LVDTSLNG-------DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 273 ----~~~~-~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.... +....... .........+.+|+.+||+.||++|||+.|++++-+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 0000 00000000 011122456888999999999999999999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=326.82 Aligned_cols=264 Identities=22% Similarity=0.345 Sum_probs=206.2
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeCC------CcEEEEEEecccc-hhcHHHHHHHHHHHhcCC-CCceeEEEEEEEeC
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLKD------GKIAAIKVLSAES-RQGVKEFLTEIQVISEIE-HENLVKLYGCCVEG 112 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 112 (391)
...++|++.++||+|+||.||+|.+.. +..||||++.... ....+.+.+|+++++++. ||||+++++++.+.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 345789999999999999999998531 3469999987543 334467889999999995 99999999999999
Q ss_pred CeeEEEEecccCCCHHHHHhcCCCC-------------------------------------------------------
Q 016347 113 NHRILVYNYLENNSLAQTLIGGGHH------------------------------------------------------- 137 (391)
Q Consensus 113 ~~~~lv~e~~~~~sL~~~i~~~~~~------------------------------------------------------- 137 (391)
...++||||+++|+|.+++......
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 9999999999999999988653210
Q ss_pred -----------------------------------CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 016347 138 -----------------------------------YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL 182 (391)
Q Consensus 138 -----------------------------------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv 182 (391)
.....+++..+..++.||+.||.|||+. +++|+||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEE
Confidence 0012478888999999999999999999 99999999999999
Q ss_pred CCCCcEEEEecccccccCCCCce-eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhh
Q 016347 183 DKDLTPKISDFGLAKLIPANMTH-VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQY 260 (391)
Q Consensus 183 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~ 260 (391)
+.++.+||+|||++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.........
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~- 349 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF- 349 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH-
Confidence 99999999999999865332221 1122346778999999988899999999999999999997 88888654321111
Q ss_pred HHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 261 LLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
....... .....+...+..+.+++.+||+.||++||++.+|.+.|...
T Consensus 350 -----~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 350 -----YNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred -----HHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 1111110 01111223456788999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=317.50 Aligned_cols=255 Identities=25% Similarity=0.389 Sum_probs=202.0
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCc----EEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGK----IAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
..+|++.+.||+|+||.||+|.+. +++ .||+|.+.... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 467999999999999999999864 333 48999987543 34456788999999999999999999998764 578
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+++||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||++
T Consensus 85 ~v~e~~~~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a 156 (316)
T cd05108 85 LITQLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLA 156 (316)
T ss_pred eeeecCCCCCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccc
Confidence 9999999999999997532 2578899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCceee-eeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 197 KLIPANMTHVS-TRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 197 ~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
........... ....++..|+|||++.+..++.++|||||||++|+|++ |..||......+. ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~- 228 (316)
T cd05108 157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKGE- 228 (316)
T ss_pred ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHhCCC-
Confidence 87643322211 12234668999999999999999999999999999997 9999865432111 11111110
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
....+......+.+++.+||+.+|.+||++.+++..+...
T Consensus 229 --------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 229 --------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred --------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0011122345688899999999999999999999988655
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=316.20 Aligned_cols=241 Identities=25% Similarity=0.362 Sum_probs=194.1
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCC-CCceeEEEEEEEeCCeeEEEE
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIE-HENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 119 (391)
+|++.+.||+|+||.||+|... +|+.||+|++.... ......+..|..++..+. |++|+++++++......++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788899999999999999976 58999999987542 233456777888888885 577888999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++|+|.+++...+ .+++..+..++.||+.||.|||++ |++||||||+|||++.++.++|+|||++...
T Consensus 81 Ey~~~g~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~ 151 (323)
T cd05615 81 EYVNGGDLMYHIQQVG------KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEH 151 (323)
T ss_pred cCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEecccccccc
Confidence 9999999999986543 489999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...... . ..
T Consensus 152 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i~---~-~~------ 217 (323)
T cd05615 152 MVDG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQSIM---E-HN------ 217 (323)
T ss_pred CCCC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHH---h-CC------
Confidence 2221 12234568999999999999999999999999999999999999997653321 111111 0 00
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSM 312 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 312 (391)
...+......+.+++.+||+.+|.+|++.
T Consensus 218 ----~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 ----VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ----CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 01122234567889999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=313.42 Aligned_cols=249 Identities=35% Similarity=0.563 Sum_probs=193.3
Q ss_pred CCceeeccCceEEEEEEeC-----CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 48 PINKIGEGGFGSVYKGRLK-----DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 48 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
+.+.||.|.||.||+|.+. .+..|+||.+... .....+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999976 2678999999654 334478899999999999999999999999988889999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++|+|.+++... ....+++..+..|+.||+.||.|||++ +++|+||+++||+++.++.+||+|||+......
T Consensus 83 ~~~g~L~~~L~~~----~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 83 CPGGSLDDYLKSK----NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp -TTEBHHHHHHHT----CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred ccccccccccccc----ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 9999999999764 234689999999999999999999999 999999999999999999999999999987632
Q ss_pred CCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 202 NMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 202 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
... .......+...|+|||.+.+..++.++||||||+++|||++ |..|+....... +.... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~~~~---~~~~~------ 223 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---IIEKL---KQGQR------ 223 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HHHHH---HTTEE------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccc---ccccc------
Confidence 211 22223446778999999999999999999999999999999 678875442211 11111 11111
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
...+...+..+.+++..||+.||++||++.++++.|
T Consensus 224 ----~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 ----LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111223455788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=307.07 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=204.4
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-----hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-----RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (391)
++|++.+.||+|++|.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++..+...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57999999999999999999875 58999999886442 1234568889999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
|+||+++++|.+.+...+ .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 82 v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~ 152 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 152 (263)
T ss_pred EEEECCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccce
Confidence 999999999999986543 488999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCceee--eeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 198 LIPANMTHVS--TRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 198 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
.......... ....|+..|+|||++.+..++.++||||||+++|+|++|+.||......... .....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~----- 221 (263)
T cd06625 153 RLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI------FKIAT----- 221 (263)
T ss_pred eccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH------HHHhc-----
Confidence 6533211111 2345788999999999888999999999999999999999998643221110 00000
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.......+......+.+++.+||..+|.+||++.+++++.
T Consensus 222 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 222 ----QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred ----cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 0011122234456788999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=305.08 Aligned_cols=250 Identities=28% Similarity=0.426 Sum_probs=205.9
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
+|++.+.||+|++|.||+|.+. +++.|++|.+... .......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 5888899999999999999976 5899999988643 334566788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++++|.+++... ....+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~L~~~l~~~----~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~ 153 (256)
T cd08529 81 AENGDLHKLLKMQ----RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD 153 (256)
T ss_pred CCCCcHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccC
Confidence 9999999999653 224689999999999999999999999 999999999999999999999999999887643
Q ss_pred CCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
... ......|++.|+|||++.+..++.++|||||||++|+|++|..||....... .... ....
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~----~~~~--------- 216 (256)
T cd08529 154 NTN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LILK----IIRG--------- 216 (256)
T ss_pred ccc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----HHcC---------
Confidence 322 2233568899999999999999999999999999999999999997554211 0110 0000
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
.....+......+.+++.+||+.+|++||++.+++++
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 217 VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0112222445678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=318.00 Aligned_cols=255 Identities=24% Similarity=0.315 Sum_probs=215.1
Q ss_pred hhCCCCCCceeeccCceEEEEEEeCC-CcEEEEEEecccch---hcHHHHHHHHHHHhcCC-CCceeEEEEEEEeCCeeE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESR---QGVKEFLTEIQVISEIE-HENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 116 (391)
..+.|++.+.||+|.||.||++..+. |+.+|+|.+.+... .....+.+|+.+|+++. |||||.+++.|++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34679999999999999999999885 99999999977633 23467899999999998 999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC----CcEEEEe
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD----LTPKISD 192 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~----~~~kl~D 192 (391)
+|||++.||.|.+.|... .+++..+..++.|++.++.|||+. |++||||||+|+|+... +.+|++|
T Consensus 113 lvmEL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EEEEecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEee
Confidence 999999999999999754 299999999999999999999999 99999999999999543 5899999
Q ss_pred cccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 193 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
||++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||...........+. ..
T Consensus 183 FGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~-------~~ 253 (382)
T KOG0032|consen 183 FGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL-------RG 253 (382)
T ss_pred CCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH-------cC
Confidence 999998755 445667899999999999998999999999999999999999999998765443322111 11
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
+. .+..+.-........+++..|+..||.+|+++.+++++.|-
T Consensus 254 ~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi 296 (382)
T KOG0032|consen 254 DF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWI 296 (382)
T ss_pred CC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccc
Confidence 11 11222223446678889999999999999999999998653
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=309.14 Aligned_cols=261 Identities=25% Similarity=0.301 Sum_probs=213.7
Q ss_pred hHHHHHhhCCCCCCceeeccCceEEEEEEeCC-CcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEe
Q 016347 36 YKELSIATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVE 111 (391)
Q Consensus 36 ~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 111 (391)
.+...+..++|++++.||+|.-|+||++++.+ +..+|+|++.+.. .+...+...|-++|+.+.||.++.+|+.++.
T Consensus 69 ~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet 148 (459)
T KOG0610|consen 69 SKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET 148 (459)
T ss_pred cCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec
Confidence 34445556889999999999999999999885 6899999998763 3445567789999999999999999999999
Q ss_pred CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEE
Q 016347 112 GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKIS 191 (391)
Q Consensus 112 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~ 191 (391)
++..+++||||+||+|..+.+.+ ..+.+++..++.++..|+.||+|||.. |||+|||||+||||.++|++-|+
T Consensus 149 ~~~~cl~meyCpGGdL~~LrqkQ----p~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLs 221 (459)
T KOG0610|consen 149 DKYSCLVMEYCPGGDLHSLRQKQ----PGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLS 221 (459)
T ss_pred cceeEEEEecCCCccHHHHHhhC----CCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEee
Confidence 99999999999999999988654 556899999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCC---------------------------------CCc----------------------eeeeeecccccc
Q 016347 192 DFGLAKLIPA---------------------------------NMT----------------------HVSTRVAGTIGY 216 (391)
Q Consensus 192 Dfg~~~~~~~---------------------------------~~~----------------------~~~~~~~gt~~y 216 (391)
||.|+..+.. ... .....++||-.|
T Consensus 222 DFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEY 301 (459)
T KOG0610|consen 222 DFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEY 301 (459)
T ss_pred eccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccc
Confidence 9998754310 000 001125799999
Q ss_pred cChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHH
Q 016347 217 LAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLK 296 (391)
Q Consensus 217 ~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 296 (391)
+|||++.+...+.++|.|+|||++|||+.|..||.+....+.-. .++.+.+.-.-....+..+.+
T Consensus 302 lAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~---------------NIv~~~l~Fp~~~~vs~~akD 366 (459)
T KOG0610|consen 302 LAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR---------------NIVGQPLKFPEEPEVSSAAKD 366 (459)
T ss_pred ccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH---------------HHhcCCCcCCCCCcchhHHHH
Confidence 99999999999999999999999999999999998876543211 111111111222255678899
Q ss_pred HHhhccCCCCCCCCC----HHHHHHH
Q 016347 297 VGLLCTQDTPKLRPS----MSTVVQM 318 (391)
Q Consensus 297 li~~cl~~dP~~Rps----~~evl~~ 318 (391)
||.+.|.+||++|.. +.||-++
T Consensus 367 LIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 367 LIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred HHHHHhccChhhhhccccchHHhhcC
Confidence 999999999999998 7777655
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=304.10 Aligned_cols=247 Identities=27% Similarity=0.420 Sum_probs=198.7
Q ss_pred ceeeccCceEEEEEEeCCCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCCCHH
Q 016347 50 NKIGEGGFGSVYKGRLKDGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLA 128 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~ 128 (391)
+.||.|+||.||+|...+++.+|+|.+.... ......+.+|+++++.++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 4699999999999998888999999987653 233456889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCceeee
Q 016347 129 QTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVST 208 (391)
Q Consensus 129 ~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~~~ 208 (391)
+++.... ..+++..+..++.|++.||.|+|+. +++|+||||+||+++.++.++|+|||++............
T Consensus 81 ~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 81 SFLRKKK-----DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence 9986432 2478999999999999999999999 9999999999999999999999999998754332211111
Q ss_pred eecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCC
Q 016347 209 RVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFD 287 (391)
Q Consensus 209 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (391)
...++..|+|||++.+..++.++||||||+++|+|++ |..||......... .. .... .....+
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~---~~----~~~~---------~~~~~~ 216 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR---EQ----VEKG---------YRMSCP 216 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH---HH----HHcC---------CCCCCC
Confidence 2234567999999988899999999999999999998 99998654332111 11 1110 011112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 288 AEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 288 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 234567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=306.27 Aligned_cols=247 Identities=26% Similarity=0.403 Sum_probs=196.5
Q ss_pred ceeeccCceEEEEEEeC-CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCCCH
Q 016347 50 NKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSL 127 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 127 (391)
+.||+|+||.||+|.+. +++.||+|.+... .......+.+|+++++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999976 6899999987654 234456789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCceee
Q 016347 128 AQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVS 207 (391)
Q Consensus 128 ~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~~ 207 (391)
.+++...+ ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 81 LTFLRTEG-----PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred HHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 99986422 2588999999999999999999999 999999999999999999999999999876432211100
Q ss_pred -eeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCC
Q 016347 208 -TRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGD 285 (391)
Q Consensus 208 -~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (391)
....++..|+|||.+.++.++.++|||||||++|+|++ |..||........ ...... .....
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-------~~~~~~---------~~~~~ 216 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-------REAIEQ---------GVRLP 216 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-------HHHHHc---------CCCCC
Confidence 11123456999999988899999999999999999998 8888864332111 111110 01111
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 286 FDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 286 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 22233557889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=307.84 Aligned_cols=254 Identities=22% Similarity=0.377 Sum_probs=202.2
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
++|++++.||+|+||.||+|.+. +++.||+|.+... .......+.+|++++++++||||+++++++......++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 47899999999999999999875 6889999998654 233446788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++++|..+. .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 81 MDGGSLDVYR----------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred CCCCChHHhh----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 9999986543 378888999999999999999999 999999999999999999999999999876533
Q ss_pred CCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
.. .....|+..|+|||++.+..++.++|||||||++|+|++|..||....................... ...
T Consensus 148 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~ 219 (279)
T cd06619 148 SI---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPV 219 (279)
T ss_pred cc---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCC
Confidence 21 2335789999999999988999999999999999999999999965332221111011011000000 000
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
+ ........+.+++.+||+.+|.+||+++|++++.+-
T Consensus 220 ~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~ 256 (279)
T cd06619 220 L---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFI 256 (279)
T ss_pred C---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccc
Confidence 0 011234568899999999999999999999987544
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=320.90 Aligned_cols=266 Identities=27% Similarity=0.397 Sum_probs=206.4
Q ss_pred HHHhhCCCCCCceeeccCceEEEEEEeC------CCcEEEEEEecccc-hhcHHHHHHHHHHHhcC-CCCceeEEEEEEE
Q 016347 39 LSIATDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAES-RQGVKEFLTEIQVISEI-EHENLVKLYGCCV 110 (391)
Q Consensus 39 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 110 (391)
|+++.++|++.+.||.|+||.||+|... +++.||+|++.... ......+..|+.++.++ +|+||+++++++.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 5667789999999999999999999642 25789999987542 23345678899999999 8999999999886
Q ss_pred e-CCeeEEEEecccCCCHHHHHhcCCCCC---------------------------------------------------
Q 016347 111 E-GNHRILVYNYLENNSLAQTLIGGGHHY--------------------------------------------------- 138 (391)
Q Consensus 111 ~-~~~~~lv~e~~~~~sL~~~i~~~~~~~--------------------------------------------------- 138 (391)
. +...+++|||+++++|.+++.......
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 4 457889999999999999986432100
Q ss_pred ----CccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCcee-eeeeccc
Q 016347 139 ----SNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHV-STRVAGT 213 (391)
Q Consensus 139 ----~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt 213 (391)
....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.++|+|||++..+....... .....++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 013688999999999999999999999 99999999999999999999999999998753322111 1223456
Q ss_pred ccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHH
Q 016347 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEAC 292 (391)
Q Consensus 214 ~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (391)
..|+|||++.+..++.++|||||||++|+|++ |..||......+. ......... ....+.....
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~---------~~~~~~~~~~ 303 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGT---------RMRAPEYATP 303 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccC---------CCCCCccCCH
Confidence 78999999999999999999999999999998 9999865332211 011111110 0011123345
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 293 RFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 293 ~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.+.+++.+||+.+|++||++.|++++|...
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 788999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=310.93 Aligned_cols=262 Identities=26% Similarity=0.401 Sum_probs=207.8
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeCC------CcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLKD------GKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEG 112 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (391)
++..++|++.+.||+|+||.||+|.+.. +..||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 4556889999999999999999998652 4689999986542 34456788999999999999999999999999
Q ss_pred CeeEEEEecccCCCHHHHHhcCCCCC----CccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcE
Q 016347 113 NHRILVYNYLENNSLAQTLIGGGHHY----SNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTP 188 (391)
Q Consensus 113 ~~~~lv~e~~~~~sL~~~i~~~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~ 188 (391)
...++||||+++++|.+++....... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCE
Confidence 99999999999999999996532211 123478899999999999999999999 99999999999999999999
Q ss_pred EEEecccccccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 016347 189 KISDFGLAKLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTW 266 (391)
Q Consensus 189 kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 266 (391)
+|+|||+++....... .......++..|+|||.+.++.++.++|||||||++|+|++ |..||........ ...
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~~-- 233 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---LKF-- 233 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---HHH--
Confidence 9999999876543221 11223346788999999988899999999999999999998 8888865433221 111
Q ss_pred HHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 267 DLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
..... ....+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 234 --~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 234 --VIDGG---------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred --HhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11110 00112223567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=310.37 Aligned_cols=259 Identities=29% Similarity=0.455 Sum_probs=204.1
Q ss_pred CCCCCCceeeccCceEEEEEEe-----CCCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRL-----KDGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (391)
.+|++.+.||+|+||.||+|.+ ..+..|++|.+... .......+.+|+.+++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 6789999999999999999984 24678999998754 33344678899999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCC-----------CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC
Q 016347 118 VYNYLENNSLAQTLIGGGHH-----------YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL 186 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~-----------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~ 186 (391)
||||+++++|.+++...... .....+++..+..++.|++.||.|||++ +++|+||||+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 99999999999998643210 0123478899999999999999999999 999999999999999999
Q ss_pred cEEEEecccccccCCCC-ceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHH
Q 016347 187 TPKISDFGLAKLIPANM-THVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLER 264 (391)
Q Consensus 187 ~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 264 (391)
.++|+|||++....... ........++..|+|||++.+..++.++|||||||++|+|++ |..||....+... ...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~---~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV---IEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH
Confidence 99999999997653322 112223345678999999988889999999999999999998 8888865432111 111
Q ss_pred HHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 265 TWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
....... ..+...+..+.+++.+||+.||.+||++.+++++|..
T Consensus 239 ----~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 ----VRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----HHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111100 1112234578889999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=311.41 Aligned_cols=272 Identities=24% Similarity=0.371 Sum_probs=202.5
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-----CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEe--CCee
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-----DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVE--GNHR 115 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 115 (391)
.++|++++.||+|+||.||++... ++..||+|.+..........+.+|+++++.++||||+++++++.. ....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 368999999999999999999742 488999999887666666788999999999999999999998754 3468
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+. |++|+||||+||+++.++.++|+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHR-----ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred EEEEEecCCCCHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcc
Confidence 89999999999999986432 2589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCceee--eeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcc
Q 016347 196 AKLIPANMTHVS--TRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRE 273 (391)
Q Consensus 196 ~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (391)
+........... ....++..|+|||++.+..++.++|||||||++|||++|..++.......................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH 234 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence 987643322111 112234469999999888999999999999999999998766532211000000000000000000
Q ss_pred cceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
....+............+..+.+++.+||+.+|++|||+.||++.|..+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000011111111123345788999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=307.64 Aligned_cols=257 Identities=24% Similarity=0.393 Sum_probs=202.1
Q ss_pred CCCCceeeccCceEEEEEEeCC----CcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCe-----
Q 016347 46 FSPINKIGEGGFGSVYKGRLKD----GKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNH----- 114 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 114 (391)
|.+.+.||+|+||.||+|.+.. +..||+|.+... .......+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 6788999999999999998642 477999998754 23345678899999999999999999998865544
Q ss_pred -eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 115 -RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 115 -~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
.++++||+++++|..++...........+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 799999999999999986543222345689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCcee-eeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhh
Q 016347 194 GLAKLIPANMTHV-STRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYER 271 (391)
Q Consensus 194 g~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 271 (391)
|+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||....... ..... ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~----~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYL----RH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----Hc
Confidence 9998654332211 112234678999999988889999999999999999999 888886433211 11111 11
Q ss_pred cccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 272 RELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.. ....+......+.+++.+||+.||++||++.|+++.|..
T Consensus 231 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 231 GN---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred CC---------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 11 011222345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=315.98 Aligned_cols=268 Identities=22% Similarity=0.328 Sum_probs=202.2
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
++|++.++||+|+||.||+|.+. +++.||+|.+.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 67999999999999999999976 58889999987543 22334577899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++ +|.+++...+ ..+++..+..++.||+.||.|||++ |++||||||+||+++.++.+||+|||++.....
T Consensus 86 ~~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 86 LDK-DLKQYMDDCG-----NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred CCC-CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 975 7888875432 2478899999999999999999999 999999999999999999999999999876432
Q ss_pred CCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHH--------HHhhhc
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTW--------DLYERR 272 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~ 272 (391)
... ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......+......... ......
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 157 PTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred Ccc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence 211 1223457899999998865 468999999999999999999999997654433221111110 000000
Q ss_pred ccceeee-ccCCC----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 273 ELILLVD-TSLNG----DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 273 ~~~~~~~-~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
......+ ..... .........+.+++.+||+.||.+|||+.|++++-+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 289 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhh
Confidence 0000000 00000 0001234567889999999999999999999986543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=331.49 Aligned_cols=268 Identities=19% Similarity=0.236 Sum_probs=197.3
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC-------
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG------- 112 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------- 112 (391)
...++|++.+.||+|+||.||+|.+. +++.||||.+.... ....+|+.+++.++||||+++++++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 34578999999999999999999976 58899999886432 2234699999999999999999887432
Q ss_pred -CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC-cEEE
Q 016347 113 -NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL-TPKI 190 (391)
Q Consensus 113 -~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~-~~kl 190 (391)
..+++||||+++ +|.+++..... ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYAR--NNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceee
Confidence 246789999975 67776643211 334689999999999999999999999 999999999999998764 7999
Q ss_pred EecccccccCCCCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh
Q 016347 191 SDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLY 269 (391)
Q Consensus 191 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 269 (391)
+|||+++.+.... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...................
T Consensus 213 ~DFGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p 290 (440)
T PTZ00036 213 CDFGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP 290 (440)
T ss_pred eccccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999998654322 12335689999999998764 68999999999999999999999997655432211111100000
Q ss_pred hhcc-------c-----ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 270 ERRE-------L-----ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 270 ~~~~-------~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.... . .......+...++...+.++.+|+.+||+.||.+|||+.|++++-+
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 0000 0 0000000001111123457889999999999999999999998754
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=312.23 Aligned_cols=260 Identities=25% Similarity=0.383 Sum_probs=204.2
Q ss_pred hCCCCCCceeeccCceEEEEEEeC------CCcEEEEEEecccch-hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAESR-QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
..+|++.++||+|+||.||+|.+. .++.||+|++..... .....+.+|+.++..++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 356888999999999999999864 257899999875532 3345688899999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCC----------CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC
Q 016347 116 ILVYNYLENNSLAQTLIGGGHH----------YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD 185 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~----------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~ 185 (391)
++++||+.+++|.+++...... .....+++..+..++.|++.||.|||++ |++||||||.||+++.+
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCC
Confidence 9999999999999998532210 0123578889999999999999999999 99999999999999999
Q ss_pred CcEEEEecccccccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHH
Q 016347 186 LTPKISDFGLAKLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLE 263 (391)
Q Consensus 186 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~ 263 (391)
+.+||+|||+++....... .......+++.|+|||.+.++.++.++|||||||++|||++ |..||....... .
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~-- 235 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---V-- 235 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---H--
Confidence 9999999999886533221 11223345778999999988899999999999999999998 777876533211 1
Q ss_pred HHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 264 RTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
......... ...+...+..+.+++..||+.+|.+||++.+|+..|+.
T Consensus 236 --~~~i~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 --IEMIRNRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred --HHHHHcCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111110 11122345568899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=305.31 Aligned_cols=247 Identities=24% Similarity=0.300 Sum_probs=193.9
Q ss_pred eeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCCCH
Q 016347 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSL 127 (391)
Q Consensus 52 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 127 (391)
||+|+||.||++... +|+.||+|.+.... ......+..|+++++.++||||+++++++..+...++||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999976 58999999986432 12234456799999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCceee
Q 016347 128 AQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVS 207 (391)
Q Consensus 128 ~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~~ 207 (391)
.+++... ....+++..+..++.||+.||.|||+. +++||||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~ 151 (277)
T cd05607 81 KYHIYNV----GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TI 151 (277)
T ss_pred HHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--ee
Confidence 9888543 223588999999999999999999999 99999999999999999999999999987654322 22
Q ss_pred eeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCC
Q 016347 208 TRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFD 287 (391)
Q Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (391)
....|+..|+|||++.+..++.++|||||||++|+|++|..||.......... ........ .. .. ...
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~--~~~~~~~~-~~--------~~-~~~ 219 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE--ELKRRTLE-DE--------VK-FEH 219 (277)
T ss_pred eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH--HHHHHhhc-cc--------cc-ccc
Confidence 33568999999999998889999999999999999999999996533211110 00000000 00 00 001
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 288 AEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 288 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
......+.+++.+||+.||++||++.|+++.+
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 12345678899999999999999997766544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=309.87 Aligned_cols=259 Identities=27% Similarity=0.434 Sum_probs=205.7
Q ss_pred hCCCCCCceeeccCceEEEEEEeC------CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
..+|.+.++||+|+||.||+|... ++..+++|.+..........+.+|+++++.++|+||+++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 467899999999999999999742 36688999887666666678999999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCC---------CCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCc
Q 016347 117 LVYNYLENNSLAQTLIGGGH---------HYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLT 187 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~---------~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~ 187 (391)
++|||+++++|.+++..... ......+++..++.++.||+.||+|||+. +++|+||||+||+++.++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 99999999999999975431 11124588999999999999999999999 9999999999999999999
Q ss_pred EEEEecccccccCCCCce-eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHH
Q 016347 188 PKISDFGLAKLIPANMTH-VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERT 265 (391)
Q Consensus 188 ~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 265 (391)
++|+|||++......... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||........ ...
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~- 236 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---IEC- 236 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---HHH-
Confidence 999999998765332211 1122335678999999999999999999999999999998 8888854332111 000
Q ss_pred HHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 266 WDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
..... ....+...+..+.+++.+||+.||.+||++.+|++.|.
T Consensus 237 ---~~~~~---------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 ---ITQGR---------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ---HHcCc---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00000 00111223456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=311.77 Aligned_cols=267 Identities=25% Similarity=0.359 Sum_probs=205.0
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
++|++.+.||+|+||.||+|.+. ++..+|+|.+... .......+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 47999999999999999999976 5888999988754 333456688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 81 MDGGSLDQVLKKA------GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred cCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 9999999999654 34889999999999999999999732 899999999999999999999999999875432
Q ss_pred CCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccc-------
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERREL------- 274 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 274 (391)
. ......|+..|+|||.+.+..++.++|||||||++|+|++|..||........................
T Consensus 153 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 153 S---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred c---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence 2 123356889999999998888999999999999999999999998654322211111000000000000
Q ss_pred --------------ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 275 --------------ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 275 --------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
...................+.+++.+||+.+|++||++.+++++.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 290 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 00000000000001134568899999999999999999999988654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=306.93 Aligned_cols=254 Identities=28% Similarity=0.441 Sum_probs=202.5
Q ss_pred CCCCceeeccCceEEEEEEeCC-CcEEEEEEecccchhcH--HHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecc
Q 016347 46 FSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGV--KEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYL 122 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 122 (391)
|++++.||+|+||+||+++... ++.||+|++........ ....+|+.++++++||||+++++++......++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6788999999999999999875 77899999987644322 23456999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCC
Q 016347 123 ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN 202 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~ 202 (391)
++++|.+++.. ...+++..++.++.||+.||.+||+. +++|+||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~L~~~l~~------~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQK------NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN 151 (260)
T ss_dssp TTEBHHHHHHH------HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTST
T ss_pred ccccccccccc------cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 99999999962 33589999999999999999999999 9999999999999999999999999998764222
Q ss_pred CceeeeeecccccccChhhhh-cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 203 MTHVSTRVAGTIGYLAPEYAI-RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 203 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
........++..|+|||++. +..++.++||||||+++|+|++|..||........................
T Consensus 152 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 223 (260)
T PF00069_consen 152 -NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS------- 223 (260)
T ss_dssp -TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT-------
T ss_pred -ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc-------
Confidence 22334467899999999988 788999999999999999999999999765222222111111110000000
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.........+.+++.+||+.||++||++.+++++-
T Consensus 224 ---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~ 258 (260)
T PF00069_consen 224 ---QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHP 258 (260)
T ss_dssp ---TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSG
T ss_pred ---cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCC
Confidence 00001126888999999999999999999998764
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=310.20 Aligned_cols=259 Identities=25% Similarity=0.408 Sum_probs=204.0
Q ss_pred CCCCCceeeccCceEEEEEEeC------CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEE
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (391)
+|++.+.||+|+||.||+|... ....+++|.+.... ......+.+|+.+++.++||||+++++.+......++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 5788999999999999999853 23578899887543 2345678899999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCC------------------CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 016347 118 VYNYLENNSLAQTLIGGGHH------------------YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASN 179 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~------------------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~N 179 (391)
++||+.+++|.+++...... .....+++..++.++.|++.||.|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 99999999999998643210 1224588999999999999999999999 99999999999
Q ss_pred EEECCCCcEEEEecccccccCCCCcee-eeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcc
Q 016347 180 ILLDKDLTPKISDFGLAKLIPANMTHV-STRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTE 257 (391)
Q Consensus 180 Ilv~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~ 257 (391)
|+++.++.++|+|||+++......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||....+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999987653322111 122345678999999988889999999999999999998 998986543321
Q ss_pred hhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 258 EQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
. +..... ......+......+.+++.+||+.+|++||++.++++.|+..
T Consensus 238 ~-------~~~~~~---------~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 238 L-------FNLLKT---------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred H-------HHHHhC---------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 1 111111 011111223345788999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=303.19 Aligned_cols=250 Identities=22% Similarity=0.322 Sum_probs=203.3
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecc
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYL 122 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 122 (391)
+|++.++||.|+||.||++.+. +++.+|+|.+... .....+.+.+|+.+++.++|+||+++++.+..+...+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5889999999999999999976 5889999988643 3344567888999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCC
Q 016347 123 ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN 202 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~ 202 (391)
++++|.+++... ....++...+..++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~l~~~~~~~----~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 81 DGGDLMQKIKLQ----RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred CCCcHHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 999999988542 223578999999999999999999999 9999999999999999999999999998765432
Q ss_pred CceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccC
Q 016347 203 MTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSL 282 (391)
Q Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (391)
. .......|++.|+|||++.+..++.++|+||||+++|+|++|..||........ .. .. .....
T Consensus 154 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~~---~~-~~~~~-------- 217 (255)
T cd08219 154 G-AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL---IL---KV-CQGSY-------- 217 (255)
T ss_pred c-cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH---HH---HH-hcCCC--------
Confidence 2 122345688999999999888899999999999999999999999975432111 01 00 00110
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 283 NGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 283 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
...+......+.+++.+||+.||++||++.+++..
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 -KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 01122334568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=310.28 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=206.3
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
.++|++.+.||.|++|.||+|.+. +++.|++|.+..........+.+|+.+++.+.||||+++++.+..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 468999999999999999999975 5889999998766555557788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++++|.+++.. ..+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++.....
T Consensus 99 ~~~~~L~~~~~~-------~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 99 LAGGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred cCCCCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 999999999853 2478899999999999999999999 999999999999999999999999999876533
Q ss_pred CCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
... ......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+..... ...... .
T Consensus 169 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~------~~~~~~--------~ 233 (296)
T cd06654 169 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNG--------T 233 (296)
T ss_pred ccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH------HHhcCC--------C
Confidence 221 1223468889999999988889999999999999999999999997654322111 000000 0
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.....+......+.+++.+||..+|++||++.+++++-
T Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~ 271 (296)
T cd06654 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ 271 (296)
T ss_pred CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhCh
Confidence 00011223445788899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=308.05 Aligned_cols=267 Identities=24% Similarity=0.397 Sum_probs=204.5
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-----------------CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCcee
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-----------------DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLV 103 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv 103 (391)
+.++|++.++||+|+||.||++.+. ++..+|+|.+... .......+.+|+++++.++|+||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3568999999999999999998643 2446899998754 334456789999999999999999
Q ss_pred EEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCC-----CccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 016347 104 KLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHY-----SNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKAS 178 (391)
Q Consensus 104 ~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~-----~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~ 178 (391)
++++++......++||||+++++|.+++....... ....+++..+..++.|++.||.|||+. +++|+||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChh
Confidence 99999999999999999999999999997643211 123578889999999999999999999 9999999999
Q ss_pred cEEECCCCcEEEEecccccccCCCCce-eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh--CCCCCCCCCC
Q 016347 179 NILLDKDLTPKISDFGLAKLIPANMTH-VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS--GRCNTNMRLP 255 (391)
Q Consensus 179 NIlv~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt--g~~p~~~~~~ 255 (391)
||+++.++.++|+|||++..+...... ......++..|++||...++.++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 999999999999999998765332211 1122334678999999888899999999999999999998 6677754332
Q ss_pred cchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 256 TEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
... ............ ... ....+...+..+.+++.+||+.||++||++.+|++.|+
T Consensus 240 ~~~---~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 EQV---IENTGEFFRDQG-RQV-----YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHH---HHHHHHHHhhcc-ccc-----cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 211 111111110000 000 00111234467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=314.65 Aligned_cols=264 Identities=25% Similarity=0.387 Sum_probs=206.4
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeC--------CCcEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCceeEEEEEE
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLK--------DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHENLVKLYGCC 109 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 109 (391)
++..++|.+.+.||+|+||.||+|.+. ++..+|+|.+... .......+..|+.+++.+ +||||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 444578999999999999999999753 2356999998764 234456788899999999 799999999999
Q ss_pred EeCCeeEEEEecccCCCHHHHHhcCCCC----------CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 016347 110 VEGNHRILVYNYLENNSLAQTLIGGGHH----------YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASN 179 (391)
Q Consensus 110 ~~~~~~~lv~e~~~~~sL~~~i~~~~~~----------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~N 179 (391)
......++||||+++++|.+++...... .....+++..+..++.|++.||+|||+. |++|+||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence 9999999999999999999999754321 1223588999999999999999999999 99999999999
Q ss_pred EEECCCCcEEEEecccccccCCCCce-eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcc
Q 016347 180 ILLDKDLTPKISDFGLAKLIPANMTH-VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTE 257 (391)
Q Consensus 180 Ilv~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~ 257 (391)
|+++.++.++|+|||++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 99999999999999998765322111 1111224568999999988889999999999999999998 788885432211
Q ss_pred hhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 258 EQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
........ .....+......+.+++.+||+.+|++||++.+|++.|..+
T Consensus 251 -------~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 251 -------LFKLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred -------HHHHHHcC---------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 00011111 01122223456788899999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=306.56 Aligned_cols=254 Identities=26% Similarity=0.356 Sum_probs=202.1
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
.|+..+.||+|+||.||++.+. +++.||+|.+.... ......+.+|+.++++++|++|+++++.+.+....++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3778899999999999999977 58899999886542 2223457789999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~~~g~~L~~~l~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05630 81 LMNGGDLKFHIYHM----GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 153 (285)
T ss_pred ecCCCcHHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence 99999999988543 223589999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeec
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT 280 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (391)
.... .....|+..|+|||++.+..++.++|||||||++|+|++|..||................... .
T Consensus 154 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~---------~- 221 (285)
T cd05630 154 EGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---------Q- 221 (285)
T ss_pred CCcc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh---------h-
Confidence 3221 123468999999999999999999999999999999999999997543321111111100000 0
Q ss_pred cCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHhc
Q 016347 281 SLNGDFDAEEACRFLKVGLLCTQDTPKLRPS-----MSTVVQMLM 320 (391)
Q Consensus 281 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l~ 320 (391)
...+......+.+++.+||+.||++||| +.|++++-+
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 222 ---EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred ---hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence 0111223456788999999999999999 889987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=304.66 Aligned_cols=252 Identities=29% Similarity=0.469 Sum_probs=206.4
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
+..++|++.+.||.|++|.||+|... |+.||+|.+..... ..+.+.+|+.+++.++|+||+++++++.+....++|||
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 35678999999999999999999986 78899999876644 45778999999999999999999999998899999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.++...
T Consensus 81 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 81 YMAKGSLVDYLRSRG----RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred ecCCCcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccc
Confidence 999999999996532 23589999999999999999999999 99999999999999999999999999998653
Q ss_pred CCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
.... ...++..|+|||.+.++.++.++||||||+++|+|++ |..||....... +... ....
T Consensus 154 ~~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~----~~~~------- 215 (256)
T cd05039 154 QGQD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPH----VEKG------- 215 (256)
T ss_pred cccc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH----HhcC-------
Confidence 2211 2234567999999988889999999999999999997 998886442211 1111 0100
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.....+...+..+.+++.+||+.+|++||++.++++.|..
T Consensus 216 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 216 --YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred --CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0011122335678899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=305.54 Aligned_cols=259 Identities=22% Similarity=0.344 Sum_probs=207.4
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++|++.+.||.|++|.||+|.+. +++.+|||.+... .......+.+|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57899999999999999999965 6899999987643 2334467889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++..... ....+++..++.++.||+.||.|||++ |++|+||||+||+++.++.++|+|||++...
T Consensus 82 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 82 ELADAGDLSRMIKHFKK--QKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EecCCCCHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 99999999998864221 234689999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
..... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||......... ... ....
T Consensus 157 ~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~----~~~~-------- 222 (267)
T cd08229 157 SSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LCK----KIEQ-------- 222 (267)
T ss_pred ccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHH-Hhh----hhhc--------
Confidence 43221 122346888999999998889999999999999999999999998643321110 000 0000
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
..............+.+++.+||+.||++|||+.+|++.+..
T Consensus 223 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 223 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 000111112345678899999999999999999999998854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=310.92 Aligned_cols=265 Identities=24% Similarity=0.384 Sum_probs=205.6
Q ss_pred HHHhhCCCCCCceeeccCceEEEEEEeC------CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEe
Q 016347 39 LSIATDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVE 111 (391)
Q Consensus 39 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 111 (391)
|++..++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 3567789999999999999999999753 24579999886543 2333467889999999999999999999998
Q ss_pred CCeeEEEEecccCCCHHHHHhcCCCCC----CccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCc
Q 016347 112 GNHRILVYNYLENNSLAQTLIGGGHHY----SNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLT 187 (391)
Q Consensus 112 ~~~~~lv~e~~~~~sL~~~i~~~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~ 187 (391)
....++||||+++|+|.+++...+... ....+....+..++.||+.||.|||++ +++||||||+||+++.++.
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCc
Confidence 899999999999999999997532111 123456778899999999999999999 9999999999999999999
Q ss_pred EEEEecccccccCCCCce-eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHH
Q 016347 188 PKISDFGLAKLIPANMTH-VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERT 265 (391)
Q Consensus 188 ~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 265 (391)
++|+|||+++........ ......++..|+|||.+.++.++.++|||||||++|+|++ |..||....... ....
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~~- 233 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLKF- 233 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-
Confidence 999999998765332211 1112235678999999988899999999999999999998 677886433211 1110
Q ss_pred HHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 266 WDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
...... ...+...+..+.+++.+||+.||++||++.++++.|...
T Consensus 234 ---~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 234 ---VMDGGY---------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred ---HHcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 000000 011122346789999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=315.69 Aligned_cols=269 Identities=24% Similarity=0.378 Sum_probs=209.6
Q ss_pred HHHHHhhCCCCCCceeeccCceEEEEEEeCC--------CcEEEEEEecccc-hhcHHHHHHHHHHHhcC-CCCceeEEE
Q 016347 37 KELSIATDDFSPINKIGEGGFGSVYKGRLKD--------GKIAAIKVLSAES-RQGVKEFLTEIQVISEI-EHENLVKLY 106 (391)
Q Consensus 37 ~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~ 106 (391)
.++++...+|++.+.||+|+||.||+|.+.. +..||+|.+.... ......+.+|+++++++ +||||++++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 4556667889999999999999999997531 2368999887542 33456788999999999 899999999
Q ss_pred EEEEeCCeeEEEEecccCCCHHHHHhcCCCC----------CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 016347 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHH----------YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIK 176 (391)
Q Consensus 107 ~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~----------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dik 176 (391)
+++......++++||+++++|.+++...... .....+++..+..++.|++.||.|||++ |++|+|||
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlk 161 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLA 161 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccc
Confidence 9999989999999999999999999753211 1234588899999999999999999999 99999999
Q ss_pred CCcEEECCCCcEEEEecccccccCCCCce-eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCC
Q 016347 177 ASNILLDKDLTPKISDFGLAKLIPANMTH-VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRL 254 (391)
Q Consensus 177 p~NIlv~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~ 254 (391)
|+||+++.++.++|+|||+++........ ......++..|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred cceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999999998765432211 1111234567999999999999999999999999999998 788885432
Q ss_pred CcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 016347 255 PTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKD 324 (391)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~ 324 (391)
... ........ .....+......+.+++.+||+.+|.+||++.|+++.|.....
T Consensus 242 ~~~-------~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 242 VEE-------LFKLLKEG---------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHH-------HHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 211 11111111 0111122334578899999999999999999999999976643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=303.65 Aligned_cols=245 Identities=27% Similarity=0.383 Sum_probs=195.3
Q ss_pred eeeccCceEEEEEEeC---CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCC
Q 016347 51 KIGEGGFGSVYKGRLK---DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENN 125 (391)
Q Consensus 51 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 125 (391)
+||+|+||.||+|.+. +++.+|+|++.... ....+.+.+|+.+++.+.||||+++++++. ....++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999753 47889999986543 334567889999999999999999999875 45678999999999
Q ss_pred CHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCce
Q 016347 126 SLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTH 205 (391)
Q Consensus 126 sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~ 205 (391)
+|.+++.... .+++..+..++.|++.||.|||++ +++|+||||.||+++.++.++|+|||++.........
T Consensus 81 ~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 81 PLNKFLQKNK------HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred cHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 9999986432 489999999999999999999999 9999999999999999999999999999876433221
Q ss_pred ee--eeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccC
Q 016347 206 VS--TRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSL 282 (391)
Q Consensus 206 ~~--~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (391)
.. ....++..|+|||.+....++.++|||||||++|||++ |..||........ ... .... .
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~----i~~~---------~ 215 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV---TQM----IESG---------E 215 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----HHCC---------C
Confidence 11 11234578999999988889999999999999999998 9999975433211 111 1111 1
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 283 NGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 283 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
....+...+..+.+++.+||+.||++||++.+|.+.|..
T Consensus 216 ~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 216 RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 111222345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=306.41 Aligned_cols=267 Identities=24% Similarity=0.397 Sum_probs=206.0
Q ss_pred hhCCCCCCceeeccCceEEEEEEeCC-----------------CcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCcee
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLKD-----------------GKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLV 103 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv 103 (391)
..++|++++.||+|+||.||+|.+.. +..||+|.+.... ......+.+|++++++++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 34789999999999999999998652 2458999987653 34456788999999999999999
Q ss_pred EEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCC-----CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 016347 104 KLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHH-----YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKAS 178 (391)
Q Consensus 104 ~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~-----~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~ 178 (391)
++++++..+...+++|||+++++|.+++...... .....+++..++.++.|++.||.|||+. +++|+||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchh
Confidence 9999999999999999999999999999754311 1223689999999999999999999999 9999999999
Q ss_pred cEEECCCCcEEEEecccccccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh--CCCCCCCCCC
Q 016347 179 NILLDKDLTPKISDFGLAKLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS--GRCNTNMRLP 255 (391)
Q Consensus 179 NIlv~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt--g~~p~~~~~~ 255 (391)
||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999999876533221 11223446778999999988899999999999999999998 6667754322
Q ss_pred cchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 256 TEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.. ........+.... .......+...+..+.+++.+||+.||.+||++.||++.|.
T Consensus 240 ~~---~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 QQ---VIENAGHFFRDDG------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HH---HHHHHHhcccccc------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11 1111111100000 00001112223457899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=309.21 Aligned_cols=267 Identities=24% Similarity=0.396 Sum_probs=203.3
Q ss_pred hhCCCCCCceeeccCceEEEEEEeCC---------------CcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLKD---------------GKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKL 105 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~ 105 (391)
..++|++.+.||+|+||.||++.... ...||+|.+... .......+.+|++++++++|||++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 45789999999999999999987642 235899998764 33445678899999999999999999
Q ss_pred EEEEEeCCeeEEEEecccCCCHHHHHhcCCCC------CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 016347 106 YGCCVEGNHRILVYNYLENNSLAQTLIGGGHH------YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASN 179 (391)
Q Consensus 106 ~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~N 179 (391)
++++......++||||+++++|.+++...... .....+++..++.++.|++.||.|||+. +++|+||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence 99999999999999999999999998643210 0112468899999999999999999999 99999999999
Q ss_pred EEECCCCcEEEEecccccccCCCCce-eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh--CCCCCCCCCCc
Q 016347 180 ILLDKDLTPKISDFGLAKLIPANMTH-VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS--GRCNTNMRLPT 256 (391)
Q Consensus 180 Ilv~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt--g~~p~~~~~~~ 256 (391)
|+++.++.+||+|||++......... ......++..|+|||++.++.++.++|||||||++|+|++ |..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 99999999999999998765332211 1122345678999999988899999999999999999998 55666543322
Q ss_pred chhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 257 EEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
. .............. ......+...+..+.+++.+||+.||++||++.+|++.|.
T Consensus 240 ~---~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 Q---VIENTGEFFRNQGR------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred H---HHHHHHHhhhhccc------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1 11111111110000 0000111123458999999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=305.80 Aligned_cols=255 Identities=27% Similarity=0.410 Sum_probs=203.9
Q ss_pred hCCCCCCceeeccCceEEEEEEeC----CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK----DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (391)
.++|++.+.||+|+||.||+|.+. .+..+|+|.+.... ......+..|+.++++++||||+++++++..+...++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 468999999999999999999864 23479999886542 3345678899999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 83 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD-----GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (267)
T ss_pred EEEcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccc
Confidence 999999999999996532 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCceeeee--ecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 198 LIPANMTHVSTR--VAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 198 ~~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
............ ..++..|+|||.+.+..++.++|||||||++|++++ |..||......+. .... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~----~~~-- 225 (267)
T cd05066 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAI----EEG-- 225 (267)
T ss_pred ccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHH----hCC--
Confidence 764432222111 123467999999998899999999999999999886 9999865433211 1111 100
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.....+...+..+.+++.+||+.+|.+||++.++++.|..
T Consensus 226 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 226 -------YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred -------CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 0001112334578899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=305.87 Aligned_cols=257 Identities=24% Similarity=0.387 Sum_probs=199.1
Q ss_pred CCCCceeeccCceEEEEEEeCC-Cc--EEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC------Ce
Q 016347 46 FSPINKIGEGGFGSVYKGRLKD-GK--IAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG------NH 114 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~ 114 (391)
|.+.+.||+|+||.||+|.+.. +. .+|+|.+... .......+.+|+++++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4567899999999999999764 33 5899987654 344456788999999999999999999987532 25
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.+++|||+++|+|.+++...........+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999885432222334589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcee-eeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 195 LAKLIPANMTHV-STRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 195 ~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
++.......... .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||....... . .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~----~~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---I----YDYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHcC
Confidence 998764332211 122345678999999988899999999999999999999 788886532211 1 1111111
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
... ..+...+..+.+++.+||+.||++|||+.++++.|+.
T Consensus 231 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 231 NRL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 100 1112334568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=303.88 Aligned_cols=252 Identities=28% Similarity=0.498 Sum_probs=202.4
Q ss_pred hCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecc
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYL 122 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 122 (391)
..+|++.+.||.|+||.||+|.+.++..+|+|.+..... ....+.+|+++++.+.|||++++++++......++||||+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 467899999999999999999987788899998875432 3457889999999999999999999999989999999999
Q ss_pred cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCC
Q 016347 123 ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN 202 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~ 202 (391)
++++|.+++.... ..+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 82 EHGCLSDYLRAQR-----GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred CCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 9999999986432 2478999999999999999999999 9999999999999999999999999998765432
Q ss_pred CceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 203 MTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
.........++..|+|||.+.++.++.++||||||+++|+|++ |..||....... .... .... ...
T Consensus 154 ~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~----~~~~--~~~---- 220 (256)
T cd05112 154 QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVET----INAG--FRL---- 220 (256)
T ss_pred cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHH----HhCC--CCC----
Confidence 2211112234578999999988899999999999999999998 888886433211 1111 0000 000
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
..+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 221 ---~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 221 ---YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 01111345788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=317.76 Aligned_cols=265 Identities=24% Similarity=0.291 Sum_probs=199.4
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC-----
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN----- 113 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 113 (391)
..++|++.+.||+|+||.||+|.+. +|+.||+|.+... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4589999999999999999999976 5899999998653 2334566788999999999999999999986443
Q ss_pred -eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEe
Q 016347 114 -HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISD 192 (391)
Q Consensus 114 -~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~D 192 (391)
..++||||+++ +|.+.+.. .++...+..++.||+.||.|||++ |++||||||+|||++.++.+||+|
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~D 166 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 166 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEec
Confidence 57999999976 56666532 378889999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHH----------
Q 016347 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLL---------- 262 (391)
Q Consensus 193 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~---------- 262 (391)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||............
T Consensus 167 fg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 244 (359)
T cd07876 167 FGLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE 244 (359)
T ss_pred CCCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHH
Confidence 99997643221 223456899999999999999999999999999999999999999765432110000
Q ss_pred --HH----HHHHhhhc-c-----cceeeeccC---CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 263 --ER----TWDLYERR-E-----LILLVDTSL---NGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 263 --~~----~~~~~~~~-~-----~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.. ........ . ....+.... ...........+.+|+.+||+.||++|||+.|++++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 00 00000000 0 000000000 00011122456789999999999999999999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=316.14 Aligned_cols=242 Identities=26% Similarity=0.309 Sum_probs=188.1
Q ss_pred eeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcC---CCCceeEEEEEEEeCCeeEEEEecccC
Q 016347 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEI---EHENLVKLYGCCVEGNHRILVYNYLEN 124 (391)
Q Consensus 52 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~ 124 (391)
||+|+||+||+|++. +++.||+|++.... ......+..|..++..+ .||||+++++.+......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999976 58999999986532 12233445566666655 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc
Q 016347 125 NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204 (391)
Q Consensus 125 ~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~ 204 (391)
++|.+++...+ .+++..+..++.||+.||+|||++ +++||||||+|||++.++.++|+|||++.......
T Consensus 81 g~L~~~l~~~~------~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~- 150 (330)
T cd05586 81 GELFWHLQKEG------RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN- 150 (330)
T ss_pred ChHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-
Confidence 99999886543 489999999999999999999999 99999999999999999999999999987542221
Q ss_pred eeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCC
Q 016347 205 HVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLN 283 (391)
Q Consensus 205 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (391)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||........ .. ....... .+.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~---~~----~i~~~~~------~~~ 217 (330)
T cd05586 151 KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM---YR----NIAFGKV------RFP 217 (330)
T ss_pred CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH---HH----HHHcCCC------CCC
Confidence 223346799999999998764 489999999999999999999999975432111 11 1111100 000
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCC----CHHHHHHHh
Q 016347 284 GDFDAEEACRFLKVGLLCTQDTPKLRP----SMSTVVQML 319 (391)
Q Consensus 284 ~~~~~~~~~~l~~li~~cl~~dP~~Rp----s~~evl~~l 319 (391)
. ......+.+++.+||+.||.+|| ++.+++++-
T Consensus 218 ~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~ 254 (330)
T cd05586 218 K---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHP 254 (330)
T ss_pred C---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCc
Confidence 0 11344677889999999999998 567776654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=308.45 Aligned_cols=261 Identities=25% Similarity=0.398 Sum_probs=202.4
Q ss_pred CCCCCCceeeccCceEEEEEEe-----CCCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC--Cee
Q 016347 44 DDFSPINKIGEGGFGSVYKGRL-----KDGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEG--NHR 115 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 115 (391)
+-|++++.||+|+||.||++.. .++..||+|.+.... ......+.+|+++++.+.||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4579999999999999999974 247889999987553 34456788999999999999999999998865 568
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||||++|++|.+++.... ..+++..+..++.|++.||+|||++ |++||||||+||+++.++.++|+|||+
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK-----NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcc
Confidence 99999999999999986432 2589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCce--eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcc--------hhhHHHHH
Q 016347 196 AKLIPANMTH--VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTE--------EQYLLERT 265 (391)
Q Consensus 196 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~--------~~~~~~~~ 265 (391)
+......... ......++..|+|||++.+..++.++|||||||++|+|+++..|........ ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 9876433221 1223456778999999988899999999999999999999876543221100 00000111
Q ss_pred HHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 266 WDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
..... .......+...+..+.+|+.+||+.+|++||++.++++.|..
T Consensus 236 ~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 236 VRVLE---------EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred HHHHH---------cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 01010 001111122345679999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=308.79 Aligned_cols=257 Identities=24% Similarity=0.391 Sum_probs=206.2
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeCC-CcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
....+.|+++++||.|+||.||+|.+.. ++.+++|.+..........+.+|+.+++.++||||+++++.+..+...++|
T Consensus 8 ~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 8 LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred cCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 3456789999999999999999999864 899999999877666677889999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|||+++++|..++... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 88 ~e~~~~~~l~~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 159 (292)
T cd06644 88 IEFCPGGAVDAIMLEL-----DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159 (292)
T ss_pred EecCCCCcHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCcccee
Confidence 9999999998887542 23589999999999999999999999 999999999999999999999999998875
Q ss_pred cCCCCceeeeeecccccccChhhhh-----cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcc
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAI-----RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRE 273 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (391)
..... .......+++.|+|||++. ...++.++|||||||++|+|++|..||....+... ... .....
T Consensus 160 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~-~~~~~ 231 (292)
T cd06644 160 NVKTL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLK-IAKSE 231 (292)
T ss_pred ccccc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH------HHH-HhcCC
Confidence 43221 1223356788999999874 34578899999999999999999999865432111 000 00000
Q ss_pred cceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
. +. ...+......+.+++.+||+.+|++||++.+++++-
T Consensus 232 ~-----~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 270 (292)
T cd06644 232 P-----PT--LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHP 270 (292)
T ss_pred C-----cc--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0 00 011223345688899999999999999999998764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=313.51 Aligned_cols=267 Identities=24% Similarity=0.387 Sum_probs=208.9
Q ss_pred HHHhhCCCCCCceeeccCceEEEEEEeC--------CCcEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCceeEEEEE
Q 016347 39 LSIATDDFSPINKIGEGGFGSVYKGRLK--------DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHENLVKLYGC 108 (391)
Q Consensus 39 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 108 (391)
+.+..++|++.+.||+|+||.||+|+.. ++..||+|.+... .......+.+|+.+++.+ +||||++++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 3456788999999999999999999741 2457999998754 234456788999999999 89999999999
Q ss_pred EEeCCeeEEEEecccCCCHHHHHhcCCCC----------CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 016347 109 CVEGNHRILVYNYLENNSLAQTLIGGGHH----------YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKAS 178 (391)
Q Consensus 109 ~~~~~~~~lv~e~~~~~sL~~~i~~~~~~----------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~ 178 (391)
+......++||||+++++|.+++...... .....+++..+..++.||+.||.|||++ |++|+||||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 166 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAAR 166 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccc
Confidence 99999999999999999999999764321 1124578899999999999999999999 9999999999
Q ss_pred cEEECCCCcEEEEecccccccCCCCce-eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCc
Q 016347 179 NILLDKDLTPKISDFGLAKLIPANMTH-VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPT 256 (391)
Q Consensus 179 NIlv~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~ 256 (391)
||+++.++.++|+|||++......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 999999999999999999876432221 1122345678999999988889999999999999999998 77777543221
Q ss_pred chhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 016347 257 EEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKD 324 (391)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~ 324 (391)
. ... ..... .....+...+..+.+++.+||+.+|.+||++.|+++.|..+..
T Consensus 247 ~---~~~----~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 247 E---LFK----LLKEG---------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred H---HHH----HHHcC---------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 1 111 11111 0011122345678889999999999999999999999866543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=307.37 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=207.0
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
.++|++++.||.|++|.||+|... +++.||+|.+..........+.+|+.+++.++|+||+++++++..+...++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 478999999999999999999975 6999999998765555556788899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++++|.+++... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 98 ~~~~~L~~~~~~~-------~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 98 LAGGSLTDVVTET-------CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred cCCCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 9999999998532 478899999999999999999999 999999999999999999999999999876533
Q ss_pred CCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
... ......+++.|+|||.+.+..++.++|||||||++|+|++|..||....+....... .....
T Consensus 168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~--------------~~~~~ 232 (297)
T cd06656 168 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--------------ATNGT 232 (297)
T ss_pred Ccc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee--------------ccCCC
Confidence 221 122346888999999999888999999999999999999999999754432211000 00000
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.....+......+.+++.+||+.+|++||++.+++++-+
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (297)
T cd06656 233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPF 271 (297)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 001112234456788999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=307.04 Aligned_cols=265 Identities=24% Similarity=0.332 Sum_probs=195.1
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcC---CCCceeEEEEEEEe-----CC
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEI---EHENLVKLYGCCVE-----GN 113 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~~ 113 (391)
+|++.+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5889999999999999999977 58999999987542 12223455677777665 79999999998864 34
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
..++||||+.+ +|.+++... ....+++..+..++.||+.||.|||++ |++|+||||+||+++.++.+||+||
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~df 152 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV----PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADF 152 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcc
Confidence 57999999975 888888543 223489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcc
Q 016347 194 GLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRE 273 (391)
Q Consensus 194 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (391)
|++....... ......|+..|+|||++.+..++.++|||||||++|+|++|..||.......................
T Consensus 153 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07863 153 GLARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 230 (288)
T ss_pred CccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 9998654321 12335678999999999999999999999999999999999999965433221111000000000000
Q ss_pred cce---eeeccCC-------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 274 LIL---LVDTSLN-------GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 274 ~~~---~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
... ....... ..........+.+++.+||+.||++|||+.|++.+-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp 286 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHP 286 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence 000 0000000 001112345678999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=306.75 Aligned_cols=255 Identities=25% Similarity=0.384 Sum_probs=199.7
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCc----EEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGK----IAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
.++|++.+.||+|+||.||+|.+. +++ .+++|.+.... .....++..|+..++.+.||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 467889999999999999999975 344 47788875432 2334567788889999999999999998754 4578
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+++||+++|+|.+++.... ..+++..+..|+.||+.||.|||++ +++|+||||+||+++.++.+||+|||++
T Consensus 85 ~i~e~~~~gsL~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~ 156 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHR-----DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVA 156 (279)
T ss_pred EEEEeCCCCcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccc
Confidence 8999999999999996532 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 197 KLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 197 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
+....... .......++..|+|||.+.++.++.++|||||||++|||++ |..||....+...... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-------~~~~~~ 229 (279)
T cd05111 157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL-------LEKGER 229 (279)
T ss_pred eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HHCCCc
Confidence 86543222 12223456778999999998999999999999999999998 9999876543221111 111111
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
. ..+......+.+++.+||..||.+||++.|+++.|...
T Consensus 230 ~---------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 230 L---------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred C---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 0 00111234677889999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=311.39 Aligned_cols=266 Identities=23% Similarity=0.372 Sum_probs=207.2
Q ss_pred HHHhhCCCCCCceeeccCceEEEEEEeC--------CCcEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCceeEEEEE
Q 016347 39 LSIATDDFSPINKIGEGGFGSVYKGRLK--------DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHENLVKLYGC 108 (391)
Q Consensus 39 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 108 (391)
+.+..++|.+.++||+|+||.||+|... .+..+|+|.+... .......+..|+.+++.+ .||||++++++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 3455688999999999999999999752 2457899998754 234456788899999999 69999999999
Q ss_pred EEeCCeeEEEEecccCCCHHHHHhcCCCC----------CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 016347 109 CVEGNHRILVYNYLENNSLAQTLIGGGHH----------YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKAS 178 (391)
Q Consensus 109 ~~~~~~~~lv~e~~~~~sL~~~i~~~~~~----------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~ 178 (391)
+......+++|||+++++|.+++...... .....+++..+..++.||+.||.|||++ |++|+||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~ 163 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAAR 163 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccce
Confidence 99888999999999999999999754210 1234589999999999999999999999 9999999999
Q ss_pred cEEECCCCcEEEEecccccccCCCCcee-eeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCc
Q 016347 179 NILLDKDLTPKISDFGLAKLIPANMTHV-STRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPT 256 (391)
Q Consensus 179 NIlv~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~ 256 (391)
||+++.++.+||+|||+++......... .....++..|+|||++.++.++.++|||||||++|+|++ |..||......
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999998654321111 111223467999999988899999999999999999999 88888543321
Q ss_pred chhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 257 EEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
.. ... ..... ....+...+..+.+++.+||+.+|++||++.++++.|....
T Consensus 244 ~~---~~~----~~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 244 EL---FKL----LREGH---------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HH---HHH----HHcCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11 111 11110 01112233457888999999999999999999999986553
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=337.29 Aligned_cols=265 Identities=30% Similarity=0.469 Sum_probs=212.7
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeCC--Cc----EEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLKD--GK----IAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN 113 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (391)
+..+..++.+.||+|+||.||.|...+ |. .||+|.+... +.....+|.+|..+|+.++|||||+++|++.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 335677888999999999999998653 43 4899988765 5567788999999999999999999999999999
Q ss_pred eeEEEEecccCCCHHHHHhcCCCC-CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEe
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHH-YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISD 192 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~-~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~D 192 (391)
..++++|||+||+|..+|++.... .....+.....+.++.|||+|+.||+++ ++|||||..+|+|++....|||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence 999999999999999999875322 1245689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCce-eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhC-CCCCCCCCCcchhhHHHHHHHHhh
Q 016347 193 FGLAKLIPANMTH-VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSG-RCNTNMRLPTEEQYLLERTWDLYE 270 (391)
Q Consensus 193 fg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~ 270 (391)
||+++.+...... ......-...|||||.+..+.++.|+|||||||+|||++|. ..|+......+... ....
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~------~~~~ 919 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL------DVLE 919 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH------HHHh
Confidence 9999954322211 11111234689999999999999999999999999999984 55665433322111 0111
Q ss_pred hcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 016347 271 RRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKD 324 (391)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~ 324 (391)
.+ +-+.+..++..+.+++..||+.+|++||++..+++.+..+.+
T Consensus 920 gg----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 920 GG----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred CC----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 11 224556778889999999999999999999999997755533
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=304.56 Aligned_cols=257 Identities=27% Similarity=0.438 Sum_probs=204.1
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeCC-C---cEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLKD-G---KIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
+..++|+..+.||+|+||.||+|.+.. + ..+|+|.+... .......+.+|+++++.++||||+++++++......
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 345688999999999999999999753 3 37899998754 334456788999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+
T Consensus 82 ~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~ 153 (268)
T cd05063 82 MIITEYMENGALDKYLRDH-----DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGL 153 (268)
T ss_pred EEEEEcCCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCcc
Confidence 9999999999999998642 23589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCceeeee--ecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 196 AKLIPANMTHVSTR--VAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 196 ~~~~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
+............. ...+..|+|||++.+..++.++|||||||++|+|++ |..||....... .... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~~----i~~~ 226 (268)
T cd05063 154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMKA----INDG 226 (268)
T ss_pred ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHH----HhcC
Confidence 87654322211111 123457999999988899999999999999999997 999986443211 1111 1100
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.........+..+.+++.+||+.+|++||++.+|++.|..
T Consensus 227 ---------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 227 ---------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred ---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0111112334578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=340.38 Aligned_cols=263 Identities=21% Similarity=0.330 Sum_probs=203.0
Q ss_pred hHHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEe-
Q 016347 36 YKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVE- 111 (391)
Q Consensus 36 ~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 111 (391)
+...+...++|+++++||+|+||+||+|.+. +++.+|+|++... .......+..|+.+++.++||||+++++++..
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 4445566689999999999999999999987 4788999988654 33345678899999999999999999998864
Q ss_pred -CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCC----CCeeecCCCCCcEEECC--
Q 016347 112 -GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVR----PHIIHRDIKASNILLDK-- 184 (391)
Q Consensus 112 -~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~----~~i~H~dikp~NIlv~~-- 184 (391)
...++|||||+++++|.++|..... ....+++..++.|+.||+.||.|||+... .+|+|+||||+||||+.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~--~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~ 162 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYK--MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence 4578999999999999999864221 22358999999999999999999998510 15999999999999964
Q ss_pred ---------------CCcEEEEecccccccCCCCceeeeeecccccccChhhhhc--CCCCCCCcEeehhHHHHHHHhCC
Q 016347 185 ---------------DLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIR--GQVTRKADIYSFGVLLVEIVSGR 247 (391)
Q Consensus 185 ---------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlG~vl~elltg~ 247 (391)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||||+|++|.
T Consensus 163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred cccccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 2458999999998653321 2234578999999999864 45899999999999999999999
Q ss_pred CCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 248 CNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
.||........ +.. ...... .+. ....+..+.+||..||+.+|.+||++.|++.+
T Consensus 241 ~PF~~~~~~~q--li~----~lk~~p-------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 241 TPFHKANNFSQ--LIS----ELKRGP-------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCCCcCCcHHH--HHH----HHhcCC-------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 99965432211 111 111100 000 01224568889999999999999999999954
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=307.12 Aligned_cols=264 Identities=25% Similarity=0.366 Sum_probs=208.7
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeCC-----CcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEe-C
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLKD-----GKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVE-G 112 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~ 112 (391)
.+..++|++.+.||+|+||.||+|.+.. +..|++|.+... .......+.+|+.+++.++||||+++++++.. +
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 3567899999999999999999999765 688999988754 33445678899999999999999999998775 5
Q ss_pred CeeEEEEecccCCCHHHHHhcCCCC--CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEE
Q 016347 113 NHRILVYNYLENNSLAQTLIGGGHH--YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKI 190 (391)
Q Consensus 113 ~~~~lv~e~~~~~sL~~~i~~~~~~--~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl 190 (391)
...+++++|+++++|.+++...... .....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEE
Confidence 6789999999999999998653211 0124689999999999999999999999 9999999999999999999999
Q ss_pred EecccccccCCCCce-eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHH
Q 016347 191 SDFGLAKLIPANMTH-VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDL 268 (391)
Q Consensus 191 ~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 268 (391)
+|||+++.+...... ......++..|+|||++.+..++.++|||||||++|++++ |..||....+... ...
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~---- 231 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM---AAY---- 231 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH---HHH----
Confidence 999999865332221 1122345678999999988889999999999999999999 9999975433221 111
Q ss_pred hhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 269 YERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.... .........+..+.+++.+||+.||++||++.++++.|...
T Consensus 232 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 232 LKDG---------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred HHcC---------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1110 00011122345788999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=308.76 Aligned_cols=260 Identities=26% Similarity=0.445 Sum_probs=204.7
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC------CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCe
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNH 114 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (391)
..++|++.+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 4578999999999999999999864 46789999987553 3345678899999999999999999999999889
Q ss_pred eEEEEecccCCCHHHHHhcCCCC----------------CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 016347 115 RILVYNYLENNSLAQTLIGGGHH----------------YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKAS 178 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~----------------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~ 178 (391)
.++||||+++++|.+++...... .....+++..++.++.|++.||.|||+. +++|+||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 99999999999999999743211 1123578899999999999999999999 9999999999
Q ss_pred cEEECCCCcEEEEecccccccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCc
Q 016347 179 NILLDKDLTPKISDFGLAKLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPT 256 (391)
Q Consensus 179 NIlv~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~ 256 (391)
||+++.++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999876432211 11112234567999999988999999999999999999997 77787543321
Q ss_pred chhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 257 EEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
+. . ......... ..+...+..+.+++.+||+.+|.+||++.|+++.|+
T Consensus 240 ~~---~----~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 240 EV---I----YYVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HH---H----HHHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 11 1 111111110 111233467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=304.65 Aligned_cols=251 Identities=29% Similarity=0.451 Sum_probs=206.5
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
++|++.+.||.|++|.||+|.+. +++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 47899999999999999999976 58999999987553 34456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++++|.+++... ++++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 81 CGGGSCLDLLKPG-------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred eCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 9999999998542 689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
... ......+++.|+|||.+.+..++.++|||||||++|+|++|..||....+..... . ..... .+
T Consensus 151 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~---~----~~~~~-----~~- 216 (274)
T cd06609 151 TMS-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF---L----IPKNN-----PP- 216 (274)
T ss_pred ccc-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH---H----hhhcC-----CC-
Confidence 322 2233467889999999998889999999999999999999999997544321110 0 00000 00
Q ss_pred CCCCCCHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 282 LNGDFDAE-EACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 282 ~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
..... .+..+.+++.+||..+|++||++++++++-+-
T Consensus 217 ---~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~ 254 (274)
T cd06609 217 ---SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFI 254 (274)
T ss_pred ---CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhh
Confidence 11111 44578889999999999999999999986543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=309.07 Aligned_cols=259 Identities=27% Similarity=0.383 Sum_probs=201.7
Q ss_pred CCCCCCceeeccCceEEEEEEeCC-Cc--EEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLKD-GK--IAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 118 (391)
++|++.+.||+|+||.||+|.+.+ +. .+++|.+... .......+.+|++++.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 579999999999999999998763 33 4688887643 333456788999999999 799999999999998999999
Q ss_pred EecccCCCHHHHHhcCCCCC----------CccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcE
Q 016347 119 YNYLENNSLAQTLIGGGHHY----------SNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTP 188 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~----------~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~ 188 (391)
+||+++++|.+++....... ....+++..+..++.|++.||+|||+. |++|+||||+||+++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 99999999999996543111 123588999999999999999999999 99999999999999999999
Q ss_pred EEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 016347 189 KISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWD 267 (391)
Q Consensus 189 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 267 (391)
||+|||++........ ......+..|+|||++.+..++.++|||||||++|+|++ |..||........ ...
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~---~~~--- 230 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL---YEK--- 230 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH---
Confidence 9999999864321111 111123457999999988899999999999999999997 9999965433211 111
Q ss_pred HhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 268 LYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
... ......+...+..+.+++.+||+.+|.+||++.++++.|....
T Consensus 231 -~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 231 -LPQ---------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred -Hhc---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 110 0111112234457889999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=309.72 Aligned_cols=259 Identities=28% Similarity=0.392 Sum_probs=201.3
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCc--EEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGK--IAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 117 (391)
.++|++.+.||+|+||.||+|.+. ++. .+++|.+... .......+.+|++++.++ +||||+++++++......++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 468999999999999999999975 344 4577776543 234456788899999999 89999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCC----------CccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCc
Q 016347 118 VYNYLENNSLAQTLIGGGHHY----------SNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLT 187 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~----------~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~ 187 (391)
||||+++++|.+++...+... ....+++..++.++.||+.||+|||++ |++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 999999999999997543211 123588999999999999999999999 9999999999999999999
Q ss_pred EEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 016347 188 PKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTW 266 (391)
Q Consensus 188 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 266 (391)
++|+|||++........ .....++..|+|||++.+..++.++|||||||++|+|+| |..||......+. ...
T Consensus 163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~-- 235 (303)
T cd05088 163 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YEK-- 235 (303)
T ss_pred EEeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH---HHH--
Confidence 99999999864321111 111223567999999988889999999999999999998 9999864432211 111
Q ss_pred HHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 267 DLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.... .....+...+..+.+++.+||+.+|++||++.++++.|...
T Consensus 236 --~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 236 --LPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred --HhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1100 00111122345688999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=300.66 Aligned_cols=246 Identities=25% Similarity=0.369 Sum_probs=194.5
Q ss_pred eeeccCceEEEEEEeC---CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCCC
Q 016347 51 KIGEGGFGSVYKGRLK---DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNS 126 (391)
Q Consensus 51 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~s 126 (391)
.||+|+||.||+|.+. .+..||+|++.... ......+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 35679999987653 333466889999999999999999999875 457899999999999
Q ss_pred HHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCcee
Q 016347 127 LAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHV 206 (391)
Q Consensus 127 L~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~ 206 (391)
|.+++... ...+++..++.++.|++.||.|||++ |++|+||||+||+++.++.+||+|||++..........
T Consensus 81 L~~~l~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 81 LNKFLSGK-----KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred HHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 99998642 23589999999999999999999999 99999999999999999999999999987653332211
Q ss_pred eee--ecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCC
Q 016347 207 STR--VAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLN 283 (391)
Q Consensus 207 ~~~--~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (391)
... ..++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ....... ..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~---------~~ 216 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV-------MSFIEQG---------KR 216 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH-------HHHHHCC---------CC
Confidence 111 123568999999988889999999999999999996 9999865433211 1111111 11
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 284 GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 284 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
...+...+..+.+++.+||+.+|++||++.+|.+.|..
T Consensus 217 ~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 217 LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 12223345678889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=304.67 Aligned_cols=252 Identities=26% Similarity=0.348 Sum_probs=200.1
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
.|+..+.||.|+||+||+|.+. +++.||+|.+.... ......+.+|+++++.++|+||+++++.+..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3777889999999999999876 58899999986542 2223457789999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+++++|.+.+...+ ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 81 IMNGGDLKFHIYNMG----NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred eccCccHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 999999998885432 23589999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeec
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT 280 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (391)
... ......|+..|+|||++.+..++.++|+|||||++|+|++|..||............. ...... ..
T Consensus 154 ~~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~---~~~~~~------~~ 222 (285)
T cd05632 154 EGE--SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD---RRVLET------EE 222 (285)
T ss_pred CCC--cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---Hhhhcc------cc
Confidence 221 1233468999999999988899999999999999999999999997543322111100 000000 00
Q ss_pred cCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 016347 281 SLNGDFDAEEACRFLKVGLLCTQDTPKLRPS-----MSTVVQM 318 (391)
Q Consensus 281 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 318 (391)
.........+.+|+..||+.||++||+ +.+++++
T Consensus 223 ----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 223 ----VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ----ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 111223446788999999999999999 6677665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=309.28 Aligned_cols=253 Identities=26% Similarity=0.408 Sum_probs=207.1
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
.++|++.+.||.|++|.||+|.+. +|+.|++|.+..........+.+|+.+++.++||||+++++++......++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 357999999999999999999875 6899999998766555567788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++++|.+++.. ..+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++.....
T Consensus 98 ~~~~~L~~~~~~-------~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 98 LAGGSLTDVVTE-------TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred cCCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 999999998853 2489999999999999999999999 999999999999999999999999999876533
Q ss_pred CCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
... ......++..|+|||.+.+..++.++|||||||++|+|++|..||....+....... ..... ..
T Consensus 168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~------~~~~~------~~ 234 (296)
T cd06655 168 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNGT------PE 234 (296)
T ss_pred ccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhcCC------cc
Confidence 221 122346888999999998888999999999999999999999999765442221110 00000 00
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
+ ..+......+.+++.+||..||.+||++.+++.+-+
T Consensus 235 ~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~ 271 (296)
T cd06655 235 L--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPF 271 (296)
T ss_pred c--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 0 111233456888999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=310.58 Aligned_cols=250 Identities=20% Similarity=0.326 Sum_probs=213.1
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchh--cHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQ--GVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
.+-|.+.+.||+|.|+.|-+|++- +|..||||++.+..-+ ....+.+|+..|+.++|||||++|++...+..+|||.
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 456999999999999999999865 7999999999876433 3346889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC-CcEEEEecccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD-LTPKISDFGLAKL 198 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~-~~~kl~Dfg~~~~ 198 (391)
|.=++|+|.++|.+.. ..+.+..+.+++.||+.|+.|+|+. .+|||||||+||.+-+. |-|||+|||++-.
T Consensus 97 ELGD~GDl~DyImKHe-----~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNk 168 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHE-----EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNK 168 (864)
T ss_pred EecCCchHHHHHHhhh-----ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeecccccc
Confidence 9999999999998743 4699999999999999999999999 99999999999987555 8999999999987
Q ss_pred cCCCCceeeeeecccccccChhhhhcCCCC-CCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccccee
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIRGQVT-RKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILL 277 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (391)
+... ..-.+.||+..|.|||++.+..|+ ++.||||||||||.|++|+.||......+... .+
T Consensus 169 f~PG--~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT---------------mI 231 (864)
T KOG4717|consen 169 FQPG--KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT---------------MI 231 (864)
T ss_pred CCCc--chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh---------------hh
Confidence 6543 344668999999999999999996 68999999999999999999997655443221 22
Q ss_pred eeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 278 VDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 278 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
+|=.+ ..+.....++.+||..||..||++|.+.+||...-
T Consensus 232 mDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~ 271 (864)
T KOG4717|consen 232 MDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTS 271 (864)
T ss_pred hcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccc
Confidence 22222 44567778999999999999999999999998653
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=328.58 Aligned_cols=273 Identities=20% Similarity=0.261 Sum_probs=199.4
Q ss_pred hHHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCC------CCceeEEEEE
Q 016347 36 YKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIE------HENLVKLYGC 108 (391)
Q Consensus 36 ~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~ 108 (391)
.+++.+.+++|+++++||+|+||+||+|.+. .++.||||++.... .....+..|+++++.++ |.++++++++
T Consensus 121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 4455667899999999999999999999976 58899999986432 22334556777766664 4568889998
Q ss_pred EEeC-CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEECCCC
Q 016347 109 CVEG-NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHE-EVRPHIIHRDIKASNILLDKDL 186 (391)
Q Consensus 109 ~~~~-~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~i~H~dikp~NIlv~~~~ 186 (391)
+... .+.++||+++ +++|.+++...+ .+++..+..|+.||+.||.|||+ . ||+||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~ 269 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMKHG------PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSD 269 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCC
Confidence 8754 5788999988 678888886543 58999999999999999999997 5 899999999999998765
Q ss_pred ----------------cEEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCC
Q 016347 187 ----------------TPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNT 250 (391)
Q Consensus 187 ----------------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~ 250 (391)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf 345 (467)
T PTZ00284 270 TVVDPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345 (467)
T ss_pred cccccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 499999998764321 223467999999999999999999999999999999999999999
Q ss_pred CCCCCcchhhHHHHHHHHhh--------hcccceeeec--cCCCCC---------------CHHHHHHHHHHHhhccCCC
Q 016347 251 NMRLPTEEQYLLERTWDLYE--------RRELILLVDT--SLNGDF---------------DAEEACRFLKVGLLCTQDT 305 (391)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~--~~~~~~---------------~~~~~~~l~~li~~cl~~d 305 (391)
......+............. ......+++. .+.... .......+.+||.+||+.|
T Consensus 346 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 425 (467)
T PTZ00284 346 DTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD 425 (467)
T ss_pred CCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcC
Confidence 76554322211111100000 0000000000 000000 0012346789999999999
Q ss_pred CCCCCCHHHHHHHhcCCC
Q 016347 306 PKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 306 P~~Rps~~evl~~l~~~~ 323 (391)
|++|||++|++++-+...
T Consensus 426 P~~R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 426 RQKRLNARQMTTHPYVLK 443 (467)
T ss_pred hhhCCCHHHHhcCccccc
Confidence 999999999999765543
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=309.41 Aligned_cols=268 Identities=21% Similarity=0.317 Sum_probs=201.8
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
++|++.++||.|+||.||+|.+. +++.||+|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 67999999999999999999976 58899999987543 23334677899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
++ ++|.+++.... ..+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 86 ~~-~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 86 LD-KDLKQYLDDCG-----NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred cc-cCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 97 58888886532 2578999999999999999999999 999999999999999999999999999876432
Q ss_pred CCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeee-
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD- 279 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 279 (391)
... ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||.............................
T Consensus 157 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 157 PTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred CCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence 211 12233568899999988654 578999999999999999999999976543221111111000000000000000
Q ss_pred --------ccCCCCC----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 280 --------TSLNGDF----DAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 280 --------~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
+...... .......+.+++.+||+.||.+|||+.|++++-+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f 289 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 0000000 01224467889999999999999999999987544
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=316.99 Aligned_cols=267 Identities=24% Similarity=0.271 Sum_probs=200.8
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC-----
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG----- 112 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 112 (391)
...++|++.+.||+|+||.||+|.+. .++.||+|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34689999999999999999999876 5889999998754 233456678899999999999999999988643
Q ss_pred -CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEE
Q 016347 113 -NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKIS 191 (391)
Q Consensus 113 -~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~ 191 (391)
...++||||+++ +|.+.+.. .+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~ 161 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 161 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEe
Confidence 357999999976 56666632 378889999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHH------
Q 016347 192 DFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERT------ 265 (391)
Q Consensus 192 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~------ 265 (391)
|||+++...... ......||..|+|||++.+..++.++|||||||++|+|++|+.||...............
T Consensus 162 Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (355)
T cd07874 162 DFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239 (355)
T ss_pred eCcccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 999998653321 223457899999999999989999999999999999999999999765422110000000
Q ss_pred ---------HHHh-hhc-cc-----ceeeeccCC---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 266 ---------WDLY-ERR-EL-----ILLVDTSLN---GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 266 ---------~~~~-~~~-~~-----~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
...+ ... .. ......... ..........+.+++.+||+.||++|||+.|++++-+-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~ 314 (355)
T cd07874 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI 314 (355)
T ss_pred HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcch
Confidence 0000 000 00 000000000 00111224567899999999999999999999987543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=305.72 Aligned_cols=263 Identities=24% Similarity=0.379 Sum_probs=208.6
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
..++|++++.||+|+||+||+|.+. +|+.||+|++.... ......+.+|+++++.++||||+++++++......++||
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 4578999999999999999999976 58899999876542 344567889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++...+ .+++..+..++.+++.||.|||+.. +++|+||+|+||+++.++.++|+|||++...
T Consensus 83 e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~ 154 (284)
T cd06620 83 EFMDCGSLDRIYKKGG------PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGEL 154 (284)
T ss_pred ecCCCCCHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence 9999999999886533 4899999999999999999999731 8999999999999999999999999998654
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcch-----hhHHHHHHHHhhhccc
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEE-----QYLLERTWDLYERREL 274 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~ 274 (391)
.... .....|+..|+|||++.+..++.++|||||||++|+|++|..||........ ............ .
T Consensus 155 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~-- 228 (284)
T cd06620 155 INSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-E-- 228 (284)
T ss_pred hhhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-c--
Confidence 3221 1235689999999999888999999999999999999999999975543211 000011000000 0
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKD 324 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~ 324 (391)
..........+..+.+++.+||+.||.+||++.|++++....+.
T Consensus 229 ------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 229 ------PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred ------cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 00000011244578899999999999999999999998655443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=301.81 Aligned_cols=251 Identities=22% Similarity=0.390 Sum_probs=202.2
Q ss_pred CCCCCceeeccCceEEEEEEeCCCcEEEEEEecccc------hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 45 DFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAES------RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
+|++.+.||.|+||.||+|...+++.+|+|.+.... ......+.+|+++++.++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 588999999999999999998889999999886432 22345688899999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
+||+++++|.+++...+ .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 151 (265)
T cd06631 81 MEFVPGGSISSILNRFG------PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARR 151 (265)
T ss_pred EecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHh
Confidence 99999999999996533 478999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCC-----ceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcc
Q 016347 199 IPANM-----THVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRE 273 (391)
Q Consensus 199 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (391)
..... ........|+..|+|||++.+..++.++|||||||++|+|++|..||............ .....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~~~~~ 225 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI------GAHRG 225 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh------hhccC
Confidence 42211 11122346889999999998888999999999999999999999999654322111000 00000
Q ss_pred cceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
. ....+......+.+++.+||+.+|.+||++.+++++
T Consensus 226 ~--------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 226 L--------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred C--------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 011122345567889999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=304.27 Aligned_cols=254 Identities=26% Similarity=0.432 Sum_probs=203.2
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
.++|++.+.||+|+||.||+|.+. +++.||+|++..........+.+|+.+++.++||||+++++.+......++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 468899999999999999999876 5889999998766555556788899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++++|.+++...+ .+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++.....
T Consensus 88 ~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 88 CGGGSLQDIYHVTG------PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred cCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 99999999986443 489999999999999999999999 999999999999999999999999999876532
Q ss_pred CCceeeeeecccccccChhhhh---cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAI---RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
... ......|+..|+|||++. ...++.++|||||||++|+|++|..||....+....... .. ... .
T Consensus 159 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~------~~-~~~---~ 227 (267)
T cd06645 159 TIA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM------TK-SNF---Q 227 (267)
T ss_pred ccc-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh------hc-cCC---C
Confidence 211 123346899999999874 456889999999999999999999998654332211100 00 000 0
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
...... ....+..+.+++.+||+.+|++||++.+++++
T Consensus 228 ~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 228 PPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000000 01223467889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=315.53 Aligned_cols=266 Identities=23% Similarity=0.259 Sum_probs=200.5
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC------
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG------ 112 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 112 (391)
..++|++.+.||+|+||.||+|.+. .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3588999999999999999999976 5889999998754 233456678899999999999999999987543
Q ss_pred CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEe
Q 016347 113 NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISD 192 (391)
Q Consensus 113 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~D 192 (391)
...++||||+++ +|.+.+.. .+++..+..++.|++.||.|||++ |++||||||+|||++.++.+||+|
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D 169 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 169 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh--------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEe
Confidence 357999999975 67776632 378889999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHH-------
Q 016347 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERT------- 265 (391)
Q Consensus 193 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~------- 265 (391)
||+++...... ......||..|+|||++.+..++.++|||||||++|+|++|+.||...............
T Consensus 170 fG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (364)
T cd07875 170 FGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 247 (364)
T ss_pred CCCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 99998653321 223456899999999999999999999999999999999999999765432211000000
Q ss_pred -H--------HHhhhcc-c-----ceeeeccC---CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 266 -W--------DLYERRE-L-----ILLVDTSL---NGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 266 -~--------~~~~~~~-~-----~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
. ....... . ........ ...........+.+++.+||+.||.+|||+.|++++-+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~ 321 (364)
T cd07875 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321 (364)
T ss_pred HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 0 0000000 0 00000000 001111123467899999999999999999999987543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=306.53 Aligned_cols=256 Identities=28% Similarity=0.439 Sum_probs=207.0
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
..++|++.++||.|++|.||+|.+. +++.+|+|++..........+..|+++++.++||||+++++.+..+...++|||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 3578999999999999999999976 589999999887666666789999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+++++|.+++...+ ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 83 ~~~~~~L~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 83 FCDGGALDSIMLELE-----RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred ccCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 999999999986532 3589999999999999999999999 99999999999999999999999999887653
Q ss_pred CCCceeeeeecccccccChhhhhc-----CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIR-----GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
.... ......+++.|+|||.+.. ..++.++|||||||++|+|++|..||........ . . .......
T Consensus 155 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~-~----~~~~~~~- 225 (280)
T cd06611 155 STLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--L-L----KILKSEP- 225 (280)
T ss_pred cccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--H-H----HHhcCCC-
Confidence 3221 2233568899999998753 4577899999999999999999999975433211 0 0 0011000
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
+.+ ..+......+.+++..||+.+|.+||++.+++++-+
T Consensus 226 ----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (280)
T cd06611 226 ----PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPF 264 (280)
T ss_pred ----CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChh
Confidence 000 111223456888999999999999999999988754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=299.82 Aligned_cols=255 Identities=28% Similarity=0.440 Sum_probs=208.1
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
.++|++.+.||.|++|.||+|.+. +++.+++|++........+.+.+|+++++.++||||+++++++......+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 478999999999999999999976 5788999999876655678899999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++++|.+++... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~~~~l~~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 82 CGGGSLQDIYQVT-----RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred CCCCcHHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 9999999988653 13589999999999999999999999 999999999999999999999999999876543
Q ss_pred CCceeeeeecccccccChhhhhcC---CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRG---QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
... ......++..|+|||.+.+. .++.++|||||||++|+|++|..||....+....... ..... .
T Consensus 154 ~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~-------~~~~~---~ 222 (262)
T cd06613 154 TIA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI-------SKSNF---P 222 (262)
T ss_pred hhh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhccC---C
Confidence 221 22335678899999998776 7899999999999999999999999754432211110 00000 0
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
...+ ......+..+.+++.+||..+|.+||++.+|+.+
T Consensus 223 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 223 PPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred Cccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 1123445678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=304.30 Aligned_cols=252 Identities=25% Similarity=0.418 Sum_probs=202.3
Q ss_pred CCCCceeeccCceEEEEEEeCC-CcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccC
Q 016347 46 FSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLEN 124 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 124 (391)
|++.++||.|+||.||+|.+.. +..+++|.+..........+.+|+++++.++||||+++++++......++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 7888999999999999999874 788899998766555667788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc
Q 016347 125 NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204 (391)
Q Consensus 125 ~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~ 204 (391)
++|..++... ..++++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++.......
T Consensus 87 ~~l~~~~~~~-----~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~- 157 (282)
T cd06643 87 GAVDAVMLEL-----ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 157 (282)
T ss_pred CcHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-
Confidence 9999887542 23589999999999999999999999 99999999999999999999999999987653221
Q ss_pred eeeeeecccccccChhhhh-----cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 205 HVSTRVAGTIGYLAPEYAI-----RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 205 ~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
.......++..|+|||++. +..++.++|||||||++|+|++|..||....+.... .. ... ...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~----~~~-~~~----- 225 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL--LK----IAK-SEP----- 225 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH--HH----Hhh-cCC-----
Confidence 1223346889999999874 345788999999999999999999998654321110 00 000 000
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
... ..+...+..+.+++.+||+.||.+||++.+++++-.
T Consensus 226 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 226 PTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred CCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 000 111223457889999999999999999999988764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=298.66 Aligned_cols=251 Identities=28% Similarity=0.447 Sum_probs=206.5
Q ss_pred hCCCCCCceeeccCceEEEEEEeCC-CcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
.++|++.++||.|++|.||+|.+.. ++.+++|.+..... ...+.+|+++++.++||||+++++++......++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 4789999999999999999999875 88999999876533 67899999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++++|.+++...+ ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 80 CGAGSVSDIMKITN-----KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred CCCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 99999999986432 3689999999999999999999999 999999999999999999999999999887644
Q ss_pred CCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
... ......++..|+|||++.+..++.++||||||+++|+|++|+.||....+...... .... ....
T Consensus 152 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------~~~~-----~~~~ 218 (256)
T cd06612 152 TMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------IPNK-----PPPT 218 (256)
T ss_pred Ccc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------hccC-----CCCC
Confidence 321 22334578899999999988999999999999999999999999875433221100 0000 0000
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
...+......+.+++.+||+.||++||++.|++++
T Consensus 219 --~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 219 --LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred --CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 01122334578899999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=310.06 Aligned_cols=261 Identities=25% Similarity=0.391 Sum_probs=206.4
Q ss_pred HHHhhCCCCCCceeeccCceEEEEEEeC------CCcEEEEEEecccc-hhcHHHHHHHHHHHhcC-CCCceeEEEEEEE
Q 016347 39 LSIATDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAES-RQGVKEFLTEIQVISEI-EHENLVKLYGCCV 110 (391)
Q Consensus 39 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 110 (391)
+.+..++|++.+.||+|+||.||+|.+. .+..||+|.+.... ......+.+|+.+++++ +||||+++++++.
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 3455678999999999999999999742 25579999887542 33456788999999999 7999999999999
Q ss_pred eCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEE
Q 016347 111 EGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKI 190 (391)
Q Consensus 111 ~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl 190 (391)
..+..++||||+++++|.+++.... ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l 182 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKR----ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKI 182 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEE
Confidence 9999999999999999999996432 12389999999999999999999999 9999999999999999999999
Q ss_pred EecccccccCCCCce-eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHH
Q 016347 191 SDFGLAKLIPANMTH-VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDL 268 (391)
Q Consensus 191 ~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 268 (391)
+|||++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||........ . ...
T Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~----~~~ 256 (302)
T cd05055 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--F----YKL 256 (302)
T ss_pred CCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--H----HHH
Confidence 999998865433221 1122345678999999999999999999999999999998 8888865432111 0 001
Q ss_pred hhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 269 YERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.... .....+...+..+.+++.+||+.+|++||++.|+++.|..
T Consensus 257 ~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 257 IKEG---------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred HHcC---------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 1100 0101111234578899999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=318.29 Aligned_cols=267 Identities=19% Similarity=0.201 Sum_probs=202.9
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeC---CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLK---DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
.+...+|+++++||+|+||.||++... .+..||+|.+... ....+|+++|+.++||||+++++++......+
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 344568999999999999999999754 3678999987643 23457999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+|||++. ++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.++|+|||++
T Consensus 163 lv~e~~~-~~l~~~l~~~------~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a 232 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRS------GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAA 232 (392)
T ss_pred EEehhcC-CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccc
Confidence 9999995 5788888432 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 197 KLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 197 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........................
T Consensus 233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~ 312 (392)
T PHA03207 233 CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE 312 (392)
T ss_pred cccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccc
Confidence 76543322 12234679999999999999999999999999999999999999997654332111111111111000000
Q ss_pred ----------e---eeeccCCCCCC-------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 276 ----------L---LVDTSLNGDFD-------AEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 276 ----------~---~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
. ........... .....++.+++.+||..||++||++.|++.+-+.
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f 378 (392)
T PHA03207 313 FPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLF 378 (392)
T ss_pred cCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchh
Confidence 0 00000000000 0123467789999999999999999999988644
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=301.74 Aligned_cols=250 Identities=27% Similarity=0.460 Sum_probs=207.2
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
..|+.+++||.|+||.||+|.+. +++.||+|.+.... ......+.+|+.+++.+.||||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 56888999999999999999976 58899999987542 34456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++++|.+++.. .++++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~L~~~i~~-------~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 84 LGGGSALDLLRA-------GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 999999999853 2478889999999999999999999 999999999999999999999999999976643
Q ss_pred CCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
... ......++..|+|||++.+..++.++|+|||||++|+|++|..||....+...... ....
T Consensus 154 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~----------------~~~~ 216 (277)
T cd06640 154 TQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL----------------IPKN 216 (277)
T ss_pred Ccc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh----------------hhcC
Confidence 321 12234578899999999888899999999999999999999999975543221110 0011
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.........+..+.+++.+||+.+|++||++.+++.+..
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 111233456678899999999999999999999988754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=304.85 Aligned_cols=257 Identities=24% Similarity=0.318 Sum_probs=204.3
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeCC----CcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLKD----GKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
+..++|.+.+.||+|+||.||+|.+.+ ...|++|...... ....+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 456789999999999999999998643 3468999887654 4455678999999999999999999998875 457
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~ 153 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNK-----YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGL 153 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCce
Confidence 89999999999999996532 2489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
+...............++..|+|||.+....++.++|||||||++|+|++ |..||......... .. .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~----~~~~~- 225 (270)
T cd05056 154 SRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---GR----IENGE- 225 (270)
T ss_pred eeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HH----HHcCC-
Confidence 88664432222222334568999999988889999999999999999986 99999655332111 11 11110
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
....+...+..+.+++.+|+..+|.+||++.++++.|...
T Consensus 226 --------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 226 --------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred --------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0011223345788899999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=301.11 Aligned_cols=250 Identities=27% Similarity=0.427 Sum_probs=200.2
Q ss_pred hhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEE-eCCeeEEEEe
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCV-EGNHRILVYN 120 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e 120 (391)
.-++|++.+.||+|+||.||+|... |..+|+|.+.... ..+.+.+|+.++++++|+|++++++++. .+...+++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 3468999999999999999999876 7789999886543 3467889999999999999999999765 4567899999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+++++|.+++.... ...+++..+..++.|++.||+|||++ |++|+||||+||+++.++.+||+|||++....
T Consensus 81 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 153 (256)
T cd05082 81 YMAKGSLVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153 (256)
T ss_pred CCCCCcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecc
Confidence 999999999986532 23478999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
... ....++..|+|||++.+..++.++|||||||++|+|++ |+.||....... .... ....
T Consensus 154 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~----~~~~------- 215 (256)
T cd05082 154 STQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKG------- 215 (256)
T ss_pred ccC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HhcC-------
Confidence 221 12334568999999988899999999999999999997 888885432211 1111 1110
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.........+..+.+++.+||+.+|++||++.++++.|..
T Consensus 216 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 216 --YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred --CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1111122345578889999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=304.87 Aligned_cols=265 Identities=25% Similarity=0.339 Sum_probs=199.7
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
+|++++.||.|++|.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5889999999999999999976 58999999986542 23346688899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
++ ++|.+++.... ....+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 153 (285)
T cd07861 81 LS-MDLKKYLDSLP---KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI 153 (285)
T ss_pred CC-CCHHHHHhcCC---CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence 97 58888875432 224689999999999999999999999 999999999999999999999999999876532
Q ss_pred CCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHH--------HHhh--
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTW--------DLYE-- 270 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~-- 270 (391)
.. .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||................ ....
T Consensus 154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 154 PV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred Cc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence 21 112223568899999988654 47899999999999999999999997654322111100000 0000
Q ss_pred ---hcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 271 ---RRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 271 ---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
............ .........++.+++.+||+.||.+|||+.+|+++
T Consensus 233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 233 PDYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000000 00011234567789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=321.23 Aligned_cols=266 Identities=23% Similarity=0.395 Sum_probs=207.9
Q ss_pred HHHHhhCCCCCCceeeccCceEEEEEEeC------CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCC-CCceeEEEEEE
Q 016347 38 ELSIATDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIE-HENLVKLYGCC 109 (391)
Q Consensus 38 e~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~ 109 (391)
++++..++|.+.++||+|+||.||+|++. .+..||+|++.... ......+.+|+.+|.++. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 46667788999999999999999999864 24679999997653 233456889999999997 99999999999
Q ss_pred EeCCeeEEEEecccCCCHHHHHhcCCCC----------------------------------------------------
Q 016347 110 VEGNHRILVYNYLENNSLAQTLIGGGHH---------------------------------------------------- 137 (391)
Q Consensus 110 ~~~~~~~lv~e~~~~~sL~~~i~~~~~~---------------------------------------------------- 137 (391)
...+..++||||+++|+|.+++...+..
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 9999999999999999999999754210
Q ss_pred ----------------------------------------CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 016347 138 ----------------------------------------YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKA 177 (391)
Q Consensus 138 ----------------------------------------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp 177 (391)
.....+++..+..++.||+.||.|||+. +++|+||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCc
Confidence 0112467788899999999999999998 999999999
Q ss_pred CcEEECCCCcEEEEecccccccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCC
Q 016347 178 SNILLDKDLTPKISDFGLAKLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLP 255 (391)
Q Consensus 178 ~NIlv~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~ 255 (391)
+|||++.++.++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999976432211 11122356788999999988889999999999999999998 8888864322
Q ss_pred cchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 256 TEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.+. . ....... .....+......+.+++.+||+.+|.+||++++|++.|+.
T Consensus 348 ~~~--~----~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 348 NEQ--F----YNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred hHH--H----HHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111 0 0101110 0011122234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=299.20 Aligned_cols=252 Identities=33% Similarity=0.485 Sum_probs=203.6
Q ss_pred ceeeccCceEEEEEEeCC----CcEEEEEEecccchh-cHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccC
Q 016347 50 NKIGEGGFGSVYKGRLKD----GKIAAIKVLSAESRQ-GVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLEN 124 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 124 (391)
+.||+|+||.||+|.+.. +..|++|.+...... ....+.+|++.++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999764 788999998866433 367788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCC---CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 125 NSLAQTLIGGGHH---YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 125 ~sL~~~i~~~~~~---~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
++|.+++...... .....+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999764210 0135689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 202 NMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 202 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
... .......++..|+|||.+....++.++|||||||++|+|++ |..||........ ... ....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~----~~~~------- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV---LEY----LRKG------- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH---HHH----HHcC-------
Confidence 321 12233457889999999988899999999999999999999 5888876532111 111 1110
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.....+...+..+.+++.+||+.+|++||++.+++++|+
T Consensus 224 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 --YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011222233568889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=316.48 Aligned_cols=247 Identities=28% Similarity=0.432 Sum_probs=204.5
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
+.|+-++.||.|+||.||-|++. +.+.||||.+... ....++++..|+..|+.+.|||+|.+.|||..+...+|||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 34667788999999999999976 6889999998766 3345678999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
|||-| |-.+++.- ..+++.+..+..|+.+.+.||+|||+. +.+|||||..|||+++.|.|||+|||.+.+.
T Consensus 106 EYClG-SAsDlleV-----hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 106 EYCLG-SASDLLEV-----HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIM 176 (948)
T ss_pred HHHhc-cHHHHHHH-----HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhc
Confidence 99954 77777754 345799999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCceeeeeecccccccChhhhh---cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccce
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAI---RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL 276 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (391)
.. ...++|||.|||||++. .+.|+-|+||||||++..||...++|.-..... ...+....+..
T Consensus 177 ~P-----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM------SALYHIAQNes--- 242 (948)
T KOG0577|consen 177 AP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNES--- 242 (948)
T ss_pred Cc-----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH------HHHHHHHhcCC---
Confidence 43 24578999999999985 478999999999999999999999885332221 11222222211
Q ss_pred eeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 277 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
+.+ ...+....|..|+..||++-|.+|||.++++++-
T Consensus 243 ---PtL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 243 ---PTL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred ---CCC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 111 1346777899999999999999999999999764
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=299.31 Aligned_cols=250 Identities=23% Similarity=0.356 Sum_probs=202.2
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEe-CCeeEEEEe
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVE-GNHRILVYN 120 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 120 (391)
+|++.+.||+|++|.||++.+. +++.||+|.+... .....+.+.+|++++++++|+|++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5899999999999999999976 4788999998654 23345668889999999999999999998764 446899999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+++++|.+++... ....+++..+..++.|++.|+.+||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~~~~~~l~~~l~~~----~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~ 153 (257)
T cd08223 81 FCEGGDLYHKLKEQ----KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE 153 (257)
T ss_pred ccCCCcHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEec
Confidence 99999999998642 223589999999999999999999999 99999999999999999999999999987664
Q ss_pred CCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeec
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT 280 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (391)
.... ......+++.|+|||++.+..++.++|||||||++++|++|+.||........ ... ......
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~-~~~~~~------ 219 (257)
T cd08223 154 NQCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VYR-IIEGKL------ 219 (257)
T ss_pred ccCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHH-HHhcCC------
Confidence 3222 22345688999999999998999999999999999999999999864332111 000 011110
Q ss_pred cCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 281 SLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 281 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
...+......+.+++.+||+.||++||++.+++++
T Consensus 220 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 ---PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11223455678899999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=297.45 Aligned_cols=247 Identities=29% Similarity=0.418 Sum_probs=198.7
Q ss_pred ceeeccCceEEEEEEeCCCcEEEEEEecccchh-cHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCCCHH
Q 016347 50 NKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQ-GVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLA 128 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~ 128 (391)
++||.|++|.||+|.+.+++.||+|.+...... ....+.+|+++++.+.|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998765333 4567899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCceee-
Q 016347 129 QTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVS- 207 (391)
Q Consensus 129 ~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~~- 207 (391)
+++.... ..+++..+..++.+++.||.|||++ +++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~l~~~~-----~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 81 TFLRKKK-----NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 9986532 2578999999999999999999999 999999999999999999999999999876532211111
Q ss_pred eeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCC
Q 016347 208 TRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDF 286 (391)
Q Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (391)
....++..|+|||.+.++.++.++|||||||++|+|++ |..||.......... . ... ......
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~---~----~~~---------~~~~~~ 216 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE---R----IES---------GYRMPA 216 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH---H----Hhc---------CCCCCC
Confidence 11223567999999988899999999999999999999 788886543321111 0 000 001111
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 287 DAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 287 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
+...+..+.+++.+||+.+|++||++.||++.|.
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 2234557889999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=303.05 Aligned_cols=254 Identities=26% Similarity=0.441 Sum_probs=201.8
Q ss_pred CCCCCCceeeccCceEEEEEEeCC-C---cEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLKD-G---KIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
.+|++.+.||+|+||.||+|.+.. + ..||+|.+... .......|..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 568899999999999999998753 3 36999998754 344567899999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|||+++++|.+++.... ..+++..++.++.|++.||.|||++ |++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 84 TEFMENGALDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred EecCCCCcHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccc
Confidence 99999999999986532 2588999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCceee--eeec--ccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcc
Q 016347 199 IPANMTHVS--TRVA--GTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRE 273 (391)
Q Consensus 199 ~~~~~~~~~--~~~~--gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (391)
......... .... .+..|+|||.+.+..++.++|||||||++|||++ |..||....... ..... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i----~~~- 227 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAI----EQD- 227 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHH----HcC-
Confidence 543221111 1111 1347999999998999999999999999999886 999986543221 11111 000
Q ss_pred cceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.....+...+..+.+++.+||+.+|.+||++.+++..|..
T Consensus 228 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 228 --------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred --------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0011122334568889999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=313.58 Aligned_cols=193 Identities=24% Similarity=0.346 Sum_probs=165.3
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
+...+|++++.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++......++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 44568999999999999999999987 4788999975432 2345899999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
|++. ++|.+++... ...+++..+..|+.||+.||.|||++ +|+||||||+|||++.++.++|+|||+++..
T Consensus 137 e~~~-~~l~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 137 PHYS-SDLYTYLTKR-----SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred EccC-CcHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 9995 5788887542 23589999999999999999999999 9999999999999999999999999998753
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCC
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNT 250 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~ 250 (391)
... .......||+.|+|||++.+..++.++|||||||++|+|+++..++
T Consensus 208 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 208 VVA--PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccC--cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 221 1223456899999999999999999999999999999999876554
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=300.32 Aligned_cols=249 Identities=29% Similarity=0.446 Sum_probs=201.5
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch---------hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCe
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR---------QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNH 114 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (391)
+|.+...||.|++|.||+|.+. +++.||+|.+..... .....+.+|+++++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 5788899999999999999876 588999998864422 123567889999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.++||||+++++|.+++...+ .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg 151 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG------AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFG 151 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccC
Confidence 999999999999999996533 488899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCc-----eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh
Q 016347 195 LAKLIPANMT-----HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLY 269 (391)
Q Consensus 195 ~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 269 (391)
++........ .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||........ .....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~ 225 (267)
T cd06628 152 ISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA------IFKIG 225 (267)
T ss_pred CCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH------HHHHh
Confidence 9887642211 111234578899999999888899999999999999999999999975322111 00000
Q ss_pred hhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 270 ERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
. ......+...+..+.+++.+||+.||.+||++.+++++
T Consensus 226 ~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 226 E----------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred c----------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0 01112223345678889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=302.55 Aligned_cols=266 Identities=24% Similarity=0.338 Sum_probs=203.4
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
++|++.+.||+|++|.||+|.+. +|+.||+|++.... ....+.+.+|+++++.++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 57999999999999999999987 58999999886442 2233567889999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+++++|..++... ..+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~~~~~~l~~~~~~~------~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07847 81 YCDHTVLNELEKNP------RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILT 151 (286)
T ss_pred ccCccHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecC
Confidence 99998888776432 2489999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh--------hh
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLY--------ER 271 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~--------~~ 271 (391)
.... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||......+............ ..
T Consensus 152 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 152 GPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST 230 (286)
T ss_pred CCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccc
Confidence 4321 1223457889999999876 457899999999999999999999997655433222111111000 00
Q ss_pred cccc-eeeeccCCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 272 RELI-LLVDTSLNGDFD-----AEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 272 ~~~~-~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.... ....+......+ ...+..+.+++.+||+.+|++||++.|++.+-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~ 284 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHP 284 (286)
T ss_pred ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCC
Confidence 0000 000000000000 12245788999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=304.67 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=201.8
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCc----EEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGK----IAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
..++|+++++||.|+||+||+|.+. +++ .||+|++... .......+.+|+.+++.+.||||+++++++... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 83 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV 83 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence 3578999999999999999999864 344 4899998754 334456788999999999999999999998754 57
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++++||+++|+|.+++... ...+++..++.++.||+.||.|||++ +++|+||||+||+++.++.+||+|||+
T Consensus 84 ~l~~~~~~~g~l~~~l~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~ 155 (279)
T cd05109 84 QLVTQLMPYGCLLDYVREN-----KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGL 155 (279)
T ss_pred EEEEEcCCCCCHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCc
Confidence 8999999999999998653 23589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCcee-eeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcc
Q 016347 196 AKLIPANMTHV-STRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRE 273 (391)
Q Consensus 196 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (391)
++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||........ .. ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~----~~~~~~ 228 (279)
T cd05109 156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI---PD----LLEKGE 228 (279)
T ss_pred eeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH----HHHCCC
Confidence 98764322211 111234678999999988899999999999999999998 8888864322111 01 011110
Q ss_pred cceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
....+...+..+.+++.+||+.||++||++.++++.|....
T Consensus 229 ---------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 229 ---------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred ---------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 01112234457889999999999999999999999886553
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=299.33 Aligned_cols=258 Identities=25% Similarity=0.326 Sum_probs=203.7
Q ss_pred HHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEE
Q 016347 39 LSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 39 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (391)
++...+.+.....||+|+||.||+|.+. ++..|++|.+..........+.+|+.+++.++|+||+++++++..+...++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3455666767779999999999999966 578899999876655566788999999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCcccc--CHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-CCcEEEEecc
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQF--SWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK-DLTPKISDFG 194 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l--~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~-~~~~kl~Dfg 194 (391)
|+||+++++|.+++.... ..+ ++..+..++.||+.||.|||++ +++|+||||+||+++. ++.++|+|||
T Consensus 83 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg 154 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW-----GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFG 154 (268)
T ss_pred EEecCCCCCHHHHHHHhc-----ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecch
Confidence 999999999999996532 124 7888899999999999999999 9999999999999976 6799999999
Q ss_pred cccccCCCCceeeeeecccccccChhhhhcCC--CCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 195 LAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQ--VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 195 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
++........ ......|+..|+|||++.+.. ++.++||||||+++|+|++|..||........... ....
T Consensus 155 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~-----~~~~-- 226 (268)
T cd06624 155 TSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF-----KVGM-- 226 (268)
T ss_pred hheecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh-----hhhh--
Confidence 9876533221 222345789999999986644 78999999999999999999999864332111100 0000
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
. ......+......+.+++.+||+.+|++||++.+++++-
T Consensus 227 -----~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 266 (268)
T cd06624 227 -----F--KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDP 266 (268)
T ss_pred -----h--ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCC
Confidence 0 001122233456788899999999999999999998763
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=298.69 Aligned_cols=247 Identities=29% Similarity=0.418 Sum_probs=196.0
Q ss_pred ceeeccCceEEEEEEeCC----CcEEEEEEecccch-hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccC
Q 016347 50 NKIGEGGFGSVYKGRLKD----GKIAAIKVLSAESR-QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLEN 124 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 124 (391)
++||+|+||.||+|.+.. +..+|+|.+..... .....+.+|+++++.+.||||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997542 36899999876543 34567889999999999999999999876 4568999999999
Q ss_pred CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc
Q 016347 125 NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204 (391)
Q Consensus 125 ~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~ 204 (391)
++|.+++.... .+++..+..++.|++.||.|||.. +++|+||||+||+++.++.++|+|||++........
T Consensus 80 ~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 80 GPLLKYLKKRR------EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 99999996543 589999999999999999999999 999999999999999999999999999986643322
Q ss_pred eeee--eecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 205 HVST--RVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 205 ~~~~--~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
.... ...++..|+|||.+.+..++.++|||||||++|+|++ |..||........ .... ....
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~---~~~~----~~~~-------- 215 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV---IAML----ESGE-------- 215 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH---HHHH----HcCC--------
Confidence 1111 1123467999999988899999999999999999998 9999865433211 1111 1110
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
....+...+..+.+++.+||..+|++||++.++++.|...
T Consensus 216 -~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 216 -RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 0111223345788999999999999999999999999654
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=304.84 Aligned_cols=263 Identities=27% Similarity=0.410 Sum_probs=206.2
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-----CCcEEEEEEecccchh-cHHHHHHHHHHHhcCCCCceeEEEEEEEe--CCe
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-----DGKIAAIKVLSAESRQ-GVKEFLTEIQVISEIEHENLVKLYGCCVE--GNH 114 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 114 (391)
.++|++.+.||+|+||.||+|.+. +++.+|+|.+...... ....+.+|+++++.+.||||+++++++.. ...
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 357889999999999999999854 3788999998766443 45779999999999999999999999887 557
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.+++|||+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~-----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 154 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHR-----DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFG 154 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCc-----cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccc
Confidence 899999999999999996532 2589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCce--eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchh--------hHHHH
Q 016347 195 LAKLIPANMTH--VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQ--------YLLER 264 (391)
Q Consensus 195 ~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~--------~~~~~ 264 (391)
++......... ......++..|+|||.+.+..++.++||||||+++|+|++|..|+......... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05038 155 LAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234 (284)
T ss_pred cccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH
Confidence 99876532211 111223456799999998889999999999999999999999988653322110 00011
Q ss_pred HHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 265 TWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
..... ........+...+..+.+++.+||+.+|.+||++.||+++|..+
T Consensus 235 ~~~~~---------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 235 LLELL---------KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHH---------HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111 11111111223346788999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=311.78 Aligned_cols=255 Identities=23% Similarity=0.360 Sum_probs=201.2
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEeccc--chhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEE
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAE--SRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 117 (391)
+.+..|+++++||+||.+.||++...+.+.||+|.+... +.....-|.+|+.+|..| .|.+||++++|-..++.+||
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 445779999999999999999999988888888876543 556677899999999999 58999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
|||| ...+|..+|.+... .++.-.++.+..|++.|+.++|++ ||||.||||.|+|+ ..|.+||+|||++.
T Consensus 438 vmE~-Gd~DL~kiL~k~~~-----~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLl-VkG~LKLIDFGIA~ 507 (677)
T KOG0596|consen 438 VMEC-GDIDLNKILKKKKS-----IDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLL-VKGRLKLIDFGIAN 507 (677)
T ss_pred Eeec-ccccHHHHHHhccC-----CCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEE-EeeeEEeeeechhc
Confidence 9996 45689999976542 122227889999999999999999 99999999999998 66899999999999
Q ss_pred ccCCCCcee-eeeecccccccChhhhhcC-----------CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 016347 198 LIPANMTHV-STRVAGTIGYLAPEYAIRG-----------QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERT 265 (391)
Q Consensus 198 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~-----------~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 265 (391)
.+....... ....+||+.||+||.+... +.+.++||||||||||+|+.|++||..-. ..
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~---------n~ 578 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII---------NQ 578 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH---------HH
Confidence 886655443 3346899999999998532 25689999999999999999999996321 11
Q ss_pred HHHhhhcccceeeeccCCCCCCH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 266 WDLYERRELILLVDTSLNGDFDA-EEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
+ .++..+.++...-+++. .....+.++++.||+.||++||++.|+|++-
T Consensus 579 ~-----aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhp 628 (677)
T KOG0596|consen 579 I-----AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHP 628 (677)
T ss_pred H-----HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence 1 11122333322212221 1122388899999999999999999999875
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=303.04 Aligned_cols=255 Identities=25% Similarity=0.415 Sum_probs=201.3
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeC------
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEG------ 112 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~------ 112 (391)
.+.+.|++.+.||+|+||.||+|.+. +++.||+|++.... .....+.+|+.+++++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35688999999999999999999976 48899999986543 3346788899999998 799999999998753
Q ss_pred CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEe
Q 016347 113 NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISD 192 (391)
Q Consensus 113 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~D 192 (391)
...+++|||+++++|.+++... ....+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~----~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~D 154 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT----KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 154 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEcc
Confidence 4688999999999999998653 223588999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCceeeeeecccccccChhhhh-----cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 016347 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAI-----RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWD 267 (391)
Q Consensus 193 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 267 (391)
||++........ ......|+..|+|||++. +..++.++|||||||++|+|++|..||....+.......
T Consensus 155 fg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~----- 228 (272)
T cd06637 155 FGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI----- 228 (272)
T ss_pred CCCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH-----
Confidence 999876533221 223456889999999986 345888999999999999999999999644332211100
Q ss_pred HhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 268 LYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.... .........+..+.+++.+||+.+|.+||++.+++++-
T Consensus 229 --~~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~ 270 (272)
T cd06637 229 --PRNP--------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHP 270 (272)
T ss_pred --hcCC--------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCC
Confidence 0000 00011112345688999999999999999999998763
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=297.26 Aligned_cols=251 Identities=22% Similarity=0.381 Sum_probs=205.5
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
+|+.++.||.|+||.||.++.. +++.+++|.+... +......+.+|++++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5899999999999999999866 5889999987654 344556788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~ 153 (256)
T cd08221 81 ANGGTLYDKIVRQK----GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGS 153 (256)
T ss_pred cCCCcHHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccc
Confidence 99999999996531 23589999999999999999999999 999999999999999999999999999886543
Q ss_pred CCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||......... . .. .....
T Consensus 154 ~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~---~---~~-~~~~~------- 218 (256)
T cd08221 154 EYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV---V---KI-VQGNY------- 218 (256)
T ss_pred ccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHH---H---HH-HcCCC-------
Confidence 321 223456899999999998888999999999999999999999998654332110 0 10 01110
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.......+..+.+++.+||+.+|.+||++.++++++
T Consensus 219 --~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 219 --TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred --CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 011123455788899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=299.22 Aligned_cols=240 Identities=23% Similarity=0.384 Sum_probs=189.7
Q ss_pred ceeeccCceEEEEEEeCC-------------CcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 50 NKIGEGGFGSVYKGRLKD-------------GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
+.||+|+||.||+|.... ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 469999999999998532 2358899887665555667889999999999999999999999988999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCc-------EE
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLT-------PK 189 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~-------~k 189 (391)
+||||+++++|..++.... ..+++..+..++.||+.||.|||++ +++|+||||+|||++.++. ++
T Consensus 81 lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-----DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred EEEecccCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence 9999999999998885422 3589999999999999999999999 9999999999999987654 89
Q ss_pred EEecccccccCCCCceeeeeecccccccChhhhh-cCCCCCCCcEeehhHHHHHHH-hCCCCCCCCCCcchhhHHHHHHH
Q 016347 190 ISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAI-RGQVTRKADIYSFGVLLVEIV-SGRCNTNMRLPTEEQYLLERTWD 267 (391)
Q Consensus 190 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwSlG~vl~ell-tg~~p~~~~~~~~~~~~~~~~~~ 267 (391)
++|||++...... ....++..|+|||.+. +..++.++|||||||++|+|+ +|..|+......+.. .
T Consensus 153 l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~----~--- 220 (262)
T cd05077 153 LSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE----R--- 220 (262)
T ss_pred eCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH----H---
Confidence 9999988754322 2235778899999886 467899999999999999998 577777543221111 0
Q ss_pred HhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 268 LYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
... ... .........+.+++.+||+.||.+||++.+|++.++
T Consensus 221 ~~~-~~~----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 221 FYE-GQC----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHh-cCc----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 000 000 001122356889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=314.57 Aligned_cols=265 Identities=21% Similarity=0.254 Sum_probs=197.7
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC------
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEG------ 112 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 112 (391)
..++|++++.||.|+||.||+|.+. +++.||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4689999999999999999999875 58899999987542 22345677899999999999999999887543
Q ss_pred CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEe
Q 016347 113 NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISD 192 (391)
Q Consensus 113 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~D 192 (391)
...+++++++ +++|.+++.. ..+++..+..++.||+.||.|||++ +++||||||+||+++.++.+||+|
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC-------QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcC
Confidence 3568999987 7789888743 3589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH----
Q 016347 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWD---- 267 (391)
Q Consensus 193 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~---- 267 (391)
||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.................
T Consensus 162 fg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07878 162 FGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237 (343)
T ss_pred CccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 9999865432 233568999999999876 5689999999999999999999999965432211100000000
Q ss_pred ----Hhhhc---ccceeeeccCCCC---CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 268 ----LYERR---ELILLVDTSLNGD---FDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 268 ----~~~~~---~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
..... .....+....... ........+.+++.+||+.||.+|||+.|++++-+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~ 301 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 00000 0000000000000 000112357789999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=318.35 Aligned_cols=263 Identities=18% Similarity=0.188 Sum_probs=196.8
Q ss_pred hCCCCCCceeeccCceEEEEEEeCC-CcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
..+|.+.+.||+|+||.||+|.+.. ++.||||.... ..+.+|+++|++++|+||+++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 5689999999999999999999874 88899996432 3356799999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+. ++|.+++.... ..+++..++.|+.||+.||.|||++ ||+||||||+||||+.++.++|+|||+++....
T Consensus 242 ~~-~~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 242 YR-SDLYTYLGARL-----RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred cC-CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 95 68888875422 2589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCC-Ccc----hhhHHHHHHHH-hhhccc
Q 016347 202 NMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRL-PTE----EQYLLERTWDL-YERREL 274 (391)
Q Consensus 202 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~-~~~----~~~~~~~~~~~-~~~~~~ 274 (391)
... .......||..|+|||++.+..++.++|||||||+||||++|..|+-... ... ...+....... ......
T Consensus 313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~ 392 (461)
T PHA03211 313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF 392 (461)
T ss_pred ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence 221 12234569999999999999999999999999999999999886643221 110 00111110000 000000
Q ss_pred ce----------------eeeccCCCCC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 275 IL----------------LVDTSLNGDF---DAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 275 ~~----------------~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.. .......... .......+.+|+.+||+.||.+|||+.|+|++-+
T Consensus 393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~ 457 (461)
T PHA03211 393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPL 457 (461)
T ss_pred CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcc
Confidence 00 0000000000 0012336788999999999999999999998754
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=334.41 Aligned_cols=261 Identities=23% Similarity=0.313 Sum_probs=202.1
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++|++.++||+|+||.||+|.+. +|+.||+|++... .....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999986 4899999998754 2233567889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCC-----CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 120 NYLENNSLAQTLIGGGHH-----YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~-----~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
||++|++|.+++...... .....+++..++.++.||+.||+|||++ |++||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998642110 0123466788899999999999999999 99999999999999999999999999
Q ss_pred cccccCCCC-----------------ceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcc
Q 016347 195 LAKLIPANM-----------------THVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTE 257 (391)
Q Consensus 195 ~~~~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~ 257 (391)
++....... ........||+.|+|||++.+..++.++|||||||++|+|+||..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 997652110 001123469999999999999999999999999999999999999996533211
Q ss_pred hhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHhcC
Q 016347 258 EQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRP-SMSTVVQMLMG 321 (391)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~l~~ 321 (391)
... . ... ..+. ........+..+.+++.+||+.||++|| +++++++.|..
T Consensus 239 i~~---~-------~~i---~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 239 ISY---R-------DVI---LSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred hhh---h-------hhc---cChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 100 0 000 0000 0000113345678899999999999997 45666665543
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=302.70 Aligned_cols=256 Identities=23% Similarity=0.406 Sum_probs=203.8
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
++|++++.||+|+||.||+|.+. +++.||+|.+... .......+.+|++++++++||||+++++.+......++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 47899999999999999999987 6899999988754 334456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++++|..++.... ....+++..+..++.|++.||.|||+.+ +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 81 MDAGSLDKLYAGGV---ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred cCCCCHHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 99999999886532 1235899999999999999999999632 899999999999999999999999999876533
Q ss_pred CCceeeeeecccccccChhhhhcC------CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRG------QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~------~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
.. .....+++.|+|||.+.+. .++.++|||||||++|+|++|..||......... ........
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~----- 224 (286)
T cd06622 156 SL---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF---AQLSAIVD----- 224 (286)
T ss_pred Cc---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH---HHHHHHhh-----
Confidence 21 2234578899999998554 3588999999999999999999999653221111 00000000
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
......+......+.+++.+||+.+|++||++.+++++.+
T Consensus 225 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 225 -----GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred -----cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 0011223345667889999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=301.94 Aligned_cols=260 Identities=25% Similarity=0.384 Sum_probs=204.7
Q ss_pred hCCCCCCceeeccCceEEEEEEeC------CCcEEEEEEecccchh-cHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAESRQ-GVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
.++|++++.||+|+||.||+|+.+ +.+.|++|.+...... ....+.+|++++++++|+||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 478999999999999999999864 2467999988654333 456789999999999999999999999998999
Q ss_pred EEEEecccCCCHHHHHhcCCCCC---CccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEe
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHY---SNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISD 192 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~D 192 (391)
++||||+++++|.+++....... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999997543111 112589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhh
Q 016347 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYER 271 (391)
Q Consensus 193 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 271 (391)
||++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~----~~~~ 233 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLN----RLQA 233 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHH----HHHc
Confidence 99987543222222223346778999999988889999999999999999998 777885432211 111 1111
Q ss_pred cccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 272 RELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.... .......+..+.+++.+||+.+|.+||++.+++..|+
T Consensus 234 ~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1110 0111233457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=303.75 Aligned_cols=266 Identities=24% Similarity=0.369 Sum_probs=204.0
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
++|++.++||.|++|.||+|.+. +++.||+|.+... .......+.+|+++++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47999999999999999999987 5889999988654 23345678899999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|++++.+..++... ..+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~~~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~ 151 (288)
T cd07833 81 YVERTLLELLEASP------GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALR 151 (288)
T ss_pred cCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccC
Confidence 99987776655432 2489999999999999999999999 99999999999999999999999999988765
Q ss_pred CCCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccccee-e
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILL-V 278 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 278 (391)
...........++..|+|||++.+. .++.++||||||+++|+|++|+.||........................... .
T Consensus 152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence 4433233345678899999999888 8899999999999999999999998754332211111111100000000000 0
Q ss_pred ec-----cCC---------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 279 DT-----SLN---------GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 279 ~~-----~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
+. .+. ..++...+..+.+++.+||..+|++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 000 00111235678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=303.95 Aligned_cols=250 Identities=27% Similarity=0.458 Sum_probs=203.7
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
+.|+..+.||.|+||.||+|.+. +++.||+|.+.... ......+.+|+++++.++||||+++++++..+...++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 45777888999999999999876 58899999987542 34456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++++|.+++.. ..+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~L~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 84 LGGGSALDLLKP-------GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred cCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccC
Confidence 999999998843 2588999999999999999999999 999999999999999999999999999876543
Q ss_pred CCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
... ......|+..|+|||++.+..++.++|||||||++|+|++|..|+....+...... . ...
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-------~---------~~~ 216 (277)
T cd06642 154 TQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL-------I---------PKN 216 (277)
T ss_pred cch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh-------h---------hcC
Confidence 221 12234578899999999988899999999999999999999999865433221100 0 000
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.........+..+.+++.+||+.+|.+||++.+++++.+
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 217 SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 011122234567889999999999999999999998643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=293.10 Aligned_cols=257 Identities=22% Similarity=0.290 Sum_probs=207.6
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
..+.|++-+.||+|.|+.|++..+. +|+.+|+|+++.. .....+++.+|+.+-+.|+||||+++.+.+......+||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3578999999999999999998765 6999999988654 334567888999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC---CCcEEEEeccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK---DLTPKISDFGL 195 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~---~~~~kl~Dfg~ 195 (391)
+|+++|+.|..-|-.. ..+++..+-..++||++||.|+|.+ +|||||+||+|+++.. ..-+||+|||+
T Consensus 89 Fe~m~G~dl~~eIV~R------~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGv 159 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR------EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGL 159 (355)
T ss_pred EecccchHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccce
Confidence 9999999998877532 3478888899999999999999999 9999999999999943 35689999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
+..+. .........|||+|||||++...+|+..+|||+.|||||-|+.|..||.+..... .+........
T Consensus 160 Ai~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-------lye~I~~g~y- 229 (355)
T KOG0033|consen 160 AIEVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYEQIKAGAY- 229 (355)
T ss_pred EEEeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-------HHHHHhcccc-
Confidence 99876 2333445789999999999999999999999999999999999999997633211 1111111111
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.+.+..=....+...+|+.+||..||.+|.|+.|.|.+-|..
T Consensus 230 -----d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~ 271 (355)
T KOG0033|consen 230 -----DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWIC 271 (355)
T ss_pred -----CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhc
Confidence 001111123445677889999999999999999999876544
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=303.67 Aligned_cols=265 Identities=24% Similarity=0.347 Sum_probs=204.5
Q ss_pred chHHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcC-CCCceeEEEEEEE--
Q 016347 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENLVKLYGCCV-- 110 (391)
Q Consensus 35 ~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-- 110 (391)
.+..+..+.++|++.+.||+|+||.||+|.+. +++.+|+|++..... ....+..|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34556667899999999999999999999876 488999998765322 235677899999999 6999999999874
Q ss_pred ---eCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCc
Q 016347 111 ---EGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLT 187 (391)
Q Consensus 111 ---~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~ 187 (391)
.+...++||||+++++|.+++..... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLK--RGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhc--cCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCC
Confidence 34578999999999999998753211 234588999999999999999999999 9999999999999999999
Q ss_pred EEEEecccccccCCCCceeeeeecccccccChhhhhc-----CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHH
Q 016347 188 PKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIR-----GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLL 262 (391)
Q Consensus 188 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~ 262 (391)
++|+|||++........ ......|++.|+|||++.. ..++.++|||||||++|+|++|..||....+.....
T Consensus 163 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~-- 239 (286)
T cd06638 163 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF-- 239 (286)
T ss_pred EEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh--
Confidence 99999999876533221 2223468999999998753 457899999999999999999999986543321100
Q ss_pred HHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 263 ERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
. ......... ..+......+.+++.+||+.||++||++.|+++++.
T Consensus 240 ----~-~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 240 ----K-IPRNPPPTL-------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred ----h-ccccCCCcc-------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 0 000000000 001112346888999999999999999999998763
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=307.08 Aligned_cols=200 Identities=26% Similarity=0.405 Sum_probs=162.2
Q ss_pred CceeeccCceEEEEEEeC---CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEe--CCeeEEEEeccc
Q 016347 49 INKIGEGGFGSVYKGRLK---DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVE--GNHRILVYNYLE 123 (391)
Q Consensus 49 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~ 123 (391)
.++||+|+||.||+|+.. +++.||+|.+.... ....+.+|+.++++++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 358999999999999865 46789999986542 23457789999999999999999998864 457899999985
Q ss_pred CCCHHHHHhcCCCC---CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----CCCCcEEEEecccc
Q 016347 124 NNSLAQTLIGGGHH---YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL----DKDLTPKISDFGLA 196 (391)
Q Consensus 124 ~~sL~~~i~~~~~~---~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv----~~~~~~kl~Dfg~~ 196 (391)
+ +|.+++...... .....+++..+..++.||+.||.|||++ |++||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 788877532211 1223589999999999999999999999 99999999999999 45679999999999
Q ss_pred cccCCCCc--eeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCC
Q 016347 197 KLIPANMT--HVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRL 254 (391)
Q Consensus 197 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~ 254 (391)
+....... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 87643321 122345789999999998774 58999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=328.76 Aligned_cols=256 Identities=27% Similarity=0.446 Sum_probs=219.6
Q ss_pred hCCCCCCceeeccCceEEEEEEeCC----CcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLKD----GKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (391)
.....+.+.||.|.||+|++|+++- ...||||.++.. .+..+.+|+.|+.+|.+++||||+++.|+....+..+|
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 3445778899999999999999763 456999999866 56677889999999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
|.|||++|+|+.+|+.+. .++.+.++..+++.|+.|+.||.++ ++|||||.++||||+.+...|++|||+++
T Consensus 708 iTEyMENGsLDsFLR~~D-----GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQND-----GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred EhhhhhCCcHHHHHhhcC-----CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEecccccee
Confidence 999999999999997643 4699999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCceeeeeecc--cccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 198 LIPANMTHVSTRVAG--TIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 198 ~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
.+.+......++..| ..+|.|||.+...+++.++||||||+|+||.++ |..|+= .+.+.++
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW----------------dmSNQdV 843 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW----------------DMSNQDV 843 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc----------------ccchHHH
Confidence 875554333333333 468999999999999999999999999999765 665642 2334555
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
++.+.+.++-..+++++..|.+|+++||++|-.+||.+.+|+..|.+.
T Consensus 844 IkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 844 IKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 566667777788889999999999999999999999999999998544
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=308.18 Aligned_cols=265 Identities=22% Similarity=0.278 Sum_probs=196.5
Q ss_pred CCCceeecc--CceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 47 SPINKIGEG--GFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 47 ~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
+++++||+| +|++||++... +|+.||+|.+.... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 356789999 67899999876 68999999987642 33345677899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++++|.+++.... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.++++||+.......
T Consensus 81 ~~~~~l~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~ 153 (327)
T cd08227 81 MAYGSAKDLICTHF----MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIN 153 (327)
T ss_pred cCCCcHHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence 99999999985431 23488999999999999999999999 999999999999999999999999986544321
Q ss_pred CCce------eeeeecccccccChhhhhc--CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh---
Q 016347 202 NMTH------VSTRVAGTIGYLAPEYAIR--GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE--- 270 (391)
Q Consensus 202 ~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--- 270 (391)
.... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||........ ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~ 231 (327)
T cd08227 154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLL 231 (327)
T ss_pred ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCccccc
Confidence 1110 1112346778999999876 4689999999999999999999999964322111 0000000000
Q ss_pred ------hcccce-----eeec-----------------cCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 271 ------RRELIL-----LVDT-----------------SLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 271 ------~~~~~~-----~~~~-----------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
...... ..+. .............+.+++.+||+.||++|||+.|++++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~ 309 (327)
T cd08227 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309 (327)
T ss_pred cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence 000000 0000 0000112234557889999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=301.83 Aligned_cols=249 Identities=28% Similarity=0.430 Sum_probs=213.3
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecc
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYL 122 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 122 (391)
+-|.++++||+|+||.||+|.++ +|+.+|||.+..++ ..+++..|+.+++++..|++|++||.|.....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 34888999999999999999877 59999999987653 4578899999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCC
Q 016347 123 ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN 202 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~ 202 (391)
..|++.+.++. .++++.+..+..++...+.||+|||.. .-+|||||..|||++.+|.+||+|||.+..+.+.
T Consensus 111 GAGSiSDI~R~-----R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT 182 (502)
T KOG0574|consen 111 GAGSISDIMRA-----RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT 182 (502)
T ss_pred CCCcHHHHHHH-----hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence 99999999975 456899999999999999999999999 8899999999999999999999999999877554
Q ss_pred CceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccC
Q 016347 203 MTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSL 282 (391)
Q Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (391)
..+ ..++.||+.|||||++..-.|+.++||||||++..||..|+.|+..--|....+. +....
T Consensus 183 MAK-RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM----------------IPT~P 245 (502)
T KOG0574|consen 183 MAK-RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM----------------IPTKP 245 (502)
T ss_pred HHh-hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe----------------ccCCC
Confidence 333 3457899999999999999999999999999999999999999875444322211 11111
Q ss_pred CC--CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 283 NG--DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 283 ~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.. ..+...+.++-++++.||-++|++|.|+.+++++-
T Consensus 246 PPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 246 PPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred CCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 11 22345677899999999999999999999999874
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=313.20 Aligned_cols=266 Identities=25% Similarity=0.373 Sum_probs=202.8
Q ss_pred HHHhhCCCCCCceeeccCceEEEEEEe------CCCcEEEEEEecccc-hhcHHHHHHHHHHHhcC-CCCceeEEEEEEE
Q 016347 39 LSIATDDFSPINKIGEGGFGSVYKGRL------KDGKIAAIKVLSAES-RQGVKEFLTEIQVISEI-EHENLVKLYGCCV 110 (391)
Q Consensus 39 ~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 110 (391)
|....++|++.+.||+|+||.||+|.+ .+++.||||++.... ......+.+|+.++.++ +||||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 345568999999999999999999974 247889999987543 33456688899999999 7899999999886
Q ss_pred e-CCeeEEEEecccCCCHHHHHhcCCCCC---------------------------------------------------
Q 016347 111 E-GNHRILVYNYLENNSLAQTLIGGGHHY--------------------------------------------------- 138 (391)
Q Consensus 111 ~-~~~~~lv~e~~~~~sL~~~i~~~~~~~--------------------------------------------------- 138 (391)
. +...+++|||+++|+|.+++.......
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 5 446789999999999999986532100
Q ss_pred ----------CccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCce-ee
Q 016347 139 ----------SNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTH-VS 207 (391)
Q Consensus 139 ----------~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~-~~ 207 (391)
....+++..+..++.||+.||.|||++ +++||||||+||+++.++.++|+|||++......... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 012467888899999999999999999 9999999999999999999999999998765322111 11
Q ss_pred eeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCC
Q 016347 208 TRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDF 286 (391)
Q Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (391)
....++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ... ....... ...
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~----~~~~~~~---------~~~ 303 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCR----RLKEGTR---------MRA 303 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHH----HHhccCC---------CCC
Confidence 12335677999999988899999999999999999997 8888864322111 111 1111100 011
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 287 DAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 287 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
+......+.+++..||+.||++||++.||+++|...
T Consensus 304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111234688899999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=300.49 Aligned_cols=239 Identities=25% Similarity=0.416 Sum_probs=188.4
Q ss_pred eeeccCceEEEEEEeCC-------------------------CcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEE
Q 016347 51 KIGEGGFGSVYKGRLKD-------------------------GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKL 105 (391)
Q Consensus 51 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 105 (391)
+||+|+||.||+|.+.. ...|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 23588998876555555678889999999999999999
Q ss_pred EEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC
Q 016347 106 YGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD 185 (391)
Q Consensus 106 ~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~ 185 (391)
++++......++||||+++++|..++... ...+++..+..++.||+.||+|||++ +++||||||+||+++..
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-----KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence 99999999999999999999999988642 23588999999999999999999999 99999999999999764
Q ss_pred C-------cEEEEecccccccCCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHH-hCCCCCCCCCCc
Q 016347 186 L-------TPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIV-SGRCNTNMRLPT 256 (391)
Q Consensus 186 ~-------~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~ell-tg~~p~~~~~~~ 256 (391)
+ .++++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|+|+ +|..||....+.
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred CcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 3 4799999987653221 12346788999998865 56899999999999999985 788888755432
Q ss_pred chhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 257 EEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
...... ... . ..+......+.+++.+||+.+|++||++.++++.|+
T Consensus 229 ~~~~~~-------~~~-------~----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 EKERFY-------EKK-------H----RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHH-------Hhc-------c----CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 211110 000 0 001112246888999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=302.23 Aligned_cols=246 Identities=28% Similarity=0.395 Sum_probs=203.4
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++|++.+.||+|++|.||++.+. +++.+|+|++.... ......+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47899999999999999999976 58999999986542 234566888999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++...+ .+++..+..++.||+.||.|||+. |++|+||+|.||+|+.++.++|+|||++...
T Consensus 81 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 151 (290)
T cd05580 81 EYVPGGELFSHLRKSG------RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV 151 (290)
T ss_pred ecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCcccc
Confidence 9999999999996543 589999999999999999999999 9999999999999999999999999998876
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||....... ..... ....
T Consensus 152 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~----~~~~------ 214 (290)
T cd05580 152 KGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ---IYEKI----LEGK------ 214 (290)
T ss_pred CCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----hcCC------
Confidence 443 234568899999999988889999999999999999999999996544211 01110 0000
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHh
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRP-----SMSTVVQML 319 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l 319 (391)
...+......+.+++.+||+.||.+|+ +++|++++-
T Consensus 215 ----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~ 255 (290)
T cd05580 215 ----VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHP 255 (290)
T ss_pred ----ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCc
Confidence 011222356788899999999999999 778887653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=294.41 Aligned_cols=248 Identities=28% Similarity=0.442 Sum_probs=199.5
Q ss_pred ceeeccCceEEEEEEeCC--C--cEEEEEEecccch-hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccC
Q 016347 50 NKIGEGGFGSVYKGRLKD--G--KIAAIKVLSAESR-QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLEN 124 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 124 (391)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998753 3 3689999987655 556789999999999999999999999988 889999999999
Q ss_pred CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc
Q 016347 125 NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204 (391)
Q Consensus 125 ~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~ 204 (391)
++|.+.+..... ..+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||++..+.....
T Consensus 80 ~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 80 GSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccc
Confidence 999999975431 4689999999999999999999999 999999999999999999999999999987644222
Q ss_pred e--eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 205 H--VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 205 ~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
. ......++..|+|||.+.+..++.++|||||||++|+|++ |+.||......+. ...... ...
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~~---~~~-------- 218 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKKIDK---EGE-------- 218 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHh---cCC--------
Confidence 1 1112346788999999988899999999999999999998 9999864432211 111100 000
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 219 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 -RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00111233467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=294.60 Aligned_cols=257 Identities=30% Similarity=0.425 Sum_probs=206.5
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
++|++.+.||.|++|+||+|... ++..+++|++.... ......+.+|++.++.++|+||+++++.+......++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 57999999999999999999976 58899999987543 23567789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++++|.+++.... ....+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 81 LSGGSLLDIMKSSY---PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred cCCCcHHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 99999999996532 123589999999999999999999999 999999999999999999999999999876644
Q ss_pred CCce---eeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccccee
Q 016347 202 NMTH---VSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILL 277 (391)
Q Consensus 202 ~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (391)
.... ......|+..|+|||++... .++.++|+|||||++|+|++|+.||....+.... ... .. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~---~~~---~~-~~---- 223 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL---MLT---LQ-ND---- 223 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH---HHH---hc-CC----
Confidence 3222 22335688999999998777 7899999999999999999999999755432211 000 00 00
Q ss_pred eeccCCCCC-CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 278 VDTSLNGDF-DAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 278 ~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
...+.... ....+..+.+++.+||+.||.+||++.+++++
T Consensus 224 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 224 -PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred -CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00111111 12345678899999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=295.31 Aligned_cols=251 Identities=33% Similarity=0.516 Sum_probs=201.2
Q ss_pred CCCCceeeccCceEEEEEEeCC-----CcEEEEEEecccchh-cHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 46 FSPINKIGEGGFGSVYKGRLKD-----GKIAAIKVLSAESRQ-GVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
+++.+.||.|+||.||++.+.. +..||+|.+...... ....+.+|+..++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4678899999999999999764 388999999765432 5678899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++..... ..+++..+..++.|++.||++||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 81 e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP----KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred eccCCCCHHHHHHhhhh----ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceec
Confidence 99999999999965321 1289999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
............+++.|+|||.+.+..++.++||||||+++++|++ |..||....... .... .....
T Consensus 154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~~----~~~~~----- 221 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLEY----LKKGY----- 221 (258)
T ss_pred ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HhcCC-----
Confidence 4432211112236789999999988889999999999999999998 777776532211 1111 11111
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
....+...+..+.+++.+||..||++|||+.++++.|
T Consensus 222 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 ----RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0111122456788899999999999999999998865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=295.55 Aligned_cols=250 Identities=25% Similarity=0.392 Sum_probs=203.3
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
+|++.+.||+|+||.||++... +|+.||+|.+... .......+.+|+.+++.++||||+++++++......++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5889999999999999999876 5889999998653 233446788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++++|.+.+.... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~l~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 81 CEGGDLYKKINAQR----GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred CCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 99999999886421 22478899999999999999999999 999999999999999999999999999986543
Q ss_pred CCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
... ......|++.|+|||++.+..++.++|||||||++++|++|..||........ ...... ..
T Consensus 154 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~~-~~-------- 217 (256)
T cd08218 154 TVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL------VLKIIR-GS-------- 217 (256)
T ss_pred chh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH------HHHHhc-CC--------
Confidence 221 12234578899999999888899999999999999999999999864322110 000000 00
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
....+......+.+++.+||+.+|.+||++.+|+++
T Consensus 218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 218 -YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 011223345678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=298.30 Aligned_cols=252 Identities=28% Similarity=0.408 Sum_probs=195.1
Q ss_pred ceeeccCceEEEEEEeCC-Cc--EEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEEEEecccC
Q 016347 50 NKIGEGGFGSVYKGRLKD-GK--IAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILVYNYLEN 124 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 124 (391)
+.||+|+||.||+|.+.+ +. .+++|.+... .......+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999764 43 4688887743 234456788999999999 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCC----------CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 125 NSLAQTLIGGGHH----------YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 125 ~sL~~~i~~~~~~----------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
++|.+++...... .....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 9999999754311 1123578999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcc
Q 016347 195 LAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRE 273 (391)
Q Consensus 195 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (391)
++........ ......+..|+|||++....++.++|||||||++|+|++ |..||....... .... ....
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~----~~~~- 227 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEK----LPQG- 227 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHHH----HhCC-
Confidence 9864221111 111223567999999988889999999999999999997 999986432211 1111 1100
Q ss_pred cceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.....+......+.+++.+||+.||.+||++.++++.|...
T Consensus 228 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 --------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred --------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 01111223345788999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=296.79 Aligned_cols=252 Identities=26% Similarity=0.390 Sum_probs=203.8
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEe--CCeeEEEE
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVE--GNHRILVY 119 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 119 (391)
+|++.+.||.|+||.||+|.+. +++.+|+|.+... .....+.+.+|+++++.++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5889999999999999999876 5889999988654 23445678889999999999999999998764 45689999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhh-----hcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH-----EEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH-----~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
||+++++|.+++..... ....+++..++.++.||+.||.||| +. +++|+||+|+||+++.++.++|+|||
T Consensus 81 e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g 155 (265)
T cd08217 81 EYCEGGDLAQLIQKCKK--ERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFG 155 (265)
T ss_pred hhccCCCHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccc
Confidence 99999999999865321 2346899999999999999999999 66 99999999999999999999999999
Q ss_pred cccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 195 LAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 195 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
++........ ......+++.|+|||.+.+..++.++||||||+++++|++|..||....... .... ...
T Consensus 156 ~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~----~~~--- 224 (265)
T cd08217 156 LAKILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASK----IKE--- 224 (265)
T ss_pred ccccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHHH----Hhc---
Confidence 9987654322 1233468999999999988889999999999999999999999997543111 1111 111
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
......+......+.+++.+||+.+|++||++.+|+++
T Consensus 225 ------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 ------GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11112333455688899999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=300.58 Aligned_cols=260 Identities=26% Similarity=0.412 Sum_probs=205.0
Q ss_pred chHHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcC-CCCceeEEEEEEEe-
Q 016347 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENLVKLYGCCVE- 111 (391)
Q Consensus 35 ~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~- 111 (391)
++.+...+.+.|++.+.||.|+||.||+|.+. +++.+|+|++.... .....+..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 56667777899999999999999999999976 58899999986543 2345678899999998 79999999999853
Q ss_pred -----CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC
Q 016347 112 -----GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL 186 (391)
Q Consensus 112 -----~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~ 186 (391)
....+++|||+++++|.+++.... ...+++..+..++.||+.||.|||+. +++|+||+|+||+++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~ 158 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK----GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA 158 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence 457899999999999999986432 23478888999999999999999999 999999999999999999
Q ss_pred cEEEEecccccccCCCCceeeeeecccccccChhhhh-----cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhH
Q 016347 187 TPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAI-----RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYL 261 (391)
Q Consensus 187 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~ 261 (391)
.++|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|+|++|..||....+......
T Consensus 159 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~ 237 (282)
T cd06636 159 EVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL 237 (282)
T ss_pred CEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh
Confidence 999999999876532211 223356889999999875 34688899999999999999999999965433221110
Q ss_pred HHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 262 LERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
. .. ...........+..+.+++.+||+.||.+||++.|++++
T Consensus 238 ~-------~~--------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 238 I-------PR--------NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred H-------hh--------CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0 00 000001111244578899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=295.09 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=197.0
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-----hhcHHHHHHHHHHHhcCCCCceeEEEEEEEe--CCee
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-----RQGVKEFLTEIQVISEIEHENLVKLYGCCVE--GNHR 115 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 115 (391)
.+|+..+.||+|+||.||+|.+. ++..|++|.+.... ......+.+|+.+++.++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47999999999999999999976 58899999876432 2334568889999999999999999999875 3578
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++++||+++++|.+++...+ .+++...+.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~ 152 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG------ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGA 152 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCC
Confidence 89999999999999996533 478899999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCc--eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcc
Q 016347 196 AKLIPANMT--HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRE 273 (391)
Q Consensus 196 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (391)
+........ .......++..|+|||.+.+..++.++|||||||++|+|++|..||......... ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~------~~~~---- 222 (266)
T cd06651 153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI------FKIA---- 222 (266)
T ss_pred ccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH------HHHh----
Confidence 876532211 1112245788999999998888999999999999999999999999754221110 0000
Q ss_pred cceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
........+......+.+++ .||..+|++||+++||+++-
T Consensus 223 -----~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp 262 (266)
T cd06651 223 -----TQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHP 262 (266)
T ss_pred -----cCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCc
Confidence 00001122233344566666 68888999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=300.19 Aligned_cols=240 Identities=25% Similarity=0.408 Sum_probs=190.3
Q ss_pred ceeeccCceEEEEEEeCC--------CcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 50 NKIGEGGFGSVYKGRLKD--------GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
+.||.|+||.||+|.... ...+++|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998642 234888887665555566788999999999999999999999998999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCc--------EEEEec
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLT--------PKISDF 193 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~--------~kl~Df 193 (391)
+++|+|.+++...+ ..+++..+..++.||+.||.|||++ +++||||||+||+++.++. ++++||
T Consensus 81 ~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 81 VKFGSLDTYLKKNK-----NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred CCCCcHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence 99999999997543 2578999999999999999999999 9999999999999987764 699999
Q ss_pred ccccccCCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCC-CCCCCCCCcchhhHHHHHHHHhhh
Q 016347 194 GLAKLIPANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGR-CNTNMRLPTEEQYLLERTWDLYER 271 (391)
Q Consensus 194 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~ 271 (391)
|++...... ....++..|+|||++.+ ..++.++|||||||++|+|++|. .|+....+..... ....
T Consensus 153 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-------~~~~ 220 (258)
T cd05078 153 GISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-------FYED 220 (258)
T ss_pred ccccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-------HHHc
Confidence 988654322 22457889999999876 45799999999999999999995 5554332211110 0000
Q ss_pred cccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 272 RELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
. ...+.....++.+++.+||+.||++||+++++++.|+
T Consensus 221 ~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 R-----------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred c-----------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0112223356889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=301.30 Aligned_cols=267 Identities=26% Similarity=0.365 Sum_probs=207.7
Q ss_pred eeechHHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcC-CCCceeEEEEEE
Q 016347 32 KLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENLVKLYGCC 109 (391)
Q Consensus 32 ~~~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 109 (391)
..++..++..+.++|++.+.||.|+||.||+|... +++.+|+|++.... .....+.+|+.+++++ +|||++++++++
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 10 SMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred hhhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 34667777778899999999999999999999976 58899999986532 2235677899999998 899999999998
Q ss_pred EeC-----CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC
Q 016347 110 VEG-----NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK 184 (391)
Q Consensus 110 ~~~-----~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~ 184 (391)
... ...++||||+++++|.+++..... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~ 163 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLI--CGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTT 163 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcC
Confidence 753 368999999999999998854211 234589999999999999999999999 9999999999999999
Q ss_pred CCcEEEEecccccccCCCCceeeeeecccccccChhhhhcC-----CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchh
Q 016347 185 DLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRG-----QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQ 259 (391)
Q Consensus 185 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~ 259 (391)
++.++|+|||++........ ......|+..|+|||.+... .++.++|||||||++|+|++|+.||....+....
T Consensus 164 ~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~ 242 (291)
T cd06639 164 EGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL 242 (291)
T ss_pred CCCEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH
Confidence 99999999999886543221 12234678899999987543 3689999999999999999999998754322111
Q ss_pred hHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 260 YLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
. . ........ + ..+......+.+++.+||+.+|++||++.|++++-
T Consensus 243 --~----~-~~~~~~~~-----~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~ 288 (291)
T cd06639 243 --F----K-IPRNPPPT-----L--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP 288 (291)
T ss_pred --H----H-HhcCCCCC-----C--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCc
Confidence 0 0 00010000 0 01122345688999999999999999999998863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=294.12 Aligned_cols=253 Identities=25% Similarity=0.433 Sum_probs=203.4
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc------hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEE
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES------RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (391)
+|+..+.||+|++|.||+|... +++.||+|++.... ......+.+|+.++++++|+||+++++++.+....++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4888899999999999999874 58999999986532 1235678899999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC-cEEEEecccc
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL-TPKISDFGLA 196 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~-~~kl~Dfg~~ 196 (391)
|+||+++++|.+++...+ ++++..+..++.||+.||.|||++ |++|+||+|+||+++.++ .++|+|||.+
T Consensus 81 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~ 151 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG------AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAA 151 (268)
T ss_pred EEeccCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccc
Confidence 999999999999986432 588999999999999999999999 999999999999998775 6999999998
Q ss_pred cccCCCCce---eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcc
Q 016347 197 KLIPANMTH---VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRE 273 (391)
Q Consensus 197 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (391)
......... ......|+..|+|||.+.+..++.++|||||||++++|++|..||.............. .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~----- 223 (268)
T cd06630 152 ARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK---I----- 223 (268)
T ss_pred cccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHH---H-----
Confidence 766432111 12234678899999999888899999999999999999999999964432221111100 0
Q ss_pred cceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
.........+......+.+++.+||+.+|.+||++.+++++
T Consensus 224 ----~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 224 ----ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ----hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 00111123334556788899999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=301.41 Aligned_cols=254 Identities=23% Similarity=0.346 Sum_probs=199.7
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++|++++.||+|+||.||++.+. .++.|++|.+.... ......+.+|+++++.++||||+++++.+..+...++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47899999999999999999987 48899999987553 233456788999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||++|++|.+++...+ .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++..
T Consensus 81 e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~ 151 (305)
T cd05609 81 EYVEGGDCATLLKNIG------ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIG 151 (305)
T ss_pred ecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCcccc
Confidence 9999999999996533 489999999999999999999999 9999999999999999999999999988642
Q ss_pred CCCCc--------------eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 016347 200 PANMT--------------HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERT 265 (391)
Q Consensus 200 ~~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 265 (391)
..... .......++..|+|||.+.+..++.++|+|||||++|+|++|..||....+.+ ....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---~~~~- 227 (305)
T cd05609 152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFGQ- 227 (305)
T ss_pred CcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH-
Confidence 11000 01112457889999999988889999999999999999999999997543321 1111
Q ss_pred HHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 266 WDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
...... ..+ ......+..+.+++.+||+.||++||++.++++.|.
T Consensus 228 ---~~~~~~---~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 228 ---VISDDI---EWP----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred ---HHhccc---CCC----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 000000 000 001123456889999999999999999655555553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=300.35 Aligned_cols=263 Identities=22% Similarity=0.310 Sum_probs=203.5
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
+|++.+.||.|++|.||+|.+. +|+.||+|++.... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5889999999999999999976 58999999987653 33356788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+ +++|.+++.... ..+++..++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~-~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 81 M-PSDLSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSE 151 (286)
T ss_pred c-CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence 9 999999986432 3589999999999999999999999 999999999999999999999999999987644
Q ss_pred CCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc--------
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR-------- 272 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 272 (391)
..........|+..|+|||.+.+. .++.++|||||||++++|++|..||......... ..........
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07832 152 EEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL---AIVFRTLGTPNEETWPGL 228 (286)
T ss_pred CCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHH---HHHHHHcCCCChHHHhhc
Confidence 332223345688999999988654 4689999999999999999998777654432211 1111100000
Q ss_pred -cccee---e-eccCC---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 273 -ELILL---V-DTSLN---GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 273 -~~~~~---~-~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
..... . ..... .....+....+.+++.+||+.+|++||++++++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~ 283 (286)
T cd07832 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP 283 (286)
T ss_pred cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 00000 0 00000 000112346888999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=296.60 Aligned_cols=248 Identities=27% Similarity=0.435 Sum_probs=199.0
Q ss_pred hCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecc
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYL 122 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 122 (391)
.++|++.+.||+|+||.||++.. +++.||+|.+.... ....+.+|+.+++.++|||++++++++..+ ..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 46799999999999999999975 47789999986543 235788999999999999999999998764 479999999
Q ss_pred cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCC
Q 016347 123 ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN 202 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~ 202 (391)
++++|.+++.... ...+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~L~~~l~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 81 SKGNLVNFLRTRG----RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred CCCCHHHHHHhcC----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 9999999996532 23578999999999999999999998 9999999999999999999999999998754321
Q ss_pred CceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 203 MTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
. .....+..|+|||.+.++.++.++|||||||++|+|++ |+.||......... ......
T Consensus 154 ~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~--------- 213 (254)
T cd05083 154 V----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK-------ECVEKG--------- 213 (254)
T ss_pred C----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH-------HHHhCC---------
Confidence 1 11234567999999988899999999999999999997 88888654332111 111111
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.........+..+.+++.+||+.+|++||++.++++.|..
T Consensus 214 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 214 YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0111122334678899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=303.83 Aligned_cols=253 Identities=25% Similarity=0.296 Sum_probs=203.1
Q ss_pred CCCCCCceeeccCceEEEEEEeCC-CcEEEEEEecccch---hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESR---QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++|+..+.||+|++|.||+|...+ ++.||+|.+..... .....+..|+++++.++||||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 478999999999999999999874 89999999876532 24556888999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+.+++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 81 e~~~~~~L~~~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 81 DYCPGGELFRLLQRQ----PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQS 153 (316)
T ss_pred EecCCCCHHHHHHhC----CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence 999999999998643 234689999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCce----------------------------eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCC
Q 016347 200 PANMTH----------------------------VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTN 251 (391)
Q Consensus 200 ~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~ 251 (391)
...... ......|+..|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 321110 0112467889999999988889999999999999999999999997
Q ss_pred CCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCC----HHHHHHH
Q 016347 252 MRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPS----MSTVVQM 318 (391)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~evl~~ 318 (391)
........ .... ............+..+.+++.+||+.||++||+ +.+++.+
T Consensus 234 ~~~~~~~~------~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 234 GSNRDETF------SNIL---------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred CCchHHHH------HHHh---------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 54332110 0000 000000111124568899999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=294.67 Aligned_cols=248 Identities=27% Similarity=0.417 Sum_probs=202.4
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-----hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-----RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
+|+..+.||+|++|.||+|... +++.|++|.+.... ......+.+|+++++.++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 5788899999999999999987 68999999886543 23456788999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
+||+++++|.+++.... .+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.+||+|||++..
T Consensus 81 ~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~ 151 (258)
T cd06632 81 LELVPGGSLAKLLKKYG------SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQ 151 (258)
T ss_pred EEecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCcccee
Confidence 99999999999996432 488999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCceeeeeecccccccChhhhhcCC-CCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccccee
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIRGQ-VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILL 277 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (391)
..... ......|+..|+|||.+.... ++.++|+|||||++|+|++|..||....+... . ........
T Consensus 152 ~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~----~~~~~~~~---- 219 (258)
T cd06632 152 VVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--V----FKIGRSKE---- 219 (258)
T ss_pred ccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--H----HHHHhccc----
Confidence 53322 223456889999999987776 89999999999999999999999965432111 1 00000000
Q ss_pred eeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 278 VDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 278 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
....+......+.+++.+||+.+|.+||++.+++++
T Consensus 220 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 220 -----LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred -----CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 011122345677889999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=304.12 Aligned_cols=251 Identities=25% Similarity=0.419 Sum_probs=202.1
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecc
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYL 122 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 122 (391)
+.|.....||.|+||.||++.+. ++..||||.+..........+.+|+..++.++|+||+++++.+..+...++||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 34555577999999999999976 58899999987655555677889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCC
Q 016347 123 ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN 202 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~ 202 (391)
++++|.+++.. ..+++..+..++.||+.||.|||++ +++||||||+||+++.++.++|+|||++......
T Consensus 102 ~~~~L~~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 102 EGGALTDIVTH-------TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE 171 (292)
T ss_pred CCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence 99999998843 2488999999999999999999999 9999999999999999999999999998765332
Q ss_pred CceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccC
Q 016347 203 MTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSL 282 (391)
Q Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (391)
.. ......|+..|+|||.+.+..++.++||||||+++|+|++|..||....+.... ... .. .+...+
T Consensus 172 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~---~~~----~~-----~~~~~~ 238 (292)
T cd06658 172 VP-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM---RRI----RD-----NLPPRV 238 (292)
T ss_pred cc-cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHH----Hh-----cCCCcc
Confidence 22 123356889999999998888999999999999999999999999754332211 100 00 011111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 283 NGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 283 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.. .......+..++.+||..||.+|||+.+++++-
T Consensus 239 ~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~ 273 (292)
T cd06658 239 KD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQHP 273 (292)
T ss_pred cc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 10 112344677888999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=333.08 Aligned_cols=263 Identities=25% Similarity=0.286 Sum_probs=216.9
Q ss_pred chHHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEE
Q 016347 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCV 110 (391)
Q Consensus 35 ~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 110 (391)
.+++.+...++|++++.||+|+||.|.+++.+ +++.||+|++++. .......|..|-++|..-..+-|++++-.|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 56777888999999999999999999999987 5999999999874 3344567889999999999999999999999
Q ss_pred eCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEE
Q 016347 111 EGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKI 190 (391)
Q Consensus 111 ~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl 190 (391)
++.++|+||||++||+|..++.+.. +++++.++.++..|..||..||+. |+|||||||+|||+|..|++||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~------~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikL 216 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD------RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKL 216 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC------CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEee
Confidence 9999999999999999999996543 599999999999999999999999 9999999999999999999999
Q ss_pred EecccccccCCCCceeeeeecccccccChhhhhc-----CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 016347 191 SDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIR-----GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERT 265 (391)
Q Consensus 191 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 265 (391)
+|||.+-.+...+.-.....+|||.|++||++.. +.|+..+|.||+||++|||+.|.+||+.+.-....
T Consensus 217 ADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY------ 290 (1317)
T KOG0612|consen 217 ADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY------ 290 (1317)
T ss_pred ccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH------
Confidence 9999999887666666777899999999999852 56999999999999999999999999865433222
Q ss_pred HHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHHhc
Q 016347 266 WDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPS---MSTVVQMLM 320 (391)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~evl~~l~ 320 (391)
...+...+...+. .....+....+||.+.+. +|+.|.. ++++-.|..
T Consensus 291 ~KIm~hk~~l~FP-------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpF 340 (1317)
T KOG0612|consen 291 GKIMNHKESLSFP-------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPF 340 (1317)
T ss_pred HHHhchhhhcCCC-------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCcc
Confidence 2222221111111 012345566677776665 8889988 888776653
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=301.99 Aligned_cols=262 Identities=22% Similarity=0.318 Sum_probs=197.7
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
+|++.+.||.|++|.||+|.+. +|+.||+|.+.... ......+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5889999999999999999986 58999999986542 22234577899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++ +|.+++... ...+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~-~l~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 81 CDQ-DLKKYFDSC-----NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGI 151 (284)
T ss_pred CCC-CHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence 975 787777542 23589999999999999999999999 999999999999999999999999999886533
Q ss_pred CCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH-----------Hh
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWD-----------LY 269 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~ 269 (391)
... ......++..|+|||++.+. .++.++|||||||++|+|++|..|+......... ...... ..
T Consensus 152 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 152 PVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred CCC-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH--HHHHHHHhCCCChHHhHHh
Confidence 221 12234578899999998765 4789999999999999999999986443322211 011000 00
Q ss_pred hhcccceeeeccCCC-----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 270 ERRELILLVDTSLNG-----DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 270 ~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
......... ..... .........+.+++.+||+.||.+|||+.+++++.
T Consensus 229 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~ 282 (284)
T cd07839 229 SKLPDYKPY-PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP 282 (284)
T ss_pred hhccccccc-CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCC
Confidence 000000000 00000 01112345778899999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=291.66 Aligned_cols=255 Identities=27% Similarity=0.353 Sum_probs=191.2
Q ss_pred ceeeccCceEEEEEEeCC---CcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCC
Q 016347 50 NKIGEGGFGSVYKGRLKD---GKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENN 125 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 125 (391)
+.||+|+||.||+|.+.+ +..+|+|.+.... ......+.+|+.++++++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 469999999999998653 4678999887553 233356888999999999999999999999888999999999999
Q ss_pred CHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCce
Q 016347 126 SLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTH 205 (391)
Q Consensus 126 sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~ 205 (391)
+|.+++..... ......++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~L~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 81 DLKGYLRSCRK-AELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred cHHHHHHHhhh-cccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 99999965321 1223467778889999999999999999 9999999999999999999999999998754322211
Q ss_pred e-eeeecccccccChhhhhcC-------CCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccce
Q 016347 206 V-STRVAGTIGYLAPEYAIRG-------QVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELIL 276 (391)
Q Consensus 206 ~-~~~~~gt~~y~aPE~~~~~-------~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (391)
. .....++..|+|||++.+. .++.++|||||||++|+|++ |..||....+.+.. ... .......
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~---~~~----~~~~~~~ 229 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL---TYT----VREQQLK 229 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH---HHH----hhcccCC
Confidence 1 1224567889999988542 35789999999999999996 99999654332211 000 0011111
Q ss_pred eeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 277 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
...+.+. ......+.+++..|+ .+|++|||+.||++.|+
T Consensus 230 ~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111111 122345677888998 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=303.78 Aligned_cols=250 Identities=24% Similarity=0.389 Sum_probs=202.0
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEeccc
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLE 123 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 123 (391)
.|+...+||+|+||.||+|.+. +++.||+|.+..........+.+|+.+++.+.||||+++++++..+...++|+||++
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 3555668999999999999876 589999999876554555678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCC
Q 016347 124 NNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANM 203 (391)
Q Consensus 124 ~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~ 203 (391)
+++|.+++.. ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 102 ~~~L~~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 102 GGALTDIVSQ-------TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred CCCHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence 9999998743 3488999999999999999999999 99999999999999999999999999987654322
Q ss_pred ceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCC
Q 016347 204 THVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLN 283 (391)
Q Consensus 204 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (391)
. ......|+..|+|||++.+..++.++|||||||++|+|++|..||....+.... .. ........ .
T Consensus 172 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~~----~~~~~~~~-----~- 237 (297)
T cd06659 172 P-KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---KR----LRDSPPPK-----L- 237 (297)
T ss_pred c-cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HH----HhccCCCC-----c-
Confidence 1 123356889999999998889999999999999999999999999754332211 00 01000000 0
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 284 GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 284 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.........+.+++.+||+.+|++||++.+++++-
T Consensus 238 -~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 238 -KNAHKISPVLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred -cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 00112344678899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=297.39 Aligned_cols=252 Identities=28% Similarity=0.452 Sum_probs=197.2
Q ss_pred ceeeccCceEEEEEEeCC-------CcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 50 NKIGEGGFGSVYKGRLKD-------GKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
+.||+|+||.||+|+..+ ++.+|+|.+.... ......+.+|+++++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998652 3578999876542 23456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCC-CccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC-----cEEEEeccc
Q 016347 122 LENNSLAQTLIGGGHHY-SNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL-----TPKISDFGL 195 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~-~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~-----~~kl~Dfg~ 195 (391)
+++++|.+++....... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532211 233478899999999999999999998 999999999999999887 899999999
Q ss_pred ccccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcc
Q 016347 196 AKLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRE 273 (391)
Q Consensus 196 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (391)
+........ .......++..|+|||++.++.++.++|||||||++|+|++ |..||........ ... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~---~~~----~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV---LQH----VTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH---HHH----HhcCC
Confidence 876532211 11112345678999999999999999999999999999998 9999864432111 010 00000
Q ss_pred cceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
....+...+..+.+++.+||+.+|.+||++.+|++.|.
T Consensus 231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 ---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00112234567889999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=297.45 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=202.6
Q ss_pred hCCCCCCceeeccCceEEEEEEeCC-Cc----EEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLKD-GK----IAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
.++|++.+.||+|+||.||+|.+.. |. .+|+|.+.... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 4778999999999999999998653 33 58999877653 3345678899999999999999999999887 7889
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 85 ~v~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~ 156 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHK-----DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLA 156 (279)
T ss_pred EEEecCCCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccc
Confidence 9999999999999996532 2489999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCceee-eeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 197 KLIPANMTHVS-TRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 197 ~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
........... ....++..|+|||.+....++.++|||||||++|+|++ |..||......+. .. ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~----~~~~~~- 228 (279)
T cd05057 157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI---PD----LLEKGE- 228 (279)
T ss_pred ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH---HH----HHhCCC-
Confidence 87643322111 11223568999999988899999999999999999998 9999876433211 11 111100
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
....+......+.+++.+||..+|.+||++.++++.|...
T Consensus 229 --------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 229 --------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0111122335678889999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=295.29 Aligned_cols=255 Identities=26% Similarity=0.426 Sum_probs=205.6
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
++|+..+.||.|++|.||+|.+. +++.+|+|.+.... ......+.+|++++++++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 47889999999999999999987 58999999987653 34456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHE-EVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
+++++|.+++.... ..+++..+..++.|++.||+|||+ . +++|+||||+||+++.++.++|+|||.+....
T Consensus 81 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 81 MDGGSLDKILKEVQ-----GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred cCCCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 99999999996532 468899999999999999999999 8 99999999999999999999999999987653
Q ss_pred CCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeec
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT 280 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (391)
.... ....++..|+|||.+.+..++.++||||||+++|+|++|..||.......... .......... .
T Consensus 153 ~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~-~------- 220 (265)
T cd06605 153 NSLA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI-FELLQYIVNE-P------- 220 (265)
T ss_pred HHHh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH-HHHHHHHhcC-C-------
Confidence 2211 12568889999999999999999999999999999999999986543211111 1111000000 0
Q ss_pred cCCCCCCHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 281 SLNGDFDAE-EACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 281 ~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
....+.. ....+.+++.+||..||++||++.+++.+-+
T Consensus 221 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 259 (265)
T cd06605 221 --PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPF 259 (265)
T ss_pred --CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCch
Confidence 0011111 4567889999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=291.87 Aligned_cols=252 Identities=30% Similarity=0.441 Sum_probs=207.7
Q ss_pred CCCCCCceeeccCceEEEEEEeCC-CcEEEEEEecccch-hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESR-QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
++|++.+.||.|++|.||+|.+.. ++.|++|.+..... .....+.+|+..+.+++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 468899999999999999999874 99999999876643 4457789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHE-EVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
+++++|.+++... ..+++..++.++.|++.|+.|||+ . +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~~~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~ 151 (264)
T cd06623 81 MDGGSLADLLKKV------GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLE 151 (264)
T ss_pred cCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 9999999999653 358999999999999999999999 8 99999999999999999999999999988764
Q ss_pred CCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeec
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT 280 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (391)
..... .....++..|+|||.+.+..++.++||||||+++|+|++|..||................ ...
T Consensus 152 ~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~------- 219 (264)
T cd06623 152 NTLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DGP------- 219 (264)
T ss_pred cCCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cCC-------
Confidence 33222 224567889999999988899999999999999999999999997654311111111111 000
Q ss_pred cCCCCCCHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 281 SLNGDFDAE-EACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 281 ~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
....+.. .+..+.+++.+||+.+|++||++.+++++
T Consensus 220 --~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 220 --PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0111222 45688899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=295.47 Aligned_cols=265 Identities=24% Similarity=0.335 Sum_probs=204.7
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEe--CCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVE--GNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 119 (391)
++|+..+.||.|++|.||+|.+. +++.+|+|.+.... ......+.+|++++++++||||+++++++.+ ....++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 47889999999999999999986 58899999987542 2345678899999999999999999999865 34789999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++..... ....++...+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 81 EYCEGGSLDSIYKKVKK--RGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EecCCCCHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 99999999988753221 234588999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
.... .....++..|+|||.+.+..++.++|||||||++|+|++|..||........... ... .......... +.
T Consensus 156 ~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~-~~~~~~~~~~-~~ 229 (287)
T cd06621 156 VNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI-ELL-SYIVNMPNPE-LK 229 (287)
T ss_pred cccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChH-HHH-HHHhcCCchh-hc
Confidence 3221 1234578899999999889999999999999999999999999976532111111 110 0001000000 00
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
... .........+.+++.+||+.+|.+|||+.|++++-+-
T Consensus 230 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~ 269 (287)
T cd06621 230 DEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269 (287)
T ss_pred cCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence 000 0011235678899999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=295.36 Aligned_cols=249 Identities=27% Similarity=0.442 Sum_probs=202.5
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
+-|+..+.||.|+||.||+|.+. +++.||+|.+.... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34788899999999999999875 58899999876442 34456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++++|.+++.. ..+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~l~~~i~~-------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 84 LGGGSALDLLEP-------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred CCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 999999999853 2488999999999999999999999 999999999999999999999999999876543
Q ss_pred CCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
... ......++..|+|||.+.+..++.++|||||||++|+|++|..||....+..... . .....
T Consensus 154 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~----~~~~~-------- 217 (277)
T cd06641 154 TQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF---L----IPKNN-------- 217 (277)
T ss_pred chh-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH---H----HhcCC--------
Confidence 221 1223467889999999988889999999999999999999999986543211110 0 00000
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
........+..+.+++.+||+.+|.+||++.+++++-
T Consensus 218 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~ 254 (277)
T cd06641 218 -PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 254 (277)
T ss_pred -CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 0111223455788899999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=317.34 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=210.1
Q ss_pred hCCCCCCceeeccCceEEEEEEeCC-CcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
.+.|+++..||.|+||.||+|..++ +-..|-|++..........|.-|+++|..+.||+||++++.|+..+.++|+.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 4568899999999999999999875 445578888777777889999999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
|.||....++..- ...+.+.++..+++|++.||.|||++ +|+|||||..|||++.+|.++|+|||.+.....
T Consensus 111 C~GGAVDaimlEL-----~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 111 CGGGAVDAIMLEL-----GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred cCCchHhHHHHHh-----ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh
Confidence 9999998888653 34799999999999999999999999 999999999999999999999999999865322
Q ss_pred CCceeeeeecccccccChhhhh-----cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccce
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAI-----RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL 276 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (391)
.......+.|||.|||||+.. ..+|+.++||||||++|.||..+.+|.....+..... . ....+...
T Consensus 183 -t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVll--K-----iaKSePPT 254 (1187)
T KOG0579|consen 183 -TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL--K-----IAKSEPPT 254 (1187)
T ss_pred -HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHH--H-----HhhcCCCc
Confidence 222334588999999999864 4679999999999999999999998876554432211 1 11111111
Q ss_pred eeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 277 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
++ .+......|.+++..||.+||..||++.+++++-+-
T Consensus 255 Ll-------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv 292 (1187)
T KOG0579|consen 255 LL-------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFV 292 (1187)
T ss_pred cc-------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCccc
Confidence 11 123456678899999999999999999999987543
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=292.83 Aligned_cols=249 Identities=26% Similarity=0.378 Sum_probs=202.2
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
+|++.+.||+|++|.||+|... +++.+|+|.+... .......+.+|++++++++|||++++++.+......++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5889999999999999999876 5889999998654 233456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC-CcEEEEecccccccC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD-LTPKISDFGLAKLIP 200 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~-~~~kl~Dfg~~~~~~ 200 (391)
+++++|.+++.... ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.+ +.++|+|||++....
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (256)
T cd08220 81 APGGTLAEYIQKRC----NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILS 153 (256)
T ss_pred CCCCCHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence 99999999996532 23589999999999999999999999 99999999999999865 468999999998764
Q ss_pred CCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeec
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT 280 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (391)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||........ .... ....
T Consensus 154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~----~~~~------- 217 (256)
T cd08220 154 SKS--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VLKI----MSGT------- 217 (256)
T ss_pred CCc--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HHHH----HhcC-------
Confidence 332 12234678899999999888899999999999999999999999865433211 1110 0000
Q ss_pred cCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 281 SLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 281 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
....+......+.+++.+||+.+|.+|||+.|++++
T Consensus 218 --~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 218 --FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 011122345578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=293.08 Aligned_cols=252 Identities=29% Similarity=0.437 Sum_probs=202.8
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch--hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR--QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
+|++.+.||+|++|.||+|... +++.|++|.+..... .....+.+|+++++.++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5889999999999999999876 688999999876543 3567889999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 81 CSGGTLEELLEHGR------ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred CCCCcHHHHHhhcC------CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence 99999999996532 478899999999999999999999 999999999999999999999999999887644
Q ss_pred CCceee---eeecccccccChhhhhcCC---CCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 202 NMTHVS---TRVAGTIGYLAPEYAIRGQ---VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 202 ~~~~~~---~~~~gt~~y~aPE~~~~~~---~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
...... ....++..|+|||++.+.. ++.++||||||+++|+|++|..||.......... ..... ..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~-----~~~~~-~~-- 223 (264)
T cd06626 152 NTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM-----FHVGA-GH-- 223 (264)
T ss_pred CCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH-----HHHhc-CC--
Confidence 322211 1346788999999988766 8999999999999999999999996543211110 00000 00
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
...+ .........+.+++.+||+.+|.+||++.+++.+
T Consensus 224 ---~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 224 ---KPPI--PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred ---CCCC--CcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 0011225567889999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=302.13 Aligned_cols=198 Identities=26% Similarity=0.422 Sum_probs=160.7
Q ss_pred ceeeccCceEEEEEEeC---CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEe--CCeeEEEEecccC
Q 016347 50 NKIGEGGFGSVYKGRLK---DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVE--GNHRILVYNYLEN 124 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 124 (391)
.+||+|+||.||+|+.. ++..||+|.+.... ....+.+|+++++.++||||+++++++.. +...++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999865 35789999886543 23457789999999999999999998853 5678999999865
Q ss_pred CCHHHHHhcCCC---CCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----CCCCcEEEEeccccc
Q 016347 125 NSLAQTLIGGGH---HYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL----DKDLTPKISDFGLAK 197 (391)
Q Consensus 125 ~sL~~~i~~~~~---~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv----~~~~~~kl~Dfg~~~ 197 (391)
+|.+++..... ......+++..+..++.||+.||.|||++ +++||||||+||++ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 77777753211 11223588999999999999999999999 99999999999999 556799999999998
Q ss_pred ccCCCCce--eeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCC
Q 016347 198 LIPANMTH--VSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMR 253 (391)
Q Consensus 198 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~ 253 (391)
........ ......||+.|+|||++.+. .++.++|||||||++|+|+||..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 76433221 12335689999999998764 5899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=296.05 Aligned_cols=256 Identities=27% Similarity=0.420 Sum_probs=202.0
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCC------
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGN------ 113 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~------ 113 (391)
++++|++.+.||.|++|.||+|.+. +++.+++|++..... ....+.+|+.+++++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 5689999999999999999999986 578999999876543 346788999999999 7999999999997644
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
..++||||+++++|.+++..... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+||
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRK--KGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCC
Confidence 48999999999999998864221 234689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCceeeeeecccccccChhhhhc-----CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 016347 194 GLAKLIPANMTHVSTRVAGTIGYLAPEYAIR-----GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDL 268 (391)
Q Consensus 194 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 268 (391)
|++........ ......|+..|+|||++.. ..++.++|||||||++|+|++|..||....+.... ..
T Consensus 158 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~----- 229 (275)
T cd06608 158 GVSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL--FK----- 229 (275)
T ss_pred ccceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH--HH-----
Confidence 99876543222 2233468899999998754 34778999999999999999999999643221110 00
Q ss_pred hhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 269 YERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
..... ...+ ..+......+.+++.+||..||++|||+.+++++
T Consensus 230 ~~~~~-----~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 230 IPRNP-----PPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hhccC-----CCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00000 0001 1122345678899999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=298.10 Aligned_cols=252 Identities=27% Similarity=0.406 Sum_probs=205.6
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
.++|++.+.||.|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++......++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 478999999999999999999865 5889999998765555557788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++++|.+++.. ..+++..+..++.|++.||.|||++ |++|+||+|+||+++.++.++|+|||++.....
T Consensus 98 ~~~~~L~~~~~~-------~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 98 LAGGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred CCCCcHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 999999999853 2478889999999999999999999 999999999999999999999999998876543
Q ss_pred CCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
... ......|++.|+|||.+.++.++.++|||||||++|+|++|..||....+........ . ...
T Consensus 168 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~------~--------~~~ 232 (293)
T cd06647 168 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------T--------NGT 232 (293)
T ss_pred ccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh------c--------CCC
Confidence 322 1223468889999999988889999999999999999999999997543322110000 0 000
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
............+.+++.+||+.+|++||++.+++.+-
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 00011223345688899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=293.01 Aligned_cols=251 Identities=24% Similarity=0.328 Sum_probs=199.0
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-----hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC--Cee
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-----RQGVKEFLTEIQVISEIEHENLVKLYGCCVEG--NHR 115 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 115 (391)
.+|++.+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57899999999999999999976 48999999875431 22345788899999999999999999988763 468
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
+++|||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~ 152 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG------ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGA 152 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcc
Confidence 89999999999999986432 478889999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCc--eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcc
Q 016347 196 AKLIPANMT--HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRE 273 (391)
Q Consensus 196 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (391)
+........ .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||......... . ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~---~~~---- 222 (265)
T cd06652 153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI---F---KIA---- 222 (265)
T ss_pred ccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH---H---HHh----
Confidence 876532111 1122345888999999998888999999999999999999999999643221110 0 000
Q ss_pred cceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
........+......+.+++.+|+. +|++||++++++++-
T Consensus 223 -----~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~ 262 (265)
T cd06652 223 -----TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHT 262 (265)
T ss_pred -----cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence 0001112334455677888889985 999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=301.61 Aligned_cols=266 Identities=26% Similarity=0.372 Sum_probs=201.6
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch--hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR--QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
++|++.++||+|+||.||+|.+. +++.||+|.+..... .....+.+|+++++.++||||+++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47899999999999999999987 489999998765422 234567889999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+++++|..+.... ..+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~~~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07846 81 FVDHTVLDDLEKYP------NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA 151 (286)
T ss_pred cCCccHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeecc
Confidence 99999888876532 2489999999999999999999999 99999999999999999999999999988654
Q ss_pred CCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH--------hhh
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDL--------YER 271 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~ 271 (391)
... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||.................. +..
T Consensus 152 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07846 152 APG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK 230 (286)
T ss_pred CCc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhcc
Confidence 332 22233457889999998865 34788999999999999999999888654432211111100000 000
Q ss_pred cccc-eeeeccCCC-----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 272 RELI-LLVDTSLNG-----DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 272 ~~~~-~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.... ....+.... ......+..+.+++.+||+.+|++||++.+++++-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~ 284 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHE 284 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCC
Confidence 0000 000000000 00112346788999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=321.73 Aligned_cols=281 Identities=18% Similarity=0.231 Sum_probs=196.8
Q ss_pred chHHHHHhhCCCCCCceeeccCceEEEEEEeCC--CcEEEEE------------------EecccchhcHHHHHHHHHHH
Q 016347 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLKD--GKIAAIK------------------VLSAESRQGVKEFLTEIQVI 94 (391)
Q Consensus 35 ~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~e~~~l 94 (391)
..+......++|+++++||+|+||+||++..+. +..+++| .+. ........+.+|+.+|
T Consensus 139 ~~~~~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il 217 (501)
T PHA03210 139 KLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILAL 217 (501)
T ss_pred hcccchhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHH
Confidence 444445556899999999999999999987542 2222222 111 1122345678899999
Q ss_pred hcCCCCceeEEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecC
Q 016347 95 SEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRD 174 (391)
Q Consensus 95 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~d 174 (391)
+.++||||+++++++...+..++|++++. ++|.+++....... ........+..|+.||+.||.|||++ ||+|||
T Consensus 218 ~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~-~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrD 292 (501)
T PHA03210 218 GRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDW-KDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRD 292 (501)
T ss_pred HhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccc-cccccHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 99999999999999999999999999985 46777775433211 12234567788999999999999999 999999
Q ss_pred CCCCcEEECCCCcEEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCC-CCCC
Q 016347 175 IKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCN-TNMR 253 (391)
Q Consensus 175 ikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p-~~~~ 253 (391)
|||+|||++.++.+||+|||++..+............||..|+|||++.+..++.++|||||||++|||++|..+ +...
T Consensus 293 LKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~ 372 (501)
T PHA03210 293 IKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDG 372 (501)
T ss_pred CCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCC
Confidence 999999999999999999999987654433333446799999999999999999999999999999999998854 4322
Q ss_pred CCcchhhHHHHHHHHh-hhc-------ccceeeec-cC---CCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 016347 254 LPTEEQYLLERTWDLY-ERR-------ELILLVDT-SL---NGDFD-----AEEACRFLKVGLLCTQDTPKLRPSMSTVV 316 (391)
Q Consensus 254 ~~~~~~~~~~~~~~~~-~~~-------~~~~~~~~-~~---~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~evl 316 (391)
.......+........ ... .....+.. .+ ....+ .....++.+++.+||+.||++|||+.|++
T Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL 452 (501)
T PHA03210 373 GGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELL 452 (501)
T ss_pred CCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHh
Confidence 2221111111110000 000 00000000 00 00000 01123567788899999999999999999
Q ss_pred HHhcC
Q 016347 317 QMLMG 321 (391)
Q Consensus 317 ~~l~~ 321 (391)
++-+.
T Consensus 453 ~hp~f 457 (501)
T PHA03210 453 ALPLF 457 (501)
T ss_pred hChhh
Confidence 87544
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=295.00 Aligned_cols=254 Identities=24% Similarity=0.397 Sum_probs=200.7
Q ss_pred CCCCCceeeccCceEEEEEEeCC--CcEEEEEEeccc----------chhcHHHHHHHHHHHhc-CCCCceeEEEEEEEe
Q 016347 45 DFSPINKIGEGGFGSVYKGRLKD--GKIAAIKVLSAE----------SRQGVKEFLTEIQVISE-IEHENLVKLYGCCVE 111 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~ 111 (391)
+|++.+.||+|+||.||+|.+.. ++.+|+|.+... .......+.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 58899999999999999999764 788999987532 12234557778888865 799999999999999
Q ss_pred CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEECCCCcEEE
Q 016347 112 GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHE-EVRPHIIHRDIKASNILLDKDLTPKI 190 (391)
Q Consensus 112 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~i~H~dikp~NIlv~~~~~~kl 190 (391)
++..+++|||+++++|.+++..... ....+++..++.++.|++.||.|||+ . +++|+||+|+||+++.++.++|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l 155 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKE--KKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTI 155 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEE
Confidence 9999999999999999998753211 23358999999999999999999996 5 8999999999999999999999
Q ss_pred EecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh
Q 016347 191 SDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE 270 (391)
Q Consensus 191 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 270 (391)
+|||.+....... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||......... .. ..
T Consensus 156 ~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~---~~----~~ 226 (269)
T cd08528 156 TDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA---TK----IV 226 (269)
T ss_pred ecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH---HH----Hh
Confidence 9999998754332 233456889999999999888999999999999999999999998644321110 00 00
Q ss_pred hcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 271 RRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
..... + .........+.+++.+||+.||++||++.|+.+++.
T Consensus 227 ~~~~~----~----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 227 EAVYE----P----LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hccCC----c----CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 01000 0 001123457888999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=290.75 Aligned_cols=281 Identities=27% Similarity=0.325 Sum_probs=218.3
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (391)
.-++|..++.||+|.||+|.+++.+ +++.||+|+++++. .+....-+.|-.+|+..+||.+..+--.|+...++++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3578999999999999999999977 59999999998773 3444556679999999999999999888999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
||||..||.|.-.+.. .+.+++...+.+-..|+.||.|||++ +||+||||-+|+|+|.+|++||+|||+++
T Consensus 246 VMeyanGGeLf~HLsr------er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCK 316 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSR------ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCK 316 (516)
T ss_pred EEEEccCceEeeehhh------hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccch
Confidence 9999999999877754 34589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccccee
Q 016347 198 LIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILL 277 (391)
Q Consensus 198 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (391)
.-- .......++||||.|+|||++....|+.+.|.|.+|||+|||++|+.||...+...- .......+
T Consensus 317 E~I-~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL-------FeLIl~ed---- 384 (516)
T KOG0690|consen 317 EEI-KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL-------FELILMED---- 384 (516)
T ss_pred hcc-cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH-------HHHHHhhh----
Confidence 532 234456789999999999999999999999999999999999999999975433211 11000011
Q ss_pred eeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHhcCCCCCCCCCCCCCCCccccccccccCCCCCCC
Q 016347 278 VDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPS-----MSTVVQMLMGEKDIDDDKITKPGLISDFMDLKVRGPPKPKL 352 (391)
Q Consensus 278 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 352 (391)
-.++.....+...|+...|.+||.+|.. +.||.++- +-....|......+..+|-+|..
T Consensus 385 ------~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~----------FF~~v~W~~~~~Kki~PPfKPqV 448 (516)
T KOG0690|consen 385 ------LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHR----------FFASVDWEATYRKKIEPPFKPQV 448 (516)
T ss_pred ------ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhh----------hhccCCHHHHHHhccCCCCCCCc
Confidence 1333444556667777899999999974 45554432 22222333444445555666666
Q ss_pred CCCCCCC
Q 016347 353 ETTTSST 359 (391)
Q Consensus 353 ~~~~~~~ 359 (391)
.+-+.+.
T Consensus 449 tSetDTr 455 (516)
T KOG0690|consen 449 TSETDTR 455 (516)
T ss_pred ccccchh
Confidence 5544433
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=293.67 Aligned_cols=255 Identities=25% Similarity=0.364 Sum_probs=200.2
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch----------hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR----------QGVKEFLTEIQVISEIEHENLVKLYGCCVEGN 113 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (391)
+|.+.+.||.|++|.||+|... +|+.||+|.+..... ...+.+..|+.+++.++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5788899999999999999876 588999998754211 12345778999999999999999999999999
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||++ +++|+||+|+||+++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~ 152 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY------GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDF 152 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeec
Confidence 999999999999999999654 2588999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCce-eeeeecccccccChhhhhcCC--CCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh
Q 016347 194 GLAKLIPANMTH-VSTRVAGTIGYLAPEYAIRGQ--VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE 270 (391)
Q Consensus 194 g~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 270 (391)
|++......... ......|+..|+|||.+.... ++.++|+||||+++|+|++|..||........ ......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~ 226 (272)
T cd06629 153 GISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA------MFKLGN 226 (272)
T ss_pred cccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH------HHHhhc
Confidence 998765332211 122346788999999987654 89999999999999999999999853322111 111000
Q ss_pred hcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 271 RRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.. ... ..........+..+.+++.+||+.+|++||++.+|+++-
T Consensus 227 ~~-~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 270 (272)
T cd06629 227 KR-SAP----PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHP 270 (272)
T ss_pred cc-cCC----cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCC
Confidence 00 000 011111123456788899999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=297.87 Aligned_cols=264 Identities=23% Similarity=0.368 Sum_probs=197.9
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch-hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR-QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
++|++.+.||.|++|.||+|... +++.||+|.+..... .....+.+|+++++.++|+||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 78999999999999999999987 589999999875432 2234567899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+.+ +|.+++.... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 85 ~~~-~L~~~~~~~~-----~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 85 LDT-DLKQYMDDCG-----GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred CCC-CHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 975 8998886432 2588999999999999999999999 999999999999999999999999999875422
Q ss_pred CCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhh---cc----
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYER---RE---- 273 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~---- 273 (391)
... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||......... ....+..... ..
T Consensus 156 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 156 PSK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ--LHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred CCc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HHHHHHhcCCCChhhhhhh
Confidence 111 1122346788999998875 45899999999999999999999999654321111 0101100000 00
Q ss_pred -----cceeeeccCC-----CCC-CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 274 -----LILLVDTSLN-----GDF-DAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 274 -----~~~~~~~~~~-----~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.......... ... .......+.+++.+||+.+|++||++.|++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~ 289 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHP 289 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCC
Confidence 0000000000 000 001125677899999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=292.60 Aligned_cols=238 Identities=26% Similarity=0.459 Sum_probs=189.5
Q ss_pred ceeeccCceEEEEEEeCC-C----------cEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 50 NKIGEGGFGSVYKGRLKD-G----------KIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
+.||+|+||.||+|.+.. + ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 469999999999999864 3 25788877654333 5778899999999999999999999888 778999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC-------cEEEE
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL-------TPKIS 191 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~-------~~kl~ 191 (391)
|||+++++|.+++..... .+++..+..++.||+.||.|||++ +++|+||||+||+++.++ .++|+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-----NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence 999999999999975431 588999999999999999999999 999999999999999887 79999
Q ss_pred ecccccccCCCCceeeeeecccccccChhhhhcC--CCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHH
Q 016347 192 DFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRG--QVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDL 268 (391)
Q Consensus 192 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 268 (391)
|||++..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..|+...........
T Consensus 151 Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~------- 218 (259)
T cd05037 151 DPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF------- 218 (259)
T ss_pred CCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH-------
Confidence 9999886533 1223467789999998776 78999999999999999999 4666755432211110
Q ss_pred hhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 269 YERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
+.... ..+......+.+++.+||..+|.+||++.++++.|+
T Consensus 219 ~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 YQDQH-----------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HhcCC-----------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 000111267889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=294.27 Aligned_cols=249 Identities=26% Similarity=0.356 Sum_probs=204.5
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
+|++.+.||.|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999987 58999999987542 2345778899999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+.+++|.+++... .++++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~~~~~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~ 151 (258)
T cd05578 81 LLLGGDLRYHLSQK------VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVT 151 (258)
T ss_pred CCCCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccC
Confidence 99999999999643 2589999999999999999999999 99999999999999999999999999988764
Q ss_pred CCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeec
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT 280 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (391)
... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.............. ...
T Consensus 152 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~~~--------- 216 (258)
T cd05578 152 PDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK----QET--------- 216 (258)
T ss_pred CCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH----hcc---------
Confidence 332 22335678899999999888899999999999999999999999976554211111111 000
Q ss_pred cCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH--HHHHHH
Q 016347 281 SLNGDFDAEEACRFLKVGLLCTQDTPKLRPSM--STVVQM 318 (391)
Q Consensus 281 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~--~evl~~ 318 (391)
.....+...+..+.+++.+||+.||.+||++ +|++++
T Consensus 217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence 0112222345788899999999999999999 776543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=290.84 Aligned_cols=255 Identities=27% Similarity=0.356 Sum_probs=188.8
Q ss_pred ceeeccCceEEEEEEeCC---CcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCC
Q 016347 50 NKIGEGGFGSVYKGRLKD---GKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENN 125 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 125 (391)
+.||+|+||.||+|...+ ...+++|.+.... ......+.+|+..++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 469999999999997543 4568888876442 333456888999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCce
Q 016347 126 SLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTH 205 (391)
Q Consensus 126 sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~ 205 (391)
+|.+++...... .....++..+..++.||+.||+|||++ +++||||||+||+++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 81 DLKNYLRSNRGM-VAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred cHHHHHHhcccc-ccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 999999764321 123356788899999999999999999 9999999999999999999999999998654222111
Q ss_pred -eeeeecccccccChhhhhc-------CCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccce
Q 016347 206 -VSTRVAGTIGYLAPEYAIR-------GQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELIL 276 (391)
Q Consensus 206 -~~~~~~gt~~y~aPE~~~~-------~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (391)
......++..|+|||++.. ..++.++|||||||++|+|++ |..||....+... .... .. .....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~~~---~~-~~~~~ 229 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV---LKQV---VR-EQDIK 229 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH---HHHH---hh-ccCcc
Confidence 1122345678999998753 356889999999999999999 6777754332111 0100 01 11111
Q ss_pred eeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 277 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
...+.. .......+.+++..|+ .||++||++++|++.|.
T Consensus 230 ~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111111 2233445667777888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=294.53 Aligned_cols=258 Identities=26% Similarity=0.390 Sum_probs=199.1
Q ss_pred CCCCceeeccCceEEEEEEeC----CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC------
Q 016347 46 FSPINKIGEGGFGSVYKGRLK----DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN------ 113 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 113 (391)
|++.+.||+|+||.||+|.+. +++.||+|++... .....+++.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 677889999999999999854 3688999998754 2344567889999999999999999999886432
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
..+++++|+.+++|.+++...........+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999998875432212233578999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCce-eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhh
Q 016347 194 GLAKLIPANMTH-VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYER 271 (391)
Q Consensus 194 g~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 271 (391)
|+++........ ......+++.|++||.+....++.++|||||||++|+|++ |..||....... ..... ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~----~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYL----IK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHH----Hc
Confidence 998865432211 1122345678999999988889999999999999999999 788886443211 11110 00
Q ss_pred cccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 272 RELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
... . ..+......+.+++.+||+.+|++||++.++++.|+.+
T Consensus 231 ~~~-------~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNR-------L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCc-------C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 0 11122345788999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=294.81 Aligned_cols=257 Identities=24% Similarity=0.392 Sum_probs=196.2
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-hhcHHHHHHHHHH-HhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQV-ISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
++|++.+.||+|+||.||+|.+. +|+.||+|.+.... ......+..|+.. ++.++||||+++++++..+...+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47899999999999999999987 59999999987542 2223445556654 566799999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|++ ++|.+++..... ....+++..++.++.||+.||.|||+++ +++||||||+||+++.++.+||+|||++....
T Consensus 81 ~~~-~~l~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYD--KGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 996 588888754322 2346899999999999999999999853 79999999999999999999999999988653
Q ss_pred CCCceeeeeecccccccChhhhhc----CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccce
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIR----GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL 276 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (391)
... ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||......... ...... ..
T Consensus 156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-----~~~~~~-~~--- 224 (283)
T cd06617 156 DSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ-----LKQVVE-EP--- 224 (283)
T ss_pred ccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH-----HHHHHh-cC---
Confidence 321 1222457889999998864 45789999999999999999999998643221110 000000 00
Q ss_pred eeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 277 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
...+ .....+..+.+++.+||+.+|.+||++.+++++-+.
T Consensus 225 --~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~ 264 (283)
T cd06617 225 --SPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264 (283)
T ss_pred --CCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchh
Confidence 0000 011234578899999999999999999999986433
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=304.38 Aligned_cols=264 Identities=25% Similarity=0.288 Sum_probs=200.1
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC------
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG------ 112 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 112 (391)
..++|++.+.||+|+||.||+|.+. +|+.||+|.+... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4688999999999999999999976 5899999998643 233445677899999999999999999988643
Q ss_pred CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEe
Q 016347 113 NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISD 192 (391)
Q Consensus 113 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~D 192 (391)
...++||||+.+ +|.+.+.. .++...+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~--------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~D 161 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM--------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 161 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence 357999999965 78887742 278889999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHH--------
Q 016347 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLER-------- 264 (391)
Q Consensus 193 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~-------- 264 (391)
||++....... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||..............
T Consensus 162 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 239 (353)
T cd07850 162 FGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE 239 (353)
T ss_pred CccceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 99998654322 12334678899999999999999999999999999999999999975532211000000
Q ss_pred -------HHHHh-hhcc------cceeeeccCC----CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 265 -------TWDLY-ERRE------LILLVDTSLN----GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 265 -------~~~~~-~~~~------~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
....+ .... ....+..... ..........+.+++.+||+.||++||++.|++++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence 00000 0000 0000000000 000113355678999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=293.39 Aligned_cols=250 Identities=26% Similarity=0.443 Sum_probs=201.4
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCC---CCceeEEEEEEEeCCeeEEEE
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIE---HENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~ 119 (391)
.|+..+.||.|+||.||+|.+. +++.||+|.+... .......+.+|+.+++.++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 5788899999999999999975 6899999998754 3344567888999999986 999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++..+ .+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++...
T Consensus 82 e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 82 EYAEGGSVRTLMKAG-------PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred ecCCCCcHHHHHHcc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 999999999998542 588999999999999999999999 9999999999999999999999999998876
Q ss_pred CCCCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
..... ......|+..|+|||.+.++ .++.++|||||||++|+|++|..||........... .... .
T Consensus 152 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-------~~~~-----~ 218 (277)
T cd06917 152 NQNSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-------IPKS-----K 218 (277)
T ss_pred CCCcc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc-------cccC-----C
Confidence 54332 22334688899999988654 478999999999999999999999975433211100 0000 0
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.+.+... .....+.+++.+||+.||++||++.+++++-+
T Consensus 219 ~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~ 257 (277)
T cd06917 219 PPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKSKW 257 (277)
T ss_pred CCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhChH
Confidence 0111111 13457888999999999999999999987643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=295.14 Aligned_cols=250 Identities=24% Similarity=0.400 Sum_probs=202.8
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEeccc
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLE 123 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 123 (391)
.|...+.||.|++|.||+|... +++.+++|.+........+.+.+|+.+++.++||||+++++++......++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 4666789999999999999975 588999999876555555678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCC
Q 016347 124 NNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANM 203 (391)
Q Consensus 124 ~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~ 203 (391)
+++|.+++.. ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||.+.......
T Consensus 100 ~~~L~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 100 GGALTDIVTH-------TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred CCCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 9999999854 2488999999999999999999999 99999999999999999999999999887653322
Q ss_pred ceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCC
Q 016347 204 THVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLN 283 (391)
Q Consensus 204 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (391)
. ......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+.... ... .... ....
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~---~~~----~~~~-----~~~~- 235 (285)
T cd06648 170 P-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM---KRI----RDNL-----PPKL- 235 (285)
T ss_pred c-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH---HHH----HhcC-----CCCC-
Confidence 1 122346889999999998888999999999999999999999998654332111 110 0000 0000
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 284 GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 284 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
......+..+.+++.+||+.+|++||++.+++++-
T Consensus 236 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 270 (285)
T cd06648 236 -KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHP 270 (285)
T ss_pred -cccccCCHHHHHHHHHHcccChhhCcCHHHHccCc
Confidence 01112345788999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=297.08 Aligned_cols=262 Identities=23% Similarity=0.293 Sum_probs=200.7
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchh-----cHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQ-----GVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
+|++.+.||.|++|.||+|.+. +|+.||+|.+...... ....+..|+++++.++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 5888999999999999999976 5899999998765322 334567899999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|||+ +++|.+++.... ..+++..+..++.||+.||.|||++ +++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~e~~-~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~ 151 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARS 151 (298)
T ss_pred Eccc-CCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeee
Confidence 9999 889999996432 2589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc-----
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR----- 272 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 272 (391)
...... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||....+.... ..........
T Consensus 152 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 227 (298)
T cd07841 152 FGSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL---GKIFEALGTPTEENW 227 (298)
T ss_pred ccCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH---HHHHHHcCCCchhhh
Confidence 643322 1222346788999998865 45789999999999999999997777654432211 1111000000
Q ss_pred ----ccceeeeccCCCCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 273 ----ELILLVDTSLNGDF-----DAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 273 ----~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.............. .......+.+++.+||+.||++||++.|++++-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~ 283 (298)
T cd07841 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHP 283 (298)
T ss_pred hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCc
Confidence 00000000000011 122356788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=282.72 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=201.5
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--------hhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCC
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--------RQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGN 113 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 113 (391)
..|...+.||+|..++|-+...+ +|+.+|+|++.... ....+.-.+|+.+|+++ .||+|+++.++|+.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 55777788999999999888765 58889999875331 12233456799999998 6999999999999999
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
..++|+|.|+.|.|.+++.. ...++++..+.|+.|+.+|++|||.+ +||||||||+|||++++.+++|+||
T Consensus 97 F~FlVFdl~prGELFDyLts------~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTS------KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred hhhhhhhhcccchHHHHhhh------heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence 99999999999999999964 34699999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCceeeeeecccccccChhhhhc------CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 016347 194 GLAKLIPANMTHVSTRVAGTIGYLAPEYAIR------GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWD 267 (391)
Q Consensus 194 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 267 (391)
|.++.+.... .-...||||+|+|||.+.. ..|+...|+|++|||+|.|+.|..||-.... .+.- .
T Consensus 168 GFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ----mlML---R 238 (411)
T KOG0599|consen 168 GFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ----MLML---R 238 (411)
T ss_pred ceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH----HHHH---H
Confidence 9999875433 3456899999999998853 3588999999999999999999999842111 0000 0
Q ss_pred HhhhcccceeeeccC--CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 268 LYERRELILLVDTSL--NGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 268 ~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
. ++...+ ..+-=.+......+||.+||+.||.+|.|++|+|++-..
T Consensus 239 ~--------ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 239 M--------IMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred H--------HHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 0 011111 111112445578899999999999999999999987654
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=291.97 Aligned_cols=249 Identities=26% Similarity=0.389 Sum_probs=190.2
Q ss_pred ceeeccCceEEEEEEeC----CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEE-eCCeeEEEEeccc
Q 016347 50 NKIGEGGFGSVYKGRLK----DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCV-EGNHRILVYNYLE 123 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~ 123 (391)
+.||+|+||.||+|.+. .+..+|+|.+... .......+.+|+.+++.++||||+++++++. .+...+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999864 2457999987543 3344567889999999999999999999775 4556899999999
Q ss_pred CCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCC
Q 016347 124 NNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANM 203 (391)
Q Consensus 124 ~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~ 203 (391)
+++|.+++.... ..+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 81 HGDLRNFIRSET-----HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 999999996432 2357778889999999999999999 99999999999999999999999999987653321
Q ss_pred ce---eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCC-CCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 204 TH---VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRC-NTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
.. ......++..|+|||.+.+..++.++|||||||++|+|++|.. ||....... ..... .....
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~---~~~~~------ 220 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYL---LQGRR------ 220 (262)
T ss_pred ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH---hcCCC------
Confidence 11 1112345678999999988899999999999999999999654 454322111 11110 00000
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
...+...+..+.+++..||+.+|++||++.+|++.|+..
T Consensus 221 ----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 221 ----LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred ----CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 011112245788999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=339.37 Aligned_cols=260 Identities=27% Similarity=0.519 Sum_probs=205.5
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecc
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYL 122 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 122 (391)
+.|.....||+|+||.||+|.+. ++..||+|.+...... ...|++.+++++|||||++++++.+....++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 56788889999999999999975 6899999998654322 234688899999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCC
Q 016347 123 ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN 202 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~ 202 (391)
++|+|.+++. .++|..+..++.|++.||+|||..+.++++||||||+||+++.++.+++. ||........
T Consensus 766 ~~g~L~~~l~---------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~ 835 (968)
T PLN00113 766 EGKNLSEVLR---------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD 835 (968)
T ss_pred CCCcHHHHHh---------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC
Confidence 9999999994 28899999999999999999996555599999999999999999888775 5554432211
Q ss_pred CceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccC
Q 016347 203 MTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSL 282 (391)
Q Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (391)
....+++.|+|||++.+..++.++|||||||++|||+||+.||........ ....+............++++.+
T Consensus 836 -----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 909 (968)
T PLN00113 836 -----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSDCHLDMWIDPSI 909 (968)
T ss_pred -----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCC-cHHHHHHHhcCccchhheeCccc
Confidence 123578999999999999999999999999999999999999965433222 22233332232233333444444
Q ss_pred CC--CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 283 NG--DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 283 ~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
.. .....+...+.+++.+||+.||++||+|+||++.|+...
T Consensus 910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 32 334566778899999999999999999999999997653
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=300.73 Aligned_cols=255 Identities=25% Similarity=0.406 Sum_probs=199.7
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCc----EEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGK----IAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
.++|+..+.||+|+||.||+|.+. +|. .+|+|.+.... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 467889999999999999999864 343 57889887543 23344688899999999999999999998754 467
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+++||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++
T Consensus 85 ~v~e~~~~g~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~ 156 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK-----DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLA 156 (303)
T ss_pred eeehhcCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccc
Confidence 8999999999999986532 2578999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCce-eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 197 KLIPANMTH-VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 197 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
+........ ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-------~~~~~~~~ 229 (303)
T cd05110 157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-------DLLEKGER 229 (303)
T ss_pred ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHCCCC
Confidence 876432221 1112335678999999988899999999999999999997 88888654321111 11111110
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
...+......+.+++..||..+|++||++.++++.|...
T Consensus 230 ---------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 230 ---------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011112345788899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=289.26 Aligned_cols=254 Identities=23% Similarity=0.348 Sum_probs=188.3
Q ss_pred ceeeccCceEEEEEEeCC---CcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCC
Q 016347 50 NKIGEGGFGSVYKGRLKD---GKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENN 125 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 125 (391)
++||+|+||.||+|...+ ...+++|.+.... ......+.+|+.+++.++||||+++++.+......++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 369999999999997543 2346677765442 334567899999999999999999999999988999999999999
Q ss_pred CHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCC-c
Q 016347 126 SLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANM-T 204 (391)
Q Consensus 126 sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~-~ 204 (391)
+|.+++..... ....++...+..++.||+.||.|||+. +++|+||||+|||++.++.++|+|||++....... .
T Consensus 81 ~L~~~l~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 81 DLKSYLSQEQW--HRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred cHHHHHHhhhc--ccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 99999975432 223467778889999999999999999 99999999999999999999999999876432111 1
Q ss_pred eeeeeecccccccChhhhhc-------CCCCCCCcEeehhHHHHHHHhC-CCCCCCCCCcchhhHHHHHHHHhhhcccce
Q 016347 205 HVSTRVAGTIGYLAPEYAIR-------GQVTRKADIYSFGVLLVEIVSG-RCNTNMRLPTEEQYLLERTWDLYERRELIL 276 (391)
Q Consensus 205 ~~~~~~~gt~~y~aPE~~~~-------~~~~~k~DvwSlG~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (391)
.......++..|+|||++.. ..++.++|||||||++|+|+++ ..||....... .... ...+....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~----~~~~~~~~ 228 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---VLNH----VIKDQQVK 228 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHhhcccc
Confidence 11223467889999998743 2457899999999999999975 55665332211 1111 11111122
Q ss_pred eeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 277 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
+.++.+.. .....+.+++..|| .+|++||++.+|++.|.
T Consensus 229 ~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 229 LFKPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 22222222 23346777888899 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=303.68 Aligned_cols=266 Identities=26% Similarity=0.411 Sum_probs=212.5
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccch-hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESR-QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
+.+-+...+.++||+|-||.|.+.....+..||+|.++.... ....+|..|+++|.+|+||||+.++|.|..++.+++|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 345577899999999999999999998889999999998744 4458899999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
+||+++|+|.+++..+... .+.-.....|+.||+.||+||.+. ++|||||.+.|+|++.++++||+|||.++.
T Consensus 614 ~EYmEnGDLnqFl~aheap----t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELP----TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred HHHHhcCcHHHHHHhccCc----ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccc
Confidence 9999999999999876431 145566678999999999999999 999999999999999999999999999996
Q ss_pred cCCCC-ceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHH--hCCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 199 IPANM-THVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIV--SGRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 199 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ell--tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
+-... .+.....+-..+|||+|.+.-++++.++|||+||+++||++ +...|+......+. .+.....+.....
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~- 762 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGR- 762 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCc-
Confidence 54332 23333445578999999999999999999999999999975 45566653322221 1111111111100
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
...-..+.-++..+.+++..||..+-++||+++++...|..
T Consensus 763 -----~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 763 -----QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred -----ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 00112345677789999999999999999999999888753
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=295.86 Aligned_cols=265 Identities=25% Similarity=0.364 Sum_probs=200.7
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC--CeeEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEG--NHRILV 118 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 118 (391)
++|++.+.||.|++|.||+|.+. +++.+++|.+.... ......+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 67999999999999999999987 58899999987543 22234567899999999999999999998877 899999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|||+++ +|.+++.... ..+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 85 ~e~~~~-~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~ 155 (293)
T cd07843 85 MEYVEH-DLKSLMETMK-----QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLARE 155 (293)
T ss_pred ehhcCc-CHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceee
Confidence 999975 8988886432 2589999999999999999999999 999999999999999999999999999887
Q ss_pred cCCCCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HHHh
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERT--------WDLY 269 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~ 269 (391)
...... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||............... |..+
T Consensus 156 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 156 YGSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred ccCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence 644321 12234578899999988764 4689999999999999999999999765433221111100 0000
Q ss_pred hh------cccceeeeccCCCCCCHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 270 ER------RELILLVDTSLNGDFDAE-EACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 270 ~~------~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
.. ..........+...++.. ....+.+++.+||+.+|++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 000000000011111111 35568889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=285.88 Aligned_cols=250 Identities=31% Similarity=0.493 Sum_probs=206.0
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEeccc
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLE 123 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 123 (391)
+|+..+.||.|++|.||+|.+. +++.+++|++..........+.+|+++++.++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 5888999999999999999987 688999999987655556789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCC
Q 016347 124 NNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANM 203 (391)
Q Consensus 124 ~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~ 203 (391)
+++|.+++.... ..+++..+..++.|++.||.+||+. +++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 81 GGSLKDLLKSTN-----QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred CCcHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 999999986532 3689999999999999999999998 99999999999999999999999999988764432
Q ss_pred ceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCC
Q 016347 204 THVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLN 283 (391)
Q Consensus 204 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (391)
. .....++..|+|||.+.+..++.++||||||+++++|++|..||............ ....... .
T Consensus 153 ~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~~~~-----~- 217 (253)
T cd05122 153 A--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI-------ATNGPPG-----L- 217 (253)
T ss_pred c--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-------HhcCCCC-----c-
Confidence 1 23456889999999998888999999999999999999999998754322211100 0000000 0
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 284 GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 284 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
.........+.+++.+||+.||++||++.+++++
T Consensus 218 -~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 218 -RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred -CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0111124578899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=294.96 Aligned_cols=269 Identities=23% Similarity=0.293 Sum_probs=198.2
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCe-----
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNH----- 114 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~----- 114 (391)
++|++.+.||.|+||.||+|.+. +++.||+|.+.... ......+.+|+.+++.+ +||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47999999999999999999976 58999999876542 22345678899999999 46999999999886655
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-CCcEEEEec
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK-DLTPKISDF 193 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~-~~~~kl~Df 193 (391)
.++||||+++ +|.+++...... ....+++..++.++.||+.||.|||++ +++|+||+|+||+++. ++.++|+||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence 8999999986 788888653321 234689999999999999999999999 9999999999999998 899999999
Q ss_pred ccccccCCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 194 GLAKLIPANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 194 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
|++..+..... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||....+.................
T Consensus 156 g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 156 GLGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred ccceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 99876533211 1122356788999998865 457999999999999999999999997654332211111000000000
Q ss_pred cccee---ee----ccCC----CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 273 ELILL---VD----TSLN----GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 273 ~~~~~---~~----~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
..... .. .... ..........+.+++.+||+.||.+||++.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 00 0000 00001234568899999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=295.96 Aligned_cols=265 Identities=24% Similarity=0.365 Sum_probs=198.5
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
+|+.++.||.|++|.||+|++. +|+.||||.+.... ......+.+|++++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4889999999999999999976 58999999887542 22345688899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+. ++|.+++... ....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~-~~l~~~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~ 152 (284)
T cd07860 81 LH-QDLKKFMDAS----PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 152 (284)
T ss_pred cc-cCHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence 96 5888888543 223589999999999999999999999 999999999999999999999999999876533
Q ss_pred CCceeeeeecccccccChhhhhcCC-CCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HHHhhh-
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRGQ-VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERT--------WDLYER- 271 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~- 271 (391)
... ......++..|+|||++.+.. ++.++|||||||++|+|+||+.||............... +.....
T Consensus 153 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 153 PVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred Ccc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 211 122234678899999876644 688999999999999999999999754432211100000 000000
Q ss_pred ----cccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 272 ----RELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 272 ----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
..........+. .........+.+++.+||+.||.+||++++++++-
T Consensus 232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 282 (284)
T cd07860 232 PDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHP 282 (284)
T ss_pred HHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCC
Confidence 000000000000 00112234677899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=297.94 Aligned_cols=269 Identities=25% Similarity=0.340 Sum_probs=199.4
Q ss_pred CCCCCceeeccCceEEEEEEeCC---CcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC--CeeE
Q 016347 45 DFSPINKIGEGGFGSVYKGRLKD---GKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEG--NHRI 116 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 116 (391)
+|++.++||+|++|.||+|.+.. ++.||+|.+.... ......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58889999999999999999754 7899999988632 33446678899999999999999999999987 8899
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC----CCcEEEEe
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK----DLTPKISD 192 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~----~~~~kl~D 192 (391)
+||||+++ +|.+.+...... ....+++..++.++.||+.||.|||+. +++|+||||+||+++. ++.+||+|
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQA-KRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccC-CCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECC
Confidence 99999975 677766432211 223689999999999999999999999 9999999999999999 89999999
Q ss_pred cccccccCCCCc--eeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchh------hHHH
Q 016347 193 FGLAKLIPANMT--HVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQ------YLLE 263 (391)
Q Consensus 193 fg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~------~~~~ 263 (391)
||++........ .......++..|+|||++.+. .++.++|||||||++++|++|+.||......... ....
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 999887643322 112234678899999988764 5899999999999999999999999765433200 0000
Q ss_pred HHHHHhhh------------cccceeeeccCCCCCC----H-------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 264 RTWDLYER------------RELILLVDTSLNGDFD----A-------EEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 264 ~~~~~~~~------------~~~~~~~~~~~~~~~~----~-------~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
.....+.. .+.....+.......+ . .....+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000000 0000000000000011 0 223468899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=292.45 Aligned_cols=257 Identities=27% Similarity=0.442 Sum_probs=208.1
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
-..+.|+..+.||.|++|.||+|.+. +++.+++|++..... ....+.+|++.++.++|+|++++++++......++++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 35677999999999999999999987 588999999876544 4567889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++.... ..+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++...
T Consensus 95 e~~~~~~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 95 EYMDGGSLTDIITQNF-----VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred eccCCCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 9999999999997542 3689999999999999999999998 9999999999999999999999999988765
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
..... ......++..|+|||.+.+..++.++|||||||++|+|++|..||....+...... ........
T Consensus 167 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~~--- 235 (286)
T cd06614 167 TKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL-------ITTKGIPP--- 235 (286)
T ss_pred ccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhcCCCC---
Confidence 33221 12234578899999999888899999999999999999999999865433211110 00000000
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.......+..+.+++.+||+.+|.+||++.+++++..-
T Consensus 236 ----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 273 (286)
T cd06614 236 ----LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFL 273 (286)
T ss_pred ----CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHh
Confidence 01111234578899999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=294.03 Aligned_cols=265 Identities=23% Similarity=0.329 Sum_probs=197.4
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
+.++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.+++.++|+||+++++++..+...++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999876 58899999986543 222345678999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+. ++|.+.+... ...+.+..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 83 e~~~-~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 83 EYMH-TDLAQYMIQH-----PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred eccc-CCHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecccccccc
Confidence 9996 5777766432 12477888899999999999999999 9999999999999999999999999998764
Q ss_pred CCCCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc------
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR------ 272 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------ 272 (391)
..... ......+++.|+|||.+.+. .++.++|||||||++|+|++|..||......... ....+......
T Consensus 154 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~--~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 154 SIPSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ--LEKIWTVLGVPTEDTWP 230 (291)
T ss_pred CCCCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH--HHHHHHHcCCCChhhhh
Confidence 32211 12234578899999988654 5788999999999999999999999754432111 11111100000
Q ss_pred ---ccceeeeccCCCCC---------CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 273 ---ELILLVDTSLNGDF---------DAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 273 ---~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
.............. .......+.+++.+|++.||.+|||+.|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000000000000 00123567789999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=289.21 Aligned_cols=250 Identities=28% Similarity=0.405 Sum_probs=205.6
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
+|++.++||+|++|.||++... +++.+++|.+... .......+.+|+++++.++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5889999999999999999876 5889999998754 233455678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++++|.+++..... ....+++..++.++.|++.||.|||+. |++|+||+|.||+++.++.++|+|||++.....
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 81 APFGDLSKAISKRKK--KRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred cCCCCHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 999999999865321 234689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
. ......+++.|++||.+.+..++.++|+||||+++|+|++|+.||......... ..... .
T Consensus 156 ~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~-------~~~~~---------~ 216 (256)
T cd08530 156 N---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR-------YKVQR---------G 216 (256)
T ss_pred C---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhc---------C
Confidence 3 222345788999999998889999999999999999999999999654322110 00111 1
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
.....+.....++.+++.+||+.+|++||++.+++++
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1112233556679999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=302.55 Aligned_cols=268 Identities=24% Similarity=0.310 Sum_probs=198.1
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC-----Ce
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG-----NH 114 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 114 (391)
.+++|++.++||+|+||.||+|.+. +|+.||+|.+... .......+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3578999999999999999999876 5899999998643 233445678899999999999999999887643 35
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.++|+||+.+ +|.+.+.. ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||
T Consensus 83 ~~lv~e~~~~-~l~~~~~~-------~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg 151 (336)
T cd07849 83 VYIVQELMET-DLYKLIKT-------QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFG 151 (336)
T ss_pred EEEEehhccc-CHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccc
Confidence 7999999965 78877743 3589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCce--eeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHH-----
Q 016347 195 LAKLIPANMTH--VSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTW----- 266 (391)
Q Consensus 195 ~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~----- 266 (391)
++......... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||................
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~ 231 (336)
T cd07849 152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQ 231 (336)
T ss_pred ceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 98765332211 1123468899999998755 468999999999999999999999996543211100000000
Q ss_pred ---HHhhhcccceeeecc-CCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 267 ---DLYERRELILLVDTS-LNGDFD-----AEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 267 ---~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
............... .....+ ......+.+++.+||+.+|++||++.|++++-+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~ 294 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 000000000000000 000000 122456889999999999999999999999843
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=292.88 Aligned_cols=252 Identities=27% Similarity=0.417 Sum_probs=200.4
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (391)
..++|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+++++.++||||+++++++.+....++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 3467999999999999999999976 58999999886432 2334568899999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
|+||+. |+|.+.+... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 93 v~e~~~-g~l~~~~~~~-----~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~ 163 (307)
T cd06607 93 VMEYCL-GSASDILEVH-----KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSAS 163 (307)
T ss_pred EHHhhC-CCHHHHHHHc-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcce
Confidence 999997 4677776432 22589999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCceeeeeecccccccChhhhh---cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 198 LIPANMTHVSTRVAGTIGYLAPEYAI---RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 198 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
..... ....++..|+|||++. .+.++.++||||||+++|+|++|..||.......... .... ...
T Consensus 164 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~------~~~~-~~~ 231 (307)
T cd06607 164 LVSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQ-NDS 231 (307)
T ss_pred ecCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH------HHhc-CCC
Confidence 64322 2346788999999874 4568899999999999999999999986443221110 0000 000
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
...........+.+++.+||+.+|++||++.+++.+.+..
T Consensus 232 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 271 (307)
T cd06607 232 --------PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271 (307)
T ss_pred --------CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 0011123456789999999999999999999999876443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=296.70 Aligned_cols=270 Identities=27% Similarity=0.337 Sum_probs=200.7
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch--hcHHHHHHHHHHHhcCCCCceeEEEEEEEeC--CeeE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR--QGVKEFLTEIQVISEIEHENLVKLYGCCVEG--NHRI 116 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 116 (391)
..++|++.+.||.|+||.||+|.+. +|+.||+|.+..... .....+.+|+.++++++|+||+++++++... ...+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3578999999999999999999986 589999999875422 2233466799999999999999999998754 4689
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+||||+.+ +|.+++.... ..+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 85 lv~e~~~~-~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~ 155 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLA 155 (309)
T ss_pred EEEecCCC-CHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcccee
Confidence 99999965 7888885422 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH--------
Q 016347 197 KLIPANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWD-------- 267 (391)
Q Consensus 197 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~-------- 267 (391)
........ ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||....+............
T Consensus 156 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 156 RTYGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred eecCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhch
Confidence 87643221 1222345788999998865 4579999999999999999999999976544332111111000
Q ss_pred Hhhhcccceee--eccCCCCC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 268 LYERRELILLV--DTSLNGDF---DAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 268 ~~~~~~~~~~~--~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
..........+ ........ .......+.+++.+||+.||++|||+.+++++-+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f 293 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 00000000000 00000000 01124567889999999999999999999987544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=292.62 Aligned_cols=265 Identities=25% Similarity=0.326 Sum_probs=200.7
Q ss_pred CCCCceeeccCceEEEEEEeCC-CcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC--CeeEEEEe
Q 016347 46 FSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEG--NHRILVYN 120 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 120 (391)
|++.++||.|++|.||+|.+.+ ++.+|+|.+.... ......+.+|+++++.++|||++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 6788999999999999999874 8899999998653 33445688899999999999999999999887 89999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+++ +|.+++.... ..+++..++.++.||+.||+|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~~~-~l~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~ 151 (287)
T cd07840 81 YMDH-DLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYT 151 (287)
T ss_pred cccc-cHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeecc
Confidence 9975 8888885432 3689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee-
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV- 278 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 278 (391)
...........++..|+|||.+.+ ..++.++||||||+++|+|++|..||............................
T Consensus 152 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 152 KRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred CCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccccc
Confidence 433222233456788999997765 457899999999999999999999997655322211111100000000000000
Q ss_pred -------------eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 279 -------------DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 279 -------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
...+........+..+.+++.+||+.+|.+||++.+++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~ 285 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE 285 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCc
Confidence 00000000011256788999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=291.10 Aligned_cols=263 Identities=25% Similarity=0.410 Sum_probs=200.8
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch-hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecc
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR-QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYL 122 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 122 (391)
+|++.++||.|++|.||+|.+. +|+.||+|.+..... .....+.+|+++++.++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5889999999999999999986 589999999876532 23456778999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCC
Q 016347 123 ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN 202 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~ 202 (391)
++ +|.+++.... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~-~l~~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 81 DK-DLKKYMDTHG---VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred Cc-cHHHHHHhcC---CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 85 8888886543 234589999999999999999999999 9999999999999999999999999998765332
Q ss_pred CceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HHHhhhcc
Q 016347 203 MTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERT--------WDLYERRE 273 (391)
Q Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~ 273 (391)
.. ......++..|++||.+.+. .++.++|||||||++|+|++|..||............... +.....
T Consensus 154 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 230 (284)
T cd07836 154 VN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ-- 230 (284)
T ss_pred cc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc--
Confidence 11 11233568899999988664 5789999999999999999999999765433211111000 000000
Q ss_pred cceeeeccCC-------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 274 LILLVDTSLN-------GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 274 ~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
.. ....... ..........+.+++.+||+.||.+||++.+++++
T Consensus 231 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 231 LP-EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred Cc-hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 0000000 00111234567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=289.75 Aligned_cols=251 Identities=24% Similarity=0.402 Sum_probs=201.8
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
+|++.+.||.|+||.||+|... +|..+|+|.+.... ....+.+.+|+++++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5888999999999999999987 48889999986542 23345678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC-cEEEEecccccccC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL-TPKISDFGLAKLIP 200 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~-~~kl~Dfg~~~~~~ 200 (391)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||.+....
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (257)
T cd08225 81 CDGGDLMKRINRQR----GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153 (257)
T ss_pred CCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence 99999999986432 23478999999999999999999999 999999999999999885 56999999988764
Q ss_pred CCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeec
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT 280 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (391)
.... ......|++.|+|||++.+..++.++||||||+++|+|++|..||....... ....... ..
T Consensus 154 ~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~-~~------- 218 (257)
T cd08225 154 DSME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKICQ-GY------- 218 (257)
T ss_pred CCcc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhc-cc-------
Confidence 3322 2223458889999999988889999999999999999999999986443211 1111000 00
Q ss_pred cCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 281 SLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 281 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
. ..........+.+++.+||+.+|++||++.+++++-
T Consensus 219 -~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~ 255 (257)
T cd08225 219 -F-APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRP 255 (257)
T ss_pred -C-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCC
Confidence 0 111223345788999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=286.42 Aligned_cols=245 Identities=23% Similarity=0.312 Sum_probs=198.8
Q ss_pred eeccCceEEEEEEeCC-CcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCCCH
Q 016347 52 IGEGGFGSVYKGRLKD-GKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSL 127 (391)
Q Consensus 52 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 127 (391)
||.|++|.||+|++.. ++.+|+|++.... ....+.+.+|+++++.++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999999874 8899999987542 23446788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCceee
Q 016347 128 AQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVS 207 (391)
Q Consensus 128 ~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~~ 207 (391)
.+++.... .+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~ 149 (262)
T cd05572 81 WTILRDRG------LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KT 149 (262)
T ss_pred HHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cc
Confidence 99996532 489999999999999999999998 99999999999999999999999999998764432 22
Q ss_pred eeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCC
Q 016347 208 TRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFD 287 (391)
Q Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (391)
....++..|++||.+.+..++.++|+||||+++|+|++|..||.......... ... . .........+
T Consensus 150 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~---~---------~~~~~~~~~~ 216 (262)
T cd05572 150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEI-YND---I---------LKGNGKLEFP 216 (262)
T ss_pred ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHH-HHH---H---------hccCCCCCCC
Confidence 33468899999999988889999999999999999999999997654311111 000 0 0000111222
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHhc
Q 016347 288 AEEACRFLKVGLLCTQDTPKLRPS-----MSTVVQMLM 320 (391)
Q Consensus 288 ~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l~ 320 (391)
......+.+++.+||+.+|++||+ +.|++++-+
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~ 254 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKW 254 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChh
Confidence 233568899999999999999999 888877543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=286.37 Aligned_cols=252 Identities=26% Similarity=0.427 Sum_probs=206.8
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch--hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR--QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
+|++.+.||.|++|.||++.+. +++.+++|++..... .....+.+|+++++.++|||++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5888999999999999999986 588999999876532 4566788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++++|.+.+..... ....+++..+..++.+++.||.|||+. |++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 81 ADGGDLSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred cCCCcHHHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 999999999975421 234689999999999999999999999 999999999999999999999999999987644
Q ss_pred CCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
.. .......|++.|+|||.+.+..++.++||||||+++++|++|..||....... ... .......
T Consensus 156 ~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~----~~~~~~~------- 220 (258)
T cd08215 156 TV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LAL----KILKGQY------- 220 (258)
T ss_pred Cc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHH----HHhcCCC-------
Confidence 32 22334568899999999988889999999999999999999999986543211 111 1111111
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
...+......+.+++.+||..+|++||++.+++++
T Consensus 221 --~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 221 --PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11122344578889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=293.83 Aligned_cols=269 Identities=25% Similarity=0.337 Sum_probs=200.0
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC---
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN--- 113 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--- 113 (391)
+...++|++.+.||.|+||.||+|.+. +|+.||+|.+.... ......+.+|+++++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 456689999999999999999999987 48899999987542 223356778999999999999999999987644
Q ss_pred -------eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC
Q 016347 114 -------HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL 186 (391)
Q Consensus 114 -------~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~ 186 (391)
..++|+||+++ +|...+... ...+++..+..++.||+.||+|||+. +++|+||+|+||+++.++
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~ 153 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG-----LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKG 153 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCC
Confidence 78999999976 677776532 23589999999999999999999999 999999999999999999
Q ss_pred cEEEEecccccccCCCCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 016347 187 TPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERT 265 (391)
Q Consensus 187 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 265 (391)
.+||+|||++...............++..|+|||.+.+. .++.++|||||||++|+|++|+.||...............
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~ 233 (302)
T cd07864 154 QIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL 233 (302)
T ss_pred cEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 999999999987643332222223457789999988653 5789999999999999999999999754432211111111
Q ss_pred HHHhhhcccceee--------ec------cCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 266 WDLYERRELILLV--------DT------SLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 266 ~~~~~~~~~~~~~--------~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
...........+. +. ..... ....+..+.+++.+||+.||.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000000000 00 00000 00124578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=289.03 Aligned_cols=245 Identities=25% Similarity=0.319 Sum_probs=190.2
Q ss_pred eeeccCceEEEEEEeC-CCcEEEEEEecccch---hcHHHHHHHHHHHh---cCCCCceeEEEEEEEeCCeeEEEEeccc
Q 016347 51 KIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR---QGVKEFLTEIQVIS---EIEHENLVKLYGCCVEGNHRILVYNYLE 123 (391)
Q Consensus 51 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~---~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 123 (391)
.||+|+||.||++.+. +++.+|+|.+..... .....+.+|..+++ ...||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999976 589999998865421 11223344444333 3479999999999999899999999999
Q ss_pred CCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCC
Q 016347 124 NNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANM 203 (391)
Q Consensus 124 ~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~ 203 (391)
+++|.+++...+ .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~ 151 (279)
T cd05633 81 GGDLHYHLSQHG------VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (279)
T ss_pred CCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence 999999886433 489999999999999999999999 99999999999999999999999999987553221
Q ss_pred ceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccC
Q 016347 204 THVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSL 282 (391)
Q Consensus 204 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (391)
.....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||............... . ..
T Consensus 152 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~----------~----~~ 214 (279)
T cd05633 152 ---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT----------L----TV 214 (279)
T ss_pred ---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh----------h----cC
Confidence 123468999999998864 56899999999999999999999999755432221111100 0 00
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHhcC
Q 016347 283 NGDFDAEEACRFLKVGLLCTQDTPKLRP-----SMSTVVQMLMG 321 (391)
Q Consensus 283 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~ 321 (391)
....+...+..+.+++.+||+.||.+|| ++.|++++...
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~ 258 (279)
T cd05633 215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFF 258 (279)
T ss_pred CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccc
Confidence 1122334456788999999999999999 69999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=283.69 Aligned_cols=252 Identities=27% Similarity=0.402 Sum_probs=207.2
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch--hcHHHHHHHHHHHhcCCCCceeEEEEEEEeC--CeeEEEE
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR--QGVKEFLTEIQVISEIEHENLVKLYGCCVEG--NHRILVY 119 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 119 (391)
+|...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999987 689999999876542 4567889999999999999999999999988 8999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++.... .+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+...
T Consensus 81 e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 151 (260)
T cd06606 81 EYVSGGSLSSLLKKFG------KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRL 151 (260)
T ss_pred EecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEec
Confidence 9999999999996532 689999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCce-eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 200 PANMTH-VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 200 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
...... ......++..|+|||.+.+..++.++||||||+++++|++|..||....... ...+...
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~--------- 217 (260)
T cd06606 152 GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-----AALYKIG--------- 217 (260)
T ss_pred ccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHHhcc---------
Confidence 544321 1233568889999999988889999999999999999999999997654111 1111110
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
........+......+.+++.+||+.+|++||++.+++.+-
T Consensus 218 ~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~ 258 (260)
T cd06606 218 SSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHP 258 (260)
T ss_pred ccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCC
Confidence 00111122333467889999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=293.47 Aligned_cols=246 Identities=25% Similarity=0.416 Sum_probs=198.4
Q ss_pred CCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCCC
Q 016347 48 PINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNS 126 (391)
Q Consensus 48 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~s 126 (391)
...+||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++|+||+++++++......++||||+++++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 3467999999999999875 689999999865555556678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCcee
Q 016347 127 LAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHV 206 (391)
Q Consensus 127 L~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~ 206 (391)
|.+++.. ..+++..+..++.|++.||+|||+. |++|+||+|+||+++.++.++|+|||++........ .
T Consensus 104 L~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~ 172 (292)
T cd06657 104 LTDIVTH-------TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 172 (292)
T ss_pred HHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-c
Confidence 9998743 2478999999999999999999999 999999999999999999999999998876543221 1
Q ss_pred eeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCC
Q 016347 207 STRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDF 286 (391)
Q Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (391)
.....|++.|+|||.+.+..++.++|+||||+++|+|++|..||............. ... ...+. .
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~---~~~---------~~~~~--~ 238 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR---DNL---------PPKLK--N 238 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hhC---------CcccC--C
Confidence 223468899999999988889999999999999999999999987543322111100 000 00000 0
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 287 DAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 287 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
.......+.+++.+||+.+|.+||++.+++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 11234467788999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=302.02 Aligned_cols=263 Identities=25% Similarity=0.404 Sum_probs=224.3
Q ss_pred chHHHHHhhCCCCCCceeeccCceEEEEEEeCC---Cc--EEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEE
Q 016347 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLKD---GK--IAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGC 108 (391)
Q Consensus 35 ~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 108 (391)
+..+.++.-+..++.+.||.|.||.||+|...+ |+ .||||..+.+ ..+..+.|.+|.-+++.++||||++++|+
T Consensus 380 ~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv 459 (974)
T KOG4257|consen 380 TVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGV 459 (974)
T ss_pred CCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeee
Confidence 566667777778888999999999999998542 33 4889998874 55667889999999999999999999999
Q ss_pred EEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcE
Q 016347 109 CVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTP 188 (391)
Q Consensus 109 ~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~ 188 (391)
|.+. ..++|||.++-|.|..++..+. ..++......++.||..||+|||++ .+|||||..+||||...-.|
T Consensus 460 ~~e~-P~WivmEL~~~GELr~yLq~nk-----~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CV 530 (974)
T KOG4257|consen 460 CVEQ-PMWIVMELAPLGELREYLQQNK-----DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCV 530 (974)
T ss_pred eecc-ceeEEEecccchhHHHHHHhcc-----ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCccee
Confidence 9764 6889999999999999997643 3688999999999999999999999 99999999999999999999
Q ss_pred EEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHH-hCCCCCCCCCCcchhhHHHHHHH
Q 016347 189 KISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIV-SGRCNTNMRLPTEEQYLLERTWD 267 (391)
Q Consensus 189 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ell-tg~~p~~~~~~~~~~~~~~~~~~ 267 (391)
||+|||+++.+.+..........-..-|||||-+....++.++|||-|||.+||++ .|..||.+
T Consensus 531 KLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg--------------- 595 (974)
T KOG4257|consen 531 KLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG--------------- 595 (974)
T ss_pred eecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc---------------
Confidence 99999999988766544444444466899999999999999999999999999976 47788854
Q ss_pred HhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 268 LYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
..+.+++..+..+-+-+.+..++..+..|+.+||..+|.+||.+.++...|..+
T Consensus 596 -vkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 596 -VKNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred -ccccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 344666677777777788889999999999999999999999999988766544
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=288.78 Aligned_cols=246 Identities=27% Similarity=0.361 Sum_probs=194.5
Q ss_pred eeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCCCH
Q 016347 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSL 127 (391)
Q Consensus 52 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 127 (391)
||+|+||+||++... +|+.||+|.+.... ......+..|+++++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999876 58899999986542 22344567899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCceee
Q 016347 128 AQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVS 207 (391)
Q Consensus 128 ~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~~ 207 (391)
.+++..... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~ 151 (277)
T cd05577 81 KYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KI 151 (277)
T ss_pred HHHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cc
Confidence 999865431 3589999999999999999999999 99999999999999999999999999987653321 12
Q ss_pred eeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCC
Q 016347 208 TRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFD 287 (391)
Q Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (391)
....++..|+|||.+.+..++.++|||||||++|+|++|+.||.............. .. .. .....+
T Consensus 152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------~~----~~--~~~~~~ 218 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR-------RT----LE--MAVEYP 218 (277)
T ss_pred ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh-------cc----cc--ccccCC
Confidence 234578899999999888899999999999999999999999965443211110000 00 00 011122
Q ss_pred HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHh
Q 016347 288 AEEACRFLKVGLLCTQDTPKLRP-----SMSTVVQML 319 (391)
Q Consensus 288 ~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l 319 (391)
......+.+++.+||+.||.+|| ++.+++++-
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~ 255 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHP 255 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhCh
Confidence 23356788999999999999999 666677643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=292.73 Aligned_cols=264 Identities=25% Similarity=0.353 Sum_probs=198.5
Q ss_pred CCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecc
Q 016347 46 FSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYL 122 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 122 (391)
|++.+.||.|++|.||+|.+. +|..||+|++.... ......+.+|+++++.++|||++++++++.+....+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 678899999999999999976 69999999987553 223356788999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCC
Q 016347 123 ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN 202 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~ 202 (391)
+ ++|.+++.... ...+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~-~~l~~~~~~~~----~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~ 152 (283)
T cd07835 81 D-LDLKKYMDSSP----LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVP 152 (283)
T ss_pred C-cCHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCC
Confidence 5 68999886432 13589999999999999999999999 9999999999999999999999999998765332
Q ss_pred CceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HHHhhh-c
Q 016347 203 MTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERT--------WDLYER-R 272 (391)
Q Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~-~ 272 (391)
.. ......++..|+|||++.+. .++.++||||||+++|+|++|..||............... +..... .
T Consensus 153 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 153 VR-TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred cc-ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence 11 11223467899999987664 5789999999999999999999999765432211110000 000000 0
Q ss_pred ccceeeeccC---CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 273 ELILLVDTSL---NGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 273 ~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
.....+.... ...........+.+++.+||+.+|.+||++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000 000111233578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=293.94 Aligned_cols=267 Identities=25% Similarity=0.336 Sum_probs=196.5
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC-------
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN------- 113 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------- 113 (391)
++|++.++||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 67999999999999999999976 58999999886542 222345667999999999999999999987543
Q ss_pred -eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEe
Q 016347 114 -HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISD 192 (391)
Q Consensus 114 -~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~D 192 (391)
..++||||+.+ +|.+.+... ...+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNK-----NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECc
Confidence 45999999965 788877542 22589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCce---eeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 016347 193 FGLAKLIPANMTH---VSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDL 268 (391)
Q Consensus 193 fg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 268 (391)
||++......... ......++..|+|||.+.+. .++.++||||||+++|+|++|..||....+.............
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS 242 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999765432211 11234567889999988664 4789999999999999999999999765543222211111110
Q ss_pred hhhccc-----ceeeec-cCCCCC---------CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 269 YERREL-----ILLVDT-SLNGDF---------DAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 269 ~~~~~~-----~~~~~~-~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
...... ....+. ...... .......+.+++.+||+.||.+||++++++++-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~ 308 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHD 308 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCC
Confidence 000000 000000 000000 001124567899999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=289.24 Aligned_cols=255 Identities=26% Similarity=0.331 Sum_probs=199.8
Q ss_pred CCCCCceeeccCceEEEEEEeC----CCcEEEEEEecccc----hhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCee
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK----DGKIAAIKVLSAES----RQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 115 (391)
+|++.+.||+|++|.||++... +++.||+|++.... ......+.+|++++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788999999999999999853 47889999987532 22345678899999999 699999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||||+++++|.+.+... ..+++..+..++.|++.||.|||+. +++|+||+|.||+++.++.++|+|||+
T Consensus 81 ~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~ 151 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR------EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGL 151 (288)
T ss_pred EEEEecCCCCcHHHHHhhc------CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcc
Confidence 9999999999999998643 2488999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhcCC--CCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcc
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIRGQ--VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRE 273 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (391)
+...............|+..|+|||.+.+.. .+.++||||||+++|+|++|..||.............. ....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~--- 226 (288)
T cd05583 152 SKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR--RILK--- 226 (288)
T ss_pred ccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH--HHHc---
Confidence 8775433322223356889999999987655 78999999999999999999999864322211100000 0000
Q ss_pred cceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
. ....+......+.+++.+||+.||++|||+.++.+.|..
T Consensus 227 ------~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 227 ------S--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ------c--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0 011222344568889999999999999998877776644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=291.38 Aligned_cols=266 Identities=23% Similarity=0.321 Sum_probs=197.0
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
++|++.+.||+|++|.||+|.+. +|+.||+|.+.... ......+.+|++++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999976 58999999986542 2334567889999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-CCcEEEEeccccccc
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK-DLTPKISDFGLAKLI 199 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~-~~~~kl~Dfg~~~~~ 199 (391)
|++ ++|.+.+.... ...+++..+..++.||+.||+|||++ +++|+||+|+||+++. ++.+||+|||++...
T Consensus 82 ~~~-~~l~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 82 YLD-LDLKKHMDSSP----DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred ccc-ccHHHHHHhCC----CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 996 47877775432 22367888899999999999999999 9999999999999985 567999999999765
Q ss_pred CCCCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccc----
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERREL---- 274 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 274 (391)
..... ......+++.|+|||++.+. .++.++|||||||++|+|++|..||........................
T Consensus 154 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 154 GIPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred CCCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence 33211 11233568899999988664 5789999999999999999999999765432211110000000000000
Q ss_pred --ceee--eccCCC----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 275 --ILLV--DTSLNG----DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 275 --~~~~--~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
.... ...... .........+.+++.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 000000 0011234567889999999999999999999875
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=300.07 Aligned_cols=270 Identities=21% Similarity=0.291 Sum_probs=202.5
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEe----CCee
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVE----GNHR 115 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~ 115 (391)
.++|++.+.||.|++|.||+|... +|+.||+|++.... ......+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999976 59999999987542 2345667789999999999999999988753 3568
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||||+. ++|.+++.... .+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||+
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~ 153 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ------PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGM 153 (334)
T ss_pred EEEEehhh-hhHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccc
Confidence 99999996 58988885432 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCc---eeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh--
Q 016347 196 AKLIPANMT---HVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLY-- 269 (391)
Q Consensus 196 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~-- 269 (391)
+........ .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...................
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~ 233 (334)
T cd07855 154 ARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE 233 (334)
T ss_pred ceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh
Confidence 876533221 11223568889999998865 468999999999999999999999997654322111111000000
Q ss_pred ------hhcccceeeecc-CCCCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 270 ------ERRELILLVDTS-LNGDF-----DAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 270 ------~~~~~~~~~~~~-~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.........+.. ..... ....+..+.+++.+||+.+|.+||++.+++.+.+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~ 298 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence 000000000000 00011 112356789999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=291.19 Aligned_cols=260 Identities=25% Similarity=0.393 Sum_probs=196.9
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCC-CCceeEEEEEEEeCCeeEEEEe
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIE-HENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 120 (391)
++|+..+.||+|+||.||++.+. +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++......+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 46677889999999999999976 48999999987542 334567888999999996 9999999999998889999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+.. +|.++...-. ......+++..+..++.|++.||+|||+.. +++||||||+||+++.++.++|+|||++....
T Consensus 84 ~~~~-~l~~l~~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVY-EVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHH-HhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9864 5555432100 002245899999999999999999999732 89999999999999999999999999987653
Q ss_pred CCCceeeeeecccccccChhhhhcC---CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccccee
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRG---QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILL 277 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (391)
.... .....|+..|+|||++.+. .++.++|||||||++|+|++|+.||..... .......... ..
T Consensus 160 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~-~~---- 227 (288)
T cd06616 160 DSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK-GD---- 227 (288)
T ss_pred cCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC-CC----
Confidence 3221 1223578899999998766 689999999999999999999999864321 0111110000 00
Q ss_pred eeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 278 VDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 278 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.+.+........+..+.+++.+||+.+|++||++.+|+++-+
T Consensus 228 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~ 269 (288)
T cd06616 228 -PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPF 269 (288)
T ss_pred -CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 011111222235567889999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=282.79 Aligned_cols=248 Identities=29% Similarity=0.456 Sum_probs=204.4
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch--hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR--QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
+|++.+.||.|++|.||+|.+. +++.|++|.+..... .....+.+|++++++++|||++++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5889999999999999999876 588999999876643 4567789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++++|.+++... ..+++..+..++.|++.||.+||+. |++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~L~~~~~~~------~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 151 (254)
T cd06627 81 AENGSLRQIIKKF------GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLND 151 (254)
T ss_pred CCCCcHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence 9999999998654 3589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
.... .....++..|+|||...+..++.++|||+||+++|+|++|..||....+... .+.... ..
T Consensus 152 ~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~------~~~~~~-~~-------- 215 (254)
T cd06627 152 VSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA------LFRIVQ-DD-------- 215 (254)
T ss_pred Cccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHhc-cC--------
Confidence 3321 2335678899999999888889999999999999999999999864432111 111000 00
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
....+......+.+++.+||..+|++||++.+++.+
T Consensus 216 -~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 216 -HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred -CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 111222335578899999999999999999999754
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=289.53 Aligned_cols=251 Identities=27% Similarity=0.411 Sum_probs=199.4
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
+.|...+.||+|+||.||+|++. +++.+|+|.+... .......+.+|+++++.++|||++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34788899999999999999976 5889999998643 2233457888999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+.| +|.+.+... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 105 e~~~g-~l~~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~ 175 (317)
T cd06635 105 EYCLG-SASDLLEVH-----KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIA 175 (317)
T ss_pred eCCCC-CHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCcccc
Confidence 99975 777776532 23589999999999999999999999 9999999999999999999999999988754
Q ss_pred CCCCceeeeeecccccccChhhhh---cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccce
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAI---RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL 276 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (391)
... ....|++.|+|||++. .+.++.++|||||||++|+|++|..||........... ... ..
T Consensus 176 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~------~~~-~~--- 240 (317)
T cd06635 176 SPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH------IAQ-NE--- 240 (317)
T ss_pred CCc-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH------HHh-cc---
Confidence 321 2346788999999874 45689999999999999999999999865432211110 000 00
Q ss_pred eeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 277 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
............+.+++.+||+.+|.+||++.++++++....
T Consensus 241 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 241 -----SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -----CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 000111233456888999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=289.19 Aligned_cols=253 Identities=25% Similarity=0.320 Sum_probs=198.4
Q ss_pred CCCCCceeeccCceEEEEEEeC----CCcEEEEEEecccc----hhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCee
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK----DGKIAAIKVLSAES----RQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 115 (391)
+|++.+.||.|+||.||+|... +|+.||+|++.... ......+.+|+.+++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4888999999999999999863 58899999987532 22345678899999999 699999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 151 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE------RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 151 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcc
Confidence 99999999999999986432 488999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhcC--CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcc
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIRG--QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRE 273 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (391)
+...............|+..|+|||.+.+. .++.++||||||+++|+|++|..||........... ........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~---~~~~~~~~- 227 (290)
T cd05613 152 SKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAE---ISRRILKS- 227 (290)
T ss_pred ceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHH---HHHHhhcc-
Confidence 886543322222345688999999998653 478899999999999999999999864322211110 00000000
Q ss_pred cceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHh
Q 016347 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRP-----SMSTVVQML 319 (391)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l 319 (391)
....+......+.+++.+||+.||++|| ++.+++.+-
T Consensus 228 ---------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~ 269 (290)
T cd05613 228 ---------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHP 269 (290)
T ss_pred ---------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCc
Confidence 0112223455788899999999999997 677777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=299.32 Aligned_cols=266 Identities=21% Similarity=0.318 Sum_probs=199.6
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC-----Ce
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG-----NH 114 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 114 (391)
.++|.+.+.||+|+||.||+|.+. +++.||+|.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 468999999999999999999976 5899999998653 233345677899999999999999999987643 35
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.++|+||+. ++|.+++...+ .+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg 153 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ------TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFG 153 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCc
Confidence 799999996 68888886432 589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH------
Q 016347 195 LAKLIPANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWD------ 267 (391)
Q Consensus 195 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~------ 267 (391)
++....... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.................
T Consensus 154 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 154 LARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED 232 (337)
T ss_pred cccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 998654322 22234467889999998865 4689999999999999999999999975432111110000000
Q ss_pred --Hhhhcccceeee---ccCC---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 268 --LYERRELILLVD---TSLN---GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 268 --~~~~~~~~~~~~---~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
............ .... .......+..+.+++.+||+.+|++||++.+++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~ 292 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHP 292 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCc
Confidence 000000000000 0000 001113456788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=299.91 Aligned_cols=253 Identities=23% Similarity=0.348 Sum_probs=211.8
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
....|.+++.||+|.|++|.+|++. ++..||||++.+.. ......+.+|+++|+.++|||||+++.+......+++|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3578999999999999999999976 59999999998763 33445688999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|||+.+|.+.+++...+. +.+..+..++.|+..|++|||++ +|+|||||++|||++.+..+||+|||++..
T Consensus 134 ~eya~~ge~~~yl~~~gr------~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~ 204 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR------MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTF 204 (596)
T ss_pred EEeccCchhHHHHHhccc------chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeecccccee
Confidence 999999999999987664 66688999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCceeeeeecccccccChhhhhcCCC-CCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccccee
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILL 277 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (391)
+.. .....+++|++.|.|||++.+..| ++++|+||+|++||.|++|..||++..-..-+ .+ .
T Consensus 205 ~~~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-----------~r----v 267 (596)
T KOG0586|consen 205 FDY--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-----------PR----V 267 (596)
T ss_pred ecc--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-----------ch----h
Confidence 753 345567899999999999999887 68999999999999999999999864322211 01 0
Q ss_pred eeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 278 VDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 278 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
+...+ .++.-...++.+++.++|-.+|.+|++++++.++-|..
T Consensus 268 l~gk~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n 310 (596)
T KOG0586|consen 268 LRGKY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRN 310 (596)
T ss_pred eeeee--cccceeechhHHHHHHhhccCccccCCHHHhhhhcccc
Confidence 11111 12223345677888899999999999999998765433
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=288.69 Aligned_cols=259 Identities=19% Similarity=0.218 Sum_probs=187.2
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeCC----CcEEEEEEecccchhcHH-----------HHHHHHHHHhcCCCCceeE
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLKD----GKIAAIKVLSAESRQGVK-----------EFLTEIQVISEIEHENLVK 104 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~-----------~~~~e~~~l~~l~h~~iv~ 104 (391)
.+..++|++.+.||+|+||.||+|.+.+ +..+|+|+.......... ....+...+..+.|+++++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 3556899999999999999999999764 456677764433221111 1223344566678999999
Q ss_pred EEEEEEeCC----eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 016347 105 LYGCCVEGN----HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNI 180 (391)
Q Consensus 105 ~~~~~~~~~----~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NI 180 (391)
+++++.... ..+++++++.. ++.+.+... ...++..+..++.|++.||.|||++ +++||||||+||
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Ni 157 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI------KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENI 157 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhcc-CHHHHHHhh------ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence 999766443 44677887743 566666432 1357788899999999999999999 999999999999
Q ss_pred EECCCCcEEEEecccccccCCCCce------eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCC
Q 016347 181 LLDKDLTPKISDFGLAKLIPANMTH------VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRL 254 (391)
Q Consensus 181 lv~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~ 254 (391)
|++.++.++|+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 158 ll~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 158 MVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred EEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 9999999999999999866322211 1122469999999999999999999999999999999999999997653
Q ss_pred Ccchh-hHHHH-HHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 255 PTEEQ-YLLER-TWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 255 ~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
..... ..... ......... .. ....+..+.+++..|++.+|++||++.++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~--------~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 238 HNGNLIHAAKCDFIKRLHEGK--------IK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred cchHHHHHhHHHHHHHhhhhh--------hc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 22211 00000 011111110 00 012245688899999999999999999999876
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=307.06 Aligned_cols=254 Identities=22% Similarity=0.348 Sum_probs=209.8
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeCC--Cc--EEEEEEecccchh-cHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLKD--GK--IAAIKVLSAESRQ-GVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
|..++..+.++||+|.||.|++|.|.. |+ .||||+++..... ....|++|+.+|.+|+|||++++||++.+ +..
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 445667778899999999999999873 44 4799999877554 67889999999999999999999999887 788
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
.||||.++.|||.+.+.+. ....|.......++.|||.||.||.++ ++|||||-.+|+++-..-.|||+|||+
T Consensus 186 mMV~ELaplGSLldrLrka----~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGL 258 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKA----KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGL 258 (1039)
T ss_pred hHHhhhcccchHHHHHhhc----cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccc
Confidence 9999999999999999762 345688899999999999999999999 999999999999998888999999999
Q ss_pred ccccCCCCcee-ee-eecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhC-CCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 196 AKLIPANMTHV-ST-RVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSG-RCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 196 ~~~~~~~~~~~-~~-~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
.+.++.+.... +. ...-...|+|||.+....++.++|||+|||++|||+++ ..||.+-...+.
T Consensus 259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI-------------- 324 (1039)
T KOG0199|consen 259 MRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI-------------- 324 (1039)
T ss_pred eeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH--------------
Confidence 99886554322 11 12235679999999999999999999999999999984 577766544221
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
.+.+|..-.-..+..++.++.++++.||..+|.+||++..|.+.
T Consensus 325 --L~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 325 --LKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred --HHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 12223222335566788999999999999999999999999643
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=284.29 Aligned_cols=251 Identities=23% Similarity=0.329 Sum_probs=199.6
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc-----chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC--Cee
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE-----SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG--NHR 115 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 115 (391)
.+|++.+.||+|+||.||+|.+. +++.||+|.+... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999976 5899999987532 223456788999999999999999999998753 468
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++++||+++++|.+++...+ .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~ 152 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG------ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGA 152 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccc
Confidence 89999999999999986432 478899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCc--eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcc
Q 016347 196 AKLIPANMT--HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRE 273 (391)
Q Consensus 196 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (391)
+........ .......++..|+|||.+.+..++.++|||||||++|+|++|+.||........ . ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~-~~~-------- 221 (264)
T cd06653 153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA--I-FKI-------- 221 (264)
T ss_pred ccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH--H-HHH--------
Confidence 986532111 111234688999999999888899999999999999999999999964322111 0 000
Q ss_pred cceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.........+......+.+++.+||+ +|..||++.+++.+.
T Consensus 222 ----~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~ 262 (264)
T cd06653 222 ----ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP 262 (264)
T ss_pred ----HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence 00001112334455678889999999 579999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=284.22 Aligned_cols=243 Identities=25% Similarity=0.311 Sum_probs=188.6
Q ss_pred ceeeccCceEEEEEEeC-CCcEEEEEEecccch---hcHHHHHHHHHH-HhcCCCCceeEEEEEEEeCCeeEEEEecccC
Q 016347 50 NKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR---QGVKEFLTEIQV-ISEIEHENLVKLYGCCVEGNHRILVYNYLEN 124 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 124 (391)
+.||.|++|.||+|... +++.||+|++..... .....+..|..+ .....|+|++++++++..+...++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999876 589999999865421 222334445444 4455899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc
Q 016347 125 NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204 (391)
Q Consensus 125 ~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~ 204 (391)
++|.+++...+ .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 149 (260)
T cd05611 82 GDCASLIKTLG------GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--- 149 (260)
T ss_pred CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc---
Confidence 99999996433 489999999999999999999999 999999999999999999999999998875432
Q ss_pred eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCC
Q 016347 205 HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNG 284 (391)
Q Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (391)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||........ +........ ....
T Consensus 150 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~------~~~~ 214 (260)
T cd05611 150 --NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-------FDNILSRRI------NWPE 214 (260)
T ss_pred --cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhccc------CCCC
Confidence 2234578899999999888899999999999999999999999975433211 111111100 0011
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 285 DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 285 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
......+..+.+++.+||+.+|++||++.++.+.|
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 11113456788999999999999999776554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=287.60 Aligned_cols=262 Identities=22% Similarity=0.276 Sum_probs=194.5
Q ss_pred CCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCC-CCceeEEEEEEEeC--CeeEEEEe
Q 016347 46 FSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIE-HENLVKLYGCCVEG--NHRILVYN 120 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e 120 (391)
|+++++||+|+||.||+|... +++.||+|.+.... .........|+..+.++. |+|++++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 678899999999999999976 58899999987542 222234457888888885 99999999999987 88999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+++ +|.+.+.... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~~~~-~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 81 LMDM-NLYELIKGRK-----RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred cCCc-cHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 9975 7878775422 3589999999999999999999999 9999999999999999 999999999998654
Q ss_pred CCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHH--------HHhhh
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTW--------DLYER 271 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~ 271 (391)
.... .....++..|+|||++.. +.++.++|||||||++|+|++|..||....+.+......... .....
T Consensus 151 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 151 SKPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred cCCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence 3221 123457889999997654 457899999999999999999999997654322111111000 00000
Q ss_pred ccccee-eeccCCC---CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 272 RELILL-VDTSLNG---DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 272 ~~~~~~-~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
...... +...... ......+..+.+++.+||+.+|++||++.+++++-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~ 280 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHP 280 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCC
Confidence 000000 0000000 00113457899999999999999999999998763
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=289.04 Aligned_cols=264 Identities=24% Similarity=0.338 Sum_probs=201.8
Q ss_pred CCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch--hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecc
Q 016347 46 FSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR--QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYL 122 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 122 (391)
|++.+.||.|++|.||+|... +++.+++|.+..... .....+.+|++++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 678899999999999999976 589999999875532 24567888999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCC
Q 016347 123 ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN 202 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~ 202 (391)
++ +|.+++.... ..+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~-~l~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 81 DT-DLYKLIKDRQ-----RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred CC-CHHHHHHhhc-----ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 75 8888876532 3689999999999999999999999 9999999999999999999999999998876443
Q ss_pred CceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeee--
Q 016347 203 MTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD-- 279 (391)
Q Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 279 (391)
. .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||.............................
T Consensus 152 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 152 V-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred c-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence 3 122234577889999998776 789999999999999999999999866543221111110000000000000000
Q ss_pred --------ccCC---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 280 --------TSLN---GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 280 --------~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.... .......+..+.+++.+||+.||.+||++.+++.+-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~ 281 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHP 281 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCC
Confidence 0000 011123456889999999999999999999998753
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=305.43 Aligned_cols=261 Identities=25% Similarity=0.376 Sum_probs=214.8
Q ss_pred HHHHHhhCCCCCCceeeccCceEEEEEEeCC-CcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 37 KELSIATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 37 ~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
.+|+..--+.+...+||.|-||.||.|.|+. .-.||||.++.+. -...+|+.|..+|+.++|||+|+++|+|..+-.+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4455555677888899999999999999985 5679999997654 4568899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
|||+|||..|+|.+++..- +...++....+.++.||..|+.||..+ +++||||..+|.||.++..||++|||+
T Consensus 339 YIiTEfM~yGNLLdYLRec----nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLREC----NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred EEEEecccCccHHHHHHHh----chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccch
Confidence 9999999999999999753 344577888899999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhC-CCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSG-RCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
++.+..............+-|.|||-+....++.|+|||+|||+|||+.|- -.|+.+-.- ..+
T Consensus 412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl----------------SqV 475 (1157)
T KOG4278|consen 412 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------------SQV 475 (1157)
T ss_pred hhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH----------------HHH
Confidence 999854432222222346789999999999999999999999999999984 344433222 222
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
..++...++-+.+.-++..+.+|++.||+++|.+||++.|+-+.++.
T Consensus 476 Y~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 476 YGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred HHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 23344445555666778899999999999999999999998776643
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=281.68 Aligned_cols=252 Identities=22% Similarity=0.294 Sum_probs=194.7
Q ss_pred hHHHHHhhCCCCCCcee--eccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcC-CCCceeEEEEEEEe
Q 016347 36 YKELSIATDDFSPINKI--GEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENLVKLYGCCVE 111 (391)
Q Consensus 36 ~~e~~~~~~~y~~~~~l--g~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 111 (391)
+.+..-..++|++.+.+ |.|+||.||++... ++..+|+|.+........ |+.....+ +||||+++++.+..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence 33444445778888877 99999999999976 588899999865422211 22222222 79999999999999
Q ss_pred CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC-cEEE
Q 016347 112 GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL-TPKI 190 (391)
Q Consensus 112 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~-~~kl 190 (391)
.+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .++|
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l 151 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEG------KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYL 151 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEE
Confidence 999999999999999999996532 689999999999999999999999 999999999999999998 9999
Q ss_pred EecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh
Q 016347 191 SDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE 270 (391)
Q Consensus 191 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 270 (391)
+|||++...... ....++..|+|||++.+..++.++|||||||++|+|++|..||......... ..... ...
T Consensus 152 ~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~-~~~- 223 (267)
T PHA03390 152 CDYGLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD-LESLL-KRQ- 223 (267)
T ss_pred ecCccceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh-HHHHH-Hhh-
Confidence 999998765322 1235789999999999889999999999999999999999999744332211 00110 000
Q ss_pred hcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHHh
Q 016347 271 RRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPS-MSTVVQML 319 (391)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl~~l 319 (391)
.. ........+..+.+++.+||+.+|.+||+ +++++++-
T Consensus 224 ~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~ 263 (267)
T PHA03390 224 QK----------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHP 263 (267)
T ss_pred cc----------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCC
Confidence 00 00111235567889999999999999996 69998653
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=297.26 Aligned_cols=265 Identities=23% Similarity=0.296 Sum_probs=202.6
Q ss_pred CCCCCceeeccCceEEEEEEeCC-CcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC-----eeE
Q 016347 45 DFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN-----HRI 116 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 116 (391)
+|++.+.||.|++|.||+|.... ++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 58899999999999999999864 8999999987643 344567889999999999999999999988765 789
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
++|||+++ +|.+++.... .+++..++.++.||+.||.+||+. |++|+||||.||+++.++.++|+|||++
T Consensus 81 lv~e~~~~-~l~~~l~~~~------~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~ 150 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ------PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLA 150 (330)
T ss_pred EEecchhh-hHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCce
Confidence 99999974 7888885432 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCc--eeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh---
Q 016347 197 KLIPANMT--HVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE--- 270 (391)
Q Consensus 197 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--- 270 (391)
........ .......++..|+|||++.+. .++.++||||||+++|+|++|..||....................
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 151 RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230 (330)
T ss_pred EeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence 87644321 112334578899999999887 789999999999999999999999976543221111110000000
Q ss_pred -----hcccceeee---ccCC---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 271 -----RRELILLVD---TSLN---GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 271 -----~~~~~~~~~---~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.......+. .... ..........+.+++.+||+.+|.+||++.+++.+-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 290 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCc
Confidence 000000000 0000 000112355788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=303.21 Aligned_cols=247 Identities=21% Similarity=0.356 Sum_probs=195.0
Q ss_pred CCCceeeccCceEEEEEEeC-CCcEEEEEEeccc----chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC--eeEEEE
Q 016347 47 SPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE----SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN--HRILVY 119 (391)
Q Consensus 47 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~ 119 (391)
++...||+|+|-+||+|.+. +|-.||--.+... .....+.|..|+.+|+.|+||||+++++++.+.. ...+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 45567999999999999986 4777773322211 3455688999999999999999999999998654 588999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC-CcEEEEecccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD-LTPKISDFGLAKL 198 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~-~~~kl~Dfg~~~~ 198 (391)
|.+..|+|..++.+.+ .++.+.+..|+.||+.||.|||++ .|.|+|||||.+||||+.+ |.|||+|+||+..
T Consensus 123 EL~TSGtLr~Y~kk~~------~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR------RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL 195 (632)
T ss_pred ecccCCcHHHHHHHhc------cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHH
Confidence 9999999999998665 488999999999999999999997 7789999999999999887 9999999999998
Q ss_pred cCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
..... ...+.|||.|||||+.. ..|++.+||||||+.++||+|+..|+..=... .+ .+.....+.-
T Consensus 196 ~r~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-----AQ-IYKKV~SGiK---- 261 (632)
T KOG0584|consen 196 LRKSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-----AQ-IYKKVTSGIK---- 261 (632)
T ss_pred hhccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-----HH-HHHHHHcCCC----
Confidence 65432 22378999999999774 89999999999999999999999998522111 11 1111111100
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
...+..-....+.+||.+||.. .++|||+.|+|+.-
T Consensus 262 ----P~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~ 297 (632)
T KOG0584|consen 262 ----PAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDP 297 (632)
T ss_pred ----HHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhCh
Confidence 0111112234788899999998 99999999999764
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=297.22 Aligned_cols=266 Identities=22% Similarity=0.323 Sum_probs=199.0
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeC--Cee
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEG--NHR 115 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~ 115 (391)
..++|++.+.||.|+||.||+|.+. +|+.+|+|.+... .......+..|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578999999999999999999976 5889999987543 223345677899999999 999999999988643 468
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||||++ ++|.+++..+ .+++..+..++.||+.||.|||+. |++|+||||+||+++.++.++|+|||+
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~ 153 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGL 153 (337)
T ss_pred EEEecccc-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 99999997 4898888542 578889999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCc----eeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH---
Q 016347 196 AKLIPANMT----HVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWD--- 267 (391)
Q Consensus 196 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~--- 267 (391)
+........ .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||....+............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 986643321 12233568899999998755 4578999999999999999999999975543322111100000
Q ss_pred -----HhhhcccceeeeccCC------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 268 -----LYERRELILLVDTSLN------GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 268 -----~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
.........+++.... .......+..+.+++.+||+.||++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000000000 00011135578899999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=300.08 Aligned_cols=308 Identities=22% Similarity=0.291 Sum_probs=242.8
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeCCCc-EEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLKDGK-IAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
+.-.+++.+..||-|+||.|-++..++.. .+|+|++++. +.........|-.+|..++.|.||++|-.|.+++..|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 33467888899999999999999987533 3788887655 3344566778999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
|+||-|-||.|+..+.+.+. ++..++..++.++++|++|||++ ||++|||||+|.+++.+|.+||.|||++
T Consensus 497 mLmEaClGGElWTiLrdRg~------Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFA 567 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGS------FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFA 567 (732)
T ss_pred hhHHhhcCchhhhhhhhcCC------cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhH
Confidence 99999999999999987664 89999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccce
Q 016347 197 KLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL 276 (391)
Q Consensus 197 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (391)
+.+..+ ...-+++|||.|.|||++..+..+.++|.|+||+++|||++|.+||.+.++.....++-...+.+
T Consensus 568 Kki~~g--~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i------- 638 (732)
T KOG0614|consen 568 KKIGSG--RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI------- 638 (732)
T ss_pred HHhccC--CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh-------
Confidence 987643 34567999999999999999999999999999999999999999999888876655544433222
Q ss_pred eeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCCCCCCCCCCccccccccccCCCCCCCCCCC
Q 016347 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKDIDDDKITKPGLISDFMDLKVRGPPKPKLETTT 356 (391)
Q Consensus 277 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 356 (391)
.++........+++++....+|.+|.... -.++..|..+.|-..-.|..+......+|-.|++.+.+
T Consensus 639 --------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~-----~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~pt 705 (732)
T KOG0614|consen 639 --------EFPRRITKTATDLIKKLCRDNPTERLGYQ-----KGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPT 705 (732)
T ss_pred --------hcccccchhHHHHHHHHHhcCcHhhhccc-----cCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcc
Confidence 22233344566777788888999997621 12333344455655666666666677778888888887
Q ss_pred CCCCCCCCCCCCCCCCCcccccc
Q 016347 357 SSTYNSSDNPDNSNLSSAATSAA 379 (391)
Q Consensus 357 ~~~~~~~~~~~~~~~ss~~~~~~ 379 (391)
..++.-+-..++.-.+..--|.+
T Consensus 706 D~s~Fd~~p~dnd~pppde~SGW 728 (732)
T KOG0614|consen 706 DVSNFDNFPPDNDEPPPDELSGW 728 (732)
T ss_pred cchhccCCCcccCCCCchhcccC
Confidence 77776554444444333333333
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=289.32 Aligned_cols=250 Identities=26% Similarity=0.364 Sum_probs=204.3
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCC-CCceeEEEEEEEeCCeeEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIE-HENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 118 (391)
++|++.+.||.|++|.||+|... +++.||+|++... .......+..|+++++++. ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999976 6999999998753 2233466888999999998 99999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
||++++++|.+++...+ .+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~ 151 (280)
T cd05581 81 LEYAPNGELLQYIRKYG------SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKV 151 (280)
T ss_pred EcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccc
Confidence 99999999999996543 599999999999999999999999 999999999999999999999999999886
Q ss_pred cCCCCc-------------------eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchh
Q 016347 199 IPANMT-------------------HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQ 259 (391)
Q Consensus 199 ~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~ 259 (391)
...... .......++..|+|||.+....++.++||||||+++++|++|..||.......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-- 229 (280)
T cd05581 152 LDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL-- 229 (280)
T ss_pred cCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH--
Confidence 543221 12223457889999999988889999999999999999999999997543211
Q ss_pred hHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH----HHHHHHh
Q 016347 260 YLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSM----STVVQML 319 (391)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~----~evl~~l 319 (391)
...... . .....+...+..+.+++.+||+.+|++||++ ++++++.
T Consensus 230 -~~~~~~---~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~ 278 (280)
T cd05581 230 -TFQKIL---K-----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP 278 (280)
T ss_pred -HHHHHH---h-----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCC
Confidence 011100 0 0112222335678899999999999999999 8887653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=293.55 Aligned_cols=273 Identities=22% Similarity=0.257 Sum_probs=202.4
Q ss_pred echHHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEE
Q 016347 34 YSYKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCV 110 (391)
Q Consensus 34 ~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 110 (391)
+..+++....++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.++++++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 355666677899999999999999999999865 68999999987542 223456778999999999999999999886
Q ss_pred eC------CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC
Q 016347 111 EG------NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK 184 (391)
Q Consensus 111 ~~------~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~ 184 (391)
.. ...+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||||+||+++.
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~ 155 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 155 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcC
Confidence 43 3467788876 7799888743 2489999999999999999999999 9999999999999999
Q ss_pred CCcEEEEecccccccCCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHH
Q 016347 185 DLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLE 263 (391)
Q Consensus 185 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~ 263 (391)
++.++|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.............
T Consensus 156 ~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (345)
T cd07877 156 DCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 231 (345)
T ss_pred CCCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999998764322 223467889999998866 568899999999999999999999996543322111000
Q ss_pred HHHH--------Hhhhc---ccceeeeccCC---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 264 RTWD--------LYERR---ELILLVDTSLN---GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 264 ~~~~--------~~~~~---~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.... ..... ........... ..........+.+++.+||+.||.+||++.+++++-+-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f 303 (345)
T cd07877 232 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303 (345)
T ss_pred HHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhh
Confidence 0000 00000 00000000000 00000124467899999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=281.70 Aligned_cols=244 Identities=25% Similarity=0.297 Sum_probs=189.2
Q ss_pred eeeccCceEEEEEEeC-CCcEEEEEEecccch---hcHHHHHHHH---HHHhcCCCCceeEEEEEEEeCCeeEEEEeccc
Q 016347 51 KIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR---QGVKEFLTEI---QVISEIEHENLVKLYGCCVEGNHRILVYNYLE 123 (391)
Q Consensus 51 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 123 (391)
.||+|+||.||+|... +++.||+|.+..... .....+..|. ..++...||+|+.+++++......++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999876 588999999865421 1112233343 34445689999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCC
Q 016347 124 NNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANM 203 (391)
Q Consensus 124 ~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~ 203 (391)
|++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 g~~L~~~l~~~------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~ 151 (278)
T cd05606 81 GGDLHYHLSQH------GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (278)
T ss_pred CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence 99999988643 2589999999999999999999999 99999999999999999999999999987653322
Q ss_pred ceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccC
Q 016347 204 THVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSL 282 (391)
Q Consensus 204 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (391)
.....|+..|+|||.+.++ .++.++|||||||++|+|++|..||............... . ...
T Consensus 152 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~----~------~~~--- 215 (278)
T cd05606 152 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT----L------TMA--- 215 (278)
T ss_pred ---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh----h------ccC---
Confidence 1234689999999998754 6899999999999999999999999765332221111000 0 000
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHhc
Q 016347 283 NGDFDAEEACRFLKVGLLCTQDTPKLRP-----SMSTVVQMLM 320 (391)
Q Consensus 283 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~ 320 (391)
...+...+..+.+++.+||..+|.+|| ++.+++++-+
T Consensus 216 -~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~ 257 (278)
T cd05606 216 -VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPF 257 (278)
T ss_pred -CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcc
Confidence 111222356788899999999999999 9999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=290.55 Aligned_cols=262 Identities=23% Similarity=0.317 Sum_probs=194.8
Q ss_pred ceeecc--CceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccC
Q 016347 50 NKIGEG--GFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLEN 124 (391)
Q Consensus 50 ~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 124 (391)
..||+| +||+||+|.+. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..+...++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456766 88999999976 69999999987542 33456788899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc
Q 016347 125 NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204 (391)
Q Consensus 125 ~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~ 204 (391)
++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+..........
T Consensus 84 ~~l~~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 84 GSANSLLKTYF----PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred CCHHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence 99999986532 23588999999999999999999999 999999999999999999999999986543321111
Q ss_pred ee------eeeecccccccChhhhhcC--CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH---------
Q 016347 205 HV------STRVAGTIGYLAPEYAIRG--QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWD--------- 267 (391)
Q Consensus 205 ~~------~~~~~gt~~y~aPE~~~~~--~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~--------- 267 (391)
.. .....++..|+|||++.+. .++.++|||||||++|+|++|..||......... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~ 234 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDIT 234 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCcccc
Confidence 00 0112345679999998764 4789999999999999999999999754322110 000000
Q ss_pred -------H-------hhh----cc-----cceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 268 -------L-------YER----RE-----LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 268 -------~-------~~~----~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
. ... .. ........+...........+.+|+.+||+.||++|||+.|++++-+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 0 000 00 00001111112223345678899999999999999999999997653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=294.62 Aligned_cols=260 Identities=23% Similarity=0.324 Sum_probs=193.3
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC------C
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG------N 113 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~ 113 (391)
.++|.+.+.||+|+||.||+|.+. +|+.||+|.+... .......+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999976 5899999998653 222345678899999999999999999998654 3
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
..++|+||+.+ +|...+. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+||
T Consensus 94 ~~~lv~e~~~~-~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~df 161 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG--------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDF 161 (342)
T ss_pred eEEEEeccccc-CHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeC
Confidence 46899999964 6766552 1488999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHH-------
Q 016347 194 GLAKLIPANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERT------- 265 (391)
Q Consensus 194 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~------- 265 (391)
|++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...............
T Consensus 162 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07879 162 GLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE 237 (342)
T ss_pred CCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 998764322 123456888999999866 46899999999999999999999999765322111000000
Q ss_pred -HHHhhh---cccceeeeccCCCCC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 266 -WDLYER---RELILLVDTSLNGDF---DAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 266 -~~~~~~---~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
...... ............... .......+.+++.+||+.||++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 000000000000000 01234567899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=289.10 Aligned_cols=263 Identities=19% Similarity=0.231 Sum_probs=192.9
Q ss_pred CCceeeccCceEEEEEEeCCCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCC
Q 016347 48 PINKIGEGGFGSVYKGRLKDGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENN 125 (391)
Q Consensus 48 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 125 (391)
+.+.+|.|+++.|+++.. +++.||+|++... .......+.+|+++++.++|+||+++++++.+....+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 333444444444444444 5899999998754 3445677999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc-
Q 016347 126 SLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT- 204 (391)
Q Consensus 126 sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~- 204 (391)
+|.+++.... ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||.+........
T Consensus 85 ~l~~~l~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 85 SCEDLLKTHF----PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred CHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence 9999996431 23588999999999999999999999 999999999999999999999999998875532211
Q ss_pred -----eeeeeecccccccChhhhhc--CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh----h---
Q 016347 205 -----HVSTRVAGTIGYLAPEYAIR--GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLY----E--- 270 (391)
Q Consensus 205 -----~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~----~--- 270 (391)
.......++..|+|||++.+ ..++.++|||||||++|+|++|..||........ ......... .
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~ 235 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKST 235 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCc
Confidence 11122456778999999866 3588999999999999999999999975432211 111110000 0
Q ss_pred ----hcccc--------eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 271 ----RRELI--------LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 271 ----~~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
..... ..................+.+++.+||+.||++|||+.+++++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 00000 000000111122344567889999999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=283.16 Aligned_cols=244 Identities=27% Similarity=0.388 Sum_probs=194.7
Q ss_pred eeccCceEEEEEEeCC-CcEEEEEEecccch---hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCCCH
Q 016347 52 IGEGGFGSVYKGRLKD-GKIAAIKVLSAESR---QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSL 127 (391)
Q Consensus 52 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 127 (391)
||.|+||.||++.+.. |+.+++|.+..... .....+.+|++++++++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999874 99999999875532 4556788899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc---
Q 016347 128 AQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT--- 204 (391)
Q Consensus 128 ~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~--- 204 (391)
.+++...+ .+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~------~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 81 ASLLENVG------SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred HHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 99996532 589999999999999999999999 999999999999999999999999999876432211
Q ss_pred ----eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeec
Q 016347 205 ----HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT 280 (391)
Q Consensus 205 ----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (391)
.......++..|+|||.+....++.++||||||+++|+|++|..||........ ... ......
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~~----~~~~~~------ 218 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI---FQN----ILNGKI------ 218 (265)
T ss_pred ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHH----HhcCCc------
Confidence 012234578899999999888899999999999999999999999975542211 000 000000
Q ss_pred cCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 281 SLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 281 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
........+..+.+++.+||+.+|.+||++.++.+.|
T Consensus 219 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 219 --EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred --CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 0000011256788999999999999999995544444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=281.66 Aligned_cols=260 Identities=27% Similarity=0.371 Sum_probs=195.6
Q ss_pred CCCCceeeccCceEEEEEEeCC-CcEEEEEEecccch--hcHHHHHHHHHHHhcC---CCCceeEEEEEEEeCCe-----
Q 016347 46 FSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESR--QGVKEFLTEIQVISEI---EHENLVKLYGCCVEGNH----- 114 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~----- 114 (391)
|++.+.||.|+||.||+|.+.. ++.||+|.+..... .....+.+|+.+++++ .|||++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6788999999999999999874 89999999874422 2234466677777666 59999999999987766
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.+++|||+.+ +|.+++.... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg 152 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP----KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFG 152 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccC
Confidence 8999999975 7888886432 12589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc--
Q 016347 195 LAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR-- 272 (391)
Q Consensus 195 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 272 (391)
++........ .....++..|+|||++.+..++.++|||||||++|+|++|..||......... ..........
T Consensus 153 ~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 227 (287)
T cd07838 153 LARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL---DKIFDVIGLPSE 227 (287)
T ss_pred cceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH---HHHHHHcCCCCh
Confidence 9877643321 12235788999999999989999999999999999999999998765432211 1111100000
Q ss_pred -c---c----ceeeeccCC---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 273 -E---L----ILLVDTSLN---GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 273 -~---~----~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
. . ......... ..........+.+++.+||+.||.+||++.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0 0 000000000 01112334677899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=297.06 Aligned_cols=268 Identities=23% Similarity=0.322 Sum_probs=197.8
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC---------
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG--------- 112 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------- 112 (391)
..+|++.+.||.|+||.||+|... +|+.||+|.+........+.+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 478999999999999999999976 5899999998766555567788999999999999999999776543
Q ss_pred -----CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-CC
Q 016347 113 -----NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK-DL 186 (391)
Q Consensus 113 -----~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~-~~ 186 (391)
...++||||++ ++|.+++.. ..+++..++.++.||+.||.|||+. |++|+||||+||+++. ++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~ 152 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-------GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL 152 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence 35789999997 588888743 2488999999999999999999999 9999999999999974 56
Q ss_pred cEEEEecccccccCCCCce--eeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHH
Q 016347 187 TPKISDFGLAKLIPANMTH--VSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLE 263 (391)
Q Consensus 187 ~~kl~Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~ 263 (391)
.++|+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....+........
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 7899999998765322111 1122357889999998754 568899999999999999999999997654322211110
Q ss_pred HHHHHhh---hcc----cceeee-ccCCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 264 RTWDLYE---RRE----LILLVD-TSLNGDFD-----AEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 264 ~~~~~~~---~~~----~~~~~~-~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
....... ... ...... .......+ ......+.+++.+||+.||.+||++.+++++-+-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~ 303 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcc
Confidence 0000000 000 000000 00000001 1233568889999999999999999999976433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=285.70 Aligned_cols=252 Identities=26% Similarity=0.406 Sum_probs=199.0
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
.+.|+..+.||+|++|.||+|++. +++.+|+|.+... .......+.+|+++++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 355888899999999999999976 5888999988643 223345678899999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|||+. ++|.+.+... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 94 ~e~~~-~~l~~~~~~~-----~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 164 (308)
T cd06634 94 MEYCL-GSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (308)
T ss_pred EEccC-CCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCccccee
Confidence 99996 5787777432 23588999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCceeeeeecccccccChhhhh---cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAI---RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
.... ....++..|+|||.+. ...++.++|||||||++|+|++|..||.......... . ......
T Consensus 165 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~-~~~~~~- 231 (308)
T cd06634 165 MAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------H-IAQNES- 231 (308)
T ss_pred ecCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH------H-HhhcCC-
Confidence 5322 2345788999999975 3568899999999999999999999986432211110 0 000000
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
...........+.+++.+||+.+|.+||++.+++++.+...
T Consensus 232 -------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 232 -------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred -------CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 00111234456888999999999999999999998865543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=300.12 Aligned_cols=205 Identities=30% Similarity=0.453 Sum_probs=177.0
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEe------CCee
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVE------GNHR 115 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~ 115 (391)
.-|...+.||+|+||.||+|+++ +|+.||||.++.. .....+....|+++|++++|+|||+++++-.+ ....
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 44677788999999999999966 6999999999875 34566778899999999999999999987543 3467
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC--CCC--cEEEE
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLD--KDL--TPKIS 191 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~--~~~--~~kl~ 191 (391)
.+|||||.||||...+..-. +...|++...+.++.++..||.|||++ ||+||||||.||++- .+| ..||+
T Consensus 93 vlvmEyC~gGsL~~~L~~PE---N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPE---NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred eEEEeecCCCcHHHHhcCcc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeee
Confidence 89999999999999997533 556799999999999999999999998 999999999999983 333 46999
Q ss_pred ecccccccCCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCc
Q 016347 192 DFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPT 256 (391)
Q Consensus 192 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~ 256 (391)
|||.++....+. ....+.||..|++||++.. +.|+..+|.|||||++|+++||..||......
T Consensus 167 DfG~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 167 DFGAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cccccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 999999886654 5667899999999999984 88999999999999999999999999765444
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=291.41 Aligned_cols=270 Identities=22% Similarity=0.247 Sum_probs=199.0
Q ss_pred hCCCCC-CceeeccCceEEEEEEeC-CCcEEEEEEecccchhc--------------HHHHHHHHHHHhcCCCCceeEEE
Q 016347 43 TDDFSP-INKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQG--------------VKEFLTEIQVISEIEHENLVKLY 106 (391)
Q Consensus 43 ~~~y~~-~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~iv~~~ 106 (391)
.++|.. .+.||.|+||.||+|.+. +++.||+|.+....... ...+.+|+++++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 467765 467999999999999976 58999999886542211 12467899999999999999999
Q ss_pred EEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC
Q 016347 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL 186 (391)
Q Consensus 107 ~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~ 186 (391)
+++......++||||+. ++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~------~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~ 156 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRK------IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKG 156 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCC
Confidence 99999999999999997 5898888543 2489999999999999999999999 999999999999999999
Q ss_pred cEEEEecccccccCCCC-------------ceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCC
Q 016347 187 TPKISDFGLAKLIPANM-------------THVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNM 252 (391)
Q Consensus 187 ~~kl~Dfg~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~ 252 (391)
.++|+|||++....... ........++..|+|||.+.+. .++.++|||||||++|+|++|..||..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999987654111 1111123467889999998764 468999999999999999999999976
Q ss_pred CCCcchhhHHHHHHHHhhhcccce--------eeeccCCC---CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 253 RLPTEEQYLLERTWDLYERRELIL--------LVDTSLNG---DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
..+..................... ........ .........+.+++.+||+.+|++||++.|++.+.+.
T Consensus 237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred CCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 554321111100000000000000 00000000 0011234568899999999999999999999987654
Q ss_pred C
Q 016347 322 E 322 (391)
Q Consensus 322 ~ 322 (391)
.
T Consensus 317 ~ 317 (335)
T PTZ00024 317 K 317 (335)
T ss_pred C
Confidence 3
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=273.40 Aligned_cols=254 Identities=21% Similarity=0.238 Sum_probs=199.8
Q ss_pred hhCCCCCCc-eeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcC-CCCceeEEEEEEEe----CCe
Q 016347 42 ATDDFSPIN-KIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENLVKLYGCCVE----GNH 114 (391)
Q Consensus 42 ~~~~y~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~ 114 (391)
.+++|++.. +||-|-.|.|-....+ +|+.+|+|++... ...++|+++.-+. .|||||.++++|.+ .+.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 367777654 7999999999988876 6999999998754 3356678776555 69999999999864 457
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC---CCcEEEE
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK---DLTPKIS 191 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~---~~~~kl~ 191 (391)
+.+|||+++||.|...|.+.+ ...+++.++..|+.||..|+.|||+. +|.||||||+|+|.+. |..+||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g----~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG----DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred eEeeeecccchHHHHHHHHcc----cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEec
Confidence 889999999999999998764 35699999999999999999999999 9999999999999965 4579999
Q ss_pred ecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhh
Q 016347 192 DFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYER 271 (391)
Q Consensus 192 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 271 (391)
|||+++.-.. .....+.+-||.|.|||++...+|+..+|+||+||++|-|++|..||...-..... ..+..
T Consensus 207 DfGFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais-------pgMk~ 277 (400)
T KOG0604|consen 207 DFGFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------PGMKR 277 (400)
T ss_pred ccccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC-------hhHHh
Confidence 9999987432 22344567899999999999999999999999999999999999999754321110 00000
Q ss_pred cccceeeeccCCCCCC----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 272 RELILLVDTSLNGDFD----AEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 272 ~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
+ +....+ .++ ...+....++|+.+|..+|.+|.|+.+++++-+..
T Consensus 278 -r---I~~gqy--~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~ 326 (400)
T KOG0604|consen 278 -R---IRTGQY--EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWIN 326 (400)
T ss_pred -H---hhccCc--cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhc
Confidence 0 000000 122 24456788899999999999999999999875443
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=316.03 Aligned_cols=252 Identities=29% Similarity=0.425 Sum_probs=189.9
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEe---------
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVE--------- 111 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------- 111 (391)
..+|+.++.||+||||.||+++.+ +|+.||||.+... +......+.+|+.+|.+|+|||||+++..+.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 356788888999999999999988 8999999998765 44556678899999999999999998742100
Q ss_pred ---------------------------------------------------------------------C----------
Q 016347 112 ---------------------------------------------------------------------G---------- 112 (391)
Q Consensus 112 ---------------------------------------------------------------------~---------- 112 (391)
.
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred -------------------------------CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHH
Q 016347 113 -------------------------------NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161 (391)
Q Consensus 113 -------------------------------~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~ 161 (391)
..+||-||||+..+|.+++..+.. .-.....++++++|++||.|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~-----~~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF-----NSQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc-----chhhHHHHHHHHHHHHHHHH
Confidence 124677999998777777754321 11477889999999999999
Q ss_pred hhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC-----------------CCCceeeeeecccccccChhhhhc
Q 016347 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP-----------------ANMTHVSTRVAGTIGYLAPEYAIR 224 (391)
Q Consensus 162 lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~ 224 (391)
+|++ |++||||||.||+++.++.|||+|||++.... .......+..+||.-|+|||++.+
T Consensus 713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 9999 99999999999999999999999999998621 001112344689999999999876
Q ss_pred C---CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhc
Q 016347 225 G---QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLC 301 (391)
Q Consensus 225 ~---~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 301 (391)
. .|+.|+|+||||+||+||+. ||...+.. ...........+... .++..+....-.++|.+|
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER------a~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~L 854 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER------ASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWL 854 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchHHH------HHHHHhcccCCCCCC------cccccccchHHHHHHHHH
Confidence 5 49999999999999999994 55433221 111111111111110 223344555667889999
Q ss_pred cCCCCCCCCCHHHHHH
Q 016347 302 TQDTPKLRPSMSTVVQ 317 (391)
Q Consensus 302 l~~dP~~Rps~~evl~ 317 (391)
++.||.+|||+.|+|.
T Consensus 855 l~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 855 LSHDPSKRPTATELLN 870 (1351)
T ss_pred hcCCCccCCCHHHHhh
Confidence 9999999999999986
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=282.91 Aligned_cols=246 Identities=26% Similarity=0.409 Sum_probs=195.2
Q ss_pred CCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 46 FSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
|...++||+|+||.||+|++. +|+.|++|.+.... ......+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 777888999999999999976 58899999986542 23345678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+. ++|.+++... ..++++..+..++.||+.||.|||+. |++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~~-----~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~ 173 (313)
T cd06633 103 CL-GSASDLLEVH-----KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP 173 (313)
T ss_pred CC-CCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC
Confidence 96 4777777542 23589999999999999999999999 999999999999999999999999998864321
Q ss_pred CCceeeeeecccccccChhhhh---cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAI---RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
.....|+..|+|||++. ...++.++|||||||++|+|++|..||.......... .... .....
T Consensus 174 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~------~~~~-~~~~~-- 239 (313)
T cd06633 174 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQ-NDSPT-- 239 (313)
T ss_pred -----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHHh-cCCCC--
Confidence 12346888999999974 4568899999999999999999999986543322111 0000 00000
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.........+.+++.+||+.+|.+||++.+++++-+
T Consensus 240 ------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~ 275 (313)
T cd06633 240 ------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDF 275 (313)
T ss_pred ------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 011122346788999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=289.46 Aligned_cols=268 Identities=25% Similarity=0.346 Sum_probs=195.7
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch--hcHHHHHHHHHHHhcCCCCceeEEEEEEEeC-------
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR--QGVKEFLTEIQVISEIEHENLVKLYGCCVEG------- 112 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------- 112 (391)
.++|++.++||.|++|.||+|.+. +++.+|+|.+..... .....+.+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 489999999999999999999976 588999998865422 2234567899999999999999999987543
Q ss_pred -CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEE
Q 016347 113 -NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKIS 191 (391)
Q Consensus 113 -~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~ 191 (391)
...++|+||+.+ +|...+... ...+++..+..++.||+.||.|||++ |++|+||||+||+++.++.++|+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~-----~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~ 157 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP-----SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIA 157 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEC
Confidence 346999999965 677766542 23589999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCce----------eeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhh
Q 016347 192 DFGLAKLIPANMTH----------VSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQY 260 (391)
Q Consensus 192 Dfg~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~ 260 (391)
|||++......... ......+++.|+|||.+.+. .++.++|||||||++|+|++|..||..........
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~ 237 (311)
T cd07866 158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH 237 (311)
T ss_pred cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999765332111 11224568889999987654 58999999999999999999999997654432211
Q ss_pred HHHHHHHHhhh------cccceeeeccCCCCCC-------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 261 LLERTWDLYER------RELILLVDTSLNGDFD-------AEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 261 ~~~~~~~~~~~------~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
........... .......+.......+ ......+.+++.+||+.||.+|||+.|++.+-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~ 309 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHP 309 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCC
Confidence 11110000000 0000000000000000 11225688999999999999999999998753
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=286.49 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=196.9
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeCC-CcEEEEEEecccc-hhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeE
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAES-RQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 116 (391)
.+..++|++.+.||.|++|.||+|.+.. ++.||||.+.... ......+..|+.++... .||||+++++++.+....+
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence 3445889999999999999999999875 8999999987542 23345566777767666 5999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHE-EVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++|||+. ++|.+++... ...+++..+..++.|++.||+|||+ . +++|+||+|+||+++.++.++|+|||+
T Consensus 91 ~v~e~~~-~~l~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~ 161 (296)
T cd06618 91 ICMELMS-TCLDKLLKRI-----QGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGI 161 (296)
T ss_pred EEeeccC-cCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECcccc
Confidence 9999985 4677776542 2268999999999999999999997 5 899999999999999999999999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhcCC----CCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhh
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIRGQ----VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYER 271 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 271 (391)
+..+..... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||....... .. ... ....
T Consensus 162 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~-~~~---~~~~ 234 (296)
T cd06618 162 SGRLVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EV-LTK---ILQE 234 (296)
T ss_pred chhccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HH-HHH---HhcC
Confidence 876543221 12235778999999987553 7899999999999999999999986422111 00 010 0110
Q ss_pred cccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 272 RELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.. ... .........+.+++.+||+.||++||++.+++++.+
T Consensus 235 -~~-----~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 235 -EP-----PSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred -CC-----CCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 00 000 001123457889999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=291.84 Aligned_cols=263 Identities=21% Similarity=0.275 Sum_probs=197.2
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC-----
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN----- 113 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 113 (391)
..++|++++.||+|+||.||+|.+. +++.||+|.+... .......+.+|+++++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4688999999999999999999866 5899999998643 2233456788999999999999999999987543
Q ss_pred -eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEe
Q 016347 114 -HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISD 192 (391)
Q Consensus 114 -~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~D 192 (391)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+. |++|+||||+||+++.++.++|+|
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-------~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-------EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence 458999998 7789888843 2589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHH------
Q 016347 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERT------ 265 (391)
Q Consensus 193 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~------ 265 (391)
||++...... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...............
T Consensus 162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 162 FGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred cccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 9998765332 123457889999999876 45889999999999999999999999754332111000000
Q ss_pred --HHHhhhccccee---eeccCCC---CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 266 --WDLYERRELILL---VDTSLNG---DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 266 --~~~~~~~~~~~~---~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
............ +...... .........+.+++.+||+.||++|||+.+++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~ 299 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHP 299 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 000000000000 0000000 00112344688999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=291.12 Aligned_cols=267 Identities=21% Similarity=0.282 Sum_probs=200.4
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEe-CCee
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVE-GNHR 115 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 115 (391)
..++++|++.+.||.|+||.||+|.+. +++.||+|.+... .......+.+|+++++.++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346789999999999999999999876 6899999987543 22334667889999999999999999999875 5678
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++++||+ +++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|.||+++.++.++|+|||+
T Consensus 86 ~lv~e~~-~~~L~~~~~~-------~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~ 154 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS-------RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGL 154 (328)
T ss_pred EEEeehh-ccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccc
Confidence 9999998 5689888843 2478888899999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH-------
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWD------- 267 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~------- 267 (391)
+...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.................
T Consensus 155 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd07856 155 ARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230 (328)
T ss_pred ccccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 8754322 123456888999998765 5689999999999999999999999975543221111111000
Q ss_pred -Hhhhcccceeeec-cCCCCCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 268 -LYERRELILLVDT-SLNGDFDA-----EEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 268 -~~~~~~~~~~~~~-~~~~~~~~-----~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
..........+.. ......+. .....+.+++.+||+.+|++||++.+++.+-+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~ 291 (328)
T cd07856 231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291 (328)
T ss_pred HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcc
Confidence 0000000000000 00011111 124578899999999999999999999887533
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=283.99 Aligned_cols=275 Identities=25% Similarity=0.373 Sum_probs=212.6
Q ss_pred cccCCCcceeechHHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch-------hcHHHHHHHHHHHh
Q 016347 24 EFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR-------QGVKEFLTEIQVIS 95 (391)
Q Consensus 24 ~~~~~~~~~~~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~ 95 (391)
++++++|-....+++-...+++|-++..||+|||+.||+|.+- .+++||+|+-..+.. ...+...+|..+.+
T Consensus 443 ELKRi~NEdnSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHK 522 (775)
T KOG1151|consen 443 ELKRIHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHK 522 (775)
T ss_pred HHHhhcccchhhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhh
Confidence 3555555555566666777899999999999999999999865 588999998654321 12334668999999
Q ss_pred cCCCCceeEEEEEEE-eCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecC
Q 016347 96 EIEHENLVKLYGCCV-EGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRD 174 (391)
Q Consensus 96 ~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~d 174 (391)
.|.||.||++++++. +...+|-|.|||+|.+|.-++..+. .++++.++.|+.||+.||.||... .+.|+|-|
T Consensus 523 eLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhk------lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYD 595 (775)
T KOG1151|consen 523 ELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK------LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYD 595 (775)
T ss_pred ccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhh------hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeec
Confidence 999999999999986 6678899999999999999997554 489999999999999999999986 56899999
Q ss_pred CCCCcEEECC---CCcEEEEecccccccCCCCc------eeeeeecccccccChhhhhcC----CCCCCCcEeehhHHHH
Q 016347 175 IKASNILLDK---DLTPKISDFGLAKLIPANMT------HVSTRVAGTIGYLAPEYAIRG----QVTRKADIYSFGVLLV 241 (391)
Q Consensus 175 ikp~NIlv~~---~~~~kl~Dfg~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~----~~~~k~DvwSlG~vl~ 241 (391)
|||.|||+-. .|.+||+|||+++++.+... .......||..|++||.+.-+ +++.|+||||.|||+|
T Consensus 596 LKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFy 675 (775)
T KOG1151|consen 596 LKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFY 675 (775)
T ss_pred cCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhh
Confidence 9999999843 38899999999999864322 233456799999999988644 4789999999999999
Q ss_pred HHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 016347 242 EIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVV 316 (391)
Q Consensus 242 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 316 (391)
+++.|+.||......+.. +....+.....-.+ +..+....+...+|++||+.--++|....++.
T Consensus 676 QClYGrKPFGhnqsQQdI---------LqeNTIlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 676 QCLYGRKPFGHNQSQQDI---------LQENTILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hhhccCCCCCCchhHHHH---------HhhhchhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 999999999876543321 12222222211111 22233455677888999999999998766653
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=322.28 Aligned_cols=254 Identities=28% Similarity=0.348 Sum_probs=205.7
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
+-++....+||.|.||.||.|... +|+..|+|-+... .......+.+|+.+|..+.|||+|+++|+-...+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 466788889999999999999866 5999999987654 2344566888999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
|||++|+|.+++..++. .++.....+..|++.|++|||+. |||||||||.||+++.+|.+|++|||.+..+
T Consensus 1314 EyC~~GsLa~ll~~gri------~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRI------EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHhccCcHHHHHHhcch------hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEe
Confidence 99999999999987653 67777888899999999999999 9999999999999999999999999999988
Q ss_pred CCCCcee---eeeecccccccChhhhhcC---CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcc
Q 016347 200 PANMTHV---STRVAGTIGYLAPEYAIRG---QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRE 273 (391)
Q Consensus 200 ~~~~~~~---~~~~~gt~~y~aPE~~~~~---~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (391)
.++.... .+...||+.|||||++.+- .-.-++||||||||+.||+||+.||...+.....+...
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V---------- 1454 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV---------- 1454 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH----------
Confidence 6553222 2235799999999999753 45679999999999999999999997544322211100
Q ss_pred cceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
..+-...++......=.+++..||+.||++|-++.|++++=.
T Consensus 1455 -----~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f 1496 (1509)
T KOG4645|consen 1455 -----AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAF 1496 (1509)
T ss_pred -----hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhc
Confidence 001111233345556667888999999999999999988753
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=284.20 Aligned_cols=251 Identities=27% Similarity=0.378 Sum_probs=202.9
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
+..+.|+.-+.||+|+||.|+-.+.. +|+.||.|.+.+. ........++|-++|..++.+.||.+--.|+..+.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 34466899999999999999999876 5999999887544 2233456788999999999999999988899999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+|+..|+||+|.-.|...+ +..+++..+..++.+|+.||++||+. +||+||+||+|||+|+.|++.|+|+|++
T Consensus 262 lVLtlMNGGDLkfHiyn~g----~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLA 334 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHG----NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLA 334 (591)
T ss_pred EEEEeecCCceeEEeeccC----CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceE
Confidence 9999999999998886653 25699999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccce
Q 016347 197 KLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL 276 (391)
Q Consensus 197 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (391)
..+...... ...+||.+|||||++.++.|+...|.|||||+||+|+.|+.||...-..... ...+++..
T Consensus 335 vei~~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~-------eEvdrr~~-- 403 (591)
T KOG0986|consen 335 VEIPEGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR-------EEVDRRTL-- 403 (591)
T ss_pred EecCCCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH-------HHHHHHHh--
Confidence 988655432 2348999999999999999999999999999999999999999654322211 01111000
Q ss_pred eeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 016347 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMS 313 (391)
Q Consensus 277 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 313 (391)
.....++...+.+...+....|++||.+|..-+
T Consensus 404 ----~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 404 ----EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred ----cchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 011234445556667777789999999998543
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=280.85 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=196.0
Q ss_pred CCCCCceeeccCceEEEEEEeCC-CcEEEEEEeccc-----chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 45 DFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE-----SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
+|.+.++||+|+||.||++.+.. +..+++|++... .......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58899999999999999998764 444555554321 122334566789999999999999999999988899999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
+||+++++|.+++..... ....+++..++.++.|++.||.|||+. |++|+||+|+||+++. +.++|+|||++..
T Consensus 81 ~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 81 TEYCEGRDLDCKLEELKH--TGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred EEeCCCCCHHHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceee
Confidence 999999999998864221 234689999999999999999999999 9999999999999975 5799999999876
Q ss_pred cCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
..... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||....... ....... .
T Consensus 155 ~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~~~-~------ 220 (260)
T cd08222 155 LMGSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VVLRIVE-G------ 220 (260)
T ss_pred cCCCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHHc-C------
Confidence 54332 22233567889999999988889999999999999999999999986432111 0000000 0
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
.....+...+..+.+++.+||+.+|++||++.+++++
T Consensus 221 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 221 ---PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ---CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 0112233455688899999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=281.95 Aligned_cols=263 Identities=27% Similarity=0.366 Sum_probs=196.6
Q ss_pred CCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch-hcHHHHHHHHHHHhcCC-CCceeEEEEEEEeCCeeEEEEecc
Q 016347 46 FSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR-QGVKEFLTEIQVISEIE-HENLVKLYGCCVEGNHRILVYNYL 122 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 122 (391)
|++.+.||.|++|+||+|... +++.|++|.+..... .......+|+..+++++ ||||+++++++..+...++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 678899999999999999986 488899998865422 22234556899999998 999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCC
Q 016347 123 ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN 202 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~ 202 (391)
+++|.+.+.... ...+++..+..++.|++.+|.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 -~~~l~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 81 -EGNLYQLMKDRK----GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred -CCCHHHHHHhcc----cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 779998886532 23589999999999999999999999 9999999999999999999999999998765432
Q ss_pred CceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HHH-h-hh
Q 016347 203 MTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERT--------WDL-Y-ER 271 (391)
Q Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~-~-~~ 271 (391)
.. .....++..|+|||++.+ ..++.++|+||||+++++|++|+.||............... +.. . ..
T Consensus 153 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 153 PP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred CC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence 21 223457889999998754 45799999999999999999999998655432211100000 000 0 00
Q ss_pred cccceeeeccCCC---CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 272 RELILLVDTSLNG---DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 272 ~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
......+...... .........+.+++.+||+.+|++||++.|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000000 0001124678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=281.20 Aligned_cols=264 Identities=25% Similarity=0.352 Sum_probs=200.9
Q ss_pred CCCCceeeccCceEEEEEEeCC-CcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecc
Q 016347 46 FSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYL 122 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 122 (391)
|+..+.||+|++|.||+|.... ++.+|+|.+.... ......+..|+.+++.++|+|++++++++.+....++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 6778899999999999999874 9999999987653 333456788999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCC
Q 016347 123 ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN 202 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~ 202 (391)
+ ++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~-~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~ 151 (282)
T cd07829 81 D-MDLKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIP 151 (282)
T ss_pred C-cCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence 7 58999996532 3589999999999999999999999 9999999999999999999999999998865432
Q ss_pred CceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHH--------HHHHhhhcc
Q 016347 203 MTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLER--------TWDLYERRE 273 (391)
Q Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~ 273 (391)
.. ......++..|+|||.+.+. .++.++|||||||++|+|++|..||.............. .|.......
T Consensus 152 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 152 LR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred cc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 21 12223457789999998776 789999999999999999999999976543221110000 000000000
Q ss_pred -cceeeeccCCC---CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 274 -LILLVDTSLNG---DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 274 -~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
....+...... .........+.+++.+||+.||++||++.+++.+-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p 280 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHP 280 (282)
T ss_pred cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCc
Confidence 00000000000 00112255789999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=292.77 Aligned_cols=264 Identities=23% Similarity=0.296 Sum_probs=199.1
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCe----
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNH---- 114 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---- 114 (391)
..++|++.+.||.|++|.||+|++. +++.||+|++... .......+.+|+.+++.+.||||+++.+++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999986 5889999998653 22334567789999999999999999988765544
Q ss_pred --eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEe
Q 016347 115 --RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISD 192 (391)
Q Consensus 115 --~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~D 192 (391)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-------QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcc
Confidence 89999998 6699998853 3589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHH-----
Q 016347 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTW----- 266 (391)
Q Consensus 193 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~----- 266 (391)
||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||................
T Consensus 162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 162 FGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237 (343)
T ss_pred cccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence 9999865332 223457889999998865 367899999999999999999999997554322111000000
Q ss_pred ---HHhhhcccceeee---ccCCCCC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 267 ---DLYERRELILLVD---TSLNGDF---DAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 267 ---~~~~~~~~~~~~~---~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
...........+. ......+ .......+.+++.+||+.+|++|||+.+|+++-+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~ 300 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCC
Confidence 0000000000000 0000000 0112567889999999999999999999988643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=266.83 Aligned_cols=253 Identities=25% Similarity=0.409 Sum_probs=198.1
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEEEEe
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
++.+.+..||.|..|.||+++.. +|..+|||.+... +....+++++.++++... .+|+||+.+|+|..+....+.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 45567788999999999999977 4899999999866 455667788888877666 48999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
.|. ..+..++.. ...++++..+-++...++.||.||..+. +|+|||+||+|||+|..|.+||+|||++-.+-
T Consensus 172 lMs-~C~ekLlkr-----ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 172 LMS-TCAEKLLKR-----IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred HHH-HHHHHHHHH-----hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceee
Confidence 884 345555543 2236899999999999999999999874 89999999999999999999999999997764
Q ss_pred CCCceeeeeecccccccChhhhhc---CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccccee
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIR---GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILL 277 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (391)
++.. .....|-+.|||||.+.- ..|+..+||||||++|+||.||..|+..-....+- .... .. .+.
T Consensus 244 dSkA--htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~--ltkv---ln-~eP--- 312 (391)
T KOG0983|consen 244 DSKA--HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV--LTKV---LN-EEP--- 312 (391)
T ss_pred cccc--cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH--HHHH---Hh-cCC---
Confidence 4332 344568889999998853 46899999999999999999999999764332211 0111 11 111
Q ss_pred eeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 278 VDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 278 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
+.+... ...+..+.+++..||++|+.+||...+++++-
T Consensus 313 --P~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 313 --PLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred --CCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 112111 12567899999999999999999999999875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=281.96 Aligned_cols=267 Identities=29% Similarity=0.457 Sum_probs=199.4
Q ss_pred CCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhc--CCCCceeEEEEEEEeC----CeeEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISE--IEHENLVKLYGCCVEG----NHRIL 117 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~----~~~~l 117 (391)
...++.+.||+|.||.||+|.+. ++.||||++..... +.|.+|-++.+. ++|+||+++++.-... ..+.|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~k---qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQEK---QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCHHHH---HHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 55677788999999999999997 68999999976543 567778777766 4899999999876543 37899
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcC------CCCeeecCCCCCcEEECCCCcEEEE
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV------RPHIIHRDIKASNILLDKDLTPKIS 191 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~------~~~i~H~dikp~NIlv~~~~~~kl~ 191 (391)
|++|.+.|+|.+++..+ .++|....+|+.-+++||+|||... .+.|+|||||.+||||..|++..|+
T Consensus 286 Vt~fh~kGsL~dyL~~n-------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKAN-------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred EeeeccCCcHHHHHHhc-------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 99999999999999654 5899999999999999999999752 5679999999999999999999999
Q ss_pred ecccccccCCCC-ceeeeeecccccccChhhhhcCC-CC-----CCCcEeehhHHHHHHHhCCCCCCC------CCCcch
Q 016347 192 DFGLAKLIPANM-THVSTRVAGTIGYLAPEYAIRGQ-VT-----RKADIYSFGVLLVEIVSGRCNTNM------RLPTEE 258 (391)
Q Consensus 192 Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~-----~k~DvwSlG~vl~elltg~~p~~~------~~~~~~ 258 (391)
|||++..+.... .......+||.+|||||++.+.- +. .+.||||+|.|||||+++..-+.. ..|.+.
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 999998875332 22223368999999999987642 22 478999999999999987644321 111110
Q ss_pred ----hhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 016347 259 ----QYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKD 324 (391)
Q Consensus 259 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~ 324 (391)
.......+......+....+....... .....+.+.+..||..||+.|.|+.=+-+.+.....
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKH---AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 011122222222222222222222222 334567788889999999999999888887765543
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=285.54 Aligned_cols=265 Identities=22% Similarity=0.284 Sum_probs=193.1
Q ss_pred CCCCCceeeccCceEEEEEEeC-C--CcEEEEEEeccc--chhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeC----Ce
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-D--GKIAAIKVLSAE--SRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEG----NH 114 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~----~~ 114 (391)
+|++.+.||+|+||.||+|+.. . +..||+|.+... .......+.+|+++++++ .||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 5888999999999999999976 3 778999988643 222345678899999999 599999999875432 45
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.+++++|+. ++|.+.+... ..+++..+..++.||+.||.|||+. |++|+||||+||+++.++.++|+|||
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg 150 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG------QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFG 150 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCC
Confidence 788889885 5898888543 3589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCce---eeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHH------
Q 016347 195 LAKLIPANMTH---VSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLER------ 264 (391)
Q Consensus 195 ~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~------ 264 (391)
++......... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||..............
T Consensus 151 ~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (332)
T cd07857 151 LARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPD 230 (332)
T ss_pred CceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCC
Confidence 99865432211 1123468899999998765 4689999999999999999999999875442111000000
Q ss_pred --HHHHhhhccc---ceeeeccCCC---CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 265 --TWDLYERREL---ILLVDTSLNG---DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 265 --~~~~~~~~~~---~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.+........ .......... .........+.+++.+||+.||++||++.+++++-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~ 293 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP 293 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000000000 0000000000 00011245788999999999999999999998653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=270.24 Aligned_cols=206 Identities=28% Similarity=0.393 Sum_probs=172.8
Q ss_pred hhCCCCCCceeeccCceEEEEEEeCC-----CcEEEEEEecccch--hcHHHHHHHHHHHhcCCCCceeEEEEEEEe-CC
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLKD-----GKIAAIKVLSAESR--QGVKEFLTEIQVISEIEHENLVKLYGCCVE-GN 113 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~ 113 (391)
--..|+.+++||+|.||.||+|.-.+ .+.+|+|.+..+.. ..-....+|+.+++.++|||++.+..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 34779999999999999999996432 33689998876521 223457789999999999999999998877 88
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC----CcEE
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD----LTPK 189 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~----~~~k 189 (391)
..+|++||.+. +|+.+|.-...... +.++...+..|+.||+.|+.|||+. =++||||||.||||..+ |+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeE
Confidence 99999999976 89999976544333 6899999999999999999999998 79999999999999887 9999
Q ss_pred EEecccccccCCCCce--eeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCC
Q 016347 190 ISDFGLAKLIPANMTH--VSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNM 252 (391)
Q Consensus 190 l~Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~ 252 (391)
|+|||+++++.+.... ....++-|..|+|||.+.+. .|+.+.|||+.|||+.||+|-.+.|.+
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999999998654332 22346779999999999875 699999999999999999998877754
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=270.83 Aligned_cols=276 Identities=21% Similarity=0.305 Sum_probs=206.1
Q ss_pred ceeeccCceEEEEEE-eCCCcEEEEEEecccchhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEEEEecccCCCH
Q 016347 50 NKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILVYNYLENNSL 127 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 127 (391)
+.||+|+++.|--.. ..+|..||||++.+...-.+....+|++++.++ .|+||++++++|+++...|||||.+.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 469999999998887 457999999999887666677889999999999 599999999999999999999999999999
Q ss_pred HHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC---cEEEEecccccccCCCC-
Q 016347 128 AQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL---TPKISDFGLAKLIPANM- 203 (391)
Q Consensus 128 ~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~---~~kl~Dfg~~~~~~~~~- 203 (391)
...|.+.. .+++..+..+..+|+.||.+||.+ ||.|||+||+|||..... -|||+||.+..-+..+.
T Consensus 164 LshI~~~~------~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 164 LSHIQKRK------HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred HHHHHHhh------hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 99997554 599999999999999999999999 999999999999996554 47999998876542111
Q ss_pred -c----eeeeeecccccccChhhhh---c--CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcc
Q 016347 204 -T----HVSTRVAGTIGYLAPEYAI---R--GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRE 273 (391)
Q Consensus 204 -~----~~~~~~~gt~~y~aPE~~~---~--~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (391)
. ..-.+.+|+..|||||+.. + -.|+.++|.||||||||-|++|..||.+.-..+.-+-........+ +.
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ-~~ 313 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ-NK 313 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH-HH
Confidence 1 1122357889999999863 2 3589999999999999999999999976544221100000000000 01
Q ss_pred cceeeeccCCCCCCHHH----HHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCCCCCCCCCCc
Q 016347 274 LILLVDTSLNGDFDAEE----ACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKDIDDDKITKPGLI 336 (391)
Q Consensus 274 ~~~~~~~~~~~~~~~~~----~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~~~~~~~~~~~~ 336 (391)
+..-+..+. -+++..+ +....+++...|-.|+.+|.++.+++.+.+...-.....++.|..+
T Consensus 314 LFesIQEGk-YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalptp~v~ 379 (463)
T KOG0607|consen 314 LFESIQEGK-YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPTPQVL 379 (463)
T ss_pred HHHHHhccC-CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCCCccc
Confidence 111111111 1333333 3356678888899999999999999987665544444555555443
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=306.52 Aligned_cols=146 Identities=31% Similarity=0.481 Sum_probs=131.6
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
.++|+++++||+|+||.||+|.+. +++.||||++.... ......+..|+.+++.++||||+++++++......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 378999999999999999999987 58999999987542 33346788899999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
|||+.+++|.+++...+ .+++..++.|+.||+.||.|||.. +|+||||||+||||+.++.++|+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~------~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG------YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999996433 478899999999999999999999 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=270.41 Aligned_cols=240 Identities=31% Similarity=0.373 Sum_probs=195.0
Q ss_pred eeccCceEEEEEEeC-CCcEEEEEEecccch---hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCCCH
Q 016347 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAESR---QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSL 127 (391)
Q Consensus 52 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 127 (391)
||.|++|.||++... +++.+|+|++..... .....+..|+++++.++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999987 489999999876532 2455788899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCceee
Q 016347 128 AQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVS 207 (391)
Q Consensus 128 ~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~~ 207 (391)
.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~ 150 (250)
T cd05123 81 FSHLSKEG------RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRT 150 (250)
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-Ccc
Confidence 99996543 489999999999999999999998 99999999999999999999999999988754321 122
Q ss_pred eeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCC
Q 016347 208 TRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFD 287 (391)
Q Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (391)
....++..|++||.+.+...+.++|+||||+++|+|++|..||....... ..... ... ....+
T Consensus 151 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~~----~~~----------~~~~~ 213 (250)
T cd05123 151 NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYEKI----LKD----------PLRFP 213 (250)
T ss_pred cCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH----hcC----------CCCCC
Confidence 33567889999999988889999999999999999999999996543211 11110 000 01122
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCH---HHHHHH
Q 016347 288 AEEACRFLKVGLLCTQDTPKLRPSM---STVVQM 318 (391)
Q Consensus 288 ~~~~~~l~~li~~cl~~dP~~Rps~---~evl~~ 318 (391)
...+..+.+++.+||..||++||++ .+++++
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 2235678889999999999999999 566554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=245.71 Aligned_cols=266 Identities=21% Similarity=0.303 Sum_probs=198.2
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
..|...++||+|.||+||+|+.. +++.||+|.++.+. +..-....+|+-+|+.++|.|||++++....++.+-+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 45777899999999999999976 58999999988663 3344568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
||.. .|..+... .+..++...+..++.|+++||.++|++ ++.|||+||+|++|+.||.+||+|||+++.++
T Consensus 82 ~cdq-dlkkyfds-----lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafg 152 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDS-----LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFG 152 (292)
T ss_pred HhhH-HHHHHHHh-----cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcC
Confidence 9954 78777743 233589999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCceeeeeecccccccChhhhhcCC-CCCCCcEeehhHHHHHHHhCCCC-CCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQ-VTRKADIYSFGVLLVEIVSGRCN-TNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlG~vl~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
-.-.. ....+-|..|.+|.++.+.+ |+...|+||.|||+.|+.....| |.+.+-.+....+-+.........+..+.
T Consensus 153 ipvrc-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t 231 (292)
T KOG0662|consen 153 IPVRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMT 231 (292)
T ss_pred CceEe-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccc
Confidence 54332 23335688999999988754 89999999999999999876655 54443333222222222222222221111
Q ss_pred ---eccCCCCCCH---------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 279 ---DTSLNGDFDA---------EEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 279 ---~~~~~~~~~~---------~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
+-.....++. .....=.+++.+.|.-+|.+|.++++.+++-
T Consensus 232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhp 284 (292)
T KOG0662|consen 232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHP 284 (292)
T ss_pred cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCc
Confidence 1111111111 1111223555567777999999999988764
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=274.67 Aligned_cols=272 Identities=22% Similarity=0.284 Sum_probs=206.4
Q ss_pred hHHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCC--CC----ceeEEEEE
Q 016347 36 YKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIE--HE----NLVKLYGC 108 (391)
Q Consensus 36 ~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~----~iv~~~~~ 108 (391)
++.....+.+|+++..+|+|.||.|-...+. .+..||||+++.- ....+..+-|+++|.++. .| -+|++.++
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 3444455899999999999999999999866 4789999998754 333455667999999982 23 37888889
Q ss_pred EEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC-----
Q 016347 109 CVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLD----- 183 (391)
Q Consensus 109 ~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~----- 183 (391)
|.-.++.++|+|.+ |.|+.+++..+ +..+++...+..++.|+++++++||+. +++|.||||+|||+.
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N----~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKEN----NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccC----CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceE
Confidence 99999999999988 67999999654 556899999999999999999999999 999999999999982
Q ss_pred ---------------CCCcEEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCC
Q 016347 184 ---------------KDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRC 248 (391)
Q Consensus 184 ---------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~ 248 (391)
.+..++|+|||.+..... ....++.|..|.|||++.+-+++..+||||+||||.||.+|..
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~ 307 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET 307 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceecc----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence 134589999999876322 1255778999999999999999999999999999999999998
Q ss_pred CCCCCCCcchhhHHHHHHHHhhhc----c-cceeeec--------c--------CC--------CCCCHHHHHHHHHHHh
Q 016347 249 NTNMRLPTEEQYLLERTWDLYERR----E-LILLVDT--------S--------LN--------GDFDAEEACRFLKVGL 299 (391)
Q Consensus 249 p~~~~~~~~~~~~~~~~~~~~~~~----~-~~~~~~~--------~--------~~--------~~~~~~~~~~l~~li~ 299 (391)
.|......+...+.+......+.. . ..+.+.. . .. ......+...|.+|+.
T Consensus 308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 887665433221222221111100 0 0000000 0 00 0112345668999999
Q ss_pred hccCCCCCCCCCHHHHHHHhc
Q 016347 300 LCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 300 ~cl~~dP~~Rps~~evl~~l~ 320 (391)
.||..||.+|+|+.|++.+-.
T Consensus 388 ~mL~fDP~~RiTl~EAL~HpF 408 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALSHPF 408 (415)
T ss_pred HHHccCccccccHHHHhcCHH
Confidence 999999999999999998753
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=271.73 Aligned_cols=266 Identities=26% Similarity=0.367 Sum_probs=201.5
Q ss_pred hhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcC--CCCceeEEEEEEEeC----Cee
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEI--EHENLVKLYGCCVEG----NHR 115 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~----~~~ 115 (391)
..++.++.+.||+|.||+||+|++. |+.||||++...++ ..+.+|.++.+.. +|+||+.+++.-..+ ..+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 4677899999999999999999998 89999999976544 4567788888664 999999999876533 268
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhc-----CCCCeeecCCCCCcEEECCCCcEEE
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEE-----VRPHIIHRDIKASNILLDKDLTPKI 190 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~-----~~~~i~H~dikp~NIlv~~~~~~kl 190 (391)
+||++|-+.|||.|++.. ..++....++++..+|.||++||.. ..|.|.|||||..||||..+|...|
T Consensus 285 wLvTdYHe~GSL~DyL~r-------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR-------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEeeecccCCcHHHHHhh-------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 999999999999999954 3589999999999999999999964 3678999999999999999999999
Q ss_pred EecccccccCCCCce---eeeeecccccccChhhhhcC----CC--CCCCcEeehhHHHHHHHhCC----------CCCC
Q 016347 191 SDFGLAKLIPANMTH---VSTRVAGTIGYLAPEYAIRG----QV--TRKADIYSFGVLLVEIVSGR----------CNTN 251 (391)
Q Consensus 191 ~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~----~~--~~k~DvwSlG~vl~elltg~----------~p~~ 251 (391)
+|+||+......... .....+||.+|||||++... .+ -..+||||||.|+||++.+. .||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 999999776443221 23456899999999998542 12 24689999999999997532 5666
Q ss_pred CCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 252 MRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
...+.+..+- ...+..-.++....+.... ...+....+.++++.||..||.-|.|+--+-+.|....
T Consensus 438 d~Vp~DPs~e--eMrkVVCv~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 438 DVVPSDPSFE--EMRKVVCVQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred cCCCCCCCHH--HHhcceeecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 5444433221 1111111111111111111 12467788999999999999999999988887776554
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=266.59 Aligned_cols=219 Identities=21% Similarity=0.133 Sum_probs=175.4
Q ss_pred cCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCCCHHHHHhc
Q 016347 55 GGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIG 133 (391)
Q Consensus 55 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~ 133 (391)
|.+|.||++.+. +++.||+|.+..... +..|...+....||||+++++++......++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999986 589999999876532 23344555556799999999999999999999999999999999865
Q ss_pred CCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCceeeeeeccc
Q 016347 134 GGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213 (391)
Q Consensus 134 ~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt 213 (391)
.. .+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||.+...... .....++
T Consensus 79 ~~------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~ 145 (237)
T cd05576 79 FL------NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVE 145 (237)
T ss_pred hc------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcC
Confidence 32 489999999999999999999999 9999999999999999999999999987655332 1223456
Q ss_pred ccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHH
Q 016347 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACR 293 (391)
Q Consensus 214 ~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (391)
..|+|||.+.+..++.++|||||||++|+|++|..|+....... . .......+......
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~---------~~~~~~~~~~~~~~ 204 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------N---------THTTLNIPEWVSEE 204 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------c---------cccccCCcccCCHH
Confidence 78999999988889999999999999999999997764321100 0 00000122233457
Q ss_pred HHHHHhhccCCCCCCCCCH
Q 016347 294 FLKVGLLCTQDTPKLRPSM 312 (391)
Q Consensus 294 l~~li~~cl~~dP~~Rps~ 312 (391)
+.+++.+||+.||++||++
T Consensus 205 ~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHHccCCHHHhcCC
Confidence 8889999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=286.29 Aligned_cols=243 Identities=23% Similarity=0.286 Sum_probs=197.9
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEEEEe
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
++.|++...+|.|+|+.|-.+.+. +++..++|++..... +-.+|+.++... +||||+++.+.+.++.+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 567999999999999999999866 588899999876622 233467666665 79999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE-CCCCcEEEEeccccccc
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL-DKDLTPKISDFGLAKLI 199 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv-~~~~~~kl~Dfg~~~~~ 199 (391)
.+.|+-|.+.+.... .....+..|+.+|+.|+.|||++ |++||||||+|||+ +..|+++|+|||.++..
T Consensus 397 ~l~g~ell~ri~~~~-------~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP-------EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred hccccHHHHHHHhcc-------hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 999998888885432 33377788999999999999999 99999999999999 58899999999999876
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
... ..+.+-|..|.|||++....|++++|+||||++||+|++|+.||....... .+...
T Consensus 467 ~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~--ei~~~--------------- 525 (612)
T KOG0603|consen 467 ERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI--EIHTR--------------- 525 (612)
T ss_pred chh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH--HHHHh---------------
Confidence 544 223456889999999999999999999999999999999999997554331 11111
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
...+.+....+....+|+.+||+.||.+||++.++..+-+.
T Consensus 526 -i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 526 -IQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -hcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 11122234556678889999999999999999999887655
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=271.99 Aligned_cols=245 Identities=27% Similarity=0.346 Sum_probs=199.6
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeCC-CcEEEEEEecccc---hhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCe
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAES---RQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNH 114 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 114 (391)
.+-.-+|.++..||+|+||+|.+|.-++ .+.+|||+++++. .+..+--..|-.+|... +-|.+++++.+|..-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 5556789999999999999999998774 7889999998762 23333344577777776 56788999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
+++||||+.||+|.-.|++-+. +-+..+..++..|+-||-+||++ ||++||||-+|||++.+|++||+|||
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~Gk------FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFG 495 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGK------FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG 495 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcc------cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecc
Confidence 9999999999999999987653 78888999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 195 LAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 195 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
+++.--- ......+++|||.|+|||++..++|+..+|.||+||+||||+.|+.||++.+..+.- +.. .+ .
T Consensus 496 mcKEni~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF---~aI---~e-h-- 565 (683)
T KOG0696|consen 496 MCKENIF-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF---QAI---ME-H-- 565 (683)
T ss_pred ccccccc-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHH---HH-c--
Confidence 9975211 123456789999999999999999999999999999999999999999987653321 111 11 0
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCC
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPS 311 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 311 (391)
...++...+.+...+....|.+.|.+|..
T Consensus 566 --------nvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 566 --------NVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred --------cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 11344455566677777889999999964
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=294.76 Aligned_cols=266 Identities=26% Similarity=0.392 Sum_probs=212.1
Q ss_pred HHHHhhCCCCCCceeeccCceEEEEEEeC----C----CcEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCceeEEEE
Q 016347 38 ELSIATDDFSPINKIGEGGFGSVYKGRLK----D----GKIAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHENLVKLYG 107 (391)
Q Consensus 38 e~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~ 107 (391)
.+++..++..+.+.||.|.||.|++|... . ...||||.+... .....+.+..|+++|+.+ .|+||+.+.|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 57777777888889999999999999743 1 456899998765 335667899999999999 7999999999
Q ss_pred EEEeCCeeEEEEecccCCCHHHHHhcCC---------CCCCc-cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 016347 108 CCVEGNHRILVYNYLENNSLAQTLIGGG---------HHYSN-IQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKA 177 (391)
Q Consensus 108 ~~~~~~~~~lv~e~~~~~sL~~~i~~~~---------~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp 177 (391)
++...+..++|+||+..|+|.++++..+ ..... ..+.....+.++.||+.|++||++. +++||||-.
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999998765 11011 2389999999999999999999999 999999999
Q ss_pred CcEEECCCCcEEEEecccccccCCCCceeeeeecc--cccccChhhhhcCCCCCCCcEeehhHHHHHHHhCC-CCCCCCC
Q 016347 178 SNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAG--TIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR-CNTNMRL 254 (391)
Q Consensus 178 ~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~-~p~~~~~ 254 (391)
+|||++.+..+|++|||+++..............| ...|||||.+....|+.|+||||||++||||++.. .|+.. .
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~-~ 525 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG-I 525 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC-C
Confidence 99999999999999999999654433322222222 34699999999999999999999999999999854 45543 2
Q ss_pred CcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 255 PTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
+..... ...+.++.+...+..+..++.++++.||+.+|++||++.++.+.+..
T Consensus 526 ~~~~~l--------------~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 526 PPTEEL--------------LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred CcHHHH--------------HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 211111 11223333335555667889999999999999999999999998866
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=276.77 Aligned_cols=209 Identities=30% Similarity=0.441 Sum_probs=180.1
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
..-|..++.||-|+||+|.++... +...||+|.+++.+ .........|-++|.....+-||++|-.|.+.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 445888999999999999999754 47789999988653 23344567799999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|+|++||++..+|...+. +.+..++.++..+..|++++|.. |++||||||+|||||.+|++||+||||+.-
T Consensus 708 MdYIPGGDmMSLLIrmgI------FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGI------FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTG 778 (1034)
T ss_pred EeccCCccHHHHHHHhcc------CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccccc
Confidence 999999999999987664 89999999999999999999999 999999999999999999999999999854
Q ss_pred cC---------CCCce--------------------------------eeeeecccccccChhhhhcCCCCCCCcEeehh
Q 016347 199 IP---------ANMTH--------------------------------VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFG 237 (391)
Q Consensus 199 ~~---------~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG 237 (391)
+. ++... .....+||+.|+|||++....|+.-+|.||.|
T Consensus 779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~g 858 (1034)
T KOG0608|consen 779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVG 858 (1034)
T ss_pred ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhh
Confidence 31 00000 00015799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCcchhh
Q 016347 238 VLLVEIVSGRCNTNMRLPTEEQY 260 (391)
Q Consensus 238 ~vl~elltg~~p~~~~~~~~~~~ 260 (391)
||||||+.|+.||..+.+.+.++
T Consensus 859 vil~em~~g~~pf~~~tp~~tq~ 881 (1034)
T KOG0608|consen 859 VILYEMLVGQPPFLADTPGETQY 881 (1034)
T ss_pred HHHHHHhhCCCCccCCCCCccee
Confidence 99999999999999888877653
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=286.51 Aligned_cols=258 Identities=26% Similarity=0.412 Sum_probs=212.2
Q ss_pred HHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcC-CCCceeEEEEEEEe-----
Q 016347 39 LSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENLVKLYGCCVE----- 111 (391)
Q Consensus 39 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----- 111 (391)
....++-|++++.||.|.+|.||+++.. +++.+|+|+...... .-+++..|.++|+.+ .|||++.+++++..
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 3445688999999999999999999966 588999999876533 336677789999888 79999999999873
Q ss_pred CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEE
Q 016347 112 GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKIS 191 (391)
Q Consensus 112 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~ 191 (391)
++.++||||||.|||..+++... ....+.|..+..|+..++.|+.+||.. .++|||||-.|||++.+|.|||+
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~----~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNT----KGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhh----cccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence 56899999999999999999653 255799999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCceeeeeecccccccChhhhhcC-----CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 016347 192 DFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRG-----QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTW 266 (391)
Q Consensus 192 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 266 (391)
|||++..+... .....+..||+.|||||++... .|+..+|+||||++..||.-|.+|+....|....+.+.
T Consensus 166 DFGvSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip--- 241 (953)
T KOG0587|consen 166 DFGVSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP--- 241 (953)
T ss_pred eeeeeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC---
Confidence 99999887543 3444567899999999998653 47889999999999999999999997765543221111
Q ss_pred HHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 267 DLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
+ ++...-..+......|.++|..||.+|..+||++.+++++-
T Consensus 242 ----R-------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hp 283 (953)
T KOG0587|consen 242 ----R-------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHP 283 (953)
T ss_pred ----C-------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCC
Confidence 0 01111123456778999999999999999999999999764
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=275.93 Aligned_cols=247 Identities=23% Similarity=0.328 Sum_probs=199.2
Q ss_pred CceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCC
Q 016347 49 INKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENN 125 (391)
Q Consensus 49 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 125 (391)
.+.||.|-||+||-|+++ +|+.||||++.+. ......++++|+.+|+.+.||.||.+--.|+..+..++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 468999999999999976 6999999998755 233447789999999999999999999999999999999999955
Q ss_pred CHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC---CcEEEEecccccccCCC
Q 016347 126 SLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD---LTPKISDFGLAKLIPAN 202 (391)
Q Consensus 126 sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~---~~~kl~Dfg~~~~~~~~ 202 (391)
+..+.|... ...++++.....++.||+.||.|||.+ +|+|+||||+|||+... -.+||+|||++++++..
T Consensus 648 DMLEMILSs----EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 648 DMLEMILSS----EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred hHHHHHHHh----hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 666666432 334699999999999999999999999 99999999999999644 58999999999998754
Q ss_pred CceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccC
Q 016347 203 MTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSL 282 (391)
Q Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (391)
.- ...++|||.|+|||++..+.|...-|+||.|||+|.-+.|..||..+.....+. +.+ .-+.
T Consensus 721 sF--RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQI--QNA---------aFMy---- 783 (888)
T KOG4236|consen 721 SF--RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQI--QNA---------AFMY---- 783 (888)
T ss_pred hh--hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHh--hcc---------cccc----
Confidence 33 345789999999999999999999999999999999999999997654322210 100 0011
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 283 NGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 283 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
....=.+......+||...|+..-.+|-+..+.+.+.|
T Consensus 784 Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 784 PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 11111244556778888999999999999888775543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=267.89 Aligned_cols=274 Identities=22% Similarity=0.297 Sum_probs=204.3
Q ss_pred chHHHHHhh-CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCC--------CCceeE
Q 016347 35 SYKELSIAT-DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIE--------HENLVK 104 (391)
Q Consensus 35 ~~~e~~~~~-~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~ 104 (391)
+++-+.+.. .+|.+.++||.|.|++||++.+. +.+.||+|+.+... -..+....|+++|++++ ..+||+
T Consensus 68 pV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~ 146 (590)
T KOG1290|consen 68 PVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQ 146 (590)
T ss_pred eeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence 555555556 89999999999999999999876 57889999987543 23355778999999983 247999
Q ss_pred EEEEEE----eCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 016347 105 LYGCCV----EGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNI 180 (391)
Q Consensus 105 ~~~~~~----~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NI 180 (391)
+++.|. ++.+.+||+|++ |.+|..+|... ..+.++...+.+|+.||+.||.|||.+| ||+|.||||+||
T Consensus 147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s----~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENv 219 (590)
T KOG1290|consen 147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS----NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENV 219 (590)
T ss_pred eeccceecCCCCcEEEEEehhh-hhHHHHHHHHh----CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCccee
Confidence 999986 467999999999 66888888653 4567999999999999999999999999 999999999999
Q ss_pred EEC-----------------------------------------------------------------------------
Q 016347 181 LLD----------------------------------------------------------------------------- 183 (391)
Q Consensus 181 lv~----------------------------------------------------------------------------- 183 (391)
|+.
T Consensus 220 Ll~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~ 299 (590)
T KOG1290|consen 220 LLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPN 299 (590)
T ss_pred eeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccc
Confidence 992
Q ss_pred -------------------------------------C------------------------------------------
Q 016347 184 -------------------------------------K------------------------------------------ 184 (391)
Q Consensus 184 -------------------------------------~------------------------------------------ 184 (391)
.
T Consensus 300 ~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~ 379 (590)
T KOG1290|consen 300 QESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPL 379 (590)
T ss_pred ccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccc
Confidence 0
Q ss_pred ----------CCcEEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCC
Q 016347 185 ----------DLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRL 254 (391)
Q Consensus 185 ----------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~ 254 (391)
+-++||+|||.++-..... +.-..|..|+|||++.+..|+..+||||++|+++||+||...|+...
T Consensus 380 v~p~~~~~~~di~vKIaDlGNACW~~khF----T~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhs 455 (590)
T KOG1290|consen 380 VNPDIPLPECDIRVKIADLGNACWVHKHF----TEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHS 455 (590)
T ss_pred cCCCCCCCccceeEEEeeccchhhhhhhh----chhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCC
Confidence 0125666666665432221 22346788999999999999999999999999999999999887654
Q ss_pred Ccc----hhhHHHHHH--HHhh------hcccceeeecc----------C---------CCCCCHHHHHHHHHHHhhccC
Q 016347 255 PTE----EQYLLERTW--DLYE------RRELILLVDTS----------L---------NGDFDAEEACRFLKVGLLCTQ 303 (391)
Q Consensus 255 ~~~----~~~~~~~~~--~~~~------~~~~~~~~~~~----------~---------~~~~~~~~~~~l~~li~~cl~ 303 (391)
... ++++..-.. ..++ .+....+++.. . .-+++.++..+|.+++.-||+
T Consensus 456 G~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLe 535 (590)
T KOG1290|consen 456 GENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLE 535 (590)
T ss_pred CCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHh
Confidence 322 222221110 0000 00000111100 0 013456778899999999999
Q ss_pred CCCCCCCCHHHHHHHhc
Q 016347 304 DTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 304 ~dP~~Rps~~evl~~l~ 320 (391)
.+|++|||+.+.+++.+
T Consensus 536 f~PeKR~tA~~cl~hPw 552 (590)
T KOG1290|consen 536 FDPEKRPTAAQCLKHPW 552 (590)
T ss_pred cCccccccHHHHhcCcc
Confidence 99999999999998764
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=261.33 Aligned_cols=273 Identities=25% Similarity=0.368 Sum_probs=205.1
Q ss_pred hhCCCCCCceeeccCceEEEEEEeCC-CcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEe-------
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVE------- 111 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------- 111 (391)
....|+-..+||+|.||.||+|+.++ |+.||+|.+-.+ .+..-....+|+.+|..++|+|++.++++|..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 34678888999999999999999774 888898876554 33334567889999999999999999887742
Q ss_pred -CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEE
Q 016347 112 -GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKI 190 (391)
Q Consensus 112 -~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl 190 (391)
...+++||++|+. +|.-++.. ....++...+.+++.+++.||.|+|.. .|+|||+||.|+||+.+|.+||
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn-----~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilkl 165 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSN-----RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKL 165 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcC-----ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEe
Confidence 3458999999975 67777743 234689999999999999999999999 9999999999999999999999
Q ss_pred EecccccccCCCCc---eeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 016347 191 SDFGLAKLIPANMT---HVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTW 266 (391)
Q Consensus 191 ~Dfg~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 266 (391)
+|||+++.+..... ...+..+-|..|++||.+.+ ..|+++.|||+.|||+.||+||.+-+.+....+...++....
T Consensus 166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~Lc 245 (376)
T KOG0669|consen 166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLC 245 (376)
T ss_pred eccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHh
Confidence 99999987643221 12334456899999999877 469999999999999999999998888776666554444332
Q ss_pred HHh--------hhcccceeeecc-C-CCCCC--HH------HHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 267 DLY--------ERRELILLVDTS-L-NGDFD--AE------EACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 267 ~~~--------~~~~~~~~~~~~-~-~~~~~--~~------~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
... ++-.+.+.+... + .+.+. .+ .....++|+..+|..||.+|+.+++++.+-...+
T Consensus 246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 222 111111111100 0 00000 01 1225667888999999999999999998865543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=284.65 Aligned_cols=251 Identities=26% Similarity=0.364 Sum_probs=204.5
Q ss_pred CCCceeeccCceEEEEEEeC-CC----cEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 47 SPINKIGEGGFGSVYKGRLK-DG----KIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 47 ~~~~~lg~G~~g~V~~~~~~-~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
...++||.|+||+||+|.+- .| -+||+|++... ......++++|+-+|.+++|||++++++++.... +.||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 45678999999999999863 33 46899988765 3455678999999999999999999999998765 889999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|++.|+|.++++.+ +..+..+..+.|..||++||.|||.+ .++||||-.+||||..-..+|+.|||+++...
T Consensus 778 ~mP~G~LlDyvr~h-----r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREH-----RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred hcccchHHHHHHHh-----hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 99999999999764 34688999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCceeeee-ecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 201 ANMTHVSTR-VAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 201 ~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
......... ..-.+.|||-|.+....|+.++|||||||++|||+| |..|..+....+.. .++
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~----------------dll 913 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP----------------DLL 913 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh----------------HHH
Confidence 544332222 123467999999999999999999999999999987 66666554332222 122
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
....+-..++.+..++..++.+||..|++.||+++++.+.+...
T Consensus 914 e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 914 EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 22222355667888999999999999999999999998766443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=287.48 Aligned_cols=270 Identities=21% Similarity=0.228 Sum_probs=173.5
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-C----CcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEE------EE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-D----GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGC------CV 110 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~------~~ 110 (391)
..++|++.++||+|+||.||+|.+. + +..||+|.+...... ..+..+ .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5689999999999999999999976 4 688999987643221 111111 1122222222221111 23
Q ss_pred eCCeeEEEEecccCCCHHHHHhcCCCCCC--------------ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 016347 111 EGNHRILVYNYLENNSLAQTLIGGGHHYS--------------NIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIK 176 (391)
Q Consensus 111 ~~~~~~lv~e~~~~~sL~~~i~~~~~~~~--------------~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dik 176 (391)
.....++|+||+.+++|.+++........ ........+..++.||+.||.|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 45678999999999999999865421100 01122345678999999999999999 99999999
Q ss_pred CCcEEECC-CCcEEEEecccccccCCCCceeeeeecccccccChhhhhcC----------------------CCCCCCcE
Q 016347 177 ASNILLDK-DLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRG----------------------QVTRKADI 233 (391)
Q Consensus 177 p~NIlv~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~k~Dv 233 (391)
|+|||++. ++.+||+|||++..+............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 58999999999986644433444557789999999976432 24456799
Q ss_pred eehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCC------CCHHHHHHHHHHHhhccCCCCC
Q 016347 234 YSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGD------FDAEEACRFLKVGLLCTQDTPK 307 (391)
Q Consensus 234 wSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~ 307 (391)
|||||+||||+++..++..........+... ......+..........+ ..........+|+.+||+.||+
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRN---DYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhc---CCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 9999999999997765432110000000000 000000000000000000 0001122345799999999999
Q ss_pred CCCCHHHHHHHhcC
Q 016347 308 LRPSMSTVVQMLMG 321 (391)
Q Consensus 308 ~Rps~~evl~~l~~ 321 (391)
+|||+.+++++-+.
T Consensus 440 kR~ta~e~L~Hpff 453 (566)
T PLN03225 440 QRISAKAALAHPYF 453 (566)
T ss_pred cCCCHHHHhCCcCc
Confidence 99999999997543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=256.11 Aligned_cols=239 Identities=29% Similarity=0.414 Sum_probs=193.2
Q ss_pred CceEEEEEEeCC-CcEEEEEEecccchhc-HHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCCCHHHHHhc
Q 016347 56 GFGSVYKGRLKD-GKIAAIKVLSAESRQG-VKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIG 133 (391)
Q Consensus 56 ~~g~V~~~~~~~-~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~ 133 (391)
+||.||+|.+.. |+.+|+|++....... ...+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999874 8999999988664443 67899999999999999999999999999999999999999999999864
Q ss_pred CCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCceeeeeeccc
Q 016347 134 GGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213 (391)
Q Consensus 134 ~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt 213 (391)
.. .+++..++.++.+++.++.+||+. +++|+||+|.||+++.++.++|+|||.+....... ......++
T Consensus 81 ~~------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~ 149 (244)
T smart00220 81 RG------RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGT 149 (244)
T ss_pred cc------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCC
Confidence 32 288999999999999999999999 99999999999999999999999999998764432 22345678
Q ss_pred ccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHH
Q 016347 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACR 293 (391)
Q Consensus 214 ~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (391)
..|++||.+.+..++.++|||+||+++++|++|..||........ .... ........ ..........
T Consensus 150 ~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~--~~~~----~~~~~~~~-------~~~~~~~~~~ 216 (244)
T smart00220 150 PEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE--LFKK----IGKPKPPF-------PPPEWKISPE 216 (244)
T ss_pred cCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHH----HhccCCCC-------ccccccCCHH
Confidence 899999999888899999999999999999999999865321111 1111 11000000 0000004457
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 294 FLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 294 l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
+.+++.+||..+|++||++.+++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhhC
Confidence 8889999999999999999999874
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=276.42 Aligned_cols=270 Identities=20% Similarity=0.241 Sum_probs=184.7
Q ss_pred HhhCCCCCCceeeccCceEEEEEEe-----------------CCCcEEEEEEecccchhcHHHHH--------------H
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRL-----------------KDGKIAAIKVLSAESRQGVKEFL--------------T 89 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~~~--------------~ 89 (391)
...++|++.++||+|+||.||+|.+ ..++.||||.+........++|. .
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 3578999999999999999999964 23567999998765433333333 3
Q ss_pred HHHHHhcCCCCce-----eEEEEEEEe--------CCeeEEEEecccCCCHHHHHhcCCCC------------------C
Q 016347 90 EIQVISEIEHENL-----VKLYGCCVE--------GNHRILVYNYLENNSLAQTLIGGGHH------------------Y 138 (391)
Q Consensus 90 e~~~l~~l~h~~i-----v~~~~~~~~--------~~~~~lv~e~~~~~sL~~~i~~~~~~------------------~ 138 (391)
|+.++.+++|.++ ++++++|.. ....++||||+++++|.+++...... .
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6666777766554 567777643 35689999999999999998642110 0
Q ss_pred CccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCceeeeeecccccccC
Q 016347 139 SNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLA 218 (391)
Q Consensus 139 ~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~a 218 (391)
....+++..+..++.|++.+|.|||+. +++||||||+|||++.++.+||+|||++...............+++.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 112356788999999999999999999 99999999999999999999999999997653322111112234789999
Q ss_pred hhhhhcCC--------------------C--CCCCcEeehhHHHHHHHhCCC-CCCCCCCcchhhH----HHHHHHHhhh
Q 016347 219 PEYAIRGQ--------------------V--TRKADIYSFGVLLVEIVSGRC-NTNMRLPTEEQYL----LERTWDLYER 271 (391)
Q Consensus 219 PE~~~~~~--------------------~--~~k~DvwSlG~vl~elltg~~-p~~~~~~~~~~~~----~~~~~~~~~~ 271 (391)
||.+.... + ..+.||||+||++++|++|.. |+........... ....|.....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99875432 1 235799999999999999875 5542211111000 0001111111
Q ss_pred cccceeeeccCCCCCCHHHHHHHHHHHhhccCCCC---CCCCCHHHHHHHhcC
Q 016347 272 RELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTP---KLRPSMSTVVQMLMG 321 (391)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~Rps~~evl~~l~~ 321 (391)
..+.-...........+++.+||..+| .+|+|+.|+|+|-+.
T Consensus 459 --------~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f 503 (507)
T PLN03224 459 --------QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFF 503 (507)
T ss_pred --------cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCc
Confidence 111111122345567788889998766 689999999988654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=259.31 Aligned_cols=261 Identities=24% Similarity=0.337 Sum_probs=197.3
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch-hcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR-QGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
.++.+-+..||.|+||+|++..++ .|+..|||.++.... ...++++.|.+....- +.||||+++|.+..++..++.|
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 355566778999999999999877 599999999987643 5566788888766554 7999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
|.|. .||..+-..- -......+++..+-.|+.....||.||-... .|+|||+||+|||++..|.+||+|||++-.+
T Consensus 143 ELMd-~SlDklYk~v-y~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 143 ELMD-ISLDKLYKRV-YSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred HHHh-hhHHHHHHHH-HHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhH
Confidence 9994 4665543210 0012345899999999999999999998764 8999999999999999999999999999776
Q ss_pred CCCCceeeeeecccccccChhhhhc--CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccccee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIR--GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILL 277 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (391)
.++.. .+.-.|-..|||||.+.. ..|+.++||||||++|+|+.||..|........++ ......++...+
T Consensus 219 v~SiA--kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeq------l~~Vv~gdpp~l 290 (361)
T KOG1006|consen 219 VDSIA--KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQ------LCQVVIGDPPIL 290 (361)
T ss_pred HHHHH--hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHH------HHHHHcCCCCee
Confidence 44322 122346678999998853 45999999999999999999999998765442211 111122222222
Q ss_pred eeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 278 VDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 278 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
..+ .-.......+..+|..||.+|-+.||...+++++-
T Consensus 291 ~~~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~ 328 (361)
T KOG1006|consen 291 LFD----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFP 328 (361)
T ss_pred cCc----ccccccCHHHHHHHHHHhhcccccCcchhhhhcCc
Confidence 111 11134556788999999999999999999998753
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=254.74 Aligned_cols=289 Identities=25% Similarity=0.339 Sum_probs=215.2
Q ss_pred HHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCC
Q 016347 39 LSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGN 113 (391)
Q Consensus 39 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 113 (391)
+.+.-++|.+++.||+|+|++|.+++++ +.+.||+|+++++ ..+.++-.+.|-.+..+. +||.+|-++.+|..+.
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 3444578999999999999999999976 5889999998765 233445566677777776 7999999999999999
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
.+++|.||++||+|.-.++.. +.++++.++.+...|..||.|||++ ||++||||-+|||++..|++||+|+
T Consensus 325 rlffvieyv~ggdlmfhmqrq------rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdy 395 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQ------RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDY 395 (593)
T ss_pred eEEEEEEEecCcceeeehhhh------hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeeccc
Confidence 999999999999987777543 4699999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCC---Ccc--hhhHHHHHHHH
Q 016347 194 GLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRL---PTE--EQYLLERTWDL 268 (391)
Q Consensus 194 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~---~~~--~~~~~~~~~~~ 268 (391)
|.++.-- .......+++|||.|+|||++.+..|....|.|+|||+++||+.|+.||+.-- +.. ++++.+...
T Consensus 396 gmcke~l-~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil-- 472 (593)
T KOG0695|consen 396 GMCKEGL-GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL-- 472 (593)
T ss_pred chhhcCC-CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh--
Confidence 9987532 23445678999999999999999999999999999999999999999996322 111 222222211
Q ss_pred hhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCCCCCCCCCCCCccccccccccCCC
Q 016347 269 YERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKDIDDDKITKPGLISDFMDLKVRGPP 348 (391)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (391)
...+ .++...+.....+++.-|++||++|..-.- + .+...+..+.+-+..-|..+....+-+|-
T Consensus 473 ----------ekqi--riprslsvkas~vlkgflnkdp~erlgc~~--~--~g~~dik~h~ffr~idwd~leqk~v~ppf 536 (593)
T KOG0695|consen 473 ----------EKQI--RIPRSLSVKASHVLKGFLNKDPKERLGCRP--Q--TGFSDIKSHAFFRSIDWDLLEQKQVLPPF 536 (593)
T ss_pred ----------hhcc--cccceeehhhHHHHHHhhcCCcHHhcCCCc--c--cchhhhhcchhhhhCCHHHHhhcccCCCC
Confidence 1111 122223334445666889999999964210 0 12233333444443344444444555556
Q ss_pred CCCCCCC
Q 016347 349 KPKLETT 355 (391)
Q Consensus 349 ~p~~~~~ 355 (391)
.|..+..
T Consensus 537 ~p~i~~d 543 (593)
T KOG0695|consen 537 QPQITDD 543 (593)
T ss_pred CCccccc
Confidence 6655443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=264.63 Aligned_cols=284 Identities=20% Similarity=0.246 Sum_probs=217.1
Q ss_pred cccCCCcceeechHHHHHhhCCCCCCceeeccCceEEEEEEeCC-CcEEEEEEecccchhcHHHHHHHHHHHhcCC----
Q 016347 24 EFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIE---- 98 (391)
Q Consensus 24 ~~~~~~~~~~~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---- 98 (391)
-|-...+ +|.|.-+++.-.+|.+....|+|-|++|.+|.+.. |+.||||+++.+ +...+.=+.|+++|+.|.
T Consensus 414 NWdDaEG--YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~ 490 (752)
T KOG0670|consen 414 NWDDAEG--YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADP 490 (752)
T ss_pred Ccccccc--eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCc
Confidence 3444443 57888888899999999999999999999999874 889999999865 333344567999999994
Q ss_pred --CCceeEEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 016347 99 --HENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIK 176 (391)
Q Consensus 99 --h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dik 176 (391)
.-|+++++-.|...+++|||+|-+ ..+|.+++...+ .+..|....+..++.|+..||..|-.. |++|.|||
T Consensus 491 Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG---~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIK 563 (752)
T KOG0670|consen 491 EDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYG---RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIK 563 (752)
T ss_pred hhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhC---cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccC
Confidence 347889998899999999999988 568999998766 456788999999999999999999997 99999999
Q ss_pred CCcEEECCC-CcEEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCC
Q 016347 177 ASNILLDKD-LTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLP 255 (391)
Q Consensus 177 p~NIlv~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~ 255 (391)
|+||||+++ ..+||||||.+.....+.. +.+.-+-.|.|||++.+.+|+...|+||.||+||||.||+..|.+...
T Consensus 564 PDNiLVNE~k~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 564 PDNILVNESKNILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred ccceEeccCcceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 999999876 6789999999987654422 223345679999999999999999999999999999999988877654
Q ss_pred cchhhHHHHHHHHhhh-----------------------------cccceee---ec------cCCC--CCC---HHHHH
Q 016347 256 TEEQYLLERTWDLYER-----------------------------RELILLV---DT------SLNG--DFD---AEEAC 292 (391)
Q Consensus 256 ~~~~~~~~~~~~~~~~-----------------------------~~~~~~~---~~------~~~~--~~~---~~~~~ 292 (391)
-+...+.......+.. .....++ .+ .+.+ .++ .....
T Consensus 641 N~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~ 720 (752)
T KOG0670|consen 641 NQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQ 720 (752)
T ss_pred HHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHH
Confidence 4432222221111111 0000000 00 0000 011 23445
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 293 RFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 293 ~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.|.+|+..||..||.+|.|..+.|.+..
T Consensus 721 ~~rdLLdkml~LdP~KRit~nqAL~HpF 748 (752)
T KOG0670|consen 721 QLRDLLDKMLILDPEKRITVNQALKHPF 748 (752)
T ss_pred HHHHHHHHHhccChhhcCCHHHHhcCCc
Confidence 7888999999999999999999988753
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=246.97 Aligned_cols=266 Identities=23% Similarity=0.297 Sum_probs=199.3
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC-----Cee
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG-----NHR 115 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~ 115 (391)
.+.+-.+.||.|+||.||.+.+. +|+.||+|.+..- +-...+.+.+|+.+|..++|.|++..+++.... ++.
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 45677889999999999999987 6999999987643 223446688899999999999999888876543 246
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
|+++|.+.. +|..+|- +...++.+.+.-+.+||++||.|||+. +|.||||||.|+||+.|..+||+|||+
T Consensus 133 YV~TELmQS-DLHKIIV------SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGL 202 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIV------SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGL 202 (449)
T ss_pred HHHHHHHHh-hhhheec------cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccc
Confidence 778888743 6777664 334688889999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh----
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE---- 270 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 270 (391)
++.........++..+-|..|.|||++.+. .|+.+.||||.|||+.||+.++..|....|.+...++........
T Consensus 203 ARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaM 282 (449)
T KOG0664|consen 203 ARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAM 282 (449)
T ss_pred ccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHH
Confidence 998765544445555678899999999875 699999999999999999999988877666655444333221111
Q ss_pred -----hcccceeeeccCCC--------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 271 -----RRELILLVDTSLNG--------DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 271 -----~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
+.+...+....... ..+......-..+...++..||+.|.+..+.+.++
T Consensus 283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 283 KYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11111110000000 01112333455667789999999999999988765
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=274.64 Aligned_cols=248 Identities=29% Similarity=0.379 Sum_probs=190.8
Q ss_pred CCCCceeeccCce-EEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEEEEeccc
Q 016347 46 FSPINKIGEGGFG-SVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILVYNYLE 123 (391)
Q Consensus 46 y~~~~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 123 (391)
|.-.+.+|.|+.| .||+|... |+.||||++-.+.. .-..+|++.|+.. .|||||++++.-.+.+..|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 4455668999988 59999986 78999998865543 4466799999988 79999999999889999999999995
Q ss_pred CCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC---C--CcEEEEecccccc
Q 016347 124 NNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK---D--LTPKISDFGLAKL 198 (391)
Q Consensus 124 ~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~---~--~~~kl~Dfg~~~~ 198 (391)
.+|.+++...+. ..........+.+..|++.||++||+. +||||||||+||||+. + .+++|+|||+++.
T Consensus 587 -~sL~dlie~~~~--d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 587 -CSLQDLIESSGL--DVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred -hhHHHHHhcccc--chhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 599999976411 111222245678899999999999998 9999999999999976 2 5789999999998
Q ss_pred cCCCCce--eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhC-CCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 199 IPANMTH--VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSG-RCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 199 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
+...... ......||.+|+|||++....-+.++||||||||+|+.++| .+||......+.+.+.. ...+.
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~-------~~~L~ 733 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTG-------NYTLV 733 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcC-------cccee
Confidence 8654332 23456799999999999998888999999999999999987 78997654433221111 01111
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.+ . ...++ ...+||.+|++++|..||++.+|+.+.
T Consensus 734 ~L-~------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HP 768 (903)
T KOG1027|consen 734 HL-E------PLPDC--EAKDLISRMLNPDPQLRPSATDVLNHP 768 (903)
T ss_pred ee-c------cCchH--HHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence 10 0 01111 677889999999999999999999764
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=250.80 Aligned_cols=268 Identities=22% Similarity=0.290 Sum_probs=216.4
Q ss_pred chHHHHHhhCCCCCCceeeccCceEEEEEEeCC------CcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEE
Q 016347 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLKD------GKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYG 107 (391)
Q Consensus 35 ~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 107 (391)
..+++.+...+++....+-+|.||.||.|.+.+ .+.|.+|.+... ++-....+++|.-++..+.|||+.++.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 457788888899999999999999999996542 345667777654 4455677889999999999999999999
Q ss_pred EEEe-CCeeEEEEecccCCCHHHHHhc--CCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC
Q 016347 108 CCVE-GNHRILVYNYLENNSLAQTLIG--GGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK 184 (391)
Q Consensus 108 ~~~~-~~~~~lv~e~~~~~sL~~~i~~--~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~ 184 (391)
++.+ ...+++++.++.-|+|..++.. +........+...+...++.|++.|++|||++ +++|.||..+|.+|++
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence 8865 4578999999999999999972 11222345678888999999999999999999 9999999999999999
Q ss_pred CCcEEEEecccccccCCC-CceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHH
Q 016347 185 DLTPKISDFGLAKLIPAN-MTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLL 262 (391)
Q Consensus 185 ~~~~kl~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~ 262 (391)
..+|||+|-.+++.+-.. .............||+||.+....|+.++|||||||+||||+| |+.|+..-+|.+....+
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl 511 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL 511 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence 999999999999875332 2222222334678999999999999999999999999999987 78888777776654433
Q ss_pred HHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 263 ERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.+. ++-..+.+++.++..++.-||..+|++||+++++..-|..
T Consensus 512 kdG----------------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 512 KDG----------------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred hcc----------------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 322 2223456788899999999999999999999999987753
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=234.75 Aligned_cols=260 Identities=16% Similarity=0.273 Sum_probs=194.0
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCC-CCceeEEEEEEEe--CCeeEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIE-HENLVKLYGCCVE--GNHRILV 118 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv 118 (391)
.++|++++++|+|.+++||-|..- ++++++||+++.-.. +.+.+|+.+|..|. ||||++++++..+ .+.+.+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 588999999999999999999854 688999999976543 56788999999996 9999999999875 4578999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC-CcEEEEeccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD-LTPKISDFGLAK 197 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~-~~~kl~Dfg~~~ 197 (391)
+||+++.+...+.. .++...+..++.+++.||.|||++ ||+|||+||.|+||+.. -.++|+|+|++.
T Consensus 114 FE~v~n~Dfk~ly~---------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP---------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred hhhhccccHHHHhh---------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHh
Confidence 99999887766552 478888999999999999999999 99999999999999876 579999999998
Q ss_pred ccCCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCC-CCCCcchhhHHHHHHHHhh-----
Q 016347 198 LIPANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTN-MRLPTEEQYLLERTWDLYE----- 270 (391)
Q Consensus 198 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~-~~~~~~~~~~~~~~~~~~~----- 270 (391)
.+..... ..-.+.+..|--||.+.. +.|+..-|+|||||+|..|+..+.||- +.+..+....+.......+
T Consensus 182 FYHp~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 182 FYHPGKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred hcCCCce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence 7754332 222345667889998754 568999999999999999999999974 3333332221111111000
Q ss_pred -h------cccceeee--------ccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 271 -R------RELILLVD--------TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 271 -~------~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
. .+...++. .....+...-...+.++++.+.|..|-.+|+|+.|.+++-
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp 323 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP 323 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence 0 00000010 0111111111234677788899999999999999998764
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=228.09 Aligned_cols=213 Identities=26% Similarity=0.410 Sum_probs=175.4
Q ss_pred chHHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCceeEEEEEEEe
Q 016347 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHENLVKLYGCCVE 111 (391)
Q Consensus 35 ~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 111 (391)
..+.+++..++...+..||+|++|.|-+.++. +|+..|+|.+... +....++.++|+.+..+. .+|.+|.++|.+..
T Consensus 37 ~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 37 GDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred ecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 55668888899999999999999999998876 6999999998765 344456778888887776 79999999999999
Q ss_pred CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEE
Q 016347 112 GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKIS 191 (391)
Q Consensus 112 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~ 191 (391)
.....+.||.|. .||..+-.+-- .....+++..+-+|+..+..||.|||++. .++|||+||.||||+.+|+||+|
T Consensus 117 egdvwIcME~M~-tSldkfy~~v~--~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiC 191 (282)
T KOG0984|consen 117 EGDVWICMELMD-TSLDKFYRKVL--KKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKIC 191 (282)
T ss_pred cccEEEeHHHhh-hhHHHHHHHHH--hcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEc
Confidence 999999999984 47766554311 12335899999999999999999999985 89999999999999999999999
Q ss_pred ecccccccCCCCceeeeeecccccccChhhhhc----CCCCCCCcEeehhHHHHHHHhCCCCCCCCC
Q 016347 192 DFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIR----GQVTRKADIYSFGVLLVEIVSGRCNTNMRL 254 (391)
Q Consensus 192 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~k~DvwSlG~vl~elltg~~p~~~~~ 254 (391)
|||++-.+.++.... --.|-..|+|||.+.. ..|+-++||||||+++.||.+++.|+....
T Consensus 192 DFGIsG~L~dSiAkt--~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 192 DFGISGYLVDSIAKT--MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred ccccceeehhhhHHH--HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 999998765443221 1245567999998753 469999999999999999999999986443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-31 Score=228.93 Aligned_cols=211 Identities=39% Similarity=0.625 Sum_probs=183.5
Q ss_pred eeccCceEEEEEEeCC-CcEEEEEEecccchh-cHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCCCHHH
Q 016347 52 IGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQ-GVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQ 129 (391)
Q Consensus 52 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~ 129 (391)
||.|.+|.||++.... ++.+++|++...... ....+.+|++.++.+.|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999875 899999998766432 34678899999999999999999999999899999999999999999
Q ss_pred HHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-CCcEEEEecccccccCCCCceeee
Q 016347 130 TLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK-DLTPKISDFGLAKLIPANMTHVST 208 (391)
Q Consensus 130 ~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~-~~~~kl~Dfg~~~~~~~~~~~~~~ 208 (391)
++.... ..++...+..++.+++.++.+||+. +++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 81 ~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~ 151 (215)
T cd00180 81 LLKENE-----GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLK 151 (215)
T ss_pred HHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhh
Confidence 986431 3589999999999999999999999 9999999999999999 89999999999987644321 123
Q ss_pred eecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCC
Q 016347 209 RVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFD 287 (391)
Q Consensus 209 ~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (391)
...+...|++||.+... .++.+.|+|+||+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence 34578899999998777 889999999999999999
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 288 AEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 288 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
..+.+++..|++.+|++||++.++++.+
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3577888999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=254.69 Aligned_cols=196 Identities=26% Similarity=0.367 Sum_probs=168.6
Q ss_pred CCCCCCceeeccCceEEEEEEeCC-CcEEEEEEecccchh---c-----HHHHHHHHHHHhcCC---CCceeEEEEEEEe
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQ---G-----VKEFLTEIQVISEIE---HENLVKLYGCCVE 111 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---~-----~~~~~~e~~~l~~l~---h~~iv~~~~~~~~ 111 (391)
.+|+.++++|.|+||.|+++.++. ...|+||.+.++.-- + .-..-.|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 469999999999999999999874 677899988765211 1 112446999999996 9999999999999
Q ss_pred CCeeEEEEecc-cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEE
Q 016347 112 GNHRILVYNYL-ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKI 190 (391)
Q Consensus 112 ~~~~~lv~e~~-~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl 190 (391)
++..+|+||.- +|.+|.++|... ..+++..+..|+.||+.|+++||++ ||||||||-+||+++.+|-+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k------p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK------PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc------CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEE
Confidence 99999999975 466899999644 3599999999999999999999999 9999999999999999999999
Q ss_pred EecccccccCCCCceeeeeecccccccChhhhhcCCC-CCCCcEeehhHHHHHHHhCCCCCC
Q 016347 191 SDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGRCNTN 251 (391)
Q Consensus 191 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlG~vl~elltg~~p~~ 251 (391)
+|||.+....+. ....++||..|.|||++.+.+| +...|||+||++||.++....|+.
T Consensus 712 idfgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 712 IDFGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eeccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999875433 3456789999999999988887 678999999999999998877764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-33 Score=263.49 Aligned_cols=254 Identities=27% Similarity=0.434 Sum_probs=208.7
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
..++|+++..+|.|.+|.||++++. .++..|+|+++.+..+...-..+|+-+++.++||||+.+++.+.....++++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 4588999999999999999999987 599999999998877777888899999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
||.||+|.+.-+..+ ++++.++....+..+++++|||++ |-+|||||-.||+++..|.+||+|||.+..+.
T Consensus 93 ycgggslQdiy~~Tg------plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred ecCCCcccceeeecc------cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhh
Confidence 999999998776554 599999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCceeeeeecccccccChhhh---hcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccccee
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYA---IRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILL 277 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (391)
..-. ....+.||+.|||||+. ..+.|..++|||++|+...|+-.-+.|.....+....++.... .+ +...+
T Consensus 164 ati~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS--~~---qpp~l 237 (829)
T KOG0576|consen 164 ATIA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKS--GF---QPPTL 237 (829)
T ss_pred hhhh-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhcc--CC---CCCcc
Confidence 4322 23457899999999986 3567999999999999999998777775444343322221110 00 00001
Q ss_pred eeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016347 278 VDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317 (391)
Q Consensus 278 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 317 (391)
.-.......|-.|++.||-++|++||+++.+|.
T Consensus 238 -------kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 238 -------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred -------cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 112244567888999999999999999987765
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=228.64 Aligned_cols=266 Identities=19% Similarity=0.333 Sum_probs=197.6
Q ss_pred CCcceeechHHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcC-CCCceeEE
Q 016347 28 IHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENLVKL 105 (391)
Q Consensus 28 ~~~~~~~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~ 105 (391)
++-++.+.++.+.. .+.|.+.+.||+|.||.+-++.++ +++.+++|.++... ....+|.+|...--.| .|.||+.-
T Consensus 9 ih~I~~~el~kv~l-~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~t 86 (378)
T KOG1345|consen 9 IHLIPMEELKKVDL-EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDT 86 (378)
T ss_pred ccccccccccccch-hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHH
Confidence 55555555555544 578999999999999999999987 48889999987653 3457789998776666 58899987
Q ss_pred EEE-EEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC-
Q 016347 106 YGC-CVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLD- 183 (391)
Q Consensus 106 ~~~-~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~- 183 (391)
++. |+..+..++++||++.|+|.+.+... .+.+.....++.|++.|+.|+|++ ++||||||.+||||-
T Consensus 87 Y~vaFqt~d~YvF~qE~aP~gdL~snv~~~-------GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~ 156 (378)
T KOG1345|consen 87 YEVAFQTSDAYVFVQEFAPRGDLRSNVEAA-------GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFD 156 (378)
T ss_pred HHHHhhcCceEEEeeccCccchhhhhcCcc-------cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEec
Confidence 654 55667888999999999999998654 488889999999999999999999 999999999999993
Q ss_pred CC-CcEEEEecccccccCCCCceeeeeecccccccChhhhhcC-----CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcc
Q 016347 184 KD-LTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRG-----QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTE 257 (391)
Q Consensus 184 ~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~ 257 (391)
.+ .+|||+|||+.+..+..-.. ..-+..|.+||+.... ...+.+|||.||++++.++||..||......+
T Consensus 157 ~df~rvKlcDFG~t~k~g~tV~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d 232 (378)
T KOG1345|consen 157 ADFYRVKLCDFGLTRKVGTTVKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD 232 (378)
T ss_pred CCccEEEeeecccccccCceehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC
Confidence 33 58999999999865432111 2234579999987542 24688999999999999999999998554444
Q ss_pred hhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 258 EQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
..+. .|..+..+....+.+. .......++++.++-|..+|++|--..++.++
T Consensus 233 ~~Y~---~~~~w~~rk~~~~P~~------F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 233 KPYW---EWEQWLKRKNPALPKK------FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred chHH---HHHHHhcccCccCchh------hcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 4332 2333333333221111 11234466777778999999999655555443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=233.58 Aligned_cols=262 Identities=24% Similarity=0.285 Sum_probs=197.4
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC------C
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG------N 113 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~ 113 (391)
..+|.-++.+|.|.- .|..|.+. .++.||+|.+... +....+...+|+.++..+.|+||+.++.++... .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 468888899999999 66677655 5889999987544 334456678899999999999999999998744 3
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
..++|||++. .+|.+.+.. .++-..+..|..|++.|+.|||+. ||+||||||+||++..++.+||.||
T Consensus 95 e~y~v~e~m~-~nl~~vi~~--------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~df 162 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVILM--------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDF 162 (369)
T ss_pred hHHHHHHhhh-hHHHHHHHH--------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccc
Confidence 5799999995 488888863 377788999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH-----
Q 016347 194 GLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDL----- 268 (391)
Q Consensus 194 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~----- 268 (391)
|+++.-... -..+..+.|..|.|||++.+-.|.+.+||||+||++.||++|+.-|.+.+-.+...........
T Consensus 163 g~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F 240 (369)
T KOG0665|consen 163 GLARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSF 240 (369)
T ss_pred hhhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHH
Confidence 999864332 3566778899999999999988999999999999999999999888765432211111000000
Q ss_pred -----------hhhc------ccceee-eccCCC--CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 269 -----------YERR------ELILLV-DTSLNG--DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 269 -----------~~~~------~~~~~~-~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.... .....+ |..+.. +.+........+++.+||-.||++|.+++++|++-
T Consensus 241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 0000 000011 111111 11112334567788899999999999999999874
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=225.62 Aligned_cols=199 Identities=37% Similarity=0.534 Sum_probs=173.5
Q ss_pred CCCCceeeccCceEEEEEEeCC-CcEEEEEEecccchh-cHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEeccc
Q 016347 46 FSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQ-GVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLE 123 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 123 (391)
|.+.+.||.|++|.||+|.... ++.+++|.+...... ....+.+|++.++.++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5678899999999999999875 899999999876544 56788999999999999999999999998899999999999
Q ss_pred CCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCC
Q 016347 124 NNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANM 203 (391)
Q Consensus 124 ~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~ 203 (391)
+++|.+++..... .+++..+..++.+++.++.+||+. +++|+||+|.||+++.++.++|+|||.+.......
T Consensus 81 ~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 81 GGDLFDYLRKKGG-----KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred CCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 9999999965321 178999999999999999999999 99999999999999999999999999998765432
Q ss_pred ceeeeeecccccccChhhh-hcCCCCCCCcEeehhHHHHHHHhCCCCCCC
Q 016347 204 THVSTRVAGTIGYLAPEYA-IRGQVTRKADIYSFGVLLVEIVSGRCNTNM 252 (391)
Q Consensus 204 ~~~~~~~~gt~~y~aPE~~-~~~~~~~k~DvwSlG~vl~elltg~~p~~~ 252 (391)
........++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 1122335678889999998 666788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-30 Score=231.90 Aligned_cols=266 Identities=26% Similarity=0.369 Sum_probs=196.7
Q ss_pred HHHhhCCCCCCceeeccCceEEEEEEeC----CCcEEEEEEecccchhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCC
Q 016347 39 LSIATDDFSPINKIGEGGFGSVYKGRLK----DGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGN 113 (391)
Q Consensus 39 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 113 (391)
+.-..+.|..+.+||.|.|++||++.+. .+..||+|.+...+. ...+..|+++|..+ -+.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3344578999999999999999999854 367899999876533 35688899999999 5899999999999999
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC-CcEEEEe
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD-LTPKISD 192 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~-~~~kl~D 192 (391)
...+|+||++.....++... ++...+..+++.++.||.++|.+ |||||||||.|++.+.. ++-.|+|
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~---------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS---------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred eeEEEecccCccCHHHHHhc---------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEe
Confidence 99999999999888888753 77889999999999999999999 99999999999999865 7789999
Q ss_pred cccccccC---------C---------C---------------Cce----------eeeeecccccccChhhhhcC-CCC
Q 016347 193 FGLAKLIP---------A---------N---------------MTH----------VSTRVAGTIGYLAPEYAIRG-QVT 228 (391)
Q Consensus 193 fg~~~~~~---------~---------~---------------~~~----------~~~~~~gt~~y~aPE~~~~~-~~~ 228 (391)
||++.... . . ... ......||++|.|||++... ..+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 99997210 0 0 000 00124699999999998764 578
Q ss_pred CCCcEeehhHHHHHHHhCCCCCCCCCCcchh-hHHHHHHHHhhh-------cccceeee--------------------c
Q 016347 229 RKADIYSFGVLLVEIVSGRCNTNMRLPTEEQ-YLLERTWDLYER-------RELILLVD--------------------T 280 (391)
Q Consensus 229 ~k~DvwSlG~vl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~-------~~~~~~~~--------------------~ 280 (391)
.++||||.|||++.+++++.||-........ .-+......... +. ..+.. .
T Consensus 257 taiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~-~~l~~ksn~~~~~e~~~~f~s~~~~~ 335 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGR-ILLWQKSNIPTIPELRVNFETLHIES 335 (418)
T ss_pred CccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCc-eeeeccccccccHHHHhchhccChhh
Confidence 9999999999999999999998543322210 000000000000 00 00000 0
Q ss_pred cCC--------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 281 SLN--------GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 281 ~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
... .......+..+++++.+||+.||.+|.|+++.|++.
T Consensus 336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 000 001112233678899999999999999999999875
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-29 Score=258.55 Aligned_cols=198 Identities=16% Similarity=0.160 Sum_probs=137.4
Q ss_pred cCCC-CceeEEEEEE-------EeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCC
Q 016347 96 EIEH-ENLVKLYGCC-------VEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVR 167 (391)
Q Consensus 96 ~l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~ 167 (391)
.++| +||+.+++++ ......++++|++ +++|.+++... ...+++..++.++.||+.||.|||++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~-- 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-----DRSVDAFECFHVFRQIVEIVNAAHSQ-- 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-----cccccHHHHHHHHHHHHHHHHHHHhC--
Confidence 3445 5777777766 2334567788887 66999999642 23589999999999999999999999
Q ss_pred CCeeecCCCCCcEEECCCCc-------------------EEEEecccccccCCCCc---------------eeeeeeccc
Q 016347 168 PHIIHRDIKASNILLDKDLT-------------------PKISDFGLAKLIPANMT---------------HVSTRVAGT 213 (391)
Q Consensus 168 ~~i~H~dikp~NIlv~~~~~-------------------~kl~Dfg~~~~~~~~~~---------------~~~~~~~gt 213 (391)
||+||||||+||||+..|. +|++|||+++....... .......||
T Consensus 100 -gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 100 -GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred -CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 9999999999999965444 45555555543210000 000113578
Q ss_pred ccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHH
Q 016347 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACR 293 (391)
Q Consensus 214 ~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (391)
+.|+|||++.+..++.++|||||||+||||++|..|+..... .... .... ...+. .......
T Consensus 179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~----~~~~----~~~~~-----~~~~~~~ 240 (793)
T PLN00181 179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSS----LRHR----VLPPQ-----ILLNWPK 240 (793)
T ss_pred cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHH----HHHh----hcChh-----hhhcCHH
Confidence 889999999999999999999999999999998877642111 0000 0000 00000 0112234
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 294 FLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 294 l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
...++.+||+.+|.+||++.|++++.+
T Consensus 241 ~~~~~~~~L~~~P~~Rps~~eil~h~~ 267 (793)
T PLN00181 241 EASFCLWLLHPEPSCRPSMSELLQSEF 267 (793)
T ss_pred HHHHHHHhCCCChhhCcChHHHhhchh
Confidence 567788999999999999999998654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=211.46 Aligned_cols=277 Identities=23% Similarity=0.391 Sum_probs=214.3
Q ss_pred CCCCCCcccccccCCC----cceeechHHHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEeccc--chhcHHHH
Q 016347 14 PRNRVPEVDEEFSGIH----NVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAE--SRQGVKEF 87 (391)
Q Consensus 14 ~~~~~~~~~~~~~~~~----~~~~~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~ 87 (391)
.-+++|+.|+.|+|.+ +.++..+..+.. ....++.+|.+...|+.|+|++..+ .++.|++... +...-..|
T Consensus 158 ~~nripfkdt~wkgtktr~rdatlsr~~gid~--~~lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdf 234 (448)
T KOG0195|consen 158 SPNRIPFKDTTWKGTKTRTRDATLSRYTGIDV--SSLNLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDF 234 (448)
T ss_pred CCCcccccccccccccccccccccccccCcch--hhhhhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchh
Confidence 4568999999999976 344445555544 6677788999999999999999854 4555666543 33444678
Q ss_pred HHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCC
Q 016347 88 LTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVR 167 (391)
Q Consensus 88 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~ 167 (391)
.+|.-.|+.+.||||+.+++.|....++.++..|++.|||...++.+ .....+..++.+++.++++|++|||+. .
T Consensus 235 neefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~----t~vvvd~sqav~faldiargmaflhsl-e 309 (448)
T KOG0195|consen 235 NEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQ----TSVVVDHSQAVRFALDIARGMAFLHSL-E 309 (448)
T ss_pred hhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcC----ccEEEecchHHHHHHHHHhhHHHHhhc-c
Confidence 99999999999999999999999999999999999999999999765 344567889999999999999999996 3
Q ss_pred CCeeecCCCCCcEEECCCCcEEEE--ecccccccCCCCceeeeeecccccccChhhhhcCCCC---CCCcEeehhHHHHH
Q 016347 168 PHIIHRDIKASNILLDKDLTPKIS--DFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVT---RKADIYSFGVLLVE 242 (391)
Q Consensus 168 ~~i~H~dikp~NIlv~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~k~DvwSlG~vl~e 242 (391)
+-|.---|+...|+||++.+.+|. |--++.... ...-.|.|++||.++.++-+ .++|+|||++++||
T Consensus 310 p~ipr~~lns~hvmidedltarismad~kfsfqe~--------gr~y~pawmspealqrkped~n~raadmwsfaillwe 381 (448)
T KOG0195|consen 310 PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEV--------GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWE 381 (448)
T ss_pred hhhhhhhcccceEEecchhhhheecccceeeeecc--------ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHH
Confidence 345555689999999999877764 322222111 11235789999999877643 68999999999999
Q ss_pred HHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 243 IVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 243 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
|.|...||....+.+.-.. +.-++++..+++.....+.+|+.-|+..||.+||.+..++-.|+.
T Consensus 382 l~trevpfadlspmecgmk---------------ialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 382 LNTREVPFADLSPMECGMK---------------IALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred hhccccccccCCchhhhhh---------------hhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 9999999987766553321 112334456666667788889999999999999999988877654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=202.26 Aligned_cols=166 Identities=22% Similarity=0.197 Sum_probs=124.8
Q ss_pred CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc
Q 016347 125 NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204 (391)
Q Consensus 125 ~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~ 204 (391)
|+|.+++... ...+++..++.|+.||+.||.|||++ + ||+|||++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~- 63 (176)
T smart00750 1 VSLADILEVR-----GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ- 63 (176)
T ss_pred CcHHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-
Confidence 6888988642 23599999999999999999999998 6 999999999999999 99987653321
Q ss_pred eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCC
Q 016347 205 HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNG 284 (391)
Q Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (391)
..||+.|+|||++.+..++.++|||||||++|||++|..||......... ............ . ...
T Consensus 64 -----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~------~-~~~ 129 (176)
T smart00750 64 -----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI--LEILLNGMPADD------P-RDR 129 (176)
T ss_pred -----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH--HHHHHHHhccCC------c-ccc
Confidence 25889999999999999999999999999999999999998654332211 111111000000 0 000
Q ss_pred CCCHHHHH--HHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 285 DFDAEEAC--RFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 285 ~~~~~~~~--~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
........ .+.+++.+||+.+|.+||++.|+++++..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 11122222 68999999999999999999999998754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=212.25 Aligned_cols=258 Identities=27% Similarity=0.310 Sum_probs=192.0
Q ss_pred CCCCCceeeccCceEEEEEEeCC--CcEEEEEEecccchhcHHHHHHHHHHHhcCCC----CceeEEEEEE-EeCCeeEE
Q 016347 45 DFSPINKIGEGGFGSVYKGRLKD--GKIAAIKVLSAESRQGVKEFLTEIQVISEIEH----ENLVKLYGCC-VEGNHRIL 117 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~~iv~~~~~~-~~~~~~~l 117 (391)
+|.+.++||+|+||.||+|.... ...+|+|+...........+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 89999999999999999999775 35789998776533322367778888888863 6899999998 47778999
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC-----CcEEEEe
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD-----LTPKISD 192 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~-----~~~kl~D 192 (391)
||+.+ |.+|.++..... ...++..++..|+.|++.+|.+||+. |++||||||.|+++... ..+.|.|
T Consensus 99 VM~l~-G~sL~dl~~~~~----~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP----PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred EEecc-CccHHHHHHhCC----CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 99987 789999885432 45799999999999999999999999 99999999999999765 3689999
Q ss_pred ccccc--ccCCCCce------e-eeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHH
Q 016347 193 FGLAK--LIPANMTH------V-STRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLE 263 (391)
Q Consensus 193 fg~~~--~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~ 263 (391)
||+++ .+...... . .....||..|+++....+...+.+.|+||++.++.+|+.|..||.............
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 99998 43221110 1 123569999999999999999999999999999999999999996544322211111
Q ss_pred HHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 264 RTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.... . ..... ....... .+.++...+-..+...+|....+...+...
T Consensus 251 ~~~~----~---~~~~~--~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 251 KDPR----K---LLTDR--FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHhh----h---hcccc--ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 1100 0 00000 1112223 344444445558999999999988876544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.5e-26 Score=210.87 Aligned_cols=166 Identities=19% Similarity=0.201 Sum_probs=130.0
Q ss_pred HHHhhCCCCCCceeeccCceEEEEEEeC--CCcEEEEEEeccc-----chhcHHHHHHHHHHHhcCCCCceeE-EEEEEE
Q 016347 39 LSIATDDFSPINKIGEGGFGSVYKGRLK--DGKIAAIKVLSAE-----SRQGVKEFLTEIQVISEIEHENLVK-LYGCCV 110 (391)
Q Consensus 39 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~ 110 (391)
.....++|++.+.||+|+||+||+|.+. +++.||||++... .......+.+|+++|+.++|+|+++ +++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--- 89 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--- 89 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence 3456789999999999999999999875 4788899986533 1223556899999999999999985 443
Q ss_pred eCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC-CCCcEEECCCCcEE
Q 016347 111 EGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDI-KASNILLDKDLTPK 189 (391)
Q Consensus 111 ~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~di-kp~NIlv~~~~~~k 189 (391)
.+..++||||++|++|.. +.. .. ...++.|++.||.|||++ ||+|||| ||+|||++.++.++
T Consensus 90 -~~~~~LVmE~~~G~~L~~-~~~---------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ik 152 (365)
T PRK09188 90 -TGKDGLVRGWTEGVPLHL-ARP---------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAA 152 (365)
T ss_pred -cCCcEEEEEccCCCCHHH-hCc---------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEE
Confidence 246899999999999963 210 11 146788999999999999 9999999 99999999999999
Q ss_pred EEecccccccCCCCcee-------eeeecccccccChhhhhc
Q 016347 190 ISDFGLAKLIPANMTHV-------STRVAGTIGYLAPEYAIR 224 (391)
Q Consensus 190 l~Dfg~~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~ 224 (391)
|+|||+++.+....... -....+++.|.|||.+.-
T Consensus 153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99999998764332111 124568888999998753
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-25 Score=186.54 Aligned_cols=208 Identities=24% Similarity=0.332 Sum_probs=173.5
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCC-CceeEEEEEEEeCCeeEEE
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEH-ENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv 118 (391)
+..+.|.++++||.|+||.+|+|..- +|..||||+-..... ..++.-|..+.+.+++ ..|..+..+..+..+-.+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 45688999999999999999999854 699999998654422 2456678888988864 6777777788888899999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC---CcEEEEeccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD---LTPKISDFGL 195 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~---~~~kl~Dfg~ 195 (391)
|+.+ |.||.+++.- ..+.++.++++-++-|++.-++|+|.+ +++||||||+|+|..-+ ..+.|+|||+
T Consensus 90 MdLL-GPsLEdLfnf-----C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNF-----CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred eecc-CccHHHHHHH-----HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccc
Confidence 9988 7899998853 445799999999999999999999999 99999999999999654 5789999999
Q ss_pred ccccCCCCce------eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchh
Q 016347 196 AKLIPANMTH------VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQ 259 (391)
Q Consensus 196 ~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~ 259 (391)
++.+.+.... ......||..|.+--...+...+...|+-|+|.+|..+.-|..||.+..+....
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~ 230 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK 230 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH
Confidence 9987543221 123467999999988888888899999999999999999999999877665543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=190.60 Aligned_cols=207 Identities=24% Similarity=0.352 Sum_probs=176.3
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEe-CCCcEEEEEEecccchhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEE
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRL-KDGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 117 (391)
.+.+-.|.+.++||+|+||+++.|+. -+++.||||.-...++ .-++..|....+.| ..+.|.+++-|..++.+-.|
T Consensus 24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred eEecccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 34567899999999999999999984 4799999998654433 35677888888888 57999999998899999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC-----CcEEEEe
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD-----LTPKISD 192 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~-----~~~kl~D 192 (391)
|+|.+ |.||.+++.- ..+.++.+++.-+|.|++.-++|+|++ .+|+|||||+|+||..- ..+.++|
T Consensus 102 VidLL-GPSLEDLFD~-----CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiD 172 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDL-----CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIID 172 (449)
T ss_pred hhhhh-CcCHHHHHHH-----hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEe
Confidence 99988 8899999854 556799999999999999999999999 99999999999999643 4689999
Q ss_pred cccccccCCCCcee--e----eeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcc
Q 016347 193 FGLAKLIPANMTHV--S----TRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTE 257 (391)
Q Consensus 193 fg~~~~~~~~~~~~--~----~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~ 257 (391)
||+++.+.+...+. . ....||.+||+--...+...+...|+-|||-|+.+.+-|..||.+.....
T Consensus 173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t 243 (449)
T KOG1165|consen 173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT 243 (449)
T ss_pred ccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence 99999875543322 1 23579999999999999999999999999999999999999998765544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-23 Score=192.91 Aligned_cols=261 Identities=31% Similarity=0.437 Sum_probs=198.2
Q ss_pred CCCCceeeccCceEEEEEEeCCCcEEEEEEecccchh---cHHHHHHHHHHHhcCCCC-ceeEEEEEEEeCCeeEEEEec
Q 016347 46 FSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQ---GVKEFLTEIQVISEIEHE-NLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~ 121 (391)
|.+.+.||.|+||.||++.+. ..+++|.+...... ....+.+|+.++..+.|+ +|+++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 778899999999999999987 78899998766332 367789999999999888 799999999777778999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC-cEEEEecccccccC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL-TPKISDFGLAKLIP 200 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~-~~kl~Dfg~~~~~~ 200 (391)
+.++++.+++...... ..+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.+....
T Consensus 80 ~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 80 VDGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred CCCCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 9999999777543211 3589999999999999999999999 999999999999999998 79999999998654
Q ss_pred CCCce-----eeeeecccccccChhhhhc---CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 201 ANMTH-----VSTRVAGTIGYLAPEYAIR---GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 201 ~~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
..... ......|+..|++||.+.+ ..++...|+|++|++++++++|..||........ ...........
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~---~~~~~~~~~~~ 230 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA---TSQTLKIILEL 230 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcccc---HHHHHHHHHhc
Confidence 33221 2355689999999999987 5789999999999999999999999765443100 00111111111
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
... .................+.+++..|+..+|..|.+..+....
T Consensus 231 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 231 PTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000 000000000002223567788889999999999998877654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=189.46 Aligned_cols=173 Identities=16% Similarity=0.161 Sum_probs=136.4
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcH---HH------HHHHHHHHhcCCCCceeEEEEEEE
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGV---KE------FLTEIQVISEIEHENLVKLYGCCV 110 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---~~------~~~e~~~l~~l~h~~iv~~~~~~~ 110 (391)
.+..++|+.++.||.|+||.||++.. ++..+|+|+++....... .. +.+|+..+.++.|++|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 46689999999999999999999766 577899999976532221 22 578999999999999999998865
Q ss_pred eC--------CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 016347 111 EG--------NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL 182 (391)
Q Consensus 111 ~~--------~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv 182 (391)
.. ...+++|||++|.+|.++.. ++. ....+++.+|..+|+. |++|||++|.||++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili 168 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIV 168 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEE
Confidence 33 35789999999999988741 232 2456899999999999 99999999999999
Q ss_pred CCCCcEEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHH
Q 016347 183 DKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIV 244 (391)
Q Consensus 183 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ell 244 (391)
+.+| ++|+|||.......... ...++....|..++|+|+||+++..+.
T Consensus 169 ~~~g-i~liDfg~~~~~~e~~a-------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 169 SKNG-LRIIDLSGKRCTAQRKA-------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred eCCC-EEEEECCCcccccchhh-------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 9998 99999998765421110 011345566778999999999988765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-25 Score=219.68 Aligned_cols=255 Identities=20% Similarity=0.243 Sum_probs=188.1
Q ss_pred CCCceeeccCceEEEEEEeC-CCcEEEEEEec-----ccchh-cHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 47 SPINKIGEGGFGSVYKGRLK-DGKIAAIKVLS-----AESRQ-GVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 47 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~-----~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
.....+|.|++|.|+.+... ..+..+.|... ..... ....+..|+-+-..++|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 56778999999988877644 23333433322 12221 1222666777888889999988777766655555569
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
|||++ +|..++...+ .+....+..++.|++.|+.|+|+. |+.|||+|++|++++.+|.+||+|||.+..+
T Consensus 401 E~~~~-Dlf~~~~~~~------~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG------KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVF 470 (601)
T ss_pred hcccH-HHHHHHhccc------ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceee
Confidence 99999 9999996542 588899999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCc---eeeeeecccccccChhhhhcCCCCC-CCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 200 PANMT---HVSTRVAGTIGYLAPEYAIRGQVTR-KADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 200 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
..... ......+|+..|+|||++.+..|.+ ..||||.|+++..|++|+.||......+.++... ....
T Consensus 471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~--------~~~~ 542 (601)
T KOG0590|consen 471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN--------NYSD 542 (601)
T ss_pred ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh--------cccc
Confidence 53332 3455678999999999999999865 6899999999999999999997665544332000 0000
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
......-........+.....++.+||+.||.+|.|+.+|++.-
T Consensus 543 ~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~ 586 (601)
T KOG0590|consen 543 QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDE 586 (601)
T ss_pred ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhCh
Confidence 00000001112234455677888999999999999999998753
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-24 Score=215.12 Aligned_cols=248 Identities=20% Similarity=0.261 Sum_probs=182.2
Q ss_pred CCCCCceeeccCceEEEEEEeCCCcEEEEEEecccc-hhcHHHHHHHHHH--HhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 45 DFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAES-RQGVKEFLTEIQV--ISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~--l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
.|...+.||.+.|=+|.+|++..|. |+||++.+.. .-....|.++++- ...+++||.+++.-....++..|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6888899999999999999999887 8889876553 3334444443333 4556999999998887788888999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc--
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI-- 199 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~-- 199 (391)
+.. +|.|.+. .+..+...+.+.|+.||+.||..+|.. ||+|||||.+||||+.-+-+.|+||..-+..
T Consensus 103 vkh-nLyDRlS------TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 103 VKH-NLYDRLS------TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred Hhh-hhhhhhc------cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccC
Confidence 855 7888884 334578889999999999999999999 9999999999999999999999999876543
Q ss_pred CCCC----ceeeeeecccccccChhhhhcC----------C-CCCCCcEeehhHHHHHHHhC-CCCCCCCCCcchhhHHH
Q 016347 200 PANM----THVSTRVAGTIGYLAPEYAIRG----------Q-VTRKADIYSFGVLLVEIVSG-RCNTNMRLPTEEQYLLE 263 (391)
Q Consensus 200 ~~~~----~~~~~~~~gt~~y~aPE~~~~~----------~-~~~k~DvwSlG~vl~elltg-~~p~~~~~~~~~~~~~~ 263 (391)
+... .....+...-.+|+|||.+... . .+++.||||+||+++||++. ++||....
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ--------- 243 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ--------- 243 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH---------
Confidence 2111 1122233345689999988542 2 67899999999999999885 56665211
Q ss_pred HHHHHhhhc---ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 264 RTWDLYERR---ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 264 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.-.+..+ ....++.. -+...+..++..|++.||++|.++++.|+.-.+.
T Consensus 244 --L~aYr~~~~~~~e~~Le~--------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 244 --LLAYRSGNADDPEQLLEK--------IEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred --HHhHhccCccCHHHHHHh--------CcCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 0011111 00000000 0112688899999999999999999999875443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.4e-23 Score=176.78 Aligned_cols=139 Identities=15% Similarity=0.192 Sum_probs=108.1
Q ss_pred CceeeccCceEEEEEEeCCCcEEEEEEecccchh--c------------------------HHHHHHHHHHHhcCCCCce
Q 016347 49 INKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQ--G------------------------VKEFLTEIQVISEIEHENL 102 (391)
Q Consensus 49 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~~i 102 (391)
.+.||+|++|.||+|.+.+|+.||+|+++..... . ......|++.+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 5789999999999999888999999998754211 0 0122349999999987766
Q ss_pred eEEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHh-hhcCCCCeeecCCCCCcEE
Q 016347 103 VKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFL-HEEVRPHIIHRDIKASNIL 181 (391)
Q Consensus 103 v~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~l-H~~~~~~i~H~dikp~NIl 181 (391)
.....+... ..++||||++|+++...+.. ...++...+..++.|++.+|.++ |+. |++||||||+|||
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~------~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIl 150 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLK------DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLL 150 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhh------cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEE
Confidence 433332222 23899999998877654322 22588999999999999999999 688 9999999999999
Q ss_pred ECCCCcEEEEeccccccc
Q 016347 182 LDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 182 v~~~~~~kl~Dfg~~~~~ 199 (391)
++ ++.++|+|||++...
T Consensus 151 i~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 151 YH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred EE-CCcEEEEEccccccC
Confidence 98 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=179.23 Aligned_cols=233 Identities=19% Similarity=0.229 Sum_probs=152.3
Q ss_pred CCCCceeeccCceEEEEEEeCC-CcEEEEEEecccc---hhcHHHHHHHHHHHhcCCC----------CceeEEEEEEE-
Q 016347 46 FSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAES---RQGVKEFLTEIQVISEIEH----------ENLVKLYGCCV- 110 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~~iv~~~~~~~- 110 (391)
+...+.||.|+++.||.+.+.. |+.+|+|++.... ....+++.+|.-....+.+ -.++..++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4556789999999999999884 9999999876442 3345667777655555322 12222222221
Q ss_pred --------eC---C-----eeEEEEecccCCCHHHHHhc---CCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 016347 111 --------EG---N-----HRILVYNYLENNSLAQTLIG---GGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHII 171 (391)
Q Consensus 111 --------~~---~-----~~~lv~e~~~~~sL~~~i~~---~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~ 171 (391)
.. . ..+++|+-+ .++|.+++.. ... ....+.......+..|+++.+++||.. |++
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~--~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlV 167 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQ--THSPLAFAARLSLTVQMIRLVANLHSY---GLV 167 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTT--TSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhccc--ccchhHHHHHHHHHHHHHHHHHHHhhc---ceE
Confidence 11 1 235677766 4578777542 211 234466677788889999999999999 999
Q ss_pred ecCCCCCcEEECCCCcEEEEecccccccCCCCceeeeeecccccccChhhhhcC--------CCCCCCcEeehhHHHHHH
Q 016347 172 HRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRG--------QVTRKADIYSFGVLLVEI 243 (391)
Q Consensus 172 H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~k~DvwSlG~vl~el 243 (391)
|+||+|+|++++.+|.++|+||+.....+.. ......+..|.+||..... .++.+.|.|+||+++|.|
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 9999999999999999999999887754321 1113345779999976442 478899999999999999
Q ss_pred HhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCC
Q 016347 244 VSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLR 309 (391)
Q Consensus 244 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 309 (391)
+||..||....+...... .+ ..+. +.+..+..||..+|+.||.+|
T Consensus 244 WC~~lPf~~~~~~~~~~~-------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW-------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG-------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc-------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999986644322110 11 2334 778889999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.7e-22 Score=169.81 Aligned_cols=141 Identities=16% Similarity=0.210 Sum_probs=110.9
Q ss_pred CCceeeccCceEEEEEEeCCCcEEEEEEecccchhc--------------------------HHHHHHHHHHHhcCCCCc
Q 016347 48 PINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQG--------------------------VKEFLTEIQVISEIEHEN 101 (391)
Q Consensus 48 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~~ 101 (391)
+.+.||+|++|.||+|.+.+|+.||||+++...... ...+..|.+.+.++.+++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 357899999999999998789999999987652110 112357889999999888
Q ss_pred eeEEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcE
Q 016347 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHE-EVRPHIIHRDIKASNI 180 (391)
Q Consensus 102 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~i~H~dikp~NI 180 (391)
+.....+... ..++||||++|+++...... ...++...+..++.|++.++.++|+ . |++|+||||+||
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~------~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NI 149 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLK------DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNI 149 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhh------hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhE
Confidence 7544433332 24899999998855443221 1247788899999999999999999 8 999999999999
Q ss_pred EECCCCcEEEEecccccccC
Q 016347 181 LLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 181 lv~~~~~~kl~Dfg~~~~~~ 200 (391)
+++ ++.++|+|||++....
T Consensus 150 ll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 150 LYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred EEE-CCCEEEEEcccceecC
Confidence 998 8899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-23 Score=197.36 Aligned_cols=231 Identities=25% Similarity=0.292 Sum_probs=182.4
Q ss_pred eeccCceEEEEEEe----CCCcEEEEEEecccch--hcHHHHHHHHHHHhcCC-CCceeEEEEEEEeCCeeEEEEecccC
Q 016347 52 IGEGGFGSVYKGRL----KDGKIAAIKVLSAESR--QGVKEFLTEIQVISEIE-HENLVKLYGCCVEGNHRILVYNYLEN 124 (391)
Q Consensus 52 lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~ 124 (391)
+|.|.||.|++++. ..|+.+|+|++.+... ........|..++..++ ||.+++++-.+..+...+++.++..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 79999999999862 2478899998876522 11224556888888886 99999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc
Q 016347 125 NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204 (391)
Q Consensus 125 ~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~ 204 (391)
|.|...+... ..+.+.....+...++-+++++|+. +++|+|+|++||+++.+|.+++.|||+.+..-....
T Consensus 82 g~lft~l~~~------~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 82 GDLFTRLSKE------VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred chhhhccccC------CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 9888777543 3477777888888999999999999 999999999999999999999999999987543322
Q ss_pred eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCC
Q 016347 205 HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNG 284 (391)
Q Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (391)
. +||..|||||++. ....++|.||||+++++|+||..||... . .... ... .-
T Consensus 153 ~-----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~---~----~~~I------------l~~--~~ 204 (612)
T KOG0603|consen 153 A-----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD---T----MKRI------------LKA--EL 204 (612)
T ss_pred c-----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH---H----HHHH------------hhh--cc
Confidence 1 8999999999987 6788999999999999999999999751 0 0100 000 11
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCH--HHHHHHh
Q 016347 285 DFDAEEACRFLKVGLLCTQDTPKLRPSM--STVVQML 319 (391)
Q Consensus 285 ~~~~~~~~~l~~li~~cl~~dP~~Rps~--~evl~~l 319 (391)
..+.+.......++..++..+|..|.-. ..+.+..
T Consensus 205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 205 EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 3455667778888889999999999865 3444443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.9e-22 Score=200.96 Aligned_cols=201 Identities=22% Similarity=0.252 Sum_probs=162.9
Q ss_pred chHHHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCC---CCceeEEEEEEEe
Q 016347 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIE---HENLVKLYGCCVE 111 (391)
Q Consensus 35 ~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~ 111 (391)
...+.++.++.|.+.+.||+|+||+||+|...+|+.||+|+-...+....-- -.+++.+|+ -+.|..+...+.-
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI---~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI---CLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee---hHHHHHhhchhhhcchHHHHHHHcc
Confidence 5566777889999999999999999999998889999999987665543221 223344443 3445556666666
Q ss_pred CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-------
Q 016347 112 GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK------- 184 (391)
Q Consensus 112 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~------- 184 (391)
.+..++|+||.+.|+|.+++. ..+.+++..++.++.|++..+..||.. +||||||||+|.||..
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N------~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~ 836 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLIN------TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSD 836 (974)
T ss_pred CCcceeeeeccccccHHHhhc------cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCc
Confidence 778899999999999999997 345699999999999999999999999 9999999999999942
Q ss_pred CCcEEEEecccccccCCCC-ceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCC
Q 016347 185 DLTPKISDFGLAKLIPANM-THVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247 (391)
Q Consensus 185 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~ 247 (391)
+..++|+|||.+-.+.--. .......++|-.+-.+|+..+.+++..+|.|+|+.+++-|+.|+
T Consensus 837 ~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 837 SKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 3468999999986542111 12334467899999999999999999999999999999999986
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.8e-21 Score=161.42 Aligned_cols=188 Identities=18% Similarity=0.100 Sum_probs=139.9
Q ss_pred CCCCceeeccCceEEEEEEeCCCcEEEEEEecccchh----cHHHHHHHHHHHhcCC-CCceeEEEEEEEeCCeeEEEEe
Q 016347 46 FSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQ----GVKEFLTEIQVISEIE-HENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 120 (391)
+.....|++|+||+|+.+.. .+.+++.+.+...... ....+.+|+++|+++. ++++++++++ ...+++||
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 34567899999999998877 5777777766544221 1225788999999995 5789999886 34699999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC-CCCcEEECCCCcEEEEeccccccc
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDI-KASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~di-kp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
|+.|.+|...+.. . ...++.|++.+|.++|++ ||+|||| ||.|||++.+|.++|+|||++...
T Consensus 79 yI~G~~L~~~~~~----------~---~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~ 142 (218)
T PRK12274 79 YLAGAAMYQRPPR----------G---DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRG 142 (218)
T ss_pred eecCccHHhhhhh----------h---hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence 9999988654311 1 134778999999999999 9999999 799999999999999999999865
Q ss_pred CCCCce----e--------eeeecccccccChhhhhcC-CCC-CCCcEeehhHHHHHHHhCCCCCCCCC
Q 016347 200 PANMTH----V--------STRVAGTIGYLAPEYAIRG-QVT-RKADIYSFGVLLVEIVSGRCNTNMRL 254 (391)
Q Consensus 200 ~~~~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~k~DvwSlG~vl~elltg~~p~~~~~ 254 (391)
...... . ......++.|++|+...-- ..+ ...+.++.|+-+|.++||+.+.-.+.
T Consensus 143 ~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 143 NPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred CCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 433210 0 0112357788888864322 223 56788999999999999998875443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.9e-20 Score=159.92 Aligned_cols=136 Identities=17% Similarity=0.278 Sum_probs=105.9
Q ss_pred CCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcC-----CCCceeEEEEEEEeCC---e-e
Q 016347 46 FSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEI-----EHENLVKLYGCCVEGN---H-R 115 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~---~-~ 115 (391)
+.-.+.||+|++|.||. ++ ++.. +||++........+.+.+|+.+++.+ .||||+++++++.++. . .
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 34567899999999996 44 3444 68988765444557789999999999 5799999999998763 3 3
Q ss_pred EEEEec--ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHH-HHhhhcCCCCeeecCCCCCcEEECC----CCcE
Q 016347 116 ILVYNY--LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGL-AFLHEEVRPHIIHRDIKASNILLDK----DLTP 188 (391)
Q Consensus 116 ~lv~e~--~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al-~~lH~~~~~~i~H~dikp~NIlv~~----~~~~ 188 (391)
.+|+|| +.+++|.+++... .+++. ..++.|++.++ .|||++ +|+||||||+|||++. ++.+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-------~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~ 148 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-------RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIP 148 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-------cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcE
Confidence 378999 5579999999542 24544 35677888777 999999 9999999999999974 3489
Q ss_pred EEEecccc
Q 016347 189 KISDFGLA 196 (391)
Q Consensus 189 kl~Dfg~~ 196 (391)
+|+||+..
T Consensus 149 ~LiDg~G~ 156 (210)
T PRK10345 149 VVCDNIGE 156 (210)
T ss_pred EEEECCCC
Confidence 99995543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.8e-20 Score=176.17 Aligned_cols=216 Identities=26% Similarity=0.421 Sum_probs=161.1
Q ss_pred HhcCCCCceeEEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCe-ee
Q 016347 94 ISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHI-IH 172 (391)
Q Consensus 94 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i-~H 172 (391)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....+++.-...++.+|+.||.|||.- .| .|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-----~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~h 72 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-----EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYH 72 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-----cccCccHHHHHHHHHHHHHHHHHHhcC---cceee
Confidence 4678999999999999999999999999999999999975 334688889999999999999999987 44 99
Q ss_pred cCCCCCcEEECCCCcEEEEecccccccCCCCc-eeeeeecccccccChhhhhcC-------CCCCCCcEeehhHHHHHHH
Q 016347 173 RDIKASNILLDKDLTPKISDFGLAKLIPANMT-HVSTRVAGTIGYLAPEYAIRG-------QVTRKADIYSFGVLLVEIV 244 (391)
Q Consensus 173 ~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-------~~~~k~DvwSlG~vl~ell 244 (391)
+.++..|.+++..+.+||+|||+......... .......-..-|.|||.+... ..+.+.||||||++++|++
T Consensus 73 g~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 73 GALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred eeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 99999999999999999999999887642111 111112234579999988653 1577899999999999999
Q ss_pred hCCCCCCCCCCcchh-hHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 245 SGRCNTNMRLPTEEQ-YLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 245 tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
+...||......... .+...... .....+.+.+... .+....+..++..||..+|.+||+++++-..+....
T Consensus 153 ~r~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 153 FRSGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred hccCccccccccCChHHHHHHHHh-----cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 999999764333221 11111111 0111122221111 033347888999999999999999999988776554
Q ss_pred C
Q 016347 324 D 324 (391)
Q Consensus 324 ~ 324 (391)
.
T Consensus 226 ~ 226 (484)
T KOG1023|consen 226 K 226 (484)
T ss_pred c
Confidence 3
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=161.07 Aligned_cols=141 Identities=17% Similarity=0.157 Sum_probs=110.8
Q ss_pred CCCCCceeeccCceEEEEEE--eCCCcEEEEEEecccchh------------------------cHHHHHHHHHHHhcCC
Q 016347 45 DFSPINKIGEGGFGSVYKGR--LKDGKIAAIKVLSAESRQ------------------------GVKEFLTEIQVISEIE 98 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~ 98 (391)
.|++.+.||+|++|.||+|. ..+|+.||+|++...... ....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48999999999999999998 457999999998754210 0123567999999996
Q ss_pred CC--ceeEEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCC-eeecCC
Q 016347 99 HE--NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPH-IIHRDI 175 (391)
Q Consensus 99 h~--~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~-i~H~di 175 (391)
+. .+.+++++ ...++||||++|.+|....... ..+....+..++.||+.++.+||+. | ++|+||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Di 175 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD------VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDL 175 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc------CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCC
Confidence 53 34445543 2358999999998886654221 2355667789999999999999999 9 999999
Q ss_pred CCCcEEECCCCcEEEEeccccccc
Q 016347 176 KASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 176 kp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+||+++ ++.++|+|||.+...
T Consensus 176 kp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 176 SEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred ChhhEEEE-CCCEEEEEChhhhcc
Confidence 99999999 889999999988754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.6e-20 Score=183.64 Aligned_cols=210 Identities=24% Similarity=0.322 Sum_probs=145.0
Q ss_pred hCCCCCCceeeccCceEEEEEEeCC-CcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
..+|..++.|..|++|.||+++++. .+.+|+|+ ++.+.- +++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li----lRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI----LRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccchh----hhc---cccccCCccee------------------
Confidence 4789999999999999999999874 77888853 322111 111 23333444433
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
|+-...+..-+ +++.. ++.+++|||+. ||+|+|+||+|++|+.=|++|++|||+.+....
T Consensus 136 ---gDc~tllk~~g------~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 ---GDCATLLKNIG------PLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred ---chhhhhcccCC------CCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 33334443221 24433 27899999999 999999999999999999999999999875421
Q ss_pred CC---------ce-----eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 016347 202 NM---------TH-----VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWD 267 (391)
Q Consensus 202 ~~---------~~-----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 267 (391)
.. .. ....++||+.|+|||++..+.|...+|.|++|+|+|+.+-|..||.++.+.+--.....
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis--- 272 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS--- 272 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh---
Confidence 10 00 11236899999999999999999999999999999999999999998866442111100
Q ss_pred HhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 016347 268 LYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSM 312 (391)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 312 (391)
+.+.+.+. ......+..+++.+.|+.+|..|.-.
T Consensus 273 -----d~i~wpE~------dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 273 -----DDIEWPEE------DEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred -----hhcccccc------CcCCCHHHHHHHHHHHHhChHhhccc
Confidence 11111111 12223456677778999999999643
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=153.13 Aligned_cols=135 Identities=24% Similarity=0.303 Sum_probs=112.5
Q ss_pred CceeeccCceEEEEEEeCCCcEEEEEEecccch--------hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 49 INKIGEGGFGSVYKGRLKDGKIAAIKVLSAESR--------QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 49 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
++.||+|++|.||+|.+ .|..+++|+...... .....+.+|+.++..+.|+++.....++......+++||
T Consensus 1 ~~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred CcccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 36799999999999988 577788997654321 112357789999999999998877777777778899999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|++|++|.+.+... .. .+..++.+++.+|.++|+. +++|+|++|.|||++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~---------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSN---------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhc---------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999988532 12 7889999999999999999 999999999999999 78999999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.1e-18 Score=149.88 Aligned_cols=145 Identities=21% Similarity=0.173 Sum_probs=112.7
Q ss_pred HHHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchh----------------------cHHHHHHHHHHH
Q 016347 37 KELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQ----------------------GVKEFLTEIQVI 94 (391)
Q Consensus 37 ~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l 94 (391)
+++.....-|.+.+.||.|+||.||++...+|+.||||++...... ....+..|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 3444444449999999999999999999888999999987643210 112356788888
Q ss_pred hcCCCC--ceeEEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 016347 95 SEIEHE--NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIH 172 (391)
Q Consensus 95 ~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H 172 (391)
..+.++ .+...++ ....++||||++|++|..... ......++.+++.++.++|+. |++|
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------------~~~~~~~~~~i~~~l~~lh~~---gi~H 148 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV------------LEDPEEVLDEILEEIVKAYKH---GIIH 148 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc------------cccHHHHHHHHHHHHHHHHHC---CCCc
Confidence 888776 4444443 235689999999998876542 034567889999999999999 9999
Q ss_pred cCCCCCcEEECCCCcEEEEecccccccC
Q 016347 173 RDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 173 ~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
+||+|.||+++.++.++|+|||.+....
T Consensus 149 ~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 149 GDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCCCcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.8e-20 Score=172.48 Aligned_cols=123 Identities=30% Similarity=0.411 Sum_probs=106.8
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
++++.|++|...+|.++|.... .....++.....++.|++.|+.| + +.+|+|+||.||++..+..+||.||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~---~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDF 400 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR---TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDF 400 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC---cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhh
Confidence 5789999999999999996543 33456788889999999999999 6 8999999999999999999999999
Q ss_pred ccccccCCCC-----ceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh
Q 016347 194 GLAKLIPANM-----THVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245 (391)
Q Consensus 194 g~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt 245 (391)
|+........ ....+...||..||+||.+.++.|+.|+|||+||++|+||+.
T Consensus 401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 9997764433 223345689999999999999999999999999999999997
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-18 Score=157.07 Aligned_cols=190 Identities=24% Similarity=0.275 Sum_probs=136.5
Q ss_pred CCCceeEEEEEEEe---------------------------CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHH
Q 016347 98 EHENLVKLYGCCVE---------------------------GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSR 150 (391)
Q Consensus 98 ~h~~iv~~~~~~~~---------------------------~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~ 150 (391)
+|||||.++++|.+ +..+|+||.-++ .+|..++- ....+.....-
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~-------~~~~s~r~~~~ 345 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLW-------TRHRSYRTGRV 345 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHh-------cCCCchHHHHH
Confidence 59999999887632 245789998875 48999984 33467778888
Q ss_pred HHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE--CCCC--cEEEEecccccccCCCCc-----eeeeeecccccccChhh
Q 016347 151 ICIGIARGLAFLHEEVRPHIIHRDIKASNILL--DKDL--TPKISDFGLAKLIPANMT-----HVSTRVAGTIGYLAPEY 221 (391)
Q Consensus 151 i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv--~~~~--~~kl~Dfg~~~~~~~~~~-----~~~~~~~gt~~y~aPE~ 221 (391)
++.|+++|+.|||.+ |+.|||+|.+|||+ ++++ .+.|+|||.+-......- .......|...-||||+
T Consensus 346 ~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi 422 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI 422 (598)
T ss_pred HHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence 999999999999999 99999999999999 3443 568899998765433211 11223457888999998
Q ss_pred hhcCC------CCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHH
Q 016347 222 AIRGQ------VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFL 295 (391)
Q Consensus 222 ~~~~~------~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 295 (391)
....+ --.|+|.|+.|.+.||+++...||...-... +... .+...++ ...+...+..+.
T Consensus 423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~---L~~r---~Yqe~qL---------Palp~~vpp~~r 487 (598)
T KOG4158|consen 423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML---LDTR---TYQESQL---------PALPSRVPPVAR 487 (598)
T ss_pred hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe---echh---hhhhhhC---------CCCcccCChHHH
Confidence 75432 2368999999999999999999997621111 0000 0111111 122344566788
Q ss_pred HHHhhccCCCCCCCCCHH
Q 016347 296 KVGLLCTQDTPKLRPSMS 313 (391)
Q Consensus 296 ~li~~cl~~dP~~Rps~~ 313 (391)
+++...|+.||++|++..
T Consensus 488 qlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 488 QLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred HHHHHHhcCCccccCCcc
Confidence 999999999999999854
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.9e-18 Score=169.24 Aligned_cols=141 Identities=21% Similarity=0.283 Sum_probs=113.0
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEeccc-c------hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAE-S------RQGVKEFLTEIQVISEIEHENLVKLYGCCVEG 112 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (391)
......|...+.||+|+||+||+|.+..+..++.+.+... . ......+.+|+++++.++|++++....++...
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 3334566778999999999999998875443332222211 1 11234678899999999999998887777777
Q ss_pred CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEe
Q 016347 113 NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISD 192 (391)
Q Consensus 113 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~D 192 (391)
...++||||++|++|.+++. ....++.+++.+|.+||+. +++||||||+|||+ .++.++|+|
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liD 470 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE--------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLID 470 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEe
Confidence 77899999999999998873 3467899999999999999 99999999999999 577999999
Q ss_pred cccccc
Q 016347 193 FGLAKL 198 (391)
Q Consensus 193 fg~~~~ 198 (391)
||+++.
T Consensus 471 FGla~~ 476 (535)
T PRK09605 471 FGLGKY 476 (535)
T ss_pred Cccccc
Confidence 999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.8e-18 Score=147.75 Aligned_cols=130 Identities=26% Similarity=0.358 Sum_probs=104.7
Q ss_pred eeeccCceEEEEEEeCCCcEEEEEEecccc--------hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecc
Q 016347 51 KIGEGGFGSVYKGRLKDGKIAAIKVLSAES--------RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYL 122 (391)
Q Consensus 51 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 122 (391)
.||+|++|.||+|.+. +..+++|...... ......+.+|++++..+.|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 3899999999999964 6788989854321 111355778999999998887655555555666779999999
Q ss_pred cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 123 ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
+|++|.+.+.... . .++.+++.+|.+||+. |++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~-------~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-------D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-------H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998874321 1 7889999999999999 999999999999999 88999999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.7e-17 Score=138.35 Aligned_cols=137 Identities=20% Similarity=0.227 Sum_probs=98.3
Q ss_pred CceeeccCceEEEEEEeCCCcEEEEEEecccchh--cHHH----------------------HHHHHHHHhcCCCC--ce
Q 016347 49 INKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQ--GVKE----------------------FLTEIQVISEIEHE--NL 102 (391)
Q Consensus 49 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~--~i 102 (391)
.+.||+|+||.||+|.+.+|+.||||++...... .... ...|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 5689999999999999888999999998754211 1111 12455556555433 24
Q ss_pred eEEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEE
Q 016347 103 VKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHE-EVRPHIIHRDIKASNIL 181 (391)
Q Consensus 103 v~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~i~H~dikp~NIl 181 (391)
.+++++ ...++||||++++.+........ ... ..+..++.+++.++.++|. . +++|+||||+||+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~------~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nil 147 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV------RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNIL 147 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh------hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEE
Confidence 444443 24689999999854322111000 011 5678899999999999999 8 9999999999999
Q ss_pred ECCCCcEEEEecccccccC
Q 016347 182 LDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 182 v~~~~~~kl~Dfg~~~~~~ 200 (391)
++ ++.++|+|||.+....
T Consensus 148 i~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred EE-CCcEEEEECccccccc
Confidence 99 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.9e-16 Score=130.77 Aligned_cols=135 Identities=21% Similarity=0.236 Sum_probs=113.1
Q ss_pred CCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCC--CceeEEEEEEEeCCeeEEEEecccCC
Q 016347 48 PINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEH--ENLVKLYGCCVEGNHRILVYNYLENN 125 (391)
Q Consensus 48 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~ 125 (391)
+++.||.|.++.||++...+ ..+++|....... ...+..|+..++.+++ .++++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 46789999999999999864 7899998865433 4678889999999976 58999998888778899999999887
Q ss_pred CHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 126 SLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 126 sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
.+..+ +......++.+++.++.++|.....+++|+|++|.||+++.++.++++|||.+..
T Consensus 79 ~~~~~-------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 66432 4556677889999999999986334799999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.68 E-value=7.1e-16 Score=137.38 Aligned_cols=134 Identities=19% Similarity=0.242 Sum_probs=103.1
Q ss_pred ceee-ccCceEEEEEEeCCCcEEEEEEecccc-------------hhcHHHHHHHHHHHhcCCCCce--eEEEEEEEeCC
Q 016347 50 NKIG-EGGFGSVYKGRLKDGKIAAIKVLSAES-------------RQGVKEFLTEIQVISEIEHENL--VKLYGCCVEGN 113 (391)
Q Consensus 50 ~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~ 113 (391)
..|| .|+.|+||.+... +..++||.+.... ......+.+|++++..+.|++| +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 3587 8999999999886 6778888774311 1223457789999999988775 66776644322
Q ss_pred ----eeEEEEecccC-CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcE
Q 016347 114 ----HRILVYNYLEN-NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTP 188 (391)
Q Consensus 114 ----~~~lv~e~~~~-~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~ 188 (391)
..++|||+++| .+|.+++... .++.. .+.+|+.+|.+||+. ||+|+||||.|||++.++.+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~-------~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA-------PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKF 181 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC-------CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCE
Confidence 23599999997 6898887432 24443 356899999999999 99999999999999999999
Q ss_pred EEEecccccc
Q 016347 189 KISDFGLAKL 198 (391)
Q Consensus 189 kl~Dfg~~~~ 198 (391)
+|+|||.+..
T Consensus 182 ~LIDfg~~~~ 191 (239)
T PRK01723 182 WLIDFDRGEL 191 (239)
T ss_pred EEEECCCccc
Confidence 9999998875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=7.9e-18 Score=167.54 Aligned_cols=255 Identities=22% Similarity=0.250 Sum_probs=191.3
Q ss_pred hhCCCCCCceeeccCceEEEEEEeCC--CcEEEEEEecccc--hhcHHHHHHHHHHHhcCC-CCceeEEEEEEEeCCeeE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLKD--GKIAAIKVLSAES--RQGVKEFLTEIQVISEIE-HENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 116 (391)
....|.+.+.||+|+|+.|-+..... ...+|+|.+.... .........|..+-..+. |+|++.+++.....+..+
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 35678999999999999998887643 4456666655442 233344455777777776 999999999999999999
Q ss_pred EEEecccCCCHHHHHh-cCCCCCCccccCHHHHHHHHHHHHHHHHHhh-hcCCCCeeecCCCCCcEEECCCC-cEEEEec
Q 016347 117 LVYNYLENNSLAQTLI-GGGHHYSNIQFSWRTRSRICIGIARGLAFLH-EEVRPHIIHRDIKASNILLDKDL-TPKISDF 193 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~-~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH-~~~~~~i~H~dikp~NIlv~~~~-~~kl~Df 193 (391)
++.+|..|+++.+.+. .. ....+...+-.++.|+..++.|+| .. ++.|+||||+|.+++.++ ..+++||
T Consensus 98 ~~~~~s~g~~~f~~i~~~~-----~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df 169 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPD-----STGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADF 169 (601)
T ss_pred cccCcccccccccccccCC-----ccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCc
Confidence 9999999999888773 22 124566677788999999999999 77 999999999999999999 9999999
Q ss_pred ccccccCC--CCceeeeeecc-cccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh
Q 016347 194 GLAKLIPA--NMTHVSTRVAG-TIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLY 269 (391)
Q Consensus 194 g~~~~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 269 (391)
|++..+.. +........+| ++.|+|||...+. ...+..|+||.|+++..+++|..|+.........+..
T Consensus 170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~------- 242 (601)
T KOG0590|consen 170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS------- 242 (601)
T ss_pred hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccccee-------
Confidence 99988755 33334445678 9999999988775 4578899999999999999999999765544322111
Q ss_pred hhcccceeeeccC--CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 270 ERRELILLVDTSL--NGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 270 ~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
+..... .............+++.+++..+|..|.+.+++-..
T Consensus 243 -------~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 243 -------WKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred -------ecccccccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 111100 011112233456677778999999999998887543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.58 E-value=9.5e-15 Score=141.19 Aligned_cols=141 Identities=21% Similarity=0.291 Sum_probs=99.0
Q ss_pred CceeeccCceEEEEEEeCCCcEEEEEEecccchhcHH----------------------------------------HHH
Q 016347 49 INKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVK----------------------------------------EFL 88 (391)
Q Consensus 49 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~ 88 (391)
.+.||.|++|.||+|++.+|+.||||+.+........ +|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 3689999999999999999999999998654211100 234
Q ss_pred HHHHHHhcC----CCCceeEEEEEE-EeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHH-HHHHh
Q 016347 89 TEIQVISEI----EHENLVKLYGCC-VEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR-GLAFL 162 (391)
Q Consensus 89 ~e~~~l~~l----~h~~iv~~~~~~-~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~-al~~l 162 (391)
+|...+.++ ++.+-+.+-..+ ......++||||++|++|.+....... .. ....++.+++. .+..+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-----~~---~~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-----GL---DRKALAENLARSFLNQV 273 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-----CC---CHHHHHHHHHHHHHHHH
Confidence 455555554 232223322222 224467999999999999887642110 11 23445666665 46788
Q ss_pred hhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 163 HEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 163 H~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|.. |++|+|++|.||+++.+|.++|+|||++..+.
T Consensus 274 ~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 274 LRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 988 99999999999999999999999999987664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.5e-15 Score=132.11 Aligned_cols=204 Identities=21% Similarity=0.299 Sum_probs=140.8
Q ss_pred HHHHhcCCCCceeEEEEEEEeCC-----eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhc
Q 016347 91 IQVISEIEHENLVKLYGCCVEGN-----HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEE 165 (391)
Q Consensus 91 ~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~ 165 (391)
...|-++.|.|||+++.|+.+.+ ...++.||+..|+|..+++.... ..+.+......+|+-||+.||.|||+
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~--~~~a~~~~~wkkw~tqIlsal~yLhs- 194 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK--NQKALFQKAWKKWCTQILSALSYLHS- 194 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH--hhhhhhHHHHHHHHHHHHhhhhhhhc-
Confidence 34455567999999999886543 46889999999999999986432 56678889999999999999999999
Q ss_pred CCCCeeecCCCCCcEEECCCCcEEEEecccccccCCC---Cc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHH
Q 016347 166 VRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN---MT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLV 241 (391)
Q Consensus 166 ~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~---~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ 241 (391)
|.+.++|+++..+-|++..+|-+|+.- +-....... .. .......+.++|.+||.=..-+.+-++|||+||...+
T Consensus 195 ~~PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 195 CDPPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL 273 (458)
T ss_pred cCCccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence 578899999999999999998888742 111111000 00 0011134678999999755566778999999999999
Q ss_pred HHHhCCCCC-CCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 242 EIVSGRCNT-NMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 242 elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
+|..+..-. .......... ............+ -..++..|++..|..||+|++++.+
T Consensus 274 emailEiq~tnseS~~~~ee---------~ia~~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 274 EMAILEIQSTNSESKVEVEE---------NIANVIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHHHheeccCCCcceeehhh---------hhhhheeeccCcc-----------ccCcCcccccCCCCCCcchhhhhcC
Confidence 998775321 1111111100 0011111112222 1245678999999999999998854
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.5e-14 Score=135.78 Aligned_cols=248 Identities=23% Similarity=0.270 Sum_probs=178.5
Q ss_pred CCCCCCceeec--cCceEEEEEEe--C-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCee
Q 016347 44 DDFSPINKIGE--GGFGSVYKGRL--K-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 44 ~~y~~~~~lg~--G~~g~V~~~~~--~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 115 (391)
+.+.+.+.+|. |.+|.||.+.. . ++..+|+|.-... .......=.+|+...+.+ .|++.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 56788889999 99999999987 3 5888898873322 122222233455555566 599999988888899999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHH----HHHHhhhcCCCCeeecCCCCCcEEECCC-CcEEE
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR----GLAFLHEEVRPHIIHRDIKASNILLDKD-LTPKI 190 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~----al~~lH~~~~~~i~H~dikp~NIlv~~~-~~~kl 190 (391)
++-+|.+. .+|..+..... ..++...++....+..+ ||.++|+. +++|-|+||.||+...+ ...++
T Consensus 194 fiqtE~~~-~sl~~~~~~~~-----~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPC-----NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred eeeecccc-chhHHhhhccc-----ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeec
Confidence 99999884 67888775432 34777888888888888 99999999 99999999999999999 78899
Q ss_pred EecccccccCCCCce----eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCC-CCcchhhHHHHH
Q 016347 191 SDFGLAKLIPANMTH----VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMR-LPTEEQYLLERT 265 (391)
Q Consensus 191 ~Dfg~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~-~~~~~~~~~~~~ 265 (391)
+|||+...+....-. ......|...|++||.. .+-++.+.|+|+||.++.+..+|..+.... .. .
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~---------~ 334 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS---------S 334 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC---------C
Confidence 999999988654311 11223577889999955 778899999999999999998886554321 11 1
Q ss_pred HHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 266 WDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
|....+.. +..++-..-...+...+..|++.+|..|++.+.+..+
T Consensus 335 W~~~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 335 WSQLRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred cccccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 11111100 1111111112234447788999999999998777654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.1e-13 Score=135.53 Aligned_cols=146 Identities=18% Similarity=0.269 Sum_probs=98.2
Q ss_pred hCCCCCCceeeccCceEEEEEEeCC-CcEEEEEEecccchhc----------------------------------HH--
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQG----------------------------------VK-- 85 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~-- 85 (391)
...|+. +.||.|++|.||+|++++ |+.||||+++..-... .+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 455776 799999999999999987 9999999997542110 01
Q ss_pred ----HHHHHHHHHhcC----CCCceeEEEEEEEe-CCeeEEEEecccCCCHHHHH--hcCCCCCCccccCHHHHHHHHHH
Q 016347 86 ----EFLTEIQVISEI----EHENLVKLYGCCVE-GNHRILVYNYLENNSLAQTL--IGGGHHYSNIQFSWRTRSRICIG 154 (391)
Q Consensus 86 ----~~~~e~~~l~~l----~h~~iv~~~~~~~~-~~~~~lv~e~~~~~sL~~~i--~~~~~~~~~~~l~~~~~~~i~~q 154 (391)
++.+|+..+.++ .+.+.+.+-..+.+ ....+|||||++|+.+.++. ...+. ....+....+..++.|
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~--d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGT--DMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCC--CHHHHHHHHHHHHHHH
Confidence 133344444444 24444444444433 45789999999999998743 22111 1223344444444444
Q ss_pred HHHHHHHhhhcCCCCeeecCCCCCcEEECCCC----cEEEEecccccccCC
Q 016347 155 IARGLAFLHEEVRPHIIHRDIKASNILLDKDL----TPKISDFGLAKLIPA 201 (391)
Q Consensus 155 i~~al~~lH~~~~~~i~H~dikp~NIlv~~~~----~~kl~Dfg~~~~~~~ 201 (391)
+. .. |++|+|++|.||+++.+| +++++|||++..+..
T Consensus 276 if-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 VF-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HH-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 43 45 999999999999999888 999999999987643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.9e-13 Score=129.95 Aligned_cols=165 Identities=15% Similarity=0.208 Sum_probs=128.0
Q ss_pred CCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCH
Q 016347 66 KDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSW 145 (391)
Q Consensus 66 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~ 145 (391)
.++.+|.|......+........+-++.|+.++||||+++++.++..+..|+|+|-+. .|..++.. +..
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---------l~~ 103 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE---------LGK 103 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH---------hHH
Confidence 3578888887776655445667788999999999999999999999999999999875 46666643 446
Q ss_pred HHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCceeeeeecccccccChhhhhcC
Q 016347 146 RTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRG 225 (391)
Q Consensus 146 ~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 225 (391)
..+...+.||+.||.+||..| +++|++|.-+.|+|+..|..||++|-++........ ......--..|..|+.+...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence 677788899999999999775 899999999999999999999999998876433221 11111122346677654322
Q ss_pred CCCCCCcEeehhHHHHHHHhC
Q 016347 226 QVTRKADIYSFGVLLVEIVSG 246 (391)
Q Consensus 226 ~~~~k~DvwSlG~vl~elltg 246 (391)
. -..|.|.|||++++++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 356999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.8e-13 Score=114.44 Aligned_cols=131 Identities=20% Similarity=0.199 Sum_probs=96.1
Q ss_pred CceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCcee-EEEEEEEeCCeeEEEEecccCCCH
Q 016347 49 INKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLV-KLYGCCVEGNHRILVYNYLENNSL 127 (391)
Q Consensus 49 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~sL 127 (391)
++.|+.|.++.||++... ++.|++|+...... ....+..|+.+++.+.+.+++ +++.+. ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 578899999999999976 77899998765432 123467789999888654443 455443 3346899999999877
Q ss_pred HHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 128 AQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV--RPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 128 ~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
.... . ....++.+++.+|+.||+.. ..+++|+|++|.||+++ ++.++++||+.+..
T Consensus 79 ~~~~-----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5420 1 11345678999999999982 11259999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.42 E-value=5e-12 Score=107.94 Aligned_cols=137 Identities=15% Similarity=0.139 Sum_probs=99.3
Q ss_pred CceeeccCceEEEEEEeCC-------CcEEEEEEecccc----------------------hhcHHHHH----HHHHHHh
Q 016347 49 INKIGEGGFGSVYKGRLKD-------GKIAAIKVLSAES----------------------RQGVKEFL----TEIQVIS 95 (391)
Q Consensus 49 ~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~~----~e~~~l~ 95 (391)
...||.|--+.||.|...+ +..+|||+.+... ......+. +|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998653 4789999864220 01122333 7999999
Q ss_pred cCCC--CceeEEEEEEEeCCeeEEEEecccCCCHHH-HHhcCCCCCCccccCHHHHHHHHHHHHHHHHHh-hhcCCCCee
Q 016347 96 EIEH--ENLVKLYGCCVEGNHRILVYNYLENNSLAQ-TLIGGGHHYSNIQFSWRTRSRICIGIARGLAFL-HEEVRPHII 171 (391)
Q Consensus 96 ~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~-~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~l-H~~~~~~i~ 171 (391)
++.. -++.+++++ ..-++||||+.+..+.. .+. ...++......+..+++.+|..+ |.. |++
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-------d~~~~~~~~~~i~~~i~~~l~~l~H~~---glV 147 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-------DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLV 147 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-------ccccCHHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 9843 456666654 45789999997654322 221 11245556678889999999999 787 999
Q ss_pred ecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 172 HRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 172 H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
||||++.|||++ ++.++|+|||.+....
T Consensus 148 HGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 148 HADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred cCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999999997 4689999999887543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.1e-12 Score=125.64 Aligned_cols=260 Identities=20% Similarity=0.198 Sum_probs=179.8
Q ss_pred CCcceeechHH-HHHhhCCCCCCceeeccCceEEEEEEeC--CCcEEEEEEecccchhcHH--HHHHHHHHHhcC-CCCc
Q 016347 28 IHNVKLYSYKE-LSIATDDFSPINKIGEGGFGSVYKGRLK--DGKIAAIKVLSAESRQGVK--EFLTEIQVISEI-EHEN 101 (391)
Q Consensus 28 ~~~~~~~~~~e-~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l-~h~~ 101 (391)
+.-.++|+-.+ ......+|..+..||.|.|+.|+..... ++..|++|-+...-..... .-..|+-+...+ .|.+
T Consensus 248 ~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 248 LKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred cchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccc
Confidence 44567777777 4555688999999999999999998744 5778888876544222112 123455555555 6888
Q ss_pred eeEEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 016347 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNIL 181 (391)
Q Consensus 102 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIl 181 (391)
++.++..+......++--|||+++++...+. ....+.+...+.+..|++.++.++|++ .++|+|++|.||+
T Consensus 328 ~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~------~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~ 398 (524)
T KOG0601|consen 328 SVGKNSSWSQLRQGYIPLEFCEGGSSSLRSV------TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNIL 398 (524)
T ss_pred cCCCCCCccccccccCchhhhcCcchhhhhH------HHHhcCcchhhhhHHHHHhccccccch---hhhccccccccee
Confidence 8887777776677778899999998877662 233578888999999999999999999 9999999999999
Q ss_pred ECCC-CcEEEEecccccccCCCCceeeeeeccccccc--ChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcch
Q 016347 182 LDKD-LTPKISDFGLAKLIPANMTHVSTRVAGTIGYL--APEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEE 258 (391)
Q Consensus 182 v~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~ 258 (391)
+..+ +.-++.|||....+.-. ........++. ++.......+-.+.|+++||..+.+.++|..--...
T Consensus 399 i~~~~~~~~~~~~~~~t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~----- 469 (524)
T KOG0601|consen 399 ISNDGFFSKLGDFGCWTRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG----- 469 (524)
T ss_pred eccchhhhhcccccccccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCccc-----
Confidence 9886 77889999988642111 11111222333 455445567889999999999999999885321100
Q ss_pred hhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 259 QYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
..+..+...... . .......++.+...+...++..||.+.++..+..
T Consensus 470 -------------~~~~~i~~~~~p-~-~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 470 -------------VQSLTIRSGDTP-N-LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred -------------ccceeeeccccc-C-CCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 001111111111 1 1122256777777899999999999988766543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.30 E-value=2e-11 Score=107.71 Aligned_cols=143 Identities=19% Similarity=0.298 Sum_probs=107.9
Q ss_pred CceeeccCceEEEEEEeCCCcEEEEEEecccch-hcHHHHHHHHHHHhcCCC--CceeEEEEEEEeC---CeeEEEEecc
Q 016347 49 INKIGEGGFGSVYKGRLKDGKIAAIKVLSAESR-QGVKEFLTEIQVISEIEH--ENLVKLYGCCVEG---NHRILVYNYL 122 (391)
Q Consensus 49 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~---~~~~lv~e~~ 122 (391)
.+.|+.|..+.||++...+|+.+++|+...... .....+..|.++++.+.+ .++.+++.+.... +..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 367899999999999987678899999765432 134568889999999965 3456677776553 2568999999
Q ss_pred cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcC------------------------------------
Q 016347 123 ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV------------------------------------ 166 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~------------------------------------ 166 (391)
+|.++.+.+.. ..++......++.+++.+|..||+..
T Consensus 83 ~G~~l~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 83 DGRVLRDRLLR-------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred CCEecCCCCCC-------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 99888765421 13666677777788888888887421
Q ss_pred -----------------CCCeeecCCCCCcEEECC--CCcEEEEecccccc
Q 016347 167 -----------------RPHIIHRDIKASNILLDK--DLTPKISDFGLAKL 198 (391)
Q Consensus 167 -----------------~~~i~H~dikp~NIlv~~--~~~~kl~Dfg~~~~ 198 (391)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 135799999999999998 66789999987764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=7.5e-13 Score=133.35 Aligned_cols=252 Identities=20% Similarity=0.213 Sum_probs=172.7
Q ss_pred HHHhhCCCCCCceeeccCceEEEEEEeCC-CcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCe
Q 016347 39 LSIATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNH 114 (391)
Q Consensus 39 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (391)
.....+++.+++.+-.|.++.++.+.-.. |...+.|+..... ....+....+-.++-...+|-++..+-.+.-...
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 45667889999999999999999987542 4333444332221 1111222222222222345555554444445667
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
..++++|+.+++|...++..+ ..+.......+..+.+++++||.. .+.|+|++|.|+++..+|..+++|||
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~------~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~ 949 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSG------CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFG 949 (1205)
T ss_pred cchhhHHhccCCchhhhhcCC------CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccc
Confidence 899999999999999887544 366666677777889999999998 78999999999999999999999998
Q ss_pred cccccCCC----------C--------------------ceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHH
Q 016347 195 LAKLIPAN----------M--------------------THVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIV 244 (391)
Q Consensus 195 ~~~~~~~~----------~--------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ell 244 (391)
.....+-. . ........||+.|.+||...+......+|.|++|+++++.+
T Consensus 950 t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 950 TLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred cccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhh
Confidence 44332100 0 00112256899999999999999999999999999999999
Q ss_pred hCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 016347 245 SGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMS 313 (391)
Q Consensus 245 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 313 (391)
+|..||....+...- ....+..+. ....+........+++...+..+|.+|..+.
T Consensus 1030 ~g~pp~na~tpq~~f-------~ni~~~~~~-------~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIF-------ENILNRDIP-------WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cCCCCCCCcchhhhh-------hccccCCCC-------CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 999999877664321 111111110 1122234445667777888899999998765
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.5e-11 Score=98.30 Aligned_cols=131 Identities=21% Similarity=0.298 Sum_probs=96.5
Q ss_pred ceeeccCceEEEEEEeCCCcEEEEEEe-ccc--chh-----cHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 50 NKIGEGGFGSVYKGRLKDGKIAAIKVL-SAE--SRQ-----GVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~~~~~vavK~~-~~~--~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
..+++|+-+.++.+.+.+. .+++|.- .+. .+. ....-.+|+.++..+.--.|.-..-+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 4588999999999987643 4566642 222 111 123455789999888654444444445566778899999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
++|..|.+.+... ...++..+-..+.-||.. ||+||||.++||++..+ .+.++|||++..
T Consensus 81 I~G~~lkd~l~~~-------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~-~i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCC-cEEEEECCcccc
Confidence 9999999888542 245666777888889999 99999999999999776 499999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=9.2e-11 Score=96.57 Aligned_cols=143 Identities=21% Similarity=0.290 Sum_probs=104.9
Q ss_pred CCceeeccCceEEEEEEeCCCcEEEEEEe-ccc-------chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 48 PINKIGEGGFGSVYKGRLKDGKIAAIKVL-SAE-------SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 48 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~-~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
.+..|-+|+-+.|+++.+. |+.++||.- .+. ..-......+|+.+|.++.--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 6778999999999999997 666666642 211 1223445678999999986555554444566666778999
Q ss_pred ecccC-CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC---cEEEEeccc
Q 016347 120 NYLEN-NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL---TPKISDFGL 195 (391)
Q Consensus 120 e~~~~-~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~---~~kl~Dfg~ 195 (391)
||++| .++.+++..... ..........++.+|-+.+.-||.. +|+||||..+||++..++ .+.|+|||+
T Consensus 90 E~~~g~~~vk~~i~~~~~----~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgl 162 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME----DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGL 162 (229)
T ss_pred EeccchhHHHHHHHHHcc----CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecc
Confidence 99987 467777765321 1223333378888999999999999 999999999999996654 458999999
Q ss_pred ccc
Q 016347 196 AKL 198 (391)
Q Consensus 196 ~~~ 198 (391)
+..
T Consensus 163 s~~ 165 (229)
T KOG3087|consen 163 SSV 165 (229)
T ss_pred hhc
Confidence 875
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.2e-10 Score=107.93 Aligned_cols=172 Identities=17% Similarity=0.259 Sum_probs=130.6
Q ss_pred CceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEE----eCCeeEEEEecccC-CCHHH
Q 016347 56 GFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCV----EGNHRILVYNYLEN-NSLAQ 129 (391)
Q Consensus 56 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~lv~e~~~~-~sL~~ 129 (391)
...+.|++... +|..|++|+++.+..........-++.++++.|+|+|++.+++. .+..+++||+|+++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 34688999865 79999999995543222223344678899999999999998876 34578999999985 47777
Q ss_pred HHhcCCCC---------CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 130 TLIGGGHH---------YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 130 ~i~~~~~~---------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
+-...... ..+...++..+|.++.|++.||.++|+. |+..+-|.|.+|+++.+.+++|...|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 66543221 1334578899999999999999999999 99999999999999999999999988877654
Q ss_pred CCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCC
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRC 248 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~ 248 (391)
.... |.+.+ -.+-|.=-||.+++.|.||..
T Consensus 445 ~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDPT---------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCC---------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 3320 11212 124677889999999999963
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1e-09 Score=101.18 Aligned_cols=260 Identities=15% Similarity=0.138 Sum_probs=157.1
Q ss_pred CCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcC-CCCceeEEEEE------EEe-CCeeEE
Q 016347 46 FSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENLVKLYGC------CVE-GNHRIL 117 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~------~~~-~~~~~l 117 (391)
....+.||+|+-+.+|-.-.- +.. +-|+.+........+ .+..|... .||-+-.=+.+ .-+ +....+
T Consensus 13 i~~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred cCCCccccCCccceeeecchh-hch-hheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 355678999999999876433 222 447766554432222 22333333 45533221111 112 223677
Q ss_pred EEecccCC-CHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 118 VYNYLENN-SLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 118 v~e~~~~~-sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+|..+.|. .+..+..-...........|.-.++.+..++.+.+-||.. |.+-||++++|+||++++.|.|.|-..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence 88887765 2333333222223445678999999999999999999999 9999999999999999999999986655
Q ss_pred cccCCCCceeeeeecccccccChhhhh-----cCCCCCCCcEeehhHHHHHHHhC-CCCCCCCC-------CcchhhHHH
Q 016347 197 KLIPANMTHVSTRVAGTIGYLAPEYAI-----RGQVTRKADIYSFGVLLVEIVSG-RCNTNMRL-------PTEEQYLLE 263 (391)
Q Consensus 197 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlG~vl~elltg-~~p~~~~~-------~~~~~~~~~ 263 (391)
.+..+.. .....+|.+.|.+||.-. +..-+...|.|.||+++++|+.| ++||.+-. +.+......
T Consensus 165 qi~~ng~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 165 QINANGT--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred eeccCCc--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 4432222 223356889999999643 34567889999999999999887 88886532 111000000
Q ss_pred HHHHHhhhcccceeeeccCCCCCCHH-HHHHHHHHHhhccCC--CCCCCCCHHHHHHHh
Q 016347 264 RTWDLYERRELILLVDTSLNGDFDAE-EACRFLKVGLLCTQD--TPKLRPSMSTVVQML 319 (391)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~--dP~~Rps~~evl~~l 319 (391)
......+.+ ..... -....+.. .+.++..+..+|+.. ++.-||+++.++..|
T Consensus 243 ~f~ya~~~~--~g~~p--~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl 297 (637)
T COG4248 243 RFAYASDQR--RGLKP--PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAAL 297 (637)
T ss_pred eeeechhcc--CCCCC--CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Confidence 000000000 00000 00112222 234566677788864 367899999887654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.4e-10 Score=99.19 Aligned_cols=136 Identities=21% Similarity=0.189 Sum_probs=100.5
Q ss_pred CCCCceeeccCceEEEEEEeCCCcEEEEEEecccch----------------------hcHHHHHHHHHHHhcCCCC--c
Q 016347 46 FSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESR----------------------QGVKEFLTEIQVISEIEHE--N 101 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~--~ 101 (391)
+.+..+||-|--+.||.|..+.|.++|||.-+.... -.+....+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 567789999999999999999999999997432210 0123466799999999654 6
Q ss_pred eeEEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 016347 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNIL 181 (391)
Q Consensus 102 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIl 181 (391)
+.+.+++ +..++|||+++|.-|...- ++......++..|+.-+.-+-.. |++|||+++-||+
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIl 234 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNIL 234 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-----------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEE
Confidence 6666654 4678999999986654422 23444445555566655555565 9999999999999
Q ss_pred ECCCCcEEEEeccccccc
Q 016347 182 LDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 182 v~~~~~~kl~Dfg~~~~~ 199 (391)
|+++|.+.++||-.+...
T Consensus 235 V~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 235 VTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred EecCCCEEEEeCcccccC
Confidence 999999999999866543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.4e-10 Score=95.14 Aligned_cols=125 Identities=22% Similarity=0.254 Sum_probs=83.5
Q ss_pred EEEEEEeCCCcEEEEEEecccch--------------------------hcHHHHHHHHHHHhcCCCC--ceeEEEEEEE
Q 016347 59 SVYKGRLKDGKIAAIKVLSAESR--------------------------QGVKEFLTEIQVISEIEHE--NLVKLYGCCV 110 (391)
Q Consensus 59 ~V~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~ 110 (391)
.||.|...+|..+|+|+.+.... .......+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999999999999998643210 0122356799999999755 456666542
Q ss_pred eCCeeEEEEeccc--CCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHH-hhhcCCCCeeecCCCCCcEEECCCCc
Q 016347 111 EGNHRILVYNYLE--NNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF-LHEEVRPHIIHRDIKASNILLDKDLT 187 (391)
Q Consensus 111 ~~~~~~lv~e~~~--~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~-lH~~~~~~i~H~dikp~NIlv~~~~~ 187 (391)
.-++||||++ |..+..+... .++......++.+++..+.. +|.. |++||||.+.||+++.+ .
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~--------~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV--------DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC--------GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-C
T ss_pred ---CCEEEEEecCCCccchhhHHhc--------cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-e
Confidence 3589999998 6555443321 12245566777788886555 5677 99999999999999887 9
Q ss_pred EEEEeccccccc
Q 016347 188 PKISDFGLAKLI 199 (391)
Q Consensus 188 ~kl~Dfg~~~~~ 199 (391)
+.++|||.+...
T Consensus 145 ~~iIDf~qav~~ 156 (188)
T PF01163_consen 145 VYIIDFGQAVDS 156 (188)
T ss_dssp EEE--GTTEEET
T ss_pred EEEEecCcceec
Confidence 999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=6.4e-09 Score=93.83 Aligned_cols=139 Identities=17% Similarity=0.063 Sum_probs=97.7
Q ss_pred eeccCceEEEEEEeCCCcEEEEEEecccchh-cH----------HHHHHHHHHHhcCCCCc--eeEEEEEEEe-----CC
Q 016347 52 IGEGGFGSVYKGRLKDGKIAAIKVLSAESRQ-GV----------KEFLTEIQVISEIEHEN--LVKLYGCCVE-----GN 113 (391)
Q Consensus 52 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~e~~~l~~l~h~~--iv~~~~~~~~-----~~ 113 (391)
+-......|.++.. +|+.|.||........ .. ..+.+|...+.+|..-+ .++++++... ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33344444667766 4778999976433211 11 13678888888884322 3344444432 23
Q ss_pred eeEEEEecccCC-CHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-------C
Q 016347 114 HRILVYNYLENN-SLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK-------D 185 (391)
Q Consensus 114 ~~~lv~e~~~~~-sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~-------~ 185 (391)
..++|+|++++. +|.+++.... ....+......++.+++..+.-||.. |++|+|+++.|||++. +
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~----~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA----TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 578999999886 8998885321 12355677789999999999999999 9999999999999975 4
Q ss_pred CcEEEEecccccc
Q 016347 186 LTPKISDFGLAKL 198 (391)
Q Consensus 186 ~~~kl~Dfg~~~~ 198 (391)
+.+.|+||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6899999998753
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.4e-09 Score=106.19 Aligned_cols=143 Identities=16% Similarity=0.235 Sum_probs=93.3
Q ss_pred ceeeccCceEEEEEEeCCCcEEEEEEecccchhcH------------------------------H----------HHHH
Q 016347 50 NKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGV------------------------------K----------EFLT 89 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~~ 89 (391)
+.|+.++-|.||+|++++|+.||||+.++.-.... + ++..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 68999999999999999999999999865522110 0 1233
Q ss_pred HHHHHhcC-----CCCceeEEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhh
Q 016347 90 EIQVISEI-----EHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHE 164 (391)
Q Consensus 90 e~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~ 164 (391)
|...+.++ ..+++.-..=+..-.+..+|+|||++|..+.+...... ..++.+.+.....++. +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-----~g~d~k~ia~~~~~~f--~~q~~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-----AGIDRKELAELLVRAF--LRQLLR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-----cCCCHHHHHHHHHHHH--HHHHHh
Confidence 55544444 23443322222233567899999999999888753211 1233333222222221 112222
Q ss_pred cCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCC
Q 016347 165 EVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN 202 (391)
Q Consensus 165 ~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~ 202 (391)
. |++|+|..|.||+++.+|++.+.|||+...+...
T Consensus 284 d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 284 D---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred c---CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 3 9999999999999999999999999999876543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=7.3e-10 Score=108.04 Aligned_cols=149 Identities=19% Similarity=0.313 Sum_probs=101.3
Q ss_pred HHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCceeeee--------ecccccccChhhhhcC
Q 016347 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTR--------VAGTIGYLAPEYAIRG 225 (391)
Q Consensus 154 qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~~~~--------~~gt~~y~aPE~~~~~ 225 (391)
+++.|+.++|.. +++||++|.|++|.++.+|..||++|+.+............. ..-...|.|||++...
T Consensus 107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 355899999987 599999999999999999999999999887654422211111 1235689999999888
Q ss_pred CCCCCCcEeehhHHHHHHHhCCCC-CCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCC
Q 016347 226 QVTRKADIYSFGVLLVEIVSGRCN-TNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQD 304 (391)
Q Consensus 226 ~~~~k~DvwSlG~vl~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 304 (391)
..+.++|+|||||++|.+..|..+ +........... .. ...+. -......+.+.++.+-+.+++..
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-~~-----------~~~~~-~~~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-SR-----------NLLNA-GAFGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhh-hh-----------ccccc-ccccccccCcHHHHHHHHHHhcC
Confidence 889999999999999999955433 332211111100 00 00000 01122234455667777789999
Q ss_pred CCCCCCCHHHHHH
Q 016347 305 TPKLRPSMSTVVQ 317 (391)
Q Consensus 305 dP~~Rps~~evl~ 317 (391)
++.-||++.++..
T Consensus 252 ~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 252 DSAVRPTLDLLLS 264 (700)
T ss_pred CcccCcchhhhhc
Confidence 9999998777653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.85 E-value=7.1e-08 Score=83.06 Aligned_cols=139 Identities=18% Similarity=0.195 Sum_probs=94.6
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHH---------HHHHHHhcCC---CCceeEEEE
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFL---------TEIQVISEIE---HENLVKLYG 107 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~---------~e~~~l~~l~---h~~iv~~~~ 107 (391)
.+...+|.+.+.+-......|.+.... |+.+++|..+.......+.|. +.+..+.++. -.....++.
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 456788999999998888888887775 788999988766443323222 2333333332 222223222
Q ss_pred EEE-----eCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 016347 108 CCV-----EGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL 182 (391)
Q Consensus 108 ~~~-----~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv 182 (391)
... -....+++|||++|..|.+... +++ .++..+.+++.-||+. |++|||..|.|+++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv 168 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLV 168 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh----------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEE
Confidence 222 1235578999999988766541 332 2445677889999999 99999999999999
Q ss_pred CCCCcEEEEeccccc
Q 016347 183 DKDLTPKISDFGLAK 197 (391)
Q Consensus 183 ~~~~~~kl~Dfg~~~ 197 (391)
+.+ .++++||+..+
T Consensus 169 ~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 169 SNN-GIRIIDTQGKR 182 (229)
T ss_pred ECC-cEEEEECcccc
Confidence 865 58999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.2e-07 Score=81.36 Aligned_cols=138 Identities=17% Similarity=0.150 Sum_probs=100.9
Q ss_pred eeccCceEEEEEEeCCCcEEEEEEeccc---c---hhcHHHHHHHHHHHhcCCC--CceeEEEEEEEe-----CCeeEEE
Q 016347 52 IGEGGFGSVYKGRLKDGKIAAIKVLSAE---S---RQGVKEFLTEIQVISEIEH--ENLVKLYGCCVE-----GNHRILV 118 (391)
Q Consensus 52 lg~G~~g~V~~~~~~~~~~vavK~~~~~---~---~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~-----~~~~~lv 118 (391)
-|+||.+.|+..... |+.+-+|..... + +.....|.+|+..|.++.. -++.++. ++.. .-..+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 467999999998876 446777875421 0 3355789999999999843 2244444 2221 1246889
Q ss_pred EecccC-CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCc--EEEEeccc
Q 016347 119 YNYLEN-NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLT--PKISDFGL 195 (391)
Q Consensus 119 ~e~~~~-~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~--~kl~Dfg~ 195 (391)
+|-++| .+|.+++.... ..+.+......++.+++.++.-||+. |+.|+|+.+.||+++.+|. +.++||--
T Consensus 104 Te~L~g~~~L~~~l~~~~----~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk 176 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA----VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEK 176 (216)
T ss_pred EEeCCCCccHHHHHhcCC----cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence 997753 48888875432 22457777889999999999999999 9999999999999986666 99999976
Q ss_pred ccc
Q 016347 196 AKL 198 (391)
Q Consensus 196 ~~~ 198 (391)
++.
T Consensus 177 ~r~ 179 (216)
T PRK09902 177 SRR 179 (216)
T ss_pred cch
Confidence 653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=4.4e-08 Score=85.42 Aligned_cols=106 Identities=21% Similarity=0.184 Sum_probs=82.4
Q ss_pred HHHHHHHHHHhcCCC--CceeEEEEEEEeC----CeeEEEEecccCC-CHHHHHhcCCCCCCccccCHHHHHHHHHHHHH
Q 016347 85 KEFLTEIQVISEIEH--ENLVKLYGCCVEG----NHRILVYNYLENN-SLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR 157 (391)
Q Consensus 85 ~~~~~e~~~l~~l~h--~~iv~~~~~~~~~----~~~~lv~e~~~~~-sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~ 157 (391)
....+|...+..|.. -...+.+++.... ...++|+|++++. +|.+++.... ..+......++.+++.
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~------~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE------QLDPSQRRELLRALAR 129 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc------ccchhhHHHHHHHHHH
Confidence 457778888877743 2344556655542 2458999999884 7999886432 1566677899999999
Q ss_pred HHHHhhhcCCCCeeecCCCCCcEEECCCC---cEEEEeccccccc
Q 016347 158 GLAFLHEEVRPHIIHRDIKASNILLDKDL---TPKISDFGLAKLI 199 (391)
Q Consensus 158 al~~lH~~~~~~i~H~dikp~NIlv~~~~---~~kl~Dfg~~~~~ 199 (391)
.+.-||.. |++|+|+++.|||++.++ .+.|+||+-++..
T Consensus 130 ~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 130 LIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999 999999999999999887 8999999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.2e-07 Score=82.51 Aligned_cols=153 Identities=17% Similarity=0.211 Sum_probs=103.4
Q ss_pred chHHHHHhhCCCCCCce---eeccCceEEEEEEeCCCcEEEEEEecccchhcH------------------------HHH
Q 016347 35 SYKELSIATDDFSPINK---IGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGV------------------------KEF 87 (391)
Q Consensus 35 ~~~e~~~~~~~y~~~~~---lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~------------------------~~~ 87 (391)
|.+.+.-...+..+... |+.|--+.||+|...++..+|+|+......... .-.
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 55666555566555554 556666789999988899999999864422110 012
Q ss_pred HHHHHHHhcCC--CCceeEEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhc
Q 016347 88 LTEIQVISEIE--HENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEE 165 (391)
Q Consensus 88 ~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~ 165 (391)
..|+..|+++. +-.+.+.+++. .-.|||||+....+ ..+.....++.......+..++++.+.-|-..
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~------pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~ 185 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGL------PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKE 185 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCC------CCCCcccCCcCchhHHHHHHHHHHHHHHHHHh
Confidence 35888888873 34455555554 34899999965311 11222333344446777888888888877763
Q ss_pred CCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 166 VRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 166 ~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
+ ++||+||+.-|||+. ++.+.++|+|.+....
T Consensus 186 a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 186 A--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred c--CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 2 999999999999999 7899999999887643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.8e-07 Score=82.60 Aligned_cols=141 Identities=15% Similarity=0.190 Sum_probs=84.8
Q ss_pred ceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCC--ceeEEEEEEEeCCeeEEEEecccCCC-
Q 016347 50 NKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHE--NLVKLYGCCVEGNHRILVYNYLENNS- 126 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~~~s- 126 (391)
.+||.|..+.||+. .|..+++|+..... ......+|.++++.+..- .+.+++++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57999999999984 24567888876533 234567899999888533 35677888777778889999999963
Q ss_pred HHHHHhc-------------------CCCCCCccccCHHHHHHHHHH----------HHH-HHHHhhhc-CCCCeeecCC
Q 016347 127 LAQTLIG-------------------GGHHYSNIQFSWRTRSRICIG----------IAR-GLAFLHEE-VRPHIIHRDI 175 (391)
Q Consensus 127 L~~~i~~-------------------~~~~~~~~~l~~~~~~~i~~q----------i~~-al~~lH~~-~~~~i~H~di 175 (391)
+...+.. +........+.. ....+..+ +.. ...+|... ....++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~-~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQS-YKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHH-HHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 2211110 000000001110 00000000 001 11222211 1336799999
Q ss_pred CCCcEEECCCCcEEEEeccccc
Q 016347 176 KASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 176 kp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
.|.||+++.++ +.++||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999888 9999998765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.61 E-value=7e-07 Score=79.17 Aligned_cols=78 Identities=14% Similarity=0.230 Sum_probs=57.3
Q ss_pred CceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCC--ceeEEEEEEE---eCCeeEEEEeccc
Q 016347 49 INKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHE--NLVKLYGCCV---EGNHRILVYNYLE 123 (391)
Q Consensus 49 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~---~~~~~~lv~e~~~ 123 (391)
++.|+.|..+.||++...+ ..+++|..... .....+..|..+++.+... .+.+++.+.. .....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4689999999999999987 58999987654 3446677888888877422 3556666443 3345789999999
Q ss_pred CCCHHH
Q 016347 124 NNSLAQ 129 (391)
Q Consensus 124 ~~sL~~ 129 (391)
|..+..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 988877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.8e-07 Score=91.21 Aligned_cols=141 Identities=21% Similarity=0.238 Sum_probs=89.8
Q ss_pred ceeeccCceEEEEEEeCCCcEEEEEEecccchhc---------------------------HH----------HHHHHHH
Q 016347 50 NKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQG---------------------------VK----------EFLTEIQ 92 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---------------------------~~----------~~~~e~~ 92 (391)
+.||..+.|.||+|++++|+.||||+.+..-+.. .+ +|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6899999999999999999999999976542111 00 1334444
Q ss_pred HHhcC----CCCc------eeEEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHh
Q 016347 93 VISEI----EHEN------LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFL 162 (391)
Q Consensus 93 ~l~~l----~h~~------iv~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~l 162 (391)
...++ .|-+ |.+++- .-.....|+|||++|..+.+.-.- ....++...+..-+.+...-+-+
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i-----~~~gi~~~~i~~~l~~~~~~qIf- 318 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAI-----DKRGISPHDILNKLVEAYLEQIF- 318 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHH-----HHcCCCHHHHHHHHHHHHHHHHH-
Confidence 44333 3444 223332 123478999999999876654321 11234544433333332221112
Q ss_pred hhcCCCCeeecCCCCCcEEECC----CCcEEEEecccccccCCC
Q 016347 163 HEEVRPHIIHRDIKASNILLDK----DLTPKISDFGLAKLIPAN 202 (391)
Q Consensus 163 H~~~~~~i~H~dikp~NIlv~~----~~~~kl~Dfg~~~~~~~~ 202 (391)
.. |++|+|-.|.||+++. ++.+.+.|||+...+...
T Consensus 319 -~~---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 319 -KT---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred -hc---CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 22 8999999999999983 678999999999876443
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.8e-06 Score=77.38 Aligned_cols=76 Identities=13% Similarity=0.114 Sum_probs=54.9
Q ss_pred eeeccCc-eEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCC-CCceeEEEEEEEeCCeeEEEEecccCCCHH
Q 016347 51 KIGEGGF-GSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIE-HENLVKLYGCCVEGNHRILVYNYLENNSLA 128 (391)
Q Consensus 51 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~ 128 (391)
.|..|.. ..||+.... +..+++|+..... ...+..|+++++.+. +-.+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555655 789999875 4778888876443 234667888888873 445667888777666789999999998776
Q ss_pred HH
Q 016347 129 QT 130 (391)
Q Consensus 129 ~~ 130 (391)
..
T Consensus 81 ~~ 82 (244)
T cd05150 81 AL 82 (244)
T ss_pred Hh
Confidence 44
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=4.8e-08 Score=94.73 Aligned_cols=188 Identities=20% Similarity=0.153 Sum_probs=137.2
Q ss_pred CCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCc-eeEEEEEEEeCCeeEEEEecc
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHEN-LVKLYGCCVEGNHRILVYNYL 122 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~ 122 (391)
+-|.....+++|++++++|.+....+....+++... ....-++++|.+++||| .+..++-+..+....++++++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 335556668899999999998654444445555433 33556899999999999 677777777778889999999
Q ss_pred cCC-CHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 123 ENN-SLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 123 ~~~-sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
.++ +-...... ....+..-+...+...-+++++++|+. .-+|+| ||+... +.+++.||+....+..
T Consensus 317 s~~rs~~~~~~~-----se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~ 383 (829)
T KOG0576|consen 317 STGRSSALEMTV-----SEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTR 383 (829)
T ss_pred cCCccccccCCh-----hhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCc
Confidence 877 22221110 222344445556666677889999987 458888 777655 6889999999887654
Q ss_pred CCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCC
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTN 251 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~ 251 (391)
.. ......+++.++|||+...+.+..+.|+|++|+-..++.-|-.|-.
T Consensus 384 ~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 384 TM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 33 3455679999999999999999999999999998888887766553
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=3.9e-06 Score=69.33 Aligned_cols=130 Identities=19% Similarity=0.265 Sum_probs=91.0
Q ss_pred CCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCcee-EEEEEEEeCCeeEEEEecccC
Q 016347 46 FSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLV-KLYGCCVEGNHRILVYNYLEN 124 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~ 124 (391)
....+.|++|..|.||++.+. |..+|+|+-+.++. ...+..|+++|..+.--++. +++.+.. .++.|||+.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G 96 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDG 96 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcC
Confidence 345678999999999999998 55788898765543 46788899999998766654 3444432 3555999999
Q ss_pred CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC-CCcEEECCCCcEEEEecccccc
Q 016347 125 NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIK-ASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 125 ~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dik-p~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
-.|.+.-.. .+.+.+ ..++++-.-|-.. ||-|+.|. |+..++..++.+.|+||..+..
T Consensus 97 ~~L~~~~~~---------~~rk~l----~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIG---------GDRKHL----LRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhc---------ccHHHH----HHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 888776532 122222 3355554445555 99999997 5555555555999999998873
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.34 E-value=6.2e-06 Score=86.71 Aligned_cols=80 Identities=19% Similarity=0.378 Sum_probs=58.2
Q ss_pred CCceeeccCceEEEEEEeCCC---cEEEEEEecccc-hhcHHHHHHHHHHHhcCC-CCce--eEEEEEEEeC---CeeEE
Q 016347 48 PINKIGEGGFGSVYKGRLKDG---KIAAIKVLSAES-RQGVKEFLTEIQVISEIE-HENL--VKLYGCCVEG---NHRIL 117 (391)
Q Consensus 48 ~~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~---~~~~l 117 (391)
.++.|+.|.++.+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++.++.+. +..++
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 367899999999999987653 467777764432 122356788999999985 6554 7788877654 46789
Q ss_pred EEecccCCCH
Q 016347 118 VYNYLENNSL 127 (391)
Q Consensus 118 v~e~~~~~sL 127 (391)
||||++|..+
T Consensus 122 VME~v~G~~~ 131 (822)
T PLN02876 122 IMEYLEGRIF 131 (822)
T ss_pred EEEecCCccc
Confidence 9999998653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.28 E-value=2.8e-05 Score=66.89 Aligned_cols=129 Identities=19% Similarity=0.305 Sum_probs=91.1
Q ss_pred CCceeeccCceEEEEEEeCCCcEEEEEEecccc----------------hhcHHHHHHHHHHHhcCC------CCceeEE
Q 016347 48 PINKIGEGGFGSVYKGRLKDGKIAAIKVLSAES----------------RQGVKEFLTEIQVISEIE------HENLVKL 105 (391)
Q Consensus 48 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~iv~~ 105 (391)
-...||+|+.=.||.= ++....+||+..... .....+..+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3457999999888864 444556888887665 122455666666666555 8899999
Q ss_pred EEEEEeCCeeEEEEecccCC------CHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 016347 106 YGCCVEGNHRILVYNYLENN------SLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASN 179 (391)
Q Consensus 106 ~~~~~~~~~~~lv~e~~~~~------sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~N 179 (391)
+|+.+.+....+|+|.+.+. +|.+++..+ .++. . +...+-+-..||-+. +|+.+|++|.|
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-------~~~~-~---~~~~L~~f~~~l~~~---~Iv~~dl~~~N 148 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-------GLTE-E---LRQALDEFKRYLLDH---HIVIRDLNPHN 148 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-------CccH-H---HHHHHHHHHHHHHHc---CCeecCCCccc
Confidence 99999999999999987532 688888443 2444 2 333344556677777 89999999999
Q ss_pred EEECCC--C--cEEEEe
Q 016347 180 ILLDKD--L--TPKISD 192 (391)
Q Consensus 180 Ilv~~~--~--~~kl~D 192 (391)
|++..+ + .+.|+|
T Consensus 149 Iv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 149 IVVQRRDSGEFRLVLID 165 (199)
T ss_pred EEEEecCCCceEEEEEe
Confidence 999543 2 567776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.5e-05 Score=73.62 Aligned_cols=80 Identities=14% Similarity=0.150 Sum_probs=59.0
Q ss_pred CCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCC---CceeEEEEEEEe---CCeeEEE
Q 016347 45 DFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEH---ENLVKLYGCCVE---GNHRILV 118 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~---~~~~~lv 118 (391)
.-.-.+.||.|..+.||.....+++ +++|..+.. .....+..|.+.|+.+.. -.+.++++++.. .+..++|
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQGN-PMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCCC-EEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 4455678999999999999876664 666774321 123568889999988843 467888887754 3668999
Q ss_pred EecccCCCH
Q 016347 119 YNYLENNSL 127 (391)
Q Consensus 119 ~e~~~~~sL 127 (391)
||+++|.++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998764
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.3e-05 Score=71.44 Aligned_cols=74 Identities=18% Similarity=0.271 Sum_probs=47.3
Q ss_pred CceeeccCce-EEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCC---ceeEEEEEEEeC---CeeEEEEec
Q 016347 49 INKIGEGGFG-SVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHE---NLVKLYGCCVEG---NHRILVYNY 121 (391)
Q Consensus 49 ~~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~---~~~~lv~e~ 121 (391)
++.|+.|+.. .||+. +..+++|+.... .....+..|.+++..+... .+.++++..... ...+++|++
T Consensus 2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 2 IEPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred ceeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 4678877776 59986 234677875542 2235688899999887532 344455443322 245889999
Q ss_pred ccCCCHH
Q 016347 122 LENNSLA 128 (391)
Q Consensus 122 ~~~~sL~ 128 (391)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.19 E-value=7.1e-06 Score=70.18 Aligned_cols=105 Identities=21% Similarity=0.249 Sum_probs=81.6
Q ss_pred HHHHHHHhcCCC-CceeEEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcC
Q 016347 88 LTEIQVISEIEH-ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV 166 (391)
Q Consensus 88 ~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ 166 (391)
..|.-+++.+.+ +++++++|+| ..++|.||...+++...-. ....-...+|..+.+|+.++++.+.+|+...
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~---~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYR---PLSQFLQSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCcccccccc---ccccccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 347888888865 6999999998 3478899998776543200 0001124799999999999999999999854
Q ss_pred CCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 167 RPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 167 ~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
...+.-.|++|+|+-++.+|++|++|...+...
T Consensus 80 ~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 80 LGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 446889999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.1e-05 Score=72.75 Aligned_cols=142 Identities=15% Similarity=0.107 Sum_probs=79.1
Q ss_pred eeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCce-eEEEEEEEeCCeeEEEEecccCCCHHH
Q 016347 51 KIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENL-VKLYGCCVEGNHRILVYNYLENNSLAQ 129 (391)
Q Consensus 51 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~sL~~ 129 (391)
.+..|-.+.+|+... +++.+++|+.............+|..+++.+....+ .+++... . .++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence 466788889999984 466788887654432211235678888888854323 3344332 2 368999999876542
Q ss_pred H--------------Hhc-CCCCCCccccCHH-HHHHHHHHH---------HHHHHHhhhc-----CCCCeeecCCCCCc
Q 016347 130 T--------------LIG-GGHHYSNIQFSWR-TRSRICIGI---------ARGLAFLHEE-----VRPHIIHRDIKASN 179 (391)
Q Consensus 130 ~--------------i~~-~~~~~~~~~l~~~-~~~~i~~qi---------~~al~~lH~~-----~~~~i~H~dikp~N 179 (391)
. +.. +.......+++.. .+..+..++ ...+..+-.. ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 100 1110011122211 111111111 1111112111 12358999999999
Q ss_pred EEECCCCcEEEEecccccc
Q 016347 180 ILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 180 Ilv~~~~~~kl~Dfg~~~~ 198 (391)
|+++.++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999987754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.13 E-value=2.7e-05 Score=69.34 Aligned_cols=75 Identities=15% Similarity=0.228 Sum_probs=49.7
Q ss_pred CceeeccCceEEEEEEeCC--CcEEEEEEecccchhcHHHHHHHHHHHhcCCCCc-eeEEEEEEEeCCeeEEEEecccCC
Q 016347 49 INKIGEGGFGSVYKGRLKD--GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHEN-LVKLYGCCVEGNHRILVYNYLENN 125 (391)
Q Consensus 49 ~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~~ 125 (391)
++.|..|-...+|++...+ ++.|++|+........ ....+|+.+++.+.... ..+++.... -.++|||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 4678888899999998764 6789999776432221 23346888888874333 344444332 24899999987
Q ss_pred CHH
Q 016347 126 SLA 128 (391)
Q Consensus 126 sL~ 128 (391)
++.
T Consensus 78 ~l~ 80 (235)
T cd05157 78 TLE 80 (235)
T ss_pred cCC
Confidence 653
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.12 E-value=2.9e-05 Score=66.32 Aligned_cols=125 Identities=26% Similarity=0.400 Sum_probs=88.9
Q ss_pred CCCCCCceeeccCc-eEEEEEEeCCCcEEEEEEeccc---ch------------------hcHHHHHHHHHHHhcCC---
Q 016347 44 DDFSPINKIGEGGF-GSVYKGRLKDGKIAAIKVLSAE---SR------------------QGVKEFLTEIQVISEIE--- 98 (391)
Q Consensus 44 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~~~---~~------------------~~~~~~~~e~~~l~~l~--- 98 (391)
.+++.++.||.|.- |.||+++.. |+.+|+|++... .. .....|..|.....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 89999999999999 999999997 779999993211 00 11234677888877774
Q ss_pred CCce--eEEEEEEEeC------------------CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHH
Q 016347 99 HENL--VKLYGCCVEG------------------NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARG 158 (391)
Q Consensus 99 h~~i--v~~~~~~~~~------------------~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~a 158 (391)
+.++ |+++|+..-. ....||.||.+... .+. ..-+.+|.+-
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------------~~~----~~~~~~~~~d 176 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------------PLQ----IRDIPQMLRD 176 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------------ccc----hhHHHHHHHH
Confidence 4455 8999987422 12356777665432 122 2234567788
Q ss_pred HHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 159 LAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 159 l~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
|..+|.. ||+-+|+++.|.. .-+|+|||.+
T Consensus 177 l~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 177 LKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 8889998 9999999999987 2289999853
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.04 E-value=0.00012 Score=69.87 Aligned_cols=77 Identities=17% Similarity=0.236 Sum_probs=55.1
Q ss_pred CCceeeccCceEEEEEEeCCC-cEEEEEEeccc------c-hhcHHHHHHHHHHHhcCC---CCceeEEEEEEEeCCeeE
Q 016347 48 PINKIGEGGFGSVYKGRLKDG-KIAAIKVLSAE------S-RQGVKEFLTEIQVISEIE---HENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 48 ~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~ 116 (391)
..+.||.|.+..||++...+| +.++||.-... . ....+.+..|.+.|+.+. ..++.+++.+ +....+
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~ 107 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV 107 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence 346899999999999999876 58999984321 1 223456677888888762 2456677766 445678
Q ss_pred EEEecccCCC
Q 016347 117 LVYNYLENNS 126 (391)
Q Consensus 117 lv~e~~~~~s 126 (391)
+|||++++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998754
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.0002 Score=66.94 Aligned_cols=146 Identities=17% Similarity=0.218 Sum_probs=77.1
Q ss_pred CceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCC--CceeEEEE------EEEeCCeeEEEEe
Q 016347 49 INKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEH--ENLVKLYG------CCVEGNHRILVYN 120 (391)
Q Consensus 49 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~------~~~~~~~~~lv~e 120 (391)
++.|+.|....+|+....+| .+++|+...... .....|+.++..|.. -.+.+++. +....+..+++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 45677888889999987655 688898752222 333345555554421 11333332 1223556789999
Q ss_pred cccCCCHH-----------HHH---hcCCCCC-----CccccCH-HHHH------------HHHHH-HHHHHHHhhhc--
Q 016347 121 YLENNSLA-----------QTL---IGGGHHY-----SNIQFSW-RTRS------------RICIG-IARGLAFLHEE-- 165 (391)
Q Consensus 121 ~~~~~sL~-----------~~i---~~~~~~~-----~~~~l~~-~~~~------------~i~~q-i~~al~~lH~~-- 165 (391)
|++|..+. +.+ +...... ....+.+ .... ..+.+ +...+..+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 99987431 111 1110000 0001111 1110 01111 11122233211
Q ss_pred --CCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 166 --VRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 166 --~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
...+++|+|+.|.||+++.+...-|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 233899999999999998765568999997753
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00014 Score=67.11 Aligned_cols=146 Identities=14% Similarity=0.165 Sum_probs=84.1
Q ss_pred CCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCC--ceeEEEEE------EEeCCeeEEEE
Q 016347 48 PINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHE--NLVKLYGC------CVEGNHRILVY 119 (391)
Q Consensus 48 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~------~~~~~~~~lv~ 119 (391)
-++.|..|....+|+....+ ..+++|+.... .......|++++..+.+. .+.+++.. ....+..++|+
T Consensus 18 ~i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 18 SFEGISAGIENTNYFVTTDS-GRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred heecccCccccceEEEEeCC-CcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 35678888889999997754 46888987642 234566677777777322 24444331 22345678999
Q ss_pred ecccCCCHHH-----------HH---hcCCCCC-----CccccCHHHH----------HHHHHHHHHHHHHhhhc----C
Q 016347 120 NYLENNSLAQ-----------TL---IGGGHHY-----SNIQFSWRTR----------SRICIGIARGLAFLHEE----V 166 (391)
Q Consensus 120 e~~~~~sL~~-----------~i---~~~~~~~-----~~~~l~~~~~----------~~i~~qi~~al~~lH~~----~ 166 (391)
+|++|..+.. .+ +...... ......|... ......+..++.++... .
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999876432 00 1000000 0001111110 01111233344444431 1
Q ss_pred CCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 167 RPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 167 ~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
..+++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 2379999999999999988777899998765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.88 E-value=1.2e-05 Score=72.70 Aligned_cols=136 Identities=18% Similarity=0.113 Sum_probs=94.8
Q ss_pred CCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchh----------------------cHHHHHHHHHHHhcCC-CC-
Q 016347 45 DFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQ----------------------GVKEFLTEIQVISEIE-HE- 100 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~-h~- 100 (391)
-+.+.++||-|.-+.+|.+.+..|++.++|+-+..... .+-...+|+..|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 47888999999999999999999999999964322100 0113456888888874 22
Q ss_pred ceeEEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 016347 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNI 180 (391)
Q Consensus 101 ~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NI 180 (391)
.+.+.+++ ...++|||++.|..|...-. ..+..++ ...+...+.-|-.+ |+||||.+--||
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~---------v~d~~~l---y~~lm~~Iv~la~~---GlIHgDFNEFNi 233 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH---------VEDPPTL---YDDLMGLIVRLANH---GLIHGDFNEFNI 233 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeee---------cCChHHH---HHHHHHHHHHHHHc---Cceecccchhee
Confidence 34444443 46688999999887765431 1223333 33344444556666 999999999999
Q ss_pred EECCCCcEEEEeccccccc
Q 016347 181 LLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 181 lv~~~~~~kl~Dfg~~~~~ 199 (391)
+|+.++.++++||-.....
T Consensus 234 mv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 234 MVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred EEecCCCEEEeechHhhcc
Confidence 9999999999999876544
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.87 E-value=3.9e-05 Score=79.78 Aligned_cols=197 Identities=21% Similarity=0.208 Sum_probs=133.7
Q ss_pred HHHHHHHHhcCCCCceeEEEEEEEeCCeeE----EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHh
Q 016347 87 FLTEIQVISEIEHENLVKLYGCCVEGNHRI----LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFL 162 (391)
Q Consensus 87 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~----lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~l 162 (391)
..-|+..+....|+|++.++.+........ +..+++.+-++...+..-+ .++....+.+..++..||.|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~------~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG------SIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc------ccCHHHHHHHHHHHhhhHHHH
Confidence 334667777789999999999987654333 3457788888888776443 588999999999999999999
Q ss_pred hhcCCCCeeecCCCCC---cEEECCCCcEEEE--ecccccccCCCCceeeeeecccccccChhhhhcCCCCC--CCcEee
Q 016347 163 HEEVRPHIIHRDIKAS---NILLDKDLTPKIS--DFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTR--KADIYS 235 (391)
Q Consensus 163 H~~~~~~i~H~dikp~---NIlv~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--k~DvwS 235 (391)
|+. .+.|.-+... +.-++..+.+... ||+............. ..-...+.++|......++. ..|+|.
T Consensus 303 h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 303 HSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred HHh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHH
Confidence 998 5555555544 5555666777776 8888876654432221 12344577888766555544 479999
Q ss_pred hhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 016347 236 FGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTV 315 (391)
Q Consensus 236 lG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 315 (391)
+|..+..+..|..+...... ....+... ....+.+....|+..++++|+++.++
T Consensus 378 lgll~~~~~~~~~i~~~~~~----------------------~~~~l~~~----~~~~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEKSAV----------------------PVSLLDVL----STSELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HHHHHhhhhhcCcccccccc----------------------hhhhhccc----cchhhhhhhhhhcchhhhhccchhhh
Confidence 99999999988643321100 00000001 11145666778999999999999999
Q ss_pred HHHhc
Q 016347 316 VQMLM 320 (391)
Q Consensus 316 l~~l~ 320 (391)
+.+..
T Consensus 432 l~~~f 436 (1351)
T KOG1035|consen 432 LTHPF 436 (1351)
T ss_pred hhchh
Confidence 98753
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.87 E-value=9.5e-05 Score=68.49 Aligned_cols=76 Identities=22% Similarity=0.308 Sum_probs=50.2
Q ss_pred CceeeccCceEEEEEEeCC-------CcEEEEEEecccchhcHHHHHHHHHHHhcCCCCc-eeEEEEEEEeCCeeEEEEe
Q 016347 49 INKIGEGGFGSVYKGRLKD-------GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHEN-LVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 49 ~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e 120 (391)
++.|..|-...+|+....+ ++.+++|+...... ......+|.+++..+.... ..++++++.. .+|+|
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e 77 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEE 77 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhh
Confidence 4567778888999998764 57899999765432 2244567888888874322 3345555432 45899
Q ss_pred cccCCCHHH
Q 016347 121 YLENNSLAQ 129 (391)
Q Consensus 121 ~~~~~sL~~ 129 (391)
|++|..+..
T Consensus 78 ~i~G~~l~~ 86 (302)
T cd05156 78 FIPSRTLTT 86 (302)
T ss_pred eeCCCcCCH
Confidence 998876643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.0012 Score=61.32 Aligned_cols=147 Identities=18% Similarity=0.278 Sum_probs=81.8
Q ss_pred CCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCC--ceeEEEEE------EEeCCeeEEEE
Q 016347 48 PINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHE--NLVKLYGC------CVEGNHRILVY 119 (391)
Q Consensus 48 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~------~~~~~~~~lv~ 119 (391)
.++.++.|....+|+....+| .+++|+...... ......|.+++..|... .+.+++.. ....+..++++
T Consensus 26 ~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred eccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 356788888889999887655 577887654321 23345566666666321 23343331 12245678999
Q ss_pred ecccCCCHH-----------HH---HhcCCCCC--C--c--cccCHHHHH------------HHHHHHHHHHHHhhh---
Q 016347 120 NYLENNSLA-----------QT---LIGGGHHY--S--N--IQFSWRTRS------------RICIGIARGLAFLHE--- 164 (391)
Q Consensus 120 e~~~~~sL~-----------~~---i~~~~~~~--~--~--~~l~~~~~~------------~i~~qi~~al~~lH~--- 164 (391)
+|++|..+. .. ++...... . . ..-.|.... .....+...++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 999886432 11 11100000 0 0 000111100 011123334555532
Q ss_pred -cCCCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 165 -EVRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 165 -~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
....+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 123489999999999999988877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00026 Score=65.38 Aligned_cols=142 Identities=18% Similarity=0.197 Sum_probs=98.1
Q ss_pred CCCCceeeccCceEEEEEEeCCCcEEEEEEeccc----------------------chhcHH----HHHHHHHHHhcCCC
Q 016347 46 FSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAE----------------------SRQGVK----EFLTEIQVISEIEH 99 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~----------------------~~~~~~----~~~~e~~~l~~l~h 99 (391)
-.+..-|..|--+.||.|...+|..+|||++.-. ....++ -...|+..|+++..
T Consensus 146 ~~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 146 VEINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred eecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 3556678899999999999999999999986322 000111 13458888888864
Q ss_pred CceeEEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 016347 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASN 179 (391)
Q Consensus 100 ~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~N 179 (391)
..|.-.--+.. ...+|||+|+.+..... +......++...+..+-.|++.-+.-|-+.| ++||.||.--|
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGrdgw~a------PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN 295 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGRDGWAA------PKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFN 295 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccCCCCcC------cccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhh
Confidence 44321111111 23578999996432111 1123445777788888899999999888887 99999999999
Q ss_pred EEECCCCcEEEEecccccc
Q 016347 180 ILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 180 Ilv~~~~~~kl~Dfg~~~~ 198 (391)
+|+. +|.+.++|-+.+..
T Consensus 296 ~Lyh-dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 296 LLYH-DGKLYIIDVSQSVE 313 (520)
T ss_pred heEE-CCEEEEEEcccccc
Confidence 9994 56899999876654
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.0004 Score=63.44 Aligned_cols=76 Identities=20% Similarity=0.289 Sum_probs=48.2
Q ss_pred CCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcC---CCCceeEEEEEEEeCCeeEEEEecc
Q 016347 46 FSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEI---EHENLVKLYGCCVEGNHRILVYNYL 122 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~ 122 (391)
-+-.+.|+.|....+|+.. .+++.+.||+-... ....|..|.+-|+.| ..-.+.+++++....+..++|+||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3455689999999999988 55788999986522 235677788888877 3446778898888777789999999
Q ss_pred cCC
Q 016347 123 ENN 125 (391)
Q Consensus 123 ~~~ 125 (391)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 866
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.0005 Score=63.33 Aligned_cols=140 Identities=19% Similarity=0.319 Sum_probs=85.9
Q ss_pred CCCCceeeccCceEEEEEEeCCCcEEEEEEecc--cchhcHHHHHHHHHHHhcCC--CCceeEEEEEEEeCC--eeEEEE
Q 016347 46 FSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSA--ESRQGVKEFLTEIQVISEIE--HENLVKLYGCCVEGN--HRILVY 119 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~--~~~lv~ 119 (391)
..+++.+..|..-.+|..... ++.+++. ... ..........+|+.+++.+. --.+...+++|.++. ..+.||
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred CceeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 344455545555566666655 7788888 331 22233455667888888774 334556677777665 779999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHH-HHHHHHHHHhh-----------------------------------
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRIC-IGIARGLAFLH----------------------------------- 163 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~-~qi~~al~~lH----------------------------------- 163 (391)
+|++|..+.+.+.... .. ...+ ..++..|+-||
T Consensus 105 ~~veGe~~~~~~~~~~-------~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~ 173 (321)
T COG3173 105 EWVEGEVVWSALPPES-------LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKEL 173 (321)
T ss_pred EEecceeccCcCCccc-------ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhc
Confidence 9999853332221100 00 1111 13334444444
Q ss_pred ---------------hcC-----CCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 164 ---------------EEV-----RPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 164 ---------------~~~-----~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
... ...++|||+.+.||++++++-+=+.||+++..
T Consensus 174 ~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 174 GGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred cCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 321 23599999999999999998899999998875
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.53 E-value=7.7e-06 Score=86.83 Aligned_cols=162 Identities=12% Similarity=0.014 Sum_probs=118.2
Q ss_pred HHHHHHHHHhcCCCCceeEEEEEEEe--CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhh
Q 016347 86 EFLTEIQVISEIEHENLVKLYGCCVE--GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH 163 (391)
Q Consensus 86 ~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH 163 (391)
....|...++...|+++.....-... +...+.+++++.+|.+.+.|.++.. ...++...-+.....+...+..-+|
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~e--e~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLE--ESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccc--cCCcchhchHHHHHHHHHhccchhh
Confidence 34455556666789988877665543 3467889999999999999987643 3333444444444444466666666
Q ss_pred hcCC--CCeeecCCCCCcEEECCCCcEEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHH
Q 016347 164 EEVR--PHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLV 241 (391)
Q Consensus 164 ~~~~--~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ 241 (391)
+..+ .-.+|+++|+-|.+|..+..++++++|+.++... .........+++.|++|++...-.++.++|+|..|+.+|
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence 6542 2379999999999999999999999999984322 222233456788899999988888999999999999999
Q ss_pred HHHhCCCCC
Q 016347 242 EIVSGRCNT 250 (391)
Q Consensus 242 elltg~~p~ 250 (391)
.+..|..+|
T Consensus 1432 ~rs~~n~~f 1440 (2724)
T KOG1826|consen 1432 LRSDGNAYF 1440 (2724)
T ss_pred HHhcccHHH
Confidence 998886555
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0015 Score=61.54 Aligned_cols=147 Identities=13% Similarity=0.176 Sum_probs=84.1
Q ss_pred CCCceeeccCceEEEEEEeCC-----CcEEEEEEecccchhcHHHHHHHHHHHhcCCCCce-eEEEEEEEeCCeeEEEEe
Q 016347 47 SPINKIGEGGFGSVYKGRLKD-----GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENL-VKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 47 ~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e 120 (391)
.-++.|..|-...+|++...+ ++.|++|+......... ...+|..+++.+..-++ .++++++.. + .|.+
T Consensus 39 ~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~e 113 (344)
T PLN02236 39 LQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEE 113 (344)
T ss_pred EEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECC-c---eEEE
Confidence 344566678888999997542 36789998766543332 23678888888854333 345555533 2 5799
Q ss_pred cccCCCHHHH-----------------HhcCCCCCCccccCHHHHHHHHHHH-----------------HHHHHHhhhc-
Q 016347 121 YLENNSLAQT-----------------LIGGGHHYSNIQFSWRTRSRICIGI-----------------ARGLAFLHEE- 165 (391)
Q Consensus 121 ~~~~~sL~~~-----------------i~~~~~~~~~~~l~~~~~~~i~~qi-----------------~~al~~lH~~- 165 (391)
|+++.+|... ++............+..+..+..++ ...+..|...
T Consensus 114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~ 193 (344)
T PLN02236 114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL 193 (344)
T ss_pred eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence 9987766421 1111100011112233333333221 1112222211
Q ss_pred ----CCCCeeecCCCCCcEEECC-CCcEEEEecccccc
Q 016347 166 ----VRPHIIHRDIKASNILLDK-DLTPKISDFGLAKL 198 (391)
Q Consensus 166 ----~~~~i~H~dikp~NIlv~~-~~~~kl~Dfg~~~~ 198 (391)
....++|+|+++.|||++. ++.+.|+||..+..
T Consensus 194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1226899999999999986 47899999987753
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0029 Score=57.73 Aligned_cols=31 Identities=29% Similarity=0.547 Sum_probs=25.6
Q ss_pred CCeeecCCCCCcEEECCCCc-EEEEecccccc
Q 016347 168 PHIIHRDIKASNILLDKDLT-PKISDFGLAKL 198 (391)
Q Consensus 168 ~~i~H~dikp~NIlv~~~~~-~kl~Dfg~~~~ 198 (391)
+.++|+|++|.|||++.++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 46999997764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0039 Score=59.43 Aligned_cols=82 Identities=20% Similarity=0.207 Sum_probs=54.1
Q ss_pred CCceeeccCceEEEEEEeCCCcEEEEEEeccc----ch---hcHHHHHHHHHHHhcCC---CCceeEEEEEEEeCCeeEE
Q 016347 48 PINKIGEGGFGSVYKGRLKDGKIAAIKVLSAE----SR---QGVKEFLTEIQVISEIE---HENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 48 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~----~~---~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~l 117 (391)
..+.||.|....||+.... +..++||.-... .. -.......|...|+.+. ..++.+++.++. ...++
T Consensus 36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 4678999999999999875 456888875411 11 12333444566676653 247778888776 35688
Q ss_pred EEecccC--CCHHHHHh
Q 016347 118 VYNYLEN--NSLAQTLI 132 (391)
Q Consensus 118 v~e~~~~--~sL~~~i~ 132 (391)
+||++++ ..+.+.+.
T Consensus 113 vME~L~~~~~ilr~~Ll 129 (418)
T PLN02756 113 GMRYLEPPHIILRKGLI 129 (418)
T ss_pred EEeecCCcceehhhhhc
Confidence 8999977 34555443
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0058 Score=56.92 Aligned_cols=143 Identities=19% Similarity=0.280 Sum_probs=82.5
Q ss_pred eeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCc------eeEEEEEE--EeCC--eeEEEEe
Q 016347 51 KIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHEN------LVKLYGCC--VEGN--HRILVYN 120 (391)
Q Consensus 51 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~--~~~~--~~~lv~e 120 (391)
.|.. .-..||+....+|+. ++|+.+.. ....++..|+..+..+.-.. +...-|-. .-.. ..+-+++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 556799999887776 89988765 33456777888887773211 11111111 1123 7788999
Q ss_pred cccCCCHHH---------------HHhcCC------CCCCccccCHHH-------------HHHHHHHHHHHHHHhhhc-
Q 016347 121 YLENNSLAQ---------------TLIGGG------HHYSNIQFSWRT-------------RSRICIGIARGLAFLHEE- 165 (391)
Q Consensus 121 ~~~~~sL~~---------------~i~~~~------~~~~~~~l~~~~-------------~~~i~~qi~~al~~lH~~- 165 (391)
|++|..+.. .++... +........|.. ......++...+..+.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999988772 011100 100111222220 011223344444444432
Q ss_pred ---CCCC---eeecCCCCCcEEECCCCc-EEEEeccccc
Q 016347 166 ---VRPH---IIHRDIKASNILLDKDLT-PKISDFGLAK 197 (391)
Q Consensus 166 ---~~~~---i~H~dikp~NIlv~~~~~-~kl~Dfg~~~ 197 (391)
...+ ++|+|+.|.||+++.+.. +-++||+-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1223 899999999999999874 8899999665
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0075 Score=56.51 Aligned_cols=81 Identities=14% Similarity=0.191 Sum_probs=51.9
Q ss_pred eeeccCceEEEEEEeCCC-cEEEEEEecc-------cchhcHHHHHHHHHHHhcCC--CC-ceeEEEEEEEeCCeeEEEE
Q 016347 51 KIGEGGFGSVYKGRLKDG-KIAAIKVLSA-------ESRQGVKEFLTEIQVISEIE--HE-NLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 51 ~lg~G~~g~V~~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~lv~ 119 (391)
.||.|....||++...+| +.|+||.-.. +-+-...+..-|.+.|+... .| .+.+++.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999998754 6799986321 11333445566777776662 34 34555543 455677999
Q ss_pred ecccCC-CHHHHHhc
Q 016347 120 NYLENN-SLAQTLIG 133 (391)
Q Consensus 120 e~~~~~-sL~~~i~~ 133 (391)
|+++.. .|...+..
T Consensus 80 EdL~~~~ilR~~Li~ 94 (370)
T TIGR01767 80 EDLSHHKIARKGLIE 94 (370)
T ss_pred hhCccchHHHHHHHc
Confidence 998654 34444443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0077 Score=55.95 Aligned_cols=31 Identities=19% Similarity=0.308 Sum_probs=28.0
Q ss_pred CCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 168 PHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 168 ~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
.+++|+|+.+.||+++.++.+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 4799999999999999999999999987764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0045 Score=58.09 Aligned_cols=146 Identities=16% Similarity=0.221 Sum_probs=81.2
Q ss_pred CCceeeccCceEEEEEEeCC----CcEEEEEEecccchhcHHHHHHHHHHHhcCCCCce-eEEEEEEEeCCeeEEEEecc
Q 016347 48 PINKIGEGGFGSVYKGRLKD----GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENL-VKLYGCCVEGNHRILVYNYL 122 (391)
Q Consensus 48 ~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~ 122 (391)
.++.|..|-...+|+....+ +..|++|+....... .-.-.+|..+++.+..-++ .++++++. ++ +|.+|+
T Consensus 18 ~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi 92 (330)
T PLN02421 18 SVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFI 92 (330)
T ss_pred EEEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehhh
Confidence 34566667788899987543 237889987654432 2334568888888854444 34555542 22 589999
Q ss_pred cCCCHHHH-----------------HhcCCCCCCccccCHHHHHHHHHHH----------------------HHHHHHhh
Q 016347 123 ENNSLAQT-----------------LIGGGHHYSNIQFSWRTRSRICIGI----------------------ARGLAFLH 163 (391)
Q Consensus 123 ~~~sL~~~-----------------i~~~~~~~~~~~l~~~~~~~i~~qi----------------------~~al~~lH 163 (391)
+|..|... ++.........+-.+..+..+..++ ..-+..+.
T Consensus 93 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~ 172 (330)
T PLN02421 93 NARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELK 172 (330)
T ss_pred cCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHH
Confidence 87755321 1111100011111222222222221 11122221
Q ss_pred hcC-----CCCeeecCCCCCcEEECC-CCcEEEEecccccc
Q 016347 164 EEV-----RPHIIHRDIKASNILLDK-DLTPKISDFGLAKL 198 (391)
Q Consensus 164 ~~~-----~~~i~H~dikp~NIlv~~-~~~~kl~Dfg~~~~ 198 (391)
... ..-++|+|+.+.|||+++ ++.++|+||..+..
T Consensus 173 ~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 173 EITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 110 114899999999999975 47899999988754
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.02 Score=53.05 Aligned_cols=29 Identities=28% Similarity=0.344 Sum_probs=25.3
Q ss_pred CCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 168 PHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 168 ~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
.+++|||+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 48999999999999987 578999998664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0053 Score=52.99 Aligned_cols=89 Identities=17% Similarity=0.132 Sum_probs=60.6
Q ss_pred HHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhh
Q 016347 84 VKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH 163 (391)
Q Consensus 84 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH 163 (391)
..-|..+..++.++. .|+++.. .+.-...++.|+|..... .... .|.. =+.+|.-.|
T Consensus 102 ~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i---------------~~~N---~i~a-gi~~L~~fH 158 (308)
T PF07387_consen 102 DALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKI---------------NFSN---FITA-GIKDLMDFH 158 (308)
T ss_pred hhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCccc---------------chhH---HHHH-hHHHHHHhh
Confidence 345777888888875 4666663 244467888998853211 1111 1111 146777888
Q ss_pred hcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 164 EEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 164 ~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+. +.+.+|||..|+|||-|..|.+||.|-+..
T Consensus 159 ~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 159 SE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred cc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence 64 458999999999999999999999997644
|
The function of this family is unknown. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.0029 Score=61.02 Aligned_cols=71 Identities=20% Similarity=0.282 Sum_probs=47.1
Q ss_pred EEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC-CeeEEEEecccCCCHHHHHhcC
Q 016347 60 VYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG-NHRILVYNYLENNSLAQTLIGG 134 (391)
Q Consensus 60 V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~sL~~~i~~~ 134 (391)
++.|....|..+ ..-+.... ...++.-..++++.+.|+|.-+++++-... ....+|+|++ +.||.+.+..+
T Consensus 5 ~~~a~~~~~~~c-~nglplt~--~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 5 TFFAQEKPGDVC-SNGLPLTP--NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred EEehhcCCCccc-cCCCcCCC--cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence 556665555533 22222211 124567778899999999999999876533 3577889998 66899888543
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.061 Score=58.10 Aligned_cols=145 Identities=17% Similarity=0.224 Sum_probs=79.3
Q ss_pred ceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcC-------CCCceeEEE-----EEEEe-CC--e
Q 016347 50 NKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEI-------EHENLVKLY-----GCCVE-GN--H 114 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~-----~~~~~-~~--~ 114 (391)
+.|+ |..-.+|+....+|+.+++|+.+.... ......|.+.|..+ .-|.+++.. ..... ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4563 456789999988888999999876422 22333444555444 233333311 11111 22 4
Q ss_pred eEEEEecccCCCHHHHH---------------------hcCCCCCCccccCHH-----------------HHHHHHHHHH
Q 016347 115 RILVYNYLENNSLAQTL---------------------IGGGHHYSNIQFSWR-----------------TRSRICIGIA 156 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i---------------------~~~~~~~~~~~l~~~-----------------~~~~i~~qi~ 156 (391)
.+.+++|++|..|.+.. ...........+.|. ....++.+++
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 67789999998776511 001110011112221 1122223333
Q ss_pred HHHH-----HhhhcCCCCeeecCCCCCcEEECCCC--cEE-EEecccccc
Q 016347 157 RGLA-----FLHEEVRPHIIHRDIKASNILLDKDL--TPK-ISDFGLAKL 198 (391)
Q Consensus 157 ~al~-----~lH~~~~~~i~H~dikp~NIlv~~~~--~~k-l~Dfg~~~~ 198 (391)
..+. .+.. ...+++|+|+++.||+++.++ ++. |+|||-+..
T Consensus 188 ~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3222 1211 233799999999999999875 555 999997753
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.013 Score=55.55 Aligned_cols=82 Identities=20% Similarity=0.222 Sum_probs=53.9
Q ss_pred CceeeccCceEEEEEEeCC-CcEEEEEEecc------cchhcHHHHHHHHHHHhcCC--CC-ceeEEEEEEEeCCeeEEE
Q 016347 49 INKIGEGGFGSVYKGRLKD-GKIAAIKVLSA------ESRQGVKEFLTEIQVISEIE--HE-NLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 49 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~------~~~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~lv 118 (391)
.+.||.|....||++.+.+ ++.|+||.-.. +-+-..++..-|.+.|+... .| ++.+++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 5689999999999999853 56788886321 11334556667888887763 34 45556644 45567888
Q ss_pred EecccCC-CHHHHHh
Q 016347 119 YNYLENN-SLAQTLI 132 (391)
Q Consensus 119 ~e~~~~~-sL~~~i~ 132 (391)
||+++.. .|.+.+.
T Consensus 112 MEdL~~~~ilR~~Li 126 (409)
T PRK12396 112 MEDLSDHTILRTALI 126 (409)
T ss_pred HHhCcccHHHHHHHH
Confidence 9988643 3444443
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.0061 Score=53.21 Aligned_cols=29 Identities=38% Similarity=0.552 Sum_probs=20.9
Q ss_pred CeeecCCCCCcEEE-CCCCcEEEEeccccc
Q 016347 169 HIIHRDIKASNILL-DKDLTPKISDFGLAK 197 (391)
Q Consensus 169 ~i~H~dikp~NIlv-~~~~~~kl~Dfg~~~ 197 (391)
.++|+|+.|.|||+ +.++.++|+||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 58999999999999 888999999998775
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.076 Score=49.70 Aligned_cols=72 Identities=17% Similarity=0.150 Sum_probs=44.9
Q ss_pred ccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCC--ceeEEE---E--EEEeCCeeEEEEecccCCC
Q 016347 54 EGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHE--NLVKLY---G--CCVEGNHRILVYNYLENNS 126 (391)
Q Consensus 54 ~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~---~--~~~~~~~~~lv~e~~~~~s 126 (391)
.+.-..||+....+++.+++|+.+... .....+..|.+.+..+... .++... | ....++..+.++++++|..
T Consensus 35 ~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 35 NSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 445668999998888889999876432 2345566677777666311 122211 1 1223456788999998764
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.039 Score=48.09 Aligned_cols=78 Identities=17% Similarity=0.239 Sum_probs=55.7
Q ss_pred CCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcC---CCCceeEEEEEEEeCCeeEEEEeccc
Q 016347 47 SPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEI---EHENLVKLYGCCVEGNHRILVYNYLE 123 (391)
Q Consensus 47 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~ 123 (391)
+..+++..|.--..|...+. ...+.||+- .......|..|+.-|..+ +.-.+.+++....+..+.++|+||++
T Consensus 19 ~er~~v~gG~inea~~v~dg-~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~ 94 (286)
T COG3001 19 KEREEVSGGDINEAWRLRDG-TDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLP 94 (286)
T ss_pred hcccccCCccccceeEeecC-CcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeecc
Confidence 34456666666677777664 567888863 334456677888777776 34567788888888999999999998
Q ss_pred CCCHH
Q 016347 124 NNSLA 128 (391)
Q Consensus 124 ~~sL~ 128 (391)
-+.+.
T Consensus 95 ~~~~d 99 (286)
T COG3001 95 TGPLD 99 (286)
T ss_pred CCCCC
Confidence 76554
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.037 Score=52.90 Aligned_cols=77 Identities=22% Similarity=0.286 Sum_probs=47.2
Q ss_pred CCCceeeccCceEEEEEEeCCC--cE-----EEEEEecccchhcHHHHHHHHHHHhcCCCCce-eEEEEEEEeCCeeEEE
Q 016347 47 SPINKIGEGGFGSVYKGRLKDG--KI-----AAIKVLSAESRQGVKEFLTEIQVISEIEHENL-VKLYGCCVEGNHRILV 118 (391)
Q Consensus 47 ~~~~~lg~G~~g~V~~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv 118 (391)
..++.|..|-...+|++...++ .. |.++.... .....-.-.+|+++++.+...++ .++++.+. -+++
T Consensus 53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l 127 (383)
T PTZ00384 53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTI 127 (383)
T ss_pred EEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC-CCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEE
Confidence 3455676788899999976532 22 44443222 22222234568889988865444 45566553 2689
Q ss_pred EecccCCCHH
Q 016347 119 YNYLENNSLA 128 (391)
Q Consensus 119 ~e~~~~~sL~ 128 (391)
.||++|.+|.
T Consensus 128 ~efIeGr~l~ 137 (383)
T PTZ00384 128 QEWVEGNTMG 137 (383)
T ss_pred EEEeccccCC
Confidence 9999988664
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.035 Score=52.44 Aligned_cols=62 Identities=15% Similarity=0.093 Sum_probs=42.5
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK 184 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~ 184 (391)
...|+-+|..|.++..++... ..++..+.+++.--++|+..+--- .+++|.|+.|.||++.-
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~-------~~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWK-------SQPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhcc-------cChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEEe
Confidence 346677788898998888543 345556666666555665433221 27999999999999953
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=95.35 E-value=0.096 Score=46.91 Aligned_cols=81 Identities=20% Similarity=0.171 Sum_probs=56.7
Q ss_pred CCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecc-cCC
Q 016347 47 SPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYL-ENN 125 (391)
Q Consensus 47 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~ 125 (391)
+....+..|..+.|+.++..+|..+++|+........ .+ ......|+...-...|++++.- .....|++|.+ ++.
T Consensus 5 ~~~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~-~E-~~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~ 80 (253)
T PF04655_consen 5 TPDGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAE-HE-ARGEAALRWWNGRGAVRLLAAD--PERGALLLERLDPGR 80 (253)
T ss_pred ccCCCCCCCcceEEEEEEcCCCCeEEEEecCCcccch-hh-hhHHhHhheeCCCCceeeeccc--cccchhhhhhccCCC
Confidence 3445677899999999999999999999976542211 11 1122557777888889998864 33567889998 555
Q ss_pred CHHHHH
Q 016347 126 SLAQTL 131 (391)
Q Consensus 126 sL~~~i 131 (391)
+|.+..
T Consensus 81 ~L~~~~ 86 (253)
T PF04655_consen 81 SLASLP 86 (253)
T ss_pred chhhcc
Confidence 776554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 391 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-65 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-64 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-49 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-49 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-41 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-41 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-39 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-25 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-24 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-24 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-24 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-24 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-24 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-24 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-24 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-23 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-23 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-23 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-23 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-23 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-23 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-23 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-23 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-23 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-23 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-23 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-23 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-23 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-23 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-23 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-23 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-23 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-22 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-22 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-22 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-22 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-22 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-21 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-21 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-20 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-20 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-20 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-19 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-19 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-19 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-19 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-19 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-19 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-19 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-19 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-19 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-19 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-19 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-18 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-18 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-18 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-18 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-17 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-17 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-17 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-17 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-17 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-17 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-17 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-17 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-17 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-17 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-17 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-17 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-17 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-17 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-16 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-16 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-16 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-16 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-16 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-16 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-16 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-15 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-14 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-14 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-14 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-14 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-14 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-14 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-14 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-14 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-14 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-13 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-13 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-13 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-13 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-13 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-12 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 9e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-10 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 9e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 9e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 9e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 9e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 9e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 9e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 509 bits (1312), Expect = 0.0
Identities = 131/315 (41%), Positives = 194/315 (61%), Gaps = 5/315 (1%)
Query: 18 VPEVDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLS 77
VP ++ + +K +S +EL +A+D+FS N +G GGFG VYKGRL DG + A+K L
Sbjct: 4 VPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLK 63
Query: 78 AESRQGVK-EFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGH 136
E QG + +F TE+++IS H NL++L G C+ R+LVY Y+ N S+A L
Sbjct: 64 EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE 123
Query: 137 HYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196
S W R RI +G ARGLA+LH+ P IIHRD+KA+NILLD++ + DFGLA
Sbjct: 124 --SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181
Query: 197 KLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPT 256
KL+ THV+T V GTIG++APEY G+ + K D++ +GV+L+E+++G+ ++
Sbjct: 182 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241
Query: 257 EEQ--YLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMST 314
+ LL+ L + ++L LVD L G++ EE + ++V LLCTQ +P RP MS
Sbjct: 242 NDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE 301
Query: 315 VVQMLMGEKDIDDDK 329
VV+ML G+ + +
Sbjct: 302 VVRMLEGDGLAERWE 316
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 439 bits (1132), Expect = e-155
Identities = 120/323 (37%), Positives = 174/323 (53%), Gaps = 6/323 (1%)
Query: 9 RRRDSPRNRVPEVDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDG 68
+ + + + + +L AT++F IG G FG VYKG L+DG
Sbjct: 4 KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63
Query: 69 KIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLA 128
A+K + ES QG++EF TEI+ +S H +LV L G C E N IL+Y Y+EN +L
Sbjct: 64 AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 129 QTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTP 188
+ L G ++ SW R ICIG ARGL +LH IIHRD+K+ NILLD++ P
Sbjct: 124 RHLYGSDLPTMSM--SWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVP 178
Query: 189 KISDFGLAKLIP-ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
KI+DFG++K + TH+ST V GT+GY+ PEY I+G++T K+D+YSFGV+L E++ R
Sbjct: 179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 248 CNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPK 307
LP E L E + + +L +VD +L E +F + C + +
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298
Query: 308 LRPSMSTVVQMLMGEKDIDDDKI 330
RPSM V+ L + + I
Sbjct: 299 DRPSMGDVLWKLEYALRLQESVI 321
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 420 bits (1083), Expect = e-148
Identities = 110/302 (36%), Positives = 163/302 (53%), Gaps = 23/302 (7%)
Query: 30 NVKLYSYKELSIATDDFSP------INKIGEGGFGSVYKGRLKDGKIAAIKVLSA----E 79
+S+ EL T++F NK+GEGGFG VYKG + + A+K L+A
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69
Query: 80 SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYS 139
+ + ++F EI+V+++ +HENLV+L G +G+ LVY Y+ N SL L
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD---G 126
Query: 140 NIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199
SW R +I G A G+ FLHE H IHRDIK++NILLD+ T KISDFGLA+
Sbjct: 127 TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARAS 183
Query: 200 PAN-MTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEE 258
T +++R+ GT Y+APE +RG++T K+DIYSFGV+L+EI++G +
Sbjct: 184 EKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--P 240
Query: 259 QYLLERTWDLY-ERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317
Q LL+ ++ E + + +D + D D+ V C + RP + V Q
Sbjct: 241 QLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299
Query: 318 ML 319
+L
Sbjct: 300 LL 301
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 2e-86
Identities = 71/309 (22%), Positives = 121/309 (39%), Gaps = 32/309 (10%)
Query: 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVI 94
+ L + + G FG V+K +L + A+K+ + +Q + E+ +
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYSL 72
Query: 95 SEIEHENLVKLYGCCVEGNH----RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSR 150
++HEN+++ G G L+ + E SL+ L SW
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-------VVSWNELCH 125
Query: 151 ICIGIARGLAFLHEEV-------RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANM 203
I +ARGLA+LHE++ +P I HRDIK+ N+LL +LT I+DFGLA A
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 204 THV-STRVAGTIGYLAPEYA-----IRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTE 257
+ + GT Y+APE + + D+Y+ G++L E+ S + +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 258 EQYLLERTWDLYERRELILLVDT-----SLNGDFDAEEACRFL-KVGLLCTQDTPKLRPS 311
E ++ +V L + L + C + R S
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 312 MSTVVQMLM 320
V + +
Sbjct: 306 AGCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 9e-73
Identities = 77/322 (23%), Positives = 128/322 (39%), Gaps = 47/322 (14%)
Query: 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVI 94
+ E S+ D+ + IG G +G+VYKG L D + A+KV S +RQ I +
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINE-KNIYRV 61
Query: 95 SEIEHENLVKLYGCCVEGN-----HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRS 149
+EH+N+ + +LV Y N SL + L S W +
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-------SLHTSDWVSSC 114
Query: 150 RICIGIARGLAFLHEEV------RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN- 202
R+ + RGLA+LH E+ +P I HRD+ + N+L+ D T ISDFGL+ + N
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 203 ------MTHVSTRVAGTIGYLAPEYAIRGQV--------TRKADIYSFGVLLVEIVSGRC 248
+ + GTI Y+APE + G V ++ D+Y+ G++ EI RC
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFM-RC 232
Query: 249 NTNMRLPTEEQYLL---ERTWDLYERRELILLVDT-----SLNGDFDAEEACRFLKVGLL 300
+ +Y + + ++ +LV + +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 301 --CTQDTPKLRPSMSTVVQMLM 320
C + R + + +
Sbjct: 293 EDCWDQDAEARLTAQXAEERMA 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 2e-62
Identities = 82/350 (23%), Positives = 139/350 (39%), Gaps = 72/350 (20%)
Query: 9 RRRDSPRNRVPEVDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDG 68
P + E ++ I D + KIG G FG+V++ G
Sbjct: 4 HHHHHPMSDYDIPTTENLYFQG--AMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-G 60
Query: 69 KIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNS 126
A+K+L + + V EFL E+ ++ + H N+V G + + +V YL S
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 127 LAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL 186
L + L + Q R R + +A+G+ +LH P I+HR++K+ N+L+DK
Sbjct: 121 LYRLLHK---SGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKY 176
Query: 187 TPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQ-VTRKADIYSFGVLLVEIVS 245
T K+ DFGL++L A+ S AGT ++APE +R + K+D+YSFGV+L E+ +
Sbjct: 177 TVKVCDFGLSRLK-ASTFLSSKSAAGTPEWMAPE-VLRDEPSNEKSDVYSFGVILWELAT 234
Query: 246 GR---------------CNTNMRL------PTEEQYLLERTWDLYERRELILLVDTSLNG 284
+ RL + ++E W
Sbjct: 235 LQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWT----------------- 277
Query: 285 DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKDIDDDKITKPG 334
+ P RPS +T++ +L + + + P
Sbjct: 278 -------------------NEPWKRPSFATIMDLL---RPLIKSAVPPPN 305
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 2e-62
Identities = 76/345 (22%), Positives = 131/345 (37%), Gaps = 58/345 (16%)
Query: 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQV 93
S D +G+G FG K ++ G++ +K L + + FL E++V
Sbjct: 1 SMPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKV 60
Query: 94 ISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICI 153
+ +EH N++K G + + Y++ +L + + Q+ W R
Sbjct: 61 MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII-----KSMDSQYPWSQRVSFAK 115
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTH-------- 205
IA G+A+LH +IIHRD+ + N L+ ++ ++DFGLA+L+ T
Sbjct: 116 DIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 206 -----VSTRVAGTIGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQ 259
V G ++APE I G+ K D++SFG++L EI+
Sbjct: 173 KPDRKKRYTVVGNPYWMAPE-MINGRSYDEKVDVFSFGIVLCEIIGRV------------ 219
Query: 260 YLLERTWDLYERRELILLVDTSLNGDFDAEEAC--RFLKVGLLCTQDTPKLRPSMSTVVQ 317
Y R + ++ D C F + + C P+ RPS +
Sbjct: 220 ----NADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275
Query: 318 MLMGEKDIDDDKITKPGLISDFMDLKVRGPPKPKLETTTSSTYNS 362
L + + M L P P+LE + +
Sbjct: 276 WL--------ETL--------RMHLAGHLPLGPQLEQLDRGFWET 304
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 2e-60
Identities = 81/308 (26%), Positives = 131/308 (42%), Gaps = 56/308 (18%)
Query: 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVL-------SAESRQGVKE 86
+ ++A ++ +IG+GGFG V+KGRL D + AIK L E + +E
Sbjct: 10 KSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQE 69
Query: 87 FLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWR 146
F E+ ++S + H N+VKLYG +V ++ L L W
Sbjct: 70 FQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRL-----LDKAHPIKWS 122
Query: 147 TRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK-----DLTPKISDFGLAKLIPA 201
+ R+ + IA G+ ++ + P I+HRD+++ NI L + K++DFGL++
Sbjct: 123 VKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ--- 178
Query: 202 NMTHVSTRVAGTIGYLAPEYAIRGQ---VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEE 258
H + + G ++APE I + T KAD YSF ++L I++G P
Sbjct: 179 -SVHSVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTG------EGP--- 227
Query: 259 QYLLERTWDLYERRELILLVDTSLNG-------DFDAEEACRFLKVGLLCTQDTPKLRPS 311
+D Y ++ + G D V LC PK RP
Sbjct: 228 -------FDEYSYGKIKFINMIREEGLRPTIPEDCPPR----LRNVIELCWSGDPKKRPH 276
Query: 312 MSTVVQML 319
S +V+ L
Sbjct: 277 FSYIVKEL 284
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 3e-60
Identities = 81/303 (26%), Positives = 126/303 (41%), Gaps = 73/303 (24%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHE 100
I + +G G FG V K + + K AIK + +ES + K F+ E++ +S + H
Sbjct: 5 IDYKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHP 61
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
N+VKLYG C+ N LV Y E SL L G ++ C+ ++G+A
Sbjct: 62 NIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAE---PLPYYTAAHAMSWCLQCSQGVA 116
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLT-PKISDFGLAKLIPANMTHVSTRVAGTIGYLAP 219
+LH +IHRD+K N+LL T KI DFG A I +M T G+ ++AP
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM----TNNKGSAAWMAP 172
Query: 220 EYAIRGQ-VTRKADIYSFGVLLVEIVSGR----------------CNTNMRL------PT 256
E G + K D++S+G++L E+++ R + R P
Sbjct: 173 E-VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPK 231
Query: 257 EEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVV 316
+ L+ R W +D P RPSM +V
Sbjct: 232 PIESLMTRCWS-----------------------------------KD-PSQRPSMEEIV 255
Query: 317 QML 319
+++
Sbjct: 256 KIM 258
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 1e-58
Identities = 62/312 (19%), Positives = 112/312 (35%), Gaps = 78/312 (25%)
Query: 37 KELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAE--SRQGVKEFLTEIQVI 94
K I + + K+ E G ++KGR + G +KVL S + ++F E +
Sbjct: 3 KHSGIDFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRL 61
Query: 95 SEIEHENLVKLYGCCVE--GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRIC 152
H N++ + G C H L+ +++ SL L H +N +
Sbjct: 62 RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL----HEGTNFVVDQSQAVKFA 117
Query: 153 IGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAG 212
+ +ARG+AFLH P I + + ++++D+D+T +IS + + S
Sbjct: 118 LDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMY 170
Query: 213 TIGYLAPEYAIRGQ----VTRKADIYSFGVLLVEIVSGR---------------CNTNMR 253
++APE A++ + R AD++SF VLL E+V+ +R
Sbjct: 171 APAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR 229
Query: 254 L------PTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPK 307
L++ + + P
Sbjct: 230 PTIPPGISPHVSKLMKICMN------------------------------------EDPA 253
Query: 308 LRPSMSTVVQML 319
RP +V +L
Sbjct: 254 KRPKFDMIVPIL 265
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 3e-57
Identities = 73/313 (23%), Positives = 121/313 (38%), Gaps = 82/313 (26%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVL----SAESRQGVKEFLTEIQVISE 96
I + + IG GGFG VY+ G A+K + Q ++ E ++ +
Sbjct: 4 IDFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 97 IEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIA 156
++H N++ L G C++ + LV + L + L S + + IA
Sbjct: 63 LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL-------SGKRIPPDILVNWAVQIA 115
Query: 157 RGLAFLHEEVRPHIIHRDIKASNILLDKDLTP--------KISDFGLAKLIPANMTHVST 208
RG+ +LH+E IIHRD+K+SNIL+ + + KI+DFGLA+
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---M 172
Query: 209 RVAGTIGYLAPEYAIRGQ-VTRKADIYSFGVLLVEIVSGR---------------CNTNM 252
AG ++APE IR ++ +D++S+GVLL E+++G +
Sbjct: 173 SAAGAYAWMAPE-VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL 231
Query: 253 RL------PTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTP 306
L P L+E W+ P
Sbjct: 232 ALPIPSTCPEPFAKLMEDCWN------------------------------------PDP 255
Query: 307 KLRPSMSTVVQML 319
RPS + ++ L
Sbjct: 256 HSRPSFTNILDQL 268
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 4e-57
Identities = 77/293 (26%), Positives = 138/293 (47%), Gaps = 32/293 (10%)
Query: 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAE--SRQGVKEFLTEIQ 92
+ + I + +IG G FG+VYKG+ G +A +K+L+ + Q ++ F E+
Sbjct: 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWH-GDVA-VKMLNVTAPTPQQLQAFKNEVG 72
Query: 93 VISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRIC 152
V+ + H N++ G I V + E +SL L H S +F + I
Sbjct: 73 VLRKTRHVNILLFMGYSTAPQLAI-VTQWCEGSSLYHHL-----HASETKFEMKKLIDIA 126
Query: 153 IGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI-PANMTHVSTRVA 211
ARG+ +LH IIHRD+K++NI L +D T KI DFGLA + +H +++
Sbjct: 127 RQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS 183
Query: 212 GTIGYLAPEYAIRGQ----VTRKADIYSFGVLLVEIVSGRC-NTNMRLPTEEQYLLERTW 266
G+I ++APE IR Q + ++D+Y+FG++L E+++G+ +N+ + ++ R
Sbjct: 184 GSILWMAPE-VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG- 241
Query: 267 DLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319
+ V ++ ++ C + RPS ++ +
Sbjct: 242 ---SLSPDLSKVRSNCPKR--------MKRLMAECLKKKRDERPSFPRILAEI 283
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-55
Identities = 74/317 (23%), Positives = 126/317 (39%), Gaps = 40/317 (12%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFL--TEIQVISEIE 98
+ +IG+G +G V+ G+ + G+ A+KV + TEI +
Sbjct: 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEA---SWFRETEIYQTVLMR 89
Query: 99 HENLVKLYGCCVEGNHRI----LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIG 154
HEN++ ++G L+ +Y EN SL L + ++ ++
Sbjct: 90 HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTT---LDAKSMLKLAYS 142
Query: 155 IARGLAFLHEEV-----RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHV--- 206
GL LH E+ +P I HRD+K+ NIL+ K+ T I+D GLA ++ V
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP 202
Query: 207 STRVAGTIGYLAPE------YAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQY 260
GT Y+ PE Q AD+YSFG++L E+ RC + + +
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLP 261
Query: 261 LLERTWDLYERRELILLVDT-----SLNGDFDAEEACRFLKVGLL--CTQDTPKLRPSMS 313
+ ++ +V S + ++E R + L+ C P R +
Sbjct: 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMG-KLMTECWAHNPASRLTAL 320
Query: 314 TVVQMLMGEKDIDDDKI 330
V + L + D K+
Sbjct: 321 RVKKTLAKMSESQDIKL 337
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 2e-54
Identities = 68/301 (22%), Positives = 123/301 (40%), Gaps = 46/301 (15%)
Query: 49 INKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFL--TEIQVISEIEHENLVKLY 106
+ +G+G +G V++G + G+ A+K+ S+ + + TE+ + HEN++
Sbjct: 13 LECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFI 68
Query: 107 GCCVEGNHRI----LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFL 162
+ H L+ +Y E SL L + + RI + IA GLA L
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTT---LDTVSCLRIVLSIASGLAHL 121
Query: 163 HEEV-----RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHV---STRVAGTI 214
H E+ +P I HRD+K+ NIL+ K+ I+D GLA + + + + GT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 215 GYLAPEYAIRGQV-------TRKADIYSFGVLLVEIVSGRCNTN-----MRLPTEE---- 258
Y+APE + + ++ DI++FG++L E+ R +N + P +
Sbjct: 182 RYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYKPPFYDVVPN 239
Query: 259 QYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318
E + + + D + +K C P R + + +
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKKT 296
Query: 319 L 319
L
Sbjct: 297 L 297
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-54
Identities = 64/303 (21%), Positives = 116/303 (38%), Gaps = 47/303 (15%)
Query: 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAE--SRQGVKEFLTEIQ 92
+E I + IG+G FG VY GR G++A I+++ E + +K F E+
Sbjct: 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH-GEVA-IRLIDIERDNEDQLKAFKREVM 81
Query: 93 VISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRIC 152
+ HEN+V G C+ H ++ + + +L + + I +I
Sbjct: 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV-----RDAKIVLDVNKTRQIA 136
Query: 153 IGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI----PANMTHVST 208
I +G+ +LH I+H+D+K+ N+ D I+DFGL +
Sbjct: 137 QEIVKGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLR 192
Query: 209 RVAGTIGYLAPEYAIRGQV----------TRKADIYSFGVLLVEIVSGRCNTNMRLPTEE 258
G + +LAPE IR ++ +D+++ G + E+ + P +
Sbjct: 193 IQNGWLCHLAPEI-IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR------EWPFKT 245
Query: 259 QYLLERTWDLYE--RRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVV 316
Q W + + L E + L C + RP+ + ++
Sbjct: 246 QPAEAIIWQMGTGMKPNLS-------QIGMGKE----ISDILLFCWAFEQEERPTFTKLM 294
Query: 317 QML 319
ML
Sbjct: 295 DML 297
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 5e-52
Identities = 71/299 (23%), Positives = 126/299 (42%), Gaps = 42/299 (14%)
Query: 49 INKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTE--IQVISEIEHENLVKLY 106
IG+G FG V++G+ + G+ A+K+ S+ + + E I + HEN++
Sbjct: 47 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFI 102
Query: 107 GCCVEGNHRI----LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFL 162
+ N LV +Y E+ SL L + Y+ + ++ + A GLA L
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYT---VTVEGMIKLALSTASGLAHL 155
Query: 163 HEEV-----RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN---MTHVSTRVAGTI 214
H E+ +P I HRD+K+ NIL+ K+ T I+D GLA + + GT
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 215 GYLAPEYAIRGQV-------TRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWD 267
Y+APE + + ++ADIY+ G++ EI RC+ + +
Sbjct: 216 RYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPS 273
Query: 268 LYERRELILLVDT-----SLNGDFDAEEACRFLKVGLL--CTQDTPKLRPSMSTVVQML 319
E+ +V ++ + + EA R + ++ C R + + + L
Sbjct: 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMA-KIMRECWYANGAARLTALRIKKTL 331
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-45
Identities = 67/283 (23%), Positives = 120/283 (42%), Gaps = 23/283 (8%)
Query: 49 INKIGEGGFGSVYKGRLK-----DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLV 103
+ ++G+G FGSV R G++ A+K L + + +++F EI+++ ++H+N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 104 KLYGCCVEGNHR--ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
K G C R L+ YL SL L +I+ + I +G+ +
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL-----QYTSQICKGMEY 129
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT--IGYLAP 219
L + IHRD+ NIL++ + KI DFGL K++P + + G I + AP
Sbjct: 130 LGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAP 186
Query: 220 EYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279
E + + +D++SFGV+L E+ + + + + LI L+
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246
Query: 280 TSLNGD-FDAEEAC--RFLKVGLLCTQDTPKLRPSMSTVVQML 319
N + C + C + RPS + +
Sbjct: 247 ---NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-45
Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 17/211 (8%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIA-AIKVL-SAESRQGVKEFLTEIQVISEIE 98
+ +D +IG G FG V+ GRL+ A+K +FL E +++ +
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS 170
Query: 99 HENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARG 158
H N+V+L G C + +V ++ L G +T ++ A G
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-----LRVKTLLQMVGDAAAG 225
Query: 159 LAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT----I 214
+ +L + IHRD+ A N L+ + KISDFG+++ V G +
Sbjct: 226 MEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG---VYAASGGLRQVPV 279
Query: 215 GYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
+ APE G+ + ++D++SFG+LL E S
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFS 310
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 4e-45
Identities = 70/327 (21%), Positives = 127/327 (38%), Gaps = 23/327 (7%)
Query: 5 SFLFRRRDSPRNRVPEVDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGR 64
S+ + + F G + ++G+G FGSV R
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCR 61
Query: 65 L-----KDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR--IL 117
G++ A+K L + + +++F EI+++ ++H+N+VK G C R L
Sbjct: 62 YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 121
Query: 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKA 177
+ YL SL L +I+ + I +G+ +L + IHRD+
Sbjct: 122 IMEYLPYGSLRDYLQKHKERIDHIKLL-----QYTSQICKGMEYLGTK---RYIHRDLAT 173
Query: 178 SNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT--IGYLAPEYAIRGQVTRKADIYS 235
NIL++ + KI DFGL K++P + + + G I + APE + + +D++S
Sbjct: 174 RNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWS 233
Query: 236 FGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGD-FDAEEAC-- 292
FGV+L E+ + + + + LI L+ N + C
Sbjct: 234 FGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK---NNGRLPRPDGCPD 290
Query: 293 RFLKVGLLCTQDTPKLRPSMSTVVQML 319
+ C + RPS + +
Sbjct: 291 EIYMIMTECWNNNVNQRPSFRDLALRV 317
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-44
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 12/209 (5%)
Query: 44 DDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKE---FLTEIQVISEIEH 99
+F KIG G F VY+ L DG A+K + K + EI ++ ++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGL 159
N++K Y +E N +V + L++ + RT + + + L
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQ--KRLIPERTVWKYFVQLCSAL 149
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAP 219
+H ++HRDIK +N+ + K+ D GL + + T + V GT Y++P
Sbjct: 150 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 205
Query: 220 EYAIRGQ-VTRKADIYSFGVLLVEIVSGR 247
E I K+DI+S G LL E+ + +
Sbjct: 206 E-RIHENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-43
Identities = 75/282 (26%), Positives = 125/282 (44%), Gaps = 22/282 (7%)
Query: 49 INKIGEGGFGSVYKGRLK-----DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLV 103
I+++G+G FGSV R G + A+K L ++F EIQ++ + + +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 104 KLYGCCVEGNHR--ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
K G + LV YL + L L + I +G+ +
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLL-----LYSSQICKGMEY 142
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT--IGYLAP 219
L +HRD+ A NIL++ + KI+DFGLAKL+P + + R G I + AP
Sbjct: 143 LGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 199
Query: 220 EYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279
E +R++D++SFGV+L E+ + C+ + E ++ D+ L+ L++
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT-YCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258
Query: 280 TSLNGDFDAEEAC--RFLKVGLLCTQDTPKLRPSMSTVVQML 319
A AC ++ LC +P+ RPS S + L
Sbjct: 259 E--GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-43
Identities = 65/284 (22%), Positives = 120/284 (42%), Gaps = 25/284 (8%)
Query: 49 INKIGEGGFGSVYKGRLK-----DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENL 102
I +GEG FG V R G+ A+K L E + + EI+++ + HEN+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 103 VKLYGCCVEGNHR--ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
VK G C E L+ +L + SL + L + + Q + + I +G+
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQL-----KYAVQICKGMD 140
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT--IGYLA 218
+L +HRD+ A N+L++ + KI DFGL K I + + + + + + A
Sbjct: 141 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA 197
Query: 219 PEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278
PE ++ + +D++SFGV L E+++ C+++ ++ T L+ +
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLT-YCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256
Query: 279 DTSLNGD-FDAEEAC--RFLKVGLLCTQDTPKLRPSMSTVVQML 319
G C ++ C + P R S +++
Sbjct: 257 K---EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-43
Identities = 70/320 (21%), Positives = 112/320 (35%), Gaps = 41/320 (12%)
Query: 7 LFRRRDSPRNRVPEVDEEFSGIHNVKLYSYKE-LSIATDDFSPINKIGEGGFGSVYKGRL 65
F+ + R E S Y S F ++++G G +G V+K R
Sbjct: 19 YFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRS 78
Query: 66 K-DGKIAAIKV--LSAESRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILVYNY 121
K DG++ A+K + L E+ ++ +H V+L EG L
Sbjct: 79 KEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL 138
Query: 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNIL 181
SL Q G LA LH + ++H D+K +NI
Sbjct: 139 CGP-SLQQHCEAWGAS-----LPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIF 189
Query: 182 LDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLV 241
L K+ DFGL + + G Y+APE ++G AD++S G+ ++
Sbjct: 190 LGPRGRCKLGDFGLLVEL-GTAGAGEVQE-GDPRYMAPE-LLQGSYGTAADVFSLGLTIL 246
Query: 242 EIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDA---EEACRFLKVG 298
E+ NM LP + L L +F A E L
Sbjct: 247 EVA-----CNMELP-------------HGGEGWQQLRQGYLPPEFTAGLSSELRSVLV-- 286
Query: 299 LLCTQDTPKLRPSMSTVVQM 318
+ + PKLR + ++ +
Sbjct: 287 -MMLEPDPKLRATAEALLAL 305
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 8e-43
Identities = 59/232 (25%), Positives = 97/232 (41%), Gaps = 37/232 (15%)
Query: 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHEN 101
DF I +G+G FG V K R D + AIK + + + L+E+ +++ + H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 102 LVKLYGCCVEGNHRILVYN-------------YLENNSLAQTLIGGGHHYSNIQFSWRTR 148
+V+ Y +E + + Y EN +L + WR
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL-NQQRDEYWR-- 120
Query: 149 SRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVS- 207
+ I L+++H + IIHRD+K NI +D+ KI DFGLAK + ++ +
Sbjct: 121 --LFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 208 ------------TRVAGTIGYLAPE-YAIRGQVTRKADIYSFGVLLVEIVSG 246
T GT Y+A E G K D+YS G++ E++
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-42
Identities = 75/283 (26%), Positives = 119/283 (42%), Gaps = 25/283 (8%)
Query: 49 INKIGEGGFGSVYKGRLKD-----GKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENL 102
I +GEG FG V G++ A+K L A+ Q + EI ++ + HE++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 103 VKLYGCCVEGNHR--ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
+K GCC + LV Y+ SL L I G+A
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-------PRHSIGLAQLLLFAQQICEGMA 148
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT--IGYLA 218
+LH + H IHRD+ A N+LLD D KI DFGLAK +P + R G + + A
Sbjct: 149 YLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 205
Query: 219 PEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278
PE + +D++SFGV L E+++ C+++ PT+ L+ L L+
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264
Query: 279 DTSLNGDFDAEEAC--RFLKVGLLCTQDTPKLRPSMSTVVQML 319
+ + C + C + RP+ ++ +L
Sbjct: 265 ER--GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-42
Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 13/208 (6%)
Query: 44 DDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKV--LSAESRQGVKEFLTEIQVISEIEHE 100
+ + + KIGEG FG + +DG+ IK +S S + +E E+ V++ ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
N+V+ E +V +Y E L + + + + F + I L
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI----NAQKGVLFQEDQILDWFVQICLALK 139
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPE 220
+H+ I+HRDIK+ NI L KD T ++ DFG+A+++ + + + GT YL+PE
Sbjct: 140 HVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPE 195
Query: 221 YAIRGQ-VTRKADIYSFGVLLVEIVSGR 247
+ K+DI++ G +L E+ + +
Sbjct: 196 -ICENKPYNNKSDIWALGCVLYELCTLK 222
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-42
Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 19/221 (8%)
Query: 30 NVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVL--SAESRQGVKEF 87
+ Y I D + + ++G G FG V G+ + AIK++ + S EF
Sbjct: 10 STAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EF 66
Query: 88 LTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRT 147
+ E +V+ + HE LV+LYG C + ++ Y+ N L L H + Q
Sbjct: 67 IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL--- 123
Query: 148 RSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVS 207
+C + + +L + +HRD+ A N L++ K+SDFGL++ + +
Sbjct: 124 --EMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---EY 175
Query: 208 TRVAGT---IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
T G+ + + PE + + + K+DI++FGVL+ EI S
Sbjct: 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-42
Identities = 58/208 (27%), Positives = 106/208 (50%), Gaps = 15/208 (7%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHE 100
I + + + +IG G FG V+ G + AIK + + ++F+ E +V+ ++ H
Sbjct: 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHP 63
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
LV+LYG C+E LV ++E+ L+ L ++ +C+ + G+A
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLL-----GMCLDVCEGMA 118
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT---IGYL 217
+L E +IHRD+ A N L+ ++ K+SDFG+ + + + T GT + +
Sbjct: 119 YLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD---QYTSSTGTKFPVKWA 172
Query: 218 APEYAIRGQVTRKADIYSFGVLLVEIVS 245
+PE + + K+D++SFGVL+ E+ S
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 6e-42
Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 19/205 (9%)
Query: 51 KIGEGGFGSVYKGR-LKDGKIAAIKV--LSAESRQGVKEFLTEIQVISEIEHENLVKLYG 107
+IG G F +VYKG + A ++ + F E +++ ++H N+V+ Y
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 108 CCVEGNHR----ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH 163
+LV + + +L L + C I +GL FLH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV------MKIKVLRSWCRQILKGLQFLH 146
Query: 164 EEVRPHIIHRDIKASNILLD-KDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYA 222
P IIHRD+K NI + + KI D GLA L A+ V GT ++APE
Sbjct: 147 TR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEM- 201
Query: 223 IRGQVTRKADIYSFGVLLVEIVSGR 247
+ D+Y+FG+ ++E+ +
Sbjct: 202 YEEKYDESVDVYAFGMCMLEMATSE 226
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-41
Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD----GKIA-AIKVLSAE-SRQGVKEFLTEIQVISEI 97
+F I +G G FG+VYKG KI AIK L S + KE L E V++ +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 98 EHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQF-SWRTRSRICIGIA 156
++ ++ +L G C+ + L+ + L + + + +W C+ IA
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 157 RGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT-IG 215
+G+ +L + ++HRD+ A N+L+ KI+DFGLAKL+ A I
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 216 YLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
++A E + T ++D++S+GV + E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-41
Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 52 IGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCV 110
+G+G +G VY GR L + AIK + + + EI + ++H+N+V+ G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 111 EGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHI 170
E + + SL+ L + ++ + +T I GL +LH+ I
Sbjct: 90 ENGFIKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QI 143
Query: 171 IHRDIKASNILLD-KDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQV-- 227
+HRDIK N+L++ KISDFG +K + T GT+ Y+APE I
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPE-IIDKGPRG 201
Query: 228 -TRKADIYSFGVLLVEIVSGR 247
+ ADI+S G ++E+ +G+
Sbjct: 202 YGKAADIWSLGCTIIEMATGK 222
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-41
Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 15/216 (6%)
Query: 31 VKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTE 90
+ ++ + + IG+G FG V G + G A+K + ++ + FL E
Sbjct: 180 QDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAE 236
Query: 91 IQVISEIEHENLVKLYGCCVEGNHRI-LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRS 149
V++++ H NLV+L G VE + +V Y+ SL L G
Sbjct: 237 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS----VLGGDCLL 292
Query: 150 RICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTR 209
+ + + + +L + +HRD+ A N+L+ +D K+SDFGL K + T + +
Sbjct: 293 KFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA--SSTQDTGK 347
Query: 210 VAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
+ + + APE + + K+D++SFG+LL EI S
Sbjct: 348 LP--VKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 58/215 (26%), Positives = 107/215 (49%), Gaps = 9/215 (4%)
Query: 32 KLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIA-AIKVLSAESRQGVKEFLTE 90
+Y + + D + +K+G G +G VY+G K + A+K L ++ + V+EFL E
Sbjct: 208 VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 266
Query: 91 IQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSR 150
V+ EI+H NLV+L G C ++ ++ +L L + S
Sbjct: 267 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ----EVSAVVLLY 322
Query: 151 ICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRV 210
+ I+ + +L ++ + IHR++ A N L+ ++ K++DFGL++L+ +
Sbjct: 323 MATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 379
Query: 211 AGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
I + APE + + K+D+++FGVLL EI +
Sbjct: 380 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-41
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHE 100
+ ++ + + ++G G FG V G+ K A+K++ S EF E Q + ++ H
Sbjct: 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHP 63
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
LVK YG C + +V Y+ N L L G Q +C + G+A
Sbjct: 64 KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLL-----EMCYDVCEGMA 118
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT---IGYL 217
FL IHRD+ A N L+D+DL K+SDFG+ + + + GT + +
Sbjct: 119 FLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVKWS 172
Query: 218 APEYAIRGQVTRKADIYSFGVLLVEIVS 245
APE + + K+D+++FG+L+ E+ S
Sbjct: 173 APEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-40
Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 44 DDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENL 102
DF I IG GGFG V+K + DGK IK + + + +E ++ +++++H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNI 66
Query: 103 VKLYGCCVEGNHRILVYNYLENNSLAQTLI------GGG------HHYSNIQFSWRTRSR 150
V GC ++ + + S + L G +
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 151 ICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRV 210
+ I +G+ ++H + +I+RD+K SNI L KI DFGL + + TR
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRS 181
Query: 211 AGTIGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSG 246
GT+ Y++PE I Q ++ D+Y+ G++L E++
Sbjct: 182 KGTLRYMSPE-QISSQDYGKEVDLYALGLILAELLHV 217
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-40
Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIA-----AIKVLSAE-SRQGVKEFLTEIQVI 94
I + IG G FG VYKG LK AIK L A + + +FL E ++
Sbjct: 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 100
Query: 95 SEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIG 154
+ H N+++L G + +++ Y+EN +L + L +FS + G
Sbjct: 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRG 155
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT- 213
IA G+ +L + +HRD+ A NIL++ +L K+SDFGL++++ + T G
Sbjct: 156 IAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212
Query: 214 -IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
I + APE + T +D++SFG+++ E+++
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-40
Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 16/220 (7%)
Query: 31 VKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTE 90
+ ++ + + IG+G FG V G + G A+K + ++ + FL E
Sbjct: 8 QDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAE 64
Query: 91 IQVISEIEHENLVKLYGCCVEGNHRI-LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRS 149
V++++ H NLV+L G VE + +V Y+ SL L G
Sbjct: 65 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS----VLGGDCLL 120
Query: 150 RICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTR 209
+ + + + +L + +HRD+ A N+L+ +D K+SDFGL K + T + +
Sbjct: 121 KFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA--SSTQDTGK 175
Query: 210 VAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRC 248
+ + + APE + + K+D++SFG+LL EI S GR
Sbjct: 176 LP--VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 213
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-40
Identities = 68/301 (22%), Positives = 124/301 (41%), Gaps = 62/301 (20%)
Query: 49 INKIGEGGFGSVYKGRLKDGK------IAAIKVLSAESRQGVKEFLTEIQVISEIEHENL 102
++GEG FG V+ + + A+K L S ++F E ++++ ++H+++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 103 VKLYGCCVEGNHRILVYNYLENNSLAQTL---------IGGGHHYSNIQFSWRTRSRICI 153
V+ +G C EG ++V+ Y+ + L + L + GG + +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213
+A G+ +L H +HRD+ N L+ + L KI DFG+++ I + RV G
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRVGGR 219
Query: 214 ----IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-------GRCNTNMRLPTEEQYLL 262
I ++ PE + + T ++D++SFGV+L EI + NT + L
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL 279
Query: 263 ER----TWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318
ER ++Y ++ C Q P+ R S+ V
Sbjct: 280 ERPRACPPEVYA-----IMRG---------------------CWQREPQQRHSIKDVHAR 313
Query: 319 L 319
L
Sbjct: 314 L 314
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-40
Identities = 60/216 (27%), Positives = 108/216 (50%), Gaps = 10/216 (4%)
Query: 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIA-AIKVLSAESRQGVKEFLTEIQV 93
+Y + + D + +K+G G +G VY+G K + A+K L ++ + V+EFL E V
Sbjct: 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 62
Query: 94 ISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICI 153
+ EI+H NLV+L G C ++ ++ +L L + S +
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMAT 118
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213
I+ + +L ++ + IHRD+ A N L+ ++ K++DFGL++L+ +
Sbjct: 119 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRC 248
I + APE + + K+D+++FGVLL EI + G
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 211
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-40
Identities = 55/201 (27%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 51 KIGEGGFGSVYKGRLK--DGKIA-AIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLY 106
++G G FGSV +G + +I AIKVL + +E + E Q++ ++++ +V+L
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV 166
G C + V L + L+G + + + ++ G+ +L E+
Sbjct: 77 GVCQAEALML-VMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEK- 129
Query: 167 RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT--IGYLAPEYAIR 224
+ +HRD+ A N+LL KISDFGL+K + A+ ++ + R AG + + APE
Sbjct: 130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 225 GQVTRKADIYSFGVLLVEIVS 245
+ + ++D++S+GV + E +S
Sbjct: 188 RKFSSRSDVWSYGVTMWEALS 208
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 7e-40
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 12/205 (5%)
Query: 43 TDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHEN 101
++ KIG+G G+VY + G+ AI+ ++ + + + + EI V+ E ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
+V + G+ +V YL SL + I + +C + L F
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-------AAVCRECLQALEF 131
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEY 221
LH +IHRDIK+ NILL D + K++DFG I + ST V GT ++APE
Sbjct: 132 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEV 187
Query: 222 AIRGQVTRKADIYSFGVLLVEIVSG 246
R K DI+S G++ +E++ G
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-40
Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 15/212 (7%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLKD---GKIA-AIKVLSAE-SRQGVKEFLTEIQVIS 95
I IG G G V GRL+ + AIK L A + + ++FL+E ++
Sbjct: 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMG 105
Query: 96 EIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGI 155
+ +H N+++L G G ++V Y+EN SL L QF+ + G+
Sbjct: 106 QFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG-----QFTIMQLVGMLRGV 160
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT-- 213
G+ +L + +HRD+ A N+L+D +L K+SDFGL++++ + T G
Sbjct: 161 GAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP 217
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
I + APE + +D++SFGV++ E+++
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-40
Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 13/206 (6%)
Query: 43 TDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQG-VKEFLTEIQVISEIEHE 100
+ F+ + KIG+G FG V+KG + K+ AIK++ E + +++ EI V+S+ +
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
+ K YG ++ ++ YL S L G + I I I +GL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-------ILREILKGLD 133
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPE 220
+LH E IHRDIKA+N+LL + K++DFG+A + +T V GT ++APE
Sbjct: 134 YLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE 189
Query: 221 YAIRGQVTRKADIYSFGVLLVEIVSG 246
+ KADI+S G+ +E+ G
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARG 215
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 9e-40
Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 15/212 (7%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLK---DGKIA-AIKVLSAE-SRQGVKEFLTEIQVIS 95
+ + S +G G FG V GRLK +I+ AIK L + + ++FL E ++
Sbjct: 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 96 EIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGI 155
+ +H N+++L G + ++V Y+EN SL L QF+ + GI
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-----QFTVIQLVGMLRGI 156
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT-- 213
A G+ +L + +HRD+ A NIL++ +L K+SDFGL +++ + T G
Sbjct: 157 ASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
I + +PE + T +D++S+G++L E++S
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-39
Identities = 53/230 (23%), Positives = 89/230 (38%), Gaps = 36/230 (15%)
Query: 43 TDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKV--LSAESRQGVKEFLTEIQVISEI-E 98
T +F + KIG G FGSV+K DG I AIK + L E+ + + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 99 HENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARG 158
H ++V+ + E +H ++ Y SLA + ++ F + + + RG
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVGRG 127
Query: 159 LAFLHEEVRPHIIHRDIKASNILLDKD-------------------LTPKISDFGLAKLI 199
L ++H ++H DIK SNI + + + KI D G I
Sbjct: 128 LRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 200 PANMTHVSTRVAGTIGYLAPEYAIRGQV--TRKADIYSFGVLLVEIVSGR 247
+ G +LA E ++ KADI++ + +V
Sbjct: 185 SSPQVEE-----GDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-39
Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 51 KIGEGGFGSVYKGRLKDGKIA---AIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKL 105
++G G FG+V KG + K+ A+K+L E E L E V+ ++++ +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 106 YGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEE 165
G C + + V E L + L H + + ++ G+ +L E
Sbjct: 84 IGICEAESWML-VMEMAELGPLNKYLQQNRH------VKDKNIIELVHQVSMGMKYLEES 136
Query: 166 VRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT--IGYLAPEYAI 223
+ +HRD+ A N+LL KISDFGL+K + A+ + + G + + APE
Sbjct: 137 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 224 RGQVTRKADIYSFGVLLVEIVS 245
+ + K+D++SFGVL+ E S
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFS 215
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-39
Identities = 69/212 (32%), Positives = 106/212 (50%), Gaps = 16/212 (7%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHE 100
+ + + ++G G FG V+ G A+K L S FL E ++ +++H+
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQ 68
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
LV+LY + ++ Y+EN SL L + + + IA G+A
Sbjct: 69 RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMA 123
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT---IGYL 217
F+ E + IHRD++A+NIL+ L+ KI+DFGLA+LI N T G I +
Sbjct: 124 FIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWT 177
Query: 218 APEYAIRGQVTRKADIYSFGVLLVEIVS-GRC 248
APE G T K+D++SFG+LL EIV+ GR
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRI 209
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-39
Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 12/212 (5%)
Query: 44 DDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKV--LSAESRQGVKEFLTEIQVISEIEHE 100
+D+ + IG G +G K R DGKI K + + + ++E+ ++ E++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 101 NLVKLYGCCVEGNHRIL--VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARG 158
N+V+ Y ++ + L V Y E LA + R+ +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK--GTKERQYLDEEFVLRVMTQLTLA 123
Query: 159 LAFLHE--EVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGY 216
L H + ++HRD+K +N+ LD K+ DFGLA+++ + + T V GT Y
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYY 182
Query: 217 LAPEYAIRGQV-TRKADIYSFGVLLVEIVSGR 247
++PE + K+DI+S G LL E+ +
Sbjct: 183 MSPE-QMNRMSYNEKSDIWSLGCLLYELCALM 213
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-39
Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIA----AIKVLSAE---SRQGVKEFLTEIQV 93
I D + K+G+G FG V +G A+K L + + + +F+ E+
Sbjct: 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 94 ISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICI 153
+ ++H NL++LYG + +V SL L H+ S R +
Sbjct: 75 MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAV 128
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213
+A G+ +L + IHRD+ A N+LL KI DFGL + +P N H +
Sbjct: 129 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
Query: 214 --IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
+ APE + +D + FGV L E+ +
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-39
Identities = 71/342 (20%), Positives = 126/342 (36%), Gaps = 60/342 (17%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD----GKIA-AIKVLSAES-RQGVKEFLTEIQVISEI 97
+F I +G G FG+VYKG KI AIK L + + KE L E V++ +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 98 EHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR 157
++ ++ +L G C+ + L+ + L + + C+ IA+
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAK 128
Query: 158 GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT-IGY 216
G+ +L + ++HRD+ A N+L+ KI+DFGLAKL+ A I +
Sbjct: 129 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 217 LAPEYAIRGQVTRKADIYSFGVLLVEIVS-------GRCNTNMRLPTEEQYLLER----T 265
+A E + T ++D++S+GV + E+++ G + + E+ L + T
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 245
Query: 266 WDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKDI 325
D+Y ++V C RP ++
Sbjct: 246 IDVYM-----IMVK---------------------CWMIDADSRPKFRELIIEF------ 273
Query: 326 DDDKITKPGLISDFMDLKVRGPPKPKLETTTSSTYNSSDNPD 367
P + P P + + D D
Sbjct: 274 -SKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDD 314
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-39
Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 9/205 (4%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHE 100
I + K+G+G FG V+ G AIK L + + FL E QV+ ++ HE
Sbjct: 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHE 239
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
LV+LY E +V Y+ SL L G Y + IA G+A
Sbjct: 240 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMA 294
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPE 220
++ + +HRD++A+NIL+ ++L K++DFGLA+LI N I + APE
Sbjct: 295 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 351
Query: 221 YAIRGQVTRKADIYSFGVLLVEIVS 245
A+ G+ T K+D++SFG+LL E+ +
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTT 376
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-39
Identities = 72/298 (24%), Positives = 108/298 (36%), Gaps = 60/298 (20%)
Query: 49 INKIGEGGFGSVYKGRLKDGKIA------AIKVLSAE-SRQGVKEFLTEIQVISEIEHEN 101
I +G G FG VY+G++ A+K L S Q +FL E +IS+ H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIG-GGHHYSNIQFSWRTRSRICIGIARGLA 160
+V+ G ++ R ++ + L L + + IA G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 161 FLHEEVRPHIIHRDIKASNILLDK---DLTPKISDFGLAKLIPANMTHVSTRVAGTIGYL 217
+L E H IHRDI A N LL KI DFG+A+ I S G L
Sbjct: 155 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----SYYRKGGCAML 207
Query: 218 -----APEYAIRGQVTRKADIYSFGVLLVEIVS-------GRCNTNMRLPTEEQYLLER- 264
PE + G T K D +SFGVLL EI S + N + ++
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 267
Query: 265 ---TWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319
+Y + C Q P+ RP+ + +++ +
Sbjct: 268 KNCPGPVYR--------------------------IMTQCWQHQPEDRPNFAIILERI 299
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-39
Identities = 55/212 (25%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLKD----GKIA-AIKVLSAES-RQGVKEFLTEIQVI 94
+ + +G G FG+V+KG KI IKV+ +S RQ + + I
Sbjct: 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAI 69
Query: 95 SEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIG 154
++H ++V+L G C + ++ V YL SL + +
Sbjct: 70 GSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLL-----NWGVQ 123
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT- 213
IA+G+ +L E ++HR++ A N+LL +++DFG+A L+P + + A T
Sbjct: 124 IAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
I ++A E G+ T ++D++S+GV + E+++
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-39
Identities = 77/328 (23%), Positives = 130/328 (39%), Gaps = 62/328 (18%)
Query: 28 IHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIA------AIKVLSAE-S 80
+Y E +A + + ++G+G FG VY+G K AIK ++ S
Sbjct: 9 FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 68
Query: 81 RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSN 140
+ EFL E V+ E ++V+L G +G +++ + L L +N
Sbjct: 69 MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 128
Query: 141 ----IQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196
S ++ IA G+A+L+ +HRD+ A N ++ +D T KI DFG+
Sbjct: 129 NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 185
Query: 197 KLIPANMTHVSTRVAGTIGYL-----APEYAIRGQVTRKADIYSFGVLLVEIVS------ 245
+ I G G L +PE G T +D++SFGV+L EI +
Sbjct: 186 RDIYET----DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 241
Query: 246 -GRCNTNMRLPTEEQYLLER----TWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLL 300
G N + E LL++ L+E L+
Sbjct: 242 QGLSNEQVLRFVMEGGLLDKPDNCPDMLFE-----LMRM--------------------- 275
Query: 301 CTQDTPKLRPSMSTVVQMLMGEKDIDDD 328
C Q PK+RPS ++ + +++++
Sbjct: 276 CWQYNPKMRPSFLEIISSI--KEEMEPG 301
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-39
Identities = 72/302 (23%), Positives = 131/302 (43%), Gaps = 63/302 (20%)
Query: 49 INKIGEGGFGSVYKGRLKDGKIA------AIKVLSAESRQGVKEFLTEIQVISEIEHENL 102
++GEG FG V+ + A+K L + K+F E ++++ ++HE++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 103 VKLYGCCVEGNHRILVYNYLENNSL----------AQTLIGGGHHYSNIQFSWRTRSRIC 152
VK YG C +G+ I+V+ Y+++ L A L+ G + + I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 153 IGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAG 212
IA G+ +L + H +HRD+ N L+ +L KI DFG+++ + + RV G
Sbjct: 140 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDV---YSTDYYRVGG 193
Query: 213 T----IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-------GRCNTNMRLPTEEQYL 261
I ++ PE + + T ++D++SFGV+L EI + NT + + +
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRV 253
Query: 262 LER----TWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317
LER ++Y+ V L C Q P+ R ++ + +
Sbjct: 254 LERPRVCPKEVYD--------------------------VMLGCWQREPQQRLNIKEIYK 287
Query: 318 ML 319
+L
Sbjct: 288 IL 289
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-39
Identities = 74/314 (23%), Positives = 119/314 (37%), Gaps = 69/314 (21%)
Query: 38 ELSIATDDFSP---------INKIGEGGFGSVYKGRLKDGK----IAAIKVLSAE-SRQG 83
EL A IG G FG VY G L D A+K L+
Sbjct: 10 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 69
Query: 84 VKEFLTEIQVISEIEHENLVKLYGCCVEGNHRIL-VYNYLENNSLAQTLIGGGHHYSNIQ 142
V +FLTE ++ + H N++ L G C+ L V Y+++ L + H+ +
Sbjct: 70 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 129
Query: 143 FSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN 202
+ +A+G+ +L + +HRD+ A N +LD+ T K++DFGLA+ +
Sbjct: 130 LI-----GFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM--- 178
Query: 203 MTHVSTRVAGTIGYL------APEYAIRGQVTRKADIYSFGVLLVEIVS-------GRCN 249
V G A E + T K+D++SFGVLL E+++
Sbjct: 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 238
Query: 250 TNMRLPTEEQYLLER----TWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDT 305
++ + + L + LYE V L C
Sbjct: 239 FDITVYLLQGRRLLQPEYCPDPLYE--------------------------VMLKCWHPK 272
Query: 306 PKLRPSMSTVVQML 319
++RPS S +V +
Sbjct: 273 AEMRPSFSELVSRI 286
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-39
Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 9/205 (4%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHE 100
I + K+G+G FG V+ G AIK L + + FL E QV+ ++ HE
Sbjct: 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHE 322
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
LV+LY E +V Y+ SL L G Y + IA G+A
Sbjct: 323 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMA 377
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPE 220
++ + +HRD++A+NIL+ ++L K++DFGLA+LI N I + APE
Sbjct: 378 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 434
Query: 221 YAIRGQVTRKADIYSFGVLLVEIVS 245
A+ G+ T K+D++SFG+LL E+ +
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTT 459
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-39
Identities = 56/205 (27%), Positives = 102/205 (49%), Gaps = 12/205 (5%)
Query: 43 TDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHEN 101
KIGEG G V R G+ A+K++ +Q + E+ ++ + +H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
+V++Y + G ++ +L+ +L + S ++ + + +C + + LA+
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIV-------SQVRLNEEQIATVCEAVLQALAY 156
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEY 221
LH + +IHRDIK+ +ILL D K+SDFG I ++ + V GT ++APE
Sbjct: 157 LHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEV 212
Query: 222 AIRGQVTRKADIYSFGVLLVEIVSG 246
R + DI+S G++++E+V G
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-39
Identities = 62/214 (28%), Positives = 110/214 (51%), Gaps = 15/214 (7%)
Query: 37 KELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGV-KEFLTEIQVI 94
K + DDF I+++G G G V+K K G + A K++ E + + + + E+QV+
Sbjct: 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 85
Query: 95 SEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIG 154
E +V YG + +++ SL Q L G + + ++ I
Sbjct: 86 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIA 139
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTI 214
+ +GL +L E+ I+HRD+K SNIL++ K+ DFG++ + +M + + V GT
Sbjct: 140 VIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFV-GTR 194
Query: 215 GYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGR 247
Y++PE ++G + ++DI+S G+ LVE+ GR
Sbjct: 195 SYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-39
Identities = 52/230 (22%), Positives = 89/230 (38%), Gaps = 27/230 (11%)
Query: 37 KELSIATDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVIS 95
+ I + I K+GEGGF V L DG A+K + +Q +E E +
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81
Query: 96 EIEHENLVKLYGCCVE---GNHRI-LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRI 151
H N+++L C+ H L+ + + +L + + +
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIER--LKDKGNFLTEDQILWL 139
Query: 152 CIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVA 211
+GI RGL +H HRD+K +NILL + P + D G ++ +
Sbjct: 140 LLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALT 196
Query: 212 --------GTIGYLAPE------YAIRGQVTRKADIYSFGVLLVEIVSGR 247
TI Y APE + + + + D++S G +L ++ G
Sbjct: 197 LQDWAAQRCTISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGE 243
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-39
Identities = 51/210 (24%), Positives = 105/210 (50%), Gaps = 15/210 (7%)
Query: 43 TDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHEN 101
+ + + ++G+G FG VYK + + G +AA KV+ +S + +++++ EI++++ +H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
+VKL G ++ + ++ ++ + Q +C + L F
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-----VCRQMLEALNF 132
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEY 221
LH + IIHRD+KA N+L+ + +++DFG++ + + + GT ++APE
Sbjct: 133 LHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEV 188
Query: 222 AIRGQVTR-----KADIYSFGVLLVEIVSG 246
+ + KADI+S G+ L+E+
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-39
Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 10/216 (4%)
Query: 34 YSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQV 93
+ I + K+G G FG V+ A+K + S V+ FL E V
Sbjct: 178 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANV 236
Query: 94 ISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICI 153
+ ++H+ LVKL+ + I + ++ SL L +
Sbjct: 237 MKTLQHDKLVKLHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGS----KQPLPKLIDFSA 291
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213
IA G+AF+ + + IHRD++A+NIL+ L KI+DFGLA++I N
Sbjct: 292 QIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 348
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRC 248
I + APE G T K+D++SFG+LL+EIV+ GR
Sbjct: 349 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI 384
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-38
Identities = 63/204 (30%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 49 INKIGEGGFGSVYKGR-LKDGKIAAIKVLS---AESRQGVKEFLTEIQVISEIEHENLVK 104
++K+G GG +VY AIK + E + +K F E+ S++ H+N+V
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 105 LYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHE 164
+ E + LV Y+E +L++ + G S T I G+ H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP------LSVDTAINFTNQILDGIKHAH- 128
Query: 165 EVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI-PANMTHVSTRVAGTIGYLAPEYAI 223
I+HRDIK NIL+D + T KI DFG+AK + ++T + V GT+ Y +PE A
Sbjct: 129 --DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQAK 185
Query: 224 RGQVTRKADIYSFGVLLVEIVSGR 247
DIYS G++L E++ G
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGE 209
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-38
Identities = 63/304 (20%), Positives = 109/304 (35%), Gaps = 66/304 (21%)
Query: 49 INKIGEGGFGSVYKGRLKDGKIA------AIKVLSAE-SRQGVKEFLTEIQVISEIEHEN 101
+ ++GE FG VYKG L AIK L + +EF E + + ++H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSL----------AQTLIGGGHHYSNIQFSWRTRSRI 151
+V L G + ++++Y + L + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 152 CIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVA 211
IA G+ +L H++H+D+ N+L+ L KISD GL + + A
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA----DYYKL 186
Query: 212 GTIGYL-----APEYAIRGQVTRKADIYSFGVLLVEIVS-------GRCNTNMRLPTEEQ 259
L APE + G+ + +DI+S+GV+L E+ S G N ++ +
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR 246
Query: 260 YLLER----TWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTV 315
+L +Y L+++ C + P RP +
Sbjct: 247 QVLPCPDDCPAWVYA-----LMIE---------------------CWNEFPSRRPRFKDI 280
Query: 316 VQML 319
L
Sbjct: 281 HSRL 284
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-38
Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 23/247 (9%)
Query: 8 FRRRDSPRNRVPEVDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGR-LK 66
+ E +E +K Y E + ++G G FG V++ + +
Sbjct: 23 GSAKLQRLGPETEDNEGVLLTEKLKPVDY-EYREEVHWMTHQPRVGRGSFGEVHRMKDKQ 81
Query: 67 DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNS 126
G A+K + E + + E+ + + +V LYG EG + LE S
Sbjct: 82 TGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136
Query: 127 LAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL 186
L Q + G GL +LH I+H D+KA N+LL D
Sbjct: 137 LGQLIKQMGC------LPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDG 187
Query: 187 TP-KISDFGLAKLIPANMTHVSTR----VAGTIGYLAPEYAIRGQ-VTRKADIYSFGVLL 240
+ + DFG A + + S + GT ++APE + G+ K DI+S ++
Sbjct: 188 SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VVMGKPCDAKVDIWSSCCMM 246
Query: 241 VEIVSGR 247
+ +++G
Sbjct: 247 LHMLNGC 253
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 74/314 (23%), Positives = 111/314 (35%), Gaps = 62/314 (19%)
Query: 49 INKIGEGGFGSVYKGRLKDGKIA------AIKVLSAE-SRQGVKEFLTEIQVISEIEHEN 101
I +G G FG VY+G++ A+K L S Q +FL E +IS+ H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIG-GGHHYSNIQFSWRTRSRICIGIARGLA 160
+V+ G ++ R ++ + L L + + IA G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 161 FLHEEVRPHIIHRDIKASNILLDK---DLTPKISDFGLAKLIPANMTHVSTRVAGTIGYL 217
+L E H IHRDI A N LL KI DFG+A+ I G L
Sbjct: 196 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----GYYRKGGCAML 248
Query: 218 -----APEYAIRGQVTRKADIYSFGVLLVEIVS-------GRCNTNMRLPTEEQYLLER- 264
PE + G T K D +SFGVLL EI S + N + ++
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP 308
Query: 265 ---TWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321
+Y + C Q P+ RP+ + +++ +
Sbjct: 309 KNCPGPVYR--------------------------IMTQCWQHQPEDRPNFAIILERI-- 340
Query: 322 EKDIDDDKITKPGL 335
E D + L
Sbjct: 341 EYCTQDPDVINTAL 354
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-38
Identities = 66/304 (21%), Positives = 116/304 (38%), Gaps = 59/304 (19%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLS-AESRQGVKEFLTEIQVISEIEHEN 101
DF PI +G GGFG V++ + K D AIK + ++ + E++ ++++EH
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 102 LVKLYGCCVEGN---------HRILVY---NYLENNSLAQTL-IGGGHHYSNIQFSWRTR 148
+V+ + +E N ++ +Y +L +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH-- 122
Query: 149 SRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI--------- 199
I + IA + FLH + ++HRD+K SNI D K+ DFGL +
Sbjct: 123 --IFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 200 --PANMTHVSTRVAGTIGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGRCNTNMRLPT 256
P T GT Y++PE I G + K DI+S G++L E++ +T M
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELLY-PFSTQM---- 231
Query: 257 EEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLL---CTQDTPKLRPSMS 313
E + + N F ++ ++ +P RP
Sbjct: 232 ----------------ERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAI 275
Query: 314 TVVQ 317
+++
Sbjct: 276 NIIE 279
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-38
Identities = 68/321 (21%), Positives = 127/321 (39%), Gaps = 61/321 (19%)
Query: 27 GIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIA----AIKVL--SAES 80
GI + +++ I F+ +G+G FGSV + +LK + A+K+L +
Sbjct: 6 GISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA 65
Query: 81 RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN------YLENNSLAQTLIGG 134
++EFL E + E +H ++ KL G + + + ++++ L L+
Sbjct: 66 SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS 125
Query: 135 GHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194
+ +T R + IA G+ +L + IHRD+ A N +L +D+T ++DFG
Sbjct: 126 RIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFG 182
Query: 195 LAKLIPANMTHVSTRVAGTIGYL-----APEYAIRGQVTRKADIYSFGVLLVEIVS---- 245
L++ I + + G L A E T +D+++FGV + EI++
Sbjct: 183 LSRKIYSGDYY----RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQT 238
Query: 246 ---GRCNTNMRLPTEEQYLLER----TWDLYERRELILLVDTSLNGDFDAEEACRFLKVG 298
G N + L++ ++Y+ +
Sbjct: 239 PYAGIENAEIYNYLIGGNRLKQPPECMEEVYD--------------------------LM 272
Query: 299 LLCTQDTPKLRPSMSTVVQML 319
C PK RPS + + L
Sbjct: 273 YQCWSADPKQRPSFTCLRMEL 293
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-38
Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 12/205 (5%)
Query: 43 TDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHEN 101
+ F + K+GEG +GSVYK + G+I AIK + ES ++E + EI ++ + + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPH 85
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
+VK YG + +V Y S++ + + + + I +GL +
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIA-----TILQSTLKGLEY 140
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEY 221
LH IHRDIKA NILL+ + K++DFG+A + M +T + GT ++APE
Sbjct: 141 LHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEV 196
Query: 222 AIRGQVTRKADIYSFGVLLVEIVSG 246
ADI+S G+ +E+ G
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEG 221
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-38
Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 20/213 (9%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIA----AIKVLSAE-SRQGVKEFLTEIQVIS 95
IA +D +GEG FG VY+G + K A+K + + ++F++E ++
Sbjct: 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 68
Query: 96 EIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGI 155
++H ++VKL G E I + L L + + + I
Sbjct: 69 NLDHPHIVKLIGIIEEEPTWI-IMELYPYGELGHYLERNKNSLKVLTLV-----LYSLQI 122
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT-- 213
+ +A+L + +HRDI NIL+ K+ DFGL++ I + + T
Sbjct: 123 CKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY---YKASVTRL 176
Query: 214 -IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
I +++PE + T +D++ F V + EI+S
Sbjct: 177 PIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-38
Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 15/201 (7%)
Query: 51 KIGEGGFGSVYKGRLKDGKIA---AIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLY 106
++G G FGSV +G + K AIKVL + +E + E Q++ ++++ +V+L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV 166
G C + V L + L+G + + + ++ G+ +L E+
Sbjct: 403 GVCQAEALML-VMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEK- 455
Query: 167 RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT--IGYLAPEYAIR 224
+ +HR++ A N+LL KISDFGL+K + A+ ++ + R AG + + APE
Sbjct: 456 --NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513
Query: 225 GQVTRKADIYSFGVLLVEIVS 245
+ + ++D++S+GV + E +S
Sbjct: 514 RKFSSRSDVWSYGVTMWEALS 534
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-38
Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 32/223 (14%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIA--------AIKVLSAESRQGVKEFLTEIQ 92
I +D +G+G F ++KG ++ +KVL R + F
Sbjct: 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAAS 64
Query: 93 VISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRIC 152
++S++ H++LV YG CV G+ ILV +++ SL L + + + +
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK-----LEVA 119
Query: 153 IGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTP--------KISDFGLAKLIPANMT 204
+A + FL E +IH ++ A NILL ++ K+SD G++ + +
Sbjct: 120 KQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV---LP 173
Query: 205 HVSTRVAGTIGYLAPEYAI--RGQVTRKADIYSFGVLLVEIVS 245
+ I ++ PE I + D +SFG L EI S
Sbjct: 174 KDILQER--IPWVPPE-CIENPKNLNLATDKWSFGTTLWEICS 213
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-38
Identities = 48/231 (20%), Positives = 97/231 (41%), Gaps = 31/231 (13%)
Query: 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKV--LSAESRQGVKEFLTEIQ 92
++ +S+ +S + +IG GG V++ + +I AIK L Q + + EI
Sbjct: 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 78
Query: 93 VISEIEHENL--VKLYGCCVEGNHRILVYNYLE--NNSLAQTLIGGGHHYSNIQFSWRTR 148
+++++ + ++LY + + +Y +E N L L R
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKS------IDPWER 129
Query: 149 SRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVST 208
+ + +H+ I+H D+K +N L+ K+ DFG+A + + T V
Sbjct: 130 KSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVK 185
Query: 209 R-VAGTIGYLAPE-----------YAIRGQVTRKADIYSFGVLLVEIVSGR 247
GT+ Y+ PE + +++ K+D++S G +L + G+
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-38
Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 14/217 (6%)
Query: 34 YSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIA----AIKVLSAESRQGVK-EFL 88
S ++ I + IGEG FG V++G + AIK + V+ +FL
Sbjct: 5 SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 64
Query: 89 TEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTR 148
E + + +H ++VKL G E I + L L +
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFLQVRKYSLDLASLI---- 119
Query: 149 SRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVST 208
++ LA+L + +HRDI A N+L+ + K+ DFGL++ + + + ++
Sbjct: 120 -LYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 175
Query: 209 RVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
+ I ++APE + T +D++ FGV + EI+
Sbjct: 176 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-38
Identities = 69/298 (23%), Positives = 121/298 (40%), Gaps = 60/298 (20%)
Query: 49 INKIGEGGFGSVYKGRLKDGKIA----AIKVLSAE--SRQGVKEFLTEIQVISEIEHENL 102
+GEG FGSV +G LK A+K + + S++ ++EFL+E + + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 103 VKLYGCCVEGNHRILVYNYL-----ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR 157
++L G C+E + + + + + L L+ +T + + IA
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 158 GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYL 217
G+ +L + +HRD+ A N +L D+T ++DFGL+K I + + G I +
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKM 211
Query: 218 -----APEYAIRGQVTRKADIYSFGVLLVEIVS-------GRCNTNMRLPTEEQYLLER- 264
A E T K+D+++FGV + EI + G N M + L++
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQP 271
Query: 265 ---TWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319
+LYE + C + P RP+ S + L
Sbjct: 272 EDCLDELYE--------------------------IMYSCWRTDPLDRPTFSVLRLQL 303
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 69/345 (20%), Positives = 130/345 (37%), Gaps = 69/345 (20%)
Query: 11 RDSPRNRVPEVDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKI 70
R + R +G+ +L + D + +GEG FG V
Sbjct: 48 RITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDK 107
Query: 71 A--------AIKVLSAE-SRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILVYN 120
A+K+L + + + + + ++E++++ I +H+N++ L G C + ++
Sbjct: 108 DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 167
Query: 121 YLENNSL----------AQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHI 170
Y +L + Q +++ +ARG+ +L +
Sbjct: 168 YASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KC 224
Query: 171 IHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYL-----APEYAIRG 225
IHRD+ A N+L+ ++ KI+DFGLA+ I T G L APE
Sbjct: 225 IHRDLAARNVLVTENNVMKIADFGLARDINNI----DYYKKTTNGRLPVKWMAPEALFDR 280
Query: 226 QVTRKADIYSFGVLLVEIVS-------GRCNTNMRLPTEEQYLLER----TWDLYERREL 274
T ++D++SFGVL+ EI + G + +E + +++ T +LY
Sbjct: 281 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYM---- 336
Query: 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319
++ C P RP+ +V+ L
Sbjct: 337 MM----------------------RDCWHAVPSQRPTFKQLVEDL 359
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-37
Identities = 68/341 (19%), Positives = 128/341 (37%), Gaps = 69/341 (20%)
Query: 15 RNRVPEVDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIA--- 71
+ D +G+ +L + D + +GEG FG V
Sbjct: 6 HHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPK 65
Query: 72 -----AIKVLSAE-SRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILVYNYLEN 124
A+K+L + + + + + ++E++++ I +H+N++ L G C + ++ Y
Sbjct: 66 EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 125
Query: 125 NSL----------AQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRD 174
+L + Q +++ +ARG+ +L + IHRD
Sbjct: 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRD 182
Query: 175 IKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYL-----APEYAIRGQVTR 229
+ A N+L+ ++ KI+DFGLA+ I T G L APE T
Sbjct: 183 LAARNVLVTENNVMKIADFGLARDINNI----DYYKKTTNGRLPVKWMAPEALFDRVYTH 238
Query: 230 KADIYSFGVLLVEIVS-------GRCNTNMRLPTEEQYLLER----TWDLYERRELILLV 278
++D++SFGVL+ EI + G + +E + +++ T +LY
Sbjct: 239 QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYM-------- 290
Query: 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319
+ C P RP+ +V+ L
Sbjct: 291 ------------------MMRDCWHAVPSQRPTFKQLVEDL 313
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-37
Identities = 72/316 (22%), Positives = 123/316 (38%), Gaps = 62/316 (19%)
Query: 49 INKIGEGGFGSVYKGRLKDGK----IAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLV 103
IG G FG VY G L D A+K L+ V +FLTE ++ + H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 104 KLYGCCVEGNHRIL-VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFL 162
L G C+ L V Y+++ L + H+ + + +A+G+ FL
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-----GFGLQVAKGMKFL 208
Query: 163 HEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT---IGYLAP 219
+ +HRD+ A N +LD+ T K++DFGLA+ + G + ++A
Sbjct: 209 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 265
Query: 220 EYAIRGQVTRKADIYSFGVLLVEIVS-------GRCNTNMRLPTEEQYLLER----TWDL 268
E + T K+D++SFGVLL E+++ ++ + + L + L
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 325
Query: 269 YERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKDIDDD 328
YE V L C ++RPS S +V +
Sbjct: 326 YE--------------------------VMLKCWHPKAEMRPSFSELVSRI--------S 351
Query: 329 KITKPGLISDFMDLKV 344
I + ++ +
Sbjct: 352 AIFSTFIGEHYVHVNA 367
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-37
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 49 INKIGEGGFGSVYKGRLKDGKIA----AIKVLSAE-SRQGVKEFLTEIQVISEIEHENLV 103
IG+G FG VY G D AIK LS Q V+ FL E ++ + H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 104 KLYGCCVEGNHRIL-VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFL 162
L G + + Y+ + L Q + + + + +ARG+ +L
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLI-----SFGLQVARGMEYL 140
Query: 163 HEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT---IGYLAP 219
E+ +HRD+ A N +LD+ T K++DFGLA+ I + + + + A
Sbjct: 141 AEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
Query: 220 EYAIRGQVTRKADIYSFGVLLVEIVS 245
E + T K+D++SFGVLL E+++
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-37
Identities = 48/229 (20%), Positives = 97/229 (42%), Gaps = 31/229 (13%)
Query: 37 KELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKV--LSAESRQGVKEFLTEIQVI 94
+ +S+ +S + +IG GG V++ + +I AIK L Q + + EI +
Sbjct: 2 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61
Query: 95 SEIEH--ENLVKLYGCCVEGNHRILVYNYLE--NNSLAQTLIGGGHHYSNIQFSWRTRSR 150
++++ + +++LY + + +Y +E N L L R
Sbjct: 62 NKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKK------SIDPWERKS 112
Query: 151 ICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTR- 209
+ + +H+ I+H D+K +N L+ K+ DFG+A + + T V
Sbjct: 113 YWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDS 168
Query: 210 VAGTIGYLAPE-----------YAIRGQVTRKADIYSFGVLLVEIVSGR 247
GT+ Y+ PE + +++ K+D++S G +L + G+
Sbjct: 169 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-37
Identities = 66/289 (22%), Positives = 115/289 (39%), Gaps = 46/289 (15%)
Query: 39 LSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVI-S 95
+ + DD PI ++G G +G V K R G+I A+K + A Q K L ++ +
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 96 EIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGI 155
++ V YG + + + SL + I +I + I
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDIL--GKIAVSI 118
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIG 215
+ L LH ++ +IHRD+K SN+L++ K+ DFG++ + ++ AG
Sbjct: 119 VKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK--DIDAGCKP 174
Query: 216 YLAPEYAIRGQVTR-----KADIYSFGVLLVEIVSGR-----CNTNMRLPTEEQYLLERT 265
Y+APE I ++ + K+DI+S G+ ++E+ R T +
Sbjct: 175 YMAPE-RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ----------- 222
Query: 266 WDLYERRELILLVDT---SLNGDFDAEEACRFLKVGLLCTQDTPKLRPS 311
L +V+ L D + E F C + K RP+
Sbjct: 223 --------LKQVVEEPSPQLPADKFSAEFVDFTS---QCLKKNSKERPT 260
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 6e-37
Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 15/219 (6%)
Query: 37 KELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVI 94
+ +D + +IG G +GSV K K G+I A+K + + + K+ L ++ V+
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 95 -SEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICI 153
+ +V+ YG + + + S + + +I +
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELM-STSFD-KFYKYVYSVLDDVIPEEILGKITL 132
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213
+ L L E + IIHRDIK SNILLD+ K+ DFG++ + ++ TR AG
Sbjct: 133 ATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRDAGC 188
Query: 214 IGYLAPEYAIRGQVTR-----KADIYSFGVLLVEIVSGR 247
Y+APE I +R ++D++S G+ L E+ +GR
Sbjct: 189 RPYMAPE-RIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-37
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 49 INKIGEGGFGSVYKGRLKDGK---IAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHENLV 103
+ IGEG FG V K R+K AAIK + S+ ++F E++V+ ++ H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 104 KLYGCCVEGNHRILVYNYLENNSL----------AQTLIGGGHHYSNIQFSWRTRSRICI 153
L G C + L Y + +L + + S +
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213
+ARG+ +L ++ IHRD+ A NIL+ ++ KI+DFGL++ + R+
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP-- 204
Query: 214 IGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVS 245
+ ++A E ++ V T +D++S+GVLL EIVS
Sbjct: 205 VRWMAIE-SLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-36
Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 14/218 (6%)
Query: 40 SIATDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQ-GVKEFLTEIQVISEI 97
SI DD+ IG G V + AIK ++ E Q + E L EIQ +S+
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC 70
Query: 98 EHENLVKLYGCCVEGNHRILVYNYLENNSLA---QTLIGGGHHYSNIQFSWRTRSRICIG 154
H N+V Y V + LV L S+ + ++ G H S + T + I
Sbjct: 71 HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-LDESTIATILRE 129
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT- 213
+ GL +LH+ IHRD+KA NILL +D + +I+DFG++ + +V T
Sbjct: 130 VLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 214 IG---YLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGR 247
+G ++APE + + KADI+SFG+ +E+ +G
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 1e-36
Identities = 47/229 (20%), Positives = 95/229 (41%), Gaps = 31/229 (13%)
Query: 37 KELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKV--LSAESRQGVKEFLTEIQVI 94
+ +S+ +S + +IG GG V++ + +I AIK L Q + + EI +
Sbjct: 49 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 95 SEIEHENL--VKLYGCCVEGNHRILVYNYLE--NNSLAQTLIGGGHHYSNIQFSWRTRSR 150
++++ + ++LY + + +Y +E N L L R
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKK------SIDPWERKS 159
Query: 151 ICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTR- 209
+ + +H+ I+H D+K +N L+ K+ DFG+A + + T V
Sbjct: 160 YWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDS 215
Query: 210 VAGTIGYLAPE-----------YAIRGQVTRKADIYSFGVLLVEIVSGR 247
G + Y+ PE + +++ K+D++S G +L + G+
Sbjct: 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-36
Identities = 53/231 (22%), Positives = 101/231 (43%), Gaps = 23/231 (9%)
Query: 37 KELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVI 94
+ +D + ++G G G V+K R + G + A+K + ++ K L ++ V+
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 95 -SEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICI 153
+ +V+ +G + + + + G R ++ +
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG------PIPERILGKMTV 131
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213
I + L +L E+ +IHRD+K SNILLD+ K+ DFG++ + + R AG
Sbjct: 132 AIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DRSAGC 187
Query: 214 IGYLAPE-----YAIRGQVTRKADIYSFGVLLVEIVSGR-----CNTNMRL 254
Y+APE + +AD++S G+ LVE+ +G+ C T+ +
Sbjct: 188 AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV 238
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-36
Identities = 68/312 (21%), Positives = 118/312 (37%), Gaps = 74/312 (23%)
Query: 49 INKIGEGGFGSVYKGRLKDGK------IAAIKVLSAE-SRQGVKEFLTEIQVISEIEHEN 101
+ IGEG FG V++ R + A+K+L E S +F E +++E ++ N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRS------------ 149
+VKL G C G L++ Y+ L + L H +
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 150 ------RICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANM 203
I +A G+A+L E +HRD+ N L+ +++ KI+DFGL++ I +
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA- 227
Query: 204 THVSTRVAGTIGYL-----APEYAIRGQVTRKADIYSFGVLLVEIVS-------GRCNTN 251
A + PE + T ++D++++GV+L EI S G +
Sbjct: 228 ---DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 284
Query: 252 MRLPTEEQYLLER----TWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPK 307
+ + +L +LY L+ C P
Sbjct: 285 VIYYVRDGNILACPENCPLELYN-----LMRL---------------------CWSKLPA 318
Query: 308 LRPSMSTVVQML 319
RPS ++ ++L
Sbjct: 319 DRPSFCSIHRIL 330
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 52/218 (23%), Positives = 93/218 (42%), Gaps = 14/218 (6%)
Query: 33 LYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIA----AIKVLSAE-SRQGVKEF 87
+ S ++ I + IGEG FG V++G + AIK S ++F
Sbjct: 379 MPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKF 438
Query: 88 LTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRT 147
L E + + +H ++VKL G E I + L L +
Sbjct: 439 LQEALTMRQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFLQVRKF-----SLDLAS 492
Query: 148 RSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVS 207
++ LA+L + +HRDI A N+L+ + K+ DFGL++ + + + +
Sbjct: 493 LILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 549
Query: 208 TRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
++ I ++APE + T +D++ FGV + EI+
Sbjct: 550 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-36
Identities = 71/323 (21%), Positives = 127/323 (39%), Gaps = 78/323 (24%)
Query: 49 INKIGEGGFGSVYKGRLKDGK------IAAIKVLSAE-SRQGVKEFLTEIQVISEIEHEN 101
+GEG FG V K K A+K+L S +++ L+E V+ ++ H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSL------------------AQTLIGGGHHYSNIQF 143
++KLYG C + +L+ Y + SL H
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 144 SWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANM 203
+ I++G+ +L E ++HRD+ A NIL+ + KISDFGL++ +
Sbjct: 148 TMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 204 THVSTRVAGTIGYL-----APEYAIRGQV-TRKADIYSFGVLLVEIVS-------GRCNT 250
++ V + G + A E ++ + T ++D++SFGVLL EIV+ G
Sbjct: 205 SY----VKRSQGRIPVKWMAIE-SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259
Query: 251 NMRLPTEEQYLLER----TWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTP 306
+ + + +ER + ++Y + L C + P
Sbjct: 260 RLFNLLKTGHRMERPDNCSEEMYR--------------------------LMLQCWKQEP 293
Query: 307 KLRPSMSTVVQMLMGEKDIDDDK 329
RP + + + L EK + +
Sbjct: 294 DKRPVFADISKDL--EKMMVKRR 314
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-36
Identities = 71/347 (20%), Positives = 127/347 (36%), Gaps = 69/347 (19%)
Query: 9 RRRDSPRNRVPEVDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDG 68
D P +G+ +L + D +GEG FG V
Sbjct: 34 HDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGL 93
Query: 69 KIA--------AIKVLSAE-SRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILV 118
A+K+L ++ + + + + ++E++++ I +H+N++ L G C + ++
Sbjct: 94 DKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 153
Query: 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSR----------ICIGIARGLAFLHEEVRP 168
Y +L + L ++ +ARG+ +L +
Sbjct: 154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK--- 210
Query: 169 HIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYL-----APEYAI 223
IHRD+ A N+L+ +D KI+DFGLA+ I T G L APE
Sbjct: 211 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI----DYYKKTTNGRLPVKWMAPEALF 266
Query: 224 RGQVTRKADIYSFGVLLVEIVS-------GRCNTNMRLPTEEQYLLER----TWDLYERR 272
T ++D++SFGVLL EI + G + +E + +++ T +LY
Sbjct: 267 DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYM-- 324
Query: 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319
+ C P RP+ +V+ L
Sbjct: 325 ------------------------MMRDCWHAVPSQRPTFKQLVEDL 347
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 65/295 (22%), Positives = 114/295 (38%), Gaps = 48/295 (16%)
Query: 40 SIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEI-E 98
+ F P + +G G G++ + D + A+K + E E+Q++ E E
Sbjct: 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDE 76
Query: 99 HENLVKLYGCCVEGNHRILVYNYLE--NNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIA 156
H N+++ + + + + +E +L + + + ++ +
Sbjct: 77 HPNVIRYFCTEKDRQFQYIA---IELCAATLQEYVEQKDFAHLGLE-----PITLLQQTT 128
Query: 157 RGLAFLHEEVRPHIIHRDIKASNILL-----DKDLTPKISDFGLAKLIPANMTHVSTR-- 209
GLA LH +I+HRD+K NIL+ + ISDFGL K + S R
Sbjct: 129 SGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 210 VAGTIGYLAPEY---AIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTW 266
V GT G++APE + T DI+S G + ++S P
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEG-----SHP---------FG 231
Query: 267 DLYERRELILLVDTSLNG----DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317
+R+ ILL SL+ + A ++ P+ RPS V++
Sbjct: 232 KSLQRQANILLGACSLDCLHPEKHEDVIARELIE---KMIAMDPQKRPSAKHVLK 283
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-35
Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 43 TDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLS---AESRQGVKEFLTEIQVISEIE 98
FS + +IG G FG+VY R +++ ++ AIK +S +S + ++ + E++ + ++
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 99 HENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARG 158
H N ++ GC + + LV Y S + L ++ + + G +G
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAA-----VTHGALQG 166
Query: 159 LAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLA 218
LA+LH ++IHRD+KA NILL + K+ DFG A + M ++ V GT ++A
Sbjct: 167 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANSFV-GTPYWMA 218
Query: 219 PEYAIRGQVTR---KADIYSFGVLLVEIVSG 246
PE + + K D++S G+ +E+
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 49 INKIGEGGFGSVYKGR-LKDGKIAAIKVLS---AESRQGVKEFLTEIQVISEIEHENLVK 104
+G GG V+ R L+D + A+KVL A F E Q + + H +V
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 105 LY--GCCVEGNHRI--LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
+Y G + +V Y++ +L + G + + + + L
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP------MTPKRAIEVIADACQALN 130
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI---PANMTHVSTRVAGTIGYL 217
F H + IIHRD+K +NI++ K+ DFG+A+ I ++T + V GT YL
Sbjct: 131 FSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-VIGTAQYL 186
Query: 218 APEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
+PE A V ++D+YS G +L E+++G
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-35
Identities = 54/222 (24%), Positives = 86/222 (38%), Gaps = 32/222 (14%)
Query: 49 INKIGEGGFGSVYKGRLKDGK------IAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHE 100
+G G FG V + A+K+L + ++E++V+S + H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSL------------AQTLIGGGHHYSNIQFSWRTR 148
N+V L G C G +++ Y L +
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 149 SRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVST 208
+A+G+AFL + + IHRD+ A NILL KI DFGLA+ I + +
Sbjct: 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY--- 201
Query: 209 RVAGTIGYL-----APEYAIRGQVTRKADIYSFGVLLVEIVS 245
V L APE T ++D++S+G+ L E+ S
Sbjct: 202 -VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-35
Identities = 42/218 (19%), Positives = 81/218 (37%), Gaps = 20/218 (9%)
Query: 43 TDDFSPINKIGEG--GFGSVYKGR-LKDGKIAAIKV--LSAESRQGVKEFLTEIQVISEI 97
+ + IG+G +V R G+ ++ L A S + V E+ V
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 98 EHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR 157
H N+V + N +V +++ S + + + + I G+ +
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI----CTHFMDGMNELAIAYILQGVLK 139
Query: 158 GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTR------VA 211
L ++H +HR +KAS+IL+ D +S + ++
Sbjct: 140 ALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 212 GTIGYLAPEYAIRGQV--TRKADIYSFGVLLVEIVSGR 247
+ +L+PE + K+DIYS G+ E+ +G
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-35
Identities = 75/278 (26%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE--SRQGVKE-FLTEIQVISEIEH 99
+DF +G+G FG+VY R K I A+KVL + GV+ E+++ S + H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGL 159
N+++LYG + L+ Y ++ + L F + + +A L
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK------FDEQRTATYITELANAL 122
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAP 219
++ H + +IHRDIK N+LL KI+DFG + P++ + GT+ YL P
Sbjct: 123 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPP 176
Query: 220 EYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279
E K D++S GVL E + G + P E E Y+R I V+
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVG------KPPFEANTYQE----TYKR---ISRVE 223
Query: 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317
+ E A + LL P RP + V++
Sbjct: 224 FTFPDFVT-EGARDLIS-RLLKHN--PSQRPMLREVLE 257
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-35
Identities = 69/319 (21%), Positives = 113/319 (35%), Gaps = 80/319 (25%)
Query: 49 INKIGEGGFGSVYKGRLKD------GKIAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHE 100
+G G FG V + A+K+L + + ++E++++S + +HE
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSL--------AQTLIGGGHHYSNIQFSWRTRSRIC 152
N+V L G C G +++ Y L +N S R
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 153 IGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAG 212
+A+G+AFL + + IHRD+ A N+LL KI DFGLA+ I + + +
Sbjct: 171 SQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY----IVK 223
Query: 213 TIGYL-----APEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTW 266
L APE T ++D++S+G+LL EI S G P
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN------P----------- 266
Query: 267 DLYERRELILLVDTSLNGDFDAEEACRFLKVG-----------------LLCTQDTPKLR 309
Y G + + +K G C P R
Sbjct: 267 --YP-------------GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHR 311
Query: 310 PSMSTVVQMLMGEKDIDDD 328
P+ + L ++ +D
Sbjct: 312 PTFQQICSFL--QEQAQED 328
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 56/221 (25%), Positives = 86/221 (38%), Gaps = 31/221 (14%)
Query: 49 INKIGEGGFGSVYKGRLKD------GKIAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHE 100
+G G FG V + + A+K+L + + ++E++++ I H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 101 NLVKLYGCCVEGNHRILV----------YNYL-ENNSLAQTLIGGGHHYSNIQFSWRTRS 149
N+V L G C + ++V YL + +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 150 RICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTR 209
+A+G+ FL IHRD+ A NILL + KI DFGLA+ I +
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----PDY 204
Query: 210 VAGTIGYL-----APEYAIRGQVTRKADIYSFGVLLVEIVS 245
V L APE T ++D++SFGVLL EI S
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 43 TDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHE 100
F + +G G +G VYKGR +K G++AAIKV+ +E EI ++ + H
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHR 81
Query: 101 NLVKLYGCCVEGNHRI------LVYNYLENNSLA---QTLIGGGHHYSNIQFSWRTRSRI 151
N+ YG ++ N LV + S+ + G I + I
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-------I 134
Query: 152 CIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVA 211
C I RGL+ LH+ +IHRDIK N+LL ++ K+ DFG++ + + +T
Sbjct: 135 CREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FI 190
Query: 212 GTIGYLAPEYAIRGQVTR-----KADIYSFGVLLVEIVSG 246
GT ++APE + K+D++S G+ +E+ G
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 78/283 (27%), Positives = 117/283 (41%), Gaps = 43/283 (15%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE--SRQGVKEFL-TEIQVISEIEH 99
DDF +G+G FG+VY R K I A+KVL ++GV+ L EI++ S + H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQ----FSWRTRSRICIGI 155
N++++Y RI Y LE G Y +Q F + + +
Sbjct: 74 PNILRMYNY-FHDRKRI--YLMLE-------FAPRGELYKELQKHGRFDEQRSATFMEEL 123
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIG 215
A L + HE +IHRDIK N+L+ KI+DFG + P+ GT+
Sbjct: 124 ADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTM---CGTLD 177
Query: 216 YLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERREL 274
YL PE I G+ K D++ GVL E + G P + E + R
Sbjct: 178 YLPPE-MIEGKTHDEKVDLWCAGVLCYEFLVG------MPPFDSPSHTE----THRR--- 223
Query: 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317
I+ VD + + + LL P R + V++
Sbjct: 224 IVNVDLKFPPFLS-DGSKDLIS-KLLRYH--PPQRLPLKGVME 262
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 69/345 (20%), Positives = 119/345 (34%), Gaps = 94/345 (27%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKE-FLTEIQVISEIEHEN 101
DF PI +G GGFG V++ + K D AIK + +R+ +E + E++ ++++EH
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRI---------- 151
+V+ + +E E ++ S + R+
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 152 -----------------CIG---------------------------IARGLAFLHEEVR 167
C IA + FLH +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-- 183
Query: 168 PHIIHRDIKASNILLDKDLTPKISDFGLAKLI-----------PANMTHVSTRVAGTIGY 216
++HRD+K SNI D K+ DFGL + P T GT Y
Sbjct: 184 -GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 217 LAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL 276
++PE + K DI+S G++L E++ +T M ER +I
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYS-FSTQM-----------------ERVRIIT 284
Query: 277 LVDTSLNGDFDAEEACRFLKVGLL---CTQDTPKLRPSMSTVVQM 318
V N F ++ + ++ +P RP + +++
Sbjct: 285 DVR---NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-34
Identities = 37/231 (16%), Positives = 67/231 (29%), Gaps = 26/231 (11%)
Query: 37 KELSIATDDFSPINKIGEGGFGSVYKGRLKD------GKIAAIKVLSAESRQGVKEFLTE 90
E + + + +GEG F VY+ D + +KV +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 91 IQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSR 150
++ + +K Y + N +LV +L I +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTL-LNAINLYKNTPEKVMPQGLVIS 176
Query: 151 ICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTP-----------KISDFGLA--- 196
+ + + +H+ IIH DIK N +L + D G +
Sbjct: 177 FAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM 233
Query: 197 KLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
KL P T T G+ E + D + + ++ G
Sbjct: 234 KLFPKGTI--FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-34
Identities = 47/202 (23%), Positives = 76/202 (37%), Gaps = 15/202 (7%)
Query: 51 KIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQG---VKEFLTEIQVISEIEHENLVKLY 106
+G GG G VY+ +I A+K++S E + ++ ++V ++
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV 166
+ + LA L G + I I L H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGP------LAPPRAVAIVRQIGSALDAAHAA- 153
Query: 167 RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP-ANMTHVSTRVAGTIGYLAPEYAIRG 225
HRD+K NIL+ D + DFG+A +T + GT+ Y+APE
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSES 210
Query: 226 QVTRKADIYSFGVLLVEIVSGR 247
T +ADIY+ +L E ++G
Sbjct: 211 HATYRADIYALTCVLYECLTGS 232
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-33
Identities = 50/227 (22%), Positives = 93/227 (40%), Gaps = 29/227 (12%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLT-------------- 89
+D+ I + +G F + KD K A+K + ++F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 90 ---EIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLI--GGGHHYSNIQFS 144
E+Q+I++I++E + G + ++Y Y+EN+S+ +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 145 WRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204
+ I + +++H +I HRD+K SNIL+DK+ K+SDFG ++ +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 205 HVSTRVAGTIGYLAPEYAIRGQVT---RKADIYSFGVLLVEIVSGRC 248
S GT ++ PE + + K DI+S G+ L +
Sbjct: 208 KGS---RGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 56/227 (24%), Positives = 94/227 (41%), Gaps = 37/227 (16%)
Query: 49 INKIGEGGFGSVYKGRLKDGK------IAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHE 100
+G G FG V A+K+L + + ++E+++++++ HE
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSR---------- 150
N+V L G C L++ Y L L +S + + + R
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 151 -------ICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANM 203
+A+G+ FL + +HRD+ A N+L+ KI DFGLA+ I ++
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 204 THVSTRVAGTIGYL-----APEYAIRGQVTRKADIYSFGVLLVEIVS 245
+ V L APE G T K+D++S+G+LL EI S
Sbjct: 227 NY----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 2e-33
Identities = 68/279 (24%), Positives = 127/279 (45%), Gaps = 32/279 (11%)
Query: 44 DDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAES--RQGVKE-FLTEIQVISEIEH 99
+DF N +G+G F VY+ + G AIK++ ++ + G+ + E+++ +++H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 100 ENLVKLYGCCVEGNHRI-LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARG 158
++++LY E ++ + LV N + + L +S R I G
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSE----NEAR-HFMHQIITG 124
Query: 159 LAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLA 218
+ +LH I+HRD+ SN+LL +++ KI+DFGLA + T + GT Y++
Sbjct: 125 MLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYIS 180
Query: 219 PEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278
PE A R ++D++S G + ++ G R P + + + ++L
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIG------RPPFDTDTVKN----TLNK---VVLA 227
Query: 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317
D + E + L LL + P R S+S+V+
Sbjct: 228 DYEMPSFLSIE--AKDLIHQLL--RRNPADRLSLSSVLD 262
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 42/206 (20%), Positives = 80/206 (38%), Gaps = 28/206 (13%)
Query: 51 KIGEGGFGSVYKG---RLKDGKIAAIKVL-SAESRQGVKEFLTEIQVISEIEHENLVKLY 106
I GG G +Y + +G+ +K L + + + E Q ++E+ H ++V+++
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 107 GCCVEGNHRI-----LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
+ +V Y+ SL ++ + + I L++
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSY 197
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEY 221
LH +++ D+K NI+L ++ K+ D G + + GT G+ APE
Sbjct: 198 LH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS----RINSFGY-LYGTPGFQAPEI 248
Query: 222 AIRGQVTRKADIYSFGVLLVEIVSGR 247
R T DIY+ G L +
Sbjct: 249 V-RTGPTVATDIYTVGRTLAALTLDL 273
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLS---AESRQGVKEFLTEIQVISEIE 98
+D + +G+G FG V + K G+ A+KV+S + + + L E+Q++ +++
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 99 HENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARG 158
H N++KLY + + LV L +I FS +RI + G
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR------FSEVDAARIIRQVLSG 138
Query: 159 LAFLHEEVRPHIIHRDIKASNILL---DKDLTPKISDFGLAKLIPANMTHVSTRVAGTIG 215
+ ++H+ I+HRD+K N+LL KD +I DFGL+ A+ GT
Sbjct: 139 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--KKMKDKIGTAY 193
Query: 216 YLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
Y+APE + G K D++S GV+L ++SG
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 9e-33
Identities = 56/225 (24%), Positives = 95/225 (42%), Gaps = 26/225 (11%)
Query: 40 SIATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLT-EIQVISEI 97
S + + + +G+G +V++GR K G + AIKV + S + E +V+ ++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 98 EHENLVKLYGC--CVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGI 155
H+N+VKL+ H++L+ + SL L + Y + +
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG---LPESEFLIVLRDV 121
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILL----DKDLTPKISDFGLAKLIPANMTHVSTRVA 211
G+ L E I+HR+IK NI+ D K++DFG A+ + + VS +
Sbjct: 122 VGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LY 176
Query: 212 GTIGYLAPEYAIRGQVTR---------KADIYSFGVLLVEIVSGR 247
GT YL P+ V R D++S GV +G
Sbjct: 177 GTEEYLHPDM-YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVL--SAESRQGVKEFLTEIQVISEIEH 99
++ + + K+G G +G V R K AIK++ ++ S + L E+ V+ ++H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGL 159
N++KLY + + LV + L +I F+ + I + G+
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK------FNEVDAAVIIKQVLSGV 149
Query: 160 AFLHEEVRPHIIHRDIKASNILL---DKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGY 216
+LH+ +I+HRD+K N+LL +KD KI DFGL+ + GT Y
Sbjct: 150 TYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--KKMKERLGTAYY 204
Query: 217 LAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
+APE +R + K D++S GV+L +++G
Sbjct: 205 IAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 57/211 (27%), Positives = 103/211 (48%), Gaps = 18/211 (8%)
Query: 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVL--SAESRQGVKEFLTEIQVISEIEH 99
+ ++ + +G+G FG V K + + + A+KV+ ++ + L E++++ +++H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGL 159
N++KL+ + + +V L +I FS +RI + G+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR------FSEHDAARIIKQVFSGI 134
Query: 160 AFLHEEVRPHIIHRDIKASNILL---DKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGY 216
++H+ +I+HRD+K NILL +KD KI DFGL+ GT Y
Sbjct: 135 TYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAYY 189
Query: 217 LAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
+APE +RG K D++S GV+L ++SG
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-32
Identities = 54/225 (24%), Positives = 93/225 (41%), Gaps = 26/225 (11%)
Query: 40 SIATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLT-EIQVISEI 97
S + + + +G+G +V++GR K G + AIKV + S + E +V+ ++
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 98 EHENLVKLYGC--CVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGI 155
H+N+VKL+ H++L+ + SL L + Y + +
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG---LPESEFLIVLRDV 121
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILL----DKDLTPKISDFGLAKLIPANMTHVSTRVA 211
G+ L E I+HR+IK NI+ D K++DFG A+ + + +
Sbjct: 122 VGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY- 176
Query: 212 GTIGYLAPEYAIRGQVTR---------KADIYSFGVLLVEIVSGR 247
GT YL P+ V R D++S GV +G
Sbjct: 177 GTEEYLHPDM-YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-31
Identities = 51/234 (21%), Positives = 88/234 (37%), Gaps = 27/234 (11%)
Query: 37 KELSIATDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVIS 95
+ + + + EGGF VY+ + + G+ A+K L + + + + E+ +
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80
Query: 96 EI-EHENLVKLYGCCV-------EGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRT 147
++ H N+V+ G L+ L L + L S S T
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK---KMESRGPLSCDT 137
Query: 148 RSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVS 207
+I R + +H + +P IIHRD+K N+LL T K+ DFG A I +
Sbjct: 138 VLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196
Query: 208 TRVA-----------GTIGYLAPE---YAIRGQVTRKADIYSFGVLLVEIVSGR 247
+ T Y PE + K DI++ G +L + +
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLS-------------AESRQGVKEFL 88
+ + + K+G G +G V + K AIKV+ + +E
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 89 TEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTR 148
EI ++ ++H N++KL+ + + LV + E L + +I F
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK------FDECDA 148
Query: 149 SRICIGIARGLAFLHEEVRPHIIHRDIKASNILL---DKDLTPKISDFGLAKLIPANMTH 205
+ I I G+ +LH+ +I+HRDIK NILL + L KI DFGL+ + +
Sbjct: 149 ANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--SKDY 203
Query: 206 VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
GT Y+APE ++ + K D++S GV++ ++ G
Sbjct: 204 KLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 46/362 (12%), Positives = 101/362 (27%), Gaps = 71/362 (19%)
Query: 52 IGEGGFGSVYKGR-LKDGKIAAIKVLSAE---SRQGVKEFLTEIQVISE----------- 96
+G+ + + + G+ + V +K+ E+ +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 97 -----------IEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQ--- 142
++ K+ ++ ++ + + L G +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 143 --FSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200
R ++ + + R LA LH ++H ++ +I+LD+ ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 201 ANMTHVSTRVAGTIGYLAPEYAIRGQ-----VTRKADIYSFGVLLVEIVSGRCNTNMRLP 255
A+ R A GQ +T D ++ G+ + I LP
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA------DLP 316
Query: 256 TEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTV 315
+ + + + R L G L + + R
Sbjct: 317 -------------NTDDAALGGSEWIFRSCKNIPQPVRALLEGFL--RYPKEDRLLPLQA 361
Query: 316 VQMLMGEKDIDDDKITKPGLISDFMDLKVRGPPKPKLETTTSSTYNSSDNPDNSNLSSAA 375
++ E+ + P +D G P + S T PD + + A
Sbjct: 362 METPEYEQLRTELSAALPLYQTD-------GEPTREGGAPPSGT----SQPDEAGAAEAV 410
Query: 376 TS 377
T+
Sbjct: 411 TA 412
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 2e-31
Identities = 61/271 (22%), Positives = 110/271 (40%), Gaps = 33/271 (12%)
Query: 52 IGEGGFGSVYKGR-LKDGKIAAIKVLSAES--RQGVKE-FLTEIQVISEIEHENLVKLYG 107
+G+GGF ++ ++ A K++ + +E EI + + H+++V +G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 108 CCVEGNHRI-LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV 166
E N + +V SL + + I G +LH
Sbjct: 83 F-FEDNDFVFVVLELCRRRSLLELHKRRKA------LTEPEARYYLRQIVLGCQYLHRN- 134
Query: 167 RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQ 226
+IHRD+K N+ L++DL KI DFGLA + + + GT Y+APE +
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKG 191
Query: 227 VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDF 286
+ + D++S G ++ ++ G + P E L E Y R I + S+
Sbjct: 192 HSFEVDVWSIGCIMYTLLVG------KPPFETSCLKE----TYLR---IKKNEYSIPKHI 238
Query: 287 DAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317
+ L +L T P RP+++ ++
Sbjct: 239 NPV--AASLIQKMLQTD--PTARPTINELLN 265
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 28/298 (9%), Positives = 68/298 (22%), Gaps = 47/298 (15%)
Query: 52 IGEGGFGSVYKGRLKD-GKIAAIKVL---SAESRQGVKEFLTEIQVISEIEHENLVKLYG 107
+ G V+ R + + A+KV + SR ++ + + E+ +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 108 CCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNI-------------------------- 141
V + + + +N
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 142 QFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201
+ + R A L + ++H N+ + D + D +
Sbjct: 190 DEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246
Query: 202 NMTHVSTRVAGTIGYLAPEYAIRG--QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQ 259
S + Y E+ T + + G+ + + LP
Sbjct: 247 RGPASS----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL------FLPFGLV 296
Query: 260 YLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317
+ + + + + L L + R ++
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFD--RRRRLLPLEAME 352
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 39/308 (12%), Positives = 89/308 (28%), Gaps = 71/308 (23%)
Query: 52 IGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKE------------------------ 86
+G+ + + + G+ + V R
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 87 ----FLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQ 142
F+ ++ + + + ++++ + + Y S QT +S+
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 143 --FSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200
R ++ + + R LA LH ++H ++ +I+LD+ ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 201 ANMTHVSTRVAGTIGYLAPEYAI-----------RGQVTRKADIYSFGVLLVEIVSGRCN 249
A + + + G+ PE R +T D ++ G+++ I
Sbjct: 258 ARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA--- 309
Query: 250 TNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLR 309
LP + E I + + R L G L + R
Sbjct: 310 ---DLPITKD-------AALGGSEWI------FRSCKNIPQPVRALLEGFLRYP--KEDR 351
Query: 310 PSMSTVVQ 317
++
Sbjct: 352 LLPLQAME 359
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 62/272 (22%), Positives = 111/272 (40%), Gaps = 35/272 (12%)
Query: 52 IGEGGFGSVYKGR-LKDGKIAAIKVLSAES--RQGVKE-FLTEIQVISEIEHENLVKLYG 107
+G+GGF ++ ++ A K++ + +E EI + + H+++V +G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 108 CCVEGNHRI-LVYNYLENNSLAQTLIGGGHHYSNIQFS-WRTRSRICIGIARGLAFLHEE 165
E N + +V SL + + R I G +LH
Sbjct: 109 F-FEDNDFVFVVLELCRRRSLLELHKRRKA------LTEPEAR-YYLRQIVLGCQYLHRN 160
Query: 166 VRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRG 225
+IHRD+K N+ L++DL KI DFGLA + + + GT Y+APE +
Sbjct: 161 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKK 216
Query: 226 QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGD 285
+ + D++S G ++ ++ G + P E L E Y R I + S+
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVG------KPPFETSCLKE----TYLR---IKKNEYSIPKH 263
Query: 286 FDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317
+ L +L T P RP+++ ++
Sbjct: 264 INPV--AASLIQKMLQTD--PTARPTINELLN 291
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 2e-30
Identities = 61/216 (28%), Positives = 91/216 (42%), Gaps = 19/216 (8%)
Query: 43 TDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLT-EIQVISEIEHE 100
+ ++G GGFG V + +D G+ AIK E +E EIQ++ ++ H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 101 NLVKLY------GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIG 154
N+V + +L Y E L + L + +
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG---LKEGPIRTLLSD 129
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLD---KDLTPKISDFGLAKLIPANMTHVSTRVA 211
I+ L +LHE IIHRD+K NI+L + L KI D G AK + + V
Sbjct: 130 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV- 184
Query: 212 GTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
GT+ YLAPE + + T D +SFG L E ++G
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 46/194 (23%), Positives = 79/194 (40%), Gaps = 16/194 (8%)
Query: 51 KIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCC 109
IG G +G V K A K + + V F EI+++ ++H N+++LY
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 110 VEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPH 169
+ LV L + ++ F +RI + +A+ H+ +
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRV------FRESDAARIMKDVLSAVAYCHKL---N 126
Query: 170 IIHRDIKASNILL---DKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQ 226
+ HRD+K N L D K+ DFGLA + GT Y++P+ + G
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKVGTPYYVSPQ-VLEGL 183
Query: 227 VTRKADIYSFGVLL 240
+ D +S GV++
Sbjct: 184 YGPECDEWSAGVMM 197
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 56/230 (24%), Positives = 91/230 (39%), Gaps = 36/230 (15%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENL 102
+ +G G G+V G+ A+K + L EI++++E +H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM---LIDFCDIALMEIKLLTESDDHPNV 71
Query: 103 VKLYGCCVEGNHRILVYNYLE--NNSLAQTLIGGGH-HYSNIQFSWRTRSRICIGIARGL 159
++ Y + LE N +L + + + IA G+
Sbjct: 72 IRYYCSETTDRFLYIA---LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 160 AFLHEEVRPHIIHRDIKASNILLD-------------KDLTPKISDFGLAKLIPANMTHV 206
A LH IIHRD+K NIL+ ++L ISDFGL K + + +
Sbjct: 129 AHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 207 STR---VAGTIGYLAPE-------YAIRGQVTRKADIYSFGVLLVEIVSG 246
T +GT G+ APE + ++TR DI+S G + I+S
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 62/232 (26%), Positives = 103/232 (44%), Gaps = 29/232 (12%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEH 99
D F +G GGFG V+ ++K GK+ A K L+ + R+G + + E ++++++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGG----HHYSNIQFSWR---TRSRIC 152
+V L LV + GG H Y+ + + R+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTI----------MNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 153 IG-IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVA 211
I GL LH+ +II+RD+K N+LLD D +ISD GLA + A T
Sbjct: 295 TAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA- 350
Query: 212 GTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRC---NTNMRLPTEEQY 260
GT G++APE + + D ++ GV L E+++ R ++ +E
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-30
Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 13/203 (6%)
Query: 43 TDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLS-AESRQGVKEFLTEIQVISEIEHE 100
D F K+G G FG V+ + G IK ++ S+ +++ EI+V+ ++H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
N++K++ + ++ +V E L + ++ S + + + LA
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKA--LSEGYVAELMKQMMNALA 138
Query: 161 FLHEEVRPHIIHRDIKASNILL---DKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYL 217
+ H + H++H+D+K NIL KI DFGLA+L ++ ST AGT Y+
Sbjct: 139 YFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGTALYM 193
Query: 218 APEYAIRGQVTRKADIYSFGVLL 240
APE + VT K DI+S GV++
Sbjct: 194 APE-VFKRDVTFKCDIWSAGVVM 215
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEH 99
+ F +G+GGFG V +++ GK+ A K L + R+G L E Q++ ++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRT-----RSRICIG 154
+V L + LV + GG +I + R+
Sbjct: 244 RFVVSLAYAYETKDALCLVLTL----------MNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 155 -IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213
I GL LH E I++RD+K NILLD +ISD GLA +P T + RV GT
Sbjct: 294 EICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GT 348
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
+GY+APE + T D ++ G LL E+++G+
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 56/204 (27%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 43 TDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVL--SAESRQGVKEFLTEIQVISEIEH 99
+ ++ + +G+G FG V K + + + A+KV+ ++ + L E++++ +++H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGL 159
N++KL+ + + +V L +I FS +RI + G+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR------FSEHDAARIIKQVFSGI 134
Query: 160 AFLHEEVRPHIIHRDIKASNILL---DKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGY 216
++H+ +I+HRD+K NILL +KD KI DFGL+ N GT Y
Sbjct: 135 TYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYY 189
Query: 217 LAPEYAIRGQVTRKADIYSFGVLL 240
+APE +RG K D++S GV+L
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 65/222 (29%), Positives = 108/222 (48%), Gaps = 34/222 (15%)
Query: 42 ATDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLT---EIQVISEI 97
++ F + K+G G + +VYKG G A+K + +S +G T EI ++ E+
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTP--STAIREISLMKEL 60
Query: 98 EHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR 157
+HEN+V+LY N LV+ +++N+ L + + + + +
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 158 GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL--IPAN-MTHVSTRVAGTI 214
GLAF HE I+HRD+K N+L++K K+ DFGLA+ IP N + V T+
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TL 172
Query: 215 GYLAPE-------Y--AIRGQVTRKADIYSFGVLLVEIVSGR 247
Y AP+ Y +I DI+S G +L E+++G+
Sbjct: 173 WYRAPDVLMGSRTYSTSI--------DIWSCGCILAEMITGK 206
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 45 DFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLV 103
S +G G FG V+K G A K++ + +E EI V+++++H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 104 KLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH 163
+LY N +LV Y++ L +I ++ + I G+ +H
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTE-----LDTILFMKQICEGIRHMH 204
Query: 164 EEVRPHIIHRDIKASNILL-DKDLTP-KISDFGLAKLIPANMTHVSTRVAGTIGYLAPEY 221
+ +I+H D+K NIL ++D KI DFGLA+ GT +LAPE
Sbjct: 205 QM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--EKLKVNFGTPEFLAPEV 259
Query: 222 AIRGQVTRKADIYSFGVLL 240
V+ D++S GV+
Sbjct: 260 VNYDFVSFPTDMWSVGVIA 278
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 38/220 (17%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIK-VLSAESRQGVKEF-LTEIQVISEIEHE 100
+ + I KIGEG +G V+K R +D G+I AIK L +E +K+ L EI+++ +++H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
NLV L LV+ Y ++ + L I + +
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDHT-VLHELDR-----YQRGVPEHLVKSITWQTLQAVN 116
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA---NMTH-VSTRVAGTIGY 216
F H+ + IHRD+K NIL+ K K+ DFG A+L+ V+TR Y
Sbjct: 117 FCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WY 168
Query: 217 LAPE-------Y--AIRGQVTRKADIYSFGVLLVEIVSGR 247
+PE Y + D+++ G + E++SG
Sbjct: 169 RSPELLVGDTQYGPPV--------DVWAIGCVFAELLSGV 200
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-29
Identities = 51/238 (21%), Positives = 91/238 (38%), Gaps = 19/238 (7%)
Query: 10 RRDSPRNRVPEVDEEFSGIHNVKLYSYKELSIATDDFSPI----NKIGEGGFGSVYKGRL 65
R ++ + D+ + I K Y + + + ++G G FG V++
Sbjct: 15 RGKYDGPKINDYDKFYEDIW--KKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVE 72
Query: 66 KD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLEN 124
K G++ K ++ EI +++++ H L+ L+ + +L+ +L
Sbjct: 73 KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132
Query: 125 NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL-D 183
L + + S GL +HE I+H DIK NI+
Sbjct: 133 GELFDRIAAEDYKMSE-----AEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCET 184
Query: 184 KDLTP-KISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLL 240
K + KI DFGLA + + + T + APE R V D+++ GVL
Sbjct: 185 KKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 76/271 (28%), Positives = 113/271 (41%), Gaps = 42/271 (15%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEH 99
+DFS IG GGFG VY R D GK+ A+K L + +QG L E ++S +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 100 EN---LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGG----HHYSNIQFSWRTRSRIC 152
+ +V + + + + + GG H + FS R
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMN----------GGDLHYHLSQHGVFS-EADMRFY 297
Query: 153 IG-IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVA 211
I GL +H +++RD+K +NILLD+ +ISD GLA H V
Sbjct: 298 AAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV- 351
Query: 212 GTIGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE 270
GT GY+APE +G AD +S G +L +++ G P + +T D +E
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG------HSP----FRQHKTKDKHE 401
Query: 271 RRELILLVDTSLNGDFDAEEACRFLKVGLLC 301
+ L + L F E L+ GLL
Sbjct: 402 IDRMTLTMAVELPDSFS-PELRSLLE-GLLQ 430
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-29
Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 35/218 (16%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAES-RQGVKEFLT---EIQVISEIEH 99
+ + + K+GEG +G VYK + G+I A+K + ++ +G+ T EI ++ E+ H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIP--STAIREISLLKELHH 78
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGL 159
N+V L LV+ ++E + L + L + + RG+
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFMEKD-LKKVL-----DENKTGLQDSQIKIYLYQLLRGV 132
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL--IPAN-MTHVSTRVAGTIGY 216
A H+ I+HRD+K N+L++ D K++DFGLA+ IP TH V T+ Y
Sbjct: 133 AHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWY 185
Query: 217 LAPE-------YAIRGQVTRKADIYSFGVLLVEIVSGR 247
AP+ Y + DI+S G + E+++G+
Sbjct: 186 RAPDVLMGSKKY------STSVDIWSIGCIFAEMITGK 217
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 44/207 (21%), Positives = 87/207 (42%), Gaps = 15/207 (7%)
Query: 43 TDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKV-----LSAESRQGVKEFLTEIQVISE 96
D + IG+G F V + ++ G+ A+K+ ++ ++ E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 97 IEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIA 156
++H ++V+L +V+ +++ L ++ + +S S I
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRAD--AGFVYSEAVASHYMRQIL 140
Query: 157 RGLAFLHEEVRPHIIHRDIKASNILL---DKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213
L + H+ +IIHRD+K +LL + K+ FG+A + + RV GT
Sbjct: 141 EALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GT 196
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLL 240
++APE R + D++ GV+L
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 66/222 (29%), Positives = 104/222 (46%), Gaps = 42/222 (18%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIK-VLSAESRQGVKEF-LTEIQVISEIEHE 100
+ + + +GEG +G V K R KD G+I AIK L ++ + VK+ + EI+++ ++ HE
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTL--IGGGHHYSNIQFSWRTRSRICIGIARG 158
NLV L C + LV+ ++++ + L G Y +Q + I G
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDHT-ILDDLELFPNGLDYQVVQ-------KYLFQIING 136
Query: 159 LAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL--IPAN-MTH-VSTRVAGTI 214
+ F H +IIHRDIK NIL+ + K+ DFG A+ P V+TR
Sbjct: 137 IGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR----- 188
Query: 215 GYLAPE-------Y--AIRGQVTRKADIYSFGVLLVEIVSGR 247
Y APE Y A+ D+++ G L+ E+ G
Sbjct: 189 WYRAPELLVGDVKYGKAV--------DVWAIGCLVTEMFMGE 222
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 35/218 (16%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAES-RQGVKEFLT---EIQVISEIEH 99
+ + + KIGEG +G VYK + G+ A+K + E +G+ T EI ++ E++H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIP--STTIREISILKELKH 59
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGL 159
N+VKLY +LV+ +L+ + L + L T + + G+
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLL-----DVCEGGLESVTAKSFLLQLLNGI 113
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL--IPAN-MTHVSTRVAGTIGY 216
A+ H+ ++HRD+K N+L++++ KI+DFGLA+ IP TH + T+ Y
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWY 166
Query: 217 LAPE-------YAIRGQVTRKADIYSFGVLLVEIVSGR 247
AP+ Y + DI+S G + E+V+G
Sbjct: 167 RAPDVLMGSKKY------STTIDIWSVGCIFAEMVNGT 198
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 51 KIGEGGFGSVYKGRLKD---GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYG 107
K+G G +G VYK + KD K A+K + EI ++ E++H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQK 85
Query: 108 CCVE-GNHRI-LVYNYLEN--NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH 163
+ + ++ L+++Y E+ + + + +Q + I G+ +LH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 164 EEVRPHIIHRDIKASNILLDKDLTP----KISDFGLAKL--IPAN-MTHVSTRVAGTIGY 216
++HRD+K +NIL+ + KI+D G A+L P + + V T Y
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 201
Query: 217 LAPE-------YAIRGQVTRKADIYSFGVLLVEIVSGR 247
APE Y T+ DI++ G + E+++
Sbjct: 202 RAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-28
Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 22/213 (10%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAES---RQGVKEFLTEIQVISEIEH 99
+DF +GEG F +V R + AIK+L V E V+S ++H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWR---TRSRICIG-I 155
VKLY + +Y + G I+ T +R I
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAK----------NGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTR-VAGTI 214
L +LH + IIHRD+K NILL++D+ +I+DFG AK++ GT
Sbjct: 140 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196
Query: 215 GYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
Y++PE + +D+++ G ++ ++V+G
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-28
Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 43 TDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHEN 101
F + +G G F V+ + + GK+ A+K + EI V+ +I+HEN
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNI----QFSWRTRSRICIGIAR 157
+V L H LV ++ L+ GG + I ++ + S + +
Sbjct: 68 IVTLEDIYESTTHYYLV---MQ-------LVSGGELFDRILERGVYTEKDASLVIQQVLS 117
Query: 158 GLAFLHEEVRPHIIHRDIKASNILL---DKDLTPKISDFGLAKLIPANMTHVSTRVAGTI 214
+ +LHE I+HRD+K N+L +++ I+DFGL+K+ + + GT
Sbjct: 118 AVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTP 171
Query: 215 GYLAPEYAIRGQVTRKADIYSFGVLL 240
GY+APE + ++ D +S GV+
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-28
Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 28/222 (12%)
Query: 42 ATDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAES-RQGVKEF----LTEI---Q 92
AT + P+ +IG G +G+VYK R G A+K + + G + E+ +
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 93 VISEIEHENLVKLYGCCVEGNHRI-----LVYNYLENNSLAQTLIGGGHHYSNIQFSWRT 147
+ EH N+V+L C LV+ +++ + L L T
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYL----DKAPPPGLPAET 121
Query: 148 RSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL--IPANMTH 205
+ RGL FLH I+HRD+K NIL+ T K++DFGLA++ +T
Sbjct: 122 IKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178
Query: 206 VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
V T+ Y APE ++ D++S G + E+ +
Sbjct: 179 ---VVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-28
Identities = 59/222 (26%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 44 DDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKE-----FLTEIQVISEI 97
+ ++ +GEG F +VYK R +I AIK + R K+ L EI+++ E+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 98 EHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR 157
H N++ L ++ LV++++E + L + +++ + + +
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFMETD-LEVII-----KDNSLVLTPSHIKAYMLMTLQ 123
Query: 158 GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL--IPAN-MTHVSTRVAGTI 214
GL +LH+ I+HRD+K +N+LLD++ K++DFGLAK P TH +V T
Sbjct: 124 GLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH---QVV-TR 176
Query: 215 GYLAPE-------Y--AIRGQVTRKADIYSFGVLLVEIVSGR 247
Y APE Y + D+++ G +L E++
Sbjct: 177 WYRAPELLFGARMYGVGV--------DMWAVGCILAELLLRV 210
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 31/216 (14%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGV-KEFLTEIQVISEIEHEN 101
+ + ++K+GEG + +VYKG+ K + A+K + E +G + E+ ++ +++H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
+V L+ LV+ YL+ + L Q L + + RGLA+
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKD-LKQYL-----DDCGNIINMHNVKLFLFQLLRGLAY 115
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL--IPAN-MTHVSTRVAGTIGYLA 218
H R ++HRD+K N+L+++ K++DFGLA+ IP + V T+ Y
Sbjct: 116 CH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-TLWYRP 168
Query: 219 PE-------YAIRGQVTRKADIYSFGVLLVEIVSGR 247
P+ Y + + D++ G + E+ +GR
Sbjct: 169 PDILLGSTDY------STQIDMWGVGCIFYEMATGR 198
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEH 99
D F + IG+G FG V + D K+ A+K ++ + R V+ E+Q++ +EH
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWR---TRSRICIG-I 155
LV L+ + +V + L GG ++Q + ++ I +
Sbjct: 75 PFLVNLWYSFQDEEDMFMVVDLLL----------GGDLRYHLQQNVHFKEETVKLFICEL 124
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIG 215
L +L + IIHRD+K NILLD+ I+DF +A ++P + +AGT
Sbjct: 125 VMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKP 179
Query: 216 YLAPE-YAIRGQV--TRKADIYSFGVLLVEIVSGR 247
Y+APE ++ R + D +S GV E++ GR
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 43 TDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKV-----LSAESRQGVKEFLTEIQVISE 96
+D++ ++G+G F V + K G A K+ LSA Q ++ E ++ +
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRK 61
Query: 97 IEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIA 156
++H N+V+L+ E + LV++ + L + ++ +S S I
Sbjct: 62 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF------YSEADASHCIQQIL 115
Query: 157 RGLAFLHEEVRPHIIHRDIKASNILL---DKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213
+A+ H I+HR++K N+LL K K++DFGLA + + AGT
Sbjct: 116 ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGT 170
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLL 240
GYL+PE + ++ DI++ GV+L
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 49/235 (20%), Positives = 89/235 (37%), Gaps = 14/235 (5%)
Query: 9 RRRDSPRNRVPEVDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKD- 67
R + + + + + + K + D + ++G G FG V++ +
Sbjct: 123 RGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHV-LDHYDIHEELGTGAFGVVHRVTERAT 181
Query: 68 GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSL 127
G A K + + EIQ +S + H LV L+ + N +++Y ++ L
Sbjct: 182 GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 241
Query: 128 AQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL--DKD 185
+ + + S + +GL +HE + +H D+K NI+ +
Sbjct: 242 FEKVADEHNKMSE-----DEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRS 293
Query: 186 LTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLL 240
K+ DFGL + GT + APE A V D++S GVL
Sbjct: 294 NELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 62/231 (26%), Positives = 107/231 (46%), Gaps = 48/231 (20%)
Query: 44 DDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAES-RQGVKEFLT---EIQVISEIE 98
+ + KIG+G FG V+K R K G+ A+K + E+ ++G +T EI+++ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP--ITALREIKILQLLK 74
Query: 99 HENLVKLYGCCVEGNHRI--------LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSR 150
HEN+V L C LV+++ E++ LA L ++F+ R
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLL-----SNVLVKFTLSEIKR 128
Query: 151 ICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA-------KLIPANM 203
+ + GL ++H I+HRD+KA+N+L+ +D K++DFGLA P
Sbjct: 129 VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 204 THVSTRVAGTIGYLAPE-------YAIRGQVTRKADIYSFGVLLVEIVSGR 247
T+ RV T+ Y PE Y D++ G ++ E+ +
Sbjct: 186 TN---RVV-TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 50/221 (22%), Positives = 102/221 (46%), Gaps = 40/221 (18%)
Query: 44 DDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAES-RQGVKEFLT---EIQVISEIE 98
+ + KIGEG +G+V+K + + +I A+K + + +GV + EI ++ E++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP--SSALREICLLKELK 59
Query: 99 HENLVKLYGCCVEGNHRILVYNYLENNSLAQTL--IGGGHHYSNIQFSWRTRSRICIGIA 156
H+N+V+L+ LV+ + + + L + G ++ +
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQD-LKKYFDSCNGDLDPEIVK-------SFLFQLL 111
Query: 157 RGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL--IPAN-MTHVSTRVAGT 213
+GL F H +++HRD+K N+L++++ K+++FGLA+ IP + V T
Sbjct: 112 KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-T 164
Query: 214 IGYLAPE-------YAIRGQVTRKADIYSFGVLLVEIVSGR 247
+ Y P+ Y + D++S G + E+ +
Sbjct: 165 LWYRPPDVLFGAKLY------STSIDMWSAGCIFAELANAG 199
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-27
Identities = 55/252 (21%), Positives = 85/252 (33%), Gaps = 50/252 (19%)
Query: 43 TDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKV-----LSAESRQGVKEFLTEIQVISE 96
+ IG+G +G V I AIK+ + + + V+ TE++++ +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 97 IEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQ-------------- 142
+ H N+ +LY + + LV L L +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 143 --------------------FSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL 182
+ S I I L +LH + I HRDIK N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLF 201
Query: 183 --DKDLTPKISDFGLAKLIPANMTHVSTR---VAGTIGYLAPE--YAIRGQVTRKADIYS 235
+K K+ DFGL+K AGT ++APE K D +S
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 236 FGVLLVEIVSGR 247
GVLL ++ G
Sbjct: 262 AGVLLHLLLMGA 273
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-27
Identities = 60/224 (26%), Positives = 93/224 (41%), Gaps = 42/224 (18%)
Query: 44 DDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAES-RQGVKEFLT---EIQVISEIE 98
D + I K+GEG +G VYK + AIK + E +GV T E+ ++ E++
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVP--GTAIREVSLLKELQ 91
Query: 99 HENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARG 158
H N+++L + L++ Y EN+ L + + N S R + G
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYAEND-LKKYMD------KNPDVSMRVIKSFLYQLING 144
Query: 159 LAFLHEEVRPHIIHRDIKASNILLDKDLTP-----KISDFGLAKL--IPAN-MTHVSTRV 210
+ F H +HRD+K N+LL KI DFGLA+ IP TH +
Sbjct: 145 VNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EI 198
Query: 211 AGTIGYLAPE-------YAIRGQVTRKADIYSFGVLLVEIVSGR 247
T+ Y PE Y + DI+S + E++
Sbjct: 199 I-TLWYRPPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-27
Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 28/215 (13%)
Query: 43 TDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLS--------AESRQGVKE-FLTEIQ 92
+++ P +G G V + K K A+K++ AE Q ++E L E+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 93 VISEI-EHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRI 151
++ ++ H N+++L LV++ ++ L L S + +I
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT------LSEKETRKI 129
Query: 152 CIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVA 211
+ + LH+ +I+HRD+K NILLD D+ K++DFG + + V
Sbjct: 130 MRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVC 184
Query: 212 GTIGYLAPE------YAIRGQVTRKADIYSFGVLL 240
GT YLAPE ++ D++S GV++
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 49/219 (22%), Positives = 86/219 (39%), Gaps = 23/219 (10%)
Query: 33 LYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLS------AESRQGVK 85
+ ++K+ + D + ++G G F V K R K G A K + + +
Sbjct: 2 METFKQQKV-EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCRE 60
Query: 86 EFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSW 145
E E+ ++ ++ H N++ L+ +L+ + L L S
Sbjct: 61 EIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES------LSE 114
Query: 146 RTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL----DKDLTPKISDFGLAKLIPA 201
+ I G+ +LH + I H D+K NI+L K+ DFGLA I
Sbjct: 115 EEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171
Query: 202 NMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLL 240
+ GT ++APE + +AD++S GV+
Sbjct: 172 G--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 57/228 (25%), Positives = 102/228 (44%), Gaps = 33/228 (14%)
Query: 37 KELSIATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQ 92
K++ + +DF + IG G FG V +LK+ K+ A+K+L+ R F E
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 126
Query: 93 VISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRIC 152
V+ + + + L+ + N+ LV +Y GG + + + R+
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYV----------GGDLLTLLS---KFEDRLP 173
Query: 153 IGIAR--------GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204
+AR + +H+ H +HRDIK NIL+D + +++DFG + + T
Sbjct: 174 EEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230
Query: 205 HVSTRVAGTIGYLAPE-----YAIRGQVTRKADIYSFGVLLVEIVSGR 247
S+ GT Y++PE +G+ + D +S GV + E++ G
Sbjct: 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 62/257 (24%), Positives = 100/257 (38%), Gaps = 26/257 (10%)
Query: 3 CFSFLFRRRDSPRNRVPEVDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYK 62
L D P R + + F + + ++L + +D+ + IG G FG V
Sbjct: 28 GLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQL 87
Query: 63 GRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118
R K K+ A+K+LS R F E +++ +V+L+ + + +V
Sbjct: 88 VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147
Query: 119 YNYLENNSLAQTLIGGG---HHYSNIQFSWRTRSRICIG-IARGLAFLHEEVRPHIIHRD 174
Y+ GG + SN +R + L +H IHRD
Sbjct: 148 MEYMP----------GGDLVNLMSNYDVP-EKWARFYTAEVVLALDAIHSM---GFIHRD 193
Query: 175 IKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPE----YAIRGQVTRK 230
+K N+LLDK K++DFG + GT Y++PE G R+
Sbjct: 194 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 253
Query: 231 ADIYSFGVLLVEIVSGR 247
D +S GV L E++ G
Sbjct: 254 CDWWSVGVFLYEMLVGD 270
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 53/213 (24%), Positives = 89/213 (41%), Gaps = 27/213 (12%)
Query: 43 TDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLS--------AESRQGVKEFLTEIQV 93
D++ +G G G V + K AI+++S A TEI++
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 94 ISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICI 153
+ ++ H ++K+ ++ +V +E L ++G T
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR------LKEATCKLYFY 246
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILL---DKDLTPKISDFGLAKLIPANMTHVSTRV 210
+ + +LHE IIHRD+K N+LL ++D KI+DFG +K++ + + T
Sbjct: 247 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLC 302
Query: 211 AGTIGYLAPE---YAIRGQVTRKADIYSFGVLL 240
GT YLAPE R D +S GV+L
Sbjct: 303 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-26
Identities = 53/195 (27%), Positives = 85/195 (43%), Gaps = 18/195 (9%)
Query: 51 KIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENLVKLYGC 108
+GEG F K K + A+K++S ++ EI + H N+VKL+
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEV 74
Query: 109 CVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRP 168
+ H LV L L + + H FS S I + ++ +H+
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKH------FSETEASYIMRKLVSAVSHMHDV--- 125
Query: 169 HIIHRDIKASNILL---DKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRG 225
++HRD+K N+L + +L KI DFG A+L P + + T T+ Y APE +
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQN 184
Query: 226 QVTRKADIYSFGVLL 240
D++S GV+L
Sbjct: 185 GYDESCDLWSLGVIL 199
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-26
Identities = 48/209 (22%), Positives = 80/209 (38%), Gaps = 22/209 (10%)
Query: 43 TDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLS------AESRQGVKEFLTEIQVIS 95
D + ++G G F V K R K G A K + + +E E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 96 EIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGI 155
++ H N++ L+ +L+ + L L S + I
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES------LSEEEATSFIKQI 124
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILL----DKDLTPKISDFGLAKLIPANMTHVSTRVA 211
G+ +LH + I H D+K NI+L K+ DFGLA I +
Sbjct: 125 LDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIF 179
Query: 212 GTIGYLAPEYAIRGQVTRKADIYSFGVLL 240
GT ++APE + +AD++S GV+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 20/220 (9%)
Query: 27 GIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVK 85
G+H++ ++ TD + IG G + + K A+K++ +S++
Sbjct: 5 GVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-KSKRDPT 63
Query: 86 EFLTEIQVI-SEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFS 144
E EI+++ +H N++ L +G + +V ++ L ++ FS
Sbjct: 64 E---EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF------FS 114
Query: 145 WRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL---DKDLTP-KISDFGLAKLIP 200
R S + I + + +LH + ++HRD+K SNIL + +I DFG AK +
Sbjct: 115 EREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171
Query: 201 ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLL 240
A + T T ++APE R DI+S GVLL
Sbjct: 172 AENGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-26
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 43 TDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKV-----LSAESRQGVKEFLTEIQVISE 96
+D++ ++G+G F V + K G A K+ LSA Q ++ E ++ +
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRK 84
Query: 97 IEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIA 156
++H N+V+L+ E + LV++ + L + ++ +S S I
Sbjct: 85 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF------YSEADASHCIQQIL 138
Query: 157 RGLAFLHEEVRPHIIHRDIKASNILL---DKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213
+A+ H I+HR++K N+LL K K++DFGLA + + AGT
Sbjct: 139 ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGT 193
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLL 240
GYL+PE + ++ DI++ GV+L
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 56/221 (25%), Positives = 92/221 (41%), Gaps = 42/221 (19%)
Query: 46 FSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKL 105
++ IG G FG V++ +L + AIK + Q + E+Q++ ++H N+V L
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIK----KVLQDKRFKNRELQIMRIVKHPNVVDL 97
Query: 106 YGCCVEGNHRI------LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIG----- 154
+ LV Y+ +T+ Y + + + + +
Sbjct: 98 KAFFYSNGDKKDEVFLNLVLEYVP-----ETV------YRASRHYAKLKQTMPMLLIKLY 146
Query: 155 ---IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTP-KISDFGLAK-LIPAN-MTH-VS 207
+ R LA++H I HRDIK N+LLD K+ DFG AK LI +
Sbjct: 147 MYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC 203
Query: 208 TRVAGTIGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGR 247
+R Y APE T DI+S G ++ E++ G+
Sbjct: 204 SRY-----YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-26
Identities = 51/209 (24%), Positives = 82/209 (39%), Gaps = 22/209 (10%)
Query: 43 TDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVL------SAESRQGVKEFLTEIQVIS 95
D + ++G G F V K R K G A K + S+ ++ E+ ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 96 EIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGI 155
EI+H N++ L+ IL+ + L L + + I
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEATEFLKQI 123
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILL----DKDLTPKISDFGLAKLIPANMTHVSTRVA 211
G+ +LH I H D+K NI+L KI DFGLA I + +
Sbjct: 124 LNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIF 178
Query: 212 GTIGYLAPEYAIRGQVTRKADIYSFGVLL 240
GT ++APE + +AD++S GV+
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-26
Identities = 50/201 (24%), Positives = 82/201 (40%), Gaps = 22/201 (10%)
Query: 51 KIGEGGFGSVYKGRLKD-GKIAAIKVL------SAESRQGVKEFLTEIQVISEIEHENLV 103
++G G F V K R K GK A K + S+ +E E+ ++ EI H N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 104 KLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH 163
L+ +L+ + L L + ++ I G+ +LH
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKES------LTEDEATQFLKQILDGVHYLH 125
Query: 164 EEVRPHIIHRDIKASNILL----DKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAP 219
+ I H D+K NI+L + K+ DFG+A I A GT ++AP
Sbjct: 126 SK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNIF-GTPEFVAP 180
Query: 220 EYAIRGQVTRKADIYSFGVLL 240
E + +AD++S GV+
Sbjct: 181 EIVNYEPLGLEADMWSIGVIT 201
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-26
Identities = 53/213 (24%), Positives = 88/213 (41%), Gaps = 27/213 (12%)
Query: 43 TDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLS--------AESRQGVKEFLTEIQV 93
D++ +G G G V + K AIK++S A TEI++
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 94 ISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICI 153
+ ++ H ++K+ ++ +V +E L ++G T
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR------LKEATCKLYFY 121
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILL---DKDLTPKISDFGLAKLIPANMTHVSTRV 210
+ + +LHE IIHRD+K N+LL ++D KI+DFG +K++ + +
Sbjct: 122 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTL 176
Query: 211 AGTIGYLAPE---YAIRGQVTRKADIYSFGVLL 240
GT YLAPE R D +S GV+L
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-26
Identities = 62/206 (30%), Positives = 92/206 (44%), Gaps = 25/206 (12%)
Query: 43 TDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHEN 101
+D F +++G G VY+ + K K A+KVL K TEI V+ + H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPN 109
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNI----QFSWRTRSRICIGIAR 157
++KL LV LE L+ GG + I +S R + I
Sbjct: 110 IIKLKEIFETPTEISLV---LE-------LVTGGELFDRIVEKGYYSERDAADAVKQILE 159
Query: 158 GLAFLHEEVRPHIIHRDIKASNILL---DKDLTPKISDFGLAKLIPANMTHVSTRVAGTI 214
+A+LHE I+HRD+K N+L D KI+DFGL+K++ + V GT
Sbjct: 160 AVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLMKTVCGTP 214
Query: 215 GYLAPEYAIRGQVTRKADIYSFGVLL 240
GY APE + D++S G++
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-26
Identities = 38/201 (18%), Positives = 73/201 (36%), Gaps = 14/201 (6%)
Query: 43 TDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHEN 101
+ + +G G FG V++ K K + EI +++ H N
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRN 62
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
++ L+ ++++ ++ + + + + R + L F
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNE-----REIVSYVHQVCEALQF 117
Query: 162 LHEEVRPHIIHRDIKASNILL--DKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAP 219
LH +I H DI+ NI+ + T KI +FG A+ + + Y AP
Sbjct: 118 LHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAP 172
Query: 220 EYAIRGQVTRKADIYSFGVLL 240
E V+ D++S G L+
Sbjct: 173 EVHQHDVVSTATDMWSLGTLV 193
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 59/230 (25%), Positives = 96/230 (41%), Gaps = 35/230 (15%)
Query: 37 KELSIATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQ 92
KE+ + DDF + IG G F V ++K G++ A+K+++ R V F E
Sbjct: 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERD 113
Query: 93 VISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRIC 152
V+ + + +L+ + N+ LV Y GG + + + RI
Sbjct: 114 VLVNGDRRWITQLHFAFQDENYLYLVMEYYV----------GGDLLTLLS---KFGERIP 160
Query: 153 IGIAR--------GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204
+AR + +H +HRDIK NILLD+ +++DFG + A+ T
Sbjct: 161 AEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217
Query: 205 HVSTRVAGTIGYLAPE-------YAIRGQVTRKADIYSFGVLLVEIVSGR 247
S GT YL+PE G + D ++ GV E+ G+
Sbjct: 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 49/248 (19%), Positives = 97/248 (39%), Gaps = 27/248 (10%)
Query: 9 RRRDSPRNRVPEVDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKD- 67
++ + + + E S +L + + P + IG G V + +
Sbjct: 59 KKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT 118
Query: 68 GKIAAIKVLS--------AESRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILV 118
G A+K++ + + + E ++ ++ H +++ L + LV
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKAS 178
++ + L L S + I + ++FLH +I+HRD+K
Sbjct: 179 FDLMRKGELFDYLTEKVA------LSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPE 229
Query: 179 NILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPE------YAIRGQVTRKAD 232
NILLD ++ ++SDFG + + + GT GYLAPE ++ D
Sbjct: 230 NILLDDNMQIRLSDFGFSCHLEPG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVD 287
Query: 233 IYSFGVLL 240
+++ GV+L
Sbjct: 288 LWACGVIL 295
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 49/207 (23%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 43 TDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKV-----LSAESRQGVKEFLTEIQVISE 96
T+++ ++G+G F V + G+ A + LSA Q ++ E ++
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRL 66
Query: 97 IEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIA 156
++H N+V+L+ E H L+++ + L + ++ + +S S I
Sbjct: 67 LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY------YSEADASHCIQQIL 120
Query: 157 RGLAFLHEEVRPHIIHRDIKASNILL---DKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213
+ H+ ++HR++K N+LL K K++DFGLA + AGT
Sbjct: 121 EAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAGT 176
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLL 240
GYL+PE + + D+++ GV+L
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 61/282 (21%), Positives = 98/282 (34%), Gaps = 73/282 (25%)
Query: 34 YSYKELSIATDDFSPINKIGEGGFGSVYKGRLKD------GKIAAIKVLSAESRQG-VKE 86
Y + D +G G FG V + + A+K+L + +
Sbjct: 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 71
Query: 87 FLTEIQVISEI-EHENLVKLYGCCVEGNHRILV----------YNYLENN--------SL 127
++E++++ I H N+V L G C + ++V YL + +
Sbjct: 72 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTK 131
Query: 128 AQTLIGGGHHYSNIQFSWRTRSRICIG--------------------------------- 154
G + I + R
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLT 191
Query: 155 ----------IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204
+A+G+ FL IHRD+ A NILL + KI DFGLA+ I +
Sbjct: 192 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248
Query: 205 HVSTRVAGT-IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
+V A + ++APE T ++D++SFGVLL EI S
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 55/220 (25%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 44 DDFSPINKIGEGGFGSVYKGR--LKDGKIAAIKVLSAES-RQGVKEFLT---EI---QVI 94
+ + +IGEG +G V+K R G+ A+K + ++ +G+ L+ E+ + +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP--LSTIREVAVLRHL 68
Query: 95 SEIEHENLVKLYGCCV----EGNHRI-LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRS 149
EH N+V+L+ C + ++ LV+ +++ + L L T
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYL----DKVPEPGVPTETIK 123
Query: 150 RICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL--IPANMTHVS 207
+ + RGL FLH ++HRD+K NIL+ K++DFGLA++ +T
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-- 178
Query: 208 TRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
V T+ Y APE ++ D++S G + E+ +
Sbjct: 179 -VVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-25
Identities = 47/206 (22%), Positives = 80/206 (38%), Gaps = 27/206 (13%)
Query: 52 IGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIE-HENLVKLYGCC 109
+GEG V + A+K++ + E++++ + + H N+++L
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 110 VEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPH 169
E + LV+ + S+ + H F+ S + +A L FLH
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRRH------FNELEASVVVQDVASALDFLHN---KG 131
Query: 170 IIHRDIKASNILL---DKDLTPKISDFGLAKLIPANMTHVSTR------VAGTIGYLAPE 220
I HRD+K NIL ++ KI DF L I N G+ Y+APE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 221 YAIRGQVTR------KADIYSFGVLL 240
+ + D++S GV+L
Sbjct: 192 -VVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 27/216 (12%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEH 99
++F + +G+G FG V + K G+ A+K+L E ++ V LTE +V+ H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQ----FSWRTRSRICIG- 154
L L + V Y GG + ++ FS R+R
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEY----------ANGGELFFHLSRERVFS-EDRARFYGAE 256
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVA--G 212
I L +LH E ++++RD+K N++LDKD KI+DFGL K + +T G
Sbjct: 257 IVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKE---GIKDGATMKTFCG 311
Query: 213 TIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRC 248
T YLAPE R D + GV++ E++ GR
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 60/231 (25%), Positives = 99/231 (42%), Gaps = 55/231 (23%)
Query: 43 TDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHEN 101
++ IG G FG VY+ +L D G++ AIK + Q + E+Q++ +++H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCN 108
Query: 102 LVKLYGCCVEGNHRI------LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIG- 154
+V+L + LV +Y+ +T+ Y + R + + +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETV------YRVARHYSRAKQTLPVIY 157
Query: 155 -------IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTP-KISDFGLAKLIPAN--MT 204
+ R LA++H I HRDIK N+LLD D K+ DFG AK +
Sbjct: 158 VKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 214
Query: 205 H-VSTRVAGTIGYLAPE-------YAIRGQVTRKADIYSFGVLLVEIVSGR 247
+ +R Y APE Y T D++S G +L E++ G+
Sbjct: 215 SYICSRY-----YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 58/246 (23%), Positives = 107/246 (43%), Gaps = 25/246 (10%)
Query: 10 RRDSPRNRVPEVDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKD-G 68
++ S + V E + K + + + D F I +G G FG V + K+ G
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66
Query: 69 KIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENN 125
A+K+L + + ++ L E +++ + LVKL + ++ +V Y
Sbjct: 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY---- 122
Query: 126 SLAQTLIGGGHHYSNIQFSWR---TRSRICIG-IARGLAFLHEEVRPHIIHRDIKASNIL 181
+ GG +S+++ R +R I +LH +I+RD+K N+L
Sbjct: 123 ------VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLL 173
Query: 182 LDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLV 241
+D+ +++DFG AK + T + GT LAPE + + D ++ GVL+
Sbjct: 174 IDQQGYIQVTDFGFAKRVK-GRTWT---LCGTPEALAPEIILSKGYNKAVDWWALGVLIY 229
Query: 242 EIVSGR 247
E+ +G
Sbjct: 230 EMAAGY 235
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 63/216 (29%), Positives = 96/216 (44%), Gaps = 28/216 (12%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEH 99
+DF + +G+G FG V R K G+ A+K+L E ++ V +TE +V+ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQ----FSWRTRSRICIG- 154
L L + V Y GG + ++ F+ R+R
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEY----------ANGGELFFHLSRERVFT-EERARFYGAE 113
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVA--G 212
I L +LH +++RDIK N++LDKD KI+DFGL K ++ +T G
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE---GISDGATMKTFCG 167
Query: 213 TIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRC 248
T YLAPE R D + GV++ E++ GR
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 51/208 (24%), Positives = 81/208 (38%), Gaps = 38/208 (18%)
Query: 51 KIGEGGFGSVYKGRLKD-GKIAAIKVL--SAESRQGVKEFLTEIQVISEIEH-ENLVKLY 106
++G G F V + K G+ A K L + E L EI V+ + ++ L+
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGG-----------HHYSNIQFSWRTRSRICIGI 155
+ IL+ LE GG S R+ I
Sbjct: 96 EVYENTSEIILI---LE-------YAAGGEIFSLCLPELAEMVSE-----NDVIRLIKQI 140
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILL---DKDLTPKISDFGLAKLIPANMTHVSTRVAG 212
G+ +LH+ +I+H D+K NILL KI DFG+++ I + + G
Sbjct: 141 LEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA-CELREIM-G 195
Query: 213 TIGYLAPEYAIRGQVTRKADIYSFGVLL 240
T YLAPE +T D+++ G++
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 61/246 (24%), Positives = 105/246 (42%), Gaps = 23/246 (9%)
Query: 11 RDSPRNRVPEVDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKD-GK 69
R +E+ + + + + DF+ + +G+G FG V K +
Sbjct: 308 RAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDE 367
Query: 70 IAAIKVLSAE---SRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILVYNYLENN 125
+ A+K+L + V+ + E +V++ + L +L+ C + V Y
Sbjct: 368 LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY---- 423
Query: 126 SLAQTLIGGGHHYSNIQFSWRT---RSRICIG-IARGLAFLHEEVRPHIIHRDIKASNIL 181
+ GG +IQ R + IA GL FL + II+RD+K N++
Sbjct: 424 ------VNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVM 474
Query: 182 LDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLV 241
LD + KI+DFG+ K + T GT Y+APE + D ++FGVLL
Sbjct: 475 LDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 533
Query: 242 EIVSGR 247
E+++G+
Sbjct: 534 EMLAGQ 539
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-23
Identities = 50/218 (22%), Positives = 77/218 (35%), Gaps = 42/218 (19%)
Query: 52 IGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIE----------HE 100
+G+GGFG+V+ G L D AIKV+ G + E+ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR--- 157
+++L +LV + I + + G +R
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLP---------AQDLFDYI----TEKGPLGEGPSRCFF 145
Query: 158 -----GLAFLHEEVRPHIIHRDIKASNILLDKD-LTPKISDFGLAKLIPANMTHVSTRVA 211
+ H ++HRDIK NIL+D K+ DFG L+
Sbjct: 146 GQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---D 199
Query: 212 GTIGYLAPEYAIRGQ--VTRKADIYSFGVLLVEIVSGR 247
GT Y PE+ I A ++S G+LL ++V G
Sbjct: 200 GTRVYSPPEW-ISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-23
Identities = 59/234 (25%), Positives = 93/234 (39%), Gaps = 55/234 (23%)
Query: 43 TDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHEN 101
D F G+G FG+V G+ K G AIK + + R +E L +Q ++ + H N
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80
Query: 102 LVKLYGCCVEGNHR-------ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIG 154
+V+L R +V Y+ TL + + +R +
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTL------HRCCRNYYRRQVAPPPI 129
Query: 155 --------IARGLAFLHEEVRPHIIHRDIKASNILLDK---DLTPKISDFGLAK-LIPAN 202
+ R + LH ++ HRDIK N+L+++ L K+ DFG AK L P+
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTL--KLCDFGSAKKLSPSE 186
Query: 203 -MTH-VSTRVAGTIGYLAPE-------YAIRGQVTRKADIYSFGVLLVEIVSGR 247
+ +R Y APE Y T DI+S G + E++ G
Sbjct: 187 PNVAYICSRY-----YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-23
Identities = 50/202 (24%), Positives = 85/202 (42%), Gaps = 30/202 (14%)
Query: 51 KIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVI-SEIEHENLVKLYGC 108
+G G G V + + G+ A+K+L ++ E+ ++V +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY--DSPKARQ---EVDHHWQASGGPHIVCILDV 90
Query: 109 CVEGNH-RILVYNYLENNSLAQTLIGGGHHYSNIQ------FSWRTRSRICIGIARGLAF 161
+H + + +E + GG +S IQ F+ R + I I + F
Sbjct: 91 YENMHHGKRCLLIIME-------CMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQF 143
Query: 162 LHEEVRPHIIHRDIKASNILL---DKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLA 218
LH +I HRD+K N+L +KD K++DFG AK N + T T Y+A
Sbjct: 144 LHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYYVA 197
Query: 219 PEYAIRGQVTRKADIYSFGVLL 240
PE + + D++S GV++
Sbjct: 198 PEVLGPEKYDKSCDMWSLGVIM 219
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-23
Identities = 58/243 (23%), Positives = 94/243 (38%), Gaps = 42/243 (17%)
Query: 26 SGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLS------- 77
+ +H KL KE + +G GGFGSVY G + D AIK +
Sbjct: 25 NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW 84
Query: 78 AESRQGVKEFLTEIQVISEIEHE--NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGG 135
E G + + E+ ++ ++ +++L + +L+ E
Sbjct: 85 GELPNGTRVPM-EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE---------PVQ 134
Query: 136 HHYSNIQFSWRTRSRICIGIAR--------GLAFLHEEVRPHIIHRDIKASNILLDKD-L 186
+ I R + +AR + H ++HRDIK NIL+D +
Sbjct: 135 DLFDFI----TERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRG 187
Query: 187 TPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQ--VTRKADIYSFGVLLVEIV 244
K+ DFG L+ + GT Y PE+ IR R A ++S G+LL ++V
Sbjct: 188 ELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEW-IRYHRYHGRSAAVWSLGILLYDMV 243
Query: 245 SGR 247
G
Sbjct: 244 CGD 246
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 3e-23
Identities = 63/213 (29%), Positives = 111/213 (52%), Gaps = 27/213 (12%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEH 99
DF + +G G FG V+ R + G+ A+KVL E + V+ E ++S + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWR---TRSRICIG-I 155
+++++G + ++ +Y+E GG +S ++ S R ++ +
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIE----------GGELFSLLRKSQRFPNPVAKFYAAEV 115
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIG 215
L +LH + II+RD+K NILLDK+ KI+DFG AK +P ++T+ T + GT
Sbjct: 116 CLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTY--T-LCGTPD 168
Query: 216 YLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGR 247
Y+APE + + + D +SFG+L+ E+++G
Sbjct: 169 YIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-23
Identities = 58/263 (22%), Positives = 99/263 (37%), Gaps = 75/263 (28%)
Query: 52 IGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLT--------------------- 89
IG+G +G V D A+KVLS + F
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 90 -----EIQVISEIEHENLVKLYGCCV----EGNHRILVYNYLENNSLAQTLIGGGHHYSN 140
EI ++ +++H N+VKL V +H +V+ + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV--EVLDDPNEDHLYMVFELVNQGPV------------- 125
Query: 141 IQFSWRTRSRICIGIAR--------GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISD 192
T + AR G+ +LH IIHRDIK SN+L+ +D KI+D
Sbjct: 126 --MEVPTLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIAD 180
Query: 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVT----RKADIYSFGVLLVEIVSGRC 248
FG++ + +S GT ++APE ++ + D+++ GV L V G
Sbjct: 181 FGVSNEFKGSDALLSN-TVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFG-- 236
Query: 249 NTNMRLPTEEQYLLERTWDLYER 271
+ P ++ ++ L+ +
Sbjct: 237 ----QCPFMDERIMC----LHSK 251
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 3e-23
Identities = 63/241 (26%), Positives = 106/241 (43%), Gaps = 32/241 (13%)
Query: 21 VDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVY---KGRLKD-GKIAAIKVL 76
++ I F + +G+G FG V+ K D ++ A+KVL
Sbjct: 1 MEGSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL 60
Query: 77 SAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIG 133
+ R V E ++ E+ H +VKL+ L+ ++ +
Sbjct: 61 KKATLKVRDRV-RTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDF----------LR 109
Query: 134 GGHHYSNIQ----FSWRTRSRICIG-IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTP 188
GG ++ + F+ + + +A L LH II+RD+K NILLD++
Sbjct: 110 GGDLFTRLSKEVMFT-EEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHI 165
Query: 189 KISDFGLAKLIPANMTHVST--RVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSG 246
K++DFGL+K ++ H GT+ Y+APE R T+ AD +SFGVL+ E+++G
Sbjct: 166 KLTDFGLSKE---SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222
Query: 247 R 247
Sbjct: 223 T 223
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 4e-23
Identities = 71/251 (28%), Positives = 105/251 (41%), Gaps = 31/251 (12%)
Query: 9 RRRDSPRNRVPEVDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKD- 67
+ N P S N+ S DF + IG+G FG V R K
Sbjct: 5 PQEPELMNANPAPPPAPSQQINLGPSSNPHAKP--SDFHFLKVIGKGSFGKVLLARHKAE 62
Query: 68 GKIAAIKVLSAE---SRQGVKEFLTEIQVISE-IEHENLVKLYGCCVEGNHRILVYNYLE 123
A+KVL + ++ K ++E V+ + ++H LV L+ + V +Y
Sbjct: 63 EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDY-- 120
Query: 124 NNSLAQTLIGGGHHYSNIQ----FSWRTRSRICIG-IARGLAFLHEEVRPHIIHRDIKAS 178
I GG + ++Q F R+R IA L +LH +I++RD+K
Sbjct: 121 --------INGGELFYHLQRERCFL-EPRARFYAAEIASALGYLHSL---NIVYRDLKPE 168
Query: 179 NILLDKDLTPKISDFGLAKLIPANMTHVSTRVA--GTIGYLAPEYAIRGQVTRKADIYSF 236
NILLD ++DFGL K N+ H ST GT YLAPE + R D +
Sbjct: 169 NILLDSQGHIVLTDFGLCKE---NIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCL 225
Query: 237 GVLLVEIVSGR 247
G +L E++ G
Sbjct: 226 GAVLYEMLYGL 236
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 6e-23
Identities = 65/218 (29%), Positives = 99/218 (45%), Gaps = 31/218 (14%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQVISEI-E 98
DF + IG G + V RLK +I A+KV+ E + + TE V +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 99 HENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQ----FSWRTRSRICIG 154
H LV L+ C + V Y + GG ++Q +R
Sbjct: 69 HPFLVGLHSCFQTESRLFFVIEY----------VNGGDLMFHMQRQRKLP-EEHARFYSA 117
Query: 155 -IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK--LIPANMTHVSTRVA 211
I+ L +LHE II+RD+K N+LLD + K++D+G+ K L P + T T
Sbjct: 118 EISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS--T-FC 171
Query: 212 GTIGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGRC 248
GT Y+APE +RG+ D ++ GVL+ E+++GR
Sbjct: 172 GTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRS 208
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 8e-23
Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 31/217 (14%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQVISEI-E 98
D+F I +G+G FG V R+K+ G + A+KVL + V+ +TE +++S
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 99 HENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQ----FSWRTRSRICIG 154
H L +L+ C + V + + GG +IQ F R+R
Sbjct: 83 HPFLTQLFCCFQTPDRLFFVMEF----------VNGGDLMFHIQKSRRFD-EARARFYAA 131
Query: 155 -IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVA-- 211
I L FLH++ II+RD+K N+LLD + K++DFG+ K + + T
Sbjct: 132 EIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE---GICNGVTTATFC 185
Query: 212 GTIGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGR 247
GT Y+APE ++ + D ++ GVLL E++ G
Sbjct: 186 GTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 8e-23
Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 44 DDFSPINKIGEGGFGSVY---KGRLKD-GKIAAIKVLS----AESRQGVKEFLTEIQVIS 95
+ F + +G+GG+G V+ K + GKI A+KVL + + E ++
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 96 EIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQ----FSWRTRSRI 151
E++H +V L G L+ Y + GG + ++ F +
Sbjct: 77 EVKHPFIVDLIYAFQTGGKLYLILEY----------LSGGELFMQLEREGIFM-EDTACF 125
Query: 152 CIG-IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTR- 209
+ I+ L LH++ II+RD+K NI+L+ K++DFGL K ++ +
Sbjct: 126 YLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE---SIHDGTVTH 179
Query: 210 -VAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
GTI Y+APE +R R D +S G L+ ++++G
Sbjct: 180 TFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 31/218 (14%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQVISEI-E 98
DF + IG G + V RLK +I A++V+ E + + TE V +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 99 HENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQ----FSWRTRSRICIG 154
H LV L+ C + V Y + GG ++Q +R
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEY----------VNGGDLMFHMQRQRKLP-EEHARFYSA 160
Query: 155 -IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK--LIPANMTHVSTRVA 211
I+ L +LHE II+RD+K N+LLD + K++D+G+ K L P + T
Sbjct: 161 EISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST---FC 214
Query: 212 GTIGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGRC 248
GT Y+APE +RG+ D ++ GVL+ E+++GR
Sbjct: 215 GTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRS 251
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 29/216 (13%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQVISEI-E 98
DF+ + +G+G FG V K ++ A+K+L + V+ + E +V++ +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 99 HENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQ----FSWRTRSRICIG 154
L +L+ C + V Y + GG +IQ F +
Sbjct: 80 PPFLTQLHSCFQTMDRLYFVMEY----------VNGGDLMYHIQQVGRFK-EPHAVFYAA 128
Query: 155 -IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK--LIPANMTHVSTRVA 211
IA GL FL + II+RD+K N++LD + KI+DFG+ K + T T
Sbjct: 129 EIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK--T-FC 182
Query: 212 GTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
GT Y+APE + D ++FGVLL E+++G+
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-22
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 33/210 (15%)
Query: 52 IGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLT-EIQVISEIEHENLVKLYGCC 109
+GEG +G V + A+K++ + E + EI + + HEN+VK YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 110 VEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR--------GLAF 161
EGN + L Y L + + A+ G+ +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDI--------------GMPEPDAQRFFHQLMAGVVY 120
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT--HVSTRVAGTIGYLAP 219
LH I HRDIK N+LLD+ KISDFGLA + N ++ GT+ Y+AP
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAP 176
Query: 220 EYAIRGQ--VTRKADIYSFGVLLVEIVSGR 247
E ++ + D++S G++L +++G
Sbjct: 177 E-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 4e-22
Identities = 52/203 (25%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 52 IGEGGFGSVYKGR-LKDGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGC 108
IG+G F V R + G+ AIK++ + +++ E++++ + H N+VKL+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 109 CVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRP 168
L+ Y + L+ G + I + + H +
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGR------MKEKEARSKFRQIVSAVQYCH---QK 133
Query: 169 HIIHRDIKASNILLDKDLTPKISDFGLAKLI-PANMTHVSTRVAGTIGYLAPEYAIRGQ- 226
I+HRD+KA N+LLD D+ KI+DFG + G Y APE +G+
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF---CGAPPYAAPE-LFQGKK 189
Query: 227 -VTRKADIYSFGVLLVEIVSGRC 248
+ D++S GV+L +VSG
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSL 212
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 8e-22
Identities = 49/218 (22%), Positives = 85/218 (38%), Gaps = 44/218 (20%)
Query: 52 IGEGGFGSVYKGR-LKDGKIAAIKVL--------SAESRQGVKEFLTEIQVISEIEHENL 102
+G G FG V+ + K +K + + + EI ++S +EH N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 103 VKLYGCCVEGNHRILV----------YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRIC 152
+K+ LV + +++ + + S I
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP---------------RLDEPLASYIF 136
Query: 153 IGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI-PANMTHVSTRVA 211
+ + +L + IIHRDIK NI++ +D T K+ DFG A + + +
Sbjct: 137 RQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF---C 190
Query: 212 GTIGYLAPEYAIRGQVTR--KADIYSFGVLLVEIVSGR 247
GTI Y APE + G R + +++S GV L +V
Sbjct: 191 GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 8e-22
Identities = 22/201 (10%), Positives = 48/201 (23%), Gaps = 43/201 (21%)
Query: 51 KIGEGGFGSVYKGR-LKDGKIAAIKVL---SAESRQGVKEFLTEIQVISEIEHENLVKLY 106
G ++ + A+ + ++E L+ +S I+ + ++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV 166
++V ++ SL + S R +A H
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADTSP--------SPVGAIRAMQSLAAAADAAHRA- 148
Query: 167 RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQ 226
+ S + + D G L +
Sbjct: 149 --GVALSIDHPSRVRVSID--------GDVVL-------------AYPATMPD------- 178
Query: 227 VTRKADIYSFGVLLVEIVSGR 247
+ DI G L ++ R
Sbjct: 179 ANPQDDIRGIGASLYALLVNR 199
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 9e-22
Identities = 57/242 (23%), Positives = 90/242 (37%), Gaps = 52/242 (21%)
Query: 52 IGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLT----EIQVISEIEHENLVKLY 106
+GEG +G V + + A+K+L + + + EIQ++ + H+N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 107 G--CCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR------- 157
E +V Y G R + A
Sbjct: 73 DVLYNEEKQKMYMVMEYCV---------CGMQEM----LDSVPEKRFPVCQAHGYFCQLI 119
Query: 158 -GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI----PANMTHVSTRVAG 212
GL +LH I+H+DIK N+LL T KIS G+A+ + + S G
Sbjct: 120 DGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS---QG 173
Query: 213 TIGYLAPEYAIRGQVT---RKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLY 269
+ + PE G T K DI+S GV L I +G P E + + L+
Sbjct: 174 SPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTG------LYPFEGDNIYK----LF 222
Query: 270 ER 271
E
Sbjct: 223 EN 224
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 1e-21
Identities = 66/216 (30%), Positives = 98/216 (45%), Gaps = 27/216 (12%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQVISE-IE 98
+DF +G+G FG V+ K + AIK L + V+ + E +V+S E
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 99 HENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWR---TRSRICIG- 154
H L ++ + V Y + GG +IQ + +R+
Sbjct: 77 HPFLTHMFCTFQTKENLFFVMEY----------LNGGDLMYHIQSCHKFDLSRATFYAAE 126
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVA--G 212
I GL FLH + I++RD+K NILLDKD KI+DFG+ K NM + G
Sbjct: 127 IILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE---NMLGDAKTNTFCG 180
Query: 213 TIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRC 248
T Y+APE + + D +SFGVLL E++ G+
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 33/210 (15%)
Query: 52 IGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLT-EIQVISEIEHENLVKLYGCC 109
+GEG +G V + A+K++ + E + EI + + HEN+VK YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 110 VEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR--------GLAF 161
EGN + L Y L + + A+ G+ +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDI--------------GMPEPDAQRFFHQLMAGVVY 120
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT--HVSTRVAGTIGYLAP 219
LH I HRDIK N+LLD+ KISDFGLA + N ++ GT+ Y+AP
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAP 176
Query: 220 EYAIRGQ--VTRKADIYSFGVLLVEIVSGR 247
E ++ + D++S G++L +++G
Sbjct: 177 E-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 65/224 (29%), Positives = 104/224 (46%), Gaps = 38/224 (16%)
Query: 44 DDFSPINKIGEGGFGSVY---KGRLKD-GKIAAIKVLS----AESRQGVKEFLTEIQVIS 95
++F + +G G +G V+ K D GK+ A+KVL + + + TE QV+
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 96 EIEHEN-LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQ----FSWRTRSR 150
I LV L+ L+ +Y I GG ++++ F+ +
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDY----------INGGELFTHLSQRERFT-EHEVQ 162
Query: 151 ICIG-IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTR 209
I +G I L LH+ II+RDIK NILLD + ++DFGL+K + + R
Sbjct: 163 IYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE---FVADETER 216
Query: 210 VA---GTIGYLAPEYAIRGQV---TRKADIYSFGVLLVEIVSGR 247
GTI Y+AP+ +RG + D +S GVL+ E+++G
Sbjct: 217 AYDFCGTIEYMAPD-IVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 44/199 (22%), Positives = 81/199 (40%), Gaps = 23/199 (11%)
Query: 51 KIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENLVKLYG- 107
+G G G V + K + A+K+L + E+++ + ++V++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDV 123
Query: 108 ---CCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHE 164
++V L+ L + G F+ R S I I + +LH
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLHS 179
Query: 165 EVRPHIIHRDIKASNILL---DKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEY 221
+I HRD+K N+L + K++DFG AK ++ + T T Y+APE
Sbjct: 180 I---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPCYTPYYVAPEV 234
Query: 222 AIRGQVTRKADIYSFGVLL 240
+ + D++S GV++
Sbjct: 235 LGPEKYDKSCDMWSLGVIM 253
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 8e-21
Identities = 48/239 (20%), Positives = 99/239 (41%), Gaps = 58/239 (24%)
Query: 34 YSYKELSIA---TDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLT 89
+ Y+ + DD+ + K+G G + V++ + + + +K+L + K+
Sbjct: 23 WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKR 79
Query: 90 EIQVISEI-EHENLVKLYGCCVEGNHR--ILVYNYLEN---NSLAQTLIGGGHHYSNIQF 143
EI+++ + N++ L + R LV+ ++ N L QTL + I+F
Sbjct: 80 EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTL--TDYD---IRF 134
Query: 144 SWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLD---KDLTPKISDFGLAKLIP 200
I + L + H I+HRD+K N+++D + L ++ D+GLA+
Sbjct: 135 -------YMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKL--RLIDWGLAEFYH 182
Query: 201 AN--MTH-VSTRVAGTIGYLAPE---------YAIRGQVTRKADIYSFGVLLVEIVSGR 247
V++R + PE Y++ D++S G +L ++ +
Sbjct: 183 PGQEYNVRVASRY-----FKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFRK 228
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 9e-20
Identities = 54/219 (24%), Positives = 94/219 (42%), Gaps = 34/219 (15%)
Query: 43 TDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSA--ESRQGVKEFLTEIQVISEIEH 99
+ +G G +GSV + G+ AIK LS +S K E+ ++ ++H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 100 ENLVKLY-----GCCVEGNHRI-LVYNYLE---NNSLAQTLIGGGHHYSNIQFSWRTRSR 150
EN++ L + + LV +++ + Y Q
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQ-------- 134
Query: 151 ICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTH-VSTR 209
+ +GL ++H ++HRD+K N+ +++D KI DFGLA+ A MT V TR
Sbjct: 135 ----MLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR 187
Query: 210 VAGTIGYLAPEYAI-RGQVTRKADIYSFGVLLVEIVSGR 247
Y APE + + DI+S G ++ E+++G+
Sbjct: 188 W-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 29/217 (13%)
Query: 43 TDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSA--ESRQGVKEFLTEIQVISEIEH 99
+ + IG G G V + AIK LS +++ K E+ ++ + H
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 100 ENLVKLY------GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICI 153
+N++ L E LV ++ N L Q +I + + + +
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQ-VIQMELDHERMSY-------LLY 171
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN--MT-HVSTRV 210
+ G+ LH IIHRD+K SNI++ D T KI DFGLA+ + MT +V TR
Sbjct: 172 QMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 228
Query: 211 AGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
Y APE + DI+S G ++ E+V +
Sbjct: 229 -----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-19
Identities = 59/235 (25%), Positives = 99/235 (42%), Gaps = 46/235 (19%)
Query: 52 IGEGGFGSVYKGR-LKDGKIAAIKVLSAES--RQGVKEFLT-EIQVISEIEHENLVKLYG 107
+G G FG V G G A+K+L+ + V + EIQ + H +++KLY
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 108 CCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR--------GL 159
+V Y+ L + G R+ AR +
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHG--------------RVEEMEARRLFQQILSAV 124
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI-PANMTHVSTRVAGTIGYLA 218
+ H R ++HRD+K N+LLD + KI+DFGL+ ++ S G+ Y A
Sbjct: 125 DYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAA 178
Query: 219 PEYAIRGQ--VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYER 271
PE I G+ + DI+S GV+L ++ G LP +++++ L+++
Sbjct: 179 PE-VISGRLYAGPEVDIWSCGVILYALLCG------TLPFDDEHVPT----LFKK 222
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 57/227 (25%), Positives = 90/227 (39%), Gaps = 38/227 (16%)
Query: 43 TDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGV-----------KEFLTEI 91
++ I G +G+V G +G AIK + G K L EI
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 92 QVISEIEHENLVKLYGCCVEGNHRI-----LVYNYLENNSLAQTLIGGGHHYSN--IQFS 144
++++ H N++ L V LV + + LAQ + S IQ+
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVIHDQRIVISPQHIQY- 138
Query: 145 WRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN-- 202
I GL LHE ++HRD+ NILL + I DF LA+ A+
Sbjct: 139 ------FMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189
Query: 203 MT-HVSTRVAGTIGYLAPEYAI-RGQVTRKADIYSFGVLLVEIVSGR 247
T +V+ R Y APE + T+ D++S G ++ E+ + +
Sbjct: 190 KTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 5e-19
Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 29/217 (13%)
Query: 43 TDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSA--ESRQGVKEFLTEIQVISEIEH 99
+ + IG G G V + AIK LS +++ K E+ ++ + H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 100 ENLVKLY------GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICI 153
+N++ L E +V ++ N L Q +I + + + +
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQ-VIQMELDHERMSY-------LLY 134
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN--MT-HVSTRV 210
+ G+ LH IIHRD+K SNI++ D T KI DFGLA+ + MT +V TR
Sbjct: 135 QMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 191
Query: 211 AGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
Y APE + DI+S G ++ E++ G
Sbjct: 192 -----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 43 TDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSA--ESRQGVKEFLTEIQVISEIEH 99
+ + ++ +G G +GSV K G A+K LS +S K E++++ ++H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 100 ENLVKLY-----GCCVEGNHRI-LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICI 153
EN++ L +E + + LV + + + L + ++QF +
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIVKCQKLTDDHVQF-------LIY 139
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT-HVSTRVAG 212
I RGL ++H IIHRD+K SN+ +++D KI DFGLA+ MT +V+TR
Sbjct: 140 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-- 194
Query: 213 TIGYLAPEYAI-RGQVTRKADIYSFGVLLVEIVSGR 247
Y APE + + DI+S G ++ E+++GR
Sbjct: 195 ---YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 6e-19
Identities = 52/253 (20%), Positives = 91/253 (35%), Gaps = 67/253 (26%)
Query: 43 TDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIK-VLSAESRQGVKEFLTEIQVISEIEHE 100
+ +S +G G FG V + + GK A+K VL + E+ ++ ++H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-----NRELDIMKVLDHV 60
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSN-------------------- 140
N++KL ++ G + +
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 141 -------IQFSWRTRSRICIG--------IARGLAFLHEEVRPHIIHRDIKASNILLD-K 184
++ R+ I + + R + F+H I HRDIK N+L++ K
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSK 177
Query: 185 DLTPKISDFGLAKLIPAN--MTH-VSTRVAGTIGYLAPE-------YAIRGQVTRKADIY 234
D T K+ DFG AK + + + +R Y APE Y T D++
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEY------TPSIDLW 226
Query: 235 SFGVLLVEIVSGR 247
S G + E++ G+
Sbjct: 227 SIGCVFGELILGK 239
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 55/211 (26%), Positives = 83/211 (39%), Gaps = 38/211 (18%)
Query: 52 IGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLT-EIQVISEIEHENLVKLYGCC 109
IG G FG R ++ A+K + E + E + EI + H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 110 VEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR--------GLAF 161
+ H ++ Y L + + G R AR G+++
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAG--------------RFSEDEARFFFQQLLSGVSY 131
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTP--KISDFGLAKLI-PANMTHVSTRVAGTIGYLA 218
H I HRD+K N LLD P KI DFG +K + + V GT Y+A
Sbjct: 132 CH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIA 185
Query: 219 PEYAIRGQ--VTRKADIYSFGVLLVEIVSGR 247
PE + Q + AD++S GV L ++ G
Sbjct: 186 PE-VLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 59/235 (25%), Positives = 104/235 (44%), Gaps = 47/235 (20%)
Query: 52 IGEGGFGSVYKGR-LKDGKIAAIKVLSAE--SRQGVKEFLT-EIQVISEIEHENLVKLYG 107
+GEG FG V K + A+K +S + + + + EI + + H +++KLY
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 108 CCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR--------GL 159
++V Y GG + I + R+ R +
Sbjct: 77 VITTPTDIVMVIEYA-----------GGELFDYIV----EKKRMTEDEGRRFFQQIICAI 121
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI-PANMTHVSTRVAGTIGYLA 218
+ H R I+HRD+K N+LLD +L KI+DFGL+ ++ N S G+ Y A
Sbjct: 122 EYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CGSPNYAA 175
Query: 219 PEYAIRGQ--VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYER 271
PE I G+ + D++S G++L ++ G RLP +++++ L+++
Sbjct: 176 PE-VINGKLYAGPEVDVWSCGIVLYVMLVG------RLPFDDEFIPN----LFKK 219
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 27/216 (12%)
Query: 43 TDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSA--ESRQGVKEFLTEIQVISEIEH 99
+ + +G G +G+V + G AIK L +S K E++++ + H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 100 ENLVKLY------GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICI 153
EN++ L + LV ++ + L + + IQF +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD-LGKLMKHEKLGEDRIQF-------LVY 135
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT-HVSTRVAG 212
+ +GL ++H IIHRD+K N+ +++D KI DFGLA+ + MT +V TR
Sbjct: 136 QMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-- 190
Query: 213 TIGYLAPEYAI-RGQVTRKADIYSFGVLLVEIVSGR 247
Y APE + + T+ DI+S G ++ E+++G+
Sbjct: 191 ---YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 52/227 (22%), Positives = 91/227 (40%), Gaps = 27/227 (11%)
Query: 35 SYKELSIATDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQV 93
S L + +F KIG G FG + G+ L + AIK+ +SR E +
Sbjct: 1 SMGVLMVG-PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRF 57
Query: 94 ISEIEH-ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRIC 152
++ + + ++Y G + +V L SL + FS +T I
Sbjct: 58 YKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLF-----DLCDRTFSLKTVLMIA 111
Query: 153 IGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPK-----ISDFGLAKLI--PANMTH 205
I + + ++H + ++I+RD+K N L+ + I DF LAK P H
Sbjct: 112 IQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKH 168
Query: 206 VSTR----VAGTIGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGR 247
+ R + GT Y G+ +R+ D+ + G + + + G
Sbjct: 169 IPYREHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 5e-18
Identities = 59/238 (24%), Positives = 101/238 (42%), Gaps = 52/238 (21%)
Query: 52 IGEGGFGSVYKGR-LKDGKIAAIKVL------SAESRQGVKEFLTEIQVISEIEHENLVK 104
+G G FG V G+ G A+K+L S + ++ EIQ + H +++K
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR---REIQNLKLFRHPHIIK 80
Query: 105 LYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR------- 157
LY + +V Y+ L + G R+ +R
Sbjct: 81 LYQVISTPSDIFMVMEYVSGGELFDYICKNG--------------RLDEKESRRLFQQIL 126
Query: 158 -GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI-PANMTHVSTRVAGTIG 215
G+ + H R ++HRD+K N+LLD + KI+DFGL+ ++ S G+
Sbjct: 127 SGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPN 180
Query: 216 YLAPEYAIRGQ--VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYER 271
Y APE I G+ + DI+S GV+L ++ G LP ++ ++ L+++
Sbjct: 181 YAAPE-VISGRLYAGPEVDIWSSGVILYALLCG------TLPFDDDHVPT----LFKK 227
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 43/226 (19%)
Query: 43 TDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSA-ESRQGVKEFLTEIQVISEIEHE 100
++ ++ IGEG +G V + AIK +S E + + L EI+++ HE
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 101 NLVKLYGC----CVEGNHRI-LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGI 155
N++ + +E + +V + +E + L + L +I + I
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHLSNDHICY-------FLYQI 137
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN------MT-HVST 208
RGL ++H +++HRD+K SN+LL+ KI DFGLA++ + +T +V+T
Sbjct: 138 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 209 RVAGTIGYLAPE-------YAIRGQVTRKADIYSFGVLLVEIVSGR 247
R Y APE Y T+ DI+S G +L E++S R
Sbjct: 195 R-----WYRAPEIMLNSKGY------TKSIDIWSVGCILAEMLSNR 229
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 82.6 bits (203), Expect = 8e-18
Identities = 48/272 (17%), Positives = 80/272 (29%), Gaps = 51/272 (18%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVL--------SAESRQGVKEFLTEIQ 92
+ T+ KIGEG FG V++ AIK++ + ++ +E L EI
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 93 VISEIE---------HENLVKLYGC-CVEGN-HRILVYNYLENNS--------------- 126
+ E+ E + L CV+G+ +L+ + NS
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 127 ---LAQTLIGGG---HHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNI 180
+ GG S T I + LA HRD+ N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNV 193
Query: 181 LLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLL 240
LL K K+ K I Y G V ++ +
Sbjct: 194 LLKKTSLKKLHYTLNGKSS---TIPSCGLQVSIIDYTLSRLERDGIV-----VFCDVSMD 245
Query: 241 VEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272
++ +G + + + W Y
Sbjct: 246 EDLFTGDGDYQFDIYRLMKKENNNRWGEYHPY 277
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 8e-18
Identities = 56/229 (24%), Positives = 105/229 (45%), Gaps = 40/229 (17%)
Query: 43 TDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHEN 101
+ + +G GG G V+ K AIK + Q VK L EI++I ++H+N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 102 LVKLY--------------GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRT 147
+VK++ G E N +V Y+E + LA L G + +
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD-LANVLEQGPLLEEHARL---- 124
Query: 148 RSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLD-KDLTPKISDFGLAKLIPAN---- 202
+ RGL ++H +++HRD+K +N+ ++ +DL KI DFGLA+++ +
Sbjct: 125 ---FMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 203 --MT-HVSTRVAGTIGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGR 247
++ + T+ Y +P + T+ D+++ G + E+++G+
Sbjct: 179 GHLSEGLVTK-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 48/224 (21%), Positives = 92/224 (41%), Gaps = 40/224 (17%)
Query: 49 INKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEI---------- 97
+ K+G G F +V+ + + + A+K++ + + EI+++ +
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 98 -EHENLVKLYGC----CVEGNHRILVYNYLENN--SLAQTLIGGGHHYSNIQFSWRTRSR 150
+++KL G H ++V+ L N +L + G ++ +
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK-------Q 135
Query: 151 ICIGIARGLAFLHEEVRPHIIHRDIKASNILLD------KDLTPKISDFGLAKLIPANMT 204
I + GL ++H IIH DIK N+L++ + KI+D G A + T
Sbjct: 136 ISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193
Query: 205 -HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
+ TR Y +PE + ADI+S L+ E+++G
Sbjct: 194 NSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-17
Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 51 KIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEH-ENLVKLYGC 108
KIG G FG +Y G + G+ AIK+ +++ E ++ ++ + + C
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTIRWC 73
Query: 109 CVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRP 168
EG++ ++V L SL ++ + +FS +T + + + ++H +
Sbjct: 74 GAEGDYNVMVMELL-GPSLEDLF-----NFCSRKFSLKTVLLLADQMISRIEYIHSK--- 124
Query: 169 HIIHRDIKASNILLDKDLTPK---ISDFGLAKLI--PANMTHVSTR----VAGTIGYLAP 219
+ IHRD+K N L+ I DFGLAK H+ R + GT Y A
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-AS 183
Query: 220 EYAIRGQV-TRKADIYSFGVLLVEIVSGR 247
G +R+ D+ S G +L+ G
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-17
Identities = 49/211 (23%), Positives = 87/211 (41%), Gaps = 26/211 (12%)
Query: 51 KIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEH-ENLVKLYGC 108
+IGEG FG +++G L + + AIK S E + + + +Y
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTGIPNVYYF 74
Query: 109 CVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRP 168
EG H +LV + L SL L +FS +T + + + +HE+
Sbjct: 75 GQEGLHNVLVIDLL-GPSLEDLL-----DLCGRKFSVKTVAMAAKQMLARVQSIHEK--- 125
Query: 169 HIIHRDIKASNILLDKDLTPK-----ISDFGLAKLI--PANMTHVSTR----VAGTIGYL 217
+++RDIK N L+ + + + DFG+ K P H+ R ++GT Y
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY- 184
Query: 218 APEYAIRG-QVTRKADIYSFGVLLVEIVSGR 247
G + +R+ D+ + G + + + G
Sbjct: 185 MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 58/237 (24%)
Query: 43 TDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSA-ESRQGVKEFLTEIQVISEIEHE 100
+ DF + +GEG +G V G+I AIK + + L EI+++ +HE
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 101 NLVKLYGC----CVEGNHRI-LVYNYLENNSLAQTLIGGGH----HYSNIQFSWRTRSRI 151
N++ ++ E + + ++ ++ + L + +I H IQ+
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQTD-LHR-VISTQMLSDDH---IQY-------F 117
Query: 152 CIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN--------- 202
R + LH ++IHRD+K SN+L++ + K+ DFGLA++I +
Sbjct: 118 IYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 203 ----MT-HVSTRVAGTIGYLAPE-------YAIRGQVTRKADIYSFGVLLVEIVSGR 247
M V+TR Y APE Y +R D++S G +L E+ R
Sbjct: 175 QQSGMVEFVATR-----WYRAPEVMLTSAKY------SRAMDVWSCGCILAELFLRR 220
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 51/209 (24%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 51 KIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIE-HENLVKLYGC 108
KIG G FG +Y G ++ + AIK+ + +++ + E ++ ++ + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVRWF 71
Query: 109 CVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRP 168
VEG++ +LV + L SL ++ + + S +T + + + F+H +
Sbjct: 72 GVEGDYNVLVMDLL-GPSLEDLF-----NFCSRKLSLKTVLMLADQMINRVEFVHSK--- 122
Query: 169 HIIHRDIKASNILLDKDLTPK---ISDFGLAKLI--PANMTHVSTR----VAGTIGYLAP 219
+HRDIK N L+ I DFGLAK + H+ R + GT Y A
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-AS 181
Query: 220 EYAIRG-QVTRKADIYSFGVLLVEIVSGR 247
G + +R+ D+ S G +L+ + G
Sbjct: 182 VNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 44/223 (19%), Positives = 79/223 (35%), Gaps = 44/223 (19%)
Query: 27 GIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVK 85
G H K+ +I D +G G G V + K + A+K+L
Sbjct: 1 GPHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CP 55
Query: 86 EFLTEIQVISEI-EHENLVKLYGCC----VEGNHRILVYNYLENNSLAQTLIGGGHHYSN 140
+ E+++ + ++V++ ++V L+ L + G
Sbjct: 56 KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-- 113
Query: 141 IQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL---DKDLTPKISDFGLAK 197
F+ R S I I + +LH +I HRD+K N+L + K++DFG AK
Sbjct: 114 --FTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
Query: 198 LIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLL 240
+Y + D++S GV++
Sbjct: 169 ET-----------------TGEKY------DKSCDMWSLGVIM 188
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 37/164 (22%), Positives = 76/164 (46%), Gaps = 22/164 (13%)
Query: 43 TDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIK-VLSAESRQGV-KEFLTEIQVISEIEH 99
D + + IG G +G V + + ++ AIK +L K L EI +++ + H
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNH 111
Query: 100 ENLVKLYGCCV----EGNHRI-LVYNYLENNSLAQTLIGGGHHYSN--IQFSWRTRSRIC 152
+++VK+ + E + +V +++ + L + + I+ +
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADSD-FKK-LFRTPVYLTELHIKT-------LL 162
Query: 153 IGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196
+ G+ ++H I+HRD+K +N L+++D + K+ DFGLA
Sbjct: 163 YNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 52/212 (24%), Positives = 88/212 (41%), Gaps = 30/212 (14%)
Query: 49 INKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESR---QGVKEFLTEIQVISEI------E 98
+ IG+G FG V K K + A+K++ E R Q EI+++ +
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDN 157
Query: 99 HENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARG 158
N++ + NH + + L N L + + FS + I +
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMN-LYELIKKNKFQG----FSLPLVRKFAHSILQC 212
Query: 159 LAFLHEEVRPHIIHRDIKASNILLDKDLTP--KISDFGLAKLIPANM-THVSTRVAGTIG 215
L LH+ IIH D+K NILL + K+ DFG + + T++ +R
Sbjct: 213 LDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF----- 264
Query: 216 YLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
Y APE + + D++S G +L E+++G
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 61/256 (23%), Positives = 99/256 (38%), Gaps = 64/256 (25%)
Query: 43 TDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSA--ESRQGVKEFLTEIQVISEIEH 99
D++ + IG G +G VY K AIK ++ E K L EI +++ ++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 100 ENLVKLYGCCVEGNHRIL--VYNYLENNSLAQT----LIGGGHHYSNIQFSWRTRSRICI 153
+ +++LY + + +Y LE +A + L + I
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLE---IADSDLKKLFKTPIFLTEEHIKT-----ILY 136
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA----------------- 196
+ G F+HE IIHRD+K +N LL++D + K+ DFGLA
Sbjct: 137 NLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193
Query: 197 --------KLIPANMT-HVSTRVAGTIGYLAPE-------YAIRGQVTRKADIYSFGVLL 240
K + +T HV TR Y APE Y T+ DI+S G +
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTR-----WYRAPELILLQENY------TKSIDIWSTGCIF 242
Query: 241 VEIVSGRCNTNMRLPT 256
E+++ +
Sbjct: 243 AELLNMLQSHINDPTN 258
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 71.9 bits (176), Expect = 6e-14
Identities = 54/263 (20%), Positives = 89/263 (33%), Gaps = 78/263 (29%)
Query: 49 INKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIE--------H 99
I K+G G F +V+ ++ K A+KV+ + + L EI+++ +
Sbjct: 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPNR 100
Query: 100 ENLVKLYGC----CVEGNHRILVYNYLENN--SLAQTLIGGGHHYSNIQFSWRTRSRICI 153
E +V+L V G H +V+ L ++ G ++ +I
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVK-------KIIQ 153
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILL------------------------------- 182
+ +GL +LH + IIH DIK NILL
Sbjct: 154 QVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 183 ------------------DKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIR 224
+ L KI+D G A + + T T Y + E I
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIG 267
Query: 225 GQVTRKADIYSFGVLLVEIVSGR 247
ADI+S + E+ +G
Sbjct: 268 SGYNTPADIWSTACMAFELATGD 290
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 8e-14
Identities = 37/181 (20%), Positives = 67/181 (37%), Gaps = 32/181 (17%)
Query: 49 INKIGEGGFGSVYKGRLKDGKI------AAIKVLSAESRQGVKE--FLTEIQVISEIEHE 100
IG+GGFG +Y + + +KV +++ E F +I+
Sbjct: 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKW 99
Query: 101 NLV---------KLYGC----CVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRT 147
K +G ++R ++ + + L + FS +T
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKR-----FSRKT 153
Query: 148 RSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKI--SDFGLAKLIPANMTH 205
++ + I L ++HE +H DIKASN+LL+ ++ D+GLA H
Sbjct: 154 VLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
Query: 206 V 206
Sbjct: 211 K 211
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 9e-14
Identities = 36/228 (15%), Positives = 78/228 (34%), Gaps = 38/228 (16%)
Query: 49 INKIGEGGFGSVYKGR---------LKDGKIAAIKVLSAES----------RQGVKEFLT 89
+ G +Y+ + ++K+ + + R +
Sbjct: 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106
Query: 90 EIQVISEIEHENLVKLYGC-CVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTR 148
+ + + + G + +R LV L SL L H S R+
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKH----VLSERSV 161
Query: 149 SRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKI--SDFGLAKLIPANMTHV 206
++ + L FLHE +H ++ A NI +D + ++ + +G A + HV
Sbjct: 162 LQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218
Query: 207 STR------VAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGR 247
+ G + + +G +R++D+ S G +++ + G
Sbjct: 219 AYVEGSRSPHEGDLEF-ISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 38/179 (21%), Positives = 68/179 (37%), Gaps = 31/179 (17%)
Query: 49 INKIGEGGFGSVYKG-RLKDGKIAAIKVLSAESRQ--------------GVKEFLTEIQV 93
KIG GGFG +Y + A V+ E ++ K+ + +
Sbjct: 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIE 101
Query: 94 ISEIEHENLVKLYGC----CVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRS 149
++++ + YG ++R +V L L + G F T
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGT------FKKSTVL 154
Query: 150 RICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKI--SDFGLAKLIPANMTHV 206
++ I + L ++HE +H DIKA+N+LL ++ +D+GL+ N H
Sbjct: 155 QLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 54/231 (23%), Positives = 85/231 (36%), Gaps = 36/231 (15%)
Query: 34 YSYKELSIATDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESR---QGVKE--F 87
Y K D + + IG+G FG V K + + AIK++ + Q E
Sbjct: 44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRL 103
Query: 88 LTEIQVISEIEHENLVKLYGCCVEGNHRILV--------YNYLENNSLAQTLIGGGHHYS 139
L + +V L + NH LV Y+ L N + G +
Sbjct: 104 LELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFR------GVSLN 157
Query: 140 NIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTP--KISDFGLAK 197
+ + + L FL IIH D+K NILL KI DFG +
Sbjct: 158 LTR-------KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209
Query: 198 LIPANM-THVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
+ + ++ +R Y +PE + D++S G +LVE+ +G
Sbjct: 210 QLGQRIYQYIQSRF-----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 57/249 (22%), Positives = 109/249 (43%), Gaps = 72/249 (28%)
Query: 43 TDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSA--ESRQGVKEFLTEIQVISEI-E 98
+ + K+G+G +G V+K + G++ A+K + ++ + EI +++E+
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 99 HENLVKLYGCCV-EGNHRI-LVYNYLENNSLAQTLIGGGHHYSN------IQFSWRTRSR 150
HEN+V L + + + LV++Y+E + L + +N Q+
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYMETD-LHAVI------RANILEPVHKQY------- 113
Query: 151 ICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN-------- 202
+ + + + +LH ++HRD+K SNILL+ + K++DFGL++
Sbjct: 114 VVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
Query: 203 ----------------MT-HVSTRVAGTIGYLAPE-------YAIRGQVTRKADIYSFGV 238
+T +V+TR Y APE Y T+ D++S G
Sbjct: 171 LSINENTENFDDDQPILTDYVATR-----WYRAPEILLGSTKY------TKGIDMWSLGC 219
Query: 239 LLVEIVSGR 247
+L EI+ G+
Sbjct: 220 ILGEILCGK 228
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 8e-11
Identities = 44/247 (17%), Positives = 78/247 (31%), Gaps = 84/247 (34%)
Query: 49 INKIGEGGFGSVYKG--RLKDGKIAAIKVLSAESR---QGVKEFLTEIQVISEIEHE--- 100
+ +GEG FG V + + A+K++ + EI V+ +I+ +
Sbjct: 24 VGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKE 79
Query: 101 ---NLVKLYGCCVEGNHRILV--------YNYLENNSLAQTLIGGGHHYSNIQFSWRTRS 149
V + H + + +L+ N+ + +++
Sbjct: 80 NKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQ------PYPLPHVR------- 126
Query: 150 RICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTP-------------------KI 190
+ + L FLHE + H D+K NIL ++
Sbjct: 127 HMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 191 SDFGLAKLIPANMTH---VSTRVAGTIGYLAPE--------YAIRGQVTRKADIYSFGVL 239
+DFG A + H V+TR Y PE D++S G +
Sbjct: 184 ADFGSA--TFDHEHHTTIVATRH-----YRPPEVILELGWAQPC--------DVWSIGCI 228
Query: 240 LVEIVSG 246
L E G
Sbjct: 229 LFEYYRG 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 55/249 (22%), Positives = 91/249 (36%), Gaps = 84/249 (33%)
Query: 49 INKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESR---QGVKEFLTEIQVISEI-----EH 99
I K+G+G FG V + + + K A+KV+ + E ++ +I +
Sbjct: 40 IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINN 95
Query: 100 ENLVKLYGCCVEGNHRILV--------YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRI 151
N+VK +G + +H L+ Y + N+ G H +I+
Sbjct: 96 NNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYN------GFHIEDIK-------LY 142
Query: 152 CIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTP----------------------- 188
CI I + L +L + + H D+K NILLD
Sbjct: 143 CIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 189 --KISDFGLAKLIPANM-THVSTRVAGTIGYLAPE--------YAIRGQVTRKADIYSFG 237
K+ DFG A + ++TR Y APE + D++SFG
Sbjct: 200 GIKLIDFGCATFKSDYHGSIINTRQ-----YRAPEVILNLGWDVSS--------DMWSFG 246
Query: 238 VLLVEIVSG 246
+L E+ +G
Sbjct: 247 CVLAELYTG 255
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 50/245 (20%), Positives = 83/245 (33%), Gaps = 80/245 (32%)
Query: 49 INKIGEGGFGSVYKG--RLKDGKIAAIKVLSAESR---QGVKEFLTEIQVISEI------ 97
++ +GEG FG V + G+ A+K++ R +EIQV+ +
Sbjct: 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPN 74
Query: 98 EHENLVKLYGCCVEGNHRILV--------YNYLENNSLAQTLIGGGHHYSNIQFSWRTRS 149
V++ H +V Y++++ N +I+
Sbjct: 75 STFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFL------PFRLDHIR------- 121
Query: 150 RICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTP-------------------KI 190
++ I + + FLH + H D+K NIL + K+
Sbjct: 122 KMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 191 SDFGLAKLIPANM-THVSTRVAGTIGYLAPE--------YAIRGQVTRKADIYSFGVLLV 241
DFG A + T VSTR Y APE D++S G +L+
Sbjct: 179 VDFGSATYDDEHHSTLVSTRH-----YRAPEVILALGWSQPC--------DVWSIGCILI 225
Query: 242 EIVSG 246
E G
Sbjct: 226 EYYLG 230
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.5 bits (143), Expect = 9e-10
Identities = 67/414 (16%), Positives = 140/414 (33%), Gaps = 100/414 (24%)
Query: 5 SFLFRRRDSPRNRVPEVDEEFSGIHNVKLYSYKELSIATDDFSPINKI---GEGGFGSVY 61
S + R R+R+ ++ F+ + +L Y +L A + P + G G G
Sbjct: 106 SMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG--- 162
Query: 62 KGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121
K + A+ V + Q +F +I ++ C + +
Sbjct: 163 KTWV------ALDVCLSYKVQCKMDF--KIFWLN----------LKNCNSPETVLEMLQK 204
Query: 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNIL 181
L I +W +RS I + + E+R + + + ++
Sbjct: 205 L---------------LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLV 249
Query: 182 LDKDL-TPKISD-FGL-AKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGV 238
L ++ K + F L K++ ++TR +L+ ++ +
Sbjct: 250 LL-NVQNAKAWNAFNLSCKIL------LTTRFKQVTDFLSAAT--TTHISLDHHSMTLTP 300
Query: 239 -----LLVEIVSGRCNTNMRLPTEEQ------------YLLER--TWDLYERR---ELIL 276
LL++ + R LP E + + TWD ++ +L
Sbjct: 301 DEVKSLLLKYLDCRPQD---LPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTT 357
Query: 277 LVDTSLNGDFDAEEACRFLKVG-----------LLC-------TQDTPKLRPSMSTVVQM 318
++++SLN AE F ++ LL D + ++ + +
Sbjct: 358 IIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVV---VNKLHKY 414
Query: 319 LMGEKDIDDDKITKPGLISDFMDLKVRGPPKPKLETTTSSTYNSSDNPDNSNLS 372
+ EK + I+ P + +++LKV+ + L + YN D+ +L
Sbjct: 415 SLVEKQPKESTISIPSI---YLELKVKLENEYALHRSIVDHYNIPKTFDSDDLI 465
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 391 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.74 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.51 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.2 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.12 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.9 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.79 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.73 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.7 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.59 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.49 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.35 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.3 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.23 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.11 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.91 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.75 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.69 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.63 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.62 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.58 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.42 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.39 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.36 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.15 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.09 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.95 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.53 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.66 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 92.99 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.42 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.52 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-59 Score=431.75 Aligned_cols=274 Identities=24% Similarity=0.360 Sum_probs=217.9
Q ss_pred cceeechHHHHHhhCCCCCCceeeccCceEEEEEEeC------CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCce
Q 016347 30 NVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENL 102 (391)
Q Consensus 30 ~~~~~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i 102 (391)
+.+.++++|+. ..+++++++||+|+||+||+|.+. +++.||||++... .....++|.+|+.++++++||||
T Consensus 14 ~~~~~~~~ei~--~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNI 91 (308)
T 4gt4_A 14 QHKQAKLKEIS--LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 91 (308)
T ss_dssp -----CCCBCC--GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTB
T ss_pred ccccCCcccCC--HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCC
Confidence 34444555543 356788899999999999999863 4688999999755 33456789999999999999999
Q ss_pred eEEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCC----------CccccCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 016347 103 VKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHY----------SNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIH 172 (391)
Q Consensus 103 v~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~----------~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H 172 (391)
|+++|++.+++..+||||||++|+|.++|....... ....+++..+..|+.||+.||+|||++ +|+|
T Consensus 92 V~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiH 168 (308)
T 4gt4_A 92 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVH 168 (308)
T ss_dssp CCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred CCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCC
Confidence 999999999999999999999999999997543211 234689999999999999999999999 9999
Q ss_pred cCCCCCcEEECCCCcEEEEecccccccCCCC-ceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCC
Q 016347 173 RDIKASNILLDKDLTPKISDFGLAKLIPANM-THVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNT 250 (391)
Q Consensus 173 ~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~ 250 (391)
|||||+||||+.++.+||+|||+++...... ........||+.|+|||++.++.|+.++|||||||+||||+| |..||
T Consensus 169 RDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf 248 (308)
T 4gt4_A 169 KDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 248 (308)
T ss_dssp SCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999998653322 222344679999999999999999999999999999999998 89999
Q ss_pred CCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 016347 251 NMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKD 324 (391)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~ 324 (391)
......+ +... ...+. ....+..++..+.+|+.+||+.||++|||+.||++.|+...+
T Consensus 249 ~~~~~~~---~~~~----i~~~~---------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 249 CGYSNQD---VVEM----IRNRQ---------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp TTCCHHH---HHHH----HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred CCCCHHH---HHHH----HHcCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 7654322 1111 11111 112334456678999999999999999999999999976544
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-60 Score=439.01 Aligned_cols=253 Identities=23% Similarity=0.373 Sum_probs=205.8
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
++|+++++||+|+||+||+|++. +|+.||||++... .....+.+.+|+++|++++|||||++++++.+++..+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 78999999999999999999986 5999999999755 34456779999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
||+||+|.++|...+ ...+++..++.|+.||+.||.|||++ ||+||||||+||||+.+|.+||+|||+++.+.
T Consensus 104 y~~gg~L~~~i~~~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK----GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176 (350)
T ss_dssp CCTTCBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred CCCCCcHHHHHHHcC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence 999999999996432 23578999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeec
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT 280 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (391)
.. .......+||+.|+|||++.+..|+.++|||||||+||||+||+.||......+. .... .. ....
T Consensus 177 ~~-~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~~~i---~~-~~~~----- 243 (350)
T 4b9d_A 177 ST-VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL---VLKI---IS-GSFP----- 243 (350)
T ss_dssp HH-HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHH---HH-TCCC-----
T ss_pred CC-cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHH---Hc-CCCC-----
Confidence 32 1223456899999999999999999999999999999999999999976543221 1111 11 1110
Q ss_pred cCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 281 SLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 281 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
..+...+..+.+||.+||+.||++|||+.|++++-+
T Consensus 244 ----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 279 (350)
T 4b9d_A 244 ----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGF 279 (350)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHH
Confidence 112233457889999999999999999999998643
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=425.60 Aligned_cols=261 Identities=26% Similarity=0.449 Sum_probs=214.5
Q ss_pred hCCCCCCceeeccCceEEEEEEeC------CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
.++|.+.++||+|+||+||+|++. ++..||||++........++|.+|+++|++++|||||+++|++.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 467899999999999999999864 37889999998777777788999999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCC-------CCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEE
Q 016347 117 LVYNYLENNSLAQTLIGGGH-------HYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPK 189 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~-------~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~k 189 (391)
||||||++|+|.+++...+. ......+++..+..|+.||+.||.|||++ +|+||||||+|||++.++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence 99999999999999975431 11345699999999999999999999999 999999999999999999999
Q ss_pred EEecccccccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 016347 190 ISDFGLAKLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWD 267 (391)
Q Consensus 190 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 267 (391)
|+|||+++....... .......||+.|+|||++.++.|+.++|||||||+||||+| |+.||......+. ....
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~~i-- 243 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---IECI-- 243 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HHHH--
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH--
Confidence 999999987643322 22234568999999999999999999999999999999998 8999976543221 1111
Q ss_pred HhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 268 LYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.... ....+...+..+.+|+.+||+.||++|||+.||++.|+..
T Consensus 244 --~~~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 244 --TQGR---------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp --HHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111 1122334456788999999999999999999999988654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-58 Score=428.63 Aligned_cols=253 Identities=23% Similarity=0.378 Sum_probs=212.9
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecc
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYL 122 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 122 (391)
+.|+++++||+|+||+||+|.+. +|+.||||++........+.+.+|+.+|+.++|||||++++++.+++.++||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999987 59999999998765555567889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCC
Q 016347 123 ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN 202 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~ 202 (391)
+||+|.+++..+ .+++..+..++.||+.||+|||++ ||+||||||+||||+.+|.+||+|||+++.+...
T Consensus 154 ~gg~L~~~l~~~-------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 154 EGGALTDIVTHT-------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp TTEEHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred CCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 999999999543 499999999999999999999999 9999999999999999999999999999876443
Q ss_pred CceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccC
Q 016347 203 MTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSL 282 (391)
Q Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (391)
. ......+||+.|+|||++.+..|+.++|||||||+||||++|..||......... .... ... ...+
T Consensus 224 ~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~---~~i~----~~~-----~~~~ 290 (346)
T 4fih_A 224 V-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KMIR----DNL-----PPRL 290 (346)
T ss_dssp S-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHH----HSS-----CCCC
T ss_pred C-CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---HHHH----cCC-----CCCC
Confidence 2 2345678999999999999999999999999999999999999999765432211 1111 000 0000
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 283 NGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 283 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
......+..+.+|+.+||+.||++|||+.|++++-+.
T Consensus 291 --~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~ 327 (346)
T 4fih_A 291 --KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 327 (346)
T ss_dssp --SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred --CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 1112345678899999999999999999999987543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-58 Score=427.12 Aligned_cols=263 Identities=25% Similarity=0.425 Sum_probs=210.4
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC------CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCe
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNH 114 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (391)
+..++|.+.++||+|+||+||+|++. +++.||||++...+....++|.+|+++|++++|||||+++++|.+.+.
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 33467888999999999999999864 478899999987777777889999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCCC---------CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC
Q 016347 115 RILVYNYLENNSLAQTLIGGGHH---------YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD 185 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~---------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~ 185 (391)
.+||||||++|+|.+++...... ....++++..++.|+.||+.||+|||++ +|+||||||+||||+.+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQG 194 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETT
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCC
Confidence 99999999999999999764321 1234699999999999999999999999 99999999999999999
Q ss_pred CcEEEEecccccccCCCC-ceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHH
Q 016347 186 LTPKISDFGLAKLIPANM-THVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLE 263 (391)
Q Consensus 186 ~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~ 263 (391)
+.+||+|||+++...... ........||+.|+|||++.+..|+.++|||||||+||||+| |+.||......+. ..
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~ 271 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---ID 271 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---HH
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---HH
Confidence 999999999998764332 223345679999999999999999999999999999999999 8999976543221 11
Q ss_pred HHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 264 RTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.. .... ....+...+..+.+|+.+||+.||++|||+.||+++|+..
T Consensus 272 ~i---~~g~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 272 CI---TQGR----------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp HH---HHTC----------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred HH---HcCC----------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 11 1111 1122334456788999999999999999999999998654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-57 Score=416.81 Aligned_cols=264 Identities=24% Similarity=0.395 Sum_probs=208.2
Q ss_pred HHHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCe
Q 016347 37 KELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNH 114 (391)
Q Consensus 37 ~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (391)
..|++..+++++.++||+|+||+||+|++.+ .||||+++.. +....+.|.+|+.+|++++|||||++++++.+ +.
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN 105 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce
Confidence 3466778999999999999999999998763 5899998644 34556789999999999999999999998754 56
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
++||||||+||+|.+++.... ..+++..+..|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~-----~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFG 177 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQE-----TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFG 177 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCS
T ss_pred EEEEEEcCCCCCHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeecc
Confidence 899999999999999996532 3599999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCC-ceeeeeecccccccChhhhhc---CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh
Q 016347 195 LAKLIPANM-THVSTRVAGTIGYLAPEYAIR---GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE 270 (391)
Q Consensus 195 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 270 (391)
+++...... .......+||+.|||||++.+ +.|+.++|||||||+||||+||+.||......... ... ..
T Consensus 178 la~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~--~~~----~~ 251 (307)
T 3omv_A 178 LATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI--IFM----VG 251 (307)
T ss_dssp SCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHH----HH
T ss_pred CceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH--HHH----Hh
Confidence 998764322 223345689999999999964 35899999999999999999999999765432211 111 11
Q ss_pred hcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 271 RRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
... ..+.+ ...+...+..+.+|+.+||+.||++|||+.||++.|+..
T Consensus 252 ~~~----~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 252 RGY----ASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp TTC----CCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred cCC----CCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 110 00111 122234556788999999999999999999999888543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-57 Score=417.47 Aligned_cols=247 Identities=24% Similarity=0.342 Sum_probs=209.4
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++|++++.||+|+||+||+|++. +|+.||||++... .....+.+.+|+++|++++|||||++++++.+++..++||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 67999999999999999999986 5999999999754 2345677999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
|||+||+|.+++...+ .+++..+..++.||+.||.|||++ +|+||||||+|||++.+|.+||+|||+++.+
T Consensus 112 Ey~~gG~L~~~i~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~ 182 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL 182 (311)
T ss_dssp CCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence 9999999999997543 599999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC-ceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 200 PANM-THVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 200 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
.... .....+.+||+.|+|||++.+..|+.++|||||||+||+|+||+.||....... +..... ....
T Consensus 183 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~----~~~~---- 251 (311)
T 4aw0_A 183 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---IFAKII----KLEY---- 251 (311)
T ss_dssp CTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HTCC----
T ss_pred CCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----cCCC----
Confidence 4332 234456789999999999999999999999999999999999999997643321 111111 1110
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVV 316 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 316 (391)
.++...+..+.+|+.+||+.||++|||++|++
T Consensus 252 ------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 ------DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ------CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11222345688899999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-57 Score=430.44 Aligned_cols=254 Identities=23% Similarity=0.381 Sum_probs=213.1
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
.+.|+++++||+|+||.||+|++. +|+.||||++........+.+.+|+.+|+.++|||||++++++.+++.++|||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 356999999999999999999987 5999999999876555566788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
|+||+|.+++..+ .+++..+..|+.||+.||+|||++ ||+||||||+||||+.+|.+||+|||+++.+..
T Consensus 230 ~~gG~L~~~i~~~-------~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 230 LEGGALTDIVTHT-------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp CTTEEHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred CCCCcHHHHHhcc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 9999999999543 489999999999999999999999 999999999999999999999999999987644
Q ss_pred CCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
.. ......+||+.|||||++.+..|+.++|||||||++|||++|..||....+.... .... . .. ...
T Consensus 300 ~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~---~~i~---~-~~-----~~~ 366 (423)
T 4fie_A 300 EV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KMIR---D-NL-----PPR 366 (423)
T ss_dssp SC-CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHH---H-SC-----CCC
T ss_pred CC-ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---HHHH---c-CC-----CCC
Confidence 32 2345678999999999999999999999999999999999999999765432211 1111 1 10 000
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
+ ......+..+.+|+.+||+.||++|||+.|++++-+.
T Consensus 367 ~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~ 404 (423)
T 4fie_A 367 L--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 404 (423)
T ss_dssp C--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred C--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHh
Confidence 1 1112234578889999999999999999999987543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-57 Score=417.52 Aligned_cols=251 Identities=22% Similarity=0.252 Sum_probs=205.9
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
.+.|++.++||+|+||+||+|++. +|+.||||+++.+.. ..+|+.+|+.++|||||++++++.+++..+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 367888999999999999999986 599999999976532 24699999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC-cEEEEecccccccC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL-TPKISDFGLAKLIP 200 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~-~~kl~Dfg~~~~~~ 200 (391)
|+||+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+||||+.+| .+||+|||+++.+.
T Consensus 132 ~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG------CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp CTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred cCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 99999999997543 599999999999999999999999 999999999999999987 69999999998764
Q ss_pred CCCce----eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccce
Q 016347 201 ANMTH----VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL 276 (391)
Q Consensus 201 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (391)
..... .....+||+.|||||++.+..|+.++|||||||+||||+||+.||...........+.. .....
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~------~~~~~- 275 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS------EPPPI- 275 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH------SCCGG-
T ss_pred CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc------CCCCc-
Confidence 33211 12346799999999999999999999999999999999999999986654432211111 00000
Q ss_pred eeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 277 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
...+...+..+.+++.+||+.||.+|||+.|++++|..
T Consensus 276 -------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 276 -------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp -------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 01222345678889999999999999999999988743
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-56 Score=403.95 Aligned_cols=249 Identities=22% Similarity=0.329 Sum_probs=194.5
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++|++++.||+|+||+||+|.+. +|+.||+|++... .......+.+|+++|+.++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999976 5999999999754 2344567899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+ +|+|.+++...+ .+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 93 Ey~-~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 162 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD------KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM 162 (275)
T ss_dssp ECC-CEEHHHHHHHSC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred eCC-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeec
Confidence 999 679999987543 599999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCceeeeeecccccccChhhhhcCCC-CCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
... ....+.+||+.|+|||++.+..+ +.++|||||||++|+|+||+.||....... +.... .....
T Consensus 163 ~~~--~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---~~~~i----~~~~~---- 229 (275)
T 3hyh_A 163 TDG--NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---LFKNI----SNGVY---- 229 (275)
T ss_dssp --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HHTCC----
T ss_pred CCC--CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH----HcCCC----
Confidence 432 23345789999999999988876 579999999999999999999997543211 11111 11110
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.++...+..+.+|+.+||+.||++|||++|++++-+.
T Consensus 230 ------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~ 266 (275)
T 3hyh_A 230 ------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF 266 (275)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence 1122234578889999999999999999999987543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-56 Score=406.38 Aligned_cols=248 Identities=24% Similarity=0.361 Sum_probs=200.0
Q ss_pred CCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEe----CCeeEEE
Q 016347 46 FSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVE----GNHRILV 118 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv 118 (391)
|++.++||+|+||+||+|.+. ++..||+|.+... .....+.|.+|+++|++++|||||++++++.+ ....+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 366778999999999999987 5899999998754 34455779999999999999999999999875 3468999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCcEEECC-CCcEEEEeccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPH--IIHRDIKASNILLDK-DLTPKISDFGL 195 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~--i~H~dikp~NIlv~~-~~~~kl~Dfg~ 195 (391)
||||+||+|.+++...+ .+++..+..|+.||+.||+|||++ + |+||||||+||||+. +|.+||+|||+
T Consensus 108 mEy~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGl 178 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred EeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcC
Confidence 99999999999997543 589999999999999999999998 7 999999999999974 79999999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
++..... .....+||+.|+|||++. +.|+.++|||||||+||||+||+.||........ +... .......
T Consensus 179 a~~~~~~---~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~~~----i~~~~~~ 248 (290)
T 3fpq_A 179 ATLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRR----VTSGVKP 248 (290)
T ss_dssp GGGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHH----HTTTCCC
T ss_pred CEeCCCC---ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HHHH----HHcCCCC
Confidence 9864332 234578999999999885 5699999999999999999999999975433221 1111 1111000
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
. ..+...+..+.+|+.+||+.||++|||+.|++++-+
T Consensus 249 ----~----~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~ 285 (290)
T 3fpq_A 249 ----A----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp ----G----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred ----C----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 0 011112346888999999999999999999998754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-56 Score=410.79 Aligned_cols=250 Identities=25% Similarity=0.323 Sum_probs=200.5
Q ss_pred CCCCCCceeeccCceEEEEEEeC----CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK----DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (391)
++|++++.||+|+||+||+|+.. +++.||||++.... ......+.+|+++|++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 67999999999999999999863 47899999987542 2233467889999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
|||||+||+|.+++...+ .+++..+..++.||+.||+|||++ ||+||||||+|||++.+|.+||+|||+++
T Consensus 104 vmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~ 174 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK 174 (304)
T ss_dssp EECCCTTCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred EEEcCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccce
Confidence 999999999999997543 599999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccccee
Q 016347 198 LIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILL 277 (391)
Q Consensus 198 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (391)
...... ......+||+.|+|||++.+..|+.++|||||||+||||+||+.||......+. ..... . ...
T Consensus 175 ~~~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~~~i~---~-~~~--- 243 (304)
T 3ubd_A 175 ESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET---MTMIL---K-AKL--- 243 (304)
T ss_dssp C------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH---H-CCC---
T ss_pred eccCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH---HHHHH---c-CCC---
Confidence 653322 233457899999999999999999999999999999999999999976543221 11111 1 110
Q ss_pred eeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHhc
Q 016347 278 VDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPS-----MSTVVQMLM 320 (391)
Q Consensus 278 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l~ 320 (391)
.++...+..+.+|+.+||+.||++||| ++|++++-+
T Consensus 244 -------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~ 284 (304)
T 3ubd_A 244 -------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284 (304)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGG
T ss_pred -------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcc
Confidence 122234457889999999999999998 467877643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-56 Score=415.23 Aligned_cols=271 Identities=25% Similarity=0.360 Sum_probs=219.4
Q ss_pred echHHHHHhhCCCCCCceeeccCceEEEEEEeCC------CcEEEEEEecccc-hhcHHHHHHHHHHHhcCCC-CceeEE
Q 016347 34 YSYKELSIATDDFSPINKIGEGGFGSVYKGRLKD------GKIAAIKVLSAES-RQGVKEFLTEIQVISEIEH-ENLVKL 105 (391)
Q Consensus 34 ~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~~iv~~ 105 (391)
|...+|++..++|++.++||+|+||+||+|.+.. ++.||||.+.... ....+.|.+|+.+|.++.| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4567899999999999999999999999998642 4689999997653 3445679999999999965 899999
Q ss_pred EEEEEeC-CeeEEEEecccCCCHHHHHhcCCCC----------CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecC
Q 016347 106 YGCCVEG-NHRILVYNYLENNSLAQTLIGGGHH----------YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRD 174 (391)
Q Consensus 106 ~~~~~~~-~~~~lv~e~~~~~sL~~~i~~~~~~----------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~d 174 (391)
+|+|.+. ..+++|||||++|+|.++|...... .....+++..+..++.||+.||+|||++ +|+|||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9998764 5789999999999999999753211 1234589999999999999999999999 999999
Q ss_pred CCCCcEEECCCCcEEEEecccccccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCC
Q 016347 175 IKASNILLDKDLTPKISDFGLAKLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNM 252 (391)
Q Consensus 175 ikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~ 252 (391)
|||+|||++.++.+||+|||+++.+..... .......||+.|||||++.++.|+.++|||||||+||||+| |..||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987644332 23345679999999999999999999999999999999998 8999976
Q ss_pred CCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 253 RLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
...... +... ...+ .....+...+..+.+++.+||+.||++|||+.||+++|...
T Consensus 291 ~~~~~~--~~~~----i~~g---------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 291 VKIDEE--FCRR----LKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CCCSHH--HHHH----HHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHHHH--HHHH----HHcC---------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 543221 1111 1111 11122233456788999999999999999999999998543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-55 Score=402.56 Aligned_cols=267 Identities=25% Similarity=0.326 Sum_probs=199.8
Q ss_pred hCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC----eeEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN----HRILV 118 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv 118 (391)
.++|.+.++||+|+||+||+|++. |+.||||++...... ...+..|+..+.+++|||||++++++.++. .++||
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 357889999999999999999985 899999999755332 122334666667889999999999998653 57999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcC-----CCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV-----RPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~-----~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
|||+++|+|.+++... .+++..+..++.|++.||+|||+++ .++|+||||||+||||+.++.+||+||
T Consensus 80 ~Ey~~~gsL~~~l~~~-------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred ecCCCCCcHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 9999999999999643 5899999999999999999999752 348999999999999999999999999
Q ss_pred ccccccCCCCce---eeeeecccccccChhhhhcC------CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhh----
Q 016347 194 GLAKLIPANMTH---VSTRVAGTIGYLAPEYAIRG------QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQY---- 260 (391)
Q Consensus 194 g~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~---- 260 (391)
|+++........ .....+||+.|+|||++.+. .++.++|||||||+||||+||..|+.........+
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 999876443222 12345799999999998764 47789999999999999999987765432211100
Q ss_pred ----HHHHHHHHhhhcccceeeeccCCC-CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 261 ----LLERTWDLYERRELILLVDTSLNG-DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 261 ----~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
............ ..++.+.. ....+....+.+|+.+||+.||++|||+.||++.|+.+
T Consensus 233 ~~~~~~~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CSSCCHHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccchHHHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 001111111111 11111111 11235667889999999999999999999999998654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-54 Score=396.64 Aligned_cols=249 Identities=24% Similarity=0.380 Sum_probs=190.7
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC--------
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN-------- 113 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-------- 113 (391)
++|++++.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45899999999999999999986 69999999987553 344567899999999999999999999987543
Q ss_pred ----eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEE
Q 016347 114 ----HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPK 189 (391)
Q Consensus 114 ----~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~k 189 (391)
..++|||||+||+|.+++...+ ......+..++.|+.||+.||+|||++ ||+||||||+|||++.+|.+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRC---TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCC---SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcC---CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEE
Confidence 3789999999999999997643 223456677899999999999999999 999999999999999999999
Q ss_pred EEecccccccCCCCce-----------eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcch
Q 016347 190 ISDFGLAKLIPANMTH-----------VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEE 258 (391)
Q Consensus 190 l~Dfg~~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~ 258 (391)
|+|||+++.+...... .....+||+.|||||++.+..|+.++|||||||+||||++ ||.....
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~--- 232 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--- 232 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH---
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH---
Confidence 9999999876432211 1234579999999999999999999999999999999996 6642110
Q ss_pred hhHHHHHHHHhhhcccceeeeccCCCCCC---HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 259 QYLLERTWDLYERRELILLVDTSLNGDFD---AEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
. ... ...... ...+ ......+.+|+.+||+.||++|||+.|++++-
T Consensus 233 ~--~~~-~~~~~~------------~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~ 281 (299)
T 4g31_A 233 R--VRT-LTDVRN------------LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENA 281 (299)
T ss_dssp H--HHH-HHHHHT------------TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred H--HHH-HHHHhc------------CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 0 000 000011 1112 22334567899999999999999999999864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=397.36 Aligned_cols=270 Identities=21% Similarity=0.290 Sum_probs=206.9
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEe------CC
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVE------GN 113 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~ 113 (391)
+++|++++.||+|+||+||+|++. +|+.||||++... .....+.+.+|+++|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 468999999999999999999986 6999999999754 23445678899999999999999999998764 35
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
.++||||||+ |+|.+++...+ .+++..+..++.||+.||.|||++ ||+||||||+|||++.+|.+||+||
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~------~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DF 202 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ------PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDF 202 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEEeCCC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeec
Confidence 7899999996 67999996543 599999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCC---ceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh
Q 016347 194 GLAKLIPANM---THVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLY 269 (391)
Q Consensus 194 g~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 269 (391)
|+++.+.... .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+.......
T Consensus 203 Gla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p 282 (398)
T 4b99_A 203 GMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP 282 (398)
T ss_dssp TTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9998764321 2233457899999999998875 46999999999999999999999998765433222111111100
Q ss_pred hhcccce--------eeeccC-CCCCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 270 ERRELIL--------LVDTSL-NGDFDA-----EEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 270 ~~~~~~~--------~~~~~~-~~~~~~-----~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
....... .+.... ....+. .....+.+|+.+||+.||++|||+.|++++-+..
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~ 349 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLA 349 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGT
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhC
Confidence 0000000 000000 001111 1235678899999999999999999999876543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=384.14 Aligned_cols=303 Identities=43% Similarity=0.749 Sum_probs=246.5
Q ss_pred CcccccccCCCcceeechHHHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccch-hcHHHHHHHHHHHhcC
Q 016347 19 PEVDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESR-QGVKEFLTEIQVISEI 97 (391)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l 97 (391)
+..++......+++.|+++++.+..++|++.+.||+|+||.||+|.+.+|+.||||++..... .....+.+|+.+++.+
T Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l 84 (326)
T 3uim_A 5 PAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMA 84 (326)
T ss_dssp ----------CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTC
T ss_pred CcccCcccccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhc
Confidence 444555566778899999999999999999999999999999999988899999999876532 2233688999999999
Q ss_pred CCCceeEEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 016347 98 EHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKA 177 (391)
Q Consensus 98 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp 177 (391)
+||||+++++++......++||||+++++|.+++..... ....+++..+..++.|++.||.|||+++.+|++||||||
T Consensus 85 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp 162 (326)
T 3uim_A 85 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE--SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKA 162 (326)
T ss_dssp CCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCST--TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSG
T ss_pred cCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCch
Confidence 999999999999999999999999999999999976543 445699999999999999999999998667899999999
Q ss_pred CcEEECCCCcEEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCC--C
Q 016347 178 SNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRL--P 255 (391)
Q Consensus 178 ~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~--~ 255 (391)
+|||++.++.+||+|||++...............||+.|+|||++.+..++.++|||||||++|+|++|..||.... .
T Consensus 163 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 242 (326)
T 3uim_A 163 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242 (326)
T ss_dssp GGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT
T ss_pred hhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccc
Confidence 99999999999999999998775554445555679999999999999999999999999999999999999995211 1
Q ss_pred cchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 256 TEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
........+..............+..+...........+.+++.+||+.||.+|||+.||+++|+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 243 DDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred ccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 11112223333333344455555666667778889999999999999999999999999999997653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=407.89 Aligned_cols=252 Identities=24% Similarity=0.304 Sum_probs=204.4
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHH---HHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVK---EFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
-++|++++.||+|+||+||+|++. +|+.||||++.... ..... ....++.+++.++|||||++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 478999999999999999999987 59999999996541 12222 233456777888999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
+|||||++||+|.++|...+ .+++..+..++.||+.||.|||++ ||+||||||+||||+.+|.+||+|||+
T Consensus 268 ylVmEy~~GGdL~~~l~~~~------~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGl 338 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGL 338 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccce
Confidence 99999999999999997543 599999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
++.+... ...+.+||+.|+|||++.+ ..|+.++|||||||+||||++|..||..........+..... . ..
T Consensus 339 A~~~~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~---~-~~- 410 (689)
T 3v5w_A 339 ACDFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---T-MA- 410 (689)
T ss_dssp CEECSSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH---H-CC-
T ss_pred eeecCCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc---C-CC-
Confidence 9876433 2345789999999999965 579999999999999999999999997544333222111111 1 00
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHhc
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPS-----MSTVVQMLM 320 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l~ 320 (391)
..++...+..+.+||.+||+.||.+|++ ++||++|-+
T Consensus 411 ---------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hpf 452 (689)
T 3v5w_A 411 ---------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452 (689)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred ---------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcc
Confidence 0122234557889999999999999998 678776543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-51 Score=385.14 Aligned_cols=200 Identities=28% Similarity=0.414 Sum_probs=172.1
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC----CCcEEEEEEecccchhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCee
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK----DGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 115 (391)
...++|++.++||+|+||+||+|+++ +++.||+|.+.... ....+.+|+++|+.+ .||||+++++++.+.++.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34688999999999999999999863 47889999986543 235678899999988 699999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC-CcEEEEecc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD-LTPKISDFG 194 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~-~~~kl~Dfg 194 (391)
++||||++||+|.+++. .+++..+..++.||+.||+|||++ ||+||||||+|||++.+ +.+||+|||
T Consensus 96 ~lvmE~~~g~~L~~~~~---------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN---------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp EEEEECCCCCCHHHHHT---------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEeCCCcccHHHHHc---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 99999999999999983 389999999999999999999999 99999999999999877 899999999
Q ss_pred cccccCCCCc---------------------------eeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhC
Q 016347 195 LAKLIPANMT---------------------------HVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSG 246 (391)
Q Consensus 195 ~~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg 246 (391)
+++....... ......+||+.|+|||++.+. .|+.++||||+||++|+|++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 9976532211 112345799999999999876 489999999999999999999
Q ss_pred CCCCCCCC
Q 016347 247 RCNTNMRL 254 (391)
Q Consensus 247 ~~p~~~~~ 254 (391)
+.||....
T Consensus 244 ~~Pf~~~~ 251 (361)
T 4f9c_A 244 RYPFYKAS 251 (361)
T ss_dssp CSSSSCCS
T ss_pred CCCCCCCC
Confidence 99996544
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=378.42 Aligned_cols=288 Identities=41% Similarity=0.651 Sum_probs=244.2
Q ss_pred eeechHHHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEe
Q 016347 32 KLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVE 111 (391)
Q Consensus 32 ~~~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 111 (391)
..+++.++...+++|++.+.||+|+||.||+|.+.+|+.||+|++..........+.+|+.+++.++||||+++++++.+
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 45566677778899999999999999999999988899999999887766667889999999999999999999999999
Q ss_pred CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEE
Q 016347 112 GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKIS 191 (391)
Q Consensus 112 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~ 191 (391)
.+..++||||+++++|.+++..... ....+++..++.++.||+.||.|||++ |++||||||+||+++.++.+||+
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~ 181 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDL--PTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKIT 181 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCC--CSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEEC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCC--CccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEe
Confidence 9999999999999999999865432 334689999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCC-ceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh
Q 016347 192 DFGLAKLIPANM-THVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE 270 (391)
Q Consensus 192 Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 270 (391)
|||++....... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....+........+......
T Consensus 182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 261 (321)
T 2qkw_B 182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261 (321)
T ss_dssp CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence 999998653221 2223345689999999999999999999999999999999999999987766655444444444444
Q ss_pred hcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 016347 271 RRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKD 324 (391)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~ 324 (391)
.......+++.+........+..+.+++.+||+.||++|||+.|++++|+....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 555556666666667788899999999999999999999999999999976543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=401.49 Aligned_cols=255 Identities=21% Similarity=0.272 Sum_probs=212.6
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecc
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYL 122 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 122 (391)
++|++++.||+|+||.||+|.+. +|+.||+|++........+.+.+|+.+|+.++|||||++++++.+....+||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 68999999999999999999987 59999999998776666678899999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC--CcEEEEecccccccC
Q 016347 123 ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD--LTPKISDFGLAKLIP 200 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~--~~~kl~Dfg~~~~~~ 200 (391)
+||+|.++|.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++.+.
T Consensus 237 ~gg~L~~~i~~~~-----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 237 SGGELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp CCCBHHHHHTCTT-----SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred CCCcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 9999999996432 3589999999999999999999999 99999999999999854 899999999999875
Q ss_pred CCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeec
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT 280 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (391)
... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||......+.. ... ..... .+..
T Consensus 309 ~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~---~~i----~~~~~--~~~~ 377 (573)
T 3uto_A 309 PKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL---RNV----KSCDW--NMDD 377 (573)
T ss_dssp TTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHH----HTTCC--CCCS
T ss_pred CCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---HHH----HhCCC--CCCc
Confidence 432 344568999999999999999999999999999999999999999765432211 111 00000 0000
Q ss_pred cCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 281 SLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 281 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
......+..+.+||.+||+.||.+|||+.|+++|-+.
T Consensus 378 ----~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~ 414 (573)
T 3uto_A 378 ----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 414 (573)
T ss_dssp ----GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred ----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCc
Confidence 1111234567889999999999999999999997543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=358.24 Aligned_cols=254 Identities=25% Similarity=0.392 Sum_probs=212.7
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
..++|++.+.||+|+||+||+|.+. +|+.||+|++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 3578999999999999999999975 699999999987666666788999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+++++|.+++... .+++..+..++.|++.||.|||++ |++||||||+|||++.++.+||+|||++....
T Consensus 98 ~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 98 YLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp CCTTCBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCCCCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999999543 489999999999999999999999 99999999999999999999999999988764
Q ss_pred CCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeec
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT 280 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (391)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....+....... ......
T Consensus 168 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~------~~~~~~------ 234 (297)
T 3fxz_A 168 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------ATNGTP------ 234 (297)
T ss_dssp STTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HHHCSC------
T ss_pred Cccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCCC------
Confidence 4322 234467999999999999999999999999999999999999999765432211111 111100
Q ss_pred cCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 281 SLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 281 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
....+...+..+.+++.+||+.||.+|||+.|++++-+
T Consensus 235 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~ 272 (297)
T 3fxz_A 235 --ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQF 272 (297)
T ss_dssp --CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred --CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 00112234457889999999999999999999998653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=354.82 Aligned_cols=260 Identities=25% Similarity=0.439 Sum_probs=213.3
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
..++|++.+.||+|+||+||+|.+. +++.||+|.+..........+.+|+++++.++||||+++++++.+++..++|||
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 3578999999999999999999986 589999999877667777889999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+++++|.+++.... ..+++..+..++.||+.||.|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 88 ~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 88 YIKGGTLRGIIKSMD-----SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMV 159 (310)
T ss_dssp CCTTCBHHHHHHHCC-----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence 999999999997532 3589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCcee-------------eeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 016347 201 ANMTHV-------------STRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWD 267 (391)
Q Consensus 201 ~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 267 (391)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|..|+....+.......... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~-~ 238 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR-G 238 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH-H
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh-c
Confidence 332211 11457999999999999999999999999999999999999998755443321110000 0
Q ss_pred HhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 268 LYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
... . ..+...+..+.+++.+||+.||.+|||+.++++.|+...
T Consensus 239 ~~~---------~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 239 FLD---------R----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp HHH---------H----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccc---------c----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000 0 011122346888999999999999999999999986553
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=358.14 Aligned_cols=252 Identities=27% Similarity=0.340 Sum_probs=209.9
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (391)
..++|++++.||+|+||.||+|+.. +|+.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 3478999999999999999999987 5999999999764 23455678899999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
||||++||+|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||++.
T Consensus 83 v~E~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 153 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 153 (337)
T ss_dssp EEECCTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEeCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchh
Confidence 99999999999998643 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccccee
Q 016347 198 LIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILL 277 (391)
Q Consensus 198 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (391)
..... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..... .....
T Consensus 154 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i----~~~~~--- 222 (337)
T 1o6l_A 154 EGISD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELI----LMEEI--- 222 (337)
T ss_dssp CSCCT-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HHCCC---
T ss_pred hcccC-CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH---HHHHH----HcCCC---
Confidence 64322 223345689999999999999999999999999999999999999997543211 11111 11110
Q ss_pred eeccCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHhc
Q 016347 278 VDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRP-----SMSTVVQMLM 320 (391)
Q Consensus 278 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~ 320 (391)
.++...+..+.+++.+||+.||.+|| ++.|++++-+
T Consensus 223 -------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~ 263 (337)
T 1o6l_A 223 -------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred -------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence 12223345788899999999999999 8999988754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=368.75 Aligned_cols=264 Identities=21% Similarity=0.277 Sum_probs=214.9
Q ss_pred chHHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEE
Q 016347 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCV 110 (391)
Q Consensus 35 ~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 110 (391)
.++++.+..++|++++.||+|+||+||+|++. +++.||+|++.... ......+.+|+.+++.++||||+++++++.
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 45667778899999999999999999999987 48999999986531 122345778999999999999999999999
Q ss_pred eCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEE
Q 016347 111 EGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKI 190 (391)
Q Consensus 111 ~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl 190 (391)
+....++||||++||+|.+++... .+++..+..++.||+.||.|||++ ||+||||||+|||++.+|.+||
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~-------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL 209 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKL 209 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEE
Confidence 999999999999999999999543 489999999999999999999999 9999999999999999999999
Q ss_pred EecccccccCCCCceeeeeecccccccChhhhhcCC----CCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 016347 191 SDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQ----VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTW 266 (391)
Q Consensus 191 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 266 (391)
+|||++..............+||+.|+|||++.+.. ++.++|||||||++|+|++|..||......... ....
T Consensus 210 ~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~---~~i~ 286 (410)
T 3v8s_A 210 ADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY---SKIM 286 (410)
T ss_dssp CCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHHH
T ss_pred eccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHH---HHHH
Confidence 999999876554433445678999999999998765 889999999999999999999999765432211 1111
Q ss_pred HHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHhcC
Q 016347 267 DLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKL--RPSMSTVVQMLMG 321 (391)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~l~~ 321 (391)
........ ......+..+.+|+.+||+.+|.+ ||+++||+++.+.
T Consensus 287 ---~~~~~~~~-------p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f 333 (410)
T 3v8s_A 287 ---NHKNSLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 333 (410)
T ss_dssp ---THHHHCCC-------CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGG
T ss_pred ---hccccccC-------CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccc
Confidence 10000000 000123456888899999999988 9999999988654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=357.78 Aligned_cols=256 Identities=22% Similarity=0.340 Sum_probs=211.8
Q ss_pred HHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 39 LSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 39 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
.....++|++++.||+|+||.||+|.+. +|+.||||++... .......+.+|+.+++.++||||+++++++...+..
T Consensus 10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 89 (328)
T 3fe3_A 10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL 89 (328)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence 3344688999999999999999999985 6999999998755 334566788999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||||+++++|.+++...+ .+++..+..++.||+.||.|||++ |++||||||+|||++.++.+||+|||+
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~ 160 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAHG------RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGF 160 (328)
T ss_dssp EEEECCCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTC
T ss_pred EEEEECCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccC
Confidence 99999999999999996543 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhcCCCC-CCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVT-RKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
+....... .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||........ .... .....
T Consensus 161 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i----~~~~~ 231 (328)
T 3fe3_A 161 SNEFTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL---RERV----LRGKY 231 (328)
T ss_dssp CGGGSSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH----HHCCC
T ss_pred ceecCCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH---HHHH----HhCCC
Confidence 98764332 23446799999999999888875 799999999999999999999976533211 1111 11100
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
..+...+..+.+++.+||+.||.+|||+.|++++-+..
T Consensus 232 ----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~ 269 (328)
T 3fe3_A 232 ----------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWIN 269 (328)
T ss_dssp ----------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTT
T ss_pred ----------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhc
Confidence 11222345688899999999999999999999876543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=358.16 Aligned_cols=265 Identities=28% Similarity=0.455 Sum_probs=206.7
Q ss_pred chHHHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC
Q 016347 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEG 112 (391)
Q Consensus 35 ~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (391)
.-.++.+..++|++.+.||+|+||.||+|++. |+.||+|++.... ......+.+|++++++++||||+++++++.+.
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 44555667789999999999999999999884 8889999987653 34456789999999999999999999999999
Q ss_pred CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCcEEECCCCcEEE
Q 016347 113 NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPH--IIHRDIKASNILLDKDLTPKI 190 (391)
Q Consensus 113 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~--i~H~dikp~NIlv~~~~~~kl 190 (391)
...++||||+++++|.+++...+ ....+++..++.++.||+.||.|||++ | ++||||||+||+++.++.+||
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL 180 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSG---AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKV 180 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTT---HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEE
T ss_pred CceEEEEecCCCCcHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEE
Confidence 99999999999999999997543 223589999999999999999999999 8 999999999999999999999
Q ss_pred EecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh
Q 016347 191 SDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE 270 (391)
Q Consensus 191 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 270 (391)
+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......... .... ..
T Consensus 181 ~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~---~~~~--~~ 254 (309)
T 3p86_A 181 CDFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV---AAVG--FK 254 (309)
T ss_dssp CCCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH---HHHH--HS
T ss_pred CCCCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH--hc
Confidence 9999997643321 1233457999999999999999999999999999999999999999755332211 1000 00
Q ss_pred hcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 271 RRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
. .....+...+..+.+++.+||+.||.+|||+.++++.|+..
T Consensus 255 ~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~ 296 (309)
T 3p86_A 255 C----------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296 (309)
T ss_dssp C----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 01122233445788999999999999999999999998654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=349.40 Aligned_cols=260 Identities=24% Similarity=0.423 Sum_probs=215.2
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++..++|++.+.||+|+||.||+|.+.++..||+|++..... ....+.+|++++++++||||+++++++.+....++||
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 455689999999999999999999999888999999976532 3467899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++... ...+++..++.++.|++.||.|||++ |++||||||+||+++.++.++|+|||++...
T Consensus 83 e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 83 EYISNGCLLNYLRSH-----GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYV 154 (268)
T ss_dssp ECCTTCBHHHHHHHH-----GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEEC
T ss_pred EccCCCcHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceec
Confidence 999999999999653 23589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
............+|+.|+|||++.+..++.++||||||+++|+|++ |..||......... .. .....
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~----~~~~~----- 222 (268)
T 3sxs_A 155 LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV---LK----VSQGH----- 222 (268)
T ss_dssp CTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH---HH----HHTTC-----
T ss_pred chhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH---HH----HHcCC-----
Confidence 5543333334456778999999999999999999999999999999 99999754332111 10 11100
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKD 324 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~ 324 (391)
....+...+..+.+++.+||+.||.+|||+.++++.|+....
T Consensus 223 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 223 ----RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp ----CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred ----CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 001112234578889999999999999999999999977654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=356.92 Aligned_cols=258 Identities=25% Similarity=0.376 Sum_probs=207.8
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
.++|++++.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999987 69999999986543 2334568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+++++|.+++... ..+++..++.++.||+.||.|||++ |++||||||+|||++.++.+||+|||++..+.
T Consensus 86 ~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 86 YCSGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp CCTTEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred cCCCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 99999999998643 3589999999999999999999999 99999999999999999999999999998653
Q ss_pred CCC-ceeeeeecccccccChhhhhcCCC-CCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 201 ANM-THVSTRVAGTIGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 201 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
... ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||............ +.....
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~------~~~~~~---- 226 (323)
T 3tki_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD------WKEKKT---- 226 (323)
T ss_dssp ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHH------HHTTCT----
T ss_pred cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH------Hhcccc----
Confidence 222 222334679999999999988776 78999999999999999999999765443222111 000000
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
...........+.+|+.+||+.||.+|||+.|++++.+...
T Consensus 227 ----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 267 (323)
T 3tki_A 227 ----YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (323)
T ss_dssp ----TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ----cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcc
Confidence 00111223456788999999999999999999998766543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=366.48 Aligned_cols=268 Identities=21% Similarity=0.259 Sum_probs=216.9
Q ss_pred echHHHHHhhCCCCCCceeeccCceEEEEEEeCC-CcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEE
Q 016347 34 YSYKELSIATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCC 109 (391)
Q Consensus 34 ~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 109 (391)
+.++++.+..++|+++++||+|+||+||+|++.. ++.||+|++.... ......+.+|..++..++||||+++++++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 4677888889999999999999999999999874 8899999987532 12223478899999999999999999999
Q ss_pred EeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEE
Q 016347 110 VEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPK 189 (391)
Q Consensus 110 ~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~k 189 (391)
.+.+..++||||++||+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.+|.+|
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vk 215 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKF-----EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIR 215 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTT-----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHc-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEE
Confidence 9999999999999999999999752 23599999999999999999999999 999999999999999999999
Q ss_pred EEecccccccCCCCceeeeeecccccccChhhhh-----cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 016347 190 ISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAI-----RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLER 264 (391)
Q Consensus 190 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~ 264 (391)
|+|||+++.............+||+.|+|||++. .+.++.++|||||||++|||++|..||......+.. ..
T Consensus 216 L~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~---~~ 292 (437)
T 4aw2_A 216 LADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY---GK 292 (437)
T ss_dssp ECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HH
T ss_pred EcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH---Hh
Confidence 9999999876554444445568999999999987 467899999999999999999999999765432221 11
Q ss_pred HHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHhcC
Q 016347 265 TWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKL--RPSMSTVVQMLMG 321 (391)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~l~~ 321 (391)
.. ....... +... ....+..+.+|+.+||..+|++ ||+++|++++-+.
T Consensus 293 i~---~~~~~~~-~p~~-----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff 342 (437)
T 4aw2_A 293 IM---NHKERFQ-FPTQ-----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF 342 (437)
T ss_dssp HH---THHHHCC-CCSS-----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGG
T ss_pred hh---hcccccc-CCcc-----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCcc
Confidence 11 0000000 0000 0123456788899999988888 9999999987543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=358.93 Aligned_cols=253 Identities=25% Similarity=0.373 Sum_probs=204.2
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCee
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 115 (391)
+..++|++++.||+|+||.||+|++. +|+.||+|++... .......+..|..+++.+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 44589999999999999999999987 5899999999754 234456688899999988 799999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||||++||+|.+++...+ .+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~ 170 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSR------RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGM 170 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccc
Confidence 99999999999999996543 599999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
++..... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||........ .... .....
T Consensus 171 a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~~~i----~~~~~- 241 (353)
T 3txo_A 171 CKEGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL---FEAI----LNDEV- 241 (353)
T ss_dssp CBCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH----HHCCC-
T ss_pred eeecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH---HHHH----HcCCC-
Confidence 9864322 2234456899999999999999999999999999999999999999976543221 1111 11110
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHHhc
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSM------STVVQMLM 320 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~~l~ 320 (391)
.++......+.+++.+||+.||.+||++ .|++++-+
T Consensus 242 ---------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~ 283 (353)
T 3txo_A 242 ---------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283 (353)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGG
T ss_pred ---------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCc
Confidence 1122234568889999999999999998 78877654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=349.16 Aligned_cols=258 Identities=27% Similarity=0.455 Sum_probs=213.0
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
.+..++|++.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+....++||
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EeChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 455688999999999999999999998899999999976533 3467899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++...
T Consensus 85 e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 156 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFV 156 (269)
T ss_dssp ECCTTCBHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred EeCCCCcHHHHHHhcC-----cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccc
Confidence 9999999999996532 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
............+++.|+|||++.+..++.++||||||+++|+|++ |..||........ .... ...
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~---~~~~----~~~------ 223 (269)
T 4hcu_A 157 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---VEDI----STG------ 223 (269)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHH----HTT------
T ss_pred cccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH---HHHH----hcC------
Confidence 4432222333456788999999999999999999999999999999 8999975433211 1111 100
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.....+...+..+.+++.+||+.||.+||++.+++++|...
T Consensus 224 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 224 ---FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 01111222345788999999999999999999999998653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=362.71 Aligned_cols=265 Identities=24% Similarity=0.374 Sum_probs=214.1
Q ss_pred HHHhhCCCCCCceeeccCceEEEEEEeC--------CCcEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCceeEEEEE
Q 016347 39 LSIATDDFSPINKIGEGGFGSVYKGRLK--------DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHENLVKLYGC 108 (391)
Q Consensus 39 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 108 (391)
+.+..++|++.+.||+|+||.||+|.+. ++..||||++... .......+.+|+.+++.+ +||||++++++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 3445688999999999999999999862 3567999999765 334567789999999999 89999999999
Q ss_pred EEeCCeeEEEEecccCCCHHHHHhcCCCC----------CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 016347 109 CVEGNHRILVYNYLENNSLAQTLIGGGHH----------YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKAS 178 (391)
Q Consensus 109 ~~~~~~~~lv~e~~~~~sL~~~i~~~~~~----------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~ 178 (391)
+...+..++||||+++|+|.+++...... .....+++..++.++.||+.||.|||++ ||+||||||+
T Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~ 232 (370)
T 2psq_A 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 232 (370)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGG
T ss_pred EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchh
Confidence 99999999999999999999999764321 1234589999999999999999999999 9999999999
Q ss_pred cEEECCCCcEEEEecccccccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCc
Q 016347 179 NILLDKDLTPKISDFGLAKLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPT 256 (391)
Q Consensus 179 NIlv~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~ 256 (391)
|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999999999986643321 12223457789999999999999999999999999999999 99999764332
Q ss_pred chhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 257 EEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
... ... .. ......+...+..+.+++.+||+.||.+||++.|+++.|..+
T Consensus 313 ~~~---~~~----~~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 313 ELF---KLL----KE---------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp GHH---HHH----HT---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH---HHH----hc---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 211 111 11 111122334456788999999999999999999999998654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=352.12 Aligned_cols=267 Identities=23% Similarity=0.380 Sum_probs=217.6
Q ss_pred cceeechHHHHHhhCC----------CCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCC
Q 016347 30 NVKLYSYKELSIATDD----------FSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIE 98 (391)
Q Consensus 30 ~~~~~~~~e~~~~~~~----------y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~ 98 (391)
....|+++++..+.+. |...++||+|+||.||+|.+. +|+.||||++........+.+.+|+.+++.++
T Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~ 100 (321)
T 2c30_A 21 QSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ 100 (321)
T ss_dssp ----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC
T ss_pred cCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC
Confidence 3456788887766653 777889999999999999987 69999999998766666778999999999999
Q ss_pred CCceeEEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 016347 99 HENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKAS 178 (391)
Q Consensus 99 h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~ 178 (391)
||||+++++++......++||||+++++|.+++.. ..+++..+..++.||+.||.|||+. |++||||||+
T Consensus 101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~ 170 (321)
T 2c30_A 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-------VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSD 170 (321)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGG
T ss_pred CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHH
Confidence 99999999999999999999999999999999853 3589999999999999999999999 9999999999
Q ss_pred cEEECCCCcEEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcch
Q 016347 179 NILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEE 258 (391)
Q Consensus 179 NIlv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~ 258 (391)
||+++.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 171 NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~ 249 (321)
T 2c30_A 171 SILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 249 (321)
T ss_dssp GEEECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred HEEECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999987643322 23346799999999999999999999999999999999999999975433221
Q ss_pred hhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 259 QYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
. .. ..... .+.+ ......+..+.+++.+||+.||++|||+.|++++.+.
T Consensus 250 ~---~~----~~~~~-----~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~ 298 (321)
T 2c30_A 250 M---KR----LRDSP-----PPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFL 298 (321)
T ss_dssp H---HH----HHHSS-----CCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred H---HH----HhcCC-----CCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 1 11 11000 0000 1112234568889999999999999999999987643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=349.59 Aligned_cols=262 Identities=27% Similarity=0.374 Sum_probs=208.0
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
+..++|++++.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 45689999999999999999999976 5899999998543 3344567899999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+||||++|++|.+++...+ .+++..++.++.||+.||.|||++ |++||||||+||+++.++.+||+|||++
T Consensus 88 lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 158 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIA 158 (294)
T ss_dssp EEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSS
T ss_pred EEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCc
Confidence 9999999999999996533 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccce
Q 016347 197 KLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL 276 (391)
Q Consensus 197 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (391)
...............||+.|+|||++.+..++.++|||||||++|+|++|..||........ ....... ...
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~-~~~- 230 (294)
T 4eqm_A 159 KALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQD-SVP- 230 (294)
T ss_dssp TTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSS-CCC-
T ss_pred cccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhc-cCC-
Confidence 87654433334456799999999999999999999999999999999999999976543211 0111110 000
Q ss_pred eeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHhcCCC
Q 016347 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRP-SMSTVVQMLMGEK 323 (391)
Q Consensus 277 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~l~~~~ 323 (391)
...... ....+..+.+++.+||+.||.+|| +++++.+.|....
T Consensus 231 ~~~~~~----~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 231 NVTTDV----RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp CHHHHS----CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred Ccchhc----ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 000111 112345788899999999999998 8999999887653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=354.83 Aligned_cols=259 Identities=26% Similarity=0.403 Sum_probs=210.1
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeC----CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCe
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLK----DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNH 114 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (391)
++..++|++.+.||+|+||.||+|.+. .+..||||++... .......+.+|+.+++.++||||+++++++.+.+.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 345678999999999999999999975 3556999999765 44455779999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.++||||+++++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg 196 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHD-----GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFG 196 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCS
T ss_pred cEEEeeCCCCCcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCC
Confidence 999999999999999996532 3589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCce--eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhh
Q 016347 195 LAKLIPANMTH--VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYER 271 (391)
Q Consensus 195 ~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 271 (391)
++......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||........ ... ...
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~~----~~~ 269 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV---ISS----VEE 269 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH---HHH----HHT
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH---HHH----HHc
Confidence 99876443221 2223346778999999999999999999999999999999 9999965433211 111 111
Q ss_pred cccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 272 RELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
......+...+..+.+++.+||+.||.+||++.+|++.|...
T Consensus 270 ---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 270 ---------GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp ---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111122234456788999999999999999999999999655
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=359.64 Aligned_cols=261 Identities=23% Similarity=0.328 Sum_probs=206.3
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCe
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNH 114 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 114 (391)
.+..++|++++.||+|+||+||+|++. +++.||+|++.... ......+..|..++.++ +||||+++++++.+...
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 344578999999999999999999987 48899999997652 22334577899999877 89999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.++||||++||+|..++...+ .+++..+..++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG 198 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYG 198 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEEcCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecc
Confidence 999999999999999996533 599999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhh--HHHHHHHHhhhc
Q 016347 195 LAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQY--LLERTWDLYERR 272 (391)
Q Consensus 195 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~ 272 (391)
+++..... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ............
T Consensus 199 la~~~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~ 277 (396)
T 4dc2_A 199 MCKEGLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 277 (396)
T ss_dssp TCBCCCCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC
T ss_pred eeeecccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc
Confidence 99863222 223455789999999999999999999999999999999999999996543221100 000011111111
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHHhc
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSM------STVVQMLM 320 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~~l~ 320 (391)
. ..++...+..+.+|+.+||+.||.+||++ .|++++-+
T Consensus 278 ~----------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpf 321 (396)
T 4dc2_A 278 Q----------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321 (396)
T ss_dssp C----------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTT
T ss_pred c----------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcc
Confidence 1 01222345578889999999999999985 67777654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=355.24 Aligned_cols=275 Identities=23% Similarity=0.350 Sum_probs=208.8
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEe-----CCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEe--C
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRL-----KDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVE--G 112 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~ 112 (391)
.+..++|+++++||+|+||.||+|++ .+++.||||++........+.+.+|+.+++.++||||+++++++.. .
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 34568899999999999999999984 2589999999987777777889999999999999999999999864 3
Q ss_pred CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEe
Q 016347 113 NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISD 192 (391)
Q Consensus 113 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~D 192 (391)
...++||||+++++|.+++.... ..+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~D 157 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD 157 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred CceEEEEEeCCCCCHHHHHHhcc-----cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEcc
Confidence 56899999999999999996532 3589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCc--eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh
Q 016347 193 FGLAKLIPANMT--HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE 270 (391)
Q Consensus 193 fg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 270 (391)
||++........ .......++..|+|||++.+..++.++|||||||++|+|++|..|+....................
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T 3ugc_A 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237 (295)
T ss_dssp CCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHH
T ss_pred CcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchh
Confidence 999987643322 122234567789999999999999999999999999999999988754211100000000000000
Q ss_pred hcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 271 RRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.......+........+...+..+.+++.+||+.||++|||+.|+++.|..+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0000011111111222334456788999999999999999999999998654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=348.93 Aligned_cols=262 Identities=24% Similarity=0.429 Sum_probs=212.3
Q ss_pred hHHHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 36 YKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 36 ~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
+..+.+..++|++++.||+|+||.||+|.+.++..||+|++..... ..+.+.+|+++++.++||||+++++++.+.+..
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence 3445666789999999999999999999999888999999976532 346789999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||||+++++|.+++... ...+++..++.++.||+.||.|||++ +++|+||||+||+++.++.+||+|||+
T Consensus 95 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~ 166 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREM-----RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGL 166 (283)
T ss_dssp EEEECCCTTCBHHHHHHCG-----GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred EEEEeccCCCcHHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccc
Confidence 9999999999999999652 23589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
+...............+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......... .. ....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~---~~----~~~~-- 237 (283)
T 3gen_A 167 SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA---EH----IAQG-- 237 (283)
T ss_dssp GGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH---HH----HHTT--
T ss_pred cccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH---HH----Hhcc--
Confidence 98764332222233456788999999999999999999999999999998 99999754432111 11 1100
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.....+...+..+.+++.+||+.||.+|||+.+++++|...
T Consensus 238 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 238 -------LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 01111222345788999999999999999999999998643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=347.17 Aligned_cols=248 Identities=26% Similarity=0.383 Sum_probs=208.3
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
.++|++++.||+|+||.||+|+.. +|+.||+|++.... ......+.+|..+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 478999999999999999999987 59999999987542 23456788899999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|||++||+|.+++...+ .+++..+..++.||+.||.|||++ |++||||||+|||++.+|.+||+|||++..
T Consensus 85 ~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~ 155 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKY 155 (318)
T ss_dssp ECCCCSCBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCccee
Confidence 99999999999997543 489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
.... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||........ .... .. ...
T Consensus 156 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i---~~-~~~---- 220 (318)
T 1fot_A 156 VPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT---YEKI---LN-AEL---- 220 (318)
T ss_dssp CSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHH---HH-CCC----
T ss_pred cCCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHH---Hh-CCC----
Confidence 5432 2346799999999999999999999999999999999999999975432211 1111 11 110
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHhc
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRP-----SMSTVVQMLM 320 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~ 320 (391)
.++......+.+++.+||+.||.+|| ++++++++-+
T Consensus 221 ------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~ 261 (318)
T 1fot_A 221 ------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261 (318)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred ------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcc
Confidence 11223345788899999999999999 8999987654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=350.77 Aligned_cols=248 Identities=23% Similarity=0.325 Sum_probs=208.6
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
.++|++++.||+|+||.||+|++. +|+.||+|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 478999999999999999999987 59999999987542 24456788999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|||++||+|.+++...+ .+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||++..
T Consensus 120 ~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~ 190 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190 (350)
T ss_dssp EECCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEccccccee
Confidence 99999999999997533 489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
.... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||........ ... ......
T Consensus 191 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~----i~~~~~---- 255 (350)
T 1rdq_E 191 VKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI---YEK----IVSGKV---- 255 (350)
T ss_dssp CSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH----HHHCCC----
T ss_pred ccCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH---HHH----HHcCCC----
Confidence 6432 2346799999999999999999999999999999999999999976533211 111 111110
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHhc
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPS-----MSTVVQMLM 320 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l~ 320 (391)
.++...+..+.+++.+||+.||.+||+ +++++++-+
T Consensus 256 ------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~ 296 (350)
T 1rdq_E 256 ------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp ------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence 112233457889999999999999998 888887654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=357.13 Aligned_cols=252 Identities=22% Similarity=0.264 Sum_probs=209.5
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch------hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCe
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR------QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNH 114 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (391)
..++|++.+.||+|+||.||+|.+. +|+.||+|++..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3578999999999999999999987 599999999876532 135678999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC----cEEE
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL----TPKI 190 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~----~~kl 190 (391)
.++||||++||+|.+++...+ .+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl 160 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKL 160 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred EEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEE
Confidence 999999999999999996433 589999999999999999999999 999999999999998876 7999
Q ss_pred EecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh
Q 016347 191 SDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE 270 (391)
Q Consensus 191 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 270 (391)
+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .... .
T Consensus 161 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~---~~~i----~ 231 (361)
T 2yab_A 161 IDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LANI----T 231 (361)
T ss_dssp CCCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHH----H
T ss_pred EecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH----H
Confidence 9999998764432 23346799999999999999999999999999999999999999976432211 1111 0
Q ss_pred hcccceeeeccCCCCCCH----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 271 RRELILLVDTSLNGDFDA----EEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
... ..++. ..+..+.+|+.+||+.||.+|||+.|++++-+.
T Consensus 232 ~~~----------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 276 (361)
T 2yab_A 232 AVS----------YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (361)
T ss_dssp TTC----------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred hcC----------CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCc
Confidence 000 01111 123468889999999999999999999987654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=340.31 Aligned_cols=283 Identities=37% Similarity=0.604 Sum_probs=227.8
Q ss_pred cceeechHHHHHhhCCCCCC------ceeeccCceEEEEEEeCCCcEEEEEEeccc----chhcHHHHHHHHHHHhcCCC
Q 016347 30 NVKLYSYKELSIATDDFSPI------NKIGEGGFGSVYKGRLKDGKIAAIKVLSAE----SRQGVKEFLTEIQVISEIEH 99 (391)
Q Consensus 30 ~~~~~~~~e~~~~~~~y~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h 99 (391)
+...|++.++.-++++|... ++||+|+||.||+|.+ +++.||+|++... .....+.+.+|+.+++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 56889999999999998877 9999999999999997 4889999998653 23445778999999999999
Q ss_pred CceeEEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 016347 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASN 179 (391)
Q Consensus 100 ~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~N 179 (391)
|||+++++++.+.+..++||||+++++|.+++.... ....+++..++.++.||+.||.|||++ |++|+||||+|
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~N 163 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD---GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSAN 163 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG---GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHH
Confidence 999999999999999999999999999999996432 234589999999999999999999999 99999999999
Q ss_pred EEECCCCcEEEEecccccccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcch
Q 016347 180 ILLDKDLTPKISDFGLAKLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEE 258 (391)
Q Consensus 180 Ilv~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~ 258 (391)
|+++.++.+||+|||++........ .......||+.|+|||++. +.++.++|||||||++|+|++|..||........
T Consensus 164 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 242 (307)
T 2nru_A 164 ILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242 (307)
T ss_dssp EEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT-TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred EEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc-CCCCccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence 9999999999999999987643322 2233457899999999875 4689999999999999999999999976544332
Q ss_pred hhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 259 QYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
......... .....+...++..+ ...+......+.+++.+||+.||.+||++.+|+++|+..
T Consensus 243 ~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 243 LLDIKEEIE-DEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp TTHHHHHHH-TTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHhh-hhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 111111100 01111122222222 245667888999999999999999999999999998654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=343.23 Aligned_cols=272 Identities=19% Similarity=0.247 Sum_probs=215.5
Q ss_pred hhCCCCCCceeeccCceEEEEEEeCC-CcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC--eeEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN--HRIL 117 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~l 117 (391)
..++|++.+.||+|+||.||+|.+.. ++.||||++.... ....+.+.+|+++++.++||||+++++++.... ..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 45789999999999999999999874 8999999987643 344677889999999999999999999998755 7899
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----CCCCcEEEEec
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL----DKDLTPKISDF 193 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv----~~~~~~kl~Df 193 (391)
||||+++++|.+++.... ....+++..++.++.||+.||.|||++ |++||||||+|||+ +.++.+||+||
T Consensus 87 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Df 160 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPS---NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (319)
T ss_dssp EEECCTTCBHHHHHHSGG---GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred EEeCCCCCCHHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccC
Confidence 999999999999997542 223389999999999999999999999 99999999999999 88889999999
Q ss_pred ccccccCCCCceeeeeecccccccChhhhh--------cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcch-hhHHHH
Q 016347 194 GLAKLIPANMTHVSTRVAGTIGYLAPEYAI--------RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEE-QYLLER 264 (391)
Q Consensus 194 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~-~~~~~~ 264 (391)
|++........ .....||+.|+|||++. +..++.++|||||||++|+|++|..||........ ......
T Consensus 161 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 238 (319)
T 4euu_A 161 GAARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (319)
T ss_dssp TTCEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH
T ss_pred CCceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Confidence 99987654322 23456999999999986 47789999999999999999999999975443222 112222
Q ss_pred HHHHhhhcccce---------eeecc--CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 265 TWDLYERRELIL---------LVDTS--LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 265 ~~~~~~~~~~~~---------~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
............ .+... ............+.+++.+||+.||++|||++|++++...
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 111111110000 01111 1124456778889999999999999999999999999854
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=349.35 Aligned_cols=270 Identities=21% Similarity=0.291 Sum_probs=206.7
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
...++|+++++||+|+||+||+|++.+|+.||+|++.... ......+.+|+++++.++||||+++++++.+....++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 3458899999999999999999999889999999987542 23346788999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|||+++ +|.+.+.... ..+++..+..++.||+.||.|||++ |++||||||+|||++.++.+||+|||++..
T Consensus 98 ~e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 168 (311)
T 3niz_A 98 FEFMEK-DLKKVLDENK-----TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARA 168 (311)
T ss_dssp EECCSE-EHHHHHHTCT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EcCCCC-CHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCcee
Confidence 999985 7888886532 3589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccce-
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL- 276 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 276 (391)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..........................
T Consensus 169 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 169 FGIPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp TTSCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred cCCCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence 643322 2334578999999999876 5689999999999999999999999976554433211111110000000000
Q ss_pred -----eeec--cCCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 277 -----LVDT--SLNGDFD-----AEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 277 -----~~~~--~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.... ......+ ......+.+|+.+||+.||++|||+.|++++-+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 303 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 0000 0000001 112346789999999999999999999998754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=371.46 Aligned_cols=266 Identities=27% Similarity=0.409 Sum_probs=218.2
Q ss_pred echHHHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC
Q 016347 34 YSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN 113 (391)
Q Consensus 34 ~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (391)
+...++++..++|++.+.||+|+||.||+|.+.++..||||++.... ...+.+.+|+.+++.++||||+++++++. ..
T Consensus 178 ~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 178 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp CCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ccccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 44567788889999999999999999999999888999999998653 34678999999999999999999999986 56
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
..++||||+++|+|.+++... ....+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+||
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DF 328 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADF 328 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSH----HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECST
T ss_pred ccEEEEeecCCCcHHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeC
Confidence 789999999999999999642 123588999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 194 GLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 194 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
|+++..............+++.|+|||++..+.++.++|||||||++|||++ |..||......+.. .. ....
T Consensus 329 G~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~---~~----i~~~ 401 (454)
T 1qcf_A 329 GLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---RA----LERG 401 (454)
T ss_dssp TGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HH----HHHT
T ss_pred CCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HH----HHcC
Confidence 9998764322111223346788999999999999999999999999999999 99999754332211 11 1111
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKD 324 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~ 324 (391)
.....+...+..+.+++.+||+.||++|||+.+|++.|+....
T Consensus 402 ---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 402 ---------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp ---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred ---------CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 1112223345678899999999999999999999999977643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=354.50 Aligned_cols=254 Identities=26% Similarity=0.379 Sum_probs=210.0
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
+..++|++++.||+|+||.||+|.+. +++.||+|++... .......+.+|+.+|+.++||||+++++++.+....+
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 91 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF 91 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34578999999999999999999987 4899999998754 2344577889999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+||||+.||+|.+++...+ .+++..+..++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||++
T Consensus 92 lv~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a 162 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQNV------HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIA 162 (384)
T ss_dssp EEECCCTTEEHHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEecccee
Confidence 9999999999999997543 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCceeeeeecccccccChhhhhc---CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcc
Q 016347 197 KLIPANMTHVSTRVAGTIGYLAPEYAIR---GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRE 273 (391)
Q Consensus 197 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (391)
...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||................. ..
T Consensus 163 ~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~----~~ 236 (384)
T 4fr4_A 163 AMLPRE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET----TV 236 (384)
T ss_dssp EECCTT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH----CC
T ss_pred eeccCC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh----cc
Confidence 876433 22345689999999999864 4589999999999999999999999976554433322222111 00
Q ss_pred cceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHHh
Q 016347 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPS-MSTVVQML 319 (391)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl~~l 319 (391)
..++...+..+.+|+.+||+.||.+||+ +++++++-
T Consensus 237 ----------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp 273 (384)
T 4fr4_A 237 ----------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFP 273 (384)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSG
T ss_pred ----------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcCh
Confidence 1122234567889999999999999998 77776543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=357.28 Aligned_cols=268 Identities=24% Similarity=0.259 Sum_probs=215.3
Q ss_pred eechHHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEE
Q 016347 33 LYSYKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGC 108 (391)
Q Consensus 33 ~~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 108 (391)
.+.++++.+..++|++++.||+|+||.||+|+.. +|+.||+|++.... ......+.+|..++..++||||++++++
T Consensus 50 ~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp HHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 3467788888999999999999999999999986 69999999997532 2233457889999999999999999999
Q ss_pred EEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcE
Q 016347 109 CVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTP 188 (391)
Q Consensus 109 ~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~ 188 (391)
+.+.+..++||||++||+|.+++...+ ..+++..++.++.||+.||.|||++ +|+||||||+|||++.+|.+
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~v 201 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSKFG-----ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHI 201 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCE
Confidence 999999999999999999999996532 2589999999999999999999999 99999999999999999999
Q ss_pred EEEecccccccCCCCceeeeeecccccccChhhhh-------cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhH
Q 016347 189 KISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAI-------RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYL 261 (391)
Q Consensus 189 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~ 261 (391)
||+|||++..............+||+.|+|||++. ...++.++|||||||++|||++|+.||.........
T Consensus 202 kL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-- 279 (412)
T 2vd5_A 202 RLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY-- 279 (412)
T ss_dssp EECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--
T ss_pred EEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH--
Confidence 99999999876544433344568999999999987 357899999999999999999999999765432211
Q ss_pred HHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCC---CCHHHHHHHhcC
Q 016347 262 LERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLR---PSMSTVVQMLMG 321 (391)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---ps~~evl~~l~~ 321 (391)
.... ........ + ......+..+.+|+.+||. +|.+| |+++|++++-+.
T Consensus 280 -~~i~---~~~~~~~~--p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff 331 (412)
T 2vd5_A 280 -GKIV---HYKEHLSL--P----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFF 331 (412)
T ss_dssp -HHHH---THHHHCCC--C--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGG
T ss_pred -HHHH---hcccCcCC--C----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCc
Confidence 1111 00000000 0 0011234578889999999 99998 589999887543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=358.14 Aligned_cols=257 Identities=22% Similarity=0.351 Sum_probs=202.6
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCC--CceeEEEEEEEeCCee
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEH--ENLVKLYGCCVEGNHR 115 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~ 115 (391)
.+.+++|++++.||+|+||.||+|.+.+++.||||++... .......+.+|+.+++.++| |||+++++++.+....
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 4557889999999999999999999988999999998754 33445778999999999976 9999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||| +.+++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||+
T Consensus 85 ~lv~e-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~ 153 (343)
T 3dbq_A 85 YMVME-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGI 153 (343)
T ss_dssp EEEEC-CCSEEHHHHHHHSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSS
T ss_pred EEEEe-CCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccc
Confidence 99999 56889999997543 589999999999999999999999 999999999999997 67899999999
Q ss_pred ccccCCCCce-eeeeecccccccChhhhhc-----------CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHH
Q 016347 196 AKLIPANMTH-VSTRVAGTIGYLAPEYAIR-----------GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLE 263 (391)
Q Consensus 196 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~ 263 (391)
+......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........
T Consensus 154 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----- 228 (343)
T 3dbq_A 154 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----- 228 (343)
T ss_dssp SCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----
T ss_pred ccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH-----
Confidence 9876433221 2334679999999999875 6789999999999999999999999975432111
Q ss_pred HHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 264 RTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
..... ++.......+......+.+++.+||+.||.+|||+.|++++.+.
T Consensus 229 ~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~ 277 (343)
T 3dbq_A 229 KLHAI---------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277 (343)
T ss_dssp HHHHH---------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HHHHH---------hcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence 11111 11111112222223568889999999999999999999987644
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=354.76 Aligned_cols=254 Identities=26% Similarity=0.368 Sum_probs=206.8
Q ss_pred HHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCC
Q 016347 39 LSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGN 113 (391)
Q Consensus 39 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 113 (391)
..+..++|++.+.||+|+||.||+|++. +|+.||+|++.... ......+..|..++..+ +||||+++++++.+.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 3456689999999999999999999987 58999999997642 33456678899999876 9999999999999999
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
..++||||++||+|.+++...+ .+++..+..++.||+.||.|||++ ||+||||||+|||++.+|.+||+||
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DF 162 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADF 162 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEC
Confidence 9999999999999999996532 589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcc
Q 016347 194 GLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRE 273 (391)
Q Consensus 194 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (391)
|+++..... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..... ....
T Consensus 163 G~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i----~~~~ 234 (345)
T 1xjd_A 163 GMCKENMLG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSI----RMDN 234 (345)
T ss_dssp TTCBCCCCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HHCC
T ss_pred hhhhhcccC-CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----HhCC
Confidence 999864322 122345689999999999999999999999999999999999999997643321 11111 1110
Q ss_pred cceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHH-HHHHHh
Q 016347 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMS-TVVQML 319 (391)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl~~l 319 (391)
. .++...+..+.+++.+||+.||.+||++. +++++-
T Consensus 235 ------~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp 271 (345)
T 1xjd_A 235 ------P----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 271 (345)
T ss_dssp ------C----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred ------C----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCc
Confidence 0 11222345788899999999999999997 666543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=363.06 Aligned_cols=263 Identities=25% Similarity=0.373 Sum_probs=213.2
Q ss_pred hHHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC
Q 016347 36 YKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN 113 (391)
Q Consensus 36 ~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (391)
...+.+..++|++.+.||+|+||.||+|.+. +++.||||++... .......+.+|+.+++.++||||+++++++...+
T Consensus 106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 3455667789999999999999999999987 6899999998754 2334456889999999999999999999999989
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
..++||||+++|+|.+++... ...+++..+..++.||+.||+|||++ +++||||||+|||++.++.+||+||
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~Df 257 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTE-----GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDF 257 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHH-----GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCG
T ss_pred CcEEEEEcCCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcC
Confidence 999999999999999999642 23589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCceee-eeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhh
Q 016347 194 GLAKLIPANMTHVS-TRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYER 271 (391)
Q Consensus 194 g~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 271 (391)
|+++.......... ....+++.|+|||++.++.++.++|||||||++|||++ |..||......... .....
T Consensus 258 G~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~-------~~~~~ 330 (377)
T 3cbl_A 258 GMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR-------EFVEK 330 (377)
T ss_dssp GGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-------HHHHT
T ss_pred CCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHc
Confidence 99986533211111 11235678999999999999999999999999999998 99998754332211 11111
Q ss_pred cccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 272 RELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
. .....+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 331 ~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 331 G---------GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 1 11122223455788999999999999999999999998643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=348.06 Aligned_cols=251 Identities=20% Similarity=0.247 Sum_probs=209.2
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 578999999999999999999987 58899999987543 3346688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC--CCcEEEEeccccccc
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK--DLTPKISDFGLAKLI 199 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~--~~~~kl~Dfg~~~~~ 199 (391)
++|++|.+++... ...+++..++.++.||+.||.|||++ |++||||||+|||++. ++.+||+|||++...
T Consensus 83 ~~g~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 83 ISGLDIFERINTS-----AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCBHHHHHTSS-----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred CCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 9999999999643 23589999999999999999999999 9999999999999987 789999999999876
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .... .....
T Consensus 155 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i----~~~~~----- 220 (321)
T 1tki_A 155 KPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI---IENI----MNAEY----- 220 (321)
T ss_dssp CTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHH----HHTCC-----
T ss_pred CCCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH---HHHH----HcCCC-----
Confidence 5432 23446799999999999988899999999999999999999999976433211 1111 10000
Q ss_pred ccCCCCCCH----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 280 TSLNGDFDA----EEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 280 ~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
..+. ..+..+.+++.+||+.||.+|||+.|++++-+.
T Consensus 221 -----~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~ 261 (321)
T 1tki_A 221 -----TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp -----CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred -----CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhh
Confidence 1111 224578899999999999999999999997654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=350.09 Aligned_cols=254 Identities=25% Similarity=0.348 Sum_probs=199.6
Q ss_pred HhhCCCCCCceeeccCceEEEEEEe----CCCcEEEEEEecccc----hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRL----KDGKIAAIKVLSAES----RQGVKEFLTEIQVISEIEHENLVKLYGCCVEG 112 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (391)
+..++|++.+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 4468899999999999999999997 368999999987542 23345678899999999999999999999999
Q ss_pred CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEe
Q 016347 113 NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISD 192 (391)
Q Consensus 113 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~D 192 (391)
+..++||||+++++|.+++...+ .+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~D 164 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLEREG------IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTD 164 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECC
T ss_pred CEEEEEEeCCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEe
Confidence 99999999999999999996433 489999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 193 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
||++...... ........||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..... . .
T Consensus 165 fg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~---~-~ 236 (327)
T 3a62_A 165 FGLCKESIHD-GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT---IDKIL---K-C 236 (327)
T ss_dssp CSCC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHH---H-T
T ss_pred CCcccccccC-CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH---HHHHH---h-C
Confidence 9998754322 1223345799999999999999999999999999999999999999975432211 11111 1 0
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHhcC
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRP-----SMSTVVQMLMG 321 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~ 321 (391)
. ...+......+.+++.+||+.||.+|| ++.|++++-+.
T Consensus 237 ~----------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f 280 (327)
T 3a62_A 237 K----------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280 (327)
T ss_dssp C----------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG
T ss_pred C----------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc
Confidence 0 011223345788899999999999999 78899887543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=349.14 Aligned_cols=273 Identities=24% Similarity=0.361 Sum_probs=217.6
Q ss_pred ceeechHHHHHhhCCCCCCceeeccCceEEEEEEeC------CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCcee
Q 016347 31 VKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLV 103 (391)
Q Consensus 31 ~~~~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv 103 (391)
.+.+...++.+..++|++.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+.+++.++||||+
T Consensus 10 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv 89 (314)
T 2ivs_A 10 FKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89 (314)
T ss_dssp ----CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBC
T ss_pred eeccCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCcee
Confidence 334444566677899999999999999999999862 3588999999764 344567789999999999999999
Q ss_pred EEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCC------------------CccccCHHHHHHHHHHHHHHHHHhhhc
Q 016347 104 KLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHY------------------SNIQFSWRTRSRICIGIARGLAFLHEE 165 (391)
Q Consensus 104 ~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~------------------~~~~l~~~~~~~i~~qi~~al~~lH~~ 165 (391)
++++++.+.+..++||||+++++|.+++....... ....+++..++.++.||+.||.|||++
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 169 (314)
T 2ivs_A 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM 169 (314)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT
T ss_pred eEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC
Confidence 99999999999999999999999999997643210 124589999999999999999999999
Q ss_pred CCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCce-eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHH
Q 016347 166 VRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTH-VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIV 244 (391)
Q Consensus 166 ~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ell 244 (391)
+++||||||+||+++.++.+||+|||++......... ......+++.|+|||++.+..++.++|||||||++|+|+
T Consensus 170 ---~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 246 (314)
T 2ivs_A 170 ---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246 (314)
T ss_dssp ---TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred ---CCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHH
Confidence 9999999999999999999999999999876443222 222345778899999999999999999999999999999
Q ss_pred h-CCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 245 S-GRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 245 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
+ |..||......... .. ..... ....+...+..+.+++.+||+.||.+||++.+++++|...
T Consensus 247 t~g~~p~~~~~~~~~~---~~----~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 247 TLGGNPYPGIPPERLF---NL----LKTGH---------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp TTSCCSSTTCCGGGHH---HH----HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hCCCCCCCCCCHHHHH---HH----hhcCC---------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 9 99999765443211 11 11110 1122223456788999999999999999999999998643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=346.68 Aligned_cols=258 Identities=23% Similarity=0.330 Sum_probs=206.4
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 117 (391)
.++|++++.||+|+||.||+|++. +++.||+|++... .......+.+|..++..+ +||||+++++++.+....++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 478999999999999999999987 5899999999765 234456688899999887 89999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
||||++||+|.+++...+ .+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+++
T Consensus 88 v~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~ 158 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK 158 (345)
T ss_dssp EECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCB
T ss_pred EEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccc
Confidence 999999999999996432 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchh--hHHHHHHHHhhhcccc
Q 016347 198 LIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQ--YLLERTWDLYERRELI 275 (391)
Q Consensus 198 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~ 275 (391)
..... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||......... ..............
T Consensus 159 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-- 235 (345)
T 3a8x_A 159 EGLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-- 235 (345)
T ss_dssp CSCCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC--
T ss_pred cccCC-CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC--
Confidence 64322 22334568999999999999999999999999999999999999999653221100 00001111111111
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHHhc
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSM------STVVQMLM 320 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~~l~ 320 (391)
..++...+..+.+++.+||+.||.+||++ .|++++-+
T Consensus 236 --------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~ 278 (345)
T 3a8x_A 236 --------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278 (345)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGG
T ss_pred --------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCc
Confidence 01222344578889999999999999995 67776543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=358.86 Aligned_cols=270 Identities=24% Similarity=0.367 Sum_probs=218.0
Q ss_pred chHHHHHhhCCCCCCceeeccCceEEEEEEeC--------CCcEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCceeE
Q 016347 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLK--------DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHENLVK 104 (391)
Q Consensus 35 ~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~ 104 (391)
....+++..++|++.++||+|+||.||+|.+. .+..||+|++... .......+.+|+++++.+ +||||++
T Consensus 60 ~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 60 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhh
Confidence 44556777899999999999999999999863 2467999998765 344557789999999999 9999999
Q ss_pred EEEEEEeCCeeEEEEecccCCCHHHHHhcCCCC----------CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecC
Q 016347 105 LYGCCVEGNHRILVYNYLENNSLAQTLIGGGHH----------YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRD 174 (391)
Q Consensus 105 ~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~----------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~d 174 (391)
+++++...+..++||||+++++|.+++...... .....+++..++.|+.||+.||.|||++ +++|||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D 216 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRD 216 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCC
Confidence 999999999999999999999999999764321 1234689999999999999999999999 999999
Q ss_pred CCCCcEEECCCCcEEEEecccccccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCC
Q 016347 175 IKASNILLDKDLTPKISDFGLAKLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNM 252 (391)
Q Consensus 175 ikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~ 252 (391)
|||+||||+.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 217 lkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 217 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp CCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987643221 22233457889999999999999999999999999999999 9999975
Q ss_pred CCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 253 RLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
...... ....... .....+...+..+.+++.+||+.||++||++.||++.|+...
T Consensus 297 ~~~~~~-------~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 297 VPVEEL-------FKLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp CCHHHH-------HHHHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHHHH-------HHHHHcC---------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 432211 1111111 111122234457889999999999999999999999986653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=344.33 Aligned_cols=261 Identities=23% Similarity=0.295 Sum_probs=199.9
Q ss_pred HHHHHhhCCCCCCceeeccCceEEEEEEeCC----CcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEe
Q 016347 37 KELSIATDDFSPINKIGEGGFGSVYKGRLKD----GKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVE 111 (391)
Q Consensus 37 ~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 111 (391)
.++++..++|++.+.||+|+||.||+|.+.. +..||+|++... .......+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 3445667899999999999999999998753 567999998754 3344567899999999999999999999974
Q ss_pred CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEE
Q 016347 112 GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKIS 191 (391)
Q Consensus 112 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~ 191 (391)
++..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 158 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLG 158 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEEC
T ss_pred cCccEEEEecCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEEC
Confidence 567899999999999999996532 2589999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhh
Q 016347 192 DFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYE 270 (391)
Q Consensus 192 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 270 (391)
|||++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||......... ... .
T Consensus 159 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---~~i----~ 231 (281)
T 1mp8_A 159 DFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRI----E 231 (281)
T ss_dssp C-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHH----H
T ss_pred ccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH---HHH----H
Confidence 999998765433323334457789999999999999999999999999999996 89999765433211 111 1
Q ss_pred hcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 271 RRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
... ....+...+..+.+++.+||+.||.+||++.++++.|...
T Consensus 232 ~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 232 NGE---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 110 0112223456788999999999999999999999998643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=346.24 Aligned_cols=263 Identities=26% Similarity=0.390 Sum_probs=219.1
Q ss_pred hHHHHHhhCCCCCCceeeccCceEEEEEEeCC-CcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCe
Q 016347 36 YKELSIATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNH 114 (391)
Q Consensus 36 ~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (391)
++++++..++|++.+.||+|+||.||+|.+.. +..||+|++.... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34566778999999999999999999999874 8899999987643 345778999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.++||||+++++|.+++... ....+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|||
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg 156 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLREC----NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFG 156 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHC----CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred EEEEEEcCCCCcHHHHHHhc----ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCc
Confidence 99999999999999999753 234589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcc
Q 016347 195 LAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRE 273 (391)
Q Consensus 195 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (391)
++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||.......... .. .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~---~~----~--- 226 (288)
T 3kfa_A 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE---LL----E--- 226 (288)
T ss_dssp GGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH---HH----H---
T ss_pred cceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HH----h---
Confidence 998776544444444567889999999999999999999999999999999 999987654332211 11 0
Q ss_pred cceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.......+...+..+.+++.+||+.||.+||++.++++.|+..
T Consensus 227 ------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 227 ------KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp ------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------ccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 0111122223446788999999999999999999999988543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=356.46 Aligned_cols=272 Identities=25% Similarity=0.364 Sum_probs=217.4
Q ss_pred eechHHHHHhhCCCCCCceeeccCceEEEEEEe------CCCcEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCceeE
Q 016347 33 LYSYKELSIATDDFSPINKIGEGGFGSVYKGRL------KDGKIAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHENLVK 104 (391)
Q Consensus 33 ~~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~ 104 (391)
-|...++++..++|++.+.||+|+||.||+|++ .+++.||||++... .......+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 356778888999999999999999999999974 24689999999764 334456789999999999 7999999
Q ss_pred EEEEEEeCC-eeEEEEecccCCCHHHHHhcCCCCC---------------------------------------------
Q 016347 105 LYGCCVEGN-HRILVYNYLENNSLAQTLIGGGHHY--------------------------------------------- 138 (391)
Q Consensus 105 ~~~~~~~~~-~~~lv~e~~~~~sL~~~i~~~~~~~--------------------------------------------- 138 (391)
+++++.+.+ ..++||||+++|+|.+++.......
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999998755 4899999999999999997643210
Q ss_pred ---------------CccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCC
Q 016347 139 ---------------SNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANM 203 (391)
Q Consensus 139 ---------------~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~ 203 (391)
....+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++.......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 012389999999999999999999999 99999999999999999999999999998764332
Q ss_pred c-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 204 T-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 204 ~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
. .......||+.|+|||++.+..++.++|||||||++|+|++ |..||......... ... .....
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~~----~~~~~-------- 313 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRR----LKEGT-------- 313 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HHH----HHHTC--------
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HHH----HHcCC--------
Confidence 2 23344568899999999999999999999999999999998 99999765433211 111 11110
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
....+...+..+.+++.+||+.||.+|||+.|++++|+..
T Consensus 314 -~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 314 -RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1111222345788999999999999999999999998643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=361.80 Aligned_cols=256 Identities=19% Similarity=0.266 Sum_probs=207.8
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
..++|++.+.||+|+||.||+|.+. +|+.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4678999999999999999999876 69999999987653 33456788999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC---CCCcEEEEeccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLD---KDLTPKISDFGL 195 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~---~~~~~kl~Dfg~ 195 (391)
|||++||+|.+.+...+ .+++..+..++.||+.||.|||++ ||+||||||+|||++ .++.+||+|||+
T Consensus 89 ~E~~~gg~L~~~i~~~~------~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE------YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp ECCCBCCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 99999999999997543 489999999999999999999999 999999999999998 468899999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
+....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ... ......
T Consensus 160 a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~---~~~----i~~~~~- 230 (444)
T 3soa_A 160 AIEVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL---YQQ----IKAGAY- 230 (444)
T ss_dssp CBCCCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHH----HHHTCC-
T ss_pred eEEecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH---HHH----HHhCCC-
Confidence 98765432 223346799999999999999999999999999999999999999965432111 111 111110
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.. ........+..+.+|+.+||+.||.+|||+.|++++-+
T Consensus 231 ~~-----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~ 270 (444)
T 3soa_A 231 DF-----PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPW 270 (444)
T ss_dssp CC-----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred CC-----CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 00 00111123457889999999999999999999999754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=353.70 Aligned_cols=272 Identities=25% Similarity=0.367 Sum_probs=209.5
Q ss_pred HHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC----
Q 016347 38 ELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN---- 113 (391)
Q Consensus 38 e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 113 (391)
++.+..++|++.++||+|+||.||+|++. ++.||||++...... ...+..|+.++++++||||+++++++....
T Consensus 18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp CEEETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence 34455688999999999999999999986 889999999765332 345566899999999999999999998744
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcC-------CCCeeecCCCCCcEEECCCC
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV-------RPHIIHRDIKASNILLDKDL 186 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~-------~~~i~H~dikp~NIlv~~~~ 186 (391)
..++||||+++|+|.+++... .+++..++.++.||+.||.|||+.+ ..+++||||||+|||++.++
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~ 168 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKAN-------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred eEEEEEecCCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence 469999999999999999543 4899999999999999999999852 23799999999999999999
Q ss_pred cEEEEecccccccCCCCce-eeeeecccccccChhhhhc-----CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhh
Q 016347 187 TPKISDFGLAKLIPANMTH-VSTRVAGTIGYLAPEYAIR-----GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQY 260 (391)
Q Consensus 187 ~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~ 260 (391)
.+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..........
T Consensus 169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 248 (322)
T 3soc_A 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248 (322)
T ss_dssp CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence 9999999999876443221 2233578999999999876 356778999999999999999999997654332211
Q ss_pred HHHH---------HHHHhhhcccceeeeccCCCC-CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 261 LLER---------TWDLYERRELILLVDTSLNGD-FDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 261 ~~~~---------~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.... .......... .+.+... .....+..+.+++.+||+.||++|||+.||++.|+.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 249 FEEEIGQHPSLEDMQEVVVHKKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhhhccCCchhhhhhhhhcccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111 0000111110 1111100 1124566799999999999999999999999998654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=351.37 Aligned_cols=269 Identities=24% Similarity=0.374 Sum_probs=199.0
Q ss_pred chHHHHHhhCCCCCCceeeccCceEEEEEEeCC-C---cEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEE
Q 016347 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLKD-G---KIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGC 108 (391)
Q Consensus 35 ~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 108 (391)
.++++.+..++|++.+.||+|+||.||+|.+.. + ..||||++... .....+.+.+|+++++.++||||++++++
T Consensus 14 ~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp --CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred HhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 445666778999999999999999999999764 3 27999998765 34456789999999999999999999999
Q ss_pred EEeCCee------EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 016347 109 CVEGNHR------ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL 182 (391)
Q Consensus 109 ~~~~~~~------~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv 182 (391)
+...... ++||||+++++|.+++...........+++..++.++.||+.||.|||++ |++||||||+||++
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli 170 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCML 170 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEE
Confidence 9876655 99999999999999996533222334689999999999999999999999 99999999999999
Q ss_pred CCCCcEEEEecccccccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhh
Q 016347 183 DKDLTPKISDFGLAKLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQY 260 (391)
Q Consensus 183 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~ 260 (391)
+.++.+||+|||++........ .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~- 249 (323)
T 3qup_A 171 AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY- 249 (323)
T ss_dssp CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-
T ss_pred cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH-
Confidence 9999999999999987543321 12223456789999999999999999999999999999999 89999765443211
Q ss_pred HHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 261 LLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
... .... ....+...+..+.+++.+||+.||.+|||+.++++.|+..
T Consensus 250 --~~~----~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 250 --NYL----IGGN---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp --HHH----HTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHH----hcCC---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 110 0000 0112223445788999999999999999999999888654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=364.20 Aligned_cols=254 Identities=26% Similarity=0.309 Sum_probs=200.1
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
+..++|++++.||+|+||.||+|.+. +|+.||||++... .......+.+|+.+++.++||||+++++++...+..+
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 34578999999999999999999976 5999999998754 2334456788999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHE-EVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
+||||+++++|.+++... ..+++..+..++.||+.||.|||+ + ||+||||||+||||+.++.+||+|||+
T Consensus 225 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~ 295 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRE------RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGL 295 (446)
T ss_dssp EEECCCSSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCC
T ss_pred EEEeeCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCC
Confidence 999999999999998643 358999999999999999999998 7 999999999999999999999999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
+...... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .... ....
T Consensus 296 a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~i----~~~~-- 365 (446)
T 4ejn_A 296 CKEGIKD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELI----LMEE-- 365 (446)
T ss_dssp CCTTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH----HHCC--
T ss_pred ceeccCC-CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HHHH----HhCC--
Confidence 9864332 2223456899999999999999999999999999999999999999975433211 1111 1111
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHhcC
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRP-----SMSTVVQMLMG 321 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~ 321 (391)
..++...+..+.+|+.+||+.||.+|| +++|++++-+.
T Consensus 366 --------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f 408 (446)
T 4ejn_A 366 --------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408 (446)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred --------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccc
Confidence 011223345788999999999999999 99999987543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=367.37 Aligned_cols=263 Identities=30% Similarity=0.456 Sum_probs=210.8
Q ss_pred hHHHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 36 YKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 36 ~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
...+++..++|++.++||+|+||.||+|.+.++..||||++.... ...+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 456677888999999999999999999999888889999998653 235679999999999999999999999866 678
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||||+++|+|.+++... ....+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||+
T Consensus 254 ~iv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~ 326 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGE----TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGL 326 (452)
T ss_dssp EEEECCCTTCBHHHHHSHH----HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred EEEehhhcCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCcc
Confidence 9999999999999999532 123589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
++..............+++.|+|||++.++.++.++|||||||++|+|++ |..||......+. ... ...
T Consensus 327 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~~----i~~--- 396 (452)
T 1fmk_A 327 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQ----VER--- 396 (452)
T ss_dssp TC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHH----HHT---
T ss_pred ceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHH----HHc---
Confidence 98764332222233456789999999999999999999999999999999 8999975433221 111 111
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
......+...+..+.+++.+||+.||++|||+.+|++.|+...
T Consensus 397 ------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 397 ------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp ------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 1111223344567889999999999999999999999997764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=349.96 Aligned_cols=285 Identities=24% Similarity=0.324 Sum_probs=218.0
Q ss_pred cccccCCCcceeechHHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCC--
Q 016347 22 DEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIE-- 98 (391)
Q Consensus 22 ~~~~~~~~~~~~~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-- 98 (391)
+.+..+......|+++++.+..++|+++++||+|+||.||+|.+. +++.||||++... ......+..|+.+++.+.
T Consensus 13 ~~~~~~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~ 91 (360)
T 3llt_A 13 NLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQND 91 (360)
T ss_dssp -------CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCC
T ss_pred ceeeecCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhccc
Confidence 344566777888999999999999999999999999999999985 5899999998753 334456778999999986
Q ss_pred ---CCceeEEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC
Q 016347 99 ---HENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDI 175 (391)
Q Consensus 99 ---h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~di 175 (391)
||||+++++++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||++ ||+||||
T Consensus 92 ~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDl 163 (360)
T 3llt_A 92 DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN----YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDL 163 (360)
T ss_dssp STTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred CCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCC
Confidence 999999999999999999999999 899999997542 23589999999999999999999999 9999999
Q ss_pred CCCcEEECC-------------------------CCcEEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCC
Q 016347 176 KASNILLDK-------------------------DLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRK 230 (391)
Q Consensus 176 kp~NIlv~~-------------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k 230 (391)
||+|||++. ++.+||+|||++...... .....||+.|+|||++.+..++.+
T Consensus 164 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~ 239 (360)
T 3llt_A 164 KPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVS 239 (360)
T ss_dssp SGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTT
T ss_pred CcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCc
Confidence 999999975 789999999999864332 234578999999999999999999
Q ss_pred CcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH--------hhhcccceeeec-c----CCCC-CCHH-------
Q 016347 231 ADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDL--------YERRELILLVDT-S----LNGD-FDAE------- 289 (391)
Q Consensus 231 ~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~-~----~~~~-~~~~------- 289 (391)
+|||||||++|+|++|+.||.................. ............ . .... ....
T Consensus 240 ~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 319 (360)
T 3llt_A 240 SDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKK 319 (360)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHT
T ss_pred cchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhh
Confidence 99999999999999999999765432211111110000 000000000000 0 0000 0000
Q ss_pred --------HHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 290 --------EACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 290 --------~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
....+.+|+.+||+.||.+|||+.|++++-
T Consensus 320 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp 357 (360)
T 3llt_A 320 CLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHK 357 (360)
T ss_dssp CCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred cccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCc
Confidence 115677999999999999999999998764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=357.81 Aligned_cols=258 Identities=26% Similarity=0.413 Sum_probs=199.7
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC----CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK----DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
+..++|++.+.||+|+||.||+|++. ++..||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 34578999999999999999999875 4778999998765 344557799999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||||+++++|.+++...+ ..+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||+
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 193 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGL 193 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EEEEeCCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcc
Confidence 99999999999999997532 3589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCceee--eeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 196 AKLIPANMTHVS--TRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 196 ~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
++.......... ....+++.|+|||++.+..++.++|||||||++|||++ |..||........ ... ....
T Consensus 194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~---~~~----i~~~ 266 (373)
T 2qol_A 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV---IKA----VDEG 266 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH---HHH----HHTT
T ss_pred ccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----HHcC
Confidence 987643322111 12235678999999999999999999999999999998 9999965432211 111 1111
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.....+...+..+.+++.+||+.||.+||++.+|++.|...
T Consensus 267 ---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 267 ---------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ---------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 01112223456788999999999999999999999998655
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=350.39 Aligned_cols=256 Identities=21% Similarity=0.296 Sum_probs=210.9
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
.++|++.+.||+|+||.||+|.+. +|+.||+|++..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 478999999999999999999987 5899999999876555566789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC--CCcEEEEeccccccc
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK--DLTPKISDFGLAKLI 199 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~--~~~~kl~Dfg~~~~~ 199 (391)
+++++|.+++... ...+++..+..++.||+.||.|||++ |++||||||+|||++. ++.+||+|||++...
T Consensus 130 ~~gg~L~~~l~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 130 LSGGELFDRIAAE-----DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp CCCCBHHHHTTCT-----TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred CCCCcHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceec
Confidence 9999999998643 23589999999999999999999999 9999999999999974 478999999999876
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .... .....
T Consensus 202 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---~~~i----~~~~~----- 267 (387)
T 1kob_A 202 NPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---LQNV----KRCDW----- 267 (387)
T ss_dssp CTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHH----HHCCC-----
T ss_pred CCCc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH---HHHH----HhCCC-----
Confidence 5432 23345799999999999999999999999999999999999999976432211 1111 11100
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
..........+..+.+++.+||+.||.+|||+.|++++.+.
T Consensus 268 -~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 308 (387)
T 1kob_A 268 -EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 308 (387)
T ss_dssp -CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred -CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccc
Confidence 01111112335578899999999999999999999987644
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=349.44 Aligned_cols=253 Identities=24% Similarity=0.342 Sum_probs=207.8
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeCC-CcEEEEEEeccc---chhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCee
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE---SRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 115 (391)
+..++|++++.||+|+||.||+|++.. |+.||+|++... .......+..|..++..+ +||+|+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 445899999999999999999999874 889999998764 234456788899999988 899999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||||++||+|.+++...+ .+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~ 167 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGM 167 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCc
Confidence 99999999999999996533 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
+...... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..... .....
T Consensus 168 a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~~i----~~~~~- 238 (353)
T 2i0e_A 168 CKENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSI----MEHNV- 238 (353)
T ss_dssp CBCCCCT-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HHCCC-
T ss_pred ccccccC-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---HHHHH----HhCCC-
Confidence 9864322 223345689999999999999999999999999999999999999997643221 11111 11110
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHhc
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPS-----MSTVVQMLM 320 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l~ 320 (391)
.++...+..+.+++.+||+.||.+||+ +++++++-+
T Consensus 239 ---------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~ 279 (353)
T 2i0e_A 239 ---------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 279 (353)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGG
T ss_pred ---------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcc
Confidence 122234557888999999999999995 578877643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=372.04 Aligned_cols=263 Identities=25% Similarity=0.395 Sum_probs=218.1
Q ss_pred hHHHHHhhCCCCCCceeeccCceEEEEEEeCC-CcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCe
Q 016347 36 YKELSIATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNH 114 (391)
Q Consensus 36 ~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (391)
+.++++..++|++.++||+|+||.||+|.+.. +..||||++.... ...+.|.+|+.+|++++||||+++++++.....
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 34566677889999999999999999999875 8899999997653 346789999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG 363 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECN----RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFG 363 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSC----TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcC----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecc
Confidence 999999999999999997532 23589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcc
Q 016347 195 LAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRE 273 (391)
Q Consensus 195 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (391)
+++..............+++.|+|||++.+..++.++|||||||+||||++ |..||......... .. .
T Consensus 364 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~---~~----~---- 432 (495)
T 1opk_A 364 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---EL----L---- 432 (495)
T ss_dssp CEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---HH----H----
T ss_pred cceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HH----H----
Confidence 998765433222233456788999999999999999999999999999999 88999765433211 11 1
Q ss_pred cceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
........+...+..+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus 433 -----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 433 -----EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp -----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -----HcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 11111122334456788999999999999999999999999765
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=353.20 Aligned_cols=270 Identities=26% Similarity=0.403 Sum_probs=216.6
Q ss_pred chHHHHHhhCCCCCCceeeccCceEEEEEEeC------CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEE
Q 016347 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYG 107 (391)
Q Consensus 35 ~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 107 (391)
....+.+..++|++.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++
T Consensus 38 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 117 (343)
T 1luf_A 38 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLG 117 (343)
T ss_dssp HHHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 34556777899999999999999999999975 3488999999765 3344567899999999999999999999
Q ss_pred EEEeCCeeEEEEecccCCCHHHHHhcCCCCC------------------CccccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 016347 108 CCVEGNHRILVYNYLENNSLAQTLIGGGHHY------------------SNIQFSWRTRSRICIGIARGLAFLHEEVRPH 169 (391)
Q Consensus 108 ~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~------------------~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ 169 (391)
++.+.+..++||||+++++|.+++....... ....+++..++.++.||+.||.|||++ +
T Consensus 118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ 194 (343)
T 1luf_A 118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---K 194 (343)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred EEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 9999999999999999999999997642110 125689999999999999999999999 9
Q ss_pred eeecCCCCCcEEECCCCcEEEEecccccccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CC
Q 016347 170 IIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GR 247 (391)
Q Consensus 170 i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~ 247 (391)
++||||||+||+++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999976533221 12233567899999999999999999999999999999999 99
Q ss_pred CCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 248 CNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
.||........ .. ....... ...+...+..+.+++.+||+.||.+||++.++++.|....
T Consensus 275 ~p~~~~~~~~~---~~----~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 275 QPYYGMAHEEV---IY----YVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp CTTTTSCHHHH---HH----HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CcCCCCChHHH---HH----HHhCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 99975432211 11 1111111 1112234457889999999999999999999999997653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=354.47 Aligned_cols=258 Identities=21% Similarity=0.292 Sum_probs=209.3
Q ss_pred HHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 39 LSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 39 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
.....++|++.+.||+|+||.||+|.+. +|+.||+|++... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 103 (362)
T 2bdw_A 24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 103 (362)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 3344678999999999999999999986 5899999999754 334456788999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC---CcEEEEe
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD---LTPKISD 192 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~---~~~kl~D 192 (391)
++||||+++++|.+.+... ..+++..+..++.||+.||.|||++ ||+||||||+|||++.+ +.+||+|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~D 174 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVAR------EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLAD 174 (362)
T ss_dssp EEEECCCCSCBHHHHHTTC------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEEecCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEee
Confidence 9999999999999999643 3589999999999999999999999 99999999999999865 4599999
Q ss_pred cccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 193 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..... ...
T Consensus 175 fG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~~i----~~~ 245 (362)
T 2bdw_A 175 FGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYAQI----KAG 245 (362)
T ss_dssp CTTCBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HHT
T ss_pred cCcceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH----HhC
Confidence 99998764332 2234679999999999999899999999999999999999999997543211 11111 111
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.. . .........+..+.+|+.+||+.||.+||++.+++++-+
T Consensus 246 ~~-~-----~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 246 AY-D-----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 287 (362)
T ss_dssp CC-C-----CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred CC-C-----CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 00 0 000001123457889999999999999999999998743
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=348.57 Aligned_cols=256 Identities=23% Similarity=0.269 Sum_probs=208.6
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch------hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCe
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR------QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNH 114 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (391)
..++|++.+.||+|+||.||+|.+. +|+.||+|++..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3467999999999999999999987 589999999875422 135778999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC----cEEE
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL----TPKI 190 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~----~~kl 190 (391)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||++ +++||||||+||+++.++ .+||
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 159 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKI 159 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTS------SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEE
T ss_pred EEEEEEcCCCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEE
Confidence 99999999999999999643 3589999999999999999999999 999999999999999887 8999
Q ss_pred EecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh
Q 016347 191 SDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE 270 (391)
Q Consensus 191 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 270 (391)
+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .... .
T Consensus 160 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~~----~ 230 (326)
T 2y0a_A 160 IDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LANV----S 230 (326)
T ss_dssp CCCTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHH----H
T ss_pred EECCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HHHH----H
Confidence 9999998764332 22345799999999999989999999999999999999999999975432211 1110 0
Q ss_pred hcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 271 RRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.... . .........+..+.+++.+||+.||.+|||+.|++++-+.
T Consensus 231 ~~~~-~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 275 (326)
T 2y0a_A 231 AVNY-E-----FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275 (326)
T ss_dssp HTCC-C-----CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred hcCC-C-----cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCc
Confidence 0000 0 0000001123568889999999999999999999997654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=347.66 Aligned_cols=260 Identities=19% Similarity=0.234 Sum_probs=209.1
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEEEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
.+++|++.+.||+|+||.||+|.+. +|+.||||++..... ...+.+|+.+++.+ +||||+++++++...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 4688999999999999999999975 699999999875432 24578899999999 9999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCc-----EEEEecc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLT-----PKISDFG 194 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~-----~kl~Dfg 194 (391)
||+ +++|.+++... ...+++..++.++.||+.||.|||++ +++||||||+|||++.++. +||+|||
T Consensus 85 e~~-~~~L~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 85 ELL-GPSLEDLFDLC-----DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155 (330)
T ss_dssp ECC-CCBHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred EeC-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence 999 99999999753 23699999999999999999999999 9999999999999999887 9999999
Q ss_pred cccccCCCCce------eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 016347 195 LAKLIPANMTH------VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDL 268 (391)
Q Consensus 195 ~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 268 (391)
++..+...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..................
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~ 235 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT 235 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh
Confidence 99876433221 123567999999999999999999999999999999999999999876544332222221111
Q ss_pred hhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 269 YERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
...... ..+.. ..+ .+.+++..||+.||.+||++.+|++.|...
T Consensus 236 ~~~~~~-----~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 236 KRATPI-----EVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HHHSCH-----HHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred hccCCH-----HHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 100000 00000 112 788999999999999999999999887543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=340.25 Aligned_cols=266 Identities=20% Similarity=0.307 Sum_probs=204.6
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
++|+++++||+|+||+||+|.+. +++.||+|++.... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 68999999999999999999987 58999999987542 3345678899999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+++ +|.+.+... ...+++..+..++.||+.||.|||++ |++||||||+||+++.++.+||+|||++....
T Consensus 82 ~~~~-~l~~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 152 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp CCSE-EHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred cCCC-CHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence 9986 555555432 23589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCceeeeeecccccccChhhhhcCC-CCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc---ccce
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQ-VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR---ELIL 276 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 276 (391)
... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..|+........ ............ ....
T Consensus 153 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 153 IPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp SCC-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTT
T ss_pred Ccc-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhhhh
Confidence 332 2233457899999999997766 79999999999999999999988644332221 111111111000 0000
Q ss_pred ee------------eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 277 LV------------DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 277 ~~------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.. ...............+.+|+.+||+.||++|||++|++++-+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 286 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccc
Confidence 00 0000011112345578899999999999999999999987543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=348.74 Aligned_cols=250 Identities=20% Similarity=0.280 Sum_probs=206.2
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++......++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 478999999999999999999975 68999999987542 22345788999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|||+ +|+|.+++...+ .+++..+..++.||+.||.|||++ |++||||||+|||++.++.+||+|||++..
T Consensus 88 ~E~~-~g~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~ 157 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK------RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNI 157 (336)
T ss_dssp ECCC-CEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBT
T ss_pred EECC-CCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEecccee
Confidence 9999 678988886433 599999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCceeeeeecccccccChhhhhcCCC-CCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccccee
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILL 277 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (391)
..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ ...
T Consensus 158 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~ 219 (336)
T 3h4j_B 158 MTDGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKK 219 (336)
T ss_dssp TTTSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCC
T ss_pred ccCCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHH
Confidence 64332 2344679999999999988776 7899999999999999999999975432211 011
Q ss_pred eeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 278 VDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 278 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
+... ....+...+..+.+++.+||+.||.+|||+.|++++-+.
T Consensus 220 i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 262 (336)
T 3h4j_B 220 VNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262 (336)
T ss_dssp CCSS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHH
T ss_pred HHcC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhh
Confidence 1110 011222345578899999999999999999999987654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=341.62 Aligned_cols=264 Identities=23% Similarity=0.352 Sum_probs=202.7
Q ss_pred CCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
++|++++.||+|+||.||+|.+.+|+.||+|++.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 6899999999999999999999889999999986543 23346788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++ +|.+++.... ..+++..+..++.||+.||.|||++ |++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp CSE-EHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred cCC-CHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 976 8999886532 3589999999999999999999999 999999999999999999999999999987643
Q ss_pred CCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc---cc---
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR---EL--- 274 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~--- 274 (391)
... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||......... .......... ..
T Consensus 153 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 228 (288)
T 1ob3_A 153 PVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL---MRIFRILGTPNSKNWPNV 228 (288)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTG
T ss_pred ccc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHHCCCChhhchhh
Confidence 221 22345689999999998764 5899999999999999999999999764332211 1111110000 00
Q ss_pred --ceeeeccCC-------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 275 --ILLVDTSLN-------GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 275 --~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
....+.... .......+..+.+++.+||+.||++|||+.|++++-+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 283 (288)
T 1ob3_A 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283 (288)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 000000000 0011123457788999999999999999999998653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=341.43 Aligned_cols=261 Identities=25% Similarity=0.383 Sum_probs=202.7
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhc--CCCCceeEEEEEEEeC----Ce
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISE--IEHENLVKLYGCCVEG----NH 114 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~----~~ 114 (391)
+..++|++.+.||+|+||.||+|++ +++.||||++.... ...+..|.+++.. ++||||+++++++... ..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 3568999999999999999999998 58999999987543 3445566666666 7999999999987642 46
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhh--------hcCCCCeeecCCCCCcEEECCCC
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH--------EEVRPHIIHRDIKASNILLDKDL 186 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH--------~~~~~~i~H~dikp~NIlv~~~~ 186 (391)
.++||||+++|+|.+++.. ..+++..++.++.||+.||.||| +. +++||||||+|||++.++
T Consensus 81 ~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~ 150 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL-------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNG 150 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT-------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTS
T ss_pred eEEehhhccCCCHHHHHhh-------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCC
Confidence 8999999999999999943 35899999999999999999999 77 999999999999999999
Q ss_pred cEEEEecccccccCCCCcee---eeeecccccccChhhhhcC------CCCCCCcEeehhHHHHHHHhC----------C
Q 016347 187 TPKISDFGLAKLIPANMTHV---STRVAGTIGYLAPEYAIRG------QVTRKADIYSFGVLLVEIVSG----------R 247 (391)
Q Consensus 187 ~~kl~Dfg~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~k~DvwSlG~vl~elltg----------~ 247 (391)
.+||+|||++.......... .....||+.|+|||++.+. .++.++|||||||++|+|++| .
T Consensus 151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~ 230 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230 (301)
T ss_dssp CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence 99999999997654333221 2234799999999999876 566799999999999999999 7
Q ss_pred CCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCC-CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 248 CNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLN-GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.||....+......... ........ ..... .......+..+.+++.+||+.||.+|||+.+|++.|+.
T Consensus 231 ~pf~~~~~~~~~~~~~~--~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 231 PPFYDVVPNDPSFEDMR--KVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp CTTTTTSCSSCCHHHHH--HHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccccccCCCCcchhhhh--HHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 77765443332211111 11110000 00000 01123567789999999999999999999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=340.46 Aligned_cols=258 Identities=27% Similarity=0.445 Sum_probs=212.0
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
.+..++|++.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 345688999999999999999999998889999999986533 3467899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++...
T Consensus 83 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 154 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFV 154 (267)
T ss_dssp CCCTTCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred eCCCCCcHHHHHhhCc-----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccc
Confidence 9999999999996532 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
............+++.|+|||++.+..++.++||||||+++|+|++ |..||........ ... ....
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~----i~~~------ 221 (267)
T 3t9t_A 155 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---VED----ISTG------ 221 (267)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHH----HHTT------
T ss_pred ccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH---HHH----HhcC------
Confidence 4322222223456788999999999999999999999999999999 8999875432211 111 1110
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.....+...+..+.+++.+||+.||.+||++.+++++|...
T Consensus 222 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 222 ---FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00111222345788999999999999999999999998654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=342.54 Aligned_cols=261 Identities=30% Similarity=0.476 Sum_probs=212.7
Q ss_pred HHHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 37 KELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 37 ~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
.++++..++|++.+.||+|+||.||+|.+.+++.||+|.+.... ...+.+.+|+++++.++||||+++++++. .+..+
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 83 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIY 83 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcE
Confidence 45667779999999999999999999999888899999987643 33577899999999999999999999876 45689
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+||||+++++|.+++... ....+++..+..++.|++.||.|||++ |++|+||||+||+++.++.+||+|||++
T Consensus 84 ~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 156 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTP----SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA 156 (279)
T ss_dssp EEEECCTTCBHHHHTTSH----HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCHHHHHhcC----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccc
Confidence 999999999999998532 123589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 197 KLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 197 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
...............++..|+|||++.++.++.++||||||+++|+|++ |..||........ ... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~----~~~~--- 226 (279)
T 1qpc_A 157 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---IQN----LERG--- 226 (279)
T ss_dssp EECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHH----HHTT---
T ss_pred ccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH---HHH----Hhcc---
Confidence 8765433222233456788999999999999999999999999999999 8999875432211 111 1111
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.....+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus 227 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 227 ------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 01111223345788999999999999999999999988654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=350.35 Aligned_cols=254 Identities=19% Similarity=0.283 Sum_probs=206.4
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-----hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-----RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
..++|++.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4578999999999999999999976 59999999986432 12457789999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCc---EEEEe
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLT---PKISD 192 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~---~kl~D 192 (391)
++||||+++++|.+.+..... ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++. +||+|
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~D 176 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRAD--AGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGG 176 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred EEEEeCCCCCCHHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEec
Confidence 999999999999988854221 223589999999999999999999999 9999999999999987654 99999
Q ss_pred cccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 193 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..... ....
T Consensus 177 fg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~----i~~~ 247 (351)
T 3c0i_A 177 FGVAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEG----IIKG 247 (351)
T ss_dssp CTTCEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHHH----HHHT
T ss_pred CcceeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHHH----HHcC
Confidence 99998765432 223345799999999999999999999999999999999999999975311 11111 1111
Q ss_pred ccceeeeccCCCCCCH----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 273 ELILLVDTSLNGDFDA----EEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.. .... ..+..+.+|+.+||+.||.+|||+.|++++-
T Consensus 248 ~~----------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp 288 (351)
T 3c0i_A 248 KY----------KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHP 288 (351)
T ss_dssp CC----------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CC----------CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence 00 0111 1245788999999999999999999999764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=346.82 Aligned_cols=254 Identities=23% Similarity=0.339 Sum_probs=201.0
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC-------
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN------- 113 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------- 113 (391)
.++|++++.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 367999999999999999999987 69999999987543 345577899999999999999999999986543
Q ss_pred --------------------------------------------------eeEEEEecccCCCHHHHHhcCCCCCCcccc
Q 016347 114 --------------------------------------------------HRILVYNYLENNSLAQTLIGGGHHYSNIQF 143 (391)
Q Consensus 114 --------------------------------------------------~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l 143 (391)
..++||||+++++|.+++.... .....
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~ 161 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC---SLEDR 161 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC---SGGGS
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc---Cccch
Confidence 3799999999999999997654 33446
Q ss_pred CHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc-----------eeeeeecc
Q 016347 144 SWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT-----------HVSTRVAG 212 (391)
Q Consensus 144 ~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~g 212 (391)
.+..++.++.||+.||.|||++ |++||||||+||+++.++.+||+|||++........ .......|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 7778999999999999999999 999999999999999999999999999987654321 11233569
Q ss_pred cccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHH
Q 016347 213 TIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEAC 292 (391)
Q Consensus 213 t~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (391)
|+.|+|||++.+..++.++|||||||++|+|++|..|+.. . ........... ..........
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~------~---~~~~~~~~~~~---------~~~~~~~~~~ 300 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME------R---VRIITDVRNLK---------FPLLFTQKYP 300 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH------H---HHHHHHHHTTC---------CCHHHHHHCH
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH------H---HHHHHHhhccC---------CCcccccCCh
Confidence 9999999999999999999999999999999998655421 0 00000000000 0011123445
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 293 RFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 293 ~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.+.+++.+||+.||++||++.|++++-+
T Consensus 301 ~~~~li~~~l~~~p~~Rps~~~~l~~~~ 328 (332)
T 3qd2_B 301 QEHMMVQDMLSPSPTERPEATDIIENAI 328 (332)
T ss_dssp HHHHHHHHHHCSSGGGSCCHHHHHHSTT
T ss_pred hHHHHHHHHccCCCCcCCCHHHHhhchh
Confidence 7789999999999999999999998753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=339.33 Aligned_cols=252 Identities=28% Similarity=0.447 Sum_probs=197.6
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccc----hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAES----RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
+..++|++.+.||+|+||.||+|.+. ++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 34588999999999999999999986 8899999987542 233567889999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCC---eeecCCCCCcEEECC--------C
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPH---IIHRDIKASNILLDK--------D 185 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~---i~H~dikp~NIlv~~--------~ 185 (391)
+||||+++++|.+++.. ..+++..++.++.|++.||.|||++ + ++||||||+||+++. +
T Consensus 83 lv~e~~~~~~L~~~~~~-------~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~ 152 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG-------KRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSN 152 (271)
T ss_dssp EEEECCTTEEHHHHHTS-------SCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred EEEEcCCCCCHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccC
Confidence 99999999999999843 3589999999999999999999999 7 899999999999986 6
Q ss_pred CcEEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 016347 186 LTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERT 265 (391)
Q Consensus 186 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 265 (391)
+.+||+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.........
T Consensus 153 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------ 223 (271)
T 3dtc_A 153 KILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA------ 223 (271)
T ss_dssp CCEEECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH------
T ss_pred cceEEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------
Confidence 789999999998654322 22356899999999999999999999999999999999999999754322111
Q ss_pred HHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 266 WDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
..... . ......+...+..+.+++.+||+.||.+|||+.|++++|+.
T Consensus 224 ~~~~~-~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 224 YGVAM-N--------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HHHHT-S--------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred Hhhhc-C--------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 01011 1 11112223345678899999999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=361.59 Aligned_cols=267 Identities=25% Similarity=0.273 Sum_probs=200.8
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC------
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG------ 112 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 112 (391)
..++|+++++||+|+||+||+|.+. +|+.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3588999999999999999999976 5899999999754 344567788999999999999999999999654
Q ss_pred CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEe
Q 016347 113 NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISD 192 (391)
Q Consensus 113 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~D 192 (391)
...++||||++++ |.+.+.. .+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~~--------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~D 207 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 207 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred CeEEEEEeCCCCC-HHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEE
Confidence 3579999999764 6666632 389999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH-----
Q 016347 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWD----- 267 (391)
Q Consensus 193 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~----- 267 (391)
||+++..... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 208 FG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 208 FGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 285 (464)
T ss_dssp CCCC-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred EEeeeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9999875432 223456899999999999999999999999999999999999999976543221111110000
Q ss_pred -----------Hhhhc------ccceeeeccCC-CC--CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 268 -----------LYERR------ELILLVDTSLN-GD--FDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 268 -----------~~~~~------~~~~~~~~~~~-~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
..... .....+...+. .. ........+.+|+.+||+.||++|||++|++++-+..
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~ 360 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 360 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhh
Confidence 00000 00000000000 00 0112256789999999999999999999999986543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=345.36 Aligned_cols=274 Identities=23% Similarity=0.338 Sum_probs=194.2
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
..++|+++++||+|+||.||+|.+. +|+.||+|++.... ......+.+|+.+++.++||||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 3578999999999999999999976 58999999987553 233467889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||++ ++|.+++...........+++..+..++.||+.||.|||++ |++||||||+|||++.++.+||+|||++...
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9998 58999886533222334689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc---
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI--- 275 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 275 (391)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........................
T Consensus 159 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 159 GIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 43221 2234578999999999876 468999999999999999999999997654322211111100000000000
Q ss_pred --eeeeccCC----C--------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 276 --LLVDTSLN----G--------DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 276 --~~~~~~~~----~--------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
........ . .........+.+|+.+||+.||++|||+.|++++-+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~ 296 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChh
Confidence 00000000 0 000112347889999999999999999999988654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=357.79 Aligned_cols=264 Identities=27% Similarity=0.383 Sum_probs=210.7
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeC------CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG 112 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (391)
++..++|++++.||+|+||.||+|.+. +++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 345688999999999999999999843 4678999998654 344456788999999999999999999999999
Q ss_pred CeeEEEEecccCCCHHHHHhcCCCC-CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC---cE
Q 016347 113 NHRILVYNYLENNSLAQTLIGGGHH-YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL---TP 188 (391)
Q Consensus 113 ~~~~lv~e~~~~~sL~~~i~~~~~~-~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~---~~ 188 (391)
...++||||+++|+|.+++...... .....+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceE
Confidence 9999999999999999999764321 1234589999999999999999999999 999999999999999555 59
Q ss_pred EEEecccccccCCC-CceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 016347 189 KISDFGLAKLIPAN-MTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTW 266 (391)
Q Consensus 189 kl~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 266 (391)
||+|||+++..... .........||+.|+|||++.+..++.++|||||||++|+|++ |..||........ ...
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~---~~~-- 298 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---LEF-- 298 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HHH--
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH--
Confidence 99999999754211 1112233567899999999999999999999999999999998 9999976433211 111
Q ss_pred HHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 267 DLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
..... ....+...+..+.+|+.+||+.||.+||++.+|+++|+..
T Consensus 299 --i~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 299 --VTSGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp --HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHcCC---------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11110 1112223445788999999999999999999999998655
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=352.95 Aligned_cols=248 Identities=25% Similarity=0.326 Sum_probs=194.5
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHH-HhcCCCCceeEEEEEEEeCCee
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQV-ISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
+..++|++++.||+|+||.||+|++. +++.||+|++.... ......+..|..+ ++.++||||+++++++.+.+..
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 34578999999999999999999987 48899999997653 2233455667666 5778999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||||++||+|.+++...+ .+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~ 185 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGL 185 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCB
T ss_pred EEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcc
Confidence 99999999999999996532 589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
++..... .......+||+.|+|||++.+..++.++|||||||++|||++|..||....... ..... .....
T Consensus 186 a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~~i----~~~~~- 256 (373)
T 2r5t_A 186 CKENIEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNI----LNKPL- 256 (373)
T ss_dssp CGGGBCC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH---HHHHH----HHSCC-
T ss_pred ccccccC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---HHHHH----Hhccc-
Confidence 9864222 223345689999999999999999999999999999999999999997543221 11111 11110
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTV 315 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev 315 (391)
.++......+.+++.+||+.||.+||++.+.
T Consensus 257 ---------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 257 ---------QLKPNITNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp ---------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred ---------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence 1112234568889999999999999998533
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=338.94 Aligned_cols=263 Identities=21% Similarity=0.273 Sum_probs=212.0
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEE
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 117 (391)
.+..++|++.+.||+|+||.||+|.+. +|+.||+|++..... ...+.+|+.+++.+ +|+|++++++++.+....++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 455789999999999999999999975 699999999865432 24577899999999 89999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCc-----EEEEe
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLT-----PKISD 192 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~-----~kl~D 192 (391)
||||+ +++|.+++...+ ..+++..+..++.||+.||.|||++ |++||||||+||+++.++. +||+|
T Consensus 84 v~e~~-~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~D 154 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVD 154 (298)
T ss_dssp EEECC-CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred EEEec-CCCHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence 99999 999999997532 2589999999999999999999999 9999999999999987766 99999
Q ss_pred cccccccCCCCce------eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 016347 193 FGLAKLIPANMTH------VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTW 266 (391)
Q Consensus 193 fg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 266 (391)
||++......... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||................
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (298)
T 1csn_A 155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 234 (298)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred CccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH
Confidence 9999876433221 2234579999999999999999999999999999999999999998765444332222221
Q ss_pred HHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 267 DLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.......... +. ...+..+.+++.+||+.||.+||++.+|++.|...
T Consensus 235 ~~~~~~~~~~-----~~----~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 235 EKKQSTPLRE-----LC----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp HHHHHSCHHH-----HT----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred hhccCccHHH-----HH----hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 1111111000 00 12245788999999999999999999999988654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=341.15 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=198.7
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch--------------------------hcHHHHHHHHHHH
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR--------------------------QGVKEFLTEIQVI 94 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l 94 (391)
..++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 3578999999999999999999976 589999999865421 1235688999999
Q ss_pred hcCCCCceeEEEEEEEe--CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 016347 95 SEIEHENLVKLYGCCVE--GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIH 172 (391)
Q Consensus 95 ~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H 172 (391)
+.++||||+++++++.+ ....++||||+++++|.+++ ....+++..+..++.||+.||.|||++ +++|
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH 160 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-------TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIH 160 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-------CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-------hcCCCCHHHHHHHHHHHHHHHHHHHHC---Ceec
Confidence 99999999999999986 56899999999999998765 234699999999999999999999999 9999
Q ss_pred cCCCCCcEEECCCCcEEEEecccccccCCCCceeeeeecccccccChhhhhcCC---CCCCCcEeehhHHHHHHHhCCCC
Q 016347 173 RDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQ---VTRKADIYSFGVLLVEIVSGRCN 249 (391)
Q Consensus 173 ~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~DvwSlG~vl~elltg~~p 249 (391)
|||||+|||++.++.+||+|||++........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|..|
T Consensus 161 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 239 (298)
T 2zv2_A 161 RDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239 (298)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 99999999999999999999999987644322 233457999999999987655 47889999999999999999999
Q ss_pred CCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 250 TNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
|....... .... ...... ........+..+.+++.+||+.||++||++.|++++-
T Consensus 240 f~~~~~~~---~~~~----~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp 294 (298)
T 2zv2_A 240 FMDERIMC---LHSK----IKSQAL--------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294 (298)
T ss_dssp SCCSSHHH---HHHH----HHHCCC--------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred CCCccHHH---HHHH----HhcccC--------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence 97543211 1111 111100 0001112345688899999999999999999998753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=349.22 Aligned_cols=268 Identities=23% Similarity=0.355 Sum_probs=213.6
Q ss_pred HHHHhhCCCCCCceeeccCceEEEEEEe------CCCcEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCceeEEEEEE
Q 016347 38 ELSIATDDFSPINKIGEGGFGSVYKGRL------KDGKIAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHENLVKLYGCC 109 (391)
Q Consensus 38 e~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 109 (391)
++++..++|++.+.||+|+||.||+|.+ .++..||+|++... .......+.+|+.+++++ .||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4667789999999999999999999996 24678999998754 233456788999999999 899999999999
Q ss_pred EeCCeeEEEEecccCCCHHHHHhcCCCCC-----------------CccccCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 016347 110 VEGNHRILVYNYLENNSLAQTLIGGGHHY-----------------SNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIH 172 (391)
Q Consensus 110 ~~~~~~~lv~e~~~~~sL~~~i~~~~~~~-----------------~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H 172 (391)
...+..++||||+++|+|.+++....... ....+++..++.++.||+.||.|||++ |++|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 99999999999999999999997643211 113479999999999999999999999 9999
Q ss_pred cCCCCCcEEECCCCcEEEEecccccccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCC
Q 016347 173 RDIKASNILLDKDLTPKISDFGLAKLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNT 250 (391)
Q Consensus 173 ~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~ 250 (391)
|||||+||+++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999999986643322 22334567889999999999999999999999999999998 99999
Q ss_pred CCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 251 NMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
......... .. ..... .....+...+..+.+++.+||+.||.+||++.+++++|+...
T Consensus 276 ~~~~~~~~~--~~----~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 276 PGIPVDANF--YK----LIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp TTCCCSHHH--HH----HHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ccCCcHHHH--HH----HHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 765432211 11 11111 111222234567889999999999999999999999997653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=350.11 Aligned_cols=272 Identities=20% Similarity=0.241 Sum_probs=207.5
Q ss_pred hhCCCCCCceeecc--CceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 42 ATDDFSPINKIGEG--GFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 42 ~~~~y~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
..++|+++++||+| +||.||+|++. +|+.||||++.... ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35789999999999 99999999987 69999999997653 344567888999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+||||+++++|.+++... ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||.+
T Consensus 103 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTH----FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSN 175 (389)
T ss_dssp EEEECCTTCBHHHHHHHT----CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred EEEEccCCCCHHHHHhhh----cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccc
Confidence 999999999999999653 123589999999999999999999999 9999999999999999999999999988
Q ss_pred cccCCCC------ceeeeeecccccccChhhhhc--CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHH-HH
Q 016347 197 KLIPANM------THVSTRVAGTIGYLAPEYAIR--GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERT-WD 267 (391)
Q Consensus 197 ~~~~~~~------~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~-~~ 267 (391)
....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||............... ..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 6542211 111222478999999999987 57999999999999999999999999765443321100000 00
Q ss_pred H-hh-----hccc-------------ceee---------eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 268 L-YE-----RREL-------------ILLV---------DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 268 ~-~~-----~~~~-------------~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
. .. .... .... ...............+.+|+.+||+.||.+|||+.|++++-
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 0 00 0000 0000 00000011223345788999999999999999999999874
Q ss_pred c
Q 016347 320 M 320 (391)
Q Consensus 320 ~ 320 (391)
+
T Consensus 336 ~ 336 (389)
T 3gni_B 336 F 336 (389)
T ss_dssp G
T ss_pred H
Confidence 3
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=346.28 Aligned_cols=259 Identities=23% Similarity=0.310 Sum_probs=200.7
Q ss_pred eeechHHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcC-CCCceeEEEE
Q 016347 32 KLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEI-EHENLVKLYG 107 (391)
Q Consensus 32 ~~~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~ 107 (391)
..+..+...+..++|+++++||+|+||+||+|.+. +|+.||||++... .......+..|+..+..+ .||||+++++
T Consensus 45 ~~~p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~ 124 (311)
T 3p1a_A 45 GYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124 (311)
T ss_dssp TCCTTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCCCCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEE
Confidence 33445555566688999999999999999999987 6999999998654 223333445555555554 9999999999
Q ss_pred EEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCc
Q 016347 108 CCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLT 187 (391)
Q Consensus 108 ~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~ 187 (391)
++.+.+..++||||+ +++|.+++...+ ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.
T Consensus 125 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~ 195 (311)
T 3p1a_A 125 AWEEGGILYLQTELC-GPSLQQHCEAWG-----ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGR 195 (311)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGC
T ss_pred EEEeCCEEEEEEecc-CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCC
Confidence 999999999999999 668999886532 3599999999999999999999999 9999999999999999999
Q ss_pred EEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 016347 188 PKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWD 267 (391)
Q Consensus 188 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 267 (391)
+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..|+... ..+.
T Consensus 196 ~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~~ 262 (311)
T 3p1a_A 196 CKLGDFGLLVELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGWQ 262 (311)
T ss_dssp EEECCCTTCEECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHHH
T ss_pred EEEccceeeeecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHHH
Confidence 9999999988754322 2334569999999998865 7999999999999999999997665421 1111
Q ss_pred HhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 268 LYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
......... ......+..+.+++.+||+.||++|||+.|++++-+
T Consensus 263 ~~~~~~~~~--------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (311)
T 3p1a_A 263 QLRQGYLPP--------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPV 307 (311)
T ss_dssp HHTTTCCCH--------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred HHhccCCCc--------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcc
Confidence 111111000 001123457889999999999999999999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=360.87 Aligned_cols=257 Identities=26% Similarity=0.404 Sum_probs=211.0
Q ss_pred hHHHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC-e
Q 016347 36 YKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN-H 114 (391)
Q Consensus 36 ~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~ 114 (391)
..++++..++|++.+.||+|+||.||+|.+. |+.||||++.... ..+.+.+|+.++++++||||+++++++.... .
T Consensus 185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp HTTCBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred ccccccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence 3455677789999999999999999999986 7899999997653 3467999999999999999999999987765 7
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.++||||+++|+|.+++...+ ...+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG 334 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFG 334 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHC----TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCT
T ss_pred eEEEEEecCCCcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCC
Confidence 899999999999999997532 22478999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcc
Q 016347 195 LAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRE 273 (391)
Q Consensus 195 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (391)
+++..... .....+++.|+|||++.+..++.++|||||||++|||++ |..||......+.. ... .
T Consensus 335 ~a~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~---~~i----~--- 400 (450)
T 1k9a_A 335 LTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PRV----E--- 400 (450)
T ss_dssp TCEECC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH---HHH----H---
T ss_pred Cccccccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH----H---
Confidence 99864322 122357889999999999999999999999999999998 99999765433221 111 1
Q ss_pred cceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.......+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 401 ------~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 401 ------KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp ------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111122334456788999999999999999999999988654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=343.72 Aligned_cols=268 Identities=23% Similarity=0.374 Sum_probs=215.4
Q ss_pred HHHHHhhCCCCCCceeeccCceEEEEEEe------CCCcEEEEEEecccc-hhcHHHHHHHHHHHhcC-CCCceeEEEEE
Q 016347 37 KELSIATDDFSPINKIGEGGFGSVYKGRL------KDGKIAAIKVLSAES-RQGVKEFLTEIQVISEI-EHENLVKLYGC 108 (391)
Q Consensus 37 ~e~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 108 (391)
.++++..++|++.+.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|+.+++++ +||||++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 34556678999999999999999999985 247889999997653 34457789999999999 99999999999
Q ss_pred EEeCCeeEEEEecccCCCHHHHHhcCCCC------------CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 016347 109 CVEGNHRILVYNYLENNSLAQTLIGGGHH------------YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIK 176 (391)
Q Consensus 109 ~~~~~~~~lv~e~~~~~sL~~~i~~~~~~------------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dik 176 (391)
+...+..++||||+++++|.+++...... .....+++..++.++.||+.||.|||++ |++|||||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlk 172 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA 172 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCc
Confidence 99999999999999999999999764321 1123589999999999999999999999 99999999
Q ss_pred CCcEEECCCCcEEEEecccccccCCCCce-eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCC
Q 016347 177 ASNILLDKDLTPKISDFGLAKLIPANMTH-VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRL 254 (391)
Q Consensus 177 p~NIlv~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~ 254 (391)
|+||+++.++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 99999999999999999999876543322 2233457889999999999999999999999999999999 999997654
Q ss_pred CcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 255 PTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
..... ... .... .....+...+..+.+++.+||+.||.+|||+.|++++|...
T Consensus 253 ~~~~~--~~~----~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 253 VDSKF--YKM----IKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp SSHHH--HHH----HHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chhHH--HHH----hccC---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 32211 111 1100 01111223345788999999999999999999999998643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=350.36 Aligned_cols=261 Identities=22% Similarity=0.280 Sum_probs=199.1
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
..++|++++.||+|+||.||+|++. +++.||+|++..... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 4578999999999999999999987 699999999876433 23568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCc--EEEEecccccc
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLT--PKISDFGLAKL 198 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~--~kl~Dfg~~~~ 198 (391)
|+++++|.+++...+ .+++..+..++.||+.||.|||++ ||+||||||+|||++.++. +||+|||+++.
T Consensus 97 ~~~~~~L~~~l~~~~------~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 97 YASGGELYERICNAG------RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp CCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred eCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 999999999996433 499999999999999999999999 9999999999999987765 99999999875
Q ss_pred cCCCCceeeeeecccccccChhhhhcCCCCCC-CcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccccee
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIRGQVTRK-ADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILL 277 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (391)
.... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........... ........
T Consensus 168 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~--~~~~~~~~------ 237 (361)
T 3uc3_A 168 SVLH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRK--TIQRILSV------ 237 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHH--HHHHHHTT------
T ss_pred cccc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHH--HHHHHhcC------
Confidence 3222 12234579999999999988887655 8999999999999999999976443322111 11111110
Q ss_pred eeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCCC
Q 016347 278 VDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKDI 325 (391)
Q Consensus 278 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~~ 325 (391)
..........+..+.+|+.+||+.||.+|||+.|++++-+....+
T Consensus 238 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 282 (361)
T 3uc3_A 238 ---KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282 (361)
T ss_dssp ---CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred ---CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence 000011112245778899999999999999999999886544433
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=340.77 Aligned_cols=268 Identities=24% Similarity=0.335 Sum_probs=203.2
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
.++|+++++||+|+||.||+|.+. +|+.||+|++.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 378999999999999999999987 49999999886543 233566889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++.... .+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||++...
T Consensus 82 e~~~~~~l~~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 152 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR------GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL 152 (311)
T ss_dssp ECCSEEHHHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EeCCCchHHHHHhhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhc
Confidence 9999999999886433 489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH--------Hhh
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWD--------LYE 270 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~ 270 (391)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||................. .+.
T Consensus 153 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 153 TGPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp C-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred cCccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccc
Confidence 43322 2334578999999999876 5689999999999999999999999976554332222111100 000
Q ss_pred hcccceeee-ccCCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 271 RRELILLVD-TSLNGDFD-----AEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 271 ~~~~~~~~~-~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
......... +....... ...+..+.+++.+||+.||.+|||++|++++-+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 287 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGG
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChH
Confidence 000000000 00000000 123446889999999999999999999998754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=342.42 Aligned_cols=260 Identities=22% Similarity=0.280 Sum_probs=203.1
Q ss_pred hCCCCCC-ceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEEEE
Q 016347 43 TDDFSPI-NKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 43 ~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
.++|++. +.||+|+||.||+|.+. +++.||||++..........+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4678885 78999999999999976 6999999999876656677899999999885 7999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCc---EEEEecccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLT---PKISDFGLA 196 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~---~kl~Dfg~~ 196 (391)
||+++++|.+++... ..+++..+..++.||+.||.|||++ +++||||||+||+++.++. +||+|||++
T Consensus 91 e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR------RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLG 161 (316)
T ss_dssp ECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred EcCCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence 999999999999653 3589999999999999999999999 9999999999999998765 999999998
Q ss_pred cccCCCCc------eeeeeecccccccChhhhhc-----CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhH----
Q 016347 197 KLIPANMT------HVSTRVAGTIGYLAPEYAIR-----GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYL---- 261 (391)
Q Consensus 197 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~---- 261 (391)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 241 (316)
T 2ac3_A 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241 (316)
T ss_dssp C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence 76532211 11223469999999999875 5689999999999999999999999976543321100
Q ss_pred ----HHHHHHHhhhcccceeeeccCCCCCCH----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 262 ----LERTWDLYERRELILLVDTSLNGDFDA----EEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 262 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
............ . ..+. ..+..+.+|+.+||+.||.+|||+.|++++-+.
T Consensus 242 ~~~~~~~~~~~i~~~~--------~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 299 (316)
T 2ac3_A 242 CPACQNMLFESIQEGK--------Y--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299 (316)
T ss_dssp CHHHHHHHHHHHHHCC--------C--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTC
T ss_pred chhHHHHHHHHHhccC--------c--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhh
Confidence 000011111110 0 1111 124578899999999999999999999997654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=346.13 Aligned_cols=255 Identities=25% Similarity=0.385 Sum_probs=201.8
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCc----EEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGK----IAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
.++|++++.||+|+||.||+|.+. +++ +||+|.+... .......+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 477999999999999999999965 344 3688887644 3345678999999999999999999999998754 78
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+|++|+.+|+|.+++.... ..+++..++.|+.||+.||.|||++ +++||||||+|||++.++.+||+|||++
T Consensus 93 ~v~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EEEECCTTCBHHHHHHHST-----TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred EEEEecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcce
Confidence 8999999999999997532 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCce-eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 197 KLIPANMTH-VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 197 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
+........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||............ .
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-------~---- 233 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-------E---- 233 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-------H----
T ss_pred eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH-------H----
Confidence 876433222 2223456889999999999999999999999999999999 99999765443221111 1
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.......+......+.+++.+||+.||.+||++.+++++|...
T Consensus 234 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 234 -----KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp -----TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred -----cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1111122233455788999999999999999999999998654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=336.21 Aligned_cols=254 Identities=29% Similarity=0.490 Sum_probs=204.8
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchh-------cHHHHHHHHHHHhcCCCCceeEEEEEEEeC
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQ-------GVKEFLTEIQVISEIEHENLVKLYGCCVEG 112 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (391)
+..++|++.+.||+|+||.||+|.+. +++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 34588999999999999999999986 6899999998654221 126788999999999999999999998655
Q ss_pred CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCcEEECCCCc---
Q 016347 113 NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPH--IIHRDIKASNILLDKDLT--- 187 (391)
Q Consensus 113 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~--i~H~dikp~NIlv~~~~~--- 187 (391)
. ++||||+++++|.+.+.... ..+++..++.++.|++.||.|||++ + ++|+||||+||+++.++.
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~ 165 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKA-----HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAP 165 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCS
T ss_pred C--eEEEEecCCCCHHHHHhccc-----CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCc
Confidence 4 79999999999999886533 3689999999999999999999999 8 999999999999988776
Q ss_pred --EEEEecccccccCCCCceeeeeecccccccChhhh--hcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHH
Q 016347 188 --PKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYA--IRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLE 263 (391)
Q Consensus 188 --~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~ 263 (391)
+||+|||++..... ......||+.|+|||++ ....++.++|||||||++|+|++|..||.............
T Consensus 166 ~~~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 241 (287)
T 4f0f_A 166 VCAKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM 241 (287)
T ss_dssp CCEEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH
T ss_pred eeEEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH
Confidence 99999999975432 23446789999999998 34567899999999999999999999997654433221111
Q ss_pred HHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 264 RTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
. ... ......+...+..+.+++.+||+.||.+||++.++++.|+.
T Consensus 242 ~-----~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 242 I-----REE--------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp H-----HHS--------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred H-----hcc--------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1 001 11112223345678899999999999999999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=343.72 Aligned_cols=269 Identities=26% Similarity=0.386 Sum_probs=208.8
Q ss_pred hCCC-CCCceeeccCceEEEEEEeC-----CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC--C
Q 016347 43 TDDF-SPINKIGEGGFGSVYKGRLK-----DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEG--N 113 (391)
Q Consensus 43 ~~~y-~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~ 113 (391)
.++| +++++||+|+||.||++.+. +++.||||++.... ......+.+|+++++.++||||+++++++.+. .
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 4455 99999999999999998643 58899999998653 34467789999999999999999999999874 6
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
..++||||+++++|.+++... .+++..++.++.||+.||.|||+. |++|+||||+||+++.++.+||+||
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Df 178 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRH-------SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDF 178 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCG
T ss_pred eEEEEEecccCCcHHHHHhhC-------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCc
Confidence 789999999999999999543 489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCce--eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhh
Q 016347 194 GLAKLIPANMTH--VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYER 271 (391)
Q Consensus 194 g~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 271 (391)
|++......... ......++..|+|||++.+..++.++|||||||++|+|++|..||.......... ..........
T Consensus 179 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~ 257 (318)
T 3lxp_A 179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL-IGIAQGQMTV 257 (318)
T ss_dssp GGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-HCSCCHHHHH
T ss_pred cccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhh-hcccccchhH
Confidence 999877543321 2233567888999999999999999999999999999999999986421110000 0000000000
Q ss_pred cccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 272 RELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
......+........+...+..+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 258 LRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 011111122222233334556889999999999999999999999998654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=346.29 Aligned_cols=268 Identities=24% Similarity=0.376 Sum_probs=214.0
Q ss_pred HHHHHhhCCCCCCceeeccCceEEEEEEeC--------CCcEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCceeEEE
Q 016347 37 KELSIATDDFSPINKIGEGGFGSVYKGRLK--------DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHENLVKLY 106 (391)
Q Consensus 37 ~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~ 106 (391)
..+.+..++|++.+.||+|+||.||+|.+. ++..||+|++... .......+.+|+.+++.+ +||||++++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 107 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 107 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence 344566799999999999999999999863 4678999999765 334567789999999999 899999999
Q ss_pred EEEEeCCeeEEEEecccCCCHHHHHhcCCCC----------CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 016347 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHH----------YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIK 176 (391)
Q Consensus 107 ~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~----------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dik 176 (391)
+++...+..++||||+++++|.+++...... .....+++..++.++.||+.||.|||++ |++|||||
T Consensus 108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlk 184 (334)
T 2pvf_A 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLA 184 (334)
T ss_dssp EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCc
Confidence 9999999999999999999999999764321 1123589999999999999999999999 99999999
Q ss_pred CCcEEECCCCcEEEEecccccccCCCCce-eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCC
Q 016347 177 ASNILLDKDLTPKISDFGLAKLIPANMTH-VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRL 254 (391)
Q Consensus 177 p~NIlv~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~ 254 (391)
|+||+++.++.+||+|||++......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 99999999999999999999876543221 2223456789999999999999999999999999999999 999997543
Q ss_pred CcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 255 PTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
.... ... ..... ....+...+..+.+++.+||+.||.+||++.|+++.|..+.
T Consensus 265 ~~~~---~~~----~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 265 VEEL---FKL----LKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp HHHH---HHH----HHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH---HHH----HhcCC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 2211 111 11111 01122234457889999999999999999999999986653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=334.67 Aligned_cols=250 Identities=27% Similarity=0.381 Sum_probs=204.9
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (391)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4578999999999999999999977 47899999986542 2345678899999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
||||+++++|.+++... ..+++..+..++.||+.||.|||+. |++||||||+||+++.++.++|+|||++.
T Consensus 87 v~e~~~~~~l~~~l~~~------~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~ 157 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV 157 (279)
T ss_dssp EECCCTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred EEecCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccc
Confidence 99999999999998643 3489999999999999999999999 99999999999999999999999999986
Q ss_pred ccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccccee
Q 016347 198 LIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILL 277 (391)
Q Consensus 198 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (391)
..... ......|++.|+|||++.+..++.++||||||+++|+|++|..||......... . .....
T Consensus 158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~----~~~~~----- 222 (279)
T 3fdn_A 158 HAPSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY---K----RISRV----- 222 (279)
T ss_dssp CC-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---H----HHHHT-----
T ss_pred cCCcc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH---H----HHHhC-----
Confidence 54322 223457899999999999999999999999999999999999999754322111 1 11110
Q ss_pred eeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 278 VDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 278 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
....+...+..+.+++.+||+.||.+||++.|++++.+
T Consensus 223 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 223 -----EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred -----CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 01112223457888999999999999999999998754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=346.94 Aligned_cols=272 Identities=25% Similarity=0.344 Sum_probs=213.5
Q ss_pred hCCCCCCceeeccCceEEEEEEe-----CCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEE--eCCee
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRL-----KDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCV--EGNHR 115 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 115 (391)
.++|++++.||+|+||.||+|.+ .+++.||+|++........+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 47899999999999999999984 358899999998777666778999999999999999999999987 45678
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||||+++++|.+++... ...+++..++.++.||+.||.|||++ |++|+||||+||+++.++.+||+|||+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH-----RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH-----GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred EEEEeecCCCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccc
Confidence 9999999999999999642 23589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCce--eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcc
Q 016347 196 AKLIPANMTH--VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRE 273 (391)
Q Consensus 196 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (391)
+......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||............. .........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 252 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGC-ERDVPALSR 252 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CCHHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccc-ccccccHHH
Confidence 9876543322 2233457888999999999999999999999999999999999986432110000000 000000001
Q ss_pred cceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
....+........+...+..+.+++.+||+.||.+|||+.+++++|+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred HHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111122222333445567899999999999999999999999997654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=361.46 Aligned_cols=258 Identities=26% Similarity=0.359 Sum_probs=212.4
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
+..++|++.+.||+|+||.||+|.+. +|+.||+|++... .......+.+|+.+|+.++||||+++++++.+.+..+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 55678999999999999999999986 6999999998654 2234566889999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+||||++||+|.+++...+ ...+++..++.++.||+.||.|||++ ||+||||||+||||+.+|.+||+|||++
T Consensus 261 lVmEy~~gg~L~~~l~~~~----~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla 333 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMG----QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA 333 (576)
T ss_dssp EEECCCCSCBHHHHHHSSS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEcCCCCcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccc
Confidence 9999999999999997542 23589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccce
Q 016347 197 KLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL 276 (391)
Q Consensus 197 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (391)
....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||............... ....
T Consensus 334 ~~~~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~---i~~~---- 404 (576)
T 2acx_A 334 VHVPEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL---VKEV---- 404 (576)
T ss_dssp EECCTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHH---HHHC----
T ss_pred eecccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHH---hhcc----
Confidence 8764332 233458999999999999999999999999999999999999999865433221111111 0000
Q ss_pred eeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHhc
Q 016347 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRP-----SMSTVVQMLM 320 (391)
Q Consensus 277 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~ 320 (391)
...++...+..+.+|+.+||+.||.+|| ++.|++++-+
T Consensus 405 ------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hpf 447 (576)
T 2acx_A 405 ------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447 (576)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGG
T ss_pred ------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChh
Confidence 0112223345788899999999999999 7899988754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=343.70 Aligned_cols=257 Identities=26% Similarity=0.310 Sum_probs=194.9
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
....++|++.+.||+|+||.||+|.+. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+....++|
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 345688999999999999999999987 48899999987543 235678899999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC---CCcEEEEeccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK---DLTPKISDFGL 195 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~---~~~~kl~Dfg~ 195 (391)
|||+++++|.+++...+ .+++..++.++.||+.||.|||+. |++||||||+|||++. ++.+||+|||+
T Consensus 127 ~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~ 197 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKG------YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGL 197 (349)
T ss_dssp ECCCCSCBHHHHHTTCS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred EEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcc
Confidence 99999999999996543 489999999999999999999999 9999999999999975 78999999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
+...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..... .....
T Consensus 198 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~i----~~~~~- 268 (349)
T 2w4o_A 198 SKIVEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFRRI----LNCEY- 268 (349)
T ss_dssp -----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHHHH----HTTCC-
T ss_pred ccccCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHHHH----HhCCC-
Confidence 9865432 123346799999999999999999999999999999999999999975443221 11111 11100
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
. .........+..+.+|+.+||+.||++|||+.|++++-+.
T Consensus 269 ~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 309 (349)
T 2w4o_A 269 Y-----FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309 (349)
T ss_dssp C-----CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred c-----cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 0 0011112344578899999999999999999999997644
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=357.07 Aligned_cols=258 Identities=26% Similarity=0.352 Sum_probs=210.6
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (391)
..++|++.+.||+|+||.||+|++. +|+.||+|++.... ......+.+|+.+++.++||||+++++++.+....++
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 3478999999999999999999986 59999999997542 2345678899999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
||||++||+|.+++..... ....+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||++.
T Consensus 263 VmE~~~gg~L~~~l~~~~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDE--DNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAV 337 (543)
T ss_dssp EECCCTTCBHHHHHHTSST--TSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEeccCCCHHHHHHHhhc--ccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceee
Confidence 9999999999999975432 244699999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchh-hHHHHHHHHhhhcccce
Q 016347 198 LIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQ-YLLERTWDLYERRELIL 276 (391)
Q Consensus 198 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 276 (391)
....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......... .+..... . ..
T Consensus 338 ~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~---~-~~--- 409 (543)
T 3c4z_A 338 ELKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL---E-QA--- 409 (543)
T ss_dssp ECCTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH---H-CC---
T ss_pred eccCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh---h-cc---
Confidence 7644322 233458999999999999999999999999999999999999999765432211 1111111 1 00
Q ss_pred eeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHHh
Q 016347 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSM-----STVVQML 319 (391)
Q Consensus 277 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~l 319 (391)
..++...+..+.+++.+||+.||.+||++ .+++++-
T Consensus 410 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hp 450 (543)
T 3c4z_A 410 -------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHP 450 (543)
T ss_dssp -------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSG
T ss_pred -------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCc
Confidence 01222345678889999999999999975 6676654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=337.63 Aligned_cols=258 Identities=24% Similarity=0.361 Sum_probs=210.1
Q ss_pred HHhhCCCCCCc-eeeccCceEEEEEEeC---CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCe
Q 016347 40 SIATDDFSPIN-KIGEGGFGSVYKGRLK---DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNH 114 (391)
Q Consensus 40 ~~~~~~y~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (391)
.+..++|.+.+ .||+|+||.||+|.+. ++..||+|++... .......+.+|+++++.++||||+++++++ ..+.
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~ 83 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA 83 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence 34557788887 9999999999999864 5788999999865 344567789999999999999999999999 5567
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.++||||+++++|.+++... ...+++..++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg 155 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGK-----REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFG 155 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTC-----TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCT
T ss_pred cEEEEEeCCCCCHHHHHHhC-----CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECccc
Confidence 89999999999999999643 23589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCcee--eeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhh
Q 016347 195 LAKLIPANMTHV--STRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYER 271 (391)
Q Consensus 195 ~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 271 (391)
++.......... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||......... .. ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~----i~~ 228 (287)
T 1u59_A 156 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AF----IEQ 228 (287)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH---HH----HHT
T ss_pred ceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH---HH----Hhc
Confidence 998764433221 122346889999999999999999999999999999998 99999765432211 11 111
Q ss_pred cccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 272 RELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.. ....+...+..+.+++.+||+.||.+||++.+++++|+..
T Consensus 229 ~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 229 GK---------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp TC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 10 1122234456888999999999999999999999998654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=370.17 Aligned_cols=263 Identities=30% Similarity=0.454 Sum_probs=215.1
Q ss_pred hHHHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 36 YKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 36 ~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
...+++..++|++.++||+|+||.||+|.+.++..||||++.... ...+.|.+|+++|+.++||||+++++++.+ ...
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 456677788999999999999999999999888889999998654 235679999999999999999999999866 678
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||||+++|+|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+
T Consensus 337 ~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~ 409 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGE----TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGL 409 (535)
T ss_dssp EEEECCCTTEEHHHHHSHH----HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred eEeeehhcCCcHHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccccc
Confidence 9999999999999999532 123589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
++..............++..|+|||++.++.++.++|||||||+||||++ |..||......+. ... ....
T Consensus 410 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~---~~~----i~~~-- 480 (535)
T 2h8h_A 410 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQ----VERG-- 480 (535)
T ss_dssp TTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH---HHH----HHTT--
T ss_pred ceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----HHcC--
Confidence 98764322111223346788999999999999999999999999999999 8999975433211 111 1111
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
.....+...+..+.+|+.+||+.||++|||+.+|++.|+...
T Consensus 481 -------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 481 -------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred -------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111222344567889999999999999999999999997664
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=347.94 Aligned_cols=259 Identities=26% Similarity=0.349 Sum_probs=208.2
Q ss_pred hhCCCCCCceeeccCceEEEEEEe----CCCcEEEEEEecccc----hhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeC
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRL----KDGKIAAIKVLSAES----RQGVKEFLTEIQVISEI-EHENLVKLYGCCVEG 112 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 112 (391)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+++++.+ +||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 347899999999999999999997 368999999987542 22334567799999999 799999999999999
Q ss_pred CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEe
Q 016347 113 NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISD 192 (391)
Q Consensus 113 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~D 192 (391)
...++||||+++++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D 202 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTD 202 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESC
T ss_pred ceEEEEeecCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEee
Confidence 9999999999999999999643 2589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCceeeeeecccccccChhhhhcC--CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh
Q 016347 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRG--QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE 270 (391)
Q Consensus 193 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 270 (391)
||+++.+............||+.|+|||++.+. .++.++|||||||++|+|++|..||............... ...
T Consensus 203 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--~~~ 280 (355)
T 1vzo_A 203 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR--ILK 280 (355)
T ss_dssp SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH--HHH
T ss_pred CCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHH--Hhc
Confidence 999987644333334456799999999999863 4789999999999999999999999755433222111111 000
Q ss_pred hcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHhcCC
Q 016347 271 RRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRP-----SMSTVVQMLMGE 322 (391)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~~~ 322 (391)
. ....+......+.+|+.+||+.||.+|| ++.|++++.+..
T Consensus 281 ~-----------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~ 326 (355)
T 1vzo_A 281 S-----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 326 (355)
T ss_dssp C-----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred c-----------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence 0 0112223445788899999999999999 999999887543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=337.82 Aligned_cols=272 Identities=25% Similarity=0.333 Sum_probs=202.6
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-----hhcHHHHHHHHHHHhcC---CCCceeEEEEEEE
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-----RQGVKEFLTEIQVISEI---EHENLVKLYGCCV 110 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~ 110 (391)
.+..++|+++++||+|+||+||+|.+. +|+.||+|++.... ......+.+|+.+++.+ .||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 456789999999999999999999975 68999999987432 11224566677777766 4999999999998
Q ss_pred eCC-----eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC
Q 016347 111 EGN-----HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD 185 (391)
Q Consensus 111 ~~~-----~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~ 185 (391)
... ..++||||+. ++|.+++.... ...+++..++.++.||+.||+|||++ +++||||||+||+++.+
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~ 156 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAP----PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSG 156 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCC----TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTT
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCC
Confidence 755 5899999997 59999997542 23489999999999999999999999 99999999999999999
Q ss_pred CcEEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 016347 186 LTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERT 265 (391)
Q Consensus 186 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 265 (391)
+.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...............
T Consensus 157 ~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (308)
T 3g33_A 157 GTVKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234 (308)
T ss_dssp SCEEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHH
T ss_pred CCEEEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999999999998764322 234467899999999999999999999999999999999999999765433221111111
Q ss_pred HHHhhhcccce---eeeccCC--CCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 266 WDLYERRELIL---LVDTSLN--GDFD-----AEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 266 ~~~~~~~~~~~---~~~~~~~--~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
........... .....+. ...+ ......+.+++.+||+.||++|||+.|++++-+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~ 300 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccc
Confidence 10000000000 0000000 0000 1234578889999999999999999999987644
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=338.93 Aligned_cols=252 Identities=26% Similarity=0.416 Sum_probs=205.8
Q ss_pred hhCCCCCCceeeccCceEEEEEEeCC-C-------cEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLKD-G-------KIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN 113 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (391)
..++|++.+.||+|+||.||+|.+.. + ..||+|++........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 45789999999999999999998663 3 579999998776677788999999999999999999999999999
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCc------
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLT------ 187 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~------ 187 (391)
..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++ +++||||||+|||++.++.
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNK-----NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred CCEEEEECCCCCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccc
Confidence 9999999999999999997532 3489999999999999999999999 9999999999999988876
Q ss_pred --EEEEecccccccCCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 016347 188 --PKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLER 264 (391)
Q Consensus 188 --~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~ 264 (391)
+||+|||++...... ....|++.|+|||++.+ ..++.++|||||||++|+|++|..|+..........
T Consensus 158 ~~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~---- 228 (289)
T 4fvq_A 158 PFIKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL---- 228 (289)
T ss_dssp CEEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH----
T ss_pred ceeeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH----
Confidence 999999998754321 23468899999999987 678999999999999999999765554332221110
Q ss_pred HHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 265 TWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
....... ..+...+..+.+++.+||+.||.+|||+.+++++|+...
T Consensus 229 --~~~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 229 --QFYEDRH-----------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp --HHHHTTC-----------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred --HHhhccC-----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 0011000 001111335788999999999999999999999997664
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=333.14 Aligned_cols=253 Identities=23% Similarity=0.359 Sum_probs=206.6
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC--CeeE
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG--NHRI 116 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 116 (391)
+..++|++.+.||+|+||.||+|++. ++.||+|++... .....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 44578999999999999999999986 889999998765 334456789999999999999999999999876 7889
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCcEEECCCCcEEEEecc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPH--IIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~--i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
+||||+++++|.+++.... ...+++..++.++.||+.||.|||++ + ++|+||||+||+++.++.++|+|||
T Consensus 86 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~ 158 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGT----NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMAD 158 (271)
T ss_dssp EEEECCTTCBHHHHHHSCS----SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGG
T ss_pred eeecccCCCcHHHHHhhcc----cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEecc
Confidence 9999999999999997542 23589999999999999999999998 8 9999999999999999999999998
Q ss_pred cccccCCCCceeeeeecccccccChhhhhcCCCCC---CCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhh
Q 016347 195 LAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTR---KADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYER 271 (391)
Q Consensus 195 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 271 (391)
+....... ...||+.|+|||++.+..++. ++|||||||++|+|++|..||......... . ....
T Consensus 159 ~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~---~~~~- 225 (271)
T 3kmu_A 159 VKFSFQSP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG---M---KVAL- 225 (271)
T ss_dssp SCCTTSCT------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH---H---HHHH-
T ss_pred ceeeeccc------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH---H---HHHh-
Confidence 87653222 246899999999998776554 799999999999999999999754322110 0 1011
Q ss_pred cccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 272 RELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.......+...+..+.+++.+||+.||++|||+.++++.|...
T Consensus 226 --------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 226 --------EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp --------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 1111122233455788999999999999999999999998654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=337.83 Aligned_cols=264 Identities=27% Similarity=0.460 Sum_probs=199.6
Q ss_pred HHHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCe
Q 016347 37 KELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNH 114 (391)
Q Consensus 37 ~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (391)
..+++..++|++.++||+|+||.||+|++.. .||+|++... .....+.+.+|+.+++.++||||++++++. ....
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQ 93 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCc
Confidence 3456778999999999999999999998753 5999998754 344557789999999999999999999965 5567
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.++||||+++++|.+++... ...+++..++.++.||+.||.|||++ +++||||||+||+++.++.++|+|||
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg 165 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHAS-----ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFG 165 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred cEEEEEecCCCcHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccce
Confidence 89999999999999999643 23689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCC-ceeeeeecccccccChhhhh---cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh
Q 016347 195 LAKLIPANM-THVSTRVAGTIGYLAPEYAI---RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE 270 (391)
Q Consensus 195 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 270 (391)
++....... ........||+.|+|||++. +..++.++|||||||++|+|++|..||........ .... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~----~~ 239 (289)
T 3og7_A 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEM----VG 239 (289)
T ss_dssp ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHH----HH
T ss_pred eccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHH----hc
Confidence 997653211 22233457899999999986 56788999999999999999999999976443221 1111 11
Q ss_pred hcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 271 RRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
...... .. .......+..+.+++.+||+.||.+||++.++++.|+..
T Consensus 240 ~~~~~~----~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 240 RGSLSP----DL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp HTSCCC----CT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ccccCc----ch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 111100 00 111223456788999999999999999999999999654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=341.64 Aligned_cols=262 Identities=24% Similarity=0.399 Sum_probs=206.7
Q ss_pred hCCCCCCceeeccCceEEEEEEe-----CCCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC--Ce
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRL-----KDGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG--NH 114 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 114 (391)
.++|++++.||+|+||.||+|++ .+++.||+|++... .......+.+|+.+++.++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 46699999999999999999983 35899999998754 334557789999999999999999999999876 67
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.++||||+++++|.+++.... ..+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|||
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK-----NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred EEEEEEeCCCCcHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccc
Confidence 899999999999999995432 3589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCc--eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCC--------cchhhHHHH
Q 016347 195 LAKLIPANMT--HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLP--------TEEQYLLER 264 (391)
Q Consensus 195 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~--------~~~~~~~~~ 264 (391)
++........ .......||..|+|||++.+..++.++|||||||++|+|++|..|+..... .........
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 9987654432 222345678889999999999999999999999999999999988643210 001101111
Q ss_pred HHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 265 TWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
... .+........+...+..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 252 ~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 252 LVN---------TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHH---------HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH---------HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 111 111111122233445678899999999999999999999999854
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=351.28 Aligned_cols=256 Identities=21% Similarity=0.340 Sum_probs=201.8
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEeccc--chhcHHHHHHHHHHHhcCC--CCceeEEEEEEEeCCeeE
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIE--HENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~ 116 (391)
+..++|++++.||+|+||.||+|.+.+++.||||++... .......+.+|+.+|+.+. ||||+++++++...+..+
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 345669999999999999999999888999999998754 3445677899999999996 599999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+||| +.+++|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||++
T Consensus 133 lv~E-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a 201 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIA 201 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSS
T ss_pred EEEe-cCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcc
Confidence 9999 56889999997543 588999999999999999999999 999999999999995 589999999999
Q ss_pred cccCCCCce-eeeeecccccccChhhhhc-----------CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 016347 197 KLIPANMTH-VSTRVAGTIGYLAPEYAIR-----------GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLER 264 (391)
Q Consensus 197 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~ 264 (391)
..+...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ .
T Consensus 202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-----~ 276 (390)
T 2zmd_A 202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----K 276 (390)
T ss_dssp CCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-----H
T ss_pred ccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH-----H
Confidence 876433221 2334679999999999865 4689999999999999999999999975432111 1
Q ss_pred HHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 265 TWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
..... +.......+......+.+|+.+||+.||.+||++.|++++.+.
T Consensus 277 ~~~~~---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 324 (390)
T 2zmd_A 277 LHAII---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324 (390)
T ss_dssp HHHHH---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HHHHh---------CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence 11111 1111111111224578889999999999999999999987543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=341.35 Aligned_cols=264 Identities=20% Similarity=0.241 Sum_probs=210.1
Q ss_pred chHHHHHhhCCCCCC-ceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcC-CCCceeEEEEEE
Q 016347 35 SYKELSIATDDFSPI-NKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEI-EHENLVKLYGCC 109 (391)
Q Consensus 35 ~~~e~~~~~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 109 (391)
.++..+...++|.+. +.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.+ .||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 455566677889888 89999999999999987 59999999987642 33467789999999999 569999999999
Q ss_pred EeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC---CC
Q 016347 110 VEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK---DL 186 (391)
Q Consensus 110 ~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~---~~ 186 (391)
.+....++||||+++++|.+++... ....+++..++.++.||+.||.|||++ |++||||||+||+++. ++
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~ 171 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPE----LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLG 171 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSC----C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBC
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCC
Confidence 9999999999999999999998542 234689999999999999999999999 9999999999999988 78
Q ss_pred cEEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 016347 187 TPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTW 266 (391)
Q Consensus 187 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 266 (391)
.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ..
T Consensus 172 ~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i- 245 (327)
T 3lm5_A 172 DIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL---NI- 245 (327)
T ss_dssp CEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HH-
T ss_pred cEEEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH---HH-
Confidence 99999999998764322 2234579999999999999999999999999999999999999997643322111 00
Q ss_pred HHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 267 DLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
... ...............+.+++.+||+.||.+|||+++++++.+
T Consensus 246 ---~~~------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~ 290 (327)
T 3lm5_A 246 ---SQV------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW 290 (327)
T ss_dssp ---HHT------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred ---Hhc------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence 000 001111112234557888999999999999999999988754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=345.00 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=196.8
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC----
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN---- 113 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 113 (391)
..++|++.+.||+|+||.||+|.+. +++.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 4588999999999999999999975 6899999999765 2344567889999999999999999999987654
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
..++||||+++++|.+++...+ .+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+||
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df 160 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF 160 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCC
T ss_pred ccEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeec
Confidence 3499999999999999996433 589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCc--eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhh
Q 016347 194 GLAKLIPANMT--HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYER 271 (391)
Q Consensus 194 g~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 271 (391)
|++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....+.... ......
T Consensus 161 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~ 234 (311)
T 3ork_A 161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVRE 234 (311)
T ss_dssp SCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHC
T ss_pred cCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhcC
Confidence 99987643322 1223356899999999999999999999999999999999999999765432211 111111
Q ss_pred cccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 272 RELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
.... .... ....+..+.+++.+||+.||.+||++.+++++
T Consensus 235 ~~~~---~~~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 235 DPIP---PSAR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp CCCC---HHHH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CCCC---cccc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 0000 0000 01134578899999999999999987776654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=344.81 Aligned_cols=273 Identities=25% Similarity=0.373 Sum_probs=217.9
Q ss_pred eeechHHHHHhhCCCCCCceeeccCceEEEEEEeC------CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeE
Q 016347 32 KLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVK 104 (391)
Q Consensus 32 ~~~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~ 104 (391)
..|...++++..++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||++
T Consensus 13 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 92 (322)
T 1p4o_A 13 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92 (322)
T ss_dssp SCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred cccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEee
Confidence 34566778888899999999999999999999864 37889999987543 344567889999999999999999
Q ss_pred EEEEEEeCCeeEEEEecccCCCHHHHHhcCCC----CCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcE
Q 016347 105 LYGCCVEGNHRILVYNYLENNSLAQTLIGGGH----HYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNI 180 (391)
Q Consensus 105 ~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~----~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NI 180 (391)
+++++.+.+..++||||+++++|.+++..... ......+++..++.++.||+.||.|||++ |++||||||+||
T Consensus 93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NI 169 (322)
T 1p4o_A 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNC 169 (322)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGE
T ss_pred eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceE
Confidence 99999999999999999999999999864211 00123578999999999999999999999 999999999999
Q ss_pred EECCCCcEEEEecccccccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcch
Q 016347 181 LLDKDLTPKISDFGLAKLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEE 258 (391)
Q Consensus 181 lv~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~ 258 (391)
+++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 170 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 249 (322)
T 1p4o_A 170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 249 (322)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH
T ss_pred EEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH
Confidence 999999999999999986533221 11223456889999999999999999999999999999999 8888865432111
Q ss_pred hhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 259 QYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
. ........ ...+...+..+.+++.+||+.||.+||++.|++++|....
T Consensus 250 ---~----~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 250 ---L----RFVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp ---H----HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred ---H----HHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 1 11111110 1112234457889999999999999999999999997653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=332.78 Aligned_cols=254 Identities=21% Similarity=0.292 Sum_probs=207.0
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
..++|++.+.||+|+||.||+|.+. +|+.||+|++... .......+.+|+.++++++||||+++++++.+....++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3689999999999999999999986 5899999998754 334456788999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCc---EEEEeccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLT---PKISDFGL 195 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~---~kl~Dfg~ 195 (391)
|||+++++|.+.+... ..+++..+..++.|++.||.|||++ |++||||||+||+++.++. +||+|||+
T Consensus 84 ~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~ 154 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR------EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGL 154 (284)
T ss_dssp ECCCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence 9999999999988643 3589999999999999999999999 9999999999999987655 99999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
+....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||........ ... ......
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~----~~~~~~- 224 (284)
T 3kk8_A 155 AIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL---YAQ----IKAGAY- 224 (284)
T ss_dssp CEECCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH----HHHTCC-
T ss_pred eEEcccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH---HHH----HHhccc-
Confidence 97764332 22345789999999999999999999999999999999999999965432211 111 111100
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.. ........+..+.+++.+||+.||++|||+.|++++-
T Consensus 225 ~~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (284)
T 3kk8_A 225 DY-----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263 (284)
T ss_dssp CC-----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred cC-----CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCc
Confidence 00 0011112345688999999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=349.94 Aligned_cols=269 Identities=23% Similarity=0.343 Sum_probs=195.2
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCC-CCceeEEEEEEEeCC--e
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIE-HENLVKLYGCCVEGN--H 114 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~ 114 (391)
...++|++++.||+|+||.||+|.+. +|+.||||++... .......+.+|+.+++.+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34689999999999999999999976 5999999998643 3445567889999999997 999999999998544 7
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.++||||++ ++|.+++..+ .+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG 154 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN-------ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFG 154 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEecccC-cCHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCc
Confidence 899999997 5899988542 589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCC--------------------CceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCC
Q 016347 195 LAKLIPAN--------------------MTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMR 253 (391)
Q Consensus 195 ~~~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~ 253 (391)
+++.+... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99865321 0112234579999999999876 67899999999999999999999999765
Q ss_pred CCcchhhHHHHHHHHhhhcccce------------------eeeccCCCCC------------CHHHHHHHHHHHhhccC
Q 016347 254 LPTEEQYLLERTWDLYERRELIL------------------LVDTSLNGDF------------DAEEACRFLKVGLLCTQ 303 (391)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~------------~~~~~~~l~~li~~cl~ 303 (391)
........+...........+.. .........+ .......+.+|+.+||+
T Consensus 235 ~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 235 STMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred CHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 43322111110000000000000 0000000000 00123468899999999
Q ss_pred CCCCCCCCHHHHHHHhc
Q 016347 304 DTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 304 ~dP~~Rps~~evl~~l~ 320 (391)
.||.+|||+.|++++-+
T Consensus 315 ~dP~~R~t~~e~l~Hp~ 331 (388)
T 3oz6_A 315 FNPNKRISANDALKHPF 331 (388)
T ss_dssp SSGGGSCCHHHHTTSTT
T ss_pred cCcccCCCHHHHhCCHH
Confidence 99999999999998754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=348.11 Aligned_cols=267 Identities=19% Similarity=0.277 Sum_probs=203.1
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeCC------CcEEEEEEecccchhcH-----------HHHHHHHHHHhcCCCCcee
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLKD------GKIAAIKVLSAESRQGV-----------KEFLTEIQVISEIEHENLV 103 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~iv 103 (391)
+..++|++.+.||+|+||.||+|.+.. ++.||||++........ ..+..|+..++.++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 345799999999999999999998764 47899999876542211 1233466677788999999
Q ss_pred EEEEEEEeC----CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 016347 104 KLYGCCVEG----NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASN 179 (391)
Q Consensus 104 ~~~~~~~~~----~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~N 179 (391)
++++++... ...++||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++ +|+||||||+|
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~N 182 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-----KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASN 182 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHH
Confidence 999998764 4589999999 999999997532 3599999999999999999999999 99999999999
Q ss_pred EEEC--CCCcEEEEecccccccCCCCce------eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCC
Q 016347 180 ILLD--KDLTPKISDFGLAKLIPANMTH------VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTN 251 (391)
Q Consensus 180 Ilv~--~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~ 251 (391)
||++ .++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~ 262 (364)
T 3op5_A 183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE 262 (364)
T ss_dssp EEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9998 8899999999999876432211 1133459999999999999999999999999999999999999998
Q ss_pred CCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 252 MRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
......... ....... ......+++..+.. ...+..+.+++..||+.||.+||++.+|++.|...
T Consensus 263 ~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 263 DNLKDPKYV--RDSKIRY-RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp GGTTCHHHH--HHHHHHH-HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ccccCHHHH--HHHHHHh-hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 543332211 1111111 11111222221110 11235788899999999999999999999887654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=332.84 Aligned_cols=249 Identities=21% Similarity=0.286 Sum_probs=206.9
Q ss_pred hhCCCCCCceeeccCceEEEEEEeCC-CcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
..++|++.+.||+|+||.||+|.+.. +..||+|.+........+.+.+|+++++.++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 35789999999999999999999874 78899999887655667889999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---CCCCcEEEEeccccc
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL---DKDLTPKISDFGLAK 197 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv---~~~~~~kl~Dfg~~~ 197 (391)
|+++++|.+++.... .+++..++.++.|++.||.|||++ |++|+||||+||++ +.++.++|+|||++.
T Consensus 87 ~~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 87 LCTGGELFERVVHKR------VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp CCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred ccCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 999999999886533 489999999999999999999999 99999999999999 788999999999998
Q ss_pred ccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccccee
Q 016347 198 LIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILL 277 (391)
Q Consensus 198 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (391)
...... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||......... .. ......
T Consensus 158 ~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~~----~~~~~~--- 224 (277)
T 3f3z_A 158 RFKPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM---LK----IREGTF--- 224 (277)
T ss_dssp ECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HH----HHHCCC---
T ss_pred eccCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH---HH----HHhCCC---
Confidence 764332 2234578999999998755 5999999999999999999999999764332111 11 111100
Q ss_pred eeccCCCCCCH----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 278 VDTSLNGDFDA----EEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 278 ~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
..+. ..+..+.+++.+||+.||.+||++.+++++-
T Consensus 225 -------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~ 263 (277)
T 3f3z_A 225 -------TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHE 263 (277)
T ss_dssp -------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred -------CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 1111 2245788999999999999999999998754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=355.09 Aligned_cols=250 Identities=22% Similarity=0.353 Sum_probs=208.4
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (391)
..++|++.+.||+|+||.||+|.+. +|+.||||++.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4578999999999999999999987 69999999987542 2345678899999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
||||+++++|.+++...+ .+++..++.++.||+.||.|||++ |++||||||+|||++.++.+||+|||++.
T Consensus 94 v~E~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~ 164 (476)
T 2y94_A 94 VMEYVSGGELFDYICKNG------RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSN 164 (476)
T ss_dssp EEECCSSEEHHHHTTSSS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchh
Confidence 999999999999996433 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCceeeeeecccccccChhhhhcCCC-CCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccce
Q 016347 198 LIPANMTHVSTRVAGTIGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL 276 (391)
Q Consensus 198 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (391)
...... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||....... ..... .....
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~~~~i----~~~~~-- 233 (476)
T 2y94_A 165 MMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---LFKKI----CDGIF-- 233 (476)
T ss_dssp ECCTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---HHHHH----HTTCC--
T ss_pred hccccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---HHHHH----hcCCc--
Confidence 764322 2345679999999999988776 789999999999999999999997644321 11111 11100
Q ss_pred eeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 277 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
..+......+.+++.+||+.||.+|||+.|++++-
T Consensus 234 --------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp 268 (476)
T 2y94_A 234 --------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHE 268 (476)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred --------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCH
Confidence 11112345688899999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=343.52 Aligned_cols=255 Identities=24% Similarity=0.331 Sum_probs=204.3
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEEEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
..++|++.+.||+|+||.||+|.+. +|+.||+|++...... ..+|++++.++ +||||+++++++.+....++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4578999999999999999999987 5899999999765432 34578888777 7999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC----CcEEEEeccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD----LTPKISDFGL 195 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~----~~~kl~Dfg~ 195 (391)
||++||+|.+.+...+ .+++..+..++.||+.||.|||++ |++||||||+|||+..+ +.+||+|||+
T Consensus 96 E~~~gg~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~ 166 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK------FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGF 166 (342)
T ss_dssp CCCCSCBHHHHHHTCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence 9999999999997543 489999999999999999999999 99999999999998443 3599999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
+....... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||..........+.... .....
T Consensus 167 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i----~~~~~- 240 (342)
T 2qr7_A 167 AKQLRAEN-GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI----GSGKF- 240 (342)
T ss_dssp CEECBCTT-CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH----HHCCC-
T ss_pred cccCcCCC-CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH----ccCCc-
Confidence 98764332 2234467899999999998888999999999999999999999999754332222222211 11111
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.+........+..+.+|+.+||+.||++||++.+++++-+
T Consensus 241 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 241 -----SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp -----CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred -----ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 0111111234457888999999999999999999998644
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=345.56 Aligned_cols=265 Identities=22% Similarity=0.204 Sum_probs=204.1
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc-----chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE-----SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN 113 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (391)
....++|++.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 345688999999999999999999986 5889999998654 2345577899999999999999999999999999
Q ss_pred eeEEEEecccCCCHHHHHhcCCCC----------------------------------CCccccCHHHHHHHHHHHHHHH
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHH----------------------------------YSNIQFSWRTRSRICIGIARGL 159 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~----------------------------------~~~~~l~~~~~~~i~~qi~~al 159 (391)
..++||||+++++|.+++...... .....+++..++.++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999998521000 0122346788899999999999
Q ss_pred HHhhhcCCCCeeecCCCCCcEEECCCC--cEEEEecccccccCCCC---ceeeeeecccccccChhhhhc--CCCCCCCc
Q 016347 160 AFLHEEVRPHIIHRDIKASNILLDKDL--TPKISDFGLAKLIPANM---THVSTRVAGTIGYLAPEYAIR--GQVTRKAD 232 (391)
Q Consensus 160 ~~lH~~~~~~i~H~dikp~NIlv~~~~--~~kl~Dfg~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~k~D 232 (391)
.|||++ +++||||||+||+++.++ .+||+|||++..+.... ........||+.|+|||++.+ ..++.++|
T Consensus 182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999 999999999999998776 89999999998653211 112344679999999999875 67899999
Q ss_pred EeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 016347 233 IYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSM 312 (391)
Q Consensus 233 vwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 312 (391)
||||||++|+|++|..||......... . ....... ..........+..+.+++.+||+.||.+||++
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~~---~---~~~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 325 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADTI---S---QVLNKKL-------CFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHH---H---HHHHCCC-------CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHHH---H---HHHhccc-------ccCCcccccCCHHHHHHHHHHcCCChhHCCCH
Confidence 999999999999999999755432211 1 1111000 00001111234578899999999999999999
Q ss_pred HHHHHHhc
Q 016347 313 STVVQMLM 320 (391)
Q Consensus 313 ~evl~~l~ 320 (391)
.+++++-+
T Consensus 326 ~~~l~hp~ 333 (345)
T 3hko_A 326 MRALQHPW 333 (345)
T ss_dssp HHHHHSHH
T ss_pred HHHhcChh
Confidence 99998643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=344.06 Aligned_cols=269 Identities=25% Similarity=0.362 Sum_probs=214.5
Q ss_pred chHHHHHhhCCCCCCceeeccCceEEEEEEeCC------CcEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCceeEEE
Q 016347 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLKD------GKIAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHENLVKLY 106 (391)
Q Consensus 35 ~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~ 106 (391)
..+++++..++|++.+.||+|+||.||+|.+.. +..||+|.+... .......+.+|+.+++.+ +||||++++
T Consensus 37 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 116 (333)
T 2i1m_A 37 YNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLL 116 (333)
T ss_dssp CCGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 445677888999999999999999999999753 247999998765 334556788999999999 899999999
Q ss_pred EEEEeCCeeEEEEecccCCCHHHHHhcCCCC--------CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 016347 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHH--------YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKAS 178 (391)
Q Consensus 107 ~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~--------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~ 178 (391)
+++...+..++||||+++|+|.+++...... .....+++..++.++.||+.||.|||++ |++||||||+
T Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~ 193 (333)
T 2i1m_A 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAAR 193 (333)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccc
Confidence 9999999999999999999999998642110 0123579999999999999999999999 9999999999
Q ss_pred cEEECCCCcEEEEecccccccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCc
Q 016347 179 NILLDKDLTPKISDFGLAKLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPT 256 (391)
Q Consensus 179 NIlv~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~ 256 (391)
||+++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 194 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 273 (333)
T 2i1m_A 194 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273 (333)
T ss_dssp GCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred eEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence 99999999999999999986533222 22233457889999999999999999999999999999998 88898765433
Q ss_pred chhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 257 EEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
... ... .... .....+...+..+.+++.+||+.||.+|||+.+|++.|..
T Consensus 274 ~~~--~~~----~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 274 SKF--YKL----VKDG---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp HHH--HHH----HHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH--HHH----HhcC---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 211 111 1110 0011112234578889999999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=340.60 Aligned_cols=268 Identities=24% Similarity=0.368 Sum_probs=204.1
Q ss_pred hHHHHHhhCCCCCCceeeccCceEEEEEEeC----CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEE
Q 016347 36 YKELSIATDDFSPINKIGEGGFGSVYKGRLK----DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCC 109 (391)
Q Consensus 36 ~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 109 (391)
++++.+..++|++.+.||+|+||.||+|.+. ++..||+|++... .......+.+|+.+++.++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 3455567789999999999999999999864 3558999998755 334456789999999999999999999999
Q ss_pred EeCC-----eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC
Q 016347 110 VEGN-----HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK 184 (391)
Q Consensus 110 ~~~~-----~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~ 184 (391)
.+.. ..++||||+++++|.+++...........+++..++.++.||+.||.|||++ +++||||||+||+++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcC
Confidence 8654 3599999999999999996543333445799999999999999999999999 9999999999999999
Q ss_pred CCcEEEEecccccccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHH
Q 016347 185 DLTPKISDFGLAKLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLL 262 (391)
Q Consensus 185 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~ 262 (391)
++.+||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.........
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--- 259 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY--- 259 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH---
Confidence 99999999999986543321 12233457889999999999999999999999999999999 88888765433211
Q ss_pred HHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 263 ERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.... . .. ....+...+..+.+++.+||+.||.+||++.+++++|...
T Consensus 260 ~~~~---~-~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 260 DYLL---H-GH---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp HHHH---T-TC---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH---c-CC---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1110 0 00 0111223345788999999999999999999999998653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=335.08 Aligned_cols=258 Identities=22% Similarity=0.300 Sum_probs=205.4
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeCC----CcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCe
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLKD----GKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNH 114 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (391)
.+..++|++.+.||+|+||.||+|.+.. +..||+|++... .......+.+|+.+++.++||||+++++++.+ +.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 3456889999999999999999998642 346999998765 34456778999999999999999999999764 45
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.++||||+++++|.+++.... ..+++..++.++.||+.||.|||++ |++|+||||+||+++.++.+||+|||
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 158 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNK-----NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFG 158 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred CEEEEecCCCCCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccC
Confidence 789999999999999996532 3589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcc
Q 016347 195 LAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRE 273 (391)
Q Consensus 195 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (391)
++...............+++.|+|||++.+..++.++|||||||++|+|++ |+.||......... ... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~---~~~----~~~~ 231 (281)
T 3cc6_A 159 LSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI---GVL----EKGD 231 (281)
T ss_dssp GGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH---HHH----HHTC
T ss_pred CCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH---HHH----hcCC
Confidence 998765433323334557889999999999999999999999999999998 99999754433221 111 0010
Q ss_pred cceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
....+...+..+.+++.+||+.||.+||++.|+++.|+..
T Consensus 232 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 232 ---------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 0011122345788999999999999999999999998654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=343.99 Aligned_cols=256 Identities=25% Similarity=0.389 Sum_probs=202.9
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcE----EEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKI----AAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
.++|++++.||+|+||.||+|.+. +++. ||+|.+.... ......+.+|+.+++.++||||+++++++. +...+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 478999999999999999999975 3443 7888775432 233355778999999999999999999886 45688
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+||||+++++|.+++... ...+++..++.++.||+.||.|||++ |++||||||+|||++.++.+||+|||++
T Consensus 91 ~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH-----RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp EEEECCTTCBSHHHHHSS-----GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred EEEEeCCCCCHHHHHHHc-----cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcc
Confidence 999999999999999653 23689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCce-eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 197 KLIPANMTH-VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 197 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
+........ ......|+..|+|||++.+..++.++|||||||++|+|++ |..||............ .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~~ 235 (325)
T 3kex_A 163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL-------EKGER 235 (325)
T ss_dssp GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH-------HTTCB
T ss_pred cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH-------HcCCC
Confidence 876543322 2334567889999999999999999999999999999999 99999765443221111 11100
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
...+...+..+.+++.+||+.||.+||++.+++++|....
T Consensus 236 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 236 ---------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp ---------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred ---------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0111122335778999999999999999999999996653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=340.33 Aligned_cols=255 Identities=21% Similarity=0.252 Sum_probs=208.2
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch------hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCe
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR------QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNH 114 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (391)
..++|++.+.||+|+||.||+|.+. +|+.||+|++..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3577999999999999999999987 589999999875432 135778999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC----cEEE
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL----TPKI 190 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~----~~kl 190 (391)
.++||||+++++|.+++...+ .+++..++.++.||+.||.|||++ |++||||||+||+++.++ .++|
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl 160 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKL 160 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCS------CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred EEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEE
Confidence 999999999999999997543 589999999999999999999999 999999999999999887 7999
Q ss_pred EecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh
Q 016347 191 SDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE 270 (391)
Q Consensus 191 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 270 (391)
+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ... ..
T Consensus 161 ~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~----i~ 231 (321)
T 2a2a_A 161 IDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LAN----IT 231 (321)
T ss_dssp CCCTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHH----HH
T ss_pred ccCccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH---HHH----HH
Confidence 9999998764432 22345689999999999999999999999999999999999999975432211 111 00
Q ss_pred hcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 271 RRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.... ...... ....+..+.+++.+||+.||++|||+.|++++-+
T Consensus 232 ~~~~--~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~ 275 (321)
T 2a2a_A 232 SVSY--DFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (321)
T ss_dssp TTCC--CCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred hccc--ccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 0000 000000 0112346889999999999999999999999754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=339.75 Aligned_cols=271 Identities=25% Similarity=0.364 Sum_probs=216.6
Q ss_pred echHHHHHhhCCCCCCceeeccCceEEEEEEe------CCCcEEEEEEecccc-hhcHHHHHHHHHHHhcC-CCCceeEE
Q 016347 34 YSYKELSIATDDFSPINKIGEGGFGSVYKGRL------KDGKIAAIKVLSAES-RQGVKEFLTEIQVISEI-EHENLVKL 105 (391)
Q Consensus 34 ~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~ 105 (391)
+...++.+..++|++.+.||+|+||.||+|.+ .+++.||+|++.... ......+.+|+.++..+ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 46677788889999999999999999999984 247899999997653 34456788999999999 79999999
Q ss_pred EEEEEeCC-eeEEEEecccCCCHHHHHhcCCCCC----------CccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecC
Q 016347 106 YGCCVEGN-HRILVYNYLENNSLAQTLIGGGHHY----------SNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRD 174 (391)
Q Consensus 106 ~~~~~~~~-~~~lv~e~~~~~sL~~~i~~~~~~~----------~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~d 174 (391)
++++...+ ..++||||+++++|.+++....... ....+++..++.++.||+.||.|||++ |++|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99987654 5899999999999999997643210 022388999999999999999999999 999999
Q ss_pred CCCCcEEECCCCcEEEEecccccccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCC
Q 016347 175 IKASNILLDKDLTPKISDFGLAKLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNM 252 (391)
Q Consensus 175 ikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~ 252 (391)
|||+||+++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987643322 22334567899999999999999999999999999999998 9999976
Q ss_pred CCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 253 RLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
....... ... ...... ...+...+..+.+++.+||+.||.+|||+.+++++|...
T Consensus 254 ~~~~~~~--~~~----~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 254 VKIDEEF--CRR----LKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCCSHHH--HHH----HHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhHHH--HHH----hccCcc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 4432211 111 111100 011222345788899999999999999999999998654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=345.59 Aligned_cols=268 Identities=23% Similarity=0.363 Sum_probs=210.8
Q ss_pred HHHHhhCCCCCCceeeccCceEEEEEEe-----CCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC
Q 016347 38 ELSIATDDFSPINKIGEGGFGSVYKGRL-----KDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG 112 (391)
Q Consensus 38 e~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (391)
...+..++|++++.||+|+||.||+|++ .+++.||+|++..........+.+|+.+++.++||||+++++++...
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 3345567899999999999999999984 35899999999877666677899999999999999999999998654
Q ss_pred C--eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEE
Q 016347 113 N--HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKI 190 (391)
Q Consensus 113 ~--~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl 190 (391)
+ ..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++ +++|+||||+||+++.++.+||
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL 186 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 186 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHST-----TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEE
T ss_pred CCCceEEEEECCCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEE
Confidence 3 7899999999999999997532 3589999999999999999999999 9999999999999999999999
Q ss_pred EecccccccCCCCcee--eeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCc---------chh
Q 016347 191 SDFGLAKLIPANMTHV--STRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPT---------EEQ 259 (391)
Q Consensus 191 ~Dfg~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~---------~~~ 259 (391)
+|||++.......... .....++..|+|||++.+..++.++|||||||++|+|++|..|+...... ...
T Consensus 187 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~ 266 (326)
T 2w1i_A 187 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 266 (326)
T ss_dssp CCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTH
T ss_pred ecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchh
Confidence 9999998765433221 22345677899999999999999999999999999999999887532100 000
Q ss_pred hHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 260 YLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
....... ..+........+...+..+.+++.+||+.||.+||++.||++.|+..
T Consensus 267 ~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 267 MIVFHLI---------ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHHHHH---------HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHH---------HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0000000 11111111122233456788999999999999999999999988643
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=343.52 Aligned_cols=256 Identities=25% Similarity=0.374 Sum_probs=201.0
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCc----EEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGK----IAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
.++|++++.||+|+||.||+|.+. +++ +||+|.+... .......+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 588999999999999999999975 344 3577777543 3445678999999999999999999999998754 78
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+|++|+.+++|.+++.... ..+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++
T Consensus 93 ~v~~~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred EEEEecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 8999999999999997532 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 197 KLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 197 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||............ .
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-------~---- 233 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-------E---- 233 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-------H----
T ss_pred eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-------H----
Confidence 87643322 12223456788999999999999999999999999999999 99999765443321111 1
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
.......+...+..+.+++.+||+.||.+||++.|+++.|....
T Consensus 234 -----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 234 -----KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -----TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 01111222334557889999999999999999999999987653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=336.16 Aligned_cols=259 Identities=24% Similarity=0.362 Sum_probs=207.7
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEe--CCeeEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVE--GNHRIL 117 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 117 (391)
.++|++.+.||+|+||.||+|.+. +|+.||+|.+... .....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 478999999999999999999987 5899999998754 33455678999999999999999999998864 568999
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCC-----eeecCCCCCcEEECCCCcEEEEe
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPH-----IIHRDIKASNILLDKDLTPKISD 192 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~-----i~H~dikp~NIlv~~~~~~kl~D 192 (391)
||||+++++|.+++..... ....+++..++.++.||+.||.|||+. + ++|+||||+||+++.++.+||+|
T Consensus 85 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~d 159 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGD 159 (279)
T ss_dssp EEECCTTEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECC
T ss_pred EEeCCCCCCHHHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence 9999999999999965321 233589999999999999999999999 7 99999999999999999999999
Q ss_pred cccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 193 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||....... .... ....
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~----i~~~ 231 (279)
T 2w5a_A 160 FGLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGK----IREG 231 (279)
T ss_dssp CCHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH----HHHT
T ss_pred Cchheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HHHH----Hhhc
Confidence 999987543221 1233568999999999999999999999999999999999999997543211 1111 1111
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
.. ...+...+..+.+++.+||+.||.+||++.|++++++...
T Consensus 232 ~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 232 KF---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp CC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred cc---------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 11 0112233457889999999999999999999999886553
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=344.92 Aligned_cols=273 Identities=20% Similarity=0.245 Sum_probs=213.9
Q ss_pred hhCCCCCCceeeccCceEEEEEEeCC-CcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC--eeEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN--HRIL 117 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~l 117 (391)
..++|++.+.||+|+||.||+|.+.. |+.||||++.... ......+.+|+++++.++||||+++++++.... ..++
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 45789999999999999999999874 9999999997643 344577889999999999999999999998755 7899
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----CCCCcEEEEec
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL----DKDLTPKISDF 193 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv----~~~~~~kl~Df 193 (391)
||||+++++|.+++.... ....+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+||
T Consensus 87 v~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DF 160 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPS---NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (396)
T ss_dssp EECCCTTEEHHHHTTSGG---GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred EEecCCCCCHHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecC
Confidence 999999999999996532 222389999999999999999999999 99999999999999 78888999999
Q ss_pred ccccccCCCCceeeeeecccccccChhhhhc--------CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcch-hhHHHH
Q 016347 194 GLAKLIPANMTHVSTRVAGTIGYLAPEYAIR--------GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEE-QYLLER 264 (391)
Q Consensus 194 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~-~~~~~~ 264 (391)
|++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ......
T Consensus 161 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 238 (396)
T 4eut_A 161 GAARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (396)
T ss_dssp GGCEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred CCceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence 9998764332 2234579999999999875 5688899999999999999999999975433221 111111
Q ss_pred HHHHhhhcccce---------eeecc--CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 265 TWDLYERRELIL---------LVDTS--LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 265 ~~~~~~~~~~~~---------~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
............ .+... ............+.+++.+||+.||++||++.++++.+..+
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 111111000000 01111 11234567788899999999999999999999999887554
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=342.24 Aligned_cols=252 Identities=23% Similarity=0.283 Sum_probs=180.9
Q ss_pred ceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCC-CCceeEEEEEEEeCCeeEEEEecccCCCH
Q 016347 50 NKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIE-HENLVKLYGCCVEGNHRILVYNYLENNSL 127 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 127 (391)
+.||+|+||.||+|.+. +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||+++++|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 78999999999999986 5899999998654 3356778999999996 99999999999999999999999999999
Q ss_pred HHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC---cEEEEecccccccCCCCc
Q 016347 128 AQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL---TPKISDFGLAKLIPANMT 204 (391)
Q Consensus 128 ~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~---~~kl~Dfg~~~~~~~~~~ 204 (391)
.+++...+ .+++..+..++.||+.||.|||++ |++||||||+|||++.++ .+||+|||++.......
T Consensus 94 ~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~- 163 (325)
T 3kn6_A 94 FERIKKKK------HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN- 163 (325)
T ss_dssp HHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-
Confidence 99997543 599999999999999999999999 999999999999997765 89999999998654332
Q ss_pred eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCC
Q 016347 205 HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNG 284 (391)
Q Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (391)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||........................ ....
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~------~~~~ 237 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF------SFEG 237 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC------CCCS
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC------CCCc
Confidence 2234457899999999999999999999999999999999999999764432111111111111111110 0000
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 285 DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 285 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
......+..+.+|+.+||+.||.+|||+.|++++-+
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w 273 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEW 273 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGG
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChh
Confidence 000123457889999999999999999999987654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=338.20 Aligned_cols=258 Identities=19% Similarity=0.223 Sum_probs=199.4
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 488999999999999999999986 58999999987552 23356788999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|||+++++|.+++...+ .+++..++.++.||+.||.|||++ +++|+||||+||+++.++.+||+|||++..
T Consensus 113 ~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG------PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp EECCCCEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred EEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 99999999999996532 589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
.............|++.|+|||++.+..++.++||||||+++|+|++|..||....... . . ..... ....
T Consensus 184 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~-~---~~~~~-~~~~-- 253 (309)
T 2h34_A 184 TTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV---M-G---AHINQ-AIPR-- 253 (309)
T ss_dssp -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH---H-H---HHHHS-CCCC--
T ss_pred ccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH---H-H---HHhcc-CCCC--
Confidence 64433233334578999999999998999999999999999999999999997542210 0 0 00110 0000
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHhcCCC
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRP-SMSTVVQMLMGEK 323 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~l~~~~ 323 (391)
.. ......+..+.+++.+||+.||++|| +++++++.|....
T Consensus 254 ~~----~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 254 PS----TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp GG----GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred cc----ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 00 11122344688899999999999999 9999999986553
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=341.44 Aligned_cols=270 Identities=21% Similarity=0.274 Sum_probs=197.3
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch--hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR--QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
....++|+++++||+|+||+||+|.+. +++.||||++..... .....+.+|+.+++.++||||+++++++.+....+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 344678999999999999999999976 699999999975532 23456778999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE-----CCCCcEEEE
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL-----DKDLTPKIS 191 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv-----~~~~~~kl~ 191 (391)
+||||+++ +|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+
T Consensus 110 lv~e~~~~-~L~~~~~~~~------~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~ 179 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKNP------DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIG 179 (329)
T ss_dssp EEEECCSE-EHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred EEEecCCC-CHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEEC
Confidence 99999975 9999997543 489999999999999999999999 99999999999999 455669999
Q ss_pred ecccccccCCCCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh
Q 016347 192 DFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE 270 (391)
Q Consensus 192 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 270 (391)
|||++........ ......||+.|+|||++.+. .++.++|||||||++|+|++|..||....................
T Consensus 180 Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 258 (329)
T 3gbz_A 180 DFGLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPD 258 (329)
T ss_dssp CTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred cCCCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCc
Confidence 9999987643322 23345689999999999874 489999999999999999999999976543322111111100000
Q ss_pred hcccce-----eeeccCC--CCCCH------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 271 RRELIL-----LVDTSLN--GDFDA------EEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 271 ~~~~~~-----~~~~~~~--~~~~~------~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
...... ....... ..... .....+.+|+.+||+.||.+|||+.|++++-+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 321 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcc
Confidence 000000 0000000 00000 12357889999999999999999999998754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=334.97 Aligned_cols=256 Identities=25% Similarity=0.361 Sum_probs=200.9
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
.++|++.++||+|+||.||+|.+. ++..+|+|++.... ......+.+|+++++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 478999999999999999999986 58999999987653 3456788999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---CCCCcEEEEeccccc
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL---DKDLTPKISDFGLAK 197 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv---~~~~~~kl~Dfg~~~ 197 (391)
|+++++|.+.+..... ....+++..++.++.||+.||.|||++ |++||||||+||++ +.++.+||+|||++.
T Consensus 101 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 101 TCEGGELLERIVSAQA--RGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp CCSCCBHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred eCCCCcHHHHHHhhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 9999999998854211 224589999999999999999999999 99999999999999 456889999999998
Q ss_pred ccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccccee
Q 016347 198 LIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILL 277 (391)
Q Consensus 198 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (391)
...... ......||+.|+|||++. +.++.++|||||||++|+|++|..||......... ... .....
T Consensus 176 ~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~---~~~----~~~~~--- 242 (285)
T 3is5_A 176 LFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ---QKA----TYKEP--- 242 (285)
T ss_dssp C------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH----HHCCC---
T ss_pred ecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH---hhh----ccCCc---
Confidence 654322 233457899999999874 67899999999999999999999999754322111 110 00000
Q ss_pred eeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 278 VDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 278 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
..... .......+.+++.+||+.||++|||+.|++++-+
T Consensus 243 ---~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 281 (285)
T 3is5_A 243 ---NYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEW 281 (285)
T ss_dssp ---CCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred ---ccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 00000 0012356788999999999999999999998643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=335.16 Aligned_cols=260 Identities=27% Similarity=0.378 Sum_probs=206.8
Q ss_pred HHHHHhhCCCCCCc-eeeccCceEEEEEEeC---CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEE
Q 016347 37 KELSIATDDFSPIN-KIGEGGFGSVYKGRLK---DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCV 110 (391)
Q Consensus 37 ~e~~~~~~~y~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 110 (391)
+++.+..++|++.+ .||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 34445567899988 9999999999999643 47889999987653 23356789999999999999999999998
Q ss_pred eCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEE
Q 016347 111 EGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKI 190 (391)
Q Consensus 111 ~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl 190 (391)
.....++||||+++++|.+++...+ .+++..++.++.||+.||.|||++ +++|+||||+||+++.++.+||
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl 158 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKI 158 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEE
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhCc------CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEE
Confidence 5667899999999999999997543 489999999999999999999999 9999999999999999999999
Q ss_pred EecccccccCCCCcee--eeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 016347 191 SDFGLAKLIPANMTHV--STRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWD 267 (391)
Q Consensus 191 ~Dfg~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 267 (391)
+|||++.......... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||........ ..
T Consensus 159 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~---- 231 (291)
T 1xbb_A 159 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TA---- 231 (291)
T ss_dssp CCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HH----
T ss_pred ccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HH----
Confidence 9999998765433222 122346788999999999999999999999999999999 9999976443211 11
Q ss_pred HhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 268 LYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
...... ....+...+..+.+++.+||+.||.+||++.++++.|+..
T Consensus 232 ~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 232 MLEKGE---------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp HHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111 1122233456788999999999999999999999988543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=344.27 Aligned_cols=248 Identities=24% Similarity=0.286 Sum_probs=198.5
Q ss_pred CceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccCCCH
Q 016347 49 INKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSL 127 (391)
Q Consensus 49 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 127 (391)
.+.||+|+||.||+|.+. +|+.||+|++..........+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 567999999999999976 5999999999876656667899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE--CCCCcEEEEecccccccCCCCce
Q 016347 128 AQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL--DKDLTPKISDFGLAKLIPANMTH 205 (391)
Q Consensus 128 ~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv--~~~~~~kl~Dfg~~~~~~~~~~~ 205 (391)
.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++........
T Consensus 174 ~~~l~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~- 244 (373)
T 2x4f_A 174 FDRIIDE-----SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK- 244 (373)
T ss_dssp HHHHHHT-----GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-
T ss_pred HHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-
Confidence 9988643 23589999999999999999999999 99999999999999 6678999999999987644322
Q ss_pred eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCC
Q 016347 206 VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGD 285 (391)
Q Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (391)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..... . ... . ....
T Consensus 245 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~i~---~-~~~-~-----~~~~ 310 (373)
T 2x4f_A 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET---LNNIL---A-CRW-D-----LEDE 310 (373)
T ss_dssp -CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHH---H-TCC-C-----SCSG
T ss_pred -cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH---h-ccC-C-----CChh
Confidence 2335699999999999989999999999999999999999999976543211 11111 0 000 0 0000
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 286 FDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 286 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.....+..+.+|+.+||+.||.+||++.|++++-
T Consensus 311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp 344 (373)
T 2x4f_A 311 EFQDISEEAKEFISKLLIKEKSWRISASEALKHP 344 (373)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 0112345788999999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=344.33 Aligned_cols=268 Identities=21% Similarity=0.318 Sum_probs=198.2
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchh-cHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQ-GVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
++|+++++||+|+||.||+|.+. +++.||+|++...... ....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 68999999999999999999987 6899999998755322 112345799999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+++ +|.+++...+ ..+++..+..++.||+.||.|||++ |++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 82 LDK-DLKQYLDDCG-----NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp CSE-EHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred ccc-CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 974 8988886532 3589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeee-
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD- 279 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 279 (391)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.............................
T Consensus 153 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 153 PT-KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred Cc-cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 22 22234568999999999876 5689999999999999999999999976543332211111110000000000000
Q ss_pred --------ccCCCC----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 280 --------TSLNGD----FDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 280 --------~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
+..... ........+.+|+.+||+.||.+|||++|++++-+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 285 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhh
Confidence 000000 001223567899999999999999999999987543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=338.40 Aligned_cols=250 Identities=20% Similarity=0.300 Sum_probs=207.6
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
.++|++.+.||+|+||.||++.+. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 478999999999999999999987 4889999998754 234556788999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|||+++++|.+++... ..+++..++.++.||+.||.|||++ |++||||||+||+++.++.+||+|||++..
T Consensus 120 ~e~~~~~~L~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 120 LELCRRRSLLELHKRR------KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATK 190 (335)
T ss_dssp ECCCTTCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCcee
Confidence 9999999999998643 3589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .........
T Consensus 191 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~~~---- 258 (335)
T 2owb_A 191 VEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-------YLRIKKNEY---- 258 (335)
T ss_dssp CCSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHHTCC----
T ss_pred cccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH-------HHHHhcCCC----
Confidence 643222 23345789999999999999999999999999999999999999975432111 111111110
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
..+......+.+++.+||+.||++||++.|++++-
T Consensus 259 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~ 293 (335)
T 2owb_A 259 ------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDE 293 (335)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred ------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 11122345678899999999999999999999864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=339.87 Aligned_cols=266 Identities=21% Similarity=0.301 Sum_probs=206.8
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEe----CCe
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVE----GNH 114 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~ 114 (391)
.+..++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|+.+++.++||||+++++++.. ...
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 345688999999999999999999985 699999999877666667789999999999999999999999873 347
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.++||||+++++|.+++..... ....+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKD--KGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred eEEEEEeCCCCcHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecC
Confidence 8999999999999999865211 234689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCce--------eeeeecccccccChhhhhcCC---CCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHH
Q 016347 195 LAKLIPANMTH--------VSTRVAGTIGYLAPEYAIRGQ---VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLE 263 (391)
Q Consensus 195 ~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~ 263 (391)
++......... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||......... ...
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~ 258 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VAL 258 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hhH
Confidence 88764321110 011235799999999987554 789999999999999999999998531110000 000
Q ss_pred HHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 016347 264 RTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKD 324 (391)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~ 324 (391)
. .. ...........+..+.+++.+||+.||.+||++.+++++|+....
T Consensus 259 ~----~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 259 A----VQ---------NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp H----HH---------CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred H----hh---------ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 0 00 000111112334578899999999999999999999999976643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=334.32 Aligned_cols=251 Identities=26% Similarity=0.442 Sum_probs=208.4
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
.+.|++++.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.+.||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 467999999999999999999876 58999999987553 3456789999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+++++|.+++.. ..+++..+..++.||+.||.|||+. |++|+||||+||+++.++.++|+|||++....
T Consensus 101 ~~~~~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 101 YLGGGSALDLLEP-------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp CCTTEEHHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred eCCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecC
Confidence 9999999999953 3589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeec
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT 280 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (391)
.... ......|++.|+|||++.+..++.++||||||+++|+|++|..||.......... . ..... ..
T Consensus 171 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~----~~~~~-----~~ 237 (303)
T 3a7i_A 171 DTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF---L----IPKNN-----PP 237 (303)
T ss_dssp TTBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---H----HHHSC-----CC
T ss_pred cccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH---H----hhcCC-----CC
Confidence 3321 2234578999999999999999999999999999999999999997543321111 0 01110 01
Q ss_pred cCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 281 SLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 281 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
......+..+.+++.+||+.||.+|||+.+++++.+
T Consensus 238 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 238 ----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp ----CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred ----CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 111223456889999999999999999999998654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=342.51 Aligned_cols=247 Identities=23% Similarity=0.297 Sum_probs=205.5
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch--------hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR--------QGVKEFLTEIQVISEIEHENLVKLYGCCVEGN 113 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (391)
.++|++.+.||+|+||.||+|.+. +++.||||++..... .....+.+|+.+++.++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 578999999999999999999976 589999999876421 12335677999999999999999999999999
Q ss_pred eeEEEEecccCC-CHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEe
Q 016347 114 HRILVYNYLENN-SLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISD 192 (391)
Q Consensus 114 ~~~lv~e~~~~~-sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~D 192 (391)
..++||||+.+| +|.+++.... .+++..+..++.||+.||.|||++ |++||||||+|||++.++.+||+|
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHP------RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred EEEEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEee
Confidence 999999999776 9999997543 489999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCceeeeeecccccccChhhhhcCCC-CCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhh
Q 016347 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYER 271 (391)
Q Consensus 193 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 271 (391)
||++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......
T Consensus 174 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------------- 237 (335)
T 3dls_A 174 FGSAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-------------- 237 (335)
T ss_dssp CTTCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT--------------
T ss_pred cccceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH--------------
Confidence 99998764432 2334679999999999988877 889999999999999999999996421100
Q ss_pred cccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 272 RELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
.... ..+...+..+.+++.+||+.||++|||+.+++++.+...
T Consensus 238 -------~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 238 -------EAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp -------TTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred -------hhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 0000 111123456889999999999999999999999865443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=352.15 Aligned_cols=261 Identities=22% Similarity=0.284 Sum_probs=207.1
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCC-CceeEEEEEEEeCCeeEEEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEH-ENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 119 (391)
..++|++.++||+|+||.||+|.+. +++.||||++...... ..+..|+++++.+.| ++|..+..++......++||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 4588999999999999999999975 6999999987654332 347789999999976 56667777778888999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---CCCCcEEEEecccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL---DKDLTPKISDFGLA 196 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv---~~~~~~kl~Dfg~~ 196 (391)
||+ +++|.+++... ...+++..++.|+.||+.||.|||++ +|+||||||+|||| +.++.+||+|||++
T Consensus 83 e~~-g~sL~~ll~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (483)
T ss_dssp ECC-CCBHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred ECC-CCCHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence 999 99999999642 23599999999999999999999999 99999999999999 57899999999999
Q ss_pred cccCCCCce------eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh
Q 016347 197 KLIPANMTH------VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE 270 (391)
Q Consensus 197 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 270 (391)
+.+...... ......||+.|+|||++.+..++.++|||||||+||+|++|..||....................
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (483)
T 3sv0_A 154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (483)
T ss_dssp EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH
T ss_pred eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc
Confidence 876443221 12246799999999999999999999999999999999999999987655443322222211111
Q ss_pred hcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 271 RRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
......+ . . ..+..+.+++..||+.||++||++.+|++.|...
T Consensus 234 ~~~~~~l-~----~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 234 ATSIEAL-C----R----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HSCHHHH-H----T----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cccHHHH-h----c----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1110000 0 0 1235788999999999999999999999887655
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=339.49 Aligned_cols=259 Identities=26% Similarity=0.410 Sum_probs=203.5
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeCC-----CcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLKD-----GKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN 113 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (391)
++..++|++.+.||+|+||.||+|.+.. +..||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 4456788999999999999999998653 346999998765 3344567889999999999999999999999999
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++ |++||||||+||+++.++.+||+||
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Df 191 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDF 191 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred CcEEEEeCCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCC
Confidence 9999999999999999996532 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCce--eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhh
Q 016347 194 GLAKLIPANMTH--VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYE 270 (391)
Q Consensus 194 g~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 270 (391)
|++......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||....... .... ..
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~~~----~~ 264 (333)
T 1mqb_A 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VMKA----IN 264 (333)
T ss_dssp CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHH----HH
T ss_pred CcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---HHHH----HH
Confidence 999876433211 1122346788999999999999999999999999999999 999996543211 1111 11
Q ss_pred hcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 271 RRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.. .....+...+..+.+++.+||+.||.+||++.++++.|+..
T Consensus 265 ~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 265 DG---------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp TT---------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CC---------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 01112223456788999999999999999999999998654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=328.74 Aligned_cols=257 Identities=25% Similarity=0.374 Sum_probs=208.5
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 478999999999999999999987 68999999987543 3445778899999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+++++|.+++... ..+++..+..++.||+.||.|||++ |++|+||||+||+++.++.++|+|||++....
T Consensus 86 ~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 86 YCSGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (276)
T ss_dssp CCTTEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred ecCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence 99999999988543 3589999999999999999999999 99999999999999999999999999997653
Q ss_pred CCC-ceeeeeecccccccChhhhhcCCC-CCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 201 ANM-THVSTRVAGTIGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 201 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
... ........|++.|+|||++.+..+ +.++||||||+++|+|++|..||........... .+.....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~~~~~~~---- 226 (276)
T 2yex_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS------DWKEKKT---- 226 (276)
T ss_dssp ETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH------HHHTTCT----
T ss_pred CCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH------Hhhhccc----
Confidence 222 112334578999999999987765 7899999999999999999999976544322111 0111000
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
........+..+.+++.+||+.||.+|||+.|++++.+..
T Consensus 227 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~ 266 (276)
T 2yex_A 227 ----YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266 (276)
T ss_dssp ----TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred ----ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCcccc
Confidence 0011112345788899999999999999999998875433
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=335.85 Aligned_cols=256 Identities=28% Similarity=0.445 Sum_probs=199.0
Q ss_pred hhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
..++|++.+.||+|+||.||+|++. ++.||+|.+... ...+.+.+|+.++++++||||+++++++.+ ..++||||
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 3478999999999999999999986 788999998654 345778999999999999999999998763 48999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCc-EEEEecccccccC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLT-PKISDFGLAKLIP 200 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~-~kl~Dfg~~~~~~ 200 (391)
+++++|.+++.... ....++...++.++.|++.||.|||+....|++||||||+||+++.++. +||+|||++....
T Consensus 81 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 81 AEGGSLYNVLHGAE---PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp CTTCBHHHHHHCSS---SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred CCCCCHHHHHhccC---CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 99999999997543 2334788999999999999999999921128999999999999988876 7999999997653
Q ss_pred CCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeec
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT 280 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (391)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... .+.... ..
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~-~~------- 221 (307)
T 2eva_A 158 TH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI----MWAVHN-GT------- 221 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH----HHHHHT-TC-------
T ss_pred cc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH----HHHHhc-CC-------
Confidence 22 223468999999999999999999999999999999999999997543322111 111111 10
Q ss_pred cCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 281 SLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 281 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
........+..+.+++.+||+.||.+|||+.++++.|....
T Consensus 222 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 222 --RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp --CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred --CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 01111223456888999999999999999999999987653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=327.58 Aligned_cols=252 Identities=24% Similarity=0.378 Sum_probs=187.2
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
.++|++.+.||+|+||.||+|.+. +|+.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 367999999999999999999975 69999999986542 23356788999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|||+++++|.+++... ...+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++..
T Consensus 90 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 161 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR-----VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQ 161 (278)
T ss_dssp EECCTTEEHHHHHHTC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence 9999999999999753 23689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......... . ...
T Consensus 162 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~------------~~~ 225 (278)
T 3cok_A 162 LKMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---N------------KVV 225 (278)
T ss_dssp CC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CC
T ss_pred ccCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---H------------HHh
Confidence 643222 223457899999999999889999999999999999999999999754332110 0 000
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.... ..+...+..+.+++.+||+.||++||++.+++++-+
T Consensus 226 ~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 265 (278)
T 3cok_A 226 LADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPF 265 (278)
T ss_dssp SSCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTT
T ss_pred hccc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCcc
Confidence 0000 112223457889999999999999999999988654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=333.75 Aligned_cols=273 Identities=25% Similarity=0.390 Sum_probs=207.3
Q ss_pred echHHHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcC--CCCceeEEEEEEEe
Q 016347 34 YSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEI--EHENLVKLYGCCVE 111 (391)
Q Consensus 34 ~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~ 111 (391)
+.........++|++.+.||+|+||.||+|++. ++.||||++..... ..+..|.+++..+ +||||+++++++..
T Consensus 27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 355566667789999999999999999999986 89999999865432 3445566666554 89999999999988
Q ss_pred C----CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcC-----CCCeeecCCCCCcEEE
Q 016347 112 G----NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV-----RPHIIHRDIKASNILL 182 (391)
Q Consensus 112 ~----~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~-----~~~i~H~dikp~NIlv 182 (391)
. ...++||||+++++|.+++... .+++..++.++.|++.||.|||+++ ..+++||||||+|||+
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill 175 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE
Confidence 7 7899999999999999999543 5899999999999999999999752 2379999999999999
Q ss_pred CCCCcEEEEecccccccCCCCcee---eeeecccccccChhhhhcCCCCCC------CcEeehhHHHHHHHhC-------
Q 016347 183 DKDLTPKISDFGLAKLIPANMTHV---STRVAGTIGYLAPEYAIRGQVTRK------ADIYSFGVLLVEIVSG------- 246 (391)
Q Consensus 183 ~~~~~~kl~Dfg~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k------~DvwSlG~vl~elltg------- 246 (391)
+.++.+||+|||++.......... .....||+.|+|||++.+...+.+ +|||||||++|+|++|
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~ 255 (337)
T 3mdy_A 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255 (337)
T ss_dssp CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence 999999999999997664332221 124579999999999988776665 9999999999999999
Q ss_pred ---CCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCC-CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 247 ---RCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGD-FDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 247 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
..||....+........ ........ ........ .....+..+.+++.+||+.||.+|||+.+|+++|+..
T Consensus 256 ~~~~~p~~~~~~~~~~~~~~--~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 256 EEYQLPYHDLVPSDPSYEDM--REIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp CCCCCTTTTTSCSSCCHHHH--HHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccHhhhcCCCCchhhh--HHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 56665443332211111 11111111 11111100 1126778899999999999999999999999999765
Q ss_pred C
Q 016347 323 K 323 (391)
Q Consensus 323 ~ 323 (391)
.
T Consensus 330 ~ 330 (337)
T 3mdy_A 330 S 330 (337)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=333.99 Aligned_cols=264 Identities=22% Similarity=0.329 Sum_probs=199.5
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
...++|++.+.||+|+||.||+|.+. +|+.||+|++... .......+.+|+.+++.++||||+++++++...+..+
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 34478999999999999999999975 6999999998753 3445667889999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+||||+++++|.+++..... ....+++..++.++.||+.||.|||++ |++|+||||+||+++.++.++|+|||++
T Consensus 109 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKK--QKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLG 183 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC---
T ss_pred EEEecCCCCCHHHHHHHhcc--cccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccce
Confidence 99999999999999864211 223589999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccce
Q 016347 197 KLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL 276 (391)
Q Consensus 197 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (391)
........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||......... ... .........
T Consensus 184 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~----~~~~~~~~~ 257 (310)
T 2wqm_A 184 RFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LCK----KIEQCDYPP 257 (310)
T ss_dssp ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH-HHH----HHHTTCSCC
T ss_pred eeecCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH-HHH----HhhcccCCC
Confidence 86543221 223456899999999999999999999999999999999999999654322111 111 111111100
Q ss_pred eeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 277 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
......+..+.+++.+||+.||.+||++.+|++.|....
T Consensus 258 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 258 --------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp --------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 011223457889999999999999999999999986553
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=344.49 Aligned_cols=270 Identities=24% Similarity=0.370 Sum_probs=208.5
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEE
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (391)
++..++|++++.||+|+||.||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++.+++..++
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 455688999999999999999999987 5899999998765 34455778999999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
||||+++++|.+++...+ .+++..+..++.|++.||.|||+++ |++||||||+||+++.++.++|+|||++.
T Consensus 109 v~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 180 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSG 180 (360)
T ss_dssp EECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred EEECCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCc
Confidence 999999999999996533 4899999999999999999999832 79999999999999999999999999987
Q ss_pred ccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH---------
Q 016347 198 LIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDL--------- 268 (391)
Q Consensus 198 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~--------- 268 (391)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..................
T Consensus 181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 181 QLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp HHHHH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred ccccc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence 54221 223457899999999999999999999999999999999999999764432211110000000
Q ss_pred h--------------hhccc----ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 269 Y--------------ERREL----ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 269 ~--------------~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
. ..... ................+..+.+|+.+||+.||.+|||+.|++++-+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 0 00000 0000000000011123457889999999999999999999998653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=344.17 Aligned_cols=255 Identities=20% Similarity=0.222 Sum_probs=194.6
Q ss_pred hCCCCCC-ceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHh-cCCCCceeEEEEEEEe----CCee
Q 016347 43 TDDFSPI-NKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVIS-EIEHENLVKLYGCCVE----GNHR 115 (391)
Q Consensus 43 ~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~----~~~~ 115 (391)
.++|.+. +.||+|+||+||+|.+. +|+.||||++... ..+.+|+.++. ..+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3566666 68999999999999987 5899999998643 34667888874 4589999999999875 5678
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC---CCcEEEEe
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK---DLTPKISD 192 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~---~~~~kl~D 192 (391)
++||||++||+|.+++...+ ...+++..+..|+.||+.||.|||+. ||+||||||+|||++. ++.+||+|
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEEeCCCCcHHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEe
Confidence 99999999999999997532 23589999999999999999999999 9999999999999987 78999999
Q ss_pred cccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhh-HHHHHHHHhhh
Q 016347 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQY-LLERTWDLYER 271 (391)
Q Consensus 193 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~ 271 (391)
||+++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ...... .
T Consensus 208 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~ 281 (400)
T 1nxk_A 208 FGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----M 281 (400)
T ss_dssp CTTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----H
T ss_pred cccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----c
Confidence 99998654321 2345678999999999999999999999999999999999999997654432110 111110 0
Q ss_pred cccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 272 RELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
... . .........+..+.+|+.+||+.||.+|||+.|++++.+.
T Consensus 282 ~~~-~-----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 325 (400)
T 1nxk_A 282 GQY-E-----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325 (400)
T ss_dssp TCC-C-----CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred Ccc-c-----CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 000 0 0000011234578899999999999999999999997543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=341.92 Aligned_cols=250 Identities=26% Similarity=0.401 Sum_probs=202.8
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
.+.|+.++.||+|+||.||+|.+. +|+.||||++.... ......+.+|+.+++.++||||+++++++......++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 356999999999999999999975 69999999987542 33456788999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|||+. |+|.+++... ...+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++..
T Consensus 133 ~e~~~-g~l~~~l~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI 203 (348)
T ss_dssp EECCS-EEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred EecCC-CCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence 99997 5788877532 23589999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCceeeeeecccccccChhhhh---cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAI---RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
.... ....||+.|+|||++. .+.++.++|||||||++|+|++|..||........ ....... ...
T Consensus 204 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~~~~-~~~ 271 (348)
T 1u5q_A 204 MAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQN-ESP 271 (348)
T ss_dssp SSSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHS-CCC
T ss_pred cCCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhc-CCC
Confidence 5322 2357999999999985 56789999999999999999999999965432211 1111111 100
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
. ......+..+.+++.+||+.||++|||+.+++++.+.
T Consensus 272 ~--------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 272 A--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp C--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred C--------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 0 0111234568889999999999999999999987543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=337.06 Aligned_cols=259 Identities=27% Similarity=0.385 Sum_probs=204.5
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEE--EEEEeccc-chhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIA--AIKVLSAE-SRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~v--avK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 117 (391)
.++|++.+.||+|+||.||+|.+. ++..+ |+|.+... .......+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 378999999999999999999976 46644 89988653 334456788999999999 99999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCC----------CCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCc
Q 016347 118 VYNYLENNSLAQTLIGGGH----------HYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLT 187 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~----------~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~ 187 (391)
||||+++++|.+++..... ......+++..++.++.||+.||.|||++ |++||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence 9999999999999976430 01234689999999999999999999999 9999999999999999999
Q ss_pred EEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 016347 188 PKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTW 266 (391)
Q Consensus 188 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 266 (391)
+||+|||++...... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||........ .
T Consensus 181 ~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~-------~ 251 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-------Y 251 (327)
T ss_dssp EEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------H
T ss_pred EEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH-------H
Confidence 999999998743211 11223456889999999999999999999999999999998 9999975432211 1
Q ss_pred HHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 267 DLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
...... .....+...+..+.+++.+||+.||.+||++.++++.|...
T Consensus 252 ~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 252 EKLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp HHGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhhcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111111 11122223456788999999999999999999999988654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=330.26 Aligned_cols=261 Identities=22% Similarity=0.294 Sum_probs=205.0
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEE-EeCCeeEEEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCC-VEGNHRILVY 119 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~ 119 (391)
..++|++.+.||+|+||.||+|.+. +|+.||+|++...... ..+.+|+.+++.++|++++..+..+ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 3588999999999999999999974 6999999998755332 4588899999999888766555544 6778889999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC---CCCcEEEEecccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLD---KDLTPKISDFGLA 196 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~---~~~~~kl~Dfg~~ 196 (391)
||+ +++|.+++.... ..+++..++.++.||+.||.|||++ +++||||||+||+++ .++.+||+|||++
T Consensus 85 e~~-~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp ECC-CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 999 899999996422 3589999999999999999999999 999999999999994 7889999999999
Q ss_pred cccCCCCce------eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh
Q 016347 197 KLIPANMTH------VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE 270 (391)
Q Consensus 197 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 270 (391)
......... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 3uzp_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence 876443221 12345799999999999999999999999999999999999999986543332222222111111
Q ss_pred hcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 271 RRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.... ..+. ...+..+.+++.+||+.||.+||++.+|++.|...
T Consensus 236 ~~~~-----~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 236 STPI-----EVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HSCH-----HHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred CCch-----HHHH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 0000 0000 11235688999999999999999999999998654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=330.00 Aligned_cols=261 Identities=22% Similarity=0.284 Sum_probs=201.4
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEE-EeCCeeEEEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCC-VEGNHRILVY 119 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~ 119 (391)
.+++|++.+.||+|+||.||+|.+. +++.||+|++...... ..+.+|+.+++.++|++++..+..+ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 4588999999999999999999975 6899999987654322 3477899999999887766655554 6778899999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---CCCCcEEEEecccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL---DKDLTPKISDFGLA 196 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv---~~~~~~kl~Dfg~~ 196 (391)
||+ +++|.+++.... ..+++..++.++.||+.||.|||++ +++||||||+|||+ +.++.+||+|||++
T Consensus 85 e~~-~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp ECC-CCBHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred Ecc-CCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 999 999999996432 3589999999999999999999999 99999999999999 78899999999999
Q ss_pred cccCCCCc------eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh
Q 016347 197 KLIPANMT------HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE 270 (391)
Q Consensus 197 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 270 (391)
........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence 87643322 122345789999999999999999999999999999999999999976554433222222211111
Q ss_pred hcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 271 RRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
..... .... ..+..+.+++.+||+.||++||++.++++.|...
T Consensus 236 ~~~~~-----~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 236 STPIE-----VLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HSCHH-----HHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred cchhh-----hhhc----cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 10000 0000 1235788999999999999999999999988654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=330.62 Aligned_cols=252 Identities=20% Similarity=0.301 Sum_probs=208.3
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (391)
..++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 3478999999999999999999987 4889999998754 23445678899999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
||||+++++|.+++... ..+++..++.++.||+.||.|||++ |++|+||||+||+++.++.+||+|||++.
T Consensus 93 v~e~~~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 163 (294)
T 2rku_A 93 VLELCRRRSLLELHKRR------KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLAT 163 (294)
T ss_dssp EEECCTTCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCce
Confidence 99999999999988643 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccccee
Q 016347 198 LIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILL 277 (391)
Q Consensus 198 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (391)
....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||........ .........
T Consensus 164 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~--- 232 (294)
T 2rku_A 164 KVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-------YLRIKKNEY--- 232 (294)
T ss_dssp ECCSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTTCC---
T ss_pred ecccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHhhccC---
Confidence 7643222 22345789999999999988999999999999999999999999975432111 111111110
Q ss_pred eeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 278 VDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 278 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
..+......+.+++.+||+.||++||++.|++++.+
T Consensus 233 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~ 268 (294)
T 2rku_A 233 -------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF 268 (294)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred -------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 111223456888999999999999999999998643
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=332.69 Aligned_cols=255 Identities=26% Similarity=0.412 Sum_probs=201.3
Q ss_pred HHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC-CeeE
Q 016347 38 ELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG-NHRI 116 (391)
Q Consensus 38 e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~ 116 (391)
.+.+..++|++.+.||+|+||.||+|.+. |+.||+|++.... ..+.+.+|+.+++.++||||+++++++.+. +..+
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 91 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred cccCChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceE
Confidence 34455689999999999999999999986 8899999987543 446789999999999999999999987654 4789
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+||||+++++|.+++... ....+++..++.++.|++.||.|||++ |++|+||||+||+++.++.++|+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 164 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSR----GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT 164 (278)
T ss_dssp EEECCCTTEEHHHHHHHH----HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred EEEecCCCCCHHHHHHhc----ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccc
Confidence 999999999999999642 122478999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 197 KLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 197 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
...... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||........ ... ....
T Consensus 165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~----~~~~--- 230 (278)
T 1byg_A 165 KEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPR----VEKG--- 230 (278)
T ss_dssp ---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHH----HTTT---
T ss_pred cccccc----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----HhcC---
Confidence 764332 123357889999999999999999999999999999998 9999975433221 111 1111
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.....+...+..+.+++.+||+.||.+||++.++++.|+..
T Consensus 231 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 231 ------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 11122233456788999999999999999999999998654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=328.42 Aligned_cols=249 Identities=26% Similarity=0.348 Sum_probs=206.9
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (391)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 3478999999999999999999987 58899999986542 2335678899999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
||||+++++|.+++...+ .+++..+..++.||+.||.|||++ |++|+||||+||+++.++.++|+|||++.
T Consensus 92 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 162 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHG------RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSV 162 (284)
T ss_dssp EECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccc
Confidence 999999999999996533 489999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccccee
Q 016347 198 LIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILL 277 (391)
Q Consensus 198 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (391)
...... .....|++.|+|||++.+..++.++||||||+++|+|++|..||........ .. ......
T Consensus 163 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~----~~~~~~---- 228 (284)
T 2vgo_A 163 HAPSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET---HR----RIVNVD---- 228 (284)
T ss_dssp ECSSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HH----HHHTTC----
T ss_pred cCcccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH---HH----HHhccc----
Confidence 653321 2345789999999999999999999999999999999999999975432111 00 011100
Q ss_pred eeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 278 VDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 278 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
...+...+..+.+++.+||+.||.+||++.+++++-
T Consensus 229 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~ 264 (284)
T 2vgo_A 229 ------LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264 (284)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred ------cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCH
Confidence 011223345788899999999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=340.45 Aligned_cols=266 Identities=20% Similarity=0.252 Sum_probs=200.1
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC----CCcEEEEEEecccchh-----------cHHHHHHHHHHHhcCCCCceeEEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK----DGKIAAIKVLSAESRQ-----------GVKEFLTEIQVISEIEHENLVKLY 106 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~iv~~~ 106 (391)
..++|++.+.||+|+||.||+|.+. ++..+|+|++...... ....+.+|+..++.+.||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 3578999999999999999999986 4778999998765321 112356788899999999999999
Q ss_pred EEEEe----CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE
Q 016347 107 GCCVE----GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL 182 (391)
Q Consensus 107 ~~~~~----~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv 182 (391)
+++.. ....++||||+ +++|.+++...+ .+++..++.++.||+.||.|||++ +++||||||+|||+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 184 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG------TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLL 184 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEE
Confidence 99987 77899999999 999999986432 699999999999999999999999 99999999999999
Q ss_pred CCCC--cEEEEecccccccCCCCce------eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCC
Q 016347 183 DKDL--TPKISDFGLAKLIPANMTH------VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRL 254 (391)
Q Consensus 183 ~~~~--~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~ 254 (391)
+.++ .+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 264 (345)
T 2v62_A 185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL 264 (345)
T ss_dssp ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8887 9999999999876422111 1134579999999999999999999999999999999999999996533
Q ss_pred CcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 255 PTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
.......... ..... .....+..... ....+..+.+++.+||+.||++||++.+|++.|+...
T Consensus 265 ~~~~~~~~~~--~~~~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 265 KDPVAVQTAK--TNLLD-ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp TCHHHHHHHH--HHHHH-TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred cccHHHHHHH--Hhhcc-cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 2222111111 11100 00000000000 0023347889999999999999999999999997653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=328.08 Aligned_cols=255 Identities=22% Similarity=0.338 Sum_probs=201.0
Q ss_pred HHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC
Q 016347 38 ELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN 113 (391)
Q Consensus 38 e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (391)
+..+..++|++.+.||+|+||.||+|.+. +|+.||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 44556689999999999999999999987 69999999986542 234567889999999999999999999999999
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
..++||||+++++|.+++...+ .+++..+..++.||+.||.|||++ |++|+||||+||+++.++.++|+||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~df 155 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHG------RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF 155 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeec
Confidence 9999999999999999996533 489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCceeeeeecccccccChhhhhcCCC-CCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 194 GLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 194 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
|++....... ......|++.|+|||++.+..+ +.++||||||+++|+|++|..||....... .... ....
T Consensus 156 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~----~~~~ 226 (276)
T 2h6d_A 156 GLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT---LFKK----IRGG 226 (276)
T ss_dssp CGGGCCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH----HHHC
T ss_pred ccccccCCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HHHH----hhcC
Confidence 9998764322 2234568999999999887765 689999999999999999999996542211 1111 1111
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.. ..+......+.+++.+||+.||.+|||+.+++++-+
T Consensus 227 ~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~ 264 (276)
T 2h6d_A 227 VF----------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEW 264 (276)
T ss_dssp CC----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred cc----------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChh
Confidence 00 111223456888999999999999999999998754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=327.52 Aligned_cols=256 Identities=23% Similarity=0.361 Sum_probs=203.1
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecc
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYL 122 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 122 (391)
++|.....||+|+||.||+|.+. +++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 45666679999999999999976 58899999998766666678999999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-CCcEEEEecccccccCC
Q 016347 123 ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK-DLTPKISDFGLAKLIPA 201 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~-~~~~kl~Dfg~~~~~~~ 201 (391)
++++|.+++.... ....+++..+..++.||+.||.|||++ |++|+||||+||+++. ++.+||+|||++.....
T Consensus 102 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 102 PGGSLSALLRSKW---GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp SEEEHHHHHHHTT---CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCCHHHHHHhhc---cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999997542 223567889999999999999999999 9999999999999987 89999999999987643
Q ss_pred CCceeeeeecccccccChhhhhcCC--CCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRGQ--VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
.. .......|++.|+|||++.+.. ++.++||||||+++|+|++|..||........... .. ...
T Consensus 176 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~--~~~---------- 241 (295)
T 2clq_A 176 IN-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KV--GMF---------- 241 (295)
T ss_dssp ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH-HH--HHH----------
T ss_pred CC-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH-hh--ccc----------
Confidence 22 1223457899999999987654 88999999999999999999999964332211110 00 000
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
......+...+..+.+++.+||+.||++||++.+++++-+
T Consensus 242 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~ 281 (295)
T 2clq_A 242 -KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEF 281 (295)
T ss_dssp -CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGG
T ss_pred -cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 0011222334557888999999999999999999998653
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=340.52 Aligned_cols=267 Identities=24% Similarity=0.391 Sum_probs=202.8
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
.++|++++.||+|+||.||+|.+. +|+.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 378999999999999999999987 48999999986542 333456789999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++.... .+++..+..++.||+.||.|||++ |++||||||+||+++.++.+||+|||++...
T Consensus 104 e~~~~~~l~~~~~~~~------~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN------GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL 174 (331)
T ss_dssp ECCSEEHHHHHHHSTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred ecCCcchHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence 9999999988875433 489999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HHHhh
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERT--------WDLYE 270 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~ 270 (391)
.... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||............... ...+.
T Consensus 175 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 175 AAPG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred cCCc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence 4322 223345689999999998775 7899999999999999999999999765433221111100 00000
Q ss_pred hccc-ceeeeccCCCCCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 271 RREL-ILLVDTSLNGDFDA-----EEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 271 ~~~~-~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.... .....+......+. ..+..+.+|+.+||+.||.+|||+.|++++-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 308 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 0000 00000111111111 2345788999999999999999999998764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=335.66 Aligned_cols=254 Identities=22% Similarity=0.356 Sum_probs=205.4
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
..++|++.+.||+|+||.||+|++. +|+.||+|++..........+.+|+.+++.++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 4578999999999999999999986 699999999986654445678899999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---CCCCcEEEEeccccc
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL---DKDLTPKISDFGLAK 197 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv---~~~~~~kl~Dfg~~~ 197 (391)
|+++++|.+++...+ .+++..+..++.||+.||.|||++ |++|+||||+||++ +.++.++|+|||++.
T Consensus 87 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 87 LVSGGELFDRILERG------VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp CCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred cCCCccHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 999999999986432 589999999999999999999999 99999999999999 778999999999987
Q ss_pred ccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccccee
Q 016347 198 LIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILL 277 (391)
Q Consensus 198 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (391)
..... ......|++.|+|||++.+..++.++|||||||++|+|++|..||....... ..... ..... .
T Consensus 158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i----~~~~~-~- 225 (304)
T 2jam_A 158 MEQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK---LFEKI----KEGYY-E- 225 (304)
T ss_dssp CCCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHH----HHCCC-C-
T ss_pred ecCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH----HcCCC-C-
Confidence 64322 2233568999999999999999999999999999999999999997543211 11111 11100 0
Q ss_pred eeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 278 VDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 278 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.........+..+.+++.+||+.||.+||++.|++++.+
T Consensus 226 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 226 ----FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp ----CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred ----CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 011111233457889999999999999999999998643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=363.35 Aligned_cols=258 Identities=24% Similarity=0.352 Sum_probs=204.8
Q ss_pred HHhhCCCCCCc-eeeccCceEEEEEEeC---CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCe
Q 016347 40 SIATDDFSPIN-KIGEGGFGSVYKGRLK---DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNH 114 (391)
Q Consensus 40 ~~~~~~y~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (391)
.+..+++.+.+ +||+|+||.||+|.+. ++..||||++.... ....+.+.+|+++|+.++||||+++++++.. +.
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~ 409 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 409 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence 34445555555 8999999999999864 46679999997653 3456789999999999999999999999876 56
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.++||||+++|+|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFG 481 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGK-----REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFG 481 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTC-----TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCS
T ss_pred eEEEEEeCCCCcHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeecc
Confidence 89999999999999999643 23589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCceee--eeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhh
Q 016347 195 LAKLIPANMTHVS--TRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYER 271 (391)
Q Consensus 195 ~~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 271 (391)
+++.......... ....+++.|+|||++.++.++.++|||||||++|||++ |..||......+.. .. ...
T Consensus 482 la~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~---~~----i~~ 554 (613)
T 2ozo_A 482 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AF----IEQ 554 (613)
T ss_dssp TTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH---HH----HHT
T ss_pred CcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---HH----HHc
Confidence 9987643322111 12345689999999999999999999999999999998 99999765543211 11 111
Q ss_pred cccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 272 RELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
. .....+...+..+.+++.+||+.||.+||++.+|++.|+..
T Consensus 555 ~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 555 G---------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp T---------CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred C---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 11122334556888999999999999999999999988654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=352.11 Aligned_cols=194 Identities=23% Similarity=0.393 Sum_probs=155.4
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC-----Ce
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG-----NH 114 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 114 (391)
.++|++++.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+.+|+.++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999976 5899999998653 334556788999999999999999999998533 57
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.++||||+ +++|.+++.... .+++..+..++.||+.||.|||+. ||+||||||+||||+.++.+||+|||
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFG 201 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV------YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFG 201 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecc-ccchhhhcccCC------CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccc
Confidence 89999998 568999986543 599999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCc--------------------------eeeeeecccccccChhhh-hcCCCCCCCcEeehhHHHHHHHhC
Q 016347 195 LAKLIPANMT--------------------------HVSTRVAGTIGYLAPEYA-IRGQVTRKADIYSFGVLLVEIVSG 246 (391)
Q Consensus 195 ~~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~k~DvwSlG~vl~elltg 246 (391)
+++....... ......+||+.|+|||++ .+..++.++|||||||+||||++|
T Consensus 202 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 9987642211 122345789999999986 456799999999999999999993
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=339.07 Aligned_cols=263 Identities=27% Similarity=0.385 Sum_probs=206.6
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC------CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN 113 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (391)
+..++|++.+.||+|+||.||+|.+. +++.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 45689999999999999999999842 4778999998654 3445567889999999999999999999999999
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCC-CccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC---CCcEE
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHY-SNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK---DLTPK 189 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~-~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~---~~~~k 189 (391)
..++||||+++++|.+++....... ....+++..++.++.||+.||.|||++ |++||||||+||+++. ++.+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999997653211 224589999999999999999999999 9999999999999984 45699
Q ss_pred EEecccccccCCCC-ceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 016347 190 ISDFGLAKLIPANM-THVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWD 267 (391)
Q Consensus 190 l~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 267 (391)
|+|||++....... ........|++.|+|||++.+..++.++|||||||++|+|++ |..||........ ...
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~--- 257 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---LEF--- 257 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HHH---
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH---HHH---
Confidence 99999997543221 122233567889999999999999999999999999999998 8899875432211 111
Q ss_pred HhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 268 LYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
..... ....+...+..+.+++.+||+.||.+||++.+++++|+..
T Consensus 258 -~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 258 -VTSGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp -HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HhcCC---------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11110 0111223345788999999999999999999999998654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=343.25 Aligned_cols=284 Identities=22% Similarity=0.261 Sum_probs=212.6
Q ss_pred ccCCCcceeechHHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCC-----
Q 016347 25 FSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIE----- 98 (391)
Q Consensus 25 ~~~~~~~~~~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~----- 98 (391)
......-..+.++...+..++|+++++||+|+||.||+|++. +++.||||++... ......+.+|+.+++.++
T Consensus 18 ~~~~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~ 96 (397)
T 1wak_A 18 PNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPN 96 (397)
T ss_dssp ----CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTT
T ss_pred cccCCCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCC
Confidence 333333444566666677899999999999999999999976 5899999999754 334567888999999985
Q ss_pred ---CCceeEEEEEEE----eCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 016347 99 ---HENLVKLYGCCV----EGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHII 171 (391)
Q Consensus 99 ---h~~iv~~~~~~~----~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~ 171 (391)
|+||+++++++. .....++||||+ +++|.+.+... ....+++..++.++.||+.||.|||+++ ||+
T Consensus 97 ~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~----~~~~~~~~~~~~i~~qi~~aL~~lH~~~--giv 169 (397)
T 1wak_A 97 DPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKS----NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RII 169 (397)
T ss_dssp CGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHT----TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEE
T ss_pred CCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhc----ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEe
Confidence 788999999987 456899999999 55666666543 2235899999999999999999999863 799
Q ss_pred ecCCCCCcEEECCCC-------------------------------------------------cEEEEecccccccCCC
Q 016347 172 HRDIKASNILLDKDL-------------------------------------------------TPKISDFGLAKLIPAN 202 (391)
Q Consensus 172 H~dikp~NIlv~~~~-------------------------------------------------~~kl~Dfg~~~~~~~~ 202 (391)
||||||+|||++.++ .+||+|||++......
T Consensus 170 HrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~ 249 (397)
T 1wak_A 170 HTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH 249 (397)
T ss_dssp CCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC
T ss_pred cCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc
Confidence 999999999999876 7999999999875432
Q ss_pred CceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhH---HHHHHHHhhh--------
Q 016347 203 MTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYL---LERTWDLYER-------- 271 (391)
Q Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~-------- 271 (391)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||........... ..........
T Consensus 250 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 325 (397)
T 1wak_A 250 ----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVA 325 (397)
T ss_dssp ----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHH
T ss_pred ----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhc
Confidence 2335789999999999999999999999999999999999999976554331110 1111000000
Q ss_pred cc-cceeeec-----cC--------------CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 272 RE-LILLVDT-----SL--------------NGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 272 ~~-~~~~~~~-----~~--------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.. ....+.. .+ ....+......+.+|+.+||+.||++|||+.|++++-+
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 394 (397)
T 1wak_A 326 GKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW 394 (397)
T ss_dssp CTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred ccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence 00 0000000 00 01235677788999999999999999999999998653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=338.15 Aligned_cols=268 Identities=23% Similarity=0.307 Sum_probs=200.9
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchh-----cHHHHHHHHHHHhcCCCCceeEEEEEEEeCCe
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQ-----GVKEFLTEIQVISEIEHENLVKLYGCCVEGNH 114 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (391)
...++|++.+.||+|+||.||+|.+. +|+.||+|++...... ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34588999999999999999999986 5899999998754221 12467889999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.++||||+++ +|.+++.... ..+++..+..++.||+.||.|||++ |++||||||+||+++.++.+||+|||
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFG 157 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred eEEEEEcCCC-CHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecc
Confidence 9999999986 8888886532 3588899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc-
Q 016347 195 LAKLIPANMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR- 272 (391)
Q Consensus 195 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 272 (391)
++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||......... ..........
T Consensus 158 ~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~---~~i~~~~~~~~ 233 (346)
T 1ua2_A 158 LAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL---TRIFETLGTPT 233 (346)
T ss_dssp GGSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCC
T ss_pred cceeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHHcCCCC
Confidence 998764332 223345789999999998764 5899999999999999999999998765432211 1111111000
Q ss_pred --ccc---eeeec---cCCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 273 --ELI---LLVDT---SLNGDFD-----AEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 273 --~~~---~~~~~---~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
... ...+. ......+ ......+.+|+.+||+.||.+|||+.|++++.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f 295 (346)
T 1ua2_A 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295 (346)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhh
Confidence 000 00000 0000111 1234678899999999999999999999998654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=333.20 Aligned_cols=270 Identities=24% Similarity=0.337 Sum_probs=211.3
Q ss_pred eechHHHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhc--CCCCceeEEEEEEE
Q 016347 33 LYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISE--IEHENLVKLYGCCV 110 (391)
Q Consensus 33 ~~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~ 110 (391)
..++.......++|++.+.||+|+||.||+|++. |+.||||++.... ...+.+|.+++.. ++||||+++++++.
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 3455556677899999999999999999999985 8999999986543 3567788888887 78999999999998
Q ss_pred eCC----eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhh--------hcCCCCeeecCCCCC
Q 016347 111 EGN----HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH--------EEVRPHIIHRDIKAS 178 (391)
Q Consensus 111 ~~~----~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH--------~~~~~~i~H~dikp~ 178 (391)
... ..++||||+++++|.+++... .+++..++.++.||+.||.||| +. +++||||||+
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~ 176 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSK 176 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGG
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhcc-------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHH
Confidence 775 789999999999999999543 4899999999999999999999 77 9999999999
Q ss_pred cEEECCCCcEEEEecccccccCCCCce---eeeeecccccccChhhhhcC------CCCCCCcEeehhHHHHHHHhC---
Q 016347 179 NILLDKDLTPKISDFGLAKLIPANMTH---VSTRVAGTIGYLAPEYAIRG------QVTRKADIYSFGVLLVEIVSG--- 246 (391)
Q Consensus 179 NIlv~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~k~DvwSlG~vl~elltg--- 246 (391)
||+++.++.+||+|||++......... ......||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 177 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~ 256 (342)
T 1b6c_B 177 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256 (342)
T ss_dssp GEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred HEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCc
Confidence 999999999999999999876443322 12345789999999998765 344789999999999999999
Q ss_pred -------CCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCC-CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 247 -------RCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGD-FDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 247 -------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
..||....+..... ........... ....+... ........+.+++.+||+.||.+|||+.+|+++
T Consensus 257 ~~~~~~~~~p~~~~~~~~~~~--~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 257 GGIHEDYQLPYYDLVPSDPSV--EEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TTBCCCCCCTTTTTSCSSCCH--HHHHHHHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CCcccccccCccccCcCcccH--HHHHHHHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 67776543322111 11111111111 11111100 123667789999999999999999999999999
Q ss_pred hcCC
Q 016347 319 LMGE 322 (391)
Q Consensus 319 l~~~ 322 (391)
|+.+
T Consensus 331 L~~i 334 (342)
T 1b6c_B 331 LSQL 334 (342)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=342.40 Aligned_cols=263 Identities=20% Similarity=0.263 Sum_probs=199.0
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC------
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN------ 113 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 113 (391)
.++|++++.||+|+||.||+|.+. +|+.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 578999999999999999999986 5999999998653 3344567889999999999999999999997653
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||++ |++||||||+||+++.++.+||+||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df 172 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 172 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEee
Confidence 469999999 7899999864 2489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh--
Q 016347 194 GLAKLIPANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE-- 270 (391)
Q Consensus 194 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-- 270 (391)
|+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+........
T Consensus 173 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 173 GLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248 (367)
T ss_dssp TTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 999875432 234578999999999887 6799999999999999999999999976543221111110000000
Q ss_pred ------h-------cccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 271 ------R-------RELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 271 ------~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
. ..........+ ..........+.+|+.+||+.||.+|||+.|++++-..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f 311 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHH
Confidence 0 00000000000 01112234578889999999999999999999997543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=338.73 Aligned_cols=270 Identities=23% Similarity=0.320 Sum_probs=204.2
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEe--------
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVE-------- 111 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------- 111 (391)
.++|+++++||+|+||.||+|.+. +|+.||+|++.... ......+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 378999999999999999999985 69999999986552 2334567889999999999999999999986
Q ss_pred CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEE
Q 016347 112 GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKIS 191 (391)
Q Consensus 112 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~ 191 (391)
.+..++||||+++ +|.+.+.... ..+++..+..++.||+.||.|||++ |++||||||+|||++.++.+||+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~ 166 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA 166 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred CceEEEEEeccCC-CHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEc
Confidence 4568999999976 7777775432 3589999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCC---ceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 016347 192 DFGLAKLIPANM---THVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWD 267 (391)
Q Consensus 192 Dfg~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 267 (391)
|||++..+.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.................
T Consensus 167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 246 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 246 (351)
T ss_dssp CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 999998764221 122234578999999999876 4589999999999999999999999986544332221111111
Q ss_pred Hhhhc--------ccceeeeccCCCCCCH-H------HHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 268 LYERR--------ELILLVDTSLNGDFDA-E------EACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 268 ~~~~~--------~~~~~~~~~~~~~~~~-~------~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
..... .....+.......... . ....+.+|+.+||+.||.+|||+.|++++-+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 315 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCc
Confidence 00000 0000000000000111 1 13458899999999999999999999997654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=330.06 Aligned_cols=256 Identities=26% Similarity=0.357 Sum_probs=201.5
Q ss_pred hCCCCCCceeeccCceEEEEEEeCC----CcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEE-eCCeeE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLKD----GKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCV-EGNHRI 116 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 116 (391)
..+|++.+.||+|+||.||+|.+.+ +..+|+|.+... .......+.+|+.++++++||||+++++++. .++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4678999999999999999998653 336899998754 3445677899999999999999999999865 456889
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++
T Consensus 104 ~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a 175 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 175 (298)
T ss_dssp EEEECCTTCBHHHHHHCTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred EEEeCCCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccc
Confidence 9999999999999996532 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCc---eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCC-CCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 197 KLIPANMT---HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR-CNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 197 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
........ .......+|+.|+|||.+.+..++.++|||||||++|+|++|. .||......... ... ....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~---~~~---~~~~ 249 (298)
T 3f66_A 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VYL---LQGR 249 (298)
T ss_dssp CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH---HHH---HTTC
T ss_pred ccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH---HHH---hcCC
Confidence 87643321 1223345788999999999999999999999999999999954 555443332211 110 0000
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
....+...+..+.+++.+||+.||.+||++.|+++.|...
T Consensus 250 ----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 250 ----------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0011122345788999999999999999999999998654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=327.92 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=201.5
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEe----CCee
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVE----GNHR 115 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~ 115 (391)
.+.|++.+.||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 345888999999999999999986 5889999998754 34456778999999999999999999999875 3568
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCcEEEC-CCCcEEEEe
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPH--IIHRDIKASNILLD-KDLTPKISD 192 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~--i~H~dikp~NIlv~-~~~~~kl~D 192 (391)
++||||+++++|.+++... ..+++..++.++.||+.||.|||+. + ++|+||||+||+++ .++.+||+|
T Consensus 105 ~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~D 175 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGD 175 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred EEEEEecCCCCHHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEee
Confidence 9999999999999999643 3589999999999999999999998 8 99999999999997 789999999
Q ss_pred cccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 193 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
||++....... .....||+.|+|||++. +.++.++|||||||++|+|++|+.||......... .......
T Consensus 176 fg~~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~------~~~~~~~ 245 (290)
T 1t4h_A 176 LGLATLKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------YRRVTSG 245 (290)
T ss_dssp TTGGGGCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH------HHHHTTT
T ss_pred CCCcccccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH------HHHHhcc
Confidence 99997654332 23457899999999875 56999999999999999999999999754332211 1111111
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
... . ..+......+.+++.+||+.||.+|||+.|++++-+
T Consensus 246 ~~~----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 285 (290)
T 1t4h_A 246 VKP----A----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp CCC----G----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCc----c----ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcc
Confidence 000 0 011112346889999999999999999999998754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=329.61 Aligned_cols=254 Identities=22% Similarity=0.293 Sum_probs=203.7
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch------hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCe
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR------QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNH 114 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (391)
..++|++.+.||+|+||.||+|.+. +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 3567999999999999999999987 589999999875421 236778999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC----cEEE
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL----TPKI 190 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~----~~kl 190 (391)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||++ |++|+||||+||+++.++ .++|
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl 153 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEK------ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKL 153 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEE
T ss_pred EEEEEeecCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEE
Confidence 99999999999999999643 3589999999999999999999999 999999999999998877 8999
Q ss_pred EecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh
Q 016347 191 SDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE 270 (391)
Q Consensus 191 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 270 (391)
+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||........ ... ..
T Consensus 154 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~----~~ 224 (283)
T 3bhy_A 154 IDFGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET---LTN----IS 224 (283)
T ss_dssp CCCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHH----HH
T ss_pred EecccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH---HHH----hH
Confidence 9999998764322 22345689999999999989999999999999999999999999976432111 110 00
Q ss_pred hcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 271 RRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.... ..........+..+.+++.+||+.||.+||++.+++++-
T Consensus 225 ~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 267 (283)
T 3bhy_A 225 AVNY------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHS 267 (283)
T ss_dssp TTCC------CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred hccc------CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence 0000 000000011234688999999999999999999999853
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=363.38 Aligned_cols=254 Identities=24% Similarity=0.342 Sum_probs=208.3
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCe
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNH 114 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 114 (391)
.+..++|++++.||+|+||.||+|++. +++.||||++... .......+..|..++..+ +||+|+++++++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 345578999999999999999999987 5889999998754 233456678899999988 79999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.++||||++||+|.+++...+ .+++..++.++.||+.||.|||++ +|+||||||+||||+.+|.+||+|||
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFG 487 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFG 487 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCT
T ss_pred EEEEEeCcCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecc
Confidence 999999999999999997533 599999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 195 LAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 195 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
+++..... .......+||+.|+|||++.+..++.++|||||||+||||++|..||......+ +.... .. ..
T Consensus 488 la~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~---~~~~i---~~-~~- 558 (674)
T 3pfq_A 488 MCKENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSI---ME-HN- 558 (674)
T ss_dssp TCEECCCT-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HS-SC-
T ss_pred eeeccccC-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH---HHHHH---Hh-CC-
Confidence 99864322 223445789999999999999999999999999999999999999997643321 11111 11 10
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHHhc
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSM-----STVVQMLM 320 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~l~ 320 (391)
..++......+.+|+.+||+.||.+||++ +||+++-+
T Consensus 559 ---------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~f 600 (674)
T 3pfq_A 559 ---------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 600 (674)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGG
T ss_pred ---------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCcc
Confidence 12223345678899999999999999997 77776543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=353.29 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=204.6
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
.++|+++++||+|+||+||+|.+. +++.||||++... .......+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999987 6999999998654 2334577899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC---CCCcEEEEecccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLD---KDLTPKISDFGLA 196 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~---~~~~~kl~Dfg~~ 196 (391)
||+.+++|.+.+... ..+++..+..++.||+.||.|||++ ||+||||||+|||++ .++.+||+|||++
T Consensus 101 e~~~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp CCCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EcCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 999999999988643 3589999999999999999999999 999999999999995 4568999999999
Q ss_pred cccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccce
Q 016347 197 KLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL 276 (391)
Q Consensus 197 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (391)
....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||........ .... .......
T Consensus 172 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i----~~~~~~~ 241 (486)
T 3mwu_A 172 TCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI---LKRV----ETGKYAF 241 (486)
T ss_dssp TTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH----HHTCCCS
T ss_pred eECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH----HhCCCCC
Confidence 8764332 2334579999999998865 699999999999999999999999976533221 1111 1111000
Q ss_pred eeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 277 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
........+..+.+++.+||+.||.+|||+.+++++.+
T Consensus 242 ------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 242 ------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp ------CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred ------CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence 00001123457889999999999999999999998754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=341.23 Aligned_cols=278 Identities=22% Similarity=0.232 Sum_probs=204.8
Q ss_pred echHHHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccch-----------hcHHHHHHHHHHHhcCCCCce
Q 016347 34 YSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESR-----------QGVKEFLTEIQVISEIEHENL 102 (391)
Q Consensus 34 ~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i 102 (391)
...+++....++|++.+.||+|+||.||+|.+.+|+.||||++..... ...+.+.+|+.+++.++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 356788889999999999999999999999988899999999865321 224678999999999999999
Q ss_pred eEEEEEEEe-----CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 016347 103 VKLYGCCVE-----GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKA 177 (391)
Q Consensus 103 v~~~~~~~~-----~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp 177 (391)
+++++++.. ....++||||++ ++|.+.+... ...+++..+..++.||+.||.|||++ |++||||||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 162 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-----RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHP 162 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCCh
Confidence 999999854 236899999997 5888888643 23689999999999999999999999 999999999
Q ss_pred CcEEECCCCcEEEEecccccccCCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCc
Q 016347 178 SNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPT 256 (391)
Q Consensus 178 ~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~ 256 (391)
+||+++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 163 ~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 240 (362)
T 3pg1_A 163 GNILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240 (362)
T ss_dssp GGEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred HHEEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999997543322 2234578999999999877 67899999999999999999999999765432
Q ss_pred chhhHHHHHHHH--------hhhcccceeeeccCC---CC----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 257 EEQYLLERTWDL--------YERRELILLVDTSLN---GD----FDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 257 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~~---~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
............ ............... .. ........+.+|+.+||+.||.+|||+.|++++-+.
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 320 (362)
T 3pg1_A 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320 (362)
T ss_dssp HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchh
Confidence 211111000000 000000000000000 00 011224568899999999999999999999987654
Q ss_pred C
Q 016347 322 E 322 (391)
Q Consensus 322 ~ 322 (391)
.
T Consensus 321 ~ 321 (362)
T 3pg1_A 321 E 321 (362)
T ss_dssp T
T ss_pred h
Confidence 3
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=336.05 Aligned_cols=256 Identities=21% Similarity=0.342 Sum_probs=207.6
Q ss_pred HHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch--------hcHHHHHHHHHHHhcC-CCCceeEEE
Q 016347 37 KELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR--------QGVKEFLTEIQVISEI-EHENLVKLY 106 (391)
Q Consensus 37 ~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~~iv~~~ 106 (391)
.......++|++.+.||+|+||.||+|.+. +|+.||||++..... .....+.+|+.+++++ .||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 333445678999999999999999999986 699999999875431 2245678899999999 899999999
Q ss_pred EEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC
Q 016347 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL 186 (391)
Q Consensus 107 ~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~ 186 (391)
+++......++||||++|++|.+++... ..+++..+..++.||+.||.|||+. |++|+||||+||+++.+|
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~ 237 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK------VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNM 237 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCC
Confidence 9999999999999999999999999643 3589999999999999999999999 999999999999999999
Q ss_pred cEEEEecccccccCCCCceeeeeecccccccChhhhhcC------CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhh
Q 016347 187 TPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRG------QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQY 260 (391)
Q Consensus 187 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~ 260 (391)
.++|+|||++..+.... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||........
T Consensus 238 ~ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-- 313 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM-- 313 (365)
T ss_dssp CEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--
T ss_pred CEEEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH--
Confidence 99999999998764332 23346799999999998643 588999999999999999999999965432111
Q ss_pred HHHHHHHHhhhcccceeeeccCCCCCCH----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 261 LLERTWDLYERRELILLVDTSLNGDFDA----EEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.... ..... .... ..+..+.+++.+||+.||++||++.+++++-+
T Consensus 314 -~~~i----~~~~~----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 362 (365)
T 2y7j_A 314 -LRMI----MEGQY----------QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPF 362 (365)
T ss_dssp -HHHH----HHTCC----------CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred -HHHH----HhCCC----------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 1110 00000 0111 12346889999999999999999999998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=354.32 Aligned_cols=256 Identities=26% Similarity=0.366 Sum_probs=208.9
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
.+..++|++.+.||+|+||.||+|.+. +|+.||||++... .......+.+|+.++++++||||+++++++.+.+..
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 345678999999999999999999987 6999999998654 234567899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE---CCCCcEEEEe
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL---DKDLTPKISD 192 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv---~~~~~~kl~D 192 (391)
++||||+.+++|.+.+...+ .+++..+..++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~D 172 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRK------RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIID 172 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCS------CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEe
Confidence 99999999999999997543 589999999999999999999999 99999999999999 5678999999
Q ss_pred cccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 193 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||........ ... ....
T Consensus 173 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~----i~~~ 242 (484)
T 3nyv_A 173 FGLSTHFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI---LKK----VEKG 242 (484)
T ss_dssp TTHHHHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH----HHHC
T ss_pred eeeeEEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH---HHH----HHcC
Confidence 99998764432 2234579999999998865 799999999999999999999999976543221 111 1111
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.... ........+..+.+|+.+||+.||.+|||+.|++++-+
T Consensus 243 ~~~~------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 243 KYTF------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp CCCC------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred CCCC------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 1000 00001123457889999999999999999999998754
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=328.66 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=201.1
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 118 (391)
.++|++.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 478999999999999999999987 6999999998754 233456788899999999 999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC-------------
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD------------- 185 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~------------- 185 (391)
|||+++++|.+++..... ....+++..++.++.||+.||.|||++ +++||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYR--IMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EECCTTCBHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------------
T ss_pred EEecCCCcHHHHHHhhcc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 999999999999965311 123589999999999999999999999 99999999999999844
Q ss_pred ------CcEEEEecccccccCCCCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcch
Q 016347 186 ------LTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEE 258 (391)
Q Consensus 186 ------~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~ 258 (391)
+.++|+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|..++.....
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--- 236 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--- 236 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred cccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence 479999999998764332 23589999999998766 567899999999999999999876542210
Q ss_pred hhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 259 QYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
+........ ...+...+..+.+++.+||+.||.+|||+.|++++-+-
T Consensus 237 -------~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 283 (289)
T 1x8b_A 237 -------WHEIRQGRL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283 (289)
T ss_dssp -------HHHHHTTCC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC
T ss_pred -------HHHHHcCCC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHh
Confidence 111111111 11122234578899999999999999999999987643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=328.98 Aligned_cols=248 Identities=24% Similarity=0.381 Sum_probs=203.6
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEe---------
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVE--------- 111 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------- 111 (391)
..++|++++.||+|+||.||+|.+. +|+.||+|++..... .+.+|+++++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4578999999999999999999987 699999999876543 46679999999999999999998864
Q ss_pred -------CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC
Q 016347 112 -------GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK 184 (391)
Q Consensus 112 -------~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~ 184 (391)
....++||||+++++|.+++... ....+++..++.++.||+.||.|||++ |++|+||||+||+++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR----RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD 157 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG----GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence 34589999999999999999643 223589999999999999999999999 9999999999999999
Q ss_pred CCcEEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 016347 185 DLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLER 264 (391)
Q Consensus 185 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~ 264 (391)
++.+||+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|..|+... ..
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~ 226 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SK 226 (284)
T ss_dssp TTEEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HH
T ss_pred CCCEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HH
Confidence 9999999999998764432 223356899999999999999999999999999999999998776311 11
Q ss_pred HHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 265 TWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
........ .+. ...+..+.+++.+||+.||.+||++.|++++|+...
T Consensus 227 ~~~~~~~~--------~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 227 FFTDLRDG--------IIS----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHHHTT--------CCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHHHhhcc--------ccc----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 11111111 111 122346788999999999999999999999997654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=352.94 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=200.7
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
..++|+++++||+|+||+||+|.+. ++..||+|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3567999999999999999999987 58999999987542 33356788999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC---CcEEEEeccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD---LTPKISDFGL 195 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~---~~~kl~Dfg~ 195 (391)
|||+++|+|.+.+... ..+++..+..++.||+.||.|||++ ||+||||||+|||++.+ +.+||+|||+
T Consensus 115 ~e~~~~g~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~ 185 (494)
T 3lij_A 115 MECYKGGELFDEIIHR------MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGL 185 (494)
T ss_dssp EECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence 9999999999988643 3589999999999999999999999 99999999999999764 4599999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
+....... ......||+.|+|||++. +.++.++|||||||++|+|++|..||........ .... .....
T Consensus 186 a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i----~~~~~- 254 (494)
T 3lij_A 186 SAVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI---LRKV----EKGKY- 254 (494)
T ss_dssp CEECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH----HHTCC-
T ss_pred CeECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH----HhCCC-
Confidence 98764332 234467999999999875 5799999999999999999999999976543221 1111 11110
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
....+. ....+..+.+++.+||+.||.+|||+.|++++-
T Consensus 255 ~~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp 293 (494)
T 3lij_A 255 TFDSPE-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHP 293 (494)
T ss_dssp CCCSGG-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred CCCchh-----cccCCHHHHHHHHHHCCCChhhCccHHHHhcCc
Confidence 000000 012345688899999999999999999999764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=350.19 Aligned_cols=248 Identities=13% Similarity=0.107 Sum_probs=193.0
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHH---HHHhcCCCCceeEEE-------E
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEI---QVISEIEHENLVKLY-------G 107 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~~iv~~~-------~ 107 (391)
..++|++.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+ +.++.++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3578999999999999999999975 5999999998743 334567788999 455555899999988 7
Q ss_pred EEEeCC-----------------eeEEEEecccCCCHHHHHhcCCCCC-CccccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 016347 108 CCVEGN-----------------HRILVYNYLENNSLAQTLIGGGHHY-SNIQFSWRTRSRICIGIARGLAFLHEEVRPH 169 (391)
Q Consensus 108 ~~~~~~-----------------~~~lv~e~~~~~sL~~~i~~~~~~~-~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~ 169 (391)
++.+.+ ..++||||+ +|+|.+++...+... ....+++..++.|+.||+.||+|||++ |
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 766553 278999999 679999997532110 123455688899999999999999999 9
Q ss_pred eeecCCCCCcEEECCCCcEEEEecccccccCCCCceeeeeecccccccChhhhhcC-----------CCCCCCcEeehhH
Q 016347 170 IIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRG-----------QVTRKADIYSFGV 238 (391)
Q Consensus 170 i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~k~DvwSlG~ 238 (391)
|+||||||+|||++.++.+||+|||++..... ......| +.|+|||++.+. .++.++|||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999999999999999999986322 2344567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 239 LLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 239 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
++|+|++|+.||.......... .+. ... . ..+..+.+++.+||+.||.+||++.|++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~---------------~~~-~~~-~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSE---------------WIF-RSC-K----NIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHSSCCC------CCSG---------------GGG-SSC-C----CCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHCCCCCcccccccchh---------------hhh-hhc-c----CCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 9999999999996543222110 000 000 1 223568889999999999999999999875
Q ss_pred h
Q 016347 319 L 319 (391)
Q Consensus 319 l 319 (391)
-
T Consensus 361 p 361 (377)
T 3byv_A 361 P 361 (377)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=340.83 Aligned_cols=271 Identities=19% Similarity=0.238 Sum_probs=206.2
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcC------CCCceeEEEEEEEeC
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEI------EHENLVKLYGCCVEG 112 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~ 112 (391)
.....+|++++.||+|+||.||+|.+. +++.||||++... ......+.+|+.+++.+ .|+||+++++++...
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 345678999999999999999999876 4899999999764 33345677788888776 577999999999999
Q ss_pred CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCc--EEE
Q 016347 113 NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLT--PKI 190 (391)
Q Consensus 113 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~--~kl 190 (391)
...++||||+. ++|.+++.... ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++. +||
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL 243 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNK----FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKV 243 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEE
T ss_pred CeEEEEEeccC-CCHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEE
Confidence 99999999996 58999886542 23589999999999999999999999 9999999999999999987 999
Q ss_pred EecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh
Q 016347 191 SDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE 270 (391)
Q Consensus 191 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 270 (391)
+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....................
T Consensus 244 ~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~ 319 (429)
T 3kvw_A 244 IDFGSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319 (429)
T ss_dssp CCCTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eecccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 999999764322 2345789999999999999999999999999999999999999976543322111111000000
Q ss_pred h------cccceeeecc------------------------------CCCCCC------HHHHHHHHHHHhhccCCCCCC
Q 016347 271 R------RELILLVDTS------------------------------LNGDFD------AEEACRFLKVGLLCTQDTPKL 308 (391)
Q Consensus 271 ~------~~~~~~~~~~------------------------------~~~~~~------~~~~~~l~~li~~cl~~dP~~ 308 (391)
. ......++.. ...... ......+.+|+.+||+.||++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~ 399 (429)
T 3kvw_A 320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAV 399 (429)
T ss_dssp HHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhh
Confidence 0 0000000000 000000 011456889999999999999
Q ss_pred CCCHHHHHHHhcCCC
Q 016347 309 RPSMSTVVQMLMGEK 323 (391)
Q Consensus 309 Rps~~evl~~l~~~~ 323 (391)
|||+.|++++-+...
T Consensus 400 Rpta~e~L~Hpw~~~ 414 (429)
T 3kvw_A 400 RMTPGQALRHPWLRR 414 (429)
T ss_dssp SCCHHHHHTSTTTC-
T ss_pred CCCHHHHhCChhhcc
Confidence 999999999865543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=341.09 Aligned_cols=254 Identities=26% Similarity=0.370 Sum_probs=193.5
Q ss_pred CCCCCceeeccCceEEEEEEeC--C--CcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEe-CCeeEEE
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK--D--GKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVE-GNHRILV 118 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~--~--~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv 118 (391)
.|++.+.||+|+||.||+|.+. + +..||+|.+... .......+.+|+.++++++||||+++++++.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4677889999999999999864 2 246899998654 33456789999999999999999999998754 5678999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|||+++++|.+++.... ..+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++.
T Consensus 170 ~e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 241 (373)
T ss_dssp EECCTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EECCCCCCHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccc
Confidence 99999999999997532 3578999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCce---eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 199 IPANMTH---VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 199 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||......+... .. .....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~---~~---~~~~~- 314 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YL---LQGRR- 314 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH---HH---HTTCC-
T ss_pred ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH---HH---HcCCC-
Confidence 5332211 1223457789999999999999999999999999999999 566776544332211 10 01110
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
...+...+..+.+++.+||+.||++||++.|+++.|...
T Consensus 315 ---------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 315 ---------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011122345788999999999999999999999998654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=333.39 Aligned_cols=266 Identities=24% Similarity=0.395 Sum_probs=202.7
Q ss_pred cceeechHHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcC-CCCceeEEEE
Q 016347 30 NVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENLVKLYG 107 (391)
Q Consensus 30 ~~~~~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~ 107 (391)
.+..+.+.++....++|++.+.||+|+||.||+|.+. +|+.||+|++..... ....+.+|+.+++++ +||||+++++
T Consensus 10 ~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~ 88 (326)
T 2x7f_A 10 SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYG 88 (326)
T ss_dssp ------CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEE
T ss_pred cchhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeee
Confidence 3444556666667899999999999999999999985 689999999875432 346788999999998 8999999999
Q ss_pred EEEe------CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEE
Q 016347 108 CCVE------GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNIL 181 (391)
Q Consensus 108 ~~~~------~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIl 181 (391)
++.. ....++||||+++++|.+++... ....+++..++.++.||+.||.|||+. |++|+||||+||+
T Consensus 89 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl 161 (326)
T 2x7f_A 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT----KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVL 161 (326)
T ss_dssp EEEECC--CCCCEEEEEEECCTTEEHHHHHHHS----GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEE
T ss_pred EEeeccCccccceEEEEEEcCCCCcHHHHHHhc----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEE
Confidence 9986 46889999999999999999653 234689999999999999999999999 9999999999999
Q ss_pred ECCCCcEEEEecccccccCCCCceeeeeecccccccChhhhh-----cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCc
Q 016347 182 LDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAI-----RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPT 256 (391)
Q Consensus 182 v~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~ 256 (391)
++.++.+||+|||++........ ......|++.|+|||++. +..++.++|||||||++|+|++|..||......
T Consensus 162 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 240 (326)
T 2x7f_A 162 LTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 240 (326)
T ss_dssp ECTTCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred EcCCCCEEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH
Confidence 99999999999999886543221 223457899999999986 567899999999999999999999999654332
Q ss_pred chhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 257 EEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.... . ......... .....+..+.+++.+||+.||.+||++.+++++-
T Consensus 241 ~~~~------~-~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp 288 (326)
T 2x7f_A 241 RALF------L-IPRNPAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288 (326)
T ss_dssp HHHH------H-HHHSCCCCC--------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred HHHH------H-hhcCccccC--------CccccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence 1111 0 011111000 0112245788899999999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=333.37 Aligned_cols=274 Identities=27% Similarity=0.347 Sum_probs=190.8
Q ss_pred HHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCe
Q 016347 37 KELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNH 114 (391)
Q Consensus 37 ~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (391)
.++.+..++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 345677899999999999999999999975 58999999987543 3345678899999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCC--CCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEe
Q 016347 115 RILVYNYLENNSLAQTLIGGG--HHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISD 192 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~--~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~D 192 (391)
.++||||+++++|.+++.... .......+++..++.++.||+.||.|||++ |++|+||||+||+++.++.+||+|
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 164 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIAD 164 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEe
Confidence 999999999999999986310 011234589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCc----eeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 016347 193 FGLAKLIPANMT----HVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWD 267 (391)
Q Consensus 193 fg~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 267 (391)
||++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......... ....
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~ 241 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM---LTLQ 241 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH---HHHT
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH---HHhc
Confidence 999876543211 11234578999999999876 568999999999999999999999997654432211 0000
Q ss_pred HhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 268 LYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
...........+... ....+..+.+++.+||+.||.+||++.+++++-+
T Consensus 242 ~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 290 (303)
T 2vwi_A 242 NDPPSLETGVQDKEM----LKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF 290 (303)
T ss_dssp SSCCCTTC-----CC----CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTT
T ss_pred cCCCccccccccchh----hhhhhHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 000000000001111 1123356888999999999999999999998654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=328.56 Aligned_cols=260 Identities=16% Similarity=0.229 Sum_probs=203.8
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCC-CCceeEEEEEEEe--CCeeEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIE-HENLVKLYGCCVE--GNHRILV 118 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv 118 (391)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ...+.+|+.+++.++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 478999999999999999999875 68999999987543 366889999999997 9999999999987 6688999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC-cEEEEeccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL-TPKISDFGLAK 197 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~-~~kl~Dfg~~~ 197 (391)
|||+++++|.+++. .+++..+..++.||+.||.|||++ |++||||||+|||++.++ .+||+|||++.
T Consensus 112 ~e~~~~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp EECCCCCCHHHHGG---------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EeccCchhHHHHHH---------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 99999999999883 388999999999999999999999 999999999999999776 89999999998
Q ss_pred ccCCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccc--
Q 016347 198 LIPANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERREL-- 274 (391)
Q Consensus 198 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 274 (391)
....... .....|+..|+|||++.+ ..++.++|||||||++|+|++|..||............ ..........
T Consensus 180 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~--~~~~~~~~~~~~ 255 (330)
T 3nsz_A 180 FYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR--IAKVLGTEDLYD 255 (330)
T ss_dssp ECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH--HHHHHCHHHHHH
T ss_pred EcCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHH--HHHhcCCchhhh
Confidence 7643322 234578999999999877 67899999999999999999999999654332211110 0000000000
Q ss_pred ---------------------ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 275 ---------------------ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 275 ---------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
................+..+.+|+.+||+.||.+|||++|++++-+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f 323 (330)
T 3nsz_A 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323 (330)
T ss_dssp HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccH
Confidence 00000111111112245678999999999999999999999987543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=351.73 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=203.6
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch-------------hcHHHHHHHHHHHhcCCCCceeEEEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR-------------QGVKEFLTEIQVISEIEHENLVKLYG 107 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~~ 107 (391)
..++|+++++||+|+||+||+|.+. +++.||+|++..... .....+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4688999999999999999999987 588999999875421 33567889999999999999999999
Q ss_pred EEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC-
Q 016347 108 CCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL- 186 (391)
Q Consensus 108 ~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~- 186 (391)
++.+....++||||+++|+|.+.+... ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR------HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNS 184 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCC
Confidence 999999999999999999999988643 3589999999999999999999999 999999999999998776
Q ss_pred --cEEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 016347 187 --TPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLER 264 (391)
Q Consensus 187 --~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~ 264 (391)
.+||+|||++....... ......||+.|+|||++. +.++.++|||||||++|+|++|..||........ ...
T Consensus 185 ~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~ 258 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI---IKK 258 (504)
T ss_dssp CSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH
T ss_pred CccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH
Confidence 69999999998764432 233457999999999875 5799999999999999999999999976543221 111
Q ss_pred HHHHhhhcccceeeeccCCCCCCH----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 265 TWDLYERRELILLVDTSLNGDFDA----EEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
. ..... ..+. ..+..+.+|+.+||+.||.+|||+.|++++-+
T Consensus 259 i----~~~~~----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 259 V----EKGKY----------YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp H----HHCCC----------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred H----HcCCC----------CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 1 11110 0111 12357889999999999999999999998754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=339.62 Aligned_cols=261 Identities=16% Similarity=0.186 Sum_probs=204.3
Q ss_pred hCCCCCCceeeccCceEEEEEEeCC---------CcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeE---------
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLKD---------GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVK--------- 104 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~--------- 104 (391)
.++|++.+.||+|+||.||+|.+.. ++.||+|++... ..+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 5789999999999999999999764 789999998754 35778999999999999887
Q ss_pred ------EEEEEEe-CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 016347 105 ------LYGCCVE-GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKA 177 (391)
Q Consensus 105 ------~~~~~~~-~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp 177 (391)
+++++.. +...++||||+ +++|.+++... ....+++..++.++.||+.||.|||++ |++||||||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp 187 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS----PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTA 187 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS----GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC----CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCH
Confidence 6777776 77899999999 99999999753 134699999999999999999999999 999999999
Q ss_pred CcEEECCCC--cEEEEecccccccCCCCce------eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCC
Q 016347 178 SNILLDKDL--TPKISDFGLAKLIPANMTH------VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCN 249 (391)
Q Consensus 178 ~NIlv~~~~--~~kl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p 249 (391)
+||+++.++ .+||+|||++..+...... ......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999998 9999999999876432211 11234789999999999999999999999999999999999999
Q ss_pred CCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 250 TNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
|....+........ ..... .....+...... ....+..+.+++.+||+.||.+||++.+|++.|...
T Consensus 268 f~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 268 WTNCLPNTEDIMKQ--KQKFV-DKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp TGGGTTCHHHHHHH--HHHHH-HSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cccCCcCHHHHHHH--HHhcc-CChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 97654332221111 11111 111111111100 001235788899999999999999999999988655
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=330.39 Aligned_cols=254 Identities=28% Similarity=0.415 Sum_probs=202.1
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
...++|++.+.||+|+||.||+|.+. +|+.||+|++.... ....+.+|+.+++.++||||+++++++......++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34688999999999999999999987 48999999987643 3467889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++... ...+++..++.++.||+.||.|||+. |++|+||||+||+++.++.++|+|||++...
T Consensus 104 e~~~~~~L~~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 175 (314)
T 3com_A 104 EYCGAGSVSDIIRLR-----NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175 (314)
T ss_dssp ECCTTEEHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence 999999999998632 23589999999999999999999999 9999999999999999999999999999775
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
..... ......|++.|+|||++.+..++.++||||||+++|+|++|..||.......... .. .....
T Consensus 176 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~-~~~~~----- 242 (314)
T 3com_A 176 TDTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF------MI-PTNPP----- 242 (314)
T ss_dssp BTTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HH-HHSCC-----
T ss_pred hhhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH------HH-hcCCC-----
Confidence 43322 2234568999999999999899999999999999999999999997543321111 00 00000
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
... ..+...+..+.+++.+||+.||.+||++.+++++-
T Consensus 243 ~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~ 280 (314)
T 3com_A 243 PTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP 280 (314)
T ss_dssp CCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred ccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 000 11122345788999999999999999999998754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=338.19 Aligned_cols=270 Identities=23% Similarity=0.295 Sum_probs=206.3
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC-----Cee
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG-----NHR 115 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~ 115 (391)
.++|++++.||+|+||.||+|.+. +++.||+|++... .......+.+|+++++.++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 578999999999999999999976 5889999998754 334457788999999999999999999998754 468
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||||+++ +|.+++... .+++..+..++.||+.||.|||++ |++||||||+|||++.++.+||+|||+
T Consensus 106 ~iv~e~~~~-~L~~~l~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp EEEEECCSE-EHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEcccCc-CHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcc
Confidence 999999974 899988543 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCce--eeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 196 AKLIPANMTH--VSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 196 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
+......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......................
T Consensus 175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254 (364)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH
T ss_pred eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 9876432221 1234579999999998765 458999999999999999999999997665443221111110000000
Q ss_pred ccce--------eeecc-CCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 273 ELIL--------LVDTS-LNGDFD-----AEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 273 ~~~~--------~~~~~-~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
.... ..... .....+ ......+.+|+.+||+.||++|||+.|++++-+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 319 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhh
Confidence 0000 00000 000111 122456889999999999999999999998765443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=327.06 Aligned_cols=255 Identities=25% Similarity=0.333 Sum_probs=201.0
Q ss_pred CCCCCceeeccCceEEEEEEeCC----CcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee-EEE
Q 016347 45 DFSPINKIGEGGFGSVYKGRLKD----GKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR-ILV 118 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~lv 118 (391)
.|.+.+.||+|+||.||+|.+.+ +..||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45667899999999999998542 337999998754 334567789999999999999999999999866554 999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|||+.+++|.+++... ...+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++..
T Consensus 102 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP-----QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp ECCCTTCBHHHHHHCT-----TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred EecccCCCHHHHHhcc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 9999999999999753 23588999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCc---eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 199 IPANMT---HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 199 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
...... .......+++.|+|||.+.+..++.++|||||||++|+|++|..|+........ ..... ...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~--~~~~~----~~~--- 244 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD--LTHFL----AQG--- 244 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG--HHHHH----HTT---
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH--HHHHh----hcC---
Confidence 543221 122334678899999999999999999999999999999996666533322211 11110 000
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.....+...+..+.+++.+||+.||.+|||+.++++.|...
T Consensus 245 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 245 ------RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01111223345788999999999999999999999998654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=332.88 Aligned_cols=257 Identities=22% Similarity=0.386 Sum_probs=202.8
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
...++|++++.||+|+||.||+|.+. +++.||+|++..........+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 35688999999999999999999987 48999999998776666788999999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++++|.+++... ...+++..+..++.||+.||.|||+. |++|+||||+||+++.++.+||+|||++...
T Consensus 96 e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 96 EFCPGGAVDAIMLEL-----DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp ECCTTEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred EeCCCCcHHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 999999999988642 23589999999999999999999999 9999999999999999999999999987542
Q ss_pred CCCCceeeeeecccccccChhhhh-----cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAI-----RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
... ........|++.|+|||++. +..++.++|||||||++|+|++|..||......... . .... ...
T Consensus 168 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~---~~~~-~~~ 239 (302)
T 2j7t_A 168 LKT-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL---L---KIAK-SDP 239 (302)
T ss_dssp HHH-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---H---HHHH-SCC
T ss_pred ccc-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH---H---HHhc-cCC
Confidence 111 11122356899999999984 567899999999999999999999999754332110 0 1111 100
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.. ...+...+..+.+++.+||+.||.+|||+.+++++-+
T Consensus 240 ~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 278 (302)
T 2j7t_A 240 PT-------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPF 278 (302)
T ss_dssp CC-------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTT
T ss_pred cc-------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChH
Confidence 00 0111233457889999999999999999999988653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=339.79 Aligned_cols=262 Identities=22% Similarity=0.257 Sum_probs=192.4
Q ss_pred hHHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCC-CCceeEEEEEEE---
Q 016347 36 YKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIE-HENLVKLYGCCV--- 110 (391)
Q Consensus 36 ~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--- 110 (391)
-+.+++...+|++.+.||+|+||.||+|.+. +++.||+|++..........+.+|+.+++.+. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 3445556678999999999999999999976 58999999987766666778899999999996 999999999985
Q ss_pred -----eCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCcEEEC
Q 016347 111 -----EGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPH--IIHRDIKASNILLD 183 (391)
Q Consensus 111 -----~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~--i~H~dikp~NIlv~ 183 (391)
.....++||||+. |+|.+++.... ....+++..++.++.||+.||.|||++ + ++|+||||+|||++
T Consensus 100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~ 172 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCK-GQLVEFLKKME---SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLS 172 (337)
T ss_dssp TTSTTSSEEEEEEEECCS-EEHHHHHHHHH---TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEEC
T ss_pred cccccCCceEEEEEEecC-CCHHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEEC
Confidence 2345799999996 68988885421 123589999999999999999999998 8 99999999999999
Q ss_pred CCCcEEEEecccccccCCCCce-----------eeeeecccccccChhhh---hcCCCCCCCcEeehhHHHHHHHhCCCC
Q 016347 184 KDLTPKISDFGLAKLIPANMTH-----------VSTRVAGTIGYLAPEYA---IRGQVTRKADIYSFGVLLVEIVSGRCN 249 (391)
Q Consensus 184 ~~~~~kl~Dfg~~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~k~DvwSlG~vl~elltg~~p 249 (391)
.++.+||+|||++......... ......||+.|+|||++ .+..++.++|||||||++|+|++|..|
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p 252 (337)
T 3ll6_A 173 NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252 (337)
T ss_dssp TTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCC
T ss_pred CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCC
Confidence 9999999999999876432211 11134689999999998 566789999999999999999999999
Q ss_pred CCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 250 TNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
|....... .................+.+++.+||+.||.+||++.|++++|+...
T Consensus 253 ~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 253 FEDGAKLR-------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp C-------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcchhHHH-------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 96432211 00001111111122235778999999999999999999999986553
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=331.85 Aligned_cols=270 Identities=27% Similarity=0.402 Sum_probs=198.4
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHH--HhcCCCCceeEEEEEEEe-----C
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQV--ISEIEHENLVKLYGCCVE-----G 112 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~~iv~~~~~~~~-----~ 112 (391)
.+..++|++.+.||+|+||.||+|+. +++.||||++..... ..+..|.++ +..++||||+++++.+.. .
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred CcChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 34568999999999999999999987 589999999875432 334444444 445899999999986642 2
Q ss_pred CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcC------CCCeeecCCCCCcEEECCCC
Q 016347 113 NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV------RPHIIHRDIKASNILLDKDL 186 (391)
Q Consensus 113 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~------~~~i~H~dikp~NIlv~~~~ 186 (391)
...++||||+++|+|.+++... ..++..++.++.||+.||.|||+.+ .++++||||||+||||+.++
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLH-------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred ceEEEEEecCCCCcHHHHHhhc-------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC
Confidence 3678999999999999999543 3688999999999999999999862 23899999999999999999
Q ss_pred cEEEEecccccccCCCC-------ceeeeeecccccccChhhhhc-------CCCCCCCcEeehhHHHHHHHhCCCCCCC
Q 016347 187 TPKISDFGLAKLIPANM-------THVSTRVAGTIGYLAPEYAIR-------GQVTRKADIYSFGVLLVEIVSGRCNTNM 252 (391)
Q Consensus 187 ~~kl~Dfg~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~k~DvwSlG~vl~elltg~~p~~~ 252 (391)
.+||+|||++..+.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 99999999998764321 111223569999999999876 4567899999999999999999877644
Q ss_pred CCCcch-hhHHH----------HHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 253 RLPTEE-QYLLE----------RTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 253 ~~~~~~-~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
...... ..... ..............+.... ......+..+.+++.+||+.||++|||+.|+++.|..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 332211 00000 0000001111101111111 1123466789999999999999999999999998866
Q ss_pred C
Q 016347 322 E 322 (391)
Q Consensus 322 ~ 322 (391)
+
T Consensus 316 l 316 (336)
T 3g2f_A 316 L 316 (336)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=330.77 Aligned_cols=259 Identities=22% Similarity=0.337 Sum_probs=190.3
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
++..++|++++.||+|+||.||+|.+. +|+.||+|++.... ......+.++...++.++||||+++++++.+.+..+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 456789999999999999999999985 69999999987652 222334455556688889999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+||||+++ +|.+++..... ....+++..++.++.||+.||.|||+++ |++||||||+||+++.++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVID--KGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGIS 157 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred EEEehhcc-chHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCc
Confidence 99999975 88777653111 2236899999999999999999999853 8999999999999999999999999999
Q ss_pred cccCCCCceeeeeecccccccChhhh----hcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 197 KLIPANMTHVSTRVAGTIGYLAPEYA----IRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 197 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
....... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||......... ........
T Consensus 158 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~ 230 (290)
T 3fme_A 158 GYLVDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ-----LKQVVEEP 230 (290)
T ss_dssp --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH-----HHHHHHSC
T ss_pred ccccccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH-----HHHHhccC
Confidence 8654332 22234689999999996 4567899999999999999999999999753322111 11111110
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
. ........+..+.+++.+||+.||++|||+.|++++-
T Consensus 231 -~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp 268 (290)
T 3fme_A 231 -S--------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHP 268 (290)
T ss_dssp -C--------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred -C--------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCc
Confidence 0 0011112345788999999999999999999998754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=334.63 Aligned_cols=264 Identities=23% Similarity=0.255 Sum_probs=195.9
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC------
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN------ 113 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 113 (391)
.++|++++.||+|+||.||+|.+. +++.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 478999999999999999999976 5899999998753 3344567889999999999999999999997654
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
..++||||+++ +|.+.+.. .+++..+..++.||+.||.|||++ |++||||||+|||++.++.+||+||
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 171 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 171 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEEcCCC-CHHHHHhh--------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEe
Confidence 78999999975 78888742 388999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHH---------
Q 016347 194 GLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLER--------- 264 (391)
Q Consensus 194 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~--------- 264 (391)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..............
T Consensus 172 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 172 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 249 (371)
T ss_dssp CC------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHH
T ss_pred eccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9998654321 23346789999999999999999999999999999999999999976543211100000
Q ss_pred -------HHHHhhhcc------cceeeeccCCCC---CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 265 -------TWDLYERRE------LILLVDTSLNGD---FDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 265 -------~~~~~~~~~------~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
......... ....+....... ........+.+|+.+||+.||.+|||++|++++-+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 321 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence 000000000 000000000000 01233667899999999999999999999998754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=342.12 Aligned_cols=270 Identities=21% Similarity=0.245 Sum_probs=198.2
Q ss_pred HHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEe------
Q 016347 39 LSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVE------ 111 (391)
Q Consensus 39 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 111 (391)
++...++|++.+.||+|+||.||+|.+. +|+.||||++...... ..+|+++++.++||||+++++++..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 4567789999999999999999999975 6999999998755322 2369999999999999999999854
Q ss_pred --------------------------------CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHH
Q 016347 112 --------------------------------GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGL 159 (391)
Q Consensus 112 --------------------------------~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al 159 (391)
....++||||+++ +|.+.+..... ....+++..+..++.||+.||
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIR--SGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp --------------------------------CCEEEEEECCCSE-EHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHH
Confidence 3348899999985 77777653111 234689999999999999999
Q ss_pred HHhhhcCCCCeeecCCCCCcEEEC-CCCcEEEEecccccccCCCCceeeeeecccccccChhhhhcC-CCCCCCcEeehh
Q 016347 160 AFLHEEVRPHIIHRDIKASNILLD-KDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFG 237 (391)
Q Consensus 160 ~~lH~~~~~~i~H~dikp~NIlv~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG 237 (391)
.|||++ ||+||||||+|||++ .++.+||+|||++....... ......||+.|+|||++.+. .++.++||||||
T Consensus 155 ~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 229 (383)
T 3eb0_A 155 GFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229 (383)
T ss_dssp HHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred HHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence 999999 999999999999997 67999999999998764332 22345689999999998775 489999999999
Q ss_pred HHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhh-------cccceeeeccCC-----CCCCHHHHHHHHHHHhhccCCC
Q 016347 238 VLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYER-------RELILLVDTSLN-----GDFDAEEACRFLKVGLLCTQDT 305 (391)
Q Consensus 238 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~d 305 (391)
|++|+|++|+.||......+.............. .......-+... ...+...+..+.+|+.+||+.|
T Consensus 230 ~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 230 CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 9999999999999865433321111110000000 000000000000 0011223456889999999999
Q ss_pred CCCCCCHHHHHHHhc
Q 016347 306 PKLRPSMSTVVQMLM 320 (391)
Q Consensus 306 P~~Rps~~evl~~l~ 320 (391)
|.+|||+.|++++-+
T Consensus 310 P~~R~t~~e~l~hp~ 324 (383)
T 3eb0_A 310 PDLRINPYEAMAHPF 324 (383)
T ss_dssp GGGSCCHHHHHTSGG
T ss_pred hhhCCCHHHHhcCHH
Confidence 999999999997643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=345.32 Aligned_cols=198 Identities=27% Similarity=0.409 Sum_probs=167.8
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC-----Ce
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG-----NH 114 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 114 (391)
.++|++.+.||+|+||.||+|.+. +++.||||++... .......+.+|+.+|+.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 589999999999999999999986 5889999999754 334556788999999999999999999999765 57
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.++||||++ ++|.+++.... .+++..+..++.||+.||.|||+. ||+||||||+||||+.++.+||+|||
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~------~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI------FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecCC-cCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCC
Confidence 899999986 59999996543 599999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCc---------------------eeeeeecccccccChhhh-hcCCCCCCCcEeehhHHHHHHHhCCCCC
Q 016347 195 LAKLIPANMT---------------------HVSTRVAGTIGYLAPEYA-IRGQVTRKADIYSFGVLLVEIVSGRCNT 250 (391)
Q Consensus 195 ~~~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~k~DvwSlG~vl~elltg~~p~ 250 (391)
+++....... ......+||+.|+|||++ ....++.++|||||||++|||++|..||
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 9987643221 123456799999999986 4566999999999999999999865444
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=358.64 Aligned_cols=246 Identities=27% Similarity=0.385 Sum_probs=197.7
Q ss_pred ceeeccCceEEEEEEeC---CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccC
Q 016347 50 NKIGEGGFGSVYKGRLK---DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLEN 124 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 124 (391)
++||+|+||.||+|.+. .++.||||++.... ....+.+.+|+++++.++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 37999999999999653 46889999997653 3446789999999999999999999999864 558899999999
Q ss_pred CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc
Q 016347 125 NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204 (391)
Q Consensus 125 ~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~ 204 (391)
|+|.+++.... .+++..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 454 g~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 454 GPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp EEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred CCHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 99999996543 589999999999999999999999 999999999999999999999999999987643322
Q ss_pred --eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 205 --HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 205 --~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
.......+|+.|+|||++.+..++.++|||||||++|||++ |..||......... ......
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-------~~i~~~--------- 588 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-------AMLEKG--------- 588 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTT---------
T ss_pred ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcC---------
Confidence 12223456789999999999999999999999999999998 99999765432211 111111
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.....+...+..+.+++..||+.||++||++.+|++.|..
T Consensus 589 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 589 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1112233445678899999999999999999999998853
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=333.06 Aligned_cols=267 Identities=21% Similarity=0.334 Sum_probs=204.9
Q ss_pred CcceeechHHHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEeccc--chhcHHHHHHHHHHHhcCC--CCceeE
Q 016347 29 HNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIE--HENLVK 104 (391)
Q Consensus 29 ~~~~~~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~iv~ 104 (391)
..-..|.++.+.+..++|++++.||+|+||.||+|.+.+++.||+|++... .......+.+|+.+++.++ ||||++
T Consensus 13 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~ 92 (313)
T 3cek_A 13 LGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92 (313)
T ss_dssp -------CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCC
T ss_pred CCCCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEE
Confidence 345566777788888999999999999999999999988999999998654 3445677899999999996 599999
Q ss_pred EEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC
Q 016347 105 LYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK 184 (391)
Q Consensus 105 ~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~ 184 (391)
+++++...+..++||| +.+++|.+++.... .+++..++.++.||+.||.|||++ +++||||||+||+++.
T Consensus 93 ~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~ 162 (313)
T 3cek_A 93 LYDYEITDQYIYMVME-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD 162 (313)
T ss_dssp EEEEEECSSEEEEEEC-CCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET
T ss_pred EEEEeecCCEEEEEEe-cCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC
Confidence 9999999999999999 56889999997543 589999999999999999999999 9999999999999964
Q ss_pred CCcEEEEecccccccCCCCce-eeeeecccccccChhhhhc-----------CCCCCCCcEeehhHHHHHHHhCCCCCCC
Q 016347 185 DLTPKISDFGLAKLIPANMTH-VSTRVAGTIGYLAPEYAIR-----------GQVTRKADIYSFGVLLVEIVSGRCNTNM 252 (391)
Q Consensus 185 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DvwSlG~vl~elltg~~p~~~ 252 (391)
+.+||+|||++......... ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 163 -~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (313)
T 3cek_A 163 -GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241 (313)
T ss_dssp -TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence 89999999999876433221 2234568999999999865 4688899999999999999999999975
Q ss_pred CCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 253 RLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
....... ..... +.......+......+.+++.+||+.||.+||++.|++++.+
T Consensus 242 ~~~~~~~-----~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 242 IINQISK-----LHAII---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp CCSHHHH-----HHHHH---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHHHHH-----HHHHH---------hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 4332111 11111 111111111222457888999999999999999999998653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=342.68 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=195.2
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--------hhcHHHHHHHHHHHhcCCCCceeEEEEEEEe
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--------RQGVKEFLTEIQVISEIEHENLVKLYGCCVE 111 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 111 (391)
...++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 44689999999999999999999976 58999999987542 112234788999999999999999999975
Q ss_pred CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC---cE
Q 016347 112 GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL---TP 188 (391)
Q Consensus 112 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~---~~ 188 (391)
....++||||+++++|.+++... ..+++..+..++.||+.||.|||++ +++||||||+|||++.++ .+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~ 281 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGN------KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLI 281 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSS------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCE
T ss_pred cCceEEEEEcCCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceE
Confidence 45689999999999999988643 3589999999999999999999999 999999999999997554 59
Q ss_pred EEEecccccccCCCCceeeeeecccccccChhhhhc---CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 016347 189 KISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIR---GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERT 265 (391)
Q Consensus 189 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 265 (391)
||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......... ....
T Consensus 282 kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--~~~i 357 (419)
T 3i6u_A 282 KITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQI 357 (419)
T ss_dssp EECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH--HHHH
T ss_pred EEeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH--HHHH
Confidence 99999999876432 22345679999999999853 67889999999999999999999999754332211 1110
Q ss_pred HHHhhhcccceeeeccCCCCCCH----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 266 WDLYERRELILLVDTSLNGDFDA----EEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
..... .... ..+..+.+++.+||+.||++||++.|++++-+.
T Consensus 358 ----~~~~~----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 403 (419)
T 3i6u_A 358 ----TSGKY----------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403 (419)
T ss_dssp ----HTTCC----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred ----hcCCC----------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCccc
Confidence 00000 0111 124578899999999999999999999997643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=334.45 Aligned_cols=259 Identities=16% Similarity=0.147 Sum_probs=205.0
Q ss_pred chHHHHHhhCCCCCCceeeccCceEEEEEE------eCCCcEEEEEEecccchhcHHHHHHHHHHHhcCC---CCceeEE
Q 016347 35 SYKELSIATDDFSPINKIGEGGFGSVYKGR------LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIE---HENLVKL 105 (391)
Q Consensus 35 ~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~ 105 (391)
...++++..++|++.+.||+|+||.||+|. ..+++.||+|++..... ..+..|++++++++ |+||+++
T Consensus 56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhh
Confidence 345566777899999999999999999994 34688999999876543 45677777777776 9999999
Q ss_pred EEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-
Q 016347 106 YGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK- 184 (391)
Q Consensus 106 ~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~- 184 (391)
++++...+..++||||+++|+|.+++..... .....+++..++.|+.||+.||.|||++ ||+||||||+|||++.
T Consensus 133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~ 208 (365)
T 3e7e_A 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKN-TPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNG 208 (365)
T ss_dssp EEEEECSSCEEEEECCCCSCBHHHHHHHHHT-STTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGG
T ss_pred heeeecCCCcEEEEeccCCCcHHHHHHHhhc-ccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEeccc
Confidence 9999999999999999999999999964211 1234599999999999999999999999 9999999999999998
Q ss_pred ----------CCcEEEEecccccccCC-CCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCC
Q 016347 185 ----------DLTPKISDFGLAKLIPA-NMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMR 253 (391)
Q Consensus 185 ----------~~~~kl~Dfg~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~ 253 (391)
++.+||+|||++..+.. .........+||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 209 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp GTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred ccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 89999999999975431 2233345567999999999999999999999999999999999999998533
Q ss_pred CCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCC-CCHHHHHHHhcC
Q 016347 254 LPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLR-PSMSTVVQMLMG 321 (391)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-ps~~evl~~l~~ 321 (391)
.... ......+.... ....+.+++..||+.+|.+| |++.++.+.|..
T Consensus 289 ~~~~------------------~~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 289 EGGE------------------CKPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp ETTE------------------EEECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred CCCc------------------eeechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 2211 01111111111 24456677889999999999 567777766643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=322.83 Aligned_cols=253 Identities=22% Similarity=0.257 Sum_probs=200.7
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc----hhcHHHHHHHHHHHhcCCCCceeEEEEEEE--eCCee
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES----RQGVKEFLTEIQVISEIEHENLVKLYGCCV--EGNHR 115 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 115 (391)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+++++.++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999986 58999999987542 234567899999999999999999999985 44578
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||||++++ |.+++... ....+++..+..++.||+.||.|||++ |++|+||||+||+++.++.++|+|||+
T Consensus 84 ~lv~e~~~~~-l~~~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~ 155 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV----PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGV 155 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS----TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEehhccCC-HHHHHHhC----cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccc
Confidence 9999999876 77777542 234689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCC-ceeeeeecccccccChhhhhcCC--CCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 196 AKLIPANM-THVSTRVAGTIGYLAPEYAIRGQ--VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 196 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
+....... ........|++.|+|||++.+.. ++.++|||||||++|+|++|..||........ .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~i~~~ 228 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL-------FENIGKG 228 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHC
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH-------HHHHhcC
Confidence 98764322 22334456899999999987644 47899999999999999999999975432111 1111111
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.. ..+......+.+++.+||+.||.+||++.|++++.+
T Consensus 229 ~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 266 (305)
T 2wtk_C 229 SY----------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266 (305)
T ss_dssp CC----------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred CC----------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 10 111223457888999999999999999999998754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=340.01 Aligned_cols=275 Identities=21% Similarity=0.298 Sum_probs=187.6
Q ss_pred hhCCCCCC-ceeeccCceEEEEEEeC---CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEe--CCee
Q 016347 42 ATDDFSPI-NKIGEGGFGSVYKGRLK---DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVE--GNHR 115 (391)
Q Consensus 42 ~~~~y~~~-~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 115 (391)
..+.|++. ++||+|+||.||+|++. +++.||+|++..... ...+.+|+.+|+.++||||+++++++.. ....
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 34557774 48999999999999965 478999999875432 2467889999999999999999999965 6789
Q ss_pred EEEEecccCCCHHHHHhcCC---CCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----CCCCcE
Q 016347 116 ILVYNYLENNSLAQTLIGGG---HHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL----DKDLTP 188 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~---~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv----~~~~~~ 188 (391)
++||||+++ +|.+++.... .......+++..++.|+.||+.||.|||++ +|+||||||+|||| +.++.+
T Consensus 96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcE
Confidence 999999965 7888775321 011223589999999999999999999999 99999999999999 677999
Q ss_pred EEEecccccccCCCCc--eeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcch------h
Q 016347 189 KISDFGLAKLIPANMT--HVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEE------Q 259 (391)
Q Consensus 189 kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~------~ 259 (391)
||+|||++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|..||........ .
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 9999999987643221 223446799999999999874 589999999999999999999999975443210 0
Q ss_pred hHHHHHHHHhhhc---cccee------------eeccCCCCCCH---------HHHHHHHHHHhhccCCCCCCCCCHHHH
Q 016347 260 YLLERTWDLYERR---ELILL------------VDTSLNGDFDA---------EEACRFLKVGLLCTQDTPKLRPSMSTV 315 (391)
Q Consensus 260 ~~~~~~~~~~~~~---~~~~~------------~~~~~~~~~~~---------~~~~~l~~li~~cl~~dP~~Rps~~ev 315 (391)
............. .+..+ +.......... .....+.+|+.+||+.||.+|||+.|+
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 0011111100000 00000 00000000000 013467889999999999999999999
Q ss_pred HHHhcCC
Q 016347 316 VQMLMGE 322 (391)
Q Consensus 316 l~~l~~~ 322 (391)
+++-+..
T Consensus 332 L~hp~f~ 338 (405)
T 3rgf_A 332 MQDPYFL 338 (405)
T ss_dssp HTSGGGT
T ss_pred hcChhhc
Confidence 9987654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=324.85 Aligned_cols=255 Identities=21% Similarity=0.294 Sum_probs=206.1
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---------hhcHHHHHHHHHHHhcCC-CCceeEEEEEEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---------RQGVKEFLTEIQVISEIE-HENLVKLYGCCV 110 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 110 (391)
..++|++.+.||+|+||.||+|.+. +|+.||||++.... ......+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3589999999999999999999987 58999999986542 223456788999999995 999999999999
Q ss_pred eCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEE
Q 016347 111 EGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKI 190 (391)
Q Consensus 111 ~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl 190 (391)
.....++||||+++++|.+++... ..+++..++.++.||+.||.|||++ |++|+||||+||+++.++.+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl 165 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKL 165 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEE
Confidence 999999999999999999999643 3589999999999999999999999 9999999999999999999999
Q ss_pred EecccccccCCCCceeeeeecccccccChhhhh------cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 016347 191 SDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAI------RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLER 264 (391)
Q Consensus 191 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~ 264 (391)
+|||++....... ......|++.|+|||++. ...++.++||||||+++|+|++|..||........ ...
T Consensus 166 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~ 240 (298)
T 1phk_A 166 TDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM---LRM 240 (298)
T ss_dssp CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH
T ss_pred ecccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH---HHH
Confidence 9999998764332 223456899999999985 45688999999999999999999999965432111 111
Q ss_pred HHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 265 TWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
...... ..........+..+.+++.+||+.||.+||++.|++++-+
T Consensus 241 ----~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (298)
T 1phk_A 241 ----IMSGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 286 (298)
T ss_dssp ----HHHTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred ----HhcCCc------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChH
Confidence 111100 0000111234557889999999999999999999988654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=342.98 Aligned_cols=267 Identities=22% Similarity=0.269 Sum_probs=196.5
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC------Cee
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG------NHR 115 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~ 115 (391)
..+|++.+.||+|+||.||+|++. +|+.||||++...... ..+|+++|+.++||||+++++++... ...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh----HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 346999999999999999999986 5999999998654322 34699999999999999999998642 246
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC-CcEEEEecc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD-LTPKISDFG 194 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~-~~~kl~Dfg 194 (391)
++||||+++ +|.+.+..... ....+++..+..++.||+.||.|||++ ||+||||||+||||+.+ +.+||+|||
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred Eeehhcccc-cHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccch
Confidence 789999976 56665542110 234689999999999999999999999 99999999999999965 678999999
Q ss_pred cccccCCCCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH-----
Q 016347 195 LAKLIPANMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDL----- 268 (391)
Q Consensus 195 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~----- 268 (391)
+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..................
T Consensus 203 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 203 SAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp TCEECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred hhhhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9987643322 2345789999999998765 7999999999999999999999999865432211111110000
Q ss_pred hh--hcccceeeeccCCCC-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 269 YE--RRELILLVDTSLNGD-----FDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 269 ~~--~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
+. ........-+.+... +....+..+.+|+.+||+.||.+||++.|++++-+.
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f 340 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence 00 000000000000000 111234678899999999999999999999987543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=330.84 Aligned_cols=270 Identities=20% Similarity=0.278 Sum_probs=208.8
Q ss_pred HHHHHhhCCCCCCceeeccCceEEEEEEe-C-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCC------ceeEEEEE
Q 016347 37 KELSIATDDFSPINKIGEGGFGSVYKGRL-K-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHE------NLVKLYGC 108 (391)
Q Consensus 37 ~e~~~~~~~y~~~~~lg~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------~iv~~~~~ 108 (391)
+...+..++|++.+.||+|+||.||+|.+ . +++.||+|++... ......+.+|+++++.++|+ ++++++++
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~ 85 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW 85 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence 34455678999999999999999999987 3 5889999998754 33456788899999888655 49999999
Q ss_pred EEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC----
Q 016347 109 CVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK---- 184 (391)
Q Consensus 109 ~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~---- 184 (391)
+...+..++||||+ +++|.+++...+ ...+++..+..++.||+.||.|||++ |++||||||+|||++.
T Consensus 86 ~~~~~~~~lv~e~~-~~~l~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 157 (339)
T 1z57_A 86 FEHHGHICIVFELL-GLSTYDFIKENG----FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYT 157 (339)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEE
T ss_pred cccCCcEEEEEcCC-CCCHHHHHHhcC----CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccc
Confidence 99999999999999 889999997542 23588999999999999999999999 9999999999999987
Q ss_pred ---------------CCcEEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCC
Q 016347 185 ---------------DLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCN 249 (391)
Q Consensus 185 ---------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p 249 (391)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 233 (339)
T 1z57_A 158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV 233 (339)
T ss_dssp EEEC----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccCCccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence 668999999999864332 2345789999999999999999999999999999999999999
Q ss_pred CCCCCCcchhhHHHHHHHHhhhc-----ccceee---------------------ec-cCCCCCCHHHHHHHHHHHhhcc
Q 016347 250 TNMRLPTEEQYLLERTWDLYERR-----ELILLV---------------------DT-SLNGDFDAEEACRFLKVGLLCT 302 (391)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~---------------------~~-~~~~~~~~~~~~~l~~li~~cl 302 (391)
|...................... .....+ .. .............+.+|+.+||
T Consensus 234 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 313 (339)
T 1z57_A 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML 313 (339)
T ss_dssp CCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHh
Confidence 97654333221111111000000 000000 00 0001122355678999999999
Q ss_pred CCCCCCCCCHHHHHHHh
Q 016347 303 QDTPKLRPSMSTVVQML 319 (391)
Q Consensus 303 ~~dP~~Rps~~evl~~l 319 (391)
+.||.+|||+.|++++-
T Consensus 314 ~~dP~~Rpt~~ell~hp 330 (339)
T 1z57_A 314 EYDPAKRITLREALKHP 330 (339)
T ss_dssp CSSTTTSCCHHHHTTSG
T ss_pred CcCcccccCHHHHhcCH
Confidence 99999999999998764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=337.94 Aligned_cols=255 Identities=11% Similarity=0.043 Sum_probs=184.5
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch---hcHHHHHHHH---HHHhcCCCCceeEEE-------EE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR---QGVKEFLTEI---QVISEIEHENLVKLY-------GC 108 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~~iv~~~-------~~ 108 (391)
...|++.+.||+|+||.||+|.+. +|+.||+|++..... .....+.+|+ ..|+. +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 355999999999999999999976 699999999987532 3445667774 55555 799988865 45
Q ss_pred EEeC-----------------CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHH------HHHHHHHHHHHHHhhhc
Q 016347 109 CVEG-----------------NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTR------SRICIGIARGLAFLHEE 165 (391)
Q Consensus 109 ~~~~-----------------~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~------~~i~~qi~~al~~lH~~ 165 (391)
+... ...++||||++ ++|.+++...+ ..+.+..+ ..++.||+.||+|||++
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~ 213 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-----FVYVFRGDEGILALHILTAQLIRLAANLQSK 213 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-----HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-----cccchhhhhhhhhHHHHHHHHHHHHHHHHHC
Confidence 5433 23799999998 89999997532 23455555 78889999999999999
Q ss_pred CCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCceeeeeecccccccChhhhhc--CCCCCCCcEeehhHHHHHH
Q 016347 166 VRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIR--GQVTRKADIYSFGVLLVEI 243 (391)
Q Consensus 166 ~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlG~vl~el 243 (391)
||+||||||+||||+.++.+||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 214 ---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~el 286 (371)
T 3q60_A 214 ---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286 (371)
T ss_dssp ---TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHH
T ss_pred ---CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHH
Confidence 9999999999999999999999999999865321 223457799999999987 6799999999999999999
Q ss_pred HhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 244 VSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 244 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
++|+.||....+..... +.....................+..+.+|+.+||+.||++|||+.+++++-
T Consensus 287 ltg~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 354 (371)
T 3q60_A 287 WCLFLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354 (371)
T ss_dssp HHSSCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSH
T ss_pred HhCCCCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCH
Confidence 99999997664432110 000000000111111111123456788999999999999999999998653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=335.21 Aligned_cols=264 Identities=22% Similarity=0.276 Sum_probs=187.4
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC------C
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG------N 113 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~ 113 (391)
.++|++++.||+|+||.||+|.+. +|+.||||++... .......+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 489999999999999999999976 5899999998653 334456788999999999999999999998754 5
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
..++|+|++ +++|.+++.. ..+++..+..++.||+.||.|||+. |++||||||+|||++.++.+||+||
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DF 176 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 176 (367)
T ss_dssp CCEEEEECC-CEECC------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-
T ss_pred eEEEEeccc-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeec
Confidence 679999998 6899888843 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhh-
Q 016347 194 GLAKLIPANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYER- 271 (391)
Q Consensus 194 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 271 (391)
|+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.........
T Consensus 177 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 177 GLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252 (367)
T ss_dssp ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred ccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 999865332 234578999999999877 67899999999999999999999999765432221111110000000
Q ss_pred -------cccceeeeccCC-CCCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 272 -------RELILLVDTSLN-GDFDA-----EEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 272 -------~~~~~~~~~~~~-~~~~~-----~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
......+..... ..... .....+.+|+.+||+.||.+|||+.|++++-+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~ 315 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhh
Confidence 000000000000 00111 123568899999999999999999999987543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=331.07 Aligned_cols=268 Identities=21% Similarity=0.337 Sum_probs=206.5
Q ss_pred ceeechHHHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEE
Q 016347 31 VKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGC 108 (391)
Q Consensus 31 ~~~~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 108 (391)
-.....+++++..++|++.+.||+|+||.||+|.+.. .+|+|++.... ....+.+.+|+.++++++||||++++++
T Consensus 20 ~~~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 97 (319)
T 2y4i_B 20 QTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97 (319)
T ss_dssp --CCCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEE
T ss_pred ccccccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEE
Confidence 3444667778888999999999999999999999864 48999987542 2333557789999999999999999999
Q ss_pred EEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcE
Q 016347 109 CVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTP 188 (391)
Q Consensus 109 ~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~ 188 (391)
+.+....++||||+++++|.+++...+ ..+++..++.++.||+.||.|||++ |++||||||+||+++ ++.+
T Consensus 98 ~~~~~~~~iv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~ 168 (319)
T 2y4i_B 98 CMSPPHLAIITSLCKGRTLYSVVRDAK-----IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKV 168 (319)
T ss_dssp EECSSCEEEECBCCCSEEHHHHTTSSC-----CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CC
T ss_pred EecCCceEEEeecccCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCE
Confidence 999999999999999999999996532 3589999999999999999999999 999999999999998 6799
Q ss_pred EEEecccccccCCCC----ceeeeeecccccccChhhhhc---------CCCCCCCcEeehhHHHHHHHhCCCCCCCCCC
Q 016347 189 KISDFGLAKLIPANM----THVSTRVAGTIGYLAPEYAIR---------GQVTRKADIYSFGVLLVEIVSGRCNTNMRLP 255 (391)
Q Consensus 189 kl~Dfg~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~k~DvwSlG~vl~elltg~~p~~~~~~ 255 (391)
+|+|||++....... ........|++.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 169 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 248 (319)
T 2y4i_B 169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA 248 (319)
T ss_dssp EECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH
T ss_pred EEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999987643211 112223468999999999864 3578999999999999999999999975433
Q ss_pred cchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 016347 256 TEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKD 324 (391)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~ 324 (391)
... .. . .......... ....+..+.+++.+||+.||.+||++.++++.|+....
T Consensus 249 ~~~---~~---~-~~~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 249 EAI---IW---Q-MGTGMKPNLS--------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp HHH---HH---H-HHTTCCCCCC--------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred HHH---HH---H-hccCCCCCCC--------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 211 11 1 1111100000 01123458889999999999999999999999987754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=328.48 Aligned_cols=258 Identities=26% Similarity=0.440 Sum_probs=198.6
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC--CCc--EEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCe
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK--DGK--IAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNH 114 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (391)
..++|++.+.||+|+||.||+|.+. +++ .||+|++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 4578999999999999999999853 233 6899998754 2345677899999999999999999999987654
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.++||||+++++|.+++... ...+++..+..++.||+.||.|||++ +++|+||||+||+++.++.+||+|||
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg 166 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKH-----QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFG 166 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHH-----GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred ceeeEecccCCCHHHHHHhc-----cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccc
Confidence 88999999999999999642 23589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCce--eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhh
Q 016347 195 LAKLIPANMTH--VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYER 271 (391)
Q Consensus 195 ~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 271 (391)
++......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||....... .... ...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~----~~~ 239 (291)
T 1u46_A 167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHK----IDK 239 (291)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHH----HHT
T ss_pred ccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH---HHHH----HHc
Confidence 99876543322 1223457888999999999999999999999999999999 999997553221 1111 111
Q ss_pred cccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 272 RELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
.. .....+...+..+.+++.+||+.||.+||++.++++.|....
T Consensus 240 ~~--------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 240 EG--------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp SC--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cC--------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 10 001112234567889999999999999999999999997654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=333.25 Aligned_cols=278 Identities=21% Similarity=0.232 Sum_probs=211.3
Q ss_pred eechHHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCC-CC-----ceeEE
Q 016347 33 LYSYKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIE-HE-----NLVKL 105 (391)
Q Consensus 33 ~~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~ 105 (391)
.|.+++.....++|++.+.||+|+||+||+|.+. +++.||||++... ......+..|+.+++.+. |+ +|+++
T Consensus 43 ~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~ 121 (382)
T 2vx3_A 43 DYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121 (382)
T ss_dssp CBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred cEEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence 3566777777899999999999999999999977 5889999999754 334466778888888874 44 49999
Q ss_pred EEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC--
Q 016347 106 YGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLD-- 183 (391)
Q Consensus 106 ~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~-- 183 (391)
++++......++||||+++ +|.+++.... ...+++..+..++.||+.||.|||++ ..||+||||||+|||++
T Consensus 122 ~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~ 195 (382)
T 2vx3_A 122 KRHFMFRNHLCLVFEMLSY-NLYDLLRNTN----FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNP 195 (382)
T ss_dssp EEEEEETTEEEEEEECCCC-BHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESST
T ss_pred eeeeccCCceEEEEecCCC-CHHHHHhhcC----cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecC
Confidence 9999999999999999964 9999997542 23589999999999999999999952 12899999999999995
Q ss_pred CCCcEEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHH
Q 016347 184 KDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLE 263 (391)
Q Consensus 184 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~ 263 (391)
.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.............
T Consensus 196 ~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~ 271 (382)
T 2vx3_A 196 KRSAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271 (382)
T ss_dssp TSCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCcEEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 4688999999999876432 234578999999999999999999999999999999999999998654332211111
Q ss_pred HHHHHh-----hh-cccceeeecc-----------------------------------------CCCCCCHHHHHHHHH
Q 016347 264 RTWDLY-----ER-RELILLVDTS-----------------------------------------LNGDFDAEEACRFLK 296 (391)
Q Consensus 264 ~~~~~~-----~~-~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~l~~ 296 (391)
...... .. ......+... -.......+...+.+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 351 (382)
T 2vx3_A 272 EVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKD 351 (382)
T ss_dssp HHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHH
T ss_pred HHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHH
Confidence 100000 00 0000000000 000112344568899
Q ss_pred HHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 297 VGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 297 li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
|+.+||+.||++|||+.|++++-+.
T Consensus 352 li~~mL~~dP~~Rpta~e~L~hp~f 376 (382)
T 2vx3_A 352 LILRMLDYDPKTRIQPYYALQHSFF 376 (382)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred HHHHhcCCChhhCCCHHHHhcCccc
Confidence 9999999999999999999987543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=322.98 Aligned_cols=255 Identities=26% Similarity=0.414 Sum_probs=196.4
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEe----------
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVE---------- 111 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---------- 111 (391)
.++|++++.||+|+||.||+|++. +|+.||+|++... ......+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 468999999999999999999976 6999999998653 3445778999999999999999999998865
Q ss_pred ---CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcE
Q 016347 112 ---GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTP 188 (391)
Q Consensus 112 ---~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~ 188 (391)
....++||||+++++|.+++.... ..+++..++.++.||+.||.|||++ |++|+||||+||+++.++.+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~ 155 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN-----LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNV 155 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC-----GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc-----cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCE
Confidence 356899999999999999997532 3578899999999999999999999 99999999999999999999
Q ss_pred EEEecccccccCCCC-------------ceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCC
Q 016347 189 KISDFGLAKLIPANM-------------THVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRL 254 (391)
Q Consensus 189 kl~Dfg~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~ 254 (391)
||+|||++....... ........|++.|+|||++.+. .++.++|||||||++|+|++ ||....
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~ 232 (303)
T 1zy4_A 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM 232 (303)
T ss_dssp EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence 999999998654221 1122345689999999998764 68999999999999999998 443210
Q ss_pred CcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 255 PTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.. .......... ...+........+..+.+++.+||+.||.+|||+.+++++.+.
T Consensus 233 --~~----~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (303)
T 1zy4_A 233 --ER----VNILKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287 (303)
T ss_dssp --HH----HHHHHHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCS
T ss_pred --hH----HHHHHhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCc
Confidence 00 0001111100 1111222333445678899999999999999999999997654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=332.56 Aligned_cols=269 Identities=20% Similarity=0.287 Sum_probs=208.6
Q ss_pred HHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhc-----------------HHHHHHHHHHHhcCCCCc
Q 016347 39 LSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQG-----------------VKEFLTEIQVISEIEHEN 101 (391)
Q Consensus 39 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~~ 101 (391)
.....++|++.+.||+|+||.||+|.+ +|+.||+|++....... ...+.+|+.+++.++|||
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 104 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence 344568999999999999999999999 89999999987542211 177899999999999999
Q ss_pred eeEEEEEEEeCCeeEEEEecccCCCHHHHHhcCC--CCCCccccCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCC
Q 016347 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGG--HHYSNIQFSWRTRSRICIGIARGLAFLHE-EVRPHIIHRDIKAS 178 (391)
Q Consensus 102 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~--~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~i~H~dikp~ 178 (391)
|+++++++.+.+..++||||+++++|.+++.... .......+++..++.++.||+.||.|||+ . |++|+||||+
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~ 181 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPS 181 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGG
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChH
Confidence 9999999999999999999999999999832110 00124569999999999999999999999 8 9999999999
Q ss_pred cEEECCCCcEEEEecccccccCCCCceeeeeecccccccChhhhhcC-CCCC-CCcEeehhHHHHHHHhCCCCCCCCCCc
Q 016347 179 NILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRG-QVTR-KADIYSFGVLLVEIVSGRCNTNMRLPT 256 (391)
Q Consensus 179 NIlv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-k~DvwSlG~vl~elltg~~p~~~~~~~ 256 (391)
||+++.++.++|+|||++...... ......|++.|+|||++.+. .++. ++|||||||++|+|++|..||......
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred hEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 999999999999999999875432 23445789999999999877 6666 999999999999999999999765442
Q ss_pred chhhHHHHHHHHhhhcccceeee-c-cCC-------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 257 EEQYLLERTWDLYERRELILLVD-T-SLN-------GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~-~-~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.. .... ........... . ... .......+..+.+++.+||+.||.+||++.|++++-+
T Consensus 259 ~~--~~~~----i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~ 325 (348)
T 2pml_X 259 VE--LFNN----IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW 325 (348)
T ss_dssp HH--HHHH----HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred HH--HHHH----HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 11 1111 11111000000 0 000 0001234457889999999999999999999998653
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=357.41 Aligned_cols=263 Identities=23% Similarity=0.302 Sum_probs=209.4
Q ss_pred chHHHHHhhCCCCCCceeeccCceEEEEEEeCC----CcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEE
Q 016347 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLKD----GKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCC 109 (391)
Q Consensus 35 ~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 109 (391)
...+.++..++|++.+.||+|+||.||+|.+.. +..||+|.+... .......+.+|+.+++.++||||+++++++
T Consensus 381 ~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 460 (656)
T 2j0j_A 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 460 (656)
T ss_dssp CGGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 455667777899999999999999999998742 567999998754 334457789999999999999999999998
Q ss_pred EeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEE
Q 016347 110 VEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPK 189 (391)
Q Consensus 110 ~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~k 189 (391)
. ++..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++ |++||||||+|||++.++.+|
T Consensus 461 ~-~~~~~lv~E~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vk 531 (656)
T 2j0j_A 461 T-ENPVWIIMELCTLGELRSFLQVRK-----FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVK 531 (656)
T ss_dssp C-SSSCEEEEECCTTCBHHHHHHHTT-----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEE
T ss_pred e-cCceEEEEEcCCCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEE
Confidence 5 456899999999999999997532 2589999999999999999999999 999999999999999999999
Q ss_pred EEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHH
Q 016347 190 ISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDL 268 (391)
Q Consensus 190 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 268 (391)
|+|||++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||........ ...
T Consensus 532 L~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~~~---- 604 (656)
T 2j0j_A 532 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGR---- 604 (656)
T ss_dssp ECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHH----
T ss_pred EEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHH----
Confidence 99999998765443333334557789999999999999999999999999999997 8999975433221 111
Q ss_pred hhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 269 YERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
..... ....+...+..+.+++.+||+.||.+||++.++++.|...
T Consensus 605 i~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 605 IENGE---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp HHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCC---------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11111 0112233456788999999999999999999999988643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=326.39 Aligned_cols=255 Identities=23% Similarity=0.318 Sum_probs=198.9
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--------hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--------RQGVKEFLTEIQVISEIEHENLVKLYGCCVEG 112 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (391)
..++|++.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+++++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3578999999999999999999986 58999999986542 12234578899999999999999999998765
Q ss_pred CeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCc---EE
Q 016347 113 NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLT---PK 189 (391)
Q Consensus 113 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~---~k 189 (391)
. .++||||+++++|.+++... ..+++..++.++.||+.||.|||++ |++||||||+||+++.++. +|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN------KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEE
T ss_pred c-eEEEEecCCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEE
Confidence 5 89999999999999998643 3589999999999999999999999 9999999999999987654 99
Q ss_pred EEecccccccCCCCceeeeeecccccccChhhhh---cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 016347 190 ISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAI---RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTW 266 (391)
Q Consensus 190 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 266 (391)
|+|||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|..||......... .....
T Consensus 158 l~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~ 233 (322)
T 2ycf_A 158 ITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQIT 233 (322)
T ss_dssp ECCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--HHHHH
T ss_pred EccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--HHHHH
Confidence 99999998764321 223456899999999974 467899999999999999999999999754432211 11110
Q ss_pred HHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 267 DLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.... ... + ......+..+.+++.+||+.||++||++.+++++-+
T Consensus 234 ----~~~~-~~~-~----~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~ 277 (322)
T 2ycf_A 234 ----SGKY-NFI-P----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 277 (322)
T ss_dssp ----HTCC-CCC-H----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred ----hCcc-ccC-c----hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcC
Confidence 0000 000 0 000112457889999999999999999999998653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=339.51 Aligned_cols=266 Identities=21% Similarity=0.249 Sum_probs=196.5
Q ss_pred hhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC------ee
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN------HR 115 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~ 115 (391)
...+|++.+.||+|+||.||+|++..+..||+|.+...... ..+|+++++.++||||+++++++.... ..
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 35679999999999999999999987667888887654322 236999999999999999999996543 37
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC-CCCcEEEEecc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLD-KDLTPKISDFG 194 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~-~~~~~kl~Dfg 194 (391)
++||||++++.+........ ....+++..+..++.||+.||.|||++ ||+||||||+|||++ .++.+||+|||
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAK---LKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEeeccCccHHHHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 89999998754433321110 233589999999999999999999999 999999999999998 78999999999
Q ss_pred cccccCCCCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH------
Q 016347 195 LAKLIPANMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWD------ 267 (391)
Q Consensus 195 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~------ 267 (391)
+++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.................
T Consensus 188 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 188 SAKILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp TCEECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CcccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9987643322 2345789999999998765 589999999999999999999999986543322111111100
Q ss_pred --HhhhcccceeeeccCCC-----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 268 --LYERRELILLVDTSLNG-----DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 268 --~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
..........+ +.... .+....+..+.+|+.+||+.||.+|||+.|++++-+
T Consensus 266 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 324 (394)
T 4e7w_A 266 IKTMNPNYMEHKF-PQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324 (394)
T ss_dssp HHHHCGGGSSSCC-CCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred HHhhChhhhhhcc-ccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChh
Confidence 00000000000 00000 011123457889999999999999999999998743
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=322.71 Aligned_cols=267 Identities=23% Similarity=0.345 Sum_probs=197.6
Q ss_pred hhCCCCCCceeeccCceEEEEEEeCC-CcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEE----------
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCV---------- 110 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---------- 110 (391)
..++|++++.||+|+||.||+|.+.. |+.||+|++........+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 35889999999999999999999874 9999999998776666788999999999999999999999873
Q ss_pred ----eCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC-CC
Q 016347 111 ----EGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLD-KD 185 (391)
Q Consensus 111 ----~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~-~~ 185 (391)
+....++||||++ ++|.+++.. ..+++..++.++.||+.||.|||++ |++||||||+||+++ .+
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ-------GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTED 157 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTT
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc-------CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCC
Confidence 3467899999997 599999853 3589999999999999999999999 999999999999997 56
Q ss_pred CcEEEEecccccccCCCCc--eeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHH
Q 016347 186 LTPKISDFGLAKLIPANMT--HVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLL 262 (391)
Q Consensus 186 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~ 262 (391)
+.+||+|||++........ .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||............
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 237 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 7999999999987643211 12233467899999998876 67899999999999999999999999765432211110
Q ss_pred HHHHHHhh---hcc----cceeeeccCC-CCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 263 ERTWDLYE---RRE----LILLVDTSLN-GDFD-----AEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 263 ~~~~~~~~---~~~----~~~~~~~~~~-~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
........ ... .......... ...+ ...+..+.+++.+||+.||.+|||+.|++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP 307 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSH
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCc
Confidence 00000000 000 0000000000 0001 12345788999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=326.91 Aligned_cols=266 Identities=24% Similarity=0.361 Sum_probs=201.6
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC--CCcEEEEEEecccch--hcHHHHHHHHHHHhcC---CCCceeEEEEEEE----
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK--DGKIAAIKVLSAESR--QGVKEFLTEIQVISEI---EHENLVKLYGCCV---- 110 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~---- 110 (391)
..++|++.+.||+|+||.||+|.+. +|+.||+|++..... .....+.+|+.+++.+ .||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4588999999999999999999984 588999999875421 1223455677766665 8999999999987
Q ss_pred -eCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEE
Q 016347 111 -EGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPK 189 (391)
Q Consensus 111 -~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~k 189 (391)
.....++||||++ ++|.+++.... ...+++..++.++.||+.||.|||++ |++|+||||+||+++.++.+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~k 160 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK 160 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEE
Confidence 4567899999997 59999986532 23489999999999999999999999 999999999999999999999
Q ss_pred EEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh
Q 016347 190 ISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLY 269 (391)
Q Consensus 190 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 269 (391)
|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... .......
T Consensus 161 l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~ 235 (326)
T 1blx_A 161 LADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKILDVI 235 (326)
T ss_dssp ECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHH
T ss_pred EecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHHHc
Confidence 99999998654221 223457899999999999999999999999999999999999999765432211 1111110
Q ss_pred hh---cccce-------eeec---cCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 270 ER---RELIL-------LVDT---SLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 270 ~~---~~~~~-------~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.. ..... .+.. ..........+..+.+++.+||+.||.+||++.|++++-+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 299 (326)
T 1blx_A 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299 (326)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 00 00000 0000 0000111223457888999999999999999999997643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=329.66 Aligned_cols=269 Identities=21% Similarity=0.257 Sum_probs=202.7
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC-----Ce
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG-----NH 114 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 114 (391)
..++|++.+.||+|+||.||+|.+. +|+.||||++... .......+.+|+.+++.++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4688999999999999999999987 5899999998754 334456788999999999999999999988654 67
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.++||||+. ++|.+++.. ..+++..+..++.||+.||.|||++ |++||||||+||+++.++.+||+|||
T Consensus 89 ~~lv~e~~~-~~L~~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST-------QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFG 157 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEeccC-ccHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecc
Confidence 899999997 589998854 3589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCce---------eeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 016347 195 LAKLIPANMTH---------VSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLER 264 (391)
Q Consensus 195 ~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~ 264 (391)
++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..............
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 237 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 99876432211 1123568999999998765 6789999999999999999999999976543221111100
Q ss_pred HHHHhhhcc---------cceeeeccC-CCCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 265 TWDLYERRE---------LILLVDTSL-NGDF-----DAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 265 ~~~~~~~~~---------~~~~~~~~~-~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
......... ......... .... ....+..+.+++.+||+.||++|||+.|++++-+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 000000000 000000000 0000 01234578899999999999999999999987543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=330.96 Aligned_cols=276 Identities=21% Similarity=0.216 Sum_probs=193.2
Q ss_pred HHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCe-
Q 016347 37 KELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNH- 114 (391)
Q Consensus 37 ~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~- 114 (391)
.......++|++.+.||+|+||.||+|.+. +|+.||||++.... .....+.++++.+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 345566799999999999999999999986 58999999886543 223456778888899999999999999975433
Q ss_pred ------eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhh--hcCCCCeeecCCCCCcEEECC-C
Q 016347 115 ------RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH--EEVRPHIIHRDIKASNILLDK-D 185 (391)
Q Consensus 115 ------~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH--~~~~~~i~H~dikp~NIlv~~-~ 185 (391)
.++||||+++ +|...+..... ....+++..+..++.|++.||.||| +. ||+||||||+|||++. +
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~ 168 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYR--RQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEAD 168 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTT
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCC
Confidence 7899999987 45444432100 2345899999999999999999999 88 9999999999999997 8
Q ss_pred CcEEEEecccccccCCCCceeeeeecccccccChhhhhcCC-CCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 016347 186 LTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQ-VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLER 264 (391)
Q Consensus 186 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~ 264 (391)
+.+||+|||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||..............
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 246 (360)
T 3e3p_A 169 GTLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246 (360)
T ss_dssp TEEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CcEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence 9999999999987653322 23456899999999986654 89999999999999999999999976543322111111
Q ss_pred HH--------HHhhhc-ccceeee-c-----cCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 265 TW--------DLYERR-ELILLVD-T-----SLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 265 ~~--------~~~~~~-~~~~~~~-~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.. ...... ....... . .............+.+|+.+||+.||.+|||+.|++++-+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 318 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF 318 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGG
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccc
Confidence 00 000000 0000000 0 00011112245688999999999999999999999987543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=328.22 Aligned_cols=263 Identities=21% Similarity=0.290 Sum_probs=199.6
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee----
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR---- 115 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~---- 115 (391)
.++|++.+.||+|+||.||+|.+. +|+.||||++... .......+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 579999999999999999999976 5999999998764 334457788999999999999999999999876654
Q ss_pred --EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 116 --ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 116 --~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
++||||+. ++|.+.+.. .+++..+..++.||+.||.|||++ |++||||||+|||++.++.+||+||
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Df 188 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM--------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF 188 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECST
T ss_pred eEEEEEcccc-ccHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEec
Confidence 99999997 588887732 389999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhh-
Q 016347 194 GLAKLIPANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYER- 271 (391)
Q Consensus 194 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 271 (391)
|++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....................
T Consensus 189 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 189 GLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 264 (371)
T ss_dssp TCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHH
Confidence 999865332 234578999999999877 67899999999999999999999999765432211111000000000
Q ss_pred -------c---ccceeeeccCCCC---CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 272 -------R---ELILLVDTSLNGD---FDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 272 -------~---~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
. .....+....... ........+.+|+.+||+.||.+|||+.|++++-+.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 327 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 327 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccc
Confidence 0 0000000000000 001224578899999999999999999999987653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=320.18 Aligned_cols=253 Identities=24% Similarity=0.344 Sum_probs=203.9
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
..++|++++.||+|+||.||+|.+. +++.||+|++... .......+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3578999999999999999999987 6899999998654 234567889999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC---CcEEEEeccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD---LTPKISDFGL 195 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~---~~~kl~Dfg~ 195 (391)
|||+++++|.+.+... ..+++..++.++.||+.||.|||++ |++|+||||+||+++.+ +.+||+|||+
T Consensus 100 ~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 100 GELYTGGELFDEIIKR------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp ECCCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence 9999999999988643 2589999999999999999999999 99999999999999764 4799999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
+........ .....|++.|+|||++.+ .++.++||||||+++|+|++|..||........ .. ........
T Consensus 171 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~----~~~~~~~~ 240 (287)
T 2wei_A 171 STCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI---LK----RVETGKYA 240 (287)
T ss_dssp GGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH----HHHHCCCC
T ss_pred ceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH---HH----HHHcCCCC
Confidence 987643321 223468999999998765 589999999999999999999999976432211 11 11111100
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
. . .......+..+.+++.+||+.||.+|||+.|++++-
T Consensus 241 ~--~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp 278 (287)
T 2wei_A 241 F--D----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (287)
T ss_dssp C--C----SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred C--C----chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCH
Confidence 0 0 000012345788999999999999999999999854
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=326.86 Aligned_cols=273 Identities=18% Similarity=0.248 Sum_probs=206.6
Q ss_pred chHHHHHhhCCCCCCceeeccCceEEEEEEeC-CC-cEEEEEEecccchhcHHHHHHHHHHHhcCCCCc------eeEEE
Q 016347 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLK-DG-KIAAIKVLSAESRQGVKEFLTEIQVISEIEHEN------LVKLY 106 (391)
Q Consensus 35 ~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~ 106 (391)
..+......++|++.+.||+|+||.||+|.+. ++ +.||+|++... ......+.+|+.+++.++|++ ++.++
T Consensus 10 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 88 (355)
T 2eu9_A 10 VCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMS 88 (355)
T ss_dssp CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred ccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence 33444556789999999999999999999976 34 78999998754 334567888999999987655 99999
Q ss_pred EEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEE----
Q 016347 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILL---- 182 (391)
Q Consensus 107 ~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv---- 182 (391)
+++...+..++||||+ +++|.+.+.... ...+++..++.++.||+.||.|||++ ||+||||||+|||+
T Consensus 89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~----~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~ 160 (355)
T 2eu9_A 89 DWFNFHGHMCIAFELL-GKNTFEFLKENN----FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSE 160 (355)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCC
T ss_pred eeeeeCCeEEEEEecc-CCChHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccc
Confidence 9999999999999999 566777775432 23589999999999999999999999 99999999999999
Q ss_pred ---------------CCCCcEEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCC
Q 016347 183 ---------------DKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247 (391)
Q Consensus 183 ---------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~ 247 (391)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 236 (355)
T 2eu9_A 161 FETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236 (355)
T ss_dssp EEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred ccccccccccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCC
Confidence 56789999999999864332 23457899999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhHHHHHHHHhhh-----c-ccceeeecc--C-------------------CCCCCHHHHHHHHHHHhh
Q 016347 248 CNTNMRLPTEEQYLLERTWDLYER-----R-ELILLVDTS--L-------------------NGDFDAEEACRFLKVGLL 300 (391)
Q Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~-----~-~~~~~~~~~--~-------------------~~~~~~~~~~~l~~li~~ 300 (391)
.||..................... . ......... . ...........+.+|+.+
T Consensus 237 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 316 (355)
T 2eu9_A 237 TLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRR 316 (355)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHH
Confidence 999765433221111111100000 0 000000000 0 001122446688999999
Q ss_pred ccCCCCCCCCCHHHHHHHhc
Q 016347 301 CTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 301 cl~~dP~~Rps~~evl~~l~ 320 (391)
||+.||.+|||+.|++++-+
T Consensus 317 ~L~~dP~~Rpt~~e~l~hp~ 336 (355)
T 2eu9_A 317 MLEFDPAQRITLAEALLHPF 336 (355)
T ss_dssp HTCSSTTTSCCHHHHTTSGG
T ss_pred HhcCChhhCcCHHHHhcChh
Confidence 99999999999999987643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=326.93 Aligned_cols=262 Identities=21% Similarity=0.281 Sum_probs=199.7
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCe-----
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNH----- 114 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 114 (391)
.++|.+.+.||+|+||.||+|.+. +|+.||||++... .......+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 478999999999999999999986 5999999998754 33445678899999999999999999999987654
Q ss_pred -eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 115 -RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 115 -~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
.++||||+. ++|.+++.. .+++..+..++.||+.||.|||++ |++||||||+||+++.++.+||+||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df 170 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL--------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF 170 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECST
T ss_pred eEEEEecccc-CCHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeec
Confidence 499999997 588777632 489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh---
Q 016347 194 GLAKLIPANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLY--- 269 (391)
Q Consensus 194 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~--- 269 (391)
|++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...................
T Consensus 171 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 171 GLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246 (353)
T ss_dssp TCTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHH
T ss_pred ccccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 999865322 234578999999999877 678999999999999999999999997654322111100000000
Q ss_pred -----hh-------cccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 270 -----ER-------RELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 270 -----~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.. ..........+ .......+..+.+++.+||+.||.+|||+.+++++-+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 309 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence 00 00000000000 11122345678899999999999999999999987543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=324.83 Aligned_cols=266 Identities=24% Similarity=0.380 Sum_probs=183.9
Q ss_pred HHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-hhcHHHHHHHHH-HHhcCCCCceeEEEEEEEeCC
Q 016347 37 KELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQ-VISEIEHENLVKLYGCCVEGN 113 (391)
Q Consensus 37 ~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~ 113 (391)
.++.+..++|++.+.||+|+||.||+|.+. +|+.||||++.... ......+..|+. +++.++||||+++++++...+
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~ 94 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG 94 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence 344455689999999999999999999986 69999999987652 333345555665 777789999999999999999
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
..++||||+++ +|.+++..... .....+++..+..++.|++.||.|||+.. |++||||||+||+++.++.+||+||
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Df 170 (327)
T 3aln_A 95 DCWICMELMST-SFDKFYKYVYS-VLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDF 170 (327)
T ss_dssp EEEEEECCCSE-EHHHHHHHHHH-TTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCC
T ss_pred ceEEEEeecCC-ChHHHHHHHHh-hhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccC
Confidence 99999999986 78877752100 01335899999999999999999999852 8999999999999999999999999
Q ss_pred ccccccCCCCceeeeeecccccccChhhh----hcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHh
Q 016347 194 GLAKLIPANMTHVSTRVAGTIGYLAPEYA----IRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLY 269 (391)
Q Consensus 194 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 269 (391)
|++....... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||......... .
T Consensus 171 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---------~ 239 (327)
T 3aln_A 171 GISGQLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ---------L 239 (327)
T ss_dssp SSSCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------
T ss_pred CCceeccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH---------H
Confidence 9998764322 12234689999999998 4567899999999999999999999999753221100 0
Q ss_pred hhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 270 ERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
..........+........+..+.+++.+||+.||.+||++.+++++.
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 287 (327)
T 3aln_A 240 --TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHP 287 (327)
T ss_dssp --CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred --HHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhCh
Confidence 000000001111111122345788999999999999999999998754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=324.41 Aligned_cols=269 Identities=20% Similarity=0.266 Sum_probs=203.4
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCC-----------CCceeEEEEEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIE-----------HENLVKLYGCC 109 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~ 109 (391)
..++|++.+.||+|+||.||+|.+. +++.||||++... ......+.+|+.+++++. ||||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 3578999999999999999999975 6899999998754 333466788999998886 89999999998
Q ss_pred EeCC----eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC--
Q 016347 110 VEGN----HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLD-- 183 (391)
Q Consensus 110 ~~~~----~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~-- 183 (391)
...+ ..++|||++ +++|.+++.... ...+++..+..++.||+.||.|||+++ ||+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYE----HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIV 168 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEE
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhh----ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEecc
Confidence 7644 789999999 889999996532 235899999999999999999999953 899999999999994
Q ss_pred ----CCCcEEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchh
Q 016347 184 ----KDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQ 259 (391)
Q Consensus 184 ----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~ 259 (391)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 4458999999999875432 23357899999999999999999999999999999999999999765432110
Q ss_pred ---hHHHHHHHHhhh------------------cccceeeec----------cCCCCCCHHHHHHHHHHHhhccCCCCCC
Q 016347 260 ---YLLERTWDLYER------------------RELILLVDT----------SLNGDFDAEEACRFLKVGLLCTQDTPKL 308 (391)
Q Consensus 260 ---~~~~~~~~~~~~------------------~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~ 308 (391)
............ ......+.. ......+......+.+|+.+||+.||.+
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 000000000000 000000000 0011345677889999999999999999
Q ss_pred CCCHHHHHHHhcCC
Q 016347 309 RPSMSTVVQMLMGE 322 (391)
Q Consensus 309 Rps~~evl~~l~~~ 322 (391)
|||+.|++++-+..
T Consensus 325 Rpt~~ell~hp~f~ 338 (373)
T 1q8y_A 325 RADAGGLVNHPWLK 338 (373)
T ss_dssp CBCHHHHHTCGGGT
T ss_pred cCCHHHHhhChhhh
Confidence 99999999876544
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=332.26 Aligned_cols=259 Identities=23% Similarity=0.267 Sum_probs=192.2
Q ss_pred CCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEEEEecc
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILVYNYL 122 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 122 (391)
+.|...+.||+|+||+||.+...+|+.||||++.... .+.+.+|+.+++.+ +||||+++++++.+.+..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 4556678899999999988777789999999986543 34577899999876 8999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCc-cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC-------------CcE
Q 016347 123 ENNSLAQTLIGGGHHYSN-IQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD-------------LTP 188 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~-------------~~~ 188 (391)
+ |+|.+++......... ....+..++.++.||+.||.|||++ ||+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 5999999765421111 1124445678999999999999999 99999999999999754 489
Q ss_pred EEEecccccccCCCCce---eeeeecccccccChhhhhc-------CCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcc
Q 016347 189 KISDFGLAKLIPANMTH---VSTRVAGTIGYLAPEYAIR-------GQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTE 257 (391)
Q Consensus 189 kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~ 257 (391)
||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999876543221 1234579999999999865 568999999999999999999 899996543322
Q ss_pred hhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 258 EQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.. . ..... . ............+..+.+++.+||+.||.+|||+.+++++.+.
T Consensus 248 ~~-----i---~~~~~--~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f 299 (434)
T 2rio_A 248 SN-----I---IRGIF--S--LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299 (434)
T ss_dssp HH-----H---HHTCC--C--CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred HH-----H---hcCCC--C--cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCcc
Confidence 11 0 00000 0 0111112245667889999999999999999999999986543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=323.63 Aligned_cols=257 Identities=20% Similarity=0.225 Sum_probs=177.1
Q ss_pred hhCCCCCCc-eeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEe----CCee
Q 016347 42 ATDDFSPIN-KIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVE----GNHR 115 (391)
Q Consensus 42 ~~~~y~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~ 115 (391)
..++|++++ .||+|+||.||+|.+. +|+.||||++..... ...+....++.+.||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 457899866 5999999999999987 599999999865321 12223344567799999999999876 4468
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC---CcEEEEe
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD---LTPKISD 192 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~---~~~kl~D 192 (391)
++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++ |++||||||+||+++.+ +.+||+|
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~----~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERG----DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-----CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEEeccCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEec
Confidence 99999999999999997542 24689999999999999999999999 99999999999999764 5599999
Q ss_pred cccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 193 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
||++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||............. ...
T Consensus 175 fg~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~--- 245 (336)
T 3fhr_A 175 FGFAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---RRI--- 245 (336)
T ss_dssp CTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred cccceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---Hhh---
Confidence 9999865422 2234578999999999988899999999999999999999999996543322110000 000
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
...............+..+.+++.+||+.||.+|||+.|++++.+.
T Consensus 246 ---~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 291 (336)
T 3fhr_A 246 ---RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291 (336)
T ss_dssp --------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred ---hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 0000001111112345578899999999999999999999987543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=328.05 Aligned_cols=257 Identities=22% Similarity=0.297 Sum_probs=202.4
Q ss_pred cceeechHHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchh------cHHHHHHHHHHHhcCC--CC
Q 016347 30 NVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQ------GVKEFLTEIQVISEIE--HE 100 (391)
Q Consensus 30 ~~~~~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~ 100 (391)
..+....++.....++|++.+.||+|+||.||+|.+. +++.||||++...... ....+.+|+.+++.+. ||
T Consensus 29 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~ 108 (320)
T 3a99_A 29 ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108 (320)
T ss_dssp -----------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSC
T ss_pred hhccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCC
Confidence 3445567778888899999999999999999999975 5899999998755221 1234667999999996 59
Q ss_pred ceeEEEEEEEeCCeeEEEEecccC-CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 016347 101 NLVKLYGCCVEGNHRILVYNYLEN-NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASN 179 (391)
Q Consensus 101 ~iv~~~~~~~~~~~~~lv~e~~~~-~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~N 179 (391)
||+++++++...+..++|||++.+ ++|.+++... ..+++..++.++.||+.||.|||++ +++||||||+|
T Consensus 109 ~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~N 179 (320)
T 3a99_A 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITER------GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDEN 179 (320)
T ss_dssp SBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred CceEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHH
Confidence 999999999999999999999976 8999998653 3589999999999999999999999 99999999999
Q ss_pred EEEC-CCCcEEEEecccccccCCCCceeeeeecccccccChhhhhcCCC-CCCCcEeehhHHHHHHHhCCCCCCCCCCcc
Q 016347 180 ILLD-KDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGRCNTNMRLPTE 257 (391)
Q Consensus 180 Ilv~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlG~vl~elltg~~p~~~~~~~~ 257 (391)
||++ .++.+||+|||++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||....
T Consensus 180 Ill~~~~~~~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--- 253 (320)
T 3a99_A 180 ILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--- 253 (320)
T ss_dssp EEEETTTTEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---
T ss_pred EEEeCCCCCEEEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---
Confidence 9998 6799999999999876432 2234568999999999987776 788999999999999999999996321
Q ss_pred hhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 258 EQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.. .. ... ..+...+..+.+++.+||+.||.+||++.|++++.+.
T Consensus 254 ------~~---~~-~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~ 297 (320)
T 3a99_A 254 ------EI---IR-GQV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297 (320)
T ss_dssp ------HH---HH-CCC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred ------hh---hc-ccc----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhh
Confidence 00 00 000 0111223568889999999999999999999987543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=323.02 Aligned_cols=251 Identities=24% Similarity=0.335 Sum_probs=194.0
Q ss_pred HHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchh------cHHHHHHHHHHHhcC----CCCceeEE
Q 016347 37 KELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQ------GVKEFLTEIQVISEI----EHENLVKL 105 (391)
Q Consensus 37 ~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~~iv~~ 105 (391)
++.+...++|++.+.||+|+||.||+|.+. +++.||+|++...... ....+.+|+.++.++ +||||+++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 345566789999999999999999999875 5899999998755321 223355688888888 89999999
Q ss_pred EEEEEeCCeeEEEEec-ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC-
Q 016347 106 YGCCVEGNHRILVYNY-LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLD- 183 (391)
Q Consensus 106 ~~~~~~~~~~~lv~e~-~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~- 183 (391)
++++...+..++|||+ +.+++|.+++...+ .+++..++.++.||+.||.|||++ |++||||||+||+++
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~ 174 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEKG------PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDL 174 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEET
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeC
Confidence 9999998999999999 78999999996533 489999999999999999999999 999999999999999
Q ss_pred CCCcEEEEecccccccCCCCceeeeeecccccccChhhhhcCCCC-CCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHH
Q 016347 184 KDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVT-RKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLL 262 (391)
Q Consensus 184 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~ 262 (391)
.++.+||+|||++....... .....|+..|+|||++.+..+. .++|||||||++|+|++|+.||....
T Consensus 175 ~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------- 243 (312)
T 2iwi_A 175 RRGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------- 243 (312)
T ss_dssp TTTEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------
T ss_pred CCCeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------
Confidence 78999999999998764332 2345689999999999877764 58999999999999999999986321
Q ss_pred HHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 263 ERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.. .. .. ...+......+.+++.+||+.||++||++.|++++.+..
T Consensus 244 -~~---~~-~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~ 288 (312)
T 2iwi_A 244 -EI---LE-AE----------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ 288 (312)
T ss_dssp -HH---HH-TC----------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTC
T ss_pred -HH---hh-hc----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence 00 00 00 011223345788899999999999999999999976543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=330.51 Aligned_cols=255 Identities=23% Similarity=0.295 Sum_probs=192.0
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEEEE
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
+...+|.+.+.||+|+||+||.....+|+.||||++...... .+.+|+++|+.+ +||||+++++++.+....++||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 344679999999999999977666667999999998755332 255799999999 8999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-----CCcEEEEecc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK-----DLTPKISDFG 194 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~-----~~~~kl~Dfg 194 (391)
||+. |+|.+++..... .+....++.++.||+.||.|||++ +|+||||||+|||++. ...+||+|||
T Consensus 98 E~~~-g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG 168 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDF-----AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFG 168 (432)
T ss_dssp ECCS-EEHHHHHHSSSC-----CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred ECCC-CCHHHHHHhcCC-----CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence 9996 599999975432 344556778999999999999999 9999999999999953 2368899999
Q ss_pred cccccCCCCc--eeeeeecccccccChhhhh---cCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHH
Q 016347 195 LAKLIPANMT--HVSTRVAGTIGYLAPEYAI---RGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDL 268 (391)
Q Consensus 195 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 268 (391)
++........ .......||+.|+|||++. ...++.++|||||||++|+|++ |..||.......... .
T Consensus 169 ~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-------~ 241 (432)
T 3p23_A 169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-------L 241 (432)
T ss_dssp EEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-------H
T ss_pred ceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-------H
Confidence 9987643321 2233467999999999987 4567889999999999999999 888986443221110 0
Q ss_pred hhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 269 YERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
..... ... ..........+.+|+.+||+.||.+|||+.+++++.+.
T Consensus 242 ~~~~~-----~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f 287 (432)
T 3p23_A 242 LGACS-----LDC--LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287 (432)
T ss_dssp TTCCC-----CTT--SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTT
T ss_pred hccCC-----ccc--cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccc
Confidence 00000 000 01122445667899999999999999999999987543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=315.71 Aligned_cols=254 Identities=22% Similarity=0.367 Sum_probs=182.3
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch--hcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR--QGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
..++|++++.||+|+||.||+|.+. +|+.||||++..... .....+.++..+++.++||||+++++++.+....++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3578999999999999999999986 689999999876532 2233444555678888999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHE-EVRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
|||+ ++.+..+.... ...+++..++.++.||+.||.|||+ . |++|+||||+||+++.++.+||+|||++.
T Consensus 103 ~e~~-~~~~~~l~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 173 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRM-----QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISG 173 (318)
T ss_dssp ECCC-SEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred Eecc-CCcHHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCch
Confidence 9999 55666555431 2358999999999999999999998 6 89999999999999999999999999997
Q ss_pred ccCCCCceeeeeecccccccChhhhh-----cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 198 LIPANMTHVSTRVAGTIGYLAPEYAI-----RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 198 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
...... ......|++.|+|||++. ...++.++|||||||++|+|++|..||........ ..... .. .
T Consensus 174 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~---~~-~ 245 (318)
T 2dyl_A 174 RLVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--VLTKV---LQ-E 245 (318)
T ss_dssp ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHHHH---HH-S
T ss_pred hccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--HHHHH---hc-c
Confidence 654322 223456899999999984 45688999999999999999999999975332211 11111 11 1
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.. ..+. .....+..+.+++.+||+.||.+||++.+++++.
T Consensus 246 ~~-----~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (318)
T 2dyl_A 246 EP-----PLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS 285 (318)
T ss_dssp CC-----CCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred CC-----CCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence 00 0000 0112345688899999999999999999998754
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=304.05 Aligned_cols=232 Identities=13% Similarity=0.075 Sum_probs=185.4
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeCC-CcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
+..++|++.+.||+|+||.||+|.+.. ++.||||++.... ......+.+|+..+..++||||+++++++.+.+..+
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 556889999999999999999999874 8999999997652 334577899999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+||||++|++|.+++..+ .....+..|+.||+.||.|||++ ||+||||||+|||++.+|.+||++++
T Consensus 108 lv~e~~~g~~L~~~l~~~--------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS--------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC--
T ss_pred EEEEecCCCCHHHHHhcC--------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc--
Confidence 999999999999999432 34556888999999999999999 99999999999999999999997433
Q ss_pred cccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccce
Q 016347 197 KLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL 276 (391)
Q Consensus 197 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (391)
|++ .++.++|||||||++|+|++|+.||........... ...
T Consensus 175 -------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~------------~~~ 216 (286)
T 3uqc_A 175 -------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP------------AER 216 (286)
T ss_dssp -------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE------------CCB
T ss_pred -------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH------------HHH
Confidence 333 368899999999999999999999986544221000 000
Q ss_pred eeeccCC--CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCCC
Q 016347 277 LVDTSLN--GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKD 324 (391)
Q Consensus 277 ~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~~ 324 (391)
....... .......+..+.+++.+||+.||.+| |+.|+++.|.....
T Consensus 217 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 217 DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp CTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred HhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 0000000 00011234568899999999999999 99999999976543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=340.96 Aligned_cols=244 Identities=20% Similarity=0.288 Sum_probs=195.9
Q ss_pred hHHHHHhhCCCCCCceeeccCceEEEEEEeC--CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC
Q 016347 36 YKELSIATDDFSPINKIGEGGFGSVYKGRLK--DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG 112 (391)
Q Consensus 36 ~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 112 (391)
+....+..++|++.+.||+|+||.||+|.+. +|+.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 72 ~~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 72 LNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT 151 (681)
T ss_dssp SCTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred CCCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence 3445566799999999999999999999986 5899999998654 334556788999999999999999999999876
Q ss_pred Ce-----eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCc
Q 016347 113 NH-----RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLT 187 (391)
Q Consensus 113 ~~-----~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~ 187 (391)
+. .++||||++|++|.+++.. .+++..++.|+.||+.||.|||++ ||+||||||+|||++.+ .
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~ 219 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-Q 219 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC----C--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-C
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-c
Confidence 55 6999999999999887632 589999999999999999999999 99999999999999885 9
Q ss_pred EEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 016347 188 PKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWD 267 (391)
Q Consensus 188 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 267 (391)
+||+|||++...... ....||+.|+|||++.++. +.++|||||||++|+|++|..|+........
T Consensus 220 ~kl~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------- 284 (681)
T 2pzi_A 220 LKLIDLGAVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------- 284 (681)
T ss_dssp EEECCCTTCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------
T ss_pred EEEEecccchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc---------
Confidence 999999999876433 3457999999999987654 8999999999999999999888753211100
Q ss_pred HhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHHhc
Q 016347 268 LYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPS-MSTVVQMLM 320 (391)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl~~l~ 320 (391)
............+.+++.+||+.||.+||+ ++++.+.|.
T Consensus 285 --------------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 285 --------------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp --------------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred --------------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 000111223457889999999999999996 455555443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=340.62 Aligned_cols=266 Identities=24% Similarity=0.279 Sum_probs=199.6
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEe------CCe
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVE------GNH 114 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~ 114 (391)
.++|++.+.||+|+||.||+|.+. +|+.||||++... .......+.+|+.+++.++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 488999999999999999999976 5899999998764 34456778999999999999999999998755 667
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCc---EEEE
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLT---PKIS 191 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~---~kl~ 191 (391)
.++||||++|++|.+++.... ....+++..++.++.||+.||.|||+. |++||||||+||+++.++. ++|+
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~---~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE---NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS---CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred EEEEEEeCCCCCHHHHHHhcc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEc
Confidence 899999999999999997643 233589999999999999999999999 9999999999999987764 9999
Q ss_pred ecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchh--hHHHHHH-HH
Q 016347 192 DFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQ--YLLERTW-DL 268 (391)
Q Consensus 192 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~--~~~~~~~-~~ 268 (391)
|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ....... ..
T Consensus 167 DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 167 DLGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244 (676)
T ss_dssp SCCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred cccccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence 999998764332 223467999999999999999999999999999999999999999653211100 0000000 00
Q ss_pred hhhcccce--eeecc--CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 016347 269 YERRELIL--LVDTS--LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVV 316 (391)
Q Consensus 269 ~~~~~~~~--~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 316 (391)
........ .+... .........+..+.+++.+||+.||.+|||+.+++
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 00000000 00000 11223445678899999999999999999997744
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=297.58 Aligned_cols=230 Identities=20% Similarity=0.269 Sum_probs=180.0
Q ss_pred hCCCCCC-ceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHH-hcCCCCceeEEEEEEEe----CCee
Q 016347 43 TDDFSPI-NKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVI-SEIEHENLVKLYGCCVE----GNHR 115 (391)
Q Consensus 43 ~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~----~~~~ 115 (391)
.++|.+. +.||+|+||.||+|.+. +++.||+|++... ..+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567776 78999999999999985 5899999998643 3466788887 56699999999999886 6788
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC---CCcEEEEe
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK---DLTPKISD 192 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~---~~~~kl~D 192 (391)
++||||+++++|.+++.... ...+++..++.++.||+.||.|||++ +++||||||+||+++. ++.+||+|
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred EEEEeecCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEec
Confidence 99999999999999997542 23589999999999999999999999 9999999999999998 78999999
Q ss_pred cccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 193 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
||++.... +..++.++|||||||++|+|++|..||......... .
T Consensus 164 fg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------------~ 208 (299)
T 3m2w_A 164 FGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------P 208 (299)
T ss_dssp CTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------C
T ss_pred cccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh------------H
Confidence 99886432 245678999999999999999999999654321100 0
Q ss_pred ccceeeeccCCCCCCH----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 273 ELILLVDTSLNGDFDA----EEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
......... ....+. ..+..+.+++.+||+.||.+|||+.|++++.+
T Consensus 209 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 209 GMKTRIRMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp CSCCSSCTT-CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHHHHhhc-cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence 000000000 001111 23457889999999999999999999998653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=316.11 Aligned_cols=248 Identities=13% Similarity=0.095 Sum_probs=182.5
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCC-Cce---------e---
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEH-ENL---------V--- 103 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~~i---------v--- 103 (391)
.....|...+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.+++.+.| +|. +
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 34456888899999999999999976 69999999987432 2335678899999999976 211 1
Q ss_pred ---------EEEEEEEe-----CCeeEEEEecccCCCHHHHHhcCC-CCCCccccCHHHHHHHHHHHHHHHHHhhhcCCC
Q 016347 104 ---------KLYGCCVE-----GNHRILVYNYLENNSLAQTLIGGG-HHYSNIQFSWRTRSRICIGIARGLAFLHEEVRP 168 (391)
Q Consensus 104 ---------~~~~~~~~-----~~~~~lv~e~~~~~sL~~~i~~~~-~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~ 168 (391)
.++.++.. ....+++|+++ +++|.+++..-. .......+++..++.++.||+.||.|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--- 230 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--- 230 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 11111111 22456677765 679999884210 001244688999999999999999999999
Q ss_pred CeeecCCCCCcEEECCCCcEEEEecccccccCCCCceeeeeecccccccChhhh----------hcCCCCCCCcEeehhH
Q 016347 169 HIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYA----------IRGQVTRKADIYSFGV 238 (391)
Q Consensus 169 ~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~k~DvwSlG~ 238 (391)
+|+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||
T Consensus 231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred CcccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 9999999999999999999999999998764322 344577 999999999 4456889999999999
Q ss_pred HHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 239 LLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 239 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
++|+|++|+.||.......... ..+... .. .+..+.+|+.+||+.||++||++.+++++
T Consensus 306 il~elltg~~Pf~~~~~~~~~~---------------~~~~~~--~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGGSE---------------WIFRSC--KN----IPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSCSG---------------GGGSSC--CC----CCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHCCCCCCCcchhhhHH---------------HHHhhc--cc----CCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 9999999999997543322110 001100 11 23568899999999999999999888754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=301.24 Aligned_cols=247 Identities=19% Similarity=0.184 Sum_probs=188.7
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccc--------hhcHHHHHHHHHHHhcCC---------CCcee
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAES--------RQGVKEFLTEIQVISEIE---------HENLV 103 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~~iv 103 (391)
+..++|++.+.||+|+||+||+|++ +|+.||||++.... ......+.+|+.+++.++ ||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 3457899999999999999999998 58999999997652 233467888999988885 88888
Q ss_pred EEEEEEE------------------------------eCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHH
Q 016347 104 KLYGCCV------------------------------EGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICI 153 (391)
Q Consensus 104 ~~~~~~~------------------------------~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~ 153 (391)
++.+.+. .....++||||+++|++.+.+.. ..+++..+..++.
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-------~~~~~~~~~~i~~ 168 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------KLSSLATAKSILH 168 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-------TCCCHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-------cCCCHHHHHHHHH
Confidence 8888753 26789999999999977676633 3489999999999
Q ss_pred HHHHHHHHhh-hcCCCCeeecCCCCCcEEECCCC--------------------cEEEEecccccccCCCCceeeeeecc
Q 016347 154 GIARGLAFLH-EEVRPHIIHRDIKASNILLDKDL--------------------TPKISDFGLAKLIPANMTHVSTRVAG 212 (391)
Q Consensus 154 qi~~al~~lH-~~~~~~i~H~dikp~NIlv~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~g 212 (391)
||+.||.||| ++ +|+||||||+|||++.++ .+||+|||+++..... ...|
T Consensus 169 qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~g 239 (336)
T 2vuw_A 169 QLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVF 239 (336)
T ss_dssp HHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEEC
T ss_pred HHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEE
Confidence 9999999999 89 999999999999999887 9999999999875432 3479
Q ss_pred cccccChhhhhcCCCCCCCcEeehhHH-HHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHH
Q 016347 213 TIGYLAPEYAIRGQVTRKADIYSFGVL-LVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEA 291 (391)
Q Consensus 213 t~~y~aPE~~~~~~~~~k~DvwSlG~v-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (391)
|+.|+|||++.+.. +.++||||||++ .+++++|..||... .. ........... ...............+
T Consensus 240 t~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----~~-~~~~~~~~~~~---~~~~~~~~~~~~~~~s 309 (336)
T 2vuw_A 240 CDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----LW-LHYLTDKMLKQ---MTFKTKCNTPAMKQIK 309 (336)
T ss_dssp CCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----HH-HHHHHHHHHHT---CCCSSCCCSHHHHHHH
T ss_pred eecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-----hh-hhHHHHhhhhh---hccCcccchhhhhhcC
Confidence 99999999987666 899999998777 77789898887310 00 00000000000 0001111111223567
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHH-HHh
Q 016347 292 CRFLKVGLLCTQDTPKLRPSMSTVV-QML 319 (391)
Q Consensus 292 ~~l~~li~~cl~~dP~~Rps~~evl-~~l 319 (391)
..+.+|+.+||+.| |+.|++ ++-
T Consensus 310 ~~~~dli~~~L~~d-----sa~e~l~~Hp 333 (336)
T 2vuw_A 310 RKIQEFHRTMLNFS-----SATDLLCQHS 333 (336)
T ss_dssp HHHHHHHHHGGGSS-----SHHHHHHHCG
T ss_pred HHHHHHHHHHhccC-----CHHHHHhcCC
Confidence 88999999999976 999999 654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-33 Score=275.48 Aligned_cols=185 Identities=17% Similarity=0.149 Sum_probs=131.3
Q ss_pred eeccCceEEEEEEeC-CCcEEEEEEeccc----------chhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEEEE
Q 016347 52 IGEGGFGSVYKGRLK-DGKIAAIKVLSAE----------SRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 52 lg~G~~g~V~~~~~~-~~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++.|+.|.+..++.. .|+.+++|++... .....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 455666655555432 4888999998654 123456799999999999 7999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||++|++|.++|..++ +++.. .|+.||+.||+|+|++ ||+||||||+|||++.+|.+||+|||+++..
T Consensus 322 Eyv~G~~L~d~i~~~~------~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE------EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp ECCCSEEHHHHHHTTC------CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred ecCCCCcHHHHHHhCC------CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 9999999999998654 35543 5889999999999999 9999999999999999999999999999876
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCC
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNT 250 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~ 250 (391)
.... ......+||+.|+|||++.+ .+..++|+|++|+++++|.++..++
T Consensus 390 ~~~~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 390 PQDC-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp C----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCC-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 5432 23345689999999998854 5678899999999999887765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-28 Score=241.92 Aligned_cols=184 Identities=19% Similarity=0.198 Sum_probs=142.9
Q ss_pred CCCceeeccCceEEEEEEeCCCcEEEEEEecccc--------hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 47 SPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAES--------RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 47 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
...+.||+|+||.||+|... ++.+++|...... ....+.+.+|++++++++||||+++..++......++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 44678999999999999554 6778888754321 11234578999999999999999665566677788999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|||++|++|.+++.. +..++.||+.||.|||++ +|+||||||+|||++. .+||+|||+++.
T Consensus 418 mE~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~ 478 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKI 478 (540)
T ss_dssp EECCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred EECCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEE
Confidence 999999999999843 568999999999999999 9999999999999998 999999999998
Q ss_pred cCCCCcee------eeeecccccccChhhhhc--CCCCCCCcEeehhHHHHHHHhCCCCC
Q 016347 199 IPANMTHV------STRVAGTIGYLAPEYAIR--GQVTRKADIYSFGVLLVEIVSGRCNT 250 (391)
Q Consensus 199 ~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlG~vl~elltg~~p~ 250 (391)
........ .....||+.|+|||++.. ..|+..+|+|+.++-..+-+.++.++
T Consensus 479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 65432211 235689999999999987 67888999999988888877665443
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-25 Score=203.58 Aligned_cols=165 Identities=14% Similarity=0.098 Sum_probs=127.6
Q ss_pred hHHHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccch------------------hcHHHHHHHHHHHhcC
Q 016347 36 YKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESR------------------QGVKEFLTEIQVISEI 97 (391)
Q Consensus 36 ~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l 97 (391)
..........|.+.+.||+|+||.||+|.+.+|+.||+|++..... .....+.+|+.+++.+
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3344444566778899999999999999997799999999864321 1345688999999999
Q ss_pred CCCceeEEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 016347 98 EHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKA 177 (391)
Q Consensus 98 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp 177 (391)
+| +++.+++.. +..++||||++|++|.+ +. . .....++.||+.||.|||++ |++||||||
T Consensus 162 ~~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~----------~--~~~~~i~~qi~~~l~~lH~~---giiHrDlkp 221 (282)
T 1zar_A 162 QG---LAVPKVYAW-EGNAVLMELIDAKELYR-VR----------V--ENPDEVLDMILEEVAKFYHR---GIVHGDLSQ 221 (282)
T ss_dssp TT---SSSCCEEEE-ETTEEEEECCCCEEGGG-CC----------C--SCHHHHHHHHHHHHHHHHHT---TEECSCCST
T ss_pred cC---CCcCeEEec-cceEEEEEecCCCcHHH-cc----------h--hhHHHHHHHHHHHHHHHHHC---CCEeCCCCH
Confidence 84 444444433 56799999999999988 41 1 23447999999999999999 999999999
Q ss_pred CcEEECCCCcEEEEecccccccCCCCceeeeeecccccccChhhhhc----------CCCCCCCcEee
Q 016347 178 SNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIR----------GQVTRKADIYS 235 (391)
Q Consensus 178 ~NIlv~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~k~DvwS 235 (391)
+|||++ ++.+||+|||++.. +..+.|||++.+ ..|...+|+|.
T Consensus 222 ~NILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 222 YNVLVS-EEGIWIIDFPQSVE--------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp TSEEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred HHEEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 999999 99999999999863 345789998754 34555566654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=2.6e-21 Score=173.99 Aligned_cols=137 Identities=17% Similarity=0.175 Sum_probs=107.5
Q ss_pred CCCCCceeeccCceEEEEEEe-CCCcE--EEEEEecccchh------------------------cHHHHHHHHHHHhcC
Q 016347 45 DFSPINKIGEGGFGSVYKGRL-KDGKI--AAIKVLSAESRQ------------------------GVKEFLTEIQVISEI 97 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l 97 (391)
-|++.+.||+|+||.||+|.+ .+|+. ||||+++..... ....+.+|+.+|.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999998 57888 999987543111 113578899999999
Q ss_pred CCCce--eEEEEEEEeCCeeEEEEecccC-C----CHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhh-hcCCCC
Q 016347 98 EHENL--VKLYGCCVEGNHRILVYNYLEN-N----SLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH-EEVRPH 169 (391)
Q Consensus 98 ~h~~i--v~~~~~~~~~~~~~lv~e~~~~-~----sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH-~~~~~~ 169 (391)
.|+++ ..++++ ...++||||+.+ | +|.+.... .++..+..++.||+.||.||| +. |
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---g 191 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQEA---E 191 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHHTS---C
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHHHC---C
Confidence 87753 444443 357899999942 3 67665421 235577899999999999999 88 9
Q ss_pred eeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 170 IIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 170 i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
++||||||.|||++. .++|+|||++...
T Consensus 192 ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999999988 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=2.2e-18 Score=161.41 Aligned_cols=137 Identities=17% Similarity=0.201 Sum_probs=101.9
Q ss_pred CCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccch--------------hcH--------HHHHHHHHHHhcCCCCc
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESR--------------QGV--------KEFLTEIQVISEIEHEN 101 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------------~~~--------~~~~~e~~~l~~l~h~~ 101 (391)
.-|++.+.||.|++|.||+|.+.+|+.||||+++.... ... .....|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34999999999999999999999999999998753210 000 11235677777775444
Q ss_pred e--eEEEEEEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 016347 102 L--VKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASN 179 (391)
Q Consensus 102 i--v~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~N 179 (391)
+ ...+++ . ..+|||||++|++|.++.. ......++.||+.+|.+||+. |||||||||.|
T Consensus 175 v~vp~p~~~--~--~~~LVME~i~G~~L~~l~~------------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~N 235 (397)
T 4gyi_A 175 FPVPEPIAQ--S--RHTIVMSLVDALPMRQVSS------------VPDPASLYADLIALILRLAKH---GLIHGDFNEFN 235 (397)
T ss_dssp CSCCCEEEE--E--TTEEEEECCSCEEGGGCCC------------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred CCCCeeeec--c--CceEEEEecCCccHhhhcc------------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHH
Confidence 3 233332 2 3479999999988865431 123457889999999999998 99999999999
Q ss_pred EEECCCC----------cEEEEeccccccc
Q 016347 180 ILLDKDL----------TPKISDFGLAKLI 199 (391)
Q Consensus 180 Ilv~~~~----------~~kl~Dfg~~~~~ 199 (391)
||++.+| .+.|+||+.+...
T Consensus 236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 236 ILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred EEEeCCCCcccccccccceEEEEeCCcccC
Confidence 9998876 4899999977643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=8e-14 Score=125.15 Aligned_cols=143 Identities=13% Similarity=0.086 Sum_probs=112.2
Q ss_pred hCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCC-CCceeEEEEEEEeCCeeEEEEec
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIE-HENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
-++|++...++.|+.+.||++... ++.+++|+...........+.+|+.+++.+. +.++.++++++.+.+..++||||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 367988889999999999999865 6789999987532122345778999998884 67788899999988899999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcC-----------------------------------
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV----------------------------------- 166 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~----------------------------------- 166 (391)
++|.+|.+.+. +......++.+++.+|..||+..
T Consensus 92 i~G~~l~~~~~-----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 92 ADGVLCSEEYE-----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp CSSEEHHHHCC-----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred cCCeehhhccC-----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999987631 12233477889999999999810
Q ss_pred ---------------------CCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 167 ---------------------RPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 167 ---------------------~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
...++|||++|.|||++.++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0259999999999999876666799998654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.32 E-value=1.9e-12 Score=115.78 Aligned_cols=137 Identities=12% Similarity=0.086 Sum_probs=98.3
Q ss_pred CCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCc--eeEEEEEEEeCCeeEEEEec
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHEN--LVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~ 121 (391)
.+|.+....+.|..+.||++...+|+.+++|+..... ...+..|+.+++.+.+.+ +.+++++....+..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 3444433334566699999988778889999976542 234677888888885434 55688888877789999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcC-----------------------------------
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV----------------------------------- 166 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~----------------------------------- 166 (391)
++|.+|. ... .. ...++.+++..|..||+..
T Consensus 97 i~G~~l~--~~~---------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 97 VPGQDLL--SSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp CSSEETT--TSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred cCCcccC--cCc---------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 9998873 210 11 1256677777888888641
Q ss_pred --------------------CCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 167 --------------------RPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 167 --------------------~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
...++|||++|.||+++.++.+.|+||+.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 0139999999999999877667799999765
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.20 E-value=2.8e-11 Score=113.66 Aligned_cols=145 Identities=14% Similarity=0.223 Sum_probs=107.1
Q ss_pred CCCCCceeeccCceEEEEEEeCCCcEEEEEEec--ccc-hhcHHHHHHHHHHHhcCC--CCceeEEEEEEEeC---CeeE
Q 016347 45 DFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLS--AES-RQGVKEFLTEIQVISEIE--HENLVKLYGCCVEG---NHRI 116 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~---~~~~ 116 (391)
....++.|+.|.++.||++...+ ..+++|+.. ... ......+.+|..+++.+. +.++.+++.++.+. +..+
T Consensus 39 ~~~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 39 GPLSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CCCEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred CCceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 34457789999999999998764 578888765 322 122346778999999886 45678888888766 4589
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcC------------------------------
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV------------------------------ 166 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~------------------------------ 166 (391)
+||||++|..+.+.. ...++......++.+++.+|..||+..
T Consensus 118 ~vme~v~G~~l~~~~--------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS--------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS 189 (359)
T ss_dssp EEEECCCCBCCCCTT--------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred EEEEecCCeecCCCc--------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence 999999997764321 123678888899999999999999721
Q ss_pred -------------------------CCCeeecCCCCCcEEECCCCc--EEEEecccccc
Q 016347 167 -------------------------RPHIIHRDIKASNILLDKDLT--PKISDFGLAKL 198 (391)
Q Consensus 167 -------------------------~~~i~H~dikp~NIlv~~~~~--~kl~Dfg~~~~ 198 (391)
...++|||++|.|||++.++. +.|+||+.+..
T Consensus 190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 147999999999999997753 68999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.12 E-value=7e-11 Score=108.30 Aligned_cols=184 Identities=18% Similarity=0.253 Sum_probs=121.4
Q ss_pred CCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcC-CCCc--eeEEEEEEEeCC---eeEEEEec
Q 016347 48 PINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHEN--LVKLYGCCVEGN---HRILVYNY 121 (391)
Q Consensus 48 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~--iv~~~~~~~~~~---~~~lv~e~ 121 (391)
-++.++.|....||++. ..+++|+.... .....+.+|..+|+.+ .+.. +.+++....... ..++||++
T Consensus 24 ~i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 24 TIEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eeEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 45679999999999874 45888886533 3346788899999887 3332 345555443332 45889999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcC-----------------------------------
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV----------------------------------- 166 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~----------------------------------- 166 (391)
++|.+|.+... ..++......++.+++..+..||+..
T Consensus 98 i~G~~l~~~~~--------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 98 IKGVPLTPLLL--------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp CCCEECCHHHH--------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred cCCeECCcccc--------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 99988865432 13677777888888888888888610
Q ss_pred --------------------CCCeeecCCCCCcEEECC--CCcEEEEecccccccCCCCceeeeeecccccc---cChhh
Q 016347 167 --------------------RPHIIHRDIKASNILLDK--DLTPKISDFGLAKLIPANMTHVSTRVAGTIGY---LAPEY 221 (391)
Q Consensus 167 --------------------~~~i~H~dikp~NIlv~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y---~aPE~ 221 (391)
...++|||++|.||+++. ++.+.|+||+.+..-... .. ......+ ..|+.
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~D----l~~~~~~~~~~~~~~ 244 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-ND----FISLMEDDEEYGMEF 244 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HH----HHTTCCTTTSCCHHH
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HH----HHHHHhhccccCHHH
Confidence 135899999999999988 556789999987653211 10 0111111 23332
Q ss_pred hhc--CCC------------CCCCcEeehhHHHHHHHhCCCCC
Q 016347 222 AIR--GQV------------TRKADIYSFGVLLVEIVSGRCNT 250 (391)
Q Consensus 222 ~~~--~~~------------~~k~DvwSlG~vl~elltg~~p~ 250 (391)
... ..| ..-.+.|++|.++|.+.+|..++
T Consensus 245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 211 001 11257899999999999997554
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.79 E-value=5.9e-08 Score=87.00 Aligned_cols=134 Identities=16% Similarity=0.100 Sum_probs=98.3
Q ss_pred eeeccCce-EEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCC-CCceeEEEEEEEeCCeeEEEEecccCCCH
Q 016347 51 KIGEGGFG-SVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIE-HENLVKLYGCCVEGNHRILVYNYLENNSL 127 (391)
Q Consensus 51 ~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 127 (391)
.+..|..| .||+.... ++..+++|+-... ....+..|...|+.+. +-.+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45666665 69998866 4677899986533 3456778999888873 34467888999999999999999999988
Q ss_pred HHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhc------------------------------------------
Q 016347 128 AQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEE------------------------------------------ 165 (391)
Q Consensus 128 ~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~------------------------------------------ 165 (391)
.+.... .......+..+++..|..||..
T Consensus 108 ~~~~~~----------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 108 FQVLEE----------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp HHHHHH----------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred cccccC----------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 776532 2223345666777777777742
Q ss_pred -------------CCCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 166 -------------VRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 166 -------------~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
....++|||+.+.|||++.++.+-|+||+.+.
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 01138999999999999987777799998664
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.73 E-value=1e-07 Score=87.22 Aligned_cols=138 Identities=19% Similarity=0.238 Sum_probs=95.2
Q ss_pred CCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCC---ceeEEEEEEE-eCCeeEEEEecc
Q 016347 47 SPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHE---NLVKLYGCCV-EGNHRILVYNYL 122 (391)
Q Consensus 47 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~~ 122 (391)
.-++.++.|....||+. |..+++|+.. .......+..|..+|+.+.+. .+.+++.+.. ..+..++|||++
T Consensus 22 ~~v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 22 QSVESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp SCEEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeeeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 34567889999999998 5668888853 233456788999999998642 3556676664 445678999999
Q ss_pred cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhc-------------------------------------
Q 016347 123 ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEE------------------------------------- 165 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~------------------------------------- 165 (391)
+|.+|.+.... .++......++.+++..|..||+.
T Consensus 96 ~G~~l~~~~~~--------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~ 167 (306)
T 3tdw_A 96 QGQILGEDGMA--------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES 167 (306)
T ss_dssp CSEECHHHHHT--------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred CCeECchhhhh--------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence 99888764221 134444455555555555555542
Q ss_pred --------------------CCCCeeecCCCCCcEEECC---CCc-EEEEecccccc
Q 016347 166 --------------------VRPHIIHRDIKASNILLDK---DLT-PKISDFGLAKL 198 (391)
Q Consensus 166 --------------------~~~~i~H~dikp~NIlv~~---~~~-~kl~Dfg~~~~ 198 (391)
....++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1225799999999999987 455 48999997754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=2.1e-07 Score=86.89 Aligned_cols=80 Identities=10% Similarity=0.035 Sum_probs=55.2
Q ss_pred Ccee-eccCceEEEEEEeC-------CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCC-C--CceeEEEEEEEeC--
Q 016347 49 INKI-GEGGFGSVYKGRLK-------DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIE-H--ENLVKLYGCCVEG-- 112 (391)
Q Consensus 49 ~~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~-- 112 (391)
.+.| +.|....+|+.... +++.+++|+..... ......+..|+.+++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 88889999998764 26678999865432 101134667888888773 2 3567788776654
Q ss_pred -CeeEEEEecccCCCHH
Q 016347 113 -NHRILVYNYLENNSLA 128 (391)
Q Consensus 113 -~~~~lv~e~~~~~sL~ 128 (391)
+..++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3578999999987654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.35 E-value=1.6e-06 Score=78.43 Aligned_cols=82 Identities=15% Similarity=0.218 Sum_probs=60.7
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCC-C--CceeEEEEEEEeCCeeEE
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIE-H--ENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~~~~~l 117 (391)
+.+....-++.+|.|..+.||+.+..+|+.|++|+...........|..|...|+.+. . -.+.++++.. ..++
T Consensus 12 l~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l 87 (288)
T 3f7w_A 12 LTGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL 87 (288)
T ss_dssp HHCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred hcCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence 3456677788999999999999999999999999876554443456778998888773 2 2345555542 3478
Q ss_pred EEecccCCC
Q 016347 118 VYNYLENNS 126 (391)
Q Consensus 118 v~e~~~~~s 126 (391)
||||++++.
T Consensus 88 v~e~l~~~~ 96 (288)
T 3f7w_A 88 AMEWVDERP 96 (288)
T ss_dssp EEECCCCCC
T ss_pred EEEeecccC
Confidence 999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=8.6e-07 Score=84.09 Aligned_cols=76 Identities=12% Similarity=0.147 Sum_probs=49.9
Q ss_pred CCceeeccCceEEEEEEeC-CCcEEEEEEecccch-------hcHHHHHHHHHHHhcCCC--C-ceeEEEEEEEeCCeeE
Q 016347 48 PINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR-------QGVKEFLTEIQVISEIEH--E-NLVKLYGCCVEGNHRI 116 (391)
Q Consensus 48 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-~iv~~~~~~~~~~~~~ 116 (391)
.++.||.|..+.||++... +++.+++|....... .....+..|.++|+.+.. + .+.+++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 3568999999999999765 467899997643211 123456778888887632 3 34455543 445678
Q ss_pred EEEecccCC
Q 016347 117 LVYNYLENN 125 (391)
Q Consensus 117 lv~e~~~~~ 125 (391)
+|||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.23 E-value=1.1e-05 Score=74.55 Aligned_cols=144 Identities=17% Similarity=0.204 Sum_probs=78.5
Q ss_pred CceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcC-----CCCceeEEE-E--EEEeCCeeEEEEe
Q 016347 49 INKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEI-----EHENLVKLY-G--CCVEGNHRILVYN 120 (391)
Q Consensus 49 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~-~--~~~~~~~~~lv~e 120 (391)
++.|+.|..+.||++...+| .+++|+.... . ..+..|..+++.+ ..|.++... + +....+..+++|+
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34566677899999988655 4889988753 2 2233344444444 234444310 0 1234667899999
Q ss_pred cccCCCHH--------------HHHhcCCC-C--CC-----ccccCHHH-------------------------------
Q 016347 121 YLENNSLA--------------QTLIGGGH-H--YS-----NIQFSWRT------------------------------- 147 (391)
Q Consensus 121 ~~~~~sL~--------------~~i~~~~~-~--~~-----~~~l~~~~------------------------------- 147 (391)
|++|..+. ..++.... . .. .....|..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 11111000 0 00 00011111
Q ss_pred HHHHHHHHHHHHHHhhh----------cCCCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 148 RSRICIGIARGLAFLHE----------EVRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 148 ~~~i~~qi~~al~~lH~----------~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
...+..++..++.+|+. .....++|||+++.|||++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11111223345666653 013489999999999999888899999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.11 E-value=2.5e-05 Score=71.30 Aligned_cols=77 Identities=14% Similarity=0.156 Sum_probs=60.9
Q ss_pred CCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCC---CCceeEEEEEEEeCCeeEEEEeccc
Q 016347 47 SPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIE---HENLVKLYGCCVEGNHRILVYNYLE 123 (391)
Q Consensus 47 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~ 123 (391)
.-++.|+.|....+|+.... +..+++|+.... ....+..|...|+.+. ...+.+++.+....+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 34568999999999999874 667888986543 2466788988888873 3678888888887888999999999
Q ss_pred CCCH
Q 016347 124 NNSL 127 (391)
Q Consensus 124 ~~sL 127 (391)
|..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.91 E-value=1.5e-05 Score=76.05 Aligned_cols=75 Identities=15% Similarity=0.146 Sum_probs=45.6
Q ss_pred CCCceeeccCceEEEEEEeCCCcEEEEEEeccc------c-h--hcHHHHHHHHHHHh-cCCCCceeEEEEEEEeCCeeE
Q 016347 47 SPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAE------S-R--QGVKEFLTEIQVIS-EIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 47 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~------~-~--~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~ 116 (391)
.-++.||.|..+.||++.. +++.++||..... . . .....+..|+..+. ......+.+++.+. ....+
T Consensus 37 ~~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 37 LVIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp CEEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred eEEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 3467899999999999975 4678999943211 0 0 02223333333222 11234566666654 56789
Q ss_pred EEEecc-cC
Q 016347 117 LVYNYL-EN 124 (391)
Q Consensus 117 lv~e~~-~~ 124 (391)
+||||+ +|
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 76
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.75 E-value=0.00018 Score=66.22 Aligned_cols=145 Identities=16% Similarity=0.106 Sum_probs=72.3
Q ss_pred CceeeccCceE-EEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCC--CCceeEEEEEEEeCCeeEEEEecccCC
Q 016347 49 INKIGEGGFGS-VYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIE--HENLVKLYGCCVEGNHRILVYNYLENN 125 (391)
Q Consensus 49 ~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~ 125 (391)
++.|+.|+... +|+....+|..+++|........ .+..|+.+++.+. .-.+.+++.+..+. -+++||++.+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~~---~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEGG---DTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTTTC---CSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCCc---cccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCc
Confidence 45676666655 66877644667778865443212 2334555555552 22345566653332 37899999877
Q ss_pred CHHHHHhcCCC--------------------CCCccccCHHHHH-------HH-------------HHHHHHHHHHhhh-
Q 016347 126 SLAQTLIGGGH--------------------HYSNIQFSWRTRS-------RI-------------CIGIARGLAFLHE- 164 (391)
Q Consensus 126 sL~~~i~~~~~--------------------~~~~~~l~~~~~~-------~i-------------~~qi~~al~~lH~- 164 (391)
.+.+.+..... ......++..... .+ ...+...+..+..
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 77654432110 0000011111000 00 0011122222211
Q ss_pred --cCCCCeeecCCCCCcEEECCC----CcEEEEecccccc
Q 016347 165 --EVRPHIIHRDIKASNILLDKD----LTPKISDFGLAKL 198 (391)
Q Consensus 165 --~~~~~i~H~dikp~NIlv~~~----~~~kl~Dfg~~~~ 198 (391)
.....++|||+.+.|||++.+ +.+.|+||+.+..
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 112379999999999999875 6899999997764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00011 Score=66.72 Aligned_cols=71 Identities=8% Similarity=0.096 Sum_probs=44.1
Q ss_pred CceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCce-eEEEEEEEeCCeeEEEEecc-cCCC
Q 016347 49 INKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENL-VKLYGCCVEGNHRILVYNYL-ENNS 126 (391)
Q Consensus 49 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~-~~~s 126 (391)
++.|+.|....+|+. +.+++|+........ .....|..+++.+....+ .+++++ +...-++++||+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 788999999999999 458888876532211 123457777766632222 345543 344457899999 6654
Q ss_pred H
Q 016347 127 L 127 (391)
Q Consensus 127 L 127 (391)
|
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00042 Score=63.44 Aligned_cols=76 Identities=12% Similarity=0.097 Sum_probs=48.7
Q ss_pred CceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCC--CceeEEEEE-----EEeCCeeEEEEec
Q 016347 49 INKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEH--ENLVKLYGC-----CVEGNHRILVYNY 121 (391)
Q Consensus 49 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~-----~~~~~~~~lv~e~ 121 (391)
+..|+ |....||++...+|+.+++|+.+... .....+..|..+++.+.. -.+++++.. ....+..+++|++
T Consensus 31 ~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 31 LTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp CEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred EEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 35677 88889999987777789999986431 123455667777776631 123333332 2234567889999
Q ss_pred ccCCC
Q 016347 122 LENNS 126 (391)
Q Consensus 122 ~~~~s 126 (391)
++|..
T Consensus 109 i~G~~ 113 (328)
T 1zyl_A 109 VGGRQ 113 (328)
T ss_dssp CCCEE
T ss_pred cCCCC
Confidence 98854
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00011 Score=68.98 Aligned_cols=144 Identities=19% Similarity=0.246 Sum_probs=82.7
Q ss_pred CceeeccCceEEEEEEeC--------CCcEEEEEEecccchhcHHHHHHHHHHHhcCC-CCceeEEEEEEEeCCeeEEEE
Q 016347 49 INKIGEGGFGSVYKGRLK--------DGKIAAIKVLSAESRQGVKEFLTEIQVISEIE-HENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 49 ~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++.|..|-...+|++... +++.+++|+.... ........+|..+++.+. +.-..++++++.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 467888888999999875 2578999986432 223455668988888873 2223556665433 3899
Q ss_pred ecccCCCHHHH-----------------HhcCCCCCCcccc-CHHHHHHHHHHHHH-------------------HHHHh
Q 016347 120 NYLENNSLAQT-----------------LIGGGHHYSNIQF-SWRTRSRICIGIAR-------------------GLAFL 162 (391)
Q Consensus 120 e~~~~~sL~~~-----------------i~~~~~~~~~~~l-~~~~~~~i~~qi~~-------------------al~~l 162 (391)
||++|..|... ++.........+. -+.++.++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998655321 1111111111111 23455555544322 22333
Q ss_pred hh----c-CCCCeeecCCCCCcEEECCC----CcEEEEeccccc
Q 016347 163 HE----E-VRPHIIHRDIKASNILLDKD----LTPKISDFGLAK 197 (391)
Q Consensus 163 H~----~-~~~~i~H~dikp~NIlv~~~----~~~kl~Dfg~~~ 197 (391)
.. . ....++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 22 1 12269999999999999876 789999998765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00046 Score=63.00 Aligned_cols=146 Identities=13% Similarity=0.135 Sum_probs=76.8
Q ss_pred CceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCC-----CCceeEEE-E--EEEeCCeeEEEEe
Q 016347 49 INKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIE-----HENLVKLY-G--CCVEGNHRILVYN 120 (391)
Q Consensus 49 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~-~--~~~~~~~~~lv~e 120 (391)
++.|+.|....+|++...+| .+++|+...... ...+..|..+++.+. -|.++... | +....+..+++++
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~--~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCCCC--HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 34577788899999988766 578898765211 123445666666552 23333210 0 1123456789999
Q ss_pred cccCCCHHH--------------HHhcCCCCCCcc-----c-cCHHHHHH------------HHHHHHHHHHHhhhc---
Q 016347 121 YLENNSLAQ--------------TLIGGGHHYSNI-----Q-FSWRTRSR------------ICIGIARGLAFLHEE--- 165 (391)
Q Consensus 121 ~~~~~sL~~--------------~i~~~~~~~~~~-----~-l~~~~~~~------------i~~qi~~al~~lH~~--- 165 (391)
|++|..+.. .++......... . ..|..... +...+...+..++..
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 999865321 111100000000 0 01111000 011133445555432
Q ss_pred -CCCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 166 -VRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 166 -~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
...+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 12379999999999999887666899998664
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00044 Score=66.50 Aligned_cols=75 Identities=13% Similarity=0.139 Sum_probs=48.6
Q ss_pred CCceeeccCceEEEEEEeCC-CcEEEEEEecccchhcHHHHHHHHHHHhcCCCCce-eEEEEEEEeCCeeEEEEecccCC
Q 016347 48 PINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENL-VKLYGCCVEGNHRILVYNYLENN 125 (391)
Q Consensus 48 ~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~ 125 (391)
-++.|+.|-...+|++...+ +..+++|+......... ....|..+++.+...++ .++++++. + .+||||++|.
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~ 186 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY 186 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence 35678889999999999875 57888998754322211 12468888888854444 46676652 2 3599999875
Q ss_pred CH
Q 016347 126 SL 127 (391)
Q Consensus 126 sL 127 (391)
+|
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00067 Score=64.76 Aligned_cols=74 Identities=19% Similarity=0.291 Sum_probs=49.6
Q ss_pred CCceeeccCceEEEEEEeCC--------CcEEEEEEecccchhcHHHHHHHHHHHhcCCCCce-eEEEEEEEeCCeeEEE
Q 016347 48 PINKIGEGGFGSVYKGRLKD--------GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENL-VKLYGCCVEGNHRILV 118 (391)
Q Consensus 48 ~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv 118 (391)
.++.|+.|....||++...+ ++.+++|+..... ....+..|..+++.+...++ .++++.+. + .+|
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v 150 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRL 150 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEE
Confidence 35678889999999998753 5789999874321 11345578888887743333 56666543 2 389
Q ss_pred EecccCCCH
Q 016347 119 YNYLENNSL 127 (391)
Q Consensus 119 ~e~~~~~sL 127 (391)
+||++|.+|
T Consensus 151 ~e~l~G~~l 159 (429)
T 1nw1_A 151 EEYIPSRPL 159 (429)
T ss_dssp ECCCCEEEC
T ss_pred EEEeCCccc
Confidence 999987443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00021 Score=66.79 Aligned_cols=74 Identities=12% Similarity=0.171 Sum_probs=44.2
Q ss_pred CceeeccCceEEEEEEeCC---------CcEEEEEEecccchhcHHHHHHHHHHHhcCCCCc-eeEEEEEEEeCCeeEEE
Q 016347 49 INKIGEGGFGSVYKGRLKD---------GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHEN-LVKLYGCCVEGNHRILV 118 (391)
Q Consensus 49 ~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv 118 (391)
++.|+.|....+|++...+ +..+++|+........ .....|..+++.+...+ ..++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-YNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-SCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-ecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 4578888889999998764 2688899875432221 12356777777764223 34555543 2 3789
Q ss_pred EecccCCCH
Q 016347 119 YNYLENNSL 127 (391)
Q Consensus 119 ~e~~~~~sL 127 (391)
|+|++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.15 E-value=0.00051 Score=58.31 Aligned_cols=103 Identities=17% Similarity=0.110 Sum_probs=66.2
Q ss_pred CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc
Q 016347 125 NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204 (391)
Q Consensus 125 ~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~ 204 (391)
-||.+++... +.+++++++|.++.|.+.+|.-+-.+. .-...=+.|..|++..+|.|.+.+ +...
T Consensus 33 vSL~eIL~~~-----~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------- 97 (229)
T 2yle_A 33 LSLEEILRLY-----NQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD------- 97 (229)
T ss_dssp EEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred ccHHHHHHHc-----CCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc-------
Confidence 3789988753 348999999999999999987762210 111233457999999999998764 1110
Q ss_pred eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCC
Q 016347 205 HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCN 249 (391)
Q Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p 249 (391)
.....+.|||... ...+.+.=|||||+++|..+--..|
T Consensus 98 ------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ---------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1122466888652 3456788899999999998865433
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0018 Score=59.64 Aligned_cols=31 Identities=29% Similarity=0.383 Sum_probs=27.1
Q ss_pred CCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 168 PHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 168 ~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3799999999999999888899999976653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0033 Score=59.69 Aligned_cols=75 Identities=7% Similarity=0.065 Sum_probs=48.6
Q ss_pred CCceeeccCceEEEEEEeCC--------CcEEEEEEecccchhcHHHHHHHHHHHhcCC-CCceeEEEEEEEeCCeeEEE
Q 016347 48 PINKIGEGGFGSVYKGRLKD--------GKIAAIKVLSAESRQGVKEFLTEIQVISEIE-HENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 48 ~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 118 (391)
.++.|..|-...+|+....+ ++.+++++........ ....+|..+++.+. +.-..++++.+ . -++|
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I 148 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF--P--EGRI 148 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEE
Confidence 35678888889999998763 5789999865433221 22346777777773 22234555433 2 3789
Q ss_pred EecccCCCH
Q 016347 119 YNYLENNSL 127 (391)
Q Consensus 119 ~e~~~~~sL 127 (391)
|+|++|..|
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999998754
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.66 E-value=0.031 Score=52.58 Aligned_cols=30 Identities=27% Similarity=0.397 Sum_probs=24.7
Q ss_pred CeeecCCCCCcEEE------CCCCcEEEEecccccc
Q 016347 169 HIIHRDIKASNILL------DKDLTPKISDFGLAKL 198 (391)
Q Consensus 169 ~i~H~dikp~NIlv------~~~~~~kl~Dfg~~~~ 198 (391)
.++|+|+.+.|||+ +.+..+.++||-++..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36899999999999 4457799999987753
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=92.99 E-value=0.33 Score=41.13 Aligned_cols=84 Identities=12% Similarity=0.134 Sum_probs=62.4
Q ss_pred CCCceeEEEEEEEeCCeeEEEEecccCC-CHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHH-HhhhcCCCCeeecCC
Q 016347 98 EHENLVKLYGCCVEGNHRILVYNYLENN-SLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA-FLHEEVRPHIIHRDI 175 (391)
Q Consensus 98 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~-sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~-~lH~~~~~~i~H~di 175 (391)
.||++ -..+-.+++.+.+.++.-+++ ++. .+. .++...+++++.+|+.... +++. -+|--|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~---------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l 110 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIR---------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIV 110 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHH---------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHH---------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEE
Confidence 57887 444456777788777765443 444 332 4888899999999988777 5554 478889
Q ss_pred CCCcEEECCCCcEEEEecccccc
Q 016347 176 KASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 176 kp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
.|+||+++.++.+++.-.|+-..
T Consensus 111 ~P~NL~f~~~~~p~i~hRGi~~~ 133 (219)
T 4ano_A 111 CPENLMFNRALEPFFLHVGVKES 133 (219)
T ss_dssp CGGGEEECTTCCEEESCCEETTT
T ss_pred eCceEEEeCCCcEEEEEcCCccc
Confidence 99999999999999988876544
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.42 E-value=0.22 Score=42.03 Aligned_cols=85 Identities=9% Similarity=0.130 Sum_probs=63.1
Q ss_pred CCCceeEEEEEEEeCCeeEEEEeccc-CCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 016347 98 EHENLVKLYGCCVEGNHRILVYNYLE-NNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIK 176 (391)
Q Consensus 98 ~h~~iv~~~~~~~~~~~~~lv~e~~~-~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dik 176 (391)
.||+.++. .+-.+.+...+.++.-+ +.++.. + +.++....++++.+|+....+++.. +|--|.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---------k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~ 106 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---------KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLA 106 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---------GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCS
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---------HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEe
Confidence 68888876 56666677777776554 223333 2 3588899999999999888666544 788899
Q ss_pred CCcEEECCCCcEEEEecccccc
Q 016347 177 ASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 177 p~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|+||+++.++.+++.-.|+...
T Consensus 107 P~NL~f~~~~~p~i~~RGik~~ 128 (215)
T 4ann_A 107 PDELFFTRDGLPIAKTRGLQNV 128 (215)
T ss_dssp GGGEEECTTSCEEESCCEETTT
T ss_pred cceEEEcCCCCEEEEEccCccC
Confidence 9999999999999987776543
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.52 E-value=0.073 Score=51.07 Aligned_cols=62 Identities=6% Similarity=0.076 Sum_probs=19.4
Q ss_pred CCCceeeccCceEEEEEEeCC-CcEEEE------EEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEe
Q 016347 47 SPINKIGEGGFGSVYKGRLKD-GKIAAI------KVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVE 111 (391)
Q Consensus 47 ~~~~~lg~G~~g~V~~~~~~~-~~~vav------K~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 111 (391)
.+.++|| ||.||+|.+.. ..+||+ |..... ..+....+.+|..+++.++|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 5567787 99999999864 457888 665432 22334567888889988999999999887653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 391 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-72 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-71 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-71 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-71 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-71 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-70 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-69 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-68 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-66 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-65 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-65 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-64 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-64 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-64 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-62 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-62 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-62 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-62 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-61 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-61 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-61 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-60 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-59 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-58 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-57 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-55 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-54 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-53 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-51 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-50 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-50 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-49 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-48 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-48 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-47 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-46 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-46 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-46 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-44 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-44 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-43 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-41 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-39 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-36 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-24 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 8e-72
Identities = 76/279 (27%), Positives = 127/279 (45%), Gaps = 24/279 (8%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHE 100
+ + + ++G G FG V+ G A+K L + FL E ++ +++H+
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQ 68
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
LV+LY + ++ Y+EN SL L S I+ + + IA G+A
Sbjct: 69 RLVRLYAVVTQ-EPIYIITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPE 220
F+ E + IHRD++A+NIL+ L+ KI+DFGLA+LI N I + APE
Sbjct: 124 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 221 YAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT 280
G T K+D++SFG+LL EIV+ R+P + E+I ++
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHG-----RIP----------YPGMTNPEVIQNLER 225
Query: 281 SLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319
++ LC ++ P+ RP+ + +L
Sbjct: 226 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 2e-71
Identities = 61/277 (22%), Positives = 117/277 (42%), Gaps = 24/277 (8%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLV 103
D + + ++G G FG V G+ + AIK++ E EF+ E +V+ + HE LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 104 KLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH 163
+LYG C + ++ Y+ N L L +F + +C + + +L
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYL-----REMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 164 EEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAI 223
+HRD+ A N L++ K+SDFGL++ + + S + + PE +
Sbjct: 118 ---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174
Query: 224 RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLN 283
+ + K+DI++FGVL+ EI S ++P ++ + E + L
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLG-----KMP----------YERFTNSETAEHIAQGLR 219
Query: 284 GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320
+ + + C + RP+ ++ ++
Sbjct: 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 3e-71
Identities = 67/276 (24%), Positives = 131/276 (47%), Gaps = 24/276 (8%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLV 103
+ + + +IG G FG V+ G + AIK + E ++F+ E +V+ ++ H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 104 KLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH 163
+LYG C+E LV+ ++E+ L+ F+ T +C+ + G+A+L
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDY-----LRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 164 EEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAI 223
E +IHRD+ A N L+ ++ K+SDFG+ + + + ST + + +PE
Sbjct: 119 E---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 224 RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLN 283
+ + K+D++SFGVL+ E+ S ++P ++ E++ + T
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEG-----KIP----------YENRSNSEVVEDISTGFR 220
Query: 284 GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319
+ ++ C ++ P+ RP+ S +++ L
Sbjct: 221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 4e-71
Identities = 72/285 (25%), Positives = 130/285 (45%), Gaps = 28/285 (9%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVL--SAESRQGVKEFLTEIQVISEIE 98
I + +IG G FG+VYKG+ A+K+L +A + Q ++ F E+ V+ +
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 99 HENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARG 158
H N++ G +V + E +SL L H +F I A+G
Sbjct: 63 HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHL-----HIIETKFEMIKLIDIARQTAQG 116
Query: 159 LAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANM-THVSTRVAGTIGYL 217
+ +LH IIHRD+K++NI L +DLT KI DFGLA + +H +++G+I ++
Sbjct: 117 MDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 218 APEYA---IRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERREL 274
APE + + ++D+Y+FG++L E+++G +LP ++ + R L
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTG------QLPYSNINNRDQIIFMVGRGYL 227
Query: 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319
+ + + ++ C + RP ++ +
Sbjct: 228 SPDLS-KVRSNCPKA----MKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 222 bits (566), Expect = 5e-71
Identities = 70/298 (23%), Positives = 129/298 (43%), Gaps = 27/298 (9%)
Query: 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQV 93
+Y + + D + +K+G G +G VY+G K A+K L ++ + V+EFL E V
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 66
Query: 94 ISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICI 153
+ EI+H NLV+L G C ++ ++ +L L + S +
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMAT 122
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213
I+ + +L + + IHRD+ A N L+ ++ K++DFGL++L+ +
Sbjct: 123 QISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRE 273
I + APE + + K+D+++FGVLL EI + + + +
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG---------------MSPYPGIDLSQ 224
Query: 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML---MGEKDIDDD 328
+ L++ + + ++ C Q P RPS + + Q E I D+
Sbjct: 225 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 282
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 1e-70
Identities = 76/338 (22%), Positives = 134/338 (39%), Gaps = 51/338 (15%)
Query: 39 LSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGV-KEFLTEIQVISE 96
+ + DDF I+++G G G V+K K G + A K++ E + + + + E+QV+ E
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 97 IEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIA 156
+V YG + +++ SL Q L G + ++ I +
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR------IPEQILGKVSIAVI 114
Query: 157 RGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGY 216
+GL +L E + I+HRD+K SNIL++ K+ DFG++ + +M GT Y
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSY 169
Query: 217 LAPEYAIRGQVTRKADIYSFGVLLVEIVSGR-----------------------CNTNMR 253
++PE + ++DI+S G+ LVE+ GR T R
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229
Query: 254 LPTEEQYLLERTWDLYERRELILLVDTSLNGDFDA-------EEACRFLKVGLLCTQDTP 306
T + L D + L+D +N E F+ C P
Sbjct: 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN---KCLIKNP 286
Query: 307 KLRPSMSTVVQM--LMGEKDIDDDKITKPGLISDFMDL 342
R + ++ + K D +++ G + + L
Sbjct: 287 AERADLKQLMVHAFI---KRSDAEEVDFAGWLCSTIGL 321
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 2e-69
Identities = 73/285 (25%), Positives = 119/285 (41%), Gaps = 24/285 (8%)
Query: 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVI 94
+ I + K+G+G FG V+ G AIK L + FL E QV+
Sbjct: 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVM 66
Query: 95 SEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIG 154
++ HE LV+LY +V Y+ SL + +
Sbjct: 67 KKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDF----LKGETGKYLRLPQLVDMAAQ 121
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTI 214
IA G+A++ R + +HRD++A+NIL+ ++L K++DFGLA+LI N I
Sbjct: 122 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 178
Query: 215 GYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERREL 274
+ APE A+ G+ T K+D++SFG+LL E+ + + RE+
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKG---------------RVPYPGMVNREV 223
Query: 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319
+ V+ E + C + P+ RP+ + L
Sbjct: 224 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 216 bits (552), Expect = 1e-68
Identities = 69/307 (22%), Positives = 135/307 (43%), Gaps = 41/307 (13%)
Query: 31 VKLYSYKELSIATDDFSP---------INKIGEGGFGSVYKGRLK----DGKIAAIKVL- 76
+ +++++ + A +F+ IG G FG V G LK AIK L
Sbjct: 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63
Query: 77 SAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGH 136
S + + ++FL+E ++ + +H N++ L G + +++ ++EN SL
Sbjct: 64 SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF-----L 118
Query: 137 HYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196
++ QF+ + GIA G+ +L + +HRD+ A NIL++ +L K+SDFGL+
Sbjct: 119 RQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLS 175
Query: 197 KLIPANMTHVSTRVA----GTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNM 252
+ + + + + A I + APE + T +D++S+G+++ E++S
Sbjct: 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG----- 230
Query: 253 RLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSM 312
ER + +++I ++ + ++ L C Q RP
Sbjct: 231 ----------ERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKF 280
Query: 313 STVVQML 319
+V L
Sbjct: 281 GQIVNTL 287
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 210 bits (536), Expect = 2e-66
Identities = 71/311 (22%), Positives = 124/311 (39%), Gaps = 44/311 (14%)
Query: 35 SYKELSIATDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAESRQGV-KEF 87
L ++ + IGEG FG V++ R + A+K+L E+ + +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 88 LTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHY--------- 138
E +++E ++ N+VKL G C G L++ Y+ L + L H
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 139 ---------SNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPK 189
S + I +A G+A+L E +HRD+ N L+ +++ K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180
Query: 190 ISDFGLAKLIP-ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRC 248
I+DFGL++ I A+ A I ++ PE + T ++D++++GV+L EI S
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 249 NTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKL 308
+ EE R ++ E + LC P
Sbjct: 241 QPYYGMAHEEVIYYVRDGNILACPE---------------NCPLELYNLMRLCWSKLPAD 285
Query: 309 RPSMSTVVQML 319
RPS ++ ++L
Sbjct: 286 RPSFCSIHRIL 296
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 2e-65
Identities = 73/307 (23%), Positives = 134/307 (43%), Gaps = 35/307 (11%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLKDG-----KIAAIKVLSAESRQG-VKEFLTEIQVI 94
I + IG G FG VYKG LK AIK L A + +FL E ++
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63
Query: 95 SEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIG 154
+ H N+++L G + +++ Y+EN +L + + +FS + G
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF-----LREKDGEFSVLQLVGMLRG 118
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANM--THVSTRVAG 212
IA G+ +L + +HRD+ A NIL++ +L K+SDFGL++++ + T+ ++
Sbjct: 119 IAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 213 TIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272
I + APE + T +D++SFG+++ E+++ ER +
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG---------------ERPYWELSNH 220
Query: 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKDIDDDKITK 332
E++ ++ + ++ + C Q RP + +V +L D T
Sbjct: 221 EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKT- 279
Query: 333 PGLISDF 339
++DF
Sbjct: 280 ---LADF 283
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 3e-65
Identities = 64/290 (22%), Positives = 126/290 (43%), Gaps = 31/290 (10%)
Query: 37 KELSIATDDFSPIN-KIGEGGFGSVYKGRLK---DGKIAAIKVLSAESRQG-VKEFLTEI 91
K+L + D+ + ++G G FGSV +G + AIKVL + + +E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 92 QVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRI 151
Q++ ++++ +V+L G C + +LV L + L+G + +
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE-----IPVSNVAEL 114
Query: 152 CIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTR-- 209
++ G+ +L + +HRD+ A N+LL KISDFGL+K + A+ ++ + R
Sbjct: 115 LHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171
Query: 210 VAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLY 269
+ + APE + + ++D++S+GV + E +S + P +
Sbjct: 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG-----QKP----------YKKM 216
Query: 270 ERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319
+ E++ ++ + E + C + RP TV Q +
Sbjct: 217 KGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 4e-64
Identities = 67/321 (20%), Positives = 119/321 (37%), Gaps = 40/321 (12%)
Query: 28 IHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAESR 81
I +L + + S +G G FG V + A+K+L +
Sbjct: 7 IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 66
Query: 82 QG-VKEFLTEIQVISEIE-HENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHY- 138
+ ++E++V+S + H N+V L G C G +++ Y L L +
Sbjct: 67 LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 126
Query: 139 -----------SNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLT 187
+ +A+G+AFL + + IHRD+ A NILL
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRI 183
Query: 188 PKISDFGLAKLIPANMTH-VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSG 246
KI DFGLA+ I + + V + ++APE T ++D++S+G+ L E+ S
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243
Query: 247 RCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTP 306
+ +P + + ++ + C P
Sbjct: 244 GSSPYPGMPVDSK--------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289
Query: 307 KLRPSMSTVVQMLMGEKDIDD 327
RP+ +VQ++ EK I +
Sbjct: 290 LKRPTFKQIVQLI--EKQISE 308
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 5e-64
Identities = 67/283 (23%), Positives = 118/283 (41%), Gaps = 32/283 (11%)
Query: 38 ELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEI 97
L++ + + IG+G FG V G + G A+K + ++ + FL E V++++
Sbjct: 3 ALNM--KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQL 57
Query: 98 EHENLVKLYGCCVEGNHRI-LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIA 156
H NLV+L G VE + +V Y+ SL L G + + +
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVC 113
Query: 157 RGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGY 216
+ +L + +HRD+ A N+L+ +D K+SDFGL K + + +
Sbjct: 114 EAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKW 166
Query: 217 LAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL 276
APE + + K+D++SFG+LL EI S R+P + ++++
Sbjct: 167 TAPEALREKKFSTKSDVWSFGILLWEIYSFG-----RVP----------YPRIPLKDVVP 211
Query: 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319
V+ D +V C +RPS + + L
Sbjct: 212 RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 5e-64
Identities = 72/303 (23%), Positives = 127/303 (41%), Gaps = 32/303 (10%)
Query: 51 KIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCV 110
IG+G FG V++G+ + G+ A+K+ S+ + EI + HEN++
Sbjct: 10 SIGKGRFGEVWRGKWR-GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 67
Query: 111 EGN----HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV 166
+ N LV +Y E+ SL L + ++ + A GLA LH E+
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLHMEI 120
Query: 167 -----RPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA---NMTHVSTRVAGTIGYLA 218
+P I HRD+K+ NIL+ K+ T I+D GLA + + GT Y+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 219 PEY------AIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQY--LLERTWDLYE 270
PE + ++ADIY+ G++ EI + + Y L+ + E
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 271 RRELIL--LVDTSLNGDFDAEEACRFL-KVGLLCTQDTPKLRPSMSTVVQMLMGEKDIDD 327
R+++ + ++ + + EA R + K+ C R + + + L +
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300
Query: 328 DKI 330
K+
Sbjct: 301 IKM 303
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 6e-64
Identities = 63/277 (22%), Positives = 115/277 (41%), Gaps = 32/277 (11%)
Query: 50 NKIGEGGFGSVYKGRLKD---GKIAAIKVLSAESRQG--VKEFLTEIQVISEIEHENLVK 104
++G G FG+V KG + K A+K+L E+ E L E V+ ++++ +V+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 105 LYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHE 164
+ G C E +LV E L + + N + + ++ G+ +L
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNK------YLQQNRHVKDKNIIELVHQVSMGMKYLE- 124
Query: 165 EVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTR--VAGTIGYLAPEYA 222
+ +HRD+ A N+LL KISDFGL+K + A+ + + + + APE
Sbjct: 125 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 223 IRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSL 282
+ + K+D++SFGVL+ E S ++ + + E+ +++
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYG---------------QKPYRGMKGSEVTAMLEKGE 227
Query: 283 NGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319
A + LC + RP + V L
Sbjct: 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 1e-62
Identities = 65/328 (19%), Positives = 118/328 (35%), Gaps = 43/328 (13%)
Query: 18 VPEVDEEFSGIHNVKLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLKD------GKIA 71
D E+ + + + ++ +G G FG V
Sbjct: 11 TGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQV 70
Query: 72 AIKVLSAESRQG-VKEFLTEIQVISEIE-HENLVKLYGCCVEGNHRILVYNYLENNSLAQ 129
A+K+L ++ + ++E+++++++ HEN+V L G C L++ Y L
Sbjct: 71 AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN 130
Query: 130 TLIGGGHHYSNIQ-----------------FSWRTRSRICIGIARGLAFLHEEVRPHIIH 172
L +S + ++ +A+G+ FL +H
Sbjct: 131 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVH 187
Query: 173 RDIKASNILLDKDLTPKISDFGLAKLIPANMTHVS-TRVAGTIGYLAPEYAIRGQVTRKA 231
RD+ A N+L+ KI DFGLA+ I ++ +V + ++APE G T K+
Sbjct: 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKS 247
Query: 232 DIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEA 291
D++S+G+LL EI S N +P + L+ D
Sbjct: 248 DVWSYGILLWEIFSLGVNPYPGIPVDAN--------------FYKLIQNGFKMDQPFYAT 293
Query: 292 CRFLKVGLLCTQDTPKLRPSMSTVVQML 319
+ C + RPS + L
Sbjct: 294 EEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 3e-62
Identities = 66/327 (20%), Positives = 127/327 (38%), Gaps = 43/327 (13%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVL-----SAESRQGVKEFLTEIQVISEI 97
+F I +G G FG+VYKG +G+ I V A S + KE L E V++ +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 98 EHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIAR 157
++ ++ +L G C+ +++ L + C+ IA+
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDY------VREHKDNIGSQYLLNWCVQIAK 122
Query: 158 GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT-HVSTRVAGTIGY 216
G+ +L ++HRD+ A N+L+ KI+DFGLAKL+ A + + I +
Sbjct: 123 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 217 LAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL 276
+A E + T ++D++S+GV + E+++ + +D E+
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFG---------------SKPYDGIPASEISS 224
Query: 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKDIDDDKITKPGLI 336
+++ + + C RP ++ K D +
Sbjct: 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF--SKMARDPQ------- 275
Query: 337 SDFMDLKVRGPPKPKLETTTSSTYNSS 363
L ++G + L + T S + +
Sbjct: 276 ---RYLVIQGDERMHLPSPTDSNFYRA 299
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 3e-62
Identities = 64/278 (23%), Positives = 110/278 (39%), Gaps = 27/278 (9%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKE-FLTEIQVISEIEHEN 101
+D+ + +GEG +G V + + A+K++ + E EI + + HEN
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
+VK YG EGN + L Y L + R + G+ +
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG------MPEPDAQRFFHQLMAGVVY 118
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANM-THVSTRVAGTIGYLAPE 220
LH I HRDIK N+LLD+ KISDFGLA + N + ++ GT+ Y+APE
Sbjct: 119 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 221 YAIRGQV-TRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279
R + D++S G++L +++G + + ++Y + Y +
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI--- 232
Query: 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317
L + P R ++ + +
Sbjct: 233 --------DSAPLALLH---KILVENPSARITIPDIKK 259
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (509), Expect = 4e-62
Identities = 66/282 (23%), Positives = 124/282 (43%), Gaps = 36/282 (12%)
Query: 43 TDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQG---VKEFLTEIQVISEIE 98
FS + +IG G FG+VY R +++ ++ AIK +S +Q ++ + E++ + ++
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 99 HENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARG 158
H N ++ GC + + LV Y ++ + + + G +G
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP------LQEVEIAAVTHGALQG 127
Query: 159 LAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLA 218
LA+LH ++IHRD+KA NILL + K+ DFG A ++ + V GT ++A
Sbjct: 128 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMA 179
Query: 219 PEYAI---RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275
PE + GQ K D++S G+ +E+ + P + + + +
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAER------KPPLFNMNAMSALYHIAQNE--- 230
Query: 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317
+L +E F+ C Q P+ RP+ +++
Sbjct: 231 ---SPALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-61
Identities = 68/285 (23%), Positives = 116/285 (40%), Gaps = 35/285 (12%)
Query: 37 KELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLS---AESRQGVKEFLTEIQ 92
++ ++ +DF +G+G FG+VY R K I A+KVL E + E++
Sbjct: 1 RQWAL--EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 58
Query: 93 VISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRIC 152
+ S + H N+++LYG + L+ Y ++ + L F + +
Sbjct: 59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK------FDEQRTATYI 112
Query: 153 IGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAG 212
+A L++ H + +IHRDIK N+LL KI+DFG + P++ + G
Sbjct: 113 TELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCG 166
Query: 213 TIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272
T+ YL PE K D++S GVL E + G+ E
Sbjct: 167 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK-------------PPFEANTYQETY 213
Query: 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317
+ I V+ + E A + + P RP + V++
Sbjct: 214 KRISRVEFTFPDFVT-EGARDLIS---RLLKHNPSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 1e-61
Identities = 64/281 (22%), Positives = 121/281 (43%), Gaps = 29/281 (10%)
Query: 43 TDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHEN 101
D + I ++G+G FG VYK + K+ +AA KV+ +S + +++++ EI +++ +H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
+VKL N+ ++ + ++ ++ + +C L +
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP-----LTESQIQVVCKQTLDALNY 125
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEY 221
LH+ IIHRD+KA NIL D K++DFG++ + + + GT ++APE
Sbjct: 126 LHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEV 181
Query: 222 AI-----RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL 276
+ KAD++S G+ L+E+ P E + + + L
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEI------EPPHHELNPMRVLLKIAKSEPPTL 235
Query: 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317
+ + FLK C + R + S ++Q
Sbjct: 236 AQPSRWS-----SNFKDFLK---KCLEKNVDARWTTSQLLQ 268
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 1e-61
Identities = 72/279 (25%), Positives = 123/279 (44%), Gaps = 32/279 (11%)
Query: 50 NKIGEGGFGSVYKGRLKDGK----IAAIKVLSAESRQG-VKEFLTEIQVISEIEHENLVK 104
IG G FG VY G L D A+K L+ + G V +FLTE ++ + H N++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 105 LYGCCVEG-NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLH 163
L G C+ ++V Y+++ L + + + +A+G+ FL
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNF-----IRNETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 164 EEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP---ANMTHVSTRVAGTIGYLAPE 220
+HRD+ A N +LD+ T K++DFGLA+ + + H T + ++A E
Sbjct: 148 ---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 221 YAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT 280
+ T K+D++SFGVLL E+++ P + + T L + R L
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRG-----APPYPDVNTFDITVYLLQGRRL------ 253
Query: 281 SLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319
L ++ + + L C ++RPS S +V +
Sbjct: 254 -LQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRI 288
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 4e-61
Identities = 68/291 (23%), Positives = 111/291 (38%), Gaps = 36/291 (12%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLK----DGKIAAIKVLSAE---SRQGVKEFLTEIQV 93
I D + K+G+G FG V +G A+K L + + + +F+ E+
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 94 ISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICI 153
+ ++H NL++LYG + ++ V SL F T SR +
Sbjct: 65 MHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDR-----LRKHQGHFLLGTLSRYAV 118
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTH--VSTRVA 211
+A G+ +L IHRD+ A N+LL KI DFGL + +P N H +
Sbjct: 119 QVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 212 GTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYER 271
+ APE + +D + FGV L E+ T + P W
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF-----TYGQEP----------WIGLNG 220
Query: 272 RELILLVDTSLNGDFDAEEAC--RFLKVGLLCTQDTPKLRPSMSTVVQMLM 320
+++ +D E C V + C P+ RP+ + L+
Sbjct: 221 SQILHKIDKE-GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 1e-60
Identities = 70/291 (24%), Positives = 118/291 (40%), Gaps = 35/291 (12%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKDG---KIAAIKVLSAE-SRQGVKEFLTEIQVISEIE- 98
+D + IGEG FG V K R+K AAIK + S+ ++F E++V+ ++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 99 HENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNI----------QFSWRTR 148
H N++ L G C + L Y + +L L ++ S +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 149 SRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVST 208
+ARG+ +L + IHRD+ A NIL+ ++ KI+DFGL++ + T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 209 RVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDL 268
+ ++A E T +D++S+GVLL EIVS P +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG-----GTP----------YCG 229
Query: 269 YERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319
EL + + + C ++ P RPS + ++ L
Sbjct: 230 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-60
Identities = 62/276 (22%), Positives = 103/276 (37%), Gaps = 33/276 (11%)
Query: 50 NKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLY 106
+IG G F +VYKG + A L ++ + F E +++ ++H N+V+ Y
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 107 GCCVE----GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFL 162
+LV + + +L L + C I +GL FL
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV------MKIKVLRSWCRQILKGLQFL 128
Query: 163 HEEVRPHIIHRDIKASNILL-DKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEY 221
H P IIHRD+K NI + + KI D GLA L A+ V GT ++APE
Sbjct: 129 HTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEM 184
Query: 222 AIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281
+ D+Y+FG+ ++E+ + P E + + D
Sbjct: 185 -YEEKYDESVDVYAFGMCMLEMATS------EYPYSECQNAAQIYRRVTSGVKPASFDKV 237
Query: 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317
E ++ C + R S+ ++
Sbjct: 238 AI-----PEVKEIIE---GCIRQNKDERYSIKDLLN 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 3e-60
Identities = 66/287 (22%), Positives = 115/287 (40%), Gaps = 38/287 (13%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHE 100
+D+ + IG G +G K R K DGKI K L S + ++E+ ++ E++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 101 NLVKLYGCCVEGNHRIL--VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARG 158
N+V+ Y ++ + L V Y E LA + G R+ +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLA 121
Query: 159 LAFLHE--EVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGY 216
L H + ++HRD+K +N+ LD K+ DFGLA+++ + + GT Y
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYY 180
Query: 217 LAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL 276
++PE R K+DI+S G LL E+ + + + ++EL
Sbjct: 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALM----------------PPFTAFSQKELAG 224
Query: 277 LVDTSLNGDFDA------EEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317
+ G F +E + RPS+ +++
Sbjct: 225 KI---REGKFRRIPYRYSDELNEIIT---RMLNLKDYHRPSVEEILE 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 5e-59
Identities = 72/287 (25%), Positives = 115/287 (40%), Gaps = 26/287 (9%)
Query: 32 KLYSYKELSIATDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTE 90
KL S + ++ KIG+G G+VY + G+ AI+ ++ + + + + E
Sbjct: 8 KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 67
Query: 91 IQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSR 150
I V+ E ++ N+V + G+ +V YL SL + +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-------DEGQIAA 120
Query: 151 ICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRV 210
+C + L FLH +IHRDIK+ NILL D + K++DFG I + ST V
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177
Query: 211 AGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE 270
GT ++APE R K DI+S G++ +E++ G P YL E
Sbjct: 178 -GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG------EPP----YLNENPLRALY 226
Query: 271 RRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317
+ FL C + R S ++Q
Sbjct: 227 LIATNGTPELQNPEKLS-AIFRDFLN---RCLDMDVEKRGSAKELLQ 269
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-58
Identities = 71/305 (23%), Positives = 128/305 (41%), Gaps = 30/305 (9%)
Query: 32 KLYSYKELSIATDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLS-AESRQGV 84
+Y E +A + + ++G+G FG VY+G K AIK ++ A S +
Sbjct: 8 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER 67
Query: 85 KEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQ-- 142
EFL E V+ E ++V+L G +G +++ + L L +N
Sbjct: 68 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127
Query: 143 --FSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200
S ++ IA G+A+L+ +HRD+ A N ++ +D T KI DFG+ + I
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 184
Query: 201 -ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQ 259
+ + + +++PE G T +D++SFGV+L EI +
Sbjct: 185 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA------------ 232
Query: 260 YLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319
E+ + +++ V D ++ +C Q PK+RPS ++ +
Sbjct: 233 ---EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
Query: 320 MGEKD 324
E +
Sbjct: 290 KEEME 294
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-57
Identities = 57/294 (19%), Positives = 104/294 (35%), Gaps = 31/294 (10%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLKD----GKIAAIKVLSAESRQGVKE-FLTEIQVIS 95
I + IGEG FG V++G AIK + V+E FL E +
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63
Query: 96 EIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGI 155
+ +H ++VKL G E N ++ L + +
Sbjct: 64 QFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSF-----LQVRKYSLDLASLILYAYQL 117
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIG 215
+ LA+L +HRDI A N+L+ + K+ DFGL++ + + + +++ I
Sbjct: 118 STALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
Query: 216 YLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275
++APE + T +D++ FGV + EI+ + + +
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 234
Query: 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEKDIDDDK 329
+ C P RP + + L ++++K
Sbjct: 235 ------------PPTLYSLMT---KCWAYDPSRRPRFTELKAQL--STILEEEK 271
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-55
Identities = 67/300 (22%), Positives = 118/300 (39%), Gaps = 39/300 (13%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLK--------DGKIAAIKVLSAE-SRQGVKEFLTEI 91
+ D +GEG FG V A+K+L ++ + + + + ++E+
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 69
Query: 92 QVISEI-EHENLVKLYGCCVEGNHRILVYNYLENNSLAQTL----------IGGGHHYSN 140
+++ I +H+N++ L G C + ++ Y +L + L H
Sbjct: 70 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 141 IQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200
Q S + +ARG+ +L IHRD+ A N+L+ +D KI+DFGLA+ I
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 201 ANMTHVSTRV-AGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQ 259
+ T + ++APE T ++D++SFGVLL EI +
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG------------ 234
Query: 260 YLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319
+ EL L+ D + + C P RP+ +V+ L
Sbjct: 235 ---GSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 9e-55
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 14/212 (6%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLS---AESRQGVKEFLTEIQVISE 96
+DF +GEG F +V R L + AIK+L V E V+S
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 97 IEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIA 156
++H VKLY + +Y +N L + + G F I
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS------FDETCTRFYTAEIV 118
Query: 157 RGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI-PANMTHVSTRVAGTIG 215
L +LH IIHRD+K NILL++D+ +I+DFG AK++ P + + GT
Sbjct: 119 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175
Query: 216 YLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
Y++PE + +D+++ G ++ ++V+G
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 3e-54
Identities = 69/306 (22%), Positives = 120/306 (39%), Gaps = 37/306 (12%)
Query: 34 YSYKELSIATDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAESRQG-VKE 86
Y + D +G G FG V + + A+K+L + +
Sbjct: 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 62
Query: 87 FLTEIQVISEIEHE-NLVKLYGCCVE-GNHRILVYNYLENNSLAQTLIGGGHHYSNIQ-- 142
++E++++ I H N+V L G C + G +++ + + +L+ L + + +
Sbjct: 63 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 143 --------FSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194
+ +A+G+ FL IHRD+ A NILL + KI DFG
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFG 179
Query: 195 LAKLIPANMTHV-STRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMR 253
LA+ I + +V + ++APE T ++D++SFGVLL EI S
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL-----GA 234
Query: 254 LPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMS 313
P + E + + D+ E + + L C P RP+ S
Sbjct: 235 SPYPGVKIDEEFCRRLKEGTRMRAP------DYTTPEMYQTM---LDCWHGEPSQRPTFS 285
Query: 314 TVVQML 319
+V+ L
Sbjct: 286 ELVEHL 291
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 178 bits (453), Expect = 2e-53
Identities = 67/327 (20%), Positives = 119/327 (36%), Gaps = 31/327 (9%)
Query: 44 DDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENL 102
D + ++G G FG V++ G A K + + EIQ +S + H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 103 VKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFL 162
V L+ + N +++Y ++ L + + + + S + +GL +
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKV-----ADEHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 163 HEEVRPHIIHRDIKASNILL--DKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPE 220
HE + +H D+K NI+ + K+ DFGL + + T GT + APE
Sbjct: 141 HEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPE 195
Query: 221 YAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT 280
A V D++S GVL ++SG P + E + +
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSG------LSP----FGGENDDETLRNVKSCDWNMD 245
Query: 281 SLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ---MLMGEKDIDDDKITKPGL-- 335
+E+ F++ P R ++ ++ + G D +I
Sbjct: 246 DSAFSGISEDGKDFIR---KLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTK 302
Query: 336 ISDFMDLKVRGPPKPKLETTTSSTYNS 362
I D + K P+P S Y+S
Sbjct: 303 IRDSIKTKYDAWPEPLPPLGRISNYSS 329
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 175 bits (445), Expect = 4e-52
Identities = 76/352 (21%), Positives = 122/352 (34%), Gaps = 54/352 (15%)
Query: 39 LSIATDDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLS---AESRQGVKEFLTE---I 91
L++ +DFS IG GGFG VY R D GK+ A+K L + +QG L E +
Sbjct: 1 LTM--NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 58
Query: 92 QVISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRI 151
++S + +V + + + + + L L G
Sbjct: 59 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS------EADMRFY 112
Query: 152 CIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVA 211
I GL +H +++RD+K +NILLD+ +ISD GLA H
Sbjct: 113 AAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASV 166
Query: 212 GTIGYLAPEYAIRGQ-VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE 270
GT GY+APE +G AD +S G +L +++ G ++ + T +
Sbjct: 167 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 226
Query: 271 RRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPS-MSTVVQMLMGE---KDID 326
D + E L+ Q R + Q + + +D
Sbjct: 227 ELP-----------DSFSPELRSLLE---GLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272
Query: 327 DDKITKPGLISDFMDLKVRGPPKPKLETTTSSTYNSSDNPDNSNLSSAATSA 378
+ K P P N++D D + T
Sbjct: 273 WQMVFLQ---------KYPPPLIPPRGEV-----NAADAFDIGSFDEEDTKG 310
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 173 bits (440), Expect = 2e-51
Identities = 60/280 (21%), Positives = 107/280 (38%), Gaps = 32/280 (11%)
Query: 44 DDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENL 102
D + + ++G G FG V++ G++ K ++ EI +++++ H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 103 VKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFL 162
+ L+ + +L+ +L L + + + S GL +
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-----KMSEAEVINYMRQACEGLKHM 143
Query: 163 HEEVRPHIIHRDIKASNILLD--KDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPE 220
HE I+H DIK NI+ + K + KI DFGLA + + T T + APE
Sbjct: 144 HEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPE 198
Query: 221 YAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT 280
R V D+++ GVL ++SG D E + + D
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGL-------------SPFAGEDDLETLQNVKRCDW 245
Query: 281 SLNGDFDA---EEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317
+ D + EA F+K Q P+ R ++ ++
Sbjct: 246 EFDEDAFSSVSPEAKDFIK---NLLQKEPRKRLTVHDALE 282
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (428), Expect = 3e-50
Identities = 64/284 (22%), Positives = 117/284 (41%), Gaps = 23/284 (8%)
Query: 36 YKELSIATDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKE-FLTEIQV 93
+K+ D + + +G G F V + K+ AIK ++ ++ +G + EI V
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 94 ISEIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICI 153
+ +I+H N+V L G H L+ + L ++ G ++ R SR+
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF------YTERDASRLIF 114
Query: 154 GIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGT 213
+ + +LH+ H + LD+D ISDFGL+K+ + V + GT
Sbjct: 115 QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGT 172
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRE 273
GY+APE + ++ D +S GV+ ++ G P + E L+E+
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG------YPPFYD----ENDAKLFEQIL 222
Query: 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317
S D ++ A F++ + P+ R + +Q
Sbjct: 223 KAEYEFDSPYWDDISDSAKDFIR---HLMEKDPEKRFTCEQALQ 263
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 169 bits (428), Expect = 4e-50
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEH 99
DF + +G G FG V+ R + +G+ A+KVL E + V+ E ++S + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGL 159
+++++G + ++ +Y+E L + +F + L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFS------LLRKSQRFPNPVAKFYAAEVCLAL 117
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAP 219
+LH II+RD+K NILLDK+ KI+DFG AK +P + GT Y+AP
Sbjct: 118 EYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAP 170
Query: 220 EYAIRGQVTRKADIYSFGVLLVEIVSGR 247
E + D +SFG+L+ E+++G
Sbjct: 171 EVVSTKPYNKSIDWWSFGILIYEMLAGY 198
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (418), Expect = 8e-49
Identities = 58/292 (19%), Positives = 108/292 (36%), Gaps = 30/292 (10%)
Query: 38 ELSIATDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISE 96
EL + + + KIG G FG +Y G + G+ AIK+ +++ + E ++
Sbjct: 2 ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKM 58
Query: 97 IEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIA 156
++ + C ++ L SL ++ + +FS +T + +
Sbjct: 59 MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDL-----FNFCSRKFSLKTVLLLADQMI 113
Query: 157 RGLAFLHEEVRPHIIHRDIKASNIL---LDKDLTPKISDFGLAKLIPANMTHV------S 207
+ ++H + + IHRD+K N L K I DFGLAK TH +
Sbjct: 114 SRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170
Query: 208 TRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWD 267
+ GT Y + + + +R+ D+ S G +L+ G ++ ER +
Sbjct: 171 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230
Query: 268 LYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319
+ +L E +L C +P S + Q+
Sbjct: 231 KKMSTPIEVLCKGY------PSEFATYLN---FCRSLRFDDKPDYSYLRQLF 273
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 6e-48
Identities = 67/297 (22%), Positives = 109/297 (36%), Gaps = 30/297 (10%)
Query: 42 ATDDFSPINKIGEGGFGSVYKGRLK--DGKIAAIKVLSAESRQG--VKEFLTEIQVISEI 97
A + + +IGEG +G V+K R G+ A+K + ++ + + E+ V+ +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 98 ---EHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIG 154
EH N+V+L+ C L + Q L T +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTI 214
+ RGL FLH ++HRD+K NIL+ K++DFGLA++ M T V T+
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTL 179
Query: 215 GYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRC--------------NTNMRLPTEEQY 260
Y APE ++ D++S G + E+ + + LP EE +
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 261 LLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317
+ D D E L C P R S + +
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDID-ELGKDLLL---KCLTFNPAKRISAYSALS 292
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 9e-48
Identities = 63/209 (30%), Positives = 90/209 (43%), Gaps = 15/209 (7%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLS---AESRQGVKEFLTEIQVIS-EIE 98
+DF +G+G FG V+ K + AIK L V+ + E +V+S E
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 99 HENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARG 158
H L ++ + V YL L + F + I G
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK------FDLSRATFYAAEIILG 115
Query: 159 LAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLA 218
L FLH I++RD+K NILLDKD KI+DFG+ K +T GT Y+A
Sbjct: 116 LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIA 171
Query: 219 PEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
PE + + D +SFGVLL E++ G+
Sbjct: 172 PEILLGQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-47
Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 43 TDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQG-VKEFLTEIQVISEIEHE 100
++ ++ IGEG +G V + AIK +S Q + L EI+++ HE
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQ---FSWRTRSRICIGIAR 157
N++ + + YL + + G Y ++ S I R
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLM------GADLYKLLKTQHLSNDHICYFLYQILR 120
Query: 158 GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVS--TRVAGTIG 215
GL ++H +++HRD+K SN+LL+ KI DFGLA++ + H T T
Sbjct: 121 GLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 216 YLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGR 247
Y APE + + T+ DI+S G +L E++S R
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 3e-47
Identities = 55/284 (19%), Positives = 100/284 (35%), Gaps = 30/284 (10%)
Query: 37 KELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVIS 95
KEL + + +G G FG V++ K K + + EI +++
Sbjct: 1 KELY---EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILN 56
Query: 96 EIEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGI 155
H N++ L+ ++++ ++ + + + + S + + R +
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERI-----NTSAFELNEREIVSYVHQV 111
Query: 156 ARGLAFLHEEVRPHIIHRDIKASNILLD--KDLTPKISDFGLAKLIPANMTHVSTRVAGT 213
L FLH +I H DI+ NI+ + T KI +FG A+ +
Sbjct: 112 CEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TA 166
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRE 273
Y APE V+ D++S G L+ ++SG P +L E + E
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG------INP----FLAETNQQIIENIM 216
Query: 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317
+ EA F+ K R + S +Q
Sbjct: 217 NAEYTFDEEAFKEISIEAMDFVD---RLLVKERKSRMTASEALQ 257
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 7e-47
Identities = 64/291 (21%), Positives = 127/291 (43%), Gaps = 34/291 (11%)
Query: 49 INKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKE-----FLTEIQVISEIEHENL 102
++ +GEG F +VYK R K +I AIK + R K+ L EI+++ E+ H N+
Sbjct: 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
Query: 103 VKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFL 162
+ L ++ LV++++E + +++ + + +GL +L
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVI------IKDNSLVLTPSHIKAYMLMTLQGLEYL 116
Query: 163 HEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYA 222
H+ I+HRD+K +N+LLD++ K++DFGLAK + + +V T Y APE
Sbjct: 117 HQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELL 172
Query: 223 IRGQV-TRKADIYSFGVLLVEIVSGR----CNTNMRL----------PTEEQYLLERTWD 267
++ D+++ G +L E++ ++++ PTEEQ+ +
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 268 LYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318
Y + + ++ ++ P R + + ++M
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALKM 280
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 159 bits (402), Expect = 1e-46
Identities = 49/221 (22%), Positives = 95/221 (42%), Gaps = 28/221 (12%)
Query: 44 DDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLS---------AESRQGVKEFLTEIQV 93
+++ P +G G V + K A+K++ E ++ + L E+ +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 94 ISEI-EHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRIC 152
+ ++ H N+++L LV++ ++ L L S + +I
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT------LSEKETRKIM 116
Query: 153 IGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAG 212
+ + LH+ +I+HRD+K NILLD D+ K++DFG + + + V G
Sbjct: 117 RALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCG 171
Query: 213 TIGYLAPEYA------IRGQVTRKADIYSFGVLLVEIVSGR 247
T YLAPE ++ D++S GV++ +++G
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 158 bits (401), Expect = 1e-46
Identities = 50/206 (24%), Positives = 94/206 (45%), Gaps = 11/206 (5%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVL--SAESRQGVKEFLTEIQVISEIEHEN 101
+ + + KIGEG +G VYK + G+ A+K + E + EI ++ E++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 102 LVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAF 161
+VKLY +LV+ +L+ + + G T + + G+A+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG------LESVTAKSFLLQLLNGIAY 115
Query: 162 LHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEY 221
H+ ++HRD+K N+L++++ KI+DFGLA+ + + +
Sbjct: 116 CHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 222 AIRGQVTRKADIYSFGVLLVEIVSGR 247
+ + DI+S G + E+V+G
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 158 bits (400), Expect = 2e-46
Identities = 62/289 (21%), Positives = 114/289 (39%), Gaps = 33/289 (11%)
Query: 43 TDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLS---AESRQGVKEFLTEIQVISEIE 98
+D + +G GG V+ R L+ + A+KVL A F E Q + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 99 HENLVKLYGCCVE----GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIG 154
H +V +Y G +V Y++ +L + G + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP------MTPKRAIEVIAD 119
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHV--STRVAG 212
+ L F H+ IIHRD+K +NI++ K+ DFG+A+ I + V + V G
Sbjct: 120 ACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 176
Query: 213 TIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272
T YL+PE A V ++D+YS G +L E+++G P + + + +
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG------EPP----FTGDSPVSVAYQH 226
Query: 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRP-SMSTVVQMLM 320
+ S + + + + P+ R + + + L+
Sbjct: 227 VREDPIPPSARHEGLSADLDAVVL---KALAKNPENRYQTAAEMRADLV 272
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 2e-46
Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 11/207 (5%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVL--SAESRQGVKEFLTEIQVISEIEHE 100
++F + KIGEG +G VYK R K G++ A+K + E+ + EI ++ E+ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
N+VKL N LV+ +L + + + +GLA
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFM-----DASALTGIPLPLIKSYLFQLLQGLA 116
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPE 220
F H ++HRD+K N+L++ + K++DFGLA+ + + V
Sbjct: 117 FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173
Query: 221 YAIRGQVTRKADIYSFGVLLVEIVSGR 247
+ DI+S G + E+V+ R
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 157 bits (397), Expect = 7e-46
Identities = 53/284 (18%), Positives = 102/284 (35%), Gaps = 33/284 (11%)
Query: 49 INKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEH-ENLVKLY 106
+IGEG FG +++G L + + AIK R + E + + + +Y
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPNVY 67
Query: 107 GCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV 166
EG H +LV + L + +FS +T + + + +HE
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDL------LDLCGRKFSVKTVAMAAKQMLARVQSIHE-- 119
Query: 167 RPHIIHRDIKASNILLDKDLTP-----KISDFGLAKLIPANMTHV------STRVAGTIG 215
+++RDIK N L+ + + + DFG+ K +T ++GT
Sbjct: 120 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 216 YLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275
Y++ + + +R+ D+ + G + + + G + ER + E+++
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER---IGEKKQST 235
Query: 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319
L L F E F K P + +
Sbjct: 236 PL--RELCAGFPEE----FYKYMHYARNLAFDATPDYDYLQGLF 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-44
Identities = 60/285 (21%), Positives = 104/285 (36%), Gaps = 35/285 (12%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVL------SAESRQGVKEFLTEIQVISE 96
D + ++G G F V K R K G A K + S+ ++ E+ ++ E
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 97 IEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIA 156
I+H N++ L+ IL+ + L + + I
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFD------FLAEKESLTEEEATEFLKQIL 123
Query: 157 RGLAFLHEEVRPHIIHRDIKASNILLDKDLTP----KISDFGLAKLIPANMTHVSTRVAG 212
G+ +LH I H D+K NI+L P KI DFGLA I + + + G
Sbjct: 124 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFG 178
Query: 213 TIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272
T ++APE + +AD++S GV+ ++SG +L + +
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS----------PFLGDTKQETLANV 228
Query: 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317
+ + A F++ PK R ++ +Q
Sbjct: 229 SAVNYEFEDEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 7e-44
Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 14/211 (6%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISE 96
+ +DF + +G+G FG V R K G+ A+K+L E ++ V +TE +V+
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 97 IEHENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIA 156
H L L + V Y L H F+ I
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFF------HLSRERVFTEERARFYGAEIV 115
Query: 157 RGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGY 216
L +LH +++RDIK N++LDKD KI+DFGL K ++ + T GT Y
Sbjct: 116 SALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEY 171
Query: 217 LAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
LAPE R D + GV++ E++ GR
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 6e-43
Identities = 59/292 (20%), Positives = 111/292 (38%), Gaps = 29/292 (9%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHE 100
+ + KIGEG +G+V+K + + +I A+K + + L EI ++ E++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
N+V+L+ LV+ + + + G + +GL
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD------PEIVKSFLFQLLKGLG 115
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPE 220
F H +++HRD+K N+L++++ K+++FGLA+ + S V
Sbjct: 116 FCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172
Query: 221 YAIRGQVTRKADIYSFGVLLVEIVSG---------------RCNTNMRLPTEEQYLLERT 265
+ D++S G + E+ + R + PTEEQ+
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 266 WDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317
Y+ + + +N R L LL P R S +Q
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCN--PVQRISAEEALQ 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 9e-43
Identities = 69/307 (22%), Positives = 122/307 (39%), Gaps = 45/307 (14%)
Query: 44 DDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQG--VKEFLTEIQVISEIEHE 100
+ + KIG+G FG V+K R K G+ A+K + E+ + L EI+++ ++HE
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 101 NLVKLYGCCVEG--------NHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRIC 152
N+V L C LV+++ E++ G ++F+ R+
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA------GLLSNVLVKFTLSEIKRVM 123
Query: 153 IGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN---MTHVSTR 209
+ GL ++H I+HRD+KA+N+L+ +D K++DFGLA+ + T
Sbjct: 124 QMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180
Query: 210 VAGTIGYLAPEYAIRGQ-VTRKADIYSFGVLLVEIVSGR----CNTNMRL---------- 254
T+ Y PE + + D++ G ++ E+ + NT
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240
Query: 255 PTEEQYLLERTWDLYERRELI----LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRP 310
T E + ++LYE+ EL+ V L A + P R
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID---KLLVLDPAQRI 297
Query: 311 SMSTVVQ 317
+
Sbjct: 298 DSDDALN 304
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 3e-42
Identities = 57/285 (20%), Positives = 92/285 (32%), Gaps = 45/285 (15%)
Query: 44 DDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIE---- 98
+ +G GGFGSVY G + D AIK + + E +V E+
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 99 ----HENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIG 154
+++L + +L+ E I
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-----TERGALQEELARSFFWQ 118
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLDKD-LTPKISDFGLAKLIPANMTHVSTRVAGT 213
+ + H ++HRDIK NIL+D + K+ DFG L+ + T GT
Sbjct: 119 VLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGT 172
Query: 214 IGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272
Y PE+ + R A ++S G+LL ++V G +E
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI-------------------PFEHD 213
Query: 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317
E I+ E ++ C P RP+ +
Sbjct: 214 EEIIRGQVFFRQRVS-SECQHLIR---WCLALRPSDRPTFEEIQN 254
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-41
Identities = 52/284 (18%), Positives = 110/284 (38%), Gaps = 33/284 (11%)
Query: 44 DDFSPINK-IGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEI-EHE 100
DD+ ++ +G G G V + + + A+K+L Q + E+++ +
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCP 65
Query: 101 NLVKLYGCC----VEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIA 156
++V++ ++V L+ L + + F+ R S I I
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI----QDRGDQAFTEREASEIMKSIG 121
Query: 157 RGLAFLHEEVRPHIIHRDIKASNILLDK---DLTPKISDFGLAKLIPANMTHVSTRVAGT 213
+ +LH +I HRD+K N+L + K++DFG AK ++ + + T
Sbjct: 122 EAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--T 176
Query: 214 IGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRE 273
Y+APE + + D++S GV++ ++ G P + L + + R
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG------YPPFYSNHGLAISPGMKTRIR 230
Query: 274 LILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317
+ + +EE ++ + P R +++ +
Sbjct: 231 MGQYEFPNPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-41
Identities = 51/212 (24%), Positives = 86/212 (40%), Gaps = 19/212 (8%)
Query: 44 DDFSPINKIGEGGFGSVYKGRLKD-GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENL 102
++ IG G FG VY+ +L D G++ AIK + Q + E+Q++ +++H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNI 75
Query: 103 VKLYGCCVEGN------HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIA 156
V+L + LV +Y+ + + +
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR---HYSRAKQTLPVIYVKLYMYQLF 132
Query: 157 RGLAFLHEEVRPHIIHRDIKASNILLDKD-LTPKISDFGLAKLIPANMTHVSTRVAGTIG 215
R LA++H I HRDIK N+LLD D K+ DFG AK + + +
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYY 188
Query: 216 YLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR 247
T D++S G +L E++ G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (364), Expect = 2e-40
Identities = 56/242 (23%), Positives = 103/242 (42%), Gaps = 23/242 (9%)
Query: 11 RDSPRNRVPEVDEEFSGIHNVKLYSYKELSIAT-DDFSPINKIGEGGFGSVYKGR-LKDG 68
++S + + + E+F +K + + A D F I +G G FG V + + G
Sbjct: 12 QESVKEFLAKAKEDF-----LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66
Query: 69 KIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLENN 125
A+K+L + + ++ L E +++ + LVKL + ++ +V Y+
Sbjct: 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 126 SLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD 185
+ L G FS I +LH +I+RD+K N+L+D+
Sbjct: 127 EMFSHLRRIGR------FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQ 177
Query: 186 LTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS 245
+++DFG AK + + GT LAPE + + D ++ GVL+ E+ +
Sbjct: 178 GYIQVTDFGFAKRVKGRTWTLC----GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 246 GR 247
G
Sbjct: 234 GY 235
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 5e-39
Identities = 46/207 (22%), Positives = 86/207 (41%), Gaps = 11/207 (5%)
Query: 44 DDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVL--SAESRQGVKEFLTEIQVISEIEHE 100
+ + +G G +G+V + G AIK L +S K E++++ + HE
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
N++ L ++ T + G + + + + +GL
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDL--GKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPE 220
++H IIHRD+K N+ +++D KI DFGLA+ + MT V
Sbjct: 136 YIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT---GYVVTRWYRAPEV 189
Query: 221 YAIRGQVTRKADIYSFGVLLVEIVSGR 247
+ T+ DI+S G ++ E+++G+
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 5e-37
Identities = 76/328 (23%), Positives = 123/328 (37%), Gaps = 46/328 (14%)
Query: 41 IATDDFSPINKIGEGGFGSVYKGRL----KDGKIAAIKVLS----AESRQGVKEFLTEIQ 92
+ ++F + +G G +G V+ R GK+ A+KVL + + + TE Q
Sbjct: 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80
Query: 93 VISEIEHE-NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRI 151
V+ I LV L+ L+ +Y+ L H +F+
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFT------HLSQRERFTEHEVQIY 134
Query: 152 CIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVA 211
I L LH+ II+RDIK NILLD + ++DFGL+K A+ T +
Sbjct: 135 VGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 191
Query: 212 GTIGYLAPEYAIRGQ--VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLY 269
GTI Y+AP+ G + D +S GVL+ E+++G P ++
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG------ASPFTVDGEKNSQAEIS 245
Query: 270 ERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMS--TVVQMLMGE--KDI 325
R IL + + A ++ PK R ++ + I
Sbjct: 246 RR---ILKSEPPYPQEMS-ALAKDLIQ---RLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298
Query: 326 DDDKITKPGLISDFMDLKVRGPPKPKLE 353
+ D + KV P KP +
Sbjct: 299 NWDDLAAK---------KVPAPFKPVIR 317
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 132 bits (333), Expect = 3e-36
Identities = 40/225 (17%), Positives = 90/225 (40%), Gaps = 26/225 (11%)
Query: 32 KLYSYKELSIAT---DDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEF 87
+ + Y+ + DD+ + K+G G + V++ + + + +K+L + K+
Sbjct: 20 EYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKI 76
Query: 88 LTEIQVISEI-EHENLVKLYGCCVEGNHR--ILVYNYLENNSLAQTLIGGGHHYSNIQFS 144
EI+++ + N++ L + R LV+ ++ N Q +
Sbjct: 77 KREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---------QTLT 127
Query: 145 WRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLD-KDLTPKISDFGLAKLIPANM 203
I + L + H I+HRD+K N+++D + ++ D+GLA+
Sbjct: 128 DYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184
Query: 204 THVSTRVAGTIGYLAPEYAIRGQ-VTRKADIYSFGVLLVEIVSGR 247
+ + + PE + Q D++S G +L ++ +
Sbjct: 185 EY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-35
Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 43 TDDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLS--AESRQGVKEFLTEIQVISEIEH 99
+ + ++ +G G +GSV K G A+K LS +S K E++++ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHH--YSNIQFSWRTRSRICIGIAR 157
EN++ L + L L+G + + + + I R
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 158 GLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYL 217
GL ++H IIHRD+K SN+ +++D KI DFGLA+ MT T Y
Sbjct: 133 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYR 185
Query: 218 APEYAIRGQ-VTRKADIYSFGVLLVEIVSGR 247
APE + + DI+S G ++ E+++GR
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 1e-34
Identities = 50/207 (24%), Positives = 80/207 (38%), Gaps = 11/207 (5%)
Query: 44 DDFSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHE 100
+ + IG G G V + AIK LS ++ K E+ ++ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 101 NLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLA 160
N++ L + L ++ S + + G+
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMD---ANLCQVIQMELDHERMSYLLYQMLCGIK 133
Query: 161 FLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPE 220
LH IIHRD+K SNI++ D T KI DFGLA+ + + T T Y APE
Sbjct: 134 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 188
Query: 221 YAIRGQVTRKADIYSFGVLLVEIVSGR 247
+ DI+S G ++ E+V +
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (292), Expect = 3e-30
Identities = 47/265 (17%), Positives = 99/265 (37%), Gaps = 20/265 (7%)
Query: 46 FSPINKIGEGGFGSVYKGR-LKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVK 104
+ + K+G G F +V+ + + + A+K++ + + + EI+++ + + K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTK 73
Query: 105 LYGCCVEGNHRIL-VYNYLENNSLAQTLIGGGH---------HYSNIQFSWRTRSRICIG 154
++L +N+ N + ++ Y + +I
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 155 IARGLAFLHEEVRPHIIHRDIKASNILLDK-DLTPKISDFGLAKLIPANMTHVSTR-VAG 212
+ GL ++H R IIH DIK N+L++ D + +A L A
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 213 TIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRC----NTNMRLPTEEQYLLERTWDL 268
T Y +PE + ADI+S L+ E+++G + ++ ++ + L
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251
Query: 269 YERRELILLVDTSLNGDFDAEEACR 293
E +L F++ R
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLR 276
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 97.9 bits (243), Expect = 1e-24
Identities = 28/164 (17%), Positives = 48/164 (29%), Gaps = 23/164 (14%)
Query: 50 NKIGEGGFGSVYKGRLKDGKIAAIKVLSAESR----------QGVKEFLTEIQVISEIEH 99
+GEG +V+ + +K G F + E
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 100 ENLVKLYGCCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGL 159
L KL G V + E N++ LI Y + + I +
Sbjct: 66 RALQKLQGLAVPKVY------AWEGNAVLMELIDAKELYRVRVENPD---EVLDMILEEV 116
Query: 160 AFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANM 203
A + I+H D+ N+L+ + I DF + +
Sbjct: 117 AKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG 156
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 391 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.93 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.4 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.01 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.4 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.36 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.95 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-56 Score=405.59 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=212.0
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
.++|+++++||+|+||+||+|.+. +|+.||||++........+.+.+|+.+|+.++|||||++++++.+++..++||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 357999999999999999999976 5999999999876655667899999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
++||+|.+++..+ .+++..+..++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+++.+..
T Consensus 99 ~~gg~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 99 LAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp CTTCBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred cCCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 9999999988543 589999999999999999999999 999999999999999999999999999987643
Q ss_pred CCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
.. ......+||+.|+|||++.++.++.++|||||||++|+|++|+.||.......... ........
T Consensus 169 ~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~~~~~~~~------- 234 (293)
T d1yhwa1 169 EQ-SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGTP------- 234 (293)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHHCSC-------
T ss_pred cc-ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH------HHHhCCCC-------
Confidence 32 23345679999999999999999999999999999999999999997544322111 11111100
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
....+...+..+.+|+.+||+.||++|||+.|++++-
T Consensus 235 -~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp 271 (293)
T d1yhwa1 235 -ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ 271 (293)
T ss_dssp -CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCG
T ss_pred -CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 0111223456788999999999999999999998764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-56 Score=405.31 Aligned_cols=257 Identities=25% Similarity=0.363 Sum_probs=208.3
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
.++|++++.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+++|+.++||||+++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 368999999999999999999986 59999999987653 2334568899999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|++||+|.+++... ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++...
T Consensus 84 y~~gg~L~~~l~~~------~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 84 YCSGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp CCTTEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred ccCCCcHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeec
Confidence 99999999998643 3599999999999999999999999 99999999999999999999999999998764
Q ss_pred CCC-ceeeeeecccccccChhhhhcCCC-CCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 201 ANM-THVSTRVAGTIGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 201 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
... .......+||+.|+|||++.+..+ +.++|||||||+||+|++|+.||............. .....
T Consensus 155 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~------~~~~~---- 224 (271)
T d1nvra_ 155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW------KEKKT---- 224 (271)
T ss_dssp ETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH------HTTCT----
T ss_pred cCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH------hcCCC----
Confidence 332 223445689999999999988876 678999999999999999999997654332211111 00000
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
........+..+.+|+.+||+.||++|||++|++++-+..
T Consensus 225 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~ 264 (271)
T d1nvra_ 225 ----YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264 (271)
T ss_dssp ----TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred ----CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhC
Confidence 0011122345778899999999999999999998875543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-56 Score=399.88 Aligned_cols=247 Identities=28% Similarity=0.403 Sum_probs=209.0
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++|++.+.||+|+||+||+|++. +|+.||+|++... .......+.+|+++++.++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 67999999999999999999986 5899999998654 2344667889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+++|+|.+++...+ .+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 86 Ey~~~g~L~~~l~~~~------~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~ 156 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 156 (263)
T ss_dssp ECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred eecCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeec
Confidence 9999999999996533 599999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
... ......||+.|+|||++.+..++.++|||||||+||+|++|+.||........ ... .....
T Consensus 157 ~~~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~~----i~~~~------ 220 (263)
T d2j4za1 157 PSS---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---YKR----ISRVE------ 220 (263)
T ss_dssp CCC---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHH----HHTTC------
T ss_pred CCC---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH---HHH----HHcCC------
Confidence 433 23456799999999999999999999999999999999999999976433221 111 11111
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
...+...+..+.+|+.+||+.||++|||++|++++-
T Consensus 221 ----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp 256 (263)
T d2j4za1 221 ----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 256 (263)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCH
T ss_pred ----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCc
Confidence 012223345788899999999999999999999753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.5e-57 Score=409.52 Aligned_cols=263 Identities=25% Similarity=0.403 Sum_probs=219.4
Q ss_pred HHHHHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 37 KELSIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 37 ~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
.+|++..++|++.++||+|+||+||+|.+. +|+.||||++..+. ...++|.+|+++|++++|||||++++++.+++..
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 456677789999999999999999999987 58899999987653 3457899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||||+++|+|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+
T Consensus 89 ~iv~E~~~~g~l~~~l~~~----~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~ 161 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLREC----NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGL 161 (287)
T ss_dssp EEEEECCTTCBHHHHHHHS----CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred EEEeecccCcchHHHhhhc----cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccc
Confidence 9999999999999999653 234689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
++..............|++.|+|||++.++.++.++|||||||++|||++|..|+........ ......
T Consensus 162 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~------~~~~i~----- 230 (287)
T d1opja_ 162 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLE----- 230 (287)
T ss_dssp TTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHHH-----
T ss_pred eeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH------HHHHHh-----
Confidence 998765544444456689999999999999999999999999999999998877654433221 111111
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.......+...+..+.+|+.+||+.||++|||++||++.|+..
T Consensus 231 ----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 231 ----KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp ----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ----cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111223334456789999999999999999999999988654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-56 Score=401.21 Aligned_cols=256 Identities=25% Similarity=0.423 Sum_probs=201.0
Q ss_pred hCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecc
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYL 122 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 122 (391)
.++|+++++||+|+||+||+|++.+++.||||++.... ...++|.+|++++++++||||++++|++..++..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 47899999999999999999999988999999997643 34577999999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCC
Q 016347 123 ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN 202 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~ 202 (391)
++|+|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~g~L~~~l~~~~-----~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 83 EHGCLSDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp TTCBHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred CCCcHHHHhhccc-----cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCC
Confidence 9999999986532 3589999999999999999999999 9999999999999999999999999999876544
Q ss_pred CceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeeccC
Q 016347 203 MTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTSL 282 (391)
Q Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (391)
.........||+.|+|||++.++.++.++|||||||++|||+|+..|+....... .+...... . .
T Consensus 155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~--~~~~~i~~----~---------~ 219 (263)
T d1sm2a_ 155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDIST----G---------F 219 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH--HHHHHHHH----T---------C
T ss_pred CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH--HHHHHHHh----c---------C
Confidence 4333445678999999999999999999999999999999999655543332211 11111111 1 1
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 283 NGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 283 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
....+...+..+.+|+.+||+.||++|||++||+++|+.+
T Consensus 220 ~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1122223345788999999999999999999999998643
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-56 Score=404.80 Aligned_cols=260 Identities=30% Similarity=0.482 Sum_probs=212.2
Q ss_pred HHHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 37 KELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 37 ~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
.+|++..++|++.++||+|+||+||+|.+++++.||||++.... ...+.|.+|++++++++|||||++++++.+ +..+
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~ 83 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence 34556678999999999999999999999988999999997643 345779999999999999999999998754 5679
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+||||+++|+|.+++... ....+++..+..|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 84 iv~Ey~~~g~L~~~~~~~----~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla 156 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTP----SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA 156 (272)
T ss_dssp EEEECCTTCBHHHHTTSH----HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccce
Confidence 999999999999987532 234589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccce
Q 016347 197 KLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL 276 (391)
Q Consensus 197 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (391)
+..............||+.|+|||++.++.++.++|||||||++|||+||..|+........ .... ...
T Consensus 157 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~--~~~~----i~~----- 225 (272)
T d1qpca_ 157 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQN----LER----- 225 (272)
T ss_dssp EECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHH----HHT-----
T ss_pred EEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH--HHHH----HHh-----
Confidence 98765444444456789999999999999999999999999999999997666543322211 1111 111
Q ss_pred eeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 277 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
......+...+..+.+|+.+||+.||++|||++||++.|+
T Consensus 226 ----~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~ 265 (272)
T d1qpca_ 226 ----GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265 (272)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----cCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 1111222334557889999999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-56 Score=404.09 Aligned_cols=258 Identities=24% Similarity=0.359 Sum_probs=197.6
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEe--CCeeEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVE--GNHRIL 117 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 117 (391)
.++|++++.||+|+||+||+|++. +|+.||+|.+... +....+.+.+|++++++++|||||++++++.+ ++..++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 368999999999999999999986 5999999998765 34445678899999999999999999999865 456899
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV--RPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
||||+++|+|.+++..... ....+++..++.++.||+.||.|||++. ..+|+||||||+|||++.++.+||+|||+
T Consensus 83 vmEy~~~g~L~~~i~~~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 83 VMEYCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEECCTTEEHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEecCCCCcHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 9999999999999864221 2346999999999999999999999971 11399999999999999999999999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
++.+.... .......||+.|+|||++.+..++.++|||||||++|||+||+.||......+ +... .......
T Consensus 161 a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~~~----i~~~~~~ 232 (269)
T d2java1 161 ARILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGK----IREGKFR 232 (269)
T ss_dssp HHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHH----HHHTCCC
T ss_pred eeecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HHHH----HHcCCCC
Confidence 98764432 23345789999999999999999999999999999999999999997543321 1111 1111111
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
..+...+..+.+|+.+||+.||++|||+.|++++-
T Consensus 233 ---------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp 267 (269)
T d2java1 233 ---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 267 (269)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred ---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCC
Confidence 11223345788999999999999999999998763
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-56 Score=400.95 Aligned_cols=263 Identities=26% Similarity=0.409 Sum_probs=206.7
Q ss_pred HHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 38 ELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 38 e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
+|++..++|++.+.||+|+||+||+|+++. .||||+++.. .....+.|.+|+.+|++++|||||++++++.+ ...
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~ 78 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL 78 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence 456677999999999999999999998753 5999998754 34556789999999999999999999998754 568
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGl 150 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIE-----TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGL 150 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCC
T ss_pred EEEEecCCCCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccc
Confidence 99999999999999996532 3589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCC-ceeeeeecccccccChhhhhcC---CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhh
Q 016347 196 AKLIPANM-THVSTRVAGTIGYLAPEYAIRG---QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYER 271 (391)
Q Consensus 196 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~---~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 271 (391)
++...... ........||+.|+|||++.+. .|+.++|||||||+||||+||+.||....+.... ..........
T Consensus 151 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~--~~~~~~~~~~ 228 (276)
T d1uwha_ 151 ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IFMVGRGYLS 228 (276)
T ss_dssp SCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHHHHHTSCC
T ss_pred eeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH--HHHHhcCCCC
Confidence 98764322 2233456799999999998643 5899999999999999999999999765433211 1111110000
Q ss_pred cccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 272 RELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
... ...+...+..+.+|+.+||+.||++|||++||+++|+..
T Consensus 229 p~~---------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 229 PDL---------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp CCG---------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Ccc---------hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 000 011223446788999999999999999999999998654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-55 Score=392.36 Aligned_cols=254 Identities=24% Similarity=0.428 Sum_probs=214.1
Q ss_pred hCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecc
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYL 122 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 122 (391)
.++|++.++||+|+||+||+|++++++.||||+++.... ..++|.+|+.++++++||||++++|++.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 478999999999999999999998888999999986533 3478999999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCC
Q 016347 123 ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN 202 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~ 202 (391)
++|+|.+++... ...+++..++.++.||++||.|||++ ||+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~g~l~~~~~~~-----~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 82 ANGCLLNYLREM-----RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp TTEEHHHHHHSG-----GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred CCCcHHHhhhcc-----ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 999999997653 34689999999999999999999999 9999999999999999999999999999876544
Q ss_pred CceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 203 MTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
.........||+.|+|||++.++.++.++|||||||++|||+| |+.||......+.. .... ..
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~---~~i~---~~---------- 217 (258)
T d1k2pa_ 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA---EHIA---QG---------- 217 (258)
T ss_dssp SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH---HHHH---TT----------
T ss_pred CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH---HHHH---hC----------
Confidence 4333444678999999999999999999999999999999998 78899765432211 1111 11
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.....+...+..+.+|+.+||+.||++|||+++++++|..
T Consensus 218 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 218 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1112223344678899999999999999999999999843
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-56 Score=402.84 Aligned_cols=253 Identities=24% Similarity=0.375 Sum_probs=209.4
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecc
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYL 122 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 122 (391)
+.|+++++||+|+||+||+|++. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 57999999999999999999986 58999999998766666678999999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCC
Q 016347 123 ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN 202 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~ 202 (391)
++|+|.+++... ...+++..+..++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||++......
T Consensus 92 ~~g~L~~~~~~~-----~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 92 AGGAVDAVMLEL-----ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp TTEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred CCCcHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence 999999987642 23599999999999999999999999 9999999999999999999999999998754221
Q ss_pred CceeeeeecccccccChhhhh-----cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccccee
Q 016347 203 MTHVSTRVAGTIGYLAPEYAI-----RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILL 277 (391)
Q Consensus 203 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (391)
........||+.|+|||++. +..|+.++|||||||++|+|++|+.||....+.+... .. .. ....
T Consensus 164 -~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~---~i---~~-~~~~-- 233 (288)
T d2jfla1 164 -IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL---KI---AK-SEPP-- 233 (288)
T ss_dssp -HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH---HH---HH-SCCC--
T ss_pred -cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH---HH---Hc-CCCC--
Confidence 11223467999999999984 4568999999999999999999999997655433211 11 11 1100
Q ss_pred eeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 278 VDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 278 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
....+...+..+.+|+.+||+.||++|||+.|++++-
T Consensus 234 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp 270 (288)
T d2jfla1 234 -----TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHP 270 (288)
T ss_dssp -----CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred -----CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 0011223456788999999999999999999998864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-55 Score=408.16 Aligned_cols=268 Identities=25% Similarity=0.379 Sum_probs=208.9
Q ss_pred HHhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEE
Q 016347 40 SIATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 40 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (391)
++..++|+++++||+|+||+||+|++. +|+.||+|+++.. .......+.+|+.+|+.++|||||++++++.+....++
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 355789999999999999999999986 6899999998765 33445678999999999999999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHE-EVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
||||++||+|.+++...+ .+++..+..++.||+.||.|||+ . ||+||||||+||||+.+|.+||+|||++
T Consensus 82 VmEy~~gg~L~~~l~~~~------~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla 152 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVS 152 (322)
T ss_dssp EEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred EEEcCCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCc
Confidence 999999999999997543 58999999999999999999997 5 8999999999999999999999999999
Q ss_pred cccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh------
Q 016347 197 KLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE------ 270 (391)
Q Consensus 197 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 270 (391)
...... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||....................
T Consensus 153 ~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
T d1s9ja_ 153 GQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229 (322)
T ss_dssp HHHHHH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred cccCCC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcc
Confidence 865321 23456899999999999999999999999999999999999999976544322111000000000
Q ss_pred ----hcccc-------------e----eeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 271 ----RRELI-------------L----LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 271 ----~~~~~-------------~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
..... . ..............+..+.+|+.+||+.||.+|||++|++++-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hp 299 (322)
T d1s9ja_ 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299 (322)
T ss_dssp ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCH
Confidence 00000 0 0000000000011235688899999999999999999999863
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-55 Score=398.75 Aligned_cols=248 Identities=24% Similarity=0.332 Sum_probs=205.3
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++|++++.||+|+||+||+|++. +|+.||||++... .......+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 67999999999999999999986 6999999998754 2345577899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||++||+|.+++...+ .+++..++.++.||+.||+|||++ ||+||||||+|||++.+|.+||+|||+++.+
T Consensus 88 Ey~~gg~L~~~~~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 158 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL 158 (288)
T ss_dssp CCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EccCCCCHHHhhhccC------CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceec
Confidence 9999999999987543 599999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC-ceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 200 PANM-THVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 200 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
.... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||........ .... .....
T Consensus 159 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~~i----~~~~~---- 227 (288)
T d1uu3a_ 159 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI---FQKI----IKLEY---- 227 (288)
T ss_dssp C----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH----HTTCC----
T ss_pred ccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH---HHHH----HcCCC----
Confidence 4332 2233456799999999999999999999999999999999999999976433211 1111 11110
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQ 317 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 317 (391)
.++...+..+.+|+.+||+.||++|||++|+++
T Consensus 228 ------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 ------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 122233457889999999999999999998754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.3e-55 Score=398.93 Aligned_cols=257 Identities=26% Similarity=0.403 Sum_probs=200.6
Q ss_pred hhCCCCCCceeeccCceEEEEEEeCC-C---cEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLKD-G---KIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
..++|++.+.||+|+||+||+|.+.. + ..||||.+... .....+.|.+|+++|++++|||||++++++.+++..+
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 34678889999999999999999763 3 36889988654 4455678999999999999999999999999999999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+||||+++|+|.+++.... ..+++..+..++.||+.||.|||++ +++||||||+||||+.++.+||+|||++
T Consensus 104 iv~Ey~~~g~L~~~~~~~~-----~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla 175 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLS 175 (299)
T ss_dssp EEEECCTTEEHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred EEEEecCCCcceeeecccc-----CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccc
Confidence 9999999999999886532 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCcee----eeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhh
Q 016347 197 KLIPANMTHV----STRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYER 271 (391)
Q Consensus 197 ~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 271 (391)
+.+....... .....||+.|+|||++.++.++.++|||||||+||||+| |..||......+. ... ..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~---~~~----i~- 247 (299)
T d1jpaa_ 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV---INA----IE- 247 (299)
T ss_dssp --------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHH----HH-
T ss_pred eEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH---HHH----HH-
Confidence 8764332211 112457899999999999999999999999999999998 8999875433211 111 11
Q ss_pred cccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 272 RELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.......+...+..+.+|+.+||+.||++|||+.||++.|+.+
T Consensus 248 --------~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 248 --------QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp --------TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --------cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111123334566788999999999999999999999998643
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.7e-55 Score=399.89 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=194.6
Q ss_pred hhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 42 ATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 42 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
..+.|++.+.||+|+||+||+|++. +|+.||||++.... ......+.+|+.+|+.++|||||++++++.+++..++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4578999999999999999999986 58999999987653 233456788999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC---CCCcEEEEecccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLD---KDLTPKISDFGLA 196 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~---~~~~~kl~Dfg~~ 196 (391)
||++||+|.+++...+ .+++..+..++.||+.||.|||++ ||+||||||+|||+. .++.+||+|||++
T Consensus 87 E~~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp CCCCSCBHHHHHHTCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred eccCCCcHHHhhhccc------CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEecccee
Confidence 9999999999997543 599999999999999999999999 999999999999994 5789999999999
Q ss_pred cccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccce
Q 016347 197 KLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL 276 (391)
Q Consensus 197 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (391)
+..... ......+||+.|+|||++.+..|+.++|||||||+||+|++|+.||........ .... .. ...
T Consensus 158 ~~~~~~--~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~~i---~~-~~~-- 226 (307)
T d1a06a_ 158 KMEDPG--SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL---FEQI---LK-AEY-- 226 (307)
T ss_dssp -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHH---HT-TCC--
T ss_pred EEccCC--CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH---HHHH---hc-cCC--
Confidence 865432 223456799999999999999999999999999999999999999975433211 1111 11 100
Q ss_pred eeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 277 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
..........+..+.+|+.+||+.||++|||+.|++++-+
T Consensus 227 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 266 (307)
T d1a06a_ 227 ----EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 266 (307)
T ss_dssp ----CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred ----CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence 0111122234567889999999999999999999999744
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=394.65 Aligned_cols=263 Identities=29% Similarity=0.442 Sum_probs=208.3
Q ss_pred HHHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeE
Q 016347 37 KELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 37 ~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 116 (391)
.+|++..++|++.+.||+|+||+||+|++++++.||||++.... ...+.|.+|+.++++++|||||++++++. ++..+
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~ 87 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 87 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeE
Confidence 34556678999999999999999999999988889999997653 34577999999999999999999999985 45689
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
+||||+++|+|..++... ....+++..+..++.||+.||+|||++ +++||||||+||||+.++.+||+|||++
T Consensus 88 lv~Ey~~~g~l~~~~~~~----~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla 160 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGE----TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 160 (285)
T ss_dssp EEECCCTTCBHHHHHSHH----HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred EEEEecCCCchhhhhhhc----ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchh
Confidence 999999999999988542 223589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccce
Q 016347 197 KLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL 276 (391)
Q Consensus 197 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (391)
+..............||+.|+|||++.++.++.++|||||||++|||++|..|+........ .... ...
T Consensus 161 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~~~~----i~~----- 229 (285)
T d1fmka3 161 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQ----VER----- 229 (285)
T ss_dssp C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHH----HHT-----
T ss_pred hhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--HHHH----HHh-----
Confidence 87654443334446789999999999999999999999999999999997766654333211 1111 111
Q ss_pred eeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCCC
Q 016347 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGEK 323 (391)
Q Consensus 277 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~~ 323 (391)
....+.+...+..+.+++.+||+.||++||++++|+++|....
T Consensus 230 ----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 230 ----GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp ----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ----cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 1111233344567899999999999999999999999987643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-54 Score=387.94 Aligned_cols=249 Identities=24% Similarity=0.364 Sum_probs=199.6
Q ss_pred CCC-CCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEe----CCee
Q 016347 44 DDF-SPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVE----GNHR 115 (391)
Q Consensus 44 ~~y-~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~ 115 (391)
++| ++.++||+|+||+||+|.+. +++.||+|.+... .....+.+.+|+++|++++|||||++++++.+ +...
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 344 67778999999999999987 5889999998754 34455678999999999999999999999875 3468
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCcEEEC-CCCcEEEEe
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPH--IIHRDIKASNILLD-KDLTPKISD 192 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~--i~H~dikp~NIlv~-~~~~~kl~D 192 (391)
++||||+++|+|.+++... ..+++..++.++.||+.||+|||++ + |+||||||+|||++ .++.+||+|
T Consensus 88 ~ivmE~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~D 158 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGD 158 (270)
T ss_dssp EEEEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred EEEEeCCCCCcHHHHHhcc------ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEee
Confidence 9999999999999999653 3589999999999999999999998 7 99999999999996 579999999
Q ss_pred cccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 193 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
||+++..... .....+||+.|+|||++. +.++.++|||||||++|+|++|+.||........ +... ....
T Consensus 159 FGla~~~~~~---~~~~~~GT~~Y~aPE~~~-~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~~----i~~~ 228 (270)
T d1t4ha_ 159 LGLATLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRR----VTSG 228 (270)
T ss_dssp TTGGGGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHH----HTTT
T ss_pred cCcceeccCC---ccCCcccCccccCHHHhC-CCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHHH----HHcC
Confidence 9999865433 234568999999999885 4699999999999999999999999975433221 1111 1111
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
... . ..+......+.+|+.+||+.||++|||+.|++++-
T Consensus 229 ~~~----~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp 267 (270)
T d1t4ha_ 229 VKP----A----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHA 267 (270)
T ss_dssp CCC----G----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CCC----c----ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCc
Confidence 000 0 01111234678899999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-54 Score=392.67 Aligned_cols=256 Identities=25% Similarity=0.362 Sum_probs=208.0
Q ss_pred HhhCCCCCCc-eeeccCceEEEEEEeC---CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 41 IATDDFSPIN-KIGEGGFGSVYKGRLK---DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 41 ~~~~~y~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
+..++|.+.+ +||+|+||+||+|.+. ++..||||++... .....+.|.+|+++|++++|||||++++++.. +..
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 3446677777 4999999999999864 3557999998755 34456789999999999999999999999865 468
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||||+++|+|.+++... ...+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||+
T Consensus 84 ~lvmE~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGl 155 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGK-----REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGL 155 (285)
T ss_dssp EEEEECCTTEEHHHHHTTC-----TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred EEEEEeCCCCcHHHHhhcc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchh
Confidence 9999999999999998543 23689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCcee--eeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 196 AKLIPANMTHV--STRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 196 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
++.+....... .....||+.|+|||++.++.++.++|||||||++|||+| |..||......+.. .. ...+
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~---~~----i~~~ 228 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AF----IEQG 228 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH---HH----HHTT
T ss_pred hhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHH---HH----HHcC
Confidence 98775433222 223468999999999999999999999999999999998 89999765432211 11 1111
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.....+...+..+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 229 ---------~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 229 ---------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp ---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1112233445678899999999999999999999988753
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-54 Score=400.60 Aligned_cols=264 Identities=23% Similarity=0.366 Sum_probs=211.1
Q ss_pred HHHhhCCCCCCceeeccCceEEEEEEeCC------CcEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCceeEEEEEEE
Q 016347 39 LSIATDDFSPINKIGEGGFGSVYKGRLKD------GKIAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHENLVKLYGCCV 110 (391)
Q Consensus 39 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 110 (391)
|++..++|++.+.||+|+||+||+|++.. ...||+|.+... .......+.+|+.++.++ +|||||++++++.
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 56677899999999999999999998653 236899998654 334456788999999988 8999999999999
Q ss_pred eCCeeEEEEecccCCCHHHHHhcCCCCC-----------------CccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeec
Q 016347 111 EGNHRILVYNYLENNSLAQTLIGGGHHY-----------------SNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHR 173 (391)
Q Consensus 111 ~~~~~~lv~e~~~~~sL~~~i~~~~~~~-----------------~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~ 173 (391)
+.+..++||||+++|+|.+++....... ....+++..++.++.||+.||+|||++ +|+||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence 9999999999999999999997643211 123589999999999999999999999 99999
Q ss_pred CCCCCcEEECCCCcEEEEecccccccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCC
Q 016347 174 DIKASNILLDKDLTPKISDFGLAKLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTN 251 (391)
Q Consensus 174 dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~ 251 (391)
||||+|||++.++.+||+|||+++....... .......||+.|+|||++.++.++.++|||||||+||||+| |..||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987643332 23345678999999999999999999999999999999998 899997
Q ss_pred CCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 252 MRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
........ .. .... ....+.+...+..+.+|+.+||+.||++|||++||+++|.
T Consensus 269 ~~~~~~~~--~~----~~~~---------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVDANF--YK----LIQN---------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCCSHHH--HH----HHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHHH--HH----HHhc---------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 65433211 11 1111 1111223344567899999999999999999999999983
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-53 Score=398.40 Aligned_cols=254 Identities=21% Similarity=0.287 Sum_probs=211.4
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecc
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYL 122 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 122 (391)
++|++++.||+|+||.||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..++||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 68999999999999999999986 69999999998776666678899999999999999999999999999999999999
Q ss_pred cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC--CCcEEEEecccccccC
Q 016347 123 ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK--DLTPKISDFGLAKLIP 200 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~--~~~~kl~Dfg~~~~~~ 200 (391)
+||+|.+++... ...+++..+..|+.||+.||.|||++ |++||||||+|||++. ++.+||+|||++..+.
T Consensus 106 ~gg~L~~~l~~~-----~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 106 SGGELFEKVADE-----HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp CSCBHHHHHTCT-----TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred CCCCHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 999999999543 23599999999999999999999999 9999999999999964 5899999999998765
Q ss_pred CCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeeec
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVDT 280 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (391)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+. ..... ....
T Consensus 178 ~~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~~i~----~~~~------ 242 (350)
T d1koaa2 178 PKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---LRNVK----SCDW------ 242 (350)
T ss_dssp TTS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH----HTCC------
T ss_pred ccc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH---HHHHH----hCCC------
Confidence 432 33456899999999999999999999999999999999999999975533211 11110 0000
Q ss_pred cCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 281 SLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 281 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
..........+..+.+|+.+||+.||++|||++|++++-+
T Consensus 243 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~ 282 (350)
T d1koaa2 243 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 282 (350)
T ss_dssp CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTT
T ss_pred CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 0001111123457889999999999999999999999743
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.4e-53 Score=397.18 Aligned_cols=255 Identities=22% Similarity=0.304 Sum_probs=212.3
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
.++|++++.||+|+||+||+|.+. +|+.||||++..........+.+|+.+|++++|||||++++++.+++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 467999999999999999999976 6999999999876655567788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEEC--CCCcEEEEeccccccc
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLD--KDLTPKISDFGLAKLI 199 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~--~~~~~kl~Dfg~~~~~ 199 (391)
|+||+|.+.+...+ .++++..++.|+.||+.||.|||++ ||+||||||+||||+ .++.+||+|||++..+
T Consensus 108 ~~gg~L~~~~~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 108 LSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp CCCCBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred CCCChHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceec
Confidence 99999998875432 3599999999999999999999999 999999999999997 5689999999999887
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
.... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||........ .... .....
T Consensus 180 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~~i----~~~~~----- 245 (352)
T d1koba_ 180 NPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---LQNV----KRCDW----- 245 (352)
T ss_dssp CTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHH----HHCCC-----
T ss_pred CCCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH----HhCCC-----
Confidence 5432 34456899999999999999999999999999999999999999975433221 1111 11110
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
..........+..+.+|+.+||+.||.+|||+.|++++-+
T Consensus 246 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~ 285 (352)
T d1koba_ 246 -EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 285 (352)
T ss_dssp -CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred -CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 0111122234557889999999999999999999998743
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=394.49 Aligned_cols=251 Identities=27% Similarity=0.339 Sum_probs=211.4
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
-++|++++.||+|+||.||+|++. +|+.||||++... .......+.+|+.+|+.++||||+++++++.+....++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 478999999999999999999986 6999999999754 234567788999999999999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|||++||+|.+++...+ .+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+++.
T Consensus 84 ~ey~~gg~L~~~~~~~~------~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~ 154 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp EECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred eeccCCCchhhhhhccc------CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccc
Confidence 99999999999997543 589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
..... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||....... +.... .....
T Consensus 155 ~~~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~~i----~~~~~---- 222 (337)
T d1o6la_ 155 GISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELI----LMEEI---- 222 (337)
T ss_dssp SCCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HHCCC----
T ss_pred cccCC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---HHHHH----hcCCC----
Confidence 54332 23445789999999999999999999999999999999999999997654322 11111 11110
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHhc
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPS-----MSTVVQMLM 320 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l~ 320 (391)
.++...+..+.+||.+||+.||.+|++ +.|++++-+
T Consensus 223 ------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~ 263 (337)
T d1o6la_ 223 ------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred ------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcc
Confidence 122234456788999999999999995 888887644
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-54 Score=396.67 Aligned_cols=246 Identities=25% Similarity=0.407 Sum_probs=203.0
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
+.|+.+++||+|+||+||+|++. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45999999999999999999976 68999999987553 334567889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
|||.+|+|..++... .++++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 95 E~~~~g~l~~~~~~~------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (309)
T ss_dssp ECCSEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EecCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeeccccccc
Confidence 999999997766543 3599999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCceeeeeecccccccChhhhhc---CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccce
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIR---GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELIL 276 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (391)
.. .....||+.|+|||++.+ +.|+.++|||||||++|+|++|..||........ ...... .....
T Consensus 166 ~~-----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~------~~~i~~-~~~~~ 233 (309)
T d1u5ra_ 166 AP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQ-NESPA 233 (309)
T ss_dssp SS-----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHH-SCCCC
T ss_pred CC-----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHh-CCCCC
Confidence 32 234579999999999864 4689999999999999999999999975433211 111111 11111
Q ss_pred eeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016347 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQM 318 (391)
Q Consensus 277 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 318 (391)
..+...+..+.+|+.+||+.||.+|||++|++++
T Consensus 234 --------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 234 --------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp --------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred --------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 1112234578889999999999999999999885
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=387.25 Aligned_cols=245 Identities=27% Similarity=0.379 Sum_probs=197.9
Q ss_pred ceeeccCceEEEEEEeC---CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEecccC
Q 016347 50 NKIGEGGFGSVYKGRLK---DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNYLEN 124 (391)
Q Consensus 50 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 124 (391)
++||+|+||+||+|.+. .++.||||++... +....+.|.+|+++|++++|||||++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999864 2578999998754 33345679999999999999999999999865 457899999999
Q ss_pred CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCCCc
Q 016347 125 NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPANMT 204 (391)
Q Consensus 125 ~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~ 204 (391)
|+|.+++.... .+++..+..|+.||+.||+|||++ +++||||||+|||++.++.+||+|||+++.+.....
T Consensus 92 g~L~~~l~~~~------~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 92 GPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CcHHHHHhhcc------CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 99999997543 599999999999999999999999 999999999999999999999999999987654333
Q ss_pred ee--eeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccceeeecc
Q 016347 205 HV--STRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELILLVDTS 281 (391)
Q Consensus 205 ~~--~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (391)
.. .....||+.|+|||++.++.++.++|||||||++|||+| |+.||......+. .. ....+
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~---~~----~i~~~--------- 226 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TA----MLEKG--------- 226 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HH----HHHTT---------
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH---HH----HHHcC---------
Confidence 22 233568999999999999999999999999999999998 8999976443221 11 11111
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 282 LNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 282 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.....+...+..+.+|+.+||+.||++|||+++|++.|+
T Consensus 227 ~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~ 265 (277)
T d1xbba_ 227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265 (277)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 111223334567889999999999999999999988774
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-54 Score=389.46 Aligned_cols=259 Identities=26% Similarity=0.421 Sum_probs=204.2
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeCC-C----cEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCe
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLKD-G----KIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNH 114 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 114 (391)
+....|++.+.||+|+||+||+|.+.. + ..||||++... .......|.+|+.++++++|||||+++|++.+...
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 345789999999999999999998763 2 46999998754 34445678999999999999999999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.++||||+.+++|.+.+.... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG 155 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFG 155 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred eEEEEEecccCcchhhhhccc-----ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccc
Confidence 999999999999999886532 3589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCce--eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 195 LAKLIPANMTH--VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 195 ~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
+++........ ......||+.|+|||++.++.++.++|||||||++|||++|..|+........ +.. ..
T Consensus 156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~--~~~----~i--- 226 (283)
T d1mqba_ 156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMK----AI--- 226 (283)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH----HH---
T ss_pred hhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH--HHH----HH---
Confidence 99876433221 22334689999999999999999999999999999999997777654433221 111 11
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
........+...+..+.+|+.+||+.||++|||+.||++.|+..
T Consensus 227 ------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 227 ------NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp ------HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ------hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 11112233334556789999999999999999999999988654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.9e-53 Score=388.74 Aligned_cols=247 Identities=26% Similarity=0.377 Sum_probs=208.6
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++|++++.||+|+||+||+|++. +|+.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999986 5999999999754 2345677899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||++||+|..++.... .+++..+..++.||+.||+|||++ ||+||||||+||||+.+|.+||+|||+++..
T Consensus 84 E~~~gg~l~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV 154 (316)
T ss_dssp CCCCSCBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred eecCCccccccccccc------cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEe
Confidence 9999999999997554 488899999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
... ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||........ .... .. ..
T Consensus 155 ~~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~i---~~-~~------ 217 (316)
T d1fota_ 155 PDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT---YEKI---LN-AE------ 217 (316)
T ss_dssp SSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHH---HH-CC------
T ss_pred ccc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH---HHHH---Hc-CC------
Confidence 433 3356899999999999999999999999999999999999999976433221 1111 11 11
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHhc
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRP-----SMSTVVQMLM 320 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~ 320 (391)
...+...+..+.+++.+||+.||.+|+ |+++++++-+
T Consensus 218 ----~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~ 259 (316)
T d1fota_ 218 ----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 259 (316)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred ----CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcc
Confidence 011223345688899999999999996 8999988743
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=389.45 Aligned_cols=254 Identities=22% Similarity=0.275 Sum_probs=208.6
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc------hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES------RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
.++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+....
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 478999999999999999999986 69999999986442 22467899999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC----cEEEE
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL----TPKIS 191 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~----~~kl~ 191 (391)
++|||||+||+|.+++...+ .+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~------~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEcCCCccccchhcccc------ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEec
Confidence 99999999999999996533 599999999999999999999999 999999999999998776 59999
Q ss_pred ecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhh
Q 016347 192 DFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYER 271 (391)
Q Consensus 192 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 271 (391)
|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+.. ... ..
T Consensus 160 DfG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~---~~i----~~ 230 (293)
T d1jksa_ 160 DFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANV----SA 230 (293)
T ss_dssp CCTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH----HT
T ss_pred chhhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHH---HHH----Hh
Confidence 999998764332 234467899999999999999999999999999999999999999765432211 110 00
Q ss_pred cccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 272 RELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
... ..........+..+.+|+.+||+.||++|||++|++++-+
T Consensus 231 ~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 273 (293)
T d1jksa_ 231 VNY------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273 (293)
T ss_dssp TCC------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred cCC------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 000 0000000123457889999999999999999999998753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-52 Score=392.25 Aligned_cols=247 Identities=23% Similarity=0.328 Sum_probs=208.5
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 119 (391)
++|++++.||+|+||.||+|++. +|+.||||++... .......+.+|+.+|+.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 67999999999999999999986 6999999998654 2345567899999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLI 199 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~ 199 (391)
||+.+|+|..++...+ .+++..+..++.||+.||.|||++ +|+||||||+|||++.+|.+||+|||+++.+
T Consensus 121 e~~~~g~l~~~l~~~~------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~ 191 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp ECCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ccccccchhhhHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence 9999999999997543 599999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
... .....||+.|+|||++.+..++.++|||||||++|+|+||..||........ ..... . ...
T Consensus 192 ~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~i~---~-~~~----- 255 (350)
T d1rdqe_ 192 KGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI---YEKIV---S-GKV----- 255 (350)
T ss_dssp SSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH---H-CCC-----
T ss_pred ccc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH---HHHHh---c-CCC-----
Confidence 432 2346799999999999999999999999999999999999999976533221 11111 1 110
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHhc
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRP-----SMSTVVQMLM 320 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~l~ 320 (391)
..+...+..+.+++.+||+.||.+|+ |+++++++-+
T Consensus 256 -----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~ 296 (350)
T d1rdqe_ 256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp -----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred -----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCcc
Confidence 11223345788999999999999994 8999987643
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=386.95 Aligned_cols=258 Identities=23% Similarity=0.295 Sum_probs=200.5
Q ss_pred HHHhhCCCCCCceeeccCceEEEEEEeCC----CcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC
Q 016347 39 LSIATDDFSPINKIGEGGFGSVYKGRLKD----GKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN 113 (391)
Q Consensus 39 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 113 (391)
+++..++|++.+.||+|+||.||+|.+.. +..||||.+... .....+.+.+|++++++++||||+++++++. ++
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 45667899999999999999999998753 456889988654 3444577999999999999999999999985 46
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+||
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~Df 152 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDF 152 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-
T ss_pred eEEEEEEeccCCcHHhhhhccC-----CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccc
Confidence 7899999999999999876532 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 194 GLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 194 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
|+++..............||+.|+|||++.++.++.++|||||||++|||++ |..||......+.. ... ...
T Consensus 153 G~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~---~~i----~~~ 225 (273)
T d1mp8a_ 153 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRI----ENG 225 (273)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHH----HTT
T ss_pred hhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH---HHH----HcC
Confidence 9998765444434445678999999999999999999999999999999998 88888765443321 111 111
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
. ....+...+..+.+|+.+||+.||++|||+.||+++|..
T Consensus 226 ~---------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 226 E---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C---------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1 112233445678999999999999999999999998854
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-53 Score=388.96 Aligned_cols=268 Identities=25% Similarity=0.394 Sum_probs=214.7
Q ss_pred hHHHHHhhCCCCCCceeeccCceEEEEEEeC------CCcEEEEEEecccc-hhcHHHHHHHHHHHhcCCCCceeEEEEE
Q 016347 36 YKELSIATDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAES-RQGVKEFLTEIQVISEIEHENLVKLYGC 108 (391)
Q Consensus 36 ~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 108 (391)
+.+++++.++|++++.||+|+||+||+|++. +++.||||++.... .....+|.+|+++|++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 4567778889999999999999999999864 35789999987653 3445679999999999999999999999
Q ss_pred EEeCCeeEEEEecccCCCHHHHHhcCCCC------------------CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 016347 109 CVEGNHRILVYNYLENNSLAQTLIGGGHH------------------YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHI 170 (391)
Q Consensus 109 ~~~~~~~~lv~e~~~~~sL~~~i~~~~~~------------------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i 170 (391)
+.+....+++|||+++|+|.+++...... .....+++..++.++.||+.||+|||++ ++
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 99999999999999999999999643211 1223589999999999999999999999 99
Q ss_pred eecCCCCCcEEECCCCcEEEEecccccccCCCC-ceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCC-
Q 016347 171 IHRDIKASNILLDKDLTPKISDFGLAKLIPANM-THVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRC- 248 (391)
Q Consensus 171 ~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~- 248 (391)
+||||||+||||+.++.+||+|||+++...... ........|++.|+|||.+.+..++.++|||||||++|||++|..
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999999999999999999998664332 223344678999999999999999999999999999999999964
Q ss_pred CCCCCCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 249 NTNMRLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 249 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
||......+. ... ...+.. ...+...+.++.+|+.+||+.||++|||+.||+++|+.+
T Consensus 242 p~~~~~~~e~---~~~----v~~~~~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 242 PYYGMAHEEV---IYY----VRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTTSCHHHH---HHH----HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCCHHHH---HHH----HHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 5654432221 111 111111 122233445788999999999999999999999999754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=380.37 Aligned_cols=254 Identities=26% Similarity=0.413 Sum_probs=202.1
Q ss_pred HHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEe-CCeeEE
Q 016347 39 LSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVE-GNHRIL 117 (391)
Q Consensus 39 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~l 117 (391)
|++..++|++++.||+|+||.||+|+++ |+.||||+++.+. ..+.+.+|++++++++||||++++|++.+ ....++
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 78 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 78 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEE
Confidence 4556788999999999999999999996 7889999997543 34779999999999999999999999865 456899
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
||||+++|+|.+++... ....+++..++.|+.||+.||.|||+. +++||||||+|||++.+|.+||+|||+++
T Consensus 79 v~ey~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~ 151 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSR----GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 151 (262)
T ss_dssp EECCCTTEEHHHHHHHH----HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred EEeccCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccce
Confidence 99999999999999643 223589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccce
Q 016347 198 LIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELIL 276 (391)
Q Consensus 198 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (391)
..... .....++..|+|||++.++.++.++|||||||++|||+| |+.||......+. ....
T Consensus 152 ~~~~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~---~~~i----------- 213 (262)
T d1byga_ 152 EASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRV----------- 213 (262)
T ss_dssp --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHHH-----------
T ss_pred ecCCC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH---HHHH-----------
Confidence 65332 233467899999999999999999999999999999998 6777765433221 1111
Q ss_pred eeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 277 LVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 277 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
........+...+..+.+|+.+||+.||.+|||+.+++++|+..
T Consensus 214 --~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 214 --EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp --TTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 11112233334456788999999999999999999999998643
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=388.03 Aligned_cols=250 Identities=20% Similarity=0.256 Sum_probs=208.3
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
.++|++.+.||+|+||+||+|.+. +|+.||+|++.....+ ...+.+|+++|+.++||||+++++++.+++..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 578999999999999999999986 5899999999876433 35688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC--CcEEEEeccccccc
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD--LTPKISDFGLAKLI 199 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~--~~~kl~Dfg~~~~~ 199 (391)
|+||+|.+++...+ ..+++..++.|+.||+.||.|||++ ||+||||||+|||++.+ +.+||+|||++...
T Consensus 83 ~~gg~L~~~i~~~~-----~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 83 ISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCBHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred CCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 99999999996532 2589999999999999999999999 99999999999999854 58999999999876
Q ss_pred CCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 200 PANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
... .......||+.|+|||.+.+..++.++|||||||++|+|++|..||......... ... .. ...
T Consensus 155 ~~~--~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~---~~i---~~-~~~----- 220 (321)
T d1tkia_ 155 KPG--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII---ENI---MN-AEY----- 220 (321)
T ss_dssp CTT--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHH---HH-TCC-----
T ss_pred ccC--CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHH---HHH---Hh-CCC-----
Confidence 433 2344567899999999999999999999999999999999999999765432211 111 00 000
Q ss_pred ccCCCCCCH----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 280 TSLNGDFDA----EEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 280 ~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.++. ..+..+.+|+.+||+.||++|||+.|++++-+
T Consensus 221 -----~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 260 (321)
T d1tkia_ 221 -----TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp -----CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred -----CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 1111 12346889999999999999999999998643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=386.59 Aligned_cols=248 Identities=27% Similarity=0.363 Sum_probs=205.1
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHh-cCCCCceeEEEEEEEeCCeeEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVIS-EIEHENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv 118 (391)
++|++++.||+|+||+||+|++. +|+.||||++... .......+..|..++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999987 5999999999754 2334456666777665 68999999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccc
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKL 198 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~ 198 (391)
|||+++|+|.+++...+ .+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++.
T Consensus 82 mEy~~~g~L~~~i~~~~------~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~ 152 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE 152 (320)
T ss_dssp EECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EeecCCCcHHHHhhccC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhh
Confidence 99999999999997543 489999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV 278 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (391)
..... .......||+.|+|||++.++.++.++|||||||++|+|++|+.||.+..+... .... ....
T Consensus 153 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~~~i----~~~~----- 219 (320)
T d1xjda_ 153 NMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL---FHSI----RMDN----- 219 (320)
T ss_dssp CCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH----HHCC-----
T ss_pred ccccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH---HHHH----HcCC-----
Confidence 54332 233456899999999999999999999999999999999999999976543221 1111 1111
Q ss_pred eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHH-HHHHH
Q 016347 279 DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMS-TVVQM 318 (391)
Q Consensus 279 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl~~ 318 (391)
. .++...+..+.+|+.+||+.||.+||++. +++++
T Consensus 220 -~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 220 -P----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp -C----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred -C----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 0 11223345688999999999999999995 77665
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.5e-52 Score=389.34 Aligned_cols=252 Identities=24% Similarity=0.306 Sum_probs=203.7
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---hhcHHHH---HHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---RQGVKEF---LTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
-++|++++.||+|+||.||+|++. +|+.||||++.... ......+ ..++.+++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 378999999999999999999986 59999999986431 1222233 3457778888999999999999999999
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||||++||+|.+++.... .+++..++.++.||+.||.|||++ |++||||||+|||++.+|.+||+|||+
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGl 153 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGL 153 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTT
T ss_pred EEEEEecCCCcHHHHHHhcc------cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeece
Confidence 99999999999999997543 589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccc
Q 016347 196 AKLIPANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERREL 274 (391)
Q Consensus 196 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (391)
++.+... ......||+.|+|||++.. ..|+.++|||||||+||+|+||+.||..........+.... ..
T Consensus 154 a~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~---~~---- 223 (364)
T d1omwa3 154 ACDFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LT---- 223 (364)
T ss_dssp CEECSSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS---SS----
T ss_pred eeecCCC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---cc----
Confidence 9876433 2344679999999999975 56899999999999999999999999765543322111110 00
Q ss_pred ceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHhc
Q 016347 275 ILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPS-----MSTVVQMLM 320 (391)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l~ 320 (391)
. ....+...+..+.+||.+||+.||++||| ++|++++-+
T Consensus 224 ---~----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~ 267 (364)
T d1omwa3 224 ---M----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 267 (364)
T ss_dssp ---C----CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGG
T ss_pred ---C----CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcc
Confidence 0 01112233457889999999999999999 688887644
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.7e-52 Score=378.75 Aligned_cols=256 Identities=23% Similarity=0.341 Sum_probs=200.7
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC----e
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN----H 114 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~ 114 (391)
.++|++.+.||+|+||+||+|.+. +|+.||||++... +......+.+|+++++.++||||+++++++.... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 578999999999999999999975 6999999999754 2344567899999999999999999999987643 4
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.++||||++|++|.+++...+ .+++..++.++.||+.||.|||++ |++||||||+|||++.++.++|+|||
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~ 156 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFG 156 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCT
T ss_pred EEEEEECCCCCEehhhhcccC------CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhh
Confidence 789999999999999886543 599999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCC--ceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 195 LAKLIPANM--THVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 195 ~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
.+....... ........||+.|+|||++.+..++.++|||||||++|+|+||+.||....+.+.. .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~~~~~~ 230 (277)
T d1o6ya_ 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVRED 230 (277)
T ss_dssp TCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCC
T ss_pred hhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH------HHHHhcC
Confidence 987653222 22334567999999999999999999999999999999999999999765432211 1111111
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHhc
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRP-SMSTVVQMLM 320 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~l~ 320 (391)
.. ..... ....+..+.+++.+||+.||.+|| |++++++.|.
T Consensus 231 ~~---~~~~~----~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 231 PI---PPSAR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp CC---CGGGT----SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred CC---CCchh----ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 00 00011 112345788899999999999999 8999988774
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.5e-52 Score=375.13 Aligned_cols=254 Identities=20% Similarity=0.282 Sum_probs=208.3
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc---------hhcHHHHHHHHHHHhcCC-CCceeEEEEEEEe
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES---------RQGVKEFLTEIQVISEIE-HENLVKLYGCCVE 111 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 111 (391)
.++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999985 69999999986542 122346888999999996 9999999999999
Q ss_pred CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEE
Q 016347 112 GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKIS 191 (391)
Q Consensus 112 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~ 191 (391)
++..+|||||++||+|.+++...+ .+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~ 152 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLT 152 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred CcceEEEEEcCCCchHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEc
Confidence 999999999999999999997543 599999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCceeeeeecccccccChhhhhc------CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 016347 192 DFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIR------GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERT 265 (391)
Q Consensus 192 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~ 265 (391)
|||++..+.... ......||+.|+|||.+.+ ..++.++||||+||+||+|++|+.||....+.... ...
T Consensus 153 DFG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~---~~i 227 (277)
T d1phka_ 153 DFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML---RMI 227 (277)
T ss_dssp CCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH
T ss_pred cchheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH---HHH
Confidence 999998765432 2344679999999999864 34788999999999999999999999865432211 111
Q ss_pred HHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 266 WDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.. ... ..........+..+.+|+.+||+.||++|||+.|++++-+
T Consensus 228 ---~~-~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~ 272 (277)
T d1phka_ 228 ---MS-GNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272 (277)
T ss_dssp ---HH-TCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred ---Hh-CCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence 11 110 0111122234567889999999999999999999988643
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-52 Score=382.88 Aligned_cols=254 Identities=25% Similarity=0.390 Sum_probs=202.1
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCc----EEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGK----IAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 117 (391)
.+|++++.||+|+||+||+|.+. +|+ +||+|.+... .....+.+.+|+.++++++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999875 344 5889988654 345567899999999999999999999999865 5678
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
++|++.+++|.+.+... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 88 v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH-----KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp EEECCTTCBHHHHHHHT-----SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred EEEeccCCccccccccc-----ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccce
Confidence 88999999999988653 23689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCce-eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhcccc
Q 016347 198 LIPANMTH-VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERRELI 275 (391)
Q Consensus 198 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (391)
........ ......||+.|+|||++.++.++.++|||||||++|||+| |..||......+...... .+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-------~~--- 229 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KG--- 229 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-------HT---
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cC---
Confidence 76543322 2233568999999999999999999999999999999998 788887554333211111 11
Q ss_pred eeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 276 LLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.....+...+..+.+|+.+||+.||.+|||+.||+++|...
T Consensus 230 ------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 230 ------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp ------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 11122334456788999999999999999999999988543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-52 Score=381.87 Aligned_cols=270 Identities=24% Similarity=0.355 Sum_probs=204.0
Q ss_pred echHHHHHhhCCCCCCceeeccCceEEEEEEeC------CCcEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCceeEE
Q 016347 34 YSYKELSIATDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHENLVKL 105 (391)
Q Consensus 34 ~~~~e~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~ 105 (391)
|...+|++..++|++.++||+|+||.||+|.+. +++.||||++... .....+.+.+|...+.++ +|+||+.+
T Consensus 3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 345677788899999999999999999999863 2578999998754 334456677888888776 78999999
Q ss_pred EEEEEeC-CeeEEEEecccCCCHHHHHhcCCCC----------CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecC
Q 016347 106 YGCCVEG-NHRILVYNYLENNSLAQTLIGGGHH----------YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRD 174 (391)
Q Consensus 106 ~~~~~~~-~~~~lv~e~~~~~sL~~~i~~~~~~----------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~d 174 (391)
++++... ...++||||+++|+|.+++...... .....+++..+..++.||+.||.|||++ +|+|||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCc
Confidence 9988754 4689999999999999999754211 1234589999999999999999999999 999999
Q ss_pred CCCCcEEECCCCcEEEEecccccccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCC-CCCCC
Q 016347 175 IKASNILLDKDLTPKISDFGLAKLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR-CNTNM 252 (391)
Q Consensus 175 ikp~NIlv~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~-~p~~~ 252 (391)
|||+||||+.++.+||+|||+++....... .......||+.|+|||++.++.++.++|||||||++|||+||. .||..
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987643322 2233467999999999999999999999999999999999975 46654
Q ss_pred CCCcchhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 253 RLPTEEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
...... +... ...+. ....+...+..+.+++.+||+.||++|||+.||+++|+.
T Consensus 240 ~~~~~~--~~~~----~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 240 VKIDEE--FCRR----LKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp CCCSHH--HHHH----HHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHHH--HHHH----HhcCC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 433221 1111 11111 112222334578899999999999999999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-51 Score=375.38 Aligned_cols=262 Identities=23% Similarity=0.270 Sum_probs=197.7
Q ss_pred CCceeeccCceEEEEEEeC-CCcEEEEEEecccchh-----cHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 48 PINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQ-----GVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 48 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
.+++||+|+||+||+|++. +|+.||||++...... ....+.+|+.+|+.++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4678999999999999986 5999999998754321 124588999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+.++++..++.. ...+++..+..++.||+.||+|||++ |++||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~~~~~~~~~------~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~ 152 (299)
T d1ua2a_ 82 METDLEVIIKDN------SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 152 (299)
T ss_dssp CSEEHHHHHTTC------CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred hcchHHhhhhhc------ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCC
Confidence 998877666543 23589999999999999999999999 999999999999999999999999999987644
Q ss_pred CCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceee--
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLV-- 278 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 278 (391)
... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+................
T Consensus 153 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 153 PNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp CCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred Ccc-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence 322 23345799999999998754 57999999999999999999999997654433211111111000000000000
Q ss_pred ----eccCCCCCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 279 ----DTSLNGDFDA-----EEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 279 ----~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
........+. .....+.+|+.+||+.||++|||++|++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp 281 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 281 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCH
Confidence 0000001111 2245788999999999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-52 Score=379.45 Aligned_cols=265 Identities=25% Similarity=0.381 Sum_probs=208.8
Q ss_pred HHHhhCCCCCCceeeccCceEEEEEEeCC--------CcEEEEEEecccc-hhcHHHHHHHHHHHhcC-CCCceeEEEEE
Q 016347 39 LSIATDDFSPINKIGEGGFGSVYKGRLKD--------GKIAAIKVLSAES-RQGVKEFLTEIQVISEI-EHENLVKLYGC 108 (391)
Q Consensus 39 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 108 (391)
|.+..++|++.+.||+|+||.||+|+... +..||||+++.+. ......+.+|...+.++ +|||||+++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 55677899999999999999999998532 3479999997653 34457788899999888 89999999999
Q ss_pred EEeCCeeEEEEecccCCCHHHHHhcCCCC----------CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 016347 109 CVEGNHRILVYNYLENNSLAQTLIGGGHH----------YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKAS 178 (391)
Q Consensus 109 ~~~~~~~~lv~e~~~~~sL~~~i~~~~~~----------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~ 178 (391)
+.++...++||||+++|+|.++|...... .....+++..++.++.||+.||+|||++ +++||||||+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~ 164 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 164 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccc
Confidence 99999999999999999999999754321 1235689999999999999999999999 9999999999
Q ss_pred cEEECCCCcEEEEecccccccCCCC-ceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCc
Q 016347 179 NILLDKDLTPKISDFGLAKLIPANM-THVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPT 256 (391)
Q Consensus 179 NIlv~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~ 256 (391)
|||++.++.+||+|||++....... ........|++.|+|||.+.++.|+.++|||||||++|||++ |+.||......
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 9999999999999999998764332 222344678999999999999999999999999999999998 67777643322
Q ss_pred chhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 257 EEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
. .......+ .....+...+..+.+|+.+||+.||++|||+.||++.|+.+
T Consensus 245 ~-------~~~~i~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 245 E-------LFKLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp H-------HHHHHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H-------HHHHHHcC---------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1 11111111 11122223445788999999999999999999999998643
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-52 Score=374.92 Aligned_cols=255 Identities=25% Similarity=0.422 Sum_probs=197.3
Q ss_pred hCCCCCCceeeccCceEEEEEEeC--CC--cEEEEEEeccc---chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCee
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK--DG--KIAAIKVLSAE---SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHR 115 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 115 (391)
.++|++++.||+|+||.||+|++. ++ ..||||++... .....+.|.+|+.+|++++||||+++++++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 467999999999999999999864 22 36899998754 33445789999999999999999999999965 467
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEeccc
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGL 195 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~ 195 (391)
++||||+++|+|.+.+... ...+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 86 ~lv~e~~~~~~l~~~~~~~-----~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl 157 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH-----QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGL 157 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH-----GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred heeeeeecCcchhhhhhcc-----cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchh
Confidence 8999999999999988642 23699999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCce--eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 196 AKLIPANMTH--VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVS-GRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 196 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
++........ ......|+..|+|||++.+..++.++|||||||++|||+| |..||......+. .... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~---~~~i---~~~- 230 (273)
T d1u46a_ 158 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---LHKI---DKE- 230 (273)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHH---HTS-
T ss_pred hhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH---HHHH---HhC-
Confidence 9987544332 2233567889999999999999999999999999999998 8999975433221 1111 111
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
......+...+..+.+|+.+||+.||++|||+.||++.|..
T Consensus 231 --------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 231 --------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp --------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 11112223334578899999999999999999999998854
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-51 Score=377.47 Aligned_cols=267 Identities=23% Similarity=0.394 Sum_probs=214.0
Q ss_pred HHHHhhCCCCCCceeeccCceEEEEEEeC------CCcEEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCceeEEEEEE
Q 016347 38 ELSIATDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHENLVKLYGCC 109 (391)
Q Consensus 38 e~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 109 (391)
+|++..++|++.++||+|+||.||+|++. +++.||||++... .......+.+|+.+++.+ +|||||++++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 46677799999999999999999999852 4678999999765 334556788999999999 699999999999
Q ss_pred EeCCeeEEEEecccCCCHHHHHhcCCCC------------CCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 016347 110 VEGNHRILVYNYLENNSLAQTLIGGGHH------------YSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKA 177 (391)
Q Consensus 110 ~~~~~~~lv~e~~~~~sL~~~i~~~~~~------------~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp 177 (391)
.+....++||||+++|+|.+++...... .....+++..+..++.||+.||+|||++ +++||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence 9999999999999999999999754321 1233589999999999999999999999 999999999
Q ss_pred CcEEECCCCcEEEEecccccccCCCCc-eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCc
Q 016347 178 SNILLDKDLTPKISDFGLAKLIPANMT-HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPT 256 (391)
Q Consensus 178 ~NIlv~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~ 256 (391)
+||+++.++.+|++|||+++....... .......||+.|+|||++.++.++.++|||||||++|||+|+..|+......
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999997754433 2334467899999999999999999999999999999999955554333322
Q ss_pred chhhHHHHHHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 257 EEQYLLERTWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
.... . ..... ......+...+..+.+|+.+||+.||++|||+.+|+++|+.
T Consensus 254 ~~~~--~---~~i~~---------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 254 DSKF--Y---KMIKE---------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp SHHH--H---HHHHH---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHH--H---HHHhc---------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 2111 0 11111 11112222345678899999999999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-51 Score=378.79 Aligned_cols=252 Identities=20% Similarity=0.218 Sum_probs=200.3
Q ss_pred hCCCCCCc-eeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhc-CCCCceeEEEEEEEe----CCee
Q 016347 43 TDDFSPIN-KIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISE-IEHENLVKLYGCCVE----GNHR 115 (391)
Q Consensus 43 ~~~y~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~----~~~~ 115 (391)
.++|++++ .||+|+||+||+|++. +|+.||||++... ..+.+|+.++.+ .+|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46898876 5999999999999975 6999999998643 456779988655 589999999999875 4578
Q ss_pred EEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC---CCcEEEEe
Q 016347 116 ILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK---DLTPKISD 192 (391)
Q Consensus 116 ~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~---~~~~kl~D 192 (391)
++|||||+||+|.+++...+ ...+++..++.|+.||+.||+|||++ ||+||||||+|||++. ++.+||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~----~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCS----CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEEECCCCCcHHHHHHhcC----CCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccc
Confidence 99999999999999997532 24699999999999999999999999 9999999999999975 46799999
Q ss_pred cccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 193 FGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 193 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
||+++...... ......||+.|+|||++.+..|+.++|||||||+||+|+||+.||............ ..
T Consensus 158 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~~----- 227 (335)
T d2ozaa1 158 FGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KT----- 227 (335)
T ss_dssp CTTCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------------
T ss_pred cceeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---HH-----
Confidence 99998764432 234567999999999999999999999999999999999999999765432211000 00
Q ss_pred ccceeeeccC--CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 273 ELILLVDTSL--NGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 273 ~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
.+..... ........+..+.+|+.+||+.||++|||+.|++++-
T Consensus 228 ---~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 273 (335)
T d2ozaa1 228 ---RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 273 (335)
T ss_dssp ---CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSH
T ss_pred ---HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCH
Confidence 0000111 1111123456789999999999999999999999863
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=370.97 Aligned_cols=267 Identities=24% Similarity=0.345 Sum_probs=201.9
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
++|+++++||+|+||+||+|++. +|+.||||++.... ......+.+|+++|++++|||||++++++.++...++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999985 69999999997553 2345678899999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
|+.++.+...... ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~~~~~~~~~~-----~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~ 153 (298)
T d1gz8a_ 82 FLHQDLKKFMDAS-----ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153 (298)
T ss_dssp CCSEEHHHHHHHT-----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred ecCCchhhhhhhh-----cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceecc
Confidence 9976544443332 234699999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCceeeeeecccccccChhhhhcCC-CCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccc---ce
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQ-VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERREL---IL 276 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 276 (391)
... .......||+.|+|||++.... ++.++|||||||++|+|++|+.||........................ ..
T Consensus 154 ~~~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 154 VPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp CCS-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CCc-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 332 2334457999999999987766 478999999999999999999999765432211111110000000000 00
Q ss_pred e--eeccCC--CCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 277 L--VDTSLN--GDFD-----AEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 277 ~--~~~~~~--~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
. ...... .... ......+.+|+.+||+.||++|||+.|++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ 284 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHP 284 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCH
Confidence 0 000000 0000 12235788899999999999999999999873
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-51 Score=374.46 Aligned_cols=259 Identities=27% Similarity=0.383 Sum_probs=204.3
Q ss_pred hCCCCCCceeeccCceEEEEEEeCC-Cc--EEEEEEeccc-chhcHHHHHHHHHHHhcC-CCCceeEEEEEEEeCCeeEE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLKD-GK--IAAIKVLSAE-SRQGVKEFLTEIQVISEI-EHENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 117 (391)
.++|++.+.||+|+||+||+|.+.+ |. .||||.+... .....+.+.+|+++|+++ +|||||++++++.+.+..++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 3789999999999999999999763 44 4678877543 334556799999999998 79999999999999999999
Q ss_pred EEecccCCCHHHHHhcCCC----------CCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCc
Q 016347 118 VYNYLENNSLAQTLIGGGH----------HYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLT 187 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~----------~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~ 187 (391)
||||+++|+|.+++..... ......+++..+..++.||+.||.|||++ +++||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCc
Confidence 9999999999999975421 11335689999999999999999999999 9999999999999999999
Q ss_pred EEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCC-CCCCCCCcchhhHHHHHH
Q 016347 188 PKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRC-NTNMRLPTEEQYLLERTW 266 (391)
Q Consensus 188 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~-p~~~~~~~~~~~~~~~~~ 266 (391)
+||+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|.. ||......+ +...
T Consensus 166 ~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~~~-- 238 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEK-- 238 (309)
T ss_dssp EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHH--
T ss_pred eEEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HHHH--
Confidence 9999999998653221 2234568999999999999999999999999999999999765 565432211 1111
Q ss_pred HHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 267 DLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
... ......+...+..+.+|+.+||+.||++|||++||+++|+.+
T Consensus 239 --i~~---------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 239 --LPQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp --GGG---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHh---------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111 111223334456888999999999999999999999998654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-50 Score=369.09 Aligned_cols=266 Identities=23% Similarity=0.334 Sum_probs=202.9
Q ss_pred CCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccc--hhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEec
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAES--RQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYNY 121 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 121 (391)
++|+++++||+|+||+||+|++++|+.||||++.... ....+.+.+|+.+|++++||||+++++++..++..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999999999999997652 33457899999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCC
Q 016347 122 LENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPA 201 (391)
Q Consensus 122 ~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~ 201 (391)
+.++.+..+.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~~~~~~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~ 152 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE------GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (286)
T ss_dssp CSEEHHHHHHTST------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred ehhhhHHHHHhhc------CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceeccc
Confidence 9887776666433 3599999999999999999999999 999999999999999999999999999987644
Q ss_pred CCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhccc---cee
Q 016347 202 NMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERREL---ILL 277 (391)
Q Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 277 (391)
... ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||......+................. ...
T Consensus 153 ~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 153 PVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred Ccc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence 322 23345689999999998764 5699999999999999999999999754332211111110000000000 000
Q ss_pred --eeccCC-------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 278 --VDTSLN-------GDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 278 --~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
...... .......+..+.+|+.+||+.||++|||++|++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp 282 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 000000 011112345788999999999999999999999764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=377.56 Aligned_cols=266 Identities=25% Similarity=0.353 Sum_probs=213.3
Q ss_pred HHHHhhCCCCCCceeeccCceEEEEEEeC------CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEE
Q 016347 38 ELSIATDDFSPINKIGEGGFGSVYKGRLK------DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCV 110 (391)
Q Consensus 38 e~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 110 (391)
+|++..++|++.++||+|+||+||+|.+. +++.||||+++.. .......|.+|++++++++||||+++++++.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 46677799999999999999999999864 2578999999754 3344567899999999999999999999999
Q ss_pred eCCeeEEEEecccCCCHHHHHhcCCC----CCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC
Q 016347 111 EGNHRILVYNYLENNSLAQTLIGGGH----HYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL 186 (391)
Q Consensus 111 ~~~~~~lv~e~~~~~sL~~~i~~~~~----~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~ 186 (391)
.....++||||+++|+|.+++..... ......+++..+..++.|++.||.|||++ +|+||||||+|||++.++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence 99999999999999999998864210 01223478999999999999999999999 999999999999999999
Q ss_pred cEEEEecccccccCCCCce-eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCC-CCCCCCCCcchhhHHHH
Q 016347 187 TPKISDFGLAKLIPANMTH-VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGR-CNTNMRLPTEEQYLLER 264 (391)
Q Consensus 187 ~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~-~p~~~~~~~~~~~~~~~ 264 (391)
.+||+|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||+||. .||......+. ...
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~---~~~ 247 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV---LRF 247 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH---HHH
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH---HHH
Confidence 9999999999876433222 223346899999999999999999999999999999999995 55644322111 111
Q ss_pred HHHHhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 265 TWDLYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
..... ..+.+...+..+.+++.+||+.||++|||+++|+++|+..
T Consensus 248 ----i~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 248 ----VMEGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp ----HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred ----HHhCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 11111 1122233456799999999999999999999999999654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=372.13 Aligned_cols=265 Identities=25% Similarity=0.347 Sum_probs=198.5
Q ss_pred hCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHH--HHHHHhcCCCCceeEEEEEEEeCC----eeE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLT--EIQVISEIEHENLVKLYGCCVEGN----HRI 116 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~--e~~~l~~l~h~~iv~~~~~~~~~~----~~~ 116 (391)
.++|.+.+.||+|+||.||+|++. |+.||||++..... ..+.. |+..+..++||||+++++++.+.. ..+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 467889999999999999999974 88999999875432 33333 555556789999999999998643 679
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcC-----CCCeeecCCCCCcEEECCCCcEEEE
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEV-----RPHIIHRDIKASNILLDKDLTPKIS 191 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~-----~~~i~H~dikp~NIlv~~~~~~kl~ 191 (391)
+||||+++|+|.+++... .+++..++.++.|++.||+|+|+.. ..||+||||||+||||+.++.+||+
T Consensus 78 lv~Ey~~~g~L~~~l~~~-------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~ 150 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred EEEecccCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence 999999999999999643 4899999999999999999999631 2389999999999999999999999
Q ss_pred ecccccccCCCCce---eeeeecccccccChhhhhcCC------CCCCCcEeehhHHHHHHHhCCCCCCCCCCcchh---
Q 016347 192 DFGLAKLIPANMTH---VSTRVAGTIGYLAPEYAIRGQ------VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQ--- 259 (391)
Q Consensus 192 Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~--- 259 (391)
|||+++........ ......||+.|+|||++.+.. ++.++|||||||+||||+||..|+.........
T Consensus 151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~ 230 (303)
T d1vjya_ 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence 99999876443322 223467999999999987643 678999999999999999998877543222110
Q ss_pred -----hHHHHHHHHhhhcccceeeeccCCCC-CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 260 -----YLLERTWDLYERRELILLVDTSLNGD-FDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 260 -----~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
.............. .++.+... ...+....+.+|+.+||+.||++|||+.||++.|+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 231 LVPSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccchHHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 01111111111111 11111111 1234566789999999999999999999999988643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-50 Score=368.12 Aligned_cols=251 Identities=27% Similarity=0.394 Sum_probs=200.6
Q ss_pred CceeeccCceEEEEEEeCC----CcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEe-CCeeEEEEecc
Q 016347 49 INKIGEGGFGSVYKGRLKD----GKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVE-GNHRILVYNYL 122 (391)
Q Consensus 49 ~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~ 122 (391)
.++||+|+||+||+|.+.. ...||||.+... +......|.+|+++|++++||||++++|++.. +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4689999999999999753 235899998753 45566789999999999999999999999875 56899999999
Q ss_pred cCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccCCC
Q 016347 123 ENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIPAN 202 (391)
Q Consensus 123 ~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~~~ 202 (391)
++|+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 112 ~~g~l~~~~~~~~-----~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 112 KHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp TTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred ecCchhhhhcccc-----ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 9999999987533 3577888999999999999999999 9999999999999999999999999999876433
Q ss_pred Cce---eeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcccceeee
Q 016347 203 MTH---VSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRELILLVD 279 (391)
Q Consensus 203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (391)
... ......||+.|+|||.+.++.++.++||||||+++|||+||+.||........ ..... ....
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~~~~i---~~g~------- 251 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYL---LQGR------- 251 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH---HTTC-------
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH--HHHHH---HcCC-------
Confidence 221 22235689999999999999999999999999999999998888765432211 11111 1111
Q ss_pred ccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 280 TSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 280 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
....+...+..+.+|+.+||+.||++||++.||+++|+.+
T Consensus 252 ---~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 252 ---RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111223345788999999999999999999999998665
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-50 Score=367.54 Aligned_cols=268 Identities=22% Similarity=0.340 Sum_probs=199.7
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-C-CcEEEEEEecccc--hhcHHHHHHHHHHHhcC---CCCceeEEEEEEEe----
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-D-GKIAAIKVLSAES--RQGVKEFLTEIQVISEI---EHENLVKLYGCCVE---- 111 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~---- 111 (391)
.++|+++++||+|+||+||+|++. + ++.||||++.... ......+.+|+.+|+.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 579999999999999999999974 4 6789999986542 22223455677776655 89999999999863
Q ss_pred -CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEE
Q 016347 112 -GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKI 190 (391)
Q Consensus 112 -~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl 190 (391)
....+++|||+.++.+...... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl 157 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV-----PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL 157 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS-----CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred cCceEEEEEEeccCCchhhhhhc-----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeee
Confidence 2478999999998876555433 234689999999999999999999999 9999999999999999999999
Q ss_pred EecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh
Q 016347 191 SDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE 270 (391)
Q Consensus 191 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 270 (391)
+|||++...... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||....+.+.............
T Consensus 158 ~dfg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 158 ADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235 (305)
T ss_dssp CSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cchhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCc
Confidence 999998864322 233456899999999999999999999999999999999999999976544332111111100000
Q ss_pred hccc---ceeeeccC-------CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 271 RREL---ILLVDTSL-------NGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 271 ~~~~---~~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.... ........ ...........+.+|+.+||+.||++|||+.|++++-+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpf 295 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 295 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence 0000 00000000 00111223456788999999999999999999998743
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=367.12 Aligned_cols=243 Identities=21% Similarity=0.311 Sum_probs=198.4
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccch------hcHHHHHHHHHHHhcCC--CCceeEEEEEEEeCC
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESR------QGVKEFLTEIQVISEIE--HENLVKLYGCCVEGN 113 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~ 113 (391)
.++|++.+.||+|+||+||+|++. +|+.||||++..... .....+.+|+.+|++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 478999999999999999999986 699999999875421 11233667999999986 899999999999999
Q ss_pred eeEEEEecccC-CCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC-CcEEEE
Q 016347 114 HRILVYNYLEN-NSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD-LTPKIS 191 (391)
Q Consensus 114 ~~~lv~e~~~~-~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~-~~~kl~ 191 (391)
..++||||+.+ +++.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+ +.+||+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~------~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~ 153 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER------GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLI 153 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEEC
T ss_pred eEEEEEEeccCcchHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEEC
Confidence 99999999976 5787887643 3599999999999999999999999 99999999999999855 799999
Q ss_pred ecccccccCCCCceeeeeecccccccChhhhhcCCC-CCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhh
Q 016347 192 DFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQV-TRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYE 270 (391)
Q Consensus 192 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 270 (391)
|||++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.... .. ..
T Consensus 154 DFG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---------~i---~~ 218 (273)
T d1xwsa_ 154 DFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EI---IR 218 (273)
T ss_dssp CCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HH---HH
T ss_pred ccccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch---------HH---hh
Confidence 99999875432 2345679999999999988775 677999999999999999999996421 00 00
Q ss_pred hcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 271 RRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
... .+. ...+.++.+|+.+||+.||++|||++|++++-+
T Consensus 219 -~~~------~~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 257 (273)
T d1xwsa_ 219 -GQV------FFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 257 (273)
T ss_dssp -CCC------CCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred -ccc------CCC----CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence 100 111 122357888999999999999999999998643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=360.93 Aligned_cols=270 Identities=21% Similarity=0.287 Sum_probs=200.5
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEe--------
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVE-------- 111 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------- 111 (391)
.++|+++++||+|+||+||+|++. +|+.||||++... .......+.+|+++|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 378999999999999999999986 6999999998654 33445678899999999999999999998854
Q ss_pred CCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEE
Q 016347 112 GNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKIS 191 (391)
Q Consensus 112 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~ 191 (391)
....++||||+.++.+..... ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~------~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~ 159 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN------VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA 159 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred CceEEEEEeccCCCccchhhh------cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEee
Confidence 346899999998876654443 233589999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCc---eeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 016347 192 DFGLAKLIPANMT---HVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWD 267 (391)
Q Consensus 192 Dfg~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 267 (391)
|||++..+..... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.................
T Consensus 160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~ 239 (318)
T d3blha1 160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239 (318)
T ss_dssp CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999976643221 122335799999999998765 689999999999999999999999976543332222222111
Q ss_pred Hhhhccc--------ceeeeccCCCCCCH-------HHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 268 LYERREL--------ILLVDTSLNGDFDA-------EEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 268 ~~~~~~~--------~~~~~~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
....... .............. .....+.+|+.+||+.||++|||++|++++-+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff 308 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhh
Confidence 1110000 00000000011111 113356789999999999999999999998653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-49 Score=363.02 Aligned_cols=255 Identities=27% Similarity=0.339 Sum_probs=207.3
Q ss_pred CCCCCCceeeccCceEEEEEEeC----CCcEEEEEEeccc----chhcHHHHHHHHHHHhcCCC-CceeEEEEEEEeCCe
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK----DGKIAAIKVLSAE----SRQGVKEFLTEIQVISEIEH-ENLVKLYGCCVEGNH 114 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~ 114 (391)
++|+++++||+|+||+||+|+.. +|+.||||++... .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 77999999999999999999862 4889999998654 22334567889999999966 899999999999999
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.+++|||+.+|+|.+++...+ .+++..+..++.||+.||.|||++ +++||||||+|||++.+|.+||+|||
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~------~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG 174 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG 174 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred eeeeeecccccHHHHHHHhcc------cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeecc
Confidence 999999999999999997543 478899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCceeeeeecccccccChhhhhcC--CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc
Q 016347 195 LAKLIPANMTHVSTRVAGTIGYLAPEYAIRG--QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR 272 (391)
Q Consensus 195 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 272 (391)
++..+............|++.|+|||.+.+. .++.++|||||||+||+|++|..||...................
T Consensus 175 ~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~--- 251 (322)
T d1vzoa_ 175 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--- 251 (322)
T ss_dssp EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC---
T ss_pred chhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC---
Confidence 9987654444444556899999999999765 46889999999999999999999997765544332222111100
Q ss_pred ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHhc
Q 016347 273 ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPS-----MSTVVQMLM 320 (391)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~l~ 320 (391)
....+...+..+.+|+.+||+.||.+||| ++|++++-+
T Consensus 252 ----------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf 294 (322)
T d1vzoa_ 252 ----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294 (322)
T ss_dssp ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred ----------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh
Confidence 01122344568888999999999999994 789987643
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=365.57 Aligned_cols=267 Identities=22% Similarity=0.283 Sum_probs=198.3
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc-chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC----eeE
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE-SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN----HRI 116 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~ 116 (391)
+.+|+++++||+|+||+||+|.+. +|+.||||++... .....+.+.+|+++|+.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 468999999999999999999875 6999999999754 3444567889999999999999999999987543 234
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccc
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLA 196 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~ 196 (391)
++++++.+|+|.+++..+ .+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 87 ~l~~~~~~g~L~~~l~~~-------~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEeecCCchhhhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCce
Confidence 555667799999999543 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCc--eeeeeecccccccChhhhh-cCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhcc
Q 016347 197 KLIPANMT--HVSTRVAGTIGYLAPEYAI-RGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERRE 273 (391)
Q Consensus 197 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (391)
........ ......+||+.|+|||++. +..++.++||||+||++|+|++|+.||.......................
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence 86543221 1234467999999999984 45678999999999999999999999976543222111111100000000
Q ss_pred c--------ce-eeeccCCCCCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 274 L--------IL-LVDTSLNGDFDA-----EEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 274 ~--------~~-~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
. .. ..........+. .....+.+|+.+||+.||++|||+.|++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hp 296 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 296 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 0 00 000000001111 1224688999999999999999999999874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=350.22 Aligned_cols=265 Identities=20% Similarity=0.309 Sum_probs=207.2
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCCeeEEEEe
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 120 (391)
++|+++++||+|+||+||+|++. +|+.||||+++.. .......+.+|+.+|+.++||||+++++++.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 68999999999999999999986 6899999998654 33456788999999999999999999999999999999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecccccccC
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFGLAKLIP 200 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~~~~ 200 (391)
++.+++|..++...+ .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.+....
T Consensus 82 ~~~~~~l~~~~~~~~------~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~ 152 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG------DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp CCSEEHHHHHHHTTT------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred ecccccccccccccc------ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhccc
Confidence 999999988886543 588999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeeeecccccccChhhhhcCC-CCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhh---ccc--
Q 016347 201 ANMTHVSTRVAGTIGYLAPEYAIRGQ-VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYER---REL-- 274 (391)
Q Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~-- 274 (391)
.... ......+++.|+|||++.+.. ++.++|||||||++|+|++|+.||.......... ......... ...
T Consensus 153 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 153 IPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL--KRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp SCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH--HHHHHHHCCCCTTTCTT
T ss_pred CCCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHH--HHHHhhcCCCChhhhhh
Confidence 4322 223345788999999987765 6899999999999999999999975433322211 111111100 000
Q ss_pred -ceee---------eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 275 -ILLV---------DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 275 -~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.... ...............+.+|+.+||+.||++|||++|++++-+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~ 285 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChh
Confidence 0000 000001112233456888999999999999999999998743
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=364.09 Aligned_cols=261 Identities=20% Similarity=0.270 Sum_probs=196.8
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeCC------
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEGN------ 113 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 113 (391)
.++|+++++||+|+||+||+|.+. +|+.||||++... .....+.+.+|+++|+.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 578999999999999999999976 5999999999754 3344567889999999999999999999997654
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
..++||||+ +.+|..++.. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+||
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Df 165 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 165 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEecc-cccHHHHHHh-------ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccc
Confidence 569999999 6678887743 3599999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhh-
Q 016347 194 GLAKLIPANMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYER- 271 (391)
Q Consensus 194 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 271 (391)
|++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....................
T Consensus 166 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 166 GLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241 (346)
T ss_dssp TTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHH
Confidence 999876433 2345789999999998764 5689999999999999999999999765432211111110000000
Q ss_pred --------------cccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 272 --------------RELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 272 --------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
..........+ ..........+.+|+.+||+.||++|||+.|++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp 302 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 302 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcCh
Confidence 00000000000 011122344678899999999999999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-48 Score=361.78 Aligned_cols=263 Identities=22% Similarity=0.264 Sum_probs=194.4
Q ss_pred CCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC------CeeEE
Q 016347 45 DFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG------NHRIL 117 (391)
Q Consensus 45 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~l 117 (391)
+|+.+++||+|+||+||+|++. +|+.||||++...... ..+|+++|++++||||+++++++... .+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888899999999999999986 5999999999765432 34699999999999999999998643 35789
Q ss_pred EEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCC-cEEEEecccc
Q 016347 118 VYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDL-TPKISDFGLA 196 (391)
Q Consensus 118 v~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~-~~kl~Dfg~~ 196 (391)
||||++++.+..+..... ....+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus 97 v~Ey~~~~~~~~l~~~~~---~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSR---AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEECCSEEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEeccCCccHHHHHhhhh---ccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence 999998764433332110 234699999999999999999999999 999999999999999875 8999999999
Q ss_pred cccCCCCceeeeeecccccccChhhhhc-CCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HH
Q 016347 197 KLIPANMTHVSTRVAGTIGYLAPEYAIR-GQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERT--------WD 267 (391)
Q Consensus 197 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~ 267 (391)
..+.... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||............... +.
T Consensus 171 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 171 KQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp EECCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred hhccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence 8764332 2334679999999998875 46899999999999999999999999765432211111000 00
Q ss_pred Hhhhc----ccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHh
Q 016347 268 LYERR----ELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQML 319 (391)
Q Consensus 268 ~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l 319 (391)
..... .....................+.+|+.+||+.||++|||+.|++++-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 304 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 00000 00000000000011122345688899999999999999999999864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.8e-47 Score=344.80 Aligned_cols=260 Identities=20% Similarity=0.280 Sum_probs=205.2
Q ss_pred HhhCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCC-CceeEEEEEEEeCCeeEEE
Q 016347 41 IATDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEH-ENLVKLYGCCVEGNHRILV 118 (391)
Q Consensus 41 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv 118 (391)
+.+++|++.++||+|+||+||+|++. +|+.||||++..... ...+.+|++.++.+.| +|++.+++++..+...++|
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 35689999999999999999999976 589999999865432 2346778899999865 8999999999999999999
Q ss_pred EecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC-----CCcEEEEec
Q 016347 119 YNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK-----DLTPKISDF 193 (391)
Q Consensus 119 ~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~-----~~~~kl~Df 193 (391)
|||+ +++|.+++...+ ..++...+..++.|++.||+|||++ ||+||||||+|||++. ++.+||+||
T Consensus 80 me~~-~~~l~~~~~~~~-----~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DF 150 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDF 150 (293)
T ss_dssp EECC-CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred EEec-CCCHHHHHHhhc-----cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEccc
Confidence 9999 689999886533 3589999999999999999999999 9999999999999964 578999999
Q ss_pred ccccccCCCCc------eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 016347 194 GLAKLIPANMT------HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWD 267 (391)
Q Consensus 194 g~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 267 (391)
|+++....... .......||+.|+|||++.+..++.++|||||||++|||++|..||.................
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~ 230 (293)
T d1csna_ 151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 230 (293)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred ceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHh
Confidence 99987643221 122346799999999999999999999999999999999999999986655443322222111
Q ss_pred HhhhcccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 268 LYERRELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
........ .+... .+..+.+++..|+..+|++||+++.+.+.|.
T Consensus 231 ~~~~~~~~-----~l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~ 274 (293)
T d1csna_ 231 KKQSTPLR-----ELCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274 (293)
T ss_dssp HHHHSCHH-----HHTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred ccCCCChH-----HhcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 11110000 01111 2346888888999999999999888776654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-47 Score=348.07 Aligned_cols=259 Identities=22% Similarity=0.290 Sum_probs=196.4
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCc-eeEEEEEEEeCCeeEEEEe
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHEN-LVKLYGCCVEGNHRILVYN 120 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e 120 (391)
+++|++.++||+|+||+||+|++. +|+.||||++...... .++..|+++++.++|+| |+.+.+++.+....++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 468999999999999999999976 5899999998765332 35778999999997665 5556666778889999999
Q ss_pred cccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECC---CCcEEEEeccccc
Q 016347 121 YLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDK---DLTPKISDFGLAK 197 (391)
Q Consensus 121 ~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~---~~~~kl~Dfg~~~ 197 (391)
|+ +++|...+... ...+++..+..++.|++.||+|||++ ||+||||||+|||++. +..++|+|||+++
T Consensus 84 ~~-~~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 84 LL-GPSLEDLFNFC-----SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp CC-CCBHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred Ec-CCchhhhhhhc-----cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcce
Confidence 99 45666666442 23689999999999999999999999 9999999999999864 4579999999998
Q ss_pred ccCCCCc------eeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhh
Q 016347 198 LIPANMT------HVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYER 271 (391)
Q Consensus 198 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 271 (391)
.+..... .......||+.|+|||++.+..++.++|||||||++|||++|..||.....................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC
Confidence 7643322 1223467999999999999999999999999999999999999999765544332222111111100
Q ss_pred cccceeeeccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcC
Q 016347 272 RELILLVDTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMG 321 (391)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~ 321 (391)
... +.+. ...+..+.+++..||+.||++||++.++.+.|+.
T Consensus 235 ~~~-----~~~~----~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 235 TPI-----EVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp SCH-----HHHT----TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred CCh-----hHhc----cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 000 0000 1223568889999999999999999988776643
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.8e-47 Score=351.95 Aligned_cols=260 Identities=17% Similarity=0.254 Sum_probs=199.9
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCC-CCceeEEEEEEEe--CCeeEEEE
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIE-HENLVKLYGCCVE--GNHRILVY 119 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~ 119 (391)
++|+++++||+|+||+||+|++. +|+.||||++.... .+.+.+|+++|+.+. ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 68999999999999999999986 69999999987543 356888999999995 9999999999984 45689999
Q ss_pred ecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCC-CcEEEEecccccc
Q 016347 120 NYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKD-LTPKISDFGLAKL 198 (391)
Q Consensus 120 e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~-~~~kl~Dfg~~~~ 198 (391)
||+.+++|..+. ..+++..+..++.||+.||.|||++ ||+||||||+||||+.+ +.+||+|||++..
T Consensus 112 e~~~~~~L~~~~---------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 112 EHVNNTDFKQLY---------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp ECCCSCBGGGTT---------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred eecCCCcHHHHh---------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccccee
Confidence 999999987654 2489999999999999999999999 99999999999999865 4699999999987
Q ss_pred cCCCCceeeeeecccccccChhhhhcC-CCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHH-HHHH------HHhh
Q 016347 199 IPANMTHVSTRVAGTIGYLAPEYAIRG-QVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLL-ERTW------DLYE 270 (391)
Q Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~-~~~~------~~~~ 270 (391)
..... ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||............ .... ....
T Consensus 180 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 180 YHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp CCTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred ccCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence 64332 23445789999999998775 4799999999999999999999999765443221111 0000 0000
Q ss_pred h--ccc----ceee--------eccCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 271 R--REL----ILLV--------DTSLNGDFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 271 ~--~~~----~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
. ... .... ..............++.+|+.+||+.||++|||++|++++-+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 321 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 0 000 0000 000111111223457889999999999999999999998654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=356.54 Aligned_cols=266 Identities=24% Similarity=0.267 Sum_probs=195.0
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEe------CC
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVE------GN 113 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~ 113 (391)
.++|+++++||+|+||+||+|.+. +|+.||||++... +......+.+|+.+|++++||||+++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 378999999999999999999987 5999999999754 34455678899999999999999999999863 36
Q ss_pred eeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEec
Q 016347 114 HRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDF 193 (391)
Q Consensus 114 ~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Df 193 (391)
..++||||+.++.+ +.+. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.++++||
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~--------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df 163 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQ--------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_dssp EEEEEEECCSEEHH-HHHT--------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred eeEEEEeccchHHH-Hhhh--------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeech
Confidence 88999999976544 4442 2489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHH-------
Q 016347 194 GLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTW------- 266 (391)
Q Consensus 194 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~------- 266 (391)
|+++..... .......||+.|+|||++.+..++.++||||+||++++|++|+.||................
T Consensus 164 ~~~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 241 (355)
T d2b1pa1 164 GLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_dssp CC-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred hhhhccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHH
Confidence 998865432 23345678999999999999999999999999999999999999997554222111000000
Q ss_pred ---------HHhhhc------ccceeeecc-CCC--CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhcCC
Q 016347 267 ---------DLYERR------ELILLVDTS-LNG--DFDAEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLMGE 322 (391)
Q Consensus 267 ---------~~~~~~------~~~~~~~~~-~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~~~ 322 (391)
...... .....+... ... .........+.+|+.+||+.||++|||++|+|++-+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~ 315 (355)
T d2b1pa1 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315 (355)
T ss_dssp HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence 000000 000000000 010 11224566889999999999999999999999886443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-46 Score=347.38 Aligned_cols=264 Identities=21% Similarity=0.262 Sum_probs=197.9
Q ss_pred hCCCCCCceeeccCceEEEEEEeC-CCcEEEEEEeccc--chhcHHHHHHHHHHHhcCCCCceeEEEEEEEeC-----Ce
Q 016347 43 TDDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAE--SRQGVKEFLTEIQVISEIEHENLVKLYGCCVEG-----NH 114 (391)
Q Consensus 43 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 114 (391)
.++|+++++||+|+||+||+|++. +|+.||||++... +....+.+.+|+++|+.++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 578999999999999999999976 6999999999755 334456788999999999999999999998633 34
Q ss_pred eEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCcEEEEecc
Q 016347 115 RILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLTPKISDFG 194 (391)
Q Consensus 115 ~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~~kl~Dfg 194 (391)
.+++++++.+|+|.+++.. ..+++..+..++.||+.||+|||++ ||+||||||+|||++.+|.+|++|||
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-------~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg 166 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 166 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred eEEEEEeecCCchhhhccc-------ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccc
Confidence 5667788889999999843 3599999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCceeeeeecccccccChhhhhcCC-CCCCCcEeehhHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHhhhc-
Q 016347 195 LAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQ-VTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQYLLERTWDLYERR- 272 (391)
Q Consensus 195 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 272 (391)
++..... ......|++.|+|||++.+.. ++.++|||||||++|+|++|+.||......................
T Consensus 167 ~a~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 167 LARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242 (348)
T ss_dssp ---CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred hhcccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 9876432 233457899999999877764 6899999999999999999999997654332211111110000000
Q ss_pred -------ccceeeeccC-CCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHhc
Q 016347 273 -------ELILLVDTSL-NGDFD-----AEEACRFLKVGLLCTQDTPKLRPSMSTVVQMLM 320 (391)
Q Consensus 273 -------~~~~~~~~~~-~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~l~ 320 (391)
.......... ..... ......+.+|+.+||+.||.+|||+.|++++-+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~ 303 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHh
Confidence 0000000000 00000 112346788999999999999999999998754
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.1e-41 Score=315.97 Aligned_cols=265 Identities=20% Similarity=0.200 Sum_probs=191.0
Q ss_pred CCCCCCceeeccCceEEEEEEeC-CCcEEEEEEecccchhcHHHHHHHHHHHhcCC-----------CCceeEEEEEEEe
Q 016347 44 DDFSPINKIGEGGFGSVYKGRLK-DGKIAAIKVLSAESRQGVKEFLTEIQVISEIE-----------HENLVKLYGCCVE 111 (391)
Q Consensus 44 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~ 111 (391)
++|+++++||+|+||+||+|++. +|+.||||+++.+. ...+.+.+|+++++.+. |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 56999999999999999999986 69999999998653 23456778998888775 5789999988754
Q ss_pred --CCeeEEEEecccCCCH-HHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCcEEECCCC-
Q 016347 112 --GNHRILVYNYLENNSL-AQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHE-EVRPHIIHRDIKASNILLDKDL- 186 (391)
Q Consensus 112 --~~~~~lv~e~~~~~sL-~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~~~~i~H~dikp~NIlv~~~~- 186 (391)
....+++++++..+.. ....... ....+++..+..++.||+.||.|||+ . ||+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~ 164 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKY----EHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDS 164 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHT----TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEET
T ss_pred ccccceeeeeeecccccccccccccc----cccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCc
Confidence 4566666666654432 2222211 33468899999999999999999998 6 999999999999997665
Q ss_pred -----cEEEEecccccccCCCCceeeeeecccccccChhhhhcCCCCCCCcEeehhHHHHHHHhCCCCCCCCCCcchh--
Q 016347 187 -----TPKISDFGLAKLIPANMTHVSTRVAGTIGYLAPEYAIRGQVTRKADIYSFGVLLVEIVSGRCNTNMRLPTEEQ-- 259 (391)
Q Consensus 187 -----~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG~vl~elltg~~p~~~~~~~~~~-- 259 (391)
.++++|||.+...... .....||+.|+|||++.+..++.++|||||||++++|++|+.||.........
T Consensus 165 ~~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~ 240 (362)
T d1q8ya_ 165 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240 (362)
T ss_dssp TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred ccccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence 4999999998764322 23467999999999999999999999999999999999999999754332111
Q ss_pred --hHHHHHHHH-------hhh----------cccceeeecc----------CCCCCCHHHHHHHHHHHhhccCCCCCCCC
Q 016347 260 --YLLERTWDL-------YER----------RELILLVDTS----------LNGDFDAEEACRFLKVGLLCTQDTPKLRP 310 (391)
Q Consensus 260 --~~~~~~~~~-------~~~----------~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 310 (391)
.+....... ... ......+... ............+.+|+.+||+.||.+||
T Consensus 241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp 320 (362)
T d1q8ya_ 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 320 (362)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence 111110000 000 0000000000 01123456778899999999999999999
Q ss_pred CHHHHHHHhc
Q 016347 311 SMSTVVQMLM 320 (391)
Q Consensus 311 s~~evl~~l~ 320 (391)
|++|+|++-+
T Consensus 321 ta~e~L~Hp~ 330 (362)
T d1q8ya_ 321 DAGGLVNHPW 330 (362)
T ss_dssp CHHHHHTCGG
T ss_pred CHHHHhcCcc
Confidence 9999998754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=1.9e-25 Score=189.75 Aligned_cols=163 Identities=14% Similarity=0.118 Sum_probs=121.9
Q ss_pred CCCCceeeccCceEEEEEEeCCCcEEEEEEecccch------------------hcHHHHHHHHHHHhcCCCCceeEEEE
Q 016347 46 FSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESR------------------QGVKEFLTEIQVISEIEHENLVKLYG 107 (391)
Q Consensus 46 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~iv~~~~ 107 (391)
+.+.++||+|+||+||+|.+.+|+.||||+++.... ........|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 346789999999999999998899999998753211 01223456888999999999998886
Q ss_pred EEEeCCeeEEEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCcEEECCCCc
Q 016347 108 CCVEGNHRILVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEEVRPHIIHRDIKASNILLDKDLT 187 (391)
Q Consensus 108 ~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~~~~i~H~dikp~NIlv~~~~~ 187 (391)
+. ..+++|||+++..+. .++...+..++.|++.+|.|||++ |++||||||+|||++++ .
T Consensus 82 ~~----~~~lvme~~~~~~~~-------------~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~ 140 (191)
T d1zara2 82 WE----GNAVLMELIDAKELY-------------RVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-G 140 (191)
T ss_dssp EE----TTEEEEECCCCEEGG-------------GCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-E
T ss_pred ec----CCEEEEEeecccccc-------------chhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-C
Confidence 53 247999999876442 245556678999999999999999 99999999999999866 5
Q ss_pred EEEEecccccccCCCCceeeeeecccccccC------hhhhhcCCCCCCCcEeehhHH
Q 016347 188 PKISDFGLAKLIPANMTHVSTRVAGTIGYLA------PEYAIRGQVTRKADIYSFGVL 239 (391)
Q Consensus 188 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~k~DvwSlG~v 239 (391)
++|+|||++......... .|.. .+ +..+.|+.++|+||+.--
T Consensus 141 ~~liDFG~a~~~~~~~~~---------~~l~rd~~~~~~-~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 141 IWIIDFPQSVEVGEEGWR---------EILERDVRNIIT-YFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp EEECCCTTCEETTSTTHH---------HHHHHHHHHHHH-HHHHHHCCCCCHHHHHHH
T ss_pred EEEEECCCcccCCCCCcH---------HHHHHHHHHHHH-HHcCCCCCcccHHHHHHH
Confidence 899999998765432211 1111 11 224678999999996443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.93 E-value=2.7e-09 Score=93.23 Aligned_cols=148 Identities=14% Similarity=0.095 Sum_probs=101.4
Q ss_pred HHHHhhCCCCCCceeeccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCC-CCceeEEEEEEEeCCeeE
Q 016347 38 ELSIATDDFSPINKIGEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIE-HENLVKLYGCCVEGNHRI 116 (391)
Q Consensus 38 e~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 116 (391)
|+.-..+.|++++..+.++.+.||+.... ++.+++|+...........+.+|...+..+. +-.+.+++.+..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 34444577887776666666799998754 5567788876554333345667888877663 334567788888888999
Q ss_pred EEEecccCCCHHHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhc-------------------------------
Q 016347 117 LVYNYLENNSLAQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEE------------------------------- 165 (391)
Q Consensus 117 lv~e~~~~~sL~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~------------------------------- 165 (391)
+||++++|.++.+.... ......++.+++..+..||+.
T Consensus 87 lv~~~l~G~~~~~~~~~-----------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYED-----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEECCSSEEHHHHTTT-----------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred EEEEecccccccccccc-----------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 99999999888665421 112233455556666666642
Q ss_pred ----------------------C---CCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 166 ----------------------V---RPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 166 ----------------------~---~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
. ...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0 1237999999999999987666799998665
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.40 E-value=9.1e-07 Score=76.17 Aligned_cols=130 Identities=14% Similarity=0.114 Sum_probs=85.8
Q ss_pred eeeccCc-eEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCC--CCceeEEEEEEEeCCeeEEEEecccCCCH
Q 016347 51 KIGEGGF-GSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIE--HENLVKLYGCCVEGNHRILVYNYLENNSL 127 (391)
Q Consensus 51 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 127 (391)
.+..|.. +.||+....++..+++|........ .+..|...++.+. .-.+.+++.+..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455554 6899999888888999987654332 3556777777663 33466788888888889999999988765
Q ss_pred HHHHhcCCCCCCccccCHHHHHHHHHHHHHHHHHhhhc------------------------------------------
Q 016347 128 AQTLIGGGHHYSNIQFSWRTRSRICIGIARGLAFLHEE------------------------------------------ 165 (391)
Q Consensus 128 ~~~i~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~------------------------------------------ 165 (391)
.+.. ... ..++.++...|.-||+.
T Consensus 94 ~~~~-----------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
T d1nd4a_ 94 LSSH-----------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 159 (255)
T ss_dssp TTSC-----------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred cccc-----------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHH
Confidence 3211 111 11222333334444421
Q ss_pred ---------C----CCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 166 ---------V----RPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 166 ---------~----~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
. ...++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 0 1248999999999999987667799998654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.01 E-value=9e-06 Score=74.64 Aligned_cols=76 Identities=14% Similarity=0.169 Sum_probs=48.8
Q ss_pred CceeeccCceEEEEEEeCC-CcEEEEEEeccc-------chhcHHHHHHHHHHHhcC-CC--CceeEEEEEEEeCCeeEE
Q 016347 49 INKIGEGGFGSVYKGRLKD-GKIAAIKVLSAE-------SRQGVKEFLTEIQVISEI-EH--ENLVKLYGCCVEGNHRIL 117 (391)
Q Consensus 49 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l-~h--~~iv~~~~~~~~~~~~~l 117 (391)
.+.||.|....||++...+ ++.++||.-... -.........|.+.|+.+ .+ ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4579999999999998764 678999964321 111223455677777766 22 345556543 4556789
Q ss_pred EEecccCCC
Q 016347 118 VYNYLENNS 126 (391)
Q Consensus 118 v~e~~~~~s 126 (391)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.40 E-value=0.00022 Score=65.05 Aligned_cols=74 Identities=19% Similarity=0.290 Sum_probs=50.2
Q ss_pred CCceeeccCceEEEEEEeCC--------CcEEEEEEecccchhcHHHHHHHHHHHhcCCCCce-eEEEEEEEeCCeeEEE
Q 016347 48 PINKIGEGGFGSVYKGRLKD--------GKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENL-VKLYGCCVEGNHRILV 118 (391)
Q Consensus 48 ~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv 118 (391)
.++.|+.|-.-.+|++...+ .+.|++++... .. ......+|..+++.+.-.++ .++++++.+ ++|
T Consensus 46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 34689999999999998653 35677777652 22 23445678888888743333 467776632 788
Q ss_pred EecccCCCH
Q 016347 119 YNYLENNSL 127 (391)
Q Consensus 119 ~e~~~~~sL 127 (391)
+||++|..|
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.36 E-value=0.00029 Score=62.45 Aligned_cols=71 Identities=14% Similarity=0.118 Sum_probs=46.6
Q ss_pred cCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCCCce--eEEE-----EEEEeCCeeEEEEecccCCC
Q 016347 55 GGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEHENL--VKLY-----GCCVEGNHRILVYNYLENNS 126 (391)
Q Consensus 55 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i--v~~~-----~~~~~~~~~~lv~e~~~~~s 126 (391)
+.--.||++...+|+.|++|+.+.. .....++..|...+..|....+ +... ..+......+.++++++|..
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cccceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 3346899999999999999998754 2234667778888877632111 1111 11234667888999987653
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.95 E-value=0.0088 Score=52.03 Aligned_cols=161 Identities=11% Similarity=-0.007 Sum_probs=80.4
Q ss_pred echHHHHHhhCCCCCCcee-----eccCceEEEEEEeCCCcEEEEEEecccchhcHHHHHHHHHHHhcCCC-----Ccee
Q 016347 34 YSYKELSIATDDFSPINKI-----GEGGFGSVYKGRLKDGKIAAIKVLSAESRQGVKEFLTEIQVISEIEH-----ENLV 103 (391)
Q Consensus 34 ~~~~e~~~~~~~y~~~~~l-----g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-----~~iv 103 (391)
-+.+|++-.-.+|.+.+.. ..|---+.|+.+..+|+ +++|+...... ...+..|++++..+.. |..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence 3556777677788775443 35666789999987665 88998765321 1334445666666532 2222
Q ss_pred EEE---EEEEeCCeeEEEEecccCCCHHH--------------HHhc-CCCCC--Cccc------------------cCH
Q 016347 104 KLY---GCCVEGNHRILVYNYLENNSLAQ--------------TLIG-GGHHY--SNIQ------------------FSW 145 (391)
Q Consensus 104 ~~~---~~~~~~~~~~lv~e~~~~~sL~~--------------~i~~-~~~~~--~~~~------------------l~~ 145 (391)
... .+..-......++.++.+..... .++. ..... .... ...
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 110 01122345566666665542211 0000 00000 0000 001
Q ss_pred HHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCcEEECCCCcEEEEeccccc
Q 016347 146 RTRSRICIGIARGLAFLHEE-VRPHIIHRDIKASNILLDKDLTPKISDFGLAK 197 (391)
Q Consensus 146 ~~~~~i~~qi~~al~~lH~~-~~~~i~H~dikp~NIlv~~~~~~kl~Dfg~~~ 197 (391)
......+..+...+.-.+.. ...|++|+|+.++||+++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 11112222222222222221 13379999999999999988777899999765
|